Unnamed: 0,PT,AU,BA,BE,GP,AF,BF,CA,TI,SO,SE,BS,LA,DT,CT,CY,CL,SP,HO,DE,ID,AB,C1,RP,EM,RI,OI,FU,FX,CR,NR,TC,Z9,U1,U2,PU,PI,PA,SN,EI,BN,J9,JI,PD,PY,VL,IS,PN,SU,SI,MA,BP,EP,AR,DI,D2,EA,EY,PG,WC,SC,GA,UT,PM,OA,HC,HP,DA,ALM_Citaions,ALM_Shares,ALM_Saves,ALM_Total Views,PMC_Total views,PMC_HTML views,PMC_PDF views,PLOS_Total views,PLOS_HTML views,PLOS_XML views,PLOS_PDF views,Mendeley Total,Twitter Total,Wikipedia Total,F1000 Prime Total,CrossRef Total,Scopus Total,Article Coverage Curated Total,Unnamed: 87,capture_reader_count,capture_export_saves,capture_mendeley,capture_citeulike,capture_EBSCO,citation_count,citation_scopus_count,citation_crossRef_count,citation_pubmed_count,mention_comment_count,mention_QA_SITE_count,mention_all_blog_count,mention_comment_reddit_count,mention_QA_SITE_StkExchg_count,mention_all_blog_blog_count,mention_NEWS_COUNT,soical_FACEBOOK_COUNT,soical_TWEET_COUNT,usage_FULL_TEXT_VIEWS,usage_DOWNLOAD_COUNT,usage_LINK_CLICK_COUNT,usage_VIEW_COUNT,usage_ABSTRACT_VIEWS,usage_LINK_OUTS,usage_FULL_TEXT_VIEWS_PLoS,usage_FULL_TEXT_VIEWS_PubMedCentral,usage_DOWNLOAD_COUNT_Figshare,usage_LINK_CLICK_COUNT_Bitly,usage_VIEW_COUNT_Figshare,usage_ABSTRACT_VIEWS_EBSCO,usage_LINK_OUTS_EBSCO,usage_FULL_TEXT_VIEWS_EBSCO,Unnamed: 120,Alt_news_outlets,Alt_Blogs,Alt_Policy_Sources,Alt_Wikipedia_Pages ,Alt_Tweeters,Alt_Peer_Review_Sites,Alt_Facebook_Pages,Alt_Redditors,Alt_Res_Highlight_Platform,Alt_Q & A,Alt_Video_uploader,Alt_Mendeley,Alt_CiteUlike,Alt_Connotea,Alt_Score,views_alm_pmc,views_alm_plos,views_pmc_plos,views_plumx_plos,views_plumx_alm,views_plumx_pmc
0,J,"Jarvis, JN; Meintjes, G; Bicanic, T; Buffa, V; Hogan, L; Mo, S; Tomlinson, G; Kropf, P; Noursadeghi, M; Harrison, TS",,,,"Jarvis, Joseph N.; Meintjes, Graeme; Bicanic, Tihana; Buffa, Viviana; Hogan, Louise; Mo, Stephanie; Tomlinson, Gillian; Kropf, Pascale; Noursadeghi, Mahdad; Harrison, Thomas S.",,,Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis,PLOS PATHOGENS,,,English,Article,,,,,,,CENTRAL-NERVOUS-SYSTEM; ALTERNATIVELY ACTIVATED MACROPHAGES; CD4(+) T-CELLS; PULMONARY CRYPTOCOCCOSIS; NEOFORMANS INFECTION; PROTECTIVE IMMUNITY; MICROGLIAL CELLS; ANTIRETROVIRAL THERAPY; RECEPTOR EXPRESSION; RANDOMIZED-TRIAL,"Understanding the host immune response during cryptococcal meningitis (CM) is of critical importance for the development of immunomodulatory therapies. We profiled the cerebrospinal fluid (CSF) immune-response in ninety patients with HIV-associated CM, and examined associations between immune phenotype and clinical outcome. CSF cytokine, chemokine, and macrophage activation marker concentrations were assayed at disease presentation, and associations between these parameters and microbiological and clinical outcomes were examined using principal component analysis (PCA). PCA demonstrated a co-correlated CSF cytokine and chemokine response consisting primarily of Th1, Th2, and Th17-type cytokines. The presence of this CSF cytokine response was associated with evidence of increased macrophage activation, more rapid clearance of Cryptococci from CSF, and survival at 2 weeks. The key components of this protective immune-response were interleukin (IL)-6 and interferon-gamma, IL-4, IL-10 and IL-17 levels also made a modest positive contribution to the PC1 score. A second component of co-correlated chemokines was identified by PCA, consisting primarily of monocyte chemotactic protein-1 (MCP-1) and macrophage inflammatory protein-1 alpha (MIP-1 alpha). High CSF chemokine concentrations were associated with low peripheral CD4 cell counts and CSF lymphocyte counts and were predictive of immune reconstitution inflammatory syndrome (IRIS). In conclusion CSF cytokine and chemokine profiles predict risk of early mortality and IRIS in HIV-associated CM. We speculate that the presence of even minimal Cryptococcus-specific Th1-type CD4+ T-cell responses lead to increased recruitment of circulating lymphocytes and monocytes into the central nervous system (CNS), more effective activation of CNS macrophages and microglial cells, and faster organism clearance; while high CNS chemokine levels may predispose to over recruitment or inappropriate recruitment of immune cells to the CNS and IRIS following peripheral immune reconstitution with ART. These results provide a rational basis for future studies of immune modulation in CM, and demonstrate the potential of baseline immune profiling to identify CM patients most at risk of mortality and subsequent IRIS.","[Jarvis, Joseph N.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1E 7HT, England; [Jarvis, Joseph N.] Botswana UPenn Partnership, Gaborone, Botswana; [Jarvis, Joseph N.] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Jarvis, Joseph N.] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7700 Rondebosch, South Africa; [Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7700 Rondebosch, South Africa; [Meintjes, Graeme; Mo, Stephanie; Kropf, Pascale] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Bicanic, Tihana; Buffa, Viviana; Hogan, Louise; Harrison, Thomas S.] St Georges Univ London, Div Clin Sci, Res Ctr Infect & Immun, London, England; [Tomlinson, Gillian; Noursadeghi, Mahdad] UCL, Div Infect & Immun, London, England","Jarvis, JN (reprint author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.",drjoejarvis@gmail.com,,"Hogan, Louise/0000-0001-5526-954X; Tomlinson, Gillian/0000-0003-4342-3161; Jarvis, Joseph/0000-0003-1459-5554; Bicanic, Tihana/0000-0002-2676-838X; Harrison, Thomas/0000-0003-3619-4348; Meintjes, Graeme/0000-0003-1196-4414; Noursadeghi, Mahdad/0000-0002-4774-0853","Wellcome Trust [WT081794, 098316]; British Infection Society; NIHR Biomedical Research Centre; National Institute of Allergy and Infectious Diseases [U01AI089244]; National Research Foundation (NRF) of South Africa [UID: 85858]; NRF; National Institute for Health Research [2604]","Funding: This work was supported by the Wellcome Trust (WT fellowship WT081794 to JNJ) and the British Infection Society (Fellowship to TB). MN and GT acknowledge NIHR Biomedical Research Centre funding to UCLH/UCL. GM was supported by a Wellcome Trust fellowship (098316); a National Institute of Allergy and Infectious Diseases grant (U01AI089244); and supported in part by the National Research Foundation (NRF) of South Africa (UID: 85858). The grantholder acknowledges that opinions, findings and conclusions or recommendations expressed in any publication generated by the NRF supported research are that of the author(s), and that the NRF accepts no liability whatsoever in this regard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aguirre K, 2002, GLIA, V39, P184, DOI 10.1002/glia.10093; Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Almeida GM, 2001, J IMMUNOL, V167, P5845, DOI 10.4049/jimmunol.167.10.5845; Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10; Bicanic T, 2009, J ACQUIRED IMMUNE DE; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; Chang CC, 2013, AIDS; Chang CC, 2013, J INFECT DIS, V208, P1604, DOI 10.1093/infdis/jit388; Chang CC, 2013, J INFECT DIS, V208, P898, DOI 10.1093/infdis/jit271; Christo PP, 2009, J NEUROL SCI, V287, P79, DOI 10.1016/j.jns.2009.09.002; Cloke TE, 2010, J INFECT DIS, V202, P374, DOI 10.1086/653736; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Hardison SE, 2012, J IMMUNOL, V189, P4060, DOI 10.4049/jimmunol.1103455; Herring AC, 2002, INFECT IMMUN, V70, P2959, DOI 10.1128/IAI.70.6.2959-2964.2002; Jarvis JN, 2013, CLIN INFECT DIS; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Jarvis JN, 2013, J INFECT DIS, V207, P1817, DOI 10.1093/infdis/jit099; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Jarvis JN, 2008, CURR OPIN INFECT DIS, V21, P596, DOI 10.1097/QCO.0b013e3283177f6c; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; Longley N, 2013, CURR OPIN INFECT DIS, V26, P26, DOI 10.1097/QCO.0b013e32835c21d1; Lortholary O, 2001, J INFECT DIS, V183, P294, DOI 10.1086/317937; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Muller U, 2012, MUCOSAL IMMUNOL, V5, P299, DOI 10.1038/mi.2012.9; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Muller U, 2013, INT IMMUNOL, V25, P459, DOI 10.1093/intimm/dxt003; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Qiu YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047853; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Siddiqui AA, 2005, J IMMUNOL, V174, P1746, DOI 10.4049/jimmunol.174.3.1746; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; Szymczak WA, 2012, AM J PATHOL, V180, P1547, DOI 10.1016/j.ajpath.2011.12.038; Uicker WC, 2006, MED MYCOL, V44, P1, DOI 10.1080/13693780500088424; Uicker WC, 2005, MED MYCOL, V43, P27, DOI 10.1080/13693780410001731510; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; Wozniak KL, 2012, MYCOPATHOLOGIA, V173, P387, DOI 10.1007/s11046-011-9505-8; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530; Zhou Q, 2007, J IMMUNOL, V178, P5753, DOI 10.4049/jimmunol.178.9.5753",52,47,47,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004754,10.1371/journal.ppat.1004754,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000009,25853653.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,49,6,33,5250,1507,1034,473,3743,3002,28,713,33,5,0,0,54,54,0,,46,6,46,0,6,54,54,45,37,0,0,0,0,0,0,0,1,6,5324,17,0,76,94,0,3767,1529,17,0,76,94,0,28,,0,0,0,0,10,0,1,0,0,0,0,53,0,0,4.7,3.4837425348374254,1.4026182206786,0.40261822067860004,1.4520438151215602,1.0352380952380953,3.60650298606503
1,J,"Jung, SA; Chapman, CA; Ng, WL",,,,"Jung, Sarah A.; Chapman, Christine A.; Ng, Wai-Leung",,,Quadruple Quorum-Sensing Inputs Control Vibrio cholerae Virulence and Maintain System Robustness,PLOS PATHOGENS,,,English,Article,,,,,,,SIGNAL-TRANSDUCTION PATHWAYS; BACILLUS-SUBTILIS; BIOFILM FORMATION; GENE-EXPRESSION; SENSOR KINASE; AUTOINDUCER CAI-1; PROTEIN-KINASE; VI SECRETION; ENZYME CQSA; SPORULATION,"Bacteria use quorum sensing (QS) for cell-cell communication to carry out group behaviors. This intercellular signaling process relies on cell density-dependent production and detection of chemical signals called autoinducers (AIs). Vibrio cholerae, the causative agent of cholera, detects two AIs, CAI-1 and AI-2, with two histidine kinases, CqsS and LuxQ, respectively, to control biofilm formation and virulence factor production. At low cell density, these two signal receptors function in parallel to activate the key regulator LuxO, which is essential for virulence of this pathogen. At high cell density, binding of AIs to their respective receptors leads to deactivation of LuxO and repression of virulence factor production. However, mutants lacking CqsS and LuxQ maintain a normal LuxO activation level and remain virulent, suggesting that LuxO is activated by additional, unidentified signaling pathways. Here we show that two other histidine kinases, CqsR (formerly known as VC1831) and VpsS, act upstream in the central QS circuit of V. cholerae to activate LuxO. V. cholerae strains expressing any one of these four receptors are QS proficient and capable of colonizing animal hosts. In contrast, mutants lacking all four receptors are phenotypically identical to LuxO-defective mutants. Importantly, these four functionally redundant receptors act together to prevent premature induction of a QS response caused by signal perturbations. We suggest that the V. cholerae QS circuit is composed of quadruple sensory inputs and has evolved to be refractory to sporadic AI level perturbations.","[Jung, Sarah A.; Chapman, Christine A.; Ng, Wai-Leung] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Jung, Sarah A.; Ng, Wai-Leung] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA","Ng, WL (reprint author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.",wai-leung.ng@tufts.edu,,,Tufts University; NIH [T32AI007422],"This work was supported by a startup fund from Tufts University to WLN. SAJ was supported by a graduate training grant from NIH (T32AI007422). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Antonova ES, 2011, FEMS MICROBIOL LETT, V322, P68, DOI 10.1111/j.1574-6968.2011.02328.x; Bari SMN, 2013, P NATL ACAD SCI USA, V110, P9926, DOI 10.1073/pnas.1307697110; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Blokesch M, 2012, MOB GENET ELEMENTS, V2, P224, DOI DOI 10.4161/MGE.22284; Borziak K, 2007, BIOINFORMATICS, V23, P2518, DOI 10.1093/bioinformatics/btm384; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Cornforth DM, 2014, P NATL ACAD SCI USA, V111, P4280, DOI 10.1073/pnas.1319175111; Drees B, 2014, BIOPHYS J, V107, P266, DOI 10.1016/j.bpj.2014.05.031; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Kamp HD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003800; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Ng WL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002767; Ng WL, 2011, MOL MICROBIOL, V79, P1407, DOI 10.1111/j.1365-2958.2011.07548.x; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; PEREGO M, 1989, J BACTERIOL, V171, P6187, DOI 10.1128/jb.171.11.6187-6196.1989; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Shao Y, 2014, MOL MICROBIOL, V92, P921, DOI 10.1111/mmi.12599; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Shikuma NJ, 2009, J BACTERIOL, V191, P5147, DOI 10.1128/JB.00401-09; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; Thelin KH, 1996, INFECT IMMUN, V64, P2853; TRACH KA, 1993, MOL MICROBIOL, V8, P69, DOI 10.1111/j.1365-2958.1993.tb01204.x; Tsou AM, 2010, INFECT IMMUN, V78, P461, DOI 10.1128/IAI.00590-09; Wei YZ, 2012, MOL MICROBIOL, V83, P1095, DOI 10.1111/j.1365-2958.2012.07992.x; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299",55,45,47,2,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004837,10.1371/journal.ppat.1004837,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000043,25874462.0,"DOAJ Gold, Green Published",,,16/08/2019,42,1,72,6778,1444,1114,330,5334,4328,29,977,72,1,0,0,40,40,0,,94,6,94,0,6,47,47,20,29,0,0,0,0,0,0,0,0,7,6816,89,0,433,104,2,5318,1444,89,0,433,104,2,54,,0,0,0,0,8,0,0,0,0,0,0,92,0,0,3.6,4.693905817174516,1.27071616047994,0.27071616047994,1.3140232470941133,1.034080849808203,4.85387811634349
2,J,"Kaschny, M; Demeler, J; Janssen, IJI; Kuzmina, TA; Besognet, B; Kanellos, T; Kerboeuf, D; von Samson-Himmelstjerna, G; Krucken, J",,,,"Kaschny, Maximiliane; Demeler, Janina; Janssen, I. Jana I.; Kuzmina, Tetiana A.; Besognet, Bruno; Kanellos, Theo; Kerboeuf, Dominique; von Samson-Himmelstjerna, Georg; Kruecken, Juergen",,,Macrocyclic Lactones Differ in Interaction with Recombinant P-Glycoprotein 9 of the Parasitic Nematode Cylicocylus elongatus and Ketoconazole in a Yeast Growth Assay,PLOS PATHOGENS,,,English,Article,,,,,,,ANTHELMINTIC RESISTANCE; HAEMONCHUS-CONTORTUS; CAENORHABDITIS-ELEGANS; COOPERIA-ONCOPHORA; IVERMECTIN RESISTANCE; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; OSTERTAGIA-OSTERTAGI; MONOCLONAL-ANTIBODY; MAXIMUM-LIKELIHOOD,"Macrocyclic lactones (MLs) are widely used parasiticides against nematodes and arthropods, but resistance is frequently observed in parasitic nematodes of horses and livestock. Reports claiming resistance or decreased susceptibility in human nematodes are increasing. Since no target site directed ML resistance mechanisms have been identified, non-specific mechanisms were frequently implicated in ML resistance, including P-glycoproteins (Pgps, designated ABCB1 in vertebrates). Nematode genomes encode many different Pgps (e.g. 10 in the sheep parasite Haemonchus contortus). ML transport was shown for mammalian Pgps, Pgps on nematode egg shells, and very recently for Pgp-2 of H. contortus. Here, Pgp-9 from the equine parasite Cylicocyclus elongatus (Cyathostominae) was expressed in a Saccharomyces cerevisiae strain lacking seven endogenous efflux transporters. Pgp was detected on these yeasts by flow cytometry and chemiluminescence using the monoclonal antibody UIC2, which is specific for the active Pgp conformation. In a growth assay, Pgp-9 increased resistance to the fungicides ketoconazole, actinomycin D, valinomycin and daunorubicin, but not to the anthelmintic fungicide thiabendazole. Since no fungicidal activity has been described for MLs, their interaction with Pgp-9 was investigated in an assay involving two drugs: Yeasts were incubated with the highest ketoconazole concentration not affecting growth plus increasing concentrations of MLs to determine competition between or modulation of transport of both drugs. Already equimolar concentrations of ivermectin and eprinomectin inhibited growth, and at fourfold higher ML concentrations growth was virtually abolished. Selamectin and doramectin did not increase susceptibility to ketoconazole at all, although doramectin has been shown previously to strongly interact with human and canine Pgp. An intermediate interaction was observed for moxidectin. This was substantiated by increased binding of UIC2 antibodies in the presence of ivermectin, moxidectin, daunorubicin and ketoconazole but not selamectin. These results demonstrate direct effects of MLs on a recombinant nematode Pgp in an ML-specific manner.","[Kaschny, Maximiliane; Demeler, Janina; Janssen, I. Jana I.; von Samson-Himmelstjerna, Georg; Kruecken, Juergen] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Kuzmina, Tetiana A.] Natl Acad Sci Ukraine, Schmalhausen Inst Zool, Kiev, Ukraine; [Besognet, Bruno] Zoetis, Paris, France; [Kanellos, Theo] Zoetis Int Serv, Paris, France; [Kerboeuf, Dominique] INRA, ISP, Anim Infect & Publ Hlth, F-37380 Nouzilly, France","Kaschny, M (reprint author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.",juergen.kruecken@fu-berlin.de,"von Samson, Georg/R-1123-2016; Demeler, Janina/A-1727-2014; Krucken, Jurgen/B-6794-2009; Kuzmina, Tetiana/A-5457-2019","Krucken, Jurgen/0000-0002-2842-8100; Kuzmina, Tetiana/0000-0002-5054-4757",Zoetis,"Funding: The present study was performed as a collaborative research project between Zoetis and the Institute of Parasitology and Tropical Veterinary Medicine, Freie Universitat Berlin. Accordingly, the Institute of Parasitology and Tropical Veterinary Medicine, Freie Universitat Berlin received a Project specific research grant from Zoetis. The funders, except for Bruno Besognet and Theo Kanellos, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","AlGusbi S, 2014, INT J PARASITOL, V44, P647, DOI 10.1016/j.ijpara.2014.04.007; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Alvarez Ana I., 2006, Current Drug Delivery, V3, P199, DOI 10.2174/156720106776359195; Ameen SM, 2013, J ANTIMICROB CHEMOTH, V68, P1936, DOI 10.1093/jac/dkt089; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Anziani OS, 2004, VET PARASITOL, V122, P303, DOI 10.1016/j.vetpar.2004.05.018; Ardelli BF, 2013, VET PARASITOL, V191, P264, DOI 10.1016/j.vetpar.2012.09.021; Ballent M, 2014, J VET PHARMACOL THER, V37, P332, DOI 10.1111/jvp.12112; Bartley DJ, 2012, VET PARASITOL, V190, P454, DOI 10.1016/j.vetpar.2012.07.022; Beech RN, 2011, PARASITOLOGY, V138, P160, DOI 10.1017/S0031182010001198; Blackhall WJ, 2011, PARASITOL RES, V109, P1199, DOI 10.1007/s00436-011-2426-0; Blackhall WJ, 1998, MOL BIOCHEM PARASIT, V95, P193, DOI 10.1016/S0166-6851(98)00087-5; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Demeler J, 2009, VET PARASITOL, V160, P109, DOI 10.1016/j.vetpar.2008.10.030; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070212; Demeler J, 2013, MOL BIOCHEM PARASIT, V188, P10, DOI 10.1016/j.molbiopara.2013.01.004; Dicker AJ, 2011, INT J PARASITOL, V41, P935, DOI 10.1016/j.ijpara.2011.03.015; Doppenschmitt S, 1998, PHARMACEUT RES, V15, P1001, DOI 10.1023/A:1011965707998; Dupuy J, 2010, CHEM-BIOL INTERACT, V186, P280, DOI 10.1016/j.cbi.2010.05.013; Edmonds MD, 2010, VET PARASITOL, V170, P224, DOI 10.1016/j.vetpar.2010.02.036; El-Abdellati A, 2011, INT J PARASITOL, V41, P951, DOI 10.1016/j.ijpara.2011.04.003; Elmshauser S, 2014, J VET PHARM THER; Fauvin A, 2010, MOL BIOCHEM PARASIT, V170, P105, DOI 10.1016/j.molbiopara.2009.11.007; Geyer J, 2012, CURR PHARM BIOTECHNO, V13, P969, DOI 10.2174/138920112800399301; Goda K, 2007, J PHARMACOL EXP THER, V320, P81, DOI 10.1124/jpet.106.110155; Godoy P, 2015, INT J PARASITOL, V45, P85, DOI 10.1016/j.ijpara.2014.09.008; Griffin J, 2005, J VET PHARMACOL THER, V28, P257, DOI 10.1111/j.1365-2885.2005.00655.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Jackson R, 2006, NEW ZEAL VET J, V54, P289, DOI 10.1080/00480169.2006.36713; Janssen IJI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061635; Janssen IJI, 2013, EXP PARASITOL, V134, P171, DOI 10.1016/j.exppara.2013.03.005; Janssen J, 2013, 24 INT C WORLD ASS A, P421; Jeong H, 2007, PLOS GENET, V3, P367, DOI 10.1371/journal.pgen.0030039; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kahm M, 2010, J STAT SOFTW, V33, P1; Kerboeuf D, 2003, INT J ANTIMICROB AG, V22, P332, DOI 10.1016/S0924-8579(03)00221-8; Kerboeuf D, 2003, PARASITOL RES, V91, P79, DOI 10.1007/s00436-003-0942-2; Kerboeuf D, 2002, PARASITOL RES, V88, P816, DOI 10.1007/s00436-002-0654-z; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Kotze AC, 2014, INT J PARASITOLOGY D, V4; Krucken J, 2008, EUKARYOT CELL, V7, P202, DOI 10.1128/EC.00292-07; Krucken J, 2012, TRENDS PARASITOL, V28, P385, DOI 10.1016/j.pt.2012.06.005; Lake SL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lespine A, 2007, EUR J PHARM SCI, V30, P84, DOI 10.1016/j.ejps.2006.10.004; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Lim LE, 2013, ANTIMICROB AGENTS CH, V57, P1040, DOI 10.1128/AAC.01696-12; Mechetner EB, 1995, EXPERT OPIN THER PAT, V5, P535; Miltsch SM, 2012, INT J PARASITOL, V42, P761, DOI 10.1016/j.ijpara.2012.05.009; Molento MB, 2008, VET REC, V162, P384, DOI 10.1136/vr.162.12.384; Molento MB, 2012, VET PARASITOL, V185, P16, DOI 10.1016/j.vetpar.2011.10.013; Neveu C, 2010, PHARMACOGENET GENOM, V20, P414, DOI 10.1097/FPC.0b013e328338ac8c; Njue AI, 2004, PARASITOLOGY, V129, P741, DOI 10.1017/s0031182004006183; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Pape M, 1999, INT J PARASITOL, V29, P1941, DOI 10.1016/S0020-7519(99)00156-3; Pettengill MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048456; R Development Core Team, 2011, LANG ENV STAT COMP; Riou M, 2005, PARASITOL RES, V96, P142, DOI 10.1007/s00436-005-1345-3; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x; Silva LV, 2013, ANTIMICROB AGENTS CH, V57, P873, DOI 10.1128/AAC.02040-12; Slocombe JOD, 2007, VET PARASITOL, V145, P371, DOI 10.1016/j.vetpar.2006.08.008; Takano M, 1998, EUR J PHARMACOL, V358, P289, DOI 10.1016/S0014-2999(98)00607-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Traversa D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S2; Trawford AF, 2005, 20 INT C WORLD ASS A; Vercruysse J., 2002, MACROCYCLIC LACTONES; von Samson-Himmelstjerna G, 2007, PARASITOLOGY, V134, P1077, DOI 10.1017/S0031182007000054; von Samson-Himmelstjerna G, 2007, VET PARASITOL, V144, P74, DOI 10.1016/j.vetpar.2006.09.036; Walker B, 2014, FEMS YEAST RES, V14, P755, DOI 10.1111/1567-1364.12164; Williamson SM, 2011, MOL BIOCHEM PARASIT, V180, P99, DOI 10.1016/j.molbiopara.2011.09.003; Wolstenholme AJ, 2012, CURR PHARM BIOTECHNO, V13, P873; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Xu M, 1998, MOL BIOCHEM PARASIT, V91, P327, DOI 10.1016/S0166-6851(97)00215-6; Yan RF, 2012, VET PARASITOL, V190, P519, DOI 10.1016/j.vetpar.2012.06.038; Zhou Y, 1999, ARCH BIOCHEM BIOPHYS, V367, P74, DOI 10.1006/abbi.1999.1221",81,15,15,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004781,10.1371/journal.ppat.1004781,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000015,25849454.0,"DOAJ Gold, Green Published",,,16/08/2019,16,0,13,2895,604,478,126,2291,1890,20,381,13,0,0,0,16,16,0,,25,3,25,0,3,16,16,16,9,0,0,0,0,0,0,0,0,5,2952,52,0,73,128,0,2303,614,52,0,73,128,0,35,,0,0,0,0,6,0,0,1,0,0,0,25,0,0,2.0,4.793046357615894,1.2636403317328677,0.2636403317328677,1.3670886075949367,1.0818652849740933,5.185430463576159
3,J,"Kim, M; Truong, NR; James, V; Bosnjak, L; Sandgren, KJ; Harman, AN; Nasr, N; Bertram, KM; Olbourne, N; Sawleshwarkar, S; McKinnon, K; Cohen, RC; Cunningham, AL",,,,"Kim, Min; Truong, Naomi R.; James, Virginia; Bosnjak, Lidija; Sandgren, Kerrie J.; Harman, Andrew N.; Nasr, Najla; Bertram, Kirstie M.; Olbourne, Norman; Sawleshwarkar, Shailandra; McKinnon, Kaylene; Cohen, Ralph C.; Cunningham, Anthony L.",,,Relay of Herpes Simplex Virus between Langerhans Cells and Dermal Dendritic Cells in Human Skin,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIGEN CROSS-PRESENTATION; T-CELLS; GENITAL HERPES; MOUSE; INFECTION; MIGRATION; RECEPTOR; SUBSET; GROWTH; CLEC9A,"The mechanism by which immunity to Herpes Simplex Virus (HSV) is initiated is not completely defined. HSV initially infects mucosal epidermis prior to entering nerve endings. In mice, epidermal Langerhans cells (LCs) are the first dendritic cells (DCs) to encounter HSV, but it is CD103(+) dermal DCs that carry viral antigen to lymph nodes for antigen presentation, suggesting DC cross-talk in skin. In this study, we compared topically HSV-1 infected human foreskin explants with biopsies of initial human genital herpes lesions to show LCs are initially infected then emigrate into the dermis. Here, LCs bearing markers of maturation and apoptosis formed large cell clusters with BDCA3(+) dermal DCs (thought to be equivalent to murine CD103(+) dermal DCs) and DC-SIGN(+) DCs/macrophages. HSV-expressing LC fragments were observed inside the dermal DCs/macrophages and the BDCA3(+) dermal DCs had up-regulated a damaged cell uptake receptor CLEC9A. No other infected epidermal cells interacted with dermal DCs. Correspondingly, LCs isolated from human skin and infected with HSV-1 in vitro also underwent apoptosis and were taken up by similarly isolated BDCA3(+) dermal DCs and DC-SIGN(+) cells. Thus, we conclude a viral antigen relay takes place where HSV infected LCs undergo apoptosis and are taken up by dermal DCs for subsequent antigen presentation. This provides a rationale for targeting these cells with mucosal or perhaps intradermal HSV immunization.","[Kim, Min; Truong, Naomi R.; James, Virginia; Bosnjak, Lidija; Sandgren, Kerrie J.; Harman, Andrew N.; Nasr, Najla; Bertram, Kirstie M.; Cunningham, Anthony L.] Westmead Millennium Inst, Ctr Virus Res, Sydney, NSW, Australia; [Kim, Min; Truong, Naomi R.; Sandgren, Kerrie J.; Harman, Andrew N.; Nasr, Najla; Bertram, Kirstie M.; Sawleshwarkar, Shailandra; Cunningham, Anthony L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Olbourne, Norman] Sydney Inst Plast & Reconstruct Surg, Sydney, NSW, Australia; [Sawleshwarkar, Shailandra; McKinnon, Kaylene] Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Cohen, Ralph C.] Childrens Hosp Westmead, Dept Surg, Sydney, NSW, Australia","Kim, M (reprint author), Westmead Millennium Inst, Ctr Virus Res, Sydney, NSW, Australia.",tony.cunningham@sydney.edu.au,,"Cunningham, Anthony/0000-0002-6744-5667; Truong, Naomi/0000-0002-9011-4014",Australian National Health and Medical Research Council (NHMRC) [1050909]; NHMRC,"Funding: This work was supported by the Australian National Health and Medical Research Council (NHMRC; 1050909). ALC is a recipient of the NHMRC funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; ASHLEY R, 1987, J VIROL, V61, P264; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eidsmo L, 2009, J IMMUNOL, V182, P3165, DOI 10.4049/jimmunol.0802950; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Fontaine-Rodriguez EC, 2008, J VIROL, V82, P3538, DOI 10.1128/JVI.02395-07; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Harman AN, 2013, J IMMUNOL, V190, P66, DOI 10.4049/jimmunol.1200779; HARRISON CJ, 1994, ANTIMICROB AGENTS CH, V38, P2059, DOI 10.1128/AAC.38.9.2059; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Kim M, 2012, J IMMUNOL, V188, P4158, DOI 10.4049/jimmunol.1103450; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; Koelle DM, 2002, J CLIN INVEST, V110, P537, DOI 10.1172/JCI200215537; MANICKAN E, 1995, J VIROL, V69, P8178; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Nasr N, 2014, J IMMUNOL, V193, P2554, DOI 10.4049/jimmunol.1400630; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Puttur FK, 2010, J IMMUNOL, V185, P477, DOI 10.4049/jimmunol.0904106; REEVES WC, 1981, NEW ENGL J MED, V305, P315, DOI 10.1056/NEJM198108063050604; Saksena MM, 2006, J VIROL, V80, P3592, DOI 10.1128/JVI.80.7.3592-3606.2006; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Segura E, 2013, J EXP MED, V210, P1035, DOI 10.1084/jem.20121103; SPRECHER E, 1986, ARCH VIROL, V91, P341, DOI 10.1007/BF01314292; SU SJ, 1995, J CLIN PATHOL, V48, P75, DOI 10.1136/jcp.48.1.75; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Yoshida Y, 2005, J MED VIROL, V75, P421, DOI 10.1002/jmv.20284; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792",40,22,24,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004812,10.1371/journal.ppat.1004812,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000030,25875649.0,"DOAJ Gold, Green Published",,,16/08/2019,23,0,20,4133,887,664,223,3246,2654,21,571,20,0,0,0,24,24,0,,70,0,39,0,0,24,24,15,17,0,0,0,0,0,0,0,0,3,4181,34,0,158,10,1,3273,897,34,0,158,10,1,11,,0,0,0,0,3,0,1,0,0,0,0,38,0,0,1.75,4.659526493799324,1.2732593961799137,0.27325939617991374,1.3016019716574245,1.022259859666102,4.763246899661781
4,J,"Kitur, K; Parker, D; Nieto, P; Ahn, DS; Cohen, TS; Chung, S; Wachtel, S; Bueno, S; Prince, A",,,,"Kitur, Kipyegon; Parker, Dane; Nieto, Pamela; Ahn, Danielle S.; Cohen, Taylor S.; Chung, Samuel; Wachtel, Sarah; Bueno, Susan; Prince, Alice",,,Toxin-Induced Necroptosis Is a Major Mechanism of Staphylococcus aureus Lung Damage,PLOS PATHOGENS,,,English,Article,,,,,,,MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; NLRP3 INFLAMMASOME; CELL-DEATH; CYTOLYTIC PEPTIDES; HUMAN NEUTROPHILS; UNITED-STATES; RIP3 KINASE; ACTIVATION; INFECTION,"Staphylococcus aureus USA300 strains cause a highly inflammatory necrotizing pneumonia. The virulence of this strain has been attributed to its expression of multiple toxins that have diverse targets including ADAM10, NLRP3 and CD11b. We demonstrate that induction of necroptosis through RIP1/RIP3/MLKL signaling is a major consequence of S. aureus toxin production. Cytotoxicity could be prevented by inhibiting either RIP1 or MLKL signaling and S. aureus mutants lacking agr, hla or Hla pore formation, lukAB or psms were deficient in inducing cell death in human and murine immune cells. Toxin-associated pore formation was essential, as cell death was blocked by exogenous K+ or dextran. MLKL inhibition also blocked caspase-1 and IL-1 beta production, suggesting a link to the inflammasome. Rip3(-/-) mice exhibited significantly improved staphylococcal clearance and retained an alveolar macrophage population with CD200R and CD206 markers in the setting of acute infection, suggesting increased susceptibility of these leukocytes to necroptosis. The importance of this anti-inflammatory signaling was indicated by the correlation between improved outcome and significantly decreased expression of KC, IL-6, TNF, IL-1 alpha and IL-1 beta in infected mice. These findings indicate that toxin-induced necroptosis is a major cause of lung pathology in S. aureus pneumonia and suggest the possibility of targeting components of this signaling pathway as a therapeutic strategy.","[Kitur, Kipyegon; Prince, Alice] Columbia Univ, Dept Pharmacol, Grad Sch Arts & Sci, New York, NY 10027 USA; [Parker, Dane; Ahn, Danielle S.; Cohen, Taylor S.; Chung, Samuel; Wachtel, Sarah; Prince, Alice] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Nieto, Pamela; Bueno, Susan] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Santiago, Chile","Kitur, K (reprint author), Columbia Univ, Dept Pharmacol, Grad Sch Arts & Sci, New York, NY 10027 USA.",asp7@columbia.edu,"Cohen, Taylor/C-9927-2016","Cohen, Taylor/0000-0001-9368-0903; Bueno, Susan M./0000-0002-7551-8088; Parker, Dane/0000-0001-7304-3392",Parker B. Francis Fellowship; NIH [2R01HL079395]; Millennium Institute on Immunology and Immunotherapy [P06/016-F],"Funding: This work was funded by a Parker B. Francis Fellowship to TSC and NIH grant 2R01HL079395 to AP. PN and SB were supported by the Millennium Institute on Immunology and Immunotherapy P06/016-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Berube BJ, 2014, INFECT IMMUN, V82, P3350, DOI 10.1128/IAI.00089-14; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chatterjee SS, 2013, NAT MED, V19, P364, DOI 10.1038/nm.3047; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Greenlee-Wacker MC, 2014, J IMMUNOL, V192, P4709, DOI 10.4049/jimmunol.1302692; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Laabei M, 2014, BBA-BIOMEMBRANES, V1838, P3153, DOI 10.1016/j.bbamem.2014.08.026; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Marriott HM, 2008, AM J RESP CRIT CARE, V177, P887, DOI 10.1164/rccm.200707-990OC; Martin FJ, 2011, INFECT IMMUN, V79, P1898, DOI 10.1128/IAI.01299-10; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Parker D, 2015, J INFECT DIS, V211, P835, DOI 10.1093/infdis/jiu525; Parker D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003951; Parker D, 2012, J IMMUNOL, V189, P4040, DOI 10.4049/jimmunol.1201055; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Powers ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003871; Robinson KM, 2013, J IMMUNOL, V191, P5153, DOI 10.4049/jimmunol.1301237; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Viboud GI, 2002, METHOD ENZYMOL, V358, P345; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008",53,83,86,2,29,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004820,10.1371/journal.ppat.1004820,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000034,25880560.0,"DOAJ Gold, Green Published",,,16/08/2019,88,122,64,13818,2355,1662,693,11463,9526,34,1903,64,0,0,0,83,83,0,,88,1,88,0,1,89,89,74,59,0,0,0,0,0,0,0,123,5,13755,29,1,104,7,5,11394,2355,29,1,104,7,5,6,,0,0,0,0,17,0,1,1,0,0,0,88,0,0,9.7,5.867515923566879,1.205443601151531,0.205443601151531,1.2030881968071185,0.9980460269214069,5.8560509554140125
5,J,"Losada, L; Sugui, JA; Eckhaus, MA; Chang, YC; Mounaud, S; Figat, A; Joardar, V; Pakala, SB; Pakala, S; Venepally, P; Fedorova, N; Nierman, WC; Kwon-Chung, KJ",,,,"Losada, Liliana; Sugui, Janyce A.; Eckhaus, Michael A.; Chang, Yun C.; Mounaud, Stephanie; Figat, Abigail; Joardar, Vinita; Pakala, Suman B.; Pakala, Suchitra; Venepally, Pratap; Fedorova, Natalie; Nierman, William C.; Kwon-Chung, Kyung J.",,,Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence,PLOS PATHOGENS,,,English,Article,,,,,,,CRYPTOCOCCUS-NEOFORMANS; GALLERIA-MELLONELLA; AMPHOTERICIN-B; HISTOPLASMA-CAPSULATUM; CONGENIC STRAINS; IN-VITRO; PROTEIN; PATHOGEN; INVASIVENESS; VORICONAZOLE,"Invasive aspergillosis (IA) due to Aspergillus fumigatus is a major cause of mortality in immunocompromised patients. The discovery of highly fertile strains of A. fumigatus opened the possibility to merge classical and contemporary genetics to address key questions about this pathogen. The merger involves sexual recombination, selection of desired traits, and genomics to identify any associated loci. We constructed a highly fertile isogenic pair of A. fumigatus strains with opposite mating types and used them to investigate whether mating type is associated with virulence and to find the genetic loci involved in azole resistance. The pair was made isogenic by 9 successive backcross cycles of the foundational strain AFB62 (MAT1-1) with a highly fertile (MAT1-2) progeny. Genome sequencing showed that the F-9 MAT1-2 progeny was essentially identical to the AFB62. The survival curves of animals infected with either strain in three different animal models showed no significant difference, suggesting that virulence in A. fumigatus was not associated with mating type. We then employed a relatively inexpensive, yet highly powerful strategy to identify genomic loci associated with azole resistance. We used traditional in vitro drug selection accompanied by classical sexual crosses of azole-sensitive with resistant isogenic strains. The offspring were plated under varying drug concentrations and pools of resulting colonies were analyzed by whole genome sequencing. We found that variants in 5 genes contributed to azole resistance, including mutations in erg11A (cyp51A), as well as multi-drug transporters, erg25, and in HMG-CoA reductase. The results demonstrated that with minimal investment into the sequencing of three pools from a cross of interest, the variation(s) that contribute any phenotype can be identified with nucleotide resolution. This approach can be applied to multiple areas of interest in A. fumigatus or other heterothallic pathogens, especially for virulence associated traits.","[Losada, Liliana; Mounaud, Stephanie; Joardar, Vinita; Pakala, Suman B.; Pakala, Suchitra; Venepally, Pratap; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Sugui, Janyce A.; Chang, Yun C.; Figat, Abigail; Kwon-Chung, Kyung J.] NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Eckhaus, Michael A.] NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA; [Fedorova, Natalie] NCI, NIH, Bethesda, MD 20892 USA","Kwon-Chung, KJ (reprint author), NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",jkchung@nih.gov,"Abrams, Natalie/F-4845-2011","Abrams, Natalie/0000-0001-9698-2819; pakala, suman/0000-0001-5156-0823; Joardar, Vinita/0000-0001-9018-3151","federal fund from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]; federal fund from the intramural program","This project was funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C (LL, SBP, SP, VJ, SM, PV, NF, and WCN) and from the intramural program (JAS, MAE, YCC, AF and KJKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32; Alcazar-Fuoli L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00439; Alvarez-Perez S, 2010, MED MYCOL, V48, P273, DOI [10.3109/13693780903095414, 10.1080/13693780903095414]; Alvarez-Perez S, 2009, MED MYCOL, V47, P601, DOI 10.1080/13693780802380537; Barton RC, 2013, SCIENTIFICA, DOI 10.1155/2013/459405; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279; Camps SMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050034; Cheema MS, 2011, MED MYCOL, V49, P202, DOI 10.3109/13693786.2010.512301; (CLSI) Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; Eschertzhuber S, 2008, TRANSPL INFECT DIS, V10, P190, DOI 10.1111/j.1399-3062.2007.00252.x; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Flannery EL, 2013, J MED CHEM, V56, P7761, DOI 10.1021/jm400325j; Fortwendel JR, 2008, EUKARYOT CELL, V7, P1530, DOI 10.1128/EC.00080-08; Freitas JS, 2011, CELL STRESS CHAPERON, V16, P565, DOI 10.1007/s12192-011-0267-5; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gautam P, 2008, ANTIMICROB AGENTS CH, V52, P4220, DOI 10.1128/AAC.01431-07; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; Grund SE, 2008, J CELL BIOL, V182, P897, DOI 10.1083/jcb.200803098; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; KWONCHUNG KJ, 1984, SABOURAUDIA, V22, P155; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1974, AM J EPIDEMIOL, V99, P44, DOI 10.1093/oxfordjournals.aje.a121583; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602; Lamoth F, 2014, ANTIMICROB AGENTS CH, V58, P1889, DOI 10.1128/AAC.02286-13; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liebmann B, 2003, MOL GENET GENOMICS, V269, P420, DOI 10.1007/s00438-003-0852-0; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; Nielsen K, 2005, GENETICS, V171, P975, DOI 10.1534/genetics.105.045039; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390390201839; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Rokas A, 2012, ANN NY ACAD SCI, V1273, P25, DOI 10.1111/j.1749-6632.2012.06755.x; Sabatelli F, 2006, ANTIMICROB AGENTS CH, V50, P2009, DOI 10.1128/AAC.00163-06; Shafaati M, 2010, J LIPID RES, V51, P318, DOI [10.1194/jlr.M900174, 10.1194/jlr.M900174-JLR200]; Singh-Babak SD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002718; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Sugui JA, 2012, J CLIN MICROBIOL, V50, P3309, DOI 10.1128/JCM.01509-12; Sugui JA, 2011, MBIO, V2, DOI 10.1128/mBio.00234-11; Szewczyk E, 2010, EUKARYOT CELL, V9, P774, DOI 10.1128/EC.00375-09; Vazquez JA, 1998, J CLIN MICROBIOL, V36, P2690; Zhai B, 2013, INFECT IMMUN, V81, P2626, DOI 10.1128/IAI.00259-13; Zhu PK, 2013, INFECT IMMUN, V81, P2616, DOI 10.1128/IAI.00018-13",55,22,22,2,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004834,10.1371/journal.ppat.1004834,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000041,25909486.0,"DOAJ Gold, Green Published",,,16/08/2019,24,0,9,3638,592,394,198,3046,2481,22,543,9,0,0,0,22,22,0,,0,1,0,0,1,25,25,22,15,0,0,0,0,0,0,0,0,7,3692,97,0,405,122,0,3081,595,97,0,405,122,0,16,,0,0,0,0,8,0,0,1,0,0,0,25,0,0,4.1,6.14527027027027,1.1943532501641496,0.1943532501641497,1.2839789888378201,1.0750412314458493,6.606418918918919
6,J,"Mahlakoiv, T; Hernandez, P; Gronke, K; Diefenbach, A; Staeheli, P",,,,"Mahlakoiv, Tanel; Hernandez, Pedro; Gronke, Konrad; Diefenbach, Andreas; Staeheli, Peter",,,Leukocyte-Derived IFN-alpha/beta and Epithelial IFN-lambda Constitute a Compartmentalized Mucosal Defense System that Restricts Enteric Virus Infections,PLOS PATHOGENS,,,English,Article,,,,,,,EXTRAHEPATIC BILIARY ATRESIA; INNATE IMMUNE-RESPONSE; III INTERFERON; I INTERFERON; ROTAVIRUS INFECTION; REOVIRUS INFECTION; VIRAL-INFECTION; S1 GENE; MICE; CELLS,"Epithelial cells are a major port of entry for many viruses, but the molecular networks which protect barrier surfaces against viral infections are incompletely understood. Viral infections induce simultaneous production of type I (IFN-alpha/beta) and type III (IFN-lambda) interferons. All nucleated cells are believed to respond to IFN-alpha/beta, whereas IFN-lambda responses are largely confined to epithelial cells. We observed that intestinal epithelial cells, unlike hematopoietic cells of this organ, express only very low levels of functional IFN-alpha/beta receptors. Accordingly, after oral infection of IFN-alpha/beta receptor-deficient mice, human reovirus type 3 specifically infected cells in the lamina propria but, strikingly, did not productively replicate in gut epithelial cells. By contrast, reovirus replicated almost exclusively in gut epithelial cells of IFN-lambda receptor-deficient mice, suggesting that the gut mucosa is equipped with a compartmentalized IFN system in which epithelial cells mainly respond to IFN-lambda that they produce after viral infection, whereas other cells of the gut mostly rely on IFN-alpha/beta for antiviral defense. In suckling mice with IFN-lambda receptor deficiency, reovirus replicated in the gut epithelium and additionally infected epithelial cells lining the bile ducts, indicating that infants may use IFN-lambda for the control of virus infections in various epithelia-rich tissues. Thus, IFN-lambda should be regarded as an autonomous virus defense system of the gut mucosa and other epithelial barriers that may have evolved to avoid unnecessarily frequent triggering of the IFN-alpha/beta system which would induce exacerbated inflammation.","[Mahlakoiv, Tanel; Staeheli, Peter] Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany; [Mahlakoiv, Tanel] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Hernandez, Pedro; Gronke, Konrad; Diefenbach, Andreas] Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Hernandez, Pedro; Gronke, Konrad] IMPRS MCB, Freiburg, Germany; [Hernandez, Pedro; Gronke, Konrad; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Immunol Res Ctr, D-55122 Mainz, Germany; [Hernandez, Pedro; Gronke, Konrad; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55122 Mainz, Germany","Mahlakoiv, T (reprint author), Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany.",peter.staeheli@uniklinik-freiburg.de,"Hernandez, Pedro P/K-4783-2015","Hernandez, Pedro P/0000-0002-2873-4298; Mahlakoiv, Tanel/0000-0001-9059-0486",Excellence Initiative of the German Federal and State Governments (Spemann Graduate School) [GSC-4]; Deutsche Forschungsgemeinschaft [SFB 620],"Funding: This study was supported in part by the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School) and the Deutsche Forschungsgemeinschaft (SFB 620). (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; AMERONGEN HM, 1994, J VIROL, V68, P8428; Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Barton ES, 2003, J CLIN INVEST, V111, P1823, DOI 10.1172/JCI200316303; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Chen DH, 2001, IMMUNOL RES, V23, P229, DOI 10.1385/IR:23:2-3:229; Clarke C. J. P., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P117, DOI 10.2174/1568008013341361; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; de Carvalho E, 2007, J PEDIAT-BRAZIL, V83, P105, DOI [10.1590/S0021-75572007000200004, 10.2223/JPED.1608]; Derrien M, 2003, VIROLOGY, V305, P25, DOI 10.1006/viro.2002.1723; Dionne KR, 2011, J NEUROVIROL, V17, P314, DOI 10.1007/s13365-011-0038-1; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Fulton JR, 2004, EXP GERONTOL, V39, P1285, DOI 10.1016/j.exger.2004.06.013; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hermant P, 2014, J INNATE IMMUN, V6, P563, DOI 10.1159/000360084; Holloway G, 2013, J GEN VIROL, V94, P1151, DOI 10.1099/vir.0.051276-0; HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945; Ioannidis I, 2013, J VIROL, V87, P3261, DOI 10.1128/JVI.01956-12; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Johansson C, 2007, J EXP MED, V204, P1349, DOI 10.1084/jem.20061587; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002; Major AS, 1998, CURR TOP MICROBIOL, V233, P163; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Mann MA, 2002, VIROLOGY, V303, P222, DOI 10.1006/viro.2002.1699; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; MORECKI R, 1982, NEW ENGL J MED, V307, P481, DOI 10.1056/NEJM198208193070806; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nice TJ, 2014, SCIENCE; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; PHILLIPS PA, 1969, PATHOLOGY, V1, P193, DOI 10.3109/00313026909071296; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; RUBIN DH, 1986, MICROB PATHOGENESIS, V1, P79, DOI 10.1016/0882-4010(86)90034-3; Sanos SL, 2010, METHODS MOL BIOL, V612, P505, DOI 10.1007/978-1-60761-362-6_32; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sen A, 2012, P NATL ACAD SCI USA, V109, P20667, DOI 10.1073/pnas.1212188109; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tyler KL, 2010, J NEUROVIROL, V16, P56, DOI 10.3109/13550280903586394; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; WILSON GAR, 1994, J VIROL, V68, P6458; Zahn S, 2011, J INVEST DERMATOL, V131, P133, DOI 10.1038/jid.2010.244",69,72,74,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004782,10.1371/journal.ppat.1004782,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000016,25849543.0,"DOAJ Gold, Green Published",,,16/08/2019,73,0,48,6569,1296,924,372,5273,3956,28,1289,47,0,0,2,73,73,0,,76,0,75,1,0,75,73,75,44,0,0,0,0,0,0,0,0,0,6556,49,0,120,24,0,5251,1296,49,0,120,24,0,9,,0,0,0,0,0,0,0,1,1,0,0,75,1,0,1.25,5.068672839506172,1.2457803906694482,0.24578039066944812,1.2571591124597004,1.0091338103212057,5.114969135802469
7,J,"Marroquin-Guzman, M; Wilson, RA",,,,"Marroquin-Guzman, Margarita; Wilson, Richard A.",,,GATA-Dependent Glutaminolysis Drives Appressorium Formation in Magnaporthe oryzae by Suppressing TOR Inhibition of cAMP/PKA Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,RICE BLAST FUNGUS; PLANT INFECTION; NUTRIENT ACQUISITION; AMINO-ACID; RAPAMYCIN; TRANSCRIPTION; GROWTH; PENETRATION; MECHANISMS; PATHWAYS,"Fungal plant pathogens are persistent and global food security threats. To invade their hosts they often form highly specialized infection structures, known as appressoria. The cAMP/PKA- and MAP kinase-signaling cascades have been functionally delineated as positive-acting pathways required for appressorium development. Negative-acting regulatory pathways that block appressorial development are not known. Here, we present the first detailed evidence that the conserved Target of Rapamycin (TOR) signaling pathway is a powerful inhibitor of appressorium formation by the rice blast fungus Magnaporthe oryzae. We determined TOR signaling was activated in an M. oryzae mutant strain lacking a functional copy of the GATA transcription factor-encoding gene ASD4. Delta asd4 mutant strains could not form appressoria and expressed GLN1, a glutamine synthetase-encoding orthologue silenced in wild type. Inappropriate expression of GLN1 increased the intracellular steady-state levels of glutamine in Delta asd4 mutant strains during axenic growth when compared to wild type. Deleting GLN1 lowered glutamine levels and promoted appressorium formation by Delta asd4 strains. Furthermore, glutamine is an agonist of TOR. Treating Delta asd4 mutant strains with the specific TOR kinase inhibitor rapamycin restored appressorium development. Rapamycin was also shown to induce appressorium formation by wild type and Delta cpka mutant strains on non-inductive hydrophilic surfaces but had no effect on the MAP kinase mutant Delta pmk1. When taken together, we implicate Asd4 in regulating intracellular glutamine levels in order to modulate TOR inhibition of appressorium formation downstream of cPKA. This study thus provides novel insight into the metabolic mechanisms that underpin the highly regulated process of appressorium development.","[Marroquin-Guzman, Margarita; Wilson, Richard A.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA","Wilson, RA (reprint author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.",rwilson10@unl.edu,,,National Science Foundation [IOS-1145347],"This work was funded by the National Science Foundation (IOS-1145347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Barbet NC, 1996, MOL BIOL CELL, V7, P25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Chen DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105811; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dean RA, 1997, ANNU REV PHYTOPATHOL, V35, P211, DOI 10.1146/annurev.phyto.35.1.211; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; EMMETT RW, 1975, ANNU REV PHYTOPATHOL, V13, P147, DOI 10.1146/annurev.py.13.090175.001051; Fernandez J, 2012, MOL PLANT MICROBE IN, V25, P1286, DOI 10.1094/MPMI-12-11-0326; Fernandez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004354; Fernandez J, 2014, MOL MICROBIOL, V94, P70, DOI 10.1111/mmi.12743; Fernandez J, 2014, ANNU REV PHYTOPATHOL, V52, P155, DOI 10.1146/annurev-phyto-102313-050135; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Franceschetti M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002441; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; JELITTO TC, 1994, PLANTA, V194, P471, DOI 10.1007/BF00714458; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Melendez HG, 2009, FUNGAL GENET BIOL, V46, P308, DOI 10.1016/j.fgb.2008.11.011; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; MORA J, 1990, MICROBIOL REV, V54, P293; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Oh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042868; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rodriguez-Romero J, 2015, NUCLEIC ACIDS RES, V43, P179, DOI 10.1093/nar/gku1297; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Saunders DGO, 2010, PLANT CELL, V22, P2417, DOI 10.1105/tpc.110.074492; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wilson RA, 1998, MICROBIOL MOL BIOL R, V62, P586; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15",55,30,30,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004851,10.1371/journal.ppat.1004851,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000049,25901357.0,"DOAJ Gold, Green Published",,,16/08/2019,30,30,35,17788,801,552,249,16987,16017,19,951,35,4,0,0,30,30,0,,38,2,38,0,2,31,31,21,13,0,0,0,0,0,0,0,26,21,17838,116,13,188,25,1,17005,812,116,13,188,25,1,21,,0,0,0,0,18,0,0,1,0,0,0,37,0,0,10.5,22.207240948813983,1.0471537057750044,0.04715370577500441,1.0583975981633014,1.010737575893861,22.44569288389513
8,J,"Mehta, K; Gunasekharan, V; Satsuka, A; Laimins, LA",,,,"Mehta, Kavi; Gunasekharan, Vignesh; Satsuka, Ayano; Laimins, Laimonis A.",,,Human Papillomaviruses Activate and Recruit SMC1 Cohesin Proteins for the Differentiation-Dependent Life Cycle through Association with CTCF Insulators,PLOS PATHOGENS,,,English,Article,,,,,,,DOUBLE-STRAND BREAKS; DNA-DAMAGE; EPITHELIAL DIFFERENTIATION; IONIZING-RADIATION; REPAIR; BINDING; GENOME; GENE; ATM; PHOSPHORYLATION,"Human papillomaviruses infect stratified epithelia and link their productive life cycle to the differentiation state of the host cell. Productive viral replication or amplification is restricted to highly differentiated suprabasal cells and is dependent on the activation of the ATM DNA damage pathway. The ATM pathway has three arms that can act independently of one another. One arm is centered on p53, another on CHK2 and a third on SMC1/NBS1 proteins. A role for CHK2 in HPV genome amplification has been demonstrated but it was unclear what other factors provided important activities. The cohesin protein, SMC1, is necessary for sister chromatid association prior to mitosis. In addition the phosphorylated form of SMC1 plays a critical role together with NBS1 in the ATM DNA damage response. In normal cells, SMC1 becomes phosphorylated in response to radiation, however, in HPV positive cells our studies demonstrate that it is constitutively activated. Furthermore, pSMC1 is found localized in distinct nuclear foci in complexes with gamma-H2AX, and CHK2 and bound to HPV DNA. Importantly, knockdown of SMC1 blocks differentiation-dependent genome amplification. pSMC1 forms complexes with the insulator transcription factor CTCF and our studies show that these factors bind to conserved sequence motifs in the L2 late region of HPV 31. Similar motifs are found in most HPV types. Knockdown of CTCF with shRNAs blocks genome amplification and mutation of the CTCF binding motifs in the L2 open reading frame inhibits stable maintenance of viral episomes in undifferentiated cells as well as amplification of genomes upon differentiation. These findings suggest a model in which SMC1 factors are constitutively activated in HPV positive cells and recruited to viral genomes through complex formation with CTCF to facilitate genome amplification. Our findings identify both SMC1 and CTCF as critical regulators of the differentiation-dependent life cycle of high-risk human papillomaviruses.","[Mehta, Kavi; Gunasekharan, Vignesh; Satsuka, Ayano; Laimins, Laimonis A.] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA","Mehta, K (reprint author), Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.",l-laimins@northwestern.edu,,,"National Cancer Institute [CA59655, Ca142861]; Cellular and Molecular Basis of Disease Training Grant [T32 NIH T32 GM08061]","Funding: This work was supported by grants to LAL from the National Cancer Institute(CA59655; Ca142861) and to KM from the Cellular and Molecular Basis of Disease Training Grant (T32 NIH T32 GM08061). Funders had no role in design of experiments, decision to publish or manuscript preparation.","Anacker DC, 2014, J VIROL, V88, P8528, DOI 10.1128/JVI.00517-14; Banerjee NS, 2011, J BIOL CHEM, V286, P15473, DOI 10.1074/jbc.M110.197574; Bauerschmidt C, 2011, EXP CELL RES, V317, P330, DOI 10.1016/j.yexcr.2010.10.021; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Feeney KM, 2010, BIOCHEM J, V428, P147, DOI 10.1042/BJ20100151; Fehrmann F, 2003, J VIROL, V77, P2819, DOI 10.1128/JVI.77.5.2819-2831.2003; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Flores ER, 1997, J VIROL, V71, P7167; Gillespie KA, 2012, J VIROL, V86, P9520, DOI 10.1128/JVI.00247-12; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Grassmann K, 1996, J VIROL, V70, P2339; Halbert CL, 1992, J VIROL; Hausen zur H., 2002, NAT REV CANCER, V2, P342; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Howley PM, 2007, PAPILLOMAVIRUSES; HUMMEL M, 1992, J VIROL, V66, P6070; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; Kadaja M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000397; Kang H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002140; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Longworth MS, 2004, J VIROL, V78, P3533, DOI 10.1128/JVI.78.7.3533-3541.2004; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McBride AA, 2012, BBA-GENE REGUL MECH, V1819, P820, DOI 10.1016/j.bbagrm.2012.01.011; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Moody CA, 2007, P NATL ACAD SCI USA, V104, P19541, DOI 10.1073/pnas.0707947104; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Ren LC, 2012, MOL CELL BIOCHEM, V360, P243, DOI 10.1007/s11010-011-1063-3; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Schar P, 2004, NUCL ACIDS RES; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sowd GA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003283; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sun MX, 2013, NUCLEIC ACIDS RES, V41, P6149, DOI 10.1093/nar/gkt303; Tempera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002180; Tempera I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001048; Thomas JT, 1999, P NATL ACAD SCI USA, V96, P8449, DOI 10.1073/pnas.96.15.8449; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990",52,18,18,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004763,10.1371/journal.ppat.1004763,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000011,25875106.0,"DOAJ Gold, Green Published",,,16/08/2019,17,11,23,4718,886,659,227,3832,3099,26,707,23,0,0,0,17,17,0,,28,23,28,0,23,18,18,18,17,0,0,0,0,0,0,0,11,6,4725,43,0,344,70,0,3819,886,43,0,344,70,0,20,,0,0,0,0,9,0,1,0,0,0,0,28,0,0,4.35,5.3250564334085775,1.2312108559498955,0.23121085594989563,1.2625260960334028,1.0254345061466723,5.460496613995486
9,J,"Merkling, SH; Bronkhorst, AW; Kramer, JM; Overheul, GJ; Schenck, A; Van Rij, RP",,,,"Merkling, Sarah H.; Bronkhorst, Alfred W.; Kramer, Jamie M.; Overheul, Gijs J.; Schenck, Annette; Van Rij, Ronald P.",,,The Epigenetic Regulator G9a Mediates Tolerance to RNA Virus Infection in Drosophila,PLOS PATHOGENS,,,English,Article,,,,,,,KAPPA-B; LYSINE-9 METHYLATION; ANTIVIRAL RESPONSE; DOWN-REGULATION; GENE; DEFENSE; IDENTIFICATION; EXPRESSION; IMMUNITY; PATHWAY,"Little is known about the tolerance mechanisms that reduce the negative effects of microbial infection on host fitness. Here, we demonstrate that the histone H3 lysine 9 methyltransferase G9a regulates tolerance to virus infection by shaping the response of the evolutionary conserved Jak-Stat pathway in Drosophila. G9a-deficient mutants are more sensitive to RNA virus infection and succumb faster to infection than wild-type controls, which was associated with strongly increased Jak-Stat dependent responses, but not with major differences in viral load. Genetic experiments indicate that hyperactivated Jak-Stat responses are associated with early lethality in virus-infected flies. Our results identify an essential epigenetic mechanism underlying tolerance to virus infection.","[Merkling, Sarah H.; Bronkhorst, Alfred W.; Overheul, Gijs J.; Van Rij, Ronald P.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands","Merkling, SH (reprint author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.",ronald.vanrij@radboudumc.nl,"Schenck, Annette/E-4514-2012; Van Rij, Ronald/I-7073-2012; Merkling, Sarah/G-3350-2016","Schenck, Annette/0000-0002-6918-3314; Van Rij, Ronald/0000-0003-0221-4689; Merkling, Sarah/0000-0002-6823-4474; Overheul, Gijs/0000-0002-8356-8165; Kramer, Jamie/0000-0002-0924-1279","Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [917.96.346, 864.08.003]; European Union [HEALTH-241995]; Horizon Breakthrough fellowship from the Netherlands Genomics Initiative [93511004]","Funding: This work is supported by a PhD fellowship from Radboud Institute for Molecular Life Sciences (http://www.rimls.nl) to SHM, VIDI fellowships from the Netherlands Organization for Scientific Research to AS and RPVR (project numbers 917.96.346 and 864.08.003; http://www.nwo.nl), a European Union FP7 large scale integrated network grant to AS (Gencodys, HEALTH-241995; http://www.gencodys.eu) and a Horizon Breakthrough fellowship from the Netherlands Genomics Initiative to RPVR (project number 93511004; http://www.genomics.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bach EA, 2003, GENETICS, V165, P1149; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109; Brower-Toland B, 2009, GENETICS, V181, P1303, DOI 10.1534/genetics.108.100271; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Coste F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033416; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Rivas ML, 2008, EMBO REP, V9, P1114, DOI 10.1038/embor.2008.170; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schneider DS, 2007, PLOS BIOL, V5, P1847, DOI 10.1371/journal.pbio.0050247; Seum C, 2007, GENETICS, V177, P1955, DOI 10.1534/genetics.107.078220; Stabell M, 2006, NUCLEIC ACIDS RES, V34, P4609, DOI 10.1093/nar/gkl640; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Taillebourg E, 2014, J INNATE IMMUN, V6, P632, DOI 10.1159/000360293; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Cleef KWR, 2011, METHODS MOL BIOL, V721, P201, DOI 10.1007/978-1-61779-037-9_12; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; van Mierlo JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002872; van Mierlo JT, 2011, METHODS MOL BIOL, V721, P3, DOI 10.1007/978-1-61779-037-9_1; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482",68,37,37,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004692,10.1371/journal.ppat.1004692,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000003,25880195.0,"DOAJ Gold, Green Published",,,16/08/2019,34,85,50,4966,780,596,184,4186,3396,36,754,50,0,0,0,34,34,0,,57,0,57,0,0,35,35,23,20,0,0,0,0,0,0,0,85,18,5029,180,0,96,10,0,4218,793,180,0,96,10,0,18,,0,0,0,0,22,0,1,0,0,0,0,57,0,0,12.4,6.366666666666666,1.186335403726708,0.18633540372670807,1.2467749641662684,1.0509464357631897,6.691025641025641
10,J,"Mondal, A; Potts, GK; Dawson, AR; Coon, JJ; Mehle, A",,,,"Mondal, Arindam; Potts, Gregory K.; Dawson, Anthony R.; Coon, Joshua J.; Mehle, Andrew",,,Phosphorylation at the Homotypic Interface Regulates Nucleoprotein Oligomerization and Assembly of the Influenza Virus Replication Machinery,PLOS PATHOGENS,,,English,Article,,,,,,,A VIRUS; RNA-BINDING; VIRAL NUCLEOPROTEIN; MUTATIONAL ANALYSIS; H5N1 NUCLEOPROTEIN; NONSPECIFIC RNA; AMINO-ACIDS; NP PROTEIN; POLYMERASE; RIBONUCLEOPROTEIN,"Negative-sense RNA viruses assemble large ribonucleoprotein (RNP) complexes that direct replication and transcription of the viral genome. Influenza virus RNPs contain the polymerase, genomic RNA and multiple copies of nucleoprotein (NP). During RNP assembly, monomeric NP oligomerizes along the length of the genomic RNA. Regulated assembly of the RNP is essential for virus replication, but how NP is maintained as a monomer that subsequently oligomerizes to form RNPs is poorly understood. Here we elucidate a mechanism whereby NP phosphorylation regulates oligomerization. We identified new evolutionarily conserved phosphorylation sites on NP and demonstrated that phosphorylation of NP decreased formation of higher-order complexes. Two phosphorylation sites were located on opposite sides of the NP: NP interface. In both influenza A and B virus, mutating or mimicking phosphorylation at these residues blocked homotypic interactions and drove NP towards a monomeric form. Highlighting the central role of this process during infection, these mutations impaired RNP formation, polymerase activity and virus replication. Thus, dynamic phosphorylation of NP regulates RNP assembly and modulates progression through the viral life cycle.","[Mondal, Arindam; Dawson, Anthony R.; Mehle, Andrew] Univ Wisconsin, Med Microbiol & Immunol, Madison, WI 53706 USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Dawson, Anthony R.] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA","Mondal, A (reprint author), Univ Wisconsin, Med Microbiol & Immunol, Madison, WI 53706 USA.",amehle@wisc.edu,,,"National Institute of General Medical Sciences [R00GM088484, GM080148]; American Lung Association [RG-310016]; Wisconsin Partnership Education and Research Committee New Investigator Program [2563]; Shaw scientist award","Funding: This work was supported by the National Institute of General Medical Sciences (R00GM088484), the American Lung Association (RG-310016), a Wisconsin Partnership Education and Research Committee New Investigator Program grant (grant 2563), and a Shaw scientist award to AMe, and the National Institute of General Medical Sciences (GM080148) to JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Arrese M, 1996, J VIROL, V70, P3385; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Biswas SK, 1998, J VIROL, V72, P5493; Boulo S, 2011, VIROLOGY, V409, P84, DOI 10.1016/j.virol.2010.10.001; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Chenavas S, 2013, FUTURE MICROBIOL, V8, P1537, DOI 10.2217/fmb.13.128; Chenavas S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003275; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; CURRAN J, 1995, J VIROL, V69, P849; Elton D, 1999, VIROLOGY, V260, P190, DOI 10.1006/viro.1999.9818; Gerritz SW, 2011, P NATL ACAD SCI USA, V108, P15366, DOI 10.1073/pnas.1107906108; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2013, VIRUSES-BASEL, V5, P2424, DOI 10.3390/v5102424; Hutchinson EC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002993; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Kirui J, 2014, J VIROL, V88, P5977, DOI 10.1128/JVI.00508-14; KISTNER O, 1989, J GEN VIROL, V70, P2421, DOI 10.1099/0022-1317-70-9-2421; KISTNER O, 1985, J GEN VIROL, V66, P465, DOI 10.1099/0022-1317-66-3-465; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Marklund JK, 2012, J VIROL, V86, P7292, DOI 10.1128/JVI.00014-12; MASTERS PS, 1988, J VIROL, V62, P2658; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P133; Mena I, 1999, J VIROL, V73, P1186; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Mondal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034623; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, J VIROL, V86, P6758, DOI 10.1128/JVI.00073-12; Palese P, 2001, FIELDS VIROLOGY, V2, P1647; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; PRIVALSKY ML, 1981, J BIOL CHEM, V256, P5368; PRIVALSKY ML, 1977, J VIROL, V24, P401; ProkudinaKantorovich EN, 1996, VIROLOGY, V223, P51, DOI 10.1006/viro.1996.0454; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Richards AL, 2013, MOL CELL PROTEOMICS, V12, P3812, DOI 10.1074/mcp.M113.028951; Rose CM, 2012, MOL CELL PROTEOMICS, V11, P724, DOI 10.1074/mcp.M112.019208; Sasaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055765; Sharma S, 2014, FEBS J, V281, P2899, DOI 10.1111/febs.12828; Shen YF, 2011, P NATL ACAD SCI USA, V108, P16515, DOI 10.1073/pnas.1113107108; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tarus B, 2012, BIOCHIMIE, V94, P776, DOI 10.1016/j.biochi.2011.11.009; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI [10.1146/annurev.pathmechdis.3.121806.154316, 10.1146/annurev.pathol.3.121806.154316]; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Turrell L, 2015, J VIROL, V89, P1452, DOI 10.1128/JVI.02332-14; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Vincent CE, 2013, ANAL CHEM, V85, P2825, DOI 10.1021/ac303352n; Vreede FT, 2011, J VIROL, V85, P12073, DOI 10.1128/JVI.00695-11; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; YAMANAKA K, 1990, J BIOL CHEM, V265, P11151; Ye QZ, 2013, MBIO, V4, DOI 10.1128/mBio.00467-12; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; YEWDELL JW, 1981, J IMMUNOL, V126, P1814; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110; Zhao HX, 1998, J GEN VIROL, V79, P2435, DOI 10.1099/0022-1317-79-10-2435; Zheng WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003624; Zheng WJ, 2013, FEBS LETT, V587, P1206, DOI 10.1016/j.febslet.2013.02.048",69,29,30,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004826,10.1371/journal.ppat.1004826,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000037,25867750.0,"DOAJ Gold, Green Published",,,16/08/2019,26,182,35,5772,1013,740,273,4759,3911,26,822,35,0,0,0,25,25,0,,51,0,51,0,0,27,27,26,17,0,0,0,0,0,0,0,182,1,5812,43,0,55,12,0,4785,1019,43,0,55,12,0,8,,0,0,0,0,1,0,0,0,0,0,0,49,0,0,1.0,5.697926949654492,1.2128598445051482,0.21285984450514814,1.232822021433074,1.0164587664587665,5.791707798617966
11,J,"Newton, ILG; Savytskyy, O; Sheehan, KB",,,,"Newton, Irene L. G.; Savytskyy, Oleksandr; Sheehan, Kathy B.",,,Wolbachia Utilize Host Actin for Efficient Maternal Transmission in Drosophila melanogaster,PLOS PATHOGENS,,,English,Article,,,,,,,STEM-CELL NICHE; APOPTOTIC NURSE CELLS; VILLIN-LIKE PROTEIN; FILARIAL NEMATODES; GENETIC-ANALYSIS; AEDES-AEGYPTI; OOGENESIS; INFECTION; GERMLINE; DYNAMICS,"Wolbachia pipientis is a ubiquitous, maternally transmitted bacterium that infects the germline of insect hosts. Estimates are that Wolbachia infect nearly 40% of insect species on the planet, making it the most prevalent infection on Earth. The bacterium, infamous for the reproductive phenotypes it induces in arthropod hosts, has risen to recent prominence due to its use in vector control. Wolbachia infection prevents the colonization of vectors by RNA viruses, including Drosophila C virus and important human pathogens such as Dengue and Chikungunya. Here we present data indicating that Wolbachia utilize the host actin cytoskeleton during oogenesis for persistence within and transmission between Drosophila melanogaster generations. We show that phenotypically wild type flies heterozygous for cytoskeletal mutations in Drosophila profilin (chic(221)/+ and chic(1320)/+) or villin (qua(6-396)/+) either clear a Wolbachia infection, or result in significantly reduced infection levels. This reduction of Wolbachia is supported by PCR evidence, Western blot results and cytological examination. This phenotype is unlikely to be the result of maternal loading defects, defects in oocyte polarization, or germline stem cell proliferation, as the flies are phenotypically wild type in egg size, shape, and number. Importantly, however, heterozygous mutant flies exhibit decreased total G-actin in the ovary, compared to control flies and chic221 heterozygous mutants exhibit decreased expression of profilin. Additionally, RNAi knockdown of profilin during development decreases Wolbachia titers. We analyze evidence in support of alternative theories to explain this Wolbachia phenotype and conclude that our results support the hypothesis that Wolbachia utilize the actin skeleton for efficient transmission and maintenance within Drosophila.","[Newton, Irene L. G.; Savytskyy, Oleksandr; Sheehan, Kathy B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA","Newton, ILG (reprint author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.",irnewton@indiana.edu,"Newton, Irene/H-5939-2019","Newton, Irene/0000-0002-7118-0374",Bloomington Drosophila Stock Center (NIH) [P40OD018537],"We thank three anonymous reviewers for their constructive feedback, which greatly improved the manuscript. We are greatly indebted to Dr. Mimi Zolan for her generosity, both in terms of reagents provided (secondary antibodies) and the use of her microscope. We would also like to thank Dr. Laura Serbus and Dr. Jack Werren for their careful review of this manuscript and for fruitful discussion of the data. We thank Dr. Luis Teixeira for providing qPCR protocols and primers. We would like to thank Dr. Robert ""Tank"" Eisman and Dr. Thom Kaufman for providing feedback in the early stages of experimentation. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. Dr. Brian Calvi also generously provided stocks and guidance with regards to the RNAi experiments included herein.","Albertson R, 2009, J CELL SCI, V122, P4570, DOI 10.1242/jcs.054981; BAKKEN AH, 1973, DEV BIOL, V33, P100, DOI 10.1016/0012-1606(73)90167-X; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Carrington LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022565; CASTRILLON DH, 1993, GENETICS, V135, P489; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Ferree Patrick M, 2005, PLoS Pathog, V1, pe14; Fischer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086383; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Genty LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094577; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gouin E, 1999, J CELL SCI, V112, P1697; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Hamm CA, 2014, MOL ECOL; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Kittayapong P, 2002, AM J TROP MED HYG, V66, P103, DOI 10.4269/ajtmh.2002.66.103; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; Landmann F, 2012, BIOL OPEN, V1, P536, DOI 10.1242/bio.2012737; LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003; MAHAJANMIKLOS S, 1994, CELL, V78, P291, DOI 10.1016/0092-8674(94)90298-4; Manseau L, 1996, DEVELOPMENT, V122, P2109; Matova N, 1999, DEVELOPMENT, V126, P5645; Matova N, 1998, MOL BIOL CELL, V9, p382A; Matova N, 1998, MOL BIOL CELL, V9, p18A; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Miller WJ, 2006, APPL ENVIRON MICROB, V72, P826, DOI 10.1128/AEM.72.1.826-835.2006; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Newton IL, 2014, APPL ENV MICROBIOL; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Perrot-Minnot MJ, 1999, J EVOLUTION BIOL, V12, P272, DOI 10.1046/j.1420-9101.1999.00025.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; Serbus LR, 2007, PLOS PATHOG, V3, P1930, DOI 10.1371/journal.ppat.0030190; Shields AR, 2014, DEVELOPMENT, V141, P73, DOI 10.1242/dev.101931; Taylor MJ, 2000, PARASITOL TODAY, V16, P179, DOI 10.1016/S0169-4758(00)01661-6; Toomey ME, 2013, P NATL ACAD SCI USA, V110, P10788, DOI 10.1073/pnas.1301524110; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1995, GENETICS, V140, P1319; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; VERHEYEN E, 1994, METHOD CELL BIOL, V44, P545, DOI 10.1016/S0091-679X(08)60931-0; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544",50,25,26,2,29,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004798,10.1371/journal.ppat.1004798,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000024,25906062.0,"DOAJ Gold, Green Published",,,16/08/2019,25,50,62,5202,701,527,174,4501,3778,21,702,62,7,0,0,24,24,0,,72,3,72,0,3,30,27,30,20,0,0,0,0,0,0,0,43,15,5285,28,6,68,68,4,4534,711,28,6,68,68,4,40,,0,0,0,0,28,0,0,1,0,0,0,73,0,0,13.2,7.420827389443652,1.1557431681848478,0.15574316818484782,1.195512108420351,1.03440984236832,7.676176890156919
12,J,"Reynaud, JM; Kim, DY; Atasheva, S; Rasalouskaya, A; White, JP; Diamond, MS; Weaver, SC; Frolova, EI; Frolov, I",,,,"Reynaud, Josephine M.; Kim, Dal Young; Atasheva, Svetlana; Rasalouskaya, Aliaksandra; White, James P.; Diamond, Michael S.; Weaver, Scott C.; Frolova, Elena I.; Frolov, Ilya",,,IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon,PLOS PATHOGENS,,,English,Article,,,,,,,EQUINE ENCEPHALITIS-VIRUS; E2 ENVELOPE GLYCOPROTEIN; 5' UNTRANSLATED REGION; DOUBLE-STRANDED-RNA; SINDBIS-VIRUS; ALPHA/BETA-INTERFERON; MESSENGER-RNA; HOST-RANGE; ENCEPHALOMYELITIS VIRUS; CHIKUNGUNYA VIRUS,"Alphaviruses are a group of widely distributed human and animal pathogens. It is well established that their replication is sensitive to type I IFN treatment, but the mechanism of IFN inhibitory function remains poorly understood. Using a new experimental system, we demonstrate that in the presence of IFN-beta, activation of interferon-stimulated genes (ISGs) does not interfere with either attachment of alphavirus virions to the cells, or their entry and nucleocapsid disassembly. However, it strongly affects translation of the virion-delivered virus-specific RNAs. One of the ISG products, IFIT1 protein, plays a major role in this translation block, although an IFIT1-independent mechanism is also involved. The 5'UTRs of the alphavirus genomes were found to differ significantly in their ability to drive translation in the presence of increased concentration of IFIT1. Prior studies have shown that adaptation of naturally circulating alphaviruses to replication in tissue culture results in accumulation of mutations in the 5'UTR, which increase the efficiency of the promoter located in the 5'end of the genome. Here, we show that these mutations also decrease resistance of viral RNA to IFIT1-induced translation inhibition. In the presence of higher levels of IFIT1, alphaviruses with wt 5'UTRs became potent inducers of type I IFN, suggesting a new mechanism of type I IFN induction. We applied this knowledge of IFIT1 interaction with alphaviruses to develop new attenuated variants of Venezuelan equine encephalitis and chikungunya viruses that are more sensitive to the antiviral effects of IFIT1, and thus could serve as novel vaccine candidates.","[Reynaud, Josephine M.; Kim, Dal Young; Atasheva, Svetlana; Rasalouskaya, Aliaksandra; Frolova, Elena I.; Frolov, Ilya] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [White, James P.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA","Frolov, I (reprint author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.",ivfrolov@uab.edu,"Weaver, Scott/D-6490-2011","Weaver, Scott/0000-0001-8016-8556; Frolov, Ilya/0000-0002-8548-2517; KIM, Dal Young/0000-0003-1756-3128; Frolova, Elena/0000-0001-6523-9336","National Institutes of Health (NIH) [AI073301, AI070207, AI095449]; University of Alabama at Birmingham IMPACT fund","This work was supported by National Institutes of Health (NIH) grants AI073301 (EIF), AI070207, AI095449 (IF) and University of Alabama at Birmingham IMPACT fund (IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Aguilar PV, 2008, J VIROL, V82, P4920, DOI 10.1128/JVI.02514-07; Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; ALEVIZATOS AC, 1967, AM J TROP MED HYG, V16, P762, DOI 10.4269/ajtmh.1967.16.762; Anishchenko M, 2004, J VIROL, V78, P1, DOI 10.1128/JVI.78.1.1-8.2004; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13; Atasheva S, 2013, J VIROL, V87, P2023, DOI 10.1128/JVI.02881-12; Atasheva S, 2012, J VIROL, V86, P8147, DOI 10.1128/JVI.00733-12; Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10; Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Bronze MS, 2002, AM J MED SCI, V323, P316, DOI 10.1097/00000441-200206000-00004; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diamond MS, 2014, CYTOKINE GROWTH F R, V25, P543, DOI 10.1016/j.cytogfr.2014.05.002; Fayzulin R, 2004, J VIROL, V78, P4953, DOI 10.1128/JVI.78.10.4953-4964.2004; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; FRIEDMAN RM, 1968, J VIROL, V2, P1081; FRIEDMAN ROBERT M., 1967, J VIROL, V1, P1168; Frolov I, 2012, J VIROL, V86, P5055, DOI 10.1128/JVI.07223-11; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Gardner CL, 2009, VIROLOGY, V390, P338, DOI 10.1016/j.virol.2009.05.030; Gorchakov R, 2004, J VIROL, V78, P61, DOI 10.1128/JVI.78.1.61-75.2004; Gorchakov R, 2008, J VIROL, V82, P6218, DOI 10.1128/JVI.02624-07; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Griffin D. E., 2001, FIELDS VIROLOGY, P917; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; HEFTI E, 1976, J VIROL, V17, P149; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010; Karki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037398; Kim DY, 2011, J VIROL, V85, P8022, DOI 10.1128/JVI.00644-11; KINNEY RM, 1989, VIROLOGY, V170, P19, DOI 10.1016/0042-6822(89)90347-4; KINNEY RM, 1993, J VIROL, V67, P1269; Kulasegaran-Shylini R, 2009, J VIROL, V83, P8327, DOI 10.1128/JVI.00586-09; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321; Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; LEMM JA, 1990, J VIROL, V64, P3001; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Lulla V, 2013, J VIROL, V87, P12003, DOI 10.1128/JVI.01960-13; McKnight KL, 1996, J VIROL, V70, P1981; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14; Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109; Palacios-Martinez D, 2014, CHIKUNGUNYA EMERGING; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142; RICE CM, 1987, J VIROL, V61, P3809; RUMENAPF T, 1994, J VIROL, V68, P56; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sokoloski KJ, 2013, J VIROL, V87, P12216, DOI 10.1128/JVI.02437-13; Spotts DR, 1998, J VIROL, V72, P10286; STRAUSS JH, 1994, MICROBIOL REV, V58, P491; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Tan SL, 1999, J INTERF CYTOK RES, V19, P543, DOI 10.1089/107999099313677; Tesfay MZ, 2008, J VIROL, V82, P2620, DOI 10.1128/JVI.01784-07; Volkova E, 2006, VIROLOGY, V344, P315, DOI 10.1016/j.virol.2005.09.010; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2005, VIROLOGY, V2, P1010; White LJ, 2001, J VIROL, V75, P3706, DOI 10.1128/JVI.75.8.3706-3718.2001",69,33,33,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004863,10.1371/journal.ppat.1004863,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000052,25927359.0,"DOAJ Gold, Green Published",,,16/08/2019,33,4,46,5714,1053,820,233,4661,3752,19,890,45,4,0,2,33,33,0,,59,2,58,1,2,36,36,16,23,0,0,0,0,0,0,0,0,2,5771,118,0,179,102,3,4688,1065,83,0,179,101,3,18,,0,0,0,0,4,0,0,1,1,0,0,58,1,0,2.75,5.426400759734093,1.2259171851534005,0.22591718515340056,1.2853464921690625,1.0484774238711936,5.689458689458689
13,J,"Safar, JG; Xiao, XZ; Kabir, ME; Chen, SG; Kim, C; Haldiman, T; Cohen, Y; Chen, W; Cohen, ML; Surewicz, WK",,,,"Safar, Jiri G.; Xiao, Xiangzhu; Kabir, Mohammad E.; Chen, Shugui; Kim, Chae; Haldiman, Tracy; Cohen, Yvonne; Chen, Wei; Cohen, Mark L.; Surewicz, Witold K.",,,Structural Determinants of Phenotypic Diversity and Replication Rate of Human Prions,PLOS PATHOGENS,,,English,Article,,,,,,,CREUTZFELDT-JAKOB-DISEASE; PROTEIN AMYLOID FIBRILS; CONFORMATIONAL STABILITY; TRANSMISSION; COEXISTENCE; PRPSC; CLASSIFICATION; PROPAGATION; MOLECULES; PARALLEL,"The infectious pathogen responsible for prion diseases is the misfolded, aggregated form of the prion protein, PrPSc. In contrast to recent progress in studies of laboratory rodent-adapted prions, current understanding of the molecular basis of human prion diseases and, especially, their vast phenotypic diversity is very limited. Here, we have purified proteinase resistant PrPSc aggregates from two major phenotypes of sporadic Creutzfeldt-Jakob disease (sCJD), determined their conformational stability and replication tempo in vitro, as well as characterized structural organization using recently emerged approaches based on hydrogen/deuterium (H/D) exchange coupled with mass spectrometry. Our data clearly demonstrate that these phenotypically distant prions differ in a major way with regard to their structural organization, both at the level of the polypeptide backbone (as indicated by backbone amide H/D exchange data) as well as the quaternary packing arrangements (as indicated by H/D exchange kinetics for histidine side chains). Furthermore, these data indicate that, in contrast to previous observations on yeast and some murine prion strains, the replication rate of sCJD prions is primarily determined not by conformational stability but by specific structural features that control the growth rate of prion protein aggregates.","[Safar, Jiri G.; Kabir, Mohammad E.; Kim, Chae; Haldiman, Tracy; Cohen, Mark L.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Safar, Jiri G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Safar, Jiri G.; Cohen, Yvonne; Chen, Wei; Cohen, Mark L.] Case Western Reserve Univ, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Xiao, Xiangzhu; Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA","Safar, JG (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.",wks3@case.edu,,,National Institutes of Health [NS074317]; Center for Disease Control and Prevention [UR8/CCU515004]; Charles S. Britton Fund,"Funding: This work was supported by National Institutes of Health (grant NS074317 to WKS and JGS), Center for Disease Control and Prevention (grant UR8/CCU515004 to JGS) and Charles S. Britton Fund (to JGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2011, ACTA NEUROPATHOL, V121, P79, DOI 10.1007/s00401-010-0761-3; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; Giles K, 2010, ANN NEUROL, V68, P151, DOI 10.1002/ana.22104; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Haldiman T, 2013, J BIOL CHEM, V288, P29846, DOI 10.1074/jbc.M113.500108; KASCSAK RJ, 1987, J VIROL, V61, P3688; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Miyagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017055; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner Stanley B., 2004, VVolume 41, P187; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2012, PRIONS DIS; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tran DT, 2012, ANAL CHEM, V84, P1653, DOI 10.1021/ac202927p; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Wadsworth JDF, 2008, P NATL ACAD SCI USA, V105, P3885, DOI 10.1073/pnas.0800190105; Wadsworth JDF, 2011, ACTA NEUROPATHOL, V121, P69, DOI 10.1007/s00401-010-0735-5; *WHO, 1999, WHO INF CONTR GUID T; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812",55,23,23,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004832,10.1371/journal.ppat.1004832,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000040,25875953.0,"DOAJ Gold, Green Published",,,16/08/2019,22,3,24,3458,567,411,156,2891,2326,22,543,24,0,0,0,22,22,0,,31,4,31,0,4,22,22,15,17,0,0,0,0,0,0,0,3,2,3526,52,0,267,99,0,2905,573,52,0,267,99,0,48,,0,1,0,0,2,0,0,0,0,0,0,31,0,0,7.75,6.098765432098766,1.1961259079903148,0.19612590799031476,1.2718782428225528,1.0633314054366685,6.485008818342152
14,J,"Tsetsarkin, KA; Liu, GP; Kenney, H; Bustos-Arriaga, J; Hanson, CT; Whitehead, SS; Pletnev, AG",,,,"Tsetsarkin, Konstantin A.; Liu, Guangping; Kenney, Heather; Bustos-Arriaga, Jose; Hanson, Christopher T.; Whitehead, Stephen S.; Pletnev, Alexander G.",,,Dual miRNA Targeting Restricts Host Range and Attenuates Neurovirulence of Flaviviruses,PLOS PATHOGENS,,,English,Article,,,,,,,DENGUE-VIRUS TYPE-4; AEDES-AEGYPTI MOSQUITOS; VACCINE CANDIDATE; GROWTH-CHARACTERISTICS; WEST-NILE; AIRBORNE TRANSMISSION; VIRAL DISSEMINATION; STRUCTURAL GENES; CHIMERIC VIRUSES; RHESUS-MONKEYS,"Mosquito-borne flaviviruses are among the most significant arboviral pathogens worldwide. Vaccinations and mosquito population control programs remain the most reliable means for flavivirus disease prevention, and live attenuated viruses remain one of the most attractive flavivirus vaccine platforms. Some live attenuated viruses are capable of infecting principle mosquito vectors, as demonstrated in the laboratory, which in combination with their intrinsic genetic instability could potentially lead to a vaccine virus reversion back to wild-type in nature, followed by introduction and dissemination of potentially dangerous viral strains into new geographic locations. To mitigate this risk we developed a microRNA-targeting approach that selectively restricts replication of flavivirus in the mosquito host. Introduction of sequences complementary to a mosquito-specific mir-184 and mir-275 miRNAs individually or in combination into the 3'NCR and/or ORF region resulted in selective restriction of dengue type 4 virus (DEN4) replication in mosquito cell lines and adult Aedes mosquitos. Moreover a combined targeting of DEN4 genome with mosquito-specific and vertebrate CNS-specific mir-124 miRNA can silence viral replication in two evolutionally distant biological systems: mosquitoes and mouse brains. Thus, this approach can reinforce the safety of newly developed or existing vaccines for use in humans and could provide an additional level of biosafety for laboratories using viruses with altered pathogenic or transmissibility characteristics.","[Tsetsarkin, Konstantin A.; Liu, Guangping; Kenney, Heather; Bustos-Arriaga, Jose; Hanson, Christopher T.; Whitehead, Stephen S.; Pletnev, Alexander G.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA","Pletnev, AG (reprint author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.",apletnev@niaid.nih.gov,,"Bustos-Arriaga, Jose/0000-0002-7368-6432","Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health","This work was supported by the Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhatt TR, 2000, AM J TROP MED HYG, V62, P480, DOI 10.4269/ajtmh.2000.62.480; Blaney JE, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-39; Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0; Blaney JE, 2008, VACCINE, V26, P4150, DOI 10.1016/j.vaccine.2008.05.075; Blaney JE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-23; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Engel AR, 2011, VECTOR-BORNE ZOONOT, V11, P665, DOI 10.1089/vbz.2010.0179; Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067638; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hanley KA, 2005, VECTOR-BORNE ZOONOT, V5, P1, DOI 10.1089/vbz.2005.5.1; Heiss BL, 2012, J VIROL, V86, P5647, DOI 10.1128/JVI.07125-11; Heiss BL, 2011, J VIROL, V85, P1464, DOI 10.1128/JVI.02091-10; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Higgs S, 2006, AM J TROP MED HYG, V75, P986, DOI 10.4269/ajtmh.2006.75.986; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512; Johnson BW, 2003, MED VET ENTOMOL, V17, P235, DOI 10.1046/j.1365-2915.2003.00438.x; Johnson BW, 2002, AM J TROP MED HYG, V67, P260, DOI 10.4269/ajtmh.2002.67.260; Johnson BW, 2004, AM J TROP MED HYG, V70, P89, DOI 10.4269/ajtmh.2004.70.89; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000820; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Langlois RA, 2013, NAT BIOTECHNOL, V31, P844, DOI 10.1038/nbt.2666; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0; McElroy KL, 2006, AM J TROP MED HYG, V75, P1158, DOI 10.4269/ajtmh.2006.75.1158; Mcgee CE, 2008, J INFECT DIS, V197, P686, DOI 10.1086/527328; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; PEDERSEN CE, 1972, AM J EPIDEMIOL, V95, P490, DOI 10.1093/oxfordjournals.aje.a121416; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; PILITT DR, 1972, J MED ENTOMOL, V9, P334, DOI 10.1093/jmedent/9.4.334; Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799; Reid M, 2006, AM J TROP MED HYG, V75, P659, DOI 10.4269/ajtmh.2006.75.659; Rurayantsev AA, 2006, VACCINE, V24, P133, DOI 10.1016/j.vaccine.2005.07.067; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sambrook J, 1989, MOL CLONING LAB MANU; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3; Simmonds P, 2011, VIRUS TAXONOMY, P1003; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Teterina NL, 2014, VIROLOGY, V456, P247, DOI 10.1016/j.virol.2014.04.001; Troyer JM, 2001, AM J TROP MED HYG, V65, P414, DOI 10.4269/ajtmh.2001.65.414; Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925; Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2; WHITMAN LORING, 1939, AMER JOUR TROP MED, V19, P19; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Ylosmaki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054506; Ylosmaki E, 2013, J VIROL, V87, P335, DOI 10.1128/JVI.01940-12",70,16,17,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004852,10.1371/journal.ppat.1004852,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000050,25906260.0,"DOAJ Gold, Green Published",,,16/08/2019,18,0,41,7612,763,549,214,6849,3229,19,3601,41,0,0,2,17,17,0,,0,2,0,0,2,19,19,17,14,0,0,0,0,0,0,0,0,4,7844,61,0,327,112,0,7043,775,61,0,327,112,0,26,,0,0,0,0,7,0,0,0,1,0,0,47,0,0,3.35,9.97640891218873,1.111403124543729,0.11140312454372901,1.1705358446488539,1.053205465055176,10.507208387942333
15,J,"Vilcinskas, A",,,,"Vilcinskas, Andreas",,,Pathogens as Biological Weapons of Invasive Species,PLOS PATHOGENS,,,English,Article,,,,,,,HARLEQUIN LADYBIRD; DISEASE,,"[Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany; [Vilcinskas, Andreas] Fraunhofer Inst Mol Biol & Appl Ecol, Dept Bioresources, Giessen, Germany","Vilcinskas, A (reprint author), Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany.",Andreas.Vilcinskas@agrar.uni-giessen.de,,,"excellence initiative of the Hessian Ministry of Science, Higher Education and Art (HMWK) via LOEWE center for 'Insect Biotechnology and Bioresources'; Biodiversa Programme of the EU [VI 219/7-1]","Funding: The author acknowledges funding by the excellence initiative of the Hessian Ministry of Science, Higher Education and Art (HMWK) via LOEWE center for 'Insect Biotechnology and Bioresources' and by the Biodiversa Programme of the EU for the project ""EXperimentally Orientated genomics to Tackle Insects adaptive Challenges during bioinvasions: the ladybird Harmonia axyridis"" as a model species (EXOTIC), VI 219/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Capinha C, 2013, CONSERV BIOL, V27, P731, DOI 10.1111/cobi.12043; Collins LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089521; Comont RF, 2014, BIOL INVASIONS, V16, P1805, DOI 10.1007/s10530-013-0628-3; Darby AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096439; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Lymbery Alan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P171, DOI 10.1016/j.ijppaw.2014.04.002; Rohrich CR, 2012, BIOL LETTERS, V8, P308, DOI 10.1098/rsbl.2011.0760; Schmidtberg H, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0006; Strauss A, 2012, FUNCT ECOL, V26, P1249, DOI 10.1111/1365-2435.12011; Troemel ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001243; Vilcinskas A, 2015, INSECT SCI, V22, P313, DOI 10.1111/1744-7917.12159; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Vilcinskas A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2113",16,15,15,1,46,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004714,10.1371/journal.ppat.1004714,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000004,25856550.0,"DOAJ Gold, Green Published",,,16/08/2019,16,83,51,9357,1810,1589,221,7547,6534,30,983,51,0,0,0,13,13,0,,68,46,65,0,46,18,18,13,3,0,0,0,0,0,0,2,83,24,9624,6,0,19,324,17,7579,1826,6,0,19,324,17,219,,1,0,0,0,30,0,4,0,0,0,0,64,0,0,29.25,5.169613259668508,1.239830396183914,0.23983039618391414,1.3189346760302108,1.063802500801539,5.499447513812155
16,J,"Wolff, KA; de la Pena, AH; Nguyen, HT; Pham, TH; Amzel, LM; Gabelli, SB; Nguyen, L",,,,"Wolff, Kerstin A.; de la Pena, Andres H.; Nguyen, Hoa T.; Pham, Thanh H.; Amzel, L. Mario; Gabelli, Sandra B.; Liem Nguyen",,,A Redox Regulatory System Critical for Mycobacterial Survival in Macrophages and Biofilm Development,PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN-KINASE-G; OXIDATIVE STRESS-RESPONSE; BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; VIRULENCE FACTOR; GENE-EXPRESSION; TUBERCULOSIS; GROWTH; DEHYDROGENASE,"Survival of M. tuberculosis in host macrophages requires the eukaryotic-type protein kinase G, PknG, but the underlying mechanism has remained unknown. Here, we show that PknG is an integral component of a novel redox homeostatic system, RHOCS, which includes the ribosomal protein L13 and RenU, a Nudix hydrolase encoded by a gene adjacent to pknG. Studies in M. smegmatis showed that PknG expression is uniquely induced by NADH, which plays a key role in metabolism and redox homeostasis. In vitro, RenU hydrolyses FAD, ADP-ribose and NADH, but not NAD+. Absence of RHOCS activities in vivo causes NADH and FAD accumulation, and increased susceptibility to oxidative stress. We show that PknG phosphorylates L13 and promotes its cytoplasmic association with RenU, and the phosphorylated L13 accelerates the RenU-catalyzed NADH hydrolysis. Importantly, interruption of RHOCS leads to impaired mycobacterial biofilms and reduced survival of M. tuberculosis in macrophages. Thus, RHOCS represents a checkpoint in the developmental program required for mycobacterial growth in these environments.","[Wolff, Kerstin A.; Nguyen, Hoa T.; Pham, Thanh H.; Liem Nguyen] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [de la Pena, Andres H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [de la Pena, Andres H.; Amzel, L. Mario; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA","Nguyen, L (reprint author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.",liem.nguyen@case.edu,"Gabelli, Sandra B/A-3705-2008","Gabelli, Sandra B/0000-0003-1205-5204; Amzel, L. Mario/0000-0002-0129-9572; PHAM, THANH/0000-0001-8959-7947; de la Pena, Andres H./0000-0002-2368-6944",National Institute of Health [R01AI087903]; STERIS Infectious Diseases Research Award; CFAR Developmental Award [AI36219],"This work was supported by the National Institute of Health Grant R01AI087903 (to LN), and in part by a STERIS Infectious Diseases Research Award, and a CFAR Developmental Award (AI36219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bitoun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044766; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Demple B, 2008, NAT CHEM BIOL, V4, P653, DOI 10.1038/nchembio1108-653; DePas WH, 2013, P NATL ACAD SCI USA, V110, P2629, DOI [10.1073/pnas.1218703110/-/DCSupplemental, 10.1073/pnas.1218703110]; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dos Vultos T, 2006, J BACTERIOL, V188, P3159, DOI 10.1128/JB.188.8.3159-3161.2006; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Geier H, 2008, APPL ENVIRON MICROB, V74, P1798, DOI 10.1128/AEM.02066-07; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; Kloosterman H, 2002, J BIOL CHEM, V277, P34785, DOI 10.1074/jbc.M205617200; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolodkin-Gal I, 2013, GENE DEV, V27, P887, DOI 10.1101/gad.215244.113; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Scott JM, 2000, J BACTERIOL, V182, P2771, DOI 10.1128/JB.182.10.2771-2777.2000; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Smith T, 2014, CURR TOP MICROBIOL, V374, P53, DOI 10.1007/82_2012_279; STUHRMANN HB, 1977, P NATL ACAD SCI USA, V74, P2316, DOI 10.1073/pnas.74.6.2316; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; van der Woude AD, 2014, CELL MICROBIOL, V16, P280, DOI 10.1111/cmi.12221; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wolff KA, 2009, ANTIMICROB AGENTS CH, V53, P3515, DOI 10.1128/AAC.00012-09",44,33,34,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004839,10.1371/journal.ppat.1004839,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000044,25884716.0,"DOAJ Gold, Green Published",,,16/08/2019,32,0,49,5666,1043,739,304,4623,3625,23,975,49,0,0,0,28,28,0,,66,0,66,0,0,34,34,23,17,0,0,0,0,0,0,0,0,1,5658,114,0,362,61,1,4602,1043,114,0,362,61,1,13,,0,0,0,0,6,0,0,1,0,0,0,66,0,0,2.25,5.432406519654842,1.225611075059485,0.2256110750594852,1.2617348042396712,1.0294740557712672,5.592521572387344
17,J,"Xiao, XP; Zhang, RD; Pang, XJ; Liang, GD; Wang, PH; Cheng, G",,,,"Xiao, Xiaoping; Zhang, Rudian; Pang, Xiaojing; Liang, Guodong; Wang, Penghua; Cheng, Gong",,,A Neuron-Specific Antiviral Mechanism Prevents Lethal Flaviviral Infection of Mosquitoes,PLOS PATHOGENS,,,English,Article,,,,,,,WEST-NILE-VIRUS; MANNOSE-BINDING LECTIN; QUINQUEFASCIATUS DIPTERA-CULICIDAE; CULEX-PIPIENS-QUINQUEFASCIATUS; AEDES-AEGYPTI MOSQUITOS; SURFACTANT PROTEIN D; DENGUE-VIRUS; RNA INTERFERENCE; SINDBIS VIRUS; HIKARU-GENKI,"Mosquitoes are natural vectors for many etiologic agents of human viral diseases. Mosquito-borne flaviviruses can persistently infect the mosquito central nervous system without causing dramatic pathology or influencing the mosquito behavior and lifespan. The mechanism by which the mosquito nervous system resists flaviviral infection is still largely unknown. Here we report that an Aedes aegypti homologue of the neural factor Hikaru genki (AaHig) efficiently restricts flavivirus infection of the central nervous system. AaHig was predominantly expressed in the mosquito nervous system and localized to the plasma membrane of neural cells. Functional blockade of AaHig enhanced Dengue virus (DENV) and Japanese encephalitis virus (JEV), but not Sindbis virus (SINV), replication in mosquito heads and consequently caused neural apoptosis and a dramatic reduction in the mosquito lifespan. Consistently, delivery of recombinant AaHig to mosquitoes reduced viral infection. Furthermore, the membrane-localized AaHig directly interfaced with a highly conserved motif in the surface envelope proteins of DENV and JEV, and consequently interrupted endocytic viral entry into mosquito cells. Loss of either plasma membrane targeting or virion-binding ability rendered AaHig nonfunctional. Interestingly, Culex pipien pallens Hig also demonstrated a prominent anti-flavivirus activity, suggesting a functionally conserved function for Hig. Our results demonstrate that an evolutionarily conserved antiviral mechanism prevents lethal flaviviral infection of the central nervous system in mosquitoes, and thus may facilitate flaviviral transmission in nature.","[Xiao, Xiaoping; Zhang, Rudian; Pang, Xiaojing; Cheng, Gong] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Xiao, Xiaoping; Liang, Guodong; Cheng, Gong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zhang, Rudian] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Liang, Guodong] Chinese Ctr Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Penghua] New York Med Coll, Dept Microbiol & Immunol, Sch Med, Valhalla, NY 10595 USA","Cheng, G (reprint author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.",gongcheng@mail.tsinghua.edu.cn,", /D-2513-2017",", /0000-0003-2214-4892","National Key Technologies Research and Development Program of China [2013ZX10004-610]; National Natural Science Foundation of China [81301412, 81422028, 61472205, 81290342]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID103]; NIH [AI099625, AI103807]; Academy of Medical Sciences; Newton Fund; Academy of Medical Sciences (AMS) [AMS-NAF1-Cheng]","This work was funded by the National Key Technologies Research and Development Program of China with grant 2013ZX10004-610 to GC, the National Natural Science Foundation of China with grants 81301412 and 81422028 to GC, 61472205 to XP and 81290342 to GL, the National Key Basic Research Program of MOST with grant 2013CB911500 to GC, the development grant of State Key Laboratory for Infectious Disease Prevention and Control 2014SKLID103 to GL, and the NIH grants AI099625 and AI103807 to PW. GC is a Newton Advanced Fellow awarded by the Academy of Medical Sciences and the Newton Fund, and a Janssen Investigator of Tsinghua University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Arjona A, 2011, CELL MICROBIOL, V13, P1648, DOI 10.1111/j.1462-5822.2011.01649.x; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; CHANG KJ, 1975, J BIOL CHEM, V250, P488; Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Cornet S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-315; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Feng Y, 2012, JPN J INFECT DIS, V65, P215, DOI 10.7883/yoken.65.215; Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148; Garza-Hernandez JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002013; Ghaninia M, 2007, ARTHROPOD STRUCT DEV, V36, P23, DOI 10.1016/j.asd.2006.06.004; Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2; Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Girard YA, 2010, J MED ENTOMOL, V47, P421, DOI 10.1603/ME09249; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; Hidari KIPJ, 2013, VIRUSES-BASEL, V5, P605, DOI 10.3390/v5020605; Hill CL, 2014, ACTA TROP, V140, P151, DOI 10.1016/j.actatropica.2014.07.015; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Hoshino M, 1996, DEVELOPMENT, V122, P589; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hubalek Z, 2008, PARASITOL RES S1, V103, pS29, DOI [10.1007/s00436-008-1064-7, DOI 10.1007/S00436-008-1064-7]; Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MOLINA H, 1991, J BIOL CHEM, V266, P12173; Mysore K, 2011, DEV GENES EVOL, V221, P281, DOI 10.1007/s00427-011-0376-2; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pan X, 2011, P NATL ACAD SCI USA, V109, pE23, DOI DOI 10.1073/PNAS.1116932108; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; PELEG J, 1968, AM J TROP MED HYG, V17, P219, DOI 10.4269/ajtmh.1968.17.219; PIZZI M, 1950, Hum Biol, V22, P151; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; SNOW PM, 1987, J NEUROSCI, V7, P4137; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Spear GT, 2003, IMMUNOLOGY, V110, P80, DOI 10.1046/j.1365-2567.2003.01707.x; SPRAY FJ, 1991, EXP PARASITOL, V73, P481, DOI 10.1016/0014-4894(91)90072-5; Stoiber H, 1997, ANNU REV IMMUNOL, V15, P649, DOI 10.1146/annurev.immunol.15.1.649; Tecle T, 2007, ARCH VIROL, V152, P1731, DOI 10.1007/s00705-007-0983-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; Wang H, 2012, J VIROL, V86, P6546, DOI 10.1128/JVI.00125-12; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027; Ying HY, 2004, AIDS RES HUM RETROV, V20, P327, DOI 10.1089/088922204322996563; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055",79,10,10,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004848,10.1371/journal.ppat.1004848,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000047,25915054.0,"DOAJ Gold, Green Published",,,16/08/2019,10,24,49,7148,1399,988,411,5749,4635,27,1087,49,3,0,0,8,8,2,,117,1,60,0,1,13,10,13,6,0,0,0,0,0,0,0,21,5,7154,168,7,133,112,3,5724,1399,168,7,133,112,3,31,,0,2,0,0,6,0,3,1,0,0,0,60,0,0,21.258000000000006,5.109363831308078,1.2433466689859105,0.2433466689859106,1.293094451208906,1.0400111919418018,5.313795568263045
18,J,"Akiyama, H; Ramirez, NGP; Gudheti, MV; Gummuluru, S",,,,"Akiyama, Hisashi; Ramirez, Nora-Guadalupe Pina; Gudheti, Manasa V.; Gummuluru, Suryaram",,,CD169-Mediated Trafficking of HIV to Plasma Membrane Invaginations in Dendritic Cells Attenuates Efficacy of Anti-gp120 Broadly Neutralizing Antibodies,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; TRANS-INFECTION; DC-SIGN; VIROLOGICAL SYNAPSE; MANNOSE RECEPTOR; IMMATURE; TRANSMISSION; ACTIVATION; MICROSCOPY,"Myeloid dendritic cells (DCs) can capture HIV-1 via the receptor CD169/Siglec-1 that binds to the ganglioside, GM3, in the virus particle membrane. In turn, HIV-1 particles captured by CD169, an I-type lectin, whose expression on DCs is enhanced upon maturation with LPS, are protected from degradation in CD169(+) virus-containing compartments (VCCs) and disseminated to CD4(+) T cells, a mechanism of DC-mediated HIV-1 trans-infection. In this study, we describe the mechanism of VCC formation and its role in immune evasion mechanisms of HIV-1. We find HIV-1-induced formation of VCCs is restricted to myeloid cells, and that the cytoplasmic tail of CD169 is dispensable for HIV-1 trafficking and retention within VCCs and subsequent trans-infection to CD4(+) T cells. Interestingly, introduction of a diaromatic endocytic motif in the cytoplasmic tail of CD169 that results in endocytosis of HIV-1 particles, suppressed CD169-mediated HIV-1 trans-infection. Furthermore, super-resolution microscopy revealed close association of CD169 and HIV-1 particles in surface-accessible but deep plasma membrane invaginations. Intriguingly, HIV-1 particles in deep VCCs were inefficiently accessed by anti-gp120 broadly neutralizing antibodies, VRC01 and NIH45-46 G54W, and thus were less susceptible to neutralization. Our study suggests that HIV-1 capture by CD169 can provide virus evasion from both innate (phagocytosis) and adaptive immune responses.","[Akiyama, Hisashi; Ramirez, Nora-Guadalupe Pina; Gummuluru, Suryaram] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Gudheti, Manasa V.] Bruker Nano Surfaces, Salt Lake City, UT USA","Akiyama, H (reprint author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.",rgummulu@bu.edu,,"Akiyama, Hisashi/0000-0001-9228-0465; Gummuluru, Suryaram/0000-0002-8606-8481; Ramirez, Nora-Guadalupe/0000-0002-7992-1683",NIH [AI064099],"This work was supported by NIH grant AI064099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aggarwal A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002762; Akiyama H, 2014, J VIROL, V88, P8813, DOI 10.1128/JVI.00992-14; Badieirostami M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499652; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanchet FP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-6; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Hatch SC, 2009, J VIROL, V83, P3496, DOI 10.1128/JVI.02249-08; Hladik F, 1999, J VIROL, V73, P5833; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Izquierdo-Useros N, 2008, BLOOD; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Mlodzianoski MJ, 2009, OPT EXPRESS, V17, P8264, DOI 10.1364/OE.17.008264; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Sagar M, 2012, J INFECT DIS, V205, P1248, DOI 10.1093/infdis/jis183; Schweizer A, 2000, J BIOL CHEM, V275, P29694, DOI 10.1074/jbc.M000571200; Sriram U, 2007, J IMMUNOL, V179, P6446, DOI 10.4049/jimmunol.179.10.6446; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; YAO QH, 1995, J VIROL, V69, P7045; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134",55,30,31,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004751,10.1371/journal.ppat.1004751,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900064,25760631.0,"DOAJ Gold, Green Published",,,16/08/2019,28,0,40,4438,989,774,215,3449,2776,18,655,39,0,3,0,27,27,0,,52,2,51,1,2,29,29,16,21,0,0,0,0,0,0,0,0,2,4458,130,0,220,117,3,3435,989,130,0,220,117,3,34,,0,0,0,0,3,0,0,1,0,0,1,50,1,0,2.0,4.487360970677452,1.2867497825456653,0.2867497825456654,1.3641635256596114,1.0601622352410995,4.757330637007078
19,J,"Bar, S; Rommelaere, J; Nuesch, JPF",,,,"Baer, Severine; Rommelaere, Jean; Nueesch, Juerg P. F.",,,PKC eta/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis,PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN-KINASE-C; MINUTE VIRUS; REPLICATIVE FUNCTIONS; FAMILY PROTEINS; NS1; ETA; ACTIVATION; RADIXIN; KILL; AKT,"The intrinsic oncotropism and oncosuppressive activities of rodent protoparvoviruses (PVs) are opening new prospects for cancer virotherapy. Virus propagation, cytolytic activity, and spread are tightly connected to activation of the PDK1 signaling cascade, which delays stress-induced cell death and sustains functioning of the parvoviral protein NS1 through PKC(eta)-driven modifications. Here we reveal a new PV-induced intracellular loop-back mechanism whereby PKC eta/Rdx phosphorylates mouse PDK1:S138 and activates it independently of PI3-kinase signaling. The corresponding human PDK1phosphoS135 appears as a hallmark of highly aggressive brain tumors and may contribute to the very effective targeting of human gliomas by H-1PV. Strikingly, although H-1PV does not trigger PDK1 activation in normal human cells, such cells show enhanced viral DNA amplification and NS1-induced death upon expression of a constitutively active PDK1 mimicking PDK1phosphoS135. This modification thus appears as a marker of human glioma malignant progression and sensitivity to H-1PV-induced tumor cell killing.","[Baer, Severine; Rommelaere, Jean; Nueesch, Juerg P. F.] German Canc Res Ctr, Infect & Canc Program, Tumor Virol Div F010, Heidelberg, Germany","Nuesch, JPF (reprint author), German Canc Res Ctr, Infect & Canc Program, Tumor Virol Div F010, Heidelberg, Germany.",jpf.nuesch@dkfz-heidelberg.de,"Bar, Severine/D-4060-2017",,"Helmholtz Gemeinschaft (HGF); Institut National de la Sante et de la Recherche Medical (INSERM, France)","This study was funded by Helmholtz Gemeinschaft (HGF): public financing of Germany and Baden-Wurttemberg and, until 2011 I part supported by the Institut National de la Sante et de la Recherche Medical (INSERM, France). SB is Research Associate at INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aeder SE, 2004, ONCOGENE, V23, P9062, DOI 10.1038/sj.onc.1208093; Bar S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003605; Bar S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000126; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; CORNELIS JJ, 1988, J VIROL, V62, P1679; Di Piazza M, 2007, J VIROL, V81, P4186, DOI 10.1128/JVI.02601-06; Falasca M, 2010, BRIT J CANCER, V102, P104, DOI 10.1038/sj.bjc.6605408; Geletneky K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-99; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HALLAUER C, 1971, ARCH GES VIRUSFORSCH, V35, P80, DOI 10.1007/BF01249755; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/vir.O.18189-O; Hoeflich KP, 2004, INT J BIOCHEM CELL B, V36, P2131, DOI 10.1016/j.biocel.2003.11.018; Kaminskyy V, 2010, J INTERN MED, V267, P473, DOI 10.1111/j.1365-2796.2010.02222.x; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Lachmann S, 2003, J VIROL, V77, P8048, DOI 10.1128/JVI.77.14.8048-8060.2003; Lachmann S, 2008, CELL MICROBIOL, V10, P755, DOI 10.1111/j.1462-5822.2007.01082.x; Li Yuwen, 2010, World J Biol Chem, V1, P239, DOI 10.4331/wjbc.v1.i8.239; Lu ZM, 2010, MOL CANCER RES, V8, P421, DOI 10.1158/1541-7786.MCR-09-0179; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nuesch JPF, 2007, P NATL ACAD SCI USA, V104, P12482, DOI 10.1073/pnas.0705533104; Nuesch JPF, 2014, ADV EXP MED BIOL, V818, P99, DOI 10.1007/978-1-4471-6458-6_5; Nuesch JPF, 2012, CLIN CANCER RES, V18, P3516, DOI 10.1158/1078-0432.CCR-11-2325; Nuesch JPF, 2009, J VIROL, V83, P5854, DOI 10.1128/JVI.00039-09; Nuesch ER, 2005, VIROLOGY, V331, P159, DOI 10.1016/j.virol.2004.10.019; Nuesch JPF, 2003, J VIROL, V77, P433, DOI 10.1128/JVI.77.1.433-442.2003; NUESCH JPF, 1992, VIROLOGY, V191, P406; Nuesch JPF, 1998, J VIROL, V72, P8002; Nuesch JPF, 2006, PARVOVIRUSES, P275; Nuesch JPF, 2006, J VIROL, V80, P4729, DOI 10.1128/JVI.80.10.4729-4739.2006; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Raimondi C, 2011, CURR MED CHEM, V18, P2763, DOI 10.2174/092986711796011238; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shahaf G, 2012, EXP CELL RES, V318, P789, DOI 10.1016/j.yexcr.2012.01.018; Wick MJ, 2002, J BIOL CHEM, V277, P16632, DOI 10.1074/jbc.M112402200; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yu HF, 2011, FRONT BIOSCI-LANDMRK, V16, P1536, DOI 10.2741/3803",40,5,6,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004703,10.1371/journal.ppat.1004703,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900031,25742010.0,"DOAJ Gold, Green Published",,,16/08/2019,6,1,12,3532,682,506,176,2850,2345,27,478,12,0,0,0,5,5,0,,16,0,16,0,0,7,7,5,4,0,0,0,0,0,0,3,1,1,3534,33,0,875,61,0,2847,682,33,0,875,61,0,5,,9,1,0,0,3,0,1,1,0,0,0,16,0,0,75.75,5.178885630498534,1.2392982456140351,0.2392982456140351,1.2729824561403509,1.02718006795017,5.319648093841642
20,J,"Billingsley, JM; Rajakumar, PA; Connole, MA; Salisch, NC; Adnan, S; Kuzmichev, YV; Hong, HS; Reeves, RK; Kang, HJ; Li, WJ; Li, QS; Haase, AT; Johnson, RP",,,,"Billingsley, James M.; Rajakumar, Premeela A.; Connole, Michelle A.; Salisch, Nadine C.; Adnan, Sama; Kuzmichev, Yury V.; Hong, Henoch S.; Reeves, R. Keith; Kang, Hyung-joo; Li, Wenjun; Li, Qingsheng; Haase, Ashley T.; Johnson, R. Paul",,,Characterization of CD8(+) T Cell Differentiation following SIV Delta nef Vaccination by Transcription Factor Expression Profiling,PLOS PATHOGENS,,,English,Article,,,,,,,SIMIAN-IMMUNODEFICIENCY-VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; I MOLECULE MAMU-A-ASTERISK-01; RHESUS MACAQUES; ATTENUATED SIV; PATHOGENIC SIVMAC239; PROTECTIVE IMMUNITY; VAGINAL CHALLENGE; CENTRAL MEMORY; LIVE,"The onset of protective immunity against pathogenic SIV challenge in SIV Delta nef-vaccinated macaques is delayed for 15-20 weeks, a process that is related to qualitative changes in CD8(+) T cell responses induced by SIV Delta nef. As a novel approach to characterize cell differentiation following vaccination, we used multi-target qPCR to measure transcription factor expression in naive and memory subsets of CD8+(+) T cells, and in SIV-specific CD8(+) T cells obtained from SIV Delta nef-vaccinated or wild type SIVmac239-infected macaques. Unsupervised clustering of expression profiles organized naive and memory CD8(+) T cells into groups concordant with cell surface phenotype. Transcription factor expression patterns in SIV-specific CD8(+) T cells in SIV Delta nef-vaccinated animals were distinct from those observed in purified CD8(+) T cell subsets obtained from naive animals, and were intermediate to expression profiles of purified central memory and effector memory T cells. Expression of transcription factors elicited by SIV Delta nef vaccination also varied over time: cells obtained at later time points, temporally associated with greater protection, appeared more central-memory like than cells obtained at earlier time points, which appeared more effector memory-like. Expression of transcription factors associated with effector differentiation, such as ID2 and RUNX3, were decreased over time, while expression of transcription factors associated with quiescence or memory differentiation, such as TCF7, BCOR and EOMES, increased. CD8(+) T cells specific for a more conserved epitope expressed higher levels of TBX21 and BATF, and appeared more effector-like than cells specific for an escaped epitope, consistent with continued activation by replicating vaccine virus. These data suggest transcription factor expression profiling is a novel method that can provide additional data complementary to the analysis of memory cell differentiation based on classical phenotypic markers. Additionally, these data support the hypothesis that ongoing stimulation by SIV Delta nef promotes a distinct protective balance of CD8(+) T cell differentiation and activation states.","[Billingsley, James M.; Rajakumar, Premeela A.; Connole, Michelle A.; Salisch, Nadine C.; Adnan, Sama; Kuzmichev, Yury V.; Hong, Henoch S.; Reeves, R. Keith; Johnson, R. Paul] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Billingsley, James M.; Rajakumar, Premeela A.; Adnan, Sama; Johnson, R. Paul] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Salisch, Nadine C.] Crucell Holland BV, Leiden, Netherlands; [Reeves, R. Keith] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Kang, Hyung-joo; Li, Wenjun] Univ Massachusetts, Med Ctr, Div Prevent & Behav Med, Worcester, MA USA; [Li, Qingsheng] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Johnson, R. Paul] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA","Billingsley, JM (reprint author), Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA.",rpaul.johnson@emory.edu,"Li, Wenjun/F-5634-2015","Li, Wenjun/0000-0001-5335-7386","National Institutes of Health from the Office of Research Infrastructure Programs [AI071306, AI095985, P51 OD011103]","This work was supported by National Institutes of Health grants AI071306, AI095985, and grant P51 OD011103 (formerly RR00168) from the Office of Research Infrastructure Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Baba TW, 1999, NAT MED, V5, P194; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.18637/JSS.V067.I01; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Burwitz BJ, 2011, J VIROL, V85, P3683, DOI 10.1128/JVI.02112-10; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cole KS, 1997, J VIROL, V71, P5069; Connor RI, 1998, J VIROL, V72, P7501; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cromwell MA, 2000, J VIROL, V74, P8762, DOI 10.1128/JVI.74.18.8762-8766.2000; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Curtis MM, 2009, J IMMUNOL, V183, P381, DOI 10.4049/jimmunol.0900939; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Gauduin MC, 1999, P NATL ACAD SCI USA, V96, P14031, DOI 10.1073/pnas.96.24.14031; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Genesca M, 2007, J IMMUNOL, V179, P4732, DOI 10.4049/jimmunol.179.7.4732; Hanke T, 1999, J VIROL, V73, P7524; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Huynh KD, 2000, GENE DEV, V14, P1810; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Johnson RP, 1999, J VIROL, V73, P4952; Johnson RP, 1997, J VIROL, V71, P7711; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1994, J VIROL, V68, P2031; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Lemon J., 2006, R NEWS, V6, P8; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; Ndhlovu ZM, 2013, BLOOD, V121, P801, DOI 10.1182/blood-2012-06-436295; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Neuwirth E., 2011, RCOLORBREWER COLORBR; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; R Core Team, 2014, R LANG ENV STAT COMP; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sasikala-Appukuttan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081623; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Tai TS, 2013, J IMMUNOL, V190, P428, DOI 10.4049/jimmunol.1201361; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Youngblood B, 2012, CURR OPIN HIV AIDS, V7, P50, DOI 10.1097/COH.0b013e32834ddcf2; Zhang SN, 2010, J EXP MED, V207, P1687, DOI 10.1084/jem.20092136; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002",91,5,5,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004740,10.1371/journal.ppat.1004740,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900057,25768938.0,"DOAJ Gold, Green Published",,,16/08/2019,4,0,3,3550,743,570,173,2807,2176,18,613,3,0,1,0,6,6,0,,32,2,32,0,2,6,4,6,5,0,0,0,0,0,0,0,0,1,3590,31,1,122,160,0,2824,751,31,1,122,160,0,15,,0,0,0,0,1,0,0,1,0,0,0,32,0,0,0.75,4.77792732166891,1.2646954043462773,0.26469540434627714,1.3469896686854292,1.0650704225352112,5.0888290713324364
21,J,"Boyce, KJ; McLauchlan, A; Schreider, L; Andrianopoulos, A",,,,"Boyce, Kylie J.; McLauchlan, Alisha; Schreider, Lena; Andrianopoulos, Alex",,,Intracellular Growth Is Dependent on Tyrosine Catabolism in the Dimorphic Fungal Pathogen Penicillium marneffei,PLOS PATHOGENS,,,English,Article,,,,,,,MELANIN-LIKE PIGMENTS; ASPERGILLUS-NIDULANS; CRYPTOCOCCUS-NEOFORMANS; PARACOCCIDIOIDES-BRASILIENSIS; GENE-CLUSTER; IN-VITRO; REGULATORY GENE; DOWN-REGULATION; NITROGEN; INFECTION,"During infection, pathogens must utilise the available nutrient sources in order to grow while simultaneously evading or tolerating the host's defence systems. Amino acids are an important nutritional source for pathogenic fungi and can be assimilated from host proteins to provide both carbon and nitrogen. The hpdA gene of the dimorphic fungus Penicillium marneffei, which encodes an enzyme which catalyses the second step of tyrosine catabolism, was identified as up-regulated in pathogenic yeast cells. As well as enabling the fungus to acquire carbon and nitrogen, tyrosine is also a precursor in the formation of two types of protective melanin; DOPA melanin and pyomelanin. Chemical inhibition of HpdA in P. marneffei inhibits ex vivo yeast cell production suggesting that tyrosine is a key nutrient source during infectious growth. The genes required for tyrosine catabolism, including hpdA, are located in a gene cluster and the expression of these genes is induced in the presence of tyrosine. A gene (hmgR) encoding a Zn(II)2-Cys6 binuclear cluster transcription factor is present within the cluster and is required for tyrosine induced expression and repression in the presence of a preferred nitrogen source. AreA, the GATA-type transcription factor which regulates the global response to limiting nitrogen conditions negatively regulates expression of cluster genes in the absence of tyrosine and is required for nitrogen metabolite repression. Deletion of the tyrosine catabolic genes in the cluster affects growth on tyrosine as either a nitrogen or carbon source and affects pyomelanin, but not DOPA melanin, production. In contrast to other genes of the tyrosine catabolic cluster, deletion of hpdA results in no growth within macrophages. This suggests that the ability to catabolise tyrosine is not required for macrophage infection and that HpdA has an additional novel role to that of tyrosine catabolism and pyomelanin production during growth in host cells.","[Boyce, Kylie J.; Schreider, Lena; Andrianopoulos, Alex] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia; [McLauchlan, Alisha] SA Pathol, South Australian Clin Genet Serv, Adelaide, SA, Australia","Boyce, KJ (reprint author), Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia.",kboyce@unimelb.edu.au,,,"National Health and Medical Research Council of Australia [566926, 1006839]","This work was funded by the National Health and Medical Research Council of Australia https://www.nhmrc.gov.au/ with grants 566926 to AA and 1006839 to AA and KJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ausubel F M, 1994, CURRENT PROTOCOLS MO; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Borneman AR, 2000, MOL MICROBIOL, V38, P1034, DOI 10.1046/j.1365-2958.2000.02202.x; Bugeja HE, 2012, FUNGAL GENET BIOL, V49, P772, DOI 10.1016/j.fgb.2012.08.003; Bugeja HE, 2012, FUNGAL BIOL-UK, V116, P145, DOI 10.1016/j.funbio.2011.10.009; Cove DJ, 1996, DEVELOPMENT, V122, P371; Ferreira MED, 2006, EUKARYOT CELL, V5, P1441, DOI 10.1128/EC.00160-06; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; DIXON DM, 1987, J MED VET MYCOL, V25, P97; Empel J, 2001, MOL GENET GENOMICS, V266, P591, DOI 10.1007/s004380100575; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Ferguson AA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004020; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FERNANDEZCANON JM, 1995, P NATL ACAD SCI USA, V92, P9132, DOI 10.1073/pnas.92.20.9132; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fu L, 2010, HEPATOLOGY, V51, P1624, DOI 10.1002/hep.23540; Gomez BL, 2001, INFECT IMMUN, V69, P5760, DOI 10.1128/IAI.69.9.5760-5767.2001; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; HAWKER KL, 1992, MOL GEN GENET, V231, P485, DOI 10.1007/BF00292720; HUFFNAGLE GB, 1995, J IMMUNOL, V155, P3507; Hwang L, 2003, MOL BIOL CELL, V14, P2314, DOI 10.1091/mbc.E03-01-0027; HYNES MJ, 1975, AUST J BIOL SCI, V28, P301, DOI 10.1071/BI9750301; Jahn B, 1997, INFECT IMMUN, V65, P5110; Jahn B, 2000, INFECT IMMUN, V68, P3736, DOI 10.1128/IAI.68.6.3736-3739.2000; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Keller S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026604; Keon J, 1998, FEMS MICROBIOL LETT, V161, P337, DOI 10.1016/S0378-1097(98)00092-5; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lock EA, 1998, J INHERIT METAB DIS, V21, P498, DOI 10.1023/A:1005458703363; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Macios M, 2012, FUNGAL GENET BIOL, V49, P189, DOI 10.1016/j.fgb.2012.01.004; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; MILLER BL, 1987, MOL CELL BIOL, V7, P427, DOI 10.1128/MCB.7.1.427; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Oestrelcher N, 2008, FUNGAL GENET BIOL, V45, P760, DOI 10.1016/j.fgb.2007.10.015; Pasricha S, 2013, G3-GENES GENOM GENET, V3, P1997, DOI 10.1534/g3.113.006809; Penalva MA, 2001, FUNGAL GENET BIOL, V34, P1, DOI 10.1006/fgbi.2001.1284; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Sambrook J, 1989, MOL CLONING LAB MANU; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; SHARMA KK, 1985, CURR GENET, V9, P299, DOI 10.1007/BF00419959; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; WANG YL, 1994, INFECT IMMUN, V62, P3004; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0",52,12,13,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004790,10.1371/journal.ppat.1004790,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900085,25812137.0,"DOAJ Gold, Green Published",,,16/08/2019,12,1,17,3835,731,486,245,3104,2416,203,485,17,0,0,0,12,12,2,,26,0,26,0,0,13,13,11,10,0,0,0,0,0,0,0,1,3,3887,51,0,147,61,1,3124,745,51,0,147,61,1,18,,0,0,0,0,4,0,1,1,0,0,0,26,0,0,1.5,5.24623803009576,1.2355025773195876,0.23550257731958762,1.2883376288659794,1.0427640156453715,5.470588235294118
22,J,"Burda, PC; Roelli, MA; Schaffner, M; Khan, SM; Janse, CJ; Heussler, VT",,,,"Burda, Paul-Christian; Roelli, Matthias A.; Schaffner, Marco; Khan, Shahid M.; Janse, Chris J.; Heussler, Volker T.",,,A Plasmodium Phospholipase Is Involved in Disruption of the Liver Stage Parasitophorous Vacuole Membrane,PLOS PATHOGENS,,,English,Article,,,,,,,PERFORIN-LIKE PROTEIN; MALARIA PARASITE; LISTERIA-MONOCYTOGENES; HOST HEPATOCYTES; CELL-MEMBRANE; EGRESS; BERGHEI; EXPRESSION; ERYTHROCYTES; TRANSMISSION,"The coordinated exit of intracellular pathogens from host cells is a process critical to the success and spread of an infection. While phospholipases have been shown to play important roles in bacteria host cell egress and virulence, their role in the release of intracellular eukaryotic parasites is largely unknown. We examined a malaria parasite protein with phospholipase activity and found it to be involved in hepatocyte egress. In hepatocytes, Plasmodium parasites are surrounded by a parasitophorous vacuole membrane (PVM), which must be disrupted before parasites are released into the blood. However, on a molecular basis, little is known about how the PVM is ruptured. We show that Plasmodium berghei phospholipase, PbPL, localizes to the PVM in infected hepatocytes. We provide evidence that parasites lacking PbPL undergo completely normal liver stage development until merozoites are produced but have a defect in egress from host hepatocytes. To investigate this further, we established a live-cell imaging-based assay, which enabled us to study the temporal dynamics of PVM rupture on a quantitative basis. Using this assay we could show that PbPL-deficient parasites exhibit impaired PVM rupture, resulting in delayed parasite egress. A wild-type phenotype could be re-established by gene complementation, demonstrating the specificity of the PbPL deletion phenotype. In conclusion, we have identified for the first time a Plasmodium phospholipase that is important for PVM rupture and in turn for parasite exit from the infected hepatocyte and therefore established a key role of a parasite phospholipase in egress.","[Burda, Paul-Christian; Roelli, Matthias A.; Schaffner, Marco; Heussler, Volker T.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Burda, Paul-Christian] Univ Bern, Grad Sch Cellular Biol, Bern, Switzerland; [Khan, Shahid M.; Janse, Chris J.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands","Burda, PC (reprint author), Univ Bern, Inst Cell Biol, Bern, Switzerland.",burda@izb.unibe.ch,"Heussler, Volker/H-9322-2019; Heussler, Volker/M-9336-2019","Heussler, Volker/0000-0001-8028-9825; Janse, Chris J/0000-0002-6410-6205; Burda, Paul-Christian/0000-0003-0461-4352; Khan, Shahid/0000-0002-0533-4670",Swiss National Foundation [310030_140691/1]; EVIMalaR EU consortium,"This work was supported by grants from the Swiss National Foundation to VTH (grant 310030_140691/1) and the EVIMalaR EU consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Agarwal S, 2013, CELL MICROBIOL, V15, P910, DOI 10.1111/cmi.12086; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; Blackman MJ, 2013, CURR OPIN MICROBIOL, V16, P459, DOI 10.1016/j.mib.2013.04.008; Carey AF, 2014, CELL MICROBIOL, V16, P768, DOI 10.1111/cmi.12289; Deligianni E, 2013, CELL MICROBIOL, V15, P1438, DOI 10.1111/cmi.12131; Delves MJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-35; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; Eickel N, 2013, AUTOPHAGY, V9, P568, DOI 10.4161/auto.23689; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; Friedrich N, 2012, MICROBIOL MOL BIOL R, V76, P707, DOI 10.1128/MMBR.00024-12; Garg S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2725; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; Goebel W, 2000, CURR OPIN MICROBIOL, V3, P49, DOI 10.1016/S1369-5274(99)00050-8; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Graewe Stefanie, 2009, Biotechnology Journal, V4, P895, DOI 10.1002/biot.200900035; Helm S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013653; Hybiske K, 2008, NAT REV MICROBIOL, V6, P99, DOI 10.1038/nrmicro1821; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquis H, 1997, J CELL BIOL, V137, P1381, DOI 10.1083/jcb.137.6.1381; Noronha FSM, 2000, INFECT IMMUN, V68, P4578, DOI 10.1128/IAI.68.8.4578-4584.2000; Orr RY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-103; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Raabe A, 2011, EXP PARASITOL, V129, P75, DOI 10.1016/j.exppara.2011.05.023; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; Ramakrishnan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036376; Rosenstein R, 2000, BIOCHIMIE, V82, P1005, DOI 10.1016/S0300-9084(00)01180-9; Ruecker A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400820; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SMITH GA, 1995, INFECT IMMUN, V63, P4231; Spielmann T, 2012, INT J MED MICROBIOL, V302, P179, DOI 10.1016/j.ijmm.2012.07.011; Stallmach R, 2015, MOL MICROBIOL; Stanway RR, 2009, NAT PROTOC, V4, P1433, DOI 10.1038/nprot.2009.172; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Suarez C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003811; Tawk L, 2013, J BIOL CHEM, V288, P33336, DOI 10.1074/jbc.M113.513234; WARD GE, 1993, J CELL SCI, V106, P237; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005; Wirth CC, 2014, CELL MICROBIOL, V16, P709, DOI 10.1111/cmi.12288; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049",52,27,27,1,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004760,10.1371/journal.ppat.1004760,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900070,25786000.0,"DOAJ Gold, Green Published",,,16/08/2019,27,87,62,5938,1061,823,238,4877,3901,25,951,62,0,3,0,29,29,1,,146,3,75,0,3,29,29,26,25,0,0,0,0,0,0,0,86,2,5945,76,0,93,93,1,4868,1061,76,0,93,93,1,16,,0,0,0,0,2,0,2,1,0,0,1,75,0,0,1.5,5.5966069745523095,1.2175517736313308,0.21755177363133074,1.2536395324994873,1.0296396092960594,5.76248821866164
23,J,"Carpentier, DCJ; Gao, WND; Ewles, H; Morgan, GW; Smith, GL",,,,"Carpentier, David C. J.; Gao, William N. D.; Ewles, Helen; Morgan, Gareth W.; Smith, Geoffrey L.",,,Vaccinia Virus Protein Complex F12/E2 Interacts with Kinesin Light Chain Isoform 2 to Engage the Kinesin-1 Motor Complex,PLOS PATHOGENS,,,English,Article,,,,,,,ACTIN-BASED MOTILITY; INTRACELLULAR ENVELOPED VIRIONS; SUPERINFECTING VIRIONS; EXTRACELLULAR VIRUS; VIRULENCE FACTOR; MATURE VIRIONS; CELL-SURFACE; A36R PROTEIN; F12L PROTEIN; HEAVY-CHAIN,"During vaccinia virus morphogenesis, intracellular mature virus (IMV) particles are wrapped by a double lipid bilayer to form triple enveloped virions called intracellular enveloped virus (IEV). IEV are then transported to the cell surface where the outer IEV membrane fuses with the cell membrane to expose a double enveloped virion outside the cell. The F12, E2 and A36 proteins are involved in transport of IEVs to the cell surface. Deletion of the F12L or E2L genes causes a severe inhibition of IEV transport and a tiny plaque size. Deletion of the A36R gene leads to a smaller reduction in plaque size and less severe inhibition of IEV egress. The A36 protein is present in the outer membrane of IEVs, and over-expressed fragments of this protein interact with kinesin light chain (KLC). However, no interaction of F12 or E2 with the kinesin complex has been reported hitherto. Here the F12/E2 complex is shown to associate with kinesin-1 through an interaction of E2 with the C-terminal tail of KLC isoform 2, which varies considerably between different KLC isoforms. siRNA-mediated knockdown of KLC isoform 1 increased IEV transport to the cell surface and virus plaque size, suggesting interaction with KLC isoform 1 is somehow inhibitory of IEV transport. In contrast, knockdown of KLC isoform 2 did not affect IEV egress or plaque formation, indicating redundancy in virion egress pathways. Lastly, the enhancement of plaque size resulting from loss of KLC isoform 1 was abrogated by removal of KLC isoforms 1 and 2 simultaneously. These observations suggest redundancy in the mechanisms used for IEV egress, with involvement of KLC isoforms 1 and 2, and provide evidence of interaction of F12/E2 complex with the kinesin-1 complex.","[Carpentier, David C. J.; Gao, William N. D.; Ewles, Helen; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Morgan, Gareth W.] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England","Carpentier, DCJ (reprint author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.",gls37@cam.ac.uk,,"Smith, Geoffrey L/0000-0002-3730-9955; Carpentier, David/0000-0002-8172-9121","Medical Research Council, UK [G1000207]; Wellcome Trust [090315]; Medical Research Council [G1000207]","This work was supported by grant G1000207 from the Medical Research Council, UK and grant 090315 from The Wellcome Trust. GLS is a Wellcome Trust Principal research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","BLASCO R, 1991, J VIROL, V65, P5910; Brum LM, 2003, VIROLOGY, V306, P289, DOI 10.1016/S0042-6822(02)00017-X; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Carter GC, 2003, J GEN VIROL, V84, P2443, DOI 10.1099/vir.0.19271-0; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cudmore S, 1996, J CELL SCI, V109, P1739; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; DALES S, 1968, VIROLOGY, V35, P564, DOI 10.1016/0042-6822(68)90286-9; Doceul V, 2012, J GEN VIROL, V93, P1876, DOI 10.1099/vir.0.043943-0; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Dodding MP, 2009, CELL MICROBIOL, V11, P808, DOI 10.1111/j.1462-5822.2009.01296.x; Domi A, 2008, J VIROL, V82, P4215, DOI 10.1128/JVI.00037-08; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; FALKNER FG, 1990, J VIROL, V64, P3108; Fenner F, 1988, SMALLPOX ITS ERADICA; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Gan K.J., 2014, BIOESSAYS; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Herrero-Martinez E, 2005, J GEN VIROL, V86, P2961, DOI 10.1099/vir.0.81660-0; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Hollinshead M, 1999, J VIROL, V73, P1503; Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002; Ichimura T, 2002, BIOCHEMISTRY-US, V41, P5566, DOI 10.1021/bi015946f; Johnson C, 2011, MOL CELL PROTEOMICS, V10, pM110; Johnston SC, 2009, J VIROL, V83, P1708, DOI 10.1128/JVI.01364-08; Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Krauss O, 2002, J GEN VIROL, V83, P2347, DOI 10.1099/0022-1317-83-10-2347; Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103; Law Mansun, 2004, Methods Mol Biol, V269, P187; Liu L, 2014, VIRUSES-BASEL, V6, P3787, DOI 10.3390/v6103787; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Manser C, 2012, ONCOGENE, V31, P2773, DOI 10.1038/onc.2011.437; McCart AE, 2003, TRAFFIC, V4, P576, DOI 10.1034/j.1600-0854.2003.00113.x; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morgan GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000785; Morihara T, 2014, P NATL ACAD SCI USA, V111, P2638, DOI 10.1073/pnas.1307345111; Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037; Moss B., 2013, FIELDS VIROLOGY; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Pernigo S, 2013, SCIENCE, V340, P356, DOI 10.1126/science.1234264; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Sanderson CM, 2000, J GEN VIROL, V81, P47, DOI 10.1099/0022-1317-81-1-47; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; SCHMELZ M, 1994, J VIROL, V68, P130; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/vir.0.18733-0; Stenoien DL, 1997, MOL BIOL CELL, V8, P675; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; van Eijl H, 2002, J GEN VIROL, V83, P195, DOI 10.1099/0022-1317-83-1-195; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Vanderplasschen A, 1998, J GEN VIROL, V79, P877, DOI 10.1099/0022-1317-79-4-877; Ward BM, 2005, J VIROL, V79, P4755, DOI 10.1128/JVI.79.8.4755-4763.2005; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001; WOLFFE EJ, 1993, J VIROL, V67, P4732; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Yutin N, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-22; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943",76,6,8,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004723,10.1371/journal.ppat.1004723,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900044,25760349.0,"DOAJ Gold, Green Published",,,16/08/2019,6,1,14,3006,539,429,110,2467,2041,20,406,14,1,0,0,6,6,0,,0,1,0,0,1,6,6,6,5,0,0,0,0,0,0,0,0,1,3034,51,0,229,111,0,2479,547,51,0,229,111,0,8,,0,0,0,0,7,0,0,1,0,0,0,15,0,0,3.0,5.5769944341372915,1.2184839886501824,0.2184839886501824,1.2955006080259424,1.0632069194943445,5.929499072356215
24,J,"Creek, DJ; Mazet, M; Achcar, F; Anderson, J; Kim, DH; Kamour, R; Morand, P; Millerioux, Y; Biran, M; Kerkhoven, EJ; Chokkathukalam, A; Weidt, SK; Burgess, KEV; Breitling, R; Watson, DG; Bringaud, F; Barrett, MP",,,,"Creek, Darren J.; Mazet, Muriel; Achcar, Fiona; Anderson, Jana; Kim, Dong-Hyun; Kamour, Ruwida; Morand, Pauline; Millerioux, Yoann; Biran, Marc; Kerkhoven, Eduard J.; Chokkathukalam, Achuthanunni; Weidt, Stefan K.; Burgess, Karl E. V.; Breitling, Rainer; Watson, David G.; Bringaud, Frederic; Barrett, Michael P.",,,Probing the Metabolic Network in Bloodstream-Form Trypanosoma brucei Using Untargeted Metabolomics with Stable Isotope Labelled Glucose,PLOS PATHOGENS,,,English,Article,,,,,,,TRICARBOXYLIC-ACID CYCLE; MASS-SPECTROMETRY DATA; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL METABOLISM; AFRICAN TRYPANOSOMES; LEISHMANIA-MEXICANA; PROLINE METABOLISM; GLYCOLYTIC-ENZYMES; LIPID BIOSYNTHESIS,"Metabolomics coupled with heavy-atom isotope-labelled glucose has been used to probe the metabolic pathways active in cultured bloodstream form trypomastigotes of Trypanosoma brucei, a parasite responsible for human African trypanosomiasis. Glucose enters many branches of metabolism beyond glycolysis, which has been widely held to be the sole route of glucose metabolism. Whilst pyruvate is the major end-product of glucose catabolism, its transamination product, alanine, is also produced in significant quantities. The oxidative branch of the pentose phosphate pathway is operative, although the non-oxidative branch is not. Ribose 5-phosphate generated through this pathway distributes widely into nucleotide synthesis and other branches of metabolism. Acetate, derived from glucose, is found associated with a range of acetylated amino acids and, to a lesser extent, fatty acids; while labelled glycerol is found in many glycerophospholipids. Glucose also enters inositol and several sugar nucleotides that serve as precursors to macromolecule biosynthesis. Although a Krebs cycle is not operative, malate, fumarate and succinate, primarily labelled in three carbons, were present, indicating an origin from phosphoenolpyruvate via oxaloacetate. Interestingly, the enzyme responsible for conversion of phosphoenolpyruvate to oxaloacetate, phosphoenolpyruvate carboxykinase, was shown to be essential to the bloodstream form trypanosomes, as demonstrated by the lethal phenotype induced by RNAi-mediated downregulation of its expression. In addition, glucose derivatives enter pyrimidine biosynthesis via oxaloacetate as a precursor to aspartate and orotate.","[Creek, Darren J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville, Vic, Australia; [Mazet, Muriel; Morand, Pauline; Millerioux, Yoann; Biran, Marc; Bringaud, Frederic] Univ Bordeaux, CNRS, UMR 5536, Ctr Resonance Magnet Syst Biol, Bordeaux, France; [Achcar, Fiona; Barrett, Michael P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Anderson, Jana] Univ Glasgow, Dept Publ Hlth, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Kim, Dong-Hyun] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England; [Kamour, Ruwida] Univ Tripoli, Fac Pharm, Dept Med & Pharmaceut Chem, Tripoli, Libya; [Kerkhoven, Eduard J.] Chalmers, Dept Chem & Biol Engn, Syst & Synthet Biol, S-41296 Gothenburg, Sweden; [Chokkathukalam, Achuthanunni; Weidt, Stefan K.; Burgess, Karl E. V.; Barrett, Michael P.] Univ Glasgow, Coll Med Vet & Life Sci, Wolfson Wohl Canc Res Ctr, Glasgow Poly, Glasgow, Lanark, Scotland; [Breitling, Rainer] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Watson, David G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland","Creek, DJ (reprint author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville Campus, Parkville, Vic, Australia.",Michael.Barrett@glasgow.ac.uk,"Kerkhoven, Eduard/P-2469-2019; Kerkhoven, Eduard/H-2072-2014","Kerkhoven, Eduard/0000-0002-3593-5792; Kerkhoven, Eduard/0000-0002-3593-5792; Barrett, Mike/0000-0001-9447-3519; Achcar, Fiona/0000-0001-8792-7615; Creek, Darren/0000-0001-7497-7082; MILLERIOUX, Yoann/0000-0003-3782-3118; Burgess, Karl/0000-0002-0881-715X; Breitling, Rainer/0000-0001-7173-0922; Kim, Dong-Hyun/0000-0002-3689-2130",Australian NHMRC fellowship; SysMO SilicoTryp Project; ParaMet PhD programme of Marie Curie Initial Training Network; BBSRC/ANR Systryp Project; Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; Laboratoire d'Excellence (LabEx) ParaFrap [ANR-11-LABX-0024]; Agence Nationale de la Recherche (ANR) through grant ACETOTRYP of the ANR-BLANC;  [085349]; Biotechnology and Biological Sciences Research Council [BB/I004599/1],"This work was supported by an Australian NHMRC fellowship awarded to DJC, the SysMO SilicoTryp Project (MPB, FA, DHK, RB), the ParaMet PhD programme of Marie Curie Initial Training Network (MPB and FB). EK was a SULSA PhD student. JA, DGW, FB and RK were supported by the BBSRC/ANR Systryp Project. MPB is part of the Wellcome Trust Centre for Molecular Parasitology (supported by grant 085349). FB's group is also supported by the Centre National de la Recherche Scientifique (CNRS), the Universite de Bordeaux, the Laboratoire d'Excellence (LabEx) ParaFrap ANR-11-LABX-0024, and the Agence Nationale de la Recherche (ANR) through grant ACETOTRYP of the ANR-BLANC-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Achcar F, 2013, FEBS J, V280, P4640, DOI 10.1111/febs.12436; Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Ali JAM, 2013, MOL PHARMACOL, V83, P439, DOI 10.1124/mol.112.082321; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aranda A, 2006, INT J PARASITOL, V36, P295, DOI 10.1016/j.ijpara.2005.09.013; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; BARRETT MP, 1993, MOL BIOCHEM PARASIT, V57, P89, DOI 10.1016/0166-6851(93)90247-U; Berger BJ, 1996, P NATL ACAD SCI USA, V93, P4126, DOI 10.1073/pnas.93.9.4126; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; BOWES AE, 1993, J BIOL CHEM, V268, P13885; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Breitling R, 2006, TRENDS BIOTECHNOL, V24, P543, DOI 10.1016/j.tibtech.2006.10.006; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BROWN RC, 1972, T ROY SOC TROP MED H, V66, P336, DOI 10.1016/0035-9203(72)90215-5; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; BURSELL E, 1963, J INSECT PHYSIOL, V9, P439, DOI 10.1016/0022-1910(63)90054-4; Chokkathukalam A, 2013, BIOINFORMATICS, V29, P281, DOI 10.1093/bioinformatics/bts674; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Creek DJ, 2012, ANAL CHEM, V84, P8442, DOI [10.1021/ac3018795, 10.1021/ac3018295]; Creek DJ, 2012, BIOINFORMATICS, V28, P1048, DOI 10.1093/bioinformatics/bts069; Creek DJ, 2012, MOL BIOCHEM PARASIT, V181, P73, DOI 10.1016/j.molbiopara.2011.10.003; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; CRONIN CN, 1989, FEBS LETT, V244, P26, DOI 10.1016/0014-5793(89)81154-8; DAVIES MJ, 1983, PARASITOLOGY, V87, P211, DOI 10.1017/S0031182000052574; Denise H, 1999, EUR J BIOCHEM, V259, P339, DOI 10.1046/j.1432-1327.1999.00048.x; DURIEUX PO, 1991, MOL BIOCHEM PARASIT, V45, P19, DOI 10.1016/0166-6851(91)90023-Y; FISH WR, 1982, BIOCHIM BIOPHYS ACTA, V719, P223, DOI 10.1016/0304-4165(82)90092-7; FULTON JD, 1945, BIOCHEM J, V39, P317, DOI 10.1042/bj0390317; Gonzalez-Salgado A, 2012, J BIOL CHEM, V287, P13313, DOI 10.1074/jbc.M112.344812; GRANT PT, 1957, BIOCHEM J, V66, P242, DOI 10.1042/bj0660242; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; Gualdron-Lopez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034530; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Haanstra JR, 2012, INT J PARASITOL, V42, P667, DOI 10.1016/j.ijpara.2012.04.009; HALL JE, 1988, COMP BIOCHEM PHYS B, V89, P679, DOI 10.1016/0305-0491(88)90308-2; Hannaert V, 2003, P NATL ACAD SCI USA, V100, P1067, DOI 10.1073/pnas.0335769100; Harlow E., 1988, ANTIBODIES LAB MANUA; HART DT, 1984, MOL BIOCHEM PARASIT, V12, P25, DOI 10.1016/0166-6851(84)90041-0; Hasne MP, 2000, MOL BIOCHEM PARASIT, V111, P299, DOI 10.1016/S0166-6851(00)00321-2; Hasne MP, 2001, AMINO ACID TRANSPORT; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kerkhoven EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003371; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; MACKENZIE NE, 1982, EUR J BIOCHEM, V121, P657, DOI 10.1111/j.1432-1033.1982.tb05836.x; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Marino K, 2010, GLYCOBIOLOGY, V20, P1619, DOI 10.1093/glycob/cwq115; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; Millerioux Y, 2013, MOL MICROBIOL, V90, P114, DOI 10.1111/mmi.12351; Millerioux Y, 2012, J BIOL CHEM, V287, P17186, DOI 10.1074/jbc.M112.355404; MONTGOMERY CM, 1956, J BIOL CHEM, V221, P359; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P29, DOI 10.1111/j.1432-1033.1977.tb11567.x; Parkin DW, 1996, J BIOL CHEM, V271, P21713, DOI 10.1074/jbc.271.36.21713; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; RYLEY JF, 1962, BIOCHEM J, V85, P211, DOI 10.1042/bj0850211; Sambrook J, 1989, MOLECULAR CLONING A, V7, DOI 10.1016/j.ijantimicag.2016.12.01810.1016/j.ijantimicag.2016.12.018; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; Stoffel SA, 2011, MOL BIOCHEM PARASIT, V179, P1, DOI 10.1016/j.molbiopara.2011.04.006; Storm J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003876; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200",82,48,48,1,35,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004689,10.1371/journal.ppat.1004689,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900021,25775470.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,56,46,101,7505,1592,1265,327,5913,4679,43,1191,101,3,0,0,50,50,1,,257,5,133,0,5,56,56,55,25,0,0,0,0,0,0,0,43,11,7530,157,0,358,226,1,5878,1592,157,0,358,226,1,60,,0,0,0,0,16,0,0,1,0,0,0,134,0,0,9.9,4.714195979899498,1.2692372738034838,0.26923727380348383,1.3382377811601556,1.0543637574950033,4.9704773869346734
25,J,"de Fabritus, L; Nougairede, A; Aubry, F; Gould, EA; de Lamballerie, X",,,,"de Fabritus, Lauriane; Nougairede, Antoine; Aubry, Fabien; Gould, Ernest A.; de Lamballerie, Xavier",,,Attenuation of Tick-Borne Encephalitis Virus Using Large-Scale Random Codon Reencoding,PLOS PATHOGENS,,,English,Article,,,,,,,FLAVIVIRUS VACCINES; OSHIMA STRAIN; CAPSID REGION; CELL-CULTURE; PAIR BIAS; WEST-NILE; INFECTION; GENOME; DEOPTIMIZATION; USAGE,"Large-scale codon re-encoding (i.e. introduction of a large number of synonymous mutations) is a novel method of generating attenuated viruses. Here, it was applied to the pathogenic flavivirus, tick-borne encephalitis virus (TBEV) which causes febrile illness and encephalitis in humans in forested regions of Europe and Asia. Using an infectious clone of the Oshima 5-10 strain (""wild-type virus""), a cassette of 1.4kb located in the NS5 coding region, was modified by randomly introducing 273 synonymous mutations (""re-encoded virus""). Whilst the in cellulo replicative fitness of the re-encoded virus was only slightly reduced, the re-encoded virus displayed an attenuated phenotype in a laboratory mouse model of non-lethal encephalitis. Following intra-peritoneal inoculation of either 2.10(5) or 2.10(6) TCID50 of virus, the frequency of viraemia, neurovirulence (measured using weight loss and appearance of symptoms) and neuroinvasiveness (detection of virus in the brain) were significantly decreased when compared with the wild-type virus. Mice infected by wildtype or re-encoded viruses produced comparable amounts of neutralising antibodies and results of challenge experiments demonstrated that mice previously infected with the re-encoded virus were protected against subsequent infection by the wild-type virus. This constitutes evidence that a mammalian species can be protected against infection by a virulent wild-type positive-stranded RNA virus following immunisation with a derived randomly reencoded strain. Our results demonstrate that random codon re-encoding is potentially a simple and effective method of generating live-attenuated vaccine candidates against pathogenic flaviviruses.","[de Fabritus, Lauriane; Nougairede, Antoine; Aubry, Fabien; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France; [Nougairede, Antoine; de Lamballerie, Xavier] Inst Hosp Univ Mediterranee Infect, Marseille, France","de Fabritus, L (reprint author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France.",la.defabritus@gmail.com,,"de Fabritus, Lauriane/0000-0003-0668-4629",project European Virus Archive (EVA) (FP7 CAPACITIES Project) [GA 22829],"This work was supported by the project European Virus Archive (EVA) (FP7 CAPACITIES Project GA 22829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bakhvalova VN, 2006, VECTOR-BORNE ZOONOT, V6, P32, DOI 10.1089/vbz.2006.6.32; Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262; Bull JJ, 2012, MOL BIOL EVOL, V29, P2997, DOI 10.1093/molbev/mss119; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Coffin JM, 2008, NEW ENGL J MED, V359, P2283, DOI 10.1056/NEJMcibr0805820; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Goto A, 2003, VACCINE, V21, P4043, DOI 10.1021/S0264(03)00269-X; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; Gubler DJ, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P1; Hayasaka D, 2004, J GEN VIROL, V85, P1007, DOI 10.1099/vir.0.19668-0; Hayasaka D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071643; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Kitchener S, 2004, VACCINE, V22, P2103, DOI 10.1016/j.vaccine.2004.01.026; Kollaritsch H, 2011, VACCINE, V29, P4556, DOI 10.1016/j.vaccine.2011.04.061; Korenberg EI, 1999, ZBL BAKT-INT J MED M, V289, P525; KOZUCH O, 1967, B WORLD HEALTH ORGAN, VS 36, P61; Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111; Lehrer Axel T, 2011, J Bioterror Biodef, V2011, P3; Lundkvist A., 2011, EURO SURVEILL, V16; Martrus G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-78; Meng J, 2014, MBIO, V5, DOI 10.1128/mBio.01704-14; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Ni YY, 2014, VIROLOGY, V450, P132, DOI 10.1016/j.virol.2013.12.009; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172; Peden J, 1997, CODONW V1 3; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROUX L, 1991, ADV VIRUS RES, V40, P181; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Suss J., 2008, EURO SURVEILL, V13; Takashima I, 1997, J CLIN MICROBIOL, V35, P1943; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tigabu B, 2009, J MED VIROL, V81, P1261, DOI 10.1002/jmv.21524; Tun MMN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05344; WAGNER RR, 1960, BACTERIOL REV, V24, P151; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C; Zhou JH, 2010, VET RES COMMUN, V34, P393, DOI 10.1007/s11259-010-9359-4",56,16,16,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004738,10.1371/journal.ppat.1004738,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900055,25734338.0,"DOAJ Gold, Green Published",,,16/08/2019,14,8,13,3419,776,555,221,2643,2039,19,585,13,0,0,0,16,16,0,,29,0,15,0,0,20,17,20,10,0,0,0,0,0,0,0,8,1,3445,18,0,79,55,2,2633,776,18,0,79,55,2,36,,0,0,0,0,4,0,2,1,0,0,0,25,0,0,6.0,4.405927835051546,1.2936057510404844,0.2936057510404843,1.331063185773742,1.0289558350394852,4.533505154639175
26,J,"Decker, R; Burdelski, C; Zobiak, M; Buttner, H; Franke, G; Christner, M; Sass, K; Zobiak, B; Henke, HA; Horswill, AR; Bischoff, M; Bur, S; Hartmann, T; Schaeffer, CR; Fey, PD; Rohde, H",,,,"Decker, Rahel; Burdelski, Christoph; Zobiak, Melanie; Buettner, Henning; Franke, Gefion; Christner, Martin; Sass, Katharina; Zobiak, Bernd; Henke, Hanae A.; Horswill, Alexander R.; Bischoff, Markus; Bur, Stephanie; Hartmann, Torsten; Schaeffer, Carolyn R.; Fey, Paul D.; Rohde, Holger",,,An 18 kDa Scaffold Protein Is Critical for Staphylococcus epidermidis Biofilm Formation,PLOS PATHOGENS,,,English,Article,,,,,,,POLYSACCHARIDE INTERCELLULAR ADHESIN; ACCUMULATION-ASSOCIATED PROTEIN; BLOOD-STREAM INFECTIONS; FOREIGN-BODY INFECTION; BACILLUS-SUBTILIS; JOINT INFECTIONS; UNITED-STATES; RT-PCR; MODEL; AUREUS,"Virulence of the nosocomial pathogen Staphylococcus epidermidis is crucially linked to formation of adherent biofilms on artificial surfaces. Biofilm assembly is significantly fostered by production of a bacteria derived extracellular matrix. However, the matrix composition, spatial organization, and relevance of specific molecular interactions for integration of bacterial cells into the multilayered biofilm community are not fully understood. Here we report on the function of novel 18 kDa Small basic protein (Sbp) that was isolated from S. epidermidis biofilm matrix preparations by an affinity chromatographic approach. Sbp accumulates within the biofilm matrix, being preferentially deposited at the biofilm-substratum interface. Analysis of Sbp-negative S. epidermidis mutants demonstrated the importance of Sbp for sustained colonization of abiotic surfaces, but also epithelial cells. In addition, Sbp promotes assembly of S. epidermidis cell aggregates and establishment of multilayered biofilms by influencing polysaccharide intercellular-adhesin (PIA) and accumulation associated protein (Aap) mediated intercellular aggregation. While inactivation of Sbp indirectly resulted in reduced PIA-synthesis and biofilm formation, Sbp serves as an essential ligand during Aap domain-B mediated biofilm accumulation. Our data support the conclusion that Sbp serves as an S. epidermidis biofilm scaffold protein that significantly contributes to key steps of surface colonization. Sbp-negative S. epidermidis mutants showed no attenuated virulence in a mouse catheter infection model. Nevertheless, the high prevalence of sbp in commensal and invasive S. epidermidis populations suggests that Sbp plays a significant role as a co-factor during both multi-factorial commensal colonization and infection of artificial surfaces.","[Decker, Rahel; Burdelski, Christoph; Zobiak, Melanie; Buettner, Henning; Franke, Gefion; Christner, Martin; Sass, Katharina; Henke, Hanae A.; Rohde, Holger] Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany; [Zobiak, Bernd] Univ Klinikum Hamburg Eppendorf, UKE Microscopy Imaging Facil, Hamburg, Germany; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Bischoff, Markus; Bur, Stephanie; Hartmann, Torsten] Univ Klinikum Saarlandes, Inst Med Mikrobiol & Hyg, Homburg, Germany; [Schaeffer, Carolyn R.; Fey, Paul D.] Univ Nebraska Med Ctr, Ctr Staphylococcal Res, Dept Pathol & Microbiol, Omaha, NE USA","Decker, R (reprint author), Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany.",rohde@uke.uni-hamburg.de,"Bischoff, Markus/D-2130-2014","Bischoff, Markus/0000-0001-6734-2732","Deutsche Forschungsgemeinschaft [Ro2413/3-1, Bi1350/1-1]; Bundesministerium fur Bildung und Forschung [0315587C]","This work was supported by the Deutsche Forschungsgemeinschaft http://www.dfg.de/; grants Ro2413/3-1, given to H.R.; Bi1350/1-1, given to M.B.) and the Bundesministerium fur Bildung und Forschung http://www.genomik-transfer.de/; grant 0315587C, given to H.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; Amini S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000432; Ammerlaan HSM, 2013, CLIN INFECT DIS, V56, P798, DOI 10.1093/cid/cis1006; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Bur S, 2013, J INVEST DERMATOL, V133, P2004, DOI 10.1038/jid.2013.87; Chokr A, 2007, MICROB PATHOGENESIS, V42, P94, DOI 10.1016/j.micpath.2006.09.001; Christner M, 2012, MOL MICROBIOL, V86, P394, DOI 10.1111/j.1365-2958.2012.08203.x; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foster CB, 2011, JAMA-J AM MED ASSOC, V305, P1480, DOI 10.1001/jama.2011.449; Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7; Franke GC, 2007, J MICROBIOL METH, V71, P123, DOI 10.1016/j.mimet.2007.08.015; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Knobloch JKM, 2005, ANTIMICROB AGENTS CH, V49, P1216, DOI 10.1128/AAC.49.3.1216-1219.2005; Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004; Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015; MACK D, 1994, INFECT IMMUN, V62, P3244; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MACK D, 1992, INFECT IMMUN, V60, P2048; Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8; Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000; MACK D, 2006, BIOFILMS INFECT ANTI, P109; Mack D, 2009, TOPICS IN CURRENT CH; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Malone CL, 2009, J MICROBIOL METHODS; Olson ME, 2014, J BACTERIOL, VJB-14; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Rupp ME, 1999, INFECT IMMUN, V67, P2656; Rupp ME, 1999, INFECT IMMUN, V67, P2627; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Schaeffer CR, 2015, INFECT IMMUN, V83, P214, DOI 10.1128/IAI.02177-14; Schommer N.N., 2011, INFECT IMMUN; Sturenburg E, 2002, INT J MED MICROBIOL, V291, P649, DOI 10.1078/1438-4221-00175; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; Ziebuhr W, 1997, INFECT IMMUN, V65, P890; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181",59,16,17,0,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004735,10.1371/journal.ppat.1004735,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900053,25799153.0,"DOAJ Gold, Green Published",,,16/08/2019,17,0,26,6044,1158,858,300,4886,3254,24,1608,25,0,0,0,14,14,2,,48,26,47,1,26,17,17,14,7,0,0,0,0,0,0,0,0,4,6202,50,0,108,171,3,4931,1176,50,0,108,171,3,95,,1,0,0,0,7,0,1,1,0,0,0,47,1,0,15.95,5.219343696027634,1.237003683995088,0.237003683995088,1.3145722472370036,1.062706816677697,5.546632124352332
27,J,"Derking, R; Ozorowski, G; Sliepen, K; Yasmeen, A; Cupo, A; Torres, JL; Julien, JP; Lee, JH; van Montfort, T; de Taeye, SW; Connors, M; Burton, DR; Wilson, IA; Klasse, PJ; Ward, AB; Moore, JP; Sanders, RW",,,,"Derking, Ronald; Ozorowski, Gabriel; Sliepen, Kwinten; Yasmeen, Anila; Cupo, Albert; Torres, Jonathan L.; Julien, Jean-Philippe; Lee, Jeong Hyun; van Montfort, Thijs; de Taeye, Steven W.; Connors, Mark; Burton, Dennis R.; Wilson, Ian A.; Klasse, Per-Johan; Ward, Andrew B.; Moore, John P.; Sanders, Rogier W.",,,Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; GP41-GP120 INTERFACE; GLYCOPROTEIN COMPLEX; DEPENDENT EPITOPE; BINDING-SITE; ENV TRIMERS; CD4 BINDING; POTENT,"The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation of many bNAbs against multiple different epitopes; 2) the generation of a soluble trimer mimic, BG505 SOSIP. 664 gp140, that expresses most bNAb epitopes; 3) facile binding assays involving the oriented immobilization of tagged trimers. Using these tools, we generated an antigenic map of the trimer by antibody cross-competition. Our analysis delineates three well-defined epitope clusters (CD4 binding site, quaternary V1V2 and Asn332-centered oligomannose patch) and new epitopes at the gp120-gp41 interface. It also identifies the relationships among these clusters. In addition to epitope overlap, we defined three more ways in which antibodies can cross-compete: steric competition from binding to proximal but non-overlapping epitopes (e.g., PGT151 inhibition of 8ANC195 binding); allosteric inhibition (e.g., PGT145 inhibition of 1NC9, 8ANC195, PGT151 and CD4 binding); and competition by reorientation of glycans (e.g., PGT135 inhibition of CD4bs bNAbs, and CD4bs bNAb inhibition of 8ANC195). We further demonstrate that bNAb binding can be complex, often affecting several other areas of the trimer surface beyond the epitope. This extensive analysis of the antigenic structure and the epitope interrelationships of the Env trimer should aid in design of both bNAb-based therapies and vaccines intended to induce bNAbs.","[Derking, Ronald; Sliepen, Kwinten; van Montfort, Thijs; de Taeye, Steven W.; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Ozorowski, Gabriel; Torres, Jonathan L.; Julien, Jean-Philippe; Lee, Jeong Hyun; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Torres, Jonathan L.; Julien, Jean-Philippe; Lee, Jeong Hyun; Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Torres, Jonathan L.; Julien, Jean-Philippe; Lee, Jeong Hyun; Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery CAVD, La Jolla, CA 92037 USA; [Yasmeen, Anila; Cupo, Albert; Klasse, Per-Johan; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Julien, Jean-Philippe] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA","Derking, R (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.",rws2002@med.cornell.edu,"Ward, Andrew/F-9203-2014","Ward, Andrew/0000-0001-7153-3769; Julien, Jean-Philippe/0000-0001-7602-3995; Lee, Jeong Hyun/0000-0001-7371-845X","National Institutes of Health [P01 AI82362, R37 AI36082]; International AIDS Vaccine Initiative (IAVI); Aids fonds Netherlands [2011032]; Vidi grant from the Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829-SHEV]; National Institutes of Health through the National Center for Research Resources' P41 Program [RR017573]","This study was sponsored by the National Institutes of Health Grants P01 AI82362 and R37 AI36082, by the International AIDS Vaccine Initiative (IAVI), and by the Aids fonds Netherlands, grant #2011032. RWS is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and obtained a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). The electron microscopy data were collected at the National Resource for Automated Molecular Microscopy (NRAMM), which is supported by the National Institutes of Health through the National Center for Research Resources' P41 Program Grant RR017573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Balla-Jhagjhoorsingh SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068863; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Carrillo J., GP120 CD4 BLOCKING A; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee JH, 2014, PRE FUSION GP41 CONF; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Moore JP, 1996, J VIROL, V70, P1863; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; MUSTER T, 1993, J VIROL, V67, P6642; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THALI M, 1993, J VIROL, V67, P3978; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; TRKOLA A, 1995, J VIROL, V69, P6609; van den Kerkhof TLGM, 2014, AIDS, V28, P1237, DOI 10.1097/QAD.0000000000000228; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; White TA, 2011, J VIROL, V85, P12114, DOI 10.1128/JVI.05297-11; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001",52,58,58,0,32,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004767,10.1371/journal.ppat.1004767,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900074,25807248.0,"DOAJ Gold, Green Published",,,16/08/2019,58,1,66,6587,1350,915,435,5237,4180,26,1031,64,1,0,0,60,60,1,,76,5,74,2,5,61,59,61,48,0,0,0,0,0,0,0,0,2,6656,65,0,803,148,1,5261,1360,65,0,803,148,1,35,,0,0,0,0,4,0,0,0,0,0,0,74,2,0,5.1,4.87925925925926,1.257781172426962,0.257781172426962,1.3116287951117052,1.0428115986033095,5.088148148148148
28,J,"Diaz, A; Zhang, JT; Ollwerther, A; Wang, XF; Ahlquist, P",,,,"Diaz, Arturo; Zhang, Jiantao; Ollwerther, Abigail; Wang, Xiaofeng; Ahlquist, Paul",,,Host ESCRT Proteins Are Required for Bromovirus RNA Replication Compartment Assembly and Function,PLOS PATHOGENS,,,English,Article,,,,,,,GENES AFFECTING REPLICATION; VIRUS GENOME REPLICATION; TOBACCO-MOSAIC-VIRUS; ENDOPLASMIC-RETICULUM; MULTIVESICULAR BODY; VIRAL REPLICATION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; MEMBRANE SCISSION; COMPLEX,"Positive-strand RNA viruses genome replication invariably is associated with vesicles or other rearranged cellular membranes. Brome mosaic virus (BMV) RNA replication occurs on perinuclear endoplasmic reticulum (ER) membranes in similar to 70 nm vesicular invaginations (spherules). BMV RNA replication vesicles show multiple parallels with membrane-enveloped, budding retrovirus virions, whose envelopment and release depend on the host ESCRT (endosomal sorting complexes required for transport) membrane-remodeling machinery. We now find that deleting components of the ESCRT pathway results in at least two distinct BMV phenotypes. One group of genes regulate RNA replication and the frequency of viral replication complex formation, but had no effect on spherule size, while a second group of genes regulate RNA replication in a way or ways independent of spherule formation. In particular, deleting SNF7 inhibits BMV RNA replication >25-fold and abolishes detectable BMV spherule formation, even though the BMV RNA replication proteins accumulate and localize normally on perinuclear ER membranes. Moreover, BMV ESCRT recruitment and spherule assembly depend on different sets of protein-protein interactions from those used by multivesicular body vesicles, HIV-1 virion budding, or tomato bushy stunt virus (TBSV) spherule formation. These and other data demonstrate that BMV requires cellular ESCRT components for proper formation and function of its vesicular RNA replication compartments. The results highlight growing but diverse interactions of ESCRT factors with many viruses and viral processes, and potential value of the ESCRT pathway as a target for broad-spectrum antiviral resistance.","[Diaz, Arturo; Ollwerther, Abigail; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Zhang, Jiantao; Wang, Xiaofeng] Virginia Tech Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Ahlquist, Paul] Univ Wisconsin, Morgridge Inst Res, Madison, WI USA","Diaz, A (reprint author), La Sierra Univ, Dept Biol, Riverside, CA 92505 USA.",reachxw@vt.edu; ahlquist@wisc.edu,"Zhang, Jiantao/I-5116-2014; Wang, Xiaofeng/E-9940-2016","Wang, Xiaofeng/0000-0002-3850-3274; Diaz, Arturo/0000-0002-4174-8950","National Institutes of Health [GM35072, T32 GM07215, T32 AI078985]; Virginia Tech University Startup fund; National Science Foundation [IOS 1265260]","This project was supported by National Institutes of Health Grant GM35072. PA is an investigator of the Howard Hughes Medical Institute and the Morgridge Institute for Research. AD was partially supported by National Institutes of Health training grants T32 GM07215 and T32 AI078985. Work in XW's lab was supported by a Virginia Tech University Startup fund and by the National Science Foundation Grant IOS 1265260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adell MA, 2014, J CELL BIOL; Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahlquist P, 1992, CURR OPIN GENET DEV, V2, P71, DOI 10.1016/S0959-437X(05)80325-9; Alonso YAM, 2011, FEBS LETTERS; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Barajas D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004087; Barajas D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000705; Belov GA, 2007, CELL CYCLE, V6, P36, DOI 10.4161/cc.6.1.3683; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Burgyan J, 1996, J GEN VIROL, V77, P1967, DOI 10.1099/0022-1317-77-8-1967; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chen JB, 2000, J VIROL, V74, P4310, DOI 10.1128/JVI.74.9.4310-4318.2000; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; den Boon JA, 2001, J VIROL, V75, P12370, DOI 10.1128/JVI.75.24.12370-12381.2001; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Diaz A, 2010, PROC NATL ACAD SCI U; Diaz A, 2012, J VIROL, V86, P821, DOI 10.1128/JVI.05684-11; Francki RIB, 1985, THE PLANT VIRUSES; FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075; Gancarz BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023988; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HARRISON BD, 1976, J GEN VIROL, V33, P237, DOI 10.1099/0022-1317-33-2-237; HATTA T, 1981, J GEN VIROL, V53, P343, DOI 10.1099/0022-1317-53-2-343; HATTA T, 1973, J GEN VIROL, V20, P37, DOI 10.1099/0022-1317-20-1-37; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Janda M, 1998, P NATL ACAD SCI USA, V95, P2227, DOI 10.1073/pnas.95.5.2227; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; KIM KS, 1977, J GEN VIROL, V35, P535, DOI 10.1099/0022-1317-35-3-535; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Krol MA, 1999, P NATL ACAD SCI USA, V96, P13650, DOI 10.1073/pnas.96.24.13650; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Liu L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000351; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; Meng B, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-5; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Nikko E, 2007, EUKARYOT CELL, V6, P1266, DOI 10.1128/EC.00024-07; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Prod'homme D, 2001, VIROLOGY, V281, P88, DOI 10.1006/viro.2000.0769; RAGHOW RS, 1973, J GEN VIROL, V21, P109, DOI 10.1099/0022-1317-21-1-109; Restrepo-Hartwig M, 1999, J VIROL, V73, P10303; RestrepoHartwig MA, 1996, J VIROL, V70, P8908; Richter CM, 2013, J CELL SCI, V126, P1881, DOI 10.1242/jcs.122499; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schwartz M, 2004, P NATL ACAD SCI USA, V101, P11263, DOI 10.1073/pnas.0404157101; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Spuul P, 2011, JOURNAL OF VIROLOGY; Sullivan ML, 1999, J VIROL, V73, P2622; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wang XF, 2005, J VIROL, V79, P13747, DOI 10.1128/JVI.79.21.13747-13758.2005; Wang XF, 2011, J VIROL, V85, P5494, DOI 10.1128/JVI.02031-10; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Zhang JT, 2012, J VIROL, V86, P5110, DOI 10.1128/JVI.06701-11",81,47,47,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004742,10.1371/journal.ppat.1004742,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900058,25748299.0,"DOAJ Gold, Green Published",,,16/08/2019,42,0,23,5314,452,348,104,4862,3776,14,1072,23,0,0,0,37,37,0,,38,3,38,0,3,43,43,34,25,0,0,0,0,0,0,0,0,0,5351,44,0,1472,66,1,4879,456,44,0,1472,66,1,16,,0,0,0,0,3,0,0,1,0,0,0,38,0,0,1.5,11.756637168141593,1.09296585767174,0.09296585767174002,1.123200329082682,1.0276627775686864,12.081858407079647
29,J,"Dinh, MH; Anderson, MR; McRaven, MD; Cianci, GC; McCoombe, SG; Kelley, ZL; Gioia, CJ; Fought, AJ; Rademaker, AW; Veazey, RS; Hope, TJ",,,,"Dinh, Minh H.; Anderson, Meegan R.; McRaven, Michael D.; Cianci, Gianguido C.; McCoombe, Scott G.; Kelley, Z. L.; Gioia, Casey J.; Fought, Angela J.; Rademaker, Alfred W.; Veazey, Ronald S.; Hope, Thomas J.",,,Visualization of HIV-1 Interactions with Penile and Foreskin Epithelia: Clues for Female-to-Male HIV Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,SIMIAN IMMUNODEFICIENCY VIRUS; MALE CIRCUMCISION; INTRAVAGINAL INOCULATION; UNCIRCUMCISED MEN; LANGERHANS CELLS; CERVICAL TISSUE; TARGET-CELLS; INFECTION; PREVENTION; TRIAL,"To gain insight into female-to-male HIV sexual transmission and how male circumcision protects against this mode of transmission, we visualized HIV-1 interactions with foreskin and penile tissues in ex vivo tissue culture and in vivo rhesus macaque models utilizing epifluorescent microscopy. 12 foreskin and 14 cadaveric penile specimens were cultured with R5-tropic photoactivatable (PA)-GFP HIV-1 for 4 or 24 hours. Tissue cryosections were immunofluorescently imaged for epithelial and immune cell markers. Images were analyzed for total virions, proportion of penetrators, depth of virion penetration, as well as immune cell counts and depths in the tissue. We visualized individual PA virions breaching penile epithelial surfaces in the explant and macaque model. Using kernel density estimated probabilities of localizing a virion or immune cell at certain tissue depths revealed that interactions between virions and cells were more likely to occur in the inner foreskin or glans penis (from local or cadaveric donors, respectively). Using statistical models to account for repeated measures and zero-inflated datasets, we found no difference in total virions visualized at 4 hours between inner and outer foreskins from local donors. At 24 hours, there were more virions in inner as compared to outer foreskin (0.0495 +/- 0.0154 and 0.0171 +/- 0.0038 virions/image, p = 0.001). In the cadaveric specimens, we observed more virions in inner foreskin (0.0507 +/- 0.0079 virions/image) than glans tissue (0.0167 +/- 0.0033 virions/image, p < 0.001), but a greater proportion was seen penetrating uncircumcised glans tissue (0.0458 +/- 0.0188 vs. 0.0151 +/- 0.0100 virions/image, p = 0.099) and to significantly greater mean depths (29.162 +/- 3.908 vs. 12.466 +/- 2.985 mu m). Our in vivo macaque model confirmed that virions can breach penile squamous epithelia in a living model. In summary, these results suggest that the inner foreskin and glans epithelia may be important sites for HIV transmission in uncircumcised men.","[Dinh, Minh H.] Northwestern Univ, Dept Med, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [Anderson, Meegan R.; McRaven, Michael D.; Cianci, Gianguido C.; McCoombe, Scott G.; Kelley, Z. L.; Gioia, Casey J.; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [McCoombe, Scott G.] Deakin Univ, Sch Med, Melbourne, Vic, Australia; [Fought, Angela J.; Rademaker, Alfred W.] Northwestern Univ, Dept Preventat Med, Biostat Collaborat Core Ctr, Chicago, IL 60611 USA; [Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Dept Comparat Pathol, Covington, LA USA","Dinh, MH (reprint author), Northwestern Univ, Dept Med, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA.",m-dinh@northwestern.edu,,,National Institutes of Allergy and Infectious Diseases [R33AI076968]; Eunice Kennedy Shriver National Institutes of Child Health & Development of the National Institutes of Health [5K08HD060451]; Bristol Meyers Squibb Virology Fellows Award,"This work was funded by: National Institutes of Allergy and Infectious Diseases under Award Number R33AI076968 (TJH), the Eunice Kennedy Shriver National Institutes of Child Health & Development of the National Institutes of Health under Award Number 5K08HD060451 (MHD), and the Bristol Meyers Squibb Virology Fellows Award (MHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Anderson DJ, 2010, AIDS, V24, P1, DOI 10.1097/QAD.0b013e328333acfb; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; Dinh MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041271; Dinh MH, 2010, AIDS, V24, P899, DOI 10.1097/QAD.0b013e3283367779; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Ganor Y, 2013, MUCOSAL IMMUNOL, V6, P776, DOI 10.1038/mi.2012.116; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hirbod T, 2010, AM J PATHOL, V176, P2798, DOI 10.2353/ajpath.2010.090926; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kurzrock EA, 1999, DIFFERENTIATION, V64, P115, DOI 10.1046/j.1432-0436.1999.6420115.x; Liu CM, 2013, MBIO, V16, P4, DOI [10.1128/mBio.00076-1, DOI 10.1128/MBIO.00076-1]; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; O'Farrell N, 2008, INT J STD AIDS, V19, P821, DOI 10.1258/ijsa.2008.008106; O'Farrell N, 2006, JAIDS-J ACQ IMM DEF, V43, P69, DOI 10.1097/01.qai.0000225014.61192.98; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Prodger JL, 2012, AIDS, V26, P1319, DOI 10.1097/QAD.0b013e328354675c; Qin Q, 2009, INT UROL NEPHROL, V41, P747, DOI 10.1007/s11255-008-9521-x; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Silverman B., 1998, DENSITY ESTIMATION S; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNAIDS, 2013, UNAIDS REP GLOB AIDS; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006",39,22,24,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004729,10.1371/journal.ppat.1004729,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900048,25748093.0,"DOAJ Gold, Green Published",,,16/08/2019,21,2,18,7715,2166,1962,204,5549,4801,19,729,18,1,0,0,21,21,0,,27,4,27,0,4,21,21,17,18,1,0,0,1,0,0,0,1,2,7691,30,0,57,168,3,5476,2166,30,0,57,168,3,49,,0,0,1,0,10,0,1,1,0,0,0,27,0,0,9.6,3.561865189289012,1.390340601910254,0.3903406019102541,1.4216976031717428,1.0225534672715488,3.642197599261311
30,J,"Dinter, J; Duong, E; Lai, NY; Berberich, MJ; Kourjian, G; Bracho-Sanchez, E; Chu, D; Su, H; Zhang, SC; Le Gall, S",,,,"Dinter, Jens; Duong, Ellen; Lai, Nicole Y.; Berberich, Matthew J.; Kourjian, Georgio; Bracho-Sanchez, Edith; Chu, Duong; Su, Hang; Zhang, Shao Chong; Le Gall, Sylvie",,,Variable Processing and Cross-presentation of HIV by Dendritic Cells and Macrophages Shapes CTL Immunodominance and Immune Escape,PLOS PATHOGENS,,,English,Article,,,,,,,MHC CLASS-I; T-LYMPHOCYTE EPITOPES; VIRUS TYPE-1 INFECTION; CONTROLS PHAGOSOMAL PH; ANTIGEN PRESENTATION; PEPTIDE STABILITY; VIRAL REPLICATION; VACCINE DESIGN; CUTTING EDGE; RESPONSES,"Dendritic cells (DCs) and macrophages (Mos) internalize and process exogenous HIV-derived antigens for cross-presentation by MHC-I to cytotoxic CD8(+) T cells (CTL). However, how degradation patterns of HIV antigens in the cross-presentation pathways affect immunodominance and immune escape is poorly defined. Here, we studied the processing and cross-presentation of dominant and subdominant HIV-1 Gag-derived epitopes and HLA-restricted mutants by monocyte-derived DCs and Mos. The cross-presentation of HIV proteins by both DCs and Mos led to higher CTL responses specific for immunodominant epitopes. The low CTL responses to subdominant epitopes were increased by pretreatment of target cells with peptidase inhibitors, suggestive of higher intracellular degradation of the corresponding peptides. Using DC and Mo cell extracts as a source of cytosolic, endosomal or lysosomal proteases to degrade long HIV peptides, we identified by mass spectrometry cell-specific and compartment-specific degradation patterns, which favored the production of peptides containing immunodominant epitopes in all compartments. The intracellular stability of optimal HIV-1 epitopes prior to loading onto MHC was highly variable and sequence-dependent in all compartments, and followed CTL hierarchy with immunodominant epitopes presenting higher stability rates. Common HLA-associated mutations in a dominant epitope appearing during acute HIV infection modified the degradation patterns of long HIV peptides, reduced intracellular stability and epitope production in cross-presentation-competent cell compartments, showing that impaired epitope production in the cross-presentation pathway contributes to immune escape. These findings highlight the contribution of degradation patterns in the cross-presentation pathway to HIV immunodominance and provide the first demonstration of immune escape affecting epitope cross-presentation.","[Dinter, Jens; Duong, Ellen; Lai, Nicole Y.; Berberich, Matthew J.; Kourjian, Georgio; Bracho-Sanchez, Edith; Chu, Duong; Su, Hang; Zhang, Shao Chong; Le Gall, Sylvie] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA 02138 USA","Dinter, J (reprint author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA 02138 USA.",sylvie_legall@hms.harvard.edu,,"Chu, Duong/0000-0002-5649-0219","NIAID [R01 AI084753, R01 AI084106]; Ernst Schering Foundation","The project was funded by grants R01 AI084753 and R01 AI084106 from NIAID to SLG. JD is funded in part by a Ph.D. training fellowship from the Ernst Schering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Ammaranond P, 2011, J IMMUNOL, V186, P479, DOI 10.4049/jimmunol.0903227; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Burster T, 2005, J IMMUNOL, V175, P5940, DOI 10.4049/jimmunol.175.9.5940; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Chateau MT, 2001, BIOCHEM BIOPH RES CO, V285, P863, DOI 10.1006/bbrc.2001.5252; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dinter J, 2014, J IMMUNOL; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Duclos S, 2011, PROTEOMICS, V11, P854, DOI 10.1002/pmic.201000577; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Friedrich D, 2011, JAIDS-J ACQ IMM DEF, V58, P248, DOI 10.1097/QAI.0b013e318228f992; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Herberts CA, 2006, J IMMUNOL, V176, P2697, DOI 10.4049/jimmunol.176.5.2697; Huang XL, 2003, J INFECT DIS, V187, P315, DOI 10.1086/346054; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kourjian G, 2014, J IMMUNOL, V192, P3496, DOI 10.4049/jimmunol.1302805; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; Lazaro E, 2011, J CLIN INVEST, V121, P2480, DOI 10.1172/JCI44932; Lazaro E, 2009, J INFECT DIS, V200, P236, DOI 10.1086/599837; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Lev A, 2008, IMMUNITY, V28, P787, DOI 10.1016/j.immuni.2008.04.015; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Lopez D, 1997, J IMMUNOL, V159, P5769; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; Luckey CJ, 1998, J IMMUNOL, V161, P112; Lutz MB, 1997, J IMMUNOL, V159, P3707; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Osuna CE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004069; Oxenius A, 2004, J INFECT DIS, V190, P713, DOI 10.1086/422760; Pereyra F, 2014, J VIROL; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; Ranasinghe SRF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001341; Rodriguez A, 1999, NAT CELL BIOL, V1, P362; Rucevic M, 2014, VIRUSES-BASEL, V6, P3271, DOI 10.3390/v6083271; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schmidt J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003042; Schmidt J, 2011, J VIROL, V85, P5232, DOI 10.1128/JVI.00093-11; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Steers NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042579; Steers NJ, 2011, J VIROL, V85, P1541, DOI 10.1128/JVI.01790-10; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Tanuma J, 2008, MICROBES INFECT, V10, P689, DOI 10.1016/j.micinf.2008.03.007; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Tjomsland V, 2013, EUR J IMMUNOL, V43, P1470, DOI 10.1002/eji.201242935; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Vaithilingam A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-35; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Yang B, 1996, J EXP MED, V183, P1545, DOI 10.1084/jem.183.4.1545; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yusim K, 2013, HIV MOL IMMUNOLOGY 2; Zhang SC, 2012, J IMMUNOL, V188, P5924, DOI 10.4049/jimmunol.1200219",76,18,18,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004725,10.1371/journal.ppat.1004725,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900045,25781895.0,"DOAJ Gold, Green Published",,,16/08/2019,17,0,36,4394,840,556,284,3554,2732,24,798,36,0,1,1,15,15,0,,43,1,43,0,1,18,18,13,13,0,0,0,0,0,0,0,0,4,4394,27,0,178,46,1,3543,840,27,0,178,46,1,11,,0,0,0,0,4,0,0,1,1,0,0,43,0,0,3.5,5.230952380952381,1.2363534046145188,0.23635340461451884,1.2568936409679234,1.016613563950842,5.317857142857143
31,J,"Doyle, JD; Stencel-Baerenwald, JE; Copeland, CA; Rhoads, JP; Brown, JJ; Boyd, KL; Atkinson, JB; Dermody, TS",,,,"Doyle, Joshua D.; Stencel-Baerenwald, Jennifer E.; Copeland, Courtney A.; Rhoads, Jillian P.; Brown, Judy J.; Boyd, Kelli L.; Atkinson, James B.; Dermody, Terence S.",,,Diminished Reovirus Capsid Stability Alters Disease Pathogenesis and Littermate Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,ATTACHMENT PROTEIN SIGMA-1; SEMLIKI-FOREST-VIRUS; INFECTIOUS SUBVIRION PARTICLES; INTERFERON REGULATORY FACTOR-3; EXTRAHEPATIC BILIARY ATRESIA; REVERSE GENETICS SYSTEM; CENTRAL-NERVOUS-SYSTEM; ADHESION MOLECULE-A; PERSISTENT INFECTIONS; CONFORMATIONAL-CHANGE,"Reovirus is a nonenveloped mammalian virus that provides a useful model system for studies of viral infections in the young. Following internalization into host cells, the outermost capsid of reovirus virions is removed by endosomal cathepsin proteases. Determinants of capsid disassembly kinetics reside in the viral sigma 3 protein. However, the contribution of capsid stability to reovirus-induced disease is unknown. In this study, we found that mice inoculated intramuscularly with a serotype 3 reovirus containing sigma 3-Y354H, a mutation that reduces viral capsid stability, succumbed at a higher rate than those infected with wild-type virus. At early times after inoculation, sigma 3-Y354H virus reached higher titers than wild-type virus at several sites within the host. Animals inoculated perorally with a serotype 1 reassortant reovirus containing sigma 3-Y354H developed exaggerated myocarditis accompanied by elaboration of pro-inflammatory cytokines. Surprisingly, unchallenged littermates of mice infected with sigma 3-Y354H virus displayed higher titers in the intestine, heart, and brain than littermates of mice inoculated with wild-type virus. Together, these findings suggest that diminished capsid stability enhances reovirus replication, dissemination, lethality, and host-to-host spread, establishing a new virulence determinant for nonenveloped viruses.","[Doyle, Joshua D.; Stencel-Baerenwald, Jennifer E.; Copeland, Courtney A.; Rhoads, Jillian P.; Brown, Judy J.; Boyd, Kelli L.; Atkinson, James B.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Doyle, Joshua D.; Stencel-Baerenwald, Jennifer E.; Copeland, Courtney A.; Rhoads, Jillian P.; Brown, Judy J.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA","Doyle, JD (reprint author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.",terry.dermody@vanderbilt.edu,,,"Public Health Service [T32 GM007347, T32 GM008554, R01 AI32539, P30 CA68485, P60 DK20593]; Elizabeth B. Lamb Center for Pediatric Research","This work was supported by Public Health Service awards T32 GM007347 and T32 GM008554 (to JDD) and R01 AI32539 (to TSD) and the Elizabeth B. Lamb Center for Pediatric Research. Additional support was provided by Public Health Service awards P30 CA68485 for the Vanderbilt-Ingram Cancer Center and P60 DK20593 for the Vanderbilt Diabetes Research and Training Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Antar AAR, 2009, CELL HOST MICROBE, V5, P59, DOI 10.1016/j.chom.2008.12.001; Baer GS, 1997, J VIROL, V71, P4921; Barton ES, 2003, J CLIN INVEST, V111, P1823, DOI 10.1172/JCI200316303; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BODKIN DK, 1989, J VIROL, V63, P1188; Boehme KW, 2011, J VIROL, V85, P11781, DOI 10.1128/JVI.02289-10; Boehme KW, 2009, P NATL ACAD SCI USA, V106, P19986, DOI 10.1073/pnas.0907412106; Bokiej M, 2012, J VIROL, V86, P10270, DOI 10.1128/JVI.01338-12; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chandran K, 2003, J VIROL, V77, P13361, DOI 10.1128/JVI.77.24.13361-13375.2003; Chandran K, 2001, IN VITRO MEMBRANE PE; Chappell JD, 1998, J VIROL, V72, P8205; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Clark KM, 2006, J VIROL, V80, P671, DOI 10.1128/JVI.80.2.671-681.2006; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; COLSTON EM, 1995, J VIROL, V69, P4823; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Cox P, 2005, APPL ENVIRON MICROB, V71, P5929, DOI 10.1128/AEM.71.10.5929-5934.2005; DERMODY TS, 1990, J VIROL, V64, P5173; Doyle JD, 2012, J BIOL CHEM, V287, P8029, DOI 10.1074/jbc.M111.334854; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ebert DH, 2001, J VIROL, V75, P3197, DOI 10.1128/JVI.75.7.3197-3206.2001; FRICKS CE, 1990, J VIROL, V64, P1934; Frierson JM, 2012, J VIROL, V86, P13164, DOI 10.1128/JVI.01822-12; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GLASER JH, 1984, J PEDIATR-US, V105, P912, DOI 10.1016/S0022-3476(84)80076-1; Glomb-Reinmund S, 1998, VIROLOGY, V248, P372, DOI 10.1006/viro.1998.9275; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; Goody RJ, 2008, J NEUROPATH EXP NEUR, V67, P231, DOI 10.1097/NEN.0b013e31816564f0; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Guglielmi KM, 2007, J BIOL CHEM, V282, P17930, DOI 10.1074/jbc.M702180200; HASHIRO G, 1977, ARCH VIROL, V54, P307, DOI 10.1007/BF01314776; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Holm GH, 2010, J VIROL, V84, P6900, DOI 10.1128/JVI.01742-09; KEDL R, 1995, J VIROL, V69, P552; KEROACK M, 1986, SCIENCE, V232, P1635, DOI 10.1126/science.3012780; Kirchner E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000235; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; LERNER AM, 1963, VIROLOGY, V19, P58, DOI 10.1016/0042-6822(63)90024-2; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Lonberg-Holm K, 1981, VIRUS RECEPTORS 2, P3; LOUIS N, 1994, J VIROL, V68, P4104; LU HH, 1994, J VIROL, V68, P7507; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mainou BA, 2012, J VIROL, V86, P8346, DOI 10.1128/JVI.00100-12; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MORECKI R, 1982, NEW ENGL J MED, V307, P481, DOI 10.1056/NEJM198208193070806; MORRISON LA, 1991, P NATL ACAD SCI USA, V88, P3852, DOI 10.1073/pnas.88.9.3852; NIBERT ML, 1995, J VIROL, V69, P5057; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1992, J VIROL, V66, P6408; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Richardson BA, 2005, J VIROL, V79, P669, DOI 10.1128/JVI.79.2.669-676.2005; RICHARDSON SC, 1994, J GASTROEN HEPATOL, V9, P264, DOI 10.1111/j.1440-1746.1994.tb01721.x; ROSEN L, 1962, ANN NY ACAD SCI, V101, P461, DOI 10.1111/j.1749-6632.1962.tb18886.x; SCOTT FW, 1970, AM J VET RES, V31, P11; SHERRY B, 1989, J VIROL, V63, P4850; Sherry B, 1998, J VIROL, V72, P1314; SHERRY B, 1989, J VIROL, V63, P4840; SHERRY B, 1993, J VIROL, V67, P6119; Sherry B, 1996, J VIROL, V70, P6709; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; STEIN BS, 1991, ADV EXP MED BIOL, V300, P71; STURZENBECKER LJ, 1987, J VIROL, V61, P2351; Tai JH, 2005, J INFECT DIS, V191, P1221, DOI 10.1086/428911; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tosteson MT, 1997, J VIROL, V71, P507; TYLER KL, 1985, NEUROLOGY, V35, P88, DOI 10.1212/WNL.35.1.88; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; VIRGIN HW, 1988, J VIROL, V62, P4594; WAHLBERG JM, 1992, J VIROL, V66, P7309; WEINER HL, 1977, P NATL ACAD SCI USA, V74, P5744, DOI 10.1073/pnas.74.12.5744; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; Wetzel JD, 1997, J VIROL, V71, P1362; Wetzel JD, 1997, J VIROL, V71, P299; Wilson GJ, 2002, J VIROL, V76, P9832, DOI 10.1128/JVI.76.19.9832-9843.2002; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102",88,7,7,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004693,10.1371/journal.ppat.1004693,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900022,25738608.0,"DOAJ Gold, Green Published",,,16/08/2019,8,52,8,2245,369,282,87,1876,1536,18,322,8,0,0,0,7,7,0,,14,2,14,0,2,8,8,8,4,0,0,0,0,0,0,0,52,0,2259,31,0,83,151,0,1867,369,31,0,83,151,0,23,,0,0,0,0,0,0,0,1,0,0,0,14,0,0,0.25,6.084010840108401,1.1966950959488274,0.19669509594882728,1.3011727078891258,1.0873051224944321,6.615176151761518
32,J,"Dupre, E; Herrou, J; Lensink, MF; Wintjens, R; Vagin, A; Lebedev, A; Crosson, S; Villeret, V; Locht, C; Antoine, R; Jacob-Dubuisson, F",,,,"Dupre, Elian; Herrou, Julien; Lensink, Marc F.; Wintjens, Rene; Vagin, Alexey; Lebedev, Andrey; Crosson, Sean; Villeret, Vincent; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise",,,Virulence Regulation with Venus Flytrap Domains: Structure and Function of the Periplasmic Moiety of the Sensor-Kinase BvgS,PLOS PATHOGENS,,,English,Article,,,,,,,2-COMPONENT SYSTEM; CRYSTAL-STRUCTURE; GENE-EXPRESSION; PAS DOMAIN; BORDETELLA; PROTEIN; RECEPTOR; RESISTANCE; REFINEMENT; DYNAMICS,"Two-component systems (TCS) represent major signal-transduction pathways for adaptation to environmental conditions, and regulate many aspects of bacterial physiology. In the whooping cough agent Bordetella pertussis, the TCS BvgAS controls the virulence regulon, and is therefore critical for pathogenicity. BvgS is a prototypical TCS sensor-kinase with tandem periplasmic Venus flytrap (VFT) domains. VFT are bi-lobed domains that typically close around specific ligands using clamshell motions. We report the X-ray structure of the periplasmic moiety of BvgS, an intricate homodimer with a novel architecture. By combining site-directed mutagenesis, functional analyses and molecular modeling, we show that the conformation of the periplasmic moiety determines the state of BvgS activity. The intertwined structure of the periplasmic portion and the different conformation and dynamics of its mobile, membrane-distal VFT1 domains, and closed, membrane-proximal VFT2 domains, exert a conformational strain onto the transmembrane helices, which sets the cytoplasmic moiety in a kinase-on state by default corresponding to the virulent phase of the bacterium. Signaling the presence of negative signals perceived by the periplasmic domains implies a shift of BvgS to a distinct state of conformation and activity, corresponding to the avirulent phase. The response to negative modulation depends on the integrity of the periplasmic dimer, indicating that the shift to the kinase-off state implies a concerted conformational transition. This work lays the bases to understand virulence regulation in Bordetella. As homologous sensor-kinases control virulence features of diverse bacterial pathogens, the BvgS structure and mechanism may pave the way for new modes of targeted therapeutic interventions.","[Dupre, Elian; Herrou, Julien; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Infect & Immun CIIL, F-59019 Lille, France; [Dupre, Elian; Herrou, Julien; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Univ Lille North France, Ctr Infect & Immun CIIL, Lille, France; [Dupre, Elian; Herrou, Julien; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Dupre, Elian; Herrou, Julien; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] INSERM, U1019, F-59045 Lille, France; [Lensink, Marc F.; Villeret, Vincent] Univ Lille North France, CNRS, UMR8576, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France; [Wintjens, Rene] Univ Libre Bruxelles, Lab Biopolymers & Supramol Nanomat, Brussels, Belgium; [Vagin, Alexey] Univ York, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Lebedev, Andrey] Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England; [Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA","Dupre, E (reprint author), Inst Pasteur, Ctr Infect & Immun CIIL, F-59019 Lille, France.",rudy.antoine@pasteur-lille.fr; francoise.jacob@ibl.cnrs.fr,"Lensink, Marc/A-1678-2008; Locht, Camille/L-3516-2018; Antoine, Rudy/L-1630-2018; Jacob-Dubuisson, Francoise/F-1610-2018","Lensink, Marc/0000-0003-3957-9470; Antoine, Rudy/0000-0002-7369-0626; Jacob-Dubuisson, Francoise/0000-0002-5102-1704; Crosson, Sean/0000-0002-1727-322X; Locht, Camille/0000-0001-7295-7336; Villeret, Vincent/0000-0003-4504-056X",Agence Nationale de la Recherche [ANR-13-BSV8-0002-01]; French Research Ministry; Fonds de la Recherche Medicale (FRM),"This work was supported by Grant No ANR-13-BSV8-0002-01 from the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) to FJD. ED acknowledges the receipt of predoctoral fellowships from the French Research Ministry and the Fonds de la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Airola MV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001479; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671; Barakat M, 2011, NUCLEIC ACIDS RES, V39, pD771, DOI 10.1093/nar/gkq1023; Beier D, 1996, MOL GEN GENET, V252, P169, DOI 10.1007/BF02173217; Bekker Martijn, 2006, Science Progress, V89, P213, DOI 10.3184/003685006783238308; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Caimano MJ, 2011, INFECT IMMUN, V79, P3117, DOI 10.1128/IAI.05136-11; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cheung J, 2009, PROTEINS, V77, P235, DOI 10.1002/prot.22485; Clarke DJ, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P333; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Dupre E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-172; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N, 2006, CURR PROTOC BIOINFOR, V15, DOI DOI 10.1002/0471250953.BI0506S15; Gao R, 2007, J BACTERIOL, V189, P6048, DOI 10.1128/JB.00459-07; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; He XL, 2005, PEPTIDES, V26, P1035, DOI 10.1016/j.peptides.2004.08.035; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Huth JR, 1997, PROTEIN SCI, V6, P2359; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781; Jacob-Dubuisson F, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P57; Johnson MD, 2014, MOL MICROBIOL, V93, P911, DOI 10.1111/mmi.12704; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Keilberg D, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P293; KNAPP S, 1988, J BACTERIOL, V170, P5059, DOI 10.1128/jb.170.11.5059-5066.1988; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacey BW, 1960, J HYG, V31, P423; Lowe EC, 2012, P NATL ACAD SCI USA, V109, P7298, DOI 10.1073/pnas.1200479109; Martinez-Wilson HF, 2008, J BACTERIOL, V190, P6439, DOI 10.1128/JB.00541-08; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; MELTON AR, 1993, INFECT IMMUN, V61, P807; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Perraud AL, 2000, BBA-PROTEIN STRUCT M, V1478, P341, DOI 10.1016/S0167-4838(00)00052-2; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Sivaneson M, 2011, MOL MICROBIOL, V79, P1353, DOI 10.1111/j.1365-2958.2010.07527.x; Smith SC, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P269; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; STENSON TH, 1995, INFECT IMMUN, V63, P3780; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Szurmant H, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P127; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522",65,25,25,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004700,10.1371/journal.ppat.1004700,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900028,25738876.0,"DOAJ Gold, Green Published",,,16/08/2019,24,4,18,3595,664,512,152,2931,2450,22,459,18,0,0,0,21,21,0,,24,9,24,0,9,24,24,23,18,0,0,0,0,0,0,0,4,5,3688,136,0,181,158,3,2941,674,136,0,181,158,3,73,,0,0,0,0,15,0,1,1,0,0,0,24,0,0,9.3,5.414156626506024,1.2265438416922552,0.2265438416922552,1.3585806891845786,1.1076495132127955,5.996987951807229
33,J,"Emmanuel, M; Nakano, YS; Nozaki, T; Datta, S",,,,"Emmanuel, Merlyn; Nakano, Yumiko Saito; Nozaki, Tomoyoshi; Datta, Sunando",,,Small GTPase Rab21 Mediates Fibronectin Induced Actin Reorganization in Entamoeba histolytica: Implications in Pathogen Invasion,PLOS PATHOGENS,,,English,Article,,,,,,,EXTRACELLULAR-MATRIX DEGRADATION; MONOCLONAL-ANTIBODIES; LEADING-EDGE; LIPID RAFTS; INVADOPODIA; MEMBRANE; PROTEINS; INTEGRIN; ADHESION; COMPLEX,"The protozoan parasite Entamoeba histolytica causes a wide spectrum of intestinal infections. In severe cases, the trophozoites can breach the mucosal barrier, invade the intestinal epithelium and travel via the portal circulation to the liver, where they cause hepatic abscesses, which can prove fatal if left untreated. The host Extra Cellular Matrix (ECM) plays a crucial role in amoebic invasion by triggering an array of cellular responses in the parasite, including induction of actin rich adhesion structures. Similar actin rich protrusive structures, known as 'invadosomes', promote chemotactic migration of the metastatic cancer cells and non-transformed cells by remodeling the ECM. Recent studies showed a central role for Rab GTPases, the master regulators of vesicular trafficking, in biogenesis of invadosomes. Here, we showed that fibronectin, a major host ECM component induced actin remodeling in the parasite in a Rab21 dependent manner. The focalized actin structures formed were reminiscent of the mammalian invadosomes. By using various approaches, such as immunofluorescence confocal microscopy and scanning electron microscopy, along with in vitro invasion assay and matrix degradation assay, we show that the fibronectin induced formation of amoebic actin dots depend on the nucleotide status of the GTPase. The ECM components, fibronectin and collagen type I, displayed differential control over the formation of actin dots, with fibronectin positively and collagen type I negatively modulating it. The cell surface adhesion molecule Gal/GalNAc complex was also found to impose additional regulation on this process, which might have implication in collagen type I mediated suppression of actin dots.","[Emmanuel, Merlyn; Datta, Sunando] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal 462066, India; [Nakano, Yumiko Saito; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan","Emmanuel, M (reprint author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal 462066, India.",sunando@iiserb.ac.in,,,"Department of Science and Technology (DST), India; Japan Society for Promotion of Science (JSPS), Japan; Max Planck Gesellschaft (MPG) Germany; Indian Institute of Science Education and Research Bhopal (IISERB), India; University Grants Commission Senior Research Fellowship, Govt. of India","The current study was supported from funds from Department of Science and Technology (DST), India, Japan Society for Promotion of Science (JSPS), Japan; Max Planck Gesellschaft (MPG) Germany; and Indian Institute of Science Education and Research Bhopal (IISERB), India. ME was supported from University Grants Commission Senior Research Fellowship, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Davies KJ, 2014, INT J BREAST CANCER, DOI 10.1155/2014/839094; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Flores-Robles D, 2003, EXP PARASITOL, V103, P8, DOI 10.1016/S0014-4894(03)00062-6; Franco E, 1997, J INFECT DIS, V176, P1597, DOI 10.1086/514160; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Furukawa A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002539; Goldenring JR, 2013, NAT REV CANCER, V13, P813, DOI 10.1038/nrc3601; Goldston AM, 2012, EUKARYOT CELL, V11, P743, DOI 10.1128/EC.00054-12; Hagedorn EJ, 2014, J CELL BIOL, V204, P1209, DOI 10.1083/jcb.201312098; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; Hooper S, 2010, BRIT J CANCER, V102, P392, DOI 10.1038/sj.bjc.6605469; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Jimenez-Delgadillo B, 2004, EXP PARASITOL, V108, P7, DOI 10.1016/j.exppara.2004.06.007; Juin A, 2012, MOL BIOL CELL, V23, P297, DOI 10.1091/mbc.E11-07-0594; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Meza I, 2000, PARASITOL TODAY, V16, P23, DOI 10.1016/S0169-4758(99)01586-0; Mitra BN, 2007, CELL MICROBIOL, V9, P2112, DOI 10.1111/j.1462-5822.2007.00941.x; Mittal K, 2008, EXP PARASITOL, V120, P127, DOI 10.1016/j.exppara.2008.06.003; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; PETRI WA, 1990, INFECT IMMUN, V58, P1802; PETRI WA, 1990, J IMMUNOL, V144, P4803; Ralston KS, 2011, TRENDS PARASITOL, V27, P253, DOI 10.1016/j.pt.2011.02.006; Recchi C, 2012, BIOCHEM SOC T, V40, P1398, DOI 10.1042/BST20120199; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rios A, 2008, CELL BIOL INT, V32, P984, DOI 10.1016/j.cellbi.2008.04.016; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Saito-Nakano Y, 2005, EXP PARASITOL, V110, P244, DOI 10.1016/j.exppara.2005.02.021; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Talamas-Rohana P, 1998, J EUKARYOT MICROBIOL, V45, P356, DOI 10.1111/j.1550-7408.1998.tb04549.x; Talamas-Rohana P, 2000, ARCH MED RES, V31, pS131, DOI 10.1016/S0188-4409(00)00190-9; TALAMASROHANA P, 1988, J CELL BIOL, V106, P1787, DOI 10.1083/jcb.106.5.1787; Tang BL, 2009, CELL MOTIL CYTOSKEL, V66, P365, DOI 10.1002/cm.20376; Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824; Wiesner C, 2013, J CELL SCI, V126, P2820, DOI 10.1242/jcs.122358; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055",57,19,19,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004666,10.1371/journal.ppat.1004666,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900008,25730114.0,"DOAJ Gold, Green Published",,,16/08/2019,19,1,17,4303,918,646,272,3385,2741,19,625,17,0,0,0,21,21,0,,30,5,30,0,5,19,19,14,10,0,0,0,0,0,0,0,1,0,4312,55,0,62,95,2,3373,918,55,0,62,95,2,21,,0,0,0,0,3,0,1,1,0,0,0,29,0,0,1.25,4.687363834422658,1.2711964549483012,0.2711964549483013,1.3181683899556869,1.0369509644434116,4.860566448801743
34,J,"Florimond, C; Sahin, A; Vidilaseris, K; Dong, G; Landrein, N; Dacheux, D; Albisetti, A; Byard, EH; Bonhivers, M; Robinson, DR",,,,"Florimond, Celia; Sahin, Annelise; Vidilaseris, Keni; Dong, Gang; Landrein, Nicolas; Dacheux, Denis; Albisetti, Anna; Byard, Edward H.; Bonhivers, Melanie; Robinson, Derrick R.",,,BILBO1 Is a Scaffold Protein of the Flagellar Pocket Collar in the Pathogen Trypanosoma brucei,PLOS PATHOGENS,,,English,Article,,,,,,,CALCIUM-BINDING PROTEINS; ALPHA-B-CRYSTALLIN; AFRICAN TRYPANOSOMES; ESCHERICHIA-COLI; CYTOSKELETON; EXPRESSION; DOMAINS; CILIA; ORGANIZATION; ARCHITECTURE,"The flagellar pocket (FP) of the pathogen Trypanosoma brucei is an important single copy structure that is formed by the invagination of the pellicular membrane. It is the unique site of endo-and exocytosis and is required for parasite pathogenicity. The FP consists of distinct structural sub-domains with the least explored being the annulus/horseshoe shaped flagellar pocket collar (FPC). To date the only known component of the FPC is the protein BILBO1, a cytoskeleton protein that has a N-terminus that contains an ubiquitin-like fold, two EF-hand domains, plus a large C-terminal coiled-coil domain. BILBO1 has been shown to bind calcium, but in this work we demonstrate that mutating either or both calcium-binding domains prevents calcium binding. The expression of deletion or mutated forms of BILBO1 in trypanosomes and mammalian cells demonstrate that the coiled-coil domain is necessary and sufficient for the formation of BILBO1 polymers. This is supported by Yeast two-hybrid analysis. Expression of full-length BILBO1 in mammalian cells induces the formation of linear polymers with comma and globular shaped termini, whereas mutation of the canonical calcium-binding domain resulted in the formation of helical polymers and mutation in both EF-hand domains prevented the formation of linear polymers. We also demonstrate that in T. brucei the coiled-coil domain is able to target BILBO1 to the FPC and to form polymers whilst the EF-hand domains influence polymers shape. This data indicates that BILBO1 has intrinsic polymer forming properties and that binding calcium can modulate the form of these polymers. We discuss whether these properties can influence the formation of the FPC.","[Florimond, Celia; Sahin, Annelise; Landrein, Nicolas; Dacheux, Denis; Albisetti, Anna; Byard, Edward H.; Bonhivers, Melanie; Robinson, Derrick R.] Univ Bordeaux, Microbiol Fondamentale & Pathogen, Bordeaux, France; [Florimond, Celia; Sahin, Annelise; Dong, Gang; Landrein, Nicolas; Dacheux, Denis; Albisetti, Anna; Byard, Edward H.; Bonhivers, Melanie; Robinson, Derrick R.] CNRS, UMR 5234, Microbiol Fondamentale & Pathogen, Bordeaux, France; [Vidilaseris, Keni; Dong, Gang] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Dacheux, Denis] Inst Polytech Bordeaux, Microbiol Fondamentale & Pathogen, CNRS, UMR 5234, Bordeaux, France","Florimond, C (reprint author), SUNY Buffalo, Sch Med, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.",derrick-roy.robinson@u-bordeaux.fr,"Vidilaseris, Keni/Q-1243-2019","Vidilaseris, Keni/0000-0002-6453-6600; Dong, Gang/0000-0001-9745-8103; BONHIVERS, Melanie/0000-0001-9179-8473","Centre National de la Recherche Scientifique (CNRS); Aquitaine Regional Council [20111301014, ANR-09-BLAN-0074]; Preciput-ANR grant from the University of Bordeaux; Labex - ""ParaFrap"" - Alliance Francaise Contre les Maladies Parasitaires; Region Martinique Ph.D. fellowship","This work was funded by the Centre National de la Recherche Scientifique (CNRS), Aquitaine Regional Council Grant - 20111301014, (ANR-09-BLAN-0074), Preciput-ANR grant from the University of Bordeaux and a Labex - ""ParaFrap"" - Alliance Francaise Contre les Maladies Parasitaires. CF was a recipient of the Region Martinique Ph.D. fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alaoui-Ismaili MH, 1998, J VIROL, V72, P2213; Bangs JD, 2011, MOL MICROBIOL, V82, P1433, DOI 10.1111/j.1365-2958.2011.07900.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Dacheux D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031344; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Gadelha C, 2009, P NATL ACAD SCI USA, V106, P17425, DOI 10.1073/pnas.0909289106; Ghossoub R, 2011, BIOL CELL, V103, P131, DOI 10.1042/BC20100128; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Han BG, 2002, FEBS LETT, V521, P24, DOI 10.1016/S0014-5793(02)02780-1; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hu QC, 2011, CYTOSKELETON, V68, P313, DOI 10.1002/cm.20514; IZARD J, 1994, PROTEIN ENG, V7, P1495, DOI 10.1093/protein/7.12.1495; Kedzierski L, 2011, HUM VACCINES, V7, P1204, DOI 10.4161/hv.7.11.17752; Lacomble S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007685; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; LINO T, 1974, Journal of Supramolecular Structure, V2, P372, DOI 10.1002/jss.400020226; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1159/000077865; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Rassi A, 2012, REV SOC BRAS MED TRO, V45, P266, DOI 10.1590/S0037-86822012000200026; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Vekilov PG, 2007, BRIT J HAEMATOL, V139, P173, DOI 10.1111/j.1365-2141.2007.06794.x; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Vidilaseris K, 2014, J BIOL CHEM, V289, P23870, DOI 10.1074/jbc.M114.554659; Vidilaseris K, 2014, ACTA CRYSTALLOGR F, V70, P628, DOI 10.1107/S2053230X14005743; Vidilaseris K, 2014, J BIOL CHEM, V289, P3724, DOI 10.1074/jbc.M113.529032; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; WILSON AK, 1992, J CELL BIOL, V119, P401, DOI 10.1083/jcb.119.2.401; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; WOODS A, 1989, J CELL SCI, V93, P491; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139",56,6,6,1,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004654,10.1371/journal.ppat.1004654,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900004,25822645.0,"DOAJ Gold, Green Published",,,16/08/2019,4,16,19,3243,555,439,116,2688,2214,22,452,19,0,0,0,3,3,2,,34,0,34,0,0,6,4,2,6,0,0,0,0,0,0,0,16,0,3254,22,0,105,119,0,2678,555,22,0,105,119,0,21,,0,0,0,0,1,0,1,0,0,0,0,34,0,0,0.5,5.8432432432432435,1.2064732142857142,0.20647321428571427,1.2630208333333333,1.0468701819303114,6.117117117117117
35,J,"Floyd, KA; Moore, JL; Eberly, AR; Good, JAD; Shaffer, CL; Zaver, H; Almqvist, F; Skaar, EP; Caprioli, RM; Hadjifrangiskou, M",,,,"Floyd, Kyle A.; Moore, Jessica L.; Eberly, Allison R.; Good, James A. D.; Shaffer, Carrie L.; Zaver, Himesh; Almqvist, Fredrik; Skaar, Eric P.; Caprioli, Richard M.; Hadjifrangiskou, Maria",,,Adhesive Fiber Stratification in Uropathogenic Escherichia coli Biofilms Unveils Oxygen-Mediated Control of Type 1 Pili,PLOS PATHOGENS,,,English,Article,,,,,,,IMAGING MASS-SPECTROMETRY; URINARY-TRACT-INFECTION; PERSISTER CELLS; PSEUDOMONAS-AERUGINOSA; AMYLOID BIOGENESIS; BLADDER INFECTION; S-NITROSYLATION; PROTEIN; EXPRESSION; PEPTIDES,"Bacterial biofilms account for a significant number of hospital-acquired infections and complicate treatment options, because bacteria within biofilms are generally more tolerant to antibiotic treatment. This resilience is attributed to transient bacterial subpopulations that arise in response to variations in the microenvironment surrounding the biofilm. Here, we probed the spatial proteome of surface-associated single-species biofilms formed by uropathogenic Escherichia coli (UPEC), the major causative agent of community-acquired and catheter-associated urinary tract infections. We used matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) imaging mass spectrometry (IMS) to analyze the spatial proteome of intact biofilms in situ. MALDI-TOF IMS revealed protein species exhibiting distinct localizations within surface-associated UPEC biofilms, including two adhesive fibers critical for UPEC biofilm formation and virulence: type 1 pili (Fim) localized exclusively to the air-exposed region, while curli amyloid fibers localized to the air-liquid interface. Comparison of cells grown aerobically, fermentatively, or utilizing an alternative terminal electron acceptor showed that the phase-variable fim promoter switched to the ""FF"" orientation under oxygen-deplete conditions, leading to marked reduction of type 1 pili on the bacterial cell surface. Conversely, S pili whose expression is inversely related to fim expression were upregulated under anoxic conditions. Tethering the fim promoter in the ""ON"" orientation in anaerobically grown cells only restored type 1 pili production in the presence of an alternative terminal electron acceptor beyond oxygen. Together these data support the presence of at least two regulatory mechanisms controlling fim expression in response to oxygen availability and may contribute to the stratification of extracellular matrix components within the biofilm. MALDI IMS facilitated the discovery of these mechanisms, and we have demonstrated that this technology can be used to interrogate subpopulations within bacterial biofilms.","[Floyd, Kyle A.; Eberly, Allison R.; Shaffer, Carrie L.; Zaver, Himesh; Skaar, Eric P.; Hadjifrangiskou, Maria] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Moore, Jessica L.; Caprioli, Richard M.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37212 USA; [Good, James A. D.; Almqvist, Fredrik] Umea Univ, Dept Chem, Umea, Sweden; [Good, James A. D.; Almqvist, Fredrik] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Zaver, Himesh] Belmont Univ, Dept Biol, Nashville, TN USA; [Zaver, Himesh] Belmont Univ, Dept Chem, Nashville, TN USA; [Caprioli, Richard M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Caprioli, Richard M.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Caprioli, Richard M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA","Floyd, KA (reprint author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.",Richard.caprioli@vanderbilt.edu; maria.hadjifrangiskou@vanderbilt.edu,,"Almqvist, Fredrik/0000-0002-0504-4446; Good, James/0000-0003-2377-030X; Shaffer, Carrie/0000-0002-7457-7422; Eberly, Allison/0000-0001-9561-0458","Academic development funds [APS 1-04-520-9211]; Swedish Research Council [621-2010-4730]; Knut and Alice Wallenberg foundation; Goran Gustafsson foundation; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases Award; Vanderbilt Chemical Biology interface training program [T32 GM065086]; Vanderbilt Infection, Pathogenesis, and Epidemiology Research Training Program [5 T32 A1007474-19]; Vanderbilt University Program in Microbial Pathogenesis Mini-Sabbatical award; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126];  [NIH/NIAID R01AI101171];  [NIH/NIGMS 5P41 GM103391-03]","This work was supported by: Academic development funds APS 1-04-520-9211 (to MH); the Swedish Research Council (621-2010-4730), the Knut and Alice Wallenberg foundation and the Goran Gustafsson foundation (to FA); the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases Award (to EPS); grants NIH/NIAID R01AI101171 (to EPS), NIH/NIGMS 5P41 GM103391-03 (formerly 8P41 RR031461-02) (to RMC); JLM was supported by Vanderbilt Chemical Biology interface training program (T32 GM065086). CLS was supported by the Vanderbilt Infection, Pathogenesis, and Epidemiology Research Training Program (5 T32 A1007474-19) and the Vanderbilt University Program in Microbial Pathogenesis Mini-Sabbatical award. SEM and TEM were performed at the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aberg V, 2005, ORG BIOMOL CHEM, V3, P2817, DOI 10.1039/b503294f; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Anderson DMG, 2013, MOL VIS, V19; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Barbieri NL, 2014, INFECT IMMUN, V82, P5086, DOI 10.1128/IAI.02315-14; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Blaze MTM, 2012, ANALYST, V137, P5018, DOI 10.1039/c2an35922g; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chen SL, 2009, P NATL ACAD SCI USA, V106, P22439, DOI 10.1073/pnas.0902179106; Corcoran CP, 2009, MOL MICROBIOL, V74, P1071, DOI 10.1111/j.1365-2958.2009.06919.x; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Debois D, 2008, PROTEOMICS, V8, P3682, DOI 10.1002/pmic.200701025; DePas WH, 2013, P NATL ACAD SCI USA, V110, P2629, DOI [10.1073/pnas.1218703110/-/DCSupplemental, 10.1073/pnas.1218703110]; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Edirisinghe PD, 2007, ANAL CHEM, V79, P508, DOI 10.1021/ac0615605; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Greene SE, 2014, MBIO, V5, DOI 10.1128/mBio.02038-14; Guckes KR, 2013, P NATL ACAD SCI USA, V110, P16592, DOI 10.1073/pnas.1315320110; Gusarov I, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003181; Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12; Hadjifrangiskou M, 2011, MOL MICROBIOL, V80, P1516, DOI 10.1111/j.1365-2958.2011.07660.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; KORHONEN TK, 1984, J BACTERIOL, V159, P762; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kostakioti M, 2012, INFECT IMMUN, V80, P2826, DOI 10.1128/IAI.00283-12; Kostakioti M, 2009, MOL MICROBIOL, V73, P1020, DOI 10.1111/j.1365-2958.2009.06826.x; Lee AI, 1999, J BACTERIOL, V181, P5309; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lim JY, 2012, APPL ENVIRON MICROB, V78, P3369, DOI 10.1128/AEM.07743-11; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Macfarlane S, 2011, ADV APPL MICROBIOL, V75, P111, DOI 10.1016/B978-0-12-387046-9.00005-0; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; McCrate OA, 2013, J MOL BIOL; Morris ML, 2013, SOFT MATTER, V9, P9857, DOI 10.1039/c3sm52086b; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Norris JL, 2013, PROTEOM CLIN APPL, V7, P733, DOI 10.1002/prca.201300055; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Parsek MR, 2008, CURR OPIN MICROBIOL, V11, P560, DOI 10.1016/j.mib.2008.09.015; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Pol J, 2010, HISTOCHEM CELL BIOL, V134, P423, DOI 10.1007/s00418-010-0753-3; Regev-Shoshani G, 2010, ANTIMICROB AGENTS CH, V54, P273, DOI 10.1128/AAC.00511-09; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwan William R, 2011, World J Clin Infect Dis, V1, P17; Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Struve C, 1999, MICROBIOL-SGM, V145, P2683, DOI 10.1099/00221287-145-10-2683; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Watrous JD, 2013, ISME J, V7, P770, DOI 10.1038/ismej.2012.155; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Yang JY, 2012, J BACTERIOL, V194, P6023, DOI 10.1128/JB.00823-12",73,34,35,1,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004697,10.1371/journal.ppat.1004697,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900026,25738819.0,"DOAJ Gold, Green Published",,,16/08/2019,34,178,66,9238,1067,780,287,8171,7099,31,1041,66,1,1,0,30,30,0,,86,6,86,0,6,35,35,29,22,0,0,0,0,0,0,1,177,24,9326,62,15,725,137,1,8217,1081,62,15,725,137,1,28,,2,0,0,0,30,0,0,1,0,0,0,87,0,0,33.7,8.657919400187442,1.1305837718761473,0.13058377187614736,1.1657079916778852,1.031067330591037,8.926897844423618
36,J,"Galbraith, DA; Yang, XY; Nino, EL; Yi, S; Grozinger, C",,,,"Galbraith, David A.; Yang, Xingyu; Nino, Elina Lastro; Yi, Soojin; Grozinger, Christina",,,Parallel Epigenomic and Transcriptomic Responses to Viral Infection in Honey Bees (Apis mellifera),PLOS PATHOGENS,,,English,Article,,,,,,,COLONY COLLAPSE DISORDER; DIFFERENTIAL EXPRESSION ANALYSIS; DNA METHYLATION; GENE-EXPRESSION; VIRUS-INFECTION; DROSOPHILA-MELANOGASTER; INTERFERON-PRODUCTION; INNATE IMMUNITY; RNA-SEQ; GENOME,"Populations of honey bees are declining throughout the world, with US beekeepers losing 30% of their colonies each winter. Though multiple factors are driving these colony losses, it is increasingly clear that viruses play a major role. However, information about the molecular mechanisms mediating antiviral immunity in honey bees is surprisingly limited. Here, we examined the transcriptional and epigenetic (DNA methylation) responses to viral infection in honey bee workers. One-day old worker honey bees were fed solutions containing Israeli Acute Paralysis Virus (IAPV), a virus which causes muscle paralysis and death and has previously been associated with colony loss. Uninfected control and infected, symptomatic bees were collected within 20-24 hours after infection. Worker fat bodies, the primary tissue involved in metabolism, detoxification and immune responses, were collected for analysis. We performed transcriptome-and bisulfite-sequencing of the worker fat bodies to identify genome-wide gene expression and DNA methylation patterns associated with viral infection. There were 753 differentially expressed genes (FDR<0.05) in infected versus control bees, including several genes involved in epigenetic and antiviral pathways. DNA methylation status of 156 genes (FDR<0.1) changed significantly as a result of the infection, including those involved in antiviral responses in humans. There was no significant overlap between the significantly differentially expressed and significantly differentially methylated genes, and indeed, the genomic characteristics of these sets of genes were quite distinct. Our results indicate that honey bees have two distinct molecular pathways, mediated by transcription and methylation, that modulate protein levels and/or function in response to viral infections.","[Galbraith, David A.; Nino, Elina Lastro; Grozinger, Christina] Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA; [Yang, Xingyu; Yi, Soojin] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA","Galbraith, DA (reprint author), Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA.",dag5031@psu.edu,,,USDA-AFRI Post-doctoral Fellowship grant [2012-01221]; NIH [R21MH102677]; NSF-MCB grant [0951200]; USDA_AFRI grant [10359159],"These studies were supported by a USDA-AFRI Post-doctoral Fellowship grant (2012-01221) to ELN, an NIH grant to SY (R21MH102677), an NSF-MCB grant to CMG and SY (0951200) and a USDA_AFRI grant to CMG (10359159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey L., 1991, HONEY BEE PATHOLOGY; Benjamini Y, 1995, J R STAT SOC B; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Boncristiani HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073429; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; Castorena KM, 2010, TARGETED FUNCTIONAL; Chen YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004261; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Desai SD, 2012, INSECT MOL BIOL, V21, P446, DOI 10.1111/j.1365-2583.2012.01150.x; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich LS, 2010, J VIROL, V84, P6438, DOI 10.1128/JVI.01588-09; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Flenniken ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077263; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; Fussnecker BL, 2013, J COMP PHYSIOL A, V197, P939, DOI [10.1007/s00359-011-0654-5cGMP, DOI 10.1007/S00359-011-0654-5CGMP]; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goodwin J, 1996, PLANT CELL, V8, P95; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Hou CS, 2014, VIRUSES-BASEL, V6, P2012, DOI 10.3390/v6052012; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh I, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-9; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kathiria P, 2010, PLANT PHYSIOL, V153, P1859, DOI 10.1104/pp.110.157263; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077354; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789; Lockett GA, 2012, GENES BRAIN BEHAV, V11, P235, DOI 10.1111/j.1601-183X.2011.00751.x; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004; Mukherjee S, 2013, INFLUENZA OTHER RESP, V7, P979, DOI 10.1111/irv.12127; Mukherjee S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-127; Niu JZ, 2014, CURR OPIN INSECT SCI, V6, P22, DOI 10.1016/j.cois.2014.09.014; Park J, 2012, HUM MOL GENET, V21, P46, DOI 10.1093/hmg/ddr436; Park J, 2011, MOL BIOL EVOL, V28, P3345, DOI 10.1093/molbev/msr168; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Richard FJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-558; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sarda S, 2012, MOL BIOL EVOL, V29, P1907, DOI 10.1093/molbev/mss062; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takacs M, 2009, MEDITERR J HEMATOL I, V1, DOI 10.4084/MJHID.2009.012; Tang BK, 2011, MOL IMMUNOL, V48, P1001, DOI 10.1016/j.molimm.2011.01.003; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; URIELISHOVAL S, 1982, FEBS LETT, V146, P148, DOI 10.1016/0014-5793(82)80723-0; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003872; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Wang Y, 2009, J MOL EVOL, V68, P700, DOI 10.1007/s00239-009-9244-3; Xi Yuanxin, 2009, BMC Bioinformatics, V10, P232, DOI 10.1186/1471-2105-10-232; Xu J, 2012, CELL HOST MICROBE, V12, P531, DOI 10.1016/j.chom.2012.08.011; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zeng J, 2010, GENOME BIOL EVOL, V2, P770, DOI 10.1093/gbe/evq060",90,40,40,0,43,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004713,10.1371/journal.ppat.1004713,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900039,25811620.0,"DOAJ Gold, Green Published",,,16/08/2019,40,126,58,8295,1100,834,266,7195,5758,25,1412,58,5,0,0,36,36,4,,205,31,105,0,31,41,41,41,24,0,0,0,0,0,0,0,121,18,8423,20,0,71,394,7,7156,1100,20,0,71,394,7,167,,7,3,0,0,32,0,1,1,0,0,0,105,0,0,89.19,7.540909090909091,1.1528839471855454,0.15288394718554552,1.2282140375260597,1.0653405666063893,8.033636363636363
37,J,"Hewitson, JP; Filbey, KJ; Esser-von Bieren, J; Camberis, M; Schwartz, C; Murray, J; Reynolds, LA; Blair, N; Robertson, E; Harcus, Y; Boon, L; Huang, SCC; Yang, LH; Tu, YZ; Miller, MJ; Voehringer, D; Le Gros, G; Harris, N; Maizels, RM",,,,"Hewitson, James P.; Filbey, Kara J.; Bieren, Julia Esser-von; Camberis, Mali; Schwartz, Christian; Murray, Janice; Reynolds, Lisa A.; Blair, Natalie; Robertson, Elaine; Harcus, Yvonne; Boon, Louis; Huang, Stanley Ching-Cheng; Yang, Lihua; Tu, Yizheng; Miller, Mark J.; Voehringer, David; Le Gros, Graham; Harris, Nicola; Maizels, Rick M.",,,"Concerted Activity of IgG1 Antibodies and IL-4/IL-25-Dependent Effector Cells Trap Helminth Larvae in the Tissues following Vaccination with Defined Secreted Antigens, Providing Sterile Immunity to Challenge Infection",PLOS PATHOGENS,,,English,Article,,,,,,,NKT CELLS; PROTECTIVE IMMUNITY; TYPE-2 IMMUNITY; IL-25; INNATE; RESPONSES; PRODUCTS; PROMOTES; ELICITS; RESISTANCE,"Over 25% of the world's population are infected with helminth parasites, the majority of which colonise the gastrointestinal tract. However, no vaccine is yet available for human use, and mechanisms of protective immunity remain unclear. In the mouse model of Heligmosomoides polygyrus infection, vaccination with excretory-secretory (HES) antigens from adult parasites elicits sterilising immunity. Notably, three purified HES antigens (VAL-1, -2 and -3) are sufficient for effective vaccination. Protection is fully dependent upon specific IgG1 antibodies, but passive transfer confers only partial immunity to infection, indicating that cellular components are also required. Moreover, immune mice show greater cellular infiltration associated with trapping of larvae in the gut wall prior to their maturation. Intravital imaging of infected intestinal tissue revealed a four-fold increase in extravasation by LysM(+)GFP(+) myeloid cells in vaccinated mice, and the massing of these cells around immature larvae. Mice deficient in FcR gamma chain or C3 complement component remain fully immune, suggesting that in the presence of antibodies that directly neutralise parasite molecules, the myeloid compartment may attack larvae more quickly and effectively. Immunity to challenge infection was compromised in IL-4R alpha- and IL-25-deficient mice, despite levels of specific antibody comparable to immune wild-type controls, while deficiencies in basophils, eosinophils or mast cells or CCR2-dependent inflammatory monocytes did not diminish immunity. Finally, we identify a suite of previously uncharacterised heat-labile vaccine antigens with homologs in human and veterinary parasites that together promote full immunity. Taken together, these data indicate that vaccine-induced immunity to intestinal helminths involves IgG1 antibodies directed against secreted proteins acting in concert with IL-25-dependent Type 2 myeloid effector populations.","[Hewitson, James P.; Filbey, Kara J.; Murray, Janice; Reynolds, Lisa A.; Blair, Natalie; Robertson, Elaine; Harcus, Yvonne; Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Hewitson, James P.; Filbey, Kara J.; Murray, Janice; Reynolds, Lisa A.; Blair, Natalie; Robertson, Elaine; Harcus, Yvonne; Maizels, Rick M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Bieren, Julia Esser-von; Harris, Nicola] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Camberis, Mali; Le Gros, Graham] Malaghan Inst, Wellington, New Zealand; [Schwartz, Christian; Voehringer, David] Univ Clin Erlangen, Dept Infect Biol, Erlangen, Germany; [Boon, Louis] Bioceros Holding BV, Utrecht, Netherlands; [Huang, Stanley Ching-Cheng] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Yang, Lihua; Tu, Yizheng; Miller, Mark J.] Washington Univ, Dept Internal Med, St Louis, MO USA","Hewitson, JP (reprint author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.",r.maizels@ed.ac.uk,"harris, nicola/E-5342-2019; Voehringer, David/K-2776-2019; Schwartz, Christian/J-5230-2019","harris, nicola/0000-0003-2922-0210; Schwartz, Christian/0000-0002-7084-268X; Le Gros, Graham/0000-0002-5721-0442; Filbey, Kara/0000-0001-5758-5730; Hewitson, James/0000-0002-3265-6763","Wellcome Trust [090281, 086629]; UK Medical Research Council; UCB Celltech [14635]; American Asthma Foundation [10-0234]; European Research Council [92854]; Swiss Vaccine Research Institute; Health Research Council of New Zealand; NIH-NIAID [AI07760]; MIST (Mucosal Immunology Studies Team) [AI09555]; NIDDK [DK097317]","The authors gratefully acknowledge the following funding sources for support: the Wellcome Trust (www.wellcome.ac.uk), Refs. 090281 and 086629 (JPH, LAR, JM, YH, RMM); the UK Medical Research Council (www.mrc.ac.uk) and UCB Celltech Ref 14635 (KJF); the American Asthma Foundation (www.americanasthmafoundation.org) Grant No. 10-0234 (NB, ER and RMM); the European Research Council (erc.europa.eu) Ref 92854 (CS and DV); the Swiss Vaccine Research Institute (www.swissvaccineresearchinstitute.ch) (JEvB and NH); the Health Research Council of New Zealand (www.hrc.govt.nz) (MC and GLG); NIH-NIAID AI07760, MIST (Mucosal Immunology Studies Team) AI09555 and NIDDK DK097317 (LY, YT and MJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1415; Assana E, 2010, INT J PARASITOL, V40, P515, DOI 10.1016/j.ijpara.2010.01.006; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Behnke JM, 2009, PARASITOLOGY, V136, P1565, DOI 10.1017/S0031182009006003; Bethony JM, 2011, IMMUNOL REV, V239, P237, DOI 10.1111/j.1600-065X.2010.00976.x; Bieren JEV, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003771; Cadman ET, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003988; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Dent LA, 1999, INFECT IMMUN, V67, P989; Diemert DJ, 2012, J ALLERGY CLIN IMMUN, V130, P169, DOI 10.1016/j.jaci.2012.04.027; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Faust N, 2000, BLOOD, V96, P719; Filbey KJ, 2014, IMMUNOL CELL BIOL, V92, P436, DOI 10.1038/icb.2013.109; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gebreselassie NG, 2012, J IMMUNOL, V188, P417, DOI 10.4049/jimmunol.1101980; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Hewitson JP, 2014, EXPERT REV VACCINES, V13, P473, DOI 10.1586/14760584.2014.893195; Hewitson JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003492; Hewitson JP, 2011, J IMMUNOL, V187, P4764, DOI 10.4049/jimmunol.1004140; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Johnston CJC, 2015, J VISUALIZE IN PRESS; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; Maizels RM, 1999, IMMUNOL REV, V171, P125, DOI 10.1111/j.1600-065X.1999.tb01345.x; Martin C, 2000, MED MICROBIOL IMMUN, V189, P67, DOI 10.1007/PL00008258; Martin RK, 2014, J LEUKOCYTE BIOL, V96, P151, DOI 10.1189/jlb.5A1213-644R; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; Mearns H, 2014, EUR J IMMUNOL, V44, P1976, DOI 10.1002/eji.201344400; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; PENTILLA IA, 1985, AUST J EXP BIOL MED, V63, P531; Petersen BC, 2012, NAT MED, V18, P751, DOI 10.1038/nm.2735; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Saleem SJ, 2012, J IMMUNOL, V189, P511, DOI 10.4049/jimmunol.1200647; Sargison ND, 2012, VET PARASITOL, V189, P79, DOI 10.1016/j.vetpar.2012.03.035; Schwartz C, 2014, P NATL ACAD SCI USA, V111, pE5169, DOI 10.1073/pnas.1412663111; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Telford G, 1998, PARASITE IMMUNOL, V20, P601; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; YANG Z, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PONE.0059441; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026",72,37,37,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004676,10.1371/journal.ppat.1004676,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900013,25816012.0,"DOAJ Gold, Green Published",,,16/08/2019,30,0,36,5542,1613,586,1027,3929,3259,24,646,36,0,0,0,28,28,2,,100,7,51,0,7,30,30,25,14,0,0,0,0,0,0,0,0,3,5536,39,0,80,198,1,3891,1613,39,0,80,198,1,32,,1,0,0,0,7,0,0,1,0,0,0,51,0,0,13.95,3.435833849969002,1.4105370323237465,0.4105370323237465,1.4693306184779842,1.0416817033561891,3.579045257284563
38,J,"Hiyoshi, H; Okada, R; Matsuda, S; Gotoh, K; Akeda, Y; Iida, T; Kodama, T",,,,"Hiyoshi, Hirotaka; Okada, Ryu; Matsuda, Shigeaki; Gotoh, Kazuyoshi; Akeda, Yukihiro; Iida, Tetsuya; Kodama, Toshio",,,Interaction between the Type III Effector VopO and GEF-H1 Activates the RhoA-ROCK Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,VIBRIO-PARAHAEMOLYTICUS TYPE-III-SECRETION-SYSTEM-2; NUCLEOTIDE-EXCHANGE FACTORS; ACTIN CYTOSKELETON; CELLULAR FUNCTIONS; SECRETION SYSTEM; MICROTUBULE; BARRIER; IDENTIFICATION; PATHOGENICITY; PROTEINS,"Vibrio parahaemolyticus is an important pathogen that causes food-borne gastroenteritis in humans. The type III secretion system encoded on chromosome 2 (T3SS2) plays a critical role in the enterotoxic activity of V. parahaemolyticus. Previous studies have demonstrated that T3SS2 induces actin stress fibers in various epithelial cell lines during infection. This stress fiber formation is strongly related to pathogenicity, but the mechanisms that underlie T3SS2-dependent actin stress fiber formation and the main effector have not been elucidated. In this study, we identified VopO as a critical T3SS2 effector protein that activates the RhoA-ROCK pathway, which is an essential pathway for the induction of the T3SS2-dependent stress fiber formation. We also determined that GEF-H1, a RhoA guanine nucleotide exchange factor (GEF), directly binds VopO and is necessary for T3SS2-dependent stress fiber formation. The GEF-H1-binding activity of VopO via an alpha helix region correlated well with its stress fiber-inducing capacity. Furthermore, we showed that VopO is involved in the T3SS2-dependent disruption of the epithelial barrier. Thus, VopO hijacks the RhoA-ROCK pathway in a different manner compared with previously reported bacterial toxins and effectors that modulate the Rho GTPase signaling pathway.","[Hiyoshi, Hirotaka; Okada, Ryu; Matsuda, Shigeaki; Gotoh, Kazuyoshi; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Lab Genom Res Pathogen Bacteria, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan; [Akeda, Yukihiro] Osaka Univ, Microbial Dis Res Inst, Lab Clin Res Infect Dis, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan; [Kodama, Toshio] Osaka Univ, Microbial Dis Res Inst, Microbe Repository Unit, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan","Hiyoshi, H (reprint author), Univ Calif Davis, Dept Med Microbiol & Immunol, Sch Med, Davis, CA 95616 USA.",kodama@biken.osaka-u.ac.jp,,,"Japan Society for the Promotion of Science (JSPS) [23790474, 25460531]; Institute for Fermentation, Osaka (IFO); NAITO Foundation; Takeda Science Foundation, Japan","This research was supported by a Grant-in-Aid for Young Scientists (B) (23790474) and by a Grant-in-Aid for Scientific Research (C) (25460531) from the Japan Society for the Promotion of Science (JSPS). This work was also supported by Grants-in-Aid from the Institute for Fermentation, Osaka (IFO), from the NAITO Foundation, and from the Takeda Science Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akeda Y, 1997, J INFECT DIS, V176, P822, DOI 10.1086/517312; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Cario-Toumaniantz C, 2012, AM J PHYSIOL-CELL PH, V302, pC1394, DOI 10.1152/ajpcell.00423.2011; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chavan A, 2009, EUR RADIOL, V19, P488, DOI 10.1007/s00330-008-1141-4; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hiyoshi H, 2011, CELL HOST MICROBE, V10, P401, DOI 10.1016/j.chom.2011.08.014; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Khounlotham M, 2012, IMMUNITY, V37, P563, DOI 10.1016/j.immuni.2012.06.017; Kodama T, 2008, INFECT IMMUN, V76, P4282, DOI 10.1128/IAI.01738-07; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Matsuzawa T, 2005, INFECT IMMUN, V73, P6283, DOI 10.1128/IAI.73.10.6283-6289.2005; Matsuzawa T, 2004, EMBO J, V23, P3570, DOI 10.1038/sj.emboj.7600359; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nakano M, 2007, J INFECT DIS, V195, P1353, DOI 10.1086/513275; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Okada R, 2014, CELL MICROBIOL, V16, P938, DOI 10.1111/cmi.12252; Orchard RC, 2012, CELL MICROBIOL, V14, P10, DOI 10.1111/j.1462-5822.2011.01703.x; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Santos MD, 2014, MBIO, V5, DOI 10.1128/mBio.01506-14; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Schlegel N, 2011, J CELL PHYSIOL, V226, P1196, DOI 10.1002/jcp.22446; Shaw RK, 2005, INFECT IMMUN, V73, P4385, DOI 10.1128/IAI.73.7.4385-4390.2005; Tomson FL, 2005, MOL MICROBIOL, V56, P447, DOI 10.1111/j.1365-2958.2005.04571.x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wilson BA, 2010, FUTURE MICROBIOL, V5, P1185, DOI 10.2217/FMB.10.91; Yoshimura Y, 2011, BIOCHEM BIOPH RES CO, V408, P322, DOI 10.1016/j.bbrc.2011.04.032; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004; Zhou XH, 2013, CELL REP, V3, P1690, DOI 10.1016/j.celrep.2013.03.039",51,6,7,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004694,10.1371/journal.ppat.1004694,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900023,25738744.0,"DOAJ Gold, Green Published",,,16/08/2019,7,0,17,3868,667,528,139,3201,2299,21,881,17,0,0,0,6,6,0,,20,0,20,0,0,7,7,6,3,0,0,0,0,0,0,0,0,0,3917,103,0,75,71,1,3214,678,103,0,75,71,1,25,,0,0,0,0,0,0,0,1,0,0,0,20,0,0,0.25,5.799100449775112,1.2083723836301157,0.2083723836301156,1.2780381130896594,1.0576525336091003,6.133433283358321
39,J,"Hodgson, A; Wier, EM; Fu, K; Sun, X; Yu, HB; Zheng, WX; Sham, HP; Johnson, K; Bailey, S; Vallance, BA; Wan, FY",,,,"Hodgson, Andrea; Wier, Eric M.; Fu, Kai; Sun, Xin; Yu, Hongbing; Zheng, Wenxin; Sham, Ho Pan; Johnson, Kaitlin; Bailey, Scott; Vallance, Bruce A.; Wan, Fengyi",,,Metalloprotease NleC Suppresses Host NF-kappa B/Inflammatory Responses by Cleaving p65 and Interfering with the p65/RPS3 Interaction,PLOS PATHOGENS,,,English,Article,,,,,,,ENTEROPATHOGENIC ESCHERICHIA-COLI; INNATE IMMUNE-RESPONSES; CITROBACTER-RODENTIUM; EPITHELIAL-CELLS; B PATHWAY; BACTERIAL PATHOGENS; PROTEOMIC ANALYSIS; SECRETION SYSTEMS; EFFECTORS NLEH1; III SECRETOME,"Attaching/Effacing (A/E) pathogens including enteropathogenic Escherichia coli (EPEC), enterohemorrhagic E. coli (EHEC) and the rodent equivalent Citrobacter rodentium are important causative agents of foodborne diseases. Upon infection, a myriad of virulence proteins (effectors) encoded by A/E pathogens are injected through their conserved type III secretion systems (T3SS) into host cells where they interfere with cell signaling cascades, in particular the nuclear factor kappaB (NF-kappa B) signaling pathway that orchestrates both innate and adaptive immune responses for host defense. Among the T3SS-secreted non-LEE-encoded (Nle) effectors, NleC, a metalloprotease, has been recently elucidated to modulate host NF-kappa B signaling by cleaving NF-kappa B Rel subunits. However, it remains elusive how NleC recognizes NF-kappa B Rel subunits and how the NleC-mediated cleavage impacts on host immune responses in infected cells and animals. In this study, we show that NleC specifically targets p65/RelA through an interaction with a unique N-terminal sequence in p65. NleC cleaves p65 in intestinal epithelial cells, albeit a small percentage of the molecule, to generate the p651-38 fragment during C. rodentium infection in cultured cells. Moreover, the NleC-mediated p65 cleavage substantially affects the expression of a subset of NF-kappa B target genes encoding proinflammatory cytokines/chemokines, immune cell infiltration in the colon, and tissue injury in C. rodentium-infected mice. Mechanistically, the NleC cleavagegenerated p651-38 fragment interferes with the interaction between p65 and ribosomal protein S3 (RPS3), a 'specifier' subunit of NF-kappa B that confers a subset of proinflammatory gene transcription, which amplifies the effect of cleaving only a small percentage of p65 to modulate NF-kappa B-mediated gene expression. Thus, our results reveal a novel mechanism for A/E pathogens to specifically block NF-kappa B signaling and inflammatory responses by cleaving a small percentage of p65 and targeting the p65/RPS3 interaction in host cells, thus providing novel insights into the pathogenic mechanisms of foodborne diseases.","[Hodgson, Andrea] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Hodgson, Andrea; Wier, Eric M.; Fu, Kai; Sun, Xin; Zheng, Wenxin; Johnson, Kaitlin; Bailey, Scott; Wan, Fengyi] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Yu, Hongbing; Sham, Ho Pan; Vallance, Bruce A.] BCs Childrens Hosp, Dept Pediat, Div Gastroenterol, Vancouver, BC, Canada; [Yu, Hongbing; Sham, Ho Pan; Vallance, Bruce A.] Child & Family Res Inst, Vancouver, BC, Canada; [Wan, Fengyi] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA","Hodgson, A (reprint author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.",fwan1@jhu.edu,"Bailey, Scott/N-7248-2019","Wier, Eric/0000-0003-3824-410X; Sun, Xin/0000-0003-2424-8011","National Institutes of Health [CA137171, CA009110]; American Cancer Society [RSG-13-052-01-MPC]","This work was supported in part by grants CA137171 (FW) and CA009110 (EMW) from the National Institutes of Health. EMW and AH are Johns Hopkins Sommer Scholars and BAV is the CHILD Foundation Research Chair in Pediatric Gastroenterology. FW was supported by a Research Scholar Grant, RSG-13-052-01-MPC from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Chen FE, 1998, NATURE, V391, P410; CHILDS WC, 1988, J DENT RES, V67, P826, DOI 10.1177/00220345880670050601; Christian J, 2010, J BIOL CHEM, V285, P41320, DOI 10.1074/jbc.M110.152280; Clarke SC, 2001, DIAGN MICR INFEC DIS, V41, P93, DOI 10.1016/S0732-8893(01)00303-0; Clements A, 2012, GUT MICROBES, P3; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Coiras M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-109; Colombo AV, 2006, J MED MICROBIOL, V55, P609, DOI 10.1099/jmm.0.46417-0; Deng WY, 2012, MOL CELL PROTEOMICS, V11, P692, DOI 10.1074/mcp.M111.013672; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Donnenberg MS, 1997, TRENDS MICROBIOL, V5, P109, DOI 10.1016/S0966-842X(97)01000-7; Dooher JE, 2011, MOL CANCER RES, V9, P1395, DOI 10.1158/1541-7786.MCR-11-0072; Doyle PS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002139; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Fu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2916; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379; IZHAR M, 1982, INFECT IMMUN, V35, P1110; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Le Negrate G, 2012, CELL MICROBIOL, V14, P155, DOI 10.1111/j.1462-5822.2011.01719.x; Li WQ, 2014, ACTA CRYSTALLOGR D, V70, P40, DOI 10.1107/S1399004713024619; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Mulhern O, 2009, ADV EXP MED BIOL, V666, P49; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Neznanov N, 2005, J BIOL CHEM, V280, P24153, DOI 10.1074/jbc.M502303200; O'Callaghan D, 2010, CURR OPIN MICROBIOL, V13, P1, DOI 10.1016/j.mib.2009.12.006; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Pham TH, 2012, INFECT IMMUN, V80, P2133, DOI 10.1128/IAI.06358-11; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Royan SV, 2010, MOL MICROBIOL, V78, P1232, DOI 10.1111/j.1365-2958.2010.07400.x; Ruchaud-Sparagano MH, 2007, CELL MICROBIOL, V9, P1909, DOI 10.1111/j.1462-5822.2007.00923.x; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; Shames SR, 2012, TRENDS MICROBIOL, V20, P214, DOI 10.1016/j.tim.2012.02.007; Shames SR, 2011, CELL MICROBIOL, V13, P1542, DOI 10.1111/j.1462-5822.2011.01640.x; Silva DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003128; Sorimachi H, 2012, BIOL CHEM, V393, P853, DOI 10.1515/hsz-2012-0143; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Turco MM, 2014, BIOCHEMISTRY-US, V53, P5131, DOI 10.1021/bi500593e; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wier EM, 2012, J BIOL CHEM, V287, P43019, DOI 10.1074/jbc.M112.388694; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231",64,22,22,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004705,10.1371/journal.ppat.1004705,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900033,25756944.0,"DOAJ Gold, Green Published",,,16/08/2019,23,2,31,4199,1103,841,262,3096,2500,23,573,31,0,0,0,21,21,0,,34,0,34,0,0,25,25,25,17,0,0,0,0,0,0,0,2,2,4223,46,0,199,153,0,3089,1103,46,0,199,153,0,31,,0,0,0,0,14,0,1,1,0,0,0,34,0,0,8.9,3.8068902991840434,1.356266149870801,0.356266149870801,1.428294573643411,1.053107882829245,4.009066183136899
40,J,"Isken, O; Langerwisch, U; Jirasko, V; Rehders, D; Redecke, L; Ramanathan, H; Lindenbach, BD; Bartenschlager, R; Tautz, N",,,,"Isken, Olaf; Langerwisch, Ulrike; Jirasko, Vlastimil; Rehders, Dirk; Redecke, Lars; Ramanathan, Harish; Lindenbach, Brett D.; Bartenschlager, Ralf; Tautz, Norbert",,,"A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication",PLOS PATHOGENS,,,English,Article,,,,,,,HEPATITIS-C VIRUS; VIRAL-RNA REPLICATION; NONSTRUCTURAL PROTEINS; FUNCTIONAL-CHARACTERIZATION; MUTATIONAL ANALYSIS; PRECURSOR PROTEIN; CRYSTAL-STRUCTURE; CELL-CULTURE; POLYPROTEIN; PHOSPHORYLATION,"Hepatitis C virus (HCV) infection is a leading cause of liver disease worldwide. The HCV RNA genome is translated into a single polyprotein. Most of the cleavage sites in the nonstructural (NS) polyprotein region are processed by the NS3/NS4A serine protease. The vital NS2-NS3 cleavage is catalyzed by the NS2 autoprotease. For efficient processing at the NS2/NS3 site, the NS2 cysteine protease depends on the NS3 serine protease domain. Despite its importance for the viral life cycle, the molecular details of the NS2 autoprotease activation by NS3 are poorly understood. Here, we report the identification of a conserved hydrophobic NS3 surface patch that is essential for NS2 protease activation. One residue within this surface region is also critical for RNA replication and NS5A hyperphosphorylation, two processes known to depend on functional replicase assembly. This dual function of the NS3 surface patch prompted us to reinvestigate the impact of the NS2-NS3 cleavage on NS5A hyperphosphorylation. Interestingly, NS2-NS3 cleavage turned out to be a prerequisite for NS5A hyperphosphorylation, indicating that this cleavage has to occur prior to replicase assembly. Based on our data, we propose a sequential cascade of molecular events: in uncleaved NS2-NS3, the hydrophobic NS3 surface patch promotes NS2 protease stimulation; upon NS2-NS3 cleavage, this surface region becomes available for functional replicase assembly. This model explains why efficient NS2-3 cleavage is pivotal for HCV RNA replication. According to our model, the hydrophobic surface patch on NS3 represents a module critically involved in the temporal coordination of HCV replicase assembly.","[Isken, Olaf; Langerwisch, Ulrike; Tautz, Norbert] Univ Lubeck, Inst Virol & Cell Biol, Hamburg, Germany; [Jirasko, Vlastimil; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, Heidelberg, Germany; [Rehders, Dirk; Redecke, Lars] Univ Hamburg, Joint Lab Struct Biol Infect & Inflammat, Hamburg, Germany; [Rehders, Dirk; Redecke, Lars] Univ Lubeck, DESY, Hamburg, Germany; [Ramanathan, Harish; Lindenbach, Brett D.] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT USA","Isken, O (reprint author), Univ Lubeck, Inst Virol & Cell Biol, Hamburg, Germany.",tautz@vuz.uni-luebeck.de,"Bartenschlager, Ralf/L-2582-2015","Bartenschlager, Ralf/0000-0001-5601-9307","German Science Foundation (DFG) [TA 218 2-1]; German Ministry for Education and Research [01KX0806, 01KX0807]","NT was funded by the German Science Foundation (DFG) (Grant TA 218 2-1). LR was funded by German Ministry for Education and Research (Grants 01KX0806 and 01KX0807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Asabe SI, 1997, J VIROL, V71, P790; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; de la Fuente C, 2013, J VIROL, V87, P4130, DOI 10.1128/JVI.03174-12; Dentzer TG, 2009, J VIROL, V83, P12702, DOI 10.1128/JVI.01184-09; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; FAILLA C, 1994, J VIROL, V68, P3753; Fridell RA, 2013, J VIROL, V87, P2320, DOI 10.1128/JVI.02861-12; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; HIJIKATA M, 1993, J VIROL, V67, P4665; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Isken O, 2014, J VIROL, V88, P82, DOI 10.1128/JVI.01957-13; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Kim DW, 1997, J VIROL, V71, P9400; Kim JE, 1999, ARCH VIROL, V144, P329, DOI 10.1007/s007050050507; Koch JO, 1999, J VIROL, V73, P7138; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; KOLYKHALOV AA, 1994, J VIROL, V68, P7525; LIN C, 1994, J VIROL, V68, P5063; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Liu QY, 1999, BIOCHEM BIOPH RES CO, V254, P572, DOI 10.1006/bbrc.1998.9986; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Lulla A, 2012, J VIROL, V86, P553, DOI 10.1128/JVI.05195-11; Ma Y, 2010, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Neddermann P, 1999, J VIROL, V73, P9984; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Pallaoro M, 2001, J VIROL, V75, P9939, DOI 10.1128/JVI.75.20.9939-9946.2001; Paul D, 2011, J VIROL, V85, P6963, DOI 10.1128/JVI.00502-11; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; SANTOLINI E, 1995, J VIROL, V69, P7461; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Schultz DE, 1996, J VIROL, V70, P1041; Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109; Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; TAKAMIZAWA A, 1991, J VIROL, V65, P1105; Tedbury PR, 2007, J MOL BIOL, V366, P1652, DOI 10.1016/j.jmb.2006.12.062; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Welbourn S, 2007, CURR ISSUES MOL BIOL, V9, P63; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403",60,9,9,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004736,10.1371/journal.ppat.1004736,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900054,25774920.0,"DOAJ Gold, Green Published",,,16/08/2019,7,0,43,3837,797,610,187,3040,2493,17,530,43,0,0,0,8,8,1,,0,0,0,0,0,9,7,8,9,0,0,0,0,0,0,0,0,0,3839,26,0,267,48,0,3034,797,26,0,267,48,0,8,,0,0,0,0,0,0,0,1,0,0,0,51,0,0,0.25,4.814303638644918,1.262171052631579,0.26217105263157897,1.287171052631579,1.0198071409955694,4.909661229611041
41,J,"Isnard, A; Christian, JG; Kodiha, M; Stochaj, U; McMaster, WR; Olivier, M",,,,"Isnard, Amandine; Christian, Jan G.; Kodiha, Mohamed; Stochaj, Ursula; McMaster, W. Robert; Olivier, Martin",,,Impact of Leishmania Infection on Host Macrophage Nuclear Physiology and Nucleopore Complex Integrity,PLOS PATHOGENS,,,English,Article,,,,,,,PORE COMPLEX; NUCLEOCYTOPLASMIC TRAFFICKING; PARASITE SURVIVAL; PHOSPHATASE SHP-1; BETA-CATENIN; PROTEIN; GP63; ENVELOPE; LOCALIZATION; TRANSPORT,"The protease GP63 is an important virulence factor of Leishmania parasites. We previously showed that GP63 reaches the perinuclear area of host macrophages and that it directly modifies nuclear translocation of the transcription factors NF-kappa B and AP-1. Here we describe for the first time, using molecular biology and in-depth proteomic analyses, that GP63 alters the host macrophage nuclear envelope, and impacts on nuclear processes. Our results suggest that GP63 does not appear to use a classical nuclear localization signal common between Leishmania species for import, but degrades nucleoporins, and is responsible for nuclear transport alterations. In the nucleoplasm, GP63 activity accounts for the degradation and mislocalization of proteins involved amongst others in gene expression and in translation. Collectively, our data indicates that Leishmania infection strongly affects nuclear physiology, suggesting that targeting of nuclear physiology may be a strategy beneficial for virulent Leishmania parasites.","[Isnard, Amandine; Christian, Jan G.; Olivier, Martin] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ, Canada; [Isnard, Amandine; Christian, Jan G.; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Kodiha, Mohamed; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [McMaster, W. Robert] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada","Isnard, A (reprint author), McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ, Canada.",martin.olivier@mcgill.ca,,,Canadian Institute of Health Research (CIHR),"Research in MO laboratory is supported by operating grants from the Canadian Institute of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; ASAHI M, 1985, BIOCHEM J, V232, P139, DOI 10.1042/bj2320139; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Bukata L, 2013, CURR OPIN CELL BIOL, V25, P378, DOI 10.1016/j.ceb.2013.03.002; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cohen S, 2012, INT REV CEL MOL BIO, V299, P117, DOI 10.1016/B978-0-12-394310-1.00003-5; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11<3185::AID-IMMU3185>3.0.CO;2-J; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Hassani K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002185; Hoek M, 2000, J CELL SCI, V113, P3959; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kima PE, 2010, PLOS NEGLECTED TROPI, V4; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lynn MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001141; MACDONALD MH, 1995, BBA-PROTEIN STRUCT M, V1253, P199, DOI 10.1016/0167-4838(95)00155-5; Malik P, 2012, J BIOL CHEM, V287, P12277, DOI 10.1074/jbc.M111.331777; Marchetti MA, 2000, J CELL SCI, V113, P899; Matte C, 2010, INFECT IMMUN, V78, P3736, DOI 10.1128/IAI.00046-10; Matunis MJ, 2006, METHODS, V39, P277, DOI 10.1016/j.ymeth.2006.06.003; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Mazumder S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001429; Mock DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002635; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Sachdeva R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007880; Sharma M, 2012, J BIOL CHEM, V287, P819, DOI 10.1074/jbc.M111.299099; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Tapley EC, 2013, CURR OPIN CELL BIOL, V25, P57, DOI 10.1016/j.ceb.2012.10.014; Younessi Parisa, 2012, Infectious Disorders - Drug Targets, V12, P59",50,16,16,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004776,10.1371/journal.ppat.1004776,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900079,25826301.0,"DOAJ Gold, Green Published",,,16/08/2019,17,1,27,5284,918,687,231,4366,3570,21,775,27,0,0,0,16,16,2,,37,0,37,0,0,17,17,16,6,0,0,0,0,0,0,0,1,2,5346,62,0,379,96,0,4392,938,62,0,379,96,0,16,,0,0,0,0,2,0,1,0,0,0,0,38,0,0,0.75,5.75599128540305,1.2102611085661934,0.21026110856619332,1.260650480989464,1.0416351249053748,5.995642701525054
42,J,"Jayasooriya, S; de Silva, TI; Njie-jobe, J; Sanyang, C; Leese, AM; Bell, AI; McAulay, KA; Yanchun, P; Long, HM; Dong, T; Whittle, HC; Rickinson, AB; Rowland-Jones, SL; Hislop, AD; Flanagan, KL",,,,"Jayasooriya, Shamanthi; de Silva, Thushan I.; Njie-jobe, Jainaba; Sanyang, Chilel; Leese, Alison M.; Bell, Andrew I.; McAulay, Karen A.; Yanchun, Peng; Long, Heather M.; Dong, Tao; Whittle, Hilton C.; Rickinson, Alan B.; Rowland-Jones, Sarah L.; Hislop, Andrew D.; Flanagan, Katie L.",,,Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children,PLOS PATHOGENS,,,English,Article,,,,,,,CD8(+) T-CELLS; PRIMARY IMMUNE-RESPONSE; PRIMARY EBV INFECTION; NATURAL-KILLER-CELLS; UNIVERSITY-STUDENTS; VIRAL-INFECTION; IN-VIVO; MONONUCLEOSIS; INFANTS; MALARIA,"Epstein-Barr virus (EBV) infection often occurs in early childhood and is asymptomatic. However, if delayed until adolescence, primary infection may manifest as acute infectious mononucleosis (AIM), a febrile illness characterised by global CD8+ T-cell lymphocytosis, much of it reflecting a huge expansion of activated EBV-specific CD8+ T-cells. While the events of AIM have been intensely studied, little is known about how these relate to asymptomatic primary infection. Here Gambian children (14-18 months old, an age at which many acquire the virus) were followed for the ensuing six months, monitoring circulating EBV loads, antibody status against virus capsid antigen (VCA) and both total and virus-specific CD8+ T-cell numbers. Many children were IgG anti-VCA-positive and, though no longer IgM-positive, still retained high virus loads comparable to AIM patients and had detectable EBV-specific T-cells, some still expressing activation markers. Virus loads and the frequency/activation status of specific T-cells decreased over time, consistent with resolution of a relatively recent primary infection. Six children with similarly high EBV loads were IgM anti-VCA-positive, indicating very recent infection. In three of these donors with HLA types allowing MHC-tetramer analysis, highly activated EBV-specific T-cells were detectable in the blood with one individual epitope response reaching 15% of all CD8+ T-cells. That response was culled and the cells lost activation markers over time, just as seen in AIM. However, unlike AIM, these events occurred without marked expansion of total CD8+ numbers. Thus asymptomatic EBV infection in children elicits a virus-specific CD8+ T-cell response that can control the infection without over-expansion; conversely, in AIM it appears the CD8 over-expansion, rather than virus load per se, is the cause of disease symptoms.","[Jayasooriya, Shamanthi; de Silva, Thushan I.; Njie-jobe, Jainaba; Sanyang, Chilel; Whittle, Hilton C.; Flanagan, Katie L.] MRC Labs, Fajara, Gambia; [Jayasooriya, Shamanthi; Leese, Alison M.; Bell, Andrew I.; Long, Heather M.; Rickinson, Alan B.; Hislop, Andrew D.] Univ Birmingham, Sch Canc Sci, Edgbaston, England; [de Silva, Thushan I.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England; [de Silva, Thushan I.; Yanchun, Peng; Dong, Tao] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [McAulay, Karen A.] Univ Glasgow, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [Whittle, Hilton C.] London Sch Hyg & Trop Med, London WC1, England; [Rowland-Jones, Sarah L.] Univ Oxford, Nuffied Dept Med, Headington, England; [Flanagan, Katie L.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia","Jayasooriya, S (reprint author), MRC Labs, Fajara, Gambia.",a.d.hislop@bham.ac.uk,,"Bell, Andrew/0000-0001-9520-4417; de Silva, Thushan/0000-0002-6498-9212","Medical Research Council (MRC), The Gambia; MRC [G9901294]; MRC; Cancer Research UK [15032]; Medical Research Council [G1001046, MC_U190092703, G0801751, G0600520, MR/L018942/1]; Worldwide Cancer Research [13-0102]","This work was funded by the Medical Research Council (MRC), The Gambia, a MRC programme grant awarded to the University of Birmingham, G9901294 and SJ was a recipient of an MRC studentship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Balfour HH, 2005, J INFECT DIS, V192, P1505; BIGGAR RJ, 1978, INT J CANCER, V22, P244, DOI 10.1002/ijc.2910220305; Callan MFC, 2000, J CLIN INVEST, V106, P1251, DOI 10.1172/JCI10590; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; Catalina MD, 2001, J IMMUNOL, V167, P4450, DOI 10.4049/jimmunol.167.8.4450; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chattopadhyay PK, 2013, J VIROL, V87, P1779, DOI 10.1128/JVI.02158-12; Chijioke O, 2013, CELL REP, V5, P1489, DOI 10.1016/j.celrep.2013.11.041; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Condon LM, 2014, CLIN INFECT DIS; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; De Martino M, 1998, PEDIATR RES, V43, P752, DOI 10.1203/00006450-199806000-00007; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Dunne PJ, 2002, BLOOD, V100, P933, DOI 10.1182/blood-2002-01-0160; FLEISHER G, 1979, J INFECT DIS, V139, P553, DOI 10.1093/infdis/139.5.553; Helminen M, 1999, J INFECT DIS, V180, P496, DOI 10.1086/314883; HENLE G, 1966, J BACTERIOL, V91, P1248; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Hislop AD, 2001, J IMMUNOL, V167, P2019, DOI 10.4049/jimmunol.167.4.2019; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Holder B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014013; HORWITZ CA, 1981, BLOOD, V57, P933; Hwang AE, 2012, EPIDEMIOL INFECT, V140, P2089, DOI 10.1017/S0950268811002457; Jia JY, 2003, VIROLOGY, V306, P236, DOI 10.1016/S0042-6822(02)00027-2; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Long HM, 2013, J EXP MED, V210, P933, DOI 10.1084/jem.20121437; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; McAulay KA, 2007, J CLIN INVEST, V117, P3042, DOI 10.1172/JCI32377; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; Rostgaard K, 2014, CLIN INFECT DIS, V58, P1684, DOI 10.1093/cid/ciu204; Silins SL, 2001, BLOOD, V98, P3739, DOI 10.1182/blood.V98.13.3739; Slyker JA, 2013, J INFECT DIS, V207, P1798, DOI 10.1093/infdis/jit093; Steven NM, 1996, J EXP MED, V184, P1801, DOI 10.1084/jem.184.5.1801; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; SUMAYA CV, 1975, J INFECT DIS, V131, P403, DOI 10.1093/infdis/131.4.403; TAMAKI H, 1995, J INFECT DIS, V172, P739, DOI 10.1093/infdis/172.3.739; TAMARU Y, 1993, BLOOD, V82, P521; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; YAO QY, 1985, INT J CANCER, V35, P35, DOI 10.1002/ijc.2910350107",49,22,23,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004746,10.1371/journal.ppat.1004746,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900060,25816224.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,23,1,30,5029,749,513,236,4280,3654,28,598,30,0,0,2,24,24,2,,70,39,36,0,39,23,23,22,12,0,0,0,0,0,0,0,2,6,5119,36,0,126,223,2,4299,759,36,0,126,223,2,61,,0,0,0,0,8,0,1,0,1,0,0,36,0,0,5.45,6.714285714285714,1.175,0.175,1.2565420560747664,1.069397494531716,7.180240320427236
43,J,"Jeong, KC; Sexton, JA; Vogel, JP",,,,"Jeong, Kwang Cheol; Sexton, Jessica A.; Vogel, Joseph P.",,,Spatiotemporal Regulation of a Legionella pneumophila T4SS Substrate by the Metaeffector SidJ,PLOS PATHOGENS,,,English,Article,,,,,,,IV SECRETION SYSTEM; EFFECTOR PROTEIN DRRA; RAB GTPASE FUNCTION; INTRACELLULAR GROWTH; LEGIONNAIRES-DISEASE; ENDOPLASMIC-RETICULUM; TRANSLOCATED SUBSTRATE; ADENYLATE-CYCLASE; COXIELLA-BURNETII; IDENTIFICATION,"Modulation of host cell function is vital for intracellular pathogens to survive and replicate within host cells. Most commonly, these pathogens utilize specialized secretion systems to inject substrates (also called effector proteins) that function as toxins within host cells. Since it would be detrimental for an intracellular pathogen to immediately kill its host cell, it is essential that secreted toxins be inactivated or degraded after they have served their purpose. The pathogen Legionella pneumophila represents an ideal system to study interactions between toxins as it survives within host cells for approximately a day and its Dot/Icm type IVB secretion system (T4SS) injects a vast number of toxins. Previously we reported that the Dot/Icm substrates SidE, SdeA, SdeB, and SdeC (known as the SidE family of effectors) are secreted into host cells, where they localize to the cytoplasmic face of the Legionella containing vacuole (LCV) in the early stages of infection. SidJ, another effector that is unrelated to the SidE family, is also encoded in the sdeC-sdeA locus. Interestingly, while over-expression of SidE family proteins in a wild type Legionella strain has no effect, we found that their over-expression in a. sidJ mutant completely inhibits intracellular growth of the strain. In addition, we found expression of SidE proteins is toxic in both yeast and mammalian HEK293 cells, but this toxicity can be suppressed by co-expression of SidJ, suggesting that SidJ may modulate the function of SidE family proteins. Finally, we were able to demonstrate both in vivo and in vitro that SidJ acts on SidE proteins to mediate their disappearance from the LCV, thereby preventing lethal intoxication of host cells. Based on these findings, we propose that SidJ acts as a metaeffector to control the activity of other Legionella effectors.","[Jeong, Kwang Cheol] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Jeong, Kwang Cheol] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Sexton, Jessica A.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Vogel, Joseph P.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA","Jeong, KC (reprint author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.",jvogel@borcim.wustl.edu,,,National Institutes of Health [AI048052],"This work was supported in part by a grant from the National Institutes of Health (AI048052 to JPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Chatfield Christa H, 2013, Methods Mol Biol, V954, P151, DOI 10.1007/978-1-62703-161-5_7; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Howe Dale, 2008, V445, P389, DOI 10.1007/978-1-59745-157-4_25; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isaac DT, 2014, FUTURE MICROBIOL, V9, P343, DOI 10.2217/fmb.13.162; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MOFFAT JF, 1992, INFECT IMMUN, V60, P296; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; O'Connor TJ, 2012, SCIENCE, V338, P1440, DOI 10.1126/science.1229556; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; PEARLMAN E, 1988, MICROB PATHOGENESIS, V5, P87, DOI 10.1016/0882-4010(88)90011-3; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sexton JA, 2005, MOL MICROBIOL, V57, P70, DOI 10.1111/j.1365-2958.2005.04667.x; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Sexton JA, 2004, J BACTERIOL, V186, P3814, DOI 10.1128/JB.186.12.3814-3825.2004; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Sherman F., 1991, METHOD ENZYMOL, V194, P4, DOI [10.1016/0076-6879(91)94004-V, DOI 10.1016/0076-6879(91)94004-V]; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Sutherland MC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002910; SWANSON MS, 1995, INFECT IMMUN, V63, P3609; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Tilney LG, 2001, J CELL SCI, V114, P4637; Vincent CD, 2006, MOL MICROBIOL, V62, P1278, DOI 10.1111/j.1365-2958.2006.05446.x; Vincent CD, 2006, J BACTERIOL, V188, P8231, DOI 10.1128/JB.00937-06; Vincent CD, 2006, MOL MICROBIOL, V61, P596, DOI 10.1111/j.1365-2958.2006.05243.x; Vincent CD, 2012, MOL MICROBIOL, V85, P378, DOI 10.1111/j.1365-2958.2012.08118.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873",50,31,32,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004695,10.1371/journal.ppat.1004695,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900024,25774515.0,"DOAJ Gold, Green Published",,,16/08/2019,33,1,23,5206,901,708,193,4305,3271,18,1016,23,0,0,0,33,33,0,,37,1,37,0,1,35,35,27,18,0,0,0,0,0,0,0,1,1,5202,116,0,93,82,0,4277,901,77,0,93,80,0,24,,0,0,0,0,2,0,1,1,0,0,0,38,0,0,1.0,5.7780244173140956,1.2092915214866435,0.20929152148664343,1.254355400696864,1.0372646945831732,5.993340732519423
44,J,"Kao, YT; Chang, BL; Liang, JJ; Tsai, HJ; Lee, YL; Lin, RJ; Lin, YL",,,,"Kao, Yu-Ting; Chang, Bi-Lan; Liang, Jian-Jong; Tsai, Hang-Jen; Lee, Yi-Ling; Lin, Ren-Jye; Lin, Yi-Ling",,,Japanese Encephalitis Virus Nonstructural Protein NS5 Interacts with Mitochondrial Trifunctional Protein and Impairs Fatty Acid beta-Oxidation,PLOS PATHOGENS,,,English,Article,,,,,,,INFLUENZA-A VIRUS; HEPATITIS-C; FUNCTIONAL-CHARACTERIZATION; DEHYDROGENASE-DEFICIENCY; 2'-O METHYLATION; LIPID-METABOLISM; INFECTED CELLS; RNA; FLAVIVIRUS; REPLICATION,"Infection with Japanese encephalitis virus (JEV) can induce the expression of pro-inflammatory cytokines and cause acute encephalitis in humans. beta-oxidation breaks down fatty acids for ATP production in mitochondria, and impaired beta-oxidation can induce pro-inflammatory cytokine expression. To address the role of fatty-acid beta-oxidation in JEV infection, we measured the oxygen consumption rate of mock-and JEV-infected cells cultured with or without long chain fatty acid (LCFA) palmitate. Cells with JEV infection showed impaired LCFA beta-oxidation and increased interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) expression. JEV nonstructural protein 5 (NS5) interacted with hydroxyacyl-CoA dehydrogenase alpha and beta subunits, two components of the mitochondrial trifunctional protein (MTP) involved in LCFA beta-oxidation, and NS5 proteins were detected in mitochondria and co-localized with MTP. LCFA beta-oxidation was impaired and higher cytokines were induced in cells overexpressing NS5 protein as compared with control cells. Deletion and mutation studies showed that the N-terminus of NS5 was involved in the MTP association, and a single point mutation of NS5 residue 19 from methionine to alanine (NS5-M19A) reduced its binding ability with MTP. The recombinant JEV with NS5-M19A mutation (JEV-NS5-M19A) was less able to block LCFA beta-oxidation and induced lower levels of IL-6 and TNF-a than wildtype JEV. Moreover, mice challenged with JEV-NS5-M19A showed less neurovirulence and neuroinvasiveness. We identified a novel function of JEV NS5 in viral pathogenesis by impairing LCFA beta-oxidation and inducing cytokine expression by association with MTP.","[Kao, Yu-Ting; Tsai, Hang-Jen; Lin, Yi-Ling] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Yu-Ting; Chang, Bi-Lan; Liang, Jian-Jong; Lee, Yi-Ling; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lin, Ren-Jye] Taipei Med Univ, Coll Med, Sch Med, Dept Gen Med, Taipei, Taiwan; [Lin, Ren-Jye] Taipei Med Univ Hosp, Dept Primary Care Med, Taipei, Taiwan; [Lin, Yi-Ling] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan","Kao, YT (reprint author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.",linrenjye@ibms.sinica.edu.tw; yll@ibms.sinica.edu.tw,"Lin, Yi-Ling/N-7128-2018","Lin, Yi-Ling/0000-0002-1838-6410","National Science Council, Taiwan [NSC 101-2321-B-001-028-MY3, NSC 103-2321-B-001-047]; Academia Sinica, Taiwan","This work was supported by grants from the National Science Council, Taiwan (NSC 101-2321-B-001-028-MY3 and NSC 103-2321-B-001-047) and from Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Angdisen J., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P27, DOI 10.2174/1568008053174796; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Belov GA, 2012, CURR OPIN VIROL, V2, P740, DOI 10.1016/j.coviro.2012.09.006; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Bononi A, 2014, METHODS IN PRESS; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chen LK, 1996, VIROLOGY, V223, P79, DOI 10.1006/viro.1996.0457; Cho HK, 2014, FEBS J, V281, P2228, DOI 10.1111/febs.12776; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Eslam M, 2011, Therap Adv Gastroenterol, V4, P419, DOI 10.1177/1756283X11405251; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerbeth C, 2013, FEBS J, V280, P4933, DOI 10.1111/febs.12445; Hall RA, 2009, J GEN VIROL, V90, P2912, DOI 10.1099/vir.0.013805-0; Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382; HASE T, 1990, INT J EXP PATHOL, V71, P857; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hobiger K, 2012, BIOPHYS J, V102, P1313, DOI 10.1016/j.bpj.2012.02.027; Hu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.369; Jonsson JR, 2008, HEPATOLOGY, V48, P80, DOI 10.1002/hep.22311; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208; Li MX, 2010, J BIOL CHEM, V285, P14871, DOI 10.1074/jbc.M109.069591; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Li ZN, 2008, J VIROL, V82, P6337, DOI 10.1128/JVI.02576-07; Liang JJ, 2009, VACCINE, V27, P2746, DOI 10.1016/j.vaccine.2009.03.007; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; McCrimmon RJ, 2012, J CLIN ENDOCR METAB, V97, P1, DOI 10.1210/jc.2011-1927; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Marie SKN, 2011, CLINICS, V66, P33, DOI 10.1590/S1807-59322011001300005; Rakheja D, 2002, LAB INVEST, V82, P815, DOI 10.1097/01.LAB.0000021175.50201.46; Ramesh G, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/480739; Ramiere C, 2014, J VIROL, V88, P3246, DOI 10.1128/JVI.02862-13; RANDLE PJ, 1963, LANCET, V1, P785; Ravi V, 1997, J MED VIROL, V51, P132; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; Roe CR, 2007, MOL GENET METAB, V92, P346, DOI 10.1016/j.ymgme.2007.07.012; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Sengupta N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090211; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116; Sperk A, 2010, MOL GENET METAB, V101, P205, DOI 10.1016/j.ymgme.2010.07.003; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; TAKEGAMI T, 1989, VIRUS RES, V13, P337; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Tien CF, 2014, BIOCHEM BIOPH RES CO, V443, P464, DOI 10.1016/j.bbrc.2013.11.128; Tonin AM, 2010, NEUROCHEM INT, V56, P930, DOI 10.1016/j.neuint.2010.03.025; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12; Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Ventura FV, 1998, J INHERIT METAB DIS, V21, P645, DOI 10.1023/A:1005480516801; Vickers AEM, 2009, TOXICOL PATHOL, V37, P78, DOI 10.1177/0192623308329285; Wang JJ, 1998, ARCH VIROL, V143, P2353, DOI 10.1007/s007050050466; Wang RYL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-471; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40; Yao DF, 2007, MOL CELL BIOCHEM, V299, P85, DOI 10.1007/s11010-005-9046-x; Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06",85,9,10,1,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004750,10.1371/journal.ppat.1004750,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900063,25816318.0,"DOAJ Gold, Green Published",,,16/08/2019,9,0,14,5255,1312,982,330,3943,3257,23,663,14,0,0,0,8,8,2,,15,0,15,0,0,9,9,8,6,0,0,0,0,0,0,0,0,2,5253,178,0,337,97,0,3925,1312,178,0,337,97,0,16,,0,0,0,0,4,0,1,1,0,0,0,15,0,0,1.75,4.005335365853658,1.3327415673345169,0.3327415673345169,1.4019781891960437,1.0519505233111321,4.213414634146342
45,J,"Khairallah, C; Netzer, S; Villacreces, A; Juzan, M; Rousseau, B; Dulanto, S; Giese, A; Costet, P; Praloran, V; Moreau, JF; Dubus, P; Vermijlen, D; Dechanet-Merville, J; Capone, M",,,,"Khairallah, Camille; Netzer, Sonia; Villacreces, Arnaud; Juzan, Marina; Rousseau, Benoit; Dulanto, Sara; Giese, Alban; Costet, Pierre; Praloran, Vincent; Moreau, Jean-Francois; Dubus, Pierre; Vermijlen, David; Dechanet-Merville, Julie; Capone, Myriam",,,gamma delta T Cells Confer Protection against Murine Cytomegalovirus (MCMV),PLOS PATHOGENS,,,English,Article,,,,,,,NATURAL-KILLER-CELLS; INTESTINAL EPITHELIAL-CELLS; ACUTE-LEUKEMIA PATIENTS; IMMUNE-RESPONSES; INTERFERON-GAMMA; MYELOID-LEUKEMIA; VIRUS-INFECTION; CMV SEROSTATUS; MUTANT MICE; TRANSPLANTATION,"Cytomegalovirus (CMV) is a leading infectious cause of morbidity in immune-compromised patients. gamma delta T cells have been involved in the response to CMV but their role in protection has not been firmly established and their dependency on other lymphocytes has not been addressed. Using C57BL/6 alpha beta and/or gamma delta T cell-deficient mice, we here show that gamma delta T cells are as competent as alpha beta T cells to protect mice from CMV-induced death. gamma delta T cell-mediated protection involved control of viral load and prevented organ damage. gamma delta T cell recovery by bone marrow transplant or adoptive transfer experiments rescued CD3e(-/-) mice from CMV-induced death confirming the protective antiviral role of gamma delta T cells. As observed in humans, different gamma delta T cell subsets were induced upon CMV challenge, which differentiated into effector memory cells. This response was observed in the liver and lungs and implicated both CD27(+) and CD27(-) gamma delta T cells. NK cells were the largely preponderant producers of IFN gamma and cytotoxic granules throughout the infection, suggesting that the protective role of gamma delta T cells did not principally rely on either of these two functions. Finally, gamma delta T cells were strikingly sufficient to fully protect Rag(-/-)gamma c(-/-) mice from death, demonstrating that they can act in the absence of B and NK cells. Altogether our results uncover an autonomous protective antiviral function of gamma delta T cells, and open new perspectives for the characterization of a non classical mode of action which should foster the design of new gamma delta T cell based therapies, especially useful in alpha beta T cell compromised patients.","[Khairallah, Camille; Netzer, Sonia; Villacreces, Arnaud; Juzan, Marina; Rousseau, Benoit; Giese, Alban; Costet, Pierre; Praloran, Vincent; Moreau, Jean-Francois; Dubus, Pierre; Dechanet-Merville, Julie; Capone, Myriam] Univ Bordeaux, Bordeaux, France; [Khairallah, Camille; Netzer, Sonia; Villacreces, Arnaud; Juzan, Marina; Praloran, Vincent; Moreau, Jean-Francois; Dechanet-Merville, Julie; Capone, Myriam] CNRS, UMR 5164, Bordeaux, France; [Rousseau, Benoit] Animalerie A2, Lab Immunol & Immunogenet, Bordeaux, France; [Dulanto, Sara; Vermijlen, David] Univ Libre Bruxelles, Fac Pharm, Brussels, Belgium; [Giese, Alban] EA2406 Histol & Pathol Mol Tumeurs, Bordeaux, France; [Costet, Pierre] Animalerie Specialisee, Bordeaux, France; [Praloran, Vincent] Ctr Hosp Univ, Lab Hematol, Bordeaux, France; [Moreau, Jean-Francois] Ctr Hosp Univ, Bordeaux, France; [Vermijlen, David] Univ Libre Bruxelles, Inst Med Immunol, Brussels, Belgium","Khairallah, C (reprint author), Univ Bordeaux, Bordeaux, France.",julie.dechanet@u-bordeaux2.fr; myriam.capone@u-bordeaux2.fr,,"Khairallah, Camille/0000-0003-2687-9634; Vermijlen, David/0000-0002-7605-8845; VILLACRECES, Arnaud/0000-0002-2868-2264",Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale [DEQ20110421287]; Agence National de la Recherche [ANR-12-BSV3-0024-02]; Ligue Nationale contre le Cancer (Comites Departementaux d'Aquitaine); Association pour la Recherche contre le Cancer [A09/1/5022]; Conseil Regional d'Aquitaine,"This work was supported in part by grants from the Centre National de la Recherche Scientifique, the Fondation pour la Recherche Medicale [DEQ20110421287], the Agence National de la Recherche [ANR-12-BSV3-0024-02], the Ligue Nationale contre le Cancer (Comites Departementaux d'Aquitaine) and the Association pour la Recherche contre le Cancer [A09/1/5022]. Camille Khairallah is supported by the Conseil Regional d'Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Andrew EM, 2005, J IMMUNOL, V175, P1741, DOI 10.4049/jimmunol.175.3.1741; Behrendt CE, 2009, BIOL BLOOD MARROW TR, V15, P54, DOI 10.1016/j.bbmt.2008.10.023; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Broers AEC, 2000, BLOOD, V95, P2240; Capone M, 2003, EUR J IMMUNOL, V33, P1471, DOI 10.1002/eji.200323754; Couzi L, 2012, BLOOD, V119, P1418, DOI 10.1182/blood-2011-06-363655; Couzi L, 2010, J AM SOC NEPHROL, V21, P181, DOI 10.1681/ASN.2008101072; Couzi L, 2009, J INFECT DIS, V200, P1415, DOI 10.1086/644509; Craddock C, 2001, BRIT J HAEMATOL, V112, P228, DOI 10.1046/j.1365-2141.2001.02519.x; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Dieli F, 2003, J IMMUNOL, V170, P463, DOI 10.4049/jimmunol.170.1.463; Dodd J, 2009, J IMMUNOL, V182, P1174, DOI 10.4049/jimmunol.182.2.1174; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Fornara C, 2011, J CLIN IMMUNOL, V31, P1054, DOI 10.1007/s10875-011-9577-8; Gardner T, 2009, EXP MOL PATHOL, V86, P32, DOI 10.1016/j.yexmp.2008.10.005; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Hsu KM, 2009, J GEN VIROL, V90, P33, DOI [10.1099/vir.0.2008/006668-0, 10.1099/vir.0.006668-0]; Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Kirby AC, 2007, EUR J IMMUNOL, V37, P3404, DOI 10.1002/eji.200737216; Knight A, 2010, BLOOD, V116, P2164, DOI 10.1182/blood-2010-01-255166; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Ninomiya T, 2000, IMMUNOLOGY, V99, P187, DOI 10.1046/j.1365-2567.2000.00938.x; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Pitard V, 2008, BLOOD, V112, P1317, DOI 10.1182/blood-2008-01-136713; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; RENARD V, 1995, P NATL ACAD SCI USA, V92, P7545, DOI 10.1073/pnas.92.16.7545; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Robert-Richard E, 2006, HAEMATOL-HEMATOL J, V91, P1384; Roux A, 2013, J IMMUNOL, V191, P1300, DOI 10.4049/jimmunol.1202940; Sandstrom A, 2012, J BIOL CHEM, V287, P6035, DOI 10.1074/jbc.M111.333153; Sauer KA, 2006, NAT PROTOC, V1, P2870, DOI 10.1038/nprot.2006.435; Scheper W, 2013, LEUKEMIA, V27, P1328, DOI 10.1038/leu.2012.374; Schmidt-Hieber M, 2013, BLOOD, V122, P3359, DOI 10.1182/blood-2013-05-499830; Schmolka N, 2013, NAT IMMUNOL, V14, P1093, DOI 10.1038/ni.2702; Sciammas R, 1997, J EXP MED, V185, P1969, DOI 10.1084/jem.185.11.1969; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Smith AL, 2000, IMMUNOLOGY, V101, P325, DOI 10.1046/j.1365-2567.2000.00122.x; Sumaria N, 2009, IMMUNOL CELL BIOL, V87, P559, DOI 10.1038/icb.2009.41; Trgovcich J, 2000, ARCH VIROL, V145, P2601, DOI 10.1007/s007050070010; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vermijlen D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00486; Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348; Welte T, 2008, FEMS IMMUNOL MED MIC, V53, P275, DOI 10.1111/j.1574-695X.2008.00430.x; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Wistuba-Hamprecht K, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-26",59,26,27,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004702,10.1371/journal.ppat.1004702,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900030,25747674.0,"DOAJ Gold, Green Published",,,16/08/2019,25,24,12,4969,1244,956,288,3725,3010,21,694,12,4,0,0,25,25,0,,45,1,45,0,1,28,28,27,15,0,0,0,0,0,0,0,20,1,5009,64,0,51,123,0,3745,1250,64,0,51,123,0,14,,0,0,0,0,5,0,1,1,0,0,0,45,0,0,2.25,3.9943729903536975,1.3339597315436242,0.3339597315436242,1.3948993288590603,1.0456832360635944,4.176848874598071
46,J,"Kim, YE; Ahn, JH",,,,"Kim, Young-Eui; Ahn, Jin-Hyun",,,Positive Role of Promyelocytic Leukemia Protein in Type I Interferon Response and Its Regulation by Human Cytomegalovirus,PLOS PATHOGENS,,,English,Article,,,,,,,VIRAL GENE-EXPRESSION; NUCLEAR-BODIES; HISTONE DEACETYLASE; ANTIVIRAL DEFENSE; STIMULATED TRANSCRIPTION; INTRINSIC IMMUNITY; DNA-REPLICATION; POLYMERASE-II; PML PROTEIN; IE1 PROTEIN,"Promyelocytic leukemia protein (PML), a major component of PML nuclear bodies (also known as nuclear domain 10), is involved in diverse cellular processes such as cell proliferation, apoptosis, gene regulation, and DNA damage response. PML also acts as a restriction factor that suppresses incoming viral genomes, therefore playing an important role in intrinsic defense. Here, we show that PML positively regulates type I interferon response by promoting transcription of interferon-stimulated genes (ISGs) and that this regulation by PML is counteracted by human cytomegalovirus (HCMV) IE1 protein. Small hairpin RNA-mediated PML knockdown in human fibroblasts reduced ISG induction by treatment of interferon-beta or infection with UV-inactivated HCMV. PML was required for accumulation of activated STAT1 and STAT2, interacted with them and HDAC1 and HDAC2, and was associated with ISG promoters after HCMV infection. During HCMV infection, viral IE1 protein interacted with PML, STAT1, STAT2, and HDACs. Analysis of IE1 mutant viruses revealed that, in addition to the STAT2-binding domain, the PML-binding domain of IE1 was necessary for suppression of interferon-beta-mediated ISG transcription, and that IE1 inhibited ISG transcription by sequestering interferon-stimulated gene factor 3 (ISGF3) in a manner requiring its binding of PML and STAT2, but not of HDACs. In conclusion, our results demonstrate that PML participates in type I interferon-induced ISG expression by regulating ISGF3, and that this regulation by PML is counteracted by HCMV IE1, highlighting a widely shared viral strategy targeting PML to evade intrinsic and innate defense mechanisms.","[Kim, Young-Eui; Ahn, Jin-Hyun] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Samsung Biomed Res Inst, Suwon, South Korea","Kim, YE (reprint author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Samsung Biomed Res Inst, Suwon, South Korea.",jahn@skku.edu,,,National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012R1A2A2A01002551],"This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (2012R1A2A2A01002551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; Ahn JH, 1997, J VIROL, V71, P4599; Ahn JH, 1998, MOL CELL BIOL, V18, P4899, DOI 10.1128/MCB.18.8.4899; Amalraj J, 2013, MOL CANCER THER, V12, P1288, DOI 10.1158/1535-7163.MCT-12-0923; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Boutell C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002245; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chattopadhyay S, 2013, MBIO, V4, DOI 10.1128/mBio.00636-12; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Choi YH, 2006, P NATL ACAD SCI USA, V103, P18715, DOI 10.1073/pnas.0604800103; El Asmi F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003975; El Bougrini J, 2011, BIOCHIMIE, V93, P389, DOI 10.1016/j.biochi.2010.11.005; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Gamell C, 2014, FEBS LETT, V588, P2653, DOI 10.1016/j.febslet.2014.02.007; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Greaves RF, 1998, J VIROL, V72, P366; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Huang YF, 1999, NAT NEUROSCI, V2, P867; Huh YH, 2008, J VIROL, V82, P10444, DOI 10.1128/JVI.00833-08; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kim ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103308; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Krauss S, 2009, J VIROL, V83, P12854, DOI 10.1128/JVI.01164-09; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; LAVAU C, 1995, ONCOGENE, V11, P871; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lee HR, 2007, BIOCHEM BIOPH RES CO, V356, P499, DOI 10.1016/j.bbrc.2007.03.007; Meng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064708; Mounce BC, 2014, J VIROL, V88, P2268, DOI 10.1128/JVI.03278-13; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Park JJ, 2007, J GEN VIROL, V88, P3214, DOI 10.1099/vir.0.83171-0; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Paulus C, 2006, P NATL ACAD SCI USA, V103, P3840, DOI 10.1073/pnas.0600007103; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scherer M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004512; Schreiner S, 2013, J VIROL, V87, P10412, DOI 10.1128/JVI.00425-13; Shin HJ, 2012, J GEN VIROL, V93, P716, DOI 10.1099/vir.0.037986-0; STUURMAN N, 1992, J CELL SCI, V101, P773; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tavalai N, 2008, J VIROL, V82, P126, DOI 10.1128/JVI.01685-07; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Ulbricht T, 2012, J CELL BIOL, V199, P49, DOI 10.1083/jcb.201112015; Wilkinson GWG, 1998, J GEN VIROL, V79, P1233, DOI 10.1099/0022-1317-79-5-1233; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Yu SS, 2000, GENE THER, V7, P797, DOI 10.1038/sj.gt.3301164; Yu YJ, 2014, P NATL ACAD SCI USA, V111, P1951, DOI 10.1073/pnas.1310779111; Zheng P, 1998, NATURE, V396, P373; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351",61,16,18,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004785,10.1371/journal.ppat.1004785,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900084,25812002.0,"DOAJ Gold, Green Published",,,16/08/2019,28,8,20,3736,800,573,227,2936,2293,18,625,20,0,0,0,26,26,2,,25,1,25,0,1,29,28,29,20,0,0,0,0,0,0,0,8,1,3769,45,0,132,102,0,2948,806,45,0,132,102,0,15,,0,0,0,0,5,0,0,1,0,0,0,25,0,0,3.45,4.67,1.2724795640326976,0.2724795640326976,1.3337874659400546,1.0481798715203425,4.895
47,J,"Kong, E; Jabra-Rizk, MA",,,,"Kong, Eric; Jabra-Rizk, Mary Ann",,,The Great Escape: Pathogen Versus Host,PLOS PATHOGENS,,,English,Article,,,,,,,CANDIDA-ALBICANS; RECOGNITION,,"[Kong, Eric] Univ Maryland, Grad Program Life Sci, Mol Microbiol & Immunol Program, Baltimore, MD 21201 USA; [Kong, Eric; Jabra-Rizk, Mary Ann] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Jabra-Rizk, Mary Ann] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA","Kong, E (reprint author), Univ Maryland, Grad Program Life Sci, Mol Microbiol & Immunol Program, Baltimore, MD 21201 USA.",mrizk@umaryland.edu,,,National Institute of Health [DE14424],"This work was supported by the National Institute of Health grant DE14424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Brogden KA, 2004, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Calderone R. A., 2012, CANDIDA CANDIDIASIS; Collette JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096203; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Jimenez-Lopez C, 2013, EUKARYOT CELL, V12, P91, DOI 10.1128/EC.00290-12; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Kong EF, 2015, INFECT IMMUN, V83, P604, DOI 10.1128/IAI.02843-14; Krysan DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004139; Kubica M, 2008, PLOS ONE, V1, P1; Laarman AJ, 2012, EMBO J, V31, P3607, DOI 10.1038/emboj.2012.212; Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, P1, DOI [10.3389/fcimb.2012.00001, DOI 10.3389/FCIMB.2012.00001]; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schlecht LM, 2015, MICROBIOL-SGM, V161, P168, DOI 10.1099/mic.0.083485-0; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14",23,6,6,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004661,10.1371/journal.ppat.1004661,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900007,25764299.0,"DOAJ Gold, Green Published",,,16/08/2019,6,14,43,8105,864,628,236,7241,6357,21,863,43,0,0,0,5,5,0,,55,2,55,0,2,6,6,6,4,0,0,1,0,0,1,0,14,13,8127,7,0,29,90,2,7234,864,7,0,29,90,2,29,,0,1,0,0,32,0,1,1,0,0,0,54,0,0,26.456,9.380787037037036,1.1193205358375915,0.11932053583759149,1.135754730009667,1.0146822948797038,9.518518518518519
48,J,"Kotha, PLN; Sharma, P; Kolawole, AO; Yan, R; Alghamri, MS; Brockman, TL; Gomez-Cambronero, J; Excoffon, KJDA",,,,"Kotha, Poornima L. N.; Sharma, Priyanka; Kolawole, Abimbola O.; Yan, Ran; Alghamri, Mahmoud S.; Brockman, Trisha L.; Gomez-Cambronero, Julian; Excoffon, Katherine J. D. A.",,,Adenovirus Entry From the Apical Surface of Polarized Epithelia Is Facilitated by the Host Innate Immune Response,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN AIRWAY EPITHELIA; TIGHT JUNCTIONS; NEUTROPHIL MIGRATION; ADHESION MOLECULE; IN-VITRO; RECEPTOR; CELLS; COXSACKIEVIRUS; PROTEIN; CAR,"Prevention of viral-induced respiratory disease begins with an understanding of the factors that increase or decrease susceptibility to viral infection. The primary receptor for most adenoviruses is the coxsackievirus and adenovirus receptor (CAR), a cell-cell adhesion protein normally localized at the basolateral surface of polarized epithelia and involved in neutrophil transepithelial migration. Recently, an alternate isoform of CAR, CAR(Ex8), has been identified at the apical surface of polarized airway epithelia and is implicated in viral infection from the apical surface. We hypothesized that the endogenous role of CAR(Ex8) may be to facilitate host innate immunity. We show that IL-8, a proinflammatory cytokine and a neutrophil chemoattractant, stimulates the protein expression and apical localization of CAR(Ex8) via activation of AKT/S6K and inhibition of GSK3 beta. Apical CAR(Ex8) tethers infiltrating neutrophils at the apical surface of a polarized epithelium. Moreover, neutrophils present on the apicalepithelial surface enhance adenovirus entry into the epithelium. These findings suggest that adenovirus evolved to co-opt an innate immune response pathway that stimulates the expression of its primary receptor, apical CAR(Ex8), to allow the initial infection the intact epithelium. In addition, CAR(Ex8) is a new target for the development of novel therapeutics for both respiratory inflammatory disease and adenoviral infection.","[Kotha, Poornima L. N.; Sharma, Priyanka; Kolawole, Abimbola O.; Yan, Ran; Alghamri, Mahmoud S.; Brockman, Trisha L.; Excoffon, Katherine J. D. A.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA","Kotha, PLN (reprint author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.",katherine.excoffon@wright.edu,,,"National Institute of Health [R15AI090625, HL056653-14]; American Heart Association [13GRNT17230097]; Wright State University Research Incentive Grant","This work was supported by grants from the National Institute of Health (R15AI090625 (KJDAE), HL056653-14 (JG)), American Heart Association (13GRNT17230097 (JG)), and Wright State University Research Incentive Grant (KJDAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Berk A, 2007, ADENOVIRIDAE THE VIR; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Carson SD, 1997, BIOCHEM BIOPH RES CO, V233, P325, DOI 10.1006/bbrc.1997.6449; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Diaz F, 2009, P NATL ACAD SCI USA, V106, P11143, DOI 10.1073/pnas.0811227106; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Excoffon KJDA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009909; Frickmann H, 2012, EUR J MICROBIOL IMMU, V2, P161, DOI 10.1556/EuJMI.2.2012.3.1; Gern JE, 2012, J INFECT DIS, V206, P1342, DOI 10.1093/infdis/jis504; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Hayashi S, 2007, CURR OPIN PHARMACOL, V7, P237, DOI 10.1016/j.coph.2007.04.014; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Keicho N, 1997, AM J PHYSIOL-LUNG C, V272, pL1046; Kidney JC, 2000, AM J RESP CELL MOL, V23, P389, DOI 10.1165/ajrcmb.23.3.4068; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kolawole AO, 2012, J VIROL, V86, P9244, DOI 10.1128/JVI.01138-12; Kuhns D, 1998, J IMMUNOL, V161, P4332; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Louis NA, 2005, FASEB J, V19, P950, DOI 10.1096/fj.04-3251com; Lutschg V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1391; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Malka R, 2012, J CLIN INVEST, V122, P3002, DOI 10.1172/JCI59832; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sabroe I, 1997, J IMMUNOL, V158, P1361; Schaller M, 2006, J ALLERGY CLIN IMMUN, V118, P295, DOI 10.1016/j.jaci.2006.05.025; Sharma P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049930; Sharma P, 2012, J GEN VIROL, V93, P155, DOI 10.1099/vir.0.036269-0; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Tebruegge M, 2012, PEDIATR INFECT DIS J, V31, P626, DOI 10.1097/INF.0b013e318250b066; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wolfrum N, 2013, CELL MICROBIOL, V15, P53, DOI 10.1111/cmi.12053; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019",51,19,19,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004696,10.1371/journal.ppat.1004696,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900025,25768646.0,"DOAJ Gold, Green Published",,,16/08/2019,20,4,35,4781,850,605,245,3931,3277,23,631,35,1,0,0,19,19,0,,48,2,48,0,2,24,22,24,11,0,0,0,0,0,0,0,3,6,4842,122,0,215,116,2,3950,853,122,0,215,116,2,39,,0,0,0,0,10,0,0,0,0,0,0,48,0,0,5.85,5.624705882352941,1.2162299669295344,0.21622996692953447,1.292292037649453,1.062539217736875,5.976470588235294
49,J,"Lawler, C; Milho, R; May, JS; Stevenson, PG",,,,"Lawler, Clara; Milho, Ricardo; May, Janet S.; Stevenson, Philip G.",,,Rhadinovirus Host Entry by Co-operative Infection,PLOS PATHOGENS,,,English,Article,,,,,,,EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; HEPARAN-SULFATE PROTEOGLYCAN; MURID HERPESVIRUS-4; DENDRITIC CELLS; IN-VIVO; EPITHELIAL-CELLS; KAPOSIS-SARCOMA; B-CELL; GAMMAHERPESVIRUS NEUTRALIZATION,"Rhadinoviruses establish chronic infections of clinical and economic importance. Several show respiratory transmission and cause lung pathologies. We used Murid Herpesvirus-4 (MuHV-4) to understand how rhadinovirus lung infection might work. A primary epithelial or B cell infection often is assumed. MuHV-4 targeted instead alveolar macrophages, and their depletion reduced markedly host entry. While host entry was efficient, alveolar macrophages lacked heparan - an important rhadinovirus binding target - and were infected poorly ex vivo. In situ analysis revealed that virions bound initially not to macrophages but to heparan(+) type 1 alveolar epithelial cells (AECs). Although epithelial cell lines endocytose MuHV-4 readily in vitro, AECs did not. Rather bound virions were acquired by macrophages; epithelial infection occurred only later. Thus, host entry was co-operative - virion binding to epithelial cells licensed macrophage infection, and this in turn licensed AEC infection. An antibody block of epithelial cell binding failed to block host entry: opsonization provided merely another route to macrophages. By contrast an antibody block of membrane fusion was effective. Therefore co-operative infection extended viral tropism beyond the normal paradigm of a target cell infected readily in vitro; and macrophage involvement in host entry required neutralization to act down-stream of cell binding.","[Lawler, Clara; Stevenson, Philip G.] Royal Childrens Hosp, Sch Chem & Mol Biosci, Sir Albert Sakzewski Virus Res Ctr, Brisbane, Qld, Australia; [Lawler, Clara; Stevenson, Philip G.] Univ Queensland, Brisbane, Qld, Australia; [Milho, Ricardo; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England","Lawler, C (reprint author), Royal Childrens Hosp, Sch Chem & Mol Biosci, Sir Albert Sakzewski Virus Res Ctr, Brisbane, Qld, Australia.",p.stevenson@uq.edu.au,"Stevenson, Philip/F-9688-2014; Lawler, Clara/G-2986-2014","Stevenson, Philip/0000-0002-3520-5060; Lawler, Clara/0000-0001-7208-9225","Australian Research Council [FT130100138]; Research Councils UK [BB/J014419/1]; National Health and Medical Research Council (Australia) [1060138, 1064015]; Belgian Science Program (BelVir); Biotechnology and Biological Sciences Research Council [BB/J014419/1]","This work was supported by grants from the Australian Research Council (FT130100138), Research Councils UK (BB/J014419/1), National Health and Medical Research Council (Australia) (1060138, 1064015), and Belgian Science Program (BelVir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Ambinder RF, 2007, HUMAN HERPESVIRUSES; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; BARTHA A, 1966, ACTA VET ACAD SCI H, V16, P357; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Bell SA, 2006, VET MICROBIOL, V116, P249, DOI 10.1016/j.vetmic.2006.05.002; BILYK N, 1991, IMMUNOLOGY, V74, P645; Blackbourn DJ, 1998, J INFECT DIS, V177, P213, DOI 10.1086/517356; Blasdell K, 2003, J GEN VIROL, V84, P111, DOI 10.1099/vir.0.18731-0; Braun V, 2006, BIOL CELL, V98, P195, DOI 10.1042/BC20050021; CASTRUCCI G, 1987, COMP IMMUNOL MICROB, V10, P41, DOI 10.1016/0147-9571(87)90039-7; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Ehlers B, 2008, J VIROL, V82, P3509, DOI 10.1128/JVI.02646-07; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Flano E, 2005, J IMMUNOL, V174, P4972, DOI 10.4049/jimmunol.174.8.4972; Francois S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003292; Frederico B, 2014, CELL HOST MICROBE, V15, P457, DOI 10.1016/j.chom.2014.03.010; Frederico B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002935; GARAY SM, 1987, CHEST, V91, P39, DOI 10.1378/chest.91.1.39; Gaspar M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002346; Geiser M, 2002, MICROSC RES TECHNIQ, V57, P512, DOI 10.1002/jemt.10105; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000899; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002811; Gillet L, 2009, J GEN VIROL, V90, P602, DOI 10.1099/vir.0.005785-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Glauser DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030152; Glauser DL, 2012, J GEN VIROL, V93, P1316, DOI 10.1099/vir.0.040790-0; Glauser DL, 2011, J GEN VIROL, V92, P2020, DOI 10.1099/vir.0.032177-0; Gordon S, 2013, SEMIN IMMUNOPATHOL, V35, P533, DOI 10.1007/s00281-013-0386-4; Hartley CA, 2013, VET MICROBIOL, V167, P86, DOI 10.1016/j.vetmic.2013.05.031; HAYASHI K, 1988, LAB INVEST, V58, P68; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; HOAGLAND RJ, 1964, AM J PUBLIC HEALTH N, V54, P1699, DOI 10.2105/AJPH.54.10.1699; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Iijima N, 2008, MUCOSAL IMMUNOL, V1, P451, DOI 10.1038/mi.2008.57; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Jarousse N, 2008, J VIROL, V82, P12591, DOI 10.1128/JVI.01167-08; Katila T, 2012, REPROD DOMEST ANIM, V47, P31, DOI 10.1111/j.1439-0531.2012.02120.x; Kayhan B, 2007, J IMMUNOL, V179, P8392, DOI 10.4049/jimmunol.179.12.8392; Knowlton ER, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00427; KOZUCH O, 1993, ACTA VIROL, V37, P101; Li H, 2008, J GEN VIROL, V89, P1699, DOI 10.1099/vir.0.2008/000554-0; Ludlow M, 2013, J VIROL, V87, P4033, DOI 10.1128/JVI.03258-12; Machiels B, 2011, J VIROL, V85, P1011, DOI 10.1128/JVI.01092-10; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; May JS, 2010, J GEN VIROL, V91, P2542, DOI 10.1099/vir.0.023085-0; Means RE, 2004, VIROLOGY, V326, P67, DOI 10.1016/j.virol.2004.05.015; Milho R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002986; Milho R, 2009, J GEN VIROL, V90, P21, DOI [10.1099/vir.0.2008/006569-0, 10.1099/vir.0.006569-0]; MINSON AC, 1994, BIOCHEM SOC T, V22, P298, DOI 10.1042/bst0220298; Moser JA, 2006, J VIROL, V80, P1592, DOI 10.1128/JVI.80.3.1592-1598.2006; O'Toole D, 2014, VET PATHOL, V51, P437, DOI 10.1177/0300985813520435; RICKINSON AB, 1985, BRIT MED BULL, V41, P75, DOI 10.1093/oxfordjournals.bmb.a072030; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Shivkumar M, 2013, J VIROL, V87, P10477, DOI 10.1128/JVI.01748-13; SIXBEY JW, 1992, SCIENCE, V255, P1578, DOI 10.1126/science.1312750; Smith CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001048; Stevenson PG, 2009, J GEN VIROL, V90, P2317, DOI 10.1099/vir.0.013300-0; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Suzuki K, 2008, GLYCOCONJUGATE J, V25, P703, DOI 10.1007/s10719-008-9130-z; Tan CSE, 2014, J VIROL, V88, P14030, DOI 10.1128/JVI.02345-14; Teleshova N, 2013, ADV EXP MED BIOL, V762, P155, DOI 10.1007/978-1-4614-4433-6_6; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06; Vanderbilt JN, 2008, AM J RESP CELL MOL, V39, P253, DOI 10.1165/rcmb.2008-0049OC; VANDERPLASSCHEN A, 1993, VIROLOGY, V196, P232, DOI 10.1006/viro.1993.1471; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Wright DE, 2009, J GEN VIROL, V90, P2592, DOI 10.1099/vir.0.014266-0; YAO QY, 1991, INT J CANCER, V48, P45; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA",83,18,18,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004761,10.1371/journal.ppat.1004761,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900071,25790477.0,"DOAJ Gold, Green Published",,,16/08/2019,16,1,15,2071,385,298,87,1686,1365,25,296,15,0,0,0,17,17,0,,18,1,18,0,1,16,16,15,11,0,0,0,0,0,0,0,1,0,2105,37,0,38,85,0,1689,390,37,0,38,85,0,26,,0,0,0,0,1,0,0,1,0,0,0,18,0,0,0.75,5.37922077922078,1.2283511269276395,0.22835112692763937,1.3208778173190985,1.0753259295026558,5.7844155844155845
50,J,"Lennemann, NJ; Coyne, CB",,,,"Lennemann, Nicholas J.; Coyne, Carolyn B.",,,Catch Me If You Can: The Link between Autophagy and Viruses,PLOS PATHOGENS,,,English,Article,,,,,,,DENGUE VIRUS; ANTIVIRAL AUTOPHAGY; INFECTION; REPLICATION; MATURATION; PROTEIN; FUSION; CELLS; MACHINERY; IMMUNITY,,"[Lennemann, Nicholas J.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA","Lennemann, NJ (reprint author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.",coynec2@pitt.edu,,,National Institute of Allergy and Infectious Diseases [AI081759]; Burroughs Wellcome Fund,"This work was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI081759) and the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Delorme-Axford E, 2014, MBIO, V5, DOI 10.1128/mBio.02147-14; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Isakson P, 2013, CELL DEATH DIFFER, V20, P12, DOI 10.1038/cdd.2012.66; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Richards AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003046; Richetta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003599; Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045; Schlegel A, 1996, J VIROL, V70, P6576; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264",33,24,25,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004685,10.1371/journal.ppat.1004685,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900017,25811485.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,24,4,64,9439,1218,882,336,8221,6659,35,1527,63,0,0,0,23,23,2,,78,2,77,1,2,25,25,21,16,0,0,0,0,0,0,0,4,9,9459,142,0,36,78,2,8197,1218,7,0,36,78,2,44,,0,0,0,0,17,0,0,1,0,0,0,75,1,0,9.55,7.749589490968801,1.1481571584965333,0.14815715849653327,1.1773506872643231,1.025426422290497,7.946633825944171
51,J,"Leong, SY; Ong, BKT; Chu, JJH",,,,"Leong, Shi Yun; Ong, Bryan Kit Teck; Chu, Justin Jang Hann",,,"The Role of Misshapen NCK-related kinase (MINK), a Novel Ste20 Family Kinase, in the IRES-Mediated Protein Translation of Human Enterovirus 71",PLOS PATHOGENS,,,English,Article,,,,,,,INTERNAL RIBOSOMAL ENTRY; PICORNAVIRUS GENE-EXPRESSION; TRACT-BINDING-PROTEIN; MOUTH-DISEASE; VIRUS-REPLICATION; EPITHELIAL-CELLS; MESSENGER-RNA; HNRNP A1; INITIATION; PHOSPHORYLATION,"Human Enterovirus 71 (EV71) commonly causes Hand, Foot and Mouth Disease in young children, and occasional occurrences of neurological complications can be fatal. In this study, a high-throughput cell-based screening on the serine/threonine kinase siRNA library was performed to identify potential antiviral agents against EV71 replication. Among the hits, Misshapen/NIKs-related kinase (MINK) was selected for detailed analysis due to its strong inhibitory profile and novelty. In the investigation of the stage at which MINK is involved in EV71 replication, virus RNA transfection in MINK siRNA-treated cells continued to cause virus inhibition despite bypassing the normal entry pathway, suggesting its involvement at the post-entry stage. We have also shown that viral RNA and protein expression level was significantly reduced upon MINK silencing, suggesting its involvement in viral protein synthesis which feeds into viral RNA replication process. Through proteomic analysis and infection inhibition assay, we found that the activation of MINK was triggered by early replication events, instead of the binding and entry of the virus. Proteomic analysis on the activation profile of p38 Mitogen-activated Protein Kinase (MAPK) indicated that the phosphorylation of p38 MAPK was stimulated by EV71 infection upon MINK activation. Luciferase reporter assay further revealed that the translation efficiency of the EV71 internal ribosomal entry site (IRES) was reduced after blocking the MINK/p38 MAPK pathway. Further investigation on the effect of MINK silencing on heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) localisation demonstrated that cytoplasmic relocalisation of hnRNP A1 upon EV71 infection may be facilitated via the MINK/p38 MAPK pathway which then positively regulates the translation of viral RNA transcripts. These novel findings hence suggest that MINK plays a functional role in the IRES-mediated translation of EV71 viral RNA and may provide a potential target for the development of specific antiviral strategies against EV71 infection.","[Leong, Shi Yun; Ong, Bryan Kit Teck; Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol RNA Virol & Antiviral Strategies, Singapore 117595, Singapore","Leong, SY (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol RNA Virol & Antiviral Strategies, Singapore 117595, Singapore.",miccjh@nus.edu.sg,,,Singapore Ministry of Health's National Medical Research Council under the NMRC IRG Grant [R182-000-199-213],"This research is funded by the Singapore Ministry of Health's National Medical Research Council under the NMRC IRG Grant number R182-000-199-213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Banerjee S, 2002, J VIROL, V76, P5937, DOI 10.1128/JVI.76.12.5937-5948.2002; Barber SA, 2002, J VIROL, V76, P817, DOI 10.1128/JVI.76.2.817-828.2002; Bedard KM, 2004, MICROBES INFECT, V6, P702, DOI 10.1016/j.micinf.2004.03.001; Bek EJ, 2010, FUTURE VIROL, V5, P453, DOI 10.2217/FVL.10.22; BLACK TL, 1989, J VIROL, V63, P2244; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Chakravortty D, 2001, INFECT IMMUN, V69, P931, DOI 10.1128/IAI.69.2.931-936.2001; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang WW, 2008, J VIRAL HEPATITIS, V15, P490, DOI 10.1111/j.1365-2893.2007.00968.x; Chen YJ, 2008, ACTA PHARMACOL SIN, V29, P1327, DOI 10.1111/j.1745-7254.2008.00876.x; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Diaz-Meco MT, 2000, J CELL BIOL, V149, P307; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; Hasan NM, 1999, INT J CANCER, V80, P400, DOI 10.1002/(SICI)1097-0215(19990129)80:3<400::AID-IJC11>3.3.CO;2-L; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Hirasawa K, 2003, J VIROL, V77, P5649, DOI 10.1128/JVI.77.10.5649-5656.2003; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsu MJ, 2010, VIRUS RES, V153, P36, DOI 10.1016/j.virusres.2010.07.002; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu CC, 2011, PLOS ONE; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1016/S0168-6445(02)00070-0; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Phuektes P, 2011, J GEN VIROL, V92, P1380, DOI 10.1099/vir.0.029371-0; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; ROMERO JR, 1995, J VIROL, V69, P1370; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Singh S, 2002, MICROBIOL IMMUNOL, V46, P801, DOI 10.1111/j.1348-0421.2002.tb02767.x; Smyth MS, 2002, J CLIN PATHOL-MOL PA, V55, P214, DOI 10.1136/mp.55.4.214; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Tomida J, 2008, DETECTION PHOSPHORYL; Tung WH, 2010, CELL SIGNAL, V22, P234, DOI 10.1016/j.cellsig.2009.09.018; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Welnowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022230; WIMMER E, 1993, BIOLOGICALS, V21, P349, DOI 10.1006/biol.1993.1095; Wong WR, 2005, LIFE SCI, V78, P82, DOI 10.1016/j.lfs.2005.04.076; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang YJ, 2012, BIOORG MED CHEM LETT, V22, P2209, DOI 10.1016/j.bmcl.2012.01.102; Ziaei S, 2012, EXP CELL RES, V318, P500, DOI 10.1016/j.yexcr.2011.12.015",67,17,18,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004686,10.1371/journal.ppat.1004686,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900018,25747578.0,"DOAJ Gold, Green Published",,,16/08/2019,17,0,23,4406,1199,887,312,3207,2519,24,664,23,0,0,0,15,15,0,,24,5,24,0,5,17,17,11,7,0,0,0,0,0,0,0,0,2,4453,61,0,528,116,0,3218,1206,61,0,528,116,0,29,,0,0,0,0,2,0,0,1,0,0,0,24,0,0,0.75,3.6747289407839867,1.3738696601184908,0.3738696601184908,1.4437168693483007,1.0508397639582387,3.8615512927439535
52,J,"Li, ZX; Liu, G; Sun, LW; Teng, Y; Guo, XJ; Jia, JH; Sha, JH; Yang, X; Chen, DH; Sun, QM",,,,"Li, Zexing; Liu, Ge; Sun, Liwei; Teng, Yan; Guo, Xuejiang; Jia, Jianhang; Sha, Jiahao; Yang, Xiao; Chen, Dahua; Sun, Qinmiao",,,PPM1A Regulates Antiviral Signaling by Antagonizing TBK1-Mediated STING Phosphorylation and Aggregation,PLOS PATHOGENS,,,English,Article,,,,,,,INNATE IMMUNE-RESPONSE; CYTOSOLIC DNA SENSOR; NF-KAPPA-B; INTRACELLULAR DNA; CYTOPLASMIC DNA; ADAPTER PROTEIN; ACTIVATION; PHOSPHATASE; PATHWAY; IRF3,"Stimulator of interferon genes (STING, also known as MITA and ERIS) is critical in protecting the host against DNA pathogen invasion. However, the molecular mechanism underlying the regulation of STING remains unclear. Here, we show that PPM1A negatively regulates antiviral signaling by targeting STING in its phosphatase activity-dependent manner, and in a line with this, PPM1A catalytically dephosphorylates STING and TBK1 in vitro. Importantly, we provide evidence that whereas TBK1 promotes STING aggregation in a phosphorylation-dependent manner, PPM1A antagonizes STING aggregation by dephos-phorylating both STING and TBK1, emphasizing that phosphorylation is crucial for the efficient activation of STING. Our findings demonstrate a novel regulatory circuit in which STING and TBK1 reciprocally regulate each other to enable efficient antiviral signaling activation, and PPM1A dephosphorylates STING and TBK1, thereby balancing this antiviral signal transduction.","[Li, Zexing; Sun, Liwei; Sun, Qinmiao] Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Liu, Ge; Chen, Dahua] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Teng, Yan; Yang, Xiao] Inst Biotechnol, State Key Lab Prote Genet Lab Dev & Dis, Beijing, Peoples R China; [Guo, Xuejiang; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Jia, Jianhang] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY USA","Li, ZX (reprint author), Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China.",qinmiaosun@ioz.ac.cn,,"Yang, Xiao/0000-0002-0298-9831","National Basic Research Program of China [2010CB945300, 2010CB945000]; Natural Science Foundation of China [31370882]","This work is supported by National Basic Research Program of China (2010CB945300 and 2010CB945000), and Natural Science Foundation of China (31370882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu S, 2015, SCIENCE; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu X, 2014, ONCOGENE, V33, P2918, DOI 10.1038/onc.2013.246; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang X, 2011, J BIOL CHEM, V286, P42267, DOI 10.1074/jbc.M111.292284; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhao YL, 2012, CELL SIGNAL, V24, P2197, DOI 10.1016/j.cellsig.2012.06.017; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008",45,32,36,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004783,10.1371/journal.ppat.1004783,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900083,25815785.0,"DOAJ Gold, Green Published",,,16/08/2019,31,0,31,7067,1395,1000,395,5672,4349,28,1295,31,0,0,0,30,30,2,,39,2,39,0,2,33,33,21,20,0,0,0,0,0,0,0,0,2,7138,251,0,535,92,1,5709,1408,193,0,535,63,1,21,,0,0,0,0,5,0,0,1,0,0,0,39,0,0,2.95,5.06594982078853,1.245944992947814,0.24594499294781383,1.318935119887165,1.0585821423517758,5.3627240143369175
53,J,"Madigan, CA; Martinot, AJ; Wei, JR; Madduri, A; Cheng, TY; Young, DC; Layre, E; Murry, JP; Rubin, EJ; Moody, DB",,,,"Madigan, Cressida A.; Martinot, Amanda Jezek; Wei, Jun-Rong; Madduri, Ashoka; Cheng, Tan-Yun; Young, David C.; Layre, Emilie; Murry, Jeffrey P.; Rubin, Eric J.; Moody, D. Branch",,,Lipidomic Analysis Links Mycobactin Synthase K to Iron Uptake and Virulence in M. tuberculosis,PLOS PATHOGENS,,,English,Article,,,,,,,POSITRON-EMISSION-TOMOGRAPHY; SIDEROPHORE BIOSYNTHESIS; COMPUTED-TOMOGRAPHY; ACQUISITION; GROWTH; IDENTIFICATION; INFECTION; MACROPHAGES; METABOLISM; EXPRESSION,"The prolonged survival of Mycobacterium tuberculosis (M. tb) in the host fundamentally depends on scavenging essential nutrients from host sources. M. tb scavenges non-heme iron using mycobactin and carboxymycobactin siderophores, synthesized by mycobactin synthases (Mbt). Although a general mechanism for mycobactin biosynthesis has been proposed, the biological functions of individual mbt genes remain largely untested. Through targeted gene deletion and global lipidomic profiling of intact bacteria, we identify the essential biochemical functions of two mycobactin synthases, MbtK and MbtN, in siderophore biosynthesis and their effects on bacterial growth in vitro and in vivo. The deletion mutant, Delta mbtN, produces only saturated mycobactin and carboxymycobactin, demonstrating an essential function of MbtN as the mycobactin dehydrogenase, which affects antigenicity but not iron uptake or M. tb growth. In contrast, deletion of mbtK ablated all known forms of mycobactin and its deoxy precursors, defining MbtK as the essential acyl transferase. The mbtK mutant showed markedly reduced iron scavenging and growth in vitro. Further, Delta mbtK was attenuated for growth in mice, demonstrating a non-redundant role of hydroxamate siderophores in virulence, even when other M. tb iron scavenging mechanisms are operative. The unbiased lipidomic approach also revealed unexpected consequences of perturbing mycobactin biosynthesis, including extreme depletion of mycobacterial phospholipids. Thus, lipidomic profiling highlights connections among iron acquisition, phospholipid homeostasis, and virulence, and identifies MbtK as a lynchpin at the crossroads of these phenotypes.","[Madigan, Cressida A.; Madduri, Ashoka; Cheng, Tan-Yun; Young, David C.; Layre, Emilie; Moody, D. Branch] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Martinot, Amanda Jezek; Wei, Jun-Rong; Murry, Jeffrey P.; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA","Madigan, CA (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.",bmoody@rics.bwh.harvard.edu,,"Layre, Emilie/0000-0003-3044-1299; Murry, Jeffrey/0000-0002-3716-1460","National Institute of Allergy and Infectious Disease [U19 AI076217, R01 AI071155, AI049313, AR048632, R01 AI071881]; National Science Foundation","National Institute of Allergy and Infectious Disease grants U19 AI076217, R01 AI071155, AI049313 and AR048632 (to DBM), R01 AI071881 (to EJR), and the National Science Foundation Graduate Research Fellowship (to CAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bacon J, 2007, MICROBIOL-SGM, V153, P1435, DOI 10.1099/mic.0.2006/004317-0; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Blumenthal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015667; Card GL, 2005, J BIOL CHEM, V280, P13978, DOI 10.1074/jbc.M413904200; Chavadi SS, 2011, J BACTERIOL; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; De Voss JJ, 1999, J BACTERIOL, V181, P4443; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Farhana A, 2010, ADV MICROB PHYSIOL, V57, P43, DOI 10.1016/B978-0-12-381045-8.00002-3; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Frankel BA, 2008, ARCH BIOCHEM BIOPHYS, V477, P259, DOI 10.1016/j.abb.2008.05.013; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Gobin J, 1999, INFECT IMMUN, V67, P2035; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Jones CM, 2014, P NATL ACAD SCI USA, V111, P1945, DOI 10.1073/pnas.1311402111; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Khayatt BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062136; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Kumar A., 2011, EXPERT REV MOL MED, V13; Layre E, 2011, CHEM BIOL, V18, P1837; Layre E, 2013, BIOCHIMIE, V95, P109, DOI 10.1016/j.biochi.2012.08.012; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lun S, 2013, ANTIMICROB AGENTS CH, V57, P5138, DOI 10.1128/AAC.00918-13; Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; McMahon MD, 2012, J BACTERIOL, V194, P2809, DOI 10.1128/JB.00088-12; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; Murry JP, 2009, J INFECT DIS, V200, P774, DOI 10.1086/605128; Quadri LEN, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P341; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Saini V, 2012, CURR OPIN CHEM BIOL, V16, P45, DOI 10.1016/j.cbpa.2012.03.004; Sartain MJ, 2011, J LIPID RES, V52, P861, DOI 10.1194/jlr.M010363; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SNOW GA, 1965, BIOCHEM J, V94, P160, DOI 10.1042/bj0940160; Snow GA, 1970, MICROBIOL MOL BIOL R, V34, P99; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Wells RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003120",54,18,18,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004792,10.1371/journal.ppat.1004792,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900086,25815898.0,"DOAJ Gold, Green Published",,,16/08/2019,17,142,36,4555,653,445,208,3902,3173,20,709,36,0,0,0,19,19,2,,42,6,42,0,6,20,18,20,13,0,0,0,0,0,0,0,141,0,4602,41,0,66,109,0,3918,658,41,0,66,109,0,26,,0,0,0,0,1,0,0,0,0,0,0,42,0,0,0.25,6.975497702909648,1.1673500768836493,0.16735007688364942,1.2178370066632496,1.0432491767288694,7.277182235834609
54,J,"Majumdar, T; Chattopadhyay, S; Ozhegov, E; Dhar, J; Goswami, R; Sen, GC; Barik, S",,,,"Majumdar, Tanmay; Chattopadhyay, Saurabh; Ozhegov, Evgeny; Dhar, Jayeeta; Goswami, Ramansu; Sen, Ganes C.; Barik, Sailen",,,Induction of Interferon-Stimulated Genes by IRF3 Promotes Replication of Toxoplasma gondii,PLOS PATHOGENS,,,English,Article,,,,,,,TOLL-LIKE RECEPTORS; GMP-AMP SYNTHASE; APICOMPLEXAN PARASITES; NONSTRUCTURAL PROTEINS; PLASMODIUM-FALCIPARUM; SIGNALING PATHWAY; VIRULENCE FACTORS; HOST-RESISTANCE; SENDAI-VIRUS; DNA SENSOR,"Innate immunity is the first line of defense against microbial insult. The transcription factor, IRF3, is needed by mammalian cells to mount innate immune responses against many microbes, especially viruses. IRF3 remains inactive in the cytoplasm of uninfected cells; upon virus infection, it gets phosphorylated and then translocates to the nucleus, where it binds to the promoters of antiviral genes and induces their expression. Such genes include type I interferons (IFNs) as well as Interferon Stimulated Genes (ISGs). IRF3(-/-) cells support enhanced replication of many viruses and therefore, the corresponding mice are highly susceptible to viral pathogenesis. Here, we provide evidence for an unexpected pro-microbial role of IRF3: the replication of the protozoan parasite, Toxoplasma gondii, was significantly impaired in IRF3(-/-) cells. In exploring whether the transcriptional activity of IRF3 was important for its pro-parasitic function, we found that ISGs induced by parasite-activated IRF3 were indeed essential, whereas type I interferons were not important. To delineate the signaling pathway that activates IRF3 in response to parasite infection, we used genetically modified human and mouse cells. The pro-parasitic signaling pathway, which we termed PISA (Parasite-IRF3 Signaling Activation), activated IRF3 without any involvement of the Toll-like receptor or RIG-I-like receptor pathways, thereby ruling out a role of parasite-derived RNA species in activating PISA. Instead, PISA needed the presence of cGAS, STING, TBK1 and IRF3, indicating the necessity of DNA-triggered signaling. To evaluate the physiological significance of our in vitro findings, IRF3(-/-) mice were challenged with parasite infection and their morbidity and mortality were measured. Unlike WT mice, the IRF3(-/-) mice did not support replication of the parasite and were resistant to pathogenesis caused by it. Our results revealed a new paradigm in which the antiviral host factor, IRF3, plays a cell-intrinsic pro-parasitic role.","[Majumdar, Tanmay; Ozhegov, Evgeny; Dhar, Jayeeta; Goswami, Ramansu; Barik, Sailen] Cleveland State Univ, Coll Sci & Hlth Profess, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Majumdar, Tanmay; Ozhegov, Evgeny; Dhar, Jayeeta; Goswami, Ramansu; Barik, Sailen] Cleveland State Univ, Coll Sci & Hlth Profess, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Chattopadhyay, Saurabh; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA","Majumdar, T (reprint author), Cleveland State Univ, Coll Sci & Hlth Profess, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.",seng@ccf.org; s.barik@csuohio.edu,"Chattopadhyay, Saurabh/I-4091-2019","Chattopadhyay, Saurabh/0000-0002-2930-1523","National Institutes of Health [AI073303, CA068782, S10 OD010381]","This work was supported by National Institutes of Health grants AI073303 (GCS), CA068782 (GCS), and S10 OD010381 (SB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abe T, 2014, J VIROL; Bafica A, 2007, J IMMUNOL, V179, P5514, DOI 10.4049/jimmunol.179.8.5514; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Beiting DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088398; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Chattopadhyay S, 2013, MBIO, V4, DOI 10.1128/mBio.00636-12; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; COSENTINO MJ, 1990, P NATL ACAD SCI USA, V87, P1431, DOI 10.1073/pnas.87.4.1431; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Evans R, 1999, EUR J CLIN MICROBIOL, V18, P879, DOI 10.1007/s100960050423; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Francia ME, 2014, NAT REV MICROBIOL, V12, P125, DOI 10.1038/nrmicro3184; FRENKEL JK, 1988, PARASITOL TODAY, V4, P273, DOI 10.1016/0169-4758(88)90018-X; Gaji RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064693; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Gissot M, 2008, EUKARYOT CELL, V7, P537, DOI 10.1128/EC.00448-07; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; KHAN IA, 1994, INFECT IMMUN, V62, P1639; Kongsaengdao Subsai, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P11, DOI 10.1177/1545109707301244; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Moser LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068129; Musiyenko A, 2012, CELL MICROBIOL, V14, P882, DOI 10.1111/j.1462-5822.2012.01763.x; Ngo HM, 2004, MOL MICROBIOL, V52, P1531, DOI 10.1111/j.1365-2958.2004.04056.x; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Ponts N, 2013, CELL HOST MICROBE, V14, P696, DOI 10.1016/j.chom.2013.11.007; Rahumatullah A, 2012, EXP PARASITOL, V131, P231, DOI 10.1016/j.exppara.2012.04.009; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Roos DS, 1996, CURR TOP MICROBIOL, V219, P247; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Sher A, 2003, IMMUNOL RES, V27, P521, DOI 10.1385/IR:27:2-3:521; Sibley LD, 2002, PHILOS T ROY SOC B, V357, P81, DOI 10.1098/rstb.2001.1017; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zhu JZ, 2010, J IMMUNOL, V184, P5768, DOI 10.4049/jimmunol.0903559",66,9,9,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004779,10.1371/journal.ppat.1004779,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900082,25811886.0,"DOAJ Gold, Green Published",,,16/08/2019,9,0,25,6360,1171,983,188,5189,4179,19,991,25,0,0,0,8,8,3,,70,1,37,0,1,11,9,11,6,0,0,0,0,0,0,0,0,3,6383,21,0,95,113,2,5183,1171,21,0,95,113,2,29,,0,1,0,0,6,0,0,1,0,0,0,37,0,0,9.258,5.4312553373185315,1.2256696858739642,0.22566968587396416,1.255925997301985,1.024685534591195,5.56532877882152
55,J,"Mengistu, M; Ray, K; Lewis, GK; DeVico, AL",,,,"Mengistu, Meron; Ray, Krishanu; Lewis, George K.; DeVico, Anthony L.",,,Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT CELLULAR CYTOTOXICITY; HUMAN MONOCLONAL-ANTIBODY; VACCINE EFFICACY TRIAL; CROSS-LINKED COMPLEXES; VIRAL MEMBRANE-FUSION; CD4 BINDING-SITE; NEUTRALIZING ANTIBODY; HIV-1 GP120; TYPE-1 GP120; MEDIATED CYTOTOXICITY,"The HIV-1 envelope glycoprotein, gp120, undergoes multiple molecular interactions and structural rearrangements during the course of host cell attachment and viral entry, which are being increasingly defined at the atomic level using isolated proteins. In comparison, antigenic markers of these dynamic changes are essentially unknown for single HIV-1 particles bound to target cells. Such markers should indicate how neutralizing and/or nonneutralizing antibodies might interdict infection by either blocking infection or sensitizing host cells for elimination by Fc-mediated effector function. Here we address this deficit by imaging fluorescently labeled CCR5-tropic HIV-1 pseudoviruses using confocal and super-resolution microscopy to track the exposure of neutralizing and non-neutralizing epitopes as they appear on single HIV-1 particles bound to target cells. Epitope exposure was followed under conditions permissive or non-permissive for viral entry to delimit changes associated with virion binding from those associated with post-attachment events. We find that a previously unexpected array of gp120 epitopes is exposed rapidly upon target cell binding. This array comprises both neutralizing and non-neutralizing epitopes, the latter being hidden on free virions yet capable of serving as potent targets for Fc-mediated effector function. Under non-permissive conditions for viral entry, both neutralizing and non-neutralizing epitope exposures were relatively static over time for the majority of bound virions. Under entry-permissive conditions, epitope exposure patterns changed over time on subsets of virions that exhibited concurrent variations in virion contents. These studies reveal that bound virions are distinguished by a broad array of both neutralizing and non-neutralizing gp120 epitopes that potentially sensitize a freshly engaged target cell for destruction by Fc-mediated effector function and/or for direct neutralization at a post-binding step. The elucidation of these epitope exposure patterns during viral entry will help clarify antibody-mediated inhibition of HIV-1 as it is measured in vitro and in vivo.","[Mengistu, Meron; Lewis, George K.; DeVico, Anthony L.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Ray, Krishanu] Univ Maryland, Sch Med, Ctr Fluorescence Spect, Baltimore, MD 21201 USA","Mengistu, M (reprint author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.",mmengistu@ihv.umaryland.edu; adevico@ihv.umaryland.edu,,,Bill and Melinda Gates Foundation [OPP1033109],"The present work was supported by the Bill and Melinda Gates Foundation, grant number OPP1033109 (GKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Anderson KI, 2006, CYTOM PART A, V69A, P920, DOI 10.1002/cyto.a.20323; Banks ND, 2002, AIDS RES HUM RETROV, V18, P1197, DOI 10.1089/08892220260387940; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Baum LL, 1996, J IMMUNOL, V157, P2168; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Bennett A, 2007, J BIOL CHEM, V282, P27754, DOI 10.1074/jbc.M702025200; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Burrer R, 2005, VIROLOGY, V333, P102, DOI 10.1016/j.virol.2004.12.034; Burton D. R., 1991, P NATL ACAD SCI US, V88, P10134; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 1997, AIDS, V11, pS87; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Campbell EM, 2007, VIROLOGY, V360, P286, DOI 10.1016/j.virol.2006.10.025; Cavacini L, 2004, AIDS RES HUM RETROV, V20, P435, DOI 10.1089/088922204323048186; Cavacini LA, 1998, AIDS RES HUM RETROV, V14, P1271, DOI 10.1089/aid.1998.14.1271; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CLAVEL F, 1994, J VIROL, V68, P1179; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; Davenport TM, 2013, J VIROL, V87, P10855, DOI 10.1128/JVI.01535-13; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dennison S. M., 2014, J VIROL; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Devico A, 1996, VIROLOGY, V218, P258, DOI 10.1006/viro.1996.0188; DEVICO AL, 1995, VIROLOGY, V211, P583; DeVico AL, 2007, CURR HIV RES, V5, P561, DOI 10.2174/157016207782418560; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Duncan CJA, 2014, J VIROL, V88, P2025, DOI 10.1128/JVI.03245-13; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckhardt M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022007; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Finnegan CM, 2002, J VIROL, V76, P12123, DOI 10.1128/JVI.76.23.12123-12134.2002; Finnegan CM, 2001, J VIROL, V75, P11096, DOI 10.1128/JVI.75.22.11096-11105.2001; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forthal DN, 1998, J IMMUNOL METHODS, V220, P129, DOI 10.1016/S0022-1759(98)00152-5; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Frank I., 2002, Current Molecular Medicine (Hilversum), V2, P229, DOI 10.2174/1566524024605716; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; FREY S, 1995, J VIROL, V69, P1462; Gomez-Roman VP, 2006, JAIDS-J ACQ IMM DEF, V43, P270; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Grove J, 2014, VIRUSES-BASEL, V6, P1365, DOI 10.3390/v6031365; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Herold N., 2014, J VIROL; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Iwasaki K, 2010, CURR OPIN STRUC BIOL, V20, P632, DOI 10.1016/j.sbi.2010.08.007; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; KIMPTON J, 1992, J VIROL, V66, P2232; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kramski M, 2012, J IMMUNOL METHODS, V384, P51, DOI 10.1016/j.jim.2012.07.006; Kramski M, 2013, CURR HIV RES, V11, P388, DOI 10.2174/15701; Kramski M, 2012, EUR J IMMUNOL, V42, P2771, DOI 10.1002/eji.201242469; Kuhmann SE, 1997, J VIROL, V71, P8642; Kwon YJ, 2003, J VIROL, V77, P5712, DOI 10.1128/JVI.77.10.5712-5720.2003; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lin J, 2012, J VIROL, V86, P5959, DOI 10.1128/JVI.05990-11; LISKA V, 1994, J GEN VIROL, V75, P2955, DOI 10.1099/0022-1317-75-11-2955; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu PH, 2013, J VIROL, V87, P7828, DOI 10.1128/JVI.02737-12; LJUNGGREN K, 1990, J INFECT DIS, V161, P198, DOI 10.1093/infdis/161.2.198; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mabuka J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002739; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Marechal V, 1998, J VIROL, V72, P2208; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; MOORE JP, 1994, J VIROL, V68, P8350; Moore JP, 1996, J VIROL, V70, P1863; MOORE JP, 1994, J VIROL, V68, P6836; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Murin C. D., 2014, J VIROL; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; Nyambi PN, 1998, J VIROL, V72, P9384; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; PAL R, 1993, VIROLOGY, V194, P833, DOI 10.1006/viro.1993.1326; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pang Y., 2014, NAT NANOTECHNOL; Peachman KK, 2010, VIROLOGY, V408, P213, DOI 10.1016/j.virol.2010.09.029; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164; Pereira CF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-84; Platt E. J., 2014, J VIROL; Platt EJ, 1998, J VIROL, V72, P2855; Platt EJ, 2012, P NATL ACAD SCI USA, V109, P7829, DOI 10.1073/pnas.1109728109; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Ray K, 2014, J VIROL, V88, P1795, DOI 10.1128/JVI.03048-13; ROBEN P, 1994, J VIROL, V68, P4821; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SATO A, 1995, MICROBIOL IMMUNOL, V39, P1015, DOI 10.1111/j.1348-0421.1995.tb03293.x; SATTENTAU QJ, 1993, J VIROL, V67, P7383; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Steffens CM, 2003, J VIROL, V77, P4985, DOI 10.1128/JVI.77.8.4985-4991.2003; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sullivan N, 1998, J VIROL, V72, P4694; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; Teleshova N, 2003, J LEUKOCYTE BIOL, V74, P683, DOI 10.1189/jlb.0403178; THALI M, 1993, J VIROL, V67, P3978; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Vidricaire G, 2004, J VIROL, V78, P11904, DOI 10.1128/JVI.78.21.11904-11915.2004; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WANG JJ, 1994, J GEN VIROL, V75, P2607, DOI 10.1099/0022-1317-75-10-2607; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weiss R. A., 1984, NATURE, V312, P5996; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; WU XY, 1995, J VIROL, V69, P3389; Wyatt R, 1997, J VIROL, V71, P9722; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817",193,27,27,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004772,10.1371/journal.ppat.1004772,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900078,25807494.0,"DOAJ Gold, Green Published",,,16/08/2019,28,1,16,3915,627,463,164,3288,2720,26,542,16,0,3,0,26,26,1,,19,14,19,0,14,28,28,26,23,0,0,0,0,0,0,0,1,2,4029,31,2,87,183,7,3338,631,31,2,87,183,7,60,,0,0,0,0,4,0,1,0,0,0,1,19,0,0,2.0,6.244019138755981,1.1906934306569343,0.1906934306569343,1.2904501216545012,1.083780332056194,6.767145135566188
56,J,"Napier, RJ; Norris, BA; Swimm, A; Giver, CR; Harris, WAC; Laval, J; Napier, BA; Patel, G; Crump, R; Peng, ZH; Bornmann, W; Pulendran, B; Buller, RM; Weiss, DS; Tirouvanziam, R; Waller, EK; Kalman, D",,,,"Napier, Ruth J.; Norris, Brian A.; Swimm, Alyson; Giver, Cynthia R.; Harris, Wayne A. C.; Laval, Julie; Napier, Brooke A.; Patel, Gopi; Crump, Ryan; Peng, Zhenghong; Bornmann, William; Pulendran, Bali; Buller, R. Mark; Weiss, David S.; Tirouvanziam, Rabindra; Waller, Edmund K.; Kalman, Daniel",,,Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity,PLOS PATHOGENS,,,English,Article,,,,,,,COLONY-STIMULATING FACTOR; CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; C-KIT; TYROSINE KINASE; BCR-ABL; BONE-MARROW; IN-VIVO; PROGENITOR CELLS; SELF-RENEWAL,"Imatinib mesylate (Gleevec) inhibits Abl1, c-Kit, and related protein tyrosine kinases (PTKs) and serves as a therapeutic for chronic myelogenous leukemia and gastrointestinal stromal tumors. Imatinib also has efficacy against various pathogens, including pathogenic mycobacteria, where it decreases bacterial load in mice, albeit at doses below those used for treating cancer. We report that imatinib at such low doses unexpectedly induces differentiation of hematopoietic stem cells and progenitors in the bone marrow, augments myelopoiesis but not lymphopoiesis, and increases numbers of myeloid cells in blood and spleen. Whereas progenitor differentiation relies on partial inhibition of c-Kit by imatinib, lineage commitment depends upon inhibition of other PTKs. Thus, imatinib mimics ""emergency hematopoiesis,"" a physiological innate immune response to infection. Increasing neutrophil numbers by adoptive transfer sufficed to reduce mycobacterial load, and imatinib reduced bacterial load of Franciscella spp., which do not utilize imatinib-sensitive PTKs for pathogenesis. Thus, potentiation of the immune response by imatinib at low doses may facilitate clearance of diverse microbial pathogens.","[Napier, Ruth J.; Napier, Brooke A.] Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Norris, Brian A.] Emory Univ, Sch Med, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA USA; [Swimm, Alyson; Patel, Gopi; Pulendran, Bali; Kalman, Daniel] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Giver, Cynthia R.; Harris, Wayne A. C.; Waller, Edmund K.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Laval, Julie; Tirouvanziam, Rabindra] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Laval, Julie; Tirouvanziam, Rabindra] Childrens Healthcare Atlanta, Cyst Fibrosis Res Ctr, Atlanta, GA USA; [Laval, Julie] Univ Montpellier, CNRS, UMR5535, IGMM, F-34059 Montpellier, France; [Crump, Ryan; Buller, R. Mark] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Peng, Zhenghong; Bornmann, William] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Pulendran, Bali; Weiss, David S.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Pulendran, Bali; Weiss, David S.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Weiss, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA","Napier, RJ (reprint author), Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA.",dkalman@emory.edu,"Swimm, Alyson/D-1025-2013; Napier, Brooke A/H-5600-2019","Tirouvanziam, Rabindra/0000-0003-3526-9985","Institute Merieux [R01A107246201, R01AI05606701];  [NCI-CA016672];  [5P01HL08773-05]","This work was supported by NCI-CA016672 (to WB), and by 5P01HL08773-05 to EKW, and by R01A107246201, R01AI05606701 and a grant from the Institute Merieux (all to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Bartolovic K, 2004, BLOOD, V103, P523, DOI 10.1182/blood-2003-05-1535; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; BODINE DM, 1993, BLOOD, V82, P445; Boitano AE, 2012, P NATL ACAD SCI USA, V109, P14019, DOI 10.1073/pnas.1212545109; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; Buchdunger E, 1996, CANCER RES, V56, P100; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Carroll M, 1997, BLOOD, V90, P4947; Carulli G, 1997, HAEMATOLOGICA, V82, P606; Cohen PR, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-34; Conlan JW, 1997, INFECT IMMUN, V65, P630; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Druker BJ, 2003, SEMIN HEMATOL, V40, P50, DOI 10.1053/shem.2003.50000; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Elkins KL, 1996, INFECT IMMUN, V64, P3288; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Evans D B, 2000, EXS, V89, P123; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; GABRILOVE JL, 1988, NEW ENGL J MED, V318, P1414, DOI 10.1056/NEJM198806023182202; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Garcia-Echeverria C, 2000, MED RES REV, V20, P28, DOI 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.3.CO;2-U; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Goldman JM, 2001, BLOOD, V98, P2039, DOI 10.1182/blood.V98.7.2039; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hawn TR, 2015, IMMUNOL REV, V264, P344, DOI 10.1111/imr.12255; Held SA, 2012, CANC IMMUNOL IMMUNOT; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Kantarjian H, 2012, BLOOD, V119, P1981, DOI 10.1182/blood-2011-08-358135; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Koretzky GA, 2007, J CLIN INVEST, V117, P2030, DOI 10.1172/JCI33032; Krauss GL, 2012, ACTA NEUROL SCAND, V125, P8, DOI 10.1111/j.1600-0404.2011.01588.x; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Lebeis SL, 2009, CELL HOST MICROBE, V5, P114, DOI 10.1016/j.chom.2009.01.008; Levesque JP, 2003, EXP HEMATOL, V31, P109, DOI 10.1016/S0301-472X(02)01028-7; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Ly KT, 2008, INFECT IMMUN; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mehra S, 2015, AM J RESP C IN PRESS; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Menon-Andersen D, 2009, CANCER CHEMOTH PHARM, V63, P229, DOI 10.1007/s00280-008-0730-x; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Napier RJ, 2012, FUTURE MICROBIOL, V7, P431, DOI [10.2217/FMB.12.19, 10.2217/fmb.12.19]; Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; OGAWA M, 1993, DEVELOPMENT, V117, P1089; OKADA S, 1992, BLOOD, V80, P3044; ORLIC D, 1993, BLOOD, V82, P762; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Pielage JF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000031; Prakash O, 2005, BLOOD, V105, P3987, DOI 10.1182/blood-2004-07-2781; Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Sato N, 2003, HEMATOL ONCOL, V21, P67, DOI 10.1002/hon.705; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shin JY, 2014, J EXP MED, V211, P217, DOI 10.1084/jem.20131128; Sinai P, 2007, J IMMUNOL, V178, P2028, DOI 10.4049/jimmunol.178.4.2028; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; Swimm AI, 2010, J VIROL, V84, P4243, DOI 10.1128/JVI.00129-10; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Wetzel DM, 2012, MOL CELL BIOL, V32, P3176, DOI 10.1128/MCB.00086-12; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048",87,23,24,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004770,10.1371/journal.ppat.1004770,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900076,25822986.0,"DOAJ Gold, Green Published",,,16/08/2019,21,142,21,6189,1265,981,284,4924,4159,32,733,21,2,0,0,20,20,5,,31,24,31,0,24,21,21,16,12,0,0,0,0,0,0,0,139,8,6309,63,0,126,353,1,4972,1281,63,0,126,353,1,56,,8,1,0,0,12,0,0,1,0,0,0,31,0,0,75.8,4.892490118577075,1.2569049553208773,0.2569049553208773,1.3657595450852964,1.086605267409921,5.316205533596838
57,J,"Pascutti, MF; Geerman, S; Slot, E; van Gisbergen, KPJM; Boon, L; Arens, R; van Lier, RAW; Wolkers, MC; Nolte, MA",,,,"Pascutti, Maria Fernanda; Geerman, Sulima; Slot, Edith; van Gisbergen, Klaas P. J. M.; Boon, Louis; Arens, Ramon; van Lier, Rene A. W.; Wolkers, Monika C.; Nolte, Martijn A.",,,Enhanced CD8 T Cell Responses through GITR-Mediated Costimulation Resolve Chronic Viral Infection,PLOS PATHOGENS,,,English,Article,,,,,,,EXPRESSION; EFFECTOR; RECEPTOR; EXHAUSTION; LIGAND; EXPANSION; MEMORY; PERSISTENCE; MODULATION; PD-1,"Chronic infections are characterized by the inability to eliminate the persisting pathogen and often associated with functional impairment of virus-specific T-cell responses. Costimulation through Glucocorticoid-induced TNFR-related protein (GITR) can increase survival and function of effector T cells. Here, we report that constitutive expression of GITR-ligand (GITRL) confers protection against chronic lymphocytic choriomeningitis virus (LCMV) infection, accelerating recovery without increasing pathology. Rapid viral clearance in GITRL transgenic mice coincided with increased numbers of poly-functional, virus-specific effector CD8+ T cells that expressed more T-bet and reduced levels of the rheostat marker PD-1. GITR triggering also boosted the helper function of virus-specific CD4 T cells already early in the infection, as was evidenced by increased IL-2 and IFN gamma production, and more expression of CD40L and T-bet. Importantly, CD4-depletion experiments revealed that the expanded pool of virus-specific effector CD8 T cells and the ensuing viral clearance in LCMV-infected GITRL tg mice was entirely dependent on CD4 T cells. We found no major differences for NK cell and regulatory T cell responses, whereas the humoral response to the virus was increased in GITRL tg mice, but only in the late phase of the infection when the virus was almost eradicated. Based on these findings, we conclude that enhanced GITR-triggering mediates its protective, anti-viral effect on the CD8 T cell compartment by boosting CD4 T cell help. As such, increasing costimulation through GITR may be an attractive strategy to increase anti-viral CTL responses without exacerbating pathology, in particular to persistent viruses such as HIV and HCV.","[Pascutti, Maria Fernanda; Geerman, Sulima; Slot, Edith; van Gisbergen, Klaas P. J. M.; van Lier, Rene A. W.; Wolkers, Monika C.; Nolte, Martijn A.] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Pascutti, Maria Fernanda; Geerman, Sulima; Slot, Edith; van Gisbergen, Klaas P. J. M.; van Lier, Rene A. W.; Wolkers, Monika C.; Nolte, Martijn A.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Arens, Ramon] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands","Pascutti, MF (reprint author), Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands.",m.nolte@sanquin.nl,,"van Lier, Rene/0000-0002-3201-7144; Pascutti, Maria Fernanda/0000-0003-3212-780X; Nolte, Martijn/0000-0002-5447-0839; van Gisbergen, Klaas/0000-0003-3623-7555; Wolkers, Monika/0000-0003-3242-1363",Landsteiner Foundation for Blood Transfusion Research [1014],"MFP, SG, and ES were financially supported by a Fellowship obtained by MAN from the Landsteiner Foundation for Blood Transfusion Research, grantnr #1014. www.lsbr.nl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amos SM, 2011, BLOOD, V118, P499, DOI 10.1182/blood-2011-01-325266; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; BATTEGAY M, 1994, J VIROL, V68, P4700; Binder D, 1998, J EXP MED, V187, P1903, DOI 10.1084/jem.187.11.1903; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Carrier Y, 2012, EUR J IMMUNOL, V42, P1393, DOI 10.1002/eji.201142162; Clouthier DL, 2014, J IMMUNOL, V193, P5033, DOI 10.4049/jimmunol.1401002; Clouthier DL, 2014, CYTOKINE GROWTH F R, V25, P91, DOI 10.1016/j.cytogfr.2013.12.003; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Cote AL, 2011, J IMMUNOL, V186, P275, DOI 10.4049/jimmunol.1001308; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Ephrem A, 2013, EUR J IMMUNOL, V43, P2421, DOI 10.1002/eji.201343451; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; He H, 2004, J VIROL, V78, P11641, DOI 10.1128/JVI.78.21.11641-11647.2004; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Kim J, 2006, J IMMUNOL, V176, P5223, DOI 10.4049/jimmunol.176.9.5223; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lu L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-36; MATLOUBIAN M, 1994, J VIROL, V68, P8056; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nocentini G, 2012, BRIT J PHARMACOL, V165, P2089, DOI 10.1111/j.1476-5381.2011.01753.x; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Nolte MA, 2006, J EXP MED, V203, P2405, DOI 10.1084/jem.20061840; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Ronchetti S, 2012, SCI WORLD J, DOI 10.1100/2012/308265; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Suvas S, 2005, J VIROL, V79, P11935, DOI 10.1128/JVI.79.18.11935-11942.2005; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZINKERNAGEL RM, 1976, P NATL ACAD SCI USA, V73, P3666, DOI 10.1073/pnas.73.10.3666; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388",63,7,8,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004675,10.1371/journal.ppat.1004675,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900012,25738498.0,"DOAJ Gold, Green Published",,,16/08/2019,9,0,46,5065,1211,904,307,3854,3147,23,684,46,0,0,0,8,8,1,,45,1,45,0,1,9,9,8,4,0,0,0,0,0,0,0,0,3,5073,36,0,449,85,0,3844,1211,36,0,449,85,0,18,,0,0,0,0,5,0,0,1,0,0,0,45,0,0,1.75,4.182493806771263,1.3142189932537622,0.31421899325376235,1.3476907109496628,1.0254689042448173,4.289017341040463
58,J,"Pentecost, M; Vashisht, AA; Lester, T; Voros, T; Beaty, SM; Park, A; Wang, YE; Yun, TE; Freiberg, AN; Wohlschlegel, JA; Lee, B",,,,"Pentecost, Mickey; Vashisht, Ajay A.; Lester, Talia; Voros, Tim; Beaty, Shannon M.; Park, Arnold; Wang, Yao E.; Yun, Tatyana E.; Freiberg, Alexander N.; Wohlschlegel, James A.; Lee, Benhur",,,Evidence for Ubiquitin-Regulated Nuclear and Subnuclear Trafficking among Paramyxovirinae Matrix Proteins,PLOS PATHOGENS,,,English,Article,,,,,,,UPSTREAM-BINDING-FACTOR; VIRUS-LIKE PARTICLES; SENDAI-VIRUS; MEASLES-VIRUS; NIPAH-VIRUS; NUCLEOLAR LOCALIZATION; PROTEASOME INHIBITORS; CYTOPLASMIC SURFACE; MASS-SPECTROMETRY; GENE-EXPRESSION,"The paramyxovirus matrix (M) protein is a molecular scaffold required for viral morphogenesis and budding at the plasma membrane. Transient nuclear residence of some M proteins hints at non-structural roles. However, little is known regarding the mechanisms that regulate the nuclear sojourn. Previously, we found that the nuclear-cytoplasmic trafficking of Nipah virus M (NiV-M) is a prerequisite for budding, and is regulated by a bipartite nuclear localization signal (NLSbp), a leucine-rich nuclear export signal (NES), and monoubiquitination of the K258 residue within the NLSbp itself (NLSbp-lysine). To define whether the sequence determinants of nuclear trafficking identified in NiV-M are common among other Paramyxovirinae M proteins, we generated the homologous NES and NLSbp-lysine mutations in M proteins from the five major Paramyxovirinae genera. Using quantitative 3D confocal microscopy, we determined that the NES and NLSbp-lysine are required for the efficient nuclear export of the M proteins of Nipah virus, Hendra virus, Sendai virus, and Mumps virus. Pharmacological depletion of free ubiquitin or mutation of the conserved NLSbp-lysine to an arginine, which inhibits M ubiquitination, also results in nuclear and nucleolar retention of these M proteins. Recombinant Sendai virus (rSeV-eGFP) bearing the NES or NLSbp-lysine M mutants rescued at similar efficiencies to wild type. However, foci of cells expressing the M mutants displayed marked fusogenicity in contrast to wild type, and infection did not spread. Recombinant Mumps virus (rMuV-eGFP) bearing the homologous mutations showed similar defects in viral morphogenesis. Finally, shotgun proteomics experiments indicated that the interactomes of Paramyxovirinae M proteins are significantly enriched for components of the nuclear pore complex, nuclear transport receptors, and nucleolar proteins. We then synthesize our functional and proteomics data to propose a working model for the ubiquitin-regulated nuclear-cytoplasmic trafficking of cognate paramyxovirus M proteins that show a consistent nuclear trafficking phenotype.","[Pentecost, Mickey; Lester, Talia; Voros, Tim; Park, Arnold; Wang, Yao E.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Beaty, Shannon M.; Lee, Benhur] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Yun, Tatyana E.; Freiberg, Alexander N.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA","Pentecost, M (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.",benhur.lee@mssm.edu,"Lee, Benhur/A-8554-2016","Lee, Benhur/0000-0003-0760-1709; Park, Arnold/0000-0001-8916-2230","Virology and Gene Therapy Training Grant from the National Institutes of Health [T32 AI060567]; Ruth L. Kirschstein National Research Service Award from the National Institutes of Health [F32 AI100498]; American Society for Microbiology undergraduate research fellowship; UCLA; National Institutes of Health [T32 AI07323, T32 GM007185, GM089778]; Pacific Southwest Regional Center of Excellence for Biodefense & Emerging Infectious Diseases [U54 AI065359]; National Institute of Allergy and Infectious Disease [R21 AI102267]","A Virology and Gene Therapy Training Grant (T32 AI060567) and the Ruth L. Kirschstein National Research Service Award (F32 AI100498) from the National Institutes of Health supported MP. An American Society for Microbiology undergraduate research fellowship supported TL. The Van Trees Award from UCLA's Undergraduate Research Scholar Program supported TV. A Microbial Pathogenesis Training Grant (T32 AI07323) from the National Institutes of Health supported SMB. A Cellular & Molecular Training Grant (T32 GM007185) from the National Institutes of Health supported AP. AAV and JAW were supported by grant GM089778 from the National Institutes of Health. This work was supported by a grant from The Pacific Southwest Regional Center of Excellence for Biodefense & Emerging Infectious Diseases awarded to BL (U54 AI065359), and by a grant from the National Institute of Allergy and Infectious Disease awarded to ANF and BL (R21 AI102267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aguilar HC, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001754; Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; [Anonymous], 2011, THE BIOLOGY OF PARAM; BACHI T, 1980, VIROLOGY, V106, P41, DOI 10.1016/0042-6822(80)90219-6; Bailey D, 2005, BIOCHEM J, V392, P271, DOI 10.1042/BJ20050873; Banerjee R, 2005, J GEN VIROL, V86, P2315, DOI 10.1099/vir.0.80817-0; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Battisti AJ, 2012, P NATL ACAD SCI USA, V109, P13996, DOI 10.1073/pnas.1210275109; Bauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097233; Bian T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038052; BUECHI M, 1982, VIROLOGY, V120, P349, DOI 10.1016/0042-6822(82)90036-8; CALDWELL SE, 1986, J VIROL, V57, P678; Cathomen T, 1998, J VIROL, V72, P1224; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; Clarke DK, 2000, J VIROL, V74, P4831, DOI 10.1128/JVI.74.10.4831-4838.2000; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; COLEMAN NA, 1993, VIROLOGY, V195, P596, DOI 10.1006/viro.1993.1411; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; Duan ZQ, 2014, VIROLOGY, V452, P212, DOI 10.1016/j.virol.2014.01.011; Duan ZQ, 2013, ARCH VIROL, V158, P2589, DOI 10.1007/s00705-013-1769-5; Duan ZQ, 2013, J VIROL METHODS, V194, P118, DOI 10.1016/j.jviromet.2013.08.014; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Essaidi-Laziosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078074; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2005, J GEN VIROL, V86, P1879, DOI 10.1099/vir.0.80829-0; Ghildyal R, 2003, ARCH VIROL, V148, P1419, DOI 10.1007/s00705-003-0112-y; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Harrison MS, 2010, INT J BIOCHEM CELL B, V42, P1416, DOI 10.1016/j.biocel.2010.04.005; HEGGENESS MH, 1982, P NATL ACAD SCI-BIOL, V79, P6232, DOI 10.1073/pnas.79.20.6232; Henderson G, 2002, VIROLOGY, V300, P244, DOI 10.1006/viro.2002.1540; HEWITT JA, 1977, J GEN VIROL, V34, P127, DOI 10.1099/0022-1317-34-1-127; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hou XG, 2005, MED MICROBIOL IMMUN, V194, P129, DOI 10.1007/s00430-004-0224-3; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue M, 2003, J VIROL, V77, P6419, DOI 10.1128/JVI.77.11.6419-6429.2003; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Irie T, 2010, VIROLOGY, V405, P334, DOI 10.1016/j.virol.2010.06.031; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jardetzky TS, 2014, CURR OPIN VIROL, V5, P24, DOI 10.1016/j.coviro.2014.01.005; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kimura M, 2014, BIOLOGICAL SIGNIFICA; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kruger T, 2010, J CELL SCI, V123, P1203, DOI 10.1242/jcs.062398; Lamb R, 2013, FIELDS VIROLOGY, P957; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Lawrence FJ, 2006, J CELL SCI, V119, P2621, DOI 10.1242/jcs.02982; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Levanic DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051184; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007; Lymberopoulos MH, 2010, J VIROL, V84, P4810, DOI 10.1128/JVI.02437-09; Manie SN, 2000, J VIROL, V74, P305, DOI 10.1128/JVI.74.1.305-311.2000; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Moore HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059096; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Patch JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-1; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; PEEPLES ME, 1992, J VIROL, V66, P3263; Pohl C, 2007, J GEN VIROL, V88, P1243, DOI 10.1099/vir.0.82578-0; Pokrovskaja K, 2001, J GEN VIROL, V82, P345, DOI 10.1099/0022-1317-82-2-345; Rawling J, 2011, J VIROL, V85, P2771, DOI 10.1128/JVI.02065-10; Raychaudhuri S, 2009, CANCER RES, V69, P2057, DOI 10.1158/0008-5472.CAN-08-3468; Riedl P, 2002, VIRUS RES, V83, P1, DOI 10.1016/S0168-1702(01)00379-3; Runkler N, 2007, CELL MICROBIOL, V9, P1203, DOI 10.1111/j.1462-5822.2006.00860.x; RUSSELL PH, 1984, J GEN VIROL, V65, P1023, DOI 10.1099/0022-1317-65-6-1023; Salvetti A, 2013, BIOCHIM BIOPHYS ACTA; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schmitt AP, 1999, J VIROL, V73, P8703; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061281; Stow ND, 2009, J GEN VIROL, V90, P69, DOI 10.1099/vir.0.006353-0; STRICKER R, 1994, J GEN VIROL, V75, P1031, DOI 10.1099/0022-1317-75-5-1031; Subhashri R, 2007, BIOCHEM BIOPH RES CO, V355, P1096, DOI 10.1016/j.bbrc.2007.02.088; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Sun W, 2014, J VIROL, V88, P13099, DOI 10.1128/JVI.02103-14; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tahara M, 2007, J VIROL, V81, P6827, DOI 10.1128/JVI.00248-07; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; Terrier O, 2009, VIRUS RES, V142, P200, DOI 10.1016/j.virusres.2008.12.017; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Vilotti S, 2012, CELL DEATH DIFFER, V19, P488, DOI 10.1038/cdd.2011.118; Vincent S, 2000, J VIROL, V74, P9911, DOI 10.1128/JVI.74.21.9911-9915.2000; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; Watanabe H, 2005, MICROBIOL IMMUNOL, V49, P835, DOI 10.1111/j.1348-0421.2005.tb03672.x; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Xu Q, 2004, MOL CANCER THER, V3, P1263; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yarbrough ML, 2014, TRAFFIC, V15, P127, DOI 10.1111/tra.12137; YOSHIDA T, 1976, VIROLOGY, V71, P143, DOI 10.1016/0042-6822(76)90101-X; Zhai WG, 1999, MOL CELL BIOL, V19, P2791",130,22,25,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004739,10.1371/journal.ppat.1004739,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900056,25782006.0,"DOAJ Gold, Green Published",,,16/08/2019,25,178,42,5290,1051,803,248,4239,3519,24,696,42,0,0,0,24,24,1,,31,1,31,0,1,25,25,15,17,0,0,0,0,0,0,0,176,5,5352,12,0,268,248,1,4272,1064,12,0,268,248,1,16,,0,0,0,0,7,0,2,1,0,0,0,33,0,0,3.75,5.033301617507136,1.247935833923095,0.24793583392309507,1.3238971455531965,1.0608695652173914,5.339676498572788
59,J,"Pujari, R; Hunte, R; Thomas, R; van der Weyden, L; Rauch, D; Ratner, L; Nyborg, JK; Ramos, JC; Takai, Y; Shembade, N",,,,"Pujari, Rajeshree; Hunte, Richard; Thomas, Remy; van der Weyden, Louise; Rauch, Dan; Ratner, Lee; Nyborg, Jennifer K.; Ramos, Juan Carlos; Takai, Yoshimi; Shembade, Noula",,,Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-kappa B Inhibitor A20 and Constitutive NF-kappa B Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,EDITING ENZYME A20; ADHESION MOLECULE; LUNG-CANCER; I TAX; PERSISTENT ACTIVATION; ONCOPROTEIN TAX; LIPID RAFTS; KINASE IKK; PROTEIN; TSLC1,"Persistent activation of NF-kappa B by the Human T-cell leukemia virus type 1 (HTLV-1) oncoprotein, Tax, is vital for the development and pathogenesis of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). K63-linked polyubiquitinated Tax activates the IKK complex in the plasma membrane-associated lipid raft microdomain. Tax also interacts with TAX1BP1 to inactivate the NF-kappa B negative regulatory ubiquitin-editing A20 enzyme complex. However, the molecular mechanisms of Tax-mediated IKK activation and A20 protein complex inactivation are poorly understood. Here, we demonstrated that membrane associated CADM1 (Cell adhesion molecule1) recruits Ubc13 to Tax, causing K63-linked polyubiquitination of Tax, and IKK complex activation in the membrane lipid raft. The c-terminal cytoplasmic tail containing PDZ binding motif of CADM1 is critical for Tax to maintain persistent NF-kappa B activation. Finally, Tax failed to inactivate the NF-kappa B negative regulator ubiquitin-editing enzyme A20 complex, and activate the IKK complex in the lipid raft in absence of CADM1. Our results thus indicate that CADM1 functions as a critical scaffold molecule for Tax and Ubc13 to form a cellular complex with NEMO, TAX1BP1 and NRP, to activate the IKK complex in the plasma membrane-associated lipid rafts, to inactivate NF-kappa B negative regulators, and maintain persistent NF-kappa B activation in HTLV-1 infected cells.","[Pujari, Rajeshree; Hunte, Richard; Thomas, Remy; Shembade, Noula] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Viral Oncol Program,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [van der Weyden, Louise] Wellcome Trust Sanger Inst, Cambridge, England; [Rauch, Dan; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; [Nyborg, Jennifer K.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Ramos, Juan Carlos] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Med,Div Hematol Oncol,Viral Oncol Program, Miami, FL 33136 USA; [Ramos, Juan Carlos] Univ Miami, Miller Sch Med, Ctr AIDS Res, Miami, FL 33136 USA; [Ramos, Juan Carlos] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan","Pujari, R (reprint author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Viral Oncol Program,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.",nshembade@med.miami.edu,,,"Stanley J. Glaser Foundation [UM SJG 2012-39]; American Cancer Society [IRG-98-277-13]; PHS [CA94056, CA10073, CA63417]; Cancer Research UK [13031]","These studies were supported in part by UM SJG 2012-39 from the Stanley J. Glaser Foundation and IRG-98-277-13 from the American Cancer Society to NS, and PHS grants: CA94056, CA10073, CA63417 to LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Arima N, 1999, EXP HEMATOL, V27, P1168, DOI 10.1016/S0301-472X(99)00053-3; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Chen KQ, 2011, INT J CANCER, V128, P266, DOI 10.1002/ijc.25356; Cortez VS, 2014, J EXP MED, V211, P623, DOI 10.1084/jem.20130904; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; de la Fuente C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-43; FRANCHINI G, 1995, BLOOD, V86, P3619; Fukami T, 2003, INT J CANCER, V107, P53, DOI 10.1002/ijc.11348; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gao LL, 2013, J VIROL, V87, P13640, DOI 10.1128/JVI.02006-13; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hasstedt SJ, 2009, BLOOD, V114, P3084, DOI 10.1182/blood-2009-05-219485; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang JN, 2009, J BIOL CHEM, V284, P6208, DOI 10.1074/jbc.M806390200; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Inoue T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100988; Ishioka K, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-71; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Jeang KT, 2004, J BIOL CHEM, V279, P31991, DOI 10.1074/jbc.R400009200; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kikuchi S, 2012, CANCER SCI, V103, P1051, DOI 10.1111/j.1349-7006.2012.02277.x; Kim HR, 2011, J EXP MED, V208, P2545, DOI 10.1084/jem.20110853; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Mao XL, 2004, ONCOGENE, V23, P5632, DOI 10.1038/sj.onc.1207756; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Minami A, 2013, J BIOL CHEM, V288, P11845, DOI 10.1074/jbc.M112.405993; Mizutani K, 2011, J BIOL CHEM, V286, P36667, DOI 10.1074/jbc.M110.200535; Momose K, 2013, GENES CELLS, V18, P195, DOI 10.1111/gtc.12027; Mori N, 1999, BLOOD, V93, P2360; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Murakami Y, 1998, P NATL ACAD SCI USA, V95, P8153, DOI 10.1073/pnas.95.14.8153; Nakahata S, 2012, J CLIN EXP HEMATOP, V52, P17; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177; Pujari R, 2013, IMMUNOL RES, V57, P166, DOI 10.1007/s12026-013-8463-2; Rauch D, 2009, BLOOD, V113, P1493, DOI 10.1182/blood-2008-07-166462; Ren T, 2013, ONCOGENE; Rudolph D, 2000, GENE DEV, V14, P854; Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222; Semmes OJ, 1996, J VIROL, V70, P6347; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, CELL CYCLE, V9, P2481, DOI 10.4161/cc.9.13.12269; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shibata Y, 2011, J BIOCHEM, V150, P679, DOI 10.1093/jb/mvr106; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006; van der Weyden L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-29; Wu XF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-27; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445",76,20,20,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004721,10.1371/journal.ppat.1004721,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900042,25774694.0,"DOAJ Gold, Green Published",,,16/08/2019,21,1,22,5349,1354,1013,341,3995,3293,20,682,20,0,0,0,16,16,0,,30,2,28,2,2,21,21,18,12,0,0,0,0,0,0,0,2,2,5427,118,0,352,140,3,4029,1367,68,0,352,136,3,31,,0,0,0,0,2,0,0,1,0,0,0,28,2,0,1.0,3.9505169867060563,1.3389236545682102,0.3389236545682103,1.4230287859824782,1.062815479528884,4.198670605612999
60,J,"Ramakrishna, C; Ferraioli, A; Calle, A; Nguyen, TK; Openshaw, H; Lundberg, PS; Lomonte, P; Cantin, EM",,,,"Ramakrishna, Chandran; Ferraioli, Adrianna; Calle, Aleth; Nguyen, Thanh K.; Openshaw, Harry; Lundberg, Patric S.; Lomonte, Patrick; Cantin, Edouard M.",,,Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient In Vivo Reactivation,PLOS PATHOGENS,,,English,Article,,,,,,,HERPES-SIMPLEX-VIRUS; CD8(+) T-CELLS; TYPE-1 INFECTION; GAMMA-INTERFERON; GANGLIONIC NEURONS; IMMUNE-RESPONSE; RESISTANT; ENCEPHALITIS; INHIBITION; ACYCLOVIR,"The establishment of latent infections in sensory neurons is a remarkably effective immune evasion strategy that accounts for the widespread dissemination of life long Herpes Simplex Virus type 1 (HSV1) infections in humans. Periodic reactivation of latent virus results in asymptomatic shedding and transmission of HSV1 or recurrent disease that is usually mild but can be severe. An in-depth understanding of the mechanisms regulating the maintenance of latency and reactivation are essential for developing new approaches to block reactivation. However, the lack of a reliable mouse model that supports efficient in vivo reactivation (IVR) resulting in production of infectious HSV1 and/or disease has hampered progress. Since HSV1 reactivation is enhanced in immunosuppressed hosts, we exploited the antiviral and immunomodulatory activities of IVIG (intravenous immunoglobulins) to promote survival of latently infected immunodeficient Rag mice. Latently infected Rag mice derived by high dose (HD), but not low dose (LD), HSV1 inoculation exhibited spontaneous reactivation. Following hyperthermia stress (HS), the majority of HD inoculated mice developed HSV1 encephalitis (HSE) rapidly and synchronously, whereas for LD inoculated mice reactivated HSV1 persisted only transiently in trigeminal ganglia (Tg). T cells, but not B cells, were required to suppress spontaneous reactivation in HD inoculated latently infected mice. Transfer of HSV1 memory but not OVA specific or naive T cells prior to HS blocked IVR, revealing the utility of this powerful Rag latency model for studying immune mechanisms involved in control of reactivation. Crossing Rag mice to various knockout strains and infecting them with wild type or mutant HSV1 strains is expected to provide novel insights into the role of specific cellular and viral genes in reactivation, thereby facilitating identification of new targets with the potential to block reactivation.","[Ramakrishna, Chandran; Cantin, Edouard M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Virol, Duarte, CA 91010 USA; [Ferraioli, Adrianna; Nguyen, Thanh K.; Lundberg, Patric S.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Calle, Aleth; Lomonte, Patrick] Univ Lyon 1, CNRS, Ctr Genet & Physiol Mol & Cellulaire, UMR5534, F-69365 Lyon, France; [Calle, Aleth; Lomonte, Patrick] Univ Lyon 1, F-69365 Lyon, France; [Calle, Aleth; Lomonte, Patrick] LabEX DEVweCAN, Lab Excellence, Lyon, France; [Openshaw, Harry; Cantin, Edouard M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurol, Duarte, CA USA; [Cantin, Edouard M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA","Ramakrishna, C (reprint author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Virol, Duarte, CA 91010 USA.",ecantin@coh.org,,,"NIH [5R01AI78399-2, 5R01EY013814-05];  [ANR-13-BSV3-0001-01 VIRUCEPTION];  [LabEX DEVweCAN ANR-10-LABX-61]","Supported by NIH grant 5R01AI78399-2 and 5R01EY013814-05 awarded to EMC and by grants ANR-13-BSV3-0001-01 VIRUCEPTION and LabEX DEVweCAN ANR-10-LABX-61 grants (http://www.agence-nationale-recherche.fr) awarded to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Azwa A, 2009, J FAM PLAN REPROD H, V35, P237, DOI 10.1783/147118909789587376; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bertke AS, 2013, J VIROL, V87, P6512, DOI 10.1128/JVI.00383-13; Boutell C, 2013, J GEN VIROL, V94, P465, DOI 10.1099/vir.0.048900-0; Cantin E, 1999, J VIROL, V73, P5196; Cantin E, 1999, J VIROL, V73, P3418; Catez dr F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat. 1002852; Catez F, 2014, JOVE-J VIS EXP, DOI 10.3791/51091; Chakraborty S, 2010, NEUROCHEM INT, V56, P727, DOI 10.1016/j.neuint.2010.02.016; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Duan R, 2009, J INFECT DIS, V200, P1402, DOI 10.1086/606028; Egan KP, 2013, J NEUROVIROL, V19, P328, DOI 10.1007/s13365-013-0189-3; Ellison AR, 2000, VIROLOGY, V268, P17, DOI 10.1006/viro.1999.0158; Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; Ferrara G, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.01.023; Frenzel K, 2012, MED MICROBIOL IMMUN, V201, P277, DOI 10.1007/s00430-012-0229-2; Frobert E, 2014, ANTIVIR RES, V111, P36, DOI 10.1016/j.antiviral.2014.08.013; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Held K, 2011, J NEUROVIROL, V17, P518, DOI 10.1007/s13365-011-0063-0; Himmelein Susanne, 2011, Herpesviridae, V2, P5, DOI 10.1186/2042-4280-2-5; Hoshino Y, 2008, VIROLOGY, V372, P56, DOI 10.1016/j.virol.2007.10.031; Imbach P, 2010, VOX SANG, V98, P385, DOI 10.1111/j.1423-0410.2009.01264.x; Jordan SC, 2009, TRANSPLANTATION, V88, P1, DOI 10.1097/TP.0b013e3181a9e89a; Jugovic P, 1998, J VIROL, V72, P5076; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Krawczyk A, 2013, P NATL ACAD SCI USA, V110, P6760, DOI 10.1073/pnas.1220019110; Lachmann RH, 1996, J GEN VIROL, V77, P2575, DOI 10.1099/0022-1317-77-10-2575; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919; Lekstrom-Himes JA, 2000, J VIROL, V74, P6680, DOI 10.1128/JVI.74.14.6680-6683.2000; Liu T, 1996, J VIROL, V70, P264; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Lundberg P, 2007, INVEST OPHTH VIS SCI, V48, P4162, DOI 10.1167/iovs.07-0261; Ma JZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004237; Margolis TP, 2007, J VIROL, V81, P11069, DOI 10.1128/JVI.00243-07; Margolis TP, 2007, J VIROL, V81, P1872, DOI 10.1128/JVI.02110-06; Nicoll MP, 2012, FEMS MICROBIOL REV, V36, P684, DOI 10.1111/j.1574-6976.2011.00320.x; OAKES JE, 1984, J VIROL, V51, P656; Orr MT, 2007, CELL HOST MICROBE, V2, P172, DOI 10.1016/j.chom.2007.06.013; PAVAN PR, 1977, J IMMUNOL, V118, P2167; Ramakrishna C, 2013, FUTURE VIROL, V8, P259, DOI 10.2217/FVL.12.138; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Sawtell NM, 1998, J VIROL, V72, P6888; SAWTELL NM, 1992, J VIROL, V66, P2150; Sawtell NM, 1997, J VIROL, V71, P5423; Schiff D, 1998, HUM PATHOL, V29, P215, DOI 10.1016/S0046-8177(98)90038-7; St Leger AJ, 2011, J NEUROVIROL, V17, P528, DOI 10.1007/s13365-011-0062-1; Stock AT, 2011, IMMUNOL CELL BIOL, V89, P143, DOI 10.1038/icb.2010.66; Stranska R, 2005, J CLIN VIROL, V32, P7, DOI 10.1016/j.jcv.2004.04.002; Tan IL, 2012, NEUROLOGY, V79, P2125, DOI 10.1212/WNL.0b013e3182752ceb; Tyler K. L., 2004, HERPES J IHMF, V11, P57; van der Beek MT, 2012, BONE MARROW TRANSPL, V47, P1222, DOI 10.1038/bmt.2012.2; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; van Lint AL, 2005, J VIROL, V79, P14843, DOI 10.1128/JVI.79.23.14843-14851.2005; van Velzen M, 2013, J INFECT DIS, V208, P1359, DOI 10.1093/infdis/jit350; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Webre JM, 2012, J BIOMED BIOTECHNOL, V2012, P18; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Yao HW, 2014, J VIROL, V88, P11264, DOI 10.1128/JVI.01616-14; Yao HW, 2012, VIROLOGY, V433, P116, DOI 10.1016/j.virol.2012.07.018; Zerboni L, 2013, J VIROL, V87, P2791, DOI 10.1128/JVI.01375-12",66,17,18,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004730,10.1371/journal.ppat.1004730,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900049,25760441.0,"DOAJ Gold, Green Published",,,16/08/2019,17,0,19,3796,1010,791,219,2786,2342,19,425,19,0,0,0,16,16,0,,24,4,24,0,4,17,17,16,10,0,0,0,0,0,0,0,0,1,3868,147,0,62,140,1,2804,1022,147,0,62,140,1,42,,0,0,0,0,2,0,0,1,0,0,0,24,0,0,1.5,3.758415841584158,1.362526920315865,0.36252692031586503,1.4913854989231874,1.094573234984194,4.1138613861386135
61,J,"Rubach, MP; Mukemba, J; Florence, S; Lopansri, BK; Hyland, K; Volkheimer, AD; Yeo, TW; Anstey, NM; Weinberg, JB; Mwaikambo, ED; Granger, DL",,,,"Rubach, Matthew P.; Mukemba, Jackson; Florence, Salvatore; Lopansri, Bert K.; Hyland, Keith; Volkheimer, Alicia D.; Yeo, Tsin W.; Anstey, Nicholas M.; Weinberg, J. Brice; Mwaikambo, Esther D.; Granger, Donald L.",,,Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Oxidized Biopterins in Pediatric Falciparum Malaria: Association with Disease Severity,PLOS PATHOGENS,,,English,Article,,,,,,,NITRIC-OXIDE SYNTHASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; CEREBRAL MALARIA; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; SUPEROXIDE-PRODUCTION; MALAWIAN CHILDREN; IMMUNE ACTIVATION; VASCULAR-DISEASE,"Decreased bioavailability of nitric oxide (NO) is a major contributor to the pathophysiology of severe falciparum malaria. Tetrahydrobiopterin (BH4) is an enzyme cofactor required for NO synthesis from L-arginine. We hypothesized that systemic levels of BH4 would be decreased in children with cerebral malaria, contributing to low NO bioavailability. In an observational study in Tanzania, we measured urine levels of biopterin in its various redox states (fully reduced [BH4] and the oxidized metabolites, dihydrobiopterin [BH2] and biopterin [B-0]) in children with uncomplicated malaria (UM, n = 55), cerebral malaria (CM, n = 45), non-malaria central nervous system conditions (NMC, n = 48), and in 111 healthy controls (HC). Median urine BH4 concentration in CM (1.10 [IQR: 0.55-2.18] mu mol/mmol creatinine) was significantly lower compared to each of the other three groups-UM (2.10 [IQR: 1.32-3.14]; p<0.001), NMC (1.52 [IQR: 1.01-2.71]; p = 0.002), and HC (1.60 [IQR: 1.15-2.23]; p = 0.005). Oxidized biopterins were increased, and the BH4: BH2 ratio markedly decreased in CM. In a multivariate logistic regression model, each Log10-unit decrease in urine BH4 was independently associated with a 3.85-fold (95% CI: 1.89-7.61) increase in odds of CM (p<0.001). Low systemic BH4 levels and increased oxidized biopterins contribute to the low NO bioavailability observed in CM. Adjunctive therapy to regenerate BH4 may have a role in improving NO bioavailability and microvascular perfusion in severe falciparum malaria.","[Rubach, Matthew P.; Volkheimer, Alicia D.; Weinberg, J. Brice] Duke Univ, Dept Med, Durham, NC 27708 USA; [Rubach, Matthew P.; Volkheimer, Alicia D.; Weinberg, J. Brice] VA Med Ctr, Durham, NC USA; [Mukemba, Jackson; Florence, Salvatore; Mwaikambo, Esther D.] Hubert Kairuki Mem Univ, Dept Pediat, Dar Es Salaam, Tanzania; [Lopansri, Bert K.] Intermt Healthcare, Dept Med, Salt Lake City, UT USA; [Lopansri, Bert K.; Granger, Donald L.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Lopansri, Bert K.; Granger, Donald L.] VA Med Ctr, Salt Lake City, UT USA; [Hyland, Keith] Med Neurogenet, Neurochem Div, Atlanta, GA USA; [Yeo, Tsin W.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Yeo, Tsin W.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Yeo, Tsin W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Dept Med, Singapore 639798, Singapore","Rubach, MP (reprint author), Duke Univ, Dept Med, Durham, NC 27708 USA.",Don.Granger@hsc.utah.edu,"Yeo, Tsin Wen/F-9505-2015",,"National Institutes of Health [U01AI057565, R01AI041764]; Fogarty International Center Global Health Fellowship [R25TW009343]; Veterans Affairs Research Service; Australian NHMRC Fellowships","The work was supported by the following agencies and grants: National Institutes of Health (U01AI057565 and R01AI041764 [DLG and JBW]); Fogarty International Center Global Health Fellowship (R25TW009343 [MPR]); the Veterans Affairs Research Service (JBW and DLG); and Australian NHMRC Fellowships (NMA and TWY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adak S, 2000, J BIOL CHEM, V275, P33554, DOI 10.1074/jbc.M004337200; Alkaitis Matthew S, 2012, Curr Heart Fail Rep, V9, P200, DOI 10.1007/s11897-012-0097-5; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; BLAIR JA, 1974, J CHEM SOC PERK T 2, P1786, DOI 10.1039/p29740001786; BLAU N, 2001, METABOLIC MOL BASES, V2, P1725; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Boutlis CS, 2003, INFECT IMMUN, V71, P3682, DOI 10.1128/IAI.71.7.3682-3689.2003; Conroy AL, 2012, CRIT CARE MED, V40, P952, DOI 10.1097/CCM.0b013e3182373157; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2011, NITRIC OXIDE-BIOL CH, V25, P81, DOI 10.1016/j.niox.2011.04.004; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Dobbie M, 2000, AM J TROP MED HYG, V62, P284, DOI 10.4269/ajtmh.2000.62.284; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; FUCHS D, 1992, CRIT REV CL LAB SCI, V29, P307, DOI 10.3109/10408369209114604; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675; Hobbs MR, 2002, LANCET, V360, P1468, DOI 10.1016/S0140-6736(02)11474-7; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; HOWELLS DW, 1986, J CHROMATOGR, V381, P285, DOI 10.1016/S0378-4347(00)83594-X; HOWELLS DW, 1987, CLIN CHIM ACTA, V167, P23, DOI 10.1016/0009-8981(87)90081-7; Huang A, 2000, J BIOL CHEM, V275, P17399, DOI 10.1074/jbc.M002248200; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; HYLAND K, 1988, J CHROMATOGR-BIOMED, V429, P95, DOI 10.1016/S0378-4347(00)83868-2; HYLAND K, 1985, J CHROMATOGR, V343, P35, DOI 10.1016/S0378-4347(00)84565-X; Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P3160, DOI 10.1073/pnas.96.6.3160; KLATT P, 1994, J BIOL CHEM, V269, P13861; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Moxon CA, 2014, J INFECT DIS, V209, P610, DOI 10.1093/infdis/jit419; Ohashi A, 2012, MOL GENET METAB, V105, P575, DOI 10.1016/j.ymgme.2012.01.009; Ong PK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003444; Opladen T, 2011, J INHERIT METAB DIS, V34, P819, DOI 10.1007/s10545-011-9300-1; Pino P, 2004, CELL MICROBIOL, V6, P839, DOI 10.1111/j.1462-5822.2004.00406.x; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699; REIBNEGGER G, 1984, T ROY SOC TROP MED H, V78, P545, DOI 10.1016/0035-9203(84)90080-4; Rubach MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035985; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; te Witt R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-255; TURNER GDH, 1994, AM J PATHOL, V145, P1057; VALLANCE P, 1992, J CARDIOVASC PHARM, V20, pS60, DOI 10.1097/00005344-199204002-00018; WEINBERG JB, 1995, BLOOD, V86, P1184; Weinberg JM, 2008, CUTIS, V81, P21; Weinberg JB, 2014, J INFECT DIS, V210, P913, DOI 10.1093/infdis/jiu156; Weiss G, 1998, J INFECT DIS, V177, P1064, DOI 10.1086/515229; WERNER ER, 1990, J BIOL CHEM, V265, P3189; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2010, GUID TREATM MAL, DOI [10.1186/1475-2875-9-212, DOI 10.1186/1475-2875-9-212]; World Health Organization, 2000, T R SOC TROP MED S1, V94; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; ZIEGLER I, 1990, J BIOL CHEM, V265, P17026; Zurfluh MR, 2005, MOL GENET METAB, V86, pS96, DOI 10.1016/j.ymgme.2005.09.011",72,16,17,1,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004655,10.1371/journal.ppat.1004655,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900005,25764173.0,"DOAJ Gold, Green Published",,,16/08/2019,17,23,10,2829,430,339,91,2399,2004,24,371,10,13,0,0,16,16,2,,12,5,12,0,5,17,17,17,13,0,0,0,0,0,0,0,10,8,2875,20,1,90,98,0,2422,435,20,1,90,98,0,18,,1,0,0,0,12,0,0,1,0,0,0,12,0,0,15.55,6.579069767441861,1.1792413505627344,0.17924135056273446,1.247603167986661,1.0579710144927537,6.96046511627907
62,J,"Shannon, JG; Bosio, CF; Hinnebusch, BJ",,,,"Shannon, Jeffrey G.; Bosio, Christopher F.; Hinnebusch, B. Joseph",,,"Dermal Neutrophil, Macrophage and Dendritic Cell Responses to Yersinia pestis Transmitted by Fleas",PLOS PATHOGENS,,,English,Article,,,,,,,ORIENTAL RAT FLEA; IN-VIVO; XENOPSYLLA-CHEOPIS; PLAGUE BACILLUS; SYSTEM; TRANSMISSION; INFECTION; EVOLUTION,"Yersinia pestis, the causative agent of plague, is typically transmitted by the bite of an infected flea. Many aspects of mammalian innate immune response early after Y. pestis infection remain poorly understood. A previous study by our lab showed that neutrophils are the most prominent cell type recruited to the injection site after intradermal needle inoculation of Y. pestis, suggesting that neutrophil interactions with Y. pestis may be important in bubonic plague pathogenesis. In the present study, we developed new tools allowing for intravital microscopy of Y. pestis in the dermis of an infected mouse after transmission by its natural route of infection, the bite of an infected flea. We found that uninfected flea bites typically induced minimal neutrophil recruitment. The magnitude of neutrophil response to flea-transmitted Y. pestis varied considerably and appeared to correspond to the number of bacteria deposited at the bite site. Macrophages migrated towards flea bite sites and interacted with small numbers of flea-transmitted bacteria. Consistent with a previous study, we observed minimal interaction between Y. pestis and dendritic cells; however, dendritic cells did consistently migrate towards flea bite sites containing Y. pestis. Interestingly, we often recovered viable Y. pestis from the draining lymph node (dLN) 1 h after flea feeding, indicating that the migration of bacteria from the dermis to the dLN may be more rapid than previously reported. Overall, the innate cellular host responses to flea-transmitted Y. pestis differed from and were more variable than responses to needle-inoculated bacteria. This work highlights the importance of studying the interactions between fleas, Y. pestis and the mammalian host to gain a better understanding of the early events in plague pathogenesis.","[Shannon, Jeffrey G.; Bosio, Christopher F.; Hinnebusch, B. Joseph] NIAID, Plague Sect, Lab Zoonot Pathogens, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA","Shannon, JG (reprint author), NIAID, Plague Sect, Lab Zoonot Pathogens, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.",jshannon@niaid.nih.gov,,"Shannon, Jeffrey/0000-0003-4211-4308","Division of Intramural Research, NIAID, NIH","This work was supported by the Division of Intramural Research, NIAID, NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Andersen JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-102; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; CAVANAUGH DC, 1971, AM J TROP MED HYG, V20, P264, DOI 10.4269/ajtmh.1971.20.264; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; DEORAS PJ, 1967, INDIAN J MED RES, V55, P1041; Faust N, 2000, BLOOD, V96, P719; Gonzalez RJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004587; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Jawetz E, 1944, J INFECT DIS, V74, P1, DOI 10.1093/infdis/74.1.1; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; LAVOIPIERRE M J, 1961, NATURE, V192, P998; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rebeil R, 2013, J BACTERIOL, V195, P1920, DOI 10.1128/JB.02000-12; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Shannon JG, 2013, MBIO, V4, DOI 10.1128/mBio.00170-13; Spinner JL, 2013, JOURNAL OF LEUKOCYTE; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; Spinner JL, 2013, INFECT IMMUN, V81, P4041, DOI 10.1128/IAI.00648-13; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x",32,19,19,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004734,10.1371/journal.ppat.1004734,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900052,25781984.0,"DOAJ Gold, Green Published",,,16/08/2019,28,2,25,3811,829,622,207,2982,2446,27,509,25,1,0,0,23,23,0,,33,16,33,0,16,29,29,19,12,0,0,0,0,0,0,0,1,1,3939,75,0,114,262,4,2970,829,75,0,114,262,4,140,,0,0,0,0,3,0,1,1,0,0,1,33,0,0,2.5,4.597104945717732,1.2780013413816231,0.2780013413816231,1.4339369550637155,1.1220152191025978,5.158021712907117
63,J,"Shor, E; Perlin, DS",,,,"Shor, Erika; Perlin, David S.",,,Coping with Stress and the Emergence of Multidrug Resistance in Fungi,PLOS PATHOGENS,,,English,Article,,,,,,,STEM-CELL TRANSPLANTATION; CANDIDA-GLABRATA; ECHINOCANDIN RESISTANCE; ANTIFUNGAL PROPHYLAXIS; SUSCEPTIBILITY; ANEUPLOIDY; MUTATIONS; EVOLUTION; ALBICANS; YEAST,"The incidence of invasive fungal infections poses a serious global health threat, killing nearly 1.4 million people a year-a number comparable to deaths from tuberculosis. Factors that contribute to this disease burden and high mortality include insufficient diagnostics and treatment, and the increasing numbers of individuals with immune system defects who are particularly susceptible to fungal pathogens [1]. Because of the high risk of fungal infections in immunocompromised individuals-e.g., low-birth-weight neonates or patients undergoing organ transplantation or chemotherapy-it has become common medical practice to utilize antifungal prophylaxis in these patients during immunosuppression [2-4]. However, the expanding use of antifungal drugs has been associated with increasing incidence of antifungal drug resistance resulting from inherently less sensitive species and/or acquisition of drug class-specific resistance mechanisms [5]. Most alarming in recent years, multidrug-resistant strains of certain Candida species have emerged that are resistant to azoles and echinocandins, the two most widely used classes of antifungal drugs [6,7]. In this article we explore the notion that frequent and prolonged exposures of fungal cells to antifungal drugs activate fungal stress responses, which both support the short-term cellular adaptation to the drugs [8,9] and promote genetic instability to facilitate the emergence of stable drug resistant mutants refractory to therapy [9,10], including multidrug-resistant (MDR) strains (Fig. 1). Antifungal drug-induced stress has been associated with genetic instability in such distantly related fungi as Candida and Cryptococcus [11,12], suggesting that it is a broadly conserved phenomenon. In this article, we focus on drug resistance in Candida spp. because of its clinical significance, especially with the development of emerging multidrug resistance, and because mechanisms of drug resistance and stress-associated genetic instability are best studied in Candida, both in the clinic and in the lab.","[Shor, Erika; Perlin, David S.] Rutgers Biomed & Hlth Sci, Publ Hlth Res Inst, Newark, NJ 07107 USA","Shor, E (reprint author), Rutgers Biomed & Hlth Sci, Publ Hlth Res Inst, Newark, NJ 07107 USA.",Perlinds@njms.rutgers.edu,,"Shor, Erika/0000-0003-3655-0963","NIH [AI109025, AI069397]; Pfizer; Astellas","This work was supported by NIH grants AI109025 and AI069397 to DSP and grants from Pfizer and Astellas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Coyle S, 2008, MOL BIOL EVOL, V25, P310, DOI 10.1093/molbev/msm256; Farmakiotis D, 2014, EMERG INFECT DIS, V20, P1833, DOI 10.3201/eid2011.140685; Flowers SA, 2015, ANTIMICROB AGENTS CH, V59, P450, DOI 10.1128/AAC.03470-14; Flowers SA, 2012, EUKARYOT CELL, V11, P1289, DOI 10.1128/EC.00215-12; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Greenberg RG, 2014, J INFECTION, V69, pS19, DOI 10.1016/j.jinf.2014.07.012; Hadany L, 2003, GENETICS, V165, P2167; Harrison BD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001815; Lewis James S 2nd, 2013, Antimicrob Agents Chemother, V57, P4559, DOI 10.1128/AAC.01144-13; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Perlin DS, 2014, DRUGS, V74, P1573, DOI 10.1007/s40265-014-0286-5; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Ram Y, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1025; Robenshtok E, 2007, J CLIN ONCOL, V25, P5471, DOI 10.1200/JCO.2007.12.3851; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07; Shor E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003680; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Slater JL, 2011, ANTIMICROB AGENTS CH, V55, P3075, DOI 10.1128/AAC.01686-10; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; Wisplinghoff H, 2014, INT J ANTIMICROB AG, V43, P78, DOI 10.1016/j.ijantimicag.2013.09.005; Ziakas PD, 2014, CLIN THER, V36, P292, DOI 10.1016/j.clinthera.2013.11.010",39,19,19,0,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004668,10.1371/journal.ppat.1004668,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900010,25790300.0,"DOAJ Gold, Green Published",,,16/08/2019,21,2,38,5394,654,426,228,4740,3909,20,811,38,1,0,0,19,19,0,,51,0,51,0,0,21,21,20,17,0,0,0,0,0,0,0,1,14,5422,0,0,0,110,3,4738,654,0,0,0,110,3,30,,0,0,0,0,20,0,1,1,0,0,0,52,0,0,9.35,8.247706422018348,1.1379746835443039,0.1379746835443038,1.1670886075949367,1.025583982202447,8.458715596330276
64,J,"Shulla, A; Randall, G",,,,"Shulla, Ana; Randall, Glenn",,,Spatiotemporal Analysis of Hepatitis C Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,NONSTRUCTURAL PROTEIN 5A; VIRAL REPLICATION COMPLEX; DEPENDENT RNA-POLYMERASE; CELL-CULTURE; LIVER-TRANSPLANTATION; LIPID DROPLET; CORE PROTEIN; STRANDED-RNA; HUH-7 CELLS; LIFE-CYCLE,"Hepatitis C virus (HCV) entry, translation, replication, and assembly occur with defined kinetics in distinct subcellular compartments. It is unclear how HCV spatially and temporally regulates these events within the host cell to coordinate its infection. We have developed a single molecule RNA detection assay that facilitates the simultaneous visualization of HCV (+) and (-) RNA strands at the single cell level using high-resolution confocal microscopy. We detect (+) strand RNAs as early as 2 hours post-infection and (-) strand RNAs as early as 4 hours post-infection. Single cell levels of (+) and (-) RNA vary considerably with an average (+):(-) RNA ratio of 10 and a range from 1-35. We next developed microscopic assays to identify HCV (+) and (-) RNAs associated with actively translating ribosomes, replication, virion assembly and intracellular virions. (+) RNAs display a defined temporal kinetics, with the majority of (+) RNAs associated with actively translating ribosomes at early times of infection, followed by a shift to replication and then virion assembly. (-) RNAs have a strong colocalization with NS5A, but not NS3, at early time points that correlate with replication compartment formation. At later times, only similar to 30% of the replication complexes appear to be active at a given time, as defined by (-) strand colocalization with either (+) RNA, NS3, or NS5A. While both (+) and (-) RNAs colocalize with the viral proteins NS3 and NS5A, only the plus strand preferentially colocalizes with the viral envelope E2 protein. These results suggest a defined spatiotemporal regulation of HCV infection with highly varied replication efficiencies at the single cell level. This approach can be applicable to all plus strand RNA viruses and enables unprecedented sensitivity for studying early events in the viral life cycle.","[Shulla, Ana; Randall, Glenn] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA","Shulla, A (reprint author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.",grandall@bsd.uchicago.edu,,,"National Institute of Allergy and Infectious Disease [AI080703]; American Cancer Society [PF-13-310-01-MPC, 118676-RSG-10-059-01-MPC]","This work is supported by National Institute of Allergy and Infectious Disease (AI080703). AS is supported by the American Cancer Society Postdoctoral Fellowship PF-13-310-01-MPC. GR acknowledges support from the National Institute of Allergy and Infectious Disease (AI080703), and the American Cancer Society (118676-RSG-10-059-01-MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Au JS, 2014, CLIN PHARMACOL THER, V95, P78, DOI 10.1038/clpt.2013.206; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Chang M, 2003, AM J PATHOL, V163, P433, DOI 10.1016/S0002-9440(10)63673-5; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Dahari H, 2005, GASTROENTEROLOGY, V128, P1056, DOI 10.1053/j.gastro.2005.01.049; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GRAKOUI A, 1993, J VIROL, V67, P1385; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Keum SJ, 2012, VIROLOGY, V433, P462, DOI 10.1016/j.virol.2012.08.046; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043600; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; McLean AK, 2010, J THEOR BIOL, V267, P565, DOI 10.1016/j.jtbi.2010.09.031; Mishchenko EL, 2007, J BIOINF COMPUT BIOL, V5, P593, DOI 10.1142/S0219720007002849; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oakland TE, 2013, J VIROL, V87, P6625, DOI 10.1128/JVI.01006-12; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Stedman C, 2014, THER ADV GASTROENTER, V7, P131, DOI 10.1177/1756283X13515825; Tai AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026300; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770",61,23,23,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004758,10.1371/journal.ppat.1004758,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900069,25822891.0,"DOAJ Gold, Green Published",,,16/08/2019,21,20,41,6445,733,483,250,5712,4575,22,1115,41,13,1,1,25,25,3,,51,0,51,0,0,26,23,26,15,0,0,0,0,0,0,0,7,15,6460,37,25,265,75,0,5703,733,37,25,265,75,0,24,,1,0,0,0,24,0,2,0,1,0,1,50,0,0,25.7,8.792633015006821,1.1283263305322129,0.12832633053221287,1.1505602240896358,1.0197051978277734,8.965893587994543
65,J,"Sivaraman, V; Pechous, RD; Stasulli, NM; Miao, EA; Goldman, WE",,,,"Sivaraman, Vijay; Pechous, Roger D.; Stasulli, Nikolas M.; Miao, Edward A.; Goldman, William E.",,,Yersinia pestis Activates Both IL-1 beta and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague,PLOS PATHOGENS,,,English,Article,,,,,,,III SECRETION APPARATUS; NLRC4 INFLAMMASOME; CASPASE-1 ACTIVATION; IMMUNE-RESPONSES; INNATE; MACROPHAGES; VIRULENCE; RECOGNITION; INFECTION; PATHOLOGY,"Pneumonic plague is the most rapid and lethal form of Yersinia pestis infection. Increasing evidence suggests that Y. pestis employs multiple levels of innate immune evasion and/or suppression to produce an early ""pre-inflammatory"" phase of pulmonary infection, after which the disease is highly inflammatory in the lung and 100% fatal. In this study, we show that IL-1 beta/IL-18 cytokine activation occurs early after bacteria enter the lung, and this activation eventually contributes to pulmonary inflammation and pathology during the later stages of infection. However, the inflammatory effects of IL-1 beta/IL-1-receptor ligation are not observed during this first stage of pneumonic plague. We show that Y. pestis also activates the induction of IL-1 receptor antagonist (IL-1RA), and this activation likely contributes to the ability of Y. pestis to establish the initial pre-inflammatory phase of disease.","[Sivaraman, Vijay; Pechous, Roger D.; Stasulli, Nikolas M.; Miao, Edward A.; Goldman, William E.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA; [Sivaraman, Vijay] N Carolina Cent Univ, Dept Biol, Durham, NC USA","Sivaraman, V (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.",goldman@med.unc.edu,,"Stasulli, Nikolas/0000-0002-9419-2634; Goldman, William/0000-0002-1551-6718; Miao, Edward/0000-0001-7295-3490","National Institutes of Health [AI057157, AI099698]","The described work was funded by National Institutes of Health grants AI057157 and AI099698. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Bubeck SS, 2007, INFECT IMMUN, V75, P697, DOI 10.1128/IAI.00403-06; Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Cantwell AM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-29; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Comer JE, 2010, INFECT IMMUN, V78, P5086, DOI 10.1128/IAI.00256-10; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jessen DL, 2014, INFECT IMMUN, V82, P2300, DOI 10.1128/IAI.01705-14; JORDAN M, 1995, J IMMUNOL, V154, P4081; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; Mao XQ, 2000, BIOCHEM BIOPH RES CO, V276, P607, DOI 10.1006/bbrc.2000.3516; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Spinner JL, 2014, J LEUKOCYTE BIOL, V95, P389, DOI 10.1189/jlb.1112551; Standiford LR, 2012, AM J PHYSIOL-LUNG C, V302, pL447, DOI 10.1152/ajplung.00415.2010; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; ZAHEDI KA, 1994, CYTOKINE, V6, P1, DOI 10.1016/1043-4666(94)90001-9; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026",35,12,13,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004688,10.1371/journal.ppat.1004688,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900020,25781467.0,"DOAJ Gold, Green Published",,,16/08/2019,14,3,10,3557,585,438,147,2972,2490,19,463,10,1,0,0,13,13,1,,23,22,23,0,22,15,15,14,7,0,0,0,0,0,0,0,2,3,3672,34,0,65,225,5,2978,592,34,0,65,225,5,102,,0,0,0,0,4,0,1,1,0,0,0,22,0,0,2.6,6.08034188034188,1.1968371467025571,0.1968371467025572,1.322678331090175,1.1051447849311218,6.71965811965812
66,J,"Taguchi, Y; Imaoka, K; Kataoka, M; Uda, A; Nakatsu, D; Horii-Okazaki, S; Kunishige, R; Kano, F; Murata, M",,,,"Taguchi, Yuki; Imaoka, Koichi; Kataoka, Michiyo; Uda, Akihiko; Nakatsu, Daiki; Horii-Okazaki, Sakuya; Kunishige, Rina; Kano, Fumi; Murata, Masayuki",,,"Yip1A, a Novel Host Factor for the Activation of the IRE1 Pathway of the Unfolded Protein Response during Brucella Infection",PLOS PATHOGENS,,,English,Article,,,,,,,ENDOPLASMIC-RETICULUM STRESS; AUTOPHAGOSOME FORMATION SITE; MAMMALIAN ATG PROTEINS; ER EXIT SITES; INTRACELLULAR REPLICATION; COPII VESICLES; ABORTUS; IDENTIFICATION; TRAFFICKING; COMPARTMENTS,"Brucella species replicate within host cells in the form of endoplasmic reticulum (ER)derived vacuoles. The mechanisms by which the bacteria are sequestered into such vacuoles and obtain a continuous membrane supply for their replication remain to be elucidated. In the present study, we provided several lines of evidence that demonstrate the mechanism by which B. abortus acquires the ER-derived membrane. First, during Brucella infection, the IRE1 pathway, but not the PERK and ATF6 pathways, of the unfolded protein response (UPR) was activated in a time-dependent manner, and the COPII vesicle components Sar1, Sec23, and Sec24D were upregulated. Second, a marked accretion of ER-derived vacuoles was observed around replicating bacteria using fluorescent microscopy and electron microscopy. Third, we identified a novel host factor, Yip1A, for the activation of the IRE1 pathway in response to both tunicamycin treatment and infection with B. abortus. We found that Yip1A is responsible for the phosphorylation of IRE1 through high-order assembly of Ire1 molecules at ER exit sites (ERES) under the UPR conditions. In Yip1A-knockdown cells, B. abortus failed to generate the ER-derived vacuoles, and remained in endosomal/lysosomal compartments. These results indicate that the activation of the IRE1 pathway and the subsequent formation of ER-derived vacuoles are critical for B. abortus to establish a safe replication niche, and that Yip1A is indispensable for these processes. Furthermore, we showed that the autophagy-related proteins Atg9 and WIPI1, but not DFCP1, were required for the biogenesis of the ER-derived membrane compartments. On the basis of our findings, we propose a model for intracellular Brucella replication that exploits the host UPR and ER-derived vacuole formation machineries, both of which depend on Yip1A-mediated IRE1 activation.","[Taguchi, Yuki; Nakatsu, Daiki; Horii-Okazaki, Sakuya; Kunishige, Rina; Kano, Fumi; Murata, Masayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Imaoka, Koichi; Uda, Akihiko] Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan; [Kataoka, Michiyo] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo, Japan; [Kano, Fumi] Japan Sci & Technol Agent, PRESTO, Kawaguchi, Saitama, Japan","Taguchi, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.",mmurata@bio.c.u-tokyo.ac.jp,,,"PRESTO, Japan Science and Technology Agency; Technology Development Program for Advanced Measurement and Analysis, JST; Ministry of Health, Labor and Welfare of Japan [H22-shinkou-ippan-010, H23-Shinkou-shitei-020]","This work was supported by grants from PRESTO, Japan Science and Technology Agency (to FK) and from Technology Development Program for Advanced Measurement and Analysis, JST (to MM). This work was also supported in part by a grant-in-aid from the Ministry of Health, Labor and Welfare of Japan (grants H22-shinkou-ippan-010 and H23-Shinkou-shitei-020, to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Baruch M, 2014, CELL, V156, P97, DOI 10.1016/j.cell.2013.12.007; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen Y, 2013, INFECT IMMUN, V81, P2226, DOI 10.1128/IAI.00157-13; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; de Barsy M, 2012, MICROBIOL-SGM, V158, P2610, DOI 10.1099/mic.0.060509-0; de Barsy M, 2011, CELL MICROBIOL, V13, P1044, DOI 10.1111/j.1462-5822.2011.01601.x; de Jong MF, 2013, MBIO, V4, DOI 10.1128/mBio.00418-12; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jin CJ, 2005, BIOCHEM BIOPH RES CO, V334, P16, DOI 10.1016/j.bbrc.2005.06.051; Kano F, 2009, J CELL SCI, V122, P2218, DOI 10.1242/jcs.043414; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Qin QM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000110; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Tan DY, 2013, P NATL ACAD SCI USA, V110, P19432, DOI 10.1073/pnas.1316356110; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Wang J, 2014, AUTOPHAGY, V10, P708, DOI 10.4161/auto.28103; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0",46,24,24,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004747,10.1371/journal.ppat.1004747,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900061,25742138.0,"DOAJ Gold, Green Published",,,16/08/2019,22,1,47,5345,1012,691,321,4333,3434,18,881,47,0,0,0,22,22,0,,53,0,53,0,0,24,24,24,15,0,0,0,0,0,0,0,1,0,5404,28,0,362,92,0,4354,1027,28,0,362,92,0,23,,0,0,0,0,2,0,1,1,0,0,0,55,0,0,1.0,5.281620553359684,1.2335564274174937,0.23355642741749366,1.274867297484422,1.033489242282507,5.458498023715415
67,J,"van der Linden, L; Vives-Adrian, L; Selisko, B; Ferrer-Orta, C; Liu, XR; Lanke, K; Ulferts, R; De Palma, AM; Tanchis, F; Goris, N; Lefebvre, D; De Clercq, K; Leyssen, P; Lacroix, C; Purstinger, G; Coutard, B; Canard, B; Boehr, DD; Arnold, JJ; Cameron, CE; Verdaguer, N; Neyts, J; Kuppeveld, FJM",,,,"van der Linden, Lonneke; Vives-Adrian, Laia; Selisko, Barbara; Ferrer-Orta, Cristina; Liu, Xinran; Lanke, Kjerstin; Ulferts, Rachel; De Palma, Armando M.; Tanchis, Federica; Goris, Nesya; Lefebvre, David; De Clercq, Kris; Leyssen, Pieter; Lacroix, Celine; Puerstinger, Gerhard; Coutard, Bruno; Canard, Bruno; Boehr, David D.; Arnold, Jamie J.; Cameron, Craig E.; Verdaguer, Nuria; Neyts, Johan; van Kuppeveld, Frank J. M.",,,The RNA Template Channel of the RNA-Dependent RNA Polymerase as a Target for Development of Antiviral Therapy of Multiple Genera within a Virus Family,PLOS PATHOGENS,,,English,Article,,,,,,,CRYSTAL-STRUCTURE; ENTEROVIRUS REPLICATION; STRUCTURAL BASIS; PROTEIN; INHIBITION; COMPLEX; PROTEOLYSIS; RHINOVIRUS; ACTIVATION; REFINEMENT,"The genus Enterovirus of the family Picornaviridae contains many important human pathogens (e.g., poliovirus, coxsackievirus, rhinovirus, and enterovirus 71) for which no antiviral drugs are available. The viral RNA-dependent RNA polymerase is an attractive target for antiviral therapy. Nucleoside-based inhibitors have broad-spectrum activity but often exhibit off-target effects. Most non-nucleoside inhibitors (NNIs) target surface cavities, which are structurally more flexible than the nucleotide-binding pocket, and hence have a more narrow spectrum of activity and are more prone to resistance development. Here, we report a novel NNI, GPC-N114 (2,2'-[(4-chloro-1,2-phenylene)bis(oxy)]bis(5-nitro-benzonitrile)) with broad-spectrum activity against enteroviruses and cardioviruses (another genus in the picornavirus family). Surprisingly, coxsackievirus B3 (CVB3) and poliovirus displayed a high genetic barrier to resistance against GPC-N114. By contrast, EMCV, a cardiovirus, rapidly acquired resistance due to mutations in 3D(pol). In vitro polymerase activity assays showed that GPC-N114 i) inhibited the elongation activity of recombinant CVB3 and EMCV 3D(pol), (ii) had reduced activity against EMCV 3D(pol) with the resistance mutations, and (iii) was most efficient in inhibiting 3D(pol) when added before the RNA template-primer duplex. Elucidation of a crystal structure of the inhibitor bound to CVB3 3D(pol) confirmed the RNA-binding channel as the target for GPC-N114. Docking studies of the compound into the crystal structures of the compound-resistant EMCV 3D(pol) mutants suggested that the resistant phenotype is due to subtle changes that interfere with the binding of GPC-N114 but not of the RNA template-primer. In conclusion, this study presents the first NNI that targets the RNA template channel of the picornavirus polymerase and identifies a new pocket that can be used for the design of broad-spectrum inhibitors. Moreover, this study provides important new insight into the plasticity of picornavirus polymerases at the template binding site.","[van der Linden, Lonneke; Lanke, Kjerstin; Ulferts, Rachel; van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [van der Linden, Lonneke; De Palma, Armando M.; Leyssen, Pieter; Lacroix, Celine; Neyts, Johan] Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium; [Vives-Adrian, Laia; Ferrer-Orta, Cristina; Verdaguer, Nuria] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Selisko, Barbara; Coutard, Bruno; Canard, Bruno] Aix Marseille Univ, AFMB UMR 7257, Marseille, France; [Selisko, Barbara; Coutard, Bruno; Canard, Bruno] CNRS, Marseille, France; [Liu, Xinran; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Ulferts, Rachel; van Kuppeveld, Frank J. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands; [Tanchis, Federica; Puerstinger, Gerhard] Univ Innsbruck, Inst Pharm, Abt Pharmazeut Chem, A-6020 Innsbruck, Austria; [Goris, Nesya] Okapi Sci NV, Heverlee, Belgium; [Lefebvre, David; De Clercq, Kris] CODA CERVA, Vet & Agrochem Res Ctr, Dept Virol, Unit Vesicular & Exot Dis, Brussels, Belgium; [Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA","van der Linden, L (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1105 AZ Amsterdam, Netherlands.",F.J.M.vanKuppeveld@uu.nl,"Neyts, Johan/U-8267-2017","Neyts, Johan/0000-0002-0033-7514; Canard, Bruno/0000-0003-4924-1991; Verdaguer, Nuria/0000-0001-8826-7129",European Union [260644]; European Virus Archive (EVA) project (European FP7 Capacities Project) [153 228292]; Convenant K.U. Leuven-Radboud University Nijmegen [GOA/10/014]; NWO-VICI [91812628]; FWO Krediet aan Navorsers [1.5.206.11]; Agency for Innovation by Science and Technology in Flanders (IWT); ESRF; ALBA,"This work was supported by research grants from the SILVER Large Scale Collaborative Project (grant agreement number 260644) project of the European Union 7th Framework, the European Virus Archive (EVA) project (European FP7 Capacities Project number 153 228292), the ""Convenant K.U. Leuven-Radboud University Nijmegen"" framework, GOA/10/014 (for work performed at KULeuven), NWO-VICI grant no. 91812628 (FJMvK), FWO Krediet aan Navorsers no. 1.5.206.11 (AMDP), the ""Agency for Innovation by Science and Technology in Flanders (IWT)"" (CL). X-ray data were collected at the ESRF Grenoble, France (beam line ID23.1) within a Block Allocation Group (BAG Barcelona) and at the Xaloc beamline at the ALBA Synchrotron Light Facility. Financial support for this was provided by the ESRF and ALBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aminev AG, 2003, VIRUS RES, V95, P59, DOI 10.1016/S0168-1702(03)00163-1; Appleby TC, 2005, J VIROL, V79, P277, DOI 10.1128/JVI.79.1.277-288.2005; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; Campagnola G, 2008, J VIROL, V82, P9458, DOI 10.1128/JVI.00647-08; Campagnola G, 2011, ANTIVIR RES, V91, P241, DOI 10.1016/j.antiviral.2011.06.006; Chen TC, 2009, ANTIMICROB AGENTS CH, V53, P2740, DOI 10.1128/AAC.00101-09; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; De Palma AM, 2008, J VIROL, V82, P4720, DOI 10.1128/JVI.01338-07; De Palma AM, 2009, ANTIMICROB AGENTS CH, V53, P1850, DOI 10.1128/AAC.00934-08; DUKE GM, 1989, J VIROL, V63, P1822; Durk RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015049; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Ferrer-Orta C, 2009, CURR OPIN STRUC BIOL, V19, P752, DOI 10.1016/j.sbi.2009.10.016; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Garriga D, 2013, J MOL BIOL; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gazina EV, 2011, J VIROL, V85, P10364, DOI 10.1128/JVI.05022-11; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Goris NE, 2009, ALTEX-ALTERN TIEREXP, V26, P52; Gruez A, 2008, J VIROL, V82, P9577, DOI 10.1128/JVI.00631-08; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Harrison DN, 2008, J VIROL, V82, P1465, DOI 10.1128/JVI.01374-07; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Jabafi I, 2007, ACTA CRYSTALLOGR F, V63, P495, DOI 10.1107/S1744309107020416; Knowles N, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kortus MG, 2012, J MOL BIOL, V417, P263, DOI 10.1016/j.jmb.2012.01.049; Lantez V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000936; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Love RA, 2004, STRUCTURE, V12, P1533, DOI 10.1016/j.str.2004.05.024; Mestas SP, 2007, ANAL BIOCHEM, V365, P194, DOI 10.1016/j.ab.2007.03.039; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Purstinger G, 2008, BIOORG MED CHEM LETT, V18, P5123, DOI 10.1016/j.bmcl.2008.07.099; Reed LJ, 2012, AM J HYG, V27, P493; RODRIGUEZ PL, 1992, J VIROL, V66, P1971; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Smart OS, 2011, GRADE VERSION 1 1 0; Tapparel C, 2012, INFECT GENET EVOL; Thibaut HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004039; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; van Ooij MJM, 2007, THESIS; VANKUPPEVELD FJM, 1995, J VIROL, V69, P7782; Vives-Adrian L, 2014, J VIROL, V88, P5595, DOI 10.1128/JVI.03502-13; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wessels E, 2005, J VIROL, V79, P5163, DOI 10.1128/JVI.79.8.5163-5173.2005; Wu Y, 2010, PROTEIN CELL, V1, P491, DOI 10.1007/s13238-010-0061-7; Zoll J, 1996, J VIROL, V70, P4948; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416",57,18,19,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004733,10.1371/journal.ppat.1004733,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900051,25799064.0,"DOAJ Gold, Green Published",,,16/08/2019,15,14,40,5477,1372,1065,307,4105,3298,27,780,40,0,0,0,16,16,1,,45,2,45,0,2,21,17,21,8,0,0,0,0,0,0,0,14,5,5493,42,2,186,163,0,4093,1372,42,2,186,163,0,28,,0,0,0,0,7,0,0,1,0,0,0,48,0,0,4.7,3.99198250728863,1.3342265529841657,0.33422655298416565,1.3880633373934226,1.0403505568742013,4.153061224489796
68,J,"Wallace, NA; Robinson, K; Howie, HL; Galloway, DA",,,,"Wallace, Nicholas A.; Robinson, Kristin; Howie, Heather L.; Galloway, Denise A.",,,beta-HPV 5 and 8 E6 Disrupt Homology Dependent Double Strand Break Repair by Attenuating BRCA1 and BRCA2 Expression and Foci Formation,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-PAPILLOMAVIRUS TYPE-16; HUMAN RAD51 PROTEIN; DNA-DAMAGE; COMPLEX-FORMATION; GENE-PRODUCT; HELA-CELLS; EPIDERMODYSPLASIA VERRUCIFORMIS; RETINOBLASTOMA PROTEIN; MAMMALIAN-CELLS; DIRECTED REPAIR,"Recent work has explored a putative role for the E6 protein from some beta-human papillomavirus genus (beta-HPVs) in the development of non-melanoma skin cancers, specifically beta-HPV 5 and 8 E6. Because these viruses are not required for tumor maintenance, they are hypothesized to act as co-factors that enhance the mutagenic capacity of UV-exposure by disrupting the repair of the resulting DNA damage. Supporting this proposal, we have previously demonstrated that UV damage signaling is hindered by beta-HPV 5 and 8 E6 resulting in an increase in both thymine dimers and UV-induced double strand breaks (DSBs). Here we show that beta-HPV 5 and 8 E6 further disrupt the repair of these DSBs and provide a mechanism for this attenuation. By binding and destabilizing a histone acetyltransferase, p300, beta-HPV 5 and 8 E6 reduce the enrichment of the transcription factor at the promoter of two genes critical to the homology dependent repair of DSBs (BRCA1 and BRCA2). The resulting diminished BRCA1/2 transcription not only leads to lower protein levels but also curtails the ability of these proteins to form repair foci at DSBs. Using a GFP-based reporter, we confirm that this reduced foci formation leads to significantly diminished homology dependent repair of DSBs. By deleting the p300 binding domain of beta-HPV 8 E6, we demonstrate that the loss of robust repair is dependent on viral-mediated degradation of p300 and confirm this observation using a combination of p300 mutants that are beta-HPV 8 E6 destabilization resistant and p300 knock-out cells. In conclusion, this work establishes an expanded ability of beta-HPV 5 and 8 E6 to attenuate UV damage repair, thus adding further support to the hypothesis that beta-HPV infections play a role in skin cancer development by increasing the oncogenic potential of UV exposure.","[Wallace, Nicholas A.; Robinson, Kristin; Galloway, Denise A.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Howie, Heather L.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA","Wallace, NA (reprint author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.",dgallowa@fhcrc.org,,"Wallace, Nicholas/0000-0002-3971-716X", [P01 CA 042792];  [T32 CA009657],"This work would not have been possible without financial support from P01 CA 042792 (DAG) and T32 CA009657 (NAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Akgul B, 2006, J PATHOL, V208, P165, DOI 10.1002/path.1893; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bavinck JNB, 2001, J INVEST DERM SYMP P, V6, P207, DOI 10.1046/j.0022-202x.2001.00048.x; Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Boyer SN, 1996, CANCER RES, V56, P4620; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Caestecker KW, 2013, EXP CELL RES, V319, P575, DOI 10.1016/j.yexcr.2012.11.013; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Desaintes C, 1999, ONCOGENE, V18, P4538, DOI 10.1038/sj.onc.1202818; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; Di LJ, 2010, NAT STRUCT MOL BIOL, V17, P1406, DOI 10.1038/nsmb.1941; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Giampieri S, 2004, BRIT J CANCER, V90, P2203, DOI 10.1038/sj.bjc.6601829; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Helleday T, 2005, CELL CYCLE, V4, P1176, DOI 10.4161/cc.4.9.2031; Howie HL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002211; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; KLINGELHUTZ AJ, 1994, MOL CELL BIOL, V14, P961, DOI 10.1128/MCB.14.2.961; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Li GL, 2010, J ETHNOPHARMACOL, V132, P56, DOI 10.1016/j.jep.2010.07.035; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lieber MR, 2010, CELL, V142, P496, DOI 10.1016/j.cell.2010.07.035; LUTZNER MA, 1984, J INVEST DERMATOL, V83, pS18, DOI 10.1111/1523-1747.ep12281128; Malanchi I, 2004, J VIROL, V78, P13769, DOI 10.1128/JVI.78.24.13769-13778.2004; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Muller-Schiffmann A, 2006, J VIROL, V80, P8718, DOI 10.1128/JVI.00250-06; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Ogiwara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052810; ORTH G, 1979, CANCER RES, V39, P1074; Panwar A, 2014, CANCER TREAT REV, V40, P215, DOI 10.1016/j.ctrv.2013.09.006; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Pfister H, 1992, Semin Cancer Biol, V3, P263; PHELPS WC, 1991, J VIROL, V65, P6922; PHELPS WC, 1992, J VIROL, V66, P2418; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Qi ZL, 2010, BIOCHEM CELL BIOL, V88, P697, DOI 10.1139/O10-005; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Veldman T, 2003, P NATL ACAD SCI USA, V100, P8211, DOI 10.1073/pnas.1435900100; Wallace NA, 2013, VIROLOGY; Wallace NA, 2014, SEMIN CANCER BIOL, V26, P30, DOI 10.1016/j.semcancer.2013.12.003; Wallace NA, 2014, J VIROL, V88, P6112, DOI 10.1128/JVI.03808-13; Wallace NA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002807; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 1999, P ASSOC AM PHYSICIAN, V111, P581, DOI 10.1046/j.1525-1381.1999.99723.x",70,20,22,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004687,10.1371/journal.ppat.1004687,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900019,25803638.0,"DOAJ Gold, Green Published",,,16/08/2019,18,0,9,4166,785,570,215,3381,2938,18,425,9,0,0,0,15,15,2,,13,2,13,0,2,18,18,16,14,0,0,0,0,0,0,0,0,1,4189,25,0,64,61,0,3378,785,25,0,64,61,0,26,,0,0,0,0,2,0,0,1,0,0,0,13,0,0,0.75,5.307006369426752,1.2321798284531205,0.23217982845312038,1.264418811002662,1.0261641862698032,5.445859872611465
69,J,"Wang, LY; Tian, YJ; Ou, JHJ",,,,"Wang, Linya; Tian, Yongjun; Ou, Jing-hsiung James",,,HCV Induces the Expression of Rubicon and UVRAG to Temporally Regulate the Maturation of Autophagosomes and Viral Replication,PLOS PATHOGENS,,,English,Article,,,,,,,HEPATITIS-C-VIRUS; UNFOLDED PROTEIN RESPONSE; BECLIN 1; PHOSPHATIDYLINOSITOL 3-KINASE; RNA REPLICATION; PATHWAY; CELLS; INDUCTION; COMPLEXES; MACHINERY,"Hepatitis C virus (HCV) induces autophagy to enhance its replication. However, how HCV regulates the autophagic pathway remains largely unclear. In this report, we demonstrated that HCV infection could induce the expression of Rubicon and UVRAG, which inhibited and stimulated the maturation of autophagosomes, respectively. The induction of Rubicon by HCV was prompt whereas the induction of UVRAG was delayed, resulting in the accumulation of autophagosomes in the early time points of viral infection. The role of Rubicon in inhibiting the maturation of autophagosomes in HCV-infected cells was confirmed by siRNA knockdown and the over-expression of Rubicon, which enhanced and suppressed the maturation of autophagosomes, respectively. Rubicon played a positive role in HCV replication, as the suppression of its expression reduced HCV replication and its over-expression enhanced HCV replication. In contrast, the over-expression of UVRAG facilitated the maturation of autophagosomes and suppressed HCV replication. The HCV subgenomic RNA replicon, which expressed only the nonstructural proteins, could also induce the expression of Rubicon and the accumulation of autophagosomes. Further analysis indicated that the HCV NS4B protein was sufficient to induce Rubicon and autophagosomes. Our results thus indicated that HCV, by differentially inducing the expression of Rubicon and UVRAG, temporally regulated the autophagic flux to enhance its replication.","[Wang, Linya; Tian, Yongjun; Ou, Jing-hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA","Wang, LY (reprint author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.",jamesou@hsc.usc.edu,,,"National Institutes of Health [DK094652, AI083025]","JH JO was supported by the research grants DK094652 and AI083025 from the National Institutes of Health. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Crawford SE, 2012, P NATL ACAD SCI USA, V109, pE3405, DOI 10.1073/pnas.1216539109; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Eng KE, 2012, J VIROL, V86, P5674, DOI 10.1128/JVI.06581-11; Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jackson WT, 2014, CURR OPIN VIROL, V9, P67, DOI 10.1016/j.coviro.2014.09.007; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang QM, 2013, J VIROL, V87, P12499, DOI 10.1128/JVI.01898-13; Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mohl BP, 2012, J VIROL, V86, P10724, DOI 10.1128/JVI.01667-12; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2008, AUTOPHAGY, V4, P830, DOI 10.4161/auto.6566; Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085; Sir D, 2010, MOL CELLS, V29, P1, DOI 10.1007/s10059-010-0014-2; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Taguwa S, 2011, J VIROL, V85, P13185, DOI 10.1128/JVI.06099-11; Taylor MP, 2008, AUTOPHAGY, V4, P286, DOI 10.4161/auto.5377; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Wirth M, 2013, SEMIN CANCER BIOL, V23, P301, DOI 10.1016/j.semcancer.2013.05.007; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08",45,38,39,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004764,10.1371/journal.ppat.1004764,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900072,25807108.0,"DOAJ Gold, Green Published",,,16/08/2019,42,0,25,5095,1246,875,371,3849,2778,24,1047,25,0,0,0,44,44,2,,37,3,37,0,3,42,42,28,22,0,0,0,0,0,0,0,0,4,5088,48,0,162,47,1,3830,1246,48,0,162,47,1,12,,0,2,0,0,8,0,0,1,0,0,0,38,0,0,16.01,4.08908507223114,1.3237204468693167,0.3237204468693167,1.34658352818914,1.0172718351324828,4.159711075441413
70,J,"Wang, P; Zhao, W; Zhao, K; Zhang, L; Gao, CJ",,,,"Wang, Peng; Zhao, Wei; Zhao, Kai; Zhang, Lei; Gao, Chengjiang",,,TRIM26 Negatively Regulates Interferon-beta Production and Antiviral Response through Polyubiquitination and Degradation of Nuclear IRF3,PLOS PATHOGENS,,,English,Article,,,,,,,I INTERFERON; ADAPTER PROTEIN; RIG-I; INTRACELLULAR DNA; FAMILY PROTEINS; INNATE IMMUNITY; MEDIATED DEGRADATION; SIGNALING PATHWAY; EMERGING ROLES; KAPPA-B,"Virus infection leads to the activation of transcription factor IRF3 and subsequent production of type I inteferons, which induce the transcription of various antiviral genes called interferon stimulated genes (ISGs) to eliminate viral infection. IRF3 activation requires phosphorylation, dimerization and nuclear translocation. However, the mechanisms for the termination of IRF3 activation in nucleus are elusive. Here we report the identification of TRIM26 to negatively regulate IFN-beta production and antiviral response by targeting nuclear IRF3. TRIM26 bound to IRF3 and promoted its K48-linked polyubiquitination and degradation in nucleus. TRIM26 degraded WT IRF3 and the constitutive active mutant IRF3 5D, but not the phosphorylation deficient mutant IRF3 5A. Furthermore, IRF3 mutant in the Nuclear Localization Signal (NLS), which could not move into nucleus, was not degraded by TRIM26. Importantly, virus infection promoted TRIM26 nuclear translocation, which was required for IRF3 degradation. As a consequence, TRIM26 attenuated IFN-beta promoter activation and IFN-beta production downstream of TLR3/4, RLR and DNA sensing pathways. TRIM26 transgenic mice showed much less IRF3 activation and IFN-beta production, while increased virus replication. Our findings delineate a novel mechanism for the termination of IRF3 activation in nucleus through TRIM26-mediated IRF3 ubiquitination and degradation.","[Wang, Peng] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Sch Med, Key Lab Infect & Immun Shandong Prov, Jinan 250100, Shandong, Peoples R China","Wang, P (reprint author), Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China.",cgao@sdu.edu.cn,,"Zhao, Wei/0000-0001-8440-2274","National Natural Science Foundation of China [81172813, 81273219]; Shandong Provincial Nature Science Foundation for Distinguished Young Scholars [JQ201120]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130131130010]","This work was supported in part by grants from the National Natural Science Foundation of China (81172813, 81273219), the Shandong Provincial Nature Science Foundation for Distinguished Young Scholars (JQ201120), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20130131130010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kumar KP, 2000, MOL CELL BIOL, V20; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meyer M, 2003, TISSUE ANTIGENS, V61, P63, DOI 10.1034/j.1399-0039.2003.610105.x; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shrivastav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00319; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003",44,33,37,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004726,10.1371/journal.ppat.1004726,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900046,25763818.0,"DOAJ Gold, Green Published",,,16/08/2019,35,1,31,7487,2406,1301,1105,5081,3779,25,1277,31,0,0,0,36,36,1,,42,0,42,0,0,38,38,28,17,0,0,0,0,0,0,0,1,1,7471,41,0,114,45,0,5052,2406,41,0,114,45,0,13,,0,0,0,0,1,0,1,1,0,0,0,44,0,0,0.75,3.1118038237738985,1.473528832906908,0.4735288329069081,1.487305648494391,1.0093495392012821,3.1408977556109727
71,J,"Xayarath, B; Alonzo, F; Freitag, NE",,,,"Xayarath, Bobbi; Alonzo, Francis, III; Freitag, Nancy E.",,,Identification of a Peptide-Pheromone that Enhances Listeria monocytogenes Escape from Host Cell Vacuoles,PLOS PATHOGENS,,,English,Article,,,,,,,SEQUENCE SPECIFICITY DETERMINANTS; CENTRAL VIRULENCE REGULATOR; ENTEROCOCCUS-FAECALIS; SEX-PHEROMONE; AGGREGATION SUBSTANCE; STREPTOCOCCUS-FAECALIS; PLASMID TRANSFER; PHOSPHOLIPASE-C; SECA2-DEPENDENT SECRETION; CONSTITUTIVE ACTIVATION,"Listeria monocytogenes is a Gram-positive facultative intracellular bacterial pathogen that invades mammalian cells and escapes from membrane-bound vacuoles to replicate within the host cell cytosol. Gene products required for intracellular bacterial growth and bacterial spread to adjacent cells are regulated by a transcriptional activator known as PrfA. PrfA becomes activated following L. monocytogenes entry into host cells, however the signal that stimulates PrfA activation has not yet been defined. Here we provide evidence for L. monocytogenes secretion of a small peptide pheromone, pPplA, which enhances the escape of L. monocytogenes from host cell vacuoles and may facilitate PrfA activation. The pPplA pheromone is generated via the proteolytic processing of the PplA lipoprotein secretion signal peptide. While the PplA lipoprotein is dispensable for pathogenesis, bacteria lacking the pPplA pheromone are significantly attenuated for virulence in mice and have a reduced efficiency of bacterial escape from the vacuoles of nonprofessional phagocytic cells. Mutational activation of PrfA restores virulence and eliminates the need for pPplA-dependent signaling. Experimental evidence suggests that the pPplA peptide may help signal to L. monocytogenes its presence within the confines of the host cell vacuole, stimulating the expression of gene products that contribute to vacuole escape and facilitating PrfA activation to promote bacterial growth within the cytosol.","[Xayarath, Bobbi; Alonzo, Francis, III; Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA","Xayarath, B (reprint author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.",nfreitag@uic.edu,,,Public Health Service [AI41816],"This work was supported by Public Health Service grant AI41816 (NEF). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aggarwal C, 2014, J BIOL CHEM, V289, P22427, DOI 10.1074/jbc.M114.583989; Alonzo 3rd F, 2009, INFECT IMMUN; Alonzo F, 2011, MOL MICROBIOL, V80, P1530, DOI 10.1111/j.1365-2958.2011.07665.x; Alonzo F, 2010, INFECT IMMUN, V78, P4944, DOI 10.1128/IAI.00532-10; Alonzo F, 2009, INFECT IMMUN, V77, P2612, DOI 10.1128/IAI.00280-09; An FY, 1999, J BACTERIOL, V181, P5915; An FY, 2002, J BACTERIOL, V184, P1880, DOI 10.1128/JB.184.7.1880-1887.2002; Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; Baumgartner M, 2007, J BACTERIOL, V189, P313, DOI 10.1128/JB.00976-06; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bhatty M, 2013, RES MICROBIOL, V164, P620, DOI 10.1016/j.resmic.2013.03.012; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bitar AP, 2008, J BACTERIOL, V190, P107, DOI 10.1128/JB.00852-07; Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000; Bortolussi R, 2008, CAN MED ASSOC J, V179, P795, DOI 10.1503/cmaj.081377; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Buttaro BA, 2000, J BACTERIOL, V182, P4926, DOI 10.1128/JB.182.17.4926-4933.2000; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; CAMILLI A, 1991, J EXP MED, V173, P751, DOI 10.1084/jem.173.3.751; CAMILLI A, 1989, P NATL ACAD SCI USA, V86, P5522, DOI 10.1073/pnas.86.14.5522; Chandler JR, 2008, J BACTERIOL, V190, P1172, DOI 10.1128/JB.01327-07; Chandler JR, 2004, PEPTIDES, V25, P1377, DOI 10.1016/j.peptides.2003.10.020; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Clewell DB, 2002, PLASMID, V48, P193, DOI 10.1016/S0147-619X(02)00113-0; Clewell DB, 2007, PLASMID, V58, P205, DOI 10.1016/j.plasmid.2007.05.001; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Czuprynski Charles J., 2005, Animal Health Research Reviews, V6, P211, DOI 10.1079/AHR2005111; de las Heras A, 2011, CURR OPIN MICROBIOL, V14, P118, DOI 10.1016/j.mib.2011.01.005; Drevets DA, 1999, INFECT IMMUN, V67, P3512; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Fixen KR, 2007, J BACTERIOL, V189, P1399, DOI 10.1128/JB.01226-06; Flannagan SE, 2002, MOL MICROBIOL, V44, P803, DOI 10.1046/j.1365-2958.2002.02922.x; Freitag NE, 2006, FUTURE MICROBIOL, V1, P89, DOI 10.2217/17460913.1.1.89; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; FREITAG NE, 1992, J BACTERIOL, V174, P1293, DOI 10.1128/jb.174.4.1293-1298.1992; GALLI D, 1989, ARCH MICROBIOL, V151, P486, DOI 10.1007/BF00454863; GALLI D, 1990, MOL MICROBIOL, V4, P895, DOI 10.1111/j.1365-2958.1990.tb00662.x; Garmyn Dominique, 2009, Commun Integr Biol, V2, P371; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; Hodgson DA, 2000, MOL MICROBIOL, V35, P312, DOI 10.1046/j.1365-2958.2000.01643.x; JONES S, 1994, INFECT IMMUN, V62, P5608; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; KATHARIOU S, 1987, J BACTERIOL, V169, P1291, DOI 10.1128/jb.169.3.1291-1297.1987; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kozlowicz BK, 2006, INT J MED MICROBIOL, V296, P141, DOI 10.1016/j.ijmm.2006.01.040; KREFT B, 1992, INFECT IMMUN, V60, P25; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; LAMPIDIS R, 1994, MOL MICROBIOL, V13, P141, DOI 10.1111/j.1365-2958.1994.tb00409.x; Last NB, 2013, PROTEIN SCI, V22, P870, DOI 10.1002/pro.2274; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; MARQUIS H, 1995, INFECT IMMUN, V63, P4531; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; MENGAUD J, 1991, MOL MICROBIOL, V5, P367, DOI 10.1111/j.1365-2958.1991.tb02118.x; Miner MD, 2008, MICROB PATHOGENESIS, V45, P273, DOI 10.1016/j.micpath.2008.06.006; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Moors MA, 1999, INFECT IMMUN, V67, P131; MORI M, 1984, FEBS LETT, V178, P97, DOI 10.1016/0014-5793(84)81248-X; MORI M, 1988, J BIOL CHEM, V263, P14574; Mostowy S, 2012, ADV IMMUNOL, V113, P19, DOI 10.1016/B978-0-12-394590-7.00007-5; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.4.1917-1926.2005; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Riordan M, 2002, TRENDS MICROBIOL, V10, P361, DOI 10.1016/S0966-842X(02)02401-0; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x; Port GC, 2007, INFECT IMMUN, V75, P5886, DOI 10.1128/IAI.00845-07; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Pottathil M, 2003, FRONT BIOSCI, V8, pD32, DOI 10.2741/913; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Rabinovich L, 2012, CELL, V150, P792, DOI 10.1016/j.cell.2012.06.036; Renier S, 2013, J PROTEOMICS, V80, P183, DOI 10.1016/j.jprot.2012.11.027; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Rieu A, 2007, APPL ENVIRON MICROB, V73, P6125, DOI 10.1128/AEM.00608-07; Rieu A, 2008, APPL ENVIRON MICROB, V74, P4491, DOI 10.1128/AEM.00255-08; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Shetron-Rama LM, 2003, MOL MICROBIOL, V48, P1537, DOI 10.1046/j.1365-2958.2003.03534.x; Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448; Smith GA, 1997, TRENDS MICROBIOL, V5, P272, DOI 10.1016/S0966-842X(97)01048-2; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; SUN AN, 1990, INFECT IMMUN, V58, P3770; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P316, DOI 10.1089/fpd.2006.3.316; TANIMOTO K, 1993, J BACTERIOL, V175, P5260; TANIMOTO K, 1993, J BACTERIOL, V175, P1008; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Travier L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003131; Vega Y, 2004, MOL MICROBIOL, V52, P1553, DOI 10.1111/j.1365-2958.2004.04052.x; Vega Y, 1998, J BACTERIOL, V180, P6655; VERHEUL A, 1995, APPL ENVIRON MICROB, V61, P226; Verheul A, 1998, APPL ENVIRON MICROB, V64, P1059; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Wouters JA, 2005, APPL ENVIRON MICROB, V71, P5771, DOI 10.1128/AEM.71.10.5771-5778.2005; Xayarath B, 2012, FUTURE MICROBIOL, V7, P839, DOI [10.2217/FMB.12.57, 10.2217/fmb.12.57]; Xayarath B, 2011, MICROBIOL-SGM, V157, P3138, DOI 10.1099/mic.0.049957-0; Xayarath B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023502; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; Youngman P, 1987, PLASMIDS PRACTICAL A, P79",116,15,15,2,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004707,10.1371/journal.ppat.1004707,,,,35,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900035,25822753.0,"DOAJ Gold, Green Published",,,16/08/2019,14,1,28,5336,1058,761,297,4278,3398,25,855,28,1,0,0,14,14,2,,40,2,40,0,2,14,14,14,9,0,0,0,0,0,0,0,0,3,5343,60,0,87,55,0,4263,1058,60,0,87,55,0,22,,0,0,0,0,7,0,0,1,0,0,0,40,0,0,3.95,5.043478260869565,1.2473118279569892,0.24731182795698925,1.2758298270219728,1.022863568215892,5.158790170132325
72,J,"Zhang, JJ; He, SP; Wang, Y; Brulois, K; Lan, K; Jung, JU; Feng, PH",,,,"Zhang, Junjie; He, Shanping; Wang, Yi; Brulois, Kevin; Lan, Ke; Jung, Jae U.; Feng, Pinghui",,,Herpesviral G Protein-Coupled Receptors Activate NFAT to Induce Tumor Formation via Inhibiting the SERCA Calcium ATPase,PLOS PATHOGENS,,,English,Article,,,,,,,KAPOSIS-SARCOMA; TRANSCRIPTION FACTOR; T-CELLS; GENE-EXPRESSION; NUCLEAR FACTOR; CANCER; ANGIOGENESIS; GROWTH; ROLES; CYCLOOXYGENASE-2,"G protein-coupled receptors (GPCRs) constitute the largest family of proteins that transmit signal to regulate an array of fundamental biological processes. Viruses deploy diverse tactics to hijack and harness intracellular signaling events induced by GPCR. Herpesviruses encode multiple GPCR homologues that are implicated in viral pathogenesis. Cellular GPCRs are primarily regulated by their cognate ligands, while herpesviral GPCRs constitutively activate downstream signaling cascades, including the nuclear factor of activated T cells (NFAT) pathway. However, the roles of NFAT activation and mechanism thereof in viral GPCR tumorigenesis remain unknown. Here we report that GPCRs of human Kaposi's sarcoma-associated herpesvirus (kGPCR) and cytomegalovirus (US28) shortcut NFAT activation by inhibiting the sarcoplasmic reticulum calcium ATPase (SERCA), which is necessary for viral GPCR tumorigenesis. Biochemical approaches, entailing pharmacological inhibitors and protein purification, demonstrate that viral GPCRs target SERCA2 to increase cytosolic calcium concentration. As such, NFAT activation induced by vGPCRs was exceedingly sensitive to cyclosporine A that targets calcineurin, but resistant to inhibition upstream of ER calcium release. Gene expression profiling identified a signature of NFAT activation in endothelial cells expressing viral GPCRs. The expression of NFAT-dependent genes was up-regulated in tumors derived from tva-kGPCR mouse and human KS. Employing recombinant kGPCR-deficient KSHV, we showed that kGPCR was critical for NFAT-dependent gene expression in KSHV lytic replication. Finally, cyclosporine A treatment diminished NFAT-dependent gene expression and tumor formation induced by viral GPCRs. These findings reveal essential roles of NFAT activation in viral GPCR tumorigenesis and a mechanism of ""constitutive"" NFAT activation by viral GPCRs.","[Zhang, Junjie; He, Shanping; Wang, Yi; Brulois, Kevin; Jung, Jae U.; Feng, Pinghui] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Lan, Ke] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China","Zhang, JJ (reprint author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.",pinghui.feng@usc.edu,,"Zhang, Junjie/0000-0003-3812-3850","American Cancer Society [RGS-11-162-01-MPC]; NIH [CA134241, DE021445, CA180779]","This work is supported by grants from American Cancer Society (RGS-11-162-01-MPC), NIH (CA134241 and DE021445) to PF and (CA180779) to JUJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ahmad SA, 2001, CANCER RES, V61, P1255; AHUJA SK, 1992, NAT GENET, V2, P31, DOI 10.1038/ng0992-31; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P700; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bala K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002927; Bandyopadhyay C, 2014, J VIROL, V88, P13858, DOI 10.1128/JVI.01674-14; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Brinkmann MM, 2007, J VIROL, V81, P42, DOI 10.1128/JVI.00648-06; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Cannon M, 2003, J VIROL, V77, P57, DOI 10.1128/JVI.77.1.57-67.2003; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Couty JP, 2005, TRENDS PHARMACOL SCI, V26, P405, DOI 10.1016/j.tips.2005.06.004; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Dong XN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002336; Dong XN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001001; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Etoh T, 2001, CANCER RES, V61, P2145; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Feng H, 2010, J VIROL, V84, P3351, DOI 10.1128/JVI.01939-09; Feng H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000157; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1016/j.semincol.2004.03.040; Gjyshi O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004460; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Ho HH, 2001, J BIOL CHEM, V276, P1376, DOI 10.1074/jbc.M007885200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holmes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011435; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maldonado-Perez D, 2009, BBA-MOL CELL RES, V1793, P1315, DOI 10.1016/j.bbamcr.2009.03.008; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Minami T, 2013, CELL REP, V4, P709, DOI 10.1016/j.celrep.2013.07.021; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535610802002374; Montaner S, 2013, ANNU REV PHARMACOL, V53, P331, DOI 10.1146/annurev-pharmtox-010510-100608; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Pati S, 2003, J VIROL, V77, P5759, DOI 10.1128/JVI.77.10.5759-5773.2003; Paul AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024379; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Sharma-Walia N, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.5; Sharma-Walia N, 2010, J VIROL, V84, P12733, DOI 10.1128/JVI.01065-10; Sharma-Walia N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000777; Slinger E, 2011, MOL CELL ENDOCRINOL, V331, P179, DOI 10.1016/j.mce.2010.04.007; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Vischer HF, 2006, TRENDS PHARMACOL SCI, V27, P56, DOI 10.1016/j.tips.2005.11.006; Wang Y, 2013, P NATL ACAD SCI USA, V110, P11139, DOI 10.1073/pnas.1219829110; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI [10.1586/epr.10.10, 10.1586/EPR.10.10]; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yu Y, 2001, INFLAMM RES, V50, P220, DOI 10.1007/s000110050747; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2",78,35,38,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004768,10.1371/journal.ppat.1004768,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900075,25811856.0,"DOAJ Gold, Green Published",,,16/08/2019,11,0,17,4096,824,593,231,3272,2651,23,598,17,0,0,0,11,11,2,,0,1,0,0,1,12,11,12,9,0,0,0,0,0,0,0,0,4,4124,54,0,83,110,0,3267,824,54,0,83,110,0,33,,0,0,0,0,8,0,0,1,0,0,0,22,0,0,5.05,4.970873786407767,1.2518337408312958,0.25183374083129584,1.3105134474327629,1.046875,5.203883495145631
73,J,"Zhao, YQ; Soh, TS; Zheng, J; Chan, KWK; Phoo, WW; Lee, CC; Tay, MYF; Swaminathan, K; Cornvik, TC; Lim, SP; Shi, PY; Lescar, J; Vasudevan, SG; Luo, DH",,,,"Zhao, Yongqian; Soh, Tingjin Sherryl; Zheng, Jie; Chan, Kitti Wing Ki; Phoo, Wint Wint; Lee, Chin Chin; Tay, Moon Y. F.; Swaminathan, Kunchithapadam; Cornvik, Tobias C.; Lim, Siew Pheng; Shi, Pei-Yong; Lescar, Julien; Vasudevan, Subhash G.; Luo, Dahai",,,A Crystal Structure of the Dengue Virus NS5 Protein Reveals a Novel Inter-domain Interface Essential for Protein Flexibility and Virus Replication,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT RNA-POLYMERASE; NUCLEAR-LOCALIZATION; METHYLTRANSFERASE DOMAIN; VIRAL HELICASE; FLAVIVIRUS; REGION; CAP; METHYLATIONS; INHIBITION; EXCHANGE,"Flavivirus RNA replication occurs within a replication complex (RC) that assembles on ER membranes and comprises both non-structural (NS) viral proteins and host cofactors. As the largest protein component within the flavivirus RC, NS5 plays key enzymatic roles through its N-terminal methyltransferase (MTase) and C-terminal RNA-dependent-RNA polymerase (RdRp) domains, and constitutes a major target for antivirals. We determined a crystal structure of the full-length NS5 protein from Dengue virus serotype 3 (DENV3) at a resolution of 2.3 angstrom in the presence of bound SAH and GTP. Although the overall molecular shape of NS5 from DENV3 resembles that of NS5 from Japanese Encephalitis Virus (JEV), the relative orientation between the MTase and RdRp domains differs between the two structures, providing direct evidence for the existence of a set of discrete stable molecular conformations that may be required for its function. While the inter-domain region is mostly disordered in NS5 from JEV, the NS5 structure from DENV3 reveals a well-ordered linker region comprising a short 310 helix that may act as a swivel. Solution Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS) analysis reveals an increased mobility of the thumb subdomain of RdRp in the context of the full length NS5 protein which correlates well with the analysis of the crystallographic temperature factors. Site-directed mutagenesis targeting the mostly polar interface between the MTase and RdRp domains identified several evolutionarily conserved residues that are important for viral replication, suggesting that inter-domain cross-talk in NS5 regulates virus replication. Collectively, a picture for the molecular origin of NS5 flexibility is emerging with profound implications for flavivirus replication and for the development of therapeutics targeting NS5.","[Zhao, Yongqian; Chan, Kitti Wing Ki; Lee, Chin Chin; Tay, Moon Y. F.; Vasudevan, Subhash G.] DUKE NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Zhao, Yongqian; Swaminathan, Kunchithapadam; Vasudevan, Subhash G.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Soh, Tingjin Sherryl; Zheng, Jie; Cornvik, Tobias C.; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Soh, Tingjin Sherryl; Lim, Siew Pheng; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore, Singapore; [Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Lescar, Julien] Ctr Hosp Univ Pitie Salpetriere, Fac Med Pierre & Marie Curie, CNRS ERL 8255, UPMC UMRS CR7,INSERM,U1135,Ctr Immunol & Malad In, Paris, France","Zhao, YQ (reprint author), DUKE NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.",julien@ntu.edu.sg; subhash.vasudevan@duke-nus.edu.sg; luodahai@ntu.edu.sg,"Luo, Dahai/J-6022-2012; Lim, Siew Pheng/P-8528-2016; Zheng, Jie/H-6488-2018","Luo, Dahai/0000-0001-7637-7275; Tay, Moon/0000-0002-4730-6133; Lim, Siew Pheng/0000-0002-7377-5662","National Medical Research Council, Singapore [NMRC/1315/2011]; National Research Foundation [CRP2008]; Lee Kong Chian School of Medicine, Nanyang Technological University; NGS scholarship from National University of Singapore; CBRG (Collaborative Basic Research Grant) grant from the Singapore National Medical Research Council","This work was supported by the National Medical Research Council, Singapore (http://www.nmrc.gov.sg), under grant NMRC/1315/2011 to the SGV Lab, a Competitive Research Program Grant CRP2008 from the National Research Foundation to the JL lab, and a start-up grant to the DL lab from Lee Kong Chian School of Medicine, Nanyang Technological University. YZ is supported by an NGS scholarship from National University of Singapore. We acknowledge support provided by a CBRG (Collaborative Basic Research Grant) grant May14 from the Singapore National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Avis Johanna M, 2012, Methods Mol Biol, V941, P83, DOI 10.1007/978-1-62703-113-4_7; Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007; Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687; Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hung M, 2002, ANTIVIR RES, V56, P99, DOI 10.1016/S0166-3542(02)00101-8; Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Keller Thomas H, 2006, Novartis Found Symp, V277, P102, DOI 10.1002/0470058005.ch8; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li K., 2014, VIROL SIN, P1, DOI DOI 10.1007/S12250-014-3437-7; Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606; Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P77; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Potisopon S., 2014, NUCL ACIDS RES; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Schrodinger L., 2010, PYMOL MOL GRAPHICS S; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tan CSE, 2013, J GEN VIROL, V94, P1961, DOI 10.1099/vir.0.054395-0; Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002; Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341; Vieira-Pires RS, 2010, J GEN PHYSIOL, V136, P585, DOI 10.1085/jgp.201010508; Wu J., 2014, J VIROL; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p; Zheng J, 2014, NUCL ACIDS IN PRESS; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189; 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112",72,57,57,0,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004682,10.1371/journal.ppat.1004682,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900015,25775415.0,"DOAJ Gold, Green Published",,,16/08/2019,77,45,94,12282,2224,1598,626,10058,8077,30,1951,94,0,3,0,70,70,2,,127,2,127,0,2,82,78,82,42,0,0,0,0,0,0,0,45,3,12302,85,0,235,146,2,10031,2224,85,0,235,146,2,47,,0,0,0,0,4,0,0,1,0,0,0,126,0,0,2.0,5.52248201438849,1.2211175183933187,0.22111751839331875,1.246072777888248,1.020436411007979,5.635341726618705
74,J,"Baquero, E; Albertini, AA; Raux, H; Buonocore, L; Rose, JK; Bressanelli, S; Gaudin, Y",,,,"Baquero, Eduard; Albertini, Aurelie A.; Raux, Helene; Buonocore, Linda; Rose, John K.; Bressanelli, Stephane; Gaudin, Yves",,,Structure of the Low pH Conformation of Chandipura Virus G Reveals Important Features in the Evolution of the Vesiculovirus Glycoprotein,PLOS PATHOGENS,,,English,Article,,,,,,,VESICULAR STOMATITIS-VIRUS; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; G-PROTEIN; RABIES; SEQUENCES; TRIMERS; RHABDOVIRUS; SANDFLIES; EPITOPES,"Chandipura virus (CHAV), a member of the vesiculovirus genus, is an emerging human pathogen. As for other rhabdoviruses, CHAV entry into susceptible cells is mediated by its single envelope glycoprotein G which is both involved in receptor recognition and fusion of viral and cellular membranes. Here, we have characterized the fusion properties of CHAV-G. As for vesicular stomatitis virus (VSV, the prototype of the genus) G, fusion is triggered at low pH below 6.5. We have also analyzed the biochemical properties of a soluble form of CHAV-G ectodomain (CHAV-G(th), generated by thermolysin limited-proteolysis of recombinant VSV particles in which the G gene was replaced by that of CHAV). The overall behavior of CHAV-G(th) is similar to that previously reported for VSV-G(th). Particularly, CHAV-G(th) pre-fusion trimer is not stable in solution and low-pH-induced membrane association of CHAV-G(th) is reversible. Furthermore, CHAV-G(th) was crystallized in its low pH post-fusion conformation and its structure was determined at 3.6 angstrom resolution. An overall comparison of this structure with the previously reported VSV-G(th) post-fusion conformation, shows a high structural similarity as expected from the comparison of primary structure. Among the three domains of G, the pleckstrin homology domain (PHD) appears to be the most divergent and the largest differences are confined to the secondary structure of the major antigenic site of rhabdoviruses. Finally, local differences indicate that CHAV has evolved alternate structural solutions in hinge regions between PH and fusion domains but also distinct pH sensitive switches. Globally the comparison between the post fusion conformation of CHAV and VSV-G highlights several features essential for the protein's function. It also reveals the remarkable plasticity of G in terms of local structures.","[Baquero, Eduard; Albertini, Aurelie A.; Raux, Helene; Bressanelli, Stephane; Gaudin, Yves] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Buonocore, Linda; Rose, John K.] Yale Univ, Sch Med, New Haven, CT USA","Baquero, E (reprint author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.",ebaquero@tx.technion.ac.il; gaudin@vms.cnrs-gif.fr,,"Gaudin, Yves/0000-0002-0122-2954; Albertini, Aurelie/0000-0002-2076-1654; Bressanelli, Stephane/0000-0002-0921-6727; Baquero, Eduard/0000-0002-4701-4181",EU through the Marie Curie ITN VIRUS ENTRY (Project 582) [235649]; Agence Nationale de la Recherche 583 [ANR-11-BSV8-002]; Fondation pour la Recherche Medicale [FRM DEQ20120323711],"This work was supported by the EU through the Marie Curie ITN VIRUS ENTRY (Project 582 reference 235649) (PhD grants for EB), grant from Agence Nationale de la Recherche 583 (ANR-11-BSV8-002) (Post-doctoral grant for EB) and from the Fondation pour la Recherche Medicale (FRM DEQ20120323711). The platforms are supported by the French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albertini AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002556; Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Baquero E, 2013, CURR OPIN VIROL, V3, P143, DOI 10.1016/j.coviro.2013.03.006; Baquero E, 2012, ACTA CRYSTALLOGR F, V68, P1094, DOI 10.1107/S1744309112030151; BENMANSOUR A, 1991, J VIROL, V65, P4198; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Cherian SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030315; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Desmezieres E, 2003, VIRUS RES, V91, P181, DOI 10.1016/S0168-1702(02)00267-8; DHANDA V, 1970, INDIAN J MED RES, V58, P179; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferlin A, 2014, J VIROL; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; GAUDIN Y, 1991, J VIROL, V65, P4853; Gaudin Y, 2000, Subcell Biochem, V34, P379; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Kongsuwan K, 1998, J GEN VIROL, V79, P2573, DOI 10.1099/0022-1317-79-11-2573; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Marriott AC, 2005, ARCH VIROL, V150, P671, DOI 10.1007/s00705-004-0452-2; MASTERS PS, 1989, VIROLOGY, V171, P285, DOI 10.1016/0042-6822(89)90540-0; Mavale MS, 2006, AM J TROP MED HYG, V75, P1151, DOI 10.4269/ajtmh.2006.75.1151; Menghani S, 2012, ACTA TROP, V124, P1, DOI 10.1016/j.actatropica.2012.06.001; Modis Y, 2014, CURR OPIN VIROL, V5, P34, DOI 10.1016/j.coviro.2014.01.009; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pasdeloup D, 2005, VIROLOGY, V334, P284, DOI 10.1016/j.virol.2005.02.005; PREHAUD C, 1988, J VIROL, V62, P1; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rose NF, 2000, J VIROL, V74, P10903, DOI 10.1128/JVI.74.23.10903-10910.2000; Sudeep AB, 2014, INDIAN J MED RES, V139, P769; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Vasilakis N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-69; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972",45,10,10,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004756,10.1371/journal.ppat.1004756,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900067,25803715.0,"DOAJ Gold, Green Published",,,16/08/2019,12,1,17,4248,786,590,196,3462,2804,23,635,17,0,0,0,10,10,0,,23,1,23,0,1,12,12,11,6,0,0,0,0,0,0,0,1,1,4294,26,0,100,60,1,3484,793,26,0,100,60,1,17,,0,0,0,0,2,0,1,1,0,0,0,24,0,0,1.0,5.404580152671755,1.2270363951473138,0.2270363951473137,1.2651646447140381,1.0310734463276836,5.572519083969466
75,J,"Brezar, V; Ruffin, N; Richert, L; Surenaud, M; Lacabaratz, C; Palucka, K; Thiebaut, R; Banchereau, J; Levy, Y; Seddiki, N",,,,"Brezar, Vedran; Ruffin, Nicolas; Richert, Laura; Surenaud, Mathieu; Lacabaratz, Christine; Palucka, Karolina; Thiebaut, Rodolphe; Banchereau, Jacques; Levy, Yves; Seddiki, Nabila",,,Decreased HIV-Specific T-Regulatory Responses Are Associated with Effective DC-Vaccine Induced Immunity,PLOS PATHOGENS,,,English,Article,,,,,,,CELL RESPONSES; THERAPEUTIC IMMUNIZATION; INFECTED PATIENTS; DENDRITIC CELLS; SUPPRESSION; PHENOTYPE; EXPANSION,"The role of regulatory T cells (Tregs) in vaccination has been poorly investigated. We have reported that vaccination with ex vivo-generated dendritic-cells (DC) loaded with HIVlipopeptides (LIPO-5-DC vaccine) in HIV-infected patients was well tolerated and highly immunogenic. These responses and their relation to viral replication following analytical treatment interruption (ATI) were variable. Here, we investigated whether the presence of HIV-specific Tregs might explain these differences. Co-expression of CD25, CD134, CD39 and FoxP3 was used to delineate both antigen-specific Tregs and effectors T cells (Teffs). Median LIPO-5 specific-CD25(+)CD134(+) polyfunctional T cells increased from 0.1%(IQR 0-0.3) before vaccination (week -4) to 2.1%(IQR 1.1-3.9) at week 16 following 4 immunizations (p=0.001) and were inversely correlated with maximum viral load following ATI (r=-0.77, p=0.001). Vaccinees who displayed lower levels of HIV-specific CD4(+)CD134(+)CD25(+)CD39(+)FoxP3(+) Tregs responded better to the LIPO-5-DC vaccine. After vaccination, the frequency of HIV-specific Tregs decreased (from 69.3 at week -4 to 31.7% at week 16) and inversely correlated with HIV-specific IFN-gamma-producing cells (r=-0.64, p=0.002). We show that therapeutic immunization skewed the HIV-specific response from regulatory to effector phenotype which impacts on the magnitude of viral replication following ATI.","[Brezar, Vedran; Ruffin, Nicolas; Surenaud, Mathieu; Lacabaratz, Christine; Banchereau, Jacques; Levy, Yves; Seddiki, Nabila] Hop Henri Mondor, INSERM, U955, Equipe 16, F-94010 Creteil, France; [Brezar, Vedran; Ruffin, Nicolas; Surenaud, Mathieu; Lacabaratz, Christine; Banchereau, Jacques; Levy, Yves; Seddiki, Nabila] Univ Paris Est, Fac Med, Creteil, France; [Brezar, Vedran; Ruffin, Nicolas; Richert, Laura; Surenaud, Mathieu; Lacabaratz, Christine; Thiebaut, Rodolphe; Banchereau, Jacques; Levy, Yves; Seddiki, Nabila] VRI, Creteil, France; [Richert, Laura; Thiebaut, Rodolphe] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Richert, Laura; Thiebaut, Rodolphe] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Richert, Laura; Thiebaut, Rodolphe] CHU Bordeaux, Pole Sante Publ, Bordeaux, France; [Richert, Laura; Thiebaut, Rodolphe] INRIA SISTM, Talence, France; [Palucka, Karolina; Banchereau, Jacques] Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX USA; [Palucka, Karolina; Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Levy, Yves] Hop H Mondor A Chenevier, AP HP, Serv Immunol Clin & Malad Infect, Creteil, France","Brezar, V (reprint author), Hop Henri Mondor, INSERM, U955, Equipe 16, F-94010 Creteil, France.",nabila.seddiki@inserm.fr,,"Lacabaratz, Christine/0000-0001-6925-0225; Ruffin, Nicolas/0000-0002-3698-5505; SURENAUD, Mathieu/0000-0002-3312-7871","Investissement d'Avenir program [ANR-10-LABX-77]; Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS), the Vaccine Research Institute (VRI)","This study was supported by the Investissement d'Avenir program managed by the ANR under reference ANR-10-LABX-77 and by the Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS), the Vaccine Research Institute (VRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Angin M, 2012, AIDS, V26, P2112, DOI 10.1097/QAD.0b013e328358cc75; Appay V, 2009, EUR J IMMUNOL, V39, P1999, DOI 10.1002/eji.200939551; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Brezar V, 2014, J IMMUNOL METHODS, V411, P70, DOI 10.1016/j.jim.2014.06.003; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Levy Y, 2006, AIDS, V20, P405, DOI 10.1097/01.aids.0000206504.09159.d3; Levy Y, 2005, AIDS, V19, P279; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; McMurchy AN, 2012, EUR J IMMUNOL, V42, P27, DOI 10.1002/eji.201141651; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Norris PJ, 2004, J VIROL, V78, P8844, DOI 10.1128/JVI.78.16.8844-8851.2004; Palucka K, 2013, CURR OPIN IMMUNOL, V25, P396, DOI 10.1016/j.coi.2013.05.001; Pen JJ, 2014, GENE THER, V21, P262, DOI 10.1038/gt.2013.80; Phetsouphanh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074946; Seddiki N, 2014, CURR OPIN HIV AIDS, V9, P452, DOI 10.1097/COH.0000000000000087; Seddiki N, 2014, EUR J IMMUNOL, V44, P1644, DOI 10.1002/eji.201344102; Sierro SR, 2011, EUR J IMMUNOL, V41, P2217, DOI 10.1002/eji.201041235; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Van Gulck E, 2012, AIDS, V26, pF1, DOI 10.1097/QAD.0b013e32834f33e8; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wittkowski KM, 2004, STAT MED, V23, P1579, DOI 10.1002/sim.1778; Zaunders JJ, 2009, J IMMUNOL, V183, P2827, DOI 10.4049/jimmunol.0803548",46,16,16,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004752,10.1371/journal.ppat.1004752,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900065,25816350.0,"DOAJ Gold, Green Published",,,16/08/2019,15,1,25,3980,663,456,207,3317,2690,19,608,25,1,0,0,15,15,2,,32,6,32,0,6,16,16,11,9,0,0,0,0,0,0,0,0,2,4001,25,0,54,144,8,3319,666,25,0,54,136,8,16,,0,0,0,0,4,0,0,1,0,0,0,33,0,0,1.5,6.003016591251885,1.1998794091046125,0.1998794091046126,1.2571600844136268,1.0477386934673367,6.289592760180995
76,J,"Caboni, M; Pedron, T; Rossi, O; Goulding, D; Pickard, D; Citiulo, F; MacLennan, CA; Dougan, G; Thomson, NR; Saul, A; Sansonetti, PJ; Gerke, C",,,,"Caboni, Mariaelena; Pedron, Thierry; Rossi, Omar; Goulding, David; Pickard, Derek; Citiulo, Francesco; MacLennan, Calman A.; Dougan, Gordon; Thomson, Nicholas R.; Saul, Allan; Sansonetti, Philippe J.; Gerke, Christiane",,,An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei,PLOS PATHOGENS,,,English,Article,,,,,,,MODAL CHAIN-LENGTH; ESCHERICHIA-COLI; FLEXNERI 2A; VIRULENCE PLASMID; STABLE EXPRESSION; RISK-FACTORS; PHASE-I; POLYSACCHARIDE; GENES; IDENTIFICATION,"Shigella is the leading cause for dysentery worldwide. Together with several virulence factors employed for invasion, the presence and length of the O antigen (OAg) of the lipopolysaccharide (LPS) plays a key role in pathogenesis. S. flexneri 2a has a bimodal OAg chain length distribution regulated in a growth-dependent manner, whereas S. sonnei LPS comprises a monomodal OAg. Here we reveal that S. sonnei, but not S. flexneri 2a, possesses a high molecular weight, immunogenic group 4 capsule, characterized by structural similarity to LPS OAg. We found that a galU mutant of S. sonnei, that is unable to produce a complete LPS with OAg attached, can still assemble OAg material on the cell surface, but a galU mutant of S. flexneri 2a cannot. High molecular weight material not linked to the LPS was purified from S. sonnei and confirmed by NMR to contain the specific sugars of the S. sonnei OAg. Deletion of genes homologous to the group 4 capsule synthesis cluster, previously described in Escherichia coli, abolished the generation of the high molecular weight OAg material. This OAg capsule strongly affects the virulence of S. sonnei. Uncapsulated knockout bacteria were highly invasive in vitro and strongly inflammatory in the rabbit intestine. But, the lack of capsule reduced the ability of S. sonnei to resist complement-mediated killing and to spread from the gut to peripheral organs. In contrast, overexpression of the capsule decreased invasiveness in vitro and inflammation in vivo compared to the wild type. In conclusion, the data indicate that in S. sonnei expression of the capsule modulates bacterial pathogenesis resulting in balanced capabilities to invade and persist in the host environment.","[Caboni, Mariaelena; Rossi, Omar; Citiulo, Francesco; MacLennan, Calman A.; Saul, Allan; Gerke, Christiane] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Pedron, Thierry; Sansonetti, Philippe J.] Inst Pasteur, INSERM, U1202, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; [Goulding, David; Pickard, Derek; Dougan, Gordon; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Sansonetti, Philippe J.] Coll France, Chaire Microbiol & Malad Infect, F-75231 Paris, France","Caboni, M (reprint author), Novartis Vaccines, Via Fiorentina, Siena, Italy.",christiane.gerke@novartis.com,"Thomson, Nicholas/P-5988-2014; MacLennan, Calman/L-9343-2014; Saul, Allan/I-6968-2013","Thomson, Nicholas/0000-0002-4432-8505; MacLennan, Calman/0000-0001-9694-0846; Saul, Allan/0000-0003-0665-4091",European Union [261472],"The research was supported in part by the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement 261472 'STOPENTERICS'. http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/projects/016_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; BARZU S, 1993, INFECT IMMUN, V61, P3825; Batta G, 1997, CARBOHYD RES, V305, P93, DOI 10.1016/S0008-6215(97)00197-3; BENNISH ML, 1990, J INFECT DIS, V161, P500, DOI 10.1093/infdis/161.3.500; BENNISH ML, 1991, REV INFECT DIS, V13, pS319; Carter JA, 2007, MICROBIOL-SGM, V153, P3499, DOI 10.1099/mic.0.2007/010066-0; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dharmasena MN, 2013, INT J MED MICROBIOL, V303, P105, DOI 10.1016/j.ijmm.2013.01.001; DROGE W, 1970, EUR J BIOCHEM, V14, P175, DOI 10.1111/j.1432-1033.1970.tb00276.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUNCAN B, 1981, AM J DIS CHILD, V135, P151, DOI 10.1001/archpedi.1981.02130260043013; FORMAL SB, 1966, J BACTERIOL, V92, P17; FORMAL SB, 1958, J BACTERIOL, V75, P604; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; KARAOLIS DKR, 1994, J CLIN MICROBIOL, V32, P796; Keddy KH, 2012, CLIN INFECT DIS, V54, P1448, DOI 10.1093/cid/cis224; KENNE L, 1980, CARBOHYD RES, V78, P119, DOI 10.1016/S0008-6215(00)83665-4; KLIGLER RM, 1984, WESTERN J MED, V141, P375; KOPECKO DJ, 1980, INFECT IMMUN, V29, P207; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MADONNA GS, 1981, INFECT IMMUN, V32, P153; MAKINO S, 1988, MICROB PATHOGENESIS, V5, P267, DOI 10.1016/0882-4010(88)90099-X; Marteyn Benoit, 2012, Gut Microbes, V3, P104, DOI 10.4161/gmic.19325; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Micoli F, 2013, ANAL BIOCHEM, V434, P136, DOI 10.1016/j.ab.2012.10.038; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; OKAMURA N, 1988, J GEN MICROBIOL, V134, P2057; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Raffatellu M, 2007, INFECT IMMUN, V75, P4342, DOI 10.1128/IAI.01571-06; Robbins JB, 2009, P NATL ACAD SCI USA, V106, P7974, DOI 10.1073/pnas.0900891106; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Robin G, 1997, J INFECT DIS, V175, P1128, DOI 10.1086/516452; Rossi O, 2014, J BIOL CHEM, V289, P24922, DOI 10.1074/jbc.M114.566570; SANDLIN RC, 1995, INFECT IMMUN, V63, P229; SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schnupf P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036446; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; Shifrin Y, 2008, J BACTERIOL, V190, P5063, DOI 10.1128/JB.00440-08; Snyder DS, 2006, CARBOHYD RES, V341, P2388, DOI 10.1016/j.carres.2006.06.010; STRUELENS MJ, 1985, J INFECT DIS, V152, P784, DOI 10.1093/infdis/152.4.784; Tokuyasu K. T., 1997, CELLS LAB MANUAL, V131, P1; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; Ud-Din AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082601; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Xu DQ, 2002, INFECT IMMUN, V70, P4414, DOI 10.1128/IAI.70.8.4414-4423.2002",61,23,23,1,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004749,10.1371/journal.ppat.1004749,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900062,25794007.0,"DOAJ Gold, Green Published",,,16/08/2019,19,1,26,6106,1554,1244,310,4552,3792,20,740,24,0,0,0,22,22,1,,38,17,36,2,17,23,23,18,16,0,0,0,0,0,0,0,1,6,6209,73,21,117,126,4,4575,1571,73,16,117,126,4,63,,0,0,0,0,6,0,1,1,0,0,0,36,2,0,4.1,3.9292149292149294,1.3413884007029877,0.3413884007029877,1.4077328646748681,1.049459547985588,4.123552123552123
77,J,"del Barrio, L; Sahoo, M; Lantier, L; Reynolds, JM; Ceballos-Olvera, I; Re, F",,,,"del Barrio, Laura; Sahoo, Manoranjan; Lantier, Louis; Reynolds, Joseph M.; Ceballos-Olvera, Ivonne; Re, Fabio",,,Production of Anti-LPS IgM by B1a B Cells Depends on IL-1 beta and Is Protective against Lung Infection with Francisella tularensis LVS,PLOS PATHOGENS,,,English,Article,,,,,,,LIVE VACCINE STRAIN; INNATE IMMUNE-RESPONSE; INFLAMMASOME ACTIVATION; GAMMA-INTERFERON; MARGINAL ZONE; RESPIRATORY-INFECTION; MICROBIAL INFECTIONS; CASPASE-1 ACTIVATION; ADAPTIVE IMMUNITY; RELAPSING FEVER,"The role of IL-1 beta and IL-18 during lung infection with the gram-negative bacterium Francisella tularensis LVS has not been characterized in detail. Here, using a mouse model of pneumonic tularemia, we show that both cytokines are protective, but through different mechanisms. Il-18(-/-) mice quickly succumb to the infection and showed higher bacterial burden in organs and lower level of IFN gamma in BALF and serum compared to wild type C57BL/6J mice. Administration of IFN gamma rescued the survival of Il-18(-/-) mice, suggesting that their decreased resistance to tularemia is due to inability to produce IFN gamma. In contrast, mice lacking IL-1 receptor or IL-1 beta, but not IL-1 alpha, appeared to control the infection in its early stages, but eventually succumbed. IFN gamma administration had no effect on Il-1r1(-/-) mice survival. Rather, Il-1r1(-/-) mice were found to have significantly reduced titer of Ft LPS-specific IgM. The antiFt LPS IgM was generated in a IL-1 beta-, TLR2-, and ASC-dependent fashion, promoted bacteria agglutination and phagocytosis, and was protective in passive immunization experiments. B1a B cells produced the anti-Ft LPS IgM and these cells were significantly decreased in the spleen and peritoneal cavity of infected Il-1b(-/-) mice, compared to C57BL/ 6J mice. Collectively, our results show that IL-1 beta and IL-18 activate non-redundant protective responses against tularemia and identify an essential role for IL-1 beta in the rapid generation of pathogen-specific IgM by B1a B cells.","[del Barrio, Laura; Sahoo, Manoranjan; Lantier, Louis; Reynolds, Joseph M.; Ceballos-Olvera, Ivonne; Re, Fabio] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, Abbott Pk, IL 60064 USA","del Barrio, L (reprint author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, Abbott Pk, IL 60064 USA.",fabio.re@rosalindfranklin.edu,"Barrio, Laura/B-3767-2017","Barrio, Laura/0000-0001-9203-3296",National Institutes of Health [AI081861],"This work was supported by National Institutes of Health grants AI081861 (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Ancuta P, 1996, INFECT IMMUN, V64, P2041; ANTHONY LSD, 1992, J IMMUNOL, V148, P1829; ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Barker JH, 2006, INFECT IMMUN, V74, P3277, DOI 10.1128/IAI.02011-05; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Ben Nasr A, 2008, J LEUKOCYTE BIOL, V84, P77, DOI 10.1189/jlb.0807526; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Cole LE, 2011, J LEUKOCYTE BIOL, V90, P787, DOI 10.1189/jlb.0111014; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Crane DD, 2013, J IMMUNOL, V190, P2756, DOI 10.4049/jimmunol.1202697; Cunha LD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00076; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; FORTIER AH, 1991, INFECT IMMUN, V59, P2922; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Jayakar HR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-179; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Malkiel S, 2009, J IMMUNOL, V182, P498, DOI 10.4049/jimmunol.182.1.498; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Nakae S, 2001, IMMUNOLOGY, V104, P402, DOI 10.1046/j.1365-2567.2001.01337.x; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schwartz JT, 2012, J IMMUNOL, V189, P3064, DOI 10.4049/jimmunol.1200816; Sorokin VM, 1996, FEMS IMMUNOL MED MIC, V13, P249, DOI 10.1111/j.1574-695X.1996.tb00246.x; Steiner DJ, 2014, INFECT DRUG RESIST, V7, P239, DOI 10.2147/IDR.S53700; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Ulland TK, 2013, INFECT IMMUN, V81, P201, DOI 10.1128/IAI.00991-12; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610",61,16,16,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004706,10.1371/journal.ppat.1004706,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900034,25768794.0,"DOAJ Gold, Green Published",,,16/08/2019,15,0,18,3413,707,523,184,2706,2243,19,444,18,0,0,0,15,15,0,,22,1,22,0,1,16,16,12,11,0,0,0,0,0,0,0,0,2,3461,23,0,409,119,0,2725,719,23,0,409,119,0,17,,0,0,0,0,2,0,0,1,0,0,0,22,0,0,1.0,4.827439886845827,1.261271249076127,0.26127124907612714,1.3314855875831486,1.0556694989745092,5.096181046676096
78,J,"Diabate, M; Munro, P; Garcia, E; Jacquel, A; Michel, G; Obba, S; Goncalves, D; Luci, C; Marchetti, S; Demon, D; Degos, C; Bechah, Y; Mege, JL; Lamkanfi, M; Auberger, P; Gorvel, JP; Stuart, LM; Landraud, L; Lemichez, E; Boyer, L",,,,"Diabate, Mamady; Munro, Patrick; Garcia, Elsa; Jacquel, Arnaud; Michel, Gregory; Obba, Sandrine; Goncalves, Diogo; Luci, Carmelo; Marchetti, Sandrine; Demon, Dieter; Degos, Clara; Bechah, Yassina; Mege, Jean-Louis; Lamkanfi, Mohamed; Auberger, Patrick; Gorvel, Jean-Pierre; Stuart, Lynda Maria; Landraud, Luce; Lemichez, Emmanuel; Boyer, Laurent",,,Escherichia coli alpha-Hemolysin Counteracts the Anti-Virulence Innate Immune Response Triggered by the Rho GTPase Activating Toxin CNF1 during Bacteremia,PLOS PATHOGENS,,,English,Article,,,,,,,INTERLEUKIN-1-BETA CONVERTING-ENZYME; PROTEASOMAL DEGRADATION; BLADDER INFECTION; E.-COLI; BACTERIAL; INFLAMMASOME; PATHOGENS; CASPASE-1; PROTEIN; SYSTEM,"The detection of the activities of pathogen-encoded virulence factors by the innate immune system has emerged as a new paradigm of pathogen recognition. Much remains to be determined with regard to the molecular and cellular components contributing to this defense mechanism in mammals and importance during infection. Here, we reveal the central role of the IL-1 beta signaling axis and Gr1+ cells in controlling the Escherichia coli burden in the blood in response to the sensing of the Rho GTPase-activating toxin CNF1. Consistently, this innate immune response is abrogated in caspase-1/11-impaired mice or following the treatment of infected mice with an IL-1 beta antagonist. In vitro experiments further revealed the synergistic effects of CNF1 and LPS in promoting the maturation/secretion of IL-1 beta and establishing the roles of Rac, ASC and caspase-1 in this pathway. Furthermore, we found that the Phi-hemolysin toxin inhibits IL-1 beta secretion without affecting the recruitment of Gr1+ cells. Here, we report the first example of anti-virulence-triggered immunity counteracted by a pore-forming toxin during bacteremia.","[Diabate, Mamady; Munro, Patrick; Garcia, Elsa; Michel, Gregory; Landraud, Luce; Lemichez, Emmanuel; Boyer, Laurent] Fac Med Nice, INSERM, C3M, Toxines Microbiennes Relat Hote Pathogenes,U1065, F-06034 Nice, France; [Diabate, Mamady; Munro, Patrick; Garcia, Elsa; Jacquel, Arnaud; Michel, Gregory; Obba, Sandrine; Goncalves, Diogo; Luci, Carmelo; Marchetti, Sandrine; Auberger, Patrick; Landraud, Luce; Lemichez, Emmanuel; Boyer, Laurent] Univ Nice Sophia Antipolis, UFR Med, F-06189 Nice, France; [Diabate, Mamady; Landraud, Luce] Hop Archet, CHU Nice, Lab Bacteriol, Nice, France; [Jacquel, Arnaud; Obba, Sandrine; Goncalves, Diogo; Marchetti, Sandrine; Auberger, Patrick] Fac Med Nice, INSERM, C3M, Mort Cellulaire Differentiat & Canc,U1065, F-06034 Nice, France; [Luci, Carmelo] CNRS, IPMC, UMR7275, Sophia Antipolis, France; [Demon, Dieter; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; [Demon, Dieter; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Degos, Clara; Gorvel, Jean-Pierre] Aix Marseille Univ UM 2, CNRS, INSERM, UMR 7280,U1104, Marseille, France; [Bechah, Yassina; Mege, Jean-Louis] Fac Med Marseille, CNRS, UMR 6236, Unite Rech Malad Infect Trop & Emergentes, F-13385 Marseille, France; [Stuart, Lynda Maria] Benaroya Res Inst Virginia Mason, Seattle, WA USA","Diabate, M (reprint author), Fac Med Nice, INSERM, C3M, Toxines Microbiennes Relat Hote Pathogenes,U1065, U210, F-06034 Nice, France.",lemichez@unice.fr; boyerl@unice.fr,"Lemichez, Emmanuel/G-3559-2013; Jacquel, Arnaud/O-1928-2017; Gorvel, Jean-Pierre/O-1332-2018; MEGE, JEAN-LOUIS/O-6063-2016; Munro, Patrick/A-6579-2009; AUBERGER, Patrick/G-1491-2013; Boyer, Laurent/F-8921-2015; Marchetti, Sandrine/P-6479-2016; LUCI, Carmelo/O-2077-2016","Lemichez, Emmanuel/0000-0001-9080-7761; Jacquel, Arnaud/0000-0001-5062-8048; Gorvel, Jean-Pierre/0000-0002-2829-9804; Munro, Patrick/0000-0003-4283-4671; AUBERGER, Patrick/0000-0002-2481-8275; Boyer, Laurent/0000-0002-1375-1706; Marchetti, Sandrine/0000-0001-8326-5730; LUCI, Carmelo/0000-0001-9687-4164","INSERM; Ligue Nationale contre le Cancer; French Government (National Research Agency, ANR) through the ""Investments for the Future"" LABEX SIGNALIFE [ANR-11-LABX-0028-01, ANR A05135AS]; Association pour la Recherche sur le Cancer [ARC 3800, RAC13006AAA]; Infectiopole Sud","Our laboratory is supported by INSERM, Ligue Nationale contre le Cancer, the French Government (National Research Agency, ANR) through the ""Investments for the Future"" LABEX SIGNALIFE ANR-11-LABX-0028-01 and ANR A05135AS, Association pour la Recherche sur le Cancer (ARC 3800, RAC13006AAA), and fellowship to M.D. from Infectiopole Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alteri CJ, 2012, CURR OPIN MICROBIOL, V15, P3, DOI 10.1016/j.mib.2011.12.004; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; CAPRIOLI A, 1989, J CLIN MICROBIOL, V27, P758; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; GADEBERG OV, 1983, INFECT IMMUN, V41, P358; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gur C, 2013, CELL HOST MICROBE, V14, P664, DOI 10.1016/j.chom.2013.11.004; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Jacquel A, 2012, BLOOD, V119, P4527, DOI 10.1182/blood-2011-11-392167; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Landraud L, 2003, MOL MICROBIOL, V47, P1653, DOI 10.1046/j.1365-2958.2003.03391.x; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Leeds JA, 1996, J BACTERIOL, V178, P1850, DOI 10.1128/jb.178.7.1850-1857.1996; Leimbach A, 2013, CURR TOP MICROBIOL, V358, P3, DOI 10.1007/82_2012_303; Lemonnier M, 2000, MOL MICROBIOL, V38, P493, DOI 10.1046/j.1365-2958.2000.02101.x; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Munro P, 2004, J BIOL CHEM, V279, P35849, DOI 10.1074/jbc.M401580200; Nagy G, 2006, MICROBES INFECT, V8, P2006, DOI 10.1016/j.micinf.2006.02.029; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Real JM, 2007, CYTOKINE, V37, P22, DOI 10.1016/j.cyto.2007.02.016; Rippere-Lampe KE, 2001, INFECT IMMUN, V69, P6515, DOI 10.1128/IAI.69.10.6515-6519.2001; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Smith SN, 2010, MED CARE S1, P1, DOI DOI 10.1097/MLR.0b013e3181e1cde5; Smith YC, 2008, INFECT IMMUN; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Wang XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004346; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wiles TJ, 2013, FUTURE MICROBIOL, V8, P73, DOI [10.2217/FMB.12.131, 10.2217/fmb.12.131]; Xu H, 2014, NATURE; YAMAMOTO S, 1995, MICROBIOL IMMUNOL, V39, P401, DOI 10.1111/j.1348-0421.1995.tb02219.x",52,17,19,2,22,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004732,10.1371/journal.ppat.1004732,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900050,25781937.0,"DOAJ Gold, Green Published",,,16/08/2019,17,17,27,4209,866,649,217,3343,2694,29,620,27,0,0,0,16,16,0,,28,0,28,0,0,18,17,18,11,0,0,0,0,0,0,0,7,2,4278,38,0,82,108,0,3363,876,38,0,82,108,0,39,,0,0,0,0,2,0,0,1,0,0,0,28,0,0,0.75,4.86027713625866,1.2590487586000598,0.2590487586000598,1.323362249476518,1.0510810168686149,5.108545034642033
79,J,"Bieren, JV; Volpe, B; Sutherland, DB; Burgi, J; Verbeek, JS; Marsland, BJ; Urban, JF; Harris, NL",,,,"Esser-von Bieren, Julia; Volpe, Beatrice; Sutherland, Duncan B.; Buergi, Jerome; Verbeek, J. Sjef; Marsland, Benjamin J.; Urban, Joseph F., Jr.; Harris, Nicola L.",,,Immune Antibodies and Helminth Products Drive CXCR2-Dependent Macrophage-Myofibroblast Crosstalk to Promote Intestinal Repair,PLOS PATHOGENS,,,English,Article,,,,,,,PROTECTIVE IMMUNITY; DENDRITIC CELLS; RESPONSES; MICE; RECEPTOR; CXCR2; ACTIVATION; EXPRESSION; INNATE; INFLAMMATION,"Helminth parasites can cause considerable damage when migrating through host tissues, thus making rapid tissue repair imperative to prevent bleeding and bacterial dissemination particularly during enteric infection. However, how protective type 2 responses targeted against these tissue-disruptive multicellular parasites might contribute to homeostatic wound healing in the intestine has remained unclear. Here, we observed that mice lacking antibodies (Aid(-/-)) or activating Fc receptors (Fcrg(-/-)) displayed impaired intestinal repair following infection with the murine helminth Heligmosomoides polygyrus bakeri (Hpb), whilst transfer of immune serum could partially restore chemokine production and rescue wound healing in Aid(-/-) mice. Impaired healing was associated with a reduced expression of CXCR2 ligands (CXCL2/3) by macrophages (M phi) and myofibroblasts (MF) within intestinal lesions. Whilst antibodies and helminths together triggered CXCL2 production by MF in vitro via surface FcR engagement, chemokine secretion by intestinal MF was elicited by helminths directly via Fcrg-chain/dectin2 signaling. Blockade of CXCR2 during Hpb challenge infection reproduced the delayed wound repair observed in helminth infected Aid(-/-) and Fcrg(-/-) mice. Finally, conditioned media from human MF stimulated with infective larvae of the helminth Ascaris suum together with immune serum, promoted CXCR2-dependent scratch wound closure by human MF in vitro. Collectively our findings suggest that helminths and antibodies instruct a chemokine driven MF-MF crosstalk to promote intestinal repair, a capacity that may be harnessed in clinical settings of impaired wound healing.","[Esser-von Bieren, Julia; Volpe, Beatrice; Sutherland, Duncan B.; Harris, Nicola L.] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lab Intestinal Immunol, Lausanne, Switzerland; [Esser-von Bieren, Julia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80290 Munich, Germany; [Esser-von Bieren, Julia] Helmholtz Ctr Munich, Munich, Germany; [Buergi, Jerome] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lab Cell & Membrane Biol, Lausanne, Switzerland; [Verbeek, J. Sjef] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Marsland, Benjamin J.] Univ Lausanne, Fac Biol & Med, Serv Pneumol, CHU Vaudois, Lausanne, Switzerland; [Urban, Joseph F., Jr.] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA","Bieren, JV (reprint author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lab Intestinal Immunol, Lausanne, Switzerland.",nicola.harris@epfl.ch,"harris, nicola/E-5342-2019; volpe, b/U-8409-2019","harris, nicola/0000-0003-2922-0210; Volpe, Bruce/0000-0002-1098-1848; Urban, Joseph/0000-0002-1590-8869",Swiss National Science Foundation [SNF310030_133104],"This study was supported by by the Swiss National Science Foundation (SNF310030_133104). http://www.snf.ch/en/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Allen J.E., 2014, SEMIN IMMUNOL; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1415; Auten RL, 2001, J PHARMACOL EXP THER, V299, P90; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blackwell NM, 2001, INFECT IMMUN, V69, P3860, DOI 10.1128/IAI.69.6.3860-3868.2001; Chen F, 2014, NAT IMMUNOL; Chen F, 2012, NAT MED; Davids JS, 2010, CANCER PREV RES, V3, P348, DOI 10.1158/1940-6207.CAPR-09-0146; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; DRISCOLL KE, 1993, AM J RESP CELL MOL, V8, P311, DOI 10.1165/ajrcmb/8.3.311; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Esser-von Bieren J, 2015, RECEPTOR I J IMMUNOL, V194, P1154, DOI [10.4049/jimmunol.1401645, DOI 10.4049/JIMMUNOL.1401645]; ESSERVONBIEREN J, 2013, PLOS PATHOG, V0009; Galioto AM, 2006, INFECT IMMUN, V74, P5730, DOI 10.1128/IAI.01958-05; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gause W. C., 2013, NAT REV IMMUNOL; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; HARVATH L, 1991, EXP SUPPL, V59, P35; Herbst T, 2012, P NATL ACAD SCI USA, V109, P14954, DOI 10.1073/pnas.1117584109; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hubner MP, 2013, PATHOG DIS, V69, P127, DOI 10.1111/2049-632X.12080; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Iwanaga K, 2012, J PHARMACOL EXP THER, V340, P604, DOI 10.1124/jpet.111.189845; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; LAUBACH HE, 1983, ZBL BAKT-INT J MED M, V255, P406; Maizels RM, 2011, TRENDS PARASITOL, V27, P100, DOI 10.1016/j.pt.2010.11.004; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Patel N, 2014, CELL HOST MICROBE, V15, P339, DOI 10.1016/j.chom.2014.02.001; Pearlman E, 1998, INVEST OPHTH VIS SCI, V39, P1176; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Reutershan J, 2006, DRUG NEWS PERSPECT, V19, P615, DOI 10.1358/dnp.2006.19.10.1068009; Rinaldi M, 2012, PARASITE IMMUNOL, V34, P254, DOI 10.1111/j.1365-3024.2011.01313.x; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schwartz C, 2014, PROC NATL ACAD SCI U; Shibata F, 2002, BIOL PHARM BULL, V25, P1217, DOI 10.1248/bpb.25.1217; Su FH, 2010, SHOCK, V34, P243, DOI 10.1097/SHK.0b013e3181d75967; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; TEKAMPOLSON P, 1990, J EXP MED, V172, P911, DOI 10.1084/jem.172.3.911; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; URBAN JF, 1981, P HELM SOC WASH, V48, P241; Urban JF, 2007, VET PARASITOL, V148, P14, DOI 10.1016/j.vetpar.2007.05.006; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Tol EAF, 1999, AM J PHYSIOL-GASTR L, V277, pG245, DOI 10.1152/ajpgi.1999.277.1.G245; Yang G. J., 2014, LANCET INFECT DIS; Yin H, 2013, INT IMMUNOPHARMACOL, V17, P432, DOI 10.1016/j.intimp.2013.07.008; Zenobia C, 2013, CELL MICROBIOL, V15, P1419, DOI 10.1111/cmi.12127; Zhou CH, 2012, INFECT GENET EVOL, V12, P1172, DOI 10.1016/j.meegid.2012.04.016",65,5,5,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004778,10.1371/journal.ppat.1004778,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900081,25806513.0,"DOAJ Gold, Green Published",,,16/08/2019,14,3,19,4081,1038,792,246,3043,2507,19,517,19,3,0,0,14,14,2,,29,7,29,0,7,14,14,13,7,0,0,0,0,0,0,1,0,6,4093,98,1,89,81,3,3025,1038,98,1,89,81,3,30,,2,1,0,0,12,0,1,1,0,0,1,29,0,0,27.644,3.9315992292870905,1.3411107459743674,0.3411107459743674,1.4038777522182058,1.0468022543494242,4.115606936416185
80,J,"Gagnon, A; Acosta, JE; Madrenas, J; Miller, MS",,,,"Gagnon, Alain; Acosta, J. Enrique; Madrenas, Joaquin; Miller, Matthew S.",,,"Is Antigenic Sin Always ""Original?"" Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu",PLOS PATHOGENS,,,English,Article,,,,,,,A-VIRUS; MORTALITY; INFECTION,"What makes the 1918 Spanish influenza pandemic stand out from all the others is its well-known W-shaped mortality signature, which was caused by unusually high mortality among adults aged 20 to 40 [1]. Much debate remains as to the exact reason for this atypical pattern [2]. A contribution by Worobey et al. [3] published recently in the Proceedings of the National Academy of Sciences (PNAS) is no doubt adding important information to this debate. In agreement with previous work [4-7], Worobey et al. propose that the very high mortality experienced by young adults during the 1918 H1N1 virus pandemic was primarily due to their childhood exposure to the heterosubtypic H3-like virus that is thought to have caused the earlier 1889-1890 Russian flu pandemic [3]. As is generally accepted, the authors also presume that older adults had immunological cross-protection from earlier exposures to a putative H1-like virus, which circulated prior the 1890 pandemic. As for the lower mortality of children and adolescents, however, a new and compelling hypothesis is put forward: this pattern may be attributed to the appearance of a new H1 influenza variant in the early 1900s, which would have provided protection in 1918 for individuals born at the turn of the century, presumably exposed early in life (or ""primed"") to this new variant. They propose that this H1N8 virus arose from reassortment between an H1 lineage virus and an avian influenza virus sometime between 1901 and 1907, replacing the H3N8 virus of the 1889-1890 pandemic. This phylogenetic reconstitution appears to be supported by (often forgotten) seroarcheological and mortality evidence.","[Gagnon, Alain; Acosta, J. Enrique] Univ Montreal, Dept Demog, Montreal, PQ, Canada; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Madrenas, Joaquin] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Miller, Matthew S.] McMaster Univ, Dept Biochem & Biomed Sci, Inst Infect Dis Res, McMaster Immunol Res Ctr, Hamilton, ON L8N 3Z5, Canada","Gagnon, A (reprint author), Univ Montreal, Dept Demog, Montreal, PQ, Canada.",mmiller@mcmaster.ca,"Madrenas, Quim/P-5008-2019","Miller, Matthew/0000-0003-3426-5069",,,"DAVENPORT FM, 1964, J EXP MED, V120, P1087, DOI 10.1084/jem.120.6.1087; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Francis T., 1960, P AM PHILOS SOC, V104, P572; FUKUMI H, 1969, B WORLD HEALTH ORGAN, V41, P469; Gagnon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069586; Hallman S, 2014, MODERN ENVIRONMENTS AND HUMAN HEALTH: REVISITING THE SECOND EPIDEMIOLOGIC TRANSITION, P123; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Ma JL, 2011, J THEOR BIOL, V288, P29, DOI 10.1016/j.jtbi.2011.08.003; MASUREL N, 1969, B WORLD HEALTH ORGAN, V41, P461; MASUREL N, 1976, LANCET, V2, P244; MASUREL N, 1969, LANCET, V1, P907; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Morens DM, 2012, EMERG INFECT DIS, V18, P332, DOI 10.3201/eid1802.111409; O'Donnell CD, 2014, CLIN VACCINE IMMUNOL, V21, P737, DOI 10.1128/CVI.00790-13; Oeppen J, 2006, POPULATION ASS AM; REISS CS, 1980, INFECT IMMUN, V29, P719; Schulman J L, 1977, Dev Biol Stand, V39, P385; Shanks GD, 2012, EMERG INFECT DIS, V18, P201, DOI 10.3201/eid1802.102042; Simonsen L, 2004, INT CONGR SER, V1263, P791, DOI 10.1016/j.ics.2004.01.029; Viboud C, 2012, J INFECT DIS; Wilson N, 2014, J INFECT DIS, V191; Worobey M, 2014, P NATL ACAD SCI USA; Yang W, 2014, INFLUENZA OTHER RESP, V8, P177, DOI 10.1111/irv.12217",25,17,18,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004615,10.1371/journal.ppat.1004615,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900001,25742615.0,"DOAJ Gold, Green Published",,,16/08/2019,19,6,22,7660,1712,1479,233,5948,5067,26,855,21,3,0,0,17,17,1,,62,52,32,1,52,20,20,18,7,0,0,0,0,0,0,9,3,10,8133,5,7,70,753,11,5972,1717,5,7,70,753,11,444,,6,0,0,0,44,0,2,1,0,0,0,31,1,0,71.9,4.474299065420561,1.2878278412911903,0.2878278412911903,1.4947881640887692,1.1607049608355091,5.193341121495327
81,J,"Garcia-Ruiz, H; Carbonell, A; Hoyer, JS; Fahlgren, N; Gilbert, KB; Takeda, A; Giampetruzzi, A; Ruiz, MTG; McGinn, MG; Lowery, N; Baladejo, MTM; Carrington, JC",,,,"Garcia-Ruiz, Hernan; Carbonell, Alberto; Hoyer, J. Steen; Fahlgren, Noah; Gilbert, Kerrigan B.; Takeda, Atsushi; Giampetruzzi, Annalisa; Ruiz, Mayra T. Garcia; McGinn, Michaela G.; Lowery, Nicholas; Baladejo, Maria T. Martinez; Carrington, James C.",,,Roles and Programming of Arabidopsis ARGONAUTE Proteins during Turnip Mosaic Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,SMALL INTERFERING RNAS; HELPER COMPONENT-PROTEINASE; DICER-LIKE PROTEINS; SIRNA BIOGENESIS; SILENCING SUPPRESSORS; ANTIVIRAL DEFENSE; VIRAL SUPPRESSOR; TRANSLATIONAL REPRESSION; FUNCTIONAL-ANALYSIS; HC-PRO,"In eukaryotes, ARGONAUTE proteins (AGOs) associate with microRNAs (miRNAs), short interfering RNAs (siRNAs), and other classes of small RNAs to regulate target RNA or target loci. Viral infection in plants induces a potent and highly specific antiviral RNA silencing response characterized by the formation of virus-derived siRNAs. Arabidopsis thaliana has ten AGO genes of which AGO1, AGO2, and AGO7 have been shown to play roles in antiviral defense. A genetic analysis was used to identify and characterize the roles of AGO proteins in antiviral defense against Turnip mosaic virus (TuMV) in Arabidopsis. AGO1, AGO2 and AGO10 promoted anti-TuMV defense in a modular way in various organs, with AGO2 providing a prominent antiviral role in leaves. AGO5, AGO7 and AGO10 had minor effects in leaves. AGO1 and AGO10 had overlapping antiviral functions in inflorescence tissues after systemic movement of the virus, although the roles of AGO1 and AGO10 accounted for only a minor amount of the overall antiviral activity. By combining AGO protein immunoprecipitation with high-throughput sequencing of associated small RNAs, AGO2, AGO10, and to a lesser extent AGO1 were shown to associate with siRNAs derived from silencing suppressor (HC-Pro)-deficient TuMV-AS9, but not with siRNAs derived from wild-type TuMV. Co-immunoprecipitation and small RNA sequencing revealed that viral siRNAs broadly associated with wild-type HC-Pro during TuMV infection. These results support the hypothesis that suppression of antiviral silencing during TuMV infection, at least in part, occurs through sequestration of virus-derived siRNAs away from antiviral AGO proteins by HC-Pro. These findings indicate that distinct AGO proteins function as antiviral modules, and provide a molecular explanation for the silencing suppressor activity of HC-Pro.","[Garcia-Ruiz, Hernan; Carbonell, Alberto; Hoyer, J. Steen; Fahlgren, Noah; Gilbert, Kerrigan B.; Ruiz, Mayra T. Garcia; McGinn, Michaela G.; Baladejo, Maria T. Martinez; Carrington, James C.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Garcia-Ruiz, Hernan; Carbonell, Alberto; Hoyer, J. Steen; Fahlgren, Noah; Takeda, Atsushi; Giampetruzzi, Annalisa; Lowery, Nicholas; Carrington, James C.] Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Hoyer, J. Steen] Washington Univ, Computat & Syst Biol Program, St Louis, MO USA","Garcia-Ruiz, H (reprint author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.",jcarrington@danforthcenter.org,"Carrington, James/A-4656-2012; Fahlgren, Noah/D-4404-2011; Carbonell, Alberto/D-4395-2011","Carrington, James/0000-0003-3572-129X; Fahlgren, Noah/0000-0002-5597-4537; Carbonell, Alberto/0000-0001-5628-6632; Gilbert, Kerrigan/0000-0002-7164-5821; Hoyer, J. Steen/0000-0002-1338-8900; Vallespir Lowery, Nick/0000-0001-7887-4179; GIAMPETRUZZI, Annalisa/0000-0002-0946-0105",National Institutes of Health [AI43288]; National Science Foundation [MCB-0956526]; Helen Hay Whitney Post-Doctoral fellowship [F-972]; USDA AFRI NIFA Postdoctoral Fellowship [MOW-2012-01361]; NSF Graduate Research Fellowship [DGE-1143954],"National Institutes of Health (www.nih.gov) grant AI43288 to JCC. National Science Foundation (www.nsf.gov) grant MCB-0956526 to JCC. Helen Hay Whitney (www.hhwf.org) Post-Doctoral fellowship (F-972) to HGR. USDA AFRI NIFA (www.csrees.usda.gov) Postdoctoral Fellowship (MOW-2012-01361) to NF. NSF (www.nsf.gov) Graduate Research Fellowship (DGE-1143954) to JSH Japan Society for the Promotion of Science (www.jsps.go.jp) Postdoctoral Fellowship to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Ballut L, 2005, J GEN VIROL, V86, P2595, DOI 10.1099/vir.0.81107-0; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bhattacharjee S, 2009, PLANT J, V58, P940, DOI 10.1111/j.1365-313X.2009.03832.x; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cao MJ, 2014, P NATL ACAD SCI USA, V111, P14613, DOI 10.1073/pnas.1407131111; Cao MX, 2010, J VIROL, V84, P7793, DOI 10.1128/JVI.02643-09; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/J.1364-3703.2010.00634.X, 10.1111/j.1364-3703.2010.00634.x]; Ciomperlik JJ, 2011, VIROLOGY, V412, P117, DOI 10.1016/j.virol.2010.12.018; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Csorba T, 2010, PLANT J, V62, P463, DOI 10.1111/j.1365-313X.2010.04163.x; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Derrien B, 2012, P NATL ACAD SCI USA, V109, P15942, DOI 10.1073/pnas.1209487109; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Dzianott A, 2012, MOL PLANT MICROBE IN, V25, P97, DOI 10.1094/MPMI-05-11-0137; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Gilbert K, 2014, BIOPROTOCOL, V4; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 1997, VIROLOGY, V228, P251, DOI 10.1006/viro.1996.8368; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nakahara KS, 2014, CURR OPIN PLANT BIOL, V20, P88, DOI 10.1016/j.pbi.2014.05.004; Omarov RT, 2007, P NATL ACAD SCI USA, V104, P1714, DOI 10.1073/pnas.0608117104; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Schuck J, 2013, NUCLEIC ACIDS RES, V41, P5090, DOI 10.1093/nar/gkt193; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Soitamo AJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-68; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-177; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhang XC, 2012, J VIROL, V86, P6847, DOI 10.1128/JVI.00497-12; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024",80,68,71,5,69,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004755,10.1371/journal.ppat.1004755,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900066,25806948.0,"DOAJ Gold, Green Published",,,16/08/2019,64,27,103,9204,1878,1330,548,7326,5649,39,1638,103,9,0,0,59,59,3,,133,1,133,0,1,68,68,44,38,0,0,0,0,0,0,0,18,8,9305,228,2,417,76,3,7372,1898,228,2,417,76,3,35,,0,1,0,0,14,0,1,1,0,0,0,132,0,0,16.258,4.900958466453674,1.2563472563472564,0.25634725634725636,1.3116298116298117,1.0440026075619295,5.116613418530352
82,J,"Honegger, A; Schilling, D; Bastian, S; Sponagel, J; Kuryshev, V; Sultmann, H; Scheffner, M; Hoppe-Seyler, K; Hoppe-Seyler, F",,,,"Honegger, Anja; Schilling, Daniela; Bastian, Sandra; Sponagel, Jasmin; Kuryshev, Vladimir; Sueltmann, Holger; Scheffner, Martin; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix",,,Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells,PLOS PATHOGENS,,,English,Article,,,,,,,CERVICAL-CARCINOMA CELLS; HUMAN-PAPILLOMAVIRUS E6; CANCER-CELLS; EXTRACELLULAR VESICLES; RNA INTERFERENCE; E7 ONCOPROTEIN; BREAST-CANCER; CIRCULATING MICRORNA; HUMAN KERATINOCYTES; PROSTATE-CANCER,"Specific types of human papillomaviruses (HPVs) cause cervical cancer. Cervical cancers exhibit aberrant cellular microRNA (miRNA) expression patterns. By genome-wide analyses, we investigate whether the intracellular and exosomal miRNA compositions of HPV-positive cancer cells are dependent on endogenous E6/E7 oncogene expression. Deep sequencing studies combined with qRT-PCR analyses show that E6/E7 silencing significantly affects ten of the 52 most abundant intracellular miRNAs in HPV18-positive HeLa cells, downregulating miR-17-5p, miR-186-5p, miR-378a-3p, miR-378f, miR-629-5p and miR-7-5p, and upregulating miR-143-3p, miR-23a-3p, miR-23b-3p and miR-27b-3p. The effects of E6/E7 silencing on miRNA levels are mainly not dependent on p53 and similarly observed in HPV16-positive SiHa cells. The E6/E7-regulated miRNAs are enriched for species involved in the control of cell proliferation, senescence and apoptosis, suggesting that they contribute to the growth of HPV-positive cancer cells. Consistently, we show that sustained E6/E7 expression is required to maintain the intracellular levels of members of the miR-17 similar to 92 cluster, which reduce expression of the anti-proliferative p21 gene in HPV-positive cancer cells. In exosomes secreted by HeLa cells, a distinct seven-miRNA-signature was identified among the most abundant miRNAs, with significant downregulation of let-7d-5p, miR-20a-5p, miR-378a-3p, miR-423-3p, miR-7-5p, miR-92a-3p and upregulation of miR-21-5p, upon E6/E7 silencing. Several of the E6/E7-dependent exosomal miRNAs have also been linked to the control of cell proliferation and apoptosis. This study represents the first global analysis of intracellular and exosomal miRNAs and shows that viral oncogene expression affects the abundance of multiple miRNAs likely contributing to the E6/E7-dependent growth of HPV-positive cancer cells.","[Honegger, Anja; Bastian, Sandra; Sponagel, Jasmin; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Mol Therapy Virus Associated Canc F065, Heidelberg, Germany; [Schilling, Daniela; Kuryshev, Vladimir; Sueltmann, Holger] German Canc Res Ctr, Canc Genome Res B063, Heidelberg, Germany; [Schilling, Daniela; Kuryshev, Vladimir; Sueltmann, Holger] German Canc Consortium DKTK, Heidelberg, Germany; [Scheffner, Martin] Univ Konstanz, Dept Biol, Constance, Germany","Honegger, A (reprint author), German Canc Res Ctr, Mol Therapy Virus Associated Canc F065, Heidelberg, Germany.",hoppe-seyler@dkfz.de,"Scheffner, Martin/K-2940-2012","Scheffner, Martin/0000-0003-2229-0128; Sponagel, Jasmin/0000-0002-2848-4276",Deutsche Forschungsgemeinschaft [SFB 969],"Part of this work was supported by a grant (SFB 969, B2) of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","[Anonymous], 2012, ANN REV PHYSL; Bellingham SA, 2012, NUCL ACIDS RES; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Butz K, 1998, ONCOGENE, V17, P781, DOI 10.1038/sj.onc.1201995; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheung TH, 2012, CELL CYCLE, V11, P2876, DOI 10.4161/cc.21278; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Crnkovic-Mertens I, 2006, J MOL MED, V84, P232, DOI 10.1007/s00109-005-0021-5; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; DeFilippis RA, 2003, J VIROL, V77, P1551, DOI 10.1128/JVI.77.2.1551-1563.2003; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding H, 2014, ASIAN PAC J CANCER P, V15, P1675, DOI 10.7314/APJCP.2014.15.4.1675; DOWHANICK JJ, 1995, J VIROL, V69, P7791; Dreher A, 2011, BIOCHEM BIOPH RES CO, V412, P20, DOI 10.1016/j.bbrc.2011.07.011; DURST M, 1989, VIROLOGY, V173, P767, DOI 10.1016/0042-6822(89)90595-3; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Goto Y, 2014, ONCOTARGET; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gunasekharan V, 2013, J VIROL, V87, P6037, DOI 10.1128/JVI.00153-13; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hengstermann A, 2005, J VIROL, V79, P9296, DOI 10.1128/JVI.79.14.9296-9300.2005; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Honegger A, 2013, INT J CANC; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; HWANG ES, 1993, J VIROL, V67, P3720; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuner R, 2007, J MOL MED-JMM, V85, P1253, DOI 10.1007/s00109-007-0230-1; Lagrange M, 2007, BIOCHEM BIOPH RES CO, V361, P487, DOI 10.1016/j.bbrc.2007.07.040; Lajer CB, 2012, BRIT J CANCER, V106, P1526, DOI 10.1038/bjc.2012.109; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lee S, 2011, CELL MOL LIFE SCI, V68, P325, DOI 10.1007/s00018-010-0457-9; Li JH, 2011, GYNECOL ONCOL, V120, P145, DOI 10.1016/j.ygyno.2010.09.009; Li M., 2014, EXP CELL RES; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Liang S, 2014, FUTURE ONCOL, V10, P2023, DOI [10.2217/FON.14.38, 10.2217/fon.14.38]; Lin C, 2014, ASIAN PAC J CANCER P, V15, P45, DOI 10.7314/APJCP.2014.15.1.45; Liu LP, 2012, MOL MED REP, V5, P753, DOI 10.3892/mmr.2011.696; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma D, 2012, CHINESE MED J-PEKING, V125, P4270, DOI 10.3760/cma.j.issn.0366-6999.2012.23.020; Magaldi TG, 2012, VIROLOGY, V422, P114, DOI 10.1016/j.virol.2011.10.012; Majid S, 2012, CANCER RES, V72, P6435, DOI 10.1158/0008-5472.CAN-12-2181; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Nouraee Nazila, 2013, Microrna, V2, P102; Nuovo GJ, 2012, MODERN PATHOL, V25, P1333, DOI 10.1038/modpathol.2012.95; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Park H, 2014, GYNECOL ONCOL, V135, P565, DOI 10.1016/j.ygyno.2014.09.010; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; Rak J, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00021; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tang T, 2013, GYNECOL ONCOL, V129, P199, DOI 10.1016/j.ygyno.2012.12.043; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor Douglas D., 2013, Frontiers in Genetics, V4, P142, DOI 10.3389/fgene.2013.00142; Thery C., 2006, CURR PROTOC CELL BIO, V3, P3, DOI DOI 10.1002/0471143030.CB0322S30; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Villegas-Ruiz V, 2014, INT J CLIN EXP PATHO, V7, P1389; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; von Knebel DM, 1988, CANCER RES, V48, P3780; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; White EA, 2014, J VIROL, V88, P8201, DOI 10.1128/JVI.01197-14; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yablonska Svitlana, 2013, Microrna, V2, P2; Yamato K, 2008, CANCER GENE THER, V15, P140, DOI 10.1038/sj.cgt.7701118; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798",133,80,85,0,26,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004712,10.1371/journal.ppat.1004712,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900038,25760330.0,"DOAJ Gold, Green Published",,,16/08/2019,81,1,90,11223,4745,3271,1474,6478,4847,39,1592,89,0,0,0,64,64,1,,115,5,114,1,5,85,85,55,46,0,0,0,0,0,0,0,1,2,11237,101,0,1238,131,2,6452,4745,101,0,1238,131,2,40,,0,0,0,0,3,0,1,1,0,0,0,113,1,0,1.25,2.3652265542676503,1.7324791602346403,0.7324791602346403,1.770453843778944,1.0219192729216786,2.4170706006322447
83,J,"Hughes, DJ; Wood, JJ; Jackson, BR; Baquero-Perez, B; Whitehouse, A",,,,"Hughes, David J.; Wood, Jennifer J.; Jackson, Brian R.; Baquero-Perez, Belinda; Whitehouse, Adrian",,,NEDDylation Is Essential for Kaposi's Sarcoma- Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; PRIMARY EFFUSION LYMPHOMA; DEPENDENT DNA-REPLICATION; GENE-EXPRESSION; NEDD8-ACTIVATING ENZYME; BORTEZOMIB PS-341; ENDOTHELIAL-CELLS; VIRAL REPLICATION; UBIQUITIN LIGASE; PROTEIN,"Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL), which are aggressive malignancies associated with immunocompromised patients. For many non-viral malignancies, therapeutically targeting the ubiquitin proteasome system (UPS) has been successful. Likewise, laboratory studies have demonstrated that inhibition of the UPS might provide a promising avenue for the treatment of KSHV-associated diseases. The largest class of E3 ubiquitin ligases are the cullin-RING ligases (CRLs) that are activated by an additional ubiquitin-like protein, NEDD8. We show that pharmacological inhibition of NEDDylation (using the small molecule inhibitor MLN4924) is cytotoxic to PEL cells by inhibiting NF-kappa B. We also show that CRL4B is a novel regulator of latency as its inhibition reactivated lytic gene expression. Furthermore, we uncovered a requirement for NEDDylation during the reactivation of the KSHV lytic cycle. Intriguingly, inhibition prevented viral DNA replication but not lytic cycle-associated gene expression, highlighting a novel mechanism that uncouples these two features of KSHV biology. Mechanistically, we show that MLN4924 treatment precluded the recruitment of the viral pre-replication complex to the origin of lytic DNA replication (OriLyt). These new findings have revealed novel mechanisms that regulate KSHV latency and reactivation. Moreover, they demonstrate that inhibition of NEDDylation represents a novel approach for the treatment of KSHV-associated malignancies.","[Hughes, David J.; Wood, Jennifer J.; Jackson, Brian R.; Baquero-Perez, Belinda; Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Jackson, Brian R.; Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England","Hughes, DJ (reprint author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.",djh25@st-andrews.ac.uk; a.whitehouse@leeds.ac.uk,"Hughes, David/P-1724-2014","Hughes, David/0000-0002-0090-5710; Jackson, Brian/0000-0002-4917-1199; Whitehouse, Adrian/0000-0003-3866-7110",Wellcome Trust; Yorkshire Cancer Research; BBSRC [BB/K000306/1]; Biotechnology and Biological Sciences Research Council [BB/K000306/1],"This work was funded in parts by The Wellcome Trust (http://www.wellcome.ac.uk), Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk) and the BBSRC (http://www.bbsrc.ac.uk, grant number BB/K000306/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alkharsah KR, 2011, J VIROL, V85, P10375, DOI 10.1128/JVI.00226-11; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bhatt S, 2013, J CLIN INVEST, V123, P2616, DOI 10.1172/JCI64503; Boulanger E, 2008, BRIT J HAEMATOL, V141, P559, DOI 10.1111/j.1365-2141.2008.07057.x; Boyne JR, 2010, EMBO J, V29, P1851, DOI 10.1038/emboj.2010.77; Brown HJ, 2005, ANTIVIR THER, V10, P745; Bu W, 2007, J VIROL, V81, P5788, DOI 10.1128/JVI.00140-07; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Dittmer DP, 2013, CURR OPIN VIROL, V3, P238, DOI 10.1016/j.coviro.2013.05.012; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Gantt S, 2011, CURR OPIN INFECT DIS, V24, P295, DOI 10.1097/QCO.0b013e3283486d04; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Goodwin DJ, 2000, J GEN VIROL, V81, P2253, DOI 10.1099/0022-1317-81-9-2253; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Hall KT, 2002, J VIROL, V76, P11612, DOI 10.1128/JVI.76.22.11612-11622.2002; Hannah J, 2009, DNA REPAIR, V8, P536, DOI 10.1016/j.dnarep.2009.01.011; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Jackson BR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004098; Jackson BR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002138; Jackson SP, 2013, MOL CELL, V49, P795, DOI [10.1016/j.molce1.2013.01.017, 10.1016/j.molcel.2013.01.017]; Jha HC, 2013, J VIROL, V87, P5255, DOI 10.1128/JVI.03575-12; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karttunen H, 2014, MOL CELL, V55, P111, DOI 10.1016/j.molcel.2014.05.020; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; La Ferla L, 2013, EUR REV MED PHARMACO, V17, P2354; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Ma T, 2013, MOL CELL, V49, P897, DOI 10.1016/j.molcel.2013.01.006; Majerciak V, 2010, J BIOL CHEM, V285, P11297, DOI 10.1074/jbc.M109.068221; Matta H, 2005, CANCER BIOL THER, V4, P77, DOI 10.4161/cbt.4.1.1379; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Nakagawa T, 2011, MOL CELL, V43, P381, DOI [10.1016/j.molce1.2011.05.033, 10.1016/j.molcel.2011.05.033]; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; O'Dowd JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003038; Pearce M, 2005, J VIROL, V79, P14457, DOI 10.1128/JVI.79.22.14457-14464.2005; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Romani B, 2009, ARCH VIROL, V154, P1579, DOI 10.1007/s00705-009-0481-y; Rossetto CC, 2011, J VIROL, V85, P3833, DOI 10.1128/JVI.02361-10; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sarosiek KA, 2010, P NATL ACAD SCI USA, V107, P13069, DOI 10.1073/pnas.1002985107; Simonelli C, 2003, J CLIN ONCOL, V21, P3948, DOI 10.1200/JCO.2003.06.013; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stanley DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003085; Sun R, 1999, J VIROL, V73, P2232; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wang Y, 2004, J VIROL, V78, P8615, DOI 10.1128/JVI.78.16.8615-8629.2004; Wang Y, 2008, J VIROL, V82, P2867, DOI 10.1128/JVI.01319-07; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591",59,20,22,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004771,10.1371/journal.ppat.1004771,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900077,25794275.0,"DOAJ Gold, Green Published",,,16/08/2019,20,0,17,3714,560,416,144,3154,2617,17,520,17,0,0,0,19,19,1,,23,1,23,0,1,20,20,18,15,0,0,0,0,0,0,0,0,5,3721,16,0,50,75,0,3149,560,16,0,50,75,0,12,,0,0,0,0,9,0,0,1,0,0,0,22,0,0,6.3,6.632142857142857,1.1775523145212428,0.17755231452124287,1.2086239695624603,1.0263866451265482,6.807142857142857
84,J,"Juneja, P; Ariani, CV; Ho, YS; Akorli, J; Palmer, WJ; Pain, A; Jiggins, FM",,,,"Juneja, Punita; Ariani, Cristina V.; Ho, Yung Shwen; Akorli, Jewelna; Palmer, William J.; Pain, Arnab; Jiggins, Francis M.",,,Exome and Transcriptome Sequencing of Aedes aegypti Identifies a Locus That Confers Resistance to Brugia malayi and Alters the Immune Response,PLOS PATHOGENS,,,English,Article,,,,,,,DIFFERENTIAL EXPRESSION ANALYSIS; MIDGUT SERINE PROTEASES; YELLOW-FEVER MOSQUITO; ANOPHELES-GAMBIAE; GENE-EXPRESSION; DISEASE-VECTOR; RNA-SEQ; FILARIAL SUSCEPTIBILITY; DROSOPHILA-MELANOGASTER; READ ALIGNMENT,"Many mosquito species are naturally polymorphic for their abilities to transmit parasites, a feature which is of great interest for controlling vector-borne disease. Aedes aegypti, the primary vector of dengue and yellow fever and a laboratory model for studying lymphatic filariasis, is genetically variable for its capacity to harbor the filarial nematode Brugia malayi. The genome of Ae. aegypti is large and repetitive, making genome resequencing difficult and expensive. We designed exome captures to target protein-coding regions of the genome, and used association mapping in a wild Kenyan population to identify a single, dominant, sex-linked locus underlying resistance. This falls in a region of the genome where a resistance locus was previously mapped in a line established in 1936, suggesting that this polymorphism has been maintained in the wild for the at least 80 years. We then crossed resistant and susceptible mosquitoes to place both alleles of the gene into a common genetic background, and used RNA-seq to measure the effect of this locus on gene expression. We found evidence for Toll, IMD, and JAK-STAT pathway activity in response to early stages of B. malayi infection when the parasites are beginning to die in the resistant genotype. We also found that resistant mosquitoes express anti-microbial peptides at the time of parasite-killing, and that this expression is suppressed in susceptible mosquitoes. Together, we have found that a single resistance locus leads to a higher immune response in resistant mosquitoes, and we identify genes in this region that may be responsible for this trait.","[Juneja, Punita; Ariani, Cristina V.; Akorli, Jewelna; Palmer, William J.; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Ho, Yung Shwen; Pain, Arnab] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn BESE Div, Thuwal, Saudi Arabia; [Akorli, Jewelna] Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana","Juneja, P (reprint author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.",pjuneja@gmail.com,"Pain, Arnab/L-5766-2015","Pain, Arnab/0000-0002-1755-2819; Jiggins, Francis Michael/0000-0001-7470-8157; Akorli, Jewelna/0000-0002-3972-0860",Cambridge-KAUST Academic Excellence Alliance (AEA2) project; Cambridge Overseas Trust Studentship; Darwin Trust of Edinburgh; Medical Research Council; Royal Society Research; Cambridge NIHR-BRC; Wellcome Trust [090532/Z/09/Z]; MRC hub grant [G0900747 91070]; Medical Research Council [G0900747],"This work was funded by a Cambridge-KAUST Academic Excellence Alliance (AEA2) project grant to AP and CVA was supported by a Cambridge Overseas Trust Studentship. JA was supported by a Darwin Trust of Edinburgh. WJP was supported by a Medical Research Council. FMJ was supported by a Royal Society Research. EASIH is supported by Cambridge NIHR-BRC. The Wellcome Trust Centre for Human Genetics is funded by Wellcome Trust grant reference 090532/Z/09/Z and MRC hub grant G0900747 91070. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aliota MT, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-463; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Bockarie MJ, 2009, ANNU REV ENTOMOL, V54, P469, DOI 10.1146/annurev.ento.54.110807.090626; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Borovsky D, 2003, J EXP BIOL, V206, P3869, DOI 10.1242/jeb.00602; Bosio CF, 2000, GENETICS, V156, P687; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; CHALK R, 1995, EXP PARASITOL, V80, P401, DOI 10.1006/expr.1995.1052; Choi YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002905; Choi YJ, 2012, INSECT BIOCHEM MOLEC, V42, P729, DOI 10.1016/j.ibmb.2012.06.005; CHRISTENSEN BM, 1986, J PARASITOL, V72, P216, DOI 10.2307/3281594; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; DISSANAIKE AS, 1979, B WORLD HEALTH ORGAN, V57, P349; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Evans AM, 2009, J EXP BIOL, V212, P3263, DOI 10.1242/jeb.029553; FERDIG MT, 1993, AM J TROP MED HYG, V49, P756, DOI 10.4269/ajtmh.1993.49.756; Gaaboub A, 1976, J INVERTEBR PATHOL, V28, P203; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hill AVS, 2012, PHILOS T R SOC B, V367, P840, DOI 10.1098/rstb.2011.0275; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; HURD H, 1995, PARASITOL TODAY, V11, P411, DOI 10.1016/0169-4758(95)80021-2; JAVADIAN E, 1974, ANN TROP MED PARASIT, V68, P477, DOI 10.1080/00034983.1974.11686973; Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim S, 2011, INT J DATA MIN BIOIN, V5, P231; Kobayashi M., 1986, Japanese Journal of Sanitary Zoology, V37, P127; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lefevre T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003365; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lowenberger CA, 1996, EXP PARASITOL, V83, P191, DOI 10.1006/expr.1996.0066; Macdonald SJ, 2004, GENETICS, V167, P2127, DOI 10.1534/genetics.104.026732; MACDONALD WW, 1962, ANN TROP MED PARASIT, V56, P373, DOI 10.1080/00034983.1962.11686135; MACDONALD WW, 1965, ANN TROP MED PARASIT, V59, P64, DOI 10.1080/00034983.1965.11686284; MACDONALD WW, 1962, ANN TROP MED PARASIT, V56, P368, DOI 10.1080/00034983.1962.11686134; Macdonald WW, 1965, ANN TROP MED PARASIT, P74; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Orr HA, 1997, EVOLUTION, V51, P1877, DOI 10.1111/j.1558-5646.1997.tb05110.x; Osei-Poku J., 2012, THESIS U CAMBRIDGE, P226; PAIGE CJ, 1975, J MED ENTOMOL, V12, P485, DOI 10.1093/jmedent/12.5.485; Poirie M, 2000, P ROY SOC B-BIOL SCI, V267, P1417, DOI 10.1098/rspb.2000.1158; RAMACHANDRAN C. P., 1966, J MED ENTOMOL, V3, P239; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Randall TA, 2013, GENOME BIOL EVOL, V5, P2344, DOI 10.1093/gbe/evt182; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RODRIGUEZ PH, 1973, AM J TROP MED HYG, V22, P53, DOI 10.4269/ajtmh.1973.22.53; RODRIGUEZ PH, 1984, J PARASITOL, V70, P1001, DOI 10.2307/3281664; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969; Schwartz A, 2002, J MED ENTOMOL, V39, P84, DOI 10.1603/0022-2585-39.1.84; Severson David W., 1994, Insect Molecular Biology, V3, P67, DOI 10.1111/j.1365-2583.1994.tb00153.x; SHAHABUDDIN M, 1995, EXP PARASITOL, V80, P212, DOI 10.1006/expr.1995.1026; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Skotte L, 2012, GENET EPIDEMIOL, V36, P430, DOI 10.1002/gepi.21636; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897; SULAIMAN I, 1980, ANN TROP MED PARASIT, V74, P635, DOI 10.1080/00034983.1980.11687397; Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; TERWEDOW H A JR, 1977, Journal of Medical Entomology, V14, P421; Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27; Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Wilfert L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-187; Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011",91,11,11,0,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004765,10.1371/journal.ppat.1004765,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900073,25815506.0,"DOAJ Gold, Green Published",,,16/08/2019,13,1,51,4599,873,666,207,3726,3081,17,628,50,0,0,0,13,13,1,,62,7,61,1,7,16,13,16,8,0,0,0,0,0,0,0,1,8,4640,259,13,60,75,0,3747,883,123,13,60,71,0,10,,0,1,0,0,12,0,0,1,0,0,0,61,1,0,18.2,5.268041237113402,1.2342995169082125,0.23429951690821257,1.3349436392914653,1.081539465101109,5.697594501718213
85,J,"Knudson, CJ; Hartwig, SM; Meyerholz, DK; Varga, SM",,,,"Knudson, Cory J.; Hartwig, Stacey M.; Meyerholz, David K.; Varga, Steven M.",,,RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets,PLOS PATHOGENS,,,English,Article,,,,,,,RESPIRATORY-SYNCYTIAL-VIRUS; FORMALIN-INACTIVATED RSV; IMMUNIZED BALB/C MICE; PULMONARY EOSINOPHILIA; G-GLYCOPROTEIN; TNF-ALPHA; PEDIATRIC POPULATION; AIRWAY-OBSTRUCTION; EPITHELIAL-CELLS; FIELD EVALUATION,"There is no currently licensed vaccine for respiratory syncytial virus (RSV) despite being the leading cause of lower respiratory tract infections in children. Children previously immunized with a formalin-inactivated RSV (FI-RSV) vaccine exhibited enhanced respiratory disease following natural RSV infection. Subsequent studies in animal models have implicated roles for CD4 T cells, eosinophils and non-neutralizing antibodies in mediating enhanced respiratory disease. However, the underlying immunological mechanisms responsible for the enhanced respiratory disease and other disease manifestations associated with FI-RSV vaccine-enhanced disease remain unclear. We demonstrate for the first time that while CD4 T cells mediate all aspects of vaccine-enhanced disease, distinct CD4 T cell subsets orchestrate discrete and specific disease parameters. A Th2-biased immune response, but not eosinophils specifically, was required for airway hyperreactivity and mucus hypersecretion. In contrast, the Th1-associated cytokine TNF-alpha was necessary to mediate airway obstruction and weight loss. Our data demonstrate that individual disease manifestations associated with FI-RSV vaccine-enhanced disease are mediated by distinct subsets of CD4 T cells.","[Knudson, Cory J.; Varga, Steven M.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Hartwig, Stacey M.; Varga, Steven M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Meyerholz, David K.; Varga, Steven M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA","Knudson, CJ (reprint author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.",steven-varga@uiowa.edu,"Meyerholz, David/J-8131-2019; Varga, Steven/C-2009-2009","Meyerholz, David/0000-0003-1552-3253; Varga, Steven/0000-0001-7332-4290","National Institutes of Health [R01AI063520, R56AI106776, T32AI007485]","Research reported in this publication was supported by National Institutes of Health grants under award numbers R01AI063520 and R56AI106776 (to SMV), and T32AI007485 (to CJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aeffner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046660; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Bell SJD, 1996, CELL IMMUNOL, V170, P185, DOI 10.1006/cimm.1996.0151; BOULET LP, 1994, CHEST, V105, P1024, DOI 10.1378/chest.105.4.1024; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P1711, DOI 10.1111/j.1365-2222.2003.01827.x; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Cohn L, 1999, J IMMUNOL, V162, P6178; Collins RA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-142; CONNORS M, 1992, J VIROL, V66, P7444; CONNORS M, 1994, J VIROL, V68, P5321; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; HEILMAN CA, 1990, J INFECT DIS, V161, P402, DOI 10.1093/infdis/161.3.402; Huck B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-6; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Johnson TR, 2008, J LEUKOCYTE BIOL, V84, P748, DOI 10.1189/jlb.0907621; Johnson TR, 2004, J VIROL, V78, P6024, DOI 10.1128/JVI.78.11.6024-6032.2004; Johnson TR, 1999, J VIROL, V73, P8485; KAKUK TJ, 1993, J INFECT DIS, V167, P553, DOI 10.1093/infdis/167.3.553; Kampf C, 1999, EUR RESPIR J, V14, P84, DOI 10.1034/j.1399-3003.1999.14a15.x; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kay AB, 2004, TRENDS IMMUNOL, V25, P477, DOI 10.1016/j.it.2004.07.006; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kwilas S, 2009, J VIROL, V83, P10710, DOI 10.1128/JVI.00986-09; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; Matthys P, 1997, NUTRITION, V13, P763, DOI 10.1016/S0899-9007(97)00185-8; Morrey JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038672; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Rutigliano JA, 2004, J IMMUNOL, V173, P3408, DOI 10.4049/jimmunol.173.5.3408; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Seki E, 2013, CELL BIOL INT; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; SPRY CJF, 1989, SPRINGER SEMIN IMMUN, V11, P471; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Szefler S, 2000, NEW ENGL J MED, V343, P1054; TAI PC, 1987, LANCET, V1, P643; Tanaka H, 2004, AM J RESP CELL MOL, V31, P62, DOI 10.1165/rcmb.2003-0305OC; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Waris ME, 1996, J VIROL, V70, P2852; WEIBEL RE, 1967, AM REV RESPIR DIS, V96, P724; Weiss KA, 2011, J IMMUNOL, V187, P3145, DOI 10.4049/jimmunol.1100764; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656",60,41,43,1,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004757,10.1371/journal.ppat.1004757,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900068,25769044.0,"DOAJ Gold, Green Published",,,16/08/2019,43,8,48,6196,1241,841,400,4955,3939,24,992,48,0,0,2,43,43,0,,73,4,73,0,4,45,45,25,29,0,0,0,0,0,0,0,8,2,6224,15,0,46,124,0,4939,1241,15,0,46,124,0,44,,0,0,0,0,5,0,1,1,1,0,0,72,0,0,4.25,4.992747784045125,1.2504540867810292,0.25045408678102926,1.2841574167507568,1.026952872821175,5.127316680096696
86,J,"Kruger, P; Saffarzadeh, M; Weber, ANR; Rieber, N; Radsak, M; von Bernuth, H; Benarafa, C; Roos, D; Skokowa, J; Hartl, D",,,,"Kruger, Philipp; Saffarzadeh, Mona; Weber, Alexander N. R.; Rieber, Nikolaus; Radsak, Markus; von Bernuth, Horst; Benarafa, Charaf; Roos, Dirk; Skokowa, Julia; Hartl, Dominik",,,"Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury",PLOS PATHOGENS,,,English,Review,,,,,,,LEUKOCYTE-ADHESION-DEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; EXTRACELLULAR TRAP FORMATION; SEVERE CONGENITAL NEUTROPENIA; GDP-FUCOSE TRANSPORTER; HEMATOLOGICALLY IMPORTANT MUTATIONS; PYOGENIC BACTERIAL-INFECTIONS; UNFOLDED PROTEIN RESPONSE; CYSTIC-FIBROSIS AIRWAYS; ACUTE LUNG INJURY,"Neutrophils, the most abundant human immune cells, are rapidly recruited to sites of infection, where they fulfill their life-saving antimicrobial functions. While traditionally regarded as short-lived phagocytes, recent findings on long-term survival, neutrophil extracellular trap (NET) formation, heterogeneity and plasticity, suppressive functions, and tissue injury have expanded our understanding of their diverse role in infection and inflammation. This review summarises our current understanding of neutrophils in host-pathogen interactions and disease involvement, illustrating the versatility and plasticity of the neutrophil, moving between host defence, immune modulation, and tissue damage.","[Kruger, Philipp] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Saffarzadeh, Mona] Univ Med Ctr Mainz, CTH, Mainz, Germany; [Weber, Alexander N. R.] Univ Tubingen, Dept Immunol, Inst Cell Biol, Tubingen, Germany; [Rieber, Nikolaus; Hartl, Dominik] Univ Tubingen, Dept Pediat 1, Tubingen, Germany; [Radsak, Markus] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med 3, D-55122 Mainz, Germany; [von Bernuth, Horst] Humboldt Univ, Charite Hosp, Dept Pediat Pneumol & Immunol, D-10099 Berlin, Germany; [von Bernuth, Horst] Labor Berlin Charite Vivantes GmbH, Fachbereich Immunol, Berlin, Germany; [Benarafa, Charaf] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Roos, Dirk] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Skokowa, Julia] Univ Tubingen, Dept Internal Med 2, Tubingen, Germany","Kruger, P (reprint author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.",dominik.hartl@med.uni-tuebingen.de,"Radsak, Markus/L-3651-2013","Radsak, Markus/0000-0002-3991-5721; Benarafa, Charaf/0000-0002-2049-7769; Weber, Alexander/0000-0002-8627-7056",German Research Foundation (DFG) [HA 5274/3-1];  [CRC/SFB685],"This work was supported by the German Research Foundation (DFG, Emmy Noether Programme HA 5274/3-1 to DH) and the CRC/SFB685 at Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Accetta D, 2011, J ALLERGY CLIN IMMUN, V127, P535, DOI 10.1016/j.jaci.2010.10.013; Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; ANDERSON DC, 1984, J CLIN INVEST, V74, P536, DOI 10.1172/JCI111451; Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Baumann M, 2013, BLOOD, V121, P3900, DOI 10.1182/blood-2012-09-455022; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Benarafa C, 2011, J LEUKOCYTE BIOL, V90, P21, DOI 10.1189/jlb.0810461; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bouma G, 2009, BRIT J HAEMATOL, V147, P153, DOI 10.1111/j.1365-2141.2009.07838.x; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Bugl S, 2013, BLOOD, V121, P723, DOI 10.1182/blood-2012-05-429589; Byrd AS, 2013, J IMMUNOL, V190, P4136, DOI 10.4049/jimmunol.1202671; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cerutti A, 2013, J LEUKOCYTE BIOL, V94, P677, DOI 10.1189/jlb.1112596; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; Dale DC, 2000, BLOOD, V96, P2317; Davidson BA, 2013, J IMMUNOL, V190, P1714, DOI 10.4049/jimmunol.1202410; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Dyugovskaya L, 2014, J LEUKOCYTE BIOL, V96, P511, DOI 10.1189/jlb.0813437; Enders A, 2004, J PEDIATR-US, V145, P698, DOI 10.1016/j.jpeds.2004.06.065; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Etzioni A, 2002, AM J MED GENET, V110, P131, DOI 10.1002/ajmg.10423; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Gargano LM, 2014, ANNU REV PUBL HEALTH, V35, P65, DOI 10.1146/annurev-publhealth-032013-182426; Geng S, 2013, BLOOD, V121, P1690, DOI 10.1182/blood-2012-07-445197; Gerber CE, 2001, BLOOD, V98, P3097, DOI 10.1182/blood.V98.10.3097; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Gong DP, 2011, J INFECT DIS, V204, P592, DOI 10.1093/infdis/jir352; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Gulino AV, 2004, BLOOD, V104, P444, DOI 10.1182/blood-2003-10-3532; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Harding MG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004379; Harris ES, 2013, CURR OPIN HEMATOL, V20, P16, DOI 10.1097/MOH.0b013e32835a0091; Harris ES, 2012, AM J HEMATOL, V87, P311, DOI 10.1002/ajh.22253; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Helmus Y, 2006, BLOOD, V107, P3959, DOI 10.1182/blood-2005-08-3334; Hibbs ML, 2007, J IMMUNOL, V178, P6435, DOI 10.4049/jimmunol.178.10.6435; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Hunter D, 2014, J ALLERGY CLIN IMMUN, V133, P901, DOI 10.1016/j.jaci.2013.09.035; Iking-Konert C, 2005, ANN RHEUM DIS, V64, P1436, DOI 10.1136/ard.2004.034132; Jakob SM, 2013, BLOOD, V121, P4184, DOI 10.1182/blood-2012-08-451385; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Jones LBKR, 2008, CLIN EXP IMMUNOL, V152, P211, DOI 10.1111/j.1365-2249.2008.03644.x; Kanther M, 2014, CELL MICROBIOL, V16, P1053, DOI 10.1111/cmi.12257; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Koffel R, 2014, BLOOD, V124, P2713, DOI 10.1182/blood-2014-07-588178; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Koker MY, 2013, J ALLERGY CLIN IMMUN; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kuijpers TW, 2007, BLOOD, V109, P3529, DOI 10.1182/blood-2006-05-021402; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Kuijpers TW, 1997, J CLIN INVEST, V100, P1725, DOI 10.1172/JCI119697; Laval J, 2013, J IMMUNOL, V190, P6043, DOI 10.4049/jimmunol.1201755; Lazaar AL, 2011, BRIT J CLIN PHARMACO, V72, P282, DOI 10.1111/j.1365-2125.2011.03968.x; Leaker BR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-137; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Loison F, 2014, J CLIN INVEST, V124, P4445, DOI 10.1172/JCI76246; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/88289; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mathew EC, 2000, CLIN EXP IMMUNOL, V121, P133, DOI 10.1046/j.1365-2249.2000.01277.x; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Mihalache CC, 2012, EXP CELL RES, V318, P1187, DOI 10.1016/j.yexcr.2011.12.021; Mitroulis I, 2010, EUR J IMMUNOL, V40, P1461, DOI 10.1002/eji.200940025; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moraes TJ, 2006, CURR OPIN HEMATOL, V13, P21, DOI 10.1097/01.moh.0000190113.31027.d5; Moss RB, 2013, J CYST FIBROS, V12, P241, DOI 10.1016/j.jcf.2012.08.016; Moutsopoulos NM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007696; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nagelkerke SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088377; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Nakamura H, 2012, EXP BIOL MED, V237, P703, DOI 10.1258/ebm.2012.011360; OHKUBO T, 1990, SCAND J IMMUNOL, V32, P727, DOI 10.1111/j.1365-3083.1990.tb03216.x; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Peschel A, 2012, NAT MED, V18, P1336, DOI 10.1038/nm.2918; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Pliyev BK, 2011, CELL IMMUNOL, V271, P214, DOI 10.1016/j.cellimm.2011.08.020; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Ribeiro-Gomes FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002536; Roos D, 2002, EXP HEMATOL, V30, P252, DOI 10.1016/S0301-472X(01)00782-2; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; Roos D, 2010, BLOOD CELL MOL DIS, V44, P291, DOI 10.1016/j.bcmd.2010.01.009; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; Rozman S, 2014, CELL DEATH DIFFER; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Schauer C, 2014, NAT MED, V20, P515, DOI 10.1038/nm.3547; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI [10.1038/nrc3610, 10.1002/path.5047]; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shelef MA, 2013, IMMUNOL REV, V256, P269, DOI 10.1111/imr.12124; Singh A, 2009, J IMMUNOL, V182, P6410, DOI 10.4049/jimmunol.0802512; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2012, NAT MED, V18, P1550, DOI 10.1038/nm.2958; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; SPRINGER TA, 1984, J EXP MED, V160, P1901, DOI 10.1084/jem.160.6.1901; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Summers C, 2014, THORAX, V69, P623, DOI 10.1136/thoraxjnl-2013-204742; Summers C, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.241; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Sutherland TE, 2014, NAT IMMUNOL; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Tirouvanziam R, 2008, P NATL ACAD SCI USA, V105, P4335, DOI 10.1073/pnas.0712386105; Tofts PS, 2011, BLOOD, V117, P6050, DOI 10.1182/blood-2010-10-310532; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Turner SM, 2011, BLOOD, V117, P6052, DOI 10.1182/blood-2010-12-322271; van Bruggen R, 2010, J INNATE IMMUN, V2, P280, DOI 10.1159/000268288; van de Vijver E, 2012, BLOOD, V119, P583, DOI 10.1182/blood-2011-02-337188; van de Vijver E, 2012, BLOOD CELL MOL DIS, V48, P53, DOI 10.1016/j.bcmd.2011.10.004; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Virtala R, 2012, CLIN EXP ALLERGY, V42, P590, DOI 10.1111/j.1365-2222.2011.03921.x; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Weckbach LT, 2014, BLOOD, V123, P1887, DOI 10.1182/blood-2013-06-510875; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96",210,202,205,7,77,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004651,10.1371/journal.ppat.1004651,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900003,25764063.0,"DOAJ Gold, Green Published",,,16/08/2019,202,142,302,30401,7400,5586,1814,23001,15341,86,7574,301,0,0,0,176,176,2,,440,7,436,2,7,206,206,195,109,0,0,0,0,0,0,0,141,4,30891,53,13,859,296,2,23326,7476,53,13,859,296,2,89,,0,0,0,0,12,0,2,1,0,0,0,442,1,0,6.6,4.108243243243243,1.3217251423851137,0.3217251423851137,1.3582018173122907,1.0275977763889346,4.221621621621622
87,J,"Longdon, B; Hadfield, JD; Day, JP; Smith, SCL; McGonigle, JE; Cogni, R; Cao, C; Jiggins, FM",,,,"Longdon, Ben; Hadfield, Jarrod D.; Day, Jonathan P.; Smith, Sophia C. L.; McGonigle, John E.; Cogni, Rodrigo; Cao, Chuan; Jiggins, Francis M.",,,The Causes and Consequences of Changes in Virulence following Pathogen Host Shifts,PLOS PATHOGENS,,,English,Article,,,,,,,EMERGING INFECTIOUS-DISEASES; PROTEIN-CODING SEQUENCES; DROSOPHILA-MELANOGASTER; MOLECULAR PHYLOGENY; ANTIVIRAL IMMUNITY; EBOLA-VIRUS; NIPAH VIRUS; C VIRUS; EVOLUTION; PARASITE,"Emerging infectious diseases are often the result of a host shift, where the pathogen originates from a different host species. Virulence-the harm a pathogen does to its host-can be extremely high following a host shift (for example Ebola, HIV, and SARs), while other host shifts may go undetected as they cause few symptoms in the new host. Here we examine how virulence varies across host species by carrying out a large cross infection experiment using 48 species of Drosophilidae and an RNA virus. Host shifts resulted in dramatic variation in virulence, with benign infections in some species and rapid death in others. The change in virulence was highly predictable from the host phylogeny, with hosts clustering together in distinct clades displaying high or low virulence. High levels of virulence are associated with high viral loads, and this may determine the transmission rate of the virus.","[Longdon, Ben; Day, Jonathan P.; Smith, Sophia C. L.; McGonigle, John E.; Cogni, Rodrigo; Cao, Chuan; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Hadfield, Jarrod D.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Cogni, Rodrigo] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil","Longdon, B (reprint author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.",b.longdon@gen.cam.ac.uk,"Longdon, Ben/F-4132-2010; Cogni, Rodrigo/C-3962-2016","Longdon, Ben/0000-0001-6936-1697; Cogni, Rodrigo/0000-0001-9907-9297; Jiggins, Francis Michael/0000-0001-7470-8157; Bayley, Sophie/0000-0003-3928-4760; Cao, Chuan/0000-0002-0320-1110","NERC [NE/L004232/1]; European Research Council [281668]; Christ's College, Cambridge; Royal Society University Research Fellowship; Natural Environment Research Council [NE/L004232/1]","BL and FMJ are supported by a NERC grant (NE/L004232/1), a European Research Council grant (281668, DrosophilaInfection), a Junior Research Fellowship from Christ's College, Cambridge (BL) and a Royal Society University Research Fellowship (FMJ). JDH is supported by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aalen OO, 2008, STAT BIOL HEALTH, P1; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Anderson R. M., 1991, INFECT DIS HUMANS DY; Andre JB, 2005, EVOLUTION, V59, P1406; Antonovics J, 2013, EVOLUTION, V67, P1, DOI 10.1111/j.1558-5646.2012.01793.x; Arnold PA, 2013, J EXP BIOL, V216, P3350, DOI 10.1242/jeb.088138; BENNETT S, 1983, J R STAT SOC C-APPL, V32, P165; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Christian PD, 1987, STUDIES DROSOPHILA V; Chtarbanova S, 2011, TISSUE SPECIFIC PATH; Chtarbanova S, 2014, J VIROL, V88, P14057, DOI 10.1128/JVI.02320-14; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; de Roode JC, 2008, P NATL ACAD SCI USA, V105, P7489, DOI 10.1073/pnas.0710909105; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Ebert D., 2008, EVOLUTION HLTH DIS, P153; Engelstadter J, 2006, EVOL ECOL, V20, P603, DOI 10.1007/s10682-006-9120-1; Faria NR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0196; FENNER F, 1965, MYXOMATOSIS; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Frank SA, 2008, J EVOLUTION BIOL, V21, P396, DOI 10.1111/j.1420-9101.2007.01480.x; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilchrist GW, 2001, GENETICA, V112, P273, DOI 10.1023/A:1013358931816; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Housworth EA, 2004, AM NAT, V163, P84, DOI 10.1086/380570; Huey RB, 2006, ZOOLOGY, V109, P318, DOI 10.1016/j.zool.2006.04.003; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; JOUSSET FX, 1976, ANN INST PASTEUR MIC, VA127, P529; JOUSSET FX, 1972, CR ACAD SCI D NAT, V275, P3043; Kapun M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012421; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Longdon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073833; Longdon B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002260; LYNCH M, 1991, EVOLUTION, V45, P1065, DOI 10.1111/j.1558-5646.1991.tb04375.x; Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057; Margolis E., 2008, INTRO EVOLUTIONARY B; MARSHALL I. D., 1958, JOUR HYGIENE, V56, P288; Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perlman SJ, 2003, EVOLUTION, V57, P544; Rambaut A, 2011, FIGTREE V1; Rambaut A, 2007, TRACER V14; Rasband W. S., 1997, IMAGEJ; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Salazar-Jaramillo L, 2014, GENOME BIOL EVOLUTIO; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SOKOLOFF A, 1966, EVOLUTION, V20, P49, DOI 10.1111/j.1558-5646.1966.tb03342.x; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Sullivan W, 2000, DROSOPHILA PROTOCOLS; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Tinsley MC, 2007, BMC EVOLUTIONARY BIO, V7; TOFT CA, 1990, TRENDS ECOL EVOL, V5, P326, DOI 10.1016/0169-5347(90)90179-H; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; Vale PF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1145; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; van Mierlo JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004256; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Waxman D, 2014, AM NAT, V184, P65, DOI 10.1086/676589; Weiss RA, 2002, TRENDS MICROBIOL, V10, P314, DOI 10.1016/S0966-842X(02)02391-0; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324",83,34,34,0,40,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004728,10.1371/journal.ppat.1004728,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900047,25774803.0,"DOAJ Gold, Green Published",,,16/08/2019,24,143,128,12015,3910,3613,297,8105,6666,29,1410,127,12,0,0,30,30,4,,331,5,168,1,5,31,31,25,24,0,1,0,0,1,0,1,129,23,12261,44,110,149,172,0,8137,4051,44,109,149,172,0,73,,4,2,0,0,62,0,5,1,0,1,0,167,1,0,80.3,3.0728900255754477,1.4824182603331277,0.4824182603331277,1.5394201110425663,1.0384519350811485,3.191048593350384
88,J,"Moon, SL; Blackinton, JG; Anderson, JR; Dozier, MK; Dodd, BJT; Keene, JD; Wilusz, CJ; Bradrick, SS; Wilusz, J",,,,"Moon, Stephanie L.; Blackinton, Jeffrey G.; Anderson, John R.; Dozier, Mary K.; Dodd, Benjamin J. T.; Keene, Jack D.; Wilusz, Carol J.; Bradrick, Shelton S.; Wilusz, Jeffrey",,,XRN1 Stalling in the 5 ' UTR of Hepatitis C Virus and Bovine Viral Diarrhea Virus Is Associated with Dysregulated Host mRNA Stability,PLOS PATHOGENS,,,English,Article,,,,,,,SUBGENOMIC FLAVIVIRUS RNA; GENE-EXPRESSION; NONCODING RNA; LIFE-CYCLE; TRANSLATION INITIATION; 3'-UNTRANSLATED REGION; EXORIBONUCLEASE XRN1; PROCESSING BODIES; REPLICATION; MIR-122,"We demonstrate that both Hepatitis C virus (HCV) and Bovine Viral Diarrhea virus (BVDV) contain regions in their 5' UTRs that stall and repress the enzymatic activity of the cellular 5'-3' exoribonuclease XRN1, resulting in dramatic changes in the stability of cellular mRNAs. We used biochemical assays, virus infections, and transfection of the HCV and BVDV 5' untranslated regions in the absence of other viral gene products to directly demonstrate the existence and mechanism of this novel host-virus interaction. In the context of HCV infection, we observed globally increased stability of mRNAs resulting in significant increases in abundance of normally short-lived mRNAs encoding a variety of relevant oncogenes and angiogenesis factors. These findings suggest that non-coding regions from multiple genera of the Flaviviridae interfere with XRN1 and impact post-transcriptional processes, causing global dysregulation of cellular gene expression which may promote cell growth and pathogenesis.","[Moon, Stephanie L.; Anderson, John R.; Dozier, Mary K.; Dodd, Benjamin J. T.; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Blackinton, Jeffrey G.; Keene, Jack D.; Bradrick, Shelton S.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA","Moon, SL (reprint author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.",jeffrey.wilusz@colostate.edu,", Jack/L-6806-2019; Wilusz, Carol/F-7241-2017","Moon, Stephanie/0000-0002-4989-0150","United States Department of Agriculture NIFA NNF [2010-38420-20367]; Boehringer Ingelheim Vetmedica, Inc.; National Institutes of Health (NIH) [5-K01-DK082613]; National Science Foundation [0842621]; NIH [R01CA157268]; National Institute of Allergy and Infectious Diseases/the Rocky Mountain Regional Center of Excellence [U54 AI-065357]","This work was supported by the following grant awards: SLM (United States Department of Agriculture NIFA NNF 2010-38420-20367), MKD (Boehringer Ingelheim Vetmedica, Inc. Student Bovine Research Assistantship), SSB (National Institutes of Health (NIH) 5-K01-DK082613), JDK (National Science Foundation 0842621 and NIH R01CA157268) and JW (National Institute of Allergy and Infectious Diseases/the Rocky Mountain Regional Center of Excellence (U54 AI-065357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bai Y, 2013, NUCLEIC ACIDS RES, V41, P7861, DOI 10.1093/nar/gkt543; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Braun JE, 2012, NAT STRUCT MOL BIOL, V19, P1324, DOI 10.1038/nsmb.2413; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Bung C, 2010, FEBS LETT, V584, P837, DOI 10.1016/j.febslet.2010.01.015; Cacace F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002772; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Cheadle C, 2005, ANN NY ACAD SCI, V1058, P196, DOI 10.1196/annals.1359.026; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Cox EM, 2013, RNA, V19, P1825, DOI 10.1261/rna.040865.113; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Grassmann CW, 2005, VIROLOGY, V333, P349, DOI 10.1016/j.virol.2005.01.007; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kumar A, 2013, J VIROL, V87, P6713, DOI 10.1128/JVI.00525-13; LAM LT, 2001, GENOME BIOL, V2; Li Y, 2013, RNA BIOL, V10, P919, DOI 10.4161/rna.25137; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Medina DA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00001; Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Mortimer SA, 2013, NUCLEIC ACIDS RES, V41, P4230, DOI 10.1093/nar/gkt075; Muhlemann O, 2012, TRENDS GENET, V28, P70, DOI 10.1016/j.tig.2011.11.001; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Niepmann M, 2013, CURR TOP MICROBIOL, V369, P143, DOI 10.1007/978-3-642-27340-7_6; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027; Payne TL, 2014, J VIROL; Perez-Vilaro G, 2012, J VIROL, V86, P8740, DOI 10.1128/JVI.07167-11; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pijlman GP, 2014, CURR OPIN VIROL, V7, P55, DOI 10.1016/j.coviro.2014.04.002; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Reis FP, 2013, WIRES RNA, V4, P607, DOI 10.1002/wrna.1180; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sedano CD, 2014, CELL HOST MICROBE, V16, P257, DOI 10.1016/j.chom.2014.07.006; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Thibault PA, 2013, VIROLOGY, V436, P179, DOI 10.1016/j.virol.2012.11.007; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wilson JA, 2013, WIRES RNA, V4, P665, DOI 10.1002/wrna.1186; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003; Zhang KB, 2002, GENE, V298, P121, DOI 10.1016/S0378-1119(02)00929-0",65,38,38,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004708,10.1371/journal.ppat.1004708,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900036,25747802.0,"DOAJ Gold, Green Published",,,16/08/2019,38,17,46,5504,1213,872,341,4291,3523,19,749,46,8,0,0,37,37,0,,144,8,72,0,8,42,39,42,27,0,0,0,0,0,0,0,9,2,5580,60,0,78,70,0,4313,1223,60,0,78,70,0,44,,0,0,0,0,11,0,1,1,0,0,0,78,0,0,6.55,4.537510305028854,1.28268468888371,0.28268468888371007,1.3306921463528316,1.0374273255813953,4.707337180544106
89,J,"Moreira, D; Rodrigues, V; Abengozar, M; Rivas, L; Rial, E; Laforge, M; Li, XL; Foretz, M; Viollet, B; Estaquier, J; da Silva, AC; Silvestre, R",,,,"Moreira, Diana; Rodrigues, Vasco; Abengozar, Maria; Rivas, Luis; Rial, Eduardo; Laforge, Mireille; Li, Xiaoling; Foretz, Marc; Viollet, Benoit; Estaquier, Jerome; da Silva, Anabela Cordeiro; Silvestre, Ricardo",,,Leishmania infantum Modulates Host Macrophage Mitochondrial Metabolism by Hijacking the SIRT1-AMPK Axis,PLOS PATHOGENS,,,English,Article,,,,,,,ACTIVATED PROTEIN-KINASE; INFECTED MACROPHAGES; UPSTREAM KINASE; DENDRITIC CELLS; AMPK; PGC-1-ALPHA; HOMEOSTASIS; REPRESSION; ADAPTATION; CYTOKINE,"Metabolic manipulation of host cells by intracellular pathogens is currently recognized to play an important role in the pathology of infection. Nevertheless, little information is available regarding mitochondrial energy metabolism in Leishmania infected macrophages. Here, we demonstrate that during L. infantum infection, macrophages switch from an early glycolytic metabolism to an oxidative phosphorylation, and this metabolic deviation requires SIRT1 and LKB1/AMPK. SIRT1 or LBK1 deficient macrophages infected with L. infantum failed to activate AMPK and up-regulate its targets such as Slc2a4 and Ppargc1a, which are essential for parasite growth. As a result, impairment of metabolic switch caused by SIRT1 or AMPK deficiency reduces parasite load in vitro and in vivo. Overall, our work demonstrates the importance of SIRT1 and AMPK energetic sensors for parasite intracellular survival and proliferation, highlighting the modulation of these proteins as potential therapeutic targets for the treatment of leishmaniasis.","[Moreira, Diana; Rodrigues, Vasco; da Silva, Anabela Cordeiro; Silvestre, Ricardo] Univ Porto, IBMC, Parasite Dis Grp, P-4100 Oporto, Portugal; [Moreira, Diana; Rodrigues, Vasco; da Silva, Anabela Cordeiro; Silvestre, Ricardo] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Rodrigues, Vasco; Laforge, Mireille; Estaquier, Jerome] Univ Paris 05, CNRS, FRE 3636, Paris, France; [Abengozar, Maria; Rivas, Luis] CSIC, Ctr Invest Biol, UMIB, Madrid, Spain; [Rial, Eduardo] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain; [Li, Xiaoling] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, U1016, Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Estaquier, Jerome] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [da Silva, Anabela Cordeiro] Univ Porto, Fac Farm, Dept Ciencias Biol, P-4100 Oporto, Portugal","Moreira, D (reprint author), Univ Porto, IBMC, Parasite Dis Grp, Rua Campo Alegre 823, P-4100 Oporto, Portugal.",cordeiro@ibmc.up.pt; rleal@ibmc.up.pt,"Cordeiro-da-Silva, Anabela/J-7807-2013; Silvestre, Ricardo/C-7243-2011; Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017; Rial, Eduardo/A-4242-2008; Rivas, Luis/O-8657-2017; Li, Xiaoling/A-2994-2015","Cordeiro-da-Silva, Anabela/0000-0003-2392-6087; Silvestre, Ricardo/0000-0002-9270-2717; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Rial, Eduardo/0000-0001-8634-8902; Rivas, Luis/0000-0002-2958-3233; Abengozar Infantes, Maria de los Angeles/0000-0002-2432-3512; Rodrigues, Vasco/0000-0002-6014-321X; Moreira, Diana/0000-0001-5766-2820; Estaquier, Jerome/0000-0002-9432-8044; Li, Xiaoling/0000-0001-5920-7784","FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-011054 (PTDC/SAU-FCF/100749/2008), PTDC/BIA-MIC/118644/2010]; European Community [602773]; ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa-FEDER [RICET RD12/0018/0007]; Spanish Ministerio de Economia y Competitividad [SAF2010-20256]; ANR grant (LEISH-APO, France); Partenariat Hubert Curien (PHC) (program Volubilis) [MA/11/262]; Canada Research Chair programme; ANR; Programa Ciencia - Programa Operacional Potencial Humano POPH - QREN - Tipologia 4.2 - Promocao do Emprego Cientifico; Fundo Social Europeu and National funding from Ministry of Science, Technology and Higher Education (MCTES);  [SFRH/BD/91543/2012];  [SFRH/BD/64064/2009];  [PN de I+D+I 2008-2011];  [PI12-02706];  [VI PN de I+D+I 2008-2011]","This work was funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the project FCOMP-01-0124-FEDER-011054 (PTDC/SAU-FCF/100749/2008) and PTDC/BIA-MIC/118644/2010. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under grant agreement No. 602773 (Project KINDRED). DM and VR were supported by SFRH/BD/91543/2012 and SFRH/BD/64064/2009, respectively. LR was supported by PN de I+D+I 2008-2011, PI12-02706 and VI PN de I+D+I 2008-2011, ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa-FEDER (RICET RD12/0018/0007). ER was supported by a project grant of the Spanish Ministerio de Economia y Competitividad (SAF2010-20256). JE was supported by an ANR grant (LEISH-APO, France) and a Partenariat Hubert Curien (PHC) (program Volubilis, MA/11/262). JE is also supported by the Canada Research Chair programme. ML was supported by a fellowship from ANR. RS was supported by Programa Ciencia financed by Programa Operacional Potencial Humano POPH - QREN - Tipologia 4.2 - Promocao do Emprego Cientifico, co-funded by Fundo Social Europeu and National funding from Ministry of Science, Technology and Higher Education (MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Brunton J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003552; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Caradonna KL, 2013, CELL HOST MICROBE, V13, P108, DOI 10.1016/j.chom.2012.11.011; Carvalho LP, 2008, J IMMUNOL, V181, P6473, DOI 10.4049/jimmunol.181.9.6473; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cronemberger-Andrade A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003161; Cunha J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-122; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Hassani K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002185; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Mankouri J, 2011, REV MED VIROL, V21, P205, DOI 10.1002/rmv.687; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moreira D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001469; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Resende LA, 2013, VET PARASITOL, V198, P371, DOI 10.1016/j.vetpar.2013.09.011; Resende M, 2013, J IMMUNOL, V191, P262, DOI 10.4049/jimmunol.1203518; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rodrigues V, 2012, CELL MICROBIOL, V14, P325, DOI 10.1111/j.1462-5822.2011.01737.x; Rodrigues V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002567; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sajic T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02350; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Santarem N, 2013, J PROTEOMICS, V84, P106, DOI 10.1016/j.jprot.2013.03.012; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Shio MT, 2012, J TROP MED, DOI 10.1155/2012/819512; SMITH SM, 1975, INFECT IMMUN, V12, P993; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436",48,25,25,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004684,10.1371/journal.ppat.1004684,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900016,25738568.0,"DOAJ Gold, Green Published",,,16/08/2019,27,6,63,7257,1589,1163,426,5668,4384,21,1263,63,6,0,0,22,22,1,,82,0,82,0,0,29,28,29,15,0,0,0,0,0,0,0,0,2,7256,128,0,422,87,2,5645,1589,128,0,422,87,2,22,,0,0,0,0,5,0,0,1,0,0,0,80,0,0,2.25,4.567023285084959,1.2803458009880029,0.2803458009880028,1.3181016231474947,1.0294887694639658,4.7016991818753935
90,J,"Moutsopoulos, NM; Chalmers, NI; Barb, JJ; Abusleme, L; Greenwell-Wild, T; Dutzan, N; Paster, BJ; Munson, PJ; Fine, DH; Uzel, G; Holland, SM",,,,"Moutsopoulos, Niki M.; Chalmers, Natalia I.; Barb, Jennifer J.; Abusleme, Loreto; Greenwell-Wild, Teresa; Dutzan, Nicolas; Paster, Bruce J.; Munson, Peter J.; Fine, Daniel H.; Uzel, Gulbu; Holland, Steven M.",,,Subgingival Microbial Communities in Leukocyte Adhesion Deficiency and Their Relationship with Local Immunopathology,PLOS PATHOGENS,,,English,Article,,,,,,,AGGRESSIVE PERIODONTITIS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; IDENTIFICATION MICROARRAY; PORPHYROMONAS-GINGIVALIS; REFRACTORY PERIODONTITIS; INFECTION; INFLAMMATION; RESPONSES; CHILDREN; HEALTH,"Leukocyte Adhesion Deficiency I (LAD-I) is a primary immunodeficiency caused by single gene mutations in the CD18 subunit of beta 2 integrins which result in defective transmigration of neutrophils into the tissues. Affected patients suffer from recurrent life threatening infections and severe oral disease (periodontitis). Microbial communities in the local environment (subgingival plaque) are thought to be the triggers for inflammatory periodontitis, yet little is known regarding the microbial communities associated with LAD-I periodontitis. Here we present the first comprehensive characterization of the subgingival communities in LAD-I, using a 16S rRNA gene-based microarray, and investigate the relationship of this tooth adherent microbiome to the local immunopathology of periodontitis. We show that the LAD subgingival microbiome is distinct from that of health and Localized Aggressive Periodontitits. Select periodontitis-associated species in the LAD microbiome included Parvimonas micra, Porphyromonas endodontalis, Eubacterium brachy and Treponema species. Pseudomonas aeruginosa, a bacterium not typically found in subgingival plaque is detected in LAD-I. We suggest that microbial products from LAD-associated communities may have a role in stimulating the local inflammatory response. We demonstrate that bacterial LPS translocates into the lesions of LAD-periodontitis potentially triggering immunopathology. We also show in in vitro assays with human macrophages and in vivo in animal models that microbial products from LAD-associated subgingival plaque trigger IL-23-related immune responses, which have been shown to dominate in patient lesions. In conclusion, our current study characterizes the subgingival microbial communities in LAD-periodontitis and supports their role as triggers of disease pathogenesis.","[Moutsopoulos, Niki M.; Abusleme, Loreto; Greenwell-Wild, Teresa; Dutzan, Nicolas] Natl Inst Dent & Craniofacial Res, Oral Immun & Inflammat Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Chalmers, Natalia I.] Natl Inst Dent & Craniofacial Res, Clin Res Core, NIH, Bethesda, MD USA; [Barb, Jennifer J.; Munson, Peter J.] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; [Paster, Bruce J.] Forsyth Inst, Cambridge, MA USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Fine, Daniel H.] Rutgers State Univ, Rutgers Sch Dent Med, Newark, NJ 07102 USA; [Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA","Moutsopoulos, NM (reprint author), Natl Inst Dent & Craniofacial Res, Oral Immun & Inflammat Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.",nmoutsop@mail.nih.gov,"Moutsopoulos, Niki/A-9538-2019; Dutzan, Nicolas/I-8838-2019","Moutsopoulos, Niki/0000-0002-7365-6735; Dutzan, Nicolas/0000-0001-8343-0214",Intramural Research Program of the NIH; National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Allergy and Infectious Diseases (NIAID),"This research was supported in part by the Intramural Research Program of the NIH, National Institute of Dental and Craniofacial Research (NIDCR) and National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; [Anonymous], 2000, J Periodontol, V71, P847; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Colombo APV, 2012, J PERIODONTOL, V83, P1279, DOI 10.1902/jop.2012.110566; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Couturier MR, 2012, J CLIN MICROBIOL, V50, P1228, DOI 10.1128/JCM.05926-11; Cox DP, 2008, ORAL SURG ORAL MED O, V105, P86, DOI 10.1016/j.tripleo.2007.02.026; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gerald L., 2009, MANDELL DOUGLAS BENN, DOI [10.1056/NEJMoa1304839.Two, DOI 10.1056/NEJMOA1304839.TWO]; Hajishengallis E, 2014, J DENT RES, V93, P231, DOI 10.1177/0022034513507956; Hajishengallis G., 2014, MOL ORAL MICROBIOL; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hanna S, 2012, ANN NY ACAD SCI, V1250, P50, DOI 10.1111/j.1749-6632.2011.06389.x; Hanna S, 2011, J ALLERGY CLIN IMMUN, V127, P1433, DOI 10.1016/j.jaci.2011.03.026; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Hasturk H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00118; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Kristoff J, 2014, J CLIN INVEST, V124, P2802, DOI 10.1172/JCI75090; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Majorana A, 1999, ORAL SURG ORAL MED O, V87, P691, DOI 10.1016/S1079-2104(99)70162-9; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Mellouli F, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-10; Moutsopoulos NM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007696; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Nares S, 2009, AM J PATHOL, V174, P1400, DOI 10.2353/ajpath.2009.080677; REIG M, 1985, J CLIN MICROBIOL, V22, P320; ROBERTS M W, 1990, Pediatric Dentistry, V12, P107; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; TAYLOR RD, 1966, AM J CLIN PATHOL, V46, P472; Uzel G, 2008, BLOOD, V111, P209, DOI 10.1182/blood-2007-04-082552",47,31,31,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004698,10.1371/journal.ppat.1004698,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900027,25741691.0,"DOAJ Gold, Green Published",,,16/08/2019,28,6,28,4248,1088,778,310,3160,2537,19,604,28,6,0,0,30,30,0,,37,3,37,0,3,29,29,23,24,0,0,0,0,0,0,0,0,0,4286,57,0,40,153,1,3151,1088,57,0,40,153,1,47,,0,0,0,0,10,0,0,1,0,0,0,37,0,0,5.6,3.9044117647058822,1.3443037974683545,0.34430379746835443,1.4227848101265823,1.0583804143126176,4.132352941176471
91,J,"Perez-Mazliah, D; Ng, DHL; do Rosario, APF; McLaughlin, S; Mastelic-Gavillet, B; Sodenkamp, J; Kushinga, G; Langhorne, J",,,,"Perez-Mazliah, Damian; Ng, Dorothy Hui Lin; Freitas do Rosario, Ana Paula; McLaughlin, Sarah; Mastelic-Gavillet, Beatris; Sodenkamp, Jan; Kushinga, Garikai; Langhorne, Jean",,,Disruption of IL-21 Signaling Affects T Cell-B Cell Interactions and Abrogates Protective Humoral Immunity to Malaria,PLOS PATHOGENS,,,English,Article,,,,,,,MEROZOITE SURFACE PROTEIN-1; FOLLICULAR-HELPER-CELLS; PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSES; ACQUIRED-IMMUNITY; INTERLEUKIN-21; RECEPTOR; MICE; DIFFERENTIATION; LYMPHOCYTES,"Interleukin-21 signaling is important for germinal center B-cell responses, isotype switching and generation of memory B cells. However, a role for IL-21 in antibody-mediated protection against pathogens has not been demonstrated. Here we show that IL-21 is produced by T follicular helper cells and co-expressed with IFN-gamma during an erythrocytic-stage malaria infection of Plasmodium chabaudi in mice. Mice deficient either in IL-21 or the IL-21 receptor fail to resolve the chronic phase of P. chabaudi infection and P. yoelii infection resulting in sustained high parasitemias, and are not immune to re-infection. This is associated with abrogated P. chabaudi-specific IgG responses, including memory B cells. Mixed bone marrow chimeric mice, with T cells carrying a targeted disruption of the Il21 gene, or B cells with a targeted disruption of the Il21r gene, demonstrate that IL-21 from T cells signaling through the IL-21 receptor on B cells is necessary to control chronic P. chabaudi infection. Our data uncover a mechanism by which CD4+ T cells and B cells control parasitemia during chronic erythrocytic-stage malaria through a single gene, Il21, and demonstrate the importance of this cytokine in the control of pathogens by humoral immune responses. These data are highly pertinent for designing malaria vaccines requiring long-lasting protective B-cell responses.","[Perez-Mazliah, Damian; Ng, Dorothy Hui Lin; Freitas do Rosario, Ana Paula; McLaughlin, Sarah; Mastelic-Gavillet, Beatris; Sodenkamp, Jan; Kushinga, Garikai; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England","Perez-Mazliah, D (reprint author), Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England.",jlangho@nimr.mrc.ac.uk,,"Perez-Mazliah, Damian/0000-0002-2156-2585; Langhorne, Jean/0000-0002-2257-9733","Medical Research Council, United Kingdom [U117584248]; European Union [242095-EVIMalaR]; Medical Research Council [MC_U117584248]; The Francis Crick Institute [10101]","This work was supported by the Medical Research Council, United Kingdom (U117584248), and received funding from the European Union (FP7/2007-2013) under grant agreement 242095-EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Barker BR, 2010, EUR J IMMUNOL, V40, P3085, DOI 10.1002/eji.200939939; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Burns JM, 1997, INFECT IMMUN, V65, P3138; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Dorfmeier CL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002129; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kashiwakuma D, 2010, J IMMUNOL, V185, P2730, DOI 10.4049/jimmunol.0903839; King IL, 2010, J IMMUNOL, V185, P6138, DOI 10.4049/jimmunol.1001703; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Li C, 1999, INFECT IMMUN, V67, P4435; Li L, 2013, SCAND J IMMUNOL, V78, P439, DOI 10.1111/sji.12099; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085; Mewono L, 2008, EUR CYTOKINE NETW, V19, P30, DOI 10.1684/ecn.2008.0114; Mewono L, 2009, EXP PARASITOL, V122, P37, DOI 10.1016/j.exppara.2009.01.007; MOGIL RJ, 1987, J IMMUNOL, V138, P1933; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Phares TW, 2013, J NEUROIMMUNOL, V263, P43, DOI 10.1016/j.jneuroim.2013.07.019; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; PODOBA JE, 1991, INFECT IMMUN, V59, P51; Quin SJ, 2001, INFECT IMMUN, V69, P2245, DOI 10.1128/IAI.69.4.2245-2251.2001; Rankin AL, 2011, J IMMUNOL, V186, P667, DOI 10.4049/jimmunol.0903207; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Roetynck S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055195; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Stumhofer JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062889; SUSS G, 1988, INFECT IMMUN, V56, P3081; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; vonderWeid T, 1996, J IMMUNOL, V156, P2510; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Williams LD, 2011, J VIROL, V85, P2316, DOI 10.1128/JVI.01476-10; Yi JS, 2010, MICROBES INFECT, V12, P1111, DOI 10.1016/j.micinf.2010.08.008; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777",64,34,34,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004715,10.1371/journal.ppat.1004715,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900040,25763578.0,"DOAJ Gold, Green Published",,,16/08/2019,30,0,32,5174,990,708,282,4184,3312,33,839,32,0,0,0,32,32,1,,55,9,55,0,9,30,30,26,23,0,0,0,0,0,0,0,0,3,5178,21,0,281,111,2,4169,990,21,0,281,111,2,19,,0,0,0,0,2,0,0,1,0,0,0,55,0,0,0.75,5.226262626262626,1.2366156787762905,0.23661567877629064,1.2691204588910134,1.0262852725164282,5.363636363636363
92,J,"Price, AM; Luftig, MA",,,,"Price, Alexander M.; Luftig, Micah A.",,,To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis,PLOS PATHOGENS,,,English,Article,,,,,,,GENE-EXPRESSION; EARLY EVENTS; INFECTION; TRANSFORMATION; INHIBITION; LEUKOCYTES; OUTGROWTH; REVEALS; IMPOSES,"Epstein-Barr virus (EBV), a gamma-herpesvirus, was the first human tumor virus discovered fifty years ago in endemic Burkitt lymphoma [1]. Surprisingly, EBV was subsequently recognized to be a ubiquitous virus infecting greater than 90% of adults worldwide. In healthy children, primary EBV infection is typically asymptomatic because of a robust T cell immune response. However, infection during adolescence or later can result in infectious mononucleosis. Regardless of the severity of primary infection, EBV establishes a lifelong latent infection in the peripheral blood memory B cell compartment [2]. Immune suppression, genetic predisposition, or environmental factors can all serve to promote EBV-driven tumors, which are primarily of B cell, but also of epithelial and NK or T cell origin. Early studies demonstrated that EBV infection in vitro transformed resting B cells into immortalized lymphoblastoid cell lines (LCL), providing a strong link to EBV-associated B cell cancers [3,4]. These pioneering studies stimulated intense investigation over the ensuing decades into the viral requirements and temporal cascade of gene expression triggering physiological cell changes associated with B cell proliferation and survival. The model that emerged indicates that B cell transformation in vitro is a latent infection including expression of a discrete set of nine proteins and many noncoding RNAs collectively called Latency III [2]. In this model, all of the Latency III gene products are expressed prior to the first cell division in the absence of lytic virus replication. However, this in vitro model does not account for the viral gene expression programs found in most EBV-positive B cell tumors or in the B cell compartment in vivo following natural infection. Moreover, a recent resurgence in studies of the earliest events following B cell infection combined with an appreciation of the heterogeneity of EBV latent gene expression during natural infection and in tumors provides the rationale for revisiting how this ubiquitous virus establishes latency and causes B cell malignancies.","[Price, Alexander M.; Luftig, Micah A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Ctr Virol, Durham, NC 27708 USA","Price, AM (reprint author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Ctr Virol, Durham, NC 27708 USA.",,,,"NIH [R01 CA140337, 5P30 AI064518, T32 CA009111, F31 CA180451]; American Cancer Society [RSG-13-228-01-MPC]; Duke CFAR","This work was supported by NIH R01 CA140337 (MAL) and American Cancer Society grant RSG-13-228-01-MPC (MAL) as well as the Duke CFAR, an NIH funded program (5P30 AI064518). AMP was supported by the NIH training grant T32 CA009111 and, additionally, AMP was supported by NIH fellowship F31 CA180451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Brink AATP, 1997, J CLIN PATHOL, V50, P911, DOI 10.1136/jcp.50.11.911; Brooks JM, 2009, J IMMUNOL, V182, P1919, DOI 10.4049/jimmunol.0713607; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Cesarman E, 2014, ANNU REV PATHOL-MECH, V9, P349, DOI 10.1146/annurev-pathol-012513-104656; DOYLE MG, 1993, LEUKEMIA, V7, P1858; EPSTEIN MA, 1964, LANCET, V1, P702; Halder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007214; HENLE W, 1967, SCIENCE, V157, P1064, DOI 10.1126/science.157.3792.1064; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Kis LL, 2010, P NATL ACAD SCI USA, V107, P872, DOI 10.1073/pnas.0912920107; Klein E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23035; Longnecker R, 2013, FIELDS VIROLOGY, P1898; Ma SD, 2011, J VIROL, V85, P165, DOI 10.1128/JVI.01512-10; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; NIEDOBITEK G, 1989, HUM PATHOL, V20, P796, DOI 10.1016/0046-8177(89)90075-0; Nikitin PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087299; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; OUDEJANS JJ, 1995, AM J PATHOL, V147, P923; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; Price AM, 2014, ADV VIRUS RES, V88, P279, DOI 10.1016/B978-0-12-800098-4.00006-4; Price AM, 2012, J VIROL, V86, P11096, DOI 10.1128/JVI.01069-12; Staege MS, 2002, P NATL ACAD SCI USA, V99, P4550, DOI 10.1073/pnas.072495599; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Wen WR, 2007, J VIROL, V81, P1037, DOI 10.1128/JVI.01416-06; WOISETSCHLAEGER M, 1989, P NATL ACAD SCI USA, V86, P6498, DOI 10.1073/pnas.86.17.6498",30,27,27,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004656,10.1371/journal.ppat.1004656,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900006,25790223.0,"DOAJ Gold, Green Published",,,16/08/2019,27,34,37,5289,738,551,187,4551,3656,37,858,37,0,0,0,26,26,0,,48,3,48,0,3,29,29,18,20,0,0,0,0,0,0,0,34,2,5290,6,0,65,61,3,4529,738,6,0,65,61,3,23,,0,0,0,0,1,0,0,1,0,0,0,48,0,0,0.75,7.166666666666667,1.162162162162162,0.16216216216216217,1.177103933201494,1.012856872754774,7.2588075880758804
93,J,"Schulz, S; Eckweiler, D; Bielecka, A; Nicolai, T; Franke, R; Dotsch, A; Hornischer, K; Bruchmann, S; Duvel, J; Haussler, S",,,,"Schulz, Sebastian; Eckweiler, Denitsa; Bielecka, Agata; Nicolai, Tanja; Franke, Raimo; Doetsch, Andreas; Hornischer, Klaus; Bruchmann, Sebastian; Duevel, Juliane; Haeussler, Susanne",,,Elucidation of Sigma Factor-Associated Networks in Pseudomonas aeruginosa Reveals a Modular Architecture with Limited and Function-Specific Crosstalk,PLOS PATHOGENS,,,English,Article,,,,,,,ESCHERICHIA-COLI; RNA-POLYMERASE; REGULATORY NETWORKS; CYSTIC-FIBROSIS; TRANSCRIPTION INITIATION; ALGINATE BIOSYNTHESIS; BACTERIAL VIRULENCE; GENE-EXPRESSION; GENOME DATABASE; DNA-SEQUENCES,"Sigma factors are essential global regulators of transcription initiation in bacteria which confer promoter recognition specificity to the RNA polymerase core enzyme. They provide effective mechanisms for simultaneously regulating expression of large numbers of genes in response to challenging conditions, and their presence has been linked to bacterial virulence and pathogenicity. In this study, we constructed nine his-tagged sigma factor expressing and/or deletion mutant strains in the opportunistic pathogen Pseudomonas aeruginosa. To uncover the direct and indirect sigma factor regulons, we performed mRNA profiling, as well as chromatin immunoprecipitation coupled to high-throughput sequencing. We furthermore elucidated the de novo binding motif of each sigma factor, and validated the RNA-and ChIP-seq results by global motif searches in the proximity of transcriptional start sites (TSS). Our integrated approach revealed a highly modular network architecture which is composed of insulated functional sigma factor modules. Analysis of the interconnectivity of the various sigma factor networks uncovered a limited, but highly function-specific, crosstalk which orchestrates complex cellular processes. Our data indicate that the modular structure of sigma factor networks enables P. aeruginosa to function adequately in its environment and at the same time is exploited to build up higher-level functions by specific interconnections that are dominated by a participation of RpoN.","[Schulz, Sebastian; Eckweiler, Denitsa; Bielecka, Agata; Doetsch, Andreas; Hornischer, Klaus; Bruchmann, Sebastian; Duevel, Juliane; Haeussler, Susanne] TWINCORE GmbH, Ctr Clin & Expt Infect Res, Inst Mol Bacteriol, Hannover, Germany; [Schulz, Sebastian; Eckweiler, Denitsa; Bielecka, Agata; Nicolai, Tanja; Doetsch, Andreas; Hornischer, Klaus; Bruchmann, Sebastian; Duevel, Juliane; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Franke, Raimo] Helmholtz Ctr Infect Res, Dept Biol Chem, Braunschweig, Germany","Schulz, S (reprint author), TWINCORE GmbH, Ctr Clin & Expt Infect Res, Inst Mol Bacteriol, Hannover, Germany.",Susanne.Haeussler@helmholtz-hzi.de,"Haussler, Susanne/I-2605-2014; Eckweiler, Denitsa/I-9009-2019; Dotsch, Andreas/H-1383-2013","Haussler, Susanne/0000-0001-6141-9102; Eckweiler, Denitsa/0000-0002-3702-8846; Dotsch, Andreas/0000-0001-9086-2584; Bruchmann, Sebastian/0000-0001-8721-5386",ERC [RESISTOME 260276]; German Research Foundation [DFG SFB 900]; Federal Ministry of Education and Research [1616038C]; President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF) [VH-GS-202],"SH was supported by an ERC starter grant (RESISTOME 260276), the German Research Foundation (DFG SFB 900) and the Federal Ministry of Education and Research (1616038C). SS and SB were supported by the President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF) under contract number VH-GS-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARNOSTI DN, 1989, P NATL ACAD SCI USA, V86, P830, DOI 10.1073/pnas.86.3.830; Aronesty E., 2011, EA UTILS COMMAND LIN; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Blanka A, 2013, J BACTERIOL; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Crabbe A, 2010, ENVIRON MICROBIOL, V12, P1545, DOI 10.1111/j.1462-2920.2010.02184.x; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; DERETIC V, 1994, J BACTERIOL, V176, P2773; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Dotsch A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-29; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Estahbanati HK, 2002, BURNS, V28, P340, DOI 10.1016/S0305-4179(02)00024-4; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Goldberg J B, 2000, Trends Microbiol, V8, P55, DOI 10.1016/S0966-842X(99)01671-6; Goodman AL, 2004, CURR OPIN MICROBIOL, V7, P39, DOI 10.1016/j.mib.2003.12.009; Grainger DC, 2009, CURR OPIN MICROBIOL, V12, P531, DOI 10.1016/j.mib.2009.08.006; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; GUSSIN GN, 1986, ANNU REV GENET, V20, P567, DOI 10.1146/annurev.ge.20.120186.003031; Hartwell LH, 1999, NATURE; Hendrickson EL, 2000, J BACTERIOL, V182, P3498, DOI 10.1128/JB.182.12.3498-3507.2000; Hendrickson EL, 2001, J BACTERIOL, V183, P7126, DOI 10.1128/JB.183.24.7126-7134.2001; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hofmann N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019235; ISHIMOTO KS, 1989, P NATL ACAD SCI USA, V86, P1954, DOI 10.1073/pnas.86.6.1954; Rodriguez-Herva JJ, 2010, ENV MICROBIOL REP, V2, P373, DOI 10.1111/j.1758-2229.2009.00084.x; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; KOHLER T, 1989, J BACTERIOL, V171, P4326; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Llamas MA, 2006, J BACTERIOL, V188, P1882, DOI 10.1128/JB.188.5.1882-1891.2006; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; MARTIN DW, 1994, J BACTERIOL, V176, P6688; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; Qiu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2743; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sala C, 2009, CELL HOST MICROBE, V5, P430, DOI 10.1016/j.chom.2009.04.007; SCHURR MJ, 1995, J BACTERIOL, V177, P5670, DOI 10.1128/jb.177.19.5670-5679.1995; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Shankaranarayanan P, 2012, NAT PROTOC, V7, P328, DOI 10.1038/nprot.2011.447; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Slamti L, 2007, J BACTERIOL, V189, P351, DOI 10.1128/JB.01297-06; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stover CK, 2000, NATURE, V406, P959; Studholme DJ, 2000, FEMS MICROBIOL LETT, V186, P1; TOTTEN PA, 1990, J BACTERIOL, V172, P389; Vani K, 2006, J IMMUNOL METHODS, V317, P80, DOI 10.1016/j.jim.2006.09.009; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xiong YQ, 2000, J INFECT DIS, V181, P1020, DOI 10.1086/315338; YU H, 1995, J BACTERIOL, V177, P3259, DOI 10.1128/jb.177.11.3259-3268.1995; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao K, 2010, NUCLEIC ACIDS RES, V38, P1273, DOI 10.1093/nar/gkp1123",90,37,37,2,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004744,10.1371/journal.ppat.1004744,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900059,25780925.0,"DOAJ Gold, Green Published",,,16/08/2019,39,0,94,8919,1642,1274,368,7277,6091,30,1156,94,0,0,0,37,37,2,,124,2,124,0,2,46,40,46,25,0,0,0,0,0,0,0,0,6,8934,182,0,185,139,1,7249,1642,182,0,185,139,1,43,,3,0,0,0,9,0,1,1,0,0,0,124,0,0,28.0,5.431790499390987,1.2256424350693966,0.22564243506939674,1.2718153085062527,1.037672384796502,5.636419001218027
94,J,"Schwessinger, B; Bahar, O; Thomas, N; Holton, N; Nekrasov, V; Ruan, DL; Canlas, PE; Daudi, A; Petzold, CJ; Singan, VR; Kuo, R; Chovatia, M; Daum, C; Heazlewood, JL; Zipfel, C; Ronald, PC",,,,"Schwessinger, Benjamin; Bahar, Ofir; Thomas, Nicolas; Holton, Nicolas; Nekrasov, Vladimir; Ruan, Deling; Canlas, Patrick E.; Daudi, Arsalan; Petzold, Christopher J.; Singan, Vasanth R.; Kuo, Rita; Chovatia, Mansi; Daum, Christopher; Heazlewood, Joshua L.; Zipfel, Cyril; Ronald, Pamela C.",,,Transgenic Expression of the Dicotyledonous Pattern Recognition Receptor EFR in Rice Leads to Ligand-Dependent Activation of Defense Responses,PLOS PATHOGENS,,,English,Article,,,,,,,ORYZAE PV.-ORYZAE; DISEASE RESISTANCE GENE; KINASE-LIKE PROTEIN; ER QUALITY-CONTROL; INNATE IMMUNITY; ENDOPLASMIC-RETICULUM; BACTERIAL-BLIGHT; GENOME SEQUENCE; INTERFAMILY TRANSFER; PLANT,"Plant plasma membrane localized pattern recognition receptors (PRRs) detect extracellular pathogen-associated molecules. PRRs such as Arabidopsis EFR and rice XA21 are taxonomically restricted and are absent from most plant genomes. Here we show that rice plants expressing EFR or the chimeric receptor EFR:: XA21, containing the EFR ectodomain and the XA21 intracellular domain, sense both Escherichia coli-and Xanthomonas oryzae pv. oryzae (Xoo)-derived elf18 peptides at sub-nanomolar concentrations. Treatment of EFR and EFR:: XA21 rice leaf tissue with elf18 leads to MAP kinase activation, reactive oxygen production and defense gene expression. Although expression of EFR does not lead to robust enhanced resistance to fully virulent Xoo isolates, it does lead to quantitatively enhanced resistance to weakly virulent Xoo isolates. EFR interacts with OsSERK2 and the XA21 binding protein 24 (XB24), two key components of the rice XA21-mediated immune response. Rice-EFR plants silenced for OsSERK2, or overexpressing rice XB24 are compromised in elf18-induced reactive oxygen production and defense gene expression indicating that these proteins are also important for EFR-mediated signaling in transgenic rice. Taken together, our results demonstrate the potential feasibility of enhancing disease resistance in rice and possibly other monocotyledonous crop species by expression of dicotyledonous PRRs. Our results also suggest that Arabidopsis EFR utilizes at least a subset of the known endogenous rice XA21 signaling components.","[Schwessinger, Benjamin; Bahar, Ofir; Thomas, Nicolas; Ruan, Deling; Canlas, Patrick E.; Daudi, Arsalan; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Schwessinger, Benjamin; Ruan, Deling; Canlas, Patrick E.; Petzold, Christopher J.; Heazlewood, Joshua L.; Ronald, Pamela C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Schwessinger, Benjamin; Ruan, Deling; Canlas, Patrick E.; Petzold, Christopher J.; Heazlewood, Joshua L.; Ronald, Pamela C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Holton, Nicolas; Nekrasov, Vladimir; Zipfel, Cyril] Sainsbury Lab, Norwich, Norfolk, England; [Singan, Vasanth R.; Kuo, Rita; Chovatia, Mansi; Daum, Christopher] Dept Energy Joint Genome Inst, Walnut Creek, CA USA","Schwessinger, B (reprint author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.",pcronald@ucdavis.edu,"Schwessinger, Benjamin/R-5869-2018; Schwessinger, Benjamin/M-4248-2019; Nekrasov, Vladimir/N-4428-2017; Nekrasov, Vladimir/H-2834-2019; ZIPFEL, CYRIL/D-7103-2011; Heazlewood, Joshua L/A-2554-2008","Schwessinger, Benjamin/0000-0002-7194-2922; Nekrasov, Vladimir/0000-0001-9386-1683; Nekrasov, Vladimir/0000-0001-9386-1683; ZIPFEL, CYRIL/0000-0003-4935-8583; Heazlewood, Joshua L/0000-0002-2080-3826; Bahar, Ofir/0000-0001-5593-9136; Singan, Vasanth/0000-0002-9983-5707; Petzold, Christopher/0000-0002-8270-5228","EMBO long-term post-doctoral fellowship [ALTF 1290-2011]; Human Frontier Science Program long-term post-doctoral fellowship [LT000674/2012]; Gatsby Charitable Foundation; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH [GM59962]; Biotechnology and Biological Sciences Research Council [BB/G024936/1]","This work was supported by an EMBO long-term post-doctoral fellowship (ALTF 1290-2011) and a Human Frontier Science Program long-term post-doctoral fellowship (LT000674/2012) to BS. This work was funded by the Gatsby Charitable Foundation (CZ). The work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported by the NIH GM59962 to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Afroz A, 2011, PLANT CELL TISS ORG, V104, P227, DOI 10.1007/s11240-010-9825-2; Albert M, 2010, EUR J CELL BIOL, V89, P200, DOI 10.1016/j.ejcb.2009.11.015; Ao Y, 2014, PLANT J, V80, P1072, DOI 10.1111/tpj.12710; Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chen XW, 2014, MOL PLANT, V7, P874, DOI 10.1093/mp/ssu003; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clarke CR, 2013, NEW PHYTOL, V200, P847, DOI 10.1111/nph.12408; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Furukawa T, 2014, MOL PLANT MICROBE IN, V27, P113, DOI 10.1094/MPMI-10-13-0304-R; Gonzalez JF, 2012, J PROTEOMICS, V75, P5911, DOI 10.1016/j.jprot.2012.07.019; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Holton N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004602; Jiang YN, 2013, PLANT J, V73, P814, DOI 10.1111/tpj.12076; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Katsuragi Y, 2015, MOL PLANT MICROBE IN, V28, P648, DOI 10.1094/MPMI-11-14-0372-R; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kishimoto K, 2010, PLANT J, V64, P343, DOI 10.1111/j.1365-313X.2010.04328.x; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SW, 2013, SCIENCE, V342, P191, DOI 10.1126/science.342.6155.191-a; Li J, 2010, CURR OPIN PLANT BIOL, V13, P509, DOI 10.1016/j.pbi.2010.09.004; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Lopez-Gomez M, 2012, J EXP BOT, V63, P393, DOI 10.1093/jxb/err291; Lozano-Duran R, 2013, ELIFE, V2, DOI 10.7554/eLife.00983; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Lu F, 2015, J INTEGR PLANT BIOL, V57, P641, DOI 10.1111/jipb.12306; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mendes BMJ, 2010, PLANT PATHOL, V59, P68, DOI 10.1111/j.1365-3059.2009.02148.x; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Park CJ, 2013, PLANT SCI, V210, P53, DOI 10.1016/j.plantsci.2013.05.003; Park CJ, 2010, PLANT SCI, V179, P466, DOI 10.1016/j.plantsci.2010.07.008; Park CJ, 2010, CELL MICROBIOL, V12, P1017, DOI 10.1111/j.1462-5822.2010.01489.x; Park CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009262; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Qian GL, 2013, J PROTEOME RES, V12, P3327, DOI 10.1021/pr4001543; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RONALD PC, 1992, MOL GEN GENET, V236, P113; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Saijo Y, 2010, CELL MICROBIOL, V12, P716, DOI 10.1111/j.1462-5822.2010.01472.x; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schoonbeek HJ, 2015, NEW PHYTOL, V206, P606, DOI 10.1111/nph.13356; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Tan SJ, 2011, GENETICA, V139, P1465, DOI 10.1007/s10709-012-9645-x; Team RC, 2012, R LANG ENV STAT COMP; Tripathi JN, 2014, PLANT BIOTECHNOL J, V12, P663, DOI 10.1111/pbi.12170; Wang SZ, 2015, MOL PLANT, V8, P1024, DOI 10.1016/j.molp.2015.01.012; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xiang Y, 2006, THEOR APPL GENET, V113, P1347, DOI 10.1007/s00122-006-0388-x; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zuo SM, 2014, J INTEGR PLANT BIOL, V56, P1179, DOI 10.1111/jipb.12290",96,49,51,0,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004809,10.1371/journal.ppat.1004809,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900087,25821973.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,48,64,66,8171,915,610,305,7256,5999,35,1222,66,3,0,0,38,38,6,,72,0,72,0,0,49,49,33,23,0,0,0,0,0,0,1,61,9,8246,308,196,622,95,0,7295,927,308,196,622,95,0,24,,4,1,0,0,26,0,1,1,0,0,0,72,0,0,52.806,8.930054644808743,1.1261025358324146,0.12610253583241454,1.1919790518191842,1.058499571655856,9.452459016393442
95,J,"Serbus, LR; White, PM; Silva, JP; Rabe, A; Teixeira, L; Albertson, R; Sullivan, W",,,,"Serbus, Laura R.; White, Pamela M.; Silva, Jessica Pintado; Rabe, Amanda; Teixeira, Luis; Albertson, Roger; Sullivan, William",,,The Impact of Host Diet on Wolbachia Titer in Drosophila,PLOS PATHOGENS,,,English,Article,,,,,,,STEM-CELL NICHE; TUBEROUS SCLEROSIS COMPLEX; EXTENDS LIFE-SPAN; INSULIN-RESISTANCE; SKELETAL-MUSCLE; CYTOPLASMIC INCOMPATIBILITY; SYMBIOTIC ASSOCIATIONS; ENDOSYMBIOTIC BACTERIA; MAMMALIAN TARGET; AEDES-AEGYPTI,"While a number of studies have identified host factors that influence endosymbiont titer, little is known concerning environmental influences on titer. Here we examined nutrient impact on maternally transmitted Wolbachia endosymbionts in Drosophila. We demonstrate that Drosophila reared on sucrose-and yeast-enriched diets exhibit increased and reduced Wolbachia titers in oogenesis, respectively. The yeast-induced Wolbachia depletion is mediated in large part by the somatic TOR and insulin signaling pathways. Disrupting TORC1 with the small molecule rapamycin dramatically increases oocyte Wolbachia titer, whereas hyper-activating somatic TORC1 suppresses oocyte titer. Furthermore, genetic ablation of insulin-producing cells located in the Drosophila brain abolished the yeast impact on oocyte titer. Exposure to yeast-enriched diets altered Wolbachia nucleoid morphology in oogenesis. Furthermore, dietary yeast increased somatic Wolbachia titer overall, though not in the central nervous system. These findings highlight the interactions between Wolbachia and germline cells as strongly nutrient-sensitive, and implicate conserved host signaling pathways by which nutrients influence Wolbachia titer.","[Serbus, Laura R.; Silva, Jessica Pintado] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Serbus, Laura R.; Silva, Jessica Pintado] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [White, Pamela M.; Rabe, Amanda; Sullivan, William] Univ Calif Santa Cruz, Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Teixeira, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Albertson, Roger] Albion Coll, Dept Biol, Albion, MI 49224 USA","Serbus, LR (reprint author), Florida Int Univ, Dept Biol Sci, Modesto A Maidique Campus, Miami, FL 33199 USA.",lserbus@fiu.edu,"Teixeira, Luis/H-6106-2013","Teixeira, Luis/0000-0001-8326-6645","Florida International University; National Institutes of Health, Minority Access to Research Careers program [GMS-2T34GM007910]; National Science Foundation [MCB-1122252]","LRS received funding from Florida International University. AR received funding from the National Institutes of Health, Minority Access to Research Careers program, GMS-2T34GM007910. WS received funding from that National Science Foundation, MCB-1122252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Albertson R, 2013, CELL MICROBIOL, V15, P1527, DOI 10.1111/cmi.12136; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Ashburner M., 1989, DROSOPHILA LAB HDB; Ashburner M., 1989, DROSOPHILA LAB HDB, P139; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Begon M., 1982, Genetics and Biology of Drosophila, V3b, P345; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Brncic D., 1983, Genetics and Biology of Drosophila, V3d, P333; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Casper-Lindley C, 2011, APPL ENVIRON MICROB, V77, P4788, DOI 10.1128/AEM.00215-11; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chrostek E., 2013, PLOS GENET, V9; Chrostek E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099025; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Colombani J, 2003, CELL, V115, P123; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Ferree Patrick M, 2005, PLoS Pathog, V1, pe14; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Gonzalez IM, 2012, DEV BIOL, V361, P286, DOI 10.1016/j.ydbio.2011.10.021; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gronke S, 2010, PLOS GENET, P6; Guertin DA, 2009, SCI SIGNALING, V2; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Haselton A, 2010, CELL CYCLE, V9, P3063, DOI 10.4161/cc.9.15.12458; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Heifetz Y, 2001, P ROY SOC B-BIOL SCI, V268, P175, DOI 10.1098/rspb.2000.1347; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 1998, GENETICS, V148, P221; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Hudson AM, 2014, METHODS STUDYING OOG; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; King R. C., 1970, OVARIAN DEV DROSOPHI; KING ROBERT C., 1959, GROWTH, V23, P37; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Kukor J.J., 1987, P791; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Landmann F, 2012, BIOL OPEN, V00, P1; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; Markov AV, 2006, PALEONTOL J+, V40, P115, DOI 10.1134/S0031030106020018; Matilainen O, 2013, CELL REP, V3, P1980, DOI 10.1016/j.celrep.2013.05.012; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Morris SNS, 2012, BBA-MOL BASIS DIS, V1822, P1230, DOI 10.1016/j.bbadis.2012.04.012; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; NOGGE G, 1981, PARASITOLOGY, V82, P101; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Norton LE, 2009, J NUTR, V139, P1103, DOI 10.3945/jn.108.103853; Ogawa W, 1998, MOL CELL BIOCHEM, V182, P13, DOI 10.1023/A:1006862807598; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce A, 2011, ARCH MICROBIOL, V193, P373, DOI 10.1007/s00203-011-0682-0; Ponton F, 2015, P BIOL SCI, P282; Puchta O, 1955, Z PARASITENK, V17; R_Development_Core_Team, 2011, LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Sabree ZL, 2013, ENVIRON MICROBIOL, V15, P1988, DOI 10.1111/1462-2920.12058; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Serbus LR, 2007, PLOS PATHOG, V3, P1930, DOI 10.1371/journal.ppat.0030190; Serbus LR, 2011, J CELL SCI, V124, P4299, DOI 10.1242/jcs.092510; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shorrocks B., 1982, Genetics and Biology of Drosophila, V3b, P385; Snook RR, 2000, GENETICS, V155, P167; Snyder AK, 2012, APPL ENVIRON MICROB, V78, P7792, DOI 10.1128/AEM.02052-12; Snyder AK, 2010, P ROY SOC B-BIOL SCI, V277, P2389, DOI 10.1098/rspb.2010.0364; Soller M, 1997, EUR J BIOCHEM, V243, P732, DOI 10.1111/j.1432-1033.1997.00732.x; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; SPRADLING AC, 1993, DEV DROSOPHILA MELAN, V1, P1; Stambler N, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P87, DOI 10.1007/978-94-007-0114-4_7; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Toomey ME, 2013, P NATL ACAD SCI USA, V110, P10788, DOI 10.1073/pnas.1301524110; TURELLI M, 1995, GENETICS, V140, P1319; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wang YX, 2012, BRIT J NUTR, V108, P1371, DOI 10.1017/S0007114511006763; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Xi PB, 2010, FASEB J, V24; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yao K, 2008, J NUTR, V138, P867; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu HB, 2014, MBIO, V5, DOI 10.1128/mBio.00865-14; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544",127,29,29,0,35,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004777,10.1371/journal.ppat.1004777,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900080,25826386.0,"DOAJ Gold, Green Published",,,16/08/2019,30,10,83,6445,991,775,216,5454,4510,27,917,83,0,0,0,25,25,2,,96,2,96,0,2,33,33,27,19,0,0,0,0,0,0,0,10,8,6485,123,0,538,260,1,5445,991,70,0,538,256,1,49,,0,0,0,0,13,0,1,0,0,0,0,99,0,0,6.45,6.503531786074672,1.1817015034836817,0.1817015034836817,1.2592592592592593,1.0656322730799068,6.9303733602421795
96,J,"Shapiro, RS",,,,"Shapiro, Rebecca S.",,,Antimicrobial-Induced DNA Damage and Genomic Instability in Microbial Pathogens,PLOS PATHOGENS,,,English,Article,,,,,,,ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CELL-DEATH; MECHANISM; MUTAGENESIS; POLYMERASE; INDUCTION; BYPASS; REPAIR,,"[Shapiro, Rebecca S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Shapiro, Rebecca S.] MIT, Dept Biol Engn, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Shapiro, Rebecca S.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Shapiro, Rebecca S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Shapiro, Rebecca S.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA","Shapiro, RS (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.",rshapiro@broadinstitute.org,"Shapiro, Rebecca/I-9247-2019","Shapiro, Rebecca/0000-0002-7119-8865",Banting Postdoctoral Fellowship,"This work was supported by a Banting Postdoctoral Fellowship to RSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Baharoglu Z, 2011, ANTIMICROB AGENTS CH, V55, P2438, DOI 10.1128/AAC.01549-10; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; Blazquez J, 2012, CURR OPIN MICROBIOL, V15, P561, DOI 10.1016/j.mib.2012.07.007; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; Mesa-Arango AC, 2014, ANTIMICROB AGENTS CH, V58, P6627, DOI 10.1128/AAC.03570-14; Chang FM, 2014, FUNGAL GENET BIOL, V70, P68, DOI 10.1016/j.fgb.2014.06.009; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Ene IV, 2014, NAT REV MICROBIOL, V12, P239, DOI 10.1038/nrmicro3236; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Harrison BD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001815; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kwon-Chung KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003022; Legrand M, 2007, EUKARYOT CELL, V6, P2194, DOI 10.1128/EC.00299-07; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Mannaert A, 2012, TRENDS PARASITOL, V28, P370, DOI 10.1016/j.pt.2012.06.003; Moreira W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.83; Muller M, 2004, ANTIMICROB AGENTS CH, V48, P1441, DOI 10.1128/AAC.48.5.1441-1453.2004; Nagel M, 2011, INT J MED MICROBIOL, V301, P229, DOI 10.1016/j.ijmm.2010.08.021; Ormerod KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003764; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; Rodriguez-Rojas A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004445; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Ryan O, 2012, SCIENCE, V337, P1353, DOI 10.1126/science.1224339; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Semighini CP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002364; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shor E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003680; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Thuy DT, 2011, J ANTIMICROB CHEMOTH, V66, P531, DOI 10.1093/jac/dkq496; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; YSERN P, 1990, MUTAGENESIS, V5, P63, DOI 10.1093/mutage/5.1.63; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008",47,13,13,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004678,10.1371/journal.ppat.1004678,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900014,25811381.0,"DOAJ Gold, Green Published",,,16/08/2019,14,13,71,8345,2206,1873,333,6139,5054,20,1065,70,1,0,0,12,12,1,,92,5,91,1,5,14,14,14,8,0,0,0,0,0,0,0,12,8,8366,3,0,26,55,0,6131,2206,3,0,26,55,0,29,,0,0,0,0,31,0,0,1,0,0,0,91,1,0,15.75,3.78286491387126,1.359341912363577,0.35934191236357715,1.372210457729272,1.0094667465548233,3.8186763372620125
97,J,"Sturdevant, CB; Joseph, SB; Schnell, G; Price, RW; Swanstrom, R; Spudich, S",,,,"Sturdevant, Christa Buckheit; Joseph, Sarah B.; Schnell, Gretja; Price, Richard W.; Swanstrom, Ronald; Spudich, Serena",,,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; MULTIPLE SEQUENCE ALIGNMENT; CEREBROSPINAL-FLUID; MACROPHAGE TROPISM; HIV-1-ASSOCIATED DEMENTIA; ENV COMPARTMENTALIZATION; ANTIRETROVIRAL TREATMENT; ENVELOPE GLYCOPROTEINS; IMMUNE ACTIVATION; CD4 DEPENDENCE,"Compartmentalized HIV-1 replication within the central nervous system (CNS) likely provides a foundation for neurocognitive impairment and a potentially important tissue reservoir. The timing of emergence and character of this local CNS replication has not been defined in a population of subjects. We examined the frequency of elevated cerebrospinal fluid (CSF) HIV-1 RNA concentration, the nature of CSF viral populations compared to the blood, and the presence of a cellular inflammatory response (with the potential to bring infected cells into the CNS) using paired CSF and blood samples obtained over the first two years of infection from 72 ART-naive subjects. Using single genome amplification (SGA) and phylodynamics analysis of full-length env sequences, we compared CSF and blood viral populations in 33 of the 72 subjects. Independent HIV-1 replication in the CNS (compartmentalization) was detected in 20% of sample pairs analyzed by SGA, or 7% of all sample pairs, and was exclusively observed after four months of infection. In subjects with longitudinal sampling, 30% showed evidence of CNS viral replication or pleocytosis/inflammation in at least one time point, and in approximately 16% of subjects we observed evolving CSF/CNS compartmentalized viral replication and/or a marked CSF inflammatory response at multiple time points suggesting an ongoing or recurrent impact of the infection in the CNS. Two subjects had one of two transmitted lineages (or their recombinant) largely sequestered within the CNS shortly after transmission, indicating an additional mechanism for establishing early CNS replication. Transmitted variants were R5 T cell-tropic. Overall, examination of the relationships between CSF viral populations, blood and CSF HIV-1 RNA concentrations, and inflammatory responses suggested four distinct states of viral population dynamics, with associated mechanisms of local viral replication and the early influx of virus into the CNS. This study considerably enhances the generalizability of our results and greatly expands our knowledge of the early interactions of HIV-1 in the CNS.","[Sturdevant, Christa Buckheit; Schnell, Gretja; Swanstrom, Ronald] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Joseph, Sarah B.; Swanstrom, Ronald] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Swanstrom, Ronald] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC USA; [Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Spudich, Serena] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA","Sturdevant, CB (reprint author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.",serena.spudich@yale.edu,,,"NIH [T32-AI07419, P01-MH094177, K23-MH074466, R01-MH81772, R01- NS37660, UL1RR024131]; UNC Center for AIDS Research (NIH) [P30-AI50410]; Lineberger Cancer Center core grant (NIH) [P30-CA16086];  [T32-AI07001]","CBS was supported by NIH Training grant T32-AI07419, and GS was supported by T32-AI07001. This work was supported by NIH award P01-MH094177 (to RS), the UNC Center for AIDS Research (NIH award P30-AI50410), a Lineberger Cancer Center core grant (NIH award P30-CA16086), NIH awards K23-MH074466 and R01-MH81772 (to SS), NIH award R01- NS37660 (to RWP), and NIH award UL1RR024131 (to UCSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; Bull ME, 2013, J INFECT DIS, V207, P1206, DOI 10.1093/infdis/jit016; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duenas-Decamp MJ, 2009, J VIROL, V83, P2575, DOI 10.1128/JVI.02133-08; Dunfee R, 2006, CURR HIV RES, V4, P267, DOI 10.2174/157016206777709500; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Eden A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enting RH, 2001, CLIN INFECT DIS, V32, P1095, DOI 10.1086/319602; Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239; Fishman RA, 1992, CEREBROSPINAL FLUID; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; Gorry PR, 2002, J VIROL, V76, P6277, DOI 10.1128/JVI.76.12.6277-6292.2002; Harrington PR, 2007, J INFECT DIS, V196, P1058, DOI 10.1086/520819; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Ho EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066188; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1992, GENETICS, V132, P583; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Johnston SH, 2009, J VIROL, V83, P11016, DOI 10.1128/JVI.01242-09; Joseph SB, 2014, J VIROL, V88, P1858, DOI 10.1128/JVI.02477-13; Joseph SB, 2013, J VIROL; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Li H S, 2010, ACTA ECOLOGICA SINIC, V1, P1, DOI DOI 10.1371/J0URNAL.PPAT.1000890; Martin-Garcia J, 2006, VIROLOGY, V346, P169, DOI 10.1016/j.virol.2005.10.031; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Pilcher CD, 2001, AIDS, V15, P837, DOI 10.1097/00002030-200105040-00004; Ping LH, 2013, J VIROL; Pomerantz RJ, 2003, HIV CLIN TRIALS, V4, P137, DOI 10.1310/80JH-148K-NADQ-U927; Price RW, 2013, J NEUROIMMUNE PHARM, V8, P1147, DOI 10.1007/s11481-013-9491-3; Ritola K, 2005, J VIROL, V79, P10830, DOI 10.1128/JVI.79.16.10830-10834.2005; Rossi F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-89; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; Shaheen F, 1999, J HUMAN VIROL, V2, P154; SLATKIN M, 1989, GENETICS, V123, P603; Smith DM, 2009, VIROLOGY, V385, P204, DOI 10.1016/j.virol.2008.11.010; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Sturdevant CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003094; Tambussi G, 2000, CLIN INFECT DIS, V30, P962, DOI 10.1086/313810; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06",61,62,63,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004720,10.1371/journal.ppat.1004720,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900041,25811757.0,"DOAJ Gold, Green Published",,,16/08/2019,72,39,42,8744,838,573,265,7906,6709,38,1159,42,2,0,0,60,60,15,,52,4,52,0,4,76,76,72,50,0,0,0,0,0,0,1,37,32,8754,71,251,63,196,0,7888,838,71,248,63,196,0,28,,15,3,0,0,54,0,7,1,0,0,0,52,0,0,169.128,10.43436754176611,1.105995446496332,0.1059954464963319,1.1410321274981028,1.0316788655077767,10.764916467780429
98,J,"Van Avondt, K; van Sorge, NM; Meyaard, L",,,,"Van Avondt, Kristof; van Sorge, Nina M.; Meyaard, Linde",,,Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN-TYROSINE-PHOSPHATASE; RESPONSES; NEUTROPHIL; MOTIFS; RECEPTORS; PATHOGEN; SHP-2; ITIM,"An innate immune response is essential for survival of the host upon infection, yet excessive inflammation can result in harmful complications [1]. Inhibitory signaling evolved to limit host responses and prevent inflammatory pathology [2,3]. Given the significance of inhibitory pathways for immunity and homeostasis, they provide ideal targets for manipulation by bacterial pathogens. Recent evidence highlights that bacteria have developed diverse strategies to exploit these inhibitory pathways to avoid host defense for their own benefit. In this review, we cover these different immune evasion strategies for the first time. The recent literature discussed emphasizes that bacteria subvert host immune responses not only by direct engagement of inhibitory receptors (i.e., often through ""molecular mimicry"" of host ligands [4,5]) but also through virulence factors that resemble intermediates of host inhibitory signaling and interfere with defense functions [6-8]. Understanding how bacteria manipulate inhibitory signaling affords promising opportunities to counteract these escape strategies and tip the balance in favor of the host. In addition, these understandings may provide useful insights on the functional roles of inhibitory pathways in limiting host responses and preventing pathology.","[Van Avondt, Kristof; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [van Sorge, Nina M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands","Van Avondt, K (reprint author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.",l.meyaard@umcutrecht.nl,"van Sorge, Nina/E-3290-2017","van Sorge, Nina/0000-0002-2695-5863; Meyaard, Linde/0000-0003-0707-4793","Netherlands Organization for Scientific Research, division of Earth and Life Sciences [819.02.002]","This work was supported by grant 819.02.002 from the Netherlands Organization for Scientific Research, division of Earth and Life Sciences (for KVA). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Bauer B, 2012, CELL HOST MICROBE, V11, P576, DOI 10.1016/j.chom.2012.04.013; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chang YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003846; Choi HW, 2013, IMMUNITY, V39, P1108, DOI 10.1016/j.immuni.2013.11.009; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Nakayama M, 2012, J IMMUNOL, V189, P5903, DOI 10.4049/jimmunol.1201940; Rolan HG, 2013, CELL HOST MICROBE, V14, P306, DOI 10.1016/j.chom.2013.08.013; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Staub E, 2004, CELL SIGNAL, V16, P435, DOI 10.1016/j.cellsig.2003.08.013; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wang YC, 2014, J IMMUNOL, V193, P4149, DOI 10.4049/jimmunol.1400594; Yan DP, 2013, CELL SIGNAL, V25, P1887, DOI 10.1016/j.cellsig.2013.05.020; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Ye Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110956; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008",29,14,14,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004644,10.1371/journal.ppat.1004644,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900002,25742647.0,"DOAJ Gold, Green Published",,,16/08/2019,16,20,59,10285,1583,1345,238,8702,6804,30,1868,59,6,0,0,13,13,0,,77,5,77,0,5,17,17,14,8,0,0,0,0,0,0,0,14,2,10254,3,0,19,39,1,8654,1583,3,0,19,39,1,17,,0,0,0,0,18,0,2,1,0,0,0,77,0,0,9.95,6.497157296272899,1.1819122040910135,0.18191220409101355,1.1831762813146403,1.0010695187165775,6.504106127605811
99,J,"van Meijgaarden, KE; Haks, MC; Caccamo, N; Dieli, F; Ottenhoff, THM; Joosten, SA",,,,"van Meijgaarden, Krista E.; Haks, Marielle C.; Caccamo, Nadia; Dieli, Francesco; Ottenhoff, Tom H. M.; Joosten, Simone A.",,,"Human CD8(+) T-cells Recognizing Peptides from Mycobacterium tuberculosis (Mtb) Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Mtb Inhibitory Phenotype and Represent a Novel Human T-cell Subset",PLOS PATHOGENS,,,English,Article,,,,,,,GENE-EXPRESSION PROFILES; TY21A TYPHOID VACCINE; IMMUNE-RESPONSE; SYSTEMIC-SCLEROSIS; ACTIVE TUBERCULOSIS; LEPROSY PATIENTS; HOST-DEFENSE; CD8+T CELLS; B-CELLS; ANTIGEN,"Mycobacterial antigens are not exclusively presented to T-cells by classical HLA-class Ia and HLA-class II molecules, but also through alternative antigen presentation molecules such as CD1a/b/c, MR1 and HLA-E. We recently described mycobacterial peptides that are presented in HLA-E and recognized by CD8(+) T-cells. Using T-cell cloning, phenotyping, microbiological, functional and RNA-expression analyses, we report here that these T-cells can exert cytolytic or suppressive functions, inhibit mycobacterial growth, yet express GATA3, produce Th2 cytokines (IL-4,-5,-10,-13) and activate B-cells via IL-4. In TB patients, Mtb specific cells were detectable by peptide-HLA-E tetramers, and IL-4 and IL-13 were produced following peptide stimulation. These results identify a novel human T-cell subset with an unorthodox, multifunctional Th2 like phenotype and cytolytic or regulatory capacities, which is involved in the human immune response to mycobacteria and demonstrable in active TB patients' blood. The results challenge the current dogma that only Th1 cells are able to inhibit Mtb growth and clearly show that Th2 like cells can strongly inhibit outgrowth of Mtb from human macrophages. These insights significantly expand our understanding of the immune response in infectious disease.","[van Meijgaarden, Krista E.; Haks, Marielle C.; Ottenhoff, Tom H. M.; Joosten, Simone A.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Cent Lab Adv Diagnost & Biomed Res CLADIBIOR, Palermo, Italy; [Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy","van Meijgaarden, KE (reprint author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.",s.a.joosten@lumc.nl,"Joosten, Simone A/F-1357-2011; Joosten, Simone/E-4731-2011","Dieli, Francesco/0000-0002-6685-352X; CACCAMO, Nadia Rosalia/0000-0002-1018-5710",European Commission FP7 NEWTBVAC [HEALTH.F3.2009 241745]; European Commission FP7 ADITEC [HEALTH.2011.1.4-4 280873]; Netherlands Organization for Scientific Research (VENI) [916.86.115]; Gisela Thier Foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation,"We acknowledge European Commission FP7 NEWTBVAC contract no. HEALTH.F3.2009 241745, European Commission FP7 ADITEC contract no. HEALTH.2011.1.4-4 280873 (the text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), The Netherlands Organization for Scientific Research (VENI grant 916.86.115), the Gisela Thier Foundation of the Leiden University Medical Center and the Netherlands Leprosy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Allard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050951; Anthony Nolan Research Institute, 2009, HLA CLASS 1 CLASS 2; Ashenafi S, 2014, CLIN IMMUNOL, V151, P84, DOI 10.1016/j.clim.2014.01.010; Boer MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094192; Boer MC, 2013, EUR J IMMUNOL, V43, P1925, DOI 10.1002/eji.201243286; Britten CM, 2012, IMMUNITY, V37, P1, DOI 10.1016/j.immuni.2012.07.010; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Dakhama A, 2013, ALLERGY, V68, P666, DOI 10.1111/all.12135; Fuschiotti P, 2013, ARTHRITIS RHEUM-US, V65, P236, DOI 10.1002/art.37706; Fuschiotti P, 2009, ARTHRITIS RHEUM-US, V60, P1119, DOI 10.1002/art.24432; Geijtenbeek TBH, 2013, NAT IMMUNOL, V14, P309, DOI 10.1038/ni.2574; Geluk A, 2014, J CLIN IMMUNOL, V34, P245, DOI 10.1007/s10875-013-9979-x; Grotzke JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000374; Hall van T, 2010, MICROBES I IN PRESS; Hammaren MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004190; Harriff MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097515; Heatley SL, 2013, J BIOL CHEM, V288, P8679, DOI 10.1074/jbc.M112.409672; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Heitmann L, 2014, J PATHOL; Hijnen D, 2013, J INVEST DERMATOL, V133, P973, DOI 10.1038/jid.2012.456; Holderried TAW, 2013, P NATL ACAD SCI USA, V110, P21089, DOI 10.1073/pnas.1320999110; Jackson-Sillah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068121; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; JANSON AAM, 1991, J IMMUNOL, V147, P3530; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Jorgensen PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046120; Jung YJ, 2002, INFECT IMMUN, V70, P6436, DOI 10.1128/IAI.70.11.6436-6443.2002; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Lo WF, 2000, NAT MED, V6, P215; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Mazzarino P, 2005, EUR J IMMUNOL, V35, P3240, DOI 10.1002/eji.200535343; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Medsger TA, 2011, ARTHRITIS RHEUM-US, V63, P1738, DOI 10.1002/art.30489; Meyer J, 2013, EXPERT REV VACCINES, V12, P443, DOI [10.1586/ERV.13.19, 10.1586/erv.13.19]; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; MUTIS T, 1993, J IMMUNOL, V150, P4641; Nagarajan NA, 2012, NAT IMMUNOL, V13, P579, DOI 10.1038/ni.2282; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Oliveira CC, 2010, J EXP MED, V207, P207, DOI 10.1084/jem.20091429; OTTENHOFF THM, 1990, J EXP MED, V171, P2011, DOI 10.1084/jem.171.6.2011; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Schulte D, 2009, J INFECT DIS, V200, P1397, DOI 10.1086/605889; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; Tai TS, 2013, J IMMUNOL, V190, P428, DOI 10.4049/jimmunol.1201361; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tang ST, 2011, J IMMUNOL, V186, P1068, DOI 10.4049/jimmunol.1002212; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van Crevel R, 2014, LANCET DIABETES ENDO, V2, P270, DOI 10.1016/S2213-8587(14)70011-7; VANELS CACM, 1992, IMMUNOGENETICS, V35, P161, DOI 10.1007/BF00185109; Varthaman A, 2010, J IMMUNOL, V184, P6585, DOI 10.4049/jimmunol.0903109; Veiga-Castelli LC, 2013, TISSUE ANTIGENS, V82, P216, DOI 10.1111/tan.12177; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029",71,42,42,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004671,10.1371/journal.ppat.1004671,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900011,25803478.0,"DOAJ Gold, Green Published",,,16/08/2019,46,9,60,5704,1175,819,356,4529,3470,23,1036,60,9,0,0,43,43,2,,76,4,76,0,4,47,47,47,28,0,0,0,0,0,0,0,0,10,5706,24,0,57,163,1,4505,1175,24,0,57,163,1,26,,0,0,0,0,11,0,0,1,0,0,0,75,0,0,6.75,4.854468085106383,1.2594391697946568,0.25943916979465664,1.301170236255244,1.0331346423562413,5.01531914893617
100,J,"Weinheimer, I; Jiu, YM; Rajamaki, ML; Matilainen, O; Kallijarvi, J; Cuellar, WJ; Lu, R; Saarma, M; Holmberg, CI; Jantti, J; Valkonen, JPT",,,,"Weinheimer, Isabel; Jiu, Yaming; Rajamaki, Minna-Liisa; Matilainen, Olli; Kallijarvi, Jukka; Cuellar, Wilmer J.; Lu, Rui; Saarma, Mart; Holmberg, Carina I.; Jantti, Jussi; Valkonen, Jari P. T.",,,Suppression of RNAi by dsRNA-Degrading RNaseIII Enzymes of Viruses in Animals and Plants,PLOS PATHOGENS,,,English,Article,,,,,,,DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; ANTIVIRAL IMMUNITY; C-ELEGANS; VIRAL SUPPRESSORS; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SILENCING SUPPRESSOR; RIBONUCLEASE-III; INTERFERENCE,"Certain RNA and DNA viruses that infect plants, insects, fish or poikilothermic animals encode Class 1 RNaseIII endoribonuclease-like proteins. dsRNA-specific endoribonuclease activity of the RNaseIII of rock bream iridovirus infecting fish and Sweet potato chlorotic stunt crinivirus (SPCSV) infecting plants has been shown. Suppression of the host antiviral RNA interference (RNAi) pathway has been documented with the RNaseIII of SPCSV and Heliothis virescens ascovirus infecting insects. Suppression of RNAi by the viral RNaseIIIs in non-host organisms of different kingdoms is not known. Here we expressed PPR3, the RNaseIII of Pike-perch iridovirus, in the non-hosts Nicotiana benthamiana (plant) and Caenorhabditis elegans (nematode) and found that it cleaves double-stranded small interfering RNA (ds-siRNA) molecules that are pivotal in the host RNA interference (RNAi) pathway and thereby suppresses RNAi in non-host tissues. In N. benthamiana, PPR3 enhanced accumulation of Tobacco rattle tobravirus RNA1 replicon lacking the 16K RNAi suppressor. Furthermore, PPR3 suppressed single-stranded RNA (ssRNA)-mediated RNAi and rescued replication of Flock House virus RNA1 replicon lacking the B2 RNAi suppressor in C. elegans. Suppression of RNAi was debilitated with the catalytically compromised mutant PPR3-Ala. However, the RNaseIII (CSR3) produced by SPCSV, which cleaves ds-siRNA and counteracts antiviral RNAi in plants, failed to suppress ssRNA-mediated RNAi in C. elegans. In leaves of N. benthamiana, PPR3 suppressed RNAi induced by ssRNA and dsRNA and reversed silencing; CSR3, however, suppressed only RNAi induced by ssRNA and was unable to reverse silencing. Neither PPR3 nor CSR3 suppressed antisense-mediated RNAi in Drosophila melanogaster. These results show that the RNaseIII enzymes of RNA and DNA viruses suppress RNAi, which requires catalytic activities of RNaseIII. In contrast to other viral silencing suppression proteins, the RNaseIII enzymes are homologous in unrelated RNA and DNA viruses and can be detected in viral genomes using gene modeling and protein structure prediction programs.","[Weinheimer, Isabel; Rajamaki, Minna-Liisa; Cuellar, Wilmer J.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Jiu, Yaming; Kallijarvi, Jukka; Saarma, Mart; Jantti, Jussi] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Matilainen, Olli; Holmberg, Carina I.] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland; [Matilainen, Olli; Holmberg, Carina I.] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Helsinki, Finland; [Lu, Rui] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Jantti, Jussi] VTT Tech Res Ctr Finland, Espoo, Finland","Weinheimer, I (reprint author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.",jari.valkonen@helsinki.fi,,"Valkonen, Jari/0000-0002-3704-9911; Holmberg-Still, Carina/0000-0001-9645-2009; Cuellar, Wilmer/0000-0003-4702-3237; Kallijarvi, Jukka/0000-0003-3773-7025; Rajamaki, Minna-Liisa/0000-0002-7952-0433","Academy of Finland [1134335, 1253126, 1276136, 133552, 259797]; Lundbeck Foundation; National Institute of Health [1R03AI092159-01A1]; Viikki Doctoral Program in Molecular Biosciences (VGSB)","This work was funded by the Academy of Finland (1134335, 1253126 and 1276136 to JPTV, 133552 to JJ, and 259797 to CIH), Lundbeck Foundation (to MS) and The National Institute of Health (1R03AI092159-01A1 to RL). IW was supported by the Viikki Doctoral Program in Molecular Biosciences (VGSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ariel E, 2010, ARCH VIROL, V155, P1261, DOI 10.1007/s00705-010-0715-z; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berry B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005866; Bigot Y, 2012, VIRUS TAXONOMY CLASS, P147; BRENNER S, 1974, GENETICS, V77, P71; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chen CCH, 2006, MOL BIOL CELL, V17, P1286; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clark CA, 2012, PLANT DIS, V96, P168, DOI 10.1094/PDIS-07-11-0550; Cogoni C, 1999, NATURE, V399, P166; Comella P, 2008, NUCLEIC ACIDS RES, V36, P1163, DOI 10.1093/nar/gkm1130; Cuellar WJ, 2009, P NATL ACAD SCI USA, V106, P10354, DOI 10.1073/pnas.0806042106; Deng XB, 2013, MOL PLANT MICROBE IN, V26, P503, DOI 10.1094/MPMI-12-12-0280-R; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Ghazala W, 2008, J GEN VIROL, V89, P1748, DOI 10.1099/vir.0.83503-0; Guo XY, 2013, J VIROL, V87, P5414, DOI 10.1128/JVI.00148-13; Guo XY, 2012, J VIROL, V86, P11645, DOI 10.1128/JVI.01501-12; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293; Holmstrom KO, 1997, THESIS ACTA U AGR SU; Hussain M, 2010, J VIROL, V84, P3624, DOI 10.1128/JVI.02362-09; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jancovich JK, 2003, VIROLOGY, V316, P90, DOI 10.1016/j.virol.2003.08.001; Jancovich JK, 2012, VIRUS TAXONOMY, P193; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Kreuze JF, 2002, J VIROL, V76, P9260, DOI 10.1128/JVI.76.18.9260-9270.2002; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Martin-Hernandez AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07; Martinez-Priego L, 2008, VIROLOGY, V376, P346, DOI 10.1016/j.virol.2008.03.024; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Melnyk CW, 2011, EMBO J, V30, P3553, DOI 10.1038/emboj.2011.274; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Rajamaki ML, 2009, PLANT CELL, V21, P2485, DOI 10.1105/tpc.108.064147; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stasiak K, 2000, J GEN VIROL, V81, P3059, DOI 10.1099/0022-1317-81-12-3059; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; Tan WGH, 2004, VIROLOGY, V323, P70, DOI 10.1016/j.virol.2004.02.019; Tapiovaara H, 1998, DIS AQUAT ORGAN, V32, P185, DOI 10.3354/dao032185; Tugume AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081479; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Weigel D, 2002, ARABIDOPSIS; Weinheimer I, 2014, J GEN VIROL, V95, P486, DOI 10.1099/vir.0.058693-0; Whittington RJ, 2010, J FISH DIS, V33, P95, DOI 10.1111/j.1365-2761.2009.01110.x; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zenke K, 2008, ARCH VIROL, V153, P1651, DOI 10.1007/s00705-008-0162-2; Zhang C, 2012, CURR BIOL, V22, P881, DOI 10.1016/j.cub.2012.04.011; Zhang YZ, 2003, VIROLOGY, V317, P73, DOI 10.1016/10.1016/j.virol.2003.08.044",75,13,13,0,41,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,e1004711,10.1371/journal.ppat.1004711,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900037,25747942.0,"DOAJ Gold, Green Published",,,16/08/2019,15,61,62,7609,1200,908,292,6409,5325,20,1064,62,0,0,0,13,13,1,,70,8,70,0,8,16,16,13,11,0,0,0,0,0,0,0,61,7,7639,43,0,370,192,0,6397,1200,43,0,370,192,0,42,,0,0,0,0,24,0,5,1,0,0,0,69,0,0,12.7,6.340833333333333,1.187236698392885,0.187236698392885,1.2285848026213138,1.0348271783414378,6.5616666666666665
101,J,"Wiesner, DL; Specht, CA; Lee, CK; Smith, KD; Mukaremera, L; Lee, ST; Lee, CG; Elias, JA; Nielsen, JN; Boulware, DR; Bohjanen, PR; Jenkins, MK; Levitz, SM; Nielsen, K",,,,"Wiesner, Darin L.; Specht, Charles A.; Lee, Chrono K.; Smith, Kyle D.; Mukaremera, Liliane; Lee, S. Thera; Lee, Chun G.; Elias, Jack A.; Nielsen, Judith N.; Boulware, David R.; Bohjanen, Paul R.; Jenkins, Marc K.; Levitz, Stuart M.; Nielsen, Kirsten",,,Chitin Recognition via Chitotriosidase Promotes Pathologic Type-2 Helper T Cell Responses to Cryptococcal Infection,PLOS PATHOGENS,,,English,Article,,,,,,,INNATE LYMPHOID-CELLS; ACIDIC MAMMALIAN CHITINASE; CD11B(+) DENDRITIC CELLS; CYTOKINE RESPONSES; FUNGAL-INFECTIONS; ADAPTIVE IMMUNITY; IN-VIVO; NEOFORMANS; RECEPTOR; LUNG,"Pulmonary mycoses are often associated with type-2 helper T (Th2) cell responses. However, mechanisms of Th2 cell accumulation are multifactorial and incompletely known. To investigate Th2 cell responses to pulmonary fungal infection, we developed a peptide-MHCII tetramer to track antigen-specific CD4+ T cells produced in response to infection with the fungal pathogen Cryptococcus neoformans. We noted massive accruement of pathologic cryptococcal antigen-specific Th2 cells in the lungs following infection that was coordinated by lung-resident CD11b+ IRF4-dependent conventional dendritic cells. Other researchers have demonstrated that this dendritic cell subset is also capable of priming protective Th17 cell responses to another pulmonary fungal infection, Aspergillus fumigatus. Thus, higher order detection of specific features of fungal infection by these dendritic cells must direct Th2 cell lineage commitment. Since chitin-containing parasites commonly elicit Th2 responses, we hypothesized that recognition of fungal chitin is an important determinant of Th2 cell-mediated mycosis. Using C. neoformans mutants or purified chitin, we found that chitin abundance impacted Th2 cell accumulation and disease. Importantly, we determined Th2 cell induction depended on cleavage of chitin via the mammalian chitinase, chitotriosidase, an enzyme that was also prevalent in humans experiencing overt cryptococcosis. The data presented herein offers a new perspective on fungal disease susceptibility, whereby chitin recognition via chitotriosidase leads to the initiation of harmful Th2 cell differentiation by CD11b+ conventional dendritic cells in response to pulmonary fungal infection.","[Wiesner, Darin L.; Smith, Kyle D.; Mukaremera, Liliane; Lee, S. Thera; Bohjanen, Paul R.; Jenkins, Marc K.; Nielsen, Kirsten] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Specht, Charles A.; Lee, Chrono K.; Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Lee, Chun G.] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm & Crit Care Med, New Haven, CT 06510 USA; [Elias, Jack A.] Brown Univ, Div Biol & Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Nielsen, Judith N.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Boulware, David R.; Bohjanen, Paul R.] Univ Minnesota, Sch Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA","Wiesner, DL (reprint author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.",knielsen@umn.edu,"Jenkins, Marc K/G-1063-2012","Jenkins, Marc K/0000-0001-8009-7655; Boulware, David/0000-0002-4715-0060; Lee, Chun Geun/0000-0002-9514-3658","NIH [AI080275, AI072195, AI093302, AI025780, AI089067, HL112671, AI039614]; NIH T32 training grant [AI007313]; University of Minnesota Doctoral Dissertation Fellowship; Dennis W. Watson Fellowship","This work was supported by NIH grant AI080275 to KN; AI072195 and AI093302 to CAS; AI025780, AI089067, and HL112671 to SML; and AI039614 to MKJ. DLW received support from NIH T32 training grant AI007313, University of Minnesota Doctoral Dissertation Fellowship, and Dennis W. Watson Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bueter CL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003080; Burton OT, 2007, TRENDS IMMUNOL, V28, P419, DOI 10.1016/j.it.2007.08.005; Choi EH, 2001, GENES IMMUN, V2, P248, DOI 10.1038/sj.gene.6363767; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Couppie P, 2004, CLIN INFECT DIS, V38, P134, DOI 10.1086/379770; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Fitz LJ, 2012, AM J RESP CELL MOL, V46, P71, DOI 10.1165/rcmb.2011-0095OC; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gordon-Thomson C, 2009, CELL MOL LIFE SCI, V66, P1116, DOI 10.1007/s00018-009-8765-7; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Kenyon C, 2013, NEW ENGL J MED, V369, P1416, DOI 10.1056/NEJMoa1215460; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kogiso M, 2011, J LEUKOCYTE BIOL, V90, P167, DOI 10.1189/jlb.1110624; Kronstad JW, 2013, TRENDS MICROBIOL, V21, P457, DOI 10.1016/j.tim.2013.05.007; Lee CG, 2012, J IMMUNOL, V189, P2635, DOI 10.4049/jimmunol.1201115; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levitz SM, 2001, P NATL ACAD SCI USA, V98, P10422, DOI 10.1073/pnas.181331398; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lowe DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069969; Malaguarnera L, 2003, GENES IMMUN, V4, P570, DOI 10.1038/sj.gene.6364025; McKenna HJ, 2000, BLOOD, V95, P3489; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; MONHEIT JE, 1984, ARCH PATHOL LAB MED, V108, P616; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Muller U, 2012, MUCOSAL IMMUNOL, V5, P299, DOI 10.1038/mi.2012.9; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2013, MBIO, V4, DOI 10.1128/mBio.00522-12; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Okagaki LH, 2011, EUKARYOT CELL, V10, P1306, DOI 10.1128/EC.05179-11; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rapaka RR, 2010, J EXP MED, V207, P2907, DOI 10.1084/jem.20100034; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Roy RM, 2012, J IMMUNOL, V189, P2545, DOI 10.4049/jimmunol.1200689; Sabiiti Wilber, 2012, Int J Microbiol, V2012, P626745, DOI 10.1155/2012/626745; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulze B, 2014, EUR J IMMUNOL; Shinya T, 2010, PLANT CELL PHYSIOL, V51, P262, DOI 10.1093/pcp/pcp185; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x; Ustianowski AP, 2008, CURR OPIN INFECT DIS, V21, P31, DOI 10.1097/QCO.0b013e3282f406ae; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wiesner DL, 2011, CURR FUNGAL INFECT R, V5, P252, DOI 10.1007/s12281-011-0064-8; Wiesner DL, 2012, MBIO, V3, DOI 10.1128/mBio.00196-12; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945; Zaragoza O, 2013, CURR OPIN MICROBIOL, V16, P409, DOI 10.1016/j.mib.2013.03.006; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P271; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336",83,77,78,1,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004701,10.1371/journal.ppat.1004701,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900029,25764512.0,"DOAJ Gold, Green Published",,,16/08/2019,72,5,53,5984,643,509,134,5341,4237,28,1076,53,0,0,0,73,73,1,,113,4,68,0,4,75,75,64,53,0,0,0,0,0,0,0,0,7,6124,226,0,143,229,1,5427,667,73,0,143,226,1,30,,0,0,0,0,8,0,0,1,0,0,0,74,0,0,3.0,9.30637636080871,1.1203894401797416,0.12038944017974162,1.2317917992885228,1.0994318181818181,10.23172628304821
102,J,"Yang, WL; Kouyos, RD; Boni, J; Yerly, S; Klimkait, T; Aubert, V; Scherrer, AU; Shilaih, M; Hinkley, T; Petropoulos, C; Bonhoeffer, S; Gunthard, HF",,,,"Yang, Wan-Lin; Kouyos, Roger D.; Boeni, Juerg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Scherrer, Alexandra U.; Shilaih, Mohaned; Hinkley, Trevor; Petropoulos, Christos; Bonhoeffer, Sebastian; Guenthard, Huldrych F.",,Swiss HIV Cohort Study SHCS,Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS-INFECTION; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL TREATMENT; VARIANTS; TRANSMISSION; PREVALENCE; AFRICA,"Transmission of drug-resistant pathogens presents an almost-universal challenge for fighting infectious diseases. Transmitted drug resistance mutations (TDRM) can persist in the absence of drugs for considerable time. It is generally believed that differential TDRM-persistence is caused, at least partially, by variations in TDRM-fitness-costs. However, in vivo epidemiological evidence for the impact of fitness costs on TDRM-persistence is rare. Here, we studied the persistence of TDRM in HIV-1 using longitudinally-sampled nucleotide sequences from the Swiss-HIV-Cohort-Study (SHCS). All treatment-naive individuals with TDRM at baseline were included. Persistence of TDRM was quantified via reversion rates (RR) determined with interval-censored survival models. Fitness costs of TDRM were estimated in the genetic background in which they occurred using a previously published and validated machine-learning algorithm (based on in vitro replicative capacities) and were included in the survival models as explanatory variables. In 857 sequential samples from 168 treatment-naive patients, 17 TDRM were analyzed. RR varied substantially and ranged from 174.0/100-person-years; CI=[51.4, 588.8] (for 184V) to 2.7/100-person-years;[0.7, 10.9] (for 215D). RR increased significantly with fitness cost (increase by 1.6[1.3,2.0] per standard deviation of fitness costs). When subdividing fitness costs into the average fitness cost of a given mutation and the deviation from the average fitness cost of a mutation in a given genetic background, we found that both components were significantly associated with reversion-rates. Our results show that the substantial variations of TDRM persistence in the absence of drugs are associated with fitness-cost differences both among mutations and among different genetic backgrounds for the same mutation.","[Yang, Wan-Lin; Kouyos, Roger D.; Scherrer, Alexandra U.; Shilaih, Mohaned; Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Yang, Wan-Lin; Kouyos, Roger D.; Boeni, Juerg; Scherrer, Alexandra U.; Shilaih, Mohaned; Guenthard, Huldrych F.] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, AIDS Ctr, Geneva, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed Peterspl, Basel, Switzerland; [Aubert, Vincent] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Aubert, Vincent] Univ Lausanne, Lausanne, Switzerland; [Hinkley, Trevor; Bonhoeffer, Sebastian] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Petropoulos, Christos] Monogram Biosci, San Francisco, CA USA","Yang, WL (reprint author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.",huldrych.guenthard@usz.ch,"Pantaleo, Giuseppe/K-6163-2016; Boeni, Juerg/B-8386-2015; Bonhoeffer, Sebastian/A-2735-2008; gunthard, huldrych f/F-1724-2011; Kouyos, Roger/G-6226-2014","Bonhoeffer, Sebastian/0000-0001-8052-3925; gunthard, huldrych f/0000-0002-1142-6723; Kouyos, Roger/0000-0002-9220-8348","Swiss HIV Cohort Study - Swiss National Science Foundation (SNF) [33CS30-134277]; SHCS [470, 528, 569, 683]; SHCS Research Foundation; Swiss National Science Foundation [324730-130865]; European Community under the Collaborative HIV and Anti-HIV Drug-resistance Network (CHAIN) [223131]; Yvonne-Jacob foundation; Union Bank of Switzerland; Gilead, Switzerland; University of Zurich; SNF [PZ00P3-142411]","This study has been financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (SNF grant #33CS30-134277) and the SHCS projects #470, 528, 569, 683, the SHCS Research Foundation, the Swiss National Science Foundation (grant #324730-130865 (to HFG), the European Community's Seventh Framework Program (grant FP7/2007-2013), under the Collaborative HIV and Anti-HIV Drug-resistance Network (CHAIN; grant 223131, to HFG), by the Yvonne-Jacob foundation and by a further research grant of the Union Bank of Switzerland, in the name of an anonymous donor to HFG, an unrestricted research grant from Gilead, Switzerland to the SHCS research foundation, and by the University of Zurich's Clinical research Priority Program (CRPP) ""Viral infectious diseases: Zurich Primary HIV Infection Study"" (to HFG). RDK was supported by SNF #PZ00P3-142411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Barbour JD, 2004, AIDS, V18, P1683, DOI 10.1097/01.aids.0000131391.91468.ff; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Kouyos RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002321; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Little SJ, 2000, ANTIVIRAL THERAPY; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Metzner KJ, 2011, PLOS ONE; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI DOI 10.1093/IJE/DYP321; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wiesch zur PA, 2011, LANCET INFECT DIS, V11, P236, DOI DOI 10.1016/S1473-3099(10)70264-4; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 1998, J VIROL, V72, P3520; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685",32,32,34,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004722,10.1371/journal.ppat.1004722,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900043,25798934.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,35,1,11,4233,832,600,232,3401,2729,21,651,11,0,0,0,35,35,1,,193,11,65,0,11,38,38,37,22,0,0,0,0,0,0,0,1,7,4276,26,0,257,178,1,3389,832,26,0,257,178,1,55,,0,0,0,0,3,0,1,1,0,0,0,64,0,0,1.25,5.087740384615385,1.244633931196707,0.24463393119670684,1.3172596295207293,1.058351051263879,5.384615384615385
103,J,"Yeo, TW; Lampah, DA; Kenangalem, E; Tjitra, E; Price, RN; Weinberg, JB; Hyland, K; Granger, DL; Anstey, NM",,,,"Yeo, Tsin W.; Lampah, Daniel A.; Kenangalem, Enny; Tjitra, Emiliana; Price, Ric N.; Weinberg, J. Brice; Hyland, Keith; Granger, Donald L.; Anstey, Nicholas M.",,,"Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Dihydrobiopterin in Adult Falciparum Malaria: Association with Disease Severity, Impaired Microvascular Function and Increased Endothelial Activation",PLOS PATHOGENS,,,English,Article,,,,,,,NITRIC-OXIDE SYNTHASE; RANDOMIZED-TRIAL; ANGIOPOIETIN-2; DYSFUNCTION; ARTESUNATE; CHILDREN; PTERINS; QUININE; SEPSIS,"Tetrahydrobiopterin (BH4) is a co-factor required for catalytic activity of nitric oxide synthase (NOS) and amino acid-monooxygenases, including phenylalanine hydroxylase. BH4 is unstable: during oxidative stress it is non-enzymatically oxidized to dihydrobiopterin (BH2), which inhibits NOS. Depending on BH4 availability, NOS oscillates between NO synthase and NADPH oxidase: as the BH4/BH2 ratio decreases, NO production falls and is replaced by superoxide. In African children and Asian adults with severe malaria, NO bioavailability decreases and plasma phenylalanine increases, together suggesting possible BH4 deficiency. The primary three biopterin metabolites (BH4, BH2 and B-0 [biopterin]) and their association with disease severity have not been assessed in falciparum malaria. We measured pterin metabolites in urine of adults with severe falciparum malaria (SM; n=12), moderatelysevere malaria (MSM, n=17), severe sepsis (SS; n=5) and healthy subjects (HC; n=20) as controls. In SM, urinary BH4 was decreased (median 0.16 1/4mol/mmol creatinine) compared to MSM (median 0.27), SS (median 0.54), and HC (median 0.34)]; p<0.001. Conversely, BH2 was increased in SM (median 0.91 1/4mol/mmol creatinine), compared to MSM (median 0.67), SS (median 0.39), and HC (median 0.52); p<0.001, suggesting increased oxidative stress and insufficient recycling of BH2 back to BH4 in severe malaria. Overall, the median BH4/BH2 ratio was lowest in SM [0.18 (IQR: 0.04-0.32)] compared to MSM (0.45, IQR 0.2761), SS (1.03; IQR 0.54-2.38) and controls (0.66; IQR 0.43-1.07); p< 0.001. In malaria, a lower BH4/BH2 ratio correlated with decreased microvascular reactivity (r= 0.41; p= 0.03) and increased ICAM-1 (r=-0.52; p= 0.005). Decreased BH4 and increased BH2 in severe malaria (but not in severe sepsis) uncouples NOS, leading to impaired NO bioavailability and potentially increased oxidative stress. Adjunctive therapy to regenerate BH4 may have a role in improving NO bioavailability and microvascular perfusion in severe falciparum malaria.","[Yeo, Tsin W.; Price, Ric N.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Yeo, Tsin W.; Price, Ric N.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Yeo, Tsin W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Yeo, Tsin W.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Lampah, Daniel A.; Kenangalem, Enny] Menzies Sch Hlth Res, Natl Inst Hlth Res & Dev, Res Program, Timika, Papua, Indonesia; [Lampah, Daniel A.; Kenangalem, Enny] Dist Minist Hlth, Timika, Papua, Indonesia; [Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Weinberg, J. Brice] Duke Univ, Durham, NC USA; [Weinberg, J. Brice] VA Med Ctr, Durham, NC USA; [Hyland, Keith] Med Neurogenet LLC, Atlanta, GA USA; [Granger, Donald L.] Univ Utah, Div Infect Dis, Salt Lake City, UT USA; [Granger, Donald L.] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia","Yeo, TW (reprint author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.",tsin.yeo@menzies.edu.au,"Yeo, Tsin Wen/F-9505-2015","Price, Richard/0000-0003-2000-2874","Australian National Health and Medical Research Council [605807, 1037304, 1042072, 605831]; Australian National Health and Medical Research Council (ICRG) [283321]; Wellcome Trust [ICRG GR071614MA, 091625]; United States National Institutes of Health [AI041764, AI057565, AI100784]; US Veterans Affairs Medical Research Service; AusAID","The study was funded by the Australian National Health and Medical Research Council (Grant numbers 605807, 1037304 and ICRG ID 283321 and Fellowships to NMA [1042072] and TWY [605831])), the Wellcome Trust (ICRG GR071614MA and Senior Fellowship to RNP [091625]), United States National Institutes of Health [grants number AI041764 (JBW); AI057565 and AI100784 (DLG)], the US Veterans Affairs Medical Research Service (JBW and DLG) and in-kind support from Medical Neurogenetics LLC. The Timika Malaria Research Facility was supported by AusAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bendall JK, 2014, ANTIOXID REDOX SIGN, V20, P3040, DOI 10.1089/ars.2013.5566; Blau N, 2001, METABOLIC MOL BASES; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Crabtree MJ, 2011, NITRIC OXIDE-BIOL CH, V25, P81, DOI 10.1016/j.niox.2011.04.004; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Faiz MA, 2005, LANCET, V366, P717; Galley HF, 2001, BRIT J ANAESTH, V86, P578, DOI 10.1093/bja/86.4.578; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Heitzer T, 2000, CIRC RES, V86, pE36, DOI 10.1161/01.RES.86.2.e36; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; HYLAND K, 1988, J CHROMATOGR-BIOMED, V429, P95, DOI 10.1016/S0378-4347(00)83868-2; HYLAND K, 1985, J CHROMATOGR, V343, P35, DOI 10.1016/S0378-4347(00)84565-X; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; Ohashi A, 2012, MOL GENET METAB, V105, P575, DOI 10.1016/j.ymgme.2012.01.009; Ong PK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003444; Opladen T, 2011, J INHERIT METAB DIS, V34, P819, DOI 10.1007/s10545-011-9300-1; REIBNEGGER G, 1984, T ROY SOC TROP MED H, V78, P545, DOI 10.1016/0035-9203(84)90080-4; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Weinberg JB, 2014, J INFECT DIS; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069587; Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; Yeo TW, 2014, J INFECT DIS; Zurfluh MR, 2005, MOL GENET METAB, V86, pS96, DOI 10.1016/j.ymgme.2005.09.011",38,17,17,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004667,10.1371/journal.ppat.1004667,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900009,25764397.0,"DOAJ Gold, Green Published",,,16/08/2019,16,1,24,2319,446,315,131,1873,1476,20,377,24,0,0,0,15,15,1,,27,4,27,0,4,17,17,9,9,0,0,0,0,0,0,0,3,3,2330,134,0,73,103,0,1867,446,134,0,73,103,0,17,,1,0,0,0,1,0,0,1,0,0,0,27,0,0,9.5,5.199551569506727,1.2381206620395089,0.2381206620395088,1.3705285638013882,1.1069426476929711,5.755605381165919
104,J,"Zhu, WH; Tao, LL; Quick, ML; Joyce, JA; Qu, JM; Luo, ZQ",,,,"Zhu, Wenhan; Tao, Lili; Quick, Marsha L.; Joyce, Johanna A.; Qu, Jie-Ming; Luo, Zhao-Qing",,,Sensing Cytosolic RpsL by Macrophages Induces Lysosomal Cell Death and Termination of Bacterial Infection,PLOS PATHOGENS,,,English,Article,,,,,,,LEGIONELLA-PNEUMOPHILA INFECTION; TUMOR-NECROSIS-FACTOR; INTRACELLULAR GROWTH; MEMBRANE PERMEABILIZATION; INFLAMMASOME ACTIVATION; MICROBIAL INFECTIONS; MOUSE MACROPHAGES; ESCHERICHIA-COLI; INNATE IMMUNITY; APOPTOSIS,"The intracellular bacterial pathogen Legionella pneumophila provokes strong host responses and has proven to be a valuable model for the discovery of novel immunosurveillance pathways. Our previous work revealed that an environmental isolate of L. pneumophila induces a noncanonical form of cell death, leading to restriction of bacterial replication in primary mouse macrophages. Here we show that such restriction also occurs in infections with wild type clinical isolates. Importantly, we found that a lysine to arginine mutation at residue 88 (K88R) in the ribosome protein RpsL that not only confers bacterial resistance to streptomycin, but more importantly, severely attenuated the induction of host cell death and enabled L. pneumophila to replicate in primary mouse macrophages. Although conferring similar resistance to streptomycin, a K43N mutation in RpsL does not allow productive intracellular bacterial replication. Further analysis indicated that RpsL is capable of effectively inducing macrophage death via a pathway involved in lysosomal membrane permeabilization; the K88R mutant elicits similar responses but is less potent. Moreover, cathepsin B, a lysosomal protease that causes cell death after being released into the cytosol upon the loss of membrane integrity, is required for efficient RpsL-induced macrophage death. Furthermore, despite the critical role of cathepsin B in delaying RpsL-induced cell death, macrophages lacking cathepsin B do not support productive intracellular replication of L. pneumophila harboring wild type RpsL. This suggests the involvement of other yet unidentified components in the restriction of bacterial replication. Our results identified RpsL as a regulator in the interactions between bacteria such as L. pneumophila and primary mouse macrophages by triggering unique cellular pathways that restrict intracellular bacterial replication.","[Zhu, Wenhan; Tao, Lili; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Tao, Lili; Qu, Jie-Ming] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Quick, Marsha L.; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA","Zhu, WH (reprint author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.",luoz@purdue.edu,,"Luo, Zhao-Qing/0000-0001-8890-6621","National Institutes of Health [R56AI103168, K02AI085403, R21AI105714]; Chinese Natural Science Foundation [81401638]; Shanghai leading Talent Projects [0362010]; American Cancer Society","This work was supported by National Institutes of Health grants R56AI103168, K02AI085403 and R21AI105714 (ZQL), Chinese Natural Science Foundation Grant 81401638 (LT) and Shanghai leading Talent Projects (No. 0362010) (JMQ), American Cancer Society (JAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Angst DC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-163; Aurell H, 2003, J CLIN MICROBIOL, V41, P3320, DOI 10.1128/JCM.41.7.3320-3322.2003; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dumenil G, 2001, MOL MICROBIOL, V40, P1113, DOI 10.1046/j.1365-2958.2001.02454.x; Erener S, 2012, MOL CELL, V46, P200, DOI 10.1016/j.molcel.2012.02.016; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fontana MF, 2011, IMMUNOL REV, V243, P26, DOI 10.1111/j.1600-065X.2011.01037.x; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2010, BIOL CHEM, V391, P937, DOI 10.1515/BC.2010.080; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Khan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067298; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Lage SL, 2013, P NATL ACAD SCI USA, V110, pE3321, DOI 10.1073/pnas.1305316110; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Miskinyte M, 2013, ANTIMICROB AGENTS CH, V57, P189, DOI 10.1128/AAC.01632-12; Molmeret M, 2004, CELL MICROBIOL, V6, P33, DOI 10.1046/j.1462-5822.2003.00335.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Rankin S, 2002, INFECT IMMUN, V70, P3637, DOI 10.1128/IAI.70.7.3637-3648.2002; Rao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064129; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Rintahaka J, 2011, J IMMUNOL, V186, P3085, DOI 10.4049/jimmunol.1002051; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Shi J, 2014, NATURE; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; SWANSON MS, 1995, INFECT IMMUN, V63, P3609; Tao LL, 2013, INFECT IMMUN, V81, P3077, DOI 10.1128/IAI.00252-13; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Vance RE, 2010, J CLIN IMMUNOL, V30, P507, DOI 10.1007/s10875-010-9389-2; VANDENEEDE G, 1992, MOL PLANT MICROBE IN, V5, P228; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037",70,11,11,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAR,2015,11,3,,,,,,,UNSP e1004704,10.1371/journal.ppat.1004704,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE9ZI,WOS:000352201900032,25738962.0,"DOAJ Gold, Green Published",,,16/08/2019,11,2,11,4102,589,436,153,3513,2989,17,507,11,0,0,0,10,10,2,,0,1,0,0,1,13,13,10,4,0,0,0,0,0,0,1,3,1,4147,41,0,99,94,0,3523,591,41,0,99,94,0,33,,5,0,0,0,11,0,2,1,0,0,0,11,0,0,44.7,6.964346349745331,1.1676629661258184,0.16766296612581838,1.2189012240250499,1.0438810336421258,7.269949066213922
105,J,"Abkallo, HM; Tangena, JA; Tang, JX; Kobayashi, N; Inoue, M; Zoungrana, A; Colegrave, N; Culleton, R",,,,"Abkallo, Hussein M.; Tangena, Julie-Anne; Tang, Jianxia; Kobayashi, Nobuyuki; Inoue, Megumi; Zoungrana, Augustin; Colegrave, Nick; Culleton, Richard",,,Within-host Competition Does Not Select for Virulence in Malaria Parasites; Studies with Plasmodium yoelii,PLOS PATHOGENS,,,English,Article,,,,,,,PAPUA-NEW-GUINEA; MIXED-GENOTYPE INFECTIONS; RODENT MALARIA; SPECIES INFECTIONS; FALCIPARUM-MALARIA; GENETIC DIVERSITY; TRANSMISSION SUCCESS; ANOPHELES-STEPHENSI; MOSQUITOS; CHILDREN,"In endemic areas with high transmission intensities, malaria infections are very often composed of multiple genetically distinct strains of malaria parasites. It has been hypothesised that this leads to intra-host competition, in which parasite strains compete for resources such as space and nutrients. This competition may have repercussions for the host, the parasite, and the vector in terms of disease severity, vector fitness, and parasite transmission potential and fitness. It has also been argued that within-host competition could lead to selection for more virulent parasites. Here we use the rodent malaria parasite Plasmodium yoelii to assess the consequences of mixed strain infections on disease severity and parasite fitness. Three isogenic strains with dramatically different growth rates (and hence virulence) were maintained in mice in single infections or in mixed strain infections with a genetically distinct strain. We compared the virulence (defined as harm to the mammalian host) of mixed strain infections with that of single infections, and assessed whether competition impacted on parasite fitness, assessed by transmission potential. We found that mixed infections were associated with a higher degree of disease severity and a prolonged infection time. In the mixed infections, the strain with the slower growth rate was often responsible for the competitive exclusion of the faster growing strain, presumably through host immune-mediated mechanisms. Importantly, and in contrast to previous work conducted with Plasmodium chabaudi, we found no correlation between parasite virulence and transmission potential to mosquitoes, suggesting that within-host competition would not drive the evolution of parasite virulence in P. yoelii.","[Abkallo, Hussein M.; Tangena, Julie-Anne; Tang, Jianxia; Inoue, Megumi; Zoungrana, Augustin; Culleton, Richard] Nagasaki Univ, Malaria Unit, Inst Trop Med, Nagasaki 852, Japan; [Abkallo, Hussein M.; Kobayashi, Nobuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Lab Mol Biol Infect Agents, Nagasaki 852, Japan; [Tangena, Julie-Anne] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Colegrave, Nick] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland","Abkallo, HM (reprint author), Nagasaki Univ, Malaria Unit, Inst Trop Med, Nagasaki 852, Japan.",richard@nagasaki-u.ac.jp,"Tangena, Julie-Anne/L-1053-2019; Culleton, Richard/H-8327-2014","Tangena, Julie-Anne/0000-0002-8188-4498; Culleton, Richard/0000-0001-8808-5771; Abkallo, Hussein/0000-0002-5594-4418","JSPS [24255009, 25870525]; Naito Foundation Natural Science Scholarship, Japan","This work was supported by the JSPS Grant-in-Aid for Scientific Research Nos. 24255009 and 25870525 (RC), and a Naito Foundation Natural Science Scholarship, Japan (to RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","A-Elbasit IE, 2007, PARASITOL RES, V102, P29, DOI 10.1007/s00436-007-0716-3; Abkallo HM, 2014, INT J PARASITOL, V44, P467, DOI 10.1016/j.ijpara.2014.03.002; Alifrangis M, 1999, PARASITOLOGY, V119, P337, DOI 10.1017/S0031182099004825; Amodu OK, 2008, ANN TROP MED PARASIT, V102, P95, DOI 10.1179/136485908X252340; Arez A. P., 1997, Parassitologia (Rome), V39, P65; BABIKER HA, 1994, PARASITOLOGY, V109, P413, DOI 10.1017/S0031182000080665; BABIKER HA, 1995, PARASITOLOGY, V111, P433, DOI 10.1017/S0031182000065938; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; BEIER MS, 1988, AM J TROP MED HYG, V39, P323, DOI 10.4269/ajtmh.1988.39.323; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1554/05-611.1; BLACK J, 1994, LANCET, V343, P1095, DOI 10.1016/S0140-6736(94)90203-8; Bruce MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002775; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Carlton JMR, 1998, MOL BIOCHEM PARASIT, V93, P285, DOI 10.1016/S0166-6851(98)00043-7; Cheesman SJ, 2003, MOL BIOCHEM PARASIT, V131, P83, DOI 10.1016/S0166-6851(03)00195-6; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Culleton R, 2012, EVOLUTION OF VIRULEN, P269; Culleton RL, 2015, PARASITOL INT, V64, P244, DOI 10.1016/j.parint.2014.07.006; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Durand R, 2008, TROP MED INT HEALTH, V13, P1392, DOI 10.1111/j.1365-3156.2008.02156.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Ferguson HM, 2003, EVOLUTION, V57, P2792; GAMAGEMENDIS AC, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90396-8; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; HACKER CS, 1974, J INVERTEBR PATHOL, V23, P101, DOI 10.1016/0022-2011(74)90079-2; Hastings IM, 2010, AM J TROP MED HYG, V83, P489, DOI 10.4269/ajtmh.2010.10-0072; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Hogg JC, 1995, PARASITOLOGY, V111, P555, DOI 10.1017/S0031182000077027; Huber W, 1998, PARASITOLOGY, V116, P95, DOI 10.1017/S0031182097002138; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Hurd H, 2005, CURR TOP MICROBIOL, V289, P185; Imwong M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-253; Inoue M, 2012, INT J PARASITOL, V42, P859, DOI 10.1016/j.ijpara.2012.07.001; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Kun JFJ, 1998, T ROY SOC TROP MED H, V92, P110, DOI 10.1016/S0035-9203(98)90979-8; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI 10.1111/j.1558-5646.1999.tb05364.x; MAIER WA, 1987, PARASITOL TODAY, V3, P216, DOI 10.1016/0169-4758(87)90063-9; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Mayengue PI, 2007, PARASITOL RES, V100, P487, DOI 10.1007/s00436-006-0287-8; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Pattaradilokrat S, 2008, MOL BIOCHEM PARASIT, V157, P244, DOI 10.1016/j.molbiopara.2007.10.011; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Pollitt LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002590; Pollitt LC, 2011, AM NAT, V177, P358, DOI 10.1086/658175; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; R Development Core Team, 2014, R LANG ENV STAT COMP; Ranjit MR, 2005, T ROY SOC TROP MED H, V99, P389, DOI 10.1016/j.trstmh.2004.09.010; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; RICHIE TL, 1988, PARASITOLOGY, V96, P607, DOI 10.1017/S0031182000080227; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; Rout R, 2009, TROP BIOMED, V26, P165; Schneider P, 2012, P ROY SOC B-BIOL SCI, V279, P4677, DOI 10.1098/rspb.2012.1792; SNOUNOU G, 1992, PARASITOLOGY, V105, P21, DOI 10.1017/S0031182000073649; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Taylor LH, 1997, P ROY SOC B-BIOL SCI, V264, P927, DOI 10.1098/rspb.1997.0128; Vernick KD, 2005, CURR TOP MICROBIOL, V295, P383; Vezilier J, 2012, P ROY SOC B-BIOL SCI, V279, P4033, DOI 10.1098/rspb.2012.1394; Wargo AR, 2007, P R SOC B, V274, P2629, DOI 10.1098/rspb.2007.0873; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004",69,10,10,1,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004628,10.1371/journal.ppat.1004628,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400017,25658331.0,"DOAJ Gold, Green Published",,,16/08/2019,10,15,55,7857,416,304,112,7441,6623,19,799,55,1,0,0,10,10,0,,65,18,65,0,18,11,11,9,7,0,0,0,0,0,0,0,14,0,7869,26,0,170,108,1,7423,416,26,0,170,108,1,30,,0,0,0,0,2,0,0,0,0,0,0,65,0,0,0.75,18.88701923076923,1.0559064641849214,0.05590646418492138,1.0755274828652064,1.0185821560392008,19.23798076923077
106,J,"Adnan, S; Colantonio, AD; Yu, Y; Gillis, J; Wong, FE; Becker, EA; Piatak, M; Reeves, RK; Lifson, JD; O'Connor, SL; Johnson, RP",,,,"Adnan, Sama; Colantonio, Arnaud D.; Yu, Yi; Gillis, Jacqueline; Wong, Fay E.; Becker, Ericka A.; Piatak, Michael, Jr.; Reeves, R. Keith; Lifson, Jeffrey D.; O'Connor, Shelby L.; Johnson, R. Paul",,,CD8 T Cell Response Maturation Defined by Anentropic Specificity and Repertoire Depth Correlates with SIV Delta nef-induced Protection,PLOS PATHOGENS,,,English,Article,,,,,,,SIMIAN-IMMUNODEFICIENCY-VIRUS; LIVE-ATTENUATED SIV; HIGHLY PATHOGENIC SIV; CLASS-I ALLELES; VACCINE PROTECTION; RHESUS MACAQUES; LYMPHOCYTE RESPONSES; CONTROL REPLICATION; VAGINAL CHALLENGE; HIV-INFECTION,"The live attenuated simian immunodeficiency virus (LASIV) vaccine SIV Delta nef is one of the most effective vaccines in inducing protection against wild-type lentiviral challenge, yet little is known about the mechanisms underlying its remarkable protective efficacy. Here, we exploit deep sequencing technology and comprehensive CD8 T cell epitope mapping to deconstruct the CD8 T cell response, to identify the regions of immune pressure and viral escape, and to delineate the effect of epitope escape on the evolution of the CD8 T cell response in SIV Delta nef-vaccinated animals. We demonstrate that the initial CD8 T cell response in the acute phase of SIV Delta nef infection is mounted predominantly against more variable epitopes, followed by widespread sequence evolution and viral escape. Furthermore, we show that epitope escape expands the CD8 T cell repertoire that targets highly conserved epitopes, defined as anentropic specificity, and generates de novo responses to the escaped epitope variants during the vaccination period. These results correlate SIV Delta nef-induced protection with expanded anentropic specificity and increased response depth. Importantly, these findings render SIV Delta nef, long the gold standard in HIV/SIV vaccine research, as a proof-of-concept vaccine that highlights the significance of the twin principles of anentropic specificity and repertoire depth in successful vaccine design.","[Adnan, Sama; Colantonio, Arnaud D.; Yu, Yi; Gillis, Jacqueline; Wong, Fay E.; Reeves, R. Keith; Johnson, R. Paul] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Becker, Ericka A.; O'Connor, Shelby L.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD USA; [Reeves, R. Keith] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Johnson, R. Paul] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Johnson, R. Paul] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA","Adnan, S (reprint author), Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough Campus, Southborough, MA 01772 USA.",pjohnson@hms.harvard.edu,,,"National Institutes of Health, NIAID [AI071306, AI095985]; Office of Research Infrastructure Programs [P51 OD011103, RR00168]; Harvard Multidisciplinary Training grant [T32 AI07387-24]","This was work was funded by the National Institutes of Health, NIAID grants AI071306, AI095985, as well as grant P51 OD011103 (formerly RR00168) from the Office of Research Infrastructure Programs. SA is supported by the Harvard Multidisciplinary Training grant (T32 AI07387-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Baba TW, 1999, NAT MED, V5, P194; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bilello JP, 2011, J VIROL, V85, P12708, DOI 10.1128/JVI.00865-11; Burwitz BJ, 2011, J VIROL, V85, P3683, DOI 10.1128/JVI.02112-10; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Connor RI, 1998, J VIROL, V72, P7501; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Desrosiers RC, 1998, J VIROL, V72, P1431; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Ganusov VV, 2011, J VIROL, V85, P10518, DOI 10.1128/JVI.00655-11; Gauduin MC, 1998, J VIROL, V72, P6315; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harris M, 2013, J VIROL, V87, P9353, DOI 10.1128/JVI.00909-13; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000272; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnson RP, 1999, J VIROL, V73, P4952; Johnson RP, 1997, J VIROL, V71, P7711; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015639; Macchia I, 2006, IMMUNOLOGY, V119, P232, DOI 10.1111/j.1365-2567.2006.02428.x; Manrique J, 2013, J VIROL, V87, P7246, DOI 10.1128/JVI.00798-13; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; National Research Council of the National Academies, 2011, GUIDE CARE USE LAB A, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Nixon DF, 2000, VIROLOGY, V266, P203, DOI 10.1006/viro.1999.0078; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Sugimoto C, 2003, J VIROL, V77, P4169, DOI 10.1128/JVI.77.7.4169-4180.2003; Tenner-Racz K, 2004, P NATL ACAD SCI USA, V101, P3017, DOI 10.1073/pnas.0308677101; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Wyand MS, 1997, NAT MED, V3, P32, DOI 10.1038/nm0197-32; Wyand MS, 1996, J VIROL, V70, P3724; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718; Yang OO, 2011, AIDS RES HUM RETROV, V27, P391, DOI 10.1089/aid.2010.0183",51,8,8,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004633,10.1371/journal.ppat.1004633,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400021,25688559.0,"DOAJ Gold, Green Published",,,16/08/2019,9,1,12,3207,672,556,116,2535,2211,19,305,12,0,0,0,8,8,0,,0,0,0,0,0,9,9,9,9,0,0,0,0,0,0,0,1,1,3215,35,4,312,142,0,2534,672,35,4,312,142,0,9,,0,0,0,0,1,0,1,1,0,0,0,13,0,0,0.75,4.772321428571429,1.2650887573964498,0.2650887573964497,1.3380670611439842,1.0576863111942625,5.0476190476190474
107,J,"Besnard, AG; Guabiraba, R; Niedbala, W; Palomo, J; Reverchon, F; Shaw, TN; Couper, KN; Ryffel, B; Liew, FY",,,,"Besnard, Anne-Gaelle; Guabiraba, Rodrigo; Niedbala, Wanda; Palomo, Jennifer; Reverchon, Flora; Shaw, Tovah N.; Couper, Kevin N.; Ryffel, Bernhard; Liew, Foo Y.",,,"IL-33-Mediated Protection against Experimental Cerebral Malaria Is Linked to Induction of Type 2 Innate Lymphoid Cells, M2 Macrophages and Regulatory T Cells",PLOS PATHOGENS,,,English,Article,,,,,,,ALTERNATIVELY ACTIVATED MACROPHAGES; MEDIATED AIRWAY INFLAMMATION; IFN-GAMMA; PLASMODIUM-FALCIPARUM; ALLOGRAFT SURVIVAL; TISSUE-REPAIR; IL-33; PATHOGENESIS; CYTOKINE; INTERLEUKIN-33,"Cerebral malaria (CM) is a complex parasitic disease caused by Plasmodium sp. Failure to establish an appropriate balance between pro-and anti-inflammatory immune responses is believed to contribute to the development of cerebral pathology. Using the blood-stage PbA (Plasmodium berghei ANKA) model of infection, we show here that administration of the pro-Th2 cytokine, IL-33, prevents the development of experimental cerebral malaria (ECM) in C57BL/6 mice and reduces the production of inflammatory mediators IFN-gamma, IL-12 and TNF-alpha. IL-33 drives the expansion of type-2 innate lymphoid cells (ILC2) that produce Type-2 cytokines (IL-4, IL-5 and IL-13), leading to the polarization of the anti-inflammatory M2 macrophages, which in turn expand Foxp3 regulatory T cells (Tregs). PbA-infectedmice adoptively transferred with ILC2 have elevated frequency of M2 and Tregs and are protected from ECM. Importantly, IL-33-treatedmice deleted of Tregs (DEREG mice) are no longer able to resist ECM. Our data therefore provide evidence that IL-33 can prevent the development of ECM by orchestrating a protective immune response via ILC2, M2 macrophages and Tregs.","[Besnard, Anne-Gaelle; Guabiraba, Rodrigo; Niedbala, Wanda; Liew, Foo Y.] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Guabiraba, Rodrigo] INRA, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Palomo, Jennifer; Reverchon, Flora; Ryffel, Bernhard] CNRS, UMR7355, F-45071 Orleans, France; [Palomo, Jennifer; Reverchon, Flora; Ryffel, Bernhard] Univ Orleans, Expt & Mol Immunol & Neurogenet, Orleans, France; [Shaw, Tovah N.; Couper, Kevin N.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med, Rondeboasch, South Africa; [Liew, Foo Y.] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China","Besnard, AG (reprint author), Univ Glasgow, Glasgow Biomed Res Ctr, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.",ag.besnard@gmail.com; foo.liew@glasgow.ac.uk,"R, Guabiraba/F-1396-2010","R, Guabiraba/0000-0003-4005-1753; Couper, Kevin/0000-0003-4659-8960; Shaw, Tovah/0000-0002-8107-2836","Wellcome Trust; Medical Research Council, UK; Medical Research Council [G0900487, G9818261]","This work was supported by the Wellcome Trust and the Medical Research Council, UK (to FYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Fauconnier M, 2011, AM J PATHOL, V178, P212, DOI 10.1016/j.ajpath.2010.11.008; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Knowles SCL, 2011, INT J PARASITOL, V41, P1041, DOI 10.1016/j.ijpara.2011.05.009; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Salmond RJ, 2012, J ALLERGY CLIN IMMUN, V130, P1159, DOI 10.1016/j.jaci.2012.05.018; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shikani HJ, 2012, AM J PATHOL, V181, P1484, DOI 10.1016/j.ajpath.2012.08.010; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steeg C, 2009, J IMMUNOL, V183, P7014, DOI 10.4049/jimmunol.0901422; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; Tamura T, 2014, PARASITE IMMUNOL, V36, P87, DOI 10.1111/pim.12085; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WATERS LS, 1987, INFECT IMMUN, V55, P877; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109",48,48,55,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004607,10.1371/journal.ppat.1004607,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400007,25659095.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,52,8,44,8793,1495,996,499,7298,5689,23,1586,44,1,0,0,48,48,1,,93,13,93,0,13,53,53,40,35,0,0,0,0,0,0,0,7,2,8887,37,0,383,117,0,7334,1517,37,0,383,117,0,36,,0,0,0,0,6,0,0,0,0,0,0,93,0,0,2.35,5.881605351170569,1.204850644012058,0.2048506440120581,1.2388325568648946,1.028204253383373,6.047491638795987
108,J,"Boutier, M; Ronsmans, M; Ouyang, P; Fournier, G; Reschner, A; Rakus, K; Wilkie, GS; Farnir, F; Bayrou, C; Lieffrig, F; Li, H; Desmecht, D; Davison, AJ; Vanderplasschen, A",,,,"Boutier, Maxime; Ronsmans, Maygane; Ouyang, Ping; Fournier, Guillaume; Reschner, Anca; Rakus, Krzysztof; Wilkie, Gavin S.; Farnir, Frederic; Bayrou, Calixte; Lieffrig, Francois; Li, Hong; Desmecht, Daniel; Davison, Andrew J.; Vanderplasschen, Alain",,,Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging,PLOS PATHOGENS,,,English,Article,,,,,,,MUCOSAL IMMUNE-SYSTEM; KOI HERPESVIRUS; CARPIO-KOI; VIRAL DISEASE; COMMON CARP; VIRUS; FISH; GENOME; INFECTION; PERSPECTIVES,"Cyprinid herpesvirus 3 (CyHV 3) is causing severe economic losses worldwide in common and koi carp industries, and a safe and efficacious attenuated vaccine compatible with mass vaccination is needed. We produced single deleted recombinants using prokaryotic mutagenesis. When producing a recombinant lacking open reading frame 134 (ORF134), we unexpectedly obtained a clone with additional deletion of ORF56 and ORF57. This triple deleted recombinant replicated efficiently in vitro and expressed an in vivo safety/efficacy profile compatible with use as an attenuated vaccine. To determine the role of the double ORF56-57 deletion in the phenotype and to improve further the quality of the vaccine candidate, a series of deleted recombinants was produced and tested in vivo. These experiments led to the selection of a double deleted recombinant lacking ORF56 and ORF57 as a vaccine candidate. The safety and efficacy of this strain were studied using an in vivo bioluminescent imaging system (IVIS), qPCR, and histopathological examination, which demonstrated that it enters fish via skin infection similar to the wild type strain. However, compared to the parental wild type strain, the vaccine candidate replicated at lower levels and spread less efficiently to secondary sites of infection. Transmission experiments allowing water contamination with or without additional physical contact between fish demonstrated that the vaccine candidate has a reduced ability to spread from vaccinated fish to naive sentinel cohabitants. Finally, IVIS analyses demonstrated that the vaccine candidate induces a protective mucosal immune response at the portal of entry. Thus, the present study is the first to report the rational development of a recombinant attenuated vaccine against CyHV 3 for mass vaccination of carp. We also demonstrated the relevance of the CyHV 3 carp model for studying alloherpesvirus transmission and mucosal immunity in teleost skin.","[Boutier, Maxime; Ronsmans, Maygane; Ouyang, Ping; Fournier, Guillaume; Reschner, Anca; Rakus, Krzysztof; Vanderplasschen, Alain] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Immunol Vaccinol,FARAH, Liege, Belgium; [Wilkie, Gavin S.; Davison, Andrew J.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Farnir, Frederic] Univ Liege, Fac Vet Med, Biostat & Bioinformat, FARAH, Liege, Belgium; [Bayrou, Calixte; Desmecht, Daniel] Univ Liege, Pathol, Dept Morphol & Pathol, FARAH,Fac Vet Med, Liege, Belgium; [Lieffrig, Francois] CER Grp, Dept Biotechnol, Fish Pathol Lab, Marloie, Belgium; [Li, Hong] Washington State Univ, USDA ARS ADRU, Pullman, WA 99164 USA","Boutier, M (reprint author), Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Immunol Vaccinol,FARAH, Liege, Belgium.",A.vdplasschen@ulg.ac.be,,,"MSD Animal Health grant [KHV2013-2014]; Belgian Science Policy grant [R.SSTC.0454-BELVIR IAP7/45]; FNRS [R.FNRS.2165 2.4622.10, R.FNRS.2597-1.A290.12]; UK Medical Research Council [MC_UU_12014/3]; Medical Research Council [G0801822, MC_UU_12014/3]","Funding: This work was supported by MSD Animal Health grant KHV2013-2014 to AV, by Belgian Science Policy grant R.SSTC.0454-BELVIR IAP7/45 to AV, by FNRS grants R.FNRS.2165 2.4622.10 and R.FNRS.2597-1.A290.12 to AV and by UK Medical Research Council grant MC_UU_12014/3 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adamek M, 2014, DEV COMP IMMUNOL, V43, P151, DOI 10.1016/j.dci.2013.08.015; Afonso CL, 2006, J VIROL, V80, P4978, DOI 10.1128/JVI.80.10.4978-4991.2006; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Brudeseth BE, 2013, FISH SHELLFISH IMMUN, V35, P1759, DOI 10.1016/j.fsi.2013.05.029; Costes B, 2008, J VIROL, V82, P4955, DOI 10.1128/JVI.00211-08; Costes B, 2009, J VIROL, V83, P2819, DOI 10.1128/JVI.02305-08; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Davison AJ, 2013, J VIROL, V87, P2908, DOI 10.1128/JVI.03206-12; F.A.O, GLOBAL AQUACULTURE P; FAO, 2014, THE STATE OF WORLD F; Fournier G, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-6; Francois S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003292; Fuchs W, 2011, ARCH VIROL, V156, P1059, DOI 10.1007/s00705-011-0953-8; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; Michel B, 2010, J GEN VIROL, V91, P452, DOI 10.1099/vir.0.015198-0; Michel B, 2010, EMERG INFECT DIS, V16, P1835, DOI 10.3201/eid1612.100593; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Minamoto T, 2012, RES VET SCI, V93, P508, DOI 10.1016/j.rvsc.2011.06.004; Miyazaki T, 2008, DIS AQUAT ORGAN, V80, P1, DOI 10.3354/dao01929; Monaghan SJ, 2015, J FISH DIS, V38, P477, DOI 10.1111/jfd.12260; Muir J, 2005, PHILOS T R SOC B, V360, P191, DOI 10.1098/rstb.2004.1572; Neukirch M, 1999, BULL EUR ASSN FISH P, V19, P221; O'Connor MR, 2014, AM J VET RES, V75, P905, DOI 10.2460/ajvr.75.10.905; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; Ouyang P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-53; Perelberg A, 2005, VACCINE, V23, P3396, DOI 10.1016/j.vaccine.2005.01.096; Perelberg A, 2008, VACCINE, V26, P3750, DOI 10.1016/j.vaccine.2008.04.057; Pikarsky E, 2004, J VIROL, V78, P9544, DOI 10.1128/JVI.78.17.9544-9551.2004; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Raj VS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-92; Rakus K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-85; Rodgers CJ, 2011, REV SCI TECH OIE, V30, P241; Rombout JHWM, 2014, FISH SHELLFISH IMMUN, V40, P634, DOI 10.1016/j.fsi.2014.08.020; Ronen A, 2003, VACCINE, V21, P4677, DOI 10.1016/S0264-410X(03)00523-1; Ronsmans M, 2014, VET RES, V45, DOI 10.1186/s13567-014-0100-0; Rueckert C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003001; Ryo S, 2010, DEV COMP IMMUNOL, V34, P1183, DOI 10.1016/j.dci.2010.06.012; Salgado-Miranda C, 2013, EXPERT REV VACCINES, V12, P567, DOI [10.1586/erv.13.38, 10.1586/ERV.13.38]; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Sunarto Agus, 2005, Bulletin of Fisheries Research Agency, P15; Sunyer JO, 2013, NAT IMMUNOL, V14, P320, DOI 10.1038/ni.2549; Tacchi L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6205; Uchii K, 2013, ANIM CONSERV, V16, P324, DOI 10.1111/j.1469-1795.2012.00604.x; van Beurden SJ, 2012, DIS AQUAT ORGAN, V101, P69, DOI 10.3354/dao02501; van Beurden SJ, 2010, J GEN VIROL, V91, P880, DOI 10.1099/vir.0.016261-0; Waltzek TB, 2005, J GEN VIROL, V86, P1659, DOI 10.1099/vir.0.80982-0; Waltzek TB, 2009, DIS AQUAT ORGAN, V84, P179, DOI 10.3354/dao02023; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weber EPS, 2014, AM J VET RES, V75, P899, DOI 10.2460/ajvr.75.10.899; Xu J, 2013, VET MICROBIOL, V166, P138, DOI 10.1016/j.vetmic.2013.05.025; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Yasumoto S, 2006, FISH PATHOL, V41, P141, DOI 10.3147/jsfp.41.141; Yi Y, 2014, VIRUS RES, V191, P108, DOI 10.1016/j.virusres.2014.07.034; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhou JX, 2014, J FISH DIS, V37, P319, DOI 10.1111/jfd.12105; Zhou JX, 2014, IN VITRO CELL DEV-AN, V50, P489, DOI 10.1007/s11626-014-9737-2",67,16,17,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004690,10.1371/journal.ppat.1004690,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400056,25700279.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,17,8,25,4933,936,677,259,3997,3310,30,657,25,7,0,0,12,12,0,,58,2,31,0,2,17,17,13,6,0,0,0,0,0,0,1,1,0,4943,89,0,350,66,0,3986,936,89,0,350,66,0,21,,39,1,0,0,7,0,2,1,0,0,0,31,0,0,330.7,5.270299145299146,1.2341756317237929,0.23417563172379285,1.2754565924443333,1.0334482059598622,5.446581196581197
109,J,"Chuang, CK; Prasanth, KR; Nagy, PD",,,,"Chuang, Chingkai; Prasanth, K. Reddisiva; Nagy, Peter D.",,,Coordinated Function of Cellular DEAD-Box Helicases in Suppression of Viral RNA Recombination and Maintenance of Viral Genome Integrity,PLOS PATHOGENS,,,English,Article,,,,,,,BUSHY-STUNT-VIRUS; BROME MOSAIC-VIRUS; TOMBUSVIRUS REPLICASE COMPLEX; PLUS-STRAND SYNTHESIS; HOST FACTORS; IN-VITRO; BINDING DOMAINS; MESSENGER-RNA; ANTIVIRAL IMMUNITY; GENE-EXPRESSION,"The intricate interactions between viruses and hosts include an evolutionary arms race and adaptation that is facilitated by the ability of RNA viruses to evolve rapidly due to high frequency mutations and genetic RNA recombination. In this paper, we show evidence that the co-opted cellular DDX3-like Ded1 DEAD-box helicase suppresses tombusviral RNA recombination in yeast model host, and the orthologous RH20 helicase functions in a similar way in plants. In vitro replication and recombination assays confirm the direct role of the ATPase function of Ded1p in suppression of viral recombination. We also present data supporting a role for Ded1 in facilitating the switch from minus-to plus-strand synthesis. Interestingly, another co-opted cellular helicase, the eIF4AIII-like AtRH2, enhances TBSV recombination in the absence of Ded1/RH20, suggesting that the coordinated actions of these helicases control viral RNA recombination events. Altogether, these helicases are the first co-opted cellular factors in the viral replicase complex that directly affect viral RNA recombination. Ded1 helicase seems to be a key factor maintaining viral genome integrity by promoting the replication of viral RNAs with correct termini, but inhibiting the replication of defective RNAs lacking correct 5' end sequences. Altogether, a co-opted cellular DEAD-box helicase facilitates the maintenance of full-length viral genome and suppresses viral recombination, thus limiting the appearance of defective viral RNAs during replication.","[Chuang, Chingkai; Prasanth, K. Reddisiva; Nagy, Peter D.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA","Chuang, CK (reprint author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.",pdnagy2@uky.edu,,,National Science Foundation [MCB-1122039],"Funding: This research was supported by the National Science Foundation (MCB-1122039) to PDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Banroques J, 2010, J MOL BIOL, V396, P949, DOI 10.1016/j.jmb.2009.12.025; Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; Cheng CP, 2007, VIROLOGY, V368, P238, DOI 10.1016/j.virol.2007.07.001; Cheng CP, 2006, J VIROL, V80, P2631, DOI 10.1128/JVI.80.6.2631-2640.2006; Cheng CP, 2005, VIROLOGY, V341, P107, DOI 10.1016/j.virol.2005.06.042; Cheng CP, 2003, J VIROL, V77, P12033, DOI 10.1128/JVI.77.22.12033-12047.2003; Chuang CK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003944; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Figlerowicz M, 1998, J VIROL, V72, P9192; Garbelli A, 2011, CURR MED CHEM, V18, P3015, DOI 10.2174/092986711796391688; Garcia I, 2012, BIOCHEMISTRY-US, V51, P10109, DOI 10.1021/bi301172s; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Huang TS, 2010, PLANT PHYSIOL, V152, P255, DOI 10.1104/pp.109.147983; Jaag HM, 2007, VIROLOGY, V368, P388, DOI 10.1016/j.virol.2007.07.003; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jaag HM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001156; Jaag HM, 2010, CELL HOST MICROBE, V7, P74, DOI 10.1016/j.chom.2009.12.009; Jaag HM, 2009, VIROLOGY, V386, P344, DOI 10.1016/j.virol.2009.01.015; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jiang Y, 2006, J VIROL, V80, P7394, DOI 10.1128/JVI.02686-05; Jiang Y, 2010, VIROLOGY, V404, P96, DOI 10.1016/j.virol.2010.04.025; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Kim MJ, 2001, P NATL ACAD SCI USA, V98, P4972, DOI 10.1073/pnas.081077198; Kovalev N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004051; Kovalev N, 2014, J VIROL, V88, P5638, DOI 10.1128/JVI.03842-13; Kovalev N, 2012, VIROLOGY, V432, P470, DOI 10.1016/j.virol.2012.06.030; Kovalev N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002537; Li ZH, 2008, J VIROL, V82, P6911, DOI 10.1128/JVI.00702-08; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Linder P, 2006, CELL, V125, P219, DOI 10.1016/j.cell.2006.03.030; Linder P, 2008, CURR BIOL, V18, pR297, DOI 10.1016/j.cub.2008.02.027; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Mendu V, 2010, VIROLOGY, V406, P342, DOI 10.1016/j.virol.2010.07.022; Monkewich S, 2005, J VIROL, V79, P4848, DOI 10.1128/JVI.79.8.4848-4858.2005; Nagy P.D., 2012, CURR OPIN VIROL, V2, P685, DOI DOI 10.1016/J.C0VIR0.2012.10.004; NAGY PD, 1995, J VIROL, V69, P2547; Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681; Nagy PD, 1997, P NATL ACAD SCI USA, V94, P1113, DOI 10.1073/pnas.94.4.1113; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Nagy PD, 2011, ADV VIRUS RES, V81, P63, DOI 10.1016/B978-0-12-385885-6.00008-0; Nagy PD, 2010, ADV VIRUS RES, V76, P123, DOI 10.1016/S0065-3527(10)76004-8; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nawaz-ul-Rehman MS, 2013, METHODS, V59, P207, DOI 10.1016/j.ymeth.2012.11.001; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; Oster SK, 1998, J VIROL, V72, P5845; Panavas T, 2005, J VIROL, V79, P9777, DOI 10.1128/JVI.79.15.9777-9785.2005; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Panavas T, 2003, VIROLOGY, V314, P315, DOI 10.1016/S0042-6822(03)00436-7; Panavas T, 2005, VIROLOGY; Panaviene Z, 2005, J VIROL, V79, P10608, DOI 10.1128/JVI.79.16.10608-10618.2005; Panaviene Z, 2003, VIROLOGY, V317, P359, DOI 10.1016/j.virol.2003.08.039; Panaviene Z, 2003, VIROLOGY, V308, P191, DOI 10.1016/S0042-6822(02)00132-0; Pogany J, 2005, J VIROL, V79, P4859, DOI 10.1128/JVI.79.8.4859-4869.2005; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Pogany J, 2008, J VIROL, V82, P5967, DOI 10.1128/JVI.02737-07; Pogany J, 2012, J VIROL, V86, P12025, DOI 10.1128/JVI.01303-12; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244-9258.2003; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; RAO ALN, 1993, J VIROL, V67, P969; Roossinck MJ, 2003, CURR OPIN MICROBIOL, V6, P406, DOI 10.1016/S1369-5274(03)00087-0; Scheel TKH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003228; SCHOLTHOF KBG, 1995, VIROLOGY, V208, P365, DOI 10.1006/viro.1995.1162; Serviene E, 2006, J VIROL, V80, P1231, DOI 10.1128/JVI.80.3.1231-1241.2006; Serviene E, 2005, P NATL ACAD SCI USA, V102, P10545, DOI 10.1073/pnas.0504844102; Shah Nawaz-Ul-Rehman M, 2012, J VIROL, V86, P9384, DOI [10.1128/ JVI. 00019- 12 PMID: 22718827, DOI 10.1128/JVI.00019-12]; Stork J, 2011, VIROLOGY, V409, P338, DOI 10.1016/j.virol.2010.10.015; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Upadya MH, 2014, WORLD J GASTROENTERO, V20, P2913, DOI 10.3748/wjg.v20.i11.2913; Weaver PL, 1997, MOL CELL BIOL, V17, P1354, DOI 10.1128/MCB.17.3.1354; White KA, 2004, PROG NUCLEIC ACID RE, V78, P187, DOI 10.1016/S0079-6603(04)78005-8; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535",79,13,13,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004680,10.1371/journal.ppat.1004680,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400053,25693185.0,"DOAJ Gold, Green Published",,,16/08/2019,14,1,9,3574,651,451,200,2923,2438,24,461,9,0,0,0,13,13,0,,19,0,19,0,0,14,14,14,5,0,0,0,0,0,0,0,1,0,3605,59,0,294,59,0,2931,653,31,0,294,53,0,21,,0,0,0,0,4,0,0,1,0,0,0,16,0,0,1.25,5.490015360983103,1.2227163872733493,0.2227163872733493,1.2736914129319192,1.0416899832120874,5.71889400921659
110,J,"Dalton, JE; Glover, AC; Hoodless, L; Lim, EK; Beattie, L; Kirby, A; Kaye, PM",,,,"Dalton, Jane E.; Glover, Amy C.; Hoodless, Laura; Lim, Eng-Kiat; Beattie, Lynette; Kirby, Alun; Kaye, Paul M.",,,The Neurotrophic Receptor Ntrk2 Directs Lymphoid Tissue Neovascularization during Leishmania donovani Infection,PLOS PATHOGENS,,,English,Article,,,,,,,EXPERIMENTAL VISCERAL LEISHMANIASIS; MONONUCLEAR PHAGOCYTE SYSTEM; TUMOR-ASSOCIATED MACROPHAGES; NECROSIS-FACTOR-ALPHA; IMMUNOHISTOCHEMICAL LOCALIZATION; SPLENIC ARCHITECTURE; IMMUNE-SYSTEM; MARGINAL ZONE; CELL-DEATH; IN-VITRO,"The neurotrophic tyrosine kinase receptor type 2 (Ntrk2, also known as TrkB) and its ligands brain derived neurotrophic factor (Bdnf), neurotrophin-4 (NT-4/5), and neurotrophin-3 (NT-3) are known primarily for their multiple effects on neuronal differentiation and survival. Here, we provide evidence that Ntrk2 plays a role in the pathologic remodeling of the spleen that accompanies chronic infection. We show that in Leishmania donovani-infected mice, Ntrk2 is aberrantly expressed on splenic endothelial cells and that new maturing blood vessels within the white pulp are intimately associated with F4/80(hi)CD11b(lo)CD11c(+) macrophages that express Bdnf and NT-4/5 and have pro-angiogenic potential in vitro. Furthermore, administration of the small molecule Ntrk2 antagonist ANA-12 to infected mice significantly inhibited white pulp neovascularization but had no effect on red pulp vascular remodeling. We believe this to be the first evidence of the Ntrk2/neurotrophin pathway driving pathogen-induced vascular remodeling in lymphoid tissue. These studies highlight the therapeutic potential of modulating this pathway to inhibit pathological angiogenesis.","[Dalton, Jane E.; Hoodless, Laura; Lim, Eng-Kiat; Beattie, Lynette; Kirby, Alun; Kaye, Paul M.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Dalton, Jane E.; Hoodless, Laura; Lim, Eng-Kiat; Beattie, Lynette; Kirby, Alun; Kaye, Paul M.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Glover, Amy C.] Univ York, Dept Biol, Jack Birch Unit, York YO10 5DD, N Yorkshire, England","Dalton, JE (reprint author), Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.",paul.kaye@york.ac.uk,,"Kirby, Alun/0000-0001-5663-2961; Hoodless, Laura/0000-0002-9679-0611; Kaye, Paul/0000-0002-8796-4755; Dalton, Jane/0000-0001-9115-8855",UK Medical Research Council [G1000230]; Medical Research Council [G1000230],"Funding: This study was supported by a grant from the UK Medical Research Council (http://www.mrc.ac.uk; G1000230 to PMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Barichello T, 2014, J NEUROIMMUNOL, V272, P35, DOI 10.1016/j.jneuroim.2014.05.003; Beattie L, 2013, CELL HOST MICROBE, V14, P357, DOI 10.1016/j.chom.2013.08.004; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Brand C, 2012, HISTOL HISTOPATHOL, V27, P1109, DOI 10.14670/HH-27.1109; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Cristofaro B, 2009, CURR OPIN PHARMACOL, V9, P102, DOI 10.1016/j.coph.2008.11.006; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Dalton JE, 2010, J CLIN INVEST, V120, P1204, DOI 10.1172/JCI41281; Diez-Roux G, 1999, DEVELOPMENT, V126, P2141; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Iyer R, 2010, CLIN CANCER RES, V16, P1478, DOI 10.1158/1078-0432.CCR-09-1531; Jackson JR, 1997, FASEB J, V11, P457; Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Mansson-Broberg A, 2008, BIOCHEM BIOPH RES CO, V373, P355, DOI 10.1016/j.bbrc.2008.06.036; Martinelli PM, 2011, INT J CARDIOL, V149, P277, DOI 10.1016/j.ijcard.2011.02.058; Mayeur S, 2010, PLACENTA, V31, P785, DOI 10.1016/j.placenta.2010.06.008; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Perez-Perez M, 2004, CELL TISSUE RES, V316, P179, DOI 10.1007/s00441-004-0876-8; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Serghides L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003980; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157; Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4",54,2,2,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004681,10.1371/journal.ppat.1004681,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400054,25710496.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,3,3,11,3139,649,471,178,2490,2122,24,344,11,3,2,0,2,2,0,,12,0,12,0,0,3,3,3,2,0,0,0,0,0,0,0,0,0,3151,61,0,311,99,0,2485,649,61,0,311,99,0,17,,0,0,0,0,4,0,0,1,0,0,1,12,0,0,2.0,4.836671802773497,1.2606425702811246,0.2606425702811245,1.329718875502008,1.0547945205479452,5.101694915254237
111,J,"Duan, SS; Meliopoulos, VA; McClaren, JL; Guo, XZJ; Sanders, CJ; Smallwood, HS; Webby, RJ; Schultz-Cherry, SL; Doherty, PC; Thomas, PG",,,,"Duan, Susu; Meliopoulos, Victoria A.; McClaren, Jennifer L.; Guo, Xi-Zhi J.; Sanders, Catherine J.; Smallwood, Heather S.; Webby, Richard J.; Schultz-Cherry, Stacey L.; Doherty, Peter C.; Thomas, Paul G.",,,Diverse Heterologous Primary Infections Radically Alter Immunodominance Hierarchies and Clinical Outcomes Following H7N9 Influenza Challenge in Mice,PLOS PATHOGENS,,,English,Article,,,,,,,T-CELL IMMUNITY; A VIRUS; AVIAN INFLUENZA; PROTECTIVE IMMUNITY; PANDEMIC INFLUENZA; CROSS-REACT; AGED MICE; RESPONSES; MEMORY; TRANSMISSION,"The recent emergence of a novel H7N9 influenza A virus (IAV) causing severe human infections in China raises concerns about a possible pandemic. The lack of pre-existing neutralizing antibodies in the broader population highlights the potential protective role of IAV-specific CD8+ cytotoxic T lymphocyte (CTL) memory specific for epitopes conserved between H7N9 and previously encountered IAVs. In the present study, the heterosubtypic immunity generated by prior H9N2 or H1N1 infections significantly, but variably, reduced morbidity and mortality, pulmonary virus load and time to clearance in mice challenged with the H7N9 virus. In all cases, the recall of established CTL memory was characterized by earlier, greater airway infiltration of effectors targeting the conserved or cross-reactive H7N9 IAV peptides; though, depending on the priming IAV, each case was accompanied by distinct CTL epitope immunodominance hierarchies for the prominent K(b)PB1(703), D(b)PA(224), and (DNP366)-N-b epitopes. While the presence of conserved, variable, or cross-reactive epitopes between the priming H9N2 and H1N1 and the challenge H7N9 IAVs clearly influenced any change in the immunodominance hierarchy, the changing patterns were not tied solely to epitope conservation. Furthermore, the total size of the IAV-specific memory CTL pool after priming was a better predictor of favorable outcomes than the extent of epitope conservation or secondary CTL expansion. Modifying the size of the memory CTL pool significantly altered its subsequent protective efficacy on disease severity or virus clearance, confirming the important role of heterologous priming. These findings establish that both the protective efficacy of heterosubtypic immunity and CTL immunodominance hierarchies are reflective of the immunological history of the host, a finding that has implications for understanding human CTL responses and the rational design of CTL-mediated vaccines.","[Duan, Susu; McClaren, Jennifer L.; Guo, Xi-Zhi J.; Sanders, Catherine J.; Smallwood, Heather S.; Doherty, Peter C.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Meliopoulos, Victoria A.; Webby, Richard J.; Schultz-Cherry, Stacey L.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA","Duan, SS (reprint author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.",Paul.Thomas@stjude.org,"Webby, Richard/N-5657-2018; Schultz-Cherry, Stacey/N-2506-2018; Thomas, Paul G./H-1063-2018","Thomas, Paul G./0000-0001-7955-0256; Doherty, Peter Charles/0000-0002-5028-3489","National Institute of Allergy and Infectious Disease, US National Institutes of Health [R01AI107625, HHSN266200700005C]; ALSAC at SJCRH","This work was supported by R01AI107625 and HHSN266200700005C awarded to PGT, from the National Institute of Allergy and Infectious Disease, US National Institutes of Health, and ALSAC at SJCRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015; Baranovich T, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.75; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BENDER BS, 1991, IMMUNOLOGY, V72, P514; BENDER BS, 1995, J LAB CLIN MED, V126, P169; Bodewes R, 2013, J VIROL, V87, P4293, DOI 10.1128/JVI.02536-12; Boon ACM, 2002, VIROLOGY, V299, P100, DOI 10.1006/viro.2002.1491; Boon ACM, 2002, J VIROL, V76, P582, DOI 10.1128/JVI.76.2.582-590.2002; CANONICA GW, 1985, MECH AGEING DEV, V32, P205, DOI 10.1016/0047-6374(85)90080-6; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; CDC, 2014, SEAS INFL Q A; Chen E, 2013, EURO SURVEILL, V18; Chen W, 2004, J IMMUNOL, V173, P5021, DOI 10.4049/jimmunol.173.8.5021; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Cukalac T, 2010, J IMMUNOL METHODS, V360, P157, DOI 10.1016/j.jim.2010.06.003; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Effros RB, 1996, EXP GERONTOL, V31, P21, DOI 10.1016/0531-5565(95)00017-8; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hillaire MLB, 2013, J GEN VIROL, V94, P583, DOI 10.1099/vir.0.048652-0; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Kedzierska K, 2006, IMMUNOL REV, V211, P133, DOI 10.1111/j.0105-2896.2006.00386.x; Kohlmeier JE, 2010, J IMMUNOL, V185, P3456, DOI 10.4049/jimmunol.1001745; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu Yang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1111; MAK NK, 1982, INFECT IMMUN, V38, P218; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Slutter B, 2014, CELL HOST MICROBE, V16, P421, DOI 10.1016/j.chom.2014.09.011; Slutter B, 2013, J IMMUNOL, V190, P3854, DOI 10.4049/jimmunol.1202790; Sridhar S, 2013, EMERG INFECT DIS, V19, P1866, DOI 10.3201/eid1911.130295; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; TANNOCK GA, 1984, INFECT IMMUN, V43, P457; Thomas PG, 2007, J IMMUNOL, V178, P3091, DOI 10.4049/jimmunol.178.5.3091; Toapanta FR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-112; Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101; Uyeki TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043948; Valkenburg SA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002544; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; Van Kerkhove MD, 2013, VIRUSES, V7, P872, DOI DOI 10.1111/IRV.12074; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wang X, 2014, CLIN INFECT DIS, V59, pE76, DOI 10.1093/cid/ciu399; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; WIEDMEIER SE, 1991, CELL IMMUNOL, V135, P501, DOI 10.1016/0008-8749(91)90293-K; Wu C, 2011, P NATL ACAD SCI USA, V108, P9178, DOI 10.1073/pnas.1105624108; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yamayoshi S, 2014, J VIROL, V88, P3127, DOI 10.1128/JVI.03155-13; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541",71,10,12,2,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004642,10.1371/journal.ppat.1004642,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400029,25668410.0,"DOAJ Gold, Green Published",,,16/08/2019,11,9,18,4131,579,399,180,3552,2972,51,529,18,7,1,0,10,10,0,,25,0,25,0,0,11,11,9,6,0,0,0,0,0,0,0,2,2,4183,21,0,218,80,0,3561,593,21,0,218,80,0,29,,0,0,0,0,5,0,2,1,0,0,0,25,0,0,3.75,7.134715025906735,1.1630067567567568,0.16300675675675674,1.2060810810810811,1.037037037037037,7.398963730569948
112,J,"Ehebauer, MT; Zimmermann, M; Jakobi, AJ; Noens, EE; Laubitz, D; Cichocki, B; Marrakchi, H; Laneelle, MA; Daffe, M; Sachse, C; Dziembowski, A; Sauer, U; Wilmanns, M",,,,"Ehebauer, Matthias T.; Zimmermann, Michael; Jakobi, Arjen J.; Noens, Elke E.; Laubitz, Daniel; Cichocki, Bogdan; Marrakchi, Hedia; Laneelle, Marie-Antoinette; Daffe, Mamadou; Sachse, Carsten; Dziembowski, Andrzej; Sauer, Uwe; Wilmanns, Matthias",,,Characterization of the Mycobacterial Acyl-CoA Carboxylase Holo Complexes Reveals Their Functional Expansion into Amino Acid Catabolism,PLOS PATHOGENS,,,English,Article,,,,,,,COENZYME-A CARBOXYLASE; ACETYL-COENZYME; CARBOXYLTRANSFERASE DOMAIN; ALPHA(6)BETA(6) HOLOENZYME; PROPIONYL-COENZYME; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; MYCOLIC ACIDS; TUBERCULOSIS; SUBUNIT,"Biotin-mediated carboxylation of short-chain fatty acid coenzyme A esters is a key step in lipid biosynthesis that is carried out by multienzyme complexes to extend fatty acids by one methylene group. Pathogenic mycobacteria have an unusually high redundancy of carboxyltransferase genes and biotin carboxylase genes, creating multiple combinations of protein/protein complexes of unknown overall composition and functional readout. By combining pull-down assays with mass spectrometry, we identified nine binary protein/protein interactions and four validated holo acyl-coenzyme A carboxylase complexes. We investigated one of these - the AccD1-AccA1 complex from Mycobacterium tuberculosis with hitherto unknown physiological function. Using genetics, metabolomics and biochemistry we found that this complex is involved in branched amino-acid catabolism with methylcrotonyl coenzyme A as the substrate. We then determined its overall architecture by electron microscopy and found it to be a four-layered dodecameric arrangement that matches the overall dimensions of a distantly related methylcrotonyl coenzyme A holo complex. Our data argue in favor of distinct structural requirements for biotin-mediated.-carboxylation of alpha-beta unsaturated acid esters and will advance the categorization of acyl-coenzyme A carboxylase complexes. Knowledge about the underlying structural/functional relationships will be crucial to make the target category amenable for future biomedical applications.","[Ehebauer, Matthias T.; Jakobi, Arjen J.; Noens, Elke E.; Wilmanns, Matthias] DESY, European Mol Biol Lab, Hamburg Unit, Hamburg, Germany; [Zimmermann, Michael; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Jakobi, Arjen J.; Sachse, Carsten] Struct Biol & Computat Biol Programme, European Mol Biol Lab, Heidelberg, Germany; [Laubitz, Daniel; Cichocki, Bogdan; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Laubitz, Daniel; Cichocki, Bogdan; Dziembowski, Andrzej] Warsaw Univ, Dept Genet & Biotechnol, Warsaw, Poland; [Marrakchi, Hedia; Laneelle, Marie-Antoinette; Daffe, Mamadou] Inst Pharmacol & Biol Struct, TB & Infect Biol Dept, Ctr Natl Rech Sci, Toulouse, France; [Wilmanns, Matthias] Ctr Struct Syst Biol, Hamburg, Germany","Ehebauer, MT (reprint author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.",wilmanns@embl-hamburg.de,"Noens, Elke/A-6742-2015; Sachse, Carsten/H-2727-2012","Sachse, Carsten/0000-0002-1168-5143; Zimmermann, Michael/0000-0002-5797-3589; Dziembowski, Andrzej/0000-0001-8492-7572; Jakobi, Arjen/0000-0002-7761-2027","European Commission [EC-HEALTH-F3-222965, FP7-HEALTH_2009-241587]; EMBO [ALTF 727-2008]; EMBL Interdisciplinary Postdoc (EIPOD) fellowship under Marie Curie Actions [PCOFUND-GA-2008-229597]","The project was supported by the European Commission grants EC-HEALTH-F3-222965 and FP7-HEALTH_2009-241587 awarded to MW http://ec.europa.eu/contracts_grants/grants_en.htm. MTE was supported by an EMBO long-term fellowship (ALTF 727-2008) http://embo.org/. AJJ is supported by an EMBL Interdisciplinary Postdoc (EIPOD) fellowship under Marie Curie Actions (PCOFUND-GA-2008-229597) http://www.embl.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balhana RJC, 2013, FEMS MICROBIOL LETT, V345, P132, DOI 10.1111/1574-6968.12196; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bilder P, 2006, BIOCHEMISTRY-US, V45, P1712, DOI 10.1021/bi0520479; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Daniel J, 2007, J BACTERIOL, V189, P911, DOI 10.1128/JB.01019-06; Diacovich L, 2002, J BIOL CHEM, V277, P31228, DOI 10.1074/jbc.M203263200; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Gago G, 2006, J BACTERIOL, V188, P477, DOI 10.1128/JB.188.2.477-486.2006; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; GUCHHAIT RB, 1974, J BIOL CHEM, V249, P6633; HAASE FC, 1982, J BIOL CHEM, V257, P1994; Holton SJ, 2006, FEBS LETT, V580, P6898, DOI 10.1016/j.febslet.2006.11.054; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Huang CS, 2012, NATURE, V481, P219, DOI 10.1038/nature10691; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurth DG, 2009, MICROBIOL-SGM, V155, P2664, DOI 10.1099/mic.0.027714-0; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; MASSEY LK, 1976, BACTERIOL REV, V40, P42; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Plocinski P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091380; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Poulsen C, 2010, FEBS LETT, V584, P669, DOI 10.1016/j.febslet.2009.12.057; Reddy MCM, 2014, ANTIMICROB AGENTS CH, V58, P6122, DOI 10.1128/AAC.02574-13; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Tran TH, 2014, NATURE, DOI [10.1038/nature14135, DOI 10.1038/NATURE14135]; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; Zimmermann M, 2013, ANAL CHEM, V85, P8284, DOI 10.1021/ac401555n",48,8,8,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004623,10.1371/journal.ppat.1004623,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400014,25695631.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,26,5453,698,546,152,4755,4076,22,657,26,0,0,0,8,8,2,,37,0,37,0,0,8,8,8,7,0,0,0,0,0,0,0,0,0,5517,186,0,308,88,0,4772,716,186,0,308,88,0,29,,1,0,0,0,13,0,0,1,0,0,0,37,0,0,17.1,7.812320916905444,1.1467928496319664,0.14679284963196634,1.217875920084122,1.0619842288648451,8.296561604584527
113,J,"El-Awady, AR; Miles, B; Scisci, E; Kurago, ZB; Palani, CD; Arce, RM; Waller, JL; Genco, CA; Slocum, C; Manning, M; Schoenlein, PV; Cutler, CW",,,,"El-Awady, Ahmed R.; Miles, Brodie; Scisci, Elizabeth; Kurago, Zoya B.; Palani, Chithra D.; Arce, Roger M.; Waller, Jennifer L.; Genco, Caroline A.; Slocum, Connie; Manning, Matthew; Schoenlein, Patricia V.; Cutler, Christopher W.",,,Porphyromonas gingivalis Evasion of Autophagy and Intracellular Killing by Human Myeloid Dendritic Cells Involves DC-SIGN-TLR2 Crosstalk,PLOS PATHOGENS,,,English,Article,,,,,,,DC-SIGN; PHAGOSOME MATURATION; GENE-EXPRESSION; PHAGOCYTOSIS; IMMUNITY; DIFFERENTIATION; HETEROGENEITY; ACTIVATION; FIMBRIAE; RECEPTOR,"Signaling via pattern recognition receptors (PRRs) expressed on professional antigen presenting cells, such as dendritic cells (DCs), is crucial to the fate of engulfed microbes. Among the many PRRs expressed by DCs are Toll-like receptors (TLRs) and C-type lectins such as DC-SIGN. DC-SIGN is targeted by several major human pathogens for immune-evasion, although its role in intracellular routing of pathogens to autophagosomes is poorly understood. Here we examined the role of DC-SIGN and TLRs in evasion of autophagy and survival of Porphyromonas gingivalis in human monocyte-derived DCs (MoDCs). We employed a panel of P. gingivalis isogenic fimbriae deficient strains with defined defects in Mfa-1 fimbriae, a DC-SIGN ligand, and FimA fimbriae, a TLR2 agonist. Our results show that DC-SIGN dependent uptake of Mfa1+P. gingivalis strains by MoDCs resulted in lower intracellular killing and higher intracellular content of P. gingivalis. Moreover, Mfa1+P. gingivalis was mostly contained within single membrane vesicles, where it survived intracellularly. Survival was decreased by activation of TLR2 and/or autophagy. Mfa1+P. gingivalis strain did not induce significant levels of Rab5, LC3-II, and LAMP1. In contrast, P. gingivalis uptake through a DC-SIGN independent manner was associated with early endosomal routing through Rab5, increased LC3-II and LAMP-1, as well as the formation of double membrane intracellular phagophores, a characteristic feature of autophagy. These results suggest that selective engagement of DC-SIGN by Mfa-1+P. gingivalis promotes evasion of antibacterial autophagy and lysosome fusion, resulting in intracellular persistence in myeloid DCs; however TLR2 activation can overcome autophagy evasion and pathogen persistence in DCs.","[El-Awady, Ahmed R.; Arce, Roger M.; Cutler, Christopher W.] Georgia Regents Univ, Dept Periodont, Augusta, GA 30912 USA; [Miles, Brodie] Univ Colorado, Dept Med, Aurora, CO USA; [Scisci, Elizabeth] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA; [Kurago, Zoya B.; Palani, Chithra D.] Georgia Regents Univ, Dept Oral Hlth & Diagnost Sci, Augusta, GA USA; [Waller, Jennifer L.] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Genco, Caroline A.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Genco, Caroline A.; Slocum, Connie] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Manning, Matthew; Schoenlein, Patricia V.] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA","El-Awady, AR (reprint author), Georgia Regents Univ, Dept Periodont, Augusta, GA 30912 USA.",chcutler@gru.edu,"Arce, Roger/E-6768-2011","Arce, Roger/0000-0002-4721-4722","U.S. Public Health Service Grants from the National Institutes of Health/National Institute of Dental and Craniofacial Research [R01 DE014328, R21 DE020916-01, R56 DE024350]; NIH/National Institute of Allergy and Infectious Diseases [T32 AI007447-22, T32 AI089673, PO1 AI078894]","This work was supported by U.S. Public Health Service Grants from the National Institutes of Health/National Institute of Dental and Craniofacial Research R01 DE014328 and R21 DE020916-01 to CWC and R56 DE024350 to CAG and NIH/National Institute of Allergy and Infectious Diseases T32 AI007447-22 to BM, and T32 AI089673 and PO1 AI078894 to CAG and CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; AMANO A, 1994, INFECT IMMUN, V62, P4682; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Baker PJ, 2000, ORAL MICROBIOL IMMUN, V15, P27, DOI 10.1034/j.1399-302x.2000.150105.x; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Carrion J, 2012, J IMMUNOL, V189, P3178, DOI 10.4049/jimmunol.1201053; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cremer I, 2002, BLOOD, V100, P3646, DOI 10.1182/blood-2002-01-0312; CUTLER CW, 1991, INFECT IMMUN, V59, P2097; Davey M, 2008, J IMMUNOL, V180, P2187, DOI 10.4049/jimmunol.180.4.2187; den Dunnen J, 2009, CANCER IMMUNOL IMMUN, V58, P1149, DOI 10.1007/s00262-008-0615-1; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Engering A, 2002, TRENDS IMMUNOL, V23, P480, DOI 10.1016/S1471-4906(02)02296-2; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, FUTURE MICROBIOL, V4, P879, DOI 10.2217/FMB.09.51; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; Jotwani R, 2004, INFECT IMMUN, V72, P1725, DOI 10.1128/IAI.72.3.1725-1732.2004; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koppel EA, 2005, IMMUNOBIOLOGY, V210, P203, DOI 10.1016/j.imbio.2005.05.014; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mehta P, 2014, CURR OPIN IMMUNOL, V26, P69, DOI 10.1016/j.coi.2013.10.012; Miles B, 2013, J LEUKOCYTE BIOL, V94, P281, DOI 10.1189/jlb.0213108; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; NEIDERS ME, 1989, J PERIODONTAL RES, V24, P192, DOI 10.1111/j.1600-0765.1989.tb02005.x; Njoroge T, 1997, INFECT IMMUN, V65, P1980; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Rodriguez A, 1999, NAT CELL BIOL, V1, P362; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Svajger U, 2011, IMMUNOL INVEST, V40, P413, DOI 10.3109/08820139.2011.556172; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Tuominen-Gustafsson H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-92; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Xie HA, 1997, INFECT IMMUN, V65, P2265; Xiong J, 2013, J CELL MOL MED; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zeituni, 2010, J ORAL MICROBIOL, V2, DOI [10.3402/jom.v2i0.2127, DOI 10.3402/JOM.V2I0.2127]; Zeituni AE, 2009, J IMMUNOL, V183, P5694, DOI 10.4049/jimmunol.0901030; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279",66,27,31,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004647,10.1371/journal.ppat.1004647,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400032,25679217.0,"DOAJ Gold, Green Published",,,16/08/2019,27,2,27,6153,1341,902,439,4812,3789,26,997,27,0,0,0,26,26,0,,42,0,42,0,0,29,29,19,18,0,0,0,0,0,0,0,2,1,6181,36,0,89,94,0,4805,1341,36,0,89,94,0,35,,0,0,0,0,2,0,0,1,0,0,0,42,0,0,1.5,4.588366890380313,1.2786783042394014,0.2786783042394015,1.311512884455528,1.0256785307979848,4.706189410887397
114,J,"Foo, SS; Chen, WQ; Taylor, A; Sheng, KC; Yu, X; Teng, TS; Reading, PC; Blanchard, H; Garlanda, C; Mantovani, A; Ng, LFP; Herrero, LJ; Mahalingam, S",,,,"Foo, Suan-Sin; Chen, Weiqiang; Taylor, Adam; Sheng, Kuo-Ching; Yu, Xing; Teng, Terk-Shin; Reading, Patrick C.; Blanchard, Helen; Garlanda, Cecilia; Mantovani, Alberto; Ng, Lisa F. P.; Herrero, Lara J.; Mahalingam, Suresh",,,Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation,PLOS PATHOGENS,,,English,Article,,,,,,,ROSS-RIVER-VIRUS; RECOGNITION MOLECULE PTX3; PULMONARY INFECTION; CHIKUNGUNYA FEVER; INNATE IMMUNITY; MOUSE MODEL; ARTHRITIS; INFLAMMATION; REPERFUSION; ARTHRALGIA,"The rising prevalence of arthritogenic alphavirus infections, including chikungunya virus (CHIKV) and Ross River virus (RRV), and the lack of antiviral treatments highlight the potential threat of a global alphavirus pandemic. The immune responses underlying alphavirus virulence remain enigmatic. We found that pentraxin 3 (PTX3) was highly expressed in CHIKV and RRV patients during acute disease. Overt expression of PTX3 in CHIKV patients was associated with increased viral load and disease severity. PTX3-deficient (PTX3(-/-)) mice acutely infected with RRV exhibited delayed disease progression and rapid recovery through diminished inflammatory responses and viral replication. Furthermore, binding of the N-terminal domain of PTX3 to RRV facilitated viral entry and replication. Thus, our study demonstrates the pivotal role of PTX3 in shaping alphavirus-triggered immunity and disease and provides new insights into alphavirus pathogenesis.","[Foo, Suan-Sin; Chen, Weiqiang; Taylor, Adam; Sheng, Kuo-Ching; Yu, Xing; Blanchard, Helen; Herrero, Lara J.; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Gold Coast, Australia; [Sheng, Kuo-Ching; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Reading, Patrick C.] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Biotechnol & Translat Med, Milan, Italy; [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore","Foo, SS (reprint author), Griffith Univ, Inst Glyc, Gold Coast, Australia.",s.mahalingam@griffith.edu.au,"Yu, Xing/G-7624-2015; Garlanda, Cecilia/K-4601-2016; Blanchard, Helen/A-4681-2009; Taylor, Adam/C-2981-2017; Herrero, Lara/A-4628-2015","Garlanda, Cecilia/0000-0002-1510-7703; Blanchard, Helen/0000-0003-3372-5027; Ng, Lisa/0000-0003-4071-5222; Mantovani, Alberto/0000-0001-5578-236X; Herrero, Lara/0000-0002-5661-9828; Reading, Patrick/0000-0002-8860-5308",Australian National Health and Medical Research Council [1012292]; Australian National Health and Medical Research Council (NHMRC) [APP1059167],"This project was supported by funding from the Australian National Health and Medical Research Council grant to SM (grant ID 1012292). SM is the recipient of an Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1059167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053; ALLES VV, 1994, BLOOD, V84, P3483; Baldini M, 2011, ARTHRITIS RHEUM; Bi P, 2009, EPIDEMIOL INFECT, V137, P1486, DOI 10.1017/S0950268809002441; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Burt FJ, 2014, LANCET INFE IN PRESS; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Chen WH, 2014, J CO2 UTIL, V5, P1, DOI 10.1016/j.jcou.2013.11.001; Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Daigo K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00378; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Foo SS, 2011, FUTURE VIROL, V6, P1407, DOI 10.2217/FVL.11.123; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gunn BM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002586; Han B, 2012, LAB INVEST, V92, P1285, DOI 10.1038/labinvest.2012.92; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Herrero LJ, 2013, ARTHRITIS RHEUM-US, V65, P2724, DOI 10.1002/art.38090; Herrero LJ, 2011, P NATL ACAD SCI USA, V108, P12048, DOI 10.1073/pnas.1101089108; Hollan I, 2010, ARTHRIT CARE RES, V62, P378, DOI 10.1002/acr.20094; Hossain I, 2009, J TRAVEL MED, V16, P420, DOI 10.1111/j.1708-8305.2009.00345.x; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jaillon S, 2014, IMMUNITY, V40, P621, DOI 10.1016/j.immuni.2014.02.015; LEE GW, 1993, J IMMUNOL, V150, P1804; Lidbury BA, 2000, J INFECT DIS, V181, P27, DOI 10.1086/315164; Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Moalli F, 2011, J IMMUNOL, V186, P5425, DOI 10.4049/jimmunol.1002035; Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006; Morrison TE, 2007, J VIROL, V81, P5132, DOI 10.1128/JVI.02799-06; Mylonas AD, 2002, MED J AUSTRALIA, V177, P356; Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261; Pan American Health Oganization WHO, 2014, NUMB REP CAS CHIK FE; Proll S, 1999, DEUT MED WOCHENSCHR, V124, P759, DOI 10.1055/s-2007-1024409; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rigamonti E, 2013, J IMMUNOL, V190, P1767, DOI 10.4049/jimmunol.1202903; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Shabman RS, 2008, J VIROL, V82, P12374, DOI 10.1128/JVI.00985-08; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; WANG YF, 1994, J VIROL, V68, P6466; Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004",59,17,17,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004649,10.1371/journal.ppat.1004649,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400034,25695775.0,"DOAJ Gold, Green Published",,,16/08/2019,18,0,23,3699,701,499,202,2998,2504,27,467,23,0,0,1,18,18,3,,17,4,17,0,4,21,19,21,10,0,0,0,0,0,0,0,0,0,3741,83,0,158,146,0,3010,708,83,0,158,146,0,23,,0,0,0,0,1,0,0,1,1,0,0,17,0,0,2.25,5.276747503566334,1.2338225483655771,0.23382254836557706,1.324216144096064,1.0732630440659638,5.663338088445078
115,J,"Goodsmith, N; Guo, XZV; Vandal, OH; Vaubourgeix, J; Wang, RJ; Botella, H; Song, S; Bhatt, K; Liba, A; Salgame, P; Schnappinger, D; Ehrt, S",,,,"Goodsmith, Nichole; Guo, Xinzheng V.; Vandal, Omar H.; Vaubourgeix, Julien; Wang, Ruojun; Botella, Helene; Song, Shuang; Bhatt, Kamlesh; Liba, Amir; Salgame, Padmini; Schnappinger, Dirk; Ehrt, Sabine",,,Disruption of an M. tuberculosis Membrane Protein Causes a Magnesium-dependent Cell Division Defect and Failure to Persist in Mice,PLOS PATHOGENS,,,English,Article,,,,,,,PENICILLIN-BINDING PROTEIN-3; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; CONTAINING PHAGOSOMES; SALMONELLA-ENTERICA; IDENTIFICATION; RESISTANCE; VIRULENCE; GENES; FTSW,"The identification of Mycobacterium tuberculosis genes necessary for persistence in vivo provides insight into bacterial biology as well as host defense strategies. We show that disruption of M. tuberculosis membrane protein PerM (Rv0955) resulted in an IFN-gamma-dependent persistence defect in chronic mouse infection despite the mutant's near normal growth during acute infection. The perM mutant required increased magnesium for replication and survival; incubation in low magnesium media resulted in cell elongation and lysis. Transcriptome analysis of the perM mutant grown in reduced magnesium revealed upregulation of cell division and cell wall biosynthesis genes, and live cell imaging showed PerM accumulation at the division septa in M. smegmatis. The mutant was acutely sensitive to beta-lactam antibiotics, including specific inhibitors of cell division-associated peptidoglycan transpeptidase FtsI. Together, these data implicate PerM as a novel player in mycobacterial cell division and pathogenesis, and are consistent with the hypothesis that immune activation deprives M. tuberculosis of magnesium.","[Goodsmith, Nichole; Guo, Xinzheng V.; Vandal, Omar H.; Vaubourgeix, Julien; Wang, Ruojun; Botella, Helene; Song, Shuang; Schnappinger, Dirk; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Bhatt, Kamlesh; Salgame, Padmini] Rutgers State Univ, New Jersey Med Sch, Ctr Emerging Pathogens, Dept Med, Newark, NJ 07102 USA; [Liba, Amir] Agilent Technol, Wilmington, DE USA","Goodsmith, N (reprint author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.",sae2004@med.cornell.edu,,"Wang, Ruojun/0000-0002-0519-2350","National Institutes of Health (NIH) [RO1 AI081725, U19 AI107774, T32GM07739]","This study was supported by National Institutes of Health (NIH) RO1 AI081725 and U19 AI107774. NG was supported by National Institutes of Health Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; BOTTA GA, 1981, J BACTERIOL, V145, P333; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Eberhardt C, 2003, J BACTERIOL, V185, P3726, DOI 10.1128/JB.185.13.3726-3734.2003; Ehrt S, 2002, METHOD MICROBIOL, V32, P169; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; GARCIADELPORTILLO F, 1992, MOL MICROBIOL, V6, P3289, DOI 10.1111/j.1365-2958.1992.tb02197.x; GARRETT AJ, 1969, BIOCHEM J, V115, P419, DOI 10.1042/bj1150419; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; HEDGE PJ, 1985, NATURE, V318, P478, DOI 10.1038/318478a0; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; McBride A, 2011, INFECT IMMUN, V79, P1118, DOI 10.1128/IAI.01076-10; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Murray T, 1998, J BACTERIOL, V180, P4555; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Prosser GA, 2013, ACS MED CHEM LETT, V4, P1233, DOI 10.1021/ml400349n; Rajagopalan M, 2005, FEMS MICROBIOL LETT, V250, P9, DOI 10.1016/j.femsle.2005.06.043; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; ROGERS HJ, 1976, J BACTERIOL, V125, P556; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Slayden RA, 2009, J ANTIMICROB CHEMOTH, V63, P451, DOI 10.1093/jac/dkn507; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Stallings CL, 2010, MICROBES INFECT, V12, P1091, DOI 10.1016/j.micinf.2010.07.014; Trapani V, 2010, ANALYST, V135, P1855, DOI 10.1039/c0an00087f; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Via LE, 1998, J CELL SCI, V111, P897; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x",63,7,7,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004645,10.1371/journal.ppat.1004645,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400031,25658098.0,"DOAJ Gold, Green Published",,,16/08/2019,5,0,32,6717,701,594,107,6016,5137,19,860,32,0,0,0,6,6,0,,41,7,41,0,7,6,6,3,4,0,0,0,0,0,0,0,0,0,6734,67,0,112,130,0,5991,701,67,0,112,130,0,42,,0,0,0,0,1,0,0,1,0,0,0,42,0,0,1.25,9.582025677603424,1.1165226063829787,0.11652260638297872,1.152094414893617,1.0318594610689296,9.887303851640514
116,J,"Herrmann, US; Sonati, T; Falsig, J; Reimann, RR; Dametto, P; O'Connor, T; Li, B; Lau, A; Hornemann, S; Sorce, S; Wagner, U; Sanoudou, D; Aguzzi, A",,,,"Herrmann, Uli S.; Sonati, Tiziana; Falsig, Jeppe; Reimann, Regina R.; Dametto, Paolo; O'Connor, Tracy; Li, Bei; Lau, Agnes; Hornemann, Simone; Sorce, Silvia; Wagner, Uli; Sanoudou, Despina; Aguzzi, Adriano",,,Prion Infections and Anti-PrP Antibodies Trigger Converging Neurotoxic Pathways,PLOS PATHOGENS,,,English,Article,,,,,,,FAB FRAGMENT; PROTEIN; SCRAPIE; ASSAY; MICE; EXPRESSION; DISEASE; SUSCEPTIBILITY; REPLICATION; ACTIVATION,"Prions induce lethal neurodegeneration and consist of PrPSc, an aggregated conformer of the cellular prion protein PrPC. Antibody-derived ligands to the globular domain of PrPC (collectively termed GDL) are also neurotoxic. Here we show that GDL and prion infections activate the same pathways. Firstly, both GDL and prion infection of cerebellar organotypic cultured slices (COCS) induced the production of reactive oxygen species (ROS). Accordingly, ROS scavenging, which counteracts GDL toxicity in vitro and in vivo, prolonged the lifespan of prion-infected mice and protected prion-infected COCS from neurodegeneration. Instead, neither glutamate receptor antagonists nor inhibitors of endoplasmic reticulum calcium channels abolished neurotoxicity in either model. Secondly, antibodies against the flexible tail (FT) of PrPC reduced neurotoxicity in both GDL-exposed and prion-infected COCS, suggesting that the FT executes toxicity in both paradigms. Thirdly, the PERK pathway of the unfolded protein response was activated in both models. Finally, 80% of transcriptionally downregulated genes overlapped between prion-infected and GDL-treated COCS. We conclude that GDL mimic the interaction of PrPSc with PrPC, thereby triggering the downstream events characteristic of prion infection.","[Herrmann, Uli S.; Sonati, Tiziana; Falsig, Jeppe; Reimann, Regina R.; Dametto, Paolo; O'Connor, Tracy; Li, Bei; Lau, Agnes; Hornemann, Simone; Sorce, Silvia; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Wagner, Uli] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Sanoudou, Despina] Univ Athens, Sch Med, Dept Pharmacol, GR-11527 Athens, Greece","Herrmann, US (reprint author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.",adriano.aguzzi@usz.ch,"Reimann, Regina Rose/A-1195-2016","Reimann, Regina Rose/0000-0002-6396-4195; Sanoudou, Despina/0000-0003-3704-1941; Sorce, Silvia/0000-0002-3843-8644","European Research Council [ERC: 250356]; European Union [PRIORITY: 222887, NEURINOX: 278611]; Swiss National Foundation [SNF: 31003A_141193, CRSI33_125073, 323530133900]; Novartis Research Foundation; Clinical Research Priority Program (CRPP) of the University of Zurich","Funding: AA is the recipient of an Advanced Grant of the European Research Council (ERC: 250356 http://erc.europa.eu/advanced-grants and is supported by grants from the European Union (PRIORITY: 222887, NEURINOX: 278611; http://cordis.europa.eu/fp7/home_en.html), the Swiss National Foundation (SNF: 31003A_141193 and Sinergia with F. Helmchen and B. Schneider: CRSI33_125073; http://www.snf.ch/en/Pages/default.aspx), the Novartis Research Foundation, and the Clinical Research Priority Program (CRPP Small RNAs and CRPP Human Hepato-Lymphatic Diseases; http://www.uzh.ch/research/priorityprograms/clinic_en.html) of the University of Zurich. USH is supported by an MD/PhD grant of the Swiss National Foundation (323530133900; http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Baral PK, 2012, ACTA CRYSTALLOGR D, V68, P1501, DOI 10.1107/S0907444912037328; Baral PK, 2011, ACTA CRYSTALLOGR F, V67, P1211, DOI 10.1107/S1744309111026273; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Falsig J ST, 2012, PLOS PATHOGENS; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jindal E, 2011, FREE RADICAL BIO MED, V51, P1512, DOI 10.1016/j.freeradbiomed.2011.07.008; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kordek R, 1996, P NATL ACAD SCI USA, V93, P9754, DOI 10.1073/pnas.93.18.9754; Lee HP, 2005, J NEUROCHEM, V95, P584, DOI 10.1111/j.1471-4159.2005.03429.x; Maghzal GJ, 2012, FREE RADICAL BIO MED, V53, P1903, DOI 10.1016/j.freeradbiomed.2012.09.002; Mahal Sukhvir P., 2008, V459, P49, DOI 10.1007/978-1-59745-234-2_4; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Murakami K, 1998, J NEUROSCI, V18, P205; Pietri M, 2013, NAT MED, V19, P1124, DOI 10.1038/nm.3302; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; SOTO C, 2010, TRENDS MOL MED; Steele AD, 2007, J NEUROSCI, V27, P13022, DOI 10.1523/JNEUROSCI.3290-07.2007; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Tribouillard-Tanvier D, 2012, J VIROL, V86, P10377, DOI 10.1128/JVI.01340-12; Yao H, 2013, ACTA BIOCH BIOPH SIN, V45, P494, DOI 10.1093/abbs/gmt022",38,35,35,1,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004662,10.1371/journal.ppat.1004662,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400042,25710374.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,36,10,42,5113,1028,766,262,4085,3399,27,659,42,0,0,0,28,28,0,,51,2,51,0,2,36,36,32,19,0,0,0,0,0,0,0,11,0,5192,140,0,282,89,0,4098,1045,140,0,282,89,0,49,,0,1,0,0,5,0,0,1,0,0,0,51,0,0,10.25,4.973735408560311,1.2516523867809057,0.25165238678090573,1.327050183598531,1.060238607471152,5.273346303501945
117,J,"Karst, SM; Wobus, CE",,,,"Karst, Stephanie M.; Wobus, Christiane E.",,,A Working Model of How Noroviruses Infect the Intestine,PLOS PATHOGENS,,,English,Article,,,,,,,BLOOD GROUP ANTIGENS; MICROFOLD M CELLS; HELICOBACTER-PYLORI; NORWALK VIRUS; ENTERIC VIRUS; COMMENSAL BACTERIA; DENDRITIC CELLS; MACROPHAGES; MICROBIOTA; GASTROENTERITIS,,"[Karst, Stephanie M.] Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Wobus, Christiane E.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA","Karst, SM (reprint author), Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.",cwobus@umich.edu,,"Wobus, Christiane/0000-0001-5286-0924","NIDDK NIH HHS [P30 DK034933]; NIAID NIH HHS [AI102106, R01 AI080611, R21 AI103961, AI080611, AI103961]",,"ANDERSSON M, 1989, CARBOHYD RES, V185, P211, DOI 10.1016/0008-6215(89)80036-9; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2498, DOI 10.1021/bi951853k; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Ball JM, 2005, VIRAL IMMUNOL, V18, P27, DOI 10.1089/vim.2005.18.27; Bansil R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00310; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Ben Mkaddem S, 2014, CURR TOP MICROBIOL, V382, P221, DOI 10.1007/978-3-319-07911-0_10; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; Gonzalez-Hernandez MB, 2013, J VIROL, V87, P12685, DOI 10.1128/JVI.02378-13; Green KY, 2013, FIELDS VIROLOGY, P582; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Miller H, 2007, WORLD J GASTROENTERO, V13, P1477, DOI 10.3748/wjg.v13.i10.1477; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Narvaez CF, 2010, J VIROL, V84, P4543, DOI 10.1128/JVI.02550-09; Otto PH, 2011, J VIROL, V85, P12013, DOI 10.1128/JVI.05342-11; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rasko DA, 2000, EUR J BIOCHEM, V267, P6059, DOI 10.1046/j.1432-1327.2000.01683.x; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Rol N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405001; Sestak K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037973; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Taube S, 2009, J VIROL, V83, P4092, DOI 10.1128/JVI.02245-08; Teunis P.F., 2014, EPIDEMIOL INFECT, P1; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Ward JM, 2006, TOXICOL PATHOL, V34, P708, DOI 10.1080/01926230600918876; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wilks J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002681; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wouters MM, 2011, NETH J MED, V69, P55; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592",47,38,39,1,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004626,10.1371/journal.ppat.1004626,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400016,25723501.0,"DOAJ Gold, Green Published",,,16/08/2019,37,4,85,11278,3904,3413,491,7374,6139,22,1213,85,2,0,0,33,33,0,,98,37,98,0,37,39,39,38,27,0,0,1,0,0,1,0,9,0,11593,11,11,21,184,4,7451,3960,11,11,21,184,4,182,,1,0,0,0,13,0,1,0,0,0,0,97,0,0,17.85,2.8888319672131146,1.5294277190127474,0.5294277190127475,1.5985896392731218,1.0452207838269196,3.019467213114754
118,J,"Kim, JJ; Flueck, C; Franz, E; Sanabria-Figueroa, E; Thompson, E; Lorenz, R; Bertinetti, D; Baker, DA; Herberg, FW; Kim, C",,,,"Kim, Jeong Joo; Flueck, Christian; Franz, Eugen; Sanabria-Figueroa, Eduardo; Thompson, Eloise; Lorenz, Robin; Bertinetti, Daniela; Baker, David A.; Herberg, Friedrich W.; Kim, Choel",,,Crystal Structures of the Carboxyl cGMP Binding Domain of the Plasmodium falciparum cGMP-dependent Protein Kinase Reveal a Novel Capping Triad Crucial for Merozoite Egress,PLOS PATHOGENS,,,English,Article,,,,,,,MYCOBACTERIOPHAGE BXB1 INTEGRASE; MALARIA PARASITES; SELECTIVE ACTIVATION; LIFE-CYCLE; SITE; PKG; REFINEMENT; STAGE,"The Plasmodium falciparum cGMP-dependent protein kinase (PfPKG) is a key regulator across the malaria parasite life cycle. Little is known about PfPKG's activation mechanism. Here we report that the carboxyl cyclic nucleotide binding domain functions as a ""gatekeeper"" for activation by providing the highest cGMP affinity and selectivity. To understand the mechanism, we have solved its crystal structures with and without cGMP at 2.0 and 1.9 angstrom, respectively. These structures revealed a PfPKG-specific capping triad that forms upon cGMP binding, and disrupting the triad reduces kinase activity by 90%. Furthermore, mutating these residues in the parasite prevents blood stage merozoite egress, confirming the essential nature of the triad in the parasite. We propose a mechanism of activation where cGMP binding allosterically triggers the conformational change at the alpha C-helix, which bridges the regulatory and catalytic domains, causing the capping triad to form and stabilize the active conformation.","[Kim, Jeong Joo; Sanabria-Figueroa, Eduardo; Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Kim, Jeong Joo; Franz, Eugen; Lorenz, Robin; Bertinetti, Daniela; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34125 Kassel, Hesse, Germany; [Flueck, Christian; Thompson, Eloise; Baker, David A.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA","Kim, JJ (reprint author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.",ckim@bcm.edu,"Bertinetti, Daniela/B-5655-2015; Herberg, Friedrich W/B-5572-2015","Bertinetti, Daniela/0000-0003-1150-3765; Herberg, Friedrich W/0000-0001-7117-7653; Baker, David/0000-0002-5490-8933","Wellcome Trust [WT094752]; UK Medical Research Council [G10000779]; Federal Ministry of Education and Research Project NO PAIN [FKZ 0316177F]; European Union (EU) FP7 collaborative project AFFINOMICS [241481]; National Institutes of Health (NIH) [R01 GM090161, R21 HL111953]; Medical Research Council [G1000779]","Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. DAB is funded by the Wellcome Trust (Ref: WT094752) and the UK Medical Research Council (REF: G10000779). FWH acknowledges the support of the Federal Ministry of Education and Research Project NO PAIN (FKZ 0316177F) and the European Union (EU) FP7 collaborative project AFFINOMICS (Contract No. 241481). CK is funded by National Institutes of Health (NIH) grant R01 GM090161 and R21 HL111953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Baker DA, 2005, FRONT BIOSCI, V10, P1229, DOI 10.2741/1615; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; BRICKMAN E, 1973, J BACTERIOL, V116, P582; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Bussow K, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-21; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Deng WS, 2002, MOL MICROBIOL, V44, P1141, DOI 10.1046/j.1365-2958.2002.02948.x; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002404; Hopp CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048206; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Huang GY, 2014, BIOCHEMISTRY-US, V53, P6725, DOI 10.1021/bi501012v; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Moll D, 2006, J NEURAL TRANSM, V113, P1015, DOI 10.1007/s00702-006-0515-5; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Olivieri A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002448; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Richie-Jannetta R, 2006, J BIOL CHEM, V281, P6977, DOI 10.1074/jbc.M510886200; Salowe SP, 2002, BIOCHEMISTRY-US, V41, P4385, DOI 10.1021/bi0156658; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wei F, 2013, PARASITOL RES, V112, P2121, DOI 10.1007/s00436-013-3451-y; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736",39,9,9,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004639,10.1371/journal.ppat.1004639,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400026,25646845.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,9,7,33,4627,432,303,129,4195,3516,22,657,33,0,0,0,11,11,0,,31,0,31,0,0,9,9,8,8,0,0,0,0,0,0,0,6,0,4640,56,0,140,81,0,4192,432,56,0,140,81,0,16,,0,0,0,0,3,0,2,0,0,0,0,32,0,0,2.1,10.710648148148149,1.102979737783075,0.10297973778307509,1.138736591179976,1.0324184136589583,11.05787037037037
119,J,"Lee, HM; Fleige, A; Forman, R; Cho, S; Khan, AA; Lin, LL; Nguyen, DT; O'Hara-Hall, A; Yin, ZN; Hunter, CA; Muller, W; Lu, LF",,,,"Lee, Hyang-Mi; Fleige, Anne; Forman, Ruth; Cho, Sunglim; Khan, Aly Azeem; Lin, Ling-Li; Nguyen, Duc T.; O'Hara-Hall, Aisling; Yin, Zhinan; Hunter, Christopher A.; Muller, Werner; Lu, Li-Fan",,,IFN gamma Signaling Endows DCs with the Capacity to Control Type I Inflammation during Parasitic Infection through Promoting T-bet plus Regulatory T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,INTERFERON-GAMMA; TOXOPLASMA-GONDII; DENDRITIC CELLS; RESPONSES; RECEPTOR; DIFFERENTIATION; MICE; INTERLEUKIN-10; SUSCEPTIBILITY; EXPRESSION,"IFN gamma signaling drives dendritic cells (DCs) to promote type I T cell (Th1) immunity. Here, we show that activation of DCs by IFN gamma is equally crucial for the differentiation of a population of T-bet+ regulatory T (Treg) cells specialized to inhibit Th1 immune responses. Conditional deletion of IFN gamma receptor in DCs but not in Treg cells resulted in a severe defect in this specific Treg cell subset, leading to exacerbated immune pathology during parasitic infections. Mechanistically, IFN gamma-unresponsive DCs failed to produce sufficient amount of IL-27, a cytokine required for optimal T-bet induction in Treg cells. Thus, IFN gamma signalling endows DCs with the ability to efficiently control a specific type of T cell immunity through promoting a corresponding Treg cell population.","[Lee, Hyang-Mi; Cho, Sunglim; Lin, Ling-Li; Nguyen, Duc T.; Lu, Li-Fan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fleige, Anne] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; [Forman, Ruth; Muller, Werner] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Khan, Aly Azeem] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [O'Hara-Hall, Aisling; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Yin, Zhinan] Jinan Univ, Key Lab Mol Immunol & Antibody Engn Guangdong Pro, Affiliated Hosp 1, Int Imunol Ctr,Biomed Translat Res Inst, Guangzhou, Guangdong, Peoples R China; [Lu, Li-Fan] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA","Lee, HM (reprint author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.",lifanlu@ucsd.edu,"Muller, Werner/R-2616-2019; Muller, Werner/B-9044-2008","Muller, Werner/0000-0002-1297-9725; Muller, Werner/0000-0002-1297-9725; Hall, Aisling/0000-0001-8198-3245; Lu, Li-Fan/0000-0002-9727-0036",National Institute of Health [R00-AI089935],"This work was supported by grants from the National Institute of Health (http://www.nih.gov/) R00-AI089935 to LFL. LFL is a Kimmel Scholar (http://www.kimmel.org/) and a Hellman Fellow (http://www.hellmanfellows.org/). HML is a Cancer Research Institue Irvington Postdoctoral Fellow (http://www.cancerresearch.org/). The conditional IFN gamma R2 mutant mouse generation was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) SFB 621 and European Network of Excellence (http://www.mugen-noe.org/) MUGEN LSHG-CT-2005-005203 to WM. The aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; Hotson AN, 2009, J IMMUNOL, V182, P7558, DOI 10.4049/jimmunol.0803666; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kernbauer E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002763; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee SH, 2013, J IMMUNOL, V191, P4223, DOI 10.4049/jimmunol.1300910; Lemoine R, 2010, BLOOD, V116, P3089, DOI 10.1182/blood-2010-02-268623; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pszenny V, 2012, INFECT IMMUN, V80, P1156, DOI 10.1128/IAI.06167-11; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; He TP, 2007, CELL MOL IMMUNOL, V4, P105; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Yamazaki S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00151; Zhang S, 2013, HEPATOLOGY, V57, P1620, DOI 10.1002/hep.26166; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674",39,8,9,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004635,10.1371/journal.ppat.1004635,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400023,25658840.0,"DOAJ Gold, Green Published",,,16/08/2019,9,0,27,4058,545,385,160,3513,2891,18,604,27,0,0,0,8,8,0,,32,11,32,0,11,9,9,4,7,0,0,0,0,0,0,0,0,1,4116,27,0,228,94,0,3526,554,27,0,228,94,0,36,,0,0,0,0,3,0,0,1,0,0,0,32,0,0,2.25,7.445871559633027,1.1551380586393396,0.1551380586393396,1.206091659550242,1.0441103992114342,7.774311926605504
120,J,"Lenman, A; Liaci, AM; Liu, Y; Aring;rdahl, C; Rajan, A; Nilsson, E; Bradford, W; Kaeshammer, L; Jones, MS; Frangsmyr, L; Stehle, TFT; Stehle, T; Arnberg, N",,,,"Lenman, Annasara; Liaci, A. Manuel; Liu, Yan; Ardahl, Carin; Rajan, Anandi; Nilsson, Emma; Bradford, Will; Kaeshammer, Lisa; Jones, Morris S.; Frangsmyr, Lars; Feizi, Ten; Stehle, Thilo; Arnberg, Niklas",,,Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells,PLOS PATHOGENS,,,English,Article,,,,,,,CELLULAR RECEPTOR; CRYSTAL-STRUCTURE; FIBER KNOBS; CD46; SEROTYPE; CAR; PROTECTION; ANTIBODIES; AFFINITY; VIRUSES,"Most adenoviruses attach to host cells by means of the protruding fiber protein that binds to host cells via the coxsackievirus and adenovirus receptor (CAR) protein. Human adenovirus type 52 (HAdV-52) is one of only three gastroenteritis-causing HAdVs that are equipped with two different fiber proteins, one long and one short. Here we show, by means of virion-cell binding and infection experiments, that HAdV-52 can also attach to host cells via CAR, but most of the binding depends on sialylated glycoproteins. Glycan microarray, flow cytometry, surface plasmon resonance and ELISA analyses reveal that the terminal knob domain of the long fiber (52LFK) binds to CAR, and the knob domain of the short fiber (52SFK) binds to sialylated glycoproteins. X-ray crystallographic analysis of 52SFK in complex with 2-O-methylated sialic acid combined with functional studies of knob mutants revealed a new sialic acid binding site compared to other, known adenovirus: glycan interactions. Our findings shed light on adenovirus biology and may help to improve targeting of adenovirus-based vectors for gene therapy.","[Lenman, Annasara; Ardahl, Carin; Rajan, Anandi; Nilsson, Emma; Frangsmyr, Lars; Arnberg, Niklas] Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden; [Liaci, A. Manuel; Bradford, Will; Kaeshammer, Lisa; Stehle, Thilo] Univ Tubingen, Inst Biochem, Tubingen, Germany; [Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London, England; [Jones, Morris S.] Naval Med Ctr, Div Infect Dis, San Diego, CA USA; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA","Lenman, A (reprint author), Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden.",annasara.lenman@climi.umu.se; thilo.stehle@uni-tuebingen.de,"Arnberg, Niklas/K-5878-2019; Liu, Yan/D-9117-2013","Lenman, Annasara/0000-0001-5109-9408","Swedish Research Council [2013-2753, 2013-8616]; Knut & Alice Wallenberg Foundation [KAW 2013.0019]; Swedish Cancer Society [CAN 2011/340]; United Kingdom Research Council Basic Technology Initiative Glycoarrays [GRS/79268]; Translational Grant [EP/G037604/1]; Wellcome Trust [WT093378MA, WT099197MA]; Deutsche Forschungsgemeinschaft [SFB-685]","This work was founded by grants from the Swedish Research Council (2013-2753 and 2013-8616, NA), Knut & Alice Wallenberg Foundation (KAW 2013.0019, NA), The Swedish Cancer Society (CAN 2011/340, NA), United Kingdom Research Council Basic Technology Initiative Glycoarrays (GRS/79268, TF), Translational Grant (EP/G037604/1, TF), Wellcome Trust Grants (WT093378MA and WT099197MA, TF), and from The Deutsche Forschungsgemeinschaft (SFB-685, ST and AML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2012, TRENDS PHARMACOL SCI, V33, P442, DOI 10.1016/j.tips.2012.04.005; Banyai K, 2009, NEW MICROBIOL, V32, P185; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Bricogne G. BE, 2011, BUSTER VERSION 2 10, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; George SJ, 2011, CIRCULATION, V124, pS135, DOI 10.1161/CIRCULATIONAHA.110.012732; Harrach B., 2011, VIRUS TAXONOMY CLASS, V9, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; Heise C, 2000, NAT MED, V6; JARECKIKHAN K, 1992, J CLIN MICROBIOL, V30, P2733; Johansson SMC, 2007, ANTIVIR RES, V73, P92, DOI 10.1016/j.antiviral.2006.08.004; KIDD AH, 1993, VIROLOGY, V192, P73, DOI 10.1006/viro.1993.1009; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; Lenman A, 2011, J VIROL, V85, P13420, DOI 10.1128/JVI.06088-11; Li HL, 2012, J VIROL, V86, P10862, DOI 10.1128/JVI.00928-12; Li YM, 1999, CANCER RES, V59, P325; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Lu ZZ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003718; Marttila M, 2005, J VIROL, V79, P14429, DOI 10.1128/JVI.79.22.14429-14436.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mistry N, 2011, J VIROL, V85, P11283, DOI 10.1128/JVI.05597-11; Neu U, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003714; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Nilsson E, 2011, CELLULAR RECEPTORS V, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190; Persson BD, 2009, J VIROL, V83, P673, DOI 10.1128/JVI.01967-08; Rademacher C, 2012, GLYCOBIOLOGY, V22, P1086, DOI 10.1093/glycob/cws073; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Roelvink PW, 1998, J VIROL, V72, P7909; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Roy S, 2012, EMERG INFECT DIS, V18, P1081, DOI 10.3201/eid1807.111665; Saderi H, 2000, J CLIN VIROL, V16, P145, DOI 10.1016/S1386-6532(99)00071-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2005, J VIROL, V79, P14088, DOI 10.1128/JVI.79.22.14088-14094.2005; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; SHINOZAKI T, 1987, J CLIN MICROBIOL, V25, P1679; Song JD, 2012, VIROLOGY, V432, P336, DOI 10.1016/j.virol.2012.05.020; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Thirion C, 2006, HUM GENE THER, V17, P193, DOI 10.1089/hum.2006.17.193; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wadell G, 1999, MANUAL CLIN MICROBIO, P970; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wold WSM, 2007, FIELDS VIROLOGY, V2, P2395; Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003; Xia D, 1995, STRUCTURE, V2, P7907; YEH HY, 1994, VIRUS RES, V33, P179; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109",65,14,16,1,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004657,10.1371/journal.ppat.1004657,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400038,25674795.0,"DOAJ Gold, Green Published",,,16/08/2019,15,0,28,5371,1138,829,309,4233,3544,31,658,28,0,0,0,14,14,0,,98,1,52,0,1,19,15,19,8,0,0,0,0,0,0,2,6,0,5390,53,0,184,98,0,4215,1138,53,0,184,98,0,37,,1,0,0,0,0,0,0,1,0,0,0,52,0,0,10.25,4.719683655536028,1.2688400661469408,0.2688400661469407,1.3090007087172217,1.0316514615527834,4.8690685413005275
121,J,"Liu, JL; Park, CH; He, F; Nagano, M; Wang, M; Bellizzi, M; Zhang, K; Zeng, XS; Liu, WD; Ning, YS; Kawano, Y; Wang, GL",,,,"Liu, Jinling; Park, Chan Ho; He, Feng; Nagano, Minoru; Wang, Mo; Bellizzi, Maria; Zhang, Kai; Zeng, Xiaoshan; Liu, Wende; Ning, Yuese; Kawano, Yoji; Wang, Guo-Liang",,,The RhoGAP SPIN6 Associates with SPL11 and OsRac1 and Negatively Regulates Programmed Cell Death and Innate Immunity in Rice,PLOS PATHOGENS,,,English,Article,,,,,,,GTPASE-ACTIVATING PROTEIN; DISEASE RESISTANCE; FLOWERING TIME; REPEAT PROTEIN; DEFENSE; RECEPTOR; UBIQUITINATION; SYSTEM; FAMILY; ENCODES,"The ubiquitin proteasome system in plants plays important roles in plant-microbe interactions and in immune responses to pathogens. We previously demonstrated that the rice U-box E3 ligase SPL11 and its Arabidopsis ortholog PUB13 negatively regulate programmed cell death (PCD) and defense response. However, the components involved in the SPL11/PUB13-mediated PCD and immune signaling pathway remain unknown. In this study, we report that SPL11-interacting Protein 6 (SPIN6) is a Rho GTPase-activating protein (RhoGAP) that interacts with SPL11 in vitro and in vivo. SPL11 ubiquitinates SPIN6 in vitro and degrades SPIN6 in vivo via the 26S proteasome-dependent pathway. Both RNAi silencing in transgenic rice and knockout of Spin6 in a T-DNA insertion mutant lead to PCD and increased resistance to the rice blast pathogen Magnaporthe oryzae and the bacterial blight pathogen Xanthomonas oryzae pv. oryzae. The levels of reactive oxygen species and defense-related gene expression are significantly elevated in both the Spin6 RNAi and mutant plants. Strikingly, SPIN6 interacts with the small GTPase OsRac1, catalyze the GTP-bound OsRac1 into the GDP-bound state in vitro and has GAP activity towards OsRac1 in rice cells. Together, our results demonstrate that the RhoGAP SPIN6 acts as a linkage between a U-box E3 ligase-mediated ubiquitination pathway and a small GTPase-associated defensome system for plant immunity.","[Liu, Jinling; He, Feng; Liu, Wende; Ning, Yuese; Wang, Guo-Liang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Jinling; He, Feng; Zeng, Xiaoshan] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Liu, Jinling; He, Feng; Zeng, Xiaoshan] Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China; [Park, Chan Ho; Wang, Mo; Bellizzi, Maria; Zhang, Kai; Wang, Guo-Liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Nagano, Minoru; Kawano, Yoji] Nara Inst Sci & Technol, Ikoma, Nara, Japan; [Nagano, Minoru] Saitama Univ, Dept Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Kawano, Yoji] Shanghai Ctr Plant Stress Biol, Signal Transduct & Immun Grp, Shanghai, Peoples R China","Liu, JL (reprint author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.",wang.620@osu.edu,"Kawano, Yoji/C-7484-2011","Kawano, Yoji/0000-0003-0687-2777","973 Project of Ministry of Science and Technology China [2012CB114005]; Program for Innovative Research Team in University [IRT1239]; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; U.S. Department of Agriculture-Cooperative State Research, Education, and Extension Service [2007-01667]; USAID-IRRI Linkage Program","This work was supported by the 973 Project (2012CB114005) of Ministry of Science and Technology China; the Program for Innovative Research Team in University (IRT1239); the Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; the U.S. Department of Agriculture-Cooperative State Research, Education, and Extension Service (grant no. 2007-01667); and the USAID-IRRI Linkage Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akamatsu A, 2013, CELL HOST MICROBE, V13, P465, DOI 10.1016/j.chom.2013.03.007; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; Ding B, 2012, PLANT CELL, V24, P3783, DOI 10.1105/tpc.112.101972; Hoefle C, 2011, PLANT CELL, V23, P2422, DOI 10.1105/tpc.110.082131; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jiang SY, 2006, PHYSIOL GENOMICS, V24, P235, DOI 10.1152/physiolgenomics.00210.2005; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kojo K, 2006, PLANT CELL PHYSIOL, V47, P1035, DOI 10.1093/pcp/pcj074; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Liu JL, 2012, PLANT PHYSIOL, V160, P28, DOI 10.1104/pp.112.199430; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Ning Y, 2011, PLANT SIGNAL BEHAV, V6, DOI [10.4161/psb.6.12.18192, DOI 10.4161/PSB.6.12.18192]; Ning YS, 2011, PLANT PHYSIOL, V157, P242, DOI 10.1104/pp.111.180893; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Vega-Sanchez ME, 2008, PLANT CELL, V20, P1456, DOI 10.1105/tpc.108.058610; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171",37,17,24,1,35,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004629,10.1371/journal.ppat.1004629,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400018,25658451.0,"DOAJ Gold, Green Published",,,16/08/2019,35,25,37,9903,1041,660,381,8862,6984,29,1849,37,3,0,0,30,30,3,,46,3,46,0,3,36,36,27,17,0,0,0,0,0,0,0,22,3,9910,75,0,408,80,0,8841,1041,75,0,408,80,0,28,,0,1,0,0,3,0,2,0,0,0,0,46,0,0,8.85,9.512968299711815,1.1174678402166554,0.11746784021665538,1.1357481381178063,1.0163586791881247,9.668587896253602
122,J,"Ma, JT; Duffy, MR; Deng, L; Dakin, RS; Uil, T; Custers, J; Kelly, SM; McVey, JH; Nicklin, SA; Baker, AH",,,,"Ma, Jiangtao; Duffy, Margaret R.; Deng, Lin; Dakin, Rachel S.; Uil, Taco; Custers, Jerome; Kelly, Sharon M.; McVey, John H.; Nicklin, Stuart A.; Baker, Andrew H.",,,Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,BONE-MARROW-TRANSPLANTATION; GENE-TRANSFER; NATURAL ANTIBODIES; VACCINE VECTORS; FACTOR-BINDING; RECEPTOR; BLOOD; INFECTION; IMMUNOGENICITY; IDENTIFICATION,"Adenoviruses are common pathogens, mostly targeting ocular, gastrointestinal and respiratory cells, but in some cases infection disseminates, presenting in severe clinical outcomes. Upon dissemination and contact with blood, coagulation factor X (FX) interacts directly with the adenovirus type 5 (Ad5) hexon. FX can act as a bridge to bind heparan sulphate proteoglycans, leading to substantial Ad5 hepatocyte uptake. FX ""coating"" also protects the virus from host IgM and complement-mediated neutralisation. However, the contribution of FX in determining Ad liver transduction whilst simultaneously shielding the virus from immune attack remains unclear. In this study, we demonstrate that the FX protection mechanism is not conserved amongst Ad types, and identify the hexon hypervariable regions (HVR) of Ad5 as the capsid proteins targeted by this host defense pathway. Using genetic and pharmacological approaches, we manipulate Ad5 HVR interactions to interrogate the interplay between viral cell transduction and immune neutralisation. We show that FX and inhibitory serum components can co-compete and virus neutralisation is influenced by both the location and extent of modifications to the Ad5 HVRs. We engineered Ad5-derived HVRs into the rare, native non FX-binding Ad26 to create Ad26. HVR5C. This enabled the virus to interact with FX at high affinity, as quantified by surface plasmon resonance, FX-mediated cell binding and transduction assays. Concomitantly, Ad26. HVR5C was also sensitised to immune attack in the absence of FX, a direct consequence of the engineered HVRs from Ad5. In both immune competent and deficient animals, Ad26. HVR5C hepatic gene transfer was mediated by FX following intravenous delivery. This study gives mechanistic insight into the pivotal role of the Ad5 HVRs in conferring sensitivity to virus neutralisation by IgM and classical complement-mediated attack. Furthermore, through this gain-of-function approach we demonstrate the dual functionality of FX in protecting Ad26. HVR5C against innate immune factors whilst determining liver targeting.","[Ma, Jiangtao; Duffy, Margaret R.; Deng, Lin; Dakin, Rachel S.; Nicklin, Stuart A.; Baker, Andrew H.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Uil, Taco; Custers, Jerome] Crucell Holland BV, Leiden, Netherlands; [Kelly, Sharon M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [McVey, John H.] Univ Surrey, Guildford GU2 5XH, Surrey, England","Ma, JT (reprint author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.",Andrew.H.Baker@glasgow.ac.uk,,"Nicklin, Stuart/0000-0002-9691-6210; McVey, John/0000-0002-7416-533X; Kelly, Sharon/0000-0002-3516-1387","Biotechnology and Biological Sciences Research Council [BB/I005927/1]; British Heart Foundation [CH/11/2/28733, BHF RG/09/005/27915]; European Commission (IAPP: ADVEC) [324325]; Biotechnology and Biological Sciences Research Council [BB/M000060/1]; British Heart Foundation [RG/09/005/27915]","Funding: This work was supported by the Biotechnology and Biological Sciences Research Council [MRD is funded by grant number BB/I005927/1 to AHB and SAN]. AHB is supported by the British Heart Foundation Chair of Translational Cardiovascular Sciences (CH/11/2/28733). This work is further supported by the British Heart Foundation Programme Grant (BHF RG/09/005/27915) and the European Commission (IAPP: ADVEC: Agreement 324325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ABZUG MJ, 1991, PEDIATRICS, V87, P890; Alba R, 2012, GENE THER, V19, P109, DOI 10.1038/gt.2011.87; Alba R, 2009, BLOOD; Alba Raul, 2012, Methods Mol Biol, V891, P55, DOI 10.1007/978-1-61779-873-3_4; Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Baden LR, 2012, J INFECT DIS; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bertheau P, 1996, BONE MARROW TRANSPL, V17, P295; Bordigoni Pierre, 2001, Clinical Infectious Diseases, V32, P1290, DOI 10.1086/319984; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chakrabarti S, 1999, BONE MARROW TRANSPL, V23, P1209, DOI 10.1038/sj.bmt.1701788; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chuang Yu-Yu, 2003, Journal of Microbiology Immunology and Infection, V36, P37; Cotter MJ, 2005, J VIROL, V79, P14622, DOI 10.1128/JVI.79.23.14622-14631.2005; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Duffy MR, 2013, J CONTROL RELEASE, V170, P132, DOI 10.1016/j.jconrel.2013.05.007; Duffy MR, 2011, J VIROL, V85, P10914, DOI 10.1128/JVI.05382-11; Echavarria M, 2001, LANCET, V358, P384, DOI 10.1016/S0140-6736(01)05580-5; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; Greig JA, 2009, MOL THER, V17, P1683, DOI 10.1038/mt.2009.152; Irons EE, 2013, J VIROL, V87, P9610, DOI 10.1128/JVI.01070-13; JOHNSON PRE, 1990, BONE MARROW TRANSPL, V5, P345; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khare R, 2012, J VIROL, V86, P2293, DOI 10.1128/JVI.05760-11; Kim M, 2002, EUR J CANCER, V38, P1917, DOI 10.1016/S0959-8049(02)00131-4; Klimovich VB, 2011, BIOCHEMISTRY-MOSCOW+, V76, P534, DOI 10.1134/S0006297911050038; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Lenaerts L, 2006, ANTIVIR RES, V71, P172, DOI 10.1016/j.antiviral.2006.04.007; Li HL, 2012, J VIROL, V86, P10862, DOI 10.1128/JVI.00928-12; Lieber A, 1997, J VIROL, V71, P8798; Lion T, 2003, BLOOD, V102, P1114, DOI 10.1182/blood-2002-07-2152; Lyons M, 2006, MOL THER, V14, P118, DOI 10.1016/j.ymthe.2006.01.003; Munoz FM, 1998, CLIN INFECT DIS, V27, P1194, DOI 10.1086/514978; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Parker AL, 2009, J VIROL, V83, P479, DOI 10.1128/JVI.01878-08; Perreau M, 2007, MOL THER, V15, P1998, DOI 10.1038/sj.mt.6300289; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Robinson CM, 2013, SCI REP, V3, DOI [10.1038/srep03544, DOI 10.1038/SREP03544]; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; Stone D, 2007, J VIROL, V81, P4866, DOI 10.1128/JVI.02819-06; Straussberg R, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e69; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Uchida K, 2014, FREE RADICAL BIO MED, V72, P156, DOI 10.1016/j.freeradbiomed.2014.03.016; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107",58,20,20,1,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004673,10.1371/journal.ppat.1004673,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400049,25658827.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,24,3,25,4043,587,437,150,3456,2917,20,519,25,0,0,0,19,19,0,,32,0,32,0,0,26,26,24,14,0,0,0,0,0,0,0,3,0,4090,33,0,227,85,0,3466,598,33,0,227,85,0,26,,0,0,0,0,0,0,0,1,0,0,0,31,0,0,0.25,6.887563884156729,1.169849537037037,0.16984953703703703,1.2175925925925926,1.040811278753401,7.1686541737649065
123,J,"Panas, MD; Schulte, T; Thaa, B; Sandalova, T; Kedersha, N; Achour, A; McInerney, GM",,,,"Panas, Marc D.; Schulte, Tim; Thaa, Bastian; Sandalova, Tatiana; Kedersha, Nancy; Achour, Adnane; McInerney, Gerald M.",,,Viral and Cellular Proteins Containing FGDF Motifs Bind G3BP to Block Stress Granule Formation,PLOS PATHOGENS,,,English,Article,,,,,,,SEMLIKI-FOREST-VIRUS; EIF2-ALPHA PHOSPHORYLATION; ENDORIBONUCLEASE G3BP; MESSENGER-RNAS; INFECTED CELLS; TRANSLATION; USP10; REPLICATION; ACCUMULATION; EXPRESSION,"The Ras-GAP SH3 domain-binding proteins (G3BP) are essential regulators of the formation of stress granules (SG), cytosolic aggregates of proteins and RNA that are induced upon cellular stress, such as virus infection. Many viruses, including Semliki Forest virus (SFV), block SG induction by targeting G3BP. In this work, we demonstrate that the G3BP-binding motif of SFV nsP3 consists of two FGDF motifs, in which both phenylalanine and the glycine residue are essential for binding. In addition, we show that binding of the cellular G3BP-binding partner USP10 is also mediated by an FGDF motif. Overexpression of wt USP10, but not a mutant lacking the FGDF-motif, blocks SG assembly. Further, we identified FGDF-mediated G3BP binding site in herpes simplex virus (HSV) protein ICP8, and show that ICP8 binding to G3BP also inhibits SG formation, which is a novel function of HSV ICP8. We present a model of the three-dimensional structure of G3BP bound to an FGDF-containing peptide, likely representing a binding mode shared by many proteins to target G3BP.","[Panas, Marc D.; Thaa, Bastian; McInerney, Gerald M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Schulte, Tim; Sandalova, Tatiana; Achour, Adnane] Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden; [Kedersha, Nancy] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA","Panas, MD (reprint author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.",gerald.mcinerney@ki.se,,"Sandalova, Tatyana/0000-0002-7694-6420; McInerney, Gerald/0000-0003-2257-7241; Achour, Adnane/0000-0003-0432-710X; Schulte, Tim/0000-0002-7322-8933",Cancerfonden (Swedish Cancer Society) [CF 2012/789],"This research was supported by a Cancerfonden (Swedish Cancer Society) Project grant (CF 2012/789) to GMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bomberger JM, 2014, J BIOL CHEM, V289, P152, DOI 10.1074/jbc.M113.459271; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Breakwell L, 2007, J VIROL, V81, P8677, DOI 10.1128/JVI.02411-06; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Dauber B, 2011, J VIROL, V85, P5363, DOI 10.1128/JVI.00115-11; Eng KE, 2012, J VIROL, V86, P5674, DOI 10.1128/JVI.06581-11; Esclatine A, 2004, J VIROL, V78, P8582, DOI 10.1128/JVI.78.16.8582-8592.2004; Finnen RL, 2012, J VIROL, V86, P8119, DOI 10.1128/JVI.00313-12; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KNIPE DM, 1982, J VIROL, V43, P314; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Muylaert I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R111.233981; Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Oi N, 2014, ONCOGENE, DOI [10.1038/onc.2014.1194, DOI 10.1038/ONC.2014.1194]; Panas MD, 2014, J VIROL, V88, P5888, DOI 10.1128/JVI.00439-14; Panas MD, 2012, MOL BIOL CELL, V23, P4701, DOI 10.1091/mbc.E12-08-0619; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; STOW ND, 1993, VIROLOGY, V196, P413, DOI 10.1006/viro.1993.1496; Suyama M, 2000, EMBO REP, V1, P53, DOI 10.1093/embo-reports/kvd009; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Tamberg N, 2007, J GEN VIROL, V88, P1225, DOI 10.1099/vir.0.82436-0; Taylor TJ, 2003, VIROLOGY, V309, P219, DOI 10.1016/S0042-6822(03)00108-9; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007; Varjak M, 2013, J VIROL, V87, P10295, DOI 10.1128/JVI.01105-13; Varjak M, 2010, J VIROL, V84, P2352, DOI 10.1128/JVI.01540-09; Vognsen T, 2013, CRYSTAL STRUCTURES H; Wehner KA, 2010, MOL CELL BIOL, V30, P2006, DOI 10.1128/MCB.01350-09; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Yi ZG, 2006, BIOCHEM BIOPH RES CO, V350, P174, DOI 10.1016/j.bbrc.2006.09.027; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032",48,39,39,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004659,10.1371/journal.ppat.1004659,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400040,25658430.0,"DOAJ Gold, Green Published",,,16/08/2019,38,0,53,7577,837,603,234,6740,5664,21,1055,53,0,0,0,42,42,1,,68,0,68,0,0,41,41,35,30,0,0,0,0,0,0,0,0,0,7731,125,0,371,69,0,6843,867,125,0,371,69,0,21,,0,0,0,0,0,0,0,1,0,0,0,68,0,0,0.25,9.052568697729988,1.1241839762611276,0.1241839762611276,1.1758160237388724,1.045928467731292,9.468339307048984
124,J,"Popa, A; Zhang, W; Harrison, MS; Goodner, K; Kazakov, T; Goodwin, EC; Lipovsky, A; Burd, CG; DiMaio, D",,,,"Popa, Andreea; Zhang, Wei; Harrison, Megan S.; Goodner, Kylia; Kazakov, Teymur; Goodwin, Edward C.; Lipovsky, Alex; Burd, Christopher G.; DiMaio, Daniel",,,Direct Binding of Retromer to Human Papillomavirus Type 16 Minor Capsid Protein L2 Mediates Endosome Exit during Viral Infection,PLOS PATHOGENS,,,English,Article,,,,,,,VIRUS-LIKE PARTICLES; TRANS-GOLGI NETWORK; HEPARAN-SULFATE; HUMAN KERATINOCYTES; PROXIMITY LIGATION; ENTRY; COMPLEX; SURFACE; SITE; L1,"Trafficking of human papillomaviruses to the Golgi apparatus during virus entry requires retromer, an endosomal coat protein complex that mediates the vesicular transport of cellular transmembrane proteins from the endosome to the Golgi apparatus or the plasma membrane. Here we show that the HPV16 L2 minor capsid protein is a retromer cargo, even though L2 is not a transmembrane protein. We show that direct binding of retromer to a conserved sequence in the carboxy-terminus of L2 is required for exit of L2 from the early endosome and delivery to the trans-Golgi network during virus entry. This binding site is different from known retromer binding motifs and can be replaced by a sorting signal from a cellular retromer cargo. Thus, HPV16 is an unconventional particulate retromer cargo, and retromer binding initiates retrograde transport of viral components from the endosome to the trans-Golgi network during virus entry. We propose that the carboxy-terminal segment of L2 protein protrudes through the endosomal membrane and is accessed by retromer in the cytoplasm.","[Popa, Andreea; Zhang, Wei; Goodner, Kylia; Kazakov, Teymur; Goodwin, Edward C.; Lipovsky, Alex; DiMaio, Daniel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Harrison, Megan S.; Burd, Christopher G.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Canc Ctr, New Haven, CT USA","Popa, A (reprint author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.",daniel.dimaio@yale.edu,,"Burd, Christopher/0000-0003-1831-8706","Yale Cancer Center; American Heart Association; National Institutes of Health [T32 HG003198, AI102876, CA016038, GM060221]","Funding: AP and WZ were supported in part by Leslie Warner Postdoctoral Fellowships from Yale Cancer Center. MSH was supported by a postdoctoral fellowship from the American Heart Association. KG was supported by a training grant from the National Institutes of Health (T32 HG003198). The work was supported by grants from the National Institutes of Health to DD (AI102876 and CA016038) and to CB (GM060221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aydin I, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004162; Bienkowska-Haba M, 2012, J VIROL, V86, P9875, DOI 10.1128/JVI.00980-12; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2012, ADV EXP MED BIOL, V726, P403, DOI 10.1007/978-1-4614-0980-9_18; Burd C, 2014, COLD SPRING HARB PER, V6; Dasgupta J, 2011, J BIOL CHEM, V286, P2617, DOI 10.1074/jbc.M110.160184; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2013, J VIROL, V87, P3862, DOI 10.1128/JVI.03222-12; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; DiGiuseppe S, 2014, VIROLOGY, V458, P93, DOI 10.1016/j.virol.2014.04.024; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Inoue T, 2011, ANNU REV MICROBIOL, V65, P287, DOI 10.1146/annurev-micro-090110-102855; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Laniosz V, 2009, J VIROL, V83, P8221, DOI 10.1128/JVI.00576-09; Letian Tan, 2010, Virol J, V7, P2, DOI 10.1186/1743-422X-7-2; Lipovsky A, 2014, MIMB MEMBRA IN PRESS; Lipovsky A, 2013, P NATL ACAD SCI USA, V110, P7452, DOI 10.1073/pnas.1302164110; Liu WJ, 1997, VIROLOGY, V227, P474, DOI 10.1006/viro.1996.8348; Magaldi TG, 2012, J VIROL, V86, P7028, DOI 10.1128/JVI.00371-12; Marusic MB, 2012, TRAFFIC, V13, P455, DOI 10.1111/j.1600-0854.2011.01320.x; Moyer CL, 2011, J VIROL, V85, P2631, DOI 10.1128/JVI.02321-10; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Regberg Jakob, 2013, Front Biosci (Elite Ed), V5, P509; Richards KF, 2013, J VIROL, V87, P11426, DOI 10.1128/JVI.01721-13; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roden RBS, 2001, J VIROL, V75, P10493, DOI 10.1128/JVI.75.21.10493-10497.2001; SAPP M, 1994, J GEN VIROL, V75, P3375, DOI 10.1099/0022-1317-75-12-3375; Sapp M, 2009, VIROLOGY, V384, P400, DOI 10.1016/j.virol.2008.12.022; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Thomas Maria A, 2007, Methods Mol Med, V130, P185; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; Yin Wenguang, 2012, Cell Regen (Lond), V1, P4, DOI 10.1186/2045-9769-1-4; Zhang W, 2014, MBIO, V5, DOI 10.1128/mBio.01777-14",54,52,52,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004699,10.1371/journal.ppat.1004699,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400058,25693203.0,"DOAJ Gold, Green Published",,,16/08/2019,54,43,36,5227,786,596,190,4441,3623,30,788,36,1,0,0,51,51,0,,87,2,48,0,2,56,56,31,40,0,0,0,0,0,0,0,42,0,5223,81,0,183,64,0,4415,786,81,0,183,64,0,22,,0,0,0,0,1,0,1,1,0,0,0,47,0,0,1.5,6.650127226463105,1.176987165052916,0.176987165052916,1.2087367709975232,1.0269753204515017,6.8295165394402035
125,J,"Radtke, AJ; Kastenmuller, W; Espinosa, DA; Gerner, MY; Tse, SW; Sinnis, P; Germain, RN; Zavala, FP; Cockburn, IA",,,,"Radtke, Andrea J.; Kastenmueller, Wolfgang; Espinosa, Diego A.; Gerner, Michael Y.; Tse, Sze-Wah; Sinnis, Photini; Germain, Ronald N.; Zavala, Fidel P.; Cockburn, Ian A.",,,Lymph-Node Resident CD8 alpha(+) Dendritic Cells Capture Antigens from Migratory Malaria Sporozoites and Induce CD8(+) T Cell Responses,PLOS PATHOGENS,,,English,Article,,,,,,,IN-VIVO; CIRCUMSPOROZOITE PROTEIN; PLASMODIUM SPOROZOITES; IMMUNE-RESPONSE; PROTECTIVE ANTIGEN; PRESENTING CELLS; LANGERHANS CELLS; LIVER-STAGES; SKIN; IMMUNIZATION,"Malaria infection begins when a female Anopheles mosquito injects Plasmodium sporozoites into the skin of its host during blood feeding. Skin-deposited sporozoites may enter the bloodstream and infect the liver, reside and develop in the skin, or migrate to the draining lymph nodes (DLNs). Importantly, the DLN is where protective CD8(+) T cell responses against malaria liver stages are induced after a dermal route of infection. However, the significance of parasites in the skin and DLN to CD8(+) T cell activation is largely unknown. In this study, we used genetically modified parasites, as well as antibody-mediated immobilization of sporozoites, to determine that active sporozoite migration to the DLNs is required for robust CD8(+) T cell responses. Through dynamic in vivo and static imaging, we show the direct uptake of parasites by lymph-node resident DCs followed by CD8(+) T cell-DC cluster formation, a surrogate for antigen presentation, in the DLNs. A few hours after sporozoite arrival to the DLNs, CD8(+) T cells are primed by resident CD8 alpha(+) DCs with no apparent role for skin-derived DCs. Together, these results establish a critical role for lymph node resident CD8 alpha(+) DCs in CD8(+) T cell priming to sporozoite antigens while emphasizing a requirement for motile sporozoites in the induction of CD8(+) T cell-mediated immunity.","[Radtke, Andrea J.; Espinosa, Diego A.; Tse, Sze-Wah; Sinnis, Photini; Zavala, Fidel P.; Cockburn, Ian A.] Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Radtke, Andrea J.; Espinosa, Diego A.; Tse, Sze-Wah; Sinnis, Photini; Zavala, Fidel P.; Cockburn, Ian A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Kastenmueller, Wolfgang; Gerner, Michael Y.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA","Radtke, AJ (reprint author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",fzavala@jhsph.edu; ian.cockburn@anu.edu.au,,"Cockburn, Ian/0000-0001-8220-9294; Espinosa, Diego A./0000-0002-4364-5031","NIH [AI44375, AI056840]; Johns Hopkins Malaria Research Institute; Bloomberg Family; NIAID, NIH","FPZ is supported by NIH grant AI44375. AJR was supported by a pre-doctoral fellowship from the Johns Hopkins Malaria Research Institute. PS is supported by NIH grant AI056840. The authors are grateful for the support of the Bloomberg Family. This work was supported in part by the Intramural Research Program of NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bachy V, 2013, P NATL ACAD SCI USA, V110, P3041, DOI 10.1073/pnas.1214449110; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; BOYD MARK F., 1939, AMER JOUR TROP MED, V19, P27; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Cockburn IA, 2014, INFECT IMMUN, V82, P1460, DOI 10.1128/IAI.01500-13; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Flacher V, 2008, IMMUNOLOGY, V123, P339, DOI 10.1111/j.1365-2567.2007.02785.x; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Gueirard P, 2010, P NATL ACAD SCI USA, V107, P18640, DOI 10.1073/pnas.1009346107; Hafalla JCR, 2006, EUR J IMMUNOL, V36, P1179, DOI 10.1002/eji.200535712; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mac-Daniel L, 2014, J IMMUNOL, V193, P1246, DOI 10.4049/jimmunol.1302669; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Obeid M, 2013, EMBO MOL MED, V5, P250, DOI 10.1002/emmm.201201677; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Plebanski M, 2005, IMMUNOL CELL BIOL, V83, P307, DOI 10.1111/j.1440-1711.2005.01325.x; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sinnis P, 2012, SEMIN IMMUNOPATHOL, V34, P787, DOI 10.1007/s00281-012-0345-5; STEWART MJ, 1986, INFECT IMMUN, V51, P859; STEWART MJ, 1992, J PROTOZOOL, V39, P663, DOI 10.1111/j.1550-7408.1992.tb04446.x; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VANDERBERG JP, 1990, J PROTOZOOL, V37, P528, DOI 10.1111/j.1550-7408.1990.tb01260.x; Voza T, 2012, INFECT IMMUN, V80, P2158, DOI 10.1128/IAI.00246-12; Voza T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-362; WEISS WR, 1992, J IMMUNOL, V149, P2103; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x",76,50,50,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004637,10.1371/journal.ppat.1004637,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400024,25658939.0,"DOAJ Gold, Green Published",,,16/08/2019,53,3,33,8260,782,586,196,7478,6199,19,1260,33,3,0,2,50,50,1,,52,5,51,0,5,56,56,38,28,0,0,0,0,0,0,0,0,2,8366,115,0,401,92,1,7526,808,115,0,401,92,1,32,,0,0,0,0,6,0,0,1,1,0,1,50,0,0,4.85,10.562659846547314,1.1045734153516984,0.10457341535169831,1.1464295266113935,1.0378934624697336,10.962915601023019
126,J,"Reid-Yu, SA; Tuinema, BR; Small, CN; Xing, L; Coombes, BK",,,,"Reid-Yu, Sarah A.; Tuinema, Brian R.; Small, Cherrie N.; Xing, Lydia; Coombes, Brian K.",,,CXCL9 Contributes to Antimicrobial Protection of the Gut during Citrobacter rodentium Infection Independent of Chemokine-Receptor Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,CHEMOATTRACTANT I-TAC; HOST-DEFENSE; ESCHERICHIA-COLI; DENDRITIC CELLS; IFN-GAMMA; T-CELLS; PSEUDOMONAS-AERUGINOSA; BACTERIAL PATHOGEN; GENE-EXPRESSION; OUTER-MEMBRANE,"Chemokines have been shown to be effective bactericidal molecules against a variety of bacteria and fungi in vitro. These direct antimicrobial effects are independent of their chemotactic activities involving immunological receptors. However, the direct biological role that these proteins may play in host defense, particularly against intestinal pathogens, is poorly understood. Here, we show that CXCL9, an ELR-chemokine, exhibits direct antimicrobial activity against Citrobacter rodentium, an attaching/effacing pathogen that infects the gut mucosa. Inhibition of this antimicrobial activity in vivo using anti-CXCL9 antibodies increases host susceptibility to C. rodentium infection with pronounced bacterial penetration into crypts, increased bacterial load, and worsened tissue pathology. Using Rag1(-/-) mice and CXCR3(-/-) mice, we demonstrate that the role for CXCL9 in protecting the gut mucosa is independent of an adaptive response or its immunological receptor, CXCR3. Finally, we provide evidence that phagocytes function in tandem with NK cells for robust CXCL9 responses to C. rodentium. These findings identify a novel role for the immune cell-derived CXCL9 chemokine in directing a protective antimicrobial response in the intestinal mucosa.","[Reid-Yu, Sarah A.; Tuinema, Brian R.; Small, Cherrie N.; Xing, Lydia; Coombes, Brian K.] Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Reid-Yu, Sarah A.; Tuinema, Brian R.; Small, Cherrie N.; Xing, Lydia; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Coombes, Brian K.] Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada","Reid-Yu, SA (reprint author), Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.",coombes@mcmaster.ca,,"Coombes, Brian/0000-0001-9883-1010",Michael DeGroote Institute for Infectious Disease Research; Canadian Institutes of Health Research [MOP-82704],"CNS is a CIHR-CAG Postdoctoral fellow, and LX was supported by a Studentship award from the Michael DeGroote Institute for Infectious Disease Research. BKC is the Canada Research Chair in Infectious Disease Pathogenesis. This work was funded by the Canadian Institutes of Health Research, Grant number MOP-82704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Assi K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-137; Barrow K, 2009, ANTIMICROB AGENTS CH, V53, P5150, DOI 10.1128/AAC.00893-09; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Crawford MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001199; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIMARZIO P, 1994, J EXP MED, V179, P1731, DOI 10.1084/jem.179.5.1731; Egesten A, 2007, INT J COLORECTAL DIS, V22, P1421, DOI 10.1007/s00384-007-0370-3; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Egesten A, 2011, J BIOL CHEM, V286, P2469, DOI 10.1074/jbc.M110.148171; Gasperini S, 1999, J IMMUNOL, V162, P4928; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Higgins LM, 1999, INFECT IMMUN, V67, P3031; Kang YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000934; Karlsson C, 2009, J BIOL CHEM, V284, P29499, DOI 10.1074/jbc.M109.025957; Kawaguchi S, 2009, IMMUNOL LETT, V123, P9, DOI 10.1016/j.imlet.2009.01.008; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Linge HM, 2008, J INTERF CYTOK RES, V28, P190, DOI 10.1089/jir.2007.0100; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Luperchio SA, 2000, J CLIN MICROBIOL, V38, P4343; Mahalingam S, 2001, J BIOL CHEM, V276, P7568, DOI 10.1074/jbc.M005773200; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McPhee JB, 2014, INFECT IMMUN, V82, P3383, DOI 10.1128/IAI.01888-14; Miller AK, 2011, ANTIMICROB AGENTS CH, V55, P5761, DOI 10.1128/AAC.05391-11; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakka S, 2010, MICROBIOL RES, V165, P665, DOI 10.1016/j.micres.2009.11.013; Reid-Yu SA, 2013, EUR J IMMUNOL, V43, P2638, DOI 10.1002/eji.201343435; Romagnani P, 2002, AM J PATHOL, V161, P195, DOI 10.1016/S0002-9440(10)64171-5; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Shim EJ, 2013, J IMMUNOL, V191, P2764, DOI 10.4049/jimmunol.1300908; Shiomi H, 2010, INFECT IMMUN, V78, P2653, DOI 10.1128/IAI.01343-09; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Veckman V, 2003, J LEUKOCYTE BIOL, V74, P395, DOI 10.1189/jlb.0402212; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a",55,10,10,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004648,10.1371/journal.ppat.1004648,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400033,25643352.0,"DOAJ Gold, Green Published",,,16/08/2019,9,1,21,4829,920,714,206,3909,3223,21,665,21,0,0,0,7,7,0,,27,0,27,0,0,11,11,5,5,0,0,0,0,0,0,0,1,1,4887,33,0,75,77,0,3944,926,33,0,75,77,0,17,,0,0,0,0,1,0,1,0,0,0,0,27,0,0,0.75,5.248913043478261,1.235354310565362,0.235354310565362,1.2783320542338195,1.0347898115551875,5.431521739130435
127,J,"Sandiford, SL; Dong, YM; Pike, A; Blumberg, BJ; Bahia, AC; Dimopoulos, G",,,,"Sandiford, Simone L.; Dong, Yuemei; Pike, Andrew; Blumberg, Benjamin J.; Bahia, Ana C.; Dimopoulos, George",,,"Cytoplasmic Actin Is an Extracellular Insect Immune Factor which Is Secreted upon Immune Challenge and Mediates Phagocytosis and Direct Killing of Bacteria, and Is a Plasmodium Antagonist",PLOS PATHOGENS,,,English,Article,,,,,,,PATTERN-RECOGNITION RECEPTOR; VECTOR ANOPHELES-GAMBIAE; COMPLEMENT-LIKE PROTEIN; DROSOPHILA-MELANOGASTER; INNATE IMMUNITY; CELLS; MOSQUITO; HEMOLYMPH; MD-2; LIPOPOLYSACCHARIDE,"Actin is a highly versatile, abundant, and conserved protein, with functions in a variety of intracellular processes. Here, we describe a novel role for insect cytoplasmic actin as an extracellular pathogen recognition factor that mediates antibacterial defense. Insect actins are secreted from cells upon immune challenge through an exosome-independent pathway. Anopheles gambiae actin interacts with the extracellular MD2-like immune factor AgMDL1, and binds to the surfaces of bacteria, mediating their phagocytosis and direct killing. Globular and filamentous actins display distinct functions as extracellular immune factors, and mosquito actin is a Plasmodium infection antagonist.","[Sandiford, Simone L.; Dong, Yuemei; Pike, Andrew; Blumberg, Benjamin J.; Bahia, Ana C.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA","Sandiford, SL (reprint author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.",gdimopou@jhsph.edu,"Bahia Nascimento, Ana/G-2372-2015","Bahia Nascimento, Ana/0000-0002-4584-1888",National Institutes of Health / National Institute of Allergy and Infectious Disease [RO1AI06157 6]; JHMRI,"This work was supported by the National Institutes of Health / National Institute of Allergy and Infectious Disease RO1AI06157 6 and a JHMRI predoctoral fellowship (to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Behrens I, 2003, EUR J PHARM SCI, V19, P433, DOI 10.1016/S0928-0987(03)00146-5; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Carta S, FRONT IMMUNOL, V4, P123; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; DREVETS DA, 1991, J IMMUNOL METHODS, V142, P31, DOI 10.1016/0022-1759(91)90289-R; Esquenet M, 1997, J STEROID BIOCHEM, V62, P391, DOI 10.1016/S0960-0760(97)00054-X; Fyrberg EA, 1998, BIOCHEM GENET, V36, P271, DOI 10.1023/A:1018785127079; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Henty-Ridilla JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003290; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Krusong K, 2012, DEV COMP IMMUNOL, V36, P208, DOI 10.1016/j.dci.2011.08.002; Kumar BA, 2008, EXP PARASITOL, V118, P297, DOI 10.1016/j.exppara.2007.08.012; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Malhotra V, 2013, EMBO J, V32, P1660, DOI 10.1038/emboj.2013.104; Martin B, 2008, PLOS ONE, V3, P2750, DOI DOI 10.1371/J0URNAL.P0NE.0002750; May RC, 2001, J CELL SCI, V114, P1061; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Salazar C. E., 1994, Insect Molecular Biology, V3, P1; Schlegelmilch T, 2013, PATHOG GLOB HEALTH, V107, P480, DOI 10.1179/2047772413Z.000000000180; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Shi XZ, 2012, INSECT BIOCHEM MOLEC, V42, P545, DOI 10.1016/j.ibmb.2012.04.002; Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vierstraete E, 2004, P NATL ACAD SCI USA, V101, P470, DOI 10.1073/pnas.0304567101; Vierstraete E, 2003, BIOCHEM BIOPH RES CO, V304, P831, DOI 10.1016/S0006-291X(03)00683-1; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Wagner CR, 2002, P NATL ACAD SCI USA, V99, P8037, DOI 10.1073/pnas.082235499; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Wenger SL, 2004, BIOSCIENCE REP, V24, P631, DOI 10.1007/s10540-005-2797-5; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740",54,24,26,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004631,10.1371/journal.ppat.1004631,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400019,25658622.0,"DOAJ Gold, Green Published",,,16/08/2019,26,2,53,6682,946,742,204,5736,4699,22,1015,53,0,0,0,22,22,0,,136,2,70,0,2,26,26,22,15,0,0,0,0,0,0,0,2,0,6692,55,0,356,90,1,5718,946,55,0,356,90,1,28,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,7.063424947145878,1.164923291492329,0.16492329149232915,1.1919456066945606,1.0231966477102663,7.2272727272727275
128,J,"Sei, E; Wang, T; Hunter, OV; Xie, Y; Conrad, NK",,,,"Sei, Emi; Wang, Tao; Hunter, Olga V.; Xie, Yang; Conrad, Nicholas K.",,,HITS-CLIP Analysis Uncovers a Link between the Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein and Host Pre-mRNA Metabolism,PLOS PATHOGENS,,,English,Article,,,,,,,POSTTRANSCRIPTIONAL GENE-REGULATION; DEPENDENT DNA-REPLICATION; VIRUS ICP27 PROTEIN; EXPORT FACTOR; IN-VIVO; TRANSCRIPTIONAL ELONGATION; FUNCTIONAL COOPERATION; REGULATORY PROTEINS; GAMMA-HERPESVIRUSES; SPLICING FACTOR,"The Kaposi's sarcoma associated herpesvirus (KSHV) is an oncogenic virus that causes Kaposi's sarcoma, primary effusion lymphoma (PEL), and some forms of multicentric Castleman's disease. The KSHV ORF57 protein is a conserved posttranscriptional regulator of gene expression that is essential for virus replication. ORF57 is multifunctional, but most of its activities are directly linked to its ability to bind RNA. We globally identified virus and host RNAs bound by ORF57 during lytic reactivation in PEL cells using high-throughput sequencing of RNA isolated by cross-linking immunoprecipitation (HITS-CLIP). As expected, ORF57-bound RNA fragments mapped throughout the KSHV genome, including the known ORF57 ligand PAN RNA. In agreement with previously published ChIP results, we observed that ORF57 bound RNAs near the oriLyt regions of the genome. Examination of the host RNA fragments revealed that a subset of the ORF57-bound RNAs was derived from transcript 5' ends. The position of these 5'-bound fragments correlated closely with the 5'-most exon-intron junction of the pre-mRNA. We selected four candidates (BTG1, EGR1, ZFP36, and TNFSF9) and analyzed their pre-mRNA and mRNA levels during lytic phase. Analysis of both steady-state and newly made RNAs revealed that these candidate ORF57-bound pre-mRNAs persisted for longer periods of time throughout infection than control RNAs, consistent with a role for ORF57 in pre-mRNA metabolism. In addition, exogenous expression of ORF57 was sufficient to increase the pre-mRNA levels and, in one case, the mRNA levels of the putative ORF57 targets. These results demonstrate that ORF57 interacts with specific host pre-mRNAs during lytic reactivation and alters their processing, likely by stabilizing pre-mRNAs. These data suggest that ORF57 is involved inmodulating host gene expression in addition to KSHV gene expression during lytic reactivation.","[Sei, Emi; Hunter, Olga V.; Conrad, Nicholas K.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Wang, Tao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA","Sei, E (reprint author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.",Yang.xie@utsouthwestern.edu; Nicholas.conrad@utsouthwestern.edu,"Wang, Tao/K-3518-2016",,"National Institutes of Health [AI081710, 5R01CA152301]; Cancer Prevention and Research Institute of Texas [RP101251]","This work was funded by the National Institutes of Health: AI081710 to NKC and 5R01CA152301 to YX. Funding was also provided by the Cancer Prevention and Research Institute of Texas: RP101251 to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; AuCoin DP, 2002, J VIROL, V76, P7890, DOI 10.1128/JVI.76.15.7890-7896.2002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Bieberstein NI, 2012, CELL REPORTS, V2, P62, DOI 10.1016/j.celrep.2012.05.019; Boyne JR, 2010, EMBO J, V29, P1851, DOI 10.1038/emboj.2010.77; Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Bresson SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003893; Brulois K, 2014, CYTOKINE GROWTH F R, V25, P597, DOI 10.1016/j.cytogfr.2014.06.001; Chanarat S, 2011, GENE DEV, V25, P1147, DOI 10.1101/gad.623411; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cheuk ATC, 2004, CANCER GENE THER, V11, P215, DOI 10.1038/sj.cgt.7700670; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Conrad NK, 2009, ADV APPL MICROBIOL, V68, P241, DOI 10.1016/S0065-2164(09)01206-4; Conrad NK, 2008, METHOD ENZYMOL, V449, P317, DOI 10.1016/S0076-6879(08)02415-4; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Dittmer DP, 2013, CURR OPIN VIROL, V3, P238, DOI 10.1016/j.coviro.2013.05.012; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gupta AK, 2000, J VIROL, V74, P1038, DOI 10.1128/JVI.74.2.1038-1044.2000; Han Z, 2006, J VIROL, V80, P5251, DOI 10.1128/JVI.02570-05; Han Z, 2009, J VIROL, V83, P11635, DOI 10.1128/JVI.01483-09; HARDWICKE MA, 1994, J VIROL, V68, P4797; HARDY WR, 1994, J VIROL, V68, P7790; Hunter OV, 2013, J VIROL, V87, P4005, DOI 10.1128/JVI.03459-12; Jackson BR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004098; Jackson BR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00059; Jackson BR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002138; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kang JG, 2011, J VIROL, V85, P2620, DOI 10.1128/JVI.02144-10; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kirshner JR, 2000, J VIROL, V74, P3586, DOI 10.1128/JVI.74.8.3586-3597.2000; Li DJ, 2012, J VIROL, V86, P9866, DOI 10.1128/JVI.01190-12; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lieberman PM, 2013, NAT REV MICROBIOL, V11, P863, DOI 10.1038/nrmicro3135; Lin Cui Li, 2003, Journal of Virology, V77, P5578, DOI 10.1128/JVI.77.10.5578-5588.2003; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Majerciak V, 2008, J VIROL, V82, P2792, DOI 10.1128/JVI.01856-07; Majerciak V, 2007, J VIROL, V81, P1062, DOI 10.1128/JVI.01558-06; Majerciak V, 2006, J VIROL, V80, P11968, DOI 10.1128/JVI.01394-06; Majerciak V, 2006, J BIOL CHEM, V281, P28365, DOI 10.1074/jbc.M603095200; Majerciak V, 2014, RNA, V20, P1747, DOI 10.1261/rna.045500.114; Majerciak V, 2011, J VIROL, V85, P1528, DOI 10.1128/JVI.01709-10; Majerciak V, 2010, J BIOL CHEM, V285, P11297, DOI 10.1074/jbc.M109.068221; Majerciak V, 2009, FRONT BIOSCI-LANDMRK, V14, P1516, DOI 10.2741/3322; Malik P, 2004, NUCLEIC ACIDS RES, V32, P5553, DOI 10.1093/nar/gkh876; Malik P, 2004, J GEN VIROL, V85, P2155, DOI 10.1099/vir.0.79784-0; Malik P, 2004, J BIOL CHEM, V279, P33001, DOI 10.1074/jbc.M313008200; Malik P, 2012, J BIOL CHEM, V287, P12277, DOI 10.1074/jbc.M111.331777; Massimelli MJ, 2013, J VIROL, V87, P243, DOI 10.1128/JVI.01693-12; Massimelli MJ, 2011, INT J BIOL SCI, V7, P1145, DOI 10.7150/ijbs.7.1145; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mili S, 2004, RNA, V10, P1692, DOI 10.1016/10.1261.rna.7151404; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nekorchuk M, 2007, J VIROL, V81, P9990, DOI 10.1128/JVI.00896-07; Nicholas J, 1998, J Natl Cancer Inst Monogr, P79; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Palmeri D, 2007, J VIROL, V81, P13299, DOI 10.1128/JVI.00732-07; Park SJ, 2012, MOL CELLS, V33, P533, DOI 10.1007/s10059-012-0077-3; Pilkington GR, 2012, J VIROL, V86, P13089, DOI 10.1128/JVI.00606-12; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Rennekamp AJ, 2011, J VIROL, V85, P2837, DOI 10.1128/JVI.02175-10; Ritchie MF, 2011, FRONT BIOSCI-LANDMRK, V16, P2402, DOI 10.2741/3862; Ruocco E, 2013, CLIN DERMATOL, V31, P413, DOI 10.1016/j.clindermatol.2013.01.008; Sahin BB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000799; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sandri-Goldin RM, 2008, FRONT BIOSCI-LANDMRK, V13, P5241, DOI 10.2741/3078; Sanduja S, 2012, FRONTIERS BIOSCIENCE, V136, P1669, DOI [10.1053/j.gastro.2009.01.010, DOI 10.1053/J.GASTRO.2009.01.010]; Schumann S, 2013, VIRUSES-BASEL, V5, P1901, DOI 10.3390/v5081901; Sei E, 2011, VIROLOGY, V419, P107, DOI 10.1016/j.virol.2011.08.006; Shan J., 2014, BIOL CHEM, V298, P24665, DOI DOI 10.1074/JBC.M114.565028; Smit A, 2010, REPEATMASKER OPEN3 0; Smith RWP, 2005, BIOCHEM SOC T, V33, P499, DOI 10.1042/BST0330499; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Staudt Michelle R., 2003, Current Drug Targets - Infectious Disorders, V3, P129, DOI 10.2174/1568005033481150; Stubbs SH, 2012, MOL CELL BIOL, V32, P1260, DOI 10.1128/MCB.06420-11; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Sun R, 1996, P NATL ACAD SCI USA, V93, P11883, DOI 10.1073/pnas.93.21.11883; Swaminathan S, 2005, J CELL BIOCHEM, V95, P698, DOI 10.1002/jcb.20465; Taylor A, 2011, J VIROL, V85, P7881, DOI 10.1128/JVI.00138-11; Taylor JL, 2005, J VIROL, V79, P15099, DOI 10.1128/JVI.79.24.15099-15106.2005; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Toth Z, 2008, FRONT BIOSCI-LANDMRK, V13, P2939, DOI 10.2741/2899; Toth Z, 2013, VIRUSES-BASEL, V5, P1346, DOI 10.3390/v5051346; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Verma D, 2008, J VIROL, V82, P7180, DOI 10.1128/JVI.00344-08; Verma D, 2013, J VIROL, V87, P10742, DOI 10.1128/JVI.01644-13; Verma D, 2010, J VIROL, V84, P11781, DOI 10.1128/JVI.01359-10; Wang T, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r11; Wang Y, 2004, J VIROL, V78, P8615, DOI 10.1128/JVI.78.16.8615-8629.2004; Wang Y, 2006, J VIROL, V80, P12171, DOI 10.1128/JVI.00990-06; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zeiner Gusti M., 2008, V419, P135, DOI 10.1007/978-1-59745-033-1_9; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhao S, 2014, HUM PATHOL, V45, P1024, DOI 10.1016/j.humpath.2013.12.019; Zheng ZM, 2003, REV MED VIROL, V13, P173, DOI 10.1002/rmv.387; Zhu Y, 2013, CURR OPIN VIROL, V3, P266, DOI 10.1016/j.coviro.2013.05.013; Zwang Y, 2012, CANCER RES, V72, P1051, DOI 10.1158/0008-5472.CAN-11-3382",104,29,29,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004652,10.1371/journal.ppat.1004652,,,,35,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400036,25710169.0,"DOAJ Gold, Green Published",,,16/08/2019,13,28,13,4011,644,487,157,3367,2894,22,451,13,5,0,0,13,13,0,,20,5,20,0,5,13,13,11,12,0,0,0,0,0,0,0,23,0,4004,69,0,104,82,0,3345,644,69,0,104,82,0,15,,0,0,0,0,6,0,1,1,0,0,0,19,0,0,2.5,6.228260869565218,1.1912681912681913,0.19126819126819128,1.234036234036234,1.0359012715033658,6.451863354037267
129,J,"Sell, S; Dietz, M; Schneider, A; Holtappels, R; Mach, M; Winkler, TH",,,,"Sell, Sabrina; Dietz, Monika; Schneider, Andrea; Holtappels, Rafaela; Mach, Michael; Winkler, Thomas H.",,,Control of Murine Cytomegalovirus Infection by gamma delta T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,LONG-TERM DEPLETION; LYMPHOCYTES-T; TRANSPLANT RECIPIENTS; MONOCLONAL-ANTIBODIES; INTERFERON-GAMMA; IMMUNE-RESPONSE; VIRUS; IMMUNOTHERAPY; DISSEMINATION; SURVEILLANCE,"Infections with cytomegalovirus (CMV) can cause severe disease in immunosuppressed patients and infected newborns. Innate as well as cellular and humoral adaptive immune effector functions contribute to the control of CMV in immunocompetent individuals. None of the innate or adaptive immune functions are essential for virus control, however. Expansion of gamma delta T cells has been observed during human CMV (HCMV) infection in the fetus and in transplant patients with HCMV reactivation but the protective function of gamma delta T cells under these conditions remains unclear. Here we show for murine CMV (MCMV) infections that mice that lack CD8 and CD4 alpha beta-T cells as well as B lymphocytes can control a MCMV infection that is lethal in RAG-1(-/-) mice lacking any T-and B-cells gamma delta T cells, isolated from infected mice can kill MCMV infected target cells in vitro and, importantly, provide long-term protection in infected RAG-1(-/-) mice after adoptive transfer gamma delta T cells in MCMV infected hosts undergo a prominent and long-lasting phenotypic change most compatible with the view that the majority of the gamma delta T cell population persists in an effector/memory state even after resolution of the acute phase of the infection. A clonotypically focused V gamma 1 and V gamma 2 repertoire was observed at later stages of the infection in the organs where MCMV persists. These findings add gamma delta T cells as yet another protective component to the anti-CMV immune response. Our data provide clear evidence that gamma delta T cells can provide an effective control mechanism of acute CMV infections, particularly when conventional adaptive immune mechanisms are insufficient or absent, like in transplant patient or in the developing immune system in utero. The findings have implications in the stem cell transplant setting, as antigen recognition by gamma delta T cells is not MHC-restricted and dual reactivity against CMV and tumors has been described.","[Sell, Sabrina; Schneider, Andrea; Winkler, Thomas H.] Univ Erlangen Nurnberg, Dept Biol, Nikolaus Fiebiger Zentrum Mol Med, D-91054 Erlangen, Germany; [Dietz, Monika; Mach, Michael] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany; [Holtappels, Rafaela] Johannes Gutenberg Univ Mainz, Univ Med, Inst Virol, D-55122 Mainz, Germany; [Holtappels, Rafaela] Johannes Gutenberg Univ Mainz, Univ Med, Forschungszentrum Immuntherapie FZI, D-55122 Mainz, Germany","Sell, S (reprint author), Univ Erlangen Nurnberg, Dept Biol, Nikolaus Fiebiger Zentrum Mol Med, D-91054 Erlangen, Germany.",thomas.winkler@fau.de,,,"Deutsche Forschungsgemeinschaft DFG [GRK1071, GRK1660]; NIH [RO1AI089956]","This work was supported by Deutsche Forschungsgemeinschaft DFG GRK1071 and GRK1660 and NIH RO1AI089956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Alejenef A, 2014, CLIN EXP IMMUNOL, V176, P418, DOI 10.1111/cei.12297; BALTHESEN M, 1993, J VIROL, V67, P5360; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Boeckh M, 2009, BLOOD, V113, P5711, DOI 10.1182/blood-2008-10-143560; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; CARDING SR, 1990, J EXP MED, V172, P1225, DOI 10.1084/jem.172.4.1225; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dyugovskaya L, 2003, IMMUNOLOGY, V108, P129, DOI 10.1046/j.1365-2567.2003.01568.x; FARRELL HE, 1991, J GEN VIROL, V72, P149, DOI 10.1099/0022-1317-72-1-149; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Hammoud B, 2013, J IMMUNOTHER, V36, P93, DOI 10.1097/CJI.0b013e31827b87cc; Handgretinger R, 2012, CURR OPIN HEMATOL, V19, P434, DOI 10.1097/MOH.0b013e3283582340; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Holtappels R, 2001, J VIROL, V75, P6584, DOI 10.1128/JVI.75.14.6584-6600.2001; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713; JONJIC S, 1990, J VIROL, V64, P5457; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Klenovsek K, 2007, BLOOD, V110, P3472, DOI 10.1182/blood-2007-06-095414; Knight A, 2010, BLOOD, V116, P2164, DOI 10.1182/blood-2010-01-255166; Kurz S, 1997, J VIROL, V71, P2980; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Mach M, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P215; Ninomiya T, 2000, IMMUNOLOGY, V99, P187, DOI 10.1046/j.1365-2567.2000.00938.x; Podlech J, 2002, METHOD MICROBIOL, V32, P493; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; REDDEHASE MJ, 1988, J VIROL, V62, P1061; REDDEHASE MJ, 1987, J VIROL, V61, P3102; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Scheper W, 2013, LEUKEMIA, V27, P1328, DOI 10.1038/leu.2012.374; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Turchinovich G, 2011, TRENDS IMMUNOL, V32, P567, DOI 10.1016/j.it.2011.09.005; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Wirtz N, 2008, MED MICROBIOL IMMUN, V197, P151, DOI 10.1007/s00430-008-0095-0",49,25,25,1,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004481,10.1371/journal.ppat.1004481,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400001,25658831.0,"DOAJ Gold, Green Published",,,16/08/2019,25,11,33,6095,713,530,183,5382,4614,22,746,33,0,0,0,25,25,0,,87,0,48,0,0,27,27,20,17,0,0,0,0,0,0,0,11,0,6095,128,0,241,73,0,5363,713,128,0,241,73,0,19,,0,0,0,0,0,0,1,0,0,0,0,48,0,0,0.25,8.548387096774194,1.1324786324786325,0.13247863247863248,1.1698253437383872,1.0329778506972929,8.830294530154278
130,J,"Shor, E; Chauhan, N",,,,"Shor, Erika; Chauhan, Neeraj",,,A Case for Two-Component Signaling Systems As Antifungal Drug Targets,PLOS PATHOGENS,,,English,Article,,,,,,,RESPONSE REGULATOR GENE; HISTIDINE KINASE GENE; CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; ASPERGILLUS-FUMIGATUS; OXIDANT ADAPTATION; HYPHAL DEVELOPMENT; VIRULENCE FACTOR; IN-VITRO; STRESS,,"[Shor, Erika; Chauhan, Neeraj] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Chauhan, Neeraj] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07102 USA","Shor, E (reprint author), Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA.",chauhan1@njms.rutgers.edu,,"Shor, Erika/0000-0003-3655-0963",Rutgers-PHRI start-up funds,"This work was supported, in part, by the Rutgers-PHRI start-up funds to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bernhardt J, 2001, J INFECT DIS, V184, P1170, DOI 10.1086/323807; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calera JA, 2000, INFECT IMMUN, V68, P518, DOI 10.1128/IAI.68.2.518-525.2000; Calera JA, 1999, MICROBIOL-UK, V145, P1431, DOI 10.1099/13500872-145-6-1431; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Clemons KV, 2002, MED MYCOL, V40, P259, DOI 10.1080/714031112; Desai C, 2011, EUKARYOT CELL, V10, P1370, DOI 10.1128/EC.05188-11; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Fassler JS, 2013, EUKARYOT CELL, V12, P1052, DOI 10.1128/EC.00083-13; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hof H, 2010, EUR J CLIN MICROBIOL, V29, P5, DOI 10.1007/s10096-009-0822-5; Kee JM, 2013, NAT CHEM BIOL, V9, P416, DOI [10.1038/NCHEMBIO.1259, 10.1038/nchembio.1259]; Kee JM, 2012, ACS CHEM BIOL, V7, P44, DOI 10.1021/cb200445w; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kruppa M, 2004, EUKARYOT CELL, V3, P1062, DOI 10.1128/EC.3.4.1062-1065.2004; Kruppa M, 2003, FEMS YEAST RES, V3, P289, DOI 10.1111/j.1567-1364.2003.tb00170.x; Kurosu M, 2010, DRUG DEVELOP RES, V71, P168, DOI 10.1002/ddr.20362; Lee JW, 2011, EUKARYOT CELL, V10, P998, DOI 10.1128/EC.05124-11; Li DM, 2002, INFECT IMMUN, V70, P1558, DOI 10.1128/IAI.70.3.1558-1565.2002; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mavrianos J, 2013, EUKARYOT CELL, V12, P913, DOI 10.1128/EC.00048-13; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Okada A, 2007, METHOD ENZYMOL, V422, P386, DOI 10.1016/S0076-6879(06)22019-6; Pappas PG, 2013, CURR OPIN INFECT DIS, V26, P545, DOI 10.1097/QCO.0000000000000013; Perlin DS, 2014, DRUGS, V74, P1573, DOI 10.1007/s40265-014-0286-5; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V68, P278, DOI 10.1016/j.diagmicrobio.2010.06.015; Singh P, 2004, INFECT IMMUN, V72, P2390, DOI 10.1128/IAI.72.4.2390-2394.2004; Srikantha T, 1998, MICROBIOL-UK, V144, P2715, DOI 10.1099/00221287-144-10-2715; Tebbets B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036021; Torosantucci A, 2002, INFECT IMMUN, V70, P985, DOI 10.1128/IAI.70.2.985-987.2002; WENZEL RP, 1995, CLIN INFECT DIS, V20, P1531, DOI 10.1093/clinids/20.6.1531; Wilke KE, 2012, J AM CHEM SOC, V134, P9150, DOI 10.1021/ja3041702; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wormley FL, 2005, INFECT IMMUN, V73, P5022, DOI 10.1128/IAI.73.8.5022-5030.2005; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243",42,14,14,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004632,10.1371/journal.ppat.1004632,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400020,25723524.0,"DOAJ Gold, Green Published",,,16/08/2019,12,1,21,3876,470,367,103,3406,2782,20,604,21,0,0,0,13,13,0,,30,1,30,0,1,12,12,11,6,0,0,0,0,0,0,0,1,0,3917,53,0,966,80,3,3421,472,53,0,966,80,3,24,,0,0,0,0,0,0,2,0,0,0,0,29,0,0,0.5,8.246808510638298,1.1379917792131533,0.13799177921315325,1.1890780974750441,1.0448916408668731,8.617021276595745
131,J,"Smith, TC",,,,"Smith, Tara C.",,,Livestock-Associated Staphylococcus aureus: The United States Experience,PLOS PATHOGENS,,,English,Article,,,,,,,METHICILLIN-RESISTANT; RETAIL MEAT; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; MULTIDRUG-RESISTANT; BROILER-CHICKENS; NEW-YORK; MRSA; USA; STRAIN,,"Kent State Univ, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA","Smith, TC (reprint author), Kent State Univ, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.",Tsmit176@kent.edu,,"Smith, Tara C./0000-0003-3747-1116",,,"Argudin MA, 2013, AVIAN PATHOL, V42, P572, DOI 10.1080/03079457.2013.854308; Bhargava K, 2011, EMERG INFECT DIS, V17, P1135, DOI [10.3201/eid1706.101095, 10.3201/eid/1706.101905]; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Buyukcangaz E, 2013, FOODBORNE PATHOG DIS, V10, P608, DOI 10.1089/fpd.2012.1427; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; David MZ, 2013, J CLIN MICROBIOL, V51, P2443, DOI 10.1128/JCM.01057-13; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Fang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088826; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gordoncillo MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P212, DOI 10.1111/j.1863-2378.2011.01437.x; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Jackson CR, 2013, J CLIN MICROBIOL, V51, P1199, DOI 10.1128/JCM.03166-12; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Larsen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031245; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; McNamee PT, 2000, AVIAN PATHOL, V29, P253, DOI 10.1080/03079450050118386; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Nemeghaire S, 2013, AVIAN PATHOL, V42, P342, DOI 10.1080/03079457.2013.805183; Neyra RC, 2014, ENVIRON HEALTH PERSP, V122, P471, DOI 10.1289/ehp.1306741; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Orscheln RC, 2009, CLIN INFECT DIS, V49, P536, DOI 10.1086/600881; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Patchanee P, 2014, J VET SCI, V15, P529, DOI 10.4142/jvs.2014.15.4.529; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Pu S, 2008, APPL ENVIRON MICROB, V75, P265, DOI [10.1128/AEM.01110-08, DOI 10.1128/AEM.01110-08]; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Shepheard MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062369; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Uhlemann A.C., 2012, MBIO, V28, P3, DOI DOI 10.1128/MBI0.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Duijkeren E, 2007, EMERG INFECT DIS, V13, P1408, DOI 10.3201/eid1309.061268; Viana D, 2007, VET MICROBIOL, V121, P288, DOI 10.1016/j.vetmic.2006.12.003; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Wendlandt S, 2013, J ANTIMICROB CHEMOTH, V68, P2458, DOI 10.1093/jac/dkt239; World Health Organization, 2014, ANT RES GLOB REP SUR, P257; World Health Organization, 1976, B WORLD HEALTH ORGAN, V56, P271; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435",58,33,33,0,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004564,10.1371/journal.ppat.1004564,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400003,25654425.0,"DOAJ Gold, Green Published",,,16/08/2019,34,236,92,21650,1039,834,205,20611,18142,50,2419,92,17,2,0,34,34,0,,276,28,140,0,28,37,35,37,14,0,0,1,0,0,1,4,222,23,21690,15,3,27,209,6,20544,1039,15,3,27,209,6,107,,1,4,0,0,14,0,7,1,0,0,0,140,0,0,48.042,20.837343599615014,1.0504099752559313,0.0504099752559313,1.063218669642424,1.0121939953810624,21.09143407122233
132,J,"Stack, G; Jones, E; Marsden, M; Stacey, MA; Snelgrove, RJ; Lacaze, P; Jacques, LC; Cuff, SM; Stanton, RJ; Gallimore, AM; Hussell, T; Wilkinson, GWG; Ghazal, P; Taylor, PR; Humphreys, IR",,,,"Stack, Gabrielle; Jones, Emma; Marsden, Morgan; Stacey, Maria A.; Snelgrove, Robert J.; Lacaze, Paul; Jacques, Laura C.; Cuff, Simone M.; Stanton, Richard J.; Gallimore, Awen M.; Hussell, Tracy; Wilkinson, Gavin W. G.; Ghazal, Peter; Taylor, Philip R.; Humphreys, Ian R.",,,CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue,PLOS PATHOGENS,,,English,Article,,,,,,,MURINE CYTOMEGALOVIRUS; MOUSE-CYTOMEGALOVIRUS; MACROPHAGE ACTIVATION; INFLUENZA INFECTION; SALIVARY-GLANDS; VIRUS-INFECTION; DOWN-REGULATION; PROTEIN; HOST; INFLAMMATION,"CD200 receptor (CD200R) negatively regulates peripheral and mucosal innate immune responses. Viruses, including herpesviruses, have acquired functional CD200 orthologs, implying that viral exploitation of this pathway is evolutionary advantageous. However, the role that CD200R signaling plays during herpesvirus infection in vivo requires clarification. Utilizing the murine cytomegalovirus (MCMV) model, we demonstrate that CD200R facilitates virus persistence within mucosal tissue. Specifically, MCMV infection of CD200R-deficient mice (CD200R(-/-)) elicited heightened mucosal virus-specific CD4 T cell responses that restricted virus persistence in the salivary glands. CD200R did not directly inhibit lymphocyte effector function. Instead, CD200R(-/-) mice exhibited enhanced APC accumulation that in the mucosa was a consequence of elevated cellular proliferation. Although MCMV does not encode an obvious CD200 homolog, productive replication in macrophages induced expression of cellular CD200. CD200 from hematopoietic and non-hematopoietic cells contributed independently to suppression of antiviral control in vivo. These results highlight the CD200-CD200R pathway as an important regulator of antiviral immunity during cytomegalovirus infection that is exploited by MCMV to establish chronicity within mucosal tissue.","[Stack, Gabrielle; Jones, Emma; Marsden, Morgan; Stacey, Maria A.; Jacques, Laura C.; Cuff, Simone M.; Stanton, Richard J.; Gallimore, Awen M.; Wilkinson, Gavin W. G.; Taylor, Philip R.; Humphreys, Ian R.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Snelgrove, Robert J.] Univ London Imperial Coll Sci Technol & Med, Leukocyte Biol Sect, Natl Heart & Lung Inst, London, England; [Lacaze, Paul; Ghazal, Peter] Univ Edinburgh, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Lacaze, Paul; Ghazal, Peter] Univ Edinburgh, Edinburgh Infect Dis, Edinburgh, Midlothian, Scotland; [Hussell, Tracy] Univ Manchester, MCCIR, Manchester, Lancs, England; [Humphreys, Ian R.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England","Stack, G (reprint author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.",humphreysir@cardiff.ac.uk,"Wilkinson, Gavin/J-6388-2015; Stanton, Richard/B-4695-2008","Wilkinson, Gavin/0000-0002-5623-0126; Stanton, Richard/0000-0002-6799-1182; Gallimore, Awen/0000-0001-6675-7004; Humphreys, Ian/0000-0002-9512-5337; Taylor, Philip/0000-0003-0163-1421; Ghazal, Peter/0000-0003-0035-2228; Jones, Emma/0000-0002-0298-2859; Stack, Gabrielle/0000-0002-5714-2136","Wellcome Trust [WT098026MA, WT066784]; MRC [G0601617/1]; President's Scholarship; BBSRC/EPSRC [BB/D019621/1]; BBSRC; Biotechnology and Biological Sciences Research Council [BB/D019621/1]; Health and Care Research Wales [HS-14-11]; Medical Research Council [MR/J002151/1, MR/L008734/1, MR/K02003X/1, G0601617]","This work was supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (WT098026MA, to IRH), an MRC Senior Fellowship (G0601617/1 to PRT) and a President's Scholarship (to GS). PG was supported by the Wellcome Trust (WT066784) and by the BBSRC/EPSRC (BB/D019621/1). PL was supported by a BBSRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Angulo A, 2000, J VIROL, V74, P11129, DOI 10.1128/JVI.74.23.11129-11136.2000; Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140; Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Chang WLW, 2010, P NATL ACAD SCI USA, V107, P22647, DOI 10.1073/pnas.1013794108; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Estep RD, 2014, J VIROL, V88, P10635, DOI 10.1128/JVI.01276-14; Foster-Cuevas M, 2004, J VIROL, V78, P7667, DOI 10.1128/JVI.78.14.7667-7676.2004; Foster-Cuevas M, 2011, J VIROL, V85, P6055, DOI 10.1128/JVI.00064-11; Gharaibeh RZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-452; Hatherley D, 2004, EUR J IMMUNOL, V34, P1688, DOI 10.1002/eji.200425080; Hatherley D, 2013, STRUCTURE, V21, P820, DOI 10.1016/j.str.2013.03.008; HENSON D, 1972, AM J PATHOL, V68, P183; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hsu KM, 2009, J GEN VIROL, V90, P33, DOI [10.1099/vir.0.2008/006668-0, 10.1099/vir.0.006668-0]; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones M, 2010, J IMMUNOL, V185, P3583, DOI 10.4049/jimmunol.1001535; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kropp KA, 2011, J VIROL, V85, P10286, DOI 10.1128/JVI.00373-11; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lacaze P, 2011, J VIROL, V85, P6065, DOI 10.1128/JVI.02341-10; Mandaric S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002846; MANNING WC, 1992, J VIROL, V66, P3794; Mason GM, 2012, P NATL ACAD SCI USA, V109, P14538, DOI 10.1073/pnas.1204836109; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Misstear K, 2012, J VIROL, V86, P6246, DOI 10.1128/JVI.07168-11; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Orange JS, 1996, J IMMUNOL, V156, P4746; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Rezaee SAR, 2005, AIDS, V19, P1907, DOI 10.1097/01.aids.0000189849.75699.46; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Sarangi PP, 2009, CLIN IMMUNOL, V131, P31, DOI 10.1016/j.clim.2008.10.008; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Smith LM, 2008, J VIROL, V82, P6689, DOI 10.1128/JVI.00160-08; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Soberman RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047740; Stack G, 2012, VIRUSES-BASEL, V4, P1182, DOI 10.3390/v4081182; STODDART CA, 1994, J VIROL, V68, P6243; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; Thom JT, 2014, EUR J IMMUNOL, V44, P706, DOI 10.1002/eji.201343992; Voigt S, 2005, J GEN VIROL, V86, P263, DOI 10.1099/vir.0.80539-0; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786",56,9,9,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004641,10.1371/journal.ppat.1004641,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400028,25654642.0,"DOAJ Gold, Green Published",,,16/08/2019,9,0,25,4426,701,533,168,3725,3214,24,487,23,0,0,0,10,10,0,,31,0,29,2,0,10,10,7,9,0,0,0,0,0,0,0,0,0,4437,91,0,187,103,0,3719,701,91,0,187,103,0,17,,0,0,0,0,1,0,0,0,0,0,0,29,2,0,0.25,6.313837375178316,1.1881879194630873,0.18818791946308724,1.243221476510067,1.0463172164482604,6.606276747503566
133,J,"Steinbrenner, AD; Goritschnig, S; Staskawicz, BJ",,,,"Steinbrenner, Adam D.; Goritschnig, Sandra; Staskawicz, Brian J.",,,Recognition and Activation Domains Contribute to Allele-Specific Responses of an Arabidopsis NLR Receptor to an Oomycete Effector Protein,PLOS PATHOGENS,,,English,Article,,,,,,,RICH REPEAT DOMAINS; DISEASE-RESISTANCE; ARTIFICIAL EVOLUTION; BACTERIAL LIGANDS; COILED-COIL; NB-ARC; PLANT; GENES; ASSOCIATION; COEVOLUTION,"In plants, specific recognition of pathogen effector proteins by nucleotide-binding leucinerich repeat (NLR) receptors leads to activation of immune responses. RPP1, an NLR from Arabidopsis thaliana, recognizes the effector ATR1, from the oomycete pathogen Hyaloperonospora arabidopsidis, by direct association via C-terminal leucine-rich repeats (LRRs). Two RPP1 alleles, RPP1-NdA and RPP1-WsB, have narrow and broad recognition spectra, respectively, with RPP1-NdA recognizing a subset of the ATR1 variants recognized by RPP1-WsB. In this work, we further characterized direct effector recognition through random mutagenesis of an unrecognized ATR1 allele, ATR1-Cala2, screening for gain-of-recognition phenotypes in a tobacco hypersensitive response assay. We identified ATR1 mutants that a) confirm surface-exposed residues contribute to recognition by RPP1, and b) are recognized by and activate the narrow-spectrum allele RPP1-NdA, but not RPP1-WsB, in co-immunoprecipitation and bacterial growth inhibition assays. Thus, RPP1 alleles have distinct recognition specificities, rather than simply different sensitivity to activation. Using chimeric RPP1 constructs, we showed that RPP1-NdA LRRs were sufficient for allele-specific recognition (association with ATR1), but insufficient for receptor activation in the form of HR. Additional inclusion of the RPP1-NdA ARC2 subdomain, from the central NB-ARC domain, was required for a full range of activation specificity. Thus, cooperation between recognition and activation domains seems to be essential for NLR function.","[Steinbrenner, Adam D.; Goritschnig, Sandra; Staskawicz, Brian J.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA","Steinbrenner, AD (reprint author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.",stask@berkeley.edu,,"Steinbrenner, Adam/0000-0002-7493-678X",National Science Foundation [NSF-IOS-1146793]; National Science Foundation Graduate Student Fellowship,"Funding: This work is supported by the National Science Foundation NSF-IOS-1146793. ADS is supported by a National Science Foundation Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chae E, 2014, CELL, V159, P1341, DOI 10.1016/j.cell.2014.10.049; Chou S, 2011, P NATL ACAD SCI USA, V108, P13323, DOI 10.1073/pnas.1109791108; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Krasileva KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028765; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Mondragon-Palomino M, 2002, GENOME RES, V12, P1305, DOI 10.1101/gr.159402; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00348; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ravensdale M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003004; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rentel MC, 2008, P NATL ACAD SCI USA, V105, P1091, DOI 10.1073/pnas.0711215105; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Steinbrenner A D, 2012, Cold Spring Harb Symp Quant Biol, V77, P249, DOI 10.1101/sqb.2012.77.014860; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Wirthmueller L, 2013, NAT REV MICROBIOL, V11, P761, DOI 10.1038/nrmicro3118",54,27,29,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004665,10.1371/journal.ppat.1004665,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400045,25671309.0,"DOAJ Gold, Green Published",,,16/08/2019,24,9,53,6576,614,420,194,5962,4965,26,971,53,8,0,0,19,19,0,,76,0,76,0,0,25,25,18,16,0,0,0,0,0,0,0,1,0,6561,47,0,267,97,0,5937,614,47,0,267,97,0,10,,0,0,0,0,0,0,1,1,0,0,0,76,0,0,0.5,10.710097719869706,1.1029855753102986,0.10298557531029856,1.1246226098624623,1.019616788321168,10.920195439739414
134,J,"Subrtova, K; Panicucci, B; Zikova, A",,,,"Subrtova, Karolna; Panicucci, Brian; Zikova, Alena",,,"ATPaseTb2, a Unique Membrane-bound FoF1-ATPase Component, Is Essential in Bloodstream and Dyskinetoplastic Trypanosomes",PLOS PATHOGENS,,,English,Article,,,,,,,MITOCHONDRIAL ATP SYNTHASE; INDUCIBLE EXPRESSION SYSTEM; SEQUENCE-ANALYSIS; RNA INTERFERENCE; KINETOPLAST DNA; OXIDATIVE-PHOSPHORYLATION; COMPREHENSIVE ANALYSIS; PERIPHERAL STALK; POLYTOMELLA SP; P-I,"In the infectious stage of Trypanosoma brucei, an important parasite of humans and livestock, the mitochondrial (mt) membrane potential (Delta psi(m)) is uniquely maintained by the ATP hydrolytic activity and subsequent proton pumping of the essential FoF1-ATPase. Intriguingly, this multiprotein complex contains several trypanosome-specific subunits of unknown function. Here, we demonstrate that one of the largest novel subunits, ATPaseTb2, ismembrane-bound and localizes with monomeric and multimeric assemblies of the FoF1-ATPase. Moreover, RNAi silencing of ATPaseTb2 quickly leads to a significant decrease of the Delta psi(m) that manifests as a decreased growth phenotype, indicating that the FoF1-ATPase is impaired. To further explore the function of this protein, we employed a trypanosoma strain that lacks mtDNA (dyskinetoplastic, Dk) and thus subunit a, an essential component of the proton pore in the membrane F-o-moiety. These Dk cells generate the Delta psi(m) by combining the hydrolytic activity of the matrix-facing F-1-ATPase and the electrogenic exchange of ATP(4)- for ADP(3)- by the ATP/ADP carrier (AAC). Surprisingly, in addition to the expected presence of F-1-ATPase, the monomeric and multimeric FoF(1)-ATPase complexes were identified. In fact, the immunoprecipitation of a F-1-ATPase subunit demonstrated that ATPaseTb2 was a component of these complexes. Furthermore, RNAi studies established that the membrane-bound ATPaseTb2 subunit is essential for maintaining normal growth and the Delta psi(m) of Dk cells. Thus, even in the absence of subunit a, a portion of the FoF1-ATPase is assembled in Dk cells.","[Subrtova, Karolna; Panicucci, Brian; Zikova, Alena] CAS, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic; [Subrtova, Karolna; Zikova, Alena] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic","Subrtova, K (reprint author), CAS, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.",azikova@paru.cas.cz,"Zikova, Alena/G-7855-2014","Zikova, Alena/0000-0002-8686-0225","Ministry of Education ERC CZ grant [LL1205]; Czech Grant Agency [P302/12/2513]; EMBO [1965]; Grant Agency of University of South Bohemia [140/2010/P, 04/092/2011/P]; European Union [316304]","Funding: This work was funded by Ministry of Education ERC CZ grant LL1205, the Czech Grant Agency grant P302/12/2513, the EMBO Installation grant 1965 (to AZ) and the Grant Agency of University of South Bohemia grants 140/2010/P and 04/092/2011/P (to KS). We acknowledge the use of research infrastructure that has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no.316304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Acestor N, 2011, MOL CELL PROTE UNPUB; Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; BORST P, 1987, MOL BIOCHEM PARASIT, V23, P31, DOI 10.1016/0166-6851(87)90184-8; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Brun R, 1998, VET PARASITOL, V79, P95, DOI 10.1016/S0304-4017(98)00146-0; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Burger G, 2003, NUCLEIC ACIDS RES, V31, P2353, DOI 10.1093/nar/gkg326; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Chen YL, 2003, MOL BIOCHEM PARASIT, V126, P275, DOI 10.1016/S0166-6851(02)00276-1; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Chi TB, 1998, MOL BIOCHEM PARASIT, V92, P29, DOI 10.1016/S0166-6851(97)00222-3; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; Hannaert Veronique, 2003, Kinetoplastid Biol Dis, V2, P11, DOI 10.1186/1475-9292-2-11; Hashimi H, 2010, INT J PARASITOL, V40, P45, DOI 10.1016/j.ijpara.2009.07.005; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kovarova J, 2014, EUKARYOT CELL, V13, P353, DOI 10.1128/EC.00235-13; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lapaille M, 2010, MOL BIOL EVOL, V27, P1630, DOI 10.1093/molbev/msq049; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mayhew TM, 2008, HISTOCHEM CELL BIOL, V129, P367, DOI 10.1007/s00418-007-0375-6; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Miranda-Astudillo H, 2014, BBA-BIOENERGETICS, V1837, P1, DOI 10.1016/j.bbabio.2013.08.001; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; NISHI A, 1962, BIOCHIM BIOPHYS ACTA, V65, P419, DOI 10.1016/0006-3002(62)90443-2; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; NORAIS N, 1991, J BIOL CHEM, V266, P16541; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; ORIAN JM, 1984, J BIOENERG BIOMEMBR, V16, P561, DOI 10.1007/BF00743246; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; STUART KD, 1971, J CELL BIOL, V49, P189, DOI 10.1083/jcb.49.1.189; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Surve S, 2012, EUKARYOT CELL, V11, P183, DOI 10.1128/EC.05282-11; Uyemura SA, 2004, J BIOL CHEM, V279, P385, DOI 10.1074/jbc.M307264200; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Vertommen D, 2008, MOL BIOCHEM PARASIT, V158, P189, DOI 10.1016/j.molbiopara.2007.12.008; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; WALKER JE, 1987, J MOL BIOL, V197, P89, DOI 10.1016/0022-2836(87)90611-5; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436",74,16,16,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004660,10.1371/journal.ppat.1004660,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400041,25714685.0,"DOAJ Gold, Green Published",,,16/08/2019,17,46,40,3151,590,483,107,2561,2159,21,381,40,1,0,0,16,16,0,,43,0,43,0,0,18,18,18,13,0,0,0,0,0,0,0,45,1,3162,48,0,1384,86,0,2558,590,48,0,1384,86,0,14,,0,0,0,0,2,0,1,1,0,0,0,42,0,0,1.25,5.340677966101695,1.23037875829754,0.23037875829754004,1.286997266692698,1.046017137416693,5.5864406779661016
135,J,"Sullivan, DJ; Berman, J; Myers, LC; Moran, GP",,,,"Sullivan, Derek J.; Berman, Judith; Myers, Lawrence C.; Moran, Gary P.",,,Telomeric ORFS in Candida albicans: Does Mediator Tail Wag the Yeast?,PLOS PATHOGENS,,,English,Article,,,,,,,TRANSCRIPTION; EXPRESSION; REGULATOR; PROTEINS; SUBUNIT; COMPLEX; CDK8,,"[Sullivan, Derek J.; Moran, Gary P.] Univ Dublin Trinity Coll, Dublin Dent Sch & Hosp, Div Oral Biosci, Dublin 2, Ireland; [Berman, Judith] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Myers, Lawrence C.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA","Sullivan, DJ (reprint author), Univ Dublin Trinity Coll, Dublin Dent Sch & Hosp, Div Oral Biosci, Dublin 2, Ireland.",gpmoran@dental.tcd.ie,"Moran, Gary/F-3116-2012; Sullivan, Derek/A-8269-2008","Moran, Gary/0000-0003-0469-1788; Sullivan, Derek/0000-0003-0195-9697; Berman, Judith/0000-0002-8577-0084","Science Foundation Ireland [RFP.1/GEN/3042, RFP.1/GEN/3044]","GPM and DJS are funded by Science Foundation Ireland, grant numbers RFP.1/GEN/3042 and RFP.1/GEN/3044 (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anderson MZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004436; Anderson MZ, 2012, EUKARYOT CELL, V11, P1268, DOI 10.1128/EC.00230-12; Ansari SA, 2011, EMBO J, V31, P44; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Firestein R, 2010, INT J CANCER, V126, P2863, DOI 10.1002/ijc.24908; Goodwin TJ, 2004, GENOME RES, V10, P174; Haran J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004658; HOOG MV, 2007, GENOME BIOL, V8, pR52, DOI [DOI 10.1186/GB-2007-8-4-R52, 10.1186/GB-2007-8-4-R52]; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Kaiser B, 1999, YEAST, V15, P585, DOI 10.1002/(SICI)1097-0061(199905)15:7<585::AID-YEA401>3.0.CO;2-9; Lindsay AK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004567; Miller C, 2012, J BIOL CHEM, V287, P44017, DOI 10.1074/jbc.M112.430140; Moran Gary P, 2012, Int J Microbiol, V2012, P205921, DOI 10.1155/2012/205921; Moran GP, 2011, EUKARYOT CELL, V10, P34, DOI 10.1128/EC.00242-10; Nemet J, 2014, BIOCHIMIE, V97, P22, DOI 10.1016/j.biochi.2013.10.004; Paul S, 2011, EUKARYOT CELL, V10, P187, DOI 10.1128/EC.00277-10; Tebbji F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004770; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14; Uwamahoro N, 2012, PLOS GENET, V8, P54, DOI 10.1371/journal.pgen.1002613; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhang AD, 2013, EUKARYOT CELL, V12, P1293, DOI 10.1128/EC.00137-13; Zhang AD, 2012, EUKARYOT CELL, V11, P874, DOI 10.1128/EC.00095-12",25,4,4,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004614,10.1371/journal.ppat.1004614,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400009,25675446.0,"DOAJ Gold, Green Published",,,16/08/2019,6,5,12,3006,262,179,83,2744,2354,18,372,12,5,0,0,5,5,0,,17,0,17,0,0,6,6,4,2,0,0,0,0,0,0,0,0,2,3012,17,0,53,38,0,2736,262,17,0,53,38,0,14,,0,0,0,0,4,0,0,1,0,0,0,16,0,0,2.0,11.473282442748092,1.095481049562682,0.09548104956268222,1.1177113702623906,1.020292747837658,11.706106870229007
136,J,"Venkatasubramanian, S; Dhiman, R; Paidipally, P; Cheekatla, SS; Tripathi, D; Welch, E; Tvinnereim, AR; Jones, B; Theodorescu, D; Barnes, PF; Vankayalapati, R",,,,"Venkatasubramanian, Sambasivan; Dhiman, Rohan; Paidipally, Padmaja; Cheekatla, Satyanarayana S.; Tripathi, Deepak; Welch, Elwyn; Tvinnereim, Amy R.; Jones, Brenda; Theodorescu, Dan; Barnes, Peter F.; Vankayalapati, Ramakrishna",,,A Rho GDP Dissociation Inhibitor Produced by Apoptotic T-Cells Inhibits Growth of Mycobacterium tuberculosis,PLOS PATHOGENS,,,English,Article,,,,,,,TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSES; HOST-DEFENSE; IN-VITRO; PULMONARY TUBERCULOSIS; ALVEOLAR MACROPHAGES; INFECTED INDIVIDUALS; TRANSCRIPTION FACTOR; HELICOBACTER-PYLORI; REGULATORY CELLS,"In this study, we found that a subpopulation of CD4(+)CD25(+) (85% Foxp3(+)) cells from persons with latent tuberculosis infection (LTBI) inhibits growth of M. tuberculosis (M. tb) in human monocyte-derived macrophages (MDMs). A soluble factor, Rho GDP dissociation inhibitor (D4GDI), produced by apoptotic CD4(+)CD25(+) (85% Foxp3(+)) cells is responsible for this inhibition of M. tb growth in human macrophages and in mice. M. tb-expanded CD4(+)CD25(+)Foxp3(+)D4GDI(+) cells do not produce IL-10, TGF-beta and IFN-gamma. D4GDI inhibited growth of M. tb in MDMs by enhancing production of IL-1 beta, TNF-alpha and ROS, and by increasing apoptosis of M. tb-infected MDMs. D4GDI was concentrated at the site of disease in tuberculosis patients, with higher levels detected in pleural fluid than in serum. However, in response to M. tb, PBMC from tuberculosis patients produced less D4GDI than PBMC from persons with LTBI. M. tb-expanded CD4(+)CD25(+) (85% Foxp3(+)) cells and D4GDI induced intracellular M. tb to express the dormancy survival regulator DosR and DosR-dependent genes, suggesting that D4GDI induces a non-replicating state in the pathogen. Our study provides the first evidence that a subpopulation of CD4(+)CD25(+) (85% Foxp3(+)) cells enhances immunity to M. tb, and that production of D4GDI by this subpopulation inhibits M. tb growth.","[Venkatasubramanian, Sambasivan; Dhiman, Rohan; Paidipally, Padmaja; Cheekatla, Satyanarayana S.; Tripathi, Deepak; Welch, Elwyn; Tvinnereim, Amy R.; Barnes, Peter F.; Vankayalapati, Ramakrishna] Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Dept Pulm Immunol, Tyler, TX 75701 USA; [Jones, Brenda] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA","Venkatasubramanian, S (reprint author), Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Dept Pulm Immunol, Tyler, TX 75701 USA.",krishna.vankayalapati@uthct.edu,"Dhiman, Rohan/N-7011-2019","Dhiman, Rohan/0000-0003-0845-7921","National Institutes of Health [AI054629, AI073612, A1085135]; Potts Memorial Foundation; Cain Foundation for Infectious Disease Research; Department of Pulmonary Immunology","This work was supported by grants from the National Institutes of Health (AI054629, AI073612 and A1085135 to RV and the Potts Memorial Foundation grant to RD), the Cain Foundation for Infectious Disease Research, and the Department of Pulmonary Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Aseffa A, 2002, J IMMUNOL, V169, P3232, DOI 10.4049/jimmunol.169.6.3232; Babior BM, 1999, BLOOD, V93, P1464; BARNES PF, 1989, J IMMUNOL, V142, P1114; BARNES PF, 1990, J IMMUNOL, V145, P149; Baumforth KRN, 2008, AM J PATHOL, V173, P195, DOI 10.2353/ajpath.2008.070845; Behar SM, 2011, MICROBES INFECT, V13, P749, DOI 10.1016/j.micinf.2011.03.002; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Freeman AF, 2007, CURR OPIN MICROBIOL, V10, P70, DOI 10.1016/j.mib.2006.11.005; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guillemot JC, 1996, BLOOD, V88, P2722; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; HIRSCH CS, 1994, J IMMUNOL, V152, P743; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Mahan CS, 2009, IMMUNOLOGY, V127, P398, DOI 10.1111/j.1365-2567.2008.02982.x; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miller J, 2010, NY TIMES BK REV, P6; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; ROOK GAW, 1987, IMMUNOLOGY, V62, P229; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Silver RF, 1998, J IMMUNOL, V160, P2408; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Watanabe T, 2012, AIDS RES HUM RETROV, V28, P913, DOI [10.1089/AID.2011.0180, 10.1089/aid.2011.0180]; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217",73,8,8,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004617,10.1371/journal.ppat.1004617,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400010,25659138.0,"DOAJ Gold, Green Published",,,16/08/2019,7,0,16,4062,526,391,135,3536,3016,20,500,16,0,0,0,8,8,0,,21,0,21,0,0,7,7,7,7,0,0,0,0,0,0,0,0,0,4105,75,0,277,51,0,3550,536,75,0,277,51,0,19,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,7.722433460076045,1.1487556561085972,0.14875565610859728,1.196549773755656,1.0416051206302315,8.043726235741445
137,J,"Walker, PJ; Firth, C; Widen, SG; Blasdell, KR; Guzman, H; Wood, TG; Paradkar, PN; Holmes, EC; Tesh, RB; Vasilakis, N",,,,"Walker, Peter J.; Firth, Cadhla; Widen, Steven G.; Blasdell, Kim R.; Guzman, Hilda; Wood, Thomas G.; Paradkar, Prasad N.; Holmes, Edward C.; Tesh, Robert B.; Vasilakis, Nikos",,,Evolution of Genome Size and Complexity in the Rhabdoviridae,PLOS PATHOGENS,,,English,Article,,,,,,,VESICULAR STOMATITIS-VIRUS; GENETICS-BASED CLASSIFICATION; G(NS)-L INTERGENIC REGION; GLYCOPROTEIN GENE; PHYLOGENETIC-RELATIONSHIPS; INDIANA SEROTYPE; P-GENE; RNA; PROTEIN; FAMILY,"RNA viruses exhibit substantial structural, ecological and genomic diversity. However, genome size in RNA viruses is likely limited by a high mutation rate, resulting in the evolution of various mechanisms to increase complexity while minimising genome expansion. Here we conduct a large-scale analysis of the genome sequences of 99 animal rhabdoviruses, including 45 genomes which we determined de novo, to identify patterns of genome expansion and the evolution of genome complexity. All but seven of the rhabdoviruses clustered into 17 well-supported monophyletic groups, of which eight corresponded to established genera, seven were assigned as new genera, and two were taxonomically ambiguous. We show that the acquisition and loss of new genes appears to have been a central theme of rhabdovirus evolution, and has been associated with the appearance of alternative, overlapping and consecutive ORFs within the major structural protein genes, and the insertion and loss of additional ORFs in each gene junction in a clade-specific manner. Changes in the lengths of gene junctions accounted for as much as 48.5% of the variation in genome size from the smallest to the largest genome, and the frequency with which new ORFs were observed increased in the 3' to 5' direction along the genome. We also identify several new families of accessory genes encoded in these regions, and show that non-canonical expression strategies involving TURBS-like termination-reinitiation, ribosomal frame-shifts and leaky ribosomal scanning appear to be common. We conclude that rhabdoviruses have an unusual capacity for genomic plasticity that may be linked to their discontinuous transcription strategy from the negative-sense single-stranded RNA genome, and propose a model that accounts for the regular occurrence of genome expansion and contraction throughout the evolution of the Rhabdoviridae.","[Walker, Peter J.; Firth, Cadhla; Blasdell, Kim R.; Paradkar, Prasad N.] CSIRO Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Widen, Steven G.; Wood, Thomas G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Guzman, Hilda; Tesh, Robert B.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA; [Guzman, Hilda; Tesh, Robert B.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Trop Dis, Galveston, TX 77555 USA; [Guzman, Hilda; Tesh, Robert B.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia","Walker, PJ (reprint author), CSIRO Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.",Peter.Walker@csiro.au,"Walker, Peter/H-6059-2013; Blasdell, Kim/G-9346-2013","Walker, Peter/0000-0003-1851-642X; Holmes, Edward/0000-0001-9596-3552; Blasdell, Kim/0000-0003-2121-0376; Firth, Cadhla/0000-0002-2040-8973","Institute for Human Infections and Immunity, University of Texas Medical Branch; National Institute of Health [HHSN272201000040I/HHSN27200004/D04]","Funding: This work was supported in part by a grant from the Institute for Human Infections and Immunity, University of Texas Medical Branch (NV), and the National Institute of Health contract HHSN272201000040I/HHSN27200004/D04 (NV, RBT)(http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Allison AB, 2011, VIRUS RES, V155, P112, DOI 10.1016/j.virusres.2010.09.007; Allison AB, 2014, VIROLOGY, V448, P284, DOI 10.1016/j.virol.2013.10.024; An HY, 2013, VIRUS RES, V171, P168, DOI 10.1016/j.virusres.2012.11.007; BANERJEE AK, 1987, CELL, V48, P363, DOI 10.1016/0092-8674(87)90184-X; Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010; Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; BILSEL PA, 1990, J VIROL, V64, P4873; Blasdell KR, 2012, VIROLOGY, V433, P236, DOI 10.1016/j.virol.2012.08.008; Blasdell KR, 2012, VIROLOGY, V425, P143, DOI 10.1016/j.virol.2012.01.004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; Ceccaldi PE, 1998, J NEUROVIROL, V4, P115, DOI 10.3109/13550289809113489; CHENIK M, 1995, J VIROL, V69, P707; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; Dietzgen RG, 2012, VIRUS TAXONOMY, P654; Diniz JAP, 2006, ARCH VIROL, V151, P2519, DOI 10.1007/s00705-006-0812-1; Drake JW, 1998, GENETICS, V148, P1667; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Faber M, 2004, P NATL ACAD SCI USA, V101, P16328, DOI 10.1073/pnas.0407289101; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gubala A, 2011, J GEN VIROL, V92, P2160, DOI 10.1099/vir.0.026120-0; Gubala A, 2010, VIROLOGY, V399, P98, DOI 10.1016/j.virol.2009.12.013; Gubala AJ, 2008, VIROLOGY, V376, P13, DOI 10.1016/j.virol.2008.03.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haglund K, 2000, VIROLOGY, V268, P112, DOI 10.1006/viro.1999.0120; HATFIELD D, 1990, TRENDS BIOCHEM SCI, V15, P186, DOI 10.1016/0968-0004(90)90159-9; HERMAN RC, 1986, J VIROL, V58, P797; Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Holmes EC, 2009, EVOLUTION EMERGENCE; HUANG AS, 1973, ANNU REV MICROBIOL, V27, P101, DOI 10.1146/annurev.mi.27.100173.000533; Jayakar HR, 2002, J VIROL, V76, P8011, DOI 10.1128/JVI.76.16.8011-8018.2002; Joubert DA, 2014, J VIROL, V88, P1591, DOI 10.1128/JVI.01812-13; Joubert DA, J VIROLOGY IN PRESS; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; King A. M., 2012, 9 INT COMM TAX VIR; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Kuzmin IV, 2006, J GEN VIROL, V87, P2323, DOI 10.1099/vir.0.81879-0; Kuzmin IV, 2008, VIRUS RES, V136, P81, DOI 10.1016/j.virusres.2008.04.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lauber C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003500; Lauber C, 2012, VIRUSES-BASEL, V4, P1425, DOI 10.3390/v4091425; Lauber C, 2012, J VIROL, V86, P3905, DOI 10.1128/JVI.07174-11; Lauber C, 2012, J VIROL, V86, P3890, DOI 10.1128/JVI.07173-11; LAZZARINI RA, 1981, CELL, V26, P145, DOI 10.1016/0092-8674(81)90298-1; Ledermann JP, 2014, J GEN VIROL, V95, P1436, DOI 10.1099/vir.0.060764-0; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; McWilliam SM, 1997, J GEN VIROL, V78, P1309, DOI 10.1099/0022-1317-78-6-1309; Nagai Y, 2004, CURR TOP MICROBIOL, V283, P197; Pagan I, 2012, J VIROL, V86, P5253, DOI 10.1128/JVI.06050-11; Peluso RW, 1996, VIROLOGY, V218, P335, DOI 10.1006/viro.1996.0202; Perrault J, 1981, Curr Top Microbiol Immunol, V93, P151; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Quan PL, 2011, VIRUS RES, V160, P206, DOI 10.1016/j.virusres.2011.06.021; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; RAVKOV EV, 1995, VIROLOGY, V206, P718, DOI 10.1016/S0042-6822(95)80095-6; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez LL, 2002, J GEN VIROL, V83, P2475, DOI 10.1099/0022-1317-83-10-2475; Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1916, DOI 10.1093/molbev/mst094; Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1263, DOI 10.1093/molbev/mst044; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; SPIROPOULOU CF, 1993, J VIROL, V67, P3103; Springfeld C, 2005, J VIROL, V79, P6781, DOI 10.1128/JVI.79.11.6781-6790.2005; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Vasilakis N, 2014, J GEN VIROL, V95, P787, DOI 10.1099/vir.0.058685-0; Vasilakis N, 2013, VIROLOGY, V444, P80, DOI 10.1016/j.virol.2013.05.035; Walker PJ, 2011, VIRUS RES, V162, P110, DOI 10.1016/j.virusres.2011.09.004; WALKER PJ, 1992, VIROLOGY, V191, P49, DOI 10.1016/0042-6822(92)90165-L; WANG YH, 1994, VIROLOGY, V203, P63, DOI 10.1006/viro.1994.1455; WANG YH, 1993, VIROLOGY, V195, P719, DOI 10.1006/viro.1993.1423; Wertz GW, 2002, J VIROL, V76, P7642, DOI 10.1128/JVI.76.15.7642-7650.2002; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0",85,64,64,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004664,10.1371/journal.ppat.1004664,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400044,25679389.0,"DOAJ Gold, Green Published",,,16/08/2019,66,0,54,8818,1983,1494,489,6835,5544,23,1268,54,0,1,1,61,61,0,,145,25,77,0,25,67,67,46,36,0,0,0,0,0,0,0,0,2,8967,96,2,163,176,0,6887,2025,96,2,163,176,0,55,,0,0,0,1,7,0,1,1,1,0,0,77,0,0,8.0,4.446797781139687,1.2901243599122165,0.2901243599122165,1.3517190929041698,1.0477432524381947,4.659102370146243
138,J,"Weiss, GE; Gilson, PR; Taechalertpaisarn, T; Tham, WH; de Jong, NWM; Harvey, KL; Fowkes, FJI; Barlow, PN; Rayner, JC; Wright, GJ; Cowman, AF; Crabb, BS",,,,"Weiss, Greta E.; Gilson, Paul R.; Taechalertpaisarn, Tana; Tham, Wai-Hong; de Jong, Nienke W. M.; Harvey, Katherine L.; Fowkes, Freya J. I.; Barlow, Paul N.; Rayner, Julian C.; Wright, Gavin J.; Cowman, Alan F.; Crabb, Brendan S.",,,Revealing the Sequence and Resulting Cellular Morphology of Receptor-Ligand Interactions during Plasmodium falciparum Invasion of Erythrocytes,PLOS PATHOGENS,,,English,Article,,,,,,,MEROZOITE SURFACE PROTEIN; MEMBRANE ANTIGEN 1; MALARIA PARASITE INVASION; INHIBITORY ANTIBODIES; MOLECULAR-MECHANISM; BINDING; CALCIUM; COMPLEX; EVENTS; AMA1,"During blood stage Plasmodium falciparum infection, merozoites invade uninfected erythrocytes via a complex, multistep process involving a series of distinct receptor-ligand binding events. Understanding each element in this process increases the potential to block the parasite's life cycle via drugs or vaccines. To investigate specific receptor-ligand interactions, they were systematically blocked using a combination of genetic deletion, enzymatic receptor cleavage and inhibition of binding via antibodies, peptides and small molecules, and the resulting temporal changes in invasion and morphological effects on erythrocytes were filmed using live cell imaging. Analysis of the videos have shown receptor-ligand interactions occur in the following sequence with the following cellular morphologies; 1) an early heparin-blockable interaction which weakly deforms the erythrocyte, 2) EBA and PfRh ligands which strongly deform the erythrocyte, a process dependant on the merozoite's actin-myosin motor, 3) a PfRh5-basigin binding step which results in a pore or opening between parasite and host through which it appears small molecules and possibly invasion components can flow and 4) an AMA1-RON2 interaction that mediates tight junction formation, which acts as an anchor point for internalization. In addition to enhancing general knowledge of apicomplexan biology, this work provides a rational basis to combine sequentially acting merozoite vaccine candidates in a single multi-receptor-blocking vaccine.","[Weiss, Greta E.; Gilson, Paul R.; Taechalertpaisarn, Tana; de Jong, Nienke W. M.; Harvey, Katherine L.; Fowkes, Freya J. I.; Crabb, Brendan S.] Burnet Inst, Melbourne, Vic, Australia; [Gilson, Paul R.; Crabb, Brendan S.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Taechalertpaisarn, Tana; Tham, Wai-Hong; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Tham, Wai-Hong; Cowman, Alan F.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Harvey, Katherine L.; Crabb, Brendan S.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Fowkes, Freya J. I.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Fowkes, Freya J. I.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Fowkes, Freya J. I.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Rayner, Julian C.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England; [Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge, England","Weiss, GE (reprint author), Burnet Inst, Melbourne, Vic, Australia.",gilson@burnet.edu.au; crabb@burnet.edu.au,"Tham, Wai-Hong/L-3173-2018; Tham, Wai-Hong/P-6474-2019","Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699; Wright, Gavin/0000-0003-0537-0863; Rayner, Julian/0000-0002-9835-1014; de Jong, Nienke/0000-0002-5807-4104",National Health and Medical Research Council of Australia [406601]; Wellcome Trust [098051]; Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS) from University of Melbourne; Australian Postgraduate Award from University of Melbourne; Biotechnology and Biological Sciences Research Council [BB/I007946/1],"Funding: The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program and the NHMRC IRIISS scheme. This work was supported by the National Health and Medical Research Council of Australia Program Grant 406601 to AFC and BSC and Project Grant to BSC and PRG. GJW and JCR were supported by the Wellcome Trust grant number [098051]. TT was supported by the Melbourne International Research Scholarship (MIRS) and the Melbourne International Fee Remission Scholarship (MIFRS) from the University of Melbourne. KH was supported by the Australian Postgraduate Award from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Azevedo MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112571; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Bartholdson SJ, 2013, CELL MICROBIOL, V15, P1304, DOI 10.1111/cmi.12151; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bustamante LY, 2013, VACCINE, V31, P373, DOI 10.1016/j.vaccine.2012.10.106; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Chen L, 2014, ELIFE, V3, DOI 10.7554/eLife.04187; Chen L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002199; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crick AJ, 2013, BIOPHYS J, V104, P997, DOI 10.1016/j.bpj.2013.01.018; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gao XH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3862; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; HOLDER AA, 1984, J EXP MED, V160, P624, DOI 10.1084/jem.160.2.624; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; JOHNSON JG, 1980, PARASITOLOGY, V80, P539, DOI 10.1017/S0031182000000998; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03178; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lew VL, 2007, TRENDS PARASITOL, V23, P481, DOI 10.1016/j.pt.2007.08.001; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCCALLUMDEIGHTON N, 1992, MOL BIOCHEM PARASIT, V50, P317, DOI 10.1016/0166-6851(92)90229-D; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Singh S, 2014, CELL MICROBIOL, V16, P50, DOI 10.1111/cmi.12177; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Wasserman M, 1996, PARASITOL RES, V82, P102, DOI 10.1007/s004360050078; Wright KE, 2014, NATURE, P13715; Yahata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050780; Yap A, 2014, CELL MICROBIOL, V16, P642, DOI 10.1111/cmi.12287",59,90,90,1,32,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004670,10.1371/journal.ppat.1004670,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400047,25723550.0,"DOAJ Gold, Green Published",,,16/08/2019,92,51,159,12780,2219,1346,873,10561,8031,46,2484,157,2,15,0,94,94,1,,226,3,224,2,3,102,102,102,54,0,0,0,0,0,0,0,49,1,12981,311,0,1044,168,0,10678,2233,311,0,1044,168,0,70,,0,0,0,0,7,0,3,1,0,0,1,229,2,0,4.0,5.759351059035602,1.2101126787236056,0.21011267872360573,1.2745005207840168,1.05320813771518,6.065795403334835
139,J,"Yuan, Q; Eckland, T; Telling, G; Bartz, J; Bartelt-Hunt, S",,,,"Yuan, Qi; Eckland, Thomas; Telling, Glenn; Bartz, Jason; Bartelt-Hunt, Shannon",,,Mitigation of Prion Infectivity and Conversion Capacity by a Simulated Natural Process-Repeated Cycles of Drying and Wetting,PLOS PATHOGENS,,,English,Article,,,,,,,CHRONIC WASTING DISEASE; MICROBIAL COMMUNITY DYNAMICS; SCRAPIE-INFECTED HAMSTERS; GASTROINTESTINAL MICROBIOTA; ENVIRONMENTAL SOURCES; STEEL SURFACES; PROTEIN PRPSC; MULE DEER; SOIL-TYPE; IN-VITRO,"Prions enter the environment from infected hosts, bind to a wide range of soil and soil minerals, and remain highly infectious. Environmental sources of prions almost certainly contribute to the transmission of chronic wasting disease in cervids and scrapie in sheep and goats. While much is known about the introduction of prions into the environment and their interaction with soil, relatively little is known about prion degradation and inactivation by natural environmental processes. In this study, we examined the effect of repeated cycles of drying and wetting on prion fitness and determined that 10 cycles of repeated drying and wetting could reduce PrPSc abundance, PMCA amplification efficiency and extend the incubation period of disease. Importantly, prions bound to soil were more susceptible to inactivation by repeated cycles of drying and wetting compared to unbound prions, a result which may be due to conformational changes in soil-bound PrPSc or consolidation of the bonding between PrPSc and soil. This novel finding demonstrates that naturally-occurring environmental process can degrade prions.","[Yuan, Qi; Bartelt-Hunt, Shannon] Univ Nebraska Lincoln, Peter Kiewit Inst, Dept Civil Engn, Omaha, NE 68182 USA; [Eckland, Thomas; Bartz, Jason] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Telling, Glenn] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA","Yuan, Q (reprint author), Univ Nebraska Lincoln, Peter Kiewit Inst, Dept Civil Engn, Omaha, NE 68182 USA.",jbartz@creighton.edu; sbartelt2@unl.edu,,"Bartz, Jason/0000-0003-4081-7886","National Science Foundation [CBET-1149424]; National Institutes of Health [P20 RR0115635, C06 RR17417]","This study was supported by the National Science Foundation (Award Number CBET-1149424) and the National Institutes of Health (Grant Number P20 RR0115635 and C06 RR17417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BEYER WN, 1994, J WILDLIFE MANAGE, V58, P375, DOI 10.2307/3809405; BROWN P, 1982, J INFECT DIS, V145, P683, DOI 10.1093/infdis/145.2.683; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Cosentino D, 2006, SOIL BIOL BIOCHEM, V38, P2053, DOI 10.1016/j.soilbio.2005.12.022; Defaweux V, 2007, CELL TISSUE RES, V329, P35, DOI 10.1007/s00441-007-0396-4; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2012, J VIROL, V86, P566, DOI 10.1128/JVI.05579-11; Huang HS, 2007, CAN J VET RES, V71, P34; HUNTER GD, 1964, J GEN MICROBIOL, V37, P251, DOI 10.1099/00221287-37-2-251; Jablonowski ND, 2012, ENVIRON TOXICOL CHEM, V31, P1941, DOI 10.1002/etc.1851; Jacobson KH, 2010, J ENVIRON QUAL, V39, P1145, DOI 10.2134/jeq2009.0137; Jacquemot C, 2005, J VIROL, V79, P8904, DOI 10.1128/JVI.79.14.8904-8908.2005; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019836; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Lemmer K, 2004, J GEN VIROL, V85, P3805, DOI 10.1099/vir.0.80346-0; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P1031, DOI 10.1016/S0038-0717(99)00017-6; Ma K, 2013, APPL ENVIRON MICROB, V79, P4932, DOI 10.1128/AEM.00850-13; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; de Motes CM, 2008, VET MICROBIOL, V131, P205, DOI 10.1016/j.vetmic.2008.02.014; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mauri AN, 2006, J SCI FOOD AGR, V86, P1064, DOI 10.1002/jsfa.2457; McLeod AH, 2004, BIOCHEM BIOPH RES CO, V317, P1165, DOI 10.1016/j.bbrc.2004.03.168; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Mitsuiki S, 2006, BIOSCI BIOTECH BIOCH, V70, P1246, DOI 10.1271/bbb.70.1246; MOULD DL, 1970, J COMP PATHOL, V80, P595, DOI 10.1016/0021-9975(70)90057-5; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; O'Hara Ruiz M, 2013, GEOSPATIAL HLTH, V8; Pilon JL, 2009, J VIROL METHODS, V161, P168, DOI 10.1016/j.jviromet.2009.04.040; PRETZER D, 1991, PHARMACEUT RES, V8, P1103, DOI 10.1023/A:1015842032164; Prusiner SB, 2004, PRION BIOLOGY AND DI; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; ROHWER RG, 1984, SCIENCE, V223, P600, DOI 10.1126/science.6420887; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Saunders SE, 2012, CHEMOSPHERE, V87, P661, DOI 10.1016/j.chemosphere.2011.12.076; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Saunders SE, 2011, APPL ENVIRON MICROB, V77, P4313, DOI 10.1128/AEM.00421-11; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI [10.1021/es901386t, 10.1021/es901385t]; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Secker TJ, 2011, J HOSP INFECT, V78, P251, DOI 10.1016/j.jhin.2011.03.021; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; SINGER MJ, 1992, SOIL SCI SOC AM J, V56, P1843, DOI 10.2136/sssaj1992.03615995005600060032x; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Wu ZY, 2006, J AGR FOOD CHEM, V54, P8589, DOI 10.1021/jf061576w",60,4,4,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004638,10.1371/journal.ppat.1004638,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400025,25665187.0,"DOAJ Gold, Green Published",,,16/08/2019,5,2,15,3194,366,265,101,2828,2441,23,364,15,1,0,0,5,5,0,,19,7,19,0,7,5,5,5,5,0,0,0,0,0,0,0,1,3,3239,17,0,140,137,0,2832,368,17,0,140,137,0,39,,0,0,0,0,6,0,1,1,0,0,0,19,0,0,2.25,8.726775956284152,1.1294200848656295,0.12942008486562942,1.1997878359264498,1.0623043206011271,9.270491803278688
140,J,"Zabel, MD; Avery, AC",,,,"Zabel, Mark D.; Avery, Anne C.",,,Prions-Not Your Immunologist's Pathogen,PLOS PATHOGENS,,,English,Article,,,,,,,FOLLICULAR DENDRITIC CELLS; CATHEPSIN-B; SCRAPIE; PROTEIN; MICE; INFECTION; PRP; DISEASE,,"[Zabel, Mark D.; Avery, Anne C.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA","Zabel, MD (reprint author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA.",mark.zabel@colostate.edu,"Avery, Anne/J-8405-2017",,,,"Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4<495::AID-PATH535>3.0.CO;2-T; Bradford BM, 2012, VIRUSES-BASEL, V4, P3389, DOI 10.3390/v4123389; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Goni F, 2008, NEUROSCIENCE, V153, P679, DOI 10.1016/j.neuroscience.2008.02.051; Gregoire S, 2005, J IMMUNOL, V175, P6443, DOI 10.4049/jimmunol.175.10.6443; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Kim SH, 2008, INFECT IMMUN, V76, P5373, DOI 10.1128/IAI.01044-08; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PORTER DD, 1973, J IMMUNOL, V111, P1407; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Sim RB, 2007, IMMUNOBIOLOGY, V212, P355, DOI 10.1016/j.imbio.2007.04.001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Xanthopoulos K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059143; Yadavalli R., 2004, J BIOL CHEM; Zabel MD, 2007, J IMMUNOL, V179, P6144, DOI 10.4049/jimmunol.179.9.6144; Zhang YH, 2003, J GEN VIROL, V84, P2279, DOI 10.1099/vir.0.19153-0",24,3,3,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004624,10.1371/journal.ppat.1004624,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400015,25695738.0,"DOAJ Gold, Green Published",,,16/08/2019,3,14,36,9949,4432,4154,278,5517,4730,35,752,34,2,0,0,3,3,0,,42,22,40,2,22,3,3,2,2,0,0,0,0,0,0,0,12,0,10671,5,0,28,334,1,5538,4955,5,0,28,334,1,178,,0,0,0,0,21,0,3,1,0,0,0,40,2,0,13.2,2.2448104693140793,1.8033351459126337,0.8033351459126337,1.9956498096791735,1.1066438838074177,2.4842057761732854
141,J,[Anonymous],,,,[Anonymous],,,PLOS Pathogens 2014 Reviewer Thank You,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,,,,,,,,"[Anonymous], 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002101; [Anonymous], 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001806; [Anonymous], 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005070; [Anonymous], 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003621; [Anonymous], 2015, PLOS COMPUT BIOL, V11, DOI [10.1371/journal.pcbi.1004184, DOI 10.1371/JOURNAL.PCBI.1004184]; [Anonymous], 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121093, DOI 10.1371/JOURNAL.PONE.0121093]",6,5,5,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004748,10.1371/journal.ppat.1004748,,,,1,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400059,,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,10,3,0,4007,91,55,36,3916,3519,12,385,0,0,0,0,10,10,0,,0,2,0,0,2,10,10,9,0,0,0,0,0,0,0,0,3,0,4017,0,0,0,24,0,3915,91,0,0,0,24,0,11,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1.1,44.032967032967036,1.0232379979570991,0.02323799795709908,1.031920326864147,1.0084851509857748,44.40659340659341
142,J,"Ahmed, MZ; Li, SJ; Xue, X; Yin, XJ; Ren, SX; Jiggins, FM; Greeff, JM; Qiu, BL",,,,"Ahmed, Muhammad Z.; Li, Shao-Jian; Xue, Xia; Yin, Xiang-Jie; Ren, Shun-Xiang; Jiggins, Francis M.; Greeff, Jaco M.; Qiu, Bao-Li",,,The Intracellular Bacterium Wolbachia Uses Parasitoid Wasps as Phoretic Vectors for Efficient Horizontal Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,BEMISIA-TABACI HEMIPTERA; DROSOPHILA-SIMULANS; HOST PLANTS; CYTOPLASMIC INCOMPATIBILITY; INTERSPECIFIC TRANSMISSION; FURUHASHII HYMENOPTERA; SYMBIONT; ALEYRODIDAE; APHELINIDAE; APHIDS,"Facultative bacterial endosymbionts are associated with many arthropods and are primarily transmitted vertically from mother to offspring. However, phylogenetic affiliations suggest that horizontal transmission must also occur. Such horizontal transfer can have important biological and agricultural consequences when endosymbionts increase host fitness. So far horizontal transmission is considered rare and has been difficult to document. Here, we use fluorescence in situ hybridization (FISH) and multi locus sequence typing (MLST) to reveal a potentially common pathway of horizontal transmission of endosymbionts via parasitoids of insects. We illustrate that the mouthparts and ovipositors of an aphelinid parasitoid become contaminated with Wolbachia when this wasp feeds on or probes Wolbachia-infected Bemisia tabaci AsiaII7, and non-lethal probing of uninfected B. tabaci AsiaII7 nymphs by parasitoids carrying Wolbachia resulted in newly and stably infected B. tabaci matrilines. After they were exposed to infected whitefly, the parasitoids were able to transmit Wolbachia efficiently for the following 48 h. Whitefly infected with Wolbachia by parasitoids had increased survival and reduced development times. Overall, our study provides evidence for the horizontal transmission of Wolbachia between insect hosts by parasitic wasps, and the enhanced survival and reproductive abilities of insect hosts may adversely affect biological control programs.","[Ahmed, Muhammad Z.; Li, Shao-Jian; Xue, Xia; Yin, Xiang-Jie; Ren, Shun-Xiang; Qiu, Bao-Li] South China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Ahmed, Muhammad Z.; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England","Ahmed, MZ (reprint author), South China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China.",baileyqiu@scau.edu.cn,"Greeff, Jaco/A-5582-2011","Jiggins, Francis Michael/0000-0001-7470-8157; Greeff, Jaco/0000-0003-2951-6791",National Basic Research Program of China [2013CB127600]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NCET program [0917-2011]; Pretoria University; European Research Council [281668],"Funding: This research was funded by the National Basic Research Program of China (973 Project 2013CB127600), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014), the NCET program (0917-2011) to BLQ, and the Postdoc scholarship of Pretoria University to MZA. FMJ is supported by the European Research Council grant Drosophila Infection 281668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ahmed MZ, 2012, J APPL ENTOMOL, V136, P510, DOI 10.1111/j.1439-0418.2011.01673.x; Ahmed MZ, 2013, ECOL ENTOMOL, V38, P147, DOI 10.1111/een.12002; Ahmed MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053084; Ahmed MZ, 2010, CURR MICROBIOL, V61, P322, DOI 10.1007/s00284-010-9614-5; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bates D., 2014, LME4 LINEAR MIXED EF, DOI DOI 10.18637/JSS.V067.I01; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P332; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Duron O, 2010, ECOL LETT, V13, P1139, DOI 10.1111/j.1461-0248.2010.01502.x; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Greenberg SM, 2008, ENTOMOL SCI, V11, P97, DOI 10.1111/j.1479-8298.2007.00246.x; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; HOFFMANN AA, 1990, GENETICS, V126, P933; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Jaenike J, 2007, BIOL LETTERS, V3, P23, DOI 10.1098/rsbl.2006.0577; Jiao XG, 2013, ENTOMOL EXP APPL, V147, P1, DOI 10.1111/eea.12040; Jiggins FM, 2011, SCIENCE, V332, P185, DOI 10.1126/science.1205386; Kang L, 2003, HEREDITY, V90, P71, DOI 10.1038/sj.hdy.6800180; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kittayapong P, 2003, MOL ECOL, V12, P1049, DOI 10.1046/j.1365-294X.2003.01793.x; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Noda H, 2001, MOL ECOL, V10, P2101, DOI 10.1046/j.0962-1083.2001.01334.x; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12796; Qiu BL, 2005, B ENTOMOL RES, V95, P313, DOI 10.1079/BER2005362; Qiu BL, 2007, BIOCONTROL SCI TECHN, V17, P823, DOI 10.1080/09583150701595042; Qiu Bao-li, 2006, Journal of South China Agricultural University, V27, P29; Qiu BL, 2011, J PEST SCI, V84, P419, DOI 10.1007/s10340-011-0367-0; Qiu BL, 2009, PROG NAT SCI-MATER, V19, P713, DOI 10.1016/j.pnsc.2008.08.013; Riegler M, 2004, APPL ENVIRON MICROB, V70, P273, DOI 10.1128/AEM.70.1.273-279.2004; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Shoemaker DD, 2002, P ROY SOC B-BIOL SCI, V269, P2257, DOI 10.1098/rspb.2002.2100; Su Q, 2013, ENVIRON ENTOMOL, V42, P1265, DOI 10.1603/EN13182; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Verne S, 2012, J EVOLUTION BIOL, V25, P264, DOI 10.1111/j.1420-9101.2011.02413.x; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Xue X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048148; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544",58,48,57,1,72,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004672,10.1371/journal.ppat.1004672,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400048,25675099.0,"DOAJ Gold, Green Published",,,16/08/2019,44,87,90,7175,714,525,189,6461,4608,30,1823,90,5,0,0,43,43,0,,116,3,116,0,3,50,46,50,20,0,0,0,0,0,0,0,81,2,7296,57,23,303,214,4,6487,729,57,23,303,214,4,80,,0,2,0,0,5,0,2,1,0,0,0,116,0,0,15.29,10.049019607843137,1.1105092091007585,0.1105092091007584,1.171180931744312,1.0546341463414635,10.598039215686274
143,J,"Augusto, LD; Moretti, NS; Ramos, TCP; de Jesus, TCL; Zhang, M; Castilho, BA; Schenkman, S",,,,"Augusto, Leonardo da Silva; Moretti, Nilmar Silvio; Prata Ramos, Thiago Cesar; Leandro de Jesus, Teresa Cristina; Zhang, Min; Castilho, Beatriz A.; Schenkman, Sergio",,,A Membrane-bound eIF2 Alpha Kinase Located in Endosomes Is Regulated by Heme and Controls Differentiation and ROS Levels in Trypanosoma cruzi,PLOS PATHOGENS,,,English,Article,,,,,,,TRANSLATION INITIATION; TOXOPLASMA-GONDII; OXIDATIVE STRESS; INSECT VECTOR; ER STRESS; BRUCEI; EXPRESSION; METACYCLOGENESIS; PLASMODIUM; PARASITES,"Translation initiation has been described as a key step for the control of growth and differentiation of several protozoan parasites in response to environmental changes. This occurs by the activation of protein kinases that phosphorylate the alpha subunit of the translation initiation factor 2 (eIF2 alpha), which decreases translation, and in higher eukaryotes favors the expression of stress remedial response genes. However, very little is known about the signals that activate eIF2 alpha kinases in protozoan parasites. Here, we characterized an eIF2 alpha kinase of Trypanosoma cruzi (TcK2), the agent of Chagas' disease, as a transmembrane protein located in organelles that accumulate nutrients in proliferating parasite forms. We found that heme binds specifically to the catalytic domain of the kinase, inhibiting its activity. In the absence of heme, TcK2 is activated, arresting cell growth and inducing differentiation of proliferative into infective and non-proliferative forms. Parasites lacking TcK2 lose this differentiation capacity and heme is not stored in reserve organelles, remaining in the cytosol. TcK2 null cells display growth deficiencies, accumulating hydrogen peroxide that drives the generation of reactive oxygen species. The augmented level of hydrogen peroxide occurs as a consequence of increased superoxide dismutase activity and decreased peroxide activity. These phenotypes could be reverted by the re-expression of the wild type but not of a TcK2 dead mutant. These findings indicate that heme is a key factor for the growth control and differentiation through regulation of an unusual type of eIF2 alpha kinase in T. cruzi.","[Augusto, Leonardo da Silva; Moretti, Nilmar Silvio; Prata Ramos, Thiago Cesar; Leandro de Jesus, Teresa Cristina; Castilho, Beatriz A.; Schenkman, Sergio] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Zhang, Min] NYU, Sch Med, Dept Pathol, New York, NY USA","Augusto, LD (reprint author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.",sschenkman@unifesp.br,"Silvio Moretti, Nilmar/J-4459-2013; Zhang, Min/G-4480-2011; Moretti, Nilmar/G-1952-2015; Schenkman, Sergio/A-9227-2013","Silvio Moretti, Nilmar/0000-0003-0455-2497; Zhang, Min/0000-0001-9794-4523; Moretti, Nilmar/0000-0003-0455-2497; Schenkman, Sergio/0000-0001-9353-8480; Castilho, Beatriz A./0000-0003-4509-5237","Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51973-3, 2009/54364-8, 2012/09403-8, 2011/50586-6, 2003/12722-9, 2012/50399-4, 2009/52047-5]; Conselho Nacional de Desenvolvimento Cientifico e tecnologico [477143/2011-3, 304359/2009-2]","This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br) through grants 2011/51973-3 to SS, 2009/54364-8 to LSA, 2012/09403-8 to NSM, 2011/50586-6 to TCPR, 2003/12722-9 to TCLJ, 2012/50399-4 to MZ, 2009/52047-5 to BAC and by Conselho Nacional de Desenvolvimento Cientifico e tecnologico (http://www.cnpq.br) through grants 477143/2011-3 and 304359/2009-2 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abuin G, 1999, J BIOL CHEM, V274, P13041, DOI 10.1074/jbc.274.19.13041; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Andrews NW, 2012, J CLIN INVEST, V122, P2352, DOI 10.1172/JCI64239; BANGS JD, 1993, J CELL SCI, V105, P1101; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cardoso J, 2008, PARASITOL RES, V103, P941, DOI 10.1007/s00436-008-1081-6; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Chung J, 2013, BIOCHEM J, V451, P257, DOI 10.1042/BJ20121553; Cloutier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035085; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cornejo A, 2012, PROTEIN PEPTIDE LETT, V19, P636, DOI 10.2174/092986612800494075; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cupello MP, 2011, ACTA TROP, V120, P211, DOI 10.1016/j.actatropica.2011.08.011; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; De Gaudenzi JG, 2013, PEERJ, V1, DOI 10.7717/peerj.118; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Dufernez F, 2006, FREE RADICAL BIO MED, V40, P210, DOI 10.1016/j.freeradbiomed.2005.06.021; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Figueiredo RCBQ, 2004, PARASITOLOGY, V129, P431, DOI 10.1017/S0031182004005797; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Garcia ES, 1995, EXP PARASITOL, V81, P255, DOI 10.1006/expr.1995.1116; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Goldenberg S, 2011, ADV PARASIT, V75, P285, DOI 10.1016/B978-0-12-385863-4.00013-7; Harding HP, 1999, NATURE, V397, P271; Hope R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005234; Huang GJ, 2006, J CELL SCI, V119, P153, DOI 10.1242/jcs.02731; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kloft N, 2012, J BIOL CHEM, V287, P35299, DOI 10.1074/jbc.M112.379883; Konrad C, 2011, EUKARYOT CELL, V10, P1403, DOI 10.1128/EC.05117-11; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Miguel DC, 2013, INFECT IMMUN, V81, P3620, DOI 10.1128/IAI.00687-13; Monteiro ACS, 2001, J CELL SCI, V114, P3933; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Pereira MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022359; Piacenza L, 2009, CURR OPIN MICROBIOL, V12, P415, DOI 10.1016/j.mib.2009.06.011; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Ron D, 2012, COLD SPRING HARB PER, V4, P1; Rothenburg S, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-12; SALZMAN TA, 1982, COMP BIOCHEM PHYS B, V72, P663, DOI 10.1016/0305-0491(82)90523-5; Sant'Anna C, 2004, MICROSC MICROANAL, V10, P637, DOI 10.1017/S1431927604040863; Sant'Anna C, 2008, MICROSC RES TECHNIQ, V71, P599, DOI 10.1002/jemt.20592; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Souza CF, 2009, BIOCHEM BIOPH RES CO, V390, P541, DOI 10.1016/j.bbrc.2009.09.135; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; ZELEDON R, 1984, ACTA TROP, V41, P39; Zhang M, 2013, EUKARYOT CELL, V12, P161, DOI 10.1128/EC.00296-12; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975",71,13,13,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004618,10.1371/journal.ppat.1004618,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400011,25658109.0,"DOAJ Gold, Green Published",,,16/08/2019,19,48,42,5279,652,502,150,4627,3802,22,803,42,1,0,0,15,15,0,,106,0,55,0,0,19,19,16,11,0,0,0,0,0,0,0,47,0,5367,23,7,231,126,3,4689,660,23,7,231,126,3,18,,0,0,0,0,1,0,0,0,0,0,0,55,0,0,0.25,8.096625766871165,1.1409120380376054,0.14091203803760535,1.1921331316187596,1.0448948664519795,8.460122699386503
144,J,"Balla, KM; Andersen, EC; Kruglyak, L; Troemel, ER",,,,"Balla, Keir M.; Andersen, Erik C.; Kruglyak, Leonid; Troemel, Emily R.",,,A Wild C. Elegans Strain Has Enhanced Epithelial Immunity to a Natural Microsporidian Parasite,PLOS PATHOGENS,,,English,Article,,,,,,,CAENORHABDITIS-ELEGANS; HOST; EVOLUTION; PATHOGEN; DEFENSE; POLYMORPHISMS; INFECTION; UBIQUITIN; NPR-1; AGE,"Microbial pathogens impose selective pressures on their hosts, and combatting these pathogens is fundamental to the propagation of a species. Innate immunity is an ancient system that provides the foundation for pathogen resistance, with epithelial cells in humans increasingly appreciated to play key roles in innate defense. Here, we show that the nematode C. elegans displays genetic variation in epithelial immunity against intestinal infection by its natural pathogen, Nematocida parisii. This pathogen belongs to the microsporidia phylum, which comprises a large phylum of over 1400 species of fungal-related parasites that can infect all animals, including humans, but are poorly understood. Strikingly, we find that a wild C. elegans strain from Hawaii is able to clear intracellular infection by N. parisii, with this ability restricted to young larval animals. Notably, infection of older larvae does not impair progeny production, while infection of younger larvae does. The early-life immunity of Hawaiian larvae enables them to produce more progeny later in life, providing a selective advantage in a laboratory setting-in the presence of parasite it is able to out-compete a susceptible strain in just a few generations. We show that enhanced immunity is dominant to susceptibility, and we use quantitative trait locus mapping to identify four genomic loci associated with resistance. Furthermore, we generate near-isogenic strains to directly demonstrate that two of these loci influence resistance. Thus, our findings show that early-life immunity of C. elegans against microsporidia is a complex trait that enables the host to produce more progeny later in life, likely improving its evolutionary success.","[Balla, Keir M.; Troemel, Emily R.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Andersen, Erik C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Kruglyak, Leonid] Univ Calif Los Angeles, Dept Biol Chem, Dept Human Genet, Los Angeles, CA 90024 USA; [Kruglyak, Leonid] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA","Balla, KM (reprint author), Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA.",etroemel@ucsd.edu,,"Balla, Keir/0000-0003-2474-7953; Andersen, Erik/0000-0003-0229-9651","National Science Foundation; National Institutes of Health NRSA [F32-GM089007]; National Cancer Institute [T32-CA009528]; James S. McDonnell Foundation; Howard Hughes Medical Institute; National Institutes of Health [R01-HG004321, R01 AI087528]; Searle Scholars Program; Packard Foundation; Burroughs Wellcome Fund fellowship","This work was supported by a National Science Foundation Predoctoral Fellowship to KMB; National Institutes of Health NRSA F32-GM089007 and a National Cancer Institute T32-CA009528 to ECA; a James S. McDonnell Foundation Centennial Fellowship, Howard Hughes Medical Institute, and National Institutes of Health grant R01-HG004321 to LK; National Institutes of Health R01 AI087528, the Searle Scholars Program, Packard Foundation and Burroughs Wellcome Fund fellowship to ERT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Andersen EC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004156; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Bakowski MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004200; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Bendesky A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003157; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; BRENNER S, 1974, GENETICS, V77, P71; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Doerge RW, 1996, GENETICS, V142, P285; Estes KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002227; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lobo ML, 2012, INT J PARASITOL, V42, P197, DOI 10.1016/j.ijpara.2011.12.002; McGhee JD, 2007, THE C ELEGANS INTEST; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Ruan QW, 2014, CURR OPIN IMMUNOL, V29, P49, DOI 10.1016/j.coi.2014.04.003; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; STIERNAGLE T, 2006, MAINTENANCE C ELEGAN; Szumowski SC, 2014, P NATL ACAD SCI USA, V111, P8215, DOI 10.1073/pnas.1400696111; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Troemel ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001243; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Twumasi-Boateng K, 2012, AGING CELL, V11, P659, DOI 10.1111/j.1474-9726.2012.00829.x; Williams BAP, 2009, CELL MICROBIOL, V11, P1551, DOI 10.1111/j.1462-5822.2009.01362.x; Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082",49,17,17,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004583,10.1371/journal.ppat.1004583,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400004,25680197.0,"DOAJ Gold, Green Published",,,16/08/2019,17,1,43,5351,799,640,159,4552,3916,23,613,43,0,0,0,16,16,0,,52,6,52,0,6,18,18,7,15,0,0,0,0,0,0,0,1,3,5398,71,0,293,164,0,4545,799,71,0,293,164,0,54,,0,0,0,0,5,0,0,1,0,0,0,51,0,0,2.25,6.69712140175219,1.1755272407732864,0.17552724077328646,1.2374780316344465,1.0527004298262006,7.050062578222779
145,J,"Bertaux-Skeirik, N; Feng, R; Schumacher, MA; Li, J; Mahe, MM; Engevik, AC; Javier, JE; Peek, RM; Ottemann, K; Orian-Rousseau, V; Boivin, GP; Helmrath, MA; Zavros, Y",,,,"Bertaux-Skeirik, Nina; Feng, Rui; Schumacher, Michael A.; Li, Jing; Mahe, Maxime M.; Engevik, Amy C.; Javier, Jose E.; Peek, Richard M., Jr.; Ottemann, Karen; Orian-Rousseau, Veronique; Boivin, Gregory P.; Helmrath, Michael A.; Zavros, Yana",,,CD44 Plays a Functional Role in Helicobacter pylori-induced Epithelial Cell Proliferation,PLOS PATHOGENS,,,English,Article,,,,,,,GASTRIC-CANCER; C-MET; STEM-CELLS; PATHOGENICITY ISLAND; MONGOLIAN GERBILS; VIRULENCE FACTORS; IMMUNE-RESPONSE; CAGA PROTEIN; IV SECRETION; RECEPTOR,"The cytotoxin-associated gene (Cag) pathogenicity island is a strain-specific constituent of Helicobacter pylori (H. pylori) that augments cancer risk. CagA translocates into the cytoplasm where it stimulates cell signaling through the interaction with tyrosine kinase c-Met receptor, leading cellular proliferation. Identified as a potential gastric stem cell marker, cluster-of-differentiation (CD) CD44 also acts as a co-receptor for c-Met, but whether it plays a functional role in H. pylori-induced epithelial proliferation is unknown. We tested the hypothesis that CD44 plays a functional role in H. pylori-induced epithelial cell proliferation. To assay changes in gastric epithelial cell proliferation in relation to the direct interaction with H. pylori, human-and mouse-derived gastric organoids were infected with the G27 H. pylori strain or a mutant G27 strain bearing cagA deletion (Delta CagA::cat). Epithelial proliferation was quantified by EdU immunostaining. Phosphorylation of c-Met was analyzed by immunoprecipitation followed by Western blot analysis for expression of CD44 and CagA. H. pylori infection of both mouse-and human-derived gastric organoids induced epithelial proliferation that correlated with c-Met phosphorylation. CagA and CD44 co-immunoprecipitated with phosphorylated c-Met. The formation of this complex did not occur in organoids infected with Delta CagA::cat. Epithelial proliferation in response to H. pylori infection was lost in infected organoids derived from CD44-deficient mouse stomachs. Human-derived fundic gastric organoids exhibited an induction in proliferation when infected with H. pylori, that was not seen in organoids pre-treated with a peptide inhibitor specific to CD44. In the well-established Mongolian gerbil model of gastric cancer, animals treated with CD44 peptide inhibitor Pep1, resulted in the inhibition of H. pylori-induced proliferation and associated atrophic gastritis. The current study reports a unique approach to study H. pylori interaction with the human gastric epithelium. Here, we show that CD44 plays a functional role in H. pyloriinduced epithelial cell proliferation.","[Bertaux-Skeirik, Nina; Feng, Rui; Schumacher, Michael A.; Li, Jing; Engevik, Amy C.; Javier, Jose E.; Zavros, Yana] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45220 USA; [Mahe, Maxime M.; Helmrath, Michael A.] Cincinnati Childrens Hosp Med Ctr, Dept Surg, Div Pediat Surg, Cincinnati, OH 45229 USA; [Peek, Richard M., Jr.] Vanderbilt Univ, Canc Biol, Nashville, TN 37235 USA; [Ottemann, Karen] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Orian-Rousseau, Veronique] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Boivin, Gregory P.] Wright State Univ, Dept Pathol, Hlth Sci, Dayton, OH 45435 USA; [Boivin, Gregory P.] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA","Bertaux-Skeirik, N (reprint author), Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45220 USA.",yana.zavros@uc.edu,"Orian-Rousseau, Veronique/H-5735-2013; Mahe, Maxime M/G-5552-2017","Orian-Rousseau, Veronique/0000-0003-2939-9257; Mahe, Maxime M/0000-0003-2560-193X",American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer; PHS [P30 DK078392]; NIH of the Digestive Diseases Research Core Center in Cincinnati [AR-47363];  [5T32GM105526],"Funding: This work was supported by the American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer (Zavros), and the 5T32GM105526 grant (Bertaux-Skeirik). This project was supported in part by PHS Grant P30 DK078392 (Integrative Morphology Core) and NIH AR-47363 (Research Flow Cytometry Core in the Division of Rheumatology) of the Digestive Diseases Research Core Center in Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartfeld S, 2014, GASTROENTER IN PRESS; Campo GM, 2013, INNATE IMMUN-LONDON, V19, P462, DOI 10.1177/1753425912470391; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; CORREA P, 1975, LANCET, V2, P58; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; da Cunha CB, 2010, LAB INVEST, V90, P1604, DOI 10.1038/labinvest.2010.155; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Feng R, 2014, GASTROENTEROLOGY, V147, P655, DOI 10.1053/j.gastro.2014.05.006; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Khurana SS, 2013, J BIOL CHEM, V288, P16085, DOI 10.1074/jbc.M112.445551; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Kuipers EJ, 1996, SCAND J GASTROENTERO, V31, P103, DOI 10.3109/00365529609094739; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Mahe Maxime M, 2013, Curr Protoc Mouse Biol, V3, P217, DOI 10.1002/9780470942390.mo130179; MARSHALL BJ, 1984, LANCET, V1, P1311; Maulik G, 2002, J CELL MOL MED, V6, P539, DOI 10.1111/j.1582-4934.2002.tb00453.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Oliveira MJ, 2009, J INFECT DIS, V200, P745, DOI 10.1086/604727; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; Romero-Gallo J, 2008, LAB INVEST, V88, P328, DOI 10.1038/labinvest.3700719; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sause WE, 2012, INFECT IMMUN, V80, P2286, DOI 10.1128/IAI.00312-12; Schumacher MA, 2014, HELICOBACTE IN PRESS; Schumacher MA, J PHYSL PRO IN PRESS; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Selbach, 2004, HEL PYL CAGA PROT IN; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wirth HP, 1998, INFECT IMMUN, V66, P4856; Wroblewski LE, 2014, GUT IN PRESS; Yamaguchi A, 2002, J SURG ONCOL, V79, P230, DOI 10.1002/jso.10082",50,63,66,1,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004663,10.1371/journal.ppat.1004663,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400043,25658601.0,"DOAJ Gold, Green Published",,,16/08/2019,66,13,55,7414,1442,1004,438,5972,4706,23,1243,55,0,1,0,57,57,1,,74,4,74,0,4,67,67,65,37,0,0,0,0,0,0,0,13,1,7469,17,0,200,161,1,5995,1442,17,0,200,161,1,32,,0,0,0,0,0,0,0,1,0,0,0,74,0,0,0.25,5.141470180305132,1.24146014735432,0.24146014735432017,1.2804755525787006,1.0314270299433503,5.3030513176144245
146,J,"Bonhoeffer, S; Fraser, C; Leventhal, GE",,,,"Bonhoeffer, Sebastian; Fraser, Christophe; Leventhal, Gabriel E.",,,High Heritability Is Compatible with the Broad Distribution of Set Point Viral Load in HIV Carriers,PLOS PATHOGENS,,,English,Article,,,,,,,DISEASE PROGRESSION; RNA LEVELS; INFECTION; VIRUS; TRANSMISSION; ASSOCIATION; EVOLUTION; PLASMA; COHORT; CONSTRUCTION,Set point viral load in HIV patients ranges over several orders of magnitude and is a key determinant of disease progression in HIV. A number of recent studies have reported high heritability of set point viral load implying that viral genetic factors contribute substantially to the overall variation in viral load. The high heritability is surprising given the diversity of host factors associated with controlling viral infection. Here we develop an analytical model that describes the temporal changes of the distribution of set point viral load as a function of heritability. This model shows that high heritability is the most parsimonious explanation for the observed variance of set point viral load. Our results thus not only reinforce the credibility of previous estimates of heritability but also shed new light onto mechanisms of viral pathogenesis.,"[Bonhoeffer, Sebastian; Leventhal, Gabriel E.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England","Bonhoeffer, S (reprint author), ETH, Inst Integrat Biol, Zurich, Switzerland.",sebastian.bonhoeffer@env.ethz.ch,"Bonhoeffer, Sebastian/A-2735-2008; Leventhal, Gabriel E/Q-6308-2018; Fraser, Christophe/A-8109-2008","Bonhoeffer, Sebastian/0000-0001-8052-3925; Leventhal, Gabriel E/0000-0002-4463-166X; Fraser, Christophe/0000-0003-2399-9657","European Research Council under the 7th Framework Programme of the European Commission (PBDR) [268540]; wiss National Foundation (SNF); Medical Research Council [MR/K010174/1, MR/K010174/1B]","SB was supported in part by the European Research Council under the 7th Framework Programme of the European Commission (PBDR: Grant Agreement Number 268540). SB also received funding from the Swiss National Foundation (SNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Barbour JD, 2004, J INFECT DIS, V190, P251, DOI 10.1086/422036; Bartha I, 2008, TRENDS IMMUNOL, V29, P322, DOI 10.1016/j.it.2008.04.005; Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Childs DZ, 2004, P ROY SOC B-BIOL SCI, V271, P425, DOI 10.1098/rspb.2003.2597; Coulson T, 2012, OIKOS, V121, P1337, DOI 10.1111/j.1600-0706.2012.00035.x; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.2307/177370; Falconer DS, INTRO QUANTITATIVE G; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hodcroft E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004112; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Hool A, 2013, EPIDEMICS-NETH, V5, P174, DOI 10.1016/j.epidem.2013.09.002; Kouyos RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002321; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lythgoe KA, 2013, EVOLUTION, V67, P2769, DOI 10.1111/evo.12166; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Meyer L, 1997, AIDS, V11, pF73, DOI 10.1097/00002030-199711000-00001; Muller V, 2011, VIRUSES-BASEL, V3, P204, DOI 10.3390/v3030204; O'Brien TR, 1998, J ACQ IMMUN DEF SYND, V18, P155, DOI 10.1097/00042560-199806010-00007; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Shankarappa R, 1999, J VIROL, V73, P10489; Shirreff G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002185; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; van der Kuyl AC, 2010, AIDS, V24, P1607, DOI 10.1097/QAD.0b013e32833b318f; Williams BG, 2011, ARXIV11084715",38,13,13,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004634,10.1371/journal.ppat.1004634,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400022,25658741.0,"DOAJ Gold, Green Published",,,16/08/2019,12,12,28,3295,205,140,65,3090,2639,21,430,27,1,0,0,12,12,0,,34,1,33,1,1,12,12,8,7,0,0,0,0,0,0,0,11,0,3323,240,0,273,70,0,3095,208,240,0,273,70,0,20,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,16.073170731707318,1.0663430420711975,0.06634304207119741,1.1757281553398058,1.1025796661608498,17.721951219512196
147,J,"da Silva, HB; Fonseca, R; Cassado, AD; de Salles, EM; de Menezes, MN; Langhorne, J; Perez, KR; Cuccovia, IM; Ryffel, B; Barreto, VM; Marinho, CRF; Boscardin, SB; Alvarez, JM; D'Imperio-Lima, MR; Tadokoro, CE",,,,"da Silva, Henrique Borges; Fonseca, Raissa; Cassado, Alexandra dos Anjos; de Salles, Erika Machado; de Menezes, Maria Nogueira; Langhorne, Jean; Perez, Katia Regina; Cuccovia, Iolanda Midea; Ryffel, Bernhard; Barreto, Vasco M.; Farias Marinho, Claudio Romero; Boscardin, Silvia Beatriz; Alvarez, Jose Maria; D'Imperio-Lima, Maria Regina; Tadokoro, Carlos Eduardo",,,In Vivo Approaches Reveal a Key Role for DCs in CD4+T Cell Activation and Parasite Clearance during the Acute Phase of Experimental Blood-Stage Malaria,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMODIUM-CHABAUDI MALARIA; CD8(+) T-CELLS; DENDRITIC CELLS; INFECTED ERYTHROCYTES; ANTIGEN PRESENTATION; IFN-GAMMA; DIFFERENTIAL REQUIREMENTS; DEPENDENT IMMUNITY; MARGINAL ZONE; MOUSE SPLEEN,"Dendritic cells (DCs) are phagocytes that are highly specialized for antigen presentation. Heterogeneous populations of macrophages and DCs form a phagocyte network inside the red pulp (RP) of the spleen, which is a major site for the control of blood-borne infections such as malaria. However, the dynamics of splenic DCs during Plasmodium infections are poorly understood, limiting our knowledge regarding their protective role in malaria. Here, we used in vivo experimental approaches that enabled us to deplete or visualize DCs in order to clarify these issues. To elucidate the roles of DCs and marginal zone macrophages in the protection against blood-stage malaria, we infected DTx (diphtheria toxin)-treated C57BL/6. CD11c-DTR mice, as well as C57BL/6 mice treated with low doses of clodronate liposomes (CILip), with Plasmodium chabaudi AS (Pc) parasites. The first evidence suggesting that DCs could contribute directly to parasite clearance was an early effect of the DTx treatment, but not of the CILip treatment, in parasitemia control. DCs were also required for CD4+ T cell responses during infection. The phagocytosis of infected red blood cells (iRBCs) by splenic DCs was analyzed by confocal intravital microscopy, as well as by flow cytometry and immunofluorescence, at three distinct phases of Pc malaria: at the first encounter, at pre-crisis concomitant with parasitemia growth and at crisis when the parasitemia decline coincides with spleen closure. In vivo and ex vivo imaging of the spleen revealed that DCs actively phagocytize iRBCs and interact with CD4+ T cells both in T cell-rich areas and in the RP. Subcapsular RP DCs were highly efficient in the recognition and capture of iRBCs during pre-crisis, while complete DC maturation was only achieved during crisis. These findings indicate that, beyond their classical role in antigen presentation, DCs also contribute to the direct elimination of iRBCs during acute Plasmodium infection.","[da Silva, Henrique Borges; Fonseca, Raissa; Cassado, Alexandra dos Anjos; de Salles, Erika Machado; de Menezes, Maria Nogueira; Farias Marinho, Claudio Romero; Boscardin, Silvia Beatriz; Alvarez, Jose Maria; D'Imperio-Lima, Maria Regina] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil; [da Silva, Henrique Borges; Barreto, Vasco M.; Tadokoro, Carlos Eduardo] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Langhorne, Jean] Charing Cross Sunley Med Res Ctr, London W6 8LW, England; [Perez, Katia Regina] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, Sao Paulo, Brazil; [Cuccovia, Iolanda Midea] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508 Sao Paulo, Brazil; [Ryffel, Bernhard] Univ Orleans, CNRS, UMR7355, Unite Immunol & Neurogenet Expt & Mol, Orleans, France","da Silva, HB (reprint author), Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.",relima@usp.br; ctadokoro@igc.gulbenkian.pt,"Barreto, Vasco M./H-2306-2018; Tadokoro, Carlos E/D-5111-2011; Perez, Katia/J-2312-2016; Salles, Erika/I-6001-2015; Boscardin, Silvia Beatriz/C-3397-2012; Alvarez, Jose M/I-6181-2012; Cassado, Alexandra/J-1680-2015; Lima, Maria Regina D'Imperio/I-4747-2012; Marinho, Claudio Romero Farias/F-7507-2012; Menezes, Maria/J-1682-2015","Barreto, Vasco M./0000-0002-0010-8607; Boscardin, Silvia Beatriz/0000-0002-7845-7110; Alvarez, Jose M/0000-0002-9711-4914; Lima, Maria Regina D'Imperio/0000-0002-4683-7709; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Tadokoro, Carlos Eduardo/0000-0002-7874-5657; , Henrique/0000-0002-5021-6200; Langhorne, Jean/0000-0002-2257-9733; Fonseca, Raissa/0000-0001-8202-4871","Sao Paulo Research Foundation [2011/24038-1, 2009/08559-1]; CAPES/IGC [04/2012]; Fundacao para a Ciencia e Tecnologia [PTDC/EBB-BIO/115514/2009]","This study was supported by grants from the Sao Paulo Research Foundation 2011/24038-1 (MRDL) and 2009/08559-1 (HBdS), CAPES/IGC 04/2012 (MRDL, CET) and Fundacao para a Ciencia e Tecnologia PTDC/EBB-BIO/115514/2009 (CET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Castillo-Mendez SI, 2007, SCAND J IMMUNOL, V66, P309, DOI 10.1111/j.1365-3083.2007.01972.x; Chotivanich K, 2002, J INFECT DIS, V185, P1538, DOI 10.1086/340213; Coombes JL, 2010, NAT REV IMMUNOL, V10, P353, DOI 10.1038/nri2746; da Silva HB, 2013, J IMMUNOL, V191, P5160, DOI 10.4049/jimmunol.1300462; da Silva HB, 2012, CELL IMMUNOL, V277, P22, DOI 10.1016/j.cellimm.2012.06.003; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; de Moraes LV, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003154; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; Engwerda CR, 2005, TRENDS PARASITOL, V21, P75, DOI 10.1016/j.pt.2004.11.008; EZEKOWITZ RAB, 1982, J EXP MED, V155, P1623; do Rosario APF, 2008, J IMMUNOL, V181, P8344; GRUN JL, 1985, INFECT IMMUN, V48, P853; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hawkes M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-299; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hou TZ, 2010, FEBS LETT, V584, P3955, DOI 10.1016/j.febslet.2010.07.053; Ing R, 2006, J IMMUNOL, V176, P441, DOI 10.4049/jimmunol.176.1.441; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Jin C, 2012, P NATL ACAD SCI USA, V109, P10053, DOI 10.1073/pnas.1120246109; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Krucken J, 2005, INFECT IMMUN, V73, P6390, DOI 10.1128/IAI.73.10.6390-6398.2005; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Leisewitz AL, 2004, INFECT IMMUN, V72, P4233, DOI 10.1128/IAI.72.7.4233-4239.2004; Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Martin-Jaular L, 2011, CELL MICROBIOL, V13, P109, DOI 10.1111/j.1462-5822.2010.01523.x; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mebius RE, 2004, CRIT REV IMMUNOL, V24, P449, DOI 10.1615/CritRevImmunol.v24.i6.40; Medeiros MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081409; Muxel SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022434; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; PODOBA JE, 1991, INFECT IMMUN, V59, P51; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Reece SE, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-183; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Spence PJ, 2011, NAT PROTOC, V6, P553, DOI 10.1038/nprot.2011.313; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Steiniger B, 2000, ADV ANAT EMBRYOL CEL, V151, P1; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Tavares J, 2013, J EXP MED, V210, P905, DOI 10.1084/jem.20121130; Urban BC, 2005, CURR TOP MICROBIOL, V297, P25; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Wykes MN, 2008, NAT REV MICROBIOL, V6, P864, DOI 10.1038/nrmicro1988; Yadava A, 1996, P NATL ACAD SCI USA, V93, P4595, DOI 10.1073/pnas.93.10.4595; YAP GS, 1994, INFECT IMMUN, V62, P4219",66,18,18,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004598,10.1371/journal.ppat.1004598,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400006,25658925.0,"DOAJ Gold, Green Published",,,16/08/2019,19,3,42,7133,685,492,193,6448,5406,17,1025,42,0,12,0,20,20,1,,103,7,52,0,7,22,20,22,10,0,0,0,0,0,0,0,3,3,7211,176,0,393,82,0,6478,690,176,0,393,82,0,43,,0,0,0,0,7,0,1,0,0,0,0,54,0,0,3.75,10.413138686131386,1.1062344913151365,0.10623449131513647,1.1583436724565757,1.0471050049067714,10.903649635036496
148,J,"Gauthier, GM",,,,"Gauthier, Gregory M.",,,"Dimorphism in Fungal Pathogens of Mammals, Plants, and Insects",PLOS PATHOGENS,,,English,Article,,,,,,,HISTOPLASMA-CAPSULATUM REVEALS; PENICILLIUM-MARNEFFEI; MATING-TYPE; VIRULENCE; YEAST; MANIPULATION; ADHESIN; DISEASE; GROWTH; GENE,,"Univ Wisconsin, Dept Med, Madison, WI 53706 USA","Gauthier, GM (reprint author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.",gmg@medicine.wisc.edu,,,National Institutes of Health [R21AI105537],"This work was supported by National Institutes of Health Grant R21AI105537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Beck MR, 2009, MOL MICROBIOL, V72, P344, DOI 10.1111/j.1365-2958.2009.06647.x; Berrocal A, 2012, J APPL MICROBIOL, V113, P126, DOI 10.1111/j.1365-2672.2012.05317.x; Beyhan S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001614; Bohse ML, 2007, INFECT IMMUN, V75, P2811, DOI 10.1128/IAI.00304-07; Bonifaz A, 2010, CLIN DERMATOL, V28, P140, DOI 10.1016/j.clindermatol.2009.12.004; Boyce KJ, 2011, MOL MICROBIOL, V82, P1164, DOI 10.1111/j.1365-2958.2011.07878.x; Brandhorst TT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003464; Bugeja HE, 2013, MOL MICROBIOL, V88, P998, DOI 10.1111/mmi.12239; Cisse OH, 2013, MBIO, V3; de Bekker C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0166-3; Edwards JA, 2011, EUKARYOT CELL, V10, P87, DOI 10.1128/EC.00214-10; Evans Harry C, 2011, Commun Integr Biol, V4, P598, DOI 10.4161/cib.4.5.16721; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Gauthier Greg, 2008, Microbe Wash DC, V3, P416; Gauthier GM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000846; Gilmore SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003799; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Hwang LH, 2012, EUKARYOT CELL, V11, P16, DOI 10.1128/EC.05274-11; Inglis DO, 2013, EUKARYOT CELL, V12, P828, DOI 10.1128/EC.00069-13; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Lee SC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003625; Li WJ, 2013, EUKARYOT CELL, V12, P109, DOI 10.1128/EC.00249-12; Litvintseva AP, 2014, CLIN INFECT DIS; Naruzawa ES, 2014, FUNGAL BIOL-UK, V118, P872, DOI 10.1016/j.funbio.2014.07.006; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Paoletti M, 2006, MOL ECOL, V15, P249, DOI 10.1111/j.1365-294X.2005.02728.x; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Todd RB, 2003, MOL MICROBIOL, V48, P85, DOI 10.1046/j.1365-2958.2003.03426.x; Torres I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068434; Vollmeister E, 2012, FEMS MICROBIOL REV, V36, P59, DOI 10.1111/j.1574-6976.2011.00296.x; Wachoo A, 2009, MICROBIOLOGY, V155, P3121, DOI [10.1099/mic.0.029157-0, DOI 10.1099/MIC.0.029157-0]; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Webster RH, 2008, P NATL ACAD SCI USA, V105, P14573, DOI 10.1073/pnas.0806221105; Youngchim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063764",39,40,40,1,29,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004608,10.1371/journal.ppat.1004608,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400008,25675433.0,"DOAJ Gold, Green Published",,,16/08/2019,44,5,56,12794,6931,6345,586,5863,4683,24,1156,56,2,0,0,37,37,0,,78,3,78,0,3,48,47,48,18,0,0,0,0,0,0,0,4,7,12797,14,0,118,109,5,5812,6931,14,0,118,109,5,54,,0,0,0,0,5,0,1,1,0,0,0,76,0,0,3.6,1.8459096811426923,2.182159304110524,1.1821593041105236,2.2036500085280575,1.0098483664217601,1.86408887606406
149,J,"Geisinger, E; Isberg, RR",,,,"Geisinger, Edward; Isberg, Ralph R.",,,Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii,PLOS PATHOGENS,,,English,Article,,,,,,,VENTILATOR-ASSOCIATED PNEUMONIA; CARE SAFETY NETWORK; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; BIOFILM INDUCTION; MOLECULAR-BASIS; GENETIC TOOLS; POLYSACCHARIDE; INFECTIONS,"Acinetobacter baumannii is an opportunistic pathogen of increasing importance due to its propensity for intractable multidrug-resistant infections in hospitals. All clinical isolates examined contain a conserved gene cluster, the K locus, which determines the production of complex polysaccharides, including an exopolysaccharide capsule known to protect against killing by host serum and to increase virulence in animal models of infection. Whether the polysaccharides determined by the K locus contribute to intrinsic defenses against antibiotics is unknown. We demonstrate here that mutants deficient in the exopolysaccharide capsule have lowered intrinsic resistance to peptide antibiotics, while a mutation affecting sugar precursors involved in both capsule and lipopolysaccharide synthesis sensitizes the bacterium to multiple antibiotic classes. We observed that, when grown in the presence of certain antibiotics below their MIC, including the translation inhibitors chloramphenicol and erythromycin, A. baumannii increases production of the K locus exopolysaccharide. Hyperproduction of capsular exopolysaccharide is reversible and non-mutational, and occurs concomitantly with increased resistance to the inducing antibiotic that is independent of the presence of the K locus. Strikingly, antibiotic-enhanced capsular exopolysaccharide production confers increased resistance to killing by host complement and increases virulence in a mouse model of systemic infection. Finally, we show that augmented capsule production upon antibiotic exposure is facilitated by transcriptional increases in K locus gene expression that are dependent on a two-component regulatory system, bfmRS. These studies reveal that the synthesis of capsule, a major pathogenicity determinant, is regulated in response to antibiotic stress. Our data are consistent with a model in which gene expression changes triggered by ineffectual antibiotic treatment cause A. baumannii to transition between states of low and high virulence potential, which may contribute to the opportunistic nature of the pathogen.","[Geisinger, Edward; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Isberg, Ralph R.] Howard Hughes Med Inst, Boston, MA 02115 USA","Geisinger, E (reprint author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.",ralph.isberg@tufts.edu,,,Howard Hughes Medical Institute; National Institute of Allergy and Infectious Diseases [F32AI098358],"Funding: This work was supported by Howard Hughes Medical Institute. EG was supported by a postdoctoral fellowship from National Institute of Allergy and Infectious Diseases # F32AI098358. RRI is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ANSTEY NM, 1992, CLIN INFECT DIS, V14, P83, DOI 10.1093/clinids/14.1.83; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; Bruhn KW, 2014, J INFECT DIS; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Chitnis AS, 2012, INFECT CONT HOSP EP, V33, P993, DOI 10.1086/667745; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Cole JN, 2010, MBIO, V1, DOI [10.1128/mBio.00307-10, DOI 10.1128/MBIO.00307-10]; Cosgrove SAE, 2013, ANTIBIOTIC GUIDELINE; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Doi Y, 2009, EMERG INFECT DIS, V15, P980, DOI 10.3201/eid1506.081006; DUGUID JP, 1951, J PATHOL BACTERIOL, V63, P673, DOI 10.1002/path.1700630413; Elliott D, 2010, ANTIMICROB AGENTS CH, V54, P3024, DOI 10.1128/AAC.00102-10; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Feldman C, 1999, EUR RESPIR J, V13, P546, DOI 10.1183/09031936.99.13354699; Food and Drug Administration H, 2013, FED REGISTER, P35155; Fregolino E, 2011, CARBOHYD RES, V346, P973, DOI 10.1016/j.carres.2011.03.024; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Garnacho-Montero J, 2005, INTENS CARE MED, V31, P649, DOI 10.1007/s00134-005-2598-0; Gil-Perotin S, 2012, CRIT CARE, V16, DOI 10.1186/cc11357; GOVAN JRW, 1975, J MED MICROBIOL, V8, P513, DOI 10.1099/00222615-8-4-513; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; HELD TK, 1995, ANTIMICROB AGENTS CH, V39, P1093, DOI 10.1128/AAC.39.5.1093; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hood MI, 2013, INFECT IMMUN, V81, P542, DOI 10.1128/IAI.00704-12; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070329; Ichimiya T, 1996, CHEMOTHERAPY, V42, P186, DOI 10.1159/000239440; Inouye Masayori, 2004, Sci STKE, V2004, ppe26, DOI 10.1126/stke.2372004pe26; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jeon B, 2009, J ANTIMICROB CHEMOTH, V63, P462, DOI 10.1093/jac/dkn529; JIANG WN, 1993, J BACTERIOL, V175, P5824; Jones A, 2009, J BACTERIOL, V191, P3861, DOI 10.1128/JB.01313-08; Joung MK, 2010, J INFECTION, V61, P212, DOI 10.1016/j.jinf.2010.06.014; Karlyshev AV, 2001, J CLIN MICROBIOL, V39, P279, DOI 10.1128/JCM.39.1.279-284.2001; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; Koeleman JGM, 2001, INFECT CONT HOSP EP, V22, P284, DOI 10.1086/501901; Kristian SA, 2007, FASEB J, V21, P1107, DOI 10.1096/fj.06-6802com; Kumar A, 2010, J MICROBIOL METH, V82, P296, DOI 10.1016/j.mimet.2010.07.002; Lees-Miller RG, 2013, MOL MICROBIOL, V89, P816, DOI 10.1111/mmi.12300; LELIVELT MJ, 1995, J BACTERIOL, V177, P4900, DOI 10.1128/jb.177.17.4900-4907.1995; Lin L, 2012, MBIO, V3, DOI [10.1128/mBio.00535-12, DOI 10.1128/MBIO.00535-12]; Liou ML, 2013, J MICROBIOL IMMUNOL, DOI [10.1016/j.jmii.2013.09.010, DOI 10.1016/J.JMII.2013.09.010]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Luke NR, 2010, INFECT IMMUN, V78, P2017, DOI 10.1128/IAI.00016-10; Luong TT, 2002, INFECT IMMUN, V70, P3389, DOI 10.1128/IAI.70.7.3389-3395.2002; Mercaldi MP, 2008, BIOMACROMOLECULES, V9, P1988, DOI 10.1021/bm800239p; Miskinyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003802; Morita Y, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00422; Nakar D, 2001, MICROBIOL-SGM, V147, P1937, DOI 10.1099/00221287-147-7-1937; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740; Park YK, 2009, EMERG INFECT DIS, V15, P1325, DOI 10.3201/eid1508.080772; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Rajagopal S, 2002, APPL ENVIRON MICROB, V68, P4117, DOI 10.1128/AEM.68.8.4117-4121.2002; ROANTREE RJ, 1977, J GEN MICROBIOL, V103, P223, DOI 10.1099/00221287-103-2-223; RUBINOVITZ C, 1982, J BACTERIOL, V152, P126; Russo TA, 2013, INFECT IMMUN, V81, P915, DOI 10.1128/IAI.01184-12; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Sugawara E, 2012, J BACTERIOL, V194, P4089, DOI 10.1128/JB.00435-12; Thakker M, 1998, INFECT IMMUN, V66, P5183; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Traub WH, 2000, CHEMOTHERAPY, V46, P282, DOI 10.1159/000007300; Umland TC, 2012, MBIO, V3, DOI [10.1128/mBio.00499-12, DOI 10.1128/MBIO.00499-12]; Valencia R, 2009, INFECT CONT HOSP EP, V30, P257, DOI 10.1086/595977; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang ND, 2014, MBIO, V5, DOI 10.1128/mBio.01163-14; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x",84,76,78,3,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004691,10.1371/journal.ppat.1004691,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400057,25679516.0,"DOAJ Gold, Green Published",,,16/08/2019,73,3,85,12754,2967,2208,759,9787,7620,43,2124,85,0,0,0,74,74,0,,122,5,122,0,5,79,79,39,53,0,0,0,0,0,0,0,3,0,12954,200,16,213,119,0,9868,3045,200,16,213,119,0,41,,0,0,0,0,2,0,0,1,0,0,0,124,0,0,0.75,4.2986181327940685,1.303157249412486,0.30315724941248595,1.356186778379483,1.0406931158852124,4.473542298618133
150,J,"Hancock, G; Yang, HB; Yorke, E; Wainwright, E; Bourne, V; Frisbee, A; Payne, TL; Berrong, M; Ferrari, G; Chopera, D; Hanke, T; Mothe, B; Brander, C; McElrath, MJ; McMichael, A; Goonetilleke, N; Tomaras, GD; Frahm, N; Dorrell, L",,,,"Hancock, Gemma; Yang, Hongbing; Yorke, Elisabeth; Wainwright, Emma; Bourne, Victoria; Frisbee, Alyse; Payne, Tamika L.; Berrong, Mark; Ferrari, Guido; Chopera, Denis; Hanke, Tomas; Mothe, Beatriz; Brander, Christian; McElrath, M. Juliana; McMichael, Andrew; Goonetilleke, Nilu; Tomaras, Georgia D.; Frahm, Nicole; Dorrell, Lucy",,,Identification of Effective Subdominant Anti-HIV-1 CD8+T Cells Within Entire Post-infection and Post-vaccination Immune Responses,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; HIV-1 VACCINE; MAJOR DETERMINANTS; FUNCTIONAL PROFILE; FITNESS COSTS; DOUBLE-BLIND; GAG; INFECTION; CAPACITY,"Defining the components of an HIV immunogen that could induce effective CD8+ T cell responses is critical to vaccine development. We addressed this question by investigating the viral targets of CD8+ T cells that potently inhibit HIV replication in vitro, as this is highly predictive of virus control in vivo. We observed broad and potent ex vivo CD8+ T cell-mediated viral inhibitory activity against a panel of HIV isolates among viremic controllers (VC, viral loads <5000 copies/ml), in contrast to unselected HIV-infected HIV Vaccine trials Network (HVTN) participants. Viral inhibition of clade-matched HIV isolates was strongly correlated with the frequency of CD8+ T cells targeting vulnerable regions within Gag, Pol, Nef and Vif that had been identified in an independent study of nearly 1000 chronically infected individuals. These vulnerable and so-called ""beneficial"" regions were of low entropy overall, yet several were not predicted by stringent conservation algorithms. Consistent with this, stronger inhibition of clade-matched than mismatched viruses was observed in the majority of subjects, indicating better targeting of clade-specific than conserved epitopes. The magnitude of CD8+ T cell responses to beneficial regions, together with viral entropy and HLA class I genotype, explained up to 59% of the variation in viral inhibitory activity, with magnitude of the T cell response making the strongest unique contribution. However, beneficial regions were infrequently targeted by CD8+ T cells elicited by vaccines encoding full-length HIV proteins, when the latter were administered to healthy volunteers and HIV-positive ART-treated subjects, suggesting that immunodominance hierarchies undermine effective anti-HIV CD8+ T cell responses. Taken together, our data support HIV immunogen design that is based on systematic selection of empirically defined vulnerable regions within the viral proteome, with exclusion of immunodominant decoy epitopes that are irrelevant for HIV control.","[Hancock, Gemma; Yang, Hongbing; Bourne, Victoria; Hanke, Tomas; Dorrell, Lucy] Univ Oxford, Nuffield Dept Med, Oxford, England; [Hancock, Gemma; Yang, Hongbing; Dorrell, Lucy] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England; [Yorke, Elisabeth] Univ Toronto, Fac Med, Toronto, ON, Canada; [Wainwright, Emma] Royal Berkshire NHS Fdn Trust, Dept Sexual Hlth, Reading, Berks, England; [Frisbee, Alyse; Payne, Tamika L.; Berrong, Mark; Ferrari, Guido; Tomaras, Georgia D.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Payne, Tamika L.; Berrong, Mark; Ferrari, Guido; Tomaras, Georgia D.] Duke Univ, Dept Surg, Durham, NC USA; [Payne, Tamika L.; Berrong, Mark; Ferrari, Guido; Tomaras, Georgia D.] Duke Univ, Dept Immunol, Durham, NC USA; [Payne, Tamika L.; Berrong, Mark; Ferrari, Guido; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Chopera, Denis] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Chopera, Denis] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Mothe, Beatriz] Hosp Badalona Germans Trias & Pujol, Irsicaixa AIDS Res Inst, Badalona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Goonetilleke, Nilu] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA","Hancock, G (reprint author), Univ Oxford, Nuffield Dept Med, Oxford, England.",lucy.dorrell@ndm.ox.ac.uk,"Ferrari, Guido/A-6088-2015; Tomaras, Georgia/J-5041-2016","Ferrari, Guido/0000-0001-7747-3349; Mothe, Beatriz/0000-0001-9975-407X; Brander, Christian/0000-0002-0548-5778","Oxford National Institutes for Health Research (NIHR) Biomedical Research Centre, UK; Jenner Vaccine Foundation, UK; Rhodes Trust; Rhodes Trust (NIH) [R01/R56, AI-52779, 1F31AI106519-01]; Center for AIDS Research [P30 AI 64518]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; ICREA; Medical Research Council [G1001757, G0701669, MC_U137884179]","This work was supported by Oxford National Institutes for Health Research (NIHR) Biomedical Research Centre, UK (LD); The Jenner Vaccine Foundation, UK (LD); the Rhodes Trust (Visiting Fellowship - EY; R01/R56 NIH Grant AI-52779 (GDT); NIH F31 Fellowship (1F31AI106519-01)(TLP); Center for AIDS Research (P30 AI 64518); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, grant number UM1-AI100645-01 (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Freel SA, 2012, J VIROL, V86, P6835, DOI 10.1128/JVI.00437-12; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Ganusov VV, 2011, J VIROL, V85, P10518, DOI 10.1128/JVI.00655-11; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE; Hertz T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003404; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Janes H, 2013, J INFECT DIS, V208, P1231, DOI 10.1093/infdis/jit322; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kopycinski J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090378; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Koup R A, 2001, Curr Protoc Immunol, VChapter 12, DOI 10.1002/0471142735.im1202s05; KOUP RA, 1994, J VIROL, V68, P4650; Kulkarni V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086254; Kulkarni V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060245; Lecuroux C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059767; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Llano A, 2013, HIV MOL IMMUNOLOGY 2, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Manocheewa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066065; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Migueles SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002002; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Riou C, 2014, J VIROL, V88, P1819, DOI 10.1128/JVI.02968-13; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2013, J VIROL, V87, P5461, DOI 10.1128/JVI.03033-12; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shapiro SZ, 2014, AIDS RES HUM RETROV, V30, P325, DOI [10.1089/aid.2013.0114, 10.1089/AID.2013.0114]; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Streeck H, 2014, J VIROL, V88, P12793, DOI 10.1128/JVI.02016-14; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Tomaras GD, 2000, P NATL ACAD SCI USA, V97, P3503, DOI 10.1073/pnas.070521097; Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Yang HB, 2007, J IMMUNOL, V179, P597, DOI 10.4049/jimmunol.179.1.597; Yang HB, 2013, J IMMUNOL METHODS, V391, P174, DOI 10.1016/j.jim.2013.03.001; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006",66,24,24,1,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004658,10.1371/journal.ppat.1004658,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400039,25723536.0,"DOAJ Gold, Green Published",,,16/08/2019,25,31,47,5466,712,476,236,4754,4087,15,652,47,7,0,2,27,27,0,,123,21,62,0,21,29,29,21,18,0,0,0,0,0,0,0,24,2,5510,88,2,387,229,1,4744,712,88,2,387,229,1,54,,0,0,0,0,12,0,0,1,1,0,0,62,0,0,7.65,7.676966292134831,1.1497686159023979,0.14976861590239798,1.225704669751788,1.066044639590194,8.183988764044944
151,J,"Harris, LM; Merrick, CJ",,,,"Harris, Lynne M.; Merrick, Catherine J.",,,G-Quadruplexes in Pathogens: A Common Route to Virulence Control?,PLOS PATHOGENS,,,English,Review,,,,,,,PILIN ANTIGENIC VARIATION; INTRAMOLECULAR G-QUADRUPLEX; TELOMERE-BINDING PROTEIN; REPEAT-CONTAINING RNA; G-QUARTET FORMATION; PLASMODIUM-FALCIPARUM; C-MYC; DNA STRUCTURES; HUMAN GENOME; IN-VITRO,"DNA can form several secondary structures besides the classic double helix: one that has received much attention in recent years is the G-quadruplex (G4). This is a stable four-stranded structure formed by the stacking of quartets of guanine bases. Recent work has convincingly shown that G4s can form in vivo as well as in vitro and can affect both replication and transcription of DNA. They also play important roles at G-rich telomeres. Now, a spate of exciting reports has begun to reveal roles for G4 structures in virulence processes in several important microbial pathogens of humans. Interestingly, these come from a range of kingdoms-bacteria and protozoa as well as viruses-and all facilitate immune evasion in different ways. In particular, roles for G4s have been posited in the antigenic variation systems of bacteria and protozoa, as well as in the silencing of at least two major human viruses, human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV). Although antigenic variation and the silencing of latent viruses are quite distinct from one another, both are routes to immune evasion and the maintenance of chronic infections. Thus, highly disparate pathogens can use G4 motifs to control DNA/RNA dynamics in ways that are relevant to common virulence phenotypes. This review explores the evidence for G4 biology in such processes across a range of important human pathogens.","[Harris, Lynne M.; Merrick, Catherine J.] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England","Harris, LM (reprint author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.",c.merrick@keele.ac.uk,,"Merrick, Catherine/0000-0001-7583-2176","Medical Research Council [MR/K000535/1, MR/L008823/1]; Medical Research Council [MR/L008823/1]","This work was supported by Medical Research Council Grants (MR/K000535/1 and MR/L008823/1) to CJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Bang, 1910, BIOCHEM Z, V26, P293; Basmaciogullari S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00232; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]; Biffi G, 2012, J AM CHEM SOC, V134, P11974, DOI 10.1021/ja305734x; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2013, J BACTERIOL, V195, P2255, DOI 10.1128/JB.02217-12; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; De Cian A, 2008, CHEMBIOCHEM, V9, P2730, DOI 10.1002/cbic.200800330; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Du XJ, 2013, NUCLEIC ACIDS RES, V41, P5965, DOI 10.1093/nar/gkt308; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Enokizono Y, 2005, J BIOL CHEM, V280, P18862, DOI 10.1074/jbc.M411822200; Etzioni S, 2005, J BIOL CHEM, V280, P26805, DOI 10.1074/jbc.M500820200; FANG GW, 1993, BIOCHEMISTRY-US, V32, P11646, DOI 10.1021/bi00094a022; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Glover L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003260; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Khateb S, 2004, NUCLEIC ACIDS RES, V32, P4145, DOI 10.1093/nar/gkh745; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Kuryavyi V, 2012, STRUCTURE, V20, P2090, DOI 10.1016/j.str.2012.09.013; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Martadinata H, 2011, BIOCHEMISTRY-US, V50, P6455, DOI 10.1021/bi200569f; McCulloch R, 2009, TRENDS PARASITOL, V25, P359, DOI 10.1016/j.pt.2009.05.007; Merrick CJ, 2012, J INFECT DIS, V205, P1593, DOI 10.1093/infdis/jis239; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/NCHEMBIO.1479, 10.1038/nchembio.1479]; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Perrone R, 2014, J ANTIMICROBIAL CHEM; Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121; Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Piekna-Przybylska D, 2013, J BIOL CHEM, V288, P24140, DOI 10.1074/jbc.M113.477265; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Smargiasso N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-362; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Tellam JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004423; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Tuteja R, 2010, CELL CYCLE, V9, P104, DOI 10.4161/cc.9.1.10241; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Voss TS, 2014, CURR OPIN MICROBIOL, V20, P88, DOI 10.1016/j.mib.2014.05.007; Walia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057792; WEISMANSHOMER P, 1994, BIOCHEM BIOPH RES CO, V205, P305, DOI 10.1006/bbrc.1994.2665; Wormann ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-253; Wong HM, 2010, J NUCL ACIDS, V2010, DOI [10.4061/2010/182894, DOI 10.4061/2010/182894]; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102",85,43,44,0,34,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004562,10.1371/journal.ppat.1004562,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400002,25654363.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,43,9,71,7778,1023,744,279,6755,5284,33,1438,70,8,1,0,42,42,1,,103,2,101,1,2,47,44,47,29,0,0,0,0,0,0,0,1,3,7770,97,0,424,96,8,6706,1023,97,0,424,96,8,41,,0,0,0,0,3,0,0,0,0,0,0,99,1,0,4.25,7.603128054740958,1.1514433752775721,0.15144337527757218,1.1788304959289415,1.023785034713294,7.783968719452591
152,J,"Kloehn, J; Saunders, EC; O'Callaghan, S; Dagley, MJ; McConville, MJ",,,,"Kloehn, Joachim; Saunders, Eleanor C.; O'Callaghan, Sean; Dagley, Michael J.; McConville, Malcolm J.",,,Characterization of Metabolically Quiescent Leishmania Parasites in Murine Lesions Using Heavy Water Labeling,PLOS PATHOGENS,,,English,Article,,,,,,,IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; INFECTION; PATHOGEN; REVEALS; RATES; MICE; DNA; KINETOPLASTIDS; PROLIFERATION,"Information on the growth rate and metabolism of microbial pathogens that cause long-term chronic infections is limited, reflecting the absence of suitable tools for measuring these parameters in vivo. Here, we have measured the replication and physiological state of Leishmania mexicana parasites in murine inflammatory lesions using (H2O)-H-2 labeling. Infected BALB/c mice were labeled with (H2O)-H-2 for up to 4 months, and the turnover of parasite DNA, RNA, protein and membrane lipids estimated from the rate of deuterium enrichment in constituent pentose sugars, amino acids, and fatty acids, respectively. We show that the replication rate of parasite stages in these tissues is very slow (doubling time of similar to 12 days), but remarkably constant throughout lesion development. Lesion parasites also exhibit markedly lower rates of RNA synthesis, protein turnover and membrane lipid synthesis than parasite stages isolated from ex vivo infected macrophages or cultured in vitro, suggesting that formation of lesions induces parasites to enter a semi-quiescent physiological state. Significantly, the determined parasite growth rate accounts for the overall increase in parasite burden indicating that parasite death and turnover of infected host cells in these lesions is minimal. We propose that the Leishmania response to lesion formation is an important adaptive strategy that minimizes macrophage activation, providing a permissive environment that supports progressive expansion of parasite burden. This labeling approach can be used to measure the dynamics of other host-microbe interactions in situ.","[Kloehn, Joachim; Saunders, Eleanor C.; Dagley, Michael J.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3052, Australia; [O'Callaghan, Sean; McConville, Malcolm J.] Univ Melbourne, Metabol Australia, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3052, Australia","Kloehn, J (reprint author), Univ Melbourne, Dept Biochem & Mol Biol, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3052, Australia.",malcolmm@unimelb.edu.au,"O'Callaghan, Sean/O-9803-2016","O'Callaghan, Sean/0000-0003-4391-8340",Australian National Health and Medical Research Council [APP1059545],"Funding: This work was supported by the Australian National Health and Medical Research Council (APP1059545). MJM is a NHMRC Principal Research Fellow (APP1059530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alloatti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014239; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Busch R, BIOCH BIOPHYS ACTA, V1760, P730; Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Cortez M, 2011, CELL HOST MICROBE, V9, P463, DOI 10.1016/j.chom.2011.04.014; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dembele L, 2014, NAT MED, V20, P307, DOI 10.1038/nm.3461; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Gosline SJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019118; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; LAHAV T, 2010, FASEB J, V25, P515, DOI DOI 10.1096/FJ.10-157529; Lang T, 2005, CELL MICROBIOL, V7, P383, DOI 10.1111/j.1462-5822.2004.00468.x; Lira R, 2000, INFECT IMMUN, V68, P5176, DOI 10.1128/IAI.68.9.5176-5182.2000; Lynn MA, 2013, J PROTEOMICS, V82, P179, DOI 10.1016/j.jprot.2013.02.010; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Michel G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001323; Moore JWJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00035; Muller AJ, 2013, CELL HOST MICROBE, V14, P460, DOI 10.1016/j.chom.2013.09.008; Mukherjee S, 2012, J BIOL CHEM, V287, P34992, DOI 10.1074/jbc.M112.389338; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Naderer T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001245; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Neese RA, 2001, ANAL BIOCHEM, V298, P189, DOI 10.1006/abio.2001.5375; Petersen HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00120; Previs SF, 2004, AM J PHYSIOL-ENDOC M, V286, pE665, DOI 10.1152/ajpendo.00271.2003; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Real F, 2014, CELL MICROBIOL, V16, P1549, DOI 10.1111/cmi.12311; Rittershaus ESC, 2013, CELL HOST MICROBE, V13, P643, DOI 10.1016/j.chom.2013.05.012; Romero I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000819; Rotureau B, 2005, EXP PARASITOL, V111, P207, DOI 10.1016/j.exppara.2005.07.003; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; Srikanta D, 2014, YEAST, V31, P47, DOI 10.1002/yea.2997; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wilson J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000179; WINTER G, 1994, J CELL SCI, V107, P2471; Wu MY, 2008, J CHROMATOGR A, V1204, P81, DOI 10.1016/j.chroma.2008.07.040; Zhang O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000692",51,45,45,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004683,10.1371/journal.ppat.1004683,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400055,25714830.0,"DOAJ Gold, Green Published",,,16/08/2019,47,3,39,5197,830,617,213,4367,3562,17,788,39,2,0,0,47,47,0,,59,0,59,0,0,53,49,53,28,0,0,0,0,0,0,0,1,2,5277,93,0,255,91,0,4410,841,93,0,255,91,0,26,,0,0,0,0,5,0,1,1,0,0,0,64,0,0,3.1,6.2614457831325305,1.1900618273414243,0.19006182734142432,1.2505152278452027,1.0507985376178564,6.579518072289156
153,J,"Lemmermann, NAW; Krmpotic, A; Podlech, J; Brizic, I; Prager, A; Adler, H; Karbach, A; Wu, YQ; Jonjic, S; Reddehase, MJ; Adler, B",,,,"Lemmermann, Niels A. W.; Krmpotic, Astrid; Podlech, Juergen; Brizic, Ilija; Prager, Adrian; Adler, Heiko; Karbach, Astrid; Wu, Yiquan; Jonjic, Stipan; Reddehase, Matthias J.; Adler, Barbara",,,Non-redundant and Redundant Roles of Cytomegalovirus gH/gL Complexes in Host Organ Entry and Intra-tissue Spread,PLOS PATHOGENS,,,English,Article,,,,,,,TO-CELL SPREAD; CHEMOKINE HOMOLOG; VIRUS DISSEMINATION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; UL131-128 GENES; BONE-MARROW; INFECTION; DETERMINANT; GH/GL/UL128-131,"Herpesviruses form different gH/gL virion envelope glycoprotein complexes that serve as entry complexes for mediating viral cell-type tropism in vitro; their roles in vivo, however, remained speculative and can be addressed experimentally only in animal models. For murine cytomegalovirus two alternative gH/gL complexes, gH/gL/gO and gH/gL/MCK-2, have been identified. A limitation of studies on viral tropism in vivo has been the difficulty in distinguishing between infection initiation by viral entry into first-hit target cells and subsequent cell-to-cell spread within tissues. As a new strategy to dissect these two events, we used a gO-transcomplemented Delta gO mutant for providing the gH/gL/gO complex selectively for the initial entry step, while progeny virions lack gO in subsequent rounds of infection. Whereas gH/gL/gO proved to be critical for establishing infection by efficient entry into diverse cell types, including liver macrophages, endothelial cells, and hepatocytes, it was dispensable for intra-tissue spread. Notably, the salivary glands, the source of virus for host-to-host transmission, represent an exception in that entry into virus-producing cells did not strictly depend on either the gH/gL/gO or the gH/gL/MCK-2 complex. Only if both complexes were absent in gO and MCK-2 double-knockout virus, in vivo infection was abolished at all sites.","[Lemmermann, Niels A. W.; Podlech, Juergen; Reddehase, Matthias J.] Johannes Gutenberg Univ Mainz, Inst Virol, D-55122 Mainz, Germany; [Lemmermann, Niels A. W.; Podlech, Juergen; Reddehase, Matthias J.] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Univ Med Ctr, D-55122 Mainz, Germany; [Krmpotic, Astrid; Brizic, Ilija; Jonjic, Stipan] Univ Rijeka, Sch Med, Rijeka, Croatia; [Brizic, Ilija; Prager, Adrian; Wu, Yiquan; Adler, Barbara] Univ Munich, Max von Pettenkofer Inst Virol, Munich, Germany; [Adler, Heiko] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Gene Vectors, Munich, Germany; [Karbach, Astrid] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany","Lemmermann, NAW (reprint author), Johannes Gutenberg Univ Mainz, Inst Virol, D-55122 Mainz, Germany.",adler_b@mvp.uni-muenchen.de,"Brizic, Ilija/O-6257-2019; Brizic, Ilija/O-4776-2018; Brizic, Ilija/N-4052-2015; Lemmermann, Niels A. W./I-3717-2013; Jonjic, Stipan/C-5657-2016; Krmpotic, Astrid/U-6224-2017","Brizic, Ilija/0000-0001-8839-7839; Brizic, Ilija/0000-0001-8839-7839; Lemmermann, Niels A. W./0000-0001-9190-6497; Jonjic, Stipan/0000-0001-5003-3108; Krmpotic, Astrid/0000-0001-5470-5370; Reddehase, Matthias/0000-0002-3509-7573","Deutsche Forschungsgemeinschaft [AD131/3-2]; Deutsche Forschungsgemeinschaft, Clinical Research Group [KFO 183]; Young Investigators Program MAIFOR at the University Medical Center of the Johannes Gutenberg-University Mainz; Croatian Science Foundation [7132]","BA was supported by the Deutsche Forschungsgemeinschaft through grant AD131/3-2. NAWL and MJR were supported by the Deutsche Forschungsgemeinschaft, Clinical Research Group KFO 183. NAWL was supported by the Young Investigators Program MAIFOR at the University Medical Center of the Johannes Gutenberg-University Mainz. AK was supported by the Croatian Science Foundation under the project 7132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adler B, 2006, J GEN VIROL, V87, P2451, DOI 10.1099/vir.0.81921-0; Adler B, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL I, P297; Becker M, 2015, CELL MOL IMMUNOL, V12, P192, DOI 10.1038/cmi.2014.73; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; BUHLER B, 1990, J VIROL, V64, P1907; Cekinovic D, 2014, METHODS MOL BIOL, V1119, P289, DOI 10.1007/978-1-62703-788-4_16; Cekinovic D, 2008, J VIROL, V82, P12172, DOI 10.1128/JVI.01214-08; Ciocco-Schmitt GM, 2002, VIROLOGY, V294, P199, DOI 10.1006/viro.2001.1311; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; Daley-Bauer LP, 2014, CELL HOST MICROBE, V15, P351, DOI 10.1016/j.chom.2014.02.002; Daley-Bauer LP, 2012, IMMUNITY, V37, P122, DOI 10.1016/j.immuni.2012.04.014; DINGWELL KS, 1994, J VIROL, V68, P834; Ebert S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004100; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Fleming P, 1999, J VIROL, V73, P6800; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Holtappels R, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P354; Hsu KM, 2009, J GEN VIROL, V90, P33, DOI [10.1099/vir.0.2008/006668-0, 10.1099/vir.0.006668-0]; Hutt-Fletcher LM, 2007, J VIROL, V81, P7825, DOI 10.1128/JVI.00445-07; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jiang XJ, 2008, J VIROL, V82, P2802, DOI 10.1128/JVI.01550-07; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; KEIL GM, 1985, J VIROL, V54, P422; LAGENAUR LA, 1994, J VIROL, V68, P7717; Lemmermann NAW, 2010, METHOD MICROBIOL, V37, P369, DOI 10.1016/S0580-9517(10)37016-4; MacDonald MR, 1999, J VIROL, V73, P3682; MANNING WC, 1992, J VIROL, V66, P3794; Mulder W, 1996, J VIROL, V70, P2191; Murrell I, 2013, J VIROL, V87, P10489, DOI 10.1128/JVI.01546-13; Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833; Nogalski MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003463; Pedersen SM, 2006, VIROLOGY, V356, P1, DOI 10.1016/j.virol.2006.07.028; Plachter B, 1996, ADV VIRUS RES, V46, P195, DOI 10.1016/S0065-3527(08)60073-1; PLENDL J, 1995, VIRCHOWS ARCH, V426, P619; Podlech J, 1998, J GEN VIROL, V79, P2099, DOI 10.1099/0022-1317-79-9-2099; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; Sacher T, 2008, CELL HOST MICROBE, V3, P263, DOI 10.1016/j.chom.2008.02.014; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scrivano L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001256; Scrivano L, 2010, J VIROL, V84, P4469, DOI 10.1128/JVI.02441-09; Seckert CK, 2009, J VIROL, V83, P8869, DOI 10.1128/JVI.00870-09; Seo S, CYTOMEGALOVIRUSES MO, VII, P337; Sinzger C, 2006, J GEN VIROL, V87, P1853, DOI 10.1099/vir.0.81595-0; Stahl FR, 2015, MUCOSAL IMMUNOL, V8, P57, DOI 10.1038/mi.2014.42; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Vanarsdall AL, 2011, J VIROL, V85, P11638, DOI 10.1128/JVI.05659-11; Wagner FM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003493; Wagner M, 1999, J VIROL, V73, P7056; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wikstrom ME, 2013, J VIROL, V87, P7911, DOI 10.1128/JVI.00187-13; Wille PT, 2010, J VIROL, V84, P2585, DOI 10.1128/JVI.02249-09; Wirtz N, 2008, MED MICROBIOL IMMUN, V197, P151, DOI 10.1007/s00430-008-0095-0; Zhou MM, 2013, J VIROL, V87, P9680, DOI 10.1128/JVI.01167-13",61,30,30,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004640,10.1371/journal.ppat.1004640,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400027,25659098.0,"DOAJ Gold, Green Published",,,16/08/2019,29,0,19,3585,650,535,115,2935,2441,27,467,19,0,0,0,30,30,0,,29,0,27,0,0,29,29,23,21,0,0,0,0,0,0,0,0,0,3604,109,0,327,46,0,2924,650,109,0,327,46,0,30,,0,0,0,0,0,0,0,1,0,0,0,27,0,0,0.25,5.515384615384615,1.221465076660988,0.22146507666098808,1.2807495741056218,1.0485355648535566,5.783076923076923
154,J,"Loures, FV; Rohm, M; Lee, CK; Santos, E; Wang, JP; Specht, CA; Calich, VLG; Urban, CF; Levitz, SM",,,,"Loures, Flavio V.; Rohm, Marc; Lee, Chrono K.; Santos, Evelyn; Wang, Jennifer P.; Specht, Charles A.; Calich, Vera L. G.; Urban, Constantin F.; Levitz, Stuart M.",,,Recognition of Aspergillus fumigatus Hyphae by Human Plasmacytoid Dendritic Cells Is Mediated by Dectin-2 and Results in Formation of Extracellular Traps,PLOS PATHOGENS,,,English,Article,,,,,,,C-TYPE LECTIN; VIRAL-INFECTIONS; KEY PLAYERS; EXPRESSION; ACTIVATION; RESPONSES; INTERFERON; CONTRIBUTES; INDUCTION; EFFECTOR,"Plasmacytoid dendritic cells (pDCs) were initially considered as critical for innate immunity to viruses. However, our group has shown that pDCs bind to and inhibit the growth of Aspergillus fumigatus hyphae and that depletion of pDCs renders mice hypersusceptible to experimental aspergillosis. In this study, we examined pDC receptors contributing to hyphal recognition and downstream events in pDCs stimulated by A. fumigatus hyphae. Our data show that Dectin-2, but not Dectin-1, participates in A. fumigatus hyphal recognition, TNF-alpha and IFN-alpha release, and antifungal activity. Moreover, Dectin-2 acts in cooperation with the FcR gamma chain to trigger signaling responses. In addition, using confocal and electron microscopy we demonstrated that the interaction between pDCs and A. fumigatus induced the formation of pDC extracellular traps (pETs) containing DNA and citrullinated histone H3. These structures closely resembled those of neutrophil extracellular traps (NETs). The microarray analysis of the pDC transcriptome upon A. fumigatus infection also demonstrated up-regulated expression of genes associated with apoptosis as well as type I interferon-induced genes. Thus, human pDCs directly recognize A. fumigatus hyphae via Dectin-2; this interaction results in cytokine release and antifungal activity. Moreover, hyphal stimulation of pDCs triggers a distinct pattern of pDC gene expression and leads to pET formation.","[Loures, Flavio V.; Lee, Chrono K.; Santos, Evelyn; Wang, Jennifer P.; Specht, Charles A.; Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Loures, Flavio V.; Calich, Vera L. G.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Rohm, Marc; Urban, Constantin F.] Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden MIMS, Umea Ctr Microbial Res, Umea, Sweden","Loures, FV (reprint author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.",Stuart.Levitz@umassmed.edu,"Urban, Constantin/H-5121-2019; Calich, Vera/G-8367-2011; Loures, Flavio/B-6913-2012","Urban, Constantin/0000-0003-1438-1134; Loures, Flavio/0000-0001-7711-4063","National Institutes of Health [RO1HL112671, RO1AI025780, RO1AI072195, T32AI095213]; National Center for Research Resources [S10RR021043]; Fundacao de Amparo Pesquisa de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Kempe foundation","SML was supported in part by National Institutes of Health Grants RO1HL112671, RO1AI025780, and RO1AI072195. ES was supported in part by National Institutes of Health Grant T32AI095213. The Electron Microscopy work was supported in part by Award #S10RR021043 from the National Center for Research Resources. FVL and VLGC acknowledge support from Fundacao de Amparo Pesquisa de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). MR and CFU acknowledge support from the Kempe foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ang DKY, 2010, J IMMUNOL, V184, P5429, DOI 10.4049/jimmunol.1000128; Barkhash AV, 2010, J INFECT DIS, V202, P1813, DOI 10.1086/657418; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Boles KS, 1999, IMMUNOGENETICS, V50, P1, DOI 10.1007/s002510050679; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gavino ACP, 2005, EXP DERMATOL, V14, P281, DOI 10.1111/j.0906-6705.2005.00312.x; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gessner MA, 2012, INFECT IMMUN, V80, P410, DOI 10.1128/IAI.05939-11; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guery L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00059; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lepelletier Y, 2010, BLOOD, V116, P3389, DOI 10.1182/blood-2010-05-282913; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Lusic M, 2013, CELL HOST MICROBE, V13, P665, DOI 10.1016/j.chom.2013.05.006; Maazi H, 2013, ALLERGY, V68, P695, DOI 10.1111/all.12166; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; McCormick A, 2010, MICROBES INFECT, V12, P928, DOI 10.1016/j.micinf.2010.06.009; MESHULAM T, 1995, J INFECT DIS, V172, P1153, DOI 10.1093/infdis/172.4.1153; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222; Pina A, 2013, INFECT IMMUN, V81, P1064, DOI 10.1128/IAI.00736-12; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Ramirez-Ortiz ZG, 2011, CELL HOST MICROBE, V9, P415, DOI 10.1016/j.chom.2011.04.007; Rivera A, 2011, ISRN IMMUNOL, V2011, p1 ; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rohm M, 2014, INFECT IMMUN, V82, P1766, DOI 10.1128/IAI.00096-14; Rubino I, 2012, J INFECT DIS, V205, P944, DOI 10.1093/infdis/jir882; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Santana-de Anda K, 2013, SEMIN ARTHRITIS RHEU, V43, P131, DOI 10.1016/j.semarthrit.2012.12.026; Seeds RE, 2011, INT IMMUNOPHARMACOL, V11, P794, DOI 10.1016/j.intimp.2011.01.013; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Simon D, 2013, ALLERGY, V68, P409, DOI 10.1111/all.12111; Sun H, 2013, CELL IMMUNOL, V284, P60, DOI 10.1016/j.cellimm.2013.06.013; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tang YJ, 2010, J IMMUNOL, V184, P5777, DOI 10.4049/jimmunol.0903588; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yu CF, 2010, J IMMUNOL, V184, P1159, DOI 10.4049/jimmunol.0901706; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156",65,54,55,2,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004643,10.1371/journal.ppat.1004643,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400030,25659141.0,"DOAJ Gold, Green Published",,,16/08/2019,63,0,44,6522,1046,755,291,5476,4490,20,966,44,0,0,0,57,57,1,,56,2,56,0,2,63,63,48,34,0,0,0,0,0,0,0,1,0,6539,71,0,298,143,0,5465,1046,24,0,298,140,0,28,,0,0,0,0,4,0,0,1,0,0,0,56,0,0,3.5,6.235181644359464,1.1910153396639882,0.19101533966398831,1.233199415631848,1.0354185832566698,6.45602294455067
155,J,"Prescher, J; Baumgartel, V; Ivanchenko, S; Torrano, AA; Brauchle, C; Muller, B; Lamb, DC",,,,"Prescher, Jens; Baumgaertel, Viola; Ivanchenko, Sergey; Torrano, Adriano A.; Braeuchle, Christoph; Mueller, Barbara; Lamb, Don C.",,,Super-Resolution Imaging of ESCRT-Proteins at HIV-1 Assembly Sites,PLOS PATHOGENS,,,English,Article,,,,,,,VIRUS TYPE-1 GAG; PLASMA-MEMBRANE; HELICAL STRUCTURES; INFECTED-CELLS; LATE DOMAINS; BRO1 DOMAIN; ALIX; MACHINERY; SCISSION; RELEASE,"The cellular endosomal sorting complex required for transport (ESCRT) machinery is involved in membrane budding processes, such as multivesicular biogenesis and cytokinesis. In HIV-infected cells, HIV-1 hijacks the ESCRT machinery to drive HIV release. Early in the HIV-1 assembly process, the ESCRT-I protein Tsg101 and the ESCRT-related protein ALIX are recruited to the assembly site. Further downstream, components such as the ESCRT-III proteins CHMP4 and CHMP2 form transient membrane associated lattices, which are involved in virus-host membrane fission. Although various geometries of ESCRT-III assemblies could be observed, the actual membrane constriction and fission mechanism is not fully understood. Fission might be driven from inside the HIV-1 budding neck by narrowing the membranes from the outside by larger lattices surrounding the neck, or from within the bud. Here, we use super-resolution fluorescence microscopy to elucidate the size and structure of the ESCRT components Tsg101, ALIX, CHMP4B and CHMP2A during HIV-1 budding below the diffraction limit. To avoid the deleterious effects of using fusion proteins attached to ESCRT components, we performed measurements on the endogenous protein or, in the case of CHMP4B, constructs modified with the small HA tag. Due to the transient nature of the ESCRT interactions, the fraction of HIV-1 assembly sites with colocalizing ESCRT complexes was low (1.5%-3.4%). All colocalizing ESCRT clusters exhibited closed, circular structures with an average size (full-width at half-maximum) between 45 and 60 nm or a diameter (determined using a Ripley's L-function analysis) of roughly 60 to 100 nm. The size distributions for colocalizing clusters were narrower than for non-colocalizing clusters, and significantly smaller than the HIV-1 bud. Hence, our results support a membrane scission process driven by ESCRT protein assemblies inside a confined structure, such as the bud neck, rather than by large lattices around the neck or in the bud lumen. In the case of ALIX, a cloud of individual molecules surrounding the central clusters was often observed, which we attribute to ALIX molecules incorporated into the nascent HIV-1 Gag shell. Experiments performed using YFP-tagged Tsg101 led to an over 10-fold increase in ESCRT structures colocalizing with HIV-1 budding sites indicating an influence of the fusion protein tag on the function of the ESCRT protein.","[Prescher, Jens; Baumgaertel, Viola; Ivanchenko, Sergey; Torrano, Adriano A.; Braeuchle, Christoph; Lamb, Don C.] Univ Munich, Dept Chem, Phys Chem, NIM,CiPSM, Munich, Germany; [Prescher, Jens; Baumgaertel, Viola; Ivanchenko, Sergey; Torrano, Adriano A.; Braeuchle, Christoph; Lamb, Don C.] Univ Munich, Ctr NanoSci CeNS, Munich, Germany; [Mueller, Barbara] Univ Klinikum Heidelberg, Dept Infect Dis, Virol, Heidelberg, Germany","Prescher, J (reprint author), Univ Munich, Dept Chem, Phys Chem, NIM,CiPSM, Munich, Germany.",d.lamb@lmu.de,"Lamb, Don C/G-9501-2014","Lamb, Don C/0000-0002-0232-1903; Muller, Barbara/0000-0001-5726-5585","DFG [SPP1175, SFB1129]; German Excellence Initiative via ""Nanosystems Initiative Munich""; ""Center for Integrated Protein Science Munich""; ""CellNetworks""; Ludwig-Maximilians-University Munich via Center of NanoScience; LMUInnovativ BioImaging Network; EU (HIV-ACE network) [HEALTH-F3-2008-201095]","Funding: We gratefully acknowledge the financial support of the DFG through the SPP1175 (DCL), SFB1129 - Project 6 (BM), the German Excellence Initiative via ""Nanosystems Initiative Munich"" (DCL, CB), ""Center for Integrated Protein Science Munich"" (DCL, CB), and ""CellNetworks"" (BM), the Ludwig-Maximilians-University Munich {via the Center of NanoScience (DCL, CB) and LMUInnovativ BioImaging Network, (DCL, CB)}, and the EU (HIV-ACE network HEALTH-F3-2008-201095; BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Bodon G, 2011, J BIOL CHEM, V286, P40276, DOI 10.1074/jbc.M111.283671; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cashikar AG, 2014, ELIFE, V3, DOI 10.7554/eLife.02184; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dobro MJ, 2013, MOL BIOL CELL, V24, P2319, DOI 10.1091/mbc.E12-11-0785; Domenico ID, 2007, MOLECULAR BIOLOGY OF, V18, P2569; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Eckhardt M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022007; Effantin G, 2013, CELL MICROBIOL, V15, P213, DOI 10.1111/cmi.12041; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Galbraith CG, 2011, J CELL SCI, V124, P1607, DOI 10.1242/jcs.080085; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; Guizetti J, 2012, TRENDS CELL BIOL, V22, P133, DOI 10.1016/j.tcb.2011.11.007; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; HUANG MJ, 1995, J VIROL, V69, P6810; Hurley JH, 2012, NAT CELL BIOL, V14, P654, DOI 10.1038/ncb2530; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Ku PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096950; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LAVALLEE C, 1994, J VIROL, V68, P1926; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lelek M, 2012, P NATL ACAD SCI USA, V109, P8564, DOI 10.1073/pnas.1013267109; Malkusch S, 2013, HISTOCHEM CELL BIOL, V139, P173, DOI 10.1007/s00418-012-1014-4; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Muller B, 2000, J VIROL, V74, P9727, DOI 10.1128/JVI.74.20.9727-9731.2000; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwedler UKv, 2003, CELL, V114, P701; STERNBERG SR, 1983, COMPUTER, V16, P22; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Sundquist WI, 2012, COLD SPRING HARBOR P, V2, DOI [10.1101/cshperspect.a007823, DOI 10.1101/CSHPERSPECT.A007823]; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Usami Y, 2012, J VIROL, V86, P3746, DOI 10.1128/JVI.06539-11; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Weissenhorn W, 2011, CELL HOST MICROBE, V9, P172, DOI 10.1016/j.chom.2011.03.005; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhai QT, 2011, J VIROL, V85, P9222, DOI 10.1128/JVI.02653-10; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002119; Zhou X, 2010, BIOCHEM J, V432, P525, DOI 10.1042/BJ20100862; Zhou X, 2009, BIOCHEM J, V418, P277, DOI 10.1042/BJ20081388",82,39,39,1,33,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004677,10.1371/journal.ppat.1004677,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400051,25710462.0,"DOAJ Gold, Green Published",,,16/08/2019,37,4,69,7417,1243,937,306,6174,4899,38,1237,69,4,0,0,36,36,1,,87,0,87,0,0,39,38,39,23,0,0,0,0,0,0,0,0,0,7418,190,0,552,84,6,6156,1243,190,0,552,84,6,19,,1,0,0,0,5,0,0,1,0,0,0,87,0,0,11.6,5.967015285599357,1.2013281503077422,0.20132815030774215,1.2458697764820215,1.0370769853040314,6.188254223652454
156,J,"Rossmann, FS; Racek, T; Wobser, D; Puchalka, J; Rabener, EM; Reiger, M; Hendrickx, APA; Diederich, AK; Jung, K; Klein, C; Huebner, J",,,,"Rossmann, Friederike S.; Racek, Tomas; Wobser, Dominique; Puchalka, Jacek; Rabener, Elaine M.; Reiger, Matthias; Hendrickx, Antoni P. A.; Diederich, Ann-Kristin; Jung, Kirsten; Klein, Christoph; Huebner, Johannes",,,Phage-mediated Dispersal of Biofilm and Distribution of Bacterial Virulence Genes Is Induced by Quorum Sensing,PLOS PATHOGENS,,,English,Article,,,,,,,ENTEROCOCCUS-FAECALIS; PROLONGED BACTEREMIA; ANTIBIOTIC-TREATMENT; AUTOINDUCER-2; LUXS; COLONIZATION; METABOLISM; EXPRESSION; GENOMICS; PROTEIN,"The microbiome and the phage meta-genome within the human gut are influenced by antibiotic treatments. Identifying a novel mechanism, here we demonstrate that bacteria use the universal communication molecule AI-2 to induce virulence genes and transfer them via phage release. High concentrations (i.e. 100 mu M) of AI-2 promote dispersal of bacteria from already established biofilms, and is associated with release of phages capable of infecting other bacteria. Enterococcus faecalis V583 Delta ABC harbours 7 prophages in its genome, and a mutant deficient in one of these prophages (i.e. prophage 5) showed a greatly reduced dispersal of biofilm. Infection of a probiotic E. faecalis strain without lytic prophages with prophage 5 resulted in increased biofilm formation and also in biofilm dispersal upon induction with AI-2. Infection of the probiotic E. faecalis strain with phage-containing supernatants released through AI-2 from E. faecalis V583 Delta ABC resulted in a strong increase in pathogenicity of this strain. The polylysogenic probiotic strain was also more virulent in a mouse sepsis model and a rat endocarditis model. Both AI-2 and ciprofloxacin lead to phage release, indicating that conditions in the gastrointestinal tract of hospitalized patients treated with antibiotics might lead to distribution of virulence genes to apathogenic enterococci and possibly also to other commensals or even to beneficial probiotic strains.","[Rossmann, Friederike S.; Wobser, Dominique; Diederich, Ann-Kristin; Huebner, Johannes] Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany; [Rossmann, Friederike S.; Diederich, Ann-Kristin] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Rossmann, Friederike S.; Racek, Tomas; Puchalka, Jacek; Diederich, Ann-Kristin; Klein, Christoph; Huebner, Johannes] Univ Munich, Dept Pediat, Dr von Hauner Childrens Hosp, Munich, Germany; [Racek, Tomas; Puchalka, Jacek; Klein, Christoph; Huebner, Johannes] Partnersite Munich, German Ctr Infect Res DZIF, Munich, Germany; [Rabener, Elaine M.; Reiger, Matthias; Jung, Kirsten] Univ Munich, Munich Ctr Integrated Prot Sci, Microbiol, Dept Biol 1, Munich, Germany; [Hendrickx, Antoni P. A.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands","Rossmann, FS (reprint author), Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany.",johannes.huebner@med.uni-muenchen.de,,,DFG [SFB1054]; BMBF (DZIF Partnersite Munich); Care-For-Rare Foundation,"This work was supported by grants from the DFG (SFB1054), BMBF (DZIF Partnersite Munich), and the Care-For-Rare Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anetzberger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048310; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Creti R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-60; Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0; Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006; Duerkop BA, 2012, P NATL ACAD SCI USA, V109, P17621, DOI 10.1073/pnas.1206136109; Fritzenwanker M, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00165-12; Godeke J, 2011, ISME J, V5, P613, DOI 10.1038/ismej.2010.153; Haller C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091863; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Matos RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003539; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Rajamani S, 2007, BIOCHEMISTRY-US, V46, P3990, DOI 10.1021/bi602479e; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Shao CL, 2012, J PROTEOME RES, V11, P4465, DOI 10.1021/pr3002244; Taga Michiko E, 2011, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01c01s23; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Winzer K, 2002, CURR OPIN MICROBIOL, V5, P216, DOI 10.1016/S1369-5274(02)00304-1; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zhu J, 2013, CURR OPIN PHARMACOL, V13, P688, DOI 10.1016/j.coph.2013.07.003",38,27,28,0,32,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004653,10.1371/journal.ppat.1004653,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400037,25706310.0,"DOAJ Gold, Green Published",,,16/08/2019,25,20,110,10148,1434,966,468,8714,7065,41,1608,110,11,0,0,27,27,0,,146,3,146,0,3,28,28,23,20,0,0,0,0,0,0,0,13,7,10186,126,27,193,105,0,8698,1434,126,27,193,105,0,54,,0,0,0,0,65,0,0,1,0,0,0,146,0,0,37.05,7.076708507670851,1.1645627725499197,0.16456277254991966,1.1954326371356438,1.026507686243595,7.264295676429568
157,J,"Seidman, D; Hebert, KS; Truchan, HK; Miller, DP; Tegels, BK; Marconi, RT; Carlyon, JA",,,,"Seidman, David; Hebert, Kathryn S.; Truchan, Hilary K.; Miller, Daniel P.; Tegels, Brittney K.; Marconi, Richard T.; Carlyon, Jason A.",,,Essential Domains of Anaplasma phagocytophilum Invasins Utilized to Infect Mammalian Host Cells,PLOS PATHOGENS,,,English,Article,,,,,,,SIALYL-LEWIS-X; OUTER-MEMBRANE PROTEIN; HUMAN GRANULOCYTIC ANAPLASMOSIS; HIGH ENDOTHELIAL VENULES; L-SELECTIN LIGAND; HUMAN LYMPH-NODES; P-SELECTIN; GLYCOPROTEIN LIGAND-1; ESCHERICHIA-COLI; EHRLICHIA-CHAFFEENSIS,"Anaplasma phagocytophilum causes granulocytic anaplasmosis, an emerging disease of humans and domestic animals. The obligate intracellular bacterium uses its invasins OmpA, Asp14, and AipA to infect myeloid and non-phagocytic cells. Identifying the domains of these proteins that mediate binding and entry, and determining the molecular basis of their interactions with host cell receptors would significantly advance understanding of A. phagocytophilum infection. Here, we identified the OmpA binding domain as residues 59 to 74. Polyclonal antibody generated against a peptide spanning OmpA residues 59 to 74 inhibited A. phagocytophilum infection of host cells and binding to its receptor, sialyl Lewis x (sLe(x)-capped P-selectin glycoprotein ligand 1. Molecular docking analyses predicted that OmpA residues G61 and K64 interact with the two sLe(x) sugars that are important for infection, alpha 2,3-sialic acid and alpha 1,3-fucose. Amino acid substitution analyses demonstrated that K64 was necessary, and G61 was contributory, for recombinant OmpA to bind to host cells and competitively inhibit A. phagocytophilum infection. Adherence of OmpA to RF/6A endothelial cells, which express little to no sLex but express the structurally similar glycan, 6-sulfo-sLe(x), required alpha 2,3-sialic acid and alpha 1,3-fucose and was antagonized by 6-sulfo-sLe(x) antibody. Binding and uptake of OmpA-coated latex beads by myeloid cells was sensitive to sialidase, fucosidase, and sLe(x) antibody. The Asp14 binding domain was also defined, as antibody specific for residues 113 to 124 inhibited infection. Because OmpA, Asp14, and AipA each contribute to the infection process, it was rationalized that the most effective blocking approach would target all three. An antibody cocktail targeting the OmpA, Asp14, and AipA binding domains neutralized A. phagocytophilum binding and infection of host cells. This study dissects OmpA-receptor interactions and demonstrates the effectiveness of binding domain-specific antibodies for blocking A. phagocytophilum infection.","[Seidman, David; Hebert, Kathryn S.; Truchan, Hilary K.; Miller, Daniel P.; Tegels, Brittney K.; Marconi, Richard T.; Carlyon, Jason A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA","Seidman, D (reprint author), Naval Med Ctr, Primary Care, Clin Pathol, Boone Branch Little Creek, Portsmouth, VA 23708 USA.",jacarlyon@vcu.edu,,"Miller, Daniel/0000-0002-1332-5870; Marconi, Richard/0000-0002-6035-7306","National Institute of Health [R01 AI072683, R01 AI67830]; United States Department of Commerce Economic Development Administration [01-79-14214]; National Institute of Health-National Cancer Institute Cancer Center [5P30 CA16059]; National Institute of Health-National Institute of Neurological Disorders and Stroke Center [5P30NS047463]; National Institute of Health-National Center for Research Resources [1S10RR022495]","Funding: This study was supported by National Institute of Health grants R01 AI072683 to JAC and R01 AI67830 to RTM. Financial Assistance Award No. 01-79-14214, which was awarded by the United States Department of Commerce Economic Development Administration to the University of Virginia and subcontracted to Virginia Commonwealth University (JAC and RTM), also supported this work. The Virginia Commonwealth University Flow Cytometry and Imaging Shared Resource Facility is supported in part by National Institute of Health-National Cancer Institute Cancer Center support grant 5P30 CA16059. Scanning Electron Microscopy was performed at the Virginia Commonwealth University Department of Anatomy and Neurobiology Microscopy Facility, which is supported in part by funding from National Institute of Health-National Institute of Neurological Disorders and Stroke Center core grant 5P30NS047463 and National Institute of Health-National Center for Research Resources grant 1S10RR022495. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aguero-Rosenfeld ME, 2002, J CLIN MICROBIOL, V40, P2612, DOI 10.1128/JCM.40.7.2612-2615.2002; Akahori T, 1997, J IMMUNOL, V158, P5384; Al-Khedery B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-678; Alhumaidan H, 2013, TRANSFUSION, V53, P181, DOI 10.1111/j.1537-2995.2012.03685.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annen K, 2012, AM J CLIN PATHOL, V137, P562, DOI 10.1309/AJCP4E4VQQQOZIAQ; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1145; Anton BP, 2004, J BACTERIOL, V186, P5699, DOI 10.1128/JB.186.17.5699-5707.2004; Baker HM, 2007, J MOL BIOL, V374, P1298, DOI 10.1016/j.jmb.2007.09.091; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakken JS, 1998, CLIN INFECT DIS, V27, P1491, DOI 10.1086/515048; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Carlyon JA, 2003, BLOOD, V102, P3387, DOI 10.1182/blood-2003-02-0621; Carlyon JA, 2002, J IMMUNOL, V169, P7009, DOI 10.4049/jimmunol.169.12.7009; Carlyon JA, 2012, INTRACELLULAR PATHOG; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P669; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; Chandrasekaran E, 2003, CARBOHYD RES, V338, P887, DOI 10.1016/S0008-6215(03)00021-1; Cheng ZH, 2011, MOL MICROBIOL, V82, P1217, DOI 10.1111/j.1365-2958.2011.07885.x; Chung MC, 2007, MOL MICROBIOL, V66, P1342, DOI 10.1111/j.1365-2958.2007.05989.x; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; Dhand A, 2007, CLIN INFECT DIS, V45, P589, DOI 10.1086/520659; DOHI T, 1993, ANTICANCER RES, V13, P1277; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; FUKUDA M, 1984, J BIOL CHEM, V259, P925; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Goodman JL, 1999, J CLIN INVEST, V103, P407, DOI 10.1172/JCI4230; Goodman JL, 1996, NEW ENGL J MED, V334, P209, DOI 10.1056/NEJM199601253340401; Govender VS, 2014, MICROBIOLOGY; Grande KK, 2007, J BACTERIOL, V189, P3960, DOI 10.1128/JB.01828-06; Granquist EG, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-25; GRIBBLE DH, 1969, J AM VET MED ASSOC, V155, P462; Ha NY, 2011, INFECT IMMUN, V79, P1718, DOI 10.1128/IAI.01239-10; Hao Q, 2013, BIOMED ENVIRON SCI, V26, P185, DOI 10.3967/0895-3988.2013.03.005; Hermans SJ, 2012, INFECT IMMUN, V80, P4004, DOI 10.1128/IAI.00764-12; Herron MJ, 2000, SCIENCE, V288, P1653, DOI 10.1126/science.288.5471.1653; Hillman RD, 2013, CELL MICROBIOL, V15, P727, DOI 10.1111/cmi.12068; Hopkins Richard S, 2005, MMWR Morb Mortal Wkly Rep, V52, P1; Huang B, 2012, FEMS IMMUNOL MED MIC, V64, P32, DOI 10.1111/j.1574-695X.2011.00873.x; Ishibashi Y, 2005, GLYCOCONJUGATE J, V22, P53, DOI 10.1007/s10719-005-0292-7; Izawa M, 2000, CANCER RES, V60, P1410; Jereb M, 2012, EMERG INFECT DIS, V18, P1354, DOI 10.3201/eid1808.120180; Johnson RC, 2011, VECTOR-BORNE ZOONOT, V11, P1529, DOI 10.1089/vbz.2011.0633; Kahlon A, 2013, INFECT IMMUN, V81, P65, DOI 10.1128/IAI.00932-12; KARAKANTZA M, 1994, BRIT J HAEMATOL, V86, P883, DOI 10.1111/j.1365-2141.1994.tb04850.x; Kari L, 2014, INFECT IMMUN, V82, P2756, DOI 10.1128/IAI.01686-14; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolbert CP, 1997, J CLIN MICROBIOL, V35, P1172; Kumar DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003666; Lee JH, 2008, J INFECT DIS, V198, P250, DOI 10.1086/589284; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; MADIGAN JE, 1987, J AM VET MED ASSOC, V190, P445; Majuri ML, 1999, FEBS LETT, V455, P97, DOI 10.1016/S0014-5793(99)00834-0; MAJURI ML, 1994, EUR J IMMUNOL, V24, P3205, DOI 10.1002/eji.1830241244; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Martinez E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004013; Massung RF, 2007, J CLIN MICROBIOL, V45, P2138, DOI 10.1128/JCM.00478-07; Mastronunzio JE, 2012, J BACTERIOL, V194, P2238, DOI 10.1128/JB.06791-11; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4587; Miller DP, 2011, ACTA CRYSTALLOGR F, V67, P678, DOI 10.1107/S1744309111011298; Minnick MF, 2012, ADV EXP MED BIOL, V984, P231, DOI 10.1007/978-94-007-4315-1_12; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; MORSCHHAUSER J, 1990, INFECT IMMUN, V58, P2133; Munderloh UG, 2004, VET MICROBIOL, V101, P53, DOI 10.1016/j.vetmic.2004.02.011; MUNRO JM, 1992, AM J PATHOL, V141, P1397; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ojogun N, 2012, INFECT IMMUN, V80, P3748, DOI 10.1128/IAI.00654-12; Ojogun N, 2011, INFECT IMMUN, V79, P2717, DOI 10.1128/IAI.00181-11; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; PAAVONEN T, 1992, AM J PATHOL, V141, P1259; Popov VL, 2000, MICROB PATHOGENESIS, V28, P71, DOI 10.1006/mpat.1999.0327; Rademacher C, 2012, GLYCOBIOLOGY, V22, P1086, DOI 10.1093/glycob/cws073; Reneer DV, 2006, CELL MICROBIOL, V8, P1972, DOI 10.1111/j.1462-5822.2006.00764.x; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; Rikihisa Y, 1997, J INFECT DIS, V175, P210, DOI 10.1093/infdis/175.1.210; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; SAWADA M, 1993, BIOCHEM BIOPH RES CO, V193, P337, DOI 10.1006/bbrc.1993.1629; Schaff UY, 2010, AM J PHYSIOL-CELL PH, V299, pC87, DOI 10.1152/ajpcell.00165.2009; SCHOREY JS, 1995, INFECT IMMUN, V63, P2652; Seidman D, 2014, CELL MICROBIOL, V16, P1133, DOI 10.1111/cmi.12286; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Snapp KR, 1998, BLOOD, V91, P154; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2006, FEBS J, V273, P4377, DOI 10.1111/j.1742-4658.2006.05437.x; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; SU H, 1990, INFECT IMMUN, V58, P1017; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Sukumaran B, 2011, CELL MICROBIOL, V13, P47, DOI 10.1111/j.1462-5822.2010.01516.x; SYMINGTON FW, 1985, J IMMUNOL, V134, P2498; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TING LM, 1995, INFECT IMMUN, V63, P3600; Toppila S, 2000, AM J RESP CELL MOL, V23, P492, DOI 10.1165/ajrcmb.23.4.4113; Troese MJ, 2009, INFECT IMMUN, V77, P4018, DOI 10.1128/IAI.00527-09; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Truchan HK, 2013, MICROBES INFECT; TURUNEN JP, 1995, J EXP MED, V182, P1133, DOI 10.1084/jem.182.4.1133; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wuppermann FN, 2008, J BACTERIOL, V190, P3757, DOI 10.1128/JB.01638-07; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Xiong QM, 2011, J MED MICROBIOL, V60, P744, DOI 10.1099/jmm.0.029231-0; Yago T, 2003, J BIOL CHEM, V278, P37987, DOI 10.1074/jbc.M305778200; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; Zhang SY, 2009, AM J TROP MED HYG, V81, P293, DOI 10.4269/ajtmh.2009.81.293; Zhang XC, 2012, VECTOR-BORNE ZOONOT, V12, P932, DOI 10.1089/vbz.2012.0961",112,16,16,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004669,10.1371/journal.ppat.1004669,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400046,25658707.0,"DOAJ Gold, Green Published",,,16/08/2019,18,81,15,3844,536,387,149,3308,2863,19,426,15,5,0,0,18,18,0,,16,9,16,0,9,22,19,22,15,0,0,0,0,0,0,0,75,2,3859,163,0,235,101,0,3297,536,39,0,235,94,0,26,,0,0,0,0,0,0,0,1,0,0,0,15,0,0,0.25,7.1716417910447765,1.162031438935913,0.16203143893591293,1.246372430471584,1.0725806451612903,7.692164179104478
158,J,"Simeone, R; Sayes, F; Song, O; Groschel, MI; Brodin, P; Brosch, R; Majlessi, L",,,,"Simeone, Roxane; Sayes, Fadel; Song, Okryul; Groeschel, Matthias I.; Brodin, Priscille; Brosch, Roland; Majlessi, Laleh",,,Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,ALVEOLAR MACROPHAGES; REAL-TIME; ENHANCED PROTECTION; NLRP3 INFLAMMASOME; DYNAMIC INTERPLAY; ESAT-6 SECRETION; DENDRITIC CELLS; VII SECRETION; HOST FACTORS; VIRULENCE,"Mycobacterium tuberculosis (Mtb) uses efficient strategies to evade the eradication by professional phagocytes, involving-as recently confirmed-escape from phagosomal confinement. While Mtb determinants, such as the ESX-1 type VII secretion system, that contribute to this phenomenon are known, the host cell factors governing this important biological process are yet unexplored. Using a newly developed flow-cytometric approach for Mtb, we show that macrophages expressing the phagosomal bivalent cation transporter Nramp-1, are much less susceptible to phagosomal rupture. Together with results from the use of the phagosome acidification inhibitor bafilomycin, we demonstrate that restriction of phagosomal acidification is a prerequisite for mycobacterial phagosomal rupture and cytosolic contact. Using different in vivo approaches including an enrichment and screen for tracking rare infected phagocytes carrying the CD45.1 hematopoietic allelic marker, we here provide first and unique evidence of M. tuberculosis-mediated phagosomal rupture in mouse spleen and lungs and in numerous phagocyte types. Our results, linking the ability of restriction of phagosome acidification to cytosolic access, provide an important conceptual advance for our knowledge on host processes targeted by Mtb evasion strategies.","[Simeone, Roxane; Sayes, Fadel; Groeschel, Matthias I.; Brosch, Roland; Majlessi, Laleh] Inst Pasteur, Unit Integrated Mycobacterial Pathogen, Paris, France; [Simeone, Roxane; Song, Okryul; Brodin, Priscille] Univ Lille Nord France, CNRS, INSERM, U1019,UMR8204,Inst Pasteur Lille,Ctr Infect & Imm, Lille, France","Simeone, R (reprint author), Inst Pasteur, Unit Integrated Mycobacterial Pathogen, Paris, France.",roland.brosch@pasteur.fr; laleh.majlessi@pasteur.fr,"Brodin, Priscille/N-6979-2019; Brodin, Priscille/E-5802-2014","Brodin, Priscille/0000-0003-0991-7344; Brodin, Priscille/0000-0003-0991-7344; deboosere, Nathalie/0000-0002-2873-5485; Brosch, Roland/0000-0003-2587-3863","European Community [NEWTBVAC 241745, MM4TB 260872, INTRACELLTB 260901]; Institut Pasteur [PTR441]; Agence Nationale de Recherche; Feder [12001407]; Region Nord Pas de Calais; Fondation pour la Recherche Medicale FRM [DEQ20130326471]; Jan Kornelis de Cock Stichting scholarship","This work was supported by the European Community's Framework Programme 7 grants NEWTBVAC 241745, MM4TB 260872 and INTRACELLTB 260901, the Institut Pasteur (PTR441), the Agence Nationale de Recherche, the Feder (12001407 (D-AL) Equipex Imaginex BioMed), the Region Nord Pas de Calais and the Fondation pour la Recherche Medicale FRM noDEQ20130326471 (to RB). MIG is a recipient of a Jan Kornelis de Cock Stichting scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Aguilo JI, 2013, CELL MICROBIOL, V15, P1994, DOI 10.1111/cmi.12169; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Barel M, 2013, MICROBES INFECT, V25; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Boritsch EC, 2014, MOL MICROBIOL, V93, P835, DOI 10.1111/mmi.12720; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Brodin P, 2004, J INFECT DIS, V190, P115, DOI 10.1086/421468; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Conzelmann KK, 2005, J VIROL, V79, P5241, DOI 10.1128/JVI.79.9.5241-5248.2005; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Creasey EA, 2014, CURR OPIN MICROBIOL, V17, P46, DOI 10.1016/j.mib.2013.11.005; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fortune SM, 2007, CELL HOST MICROBE, V2, P5, DOI 10.1016/j.chom.2007.06.008; Friedrich N, 2012, MICROBIOL MOL BIOL R, V76, P707, DOI 10.1128/MMBR.00024-12; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Harriff MJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00040; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; KONDO E, 1982, JPN J MED SCI BIOL, V35, P197, DOI 10.7883/yoken1952.35.197; Lang T, 1997, INFECT IMMUN, V65, P380; LEAKE ES, 1984, INFECT IMMUN, V45, P443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Majlessi L, 2015, IMMUNOL REV IN PRESS, V264, P1; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763; MERCKX JJ, 1964, AM REV RESPIR DIS, V89, P485; Molloy S, 2012, NAT REV MICROBIOL, V10, P442, DOI 10.1038/nrmicro2825; Moreira AL, 1997, INFECT IMMUN, V65, P305; Mwandumba HC, 2004, J IMMUNOL, V172, P4592, DOI 10.4049/jimmunol.172.7.4592; MYRVIK QN, 1984, AM REV RESPIR DIS, V129, P322; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Nothelfer K, 2011, VIRULENCE, V2, P54, DOI 10.4161/viru.2.1.14666; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Rybniker J, 2014, CELL HOST MICROBE, V16, P538, DOI 10.1016/j.chom.2014.09.008; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; VIDAL MJ, 1993, EUR J CELL BIOL, V60, P261; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707",76,84,84,3,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004650,10.1371/journal.ppat.1004650,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400035,25658322.0,"DOAJ Gold, Green Published",,,16/08/2019,86,7,84,7880,1222,902,320,6658,5269,20,1369,84,6,0,0,81,81,0,,112,0,112,0,0,90,89,90,49,0,0,0,0,0,0,0,1,3,7880,89,0,156,127,0,6627,1222,89,0,156,127,0,31,,0,0,0,0,6,0,1,1,0,0,0,114,0,0,3.25,6.448445171849428,1.1835386001802344,0.1835386001802343,1.2159807750075098,1.0274111675126905,6.625204582651391
159,J,"Stahl, AL; Arvidsson, I; Johansson, KE; Chromek, M; Rebetz, J; Loos, S; Kristoffersson, AC; Bekassy, ZD; Morgelin, M; Karpman, D",,,,"Stahl, Anne-Lie; Arvidsson, Ida; Johansson, Karl E.; Chromek, Milan; Rebetz, Johan; Loos, Sebastian; Kristoffersson, Ann-Charlotte; Bekassy, Zivile D.; Morgelin, Matthias; Karpman, Diana",,,A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles,PLOS PATHOGENS,,,English,Article,,,,,,,HEMOLYTIC-UREMIC SYNDROME; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; SHIGA-LIKE TOXIN; POLYMORPHONUCLEAR LEUKOCYTES; MEMBRANE MICROPARTICLES; GLOBOTRIAOSYL CERAMIDE; RETROGRADE TRANSPORT; PLATELET ACTIVATION; MOUSE MODEL; IN-VITRO,"Shiga toxin (Stx) is the main virulence factor of enterohemorrhagic Escherichia coli, which are non-invasive strains that can lead to hemolytic uremic syndrome (HUS), associated with renal failure and death. Although bacteremia does not occur, bacterial virulence factors gain access to the circulation and are thereafter presumed to cause target organ damage. Stx was previously shown to circulate bound to blood cells but the mechanism by which it would potentially transfer to target organ cells has not been elucidated. Here we show that blood cell-derived microvesicles, shed during HUS, contain Stx and are found within patient renal cortical cells. The finding was reproduced in mice infected with Stx-producing Escherichia coli exhibiting Stx-containing blood cell-derived microvesicles in the circulation that reached the kidney where they were transferred into glomerular and peritubular capillary endothelial cells and further through their basement membranes followed by podocytes and tubular epithelial cells, respectively. In vitro studies demonstrated that blood cell-derived microvesicles containing Stx undergo endocytosis in glomerular endothelial cells leading to cell death secondary to inhibited protein synthesis. This study demonstrates a novel virulence mechanism whereby bacterial toxin is transferred within host blood cell-derived microvesicles in which it may evade the host immune system.","[Stahl, Anne-Lie; Arvidsson, Ida; Johansson, Karl E.; Chromek, Milan; Rebetz, Johan; Loos, Sebastian; Kristoffersson, Ann-Charlotte; Bekassy, Zivile D.; Karpman, Diana] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Clin Sci Lund, Lund, Sweden","Stahl, AL (reprint author), Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden.",diana.karpman@med.lu.se,"Uhlen, Mathias/B-3262-2016","Uhlen, Mathias/0000-0002-4858-8056; Aradottir, Sigridur Sunna/0000-0002-6898-3256; Karpman, Diana/0000-0001-7220-7658; Rebetz, Johan/0000-0003-1673-0684","Swedish Research Council [K2013-64X-14008, K2015-99X-22877-01-6, 7480]; Torsten Soderberg Foundation; Crown Princess Lovisa's Society for Child Care; Konung Gustaf V:s 80-arsfond; Crafoord Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Medical Faculty at Lund University; Deutsche Forschungsgemeinschaft [LO 2021/2-1]","This study was supported by grants from The Swedish Research Council (K2013-64X-14008 and K2015-99X-22877-01-6 to DK and 7480 to MM), The Torsten Soderberg Foundation, Crown Princess Lovisa's Society for Child Care (both to DK), The Konung Gustaf V:s 80-arsfond (to DK and MM), The Crafoord Foundation, Greta and Johan Kock Foundation, Alfred Osterlund Foundation, and the Medical Faculty at Lund University (all to MM). SL was supported by a research fellowship from the Deutsche Forschungsgemeinschaft (LO 2021/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Arfilli V, 2010, BIOCHEM J, V432, P173, DOI 10.1042/BJ20100455; Bauwens A, 2013, CELL MOL LIFE SCI, V70, P425, DOI 10.1007/s00018-012-1060-z; Bekassy ZD, 2011, PEDIATR NEPHROL, V26, P2059, DOI 10.1007/s00467-010-1616-9; BITZAN M, 1994, INFECT IMMUN, V62, P3337; Brigotti M, 2006, J CLIN MICROBIOL, V44, P313, DOI 10.1128/JCM.44.2.313-317.2006; Brigotti M, 2013, J IMMUNOL, V191, P4748, DOI 10.4049/jimmunol.1300122; Brigotti M, 2011, PEDIATR INFECT DIS J, V30, P486, DOI 10.1097/INF.0b013e3182074d22; Brigotti M, 2010, J LEUKOCYTE BIOL, V88, P201, DOI 10.1189/jlb.0709475; Toledo CC, 2011, INFECT IMMUN, V79, P2224, DOI 10.1128/IAI.01024-10; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; Chark D, 2004, EUR J BIOCHEM, V271, P405, DOI 10.1046/j.1432-1033.2003.03941.x; Chromek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046476; Cooling LLW, 1998, INFECT IMMUN, V66, P4355; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; FONTAINE A, 1988, INFECT IMMUN, V56, P3099; Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016/j.ijfoodmicro.2006.04.041; Galli M, 1996, THROMB HAEMOSTASIS, V75, P427; Ge SW, 2012, NEPHROL DIAL TRANSPL, V27, P2768, DOI 10.1093/ndt/gfr748; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361; Griener TP, 2007, J MED MICROBIOL, V56, P1423, DOI 10.1099/jmm.0.47282-0; Habib R, 1992, HEMOLYTIC UREMIC SYN; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; JACEWICZ MS, 1994, J INFECT DIS, V169, P538, DOI 10.1093/infdis/169.3.538; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769; Karpman D, 2001, BLOOD, V97, P3100, DOI 10.1182/blood.V97.10.3100; Karpman D, 1998, INFECT IMMUN, V66, P636; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Malyukova I, 2009, AM J PHYSIOL-GASTR L, V296, pG78, DOI 10.1152/ajpgi.90347.2008; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; MCKEE ML, 1995, INFECT IMMUN, V63, P2070; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Palermo M, 2000, CLIN EXP IMMUNOL, V119, P77, DOI 10.1046/j.1365-2249.2000.01103.x; PETRIC M, 1987, J CLIN MICROBIOL, V25, P1265; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Porubsky S, 2014, J PATHOL, V234, P120, DOI 10.1002/path.4388; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/01.aids.0000042948.95433.3d; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Schuller S, 2011, TOXINS, V3, P626, DOI 10.3390/toxins3060626; Schuller S, 2004, CELL MICROBIOL, V6, P289, DOI 10.1111/j.1462-5822.2004.00370.x; Simak J, 2006, TRANSFUS MED REV, V20, P1, DOI 10.1016/j.tmrv.2005.08.001; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stahl AL, 2011, BLOOD, V117, P5503, DOI 10.1182/blood-2010-09-309161; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STIRLING JW, 1995, J HISTOCHEM CYTOCHEM, V43, P115, DOI 10.1177/43.2.7529784; Stone SM, 2012, FRONT CELL INFECT MI, V135, P1; te Loo DMWM, 2000, BLOOD, V95, P3396; te Loo DMWM, 2001, J AM SOC NEPHROL, V12, P800; te Loo DMWM, 2001, J INFECT DIS, V184, P446, DOI 10.1086/322782; Toledo CC, 2008, AM J PATHOL, V173, P1428, DOI 10.2353/ajpath.2008.071218; vanSetten PA, 1996, BLOOD, V88, P174; WADDELL T, 1990, P NATL ACAD SCI USA, V87, P7898, DOI 10.1073/pnas.87.20.7898; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P3959",67,33,34,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004619,10.1371/journal.ppat.1004619,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400012,25719452.0,"DOAJ Gold, Green Published",,,16/08/2019,33,7,43,6234,1474,1140,334,4760,3858,24,878,43,6,0,0,33,33,0,,109,3,55,0,3,34,33,34,20,0,0,0,0,0,0,0,1,3,6321,51,28,320,130,0,4780,1484,51,28,320,130,0,57,,0,1,0,0,14,0,0,1,0,0,0,55,0,0,13.6,4.229308005427408,1.3096638655462185,0.3096638655462185,1.3659663865546219,1.0429900545396213,4.41112618724559
160,J,"VanderVen, BC; Fahey, RJ; Lee, W; Liu, YC; Abramovitch, RB; Memmott, C; Crowe, AM; Eltis, LD; Perola, E; Deininger, DD; Wang, TS; Locher, CP; Russell, DG",,,,"VanderVen, Brian C.; Fahey, Ruth J.; Lee, Wonsik; Liu, Yancheng; Abramovitch, Robert B.; Memmott, Christine; Crowe, Adam M.; Eltis, Lindsay D.; Perola, Emanuele; Deininger, David D.; Wang, Tiansheng; Locher, Christopher P.; Russell, David G.",,,Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium's Metabolism Is Constrained by the Intracellular Environment,PLOS PATHOGENS,,,English,Article,,,,,,,REVERSIBLE ACETYLATION; PROPIONATE METABOLISM; ISOCITRATE LYASE-1; MACROPHAGES; GROWTH; REQUIRES; PERSISTENCE; ADAPTATION; CATABOLISM; RESISTANCE,"Mycobacterium tuberculosis (Mtb) relies on a specialized set of metabolic pathways to support growth in macrophages. By conducting an extensive, unbiased chemical screen to identify small molecules that inhibit Mtb metabolism within macrophages, we identified a significant number of novel compounds that limit Mtb growth in macrophages and in medium containing cholesterol as the principle carbon source. Based on this observation, we developed a chemical-rescue strategy to identify compounds that target metabolic enzymes involved in cholesterol metabolism. This approach identified two compounds that inhibit the HsaAB enzyme complex, which is required for complete degradation of the cholesterol A/B rings. The strategy also identified an inhibitor of PrpC, the 2-methylcitrate synthase, which is required for assimilation of cholesterol-derived propionyl-CoA into the TCA cycle. These chemical probes represent new classes of inhibitors with novel modes of action, and target metabolic pathways required to support growth of Mtb in its host cell. The screen also revealed a structurally-diverse set of compounds that target additional stage(s) of cholesterol utilization. Mutants resistant to this class of compounds are defective in the bacterial adenylate cyclase Rv1625/Cya. These data implicate cyclic-AMP (cAMP) in regulating cholesterol utilization in Mtb, and are consistent with published reports indicating that propionate metabolism is regulated by cAMP levels. Intriguingly, reversal of the cholesterol-dependent growth inhibition caused by this subset of compounds could be achieved by supplementing the media with acetate, but not with glucose, indicating that Mtb is subject to a unique form of metabolic constraint induced by the presence of cholesterol.","[VanderVen, Brian C.; Fahey, Ruth J.; Lee, Wonsik; Liu, Yancheng; Abramovitch, Robert B.; Russell, David G.] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14850 USA; [Memmott, Christine; Perola, Emanuele; Deininger, David D.; Wang, Tiansheng; Locher, Christopher P.] Vertex Pharmaceut Inc, Boston, MA USA; [Crowe, Adam M.; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol, Vancouver, BC, Canada; [Crowe, Adam M.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem, Vancouver, BC, Canada","VanderVen, BC (reprint author), Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14850 USA.",bcv8@cornell.edu,"Russell, David/D-4533-2009; Abramovitch, Robert/O-6798-2019; Eltis, Lindsay/J-8272-2015; Russell, David G/N-5280-2019","Russell, David/0000-0002-9748-750X; Abramovitch, Robert/0000-0002-4119-4169; Eltis, Lindsay/0000-0002-6774-8158; Russell, David G/0000-0002-9748-750X","NIH [AI067027, AI080651, AI099569, AI081482]; Canadian Institutes of Health Research; Vertex Pharmaceuticals","Funding: This work was supported by grants from the NIH to DGR (AI067027 and AI080651) and to BCV (AI099569) and to RBA (AI081482), as well as an operating grant from the Canadian Institutes of Health Research to LDE. Additional support was received from Vertex Pharmaceuticals to DGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Balganesh M, 2010, ANTIMICROB AGENTS CH, DOI [10.1128/AAC.00942-10, DOI 10.1128/AAC.00942-10]; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Casabon I, 2013, MOL MICROBIOL, V89, P1201, DOI 10.1111/mmi.12340; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Gouzy A, 2014, NAT REV MICROBIOL, DOI [10.1038/nrmicro3423, DOI 10.1038/NRMICRO3423]; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14; Hayden JD, 2013, MICROBIOL-SGM, V159, P1986, DOI 10.1099/mic.0.068585-0; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Masiewicz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043651; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Murima P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069191; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Owens RM, 2006, MOL MICROBIOL, V60, P1152, DOI 10.1111/j.1365-2958.2006.05174.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Prod'hom G, 1998, FEMS MICROBIOL LETT, V158, P75, DOI 10.1016/S0378-1097(97)00503-X; Puckett S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004144; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rohde KH, 2012, PLOS PATHOG, V8, DOI [10.1371/journal.ppat.1003097, DOI 10.1371/JOURNAL.PPAT.1003097]; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SEGAL W, 1956, J BACTERIOL, V72, P132; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Townsend PD, 2009, J BIOL CHEM, V284, P784, DOI 10.1074/jbc.M807239200; Trujillo C, 2014, MBIO, V5, DOI 10.1128/mBio.00085-14; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140",56,96,96,2,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004679,10.1371/journal.ppat.1004679,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400052,25675247.0,"DOAJ Gold, Green Published",,,16/08/2019,93,21,110,11740,1081,788,293,10659,8391,27,2241,110,12,0,2,86,86,1,,156,2,156,0,2,94,94,93,54,0,0,0,0,0,0,0,9,4,11754,64,27,351,155,2,10617,1081,64,27,351,155,2,56,,0,0,0,0,12,0,2,1,1,0,0,156,0,0,7.25,10.860314523589269,1.101416643212309,0.10141664321230885,1.1232761047002533,1.01984667802385,11.075855689176688
161,J,"Wang, GF; Ji, JB; Ei-Kasmi, F; Dangl, JL; Johal, G; Balint-Kurti, PJ",,,,"Wang, Guan-Feng; Ji, Jiabing; Ei-Kasmi, Farid; Dangl, Jeffery L.; Johal, Guri; Balint-Kurti, Peter J.",,,Molecular and Functional Analyses of a Maize Autoactive NB-LRR Protein Identify Precise Structural Requirements for Activity,PLOS PATHOGENS,,,English,Article,,,,,,,ASSISTED GENE IDENTIFICATION; DISEASE-RESISTANCE GENE; RICH REPEAT DOMAINS; HYPERSENSITIVE RESPONSE; COILED-COIL; PHYSICAL ASSOCIATION; TRANSIENT EXPRESSION; ARTIFICIAL EVOLUTION; DEFENSE RESPONSE; PLANT,"Plant disease resistance is often mediated by nucleotide binding-leucine rich repeat (NLR) proteins which remain auto-inhibited until recognition of specific pathogen-derived molecules causes their activation, triggering a rapid, localized cell death called a hypersensitive response (HR). Three domains are recognized in one of the major classes of NLR proteins: a coiled-coil (CC), a nucleotide binding (NB-ARC) and a leucine rich repeat (LRR) domains. The maize NLR gene Rp1-D21 derives from an intergenic recombination event between two NLR genes, Rp1-D and Rp1-dp2 and confers an autoactive HR. We report systematic structural and functional analyses of Rp1 proteins in maize and N. benthamiana to characterize the molecular mechanism of NLR activation/auto-inhibition. We derive a model comprising the following three main features: Rp1 proteins appear to self-associate to become competent for activity. The CC domain is signaling-competent and is sufficient to induce HR. This can be suppressed by the NB-ARC domain through direct interaction. In autoactive proteins, the interaction of the LRR domain with the NB-ARC domain causes de-repression and thus disrupts the inhibition of HR. Further, we identify specific amino acids and combinations thereof that are important for the auto-inhibition/activity of Rp1 proteins. We also provide evidence for the function of MHD2, a previously uncharacterized, though widely conserved NLR motif. This work reports several novel insights into the precise structural requirement for NLR function and informs efforts towards utilizing these proteins for engineering disease resistance.","[Wang, Guan-Feng; Balint-Kurti, Peter J.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Ji, Jiabing; Johal, Guri] Purdue Univ, Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Ei-Kasmi, Farid; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Howard Hughes Med Inst, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Balint-Kurti, Peter J.] USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA","Wang, GF (reprint author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.",gwang11@ncsu.edu; peter.balint-kurti@ars.usda.gov,"Johal, Guri/F-5056-2017","Johal, Guri/0000-0001-8101-8410; El Kasmi, Farid/0000-0002-4634-7689; Balint-Kurti, Peter/0000-0002-3916-194X",National Science Foundation [0822495]; U.S. Department of Agriculture-Agricultural Research Service; German science foundation (DFG) [EL734/1-1]; NSF [IOS-1257373]; HHMI; Gordon and Betty Moore Foundation [GBMF3030],"Funding: This work was supported by National Science Foundation (grant no. 0822495) and the U.S. Department of Agriculture-Agricultural Research Service. FEK is funded by a German science foundation (DFG) postdoctoral fellowship (EL734/1-1). Work in the lab of JLD was supported by NSF grant IOS-1257373 to JLD. JLD is an Investigator of the Howard Hughes Medical Institute and is supported by the HHMI and the Gordon and Betty Moore Foundation (GBMF3030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Chaikam V, 2011, THEOR APPL GENET, V123, P985, DOI 10.1007/s00122-011-1641-5; Chintamanani S, 2010, GENETICS, V184, P813, DOI 10.1534/genetics.109.111880; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Hao W, 2013, J BIOL CHEM, V288, P35868, DOI 10.1074/jbc.M113.517417; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Hoser R, 2013, NEW PHYTOL, V200, P158, DOI 10.1111/nph.12347; Howles P, 2005, MOL PLANT MICROBE IN, V18, P570, DOI 10.1094/MPMI-18-0570; Hu GS, 1996, PLANT CELL, V8, P1367; Hwang CF, 2000, PLANT CELL, V12, P1319, DOI 10.1105/tpc.12.8.1319; Hwang CF, 2003, PLANT J, V34, P585, DOI 10.1046/j.1365-313X.2003.01749.x; Inoue H, 2013, P NATL ACAD SCI US; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maekawa T, 2012, P NATL ACAD SCI USA, V109, P20119, DOI 10.1073/pnas.1218059109; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.00606.x; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Moffett P, 2009, ADV VIRUS RES, V75, P1, DOI 10.1016/S0065-3527(09)07501-0; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Narusaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055954; Negeri A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-106; Olukolu BA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004562; Olukolu BA, 2013, GENETICS, V193, P609, DOI 10.1534/genetics.112.147595; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Sacco MA, 2007, PLANT J, V52, P82, DOI 10.1111/j.1365-313X.2007.03213.x; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; Smith SM, 2010, MOL GENET GENOMICS, V283, P591, DOI 10.1007/s00438-010-0536-5; Smith SM, 2004, GENETICS, V167, P1939, DOI 10.1534/genetics.104.029371; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; Sun Q, 2001, GENETICS, V158, P423; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052",70,47,49,0,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004674,10.1371/journal.ppat.1004674,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400050,25719542.0,"DOAJ Gold, Green Published",,,16/08/2019,45,4,66,8947,1193,843,350,7754,5551,31,2172,66,2,0,0,33,33,0,,156,1,79,0,1,50,50,22,22,0,0,0,0,0,0,0,2,0,8963,41,0,250,116,0,7730,1193,41,0,250,116,0,40,,0,0,0,0,8,0,1,1,0,0,0,82,0,0,4.8,7.499580888516346,1.1538560742842403,0.1538560742842404,1.1761671395408821,1.019336090309601,7.644593461860855
162,J,"Wickner, RB; Edskes, HK; Bateman, DA; Gorkovskiy, A; Dayani, Y; Bezsonov, EE; Mukhamedova, M",,,,"Wickner, Reed B.; Edskes, Herman K.; Bateman, David A.; Gorkovskiy, Anton; Dayani, Yaron; Bezsonov, Evgeny E.; Mukhamedova, Maryam",,,Yeast Prions: Proteins Templating Conformation and an Anti-prion System,PLOS PATHOGENS,,,English,Article,,,,,,,SACCHAROMYCES-CEREVISIAE; URE3 PRION; STRAINS; MECHANISM; DISEASES; PSI+,,"[Wickner, Reed B.; Edskes, Herman K.; Bateman, David A.; Gorkovskiy, Anton; Dayani, Yaron; Bezsonov, Evgeny E.; Mukhamedova, Maryam] Natl Inst Diabet & Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA","Wickner, RB (reprint author), Natl Inst Diabet & Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.",wickner@helix.nih.gov,"Gorkovskiy, Anton/J-8930-2016","Gorkovskiy, Anton/0000-0003-4811-2282",National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health,"This work was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","BESSEN RA, 1992, J VIROL, V66, P2096; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Derkatch IL, 1996, GENETICS, V144, P1375; Edskes HE, 2014, SPORADIC DISTRIBUTIO; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gorkovskiy A, 2014, P NATL ACAD IN PRESS, V111, DOI [10.1073/pnas.1421566112, DOI 10.1073/PNAS.1421566112]; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Kryndushkin D, 2012, MOL MICROBIOL; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2014, P NATL ACAD SCI USA, DOI [10.1073/pnas.1421566112, DOI 10.1073/PNAS.1421566112]; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a",27,4,4,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,e1004584,10.1371/journal.ppat.1004584,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400005,25654539.0,"DOAJ Gold, Green Published",,,16/08/2019,4,6,15,4374,309,234,75,4065,3504,17,544,15,1,0,0,3,3,0,,20,1,20,0,1,4,4,4,3,0,0,0,0,0,0,1,5,0,4418,88,0,162,77,1,4061,309,88,0,162,77,1,48,,0,1,0,0,1,0,0,0,0,0,0,20,0,0,7.666,14.155339805825243,1.0760147601476016,0.07601476014760147,1.127429274292743,1.047782350251486,14.831715210355988
163,J,"Zhang, XS; Tegtmeyer, N; Traube, L; Jindal, S; Perez-Perez, G; Sticht, H; Backert, S; Blaser, MJ",,,,"Zhang, Xue-Song; Tegtmeyer, Nicole; Traube, Leah; Jindal, Shawn; Perez-Perez, Guillermo; Sticht, Heinrich; Backert, Steffen; Blaser, Martin J.",,,A Specific A/T Polymorphism in Western Tyrosine Phosphorylation B-Motifs Regulates Helicobacter pylori CagA Epithelial Cell Interactions,PLOS PATHOGENS,,,English,Article,,,,,,,VIRULENCE FACTOR CAGA; FOCAL ADHESION KINASE; GENETIC DIVERSITY; EFFECTOR PROTEIN; GASTRIC-CANCER; SH2 DOMAIN; LOW PH; ACTIVATION; PATHWAY; INTERLEUKIN-8,"Helicobacter pylori persistently colonizes the human stomach, with mixed roles in human health. The CagA protein, a key host-interaction factor, is translocated by a type IV secretion system into host epithelial cells, where its EPIYA tyrosine phosphorylation motifs (TPMs) are recognized by host cell kinases, leading to multiple host cell signaling cascades. The CagA TPMs have been described as type A, B, C or D, each with a specific conserved amino acid sequence surrounding EPIYA. Database searching revealed strong non-random distribution of the B-motifs (including EPIYA and EPIYT) in Western H. pylori isolates. In silico analysis of Western H. pylori CagA sequences provided evidence that the EPIYT B-TPMs are significantly less associated with gastric cancer than the EPIYA B-TPMs. By generating and using a phosphorylated CagA B-TPM-specific antibody, we demonstrated the phosphorylated state of the CagA B-TPM EPIYT during H. pylori co-culture with host cells. We also showed that within host cells, CagA interaction with phosphoinositol 3-kinase (PI3-kinase) was B-TPM tyrosine-phosphorylation-dependent, and the recombinant CagA with EPIYT B-TPM had higher affinity to PI3-kinase and enhanced induction of AKT than the isogenic CagA with EPIYA B-TPM. Structural modeling of the CagA B-TPM motif bound to PI3-kinase indicated that the threonine residue at the pY+1 position forms a side-chain hydrogen bond to N-417 of PI3-kinase, which cannot be formed by alanine. During co-culture with AGS cells, an H. pylori strain with a CagA EPIYT B-TPM had significantly attenuated induction of interleukin-8 and hummingbird phenotype, compared to the isogenic strain with B-TPM EPIYA. These results suggest that the A/T polymorphisms could regulate CagA activity through interfering with host signaling pathways related to carcinogenesis, thus influencing cancer risk.","[Zhang, Xue-Song; Traube, Leah; Jindal, Shawn; Perez-Perez, Guillermo; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10012 USA; [Zhang, Xue-Song; Traube, Leah; Jindal, Shawn; Perez-Perez, Guillermo; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Zhang, Xue-Song; Traube, Leah; Jindal, Shawn; Perez-Perez, Guillermo; Blaser, Martin J.] VA Med Ctr, New York, NY USA; [Tegtmeyer, Nicole; Backert, Steffen] Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Bioinformat, Inst Biochem, D-91054 Erlangen, Germany","Zhang, XS (reprint author), NYU, Sch Med, Dept Med, New York, NY 10012 USA.",xuesong.zhang@nyumc.org,,"Sticht, Heinrich/0000-0001-5644-045X; Zhang, Xue-Song/0000-0001-5080-0098; Perez Perez, Guillermo/0000-0002-0131-5798",National Institutes of Health [R01GM63270]; Knapp Family Fund; Ziff Foundation; Diane Belfer Program for Human Microbial Ecology; DFG [CRC-796],"The work of XSZ, LT, SJ, GPP, and MJB is supported by the National Institutes of Health (R01GM63270), by the Knapp Family Fund, the Ziff Foundation, and the Diane Belfer Program for Human Microbial Ecology. The work of NT, SB, and HS is supported through DFG grants (projects B10 and A2 of CRC-796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; Ando T, 2002, CLIN DIAGN LAB IMMUN, V9, P167, DOI 10.1128/CDLI.9.1.167-175.2002; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Argent RH, 2008, J MED MICROBIOL, V57, P1062, DOI 10.1099/jmm.0.2008/001818-0; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Azuma T, 2002, J INFECT DIS, V186, P1621, DOI 10.1086/345374; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Beswick EJ, 2008, INFECT IMMUN, V76, P3233, DOI 10.1128/IAI.01534-07; BLASER MJ, 1995, CANCER RES, V55, P2111; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; Eucker TP, 2014, CELL MICROBIOL; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Furuta Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023499; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirsch C, 2012, J GASTROENTEROL, V47, P936, DOI 10.1007/s00535-012-0618-8; Huang FC, 2005, FEMS MICROBIOL LETT, V243, P265, DOI 10.1016/j.femsle.2004.12.013; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jones KR, 2009, J CLIN MICROBIOL; Jurik A, 2010, INFECT IMMUN; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Li SP, 2010, BIOMED ENVIRON SCI, V23, P273, DOI 10.1016/S0895-3988(10)60063-3; Lind J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096488; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Logan RPH, 1996, LANCET, V348, P1462, DOI 10.1016/S0140-6736(05)65885-0; MARSHALL BJ, 1984, LANCET, V1, P1311; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Muller A, 2012, J CLIN INVEST, V122, P1192, DOI 10.1172/JCI61578; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Murata-Kamiya N, 2011, MICROBES INFECT, V13, P799, DOI 10.1016/j.micinf.2011.03.011; NAGASE L, 2011, J BIOL CHEM; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nesic D, 2014, P NATL ACAD SCI USA, V111, P1562, DOI 10.1073/pnas.1320631111; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Oertli Mathias, 2012, Gut Microbes, V3, P566, DOI 10.4161/gmic.21750; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Pillinger MH, 2005, J BIOL CHEM, V280, P9973, DOI 10.1074/jbc.M413522200; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Sambrook J, 1989, MOLECULAR CLONING A, V7, DOI 10.1016/j.ijantimicag.2016.12.01810.1016/j.ijantimicag.2016.12.018; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Sbreve Ic D Ne, 2009, NAT STRUCT MOL BIOL; Schneider N, 2009, J INFECT DIS, V199, P1218, DOI 10.1086/597416; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Takata S, 2009, J GASTROENTEROL; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tegtmeyer N, 2011, FEBS J; Tegtmeyer N, 2010, J BIOL CHEM; Tegtmeyer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097782; Tegtmeyer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071220; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wiseman EF, 2011, WORLD J GASTROENTERO, V17, P3672, DOI 10.3748/wjg.v17.i32.3672; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang XS, 2012, J BACTERIOL, V194, P3891, DOI 10.1128/JB.00346-12; Zhang XS, 2012, J BACTERIOL, V194, P3407, DOI 10.1128/JB.00113-12; Zhang YA, 2009, MICROBIOL RES, V164, P180, DOI 10.1016/j.micres.2006.10.010; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551",86,35,37,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,FEB,2015,11,2,,,,,,,UNSP e1004621,10.1371/journal.ppat.1004621,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CE8HU,WOS:000352083400013,25646814.0,"DOAJ Gold, Green Published",,,16/08/2019,47,0,20,3735,708,485,223,3027,2526,21,480,20,0,0,0,31,31,0,,25,0,25,0,0,49,49,32,25,0,0,0,0,0,0,0,0,0,3784,20,0,335,125,1,3045,717,20,0,335,125,1,22,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,5.27542372881356,1.2338949454905848,0.23389494549058473,1.297984803435745,1.0519410977242303,5.549435028248587
164,J,"Alteri, CJ; Himpsl, SD; Mobley, HLT",,,,"Alteri, Christopher J.; Himpsl, Stephanie D.; Mobley, Harry L. T.",,,Preferential Use of Central Metabolism In Vivo Reveals a Nutritional Basis for Polymicrobial Infection,PLOS PATHOGENS,,,English,Article,,,,,,,URINARY-TRACT-INFECTION; UROPATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; PROTEUS-MIRABILIS; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; CARBON METABOLISM; SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; MOUSE INTESTINE,"The human genitourinary tract is a common anatomical niche for polymicrobial infection and a leading site for the development of bacteremia and sepsis. Most uncomplicated, community-acquired urinary tract infections (UTI) are caused by Escherichia coli, while another bacterium, Proteus mirabilis, is more often associated with complicated UTI. Here, we report that uropathogenic E. coli and P. mirabilis have divergent requirements for specific central pathways in vivo despite colonizing and occupying the same host environment. Using mutants of specific central metabolism enzymes, we determined glycolysis mutants lacking pgi, tpiA, pfkA, or pykA all have fitness defects in vivo for P. mirabilis but do not affect colonization of E. coli during UTI. Similarly, the oxidative pentose phosphate pathway is required only for P. mirabilis in vivo. In contrast, gluconeogenesis is required only for E. coli fitness in vivo. The remarkable difference in central pathway utilization between E. coli and P. mirabilis during experimental UTI was also observed for TCA cycle mutants in sdhB, fumC, and frdA. The distinct in vivo requirements between these pathogens suggest E. coli and P. mirabilis are not direct competitors within host urinary tract nutritional niche. In support of this, we found that co-infection with E. coli and P. mirabilis wild-type strains enhanced bacterial colonization and persistence of both pathogens during UTI. Our results reveal that complementary utilization of central carbon metabolism facilitates polymicrobial disease and suggests microbial activity in vivo alters the host urinary tract nutritional niche.","[Alteri, Christopher J.; Himpsl, Stephanie D.; Mobley, Harry L. T.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA","Mobley, HLT (reprint author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.",hmobley@umich.edu,"Alteri, Christopher/G-3243-2015","Alteri, Christopher/0000-0002-6367-5684; Mobley, Harry/0000-0001-9195-7665","Public Health Service from the National Institutes of Health [AI059722, AI043363, DK094777]","This work was supported in part by Public Health Service grants to HLTM (AI059722, AI043363 and DK094777) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ALLISON C, 1992, INFECT IMMUN, V60, P4740; Alteri CJ, 2012, CURR OPIN MICROBIOL, V15, P3, DOI 10.1016/j.mib.2011.12.004; Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Anfora AT, 2008, INFECT IMMUN, V76, P5760, DOI 10.1128/IAI.00618-08; Anfora AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07; BELAS R, 1991, J BACTERIOL, V173, P6289, DOI 10.1128/jb.173.19.6289-6293.1991; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brogden KA, 2004, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004; Cai WT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003428; Cersini A, 2003, INFECT IMMUN, V71, P7002, DOI 10.1128/IAI.71.12.7002-7013.2003; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Croxall G, 2011, J MED MICROBIOL, V60, P102, DOI 10.1099/jmm.0.020602-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; FRETER R, 1983, INFECT IMMUN, V39, P676; Galen JE, 1999, INFECT IMMUN, V67, P6424; Hadjifrangiskou M, 2011, MOL MICROBIOL, V80, P1516, DOI 10.1111/j.1365-2958.2011.07660.x; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; HAGBERG L, 1983, INFECT IMMUN, V40, P273; Himpsl SD, 2008, J MED MICROBIOL, V57, P1068, DOI 10.1099/jmm.0.2008/002071-0; JOHNSON DE, 1987, J UROLOGY, V138, P632, DOI 10.1016/S0022-5347(17)43287-3; JONES BD, 1988, J BACTERIOL, V170, P3342, DOI 10.1128/jb.170.8.3342-3349.1988; JONES BD, 1990, INFECT IMMUN, V58, P1120; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Mao XJ, 2007, NUCLEIC ACIDS RES, V35, P1432, DOI 10.1093/nar/gkl1142; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Mobley HLT, 1996, INFECT IMMUN, V64, P5332; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281; MOBLEY HLT, 1987, J CLIN MICROBIOL, V25, P2216; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736; Noriega FR, 1996, INFECT IMMUN, V64, P3055; Pearson MM, 2011, INFECT IMMUN, V79, P2619, DOI 10.1128/IAI.05152-11; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Roesch Paula L., 2003, Molecular Microbiology, V49, P55, DOI 10.1046/j.1365-2958.2003.03543.x; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Saverino D, 2011, FEMS IMMUNOL MED MIC, V61, P84, DOI 10.1111/j.1574-695X.2010.00751.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schumacher J, 2013, MBIO, V4, DOI 10.1128/mBio.00881-13; Smith H, 2000, PHILOS T R SOC B, V355, P551, DOI 10.1098/rstb.2000.0597; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Sprenger GA, 1995, ARCH MICROBIOL, V164, P324, DOI 10.1007/BF02529978; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; TCHAWA YM, 2006, INFECT IMMUN, V74, P1130, DOI DOI 10.1128/IAI.74.2.1130-1140.2006; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; WARREN JW, 1982, J INFECT DIS, V146, P719, DOI 10.1093/infdis/146.6.719; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415",65,37,37,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004601,10.1371/journal.ppat.1004601,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100031,25568946.0,"DOAJ Gold, Green Published",,,16/08/2019,39,5,44,5247,806,562,244,4441,3773,28,640,44,5,0,0,36,36,0,,51,1,51,0,1,40,40,39,24,0,0,0,0,0,0,0,0,2,5328,53,0,860,78,0,4464,817,53,0,860,78,0,47,,0,0,0,0,7,0,0,1,0,0,0,51,0,0,3.0,6.509925558312655,1.1814906552578248,0.18149065525782482,1.2292276514298581,1.0404040404040404,6.772952853598015
165,J,"Ballon, G; Akar, G; Cesarman, E",,,,"Ballon, Gianna; Akar, Gunkut; Cesarman, Ethel",,,Systemic Expression of Kaposi Sarcoma Herpesvirus (KSHV) Vflip in Endothelial Cells Leads to a Profound Proinflammatory Phenotype and Myeloid Lineage Remodeling In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; MULTICENTRIC CASTLEMANS-DISEASE; PRIMARY EFFUSION LYMPHOMA; FLICE-INHIBITORY PROTEINS; POEMS-SYNDROME; DNA-SEQUENCES; HUMAN-HERPESVIRUS-8 INFECTION; COUPLED RECEPTOR; TRANSGENIC MICE; GROWTH-FACTOR,"KSHV is the causative agent of Kaposi sarcoma (KS), a spindle-shaped endothelial cell neoplasm accompanied by an inflammatory infiltrate. To evaluate the role of KSHV vFLIP in the pathogenesis of KS, we constructed mice with inducible expression of vFLIP in endothelial cells. Abnormal cells with endothelial marker expression and fusiform appearance were observed in several tissues reminiscent of the spindle cells found in KS. Serum cytokines displayed a profound perturbation similar to that described in KSHV inflammatory cytokine syndrome (KICS), a recently described clinical condition characterized by elevated IL6 and IL10. An increased myeloid component with suppressive immune phenotype was found, which may contribute to functional changes in the microenvironment and cellular heterogeneity as observed in KS. These mice represent the first in vivo demonstration that vFLIP is capable of inducing vascular abnormalities and changes in host microenvironment with important implications for understanding the pathogenesis and treating KSHV-associated diseases.","[Ballon, Gianna; Akar, Gunkut; Cesarman, Ethel] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA","Ballon, G (reprint author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.",gballon@nshs.edu; ecesarm@med.cornell.edu,,,National Cancer Institute [R01CA103646],"This work was funded by the National Cancer Institute (R01CA103646 grant to EC, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alkharsah KR, 2011, J VIROL, V85, P10375, DOI 10.1128/JVI.00226-11; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Aoki Y, 1999, BLOOD, V93, P4034; Apolloni E, 2000, J IMMUNOL, V165, P6723, DOI 10.4049/jimmunol.165.12.6723; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; Ballon G, 2011, J CLIN INVEST, V121, P1141, DOI 10.1172/JCI44417; Belec L, 1999, CLIN INFECT DIS, V28, P678, DOI 10.1086/515169; Belec L, 1999, BLOOD, V93, P3643; Burger R, 1998, BLOOD, V91, P1858; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Cesarman E, 2000, J EXP MED, V191, P417, DOI 10.1084/jem.191.3.417; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang HH, 2013, CELL HOST MICROBE, V13, P429, DOI 10.1016/j.chom.2013.03.009; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Cirone M, 2008, IMMUNOL LETT, V120, P37, DOI 10.1016/j.imlet.2008.06.011; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Della Bella S, 2006, CLIN IMMUNOL, V119, P317, DOI 10.1016/j.clim.2006.01.011; Dispenzieri A, 2007, BLOOD REV, V21, P285, DOI 10.1016/j.blre.2007.07.004; Douglas JL, 2007, PANMINERVA MED, V49, P119; Drexler HG, 1999, LEUKEMIA, V13, P634, DOI 10.1038/sj.leu.2401371; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Fainaru O, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.060; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Hudnall SD, 2003, ARCH PATHOL LAB MED, V127, P1034; Hussein MR, 2008, CELL BIOL INT, V32, P157, DOI 10.1016/j.cellbi.2007.08.021; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jones KD, 1999, BLOOD, V94, P2871; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; Kahn HJ, 2002, MODERN PATHOL, V15, P434, DOI 10.1038/modpathol.3880543; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Keller SA, 2000, BLOOD, V96, P2537; Kim DE, 2000, MUSCLE NERVE, V23, P436, DOI 10.1002/(SICI)1097-4598(200003)23:3<436::AID-MUS18>3.0.CO;2-I; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lambert M, 2006, BLOOD, V108, P3871, DOI 10.1182/blood-2006-03-014225; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Li CF, 2006, AM J SURG PATHOL, V30, P123, DOI 10.1097/01.pas.0000172293.59785.b4; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535610802002374; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Papo T, 1999, BRIT J HAEMATOL, V104, P932, DOI 10.1046/j.1365-2141.1999.1331e.x; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Polizzotto MN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00073; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; REGEZI JA, 1993, AM J PATHOL, V143, P240; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Santee SM, 1996, J BIOL CHEM, V271, P21151, DOI 10.1074/jbc.271.35.21151; Sarid R, 1998, J VIROL, V72, P1005; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Sin SH, 2013, BLOOD, V121, P2952, DOI 10.1182/blood-2012-03-415620; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Soubrier M, 1997, ARTHRITIS RHEUM-US, V40, P786, DOI 10.1002/art.1780400430; SOULIER J, 1995, BLOOD, V86, P1276; Staszel T, 2011, POL ARCH MED WEWN, V121, P361; Sugaya M, 2005, BLOOD, V105, P2356, DOI 10.1182/blood-2004-08-3364; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weninger W, 1999, LAB INVEST, V79, P243; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zhu Y, 2013, CURR OPIN VIROL, V3, P266, DOI 10.1016/j.coviro.2013.05.013; Zumo L, 2002, J NEUROL SCI, V195, P47, DOI 10.1016/S0022-510X(01)00679-7",76,16,17,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004581,10.1371/journal.ppat.1004581,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100018,25607954.0,"DOAJ Gold, Green Published",,,16/08/2019,18,0,12,3797,761,548,213,3036,2536,21,479,12,0,0,0,16,16,0,,18,0,18,0,0,18,18,14,13,0,0,0,0,0,0,0,0,0,3817,177,0,641,46,0,3028,761,177,0,641,46,0,28,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,4.989487516425756,1.2506587615283267,0.2506587615283267,1.3306982872200264,1.063997893073479,5.30880420499343
166,J,"Brandenberg, OF; Magnus, C; Rusert, P; Regoes, RR; Trkola, A",,,,"Brandenberg, Oliver F.; Magnus, Carsten; Rusert, Peter; Regoes, Roland R.; Trkola, Alexandra",,,Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; GLYCOPROTEIN-MEDIATED FUSION; VIRAL MEMBRANE-FUSION; NEUTRALIZING ANTIBODIES; ENFUVIRTIDE RESISTANCE; VACCINE DEVELOPMENT; SNARE COMPLEXES; VESICLE FUSION; PORE FORMATION; CELL ENTRY,"HIV-1 enters target cells by virtue of envelope glycoprotein trimers that are incorporated at low density in the viral membrane. How many trimers are required to interact with target cell receptors to mediate virus entry, the HIV entry stoichiometry, still awaits clarification. Here, we provide estimates of the HIV entry stoichiometry utilizing a combined approach of experimental analyses and mathematical modeling. We demonstrate that divergent HIV strains differ in their stoichiometry of entry and require between 1 to 7 trimers, with most strains depending on 2 to 3 trimers to complete infection. Envelope modifications that perturb trimer structure lead to an increase in the entry stoichiometry, as did naturally occurring antibody or entry inhibitor escape mutations. Highlighting the physiological relevance of our findings, a high entry stoichiometry correlated with low virus infectivity and slow virus entry kinetics. The entry stoichiometry therefore directly influences HIV transmission, as trimer number requirements will dictate the infectivity of virus populations and efficacy of neutralizing antibodies. Thereby our results render consideration of stoichiometric concepts relevant for developing antibody-based vaccines and therapeutics against HIV.","[Brandenberg, Oliver F.; Magnus, Carsten; Rusert, Peter; Trkola, Alexandra] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Regoes, Roland R.] ETH, Inst Integrat Biol, Zurich, Switzerland","Trkola, A (reprint author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.",trkola.alexandra@virology.uzh.ch,"Trkola, Alexandra/K-2115-2012; Regoes, Roland/A-6538-2008","Trkola, Alexandra/0000-0003-1013-876X; Regoes, Roland/0000-0001-8319-5293; Brandenberg, Oliver/0000-0001-5662-1234; Magnus, Carsten/0000-0003-1125-2783","Swiss National Science Foundation [310030_152663, 315230_130855]","Support was provided by the Swiss National Science Foundation (http://www.snf.ch, grant 310030_152663 to AT and 315230_130855 to RRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","[Anonymous], 2013, LOS AMLAMOS HIV DATA; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Brandenberg OF, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0075-y; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cao J, 1997, J VIROL, V71, P9808; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Egan MA, 1996, J VIROL, V70, P6547; Fang QH, 2014, PHYSIOLOGY, V29, P278, DOI 10.1152/physiol.00026.2013; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; FREED EO, 1992, P NATL ACAD SCI USA, V89, P70, DOI 10.1073/pnas.89.1.70; FREED EO, 1989, J VIROL, V63, P4670; Gallo SA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-90; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073; GUO HG, 1990, VIROLOGY, V174, P217, DOI 10.1016/0042-6822(90)90070-8; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ho SH, 2007, J VIROL, V81, P8621, DOI 10.1128/JVI.00759-07; Ivanovic T, 2013, ELIFE, V2, DOI 10.7554/eLife.00333; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu W, 2009, J Nanoneurosci, V1, P120; Liu W, 2010, THESCIENTIFICWORLDJO, V10, P1258, DOI 10.1100/tsw.2010.137; Louder MK, 2005, VIROLOGY, V339, P226, DOI 10.1016/j.virol.2005.06.003; Lu J, 2006, JAIDS-J ACQ IMM DEF, V43, P60, DOI 10.1097/01.qai.0000234083.34161.55; Magnus C, 2013, J IMMUNOL METHODS, V398, P1, DOI 10.1016/j.jim.2013.09.002; Magnus C, 2011, J THEOR BIOL, V283, P192, DOI 10.1016/j.jtbi.2011.06.004; Magnus C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000713; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Munro J. B., 2014, SCIENCE; Palmer C, 1996, VIROLOGY, V220, P436, DOI 10.1006/viro.1996.0331; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 2007, J MOL BIOL, V374, P64, DOI 10.1016/j.jmb.2007.09.016; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Pollakis G, 2012, CURR OPIN HIV AIDS, V7, P440, DOI 10.1097/COH.0b013e328356e9f3; Rao M, 2013, CURR HIV RES, V11, P427, DOI 10.2174/1570162X113116660064; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Salzwedel K, 2000, P NATL ACAD SCI USA, V97, P12794, DOI 10.1073/pnas.230438497; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Team RC, 2013, R LANG ENV STAT COMP; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang XZ, 2005, J VIROL, V79, P3500, DOI 10.1128/JVI.79.6.3500-3508.2005; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817",83,36,36,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004595,10.1371/journal.ppat.1004595,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100027,25569556.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,29,0,56,5458,858,631,227,4600,3677,26,897,54,0,0,0,37,37,0,,78,2,76,2,2,39,29,39,27,0,0,0,0,0,0,0,0,0,5542,67,0,70,143,1,4621,867,67,0,70,143,1,54,,0,0,0,0,0,0,0,1,0,0,0,72,2,0,0.25,6.361305361305361,1.1865217391304348,0.1865217391304348,1.2504347826086957,1.0538658849395384,6.703962703962704
167,J,"Caffrey, AK; Lehmann, MM; Zickovich, JM; Espinosa, V; Shepardson, KM; Watschke, CP; Hilmer, KM; Thammahong, A; Barker, BM; Rivera, A; Cramer, RA; Obar, JJ",,,,"Caffrey, Alayna K.; Lehmann, Margaret M.; Zickovich, Julianne M.; Espinosa, Vanessa; Shepardson, Kelly M.; Watschke, Christopher P.; Hilmer, Kimberly M.; Thammahong, Arsa; Barker, Bridget M.; Rivera, Amariliz; Cramer, Robert A.; Obar, Joshua J.",,,IL-1 alpha Signaling Is Critical for Leukocyte Recruitment after Pulmonary Aspergillus fumigatus Challenge,PLOS PATHOGENS,,,English,Article,,,,,,,CHRONIC GRANULOMATOUS-DISEASE; COLONY-STIMULATING FACTOR; T-CELL RESPONSES; HOST-DEFENSE; NLRP3 INFLAMMASOME; PARACOCCIDIOIDES-BRASILIENSIS; INVASIVE ASPERGILLOSIS; IN-VIVO; PROINFLAMMATORY CYTOKINE; STERILE INFLAMMATION,"Aspergillus fumigatus is a mold that causes severe pulmonary infections. Our knowledge of how A. fumigatus growth is controlled in the respiratory tract is developing, but still limited. Alveolar macrophages, lung resident macrophages, and airway epithelial cells constitute the first lines of defense against inhaled A. fumigatus conidia. Subsequently, neutrophils and inflammatory CCR2+ monocytes are recruited to the respiratory tract to prevent fungal growth. However, the mechanism of neutrophil and macrophage recruitment to the respiratory tract after A. fumigatus exposure remains an area of ongoing investigation. Here we show that A. fumigatus pulmonary challenge induces expression of the inflammasomedependent cytokines IL-1 beta and IL-18 within the first 12 hours, while IL-1 alpha expression continually increases over at least the first 48 hours. Strikingly, Il1r1-deficient mice are highly susceptible to pulmonary A. fumigatus challenge exemplified by robust fungal proliferation in the lung parenchyma. Enhanced susceptibility of Il1r1-deficient mice correlated with defects in leukocyte recruitment and anti-fungal activity. Importantly, IL-1 alpha rather than IL-1 beta was crucial for optimal leukocyte recruitment. IL-1 alpha signaling enhanced the production of CXCL1. Moreover, CCR2+ monocytes are required for optimal early IL-1 alpha and CXCL1 expression in the lungs, as selective depletion of these cells resulted in their diminished expression, which in turn regulated the early accumulation of neutrophils in the lung after A. fumigatus challenge. Enhancement of pulmonary neutrophil recruitment and anti-fungal activity by CXCL1 treatment could limit fungal growth in the absence of IL-1 alpha signaling. In contrast to the role of IL-1 alpha in neutrophil recruitment, the inflammasome and IL-1 beta were only essential for optimal activation of anti-fungal activity of macrophages. As such, Pycard-deficient mice are mildly susceptible to A. fumigatus infection. Taken together, our data reveal central, nonredundant roles for IL-1 alpha and IL-1 beta in controlling A. fumigatus infection in the murine lung.","[Caffrey, Alayna K.; Lehmann, Margaret M.; Zickovich, Julianne M.; Watschke, Christopher P.; Hilmer, Kimberly M.; Obar, Joshua J.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Espinosa, Vanessa; Rivera, Amariliz] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pediat, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Shepardson, Kelly M.; Thammahong, Arsa; Cramer, Robert A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA; [Barker, Bridget M.] TGen North, Pathogen Genom Res Div, Flagstaff, AZ USA","Caffrey, AK (reprint author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.",joshua.obar@montana.edu,"Barker, Bridget/H-7351-2019","Barker, Bridget/0000-0002-3439-4517; Obar, Joshua/0000-0003-4068-7911; Cramer, Robert/0000-0001-5503-5006","National Institutes of Health NIGMS [P20-GM103500]; MSU Agricultural Experiment Station; M.J. Murdock Charitable Trust; National Institutes of Health [P30-GM103415, P30-GM106394, R01-AI081838, T32-DK007301]","JJO was supported by funding from the National Institutes of Health NIGMS grant P20-GM103500 (Quinn, MT; PI), the MSU Agricultural Experiment Station, and an equipment grant from the M.J. Murdock Charitable Trust. RAC was supported by grants from the National Institutes of Health P30-GM103415 (Green, WR; PI), P30-GM106394 (Stanton, BA; PI), R01-AI081838. KMS is also supported by a National Institutes of Health training grant T32-DK007301 (Stanton, BA; PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Batra S, 2012, J IMMUNOL, V188, P3458, DOI 10.4049/jimmunol.1101985; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Ben-Ari J, 2012, EXPERT REV ANTI-INFE, V10, P881, DOI [10.1586/ERI.12.77, 10.1586/eri.12.77]; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brummer E, 2003, J INFECT DIS, V187, P705, DOI 10.1086/368383; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cohen NR, 2011, CELL HOST MICROBE, V10, P437, DOI 10.1016/j.chom.2011.09.011; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cramer RA, 2011, CURR OPIN INFECT DIS, V24, P315, DOI 10.1097/QCO.0b013e328348b159; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Deepe GS, 2006, J INFECT DIS, V194, P855; England H, 2014, J BIOL CHEM; Espinosa V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003940; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Gresnigt MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003936; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hayes GE, 2013, CURR OPIN PULM MED, V19, P259, DOI 10.1097/MCP.0b013e32835f1ad1; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jhingran A, 2012, CELL REP; Jin LL, 2014, J IMMUNOL, V193, P3549, DOI 10.4049/jimmunol.1401138; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kamberi M, 2002, CYTOKINE, V19, P14, DOI 10.1006/cyto.2002.1049; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Kurita N, 2005, MED MYCOL, V43, P417, DOI 10.1080/13693780400011088; Kurita N, 2000, MED MYCOL, V38, P177; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lei GW, 2013, CELL RES, V23, P965, DOI 10.1038/cr.2013.49; LeibundGut-Landmann S, 2011, J IMMUNOL, V186, P3130, DOI 10.4049/jimmunol.1003565; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039; Lewis RE, 2009, MED MYCOL, V47, pS271, DOI 10.1080/13693780802227159; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lin TJ, 2002, J IMMUNOL, V169, P4522, DOI 10.4049/jimmunol.169.8.4522; Mao LM, 2014, INFECT IMMUN, V82, P882, DOI 10.1128/IAI.01097-13; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mehrad B, 2002, AM J RESP CRIT CARE, V166, P1263, DOI 10.1164/rccm.200204-367OC; Mehrad B, 1999, J IMMUNOL, V163, P6086; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Park SJ, 2009, CLIN MICROBIOL REV, V22, P535, DOI 10.1128/CMR.00014-09; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Ramirez-Ortiz ZG, 2011, CELL HOST MICROBE, V9, P415, DOI 10.1016/j.chom.2011.04.007; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378; Smith NL, 2013, CLIN MICROBIOL INFEC; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stevens DA, 2011, IMMUNOL INVEST, V40, P751, DOI 10.3109/08820139.2011.614307; Swain SD, 2002, ANTIOXID REDOX SIGN, V4, P69, DOI 10.1089/152308602753625870; Tavares AH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002595; Tomalka J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002379; Torres HA, 2003, DIAGN MICR INFEC DIS, V46, P25, DOI 10.1016/S0732-8893(03)00013-0; Torres IM, 2014, INFECT IMMUN; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; VandenBergh MFQ, 1999, DIAGN MICR INFEC DIS, V34, P221, DOI 10.1016/S0732-8893(99)00026-7; Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480; Wellington M, 2013, MBIO, V4, DOI 10.1128/mBio.00433-12; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wojtowicz A, 2014, J INFECT DIS; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008",79,59,60,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004625,10.1371/journal.ppat.1004625,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100043,25629406.0,"DOAJ Gold, Green Published",,,16/08/2019,62,34,34,6871,1663,1262,401,5208,4188,26,994,34,1,0,0,60,60,1,,41,5,41,0,5,63,62,63,46,0,0,0,0,0,0,0,33,0,6883,24,0,196,64,2,5196,1663,23,0,196,64,2,24,,3,0,0,0,0,0,1,0,0,0,0,42,0,0,22.25,4.131689717378232,1.31931643625192,0.31931643625192013,1.3385176651305684,1.014553922282055,4.191822008418521
168,J,"Chatterjee, S; Nutman, TB",,,,"Chatterjee, Soumya; Nutman, Thomas B.",,,Helminth-Induced Immune Regulation: Implications for Immune Responses to Tuberculosis,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN LYMPHATIC FILARIASIS; HUMAN DENDRITIC CELLS; MYCOBACTERIUM-TUBERCULOSIS; IN-UTERO; LATENT TUBERCULOSIS; CYTOKINE RESPONSES; BCG VACCINATION; T-CELLS; INFECTION; ANTIGENS,,"[Chatterjee, Soumya; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA","Chatterjee, S (reprint author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.",chatterjees3@mail.nih.gov,,,"Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases","This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2003, J IMMUNOL, V171, P6723, DOI 10.4049/jimmunol.171.12.6723; Babu S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000489; Babu S, 2009, J INFECT DIS, V200, P288, DOI 10.1086/599797; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Cooper PJ, 2001, J INFECT DIS, V183, P1662, DOI 10.1086/320709; Elias D, 2006, TROP MED INT HEALTH, V11, P551, DOI 10.1111/j.1365-3156.2006.01578.x; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Guadalupe I, 2009, J INFECT DIS, V199, P1846, DOI 10.1086/599214; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hubner MP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001970; King CL, 2001, J IMMUNOL, V166, P7427, DOI 10.4049/jimmunol.166.12.7427; KULLBERG MC, 1992, J IMMUNOL, V148, P3264; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Malhotra I, 1999, J IMMUNOL, V162, P6843; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P732; Mejia R, 2013, AM J TROP MED HYG, V88, P1041, DOI 10.4269/ajtmh.12-0726; Metenou S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00305; Millard JD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-310; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; Porthouse KH, 2006, INFECT IMMUN, V74, P2366, DOI 10.1128/IAI.74.4.2366-2372.2006; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; RESENDE CT, 2007, CLIN EXP IMMUNOL, V147, P45, DOI DOI 10.1111/J.1365-2249.2006.03247.X; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.immunol.12.1.635; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Talaat KR, 2006, J INFECT DIS, V193, P196, DOI 10.1086/498912; Webb EL, 2011, LANCET, V377, P52, DOI 10.1016/S0140-6736(10)61457-2; WEIL GJ, 1983, J CLIN INVEST, V71, P1124, DOI 10.1172/JCI110862; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wood R, 2010, INT J TUBERC LUNG D, V14, P406",37,14,14,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004582,10.1371/journal.ppat.1004582,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100019,25632943.0,"DOAJ Gold, Green Published",,,16/08/2019,15,6,56,6034,1289,976,313,4745,3827,29,889,56,1,0,0,16,16,0,,68,7,66,0,7,15,15,13,10,0,0,0,0,0,0,0,5,2,6069,36,0,551,37,0,4734,1289,36,0,551,37,0,46,,0,0,0,0,3,0,1,0,0,0,0,67,0,0,1.25,4.681148176881304,1.271654373024236,0.27165437302423606,1.2944151738672287,1.0178985747431224,4.764934057408844
169,J,"Clouthier, DL; Zhou, AC; Wortzman, ME; Luft, O; Levy, GA; Watts, TH",,,,"Clouthier, Derek L.; Zhou, Angela C.; Wortzman, Michael E.; Luft, Olga; Levy, Gary A.; Watts, Tania H.",,,GITR Intrinsically Sustains Early Type 1 and Late Follicular Helper CD4 T Cell Accumulation to Control a Chronic Viral Infection,PLOS PATHOGENS,,,English,Article,,,,,,,INDUCED TNF RECEPTOR; IN-VIVO; EFFECTOR FUNCTION; HIV-1 INFECTION; TRANSGENIC MICE; PERSISTENCE; RESPONSES; COSTIMULATION; EXHAUSTION; EXPANSION,"CD4 T cells are critical for control of persistent infections; however, the key signals that regulate CD4 T help during chronic infection remain incompletely defined. While several studies have addressed the role of inhibitory receptors and soluble factors such as PD-1 and IL-10, significantly less work has addressed the role of T cell co-stimulatory molecules during chronic viral infection. Here we show that during a persistent infection with lymphocytic choriomeningitis virus (LCMV) clone 13, mice lacking the glucocorticoid-induced tumor necrosis factor receptor related protein (GITR) exhibit defective CD8 T cell accumulation, increased T cell exhaustion and impaired viral control. Differences in CD8 T cells and viral control between GITR(+/+) and GITR(-/-) mice were lost when CD4 T cells were depleted. More-over, mixed bone marrow chimeric mice, as well as transfer of LCMV epitope-specific CD4 or CD8 T cells, demonstrated that these effects of GITR are largely CD4 T cell-intrinsic. GITR is dispensable for initial CD4 T cell proliferation and differentiation, but supports the post-priming accumulation of IFN gamma(+) IL-2(+) Th1 cells, facilitating CD8 T cell expansion and early viral control. GITR-dependent phosphorylation of the p65 subunit of NF-kappa B as well as phosphorylation of the downstream mTORC1 target, S6 ribosomal protein, were detected at day three post-infection (p.i.), and defects in CD4 T cell accumulation in GITR-deficient T cells were apparent starting at day five p.i. Consistently, we pinpoint IL-2-dependent CD4 T cell help for CD8 T cells to between days four and eight p.i. GITR also increases the ratio of T follicular helper to T follicular regulatory cells and thereby enhances LCMV-specific IgG production. Together, these findings identify a CD4 T cell-intrinsic role for GITR in sustaining early CD8 and late humoral responses to collectively promote control of chronic LCMV clone 13 infection.","[Clouthier, Derek L.; Zhou, Angela C.; Wortzman, Michael E.; Levy, Gary A.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Luft, Olga; Levy, Gary A.] Univ Toronto, Inst Transplantat, Toronto, ON, Canada; [Luft, Olga] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada","Watts, TH (reprint author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.",tania.watts@utoronto.ca,,,Canadian Institutes of Health Research (CIHR) [MOP 123480]; CIHR; Canadian Association for HIV research; Ontario Graduate Scholarship,"This research was funded by grant MOP 123480 from the Canadian Institutes of Health Research (CIHR) to THW; DLC held studentships funded by CIHR and the Canadian Association for HIV research, ACZ was funded by an Ontario Graduate Scholarship; THW holds the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","AHMED R, 1988, J EXP MED, V167, P1719, DOI 10.1084/jem.167.5.1719; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1994, J VIROL, V68, P4700; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Clouthier DL, 2014, J IMMUNOL, V193, P5033, DOI 10.4049/jimmunol.1401002; Clouthier DL, 2014, CYTOKINE GROWTH F R, V25, P91, DOI 10.1016/j.cytogfr.2013.12.003; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Ephrem A, 2013, EUR J IMMUNOL, V43, P2421, DOI 10.1002/eji.201343451; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Han JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00245; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; MATLOUBIAN M, 1994, J VIROL, V68, P8056; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Ng CT, 2013, CELL HOST MICROBE, V13, P652, DOI 10.1016/j.chom.2013.05.014; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Teodorovic LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031632; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; von Herrath M, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1910s36; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205",49,17,18,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004517,10.1371/journal.ppat.1004517,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100003,25590581.0,"DOAJ Gold, Green Published",,,16/08/2019,16,27,24,4425,460,355,105,3965,3342,22,601,24,0,0,0,16,16,0,,31,1,31,0,1,17,16,17,10,0,0,0,0,0,0,0,27,2,4429,50,0,597,21,0,3961,460,50,0,597,21,0,8,,0,0,0,0,2,0,0,0,0,0,0,31,0,0,0.5,9.619565217391305,1.116015132408575,0.11601513240857503,1.1349306431273645,1.0169491525423728,9.782608695652174
170,J,"Corcoran, JA; Johnston, BP; McCormick, C",,,,"Corcoran, Jennifer A.; Johnston, Benjamin P.; McCormick, Craig",,,"Viral Activation of MK2-hsp27-p115RhoGEF-RhoA Signaling Axis Causes Cytoskeletal Rearrangements, P-body Disruption and ARE-mRNA Stabilization",PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN; ENDOTHELIAL-CELL MIGRATION; ACTIN-BASED MOTILITY; AU-RICH ELEMENTS; PROCESSING BODIES; RHO GTPASES; KINASE 2; STRESS GRANULES,"Kaposi's sarcoma-associated herpesvirus (KSHV) is the infectious cause of several AIDS-related cancers, including the endothelial cell (EC) neoplasm Kaposi's sarcoma (KS). KSHV-infected ECs secrete abundant host-derived pro-inflammatory molecules and angiogenic factors that contribute to tumorigenesis. The precise contributions of viral gene products to this secretory phenotype remain to be elucidated, but there is emerging evidence for post-transcriptional regulation. The Kaposin B (KapB) protein is thought to contribute to the secretory phenotype in infected cells by binding and activating the stress-responsive kinase MK2, thereby selectively blocking decay of AU-rich mRNAs (ARE-mRNAs) encoding proinflammatory cytokines and angiogenic factors. Processing bodies (PBs) are cytoplasmic ribonucleoprotein foci in which ARE-mRNAs normally undergo rapid 59 to 39 decay. Here, we demonstrate that PB dispersion is a feature of latent KSHV infection, which is dependent on kaposin protein expression. KapB is sufficient to disperse PBs, and KapB-mediated ARE-mRNA stabilization could be partially reversed by treatments that restore PBs. Using a combination of genetic and chemical approaches we provide evidence that KapB-mediated PB dispersion is dependent on activation of a non-canonical Rho-GTPase signaling axis involving MK2, hsp27, p115RhoGEF and RhoA. PB dispersion in latently infected cells is likewise dependent on p115RhoGEF. In addition to PB dispersion, KapB-mediated RhoA activation in primary ECs caused actin stress fiber formation, increased cell motility and angiogenesis; these effects were dependent on the activity of the RhoA substrate kinases ROCK1/2. By contrast, KapB-mediated PB dispersion occurred in a ROCK1/2-independent manner. Taken together, these observations position KapB as a key contributor to viral reprogramming of ECs, capable of eliciting many of the phenotypes characteristic of KS tumor cells, and strongly contributing to the post-transcriptional control of EC gene expression and secretion.","[Corcoran, Jennifer A.; Johnston, Benjamin P.; McCormick, Craig] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Corcoran, Jennifer A.; Johnston, Benjamin P.; McCormick, Craig] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada","McCormick, C (reprint author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.",craig.mccormick@dal.ca,,"McCormick, Craig/0000-0003-2794-3722",Canadian Institutes of Health Research [CIHR-MOP-84554],"This work was supported by a grant to CM from the Canadian Institutes of Health Research (CIHR-MOP-84554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Aranda E, 2009, BIOL RES, V42, P377, DOI [/S0716-97602009000300012, 10.4067/S0716-97602009000300012]; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Ciufo DM, 2001, J VIROL, V75, P5614, DOI 10.1128/JVI.75.12.5614-5626.2001; Corcoran JA, 2012, J VIROL, V86, P8859, DOI 10.1128/JVI.00597-12; Corcoran JA, 2011, METHODS, V55, P172, DOI 10.1016/j.ymeth.2011.08.005; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Cougot N, 2012, J MOL BIOL, V420, P17, DOI 10.1016/j.jmb.2012.03.027; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Fujihara H, 1997, MOL BIOL CELL, V8, P2437, DOI 10.1091/mbc.8.12.2437; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Garcia MC, 2009, J BIOL CHEM, V284, P20936, DOI 10.1074/jbc.M109.020271; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Huang J, 2014, MOL CELL BIOCHEM, V390, P115, DOI 10.1007/s11010-014-1962-1; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Landry J, 1999, BIOCHEM SOC SYMP, P79; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ojala PM, 2014, SEMIN CANCER BIOL, V26, P69, DOI 10.1016/j.semcancer.2014.01.008; Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Rajgor D, 2014, J CELL BIOL, V205, P457, DOI 10.1083/jcb.201306076; Reed JC, 2012, J CELL BIOL, V198, P439, DOI 10.1083/jcb.201111012; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Seto E, 2014, VIROLOGY, V458, P151, DOI 10.1016/j.virol.2014.04.022; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOULIER J, 1995, BLOOD, V86, P1276; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Takahashi S, 2011, NUCLEIC ACIDS RES, V39, P3446, DOI 10.1093/nar/gkq1302; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wittchen ES, 2008, METHOD ENZYMOL, V443, P285, DOI 10.1016/S0076-6879(08)02014-4; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yoo J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001046; Yoo SM, 2008, J VIROL METHODS, V154, P160, DOI 10.1016/j.jviromet.2008.07.026",88,6,8,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004597,10.1371/journal.ppat.1004597,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100028,25569678.0,"DOAJ Gold, Green Published",,,16/08/2019,7,47,17,6196,749,506,243,5447,4912,24,511,17,17,0,0,5,5,2,,24,0,24,0,0,7,7,5,3,0,0,0,0,0,0,1,75,51,6242,25,0,257,106,0,5457,759,25,0,257,106,0,26,,2,0,0,0,12,0,1,1,0,0,0,23,0,0,24.0,8.272363150867823,1.137506884523591,0.13750688452359097,1.1700018358729576,1.0285668173014848,8.5086782376502
171,J,"Craigo, JK; Ezzelarab, C; Cook, SJ; Liu, C; Horohov, D; Issel, CJ; Montelaro, RC",,,,"Craigo, Jodi K.; Ezzelarab, Corin; Cook, Sheila J.; Liu, Chong; Horohov, David; Issel, Charles J.; Montelaro, Ronald C.",,,Protective Efficacy of Centralized and Polyvalent Envelope Immunogens in an Attenuated Equine Lentivirus Vaccine,PLOS PATHOGENS,,,English,Article,,,,,,,INFECTIOUS-ANEMIA VIRUS; COMPUTATIONALLY OPTIMIZED HEMAGGLUTININ; POLYMERASE-CHAIN-REACTION; HUMORAL IMMUNE-RESPONSES; TERM INAPPARENT CARRIER; SUBTYPE-B ENVELOPE; PERSISTENT INFECTION; NEUTRALIZING ANTIBODIES; VIRAL REPLICATION; RHESUS-MONKEYS,"Lentiviral Envelope (Env) antigenic variation and related immune evasion present major hurdles to effective vaccine development. Centralized Env immunogens that minimize the genetic distance between vaccine proteins and circulating viral isolates are an area of increasing study in HIV vaccinology. To date, the efficacy of centralized immunogens has not been evaluated in the context of an animal model that could provide both immunogenicity and protective efficacy data. We previously reported on a live-attenuated (attenuated) equine infectious anemia (EIAV) virus vaccine, which provides 100% protection from disease after virulent, homologous, virus challenge. Further, protective efficacy demonstrated a significant, inverse, linear relationship between EIAV Env divergence and protection from disease when vaccinates were challenged with viral strains of increasing Env divergence from the vaccine strain Env. Here, we sought to comprehensively examine the protective efficacy of centralized immunogens in our attenuated vaccine platform. We developed, constructed, and extensively tested a consensus Env, which in a virulent proviral backbone generated a fully replication-competent pathogenic virus, and compared this consensus Env to an ancestral Env in our attenuated proviral backbone. A polyvalent attenuated vaccine was established for comparison to the centralized vaccines. Additionally, an engineered quasispecies challenge model was created for rigorous assessment of protective efficacy. Twenty-four EIAV-naive animals were vaccinated and challenged along with six-control animals six months post-second inoculation. Pre-challenge data indicated the consensus Env was more broadly immunogenic than the Env of the other attenuated vaccines. However, challenge data demonstrated a significant increase in protective efficacy of the polyvalent vaccine. These findings reveal, for the first time, a consensus Env immunogen that generated a fully-functional, replication-competent lentivirus, which when experimentally evaluated, demonstrated broader immunogenicity that does not equate to higher protective efficacy.","[Craigo, Jodi K.; Ezzelarab, Corin; Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Craigo, Jodi K.; Ezzelarab, Corin; Montelaro, Ronald C.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Cook, Sheila J.; Liu, Chong; Horohov, David; Issel, Charles J.] Univ Kentucky, Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY USA","Craigo, JK (reprint author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.",craigoj@pitt.edu,,,NIH/NIAID [RO1 AI25850],"This work was supported by NIH/NIAID (http://www.niaid.nih.gov) grant RO1 AI25850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anastassopoulou CG, 2006, CURR HIV RES, V4, P365, DOI 10.2174/157016206777709456; Brander C, 2006, CURR OPIN IMMUNOL, V18, P430, DOI 10.1016/j.coi.2006.05.012; Cook RF, 2003, VIROLOGY, V313, P588, DOI 10.1016/S0042-6822(03)00351-9; Cook RF, 2002, J VIROL METHODS, V105, P171, DOI 10.1016/S0166-0934(02)00101-5; Craigo JK, 2006, VIROLOGY, V344, P340, DOI 10.1016/j.virol.2005.09.006; Craigo JK, 2005, J VIROL, V79, P2666, DOI 10.1128/JVI.79.5.2666-2677.2005; Craigo JK, 2008, ENCY VIROLOGY, V3, P167; Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104; Craigo JK, 2007, VACCINE, V25, P834, DOI 10.1016/j.vaccine.2006.09.040; Craigo JK, 2013, VIRUSES-BASEL, V5, P2963, DOI 10.3390/v5122963; Craigo JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066093; Craigo JK, 2012, J VIROL METHODS, V185, P221, DOI 10.1016/j.jviromet.2012.07.007; Craigo JK, 2011, FUTURE VIROL, V6, P139, DOI 10.2217/FVL.10.85; Craigo JK, 2010, VACCINE, V28, P8095, DOI 10.1016/j.vaccine.2010.10.003; Craigo JK, 2010, LENTIVIRUSES AND MACROPHAGES: MOLECULAR AND CELLULAR INTERACTIONS, P1; Craigo JK, 2010, CURR HIV RES, V8, P81, DOI 10.2174/157016210790416398; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Eugene HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-102; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gao F, 2007, CURR HIV RES, V5, P572, DOI 10.2174/157016207782418498; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Giles BM, 2012, J INFECT DIS, V205, P1562, DOI 10.1093/infdis/jis232; Giles BM, 2012, EXPERT REV VACCINES, V11, P267, DOI [10.1586/ERV.12.3, 10.1586/erv.12.3]; Giles BM, 2012, CLIN VACCINE IMMUNOL, V19, P128, DOI 10.1128/CVI.05533-11; Giles BM, 2011, VACCINE, V29, P3043, DOI 10.1016/j.vaccine.2011.01.100; Hammond SA, 2000, J VIROL, V74, P5968, DOI 10.1128/JVI.74.13.5968-5981.2000; Hammond SA, 1997, J VIROL, V71, P3840; Harrold SM, 2000, J VIROL, V74, P3112, DOI 10.1128/JVI.74.7.3112-3121.2000; Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002; ISSEL CJ, 1992, J VIROL, V66, P3398; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KONO Y, 1976, NATL I ANIM HEALTH Q, V16, P8; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Leroux C, 1997, J VIROL, V71, P9627; Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020; Leroux C, 2001, J VIROL, V75, P4570, DOI 10.1128/JVI.75.10.4570-4583.2001; Li F, 1998, J VIROL, V72, P8344; Li F, 2003, J VIROL, V77, P7244, DOI 10.1128/JVI.77.13.7244-7253.2003; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Lichtenstein DL, 1996, J VIROL, V70, P3346; Liu C, 2012, VET IMMUNOL IMMUNOP, V148, P302, DOI 10.1016/j.vetimm.2012.06.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBurney SP, 2009, VACCINE, V27, P4337, DOI 10.1016/j.vaccine.2009.04.032; Mills J, 2000, AIDS RES HUM RETROV, V16, P1453, DOI 10.1089/088922200750005976; Montelaro R C, 1995, AIDS, V9 Suppl A, pS111; Montelaro R. C., 1993, The Retroviridae, volume 2., P257; Montelaro RC, 1998, AIDS RES HUM RETROV, V14, pS255; Mullins James I, 2004, Expert Rev Vaccines, V3, pS151, DOI 10.1586/14760584.3.4.S151; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Nickle DC, 2003, SCIENCE, V299, P1515; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Santra S, 2012, VIROLOGY, V428, P121, DOI 10.1016/j.virol.2012.03.012; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Tagmyer TL, 2008, J VIROL, V82, P4052, DOI 10.1128/JVI.02028-07; Tagmyer TL, 2007, J GEN VIROL, V88, P1324, DOI 10.1099/vir.0.82391-0; Uhl EW, 2002, VET IMMUNOL IMMUNOP, V90, P113, DOI 10.1016/S0165-2427(02)00227-1; Weaver EA, 2010, AIDS RES HUM RETROV, V26, P577, DOI 10.1089/aid.2009.0258; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05",62,6,7,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004610,10.1371/journal.ppat.1004610,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100038,25569288.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,6,0,6,2256,406,282,124,1850,1569,26,255,6,0,1,0,4,4,0,,8,3,8,0,3,6,6,5,3,0,0,0,0,0,0,0,0,0,2324,261,0,77,143,4,1856,409,40,0,77,141,4,59,,0,0,0,0,0,0,0,1,0,0,0,8,0,0,0.25,5.556650246305419,1.2194594594594594,0.21945945945945947,1.4745945945945946,1.2092198581560283,6.719211822660099
172,J,"Cunnington, AJ",,,,"Cunnington, Aubrey J.",,,The Importance of Pathogen Load,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,PARASITE SEQUESTRATION; MALARIA; DISEASE; RESISTANCE; TOLERANCE,,"Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England","Cunnington, AJ (reprint author), Univ London Imperial Coll Sci Technol & Med, Paediat Sect, Med Sch Bldg,St Marys Campus,Norfolk Pl, London, England.",a.cunnington@imperial.ac.uk,,"Cunnington, Aubrey/0000-0002-1305-3529",Medical Research Council [MR/L006529/1],,"Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Barber BE, 2014, PLOS PATHOG IN PRESS; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Cunnington AJ, 2013, TRENDS PARASITOL, V29, P585, DOI 10.1016/j.pt.2013.10.004; Cunnington AJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007432; Cunnington AJ, 2013, J INFECTION, V67, P220, DOI 10.1016/j.jinf.2013.04.013; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Hatano H, 2013, AIDS, V27, P2255, DOI 10.1097/QAD.0b013e328362692f; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; Imwong M, 2015, J INFECT DIS, V211, P1128, DOI 10.1093/infdis/jiu590; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meliopoulos VA, 2014, J VIROL, V88, P12982, DOI 10.1128/JVI.01571-14; Palumbo PE, 1998, JAMA-J AM MED ASSOC, V279, P756, DOI 10.1001/jama.279.10.756; Pollakis G, 2012, CURR OPIN HIV AIDS, V7, P440, DOI 10.1097/COH.0b013e328356e9f3; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Ruell J, 2007, BONE MARROW TRANSPL, V40, P55, DOI 10.1038/sj.bmt.1705671; Schmidt C, 2014, J CELL COMMUN SIGNAL, V8, P363, DOI 10.1007/s12079-014-0246-6; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116",21,6,6,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004563,10.1371/journal.ppat.1004563,,,,2,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100010,25569282.0,"DOAJ Gold, Green Published",,,16/08/2019,8,11,38,6444,2918,2727,191,3526,2985,19,522,38,10,0,0,8,8,0,,39,0,39,0,0,12,9,12,4,0,0,0,0,0,0,0,0,2,6538,0,0,0,20,0,3539,2988,0,0,0,20,0,11,,0,0,0,0,13,0,1,0,0,0,0,38,0,0,8.5,2.2083618917066485,1.827566647759501,0.8275666477595008,1.8598979013045944,1.0176908752327747,2.247429746401645
173,J,"Dai, LL; Gao, JX; Zou, CG; Ma, YC; Zhang, KQ",,,,"Dai, Li-Li; Gao, Jin-Xia; Zou, Cheng-Gang; Ma, Yi-Cheng; Zhang, Ke-Qin",,,mir-233 Modulates the Unfolded Protein Response in C. elegans during Pseudomonas aeruginosa Infection,PLOS PATHOGENS,,,English,Article,,,,,,,ENDOPLASMIC-RETICULUM STRESS; CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; MICRORNAS; HOST; RNA; ACTIVATION; SURVIVAL; REVEALS; DISEASE,"The unfolded protein response (UPR), which is activated by perturbations of the endoplasmic reticulum homeostasis, has been shown to play an important role in innate immunity and inflammation. However, little is known about the molecular mechanisms underlying activation of the UPR during immune responses. Using small RNA deep sequencing and reverse genetic analysis, we show that the microRNA mir-233 is required for activation of the UPR in Caenorhabditis elegans exposed to Pseudomonas aeruginosa PA14. P. aeruginosa infection up-regulates the expression of mir-233 in a p38 MAPK-dependent manner. Quantitative proteomic analysis identifies SCA-1, a C. elegans homologue of the sarco/endoplasmic reticulum Ca2+-ATPase, as a target of mir-233. During P. aeruginosa PA14 infection, mir-233 represses the protein levels of SCA-1, which in turn leads to activation of the UPR. Whereas mir-233 mutants are more sensitive to P. aeruginosa infection, knockdown of sca-1 leads to enhanced resistance to the killing by P. aeruginosa. Our study indicates that microRNA-dependent pathways may have an impact on innate immunity by activating the UPR.","[Dai, Li-Li; Gao, Jin-Xia; Zou, Cheng-Gang; Ma, Yi-Cheng; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China","Zou, CG (reprint author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.",chgzou@ynu.edu.cn; kqzhang1@aliyun.com,,,"National Basic Research Program of China (973) [2013CB127500, 2012CB722208]; Ministry of Education of the People's Republic of China [213035A]; National Natural Science Foundation of China [311171365]","This work was supported in part by grants (2013CB127500 and 2012CB722208) from National Basic Research Program of China (973) (to KQZ), a grant from Ministry of Education of the People's Republic of China (213035A) and a grant from the National Natural Science Foundation of China (311171365) (to CGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript","Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen Z, 2013, MOL CELL PROTEOMICS, V12, P2266, DOI 10.1074/mcp.M112.025817; Cho JH, 2000, GENE, V261, P211, DOI 10.1016/S0378-1119(00)00536-9; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Gu SG, 2007, RNA, V13, P1492, DOI 10.1261/rna.581907; Heikkinen L, 2011, BIOINFORMATICS, V27, P1247, DOI 10.1093/bioinformatics/btr144; Iatsenko I, 2013, INFECT IMMUN, V81, P3942, DOI 10.1128/IAI.00700-13; Imielinski M, 2012, MOL CELL PROTEOMICS, V11; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kudlow BA, 2012, MOL CELL, V46, P530, DOI 10.1016/j.molcel.2012.03.011; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liang CP, 2012, DIABETES, V61, P2609, DOI 10.2337/db11-1415; Liu CY, 2003, J CELL SCI, V116, P1861, DOI 10.1242/jcs.00408; Liu F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003545; Mao XR, 2010, MOL CELL BIOL, V30, P5033, DOI 10.1128/MCB.00922-10; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Nehrke K, 2008, AM J PHYSIOL-CELL PH, V294, pC333, DOI 10.1152/ajpcell.00303.2007; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200",43,22,22,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004606,10.1371/journal.ppat.1004606,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100036,25569229.0,"DOAJ Gold, Green Published",,,16/08/2019,23,0,30,4185,506,391,115,3679,3004,28,647,30,0,0,0,20,20,0,,36,2,36,0,2,23,23,19,12,0,0,0,0,0,0,0,0,1,4186,162,0,175,42,0,3656,506,162,0,175,42,0,24,,0,0,0,0,5,0,0,1,0,0,0,35,0,0,3.0,8.270750988142293,1.137537374286491,0.1375373742864909,1.193259037782006,1.048984468339307,8.67588932806324
174,J,"Darby, M; Schnoeller, C; Vira, A; Culley, F; Bobat, S; Logan, E; Kirstein, F; Wess, J; Cunningham, AF; Brombacher, F; Selkirk, ME; Horsnell, WGC",,,,"Darby, Matthew; Schnoeller, Corinna; Vira, Alykhan; Culley, Fiona; Bobat, Saeeda; Logan, Erin; Kirstein, Frank; Wess, Juergen; Cunningham, Adam F.; Brombacher, Frank; Selkirk, Murray E.; Horsnell, William G. C.",,,The M3 Muscarinic Receptor Is Required for Optimal Adaptive Immunity to Helminth and Bacterial Infection,PLOS PATHOGENS,,,English,Article,,,,,,,MUSCARINIC ACETYLCHOLINE-RECEPTORS; ENTERICA SEROVAR TYPHIMURIUM; T-CELLS; SALMONELLA-TYPHIMURIUM; MICE; M-3; HYPERCONTRACTILITY; DIFFERENTIATION; PHARMACOLOGY; ACTIVATION,"Innate immunity is regulated by cholinergic signalling through nicotinic acetylcholine receptors. We show here that signalling through the M3 muscarinic acetylcholine receptor (M3R) plays an important role in adaptive immunity to both Nippostrongylus brasiliensis and Salmonella enterica serovar Typhimurium, as M3R(-/-) mice were impaired in their ability to resolve infection with either pathogen. CD4 T cell activation and cytokine production were reduced in M3R(-/-) mice. Immunity to secondary infection with N. brasiliensis was severely impaired, with reduced cytokine responses in M3R(-/-) mice accompanied by lower numbers of mucus-producing goblet cells and alternatively activated macrophages in the lungs. Ex vivo lymphocyte stimulation of cells from intact BALB/c mice infected with N. brasiliensis and S. typhimurium with muscarinic agonists resulted in enhanced production of IL-13 and IFN-gamma respectively, which was blocked by an M3R-selective antagonist. Our data therefore indicate that cholinergic signalling via the M3R is essential for optimal Th1 and Th2 adaptive immunity to infection.","[Darby, Matthew; Vira, Alykhan; Logan, Erin; Kirstein, Frank; Brombacher, Frank; Horsnell, William G. C.] Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Darby, Matthew; Vira, Alykhan; Logan, Erin; Kirstein, Frank; Brombacher, Frank; Horsnell, William G. C.] Univ Cape Town, Div Immunol, ZA-7925 Cape Town, South Africa; [Schnoeller, Corinna; Selkirk, Murray E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Culley, Fiona] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bobat, Saeeda; Cunningham, Adam F.] Univ Birmingham, Sch Immun & Infect, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; [Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA","Darby, M (reprint author), Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.",m.selkirk@imperial.ac.uk; wghorsnell@gmail.com,,"Selkirk, Murray/0000-0002-6274-6014; Darby, Matthew/0000-0002-3701-0056; Culley, Fiona/0000-0001-5208-4259; Logan, Erin/0000-0001-7935-1337; , William/0000-0001-7172-408X",South African National Research Foundation [91555]; International Centre for Genetic Engineering and Biotechnology; National Research Foundation; World University Network; Wellcome Trust [059532]; Biotechnology and Biological Sciences Research Council [BB/L009986/1]; Medical Research Council [G1001763],"The project was funded by a South African National Research Foundation Grant (Grant #: 91555) awarded to WH and the International Centre for Genetic Engineering and Biotechnology, the National Research Foundation, the World University Network and the Wellcome Trust (Ref 059532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Akiho H, 2005, AM J PHYSIOL-GASTR L, V288, pG609, DOI 10.1152/ajpgi.00273.2004; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; CAULFIELD MP, 1993, PROG BRAIN RES, V98, P293; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Ebihara T, 2006, J BIOCHEM, V139, P449, DOI 10.1093/jb/mvj064; Eglen RM, 2005, PROGR MED CHEM, V43, P105, DOI 10.1016/S0079-6468(05)43004-0; FELDER CC, 1995, FASEB J, V9, P619; Fernandez-Cabezudo MJ, 2010, IMMUNOLOGY, V130, P388, DOI 10.1111/j.1365-2567.2009.03238.x; Fujii T, 2000, JPN J PHARMACOL, V84, P124, DOI 10.1254/jjp.84.124; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Guo LY, 2008, J IMMUNOL, V181, P3984, DOI 10.4049/jimmunol.181.6.3984; Harvie M, 2010, INFECT IMMUN, V78, P3753, DOI 10.1128/IAI.00502-09; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hess J, 1996, J IMMUNOL, V156, P3321; Horsnell WGC, 2011, MUCOSAL IMMUNOL, V4, P83, DOI 10.1038/mi.2010.46; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kistemaker LEM, 2014, AM J RESP CELL MOL, V50, P690, DOI 10.1165/rcmb.2013-0220OC; Liu PJ, 2011, BIOMED PHARMACOTHER, V65, P193, DOI 10.1016/j.biopha.2010.10.011; Matsui M, 2002, J NEUROSCI, V22, P10627; Mitsuya M, 1999, BIOORGAN MED CHEM, V7, P2555, DOI 10.1016/S0968-0896(99)00177-7; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457; Moulton BC, 2011, BRIT J PHARMACOL, V163, P44, DOI 10.1111/j.1476-5381.2010.01190.x; Ndlovu H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003906; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Razani-Boroujerdi S, 2008, J NEUROIMMUNOL, V194, P83, DOI 10.1016/j.jneuroim.2007.11.019; Reardon C, 2013, P NATL ACAD SCI USA, V110, P1410, DOI 10.1073/pnas.1221655110; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ross EA, 2011, J IMMUNOL, V187, P1553, DOI 10.4049/jimmunol.1000502; Salamone G, 2011, J NEUROIMMUNOL, V236, P47, DOI 10.1016/j.jneuroim.2011.05.007; Skok M, 2005, EUR J PHARMACOL, V517, P246, DOI 10.1016/j.ejphar.2005.05.011; Thawer SG, 2013, MUCOSAL IMMUNOL, DOI 10.1038/mi.2013.40; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Vira A, 2012, ROLE M3 MUSCARINIC R; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wick MJ, 2011, J INNATE IMMUN, V3, P543, DOI 10.1159/000330771; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zimring JC, 2005, J NEUROIMMUNOL, V164, P66, DOI 10.1016/j.jneuroim.2005.03.018",42,13,13,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004636,10.1371/journal.ppat.1004636,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100046,25629518.0,"DOAJ Gold, Green Published",,,16/08/2019,17,7,24,5087,1202,942,260,3885,3196,25,664,24,1,0,0,16,16,1,,39,2,39,0,2,17,17,16,8,0,0,0,0,0,0,0,6,3,5158,29,0,205,76,0,3905,1213,29,0,205,76,0,40,,0,2,0,0,1,0,1,0,0,0,0,39,0,0,13.796,4.232113144758736,1.3093951093951095,0.3093951093951094,1.3546975546975546,1.0345979948889326,4.378535773710483
175,J,"Gondorf, F; Berbudi, A; Buerfent, BC; Ajendra, J; Bloemker, D; Specht, S; Schmidt, D; Neumann, AL; Layland, LE; Hoerauf, A; Hubner, MP",,,,"Gondorf, Fabian; Berbudi, Afiat; Buerfent, Benedikt C.; Ajendra, Jesuthas; Bloemker, Dominique; Specht, Sabine; Schmidt, David; Neumann, Anna-Lena; Layland, Laura E.; Hoerauf, Achim; Huebner, Marc P.",,,Chronic Filarial Infection Provides Protection against Bacterial Sepsis by Functionally Reprogramming Macrophages,PLOS PATHOGENS,,,English,Article,,,,,,,NONOBESE DIABETIC MICE; REGULATORY T-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; ALLERGIC AIRWAY INFLAMMATION; HELMINTH INFECTION; LITOMOSOIDES-SIGMODONTIS; IMMUNE-RESPONSES; BRUGIA-MALAYI; MYCOBACTERIAL ANTIGENS; LYMPHATIC FILARIASIS,"Helminths immunomodulate their hosts and induce a regulatory, anti-inflammatory milieu that prevents allergies and autoimmune diseases. Helminth immunomodulation may benefit sepsis outcome by preventing exacerbated inflammation and severe pathology, but the influence on bacterial clearance remains unclear. To address this, mice were chronically infected with the filarial nematode Litomosoides sigmodontis (L.s.) and the outcome of acute systemic inflammation caused by i.p. Escherichia coli injection was determined. L.s. infection significantly improved E. coli-induced hypothermia, bacterial clearance and sepsis survival and correlated with reduced concentrations of associated pro-inflammatory cytokines/chemokines and a less pronounced pro-inflammatory macrophage gene expression profile. Improved sepsis outcome in L.s.-infected animals was mediated by macrophages, but independent of the alternatively activated macrophage subset. Endosymbiotic Wolbachia bacteria that are present in most human pathogenic filariae, as well as L.s., signal via TLR2 and modulate macrophage function. Here, gene expression profiles of peritoneal macrophages from L.s.-infected mice revealed a downregulation of genes involved in TLR signaling, and pulsing of macrophages in vitro with L.s. extract reduced LPS-triggered activation. Subsequent transfer improved sepsis outcome in naive mice in a Wolbachia-and TLR2-dependent manner. In vivo, phagocytosis was increased in macrophages from L.s.-infected wild type, but not TLR2-deficient animals. In association, L.s. infection neither improved bacterial clearance in TLR2-deficient animals nor ameliorated E. coli-induced hypothermia and sepsis survival. These results indicate that chronic L.s. infection has a dual beneficial effect on bacterial sepsis, reducing pro-inflammatory immune responses and improving bacterial control. Thus, helminths and their antigens may not only improve the outcome of autoimmune and allergic diseases, but may also present new therapeutic approaches for acute inflammatory diseases that do not impair bacterial control.","[Gondorf, Fabian; Berbudi, Afiat; Buerfent, Benedikt C.; Ajendra, Jesuthas; Bloemker, Dominique; Specht, Sabine; Schmidt, David; Neumann, Anna-Lena; Layland, Laura E.; Hoerauf, Achim; Huebner, Marc P.] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Bloemker, Dominique] Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany","Hubner, MP (reprint author), Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.",huebner@microbiology-bonn.de,"Hubner, Marc/W-9529-2018; Hubner, Marc P/O-1684-2019","Hubner, Marc/0000-0001-8885-418X; Hubner, Marc P/0000-0001-8885-418X; Berbudi, Afiat/0000-0001-8809-0810","German Research Foundation [HU 2144/1-1]; University Hospital of Bonn (BONFOR) [2010-1-16, 2011-1-10]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under Research Executive Agency [GA 276704]; German Academic Exchange Service (DAAD); Jurgen Manchot Stiftung, Dusseldorf; Excellence Cluster Immunosensation (DFG) [EXC 1023]","This work was funded by the German Research Foundation (HU 2144/1-1); intramural funding by the University Hospital of Bonn (BONFOR, 2010-1-16 and 2011-1-10); and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency Grant GA 276704. AB was supported by the German Academic Exchange Service (DAAD) and BCB was supported by the Jurgen Manchot Stiftung, Dusseldorf. AH is a member of the German Centre for Infection Research (DZIF), and of the Excellence Cluster Immunosensation (DFG, EXC 1023).","Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; AMERSFOORT ESV, 2003, CLIN MICROBIOL REV, V16, P379; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arndts K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001611; Babu S, 2005, J IMMUNOL, V175, P1170, DOI 10.4049/jimmunol.175.2.1170; BIEWENGA J, 1995, CELL TISSUE RES, V280, P189, DOI 10.1007/BF00304524; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Correale J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00112; Danilowicz-Luebert E., 2011, Journal of Biomedicine & Biotechnology, V2011, P821578, DOI 10.1155/2011/821578; de Lima TM, 2014, MOL IMMUNOL, V60, P8, DOI 10.1016/j.molimm.2014.03.010; De Pont ACJM, 2004, J THROMB HAEMOST, V2, P65, DOI 10.1111/j.1538-7836.2004.00526.x; Deiters U, 2003, INFECT IMMUN, V71, P4456, DOI 10.1128/IAI.71.8.4456-4462.2003; Dittrich AM, 2008, J IMMUNOL, V180, P1792, DOI 10.4049/jimmunol.180.3.1792; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; du Plessis N, 2013, MUCOSAL IMMUNOL, V6, P931, DOI 10.1038/mi.2012.131; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guasconi L, 2011, IMMUNOLOGY, V133, P386, DOI 10.1111/j.1365-2567.2011.03449.x; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoffmann WH, 2000, PARASITOL TODAY, V16, P387, DOI 10.1016/S0169-4758(00)01738-5; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Hubner MP, 2013, PATHOG DIS, V69, P127, DOI 10.1111/2049-632X.12080; Hubner MP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001970; Hubner MP, 2012, J IMMUNOL, V188, P559, DOI 10.4049/jimmunol.1100335; Karadjian G, 2014, PARASITE, V21, DOI 10.1051/parasite/2014017; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4<1127::AID-IMMU1127>3.0.CO;2-#; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Marshall JC, 2014, TRENDS MOL MED, P1; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Musie E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086015; Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463; Onguru D, 2011, AM J TROP MED HYG, V84, P321, DOI 10.4269/ajtmh.2011.10-0397; Panda M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-203; Panda SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002717; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; RESENDE CT, 2007, CLIN EXP IMMUNOL, V147, P45, DOI DOI 10.1111/J.1365-2249.2006.03247.X; Ritter M, 2014, CLIN EXP IMMUNOL, V178, P212, DOI 10.1111/cei.12400; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Sasisekhar B, 2005, INFECT IMMUN, V73, P3385, DOI 10.1128/IAI.73.6.3385-3393.2005; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Shi DW, 2011, INFLAMM RES, V60, P841, DOI 10.1007/s00011-011-0342-5; Stein BM, 1992, J EXP MED, V176, P287, DOI [10.1084/jem.176.1.287, DOI 10.1084/JEM.176.1.287]; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Su CW, 2012, J IMMUNOL, V189, P1459, DOI 10.4049/jimmunol.1200484; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Sutherland RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027564; Tamarozzi F, 2011, CLIN MICROBIOL REV, V24, P459, DOI 10.1128/CMR.00057-10; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Thomas GD, 2012, BLOOD, V120, pE93, DOI 10.1182/blood-2012-07-442640; Turner JD, 2006, J IMMUNOL, V177, P1240, DOI 10.4049/jimmunol.177.2.1240; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Volkmann L, 2003, MED MICROBIOL IMMUN, V192, P23, DOI 10.1007/S00430-002-0155-9; Volkmann L, 2003, TROP MED INT HEALTH, V8, P392, DOI 10.1046/j.1365-3156.2003.01040.x; Weng MQ, 2007, J IMMUNOL, V179, P4721, DOI 10.4049/jimmunol.179.7.4721; Wheeler DS, 2008, SHOCK, V30, P267, DOI [10.1097/SHK.0b013e318162c190, 10.1097/shk.0b013e318162c190]; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Ziewer S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001558",77,26,29,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004616,10.1371/journal.ppat.1004616,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100040,25611587.0,"DOAJ Gold, Green Published",,,16/08/2019,26,2,32,5999,1376,966,410,4623,3926,27,670,32,0,0,0,23,23,0,,41,7,41,0,7,27,27,16,16,0,0,0,0,0,0,0,3,5,6033,41,0,228,123,4,4614,1376,41,0,228,123,4,43,,0,0,0,0,7,0,2,0,0,0,0,41,0,0,3.25,4.359738372093023,1.2976422236642873,0.2976422236642873,1.3404715552671425,1.0330055009168195,4.503633720930233
176,J,"Gonzalez, RJ; Lane, MC; Wagner, NJ; Weening, EH; Miller, VL",,,,"Gonzalez, Rodrigo J.; Lane, M. Chelsea; Wagner, Nikki J.; Weening, Eric H.; Miller, Virginia L.",,,Dissemination of a Highly Virulent Pathogen: Tracking The Early Events That Define Infection,PLOS PATHOGENS,,,English,Article,,,,,,,YERSINIA-PESTIS; INTRADERMAL INJECTION; IMMUNE-RESPONSE; BUBONIC PLAGUE; MOUSE MODEL; TRANSMISSION; MACROPHAGES; PROGRESSION; EVOLUTION; KINETICS,"The series of events that occurs immediately after pathogen entrance into the body is largely speculative. Key aspects of these events are pathogen dissemination and pathogen interactions with the immune response as the invader moves into deeper tissues. We sought to define major events that occur early during infection of a highly virulent pathogen. To this end, we tracked early dissemination of Yersinia pestis, a highly pathogenic bacterium that causes bubonic plague in mammals. Specifically, we addressed two fundamental questions: (1) do the bacteria encounter barriers in disseminating to draining lymph nodes (LN), and (2) what mechanism does this nonmotile bacterium use to reach the LN compartment, as the prevailing model predicts trafficking in association with host cells. Infection was followed through microscopy imaging in addition to assessing bacterial population dynamics during dissemination from the skin. We found and characterized an unexpected bottleneck that severely restricts bacterial dissemination to LNs. The bacteria that do not pass through this bottleneck are confined to the skin, where large numbers of neutrophils arrive and efficiently control bacterial proliferation. Notably, bottleneck formation is route dependent, as it is abrogated after subcutaneous inoculation. Using a combination of approaches, including microscopy imaging, we tested the prevailing model of bacterial dissemination from the skin into LNs and found no evidence of involvement of migrating phagocytes in dissemination. Thus, early stages of infection are defined by a bottleneck that restricts bacterial dissemination and by neutrophil-dependent control of bacterial proliferation in the skin. Furthermore, and as opposed to current models, our data indicate an intracellular stage is not required by Y. pestis to disseminate from the skin to draining LNs. Because our findings address events that occur during early encounters of pathogen with the immune response, this work can inform efforts to prevent or control infection.","[Gonzalez, Rodrigo J.; Wagner, Nikki J.; Weening, Eric H.; Miller, Virginia L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Lane, M. Chelsea; Miller, Virginia L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA","Miller, VL (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.",vlmiller@med.unc.edu,,"Miller, Virginia/0000-0002-9522-1767","National Institutes of Health [R21AI105271, U54AI057157]; (Southeast Regional Center for Biodefense and Emerging Infectious Diseases) from the National Institutes of Health [006]; Robert D. Watkins Fellowship from American Society for Microbiology","This work was supported by R21AI105271 and U54AI057157 (Southeast Regional Center for Biodefense and Emerging Infectious Diseases, project 006) from the National Institutes of Health (www.nih.gov) to VLM and the Robert D. Watkins Fellowship from American Society for Microbiology (www.asm.org) to RJG. This research was conducted while MCL was a postdoctoral fellow at the University of North Carolina, Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Bonnotte B, 2003, CANCER RES, V63, P2145; Bosio CF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003196; Bosio CF, 2012, INFECT IMMUN, V80, P4034, DOI 10.1128/IAI.00606-12; BRUBAKER RR, 2006, PROKARYOTES, V6, P399; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Chong SZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00286; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Gonzalez RJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-147; Guinet F, 2003, ADV EXP MED BIOL, V529, P73; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197; Hoopes SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045261; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Price PA, 2012, P NATL ACAD SCI USA, V109, P3083, DOI 10.1073/pnas.1112729109; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Spinner JL, 2013, J LEUKOC BIOL; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; Titball RW, 2003, BIOCHEM SOC T, V31, P104, DOI 10.1042/bst0310104; Walters MS, 2012, MBIO, V3, DOI 10.1128/mBio.00303-11; Weiner ZP, 2012, INFECT IMMUN, V80, P1626, DOI 10.1128/IAI.06061-11; Zhang P, 2008, INFECT IMMUN, V76, P2070, DOI 10.1128/IAI.01246-07; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006",32,19,19,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004587,10.1371/journal.ppat.1004587,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100020,25611317.0,"DOAJ Gold, Green Published",,,16/08/2019,26,89,38,10773,2244,1941,303,8529,7159,45,1325,38,2,1,3,24,24,3,,49,8,49,0,8,32,29,32,16,0,0,0,0,0,0,2,87,9,10847,147,51,423,146,8,8518,2244,147,51,423,146,8,85,,5,1,0,0,15,0,6,0,1,0,1,48,0,0,58.05,4.800802139037433,1.2631023566654942,0.2631023566654942,1.3061320201664908,1.0340666481017358,4.964349376114082
177,J,"Greig, JA; Sudbery, IM; Richardson, JP; Naglik, JR; Wang, Y; Sudbery, PE",,,,"Greig, Jamie A.; Sudbery, Ian M.; Richardson, Jonathan P.; Naglik, Julian R.; Wang, Yue; Sudbery, Peter E.",,,Cell Cycle-Independent Phospho-Regulation of Fkh2 during Hyphal Growth Regulates Candida albicans Pathogenesis,PLOS PATHOGENS,,,English,Article,,,,,,,FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; POLARIZED GROWTH; MORPHOGENESIS; YEAST; PHOSPHORYLATION; DISTINCT; GENES,"The opportunistic human fungal pathogen, Candida albicans, undergoes morphological and transcriptional adaptation in the switch from commensalism to pathogenicity. Although previous gene-knockout studies have identified many factors involved in this transformation, it remains unclear how these factors are regulated to coordinate the switch. Investigating morphogenetic control by post-translational phosphorylation has generated important regulatory insights into this process, especially focusing on coordinated control by the cyclin-dependent kinase Cdc28. Here we have identified the Fkh2 transcription factor as a regulatory target of both Cdc28 and the cell wall biosynthesis kinase Cbk1, in a role distinct from its conserved function in cell cycle progression. In stationary phase yeast cells 2D gel electrophoresis shows that there is a diverse pool of Fkh2 phospho-isoforms. For a short window on hyphal induction, far before START in the cell cycle, the phosphorylation profile is transformed before reverting to the yeast profile. This transformation does not occur when stationary phase cells are reinoculated into fresh medium supporting yeast growth. Mass spectrometry and mutational analyses identified residues phosphorylated by Cdc28 and Cbk1. Substitution of these residues with non-phosphorylatable alanine altered the yeast phosphorylation profile and abrogated the characteristic transformation to the hyphal profile. Transcript profiling of the phosphorylation site mutant revealed that the hyphal phosphorylation profile is required for the expression of genes involved in pathogenesis, host interaction and biofilm formation. We confirmed that these changes in gene expression resulted in corresponding defects in pathogenic processes. Furthermore, we identified that Fkh2 interacts with the chromatin modifier Pob3 in a phosphorylation-dependent manner, thereby providing a possible mechanism by which the phosphorylation of Fkh2 regulates its specificity. Thus, we have discovered a novel cell cycle-independent phospho-regulatory event that subverts a key component of the cell cycle machinery to a role in the switch from commensalism to pathogenicity.","[Greig, Jamie A.; Sudbery, Peter E.] Univ Sheffield, Western Bank, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Greig, Jamie A.; Wang, Yue] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Sudbery, Ian M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Richardson, Jonathan P.; Naglik, Julian R.] Kings Coll London, Inst Dent, Mucosal & Salivary Biol Div, London WC2R 2LS, England; [Wang, Yue] Natl Univ Singapore, Yong Loo Ling Sch Med, Dept Biochem, Singapore 117548, Singapore","Greig, JA (reprint author), Univ Sheffield, Western Bank, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.",mcbwangy@imcb.a-star.edu.sg; P.Sudbery@shef.ac.uk,"Wang, Yue/H-2107-2011; Sudbery, Ian/H-9284-2019","Wang, Yue/0000-0002-1211-2822; Sudbery, Ian/0000-0002-5038-0190; Naglik, Julian/0000-0002-8072-7917","BBSRC [BB-130398-11-1, BB-J016411-1]; Agency of Science, Technology and Research of Singapore (A*STAR); A*STAR-Sheffield Joint PhD program; Biotechnology and Biological Sciences Research Council [BB/J016411/1, BB/J002305/1]","This work was funded by BBSRC project grants BB-130398-11-1 and BB-J016411-1, The Agency of Science, Technology and Research of Singapore (A*STAR), and the A*STAR-Sheffield Joint PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289; Benson ES, 2002, EUKARYOT CELL, V1, P787, DOI 10.1128/EC.1.5.787-798.2002; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bishop A, 2010, EMBO J, V29, P2930, DOI 10.1038/emboj.2010.158; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Caballero-Lima D, 2014, MOL BIOL CELL, V25, P1097, DOI 10.1091/mbc.E13-11-0688; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Carlisle PL, 2013, MOL BIOL CELL, V24, P246, DOI 10.1091/mbc.E12-01-0065; Chapa-Y-Lazo B, 2011, FUNGAL BIOL-UK, V115, P547, DOI 10.1016/j.funbio.2011.02.001; Chauvel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045912; Chen JY, 2000, MOL CELL BIOL, V20, P8696, DOI 10.1128/MCB.20.23.8696-8708.2000; Costanzo M, 2003, MOL CELL BIOL, V23, P5064, DOI 10.1128/MCB.23.14.5064-5077.2003; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; Csank C, 1998, INFECT IMMUN, V66, P2713; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Finley KR, 2005, EUKARYOT CELL, V4, P1697, DOI 10.1128/EC.4.10.1697-1711.2005; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; GOW NAR, 1984, SABOURAUDIA, V22, P137; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Goyard S, 2008, MOL BIOL CELL, V19, P2251, DOI 10.1091/mbc.E07-09-0960; Grubb SEW, 2009, INFECT IMMUN, V77, P3872, DOI 10.1128/IAI.00518-09; Gutierrez-Escribano P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002683; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201; Hou MC, 2003, J CELL SCI, V116, P125, DOI 10.1242/jcs.00206; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Kullberg Bart Jan, 2002, P327; Leng P, 2000, MOL MICROBIOL, V35, P1264, DOI 10.1046/j.1365-2958.2000.01801.x; Li CR, 2007, J CELL SCI, V120, P1898, DOI 10.1242/jcs.002931; Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lu Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002663; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Maerz S, 2010, CURR OPIN MICROBIOL, V13, P663, DOI 10.1016/j.mib.2010.08.010; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; McNemar MD, 2002, J BACTERIOL, V184, P2058, DOI 10.1128/JB.184.7.2058-2061.2002; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; RAY TL, 1988, INFECT IMMUN, V56, P1942; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Runke M, 2002, CANDIDA CANDIDIASIS, P307; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Sanglard D, 1997, INFECT IMMUN, V65, P3539; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; SCHERWITZ C, 1982, J INVEST DERMATOL, V78, P200, DOI 10.1111/1523-1747.ep12506451; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2004, STAT APPL GENET MOL, V3, P1, DOI DOI 10.2202/1544-6115.1027; Song Y, 2008, MOL BIOL CELL, V19, P5456, DOI 10.1091/mbc.E08-03-0272; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zeng GS, 2012, MOL BIOL CELL, V23, P3485, DOI 10.1091/mbc.E12-03-0231; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; Zhu GF, 2000, NATURE, V406, P90",80,8,8,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004630,10.1371/journal.ppat.1004630,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100045,25617770.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,8,3,36,5314,898,639,259,4416,3647,25,744,36,2,0,2,9,9,0,,40,7,40,0,7,10,8,10,4,0,0,0,0,0,0,0,1,0,5397,84,11,87,103,0,4453,906,84,11,87,103,0,38,,0,0,0,0,6,0,1,0,1,0,0,39,0,0,4.35,5.917594654788418,1.2033514492753623,0.2033514492753623,1.2644927536231885,1.0508091832894242,6.21826280623608
178,J,"Guenaga, J; de Val, N; Tran, K; Feng, Y; Satchwell, K; Ward, AB; Wyatt, RT",,,,"Guenaga, Javier; de Val, Natalia; Tran, Karen; Feng, Yu; Satchwell, Karen; Ward, Andrew B.; Wyatt, Richard T.",,,Well-Ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties,PLOS PATHOGENS,,,English,Article,,,,,,,ENVELOPE GLYCOPROTEIN TRIMERS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; BROAD NEUTRALIZATION; SHIV CHALLENGE; BINDING-SITE; GP120; RECOGNITION; PROTECTION; RESPONSES,"The structure of BG505 gp140 SOSIP, a soluble mimic of the native HIV-1 envelope glycoprotein (Env), marks the beginning of new era in Env structure-based immunogen design. Displaying a well-ordered quaternary structure, these subtype A-derived trimers display an excellent antigenic profile, discriminating recognition by broadly neutralizing antibodies (bNAbs) from non-broadly neutralizing antibodies (non-bNAbs), and provide a solid Env-based immunogenic platform starting point. Even with this important advance, obtaining homogeneous well-ordered soluble SOSIP trimers derived from other subtypes remains challenging. Here, we report the ""rescue"" of homogeneous well-ordered subtype B and C SOSIP trimers from a heterogeneous Env mixture using CD4 binding site-directed (CD4bs) non-bNAbs in a negative-selection purification process. These non-bNAbs recognize the primary receptor CD4bs only on disordered trimers but not on the native Env spike or well-ordered soluble trimers due to steric hindrance. Following negative selection to remove disordered oligomers, we demonstrated recovery of well-ordered, homogeneous trimers by electron microscopy (EM). We obtained 3D EM reconstructions of unliganded trimers, as well as in complex with sCD4, a panel of CD4bs-directed bNAbs, and the cleavage-dependent, trimer-specific bNAb, PGT151. Using bio-layer light interferometry (BLI) we demonstrated that the well-ordered trimers were efficiently recognized by bNAbs and poorly recognized by non-bNAbs, representing soluble mimics of the native viral spike. Biophysical characterization was consistent with the thermostability of a homogeneous species that could be further stabilized by specific bNAbs. This study revealed that Env trimers generate different frequencies of well-ordered versus disordered aberrant trimers even when they are genetically identical. By negatively selecting the native-like well-ordered trimers, we establish a new means to obtain soluble Env mimetics derived from subtypes B and C for expanded use as candidate vaccine immunogens.","[Guenaga, Javier; Tran, Karen; Feng, Yu; Satchwell, Karen; Ward, Andrew B.; Wyatt, Richard T.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [de Val, Natalia; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [de Val, Natalia; Ward, Andrew B.; Wyatt, Richard T.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA","Ward, AB (reprint author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.",ward@scripps.edu; wyatt@scripps.edu,"Ward, Andrew/F-9203-2014","Ward, Andrew/0000-0001-7153-3769",International AIDS Vaccine Initiative; Scripps CHAVI-ID [UM1 AI100663]; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); NIH through the National Center for Research Resources' P41 program [RR017573],"This work was supported by the International AIDS Vaccine Initiative and the Scripps CHAVI-ID (UM1 AI100663). IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. The EM data was collected at the National Resource for Automated Molecular Microscopy, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Falkowska E, 2014, IMMUNITY; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jones NG, 2009, VACCINE, V27, P1136, DOI 10.1016/j.vaccine.2008.11.071; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 1999, J VIROL, V73, P4009; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572",56,57,57,0,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004570,10.1371/journal.ppat.1004570,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100013,25569572.0,"DOAJ Gold, Green Published",,,16/08/2019,58,0,32,4727,958,695,263,3769,3031,31,707,32,0,0,0,59,59,0,,43,0,43,0,0,64,60,64,51,0,0,0,0,0,0,0,0,1,4726,32,0,562,103,1,3746,958,32,0,562,103,1,22,,0,0,0,0,1,0,0,0,0,0,0,43,0,0,6.25,4.934237995824635,1.2541788272751393,0.2541788272751393,1.2897320244096577,1.0283477892955364,5.0741127348643005
179,J,"Haycocks, JRJ; Sharma, P; Stringer, AM; Wade, JT; Grainger, DC",,,,"Haycocks, James R. J.; Sharma, Prateek; Stringer, Anne M.; Wade, Joseph T.; Grainger, David C.",,,The Molecular Basis for Control of ETEC Enterotoxin Expression in Response to Environment and Host,PLOS PATHOGENS,,,English,Article,,,,,,,HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI INFECTIONS; AMP RECEPTOR PROTEIN; H-NS PROTEIN; RNA-POLYMERASE; CHOLERA-TOXIN; TRANSCRIPTION ACTIVATION; STRUCTURAL BASIS; CRP; INITIATION,"Enterotoxigenic Escherichia coli (ETEC) cause severe diarrhoea in humans and neonatal farm animals. Annually, 380,000 human deaths, and multi-million dollar losses in the farming industry, can be attributed to ETEC infections. Illness results from the action of enterotoxins, which disrupt signalling pathways that manage water and electrolyte homeostasis in the mammalian gut. The resulting fluid loss is treated by oral rehydration. Hence, aqueous solutions of glucose and salt are ingested by the patient. Given the central role of enterotoxins in disease, we have characterised the regulatory trigger that controls toxin production. We show that, at the molecular level, the trigger is comprised of two gene regulatory proteins, CRP and H-NS. Strikingly, this renders toxin expression sensitive to both conditions encountered on host cell attachment and the components of oral rehydration therapy. For example, enterotoxin expression is induced by salt in an H-NS dependent manner. Furthermore, depending on the toxin gene, expression is activated or repressed by glucose. The precise sensitivity of the regulatory trigger to glucose differs because of variations in the regulatory setup for each toxin encoding gene.","[Haycocks, James R. J.; Sharma, Prateek; Grainger, David C.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Stringer, Anne M.; Wade, Joseph T.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Wade, Joseph T.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA","Grainger, DC (reprint author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.",d.grainger@bham.ac.uk,,"Grainger, David/0000-0003-3375-5154; Wade, Joseph/0000-0002-9779-3160",Wellcome Trust [WT085092MA]; Leverhulme Trust [RPG-2013-147]; Biotechnology and Biological Sciences Research Council [1363809],"This work was funded by Wellcome Trust (www.wellcome.ac.uk) Research Career Development Fellowship WT085092MA and Leverhulme Trust (www.leverhulme.ac.uk) project grant RPG-2013-147 awarded to DCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bodero MD, 2009, INFECT IMMUN, V77, P791, DOI 10.1128/IAI.00928-08; BUSBY S, 1983, J MOL BIOL, V167, P259, DOI 10.1016/S0022-2836(83)80335-0; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Byrd W, 2003, INFECT IMMUN, V71, P13, DOI 10.1128/IAI.71.1.13-21.2003; Byrd W, 2013, VET IMMUNOL IMMUNOP, V152, P57, DOI 10.1016/j.vetimm.2012.10.001; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Gupta S, 1997, INFECT IMMUN, V65, P1131; Gupta SK, 2008, EPIDEMIOL INFECT, V136, P721, DOI 10.1017/S095026880700934X; Hiard S, 2007, BIOCHEM BIOPH RES CO, V357, P861, DOI 10.1016/j.bbrc.2007.03.180; Kansal R, 2013, INFECT IMMUN, V81, P259, DOI 10.1128/IAI.00919-12; Kim D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002867; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lloyd GS, 2008, FEMS MICROBIOL LETT, V288, P250, DOI 10.1111/j.1574-6968.2008.01365.x; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; NALIN DR, 1968, LANCET, V2, P370; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; PAGE L, 1990, ARCH MICROBIOL, V154, P349, DOI 10.1007/BF00276530; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Rossiter AE, 2011, MOL MICROBIOL, V81, P179, DOI 10.1111/j.1365-2958.2011.07685.x; Sack RB, 2011, INDIAN J MED RES, V133, P171; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; Saslowsky DE, 2013, J BIOL CHEM, V288, P25804, DOI 10.1074/jbc.M113.474957; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Singh SS, 2014, GENE DEV, V28, P214, DOI 10.1101/gad.234336.113; Singh SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003589; Steinsland H, 2002, J INFECT DIS, V186, P1740, DOI 10.1086/345817; Stringer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044841; Taxt A, 2010, INFECT IMMUN, V78, P1824, DOI 10.1128/IAI.01397-09; YAMAMOTO T, 1984, J BIOL CHEM, V259, P5037; Yang J, 2005, MICROBIOL-SGM, V151, P1199, DOI 10.1099/mic.0.27734-0; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908",47,20,20,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004605,10.1371/journal.ppat.1004605,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100035,25569153.0,"DOAJ Gold, Green Published",,,16/08/2019,19,16,31,6185,1468,1164,304,4717,3945,33,739,31,16,0,0,19,19,0,,45,6,45,0,6,21,19,21,11,0,0,0,0,0,0,0,0,5,6221,82,0,272,109,1,4705,1468,82,0,272,109,1,48,,0,0,0,0,12,0,0,1,0,0,0,48,0,0,6.2,4.213215258855586,1.3112147551409794,0.31121475514097946,1.3593385626457495,1.0367016976556185,4.367847411444142
180,J,"Jamet, A; Jousset, AB; Euphrasie, D; Mukorako, P; Boucharlat, A; Ducousso, A; Charbit, A; Nassif, X",,,,"Jamet, Anne; Jousset, Agnes B.; Euphrasie, Daniel; Mukorako, Paulette; Boucharlat, Alix; Ducousso, Alexia; Charbit, Alain; Nassif, Xavier",,,A New Family of Secreted Toxins in Pathogenic Neisseria Species,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT GROWTH-INHIBITION; MENINGITIDIS SEROGROUP-B; COMPLETE GENOME SEQUENCE; PROTEIN SECRETION; MEMBRANE-VESICLES; ESCHERICHIA-COLI; SIGNAL PEPTIDES; TRANSMEMBRANE REGIONS; DELIVERY-SYSTEMS; EPITHELIAL-CELLS,"The genus Neisseria includes both commensal and pathogenic species which are genetically closely related. However, only meningococcus and gonococcus are important human pathogens. Very few toxins are known to be secreted by pathogenic Neisseria species. Recently, toxins secreted via type V secretion system and belonging to the widespread family of contact-dependent inhibition (CDI) toxins have been described in numerous species including meningococcus. In this study, we analyzed loci containing the maf genes in N. meningitidis and N. gonorrhoeae and proposed a novel uniform nomenclature for maf genomic islands (MGIs). We demonstrated that mafB genes encode secreted polymorphic toxins and that genes immediately downstream of mafB encode a specific immunity protein (MafI). We focused on a MafB toxin found in meningococcal strain NEM8013 and characterized its EndoU ribonuclease activity. maf genes represent 2% of the genome of pathogenic Neisseria, and are virtually absent from non-pathogenic species, thus arguing for an important biological role. Indeed, we showed that overexpression of one of the four MafB toxins of strain NEM8013 provides an advantage in competition assays, suggesting a role of maf loci in niche adaptation.","[Jamet, Anne; Jousset, Agnes B.; Euphrasie, Daniel; Mukorako, Paulette; Boucharlat, Alix; Ducousso, Alexia; Charbit, Alain; Nassif, Xavier] INSERM, U1151, Equipe 11, Inst Necker Enfants Malad, Paris, France; [Jamet, Anne; Euphrasie, Daniel; Charbit, Alain; Nassif, Xavier] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Jamet, Anne; Nassif, Xavier] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Paris, France","Jamet, A (reprint author), Inst Mol Med, Unidade Microbiol Mol & Infeccao, Lisbon, Portugal.",anne.jamet@inserm.fr,"; Jamet, Anne/E-1288-2014","charbit, alain/0000-0001-5243-4861; Jamet, Anne/0000-0002-1902-6943",Universite Paris Descartes Paris Cite Sorbonne; INSERM; CNRS; La Fondation pour la Recherche Medicale [Equipe FRM DEQ20140329533],"This work was supported by grants from Universite Paris Descartes Paris Cite Sorbonne, the INSERM, the CNRS and La Fondation pour la Recherche Medicale (Equipe FRM DEQ20140329533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anderson MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004076; Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2011, VIRULENCE, V2, P356, DOI 10.4161/viru.2.4.16463; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Bagos PG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-189; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bennett JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-652; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; Desvaux M, 2004, CURR ISSUES MOL BIOL, V6, P111; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fagnocchi L, 2012, J BACTERIOL, V194, P460, DOI 10.1128/JB.06161-11; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Garcia EC, 2013, MOL MICROBIOL, V89, P1213, DOI 10.1111/mmi.12339; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Hayes CS, 2014, COLD SPRING HARB PER, V4; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Hey A, 2013, INFECT IMMUN, V81, P4149, DOI 10.1128/IAI.00397-13; Hodak H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/j.resmic.2007.08.001; Holberger LE, 2012, FEBS LETT, V586, P132, DOI 10.1016/j.febslet.2011.12.020; Holst J, 2013, HUM VACC IMMUNOTHER, V9, P1241, DOI 10.4161/hv.24129; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Klee SR, 2000, INFECT IMMUN, V68, P2082, DOI 10.1128/IAI.68.4.2082-2095.2000; KOOMEY JM, 1982, P NATL ACAD SCI-BIOL, V79, P7881, DOI 10.1073/pnas.79.24.7881; Koskiniemi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004255; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lloubes R, 2013, RES MICROBIOL, V164, P655, DOI 10.1016/j.resmic.2013.03.015; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mehr IJ, 2000, GENETICS, V154, P523; Natt NK, 2004, PROTEINS, V56, P11, DOI 10.1002/prot.20092; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; PARUCHURI DK, 1990, P NATL ACAD SCI USA, V87, P333, DOI 10.1073/pnas.87.1.333; Peng JP, 2008, GENOMICS, V91, P78, DOI 10.1016/j.ygeno.2007.10.004; Perrin A, 2002, INFECT IMMUN, V70, P7063, DOI 10.1128/IAI.70.12.7063-7072.2002; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Rahman SU, 2014, J BIOL CHEM, V289, P19799, DOI 10.1074/jbc.M113.544627; Rahman SU, 2013, J BACTERIOL, V195, P788, DOI 10.1128/JB.01355-12; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rusniok C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r110; Schielke S, 2010, MED MICROBIOL IMMUN, V199, P185, DOI 10.1007/s00430-010-0150-5; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Schoen C, 2011, J BACTERIOL, V193, P2064, DOI 10.1128/JB.00084-11; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Sun YH, 2000, NAT MED, V6, P1269; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Unemo M, 2011, APMIS, V119, P643, DOI 10.1111/j.1600-0463.2011.02780.x; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; van Ulsen P, 2006, FEMS MICROBIOL REV, V30, P292, DOI 10.1111/j.1574-6976.2006.00013.x; van Ulsen P, 2008, INFECT IMMUN, V76, P4649, DOI 10.1128/IAI.00393-08; Vipond C, 2005, HUM VACCINES, V1, P80, DOI 10.4161/hv.1.2.1651; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036; Zielke RA, 2014, MOL CELL PROTEOMICS, V13, P1299, DOI 10.1074/mcp.M113.029538",90,30,30,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004592,10.1371/journal.ppat.1004592,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100024,25569427.0,"DOAJ Gold, Green Published",,,16/08/2019,24,13,33,8223,2530,2147,383,5693,4805,33,855,33,13,2,0,31,31,0,,46,2,46,0,2,33,25,33,25,0,0,0,0,0,0,0,1,4,8252,102,0,113,123,1,5660,2530,102,0,113,123,1,62,,0,0,0,1,11,0,0,1,0,0,0,46,0,0,9.2,3.250197628458498,1.4444054101528192,0.44440541015281926,1.4890216054804146,1.030888969962301,3.350592885375494
181,J,"Jaskowska, E; Butler, C; Preston, G; Kelly, S",,,,"Jaskowska, Eleanor; Butler, Claire; Preston, Gail; Kelly, Steven",,,Phytomonas: Trypanosomatids Adapted to Plant Environments,PLOS PATHOGENS,,,English,Review,,,,,,,LEISHMANIA-DONOVANI; GP63-LIKE MOLECULES; POOR DEVELOPMENT; SALIVARY-GLANDS; RIBOSOMAL-RNA; ROOT-SYSTEM; SERPENS; GENE; PARASITE; TOMATO,"Over 100 years after trypanosomatids were first discovered in plant tissues, Phytomonas parasites have now been isolated across the globe from members of 24 different plant families. Most identified species have not been associated with any plant pathology and to date only two species are definitively known to cause plant disease. These diseases (wilt of palm and coffee phloem necrosis) are problematic in areas of South America where they threaten the economies of developing countries. In contrast to their mammalian infective relatives, our knowledge of the biology of Phytomonas parasites and how they interact with their plant hosts is limited. This review draws together a century of research into plant trypanosomatids, from the first isolations and experimental infections to the recent publication of the first Phytomonas genomes. The availability of genomic data for these plant parasites opens a new avenue for comparative investigations into trypanosomatid biology and provides fresh insight into how this important group of parasites have adapted to survive in a spectrum of hosts from crocodiles to coconuts.","[Jaskowska, Eleanor; Butler, Claire; Preston, Gail; Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford, England","Kelly, S (reprint author), Univ Oxford, Dept Plant Sci, Oxford, England.",steven.kelly@plants.ox.ac.uk,,"Preston, Gail/0000-0003-3882-4438",Bill and Melinda Gates foundation; BBSRC [BB/F016093/1]; Biotechnology and Biological Sciences Research Council [1236164],"SK and CB are supported by the Bill and Melinda Gates foundation. EJ is supported by the BBSRC through a Doctoral Training Grant ref: BB/F016093/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Aracao HD, 1927, CR SOC BIOL, V97, P1077; Aragao H. de B., 1931, Memorias do Instituto Oswaldo Cruz, V25, P299; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BARBIERI L, 1983, BIOCHEM J, V215, P433, DOI 10.1042/bj2150433; Barry JD, 1998, MOL BIOCHEM PARASIT, V91, P93, DOI 10.1016/S0166-6851(97)00193-X; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/NCLIMATE1990, 10.1038/nclimate1990]; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Bensaude M, 1925, PHYTOPATHOLOGY, V15, P273; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berrio C, 1991, REV DIFUSION TECNOL, V38; BRAZIL RP, 1990, MEM I OSWALDO CRUZ, V85, P239, DOI 10.1590/S0074-02761990000200016; Breitenbach HH, 2014, PLANT PHYSIOL, V165, P791, DOI 10.1104/pp.114.239665; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; CAMARGO EP, 1990, PARASITOL TODAY, V6, P22, DOI 10.1016/0169-4758(90)90388-K; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; CHAUMONT F, 1994, MOL BIOCHEM PARASIT, V67, P321, DOI 10.1016/0166-6851(94)00141-3; Collingridge PW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-117; d'Avila-Levy CM, 2006, CURR MICROBIOL, V52, P439, DOI 10.1007/s00284-005-0222-8; da Silva RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068299; Dollet M, 2001, PARASITOLOGY, V122, P289, DOI 10.1017/S0031182001007417; Dollet M, 2012, INFECT GENET EVOL, V12, P299, DOI 10.1016/j.meegid.2011.11.010; Donovan C, 1909, THE LANCLET, V177, P1195; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elias CGR, 2012, EXP PARASITOL, V130, P13, DOI 10.1016/j.exppara.2011.10.005; Elias CGR, 2008, EXP PARASITOL, V120, P343, DOI 10.1016/j.exppara.2008.08.011; ELON J, 1980, EXP PARASITOL, V49, P167, DOI 10.1016/0014-4894(80)90114-9; FRANCA C., 1920, Ann. Inst. Pasteur, V34, P432; FRANCHINI G., 1922, Ann. Inst. Pasteur, V36, P873; Franchini G., 1922, Bulletin de la Societe de Pathologie Exotique Paris, V15, P109; Franchini G., 1922, Bulletin de la Societe de Pathologie Exotique Paris, V15, P18; Frankenberg N, 2003, APPL MICROBIOL BIOT, V63, P115, DOI 10.1007/s00253-003-1432-2; Gaupels F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00187; GIBBS AJ, 1957, PARASITOLOGY, V47, P297, DOI 10.1017/S0031182000021983; Gluenz E, 2010, FASEB J, V24, P3117, DOI 10.1096/fj.09-151381; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hamilton PB, 2005, INT J PARASITOL, V35, P431, DOI 10.1016/j.ijpara.2004.12.005; HOARE CA, 1966, NATURE, V212, P1385, DOI 10.1038/2121385a0; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Ienne S, 2014, PARASITOLOGY, V141, P1299, DOI 10.1017/S0031182014000547; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jaffe CL, 2003, PARASITOL RES, V91, P229, DOI 10.1007/s00436-003-0960-0; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Kelly S, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.24; KITAJIMA EW, 1986, PHYTOPATHOLOGY, V76, P638, DOI 10.1094/Phyto-76-638; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Lafont A., 1909, Compte Rendu de la Societe de Biologie Paris, V66; Lafont A., 1910, Ann Inst Pasteur Paris, V24; Lafont A, 1911, CR SOC BIOL, V70, P58; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; Magan R, 2004, MEM I OSWALDO CRUZ, V99, P651, DOI 10.1590/S0074-02762004000600021; Manna PT, 2013, MOL PHYLOGENET EVOL, V67, P123, DOI 10.1016/j.ympev.2013.01.002; Maslov DA, 1999, MOL BIOCHEM PARASIT, V99, P207, DOI 10.1016/S0166-6851(99)00028-6; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; MCNEELY TB, 1990, J IMMUNOL, V144, P2745; Molinas SM, 2003, J BIOL CHEM, V278, P36169, DOI 10.1074/jbc.M305666200; Nawathean P, 2000, CURR GENET, V38, P95, DOI 10.1007/s002940000135; Oliveira AP, 2010, J AGR FOOD CHEM, V58, P10855, DOI 10.1021/jf1031185; Overath P, 1999, PARASITOLOGY, V119, P591, DOI 10.1017/S0031182099005089; PARTHASARATHY MV, 1976, SCIENCE, V192, P1346, DOI 10.1126/science.192.4246.1346; Porcel BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004007; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; REDMAN CA, 1995, BIOCHEM J, V311, P495, DOI 10.1042/bj3110495; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; SANCHEZMORENO M, 1995, PARASITOL RES, V81, P575, DOI 10.1007/BF00932024; SANCHEZMORENO M, 1992, MOL BIOCHEM PARASIT, V54, P185, DOI 10.1016/0166-6851(92)90111-V; Santos ALS, 2006, INT J PARASITOL, V36, P47, DOI 10.1016/j.ijpara.2005.09.004; Santos ALS, 2007, MICROBES INFECT, V9, P915, DOI 10.1016/j.micinf.2007.03.018; Serrano MG, 1999, EXP PARASITOL, V91, P268, DOI 10.1006/expr.1998.4379; SIDDALL ME, 1992, J PARASITOL, V78, P562, DOI 10.2307/3283672; Siegel TN, 2011, TRENDS PARASITOL, V27, P434, DOI 10.1016/j.pt.2011.05.006; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, P NATL ACAD SCI USA, V100, P9536, DOI 10.1073/pnas.1530604100; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; STAHEL GEROLD, 1931, PHYTOPATH ZEITSCHR, V4, P65; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Sturm NR, 2007, INFECT GENET EVOL, V7, P570, DOI 10.1016/j.meegid.2007.04.002; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Teixeira MMG, 1997, J PARASITOL, V83, P58, DOI 10.2307/3284317; TEIXEIRA MMG, 1994, PARASITOL RES, V80, P512, DOI 10.1007/BF00932699; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; Di Lucca AGT, 2013, TROP PLANT PATHOL, V38, P522, DOI 10.1590/S1982-56762013000600008; Uttaro AD, 1997, MOL BIOCHEM PARASIT, V89, P51, DOI 10.1016/S0166-6851(97)00100-X; Uttaro AD, 1997, MOL BIOCHEM PARASIT, V85, P213, DOI 10.1016/S0166-6851(97)02830-2; VAINSTEIN MH, 1986, J PROTOZOOL, V33, P511, DOI 10.1111/j.1550-7408.1986.tb05652.x; VAINSTEIN MH, 1987, J PROTOZOOL, V34, P442, DOI 10.1111/j.1550-7408.1987.tb03210.x; Vasconcellos LRC, 2013, PLOS ONE, V8, DOI [10. 1371/ journal. pone. 0072076, DOI 10.1371/J0URNAL.P0NE.0072076.ACCESSED]; Votypka J, 2012, INT J PARASITOL, V42, P489, DOI 10.1016/j.ijpara.2012.03.007; Wheeler RJ, 2011, MOL MICROBIOL, V79, P647, DOI 10.1111/j.1365-2958.2010.07479.x; Wheeler RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079581; Zakai HA, 1998, PARASITOLOGY, V116, P305, DOI 10.1017/S0031182097002382",97,26,29,0,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004484,10.1371/journal.ppat.1004484,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100002,25607944.0,"DOAJ Gold, Green Published",,,16/08/2019,27,131,59,9163,1940,1636,304,7223,6187,33,1003,59,1,1,0,23,23,0,,79,7,79,0,7,28,28,23,14,0,0,0,0,0,0,0,130,2,9375,40,0,938,123,0,7349,1974,40,0,938,123,0,52,,0,2,0,1,3,0,2,0,0,0,0,79,0,0,19.174,4.72319587628866,1.268586459919701,0.268586459919701,1.3205039457289216,1.0409254610935283,4.916494845360825
182,J,"Jenne, CN; Kubes, P",,,,"Jenne, Craig N.; Kubes, Paul",,,Virus-Induced NETs - Critical Component of Host Defense or Pathogenic Mediator?,PLOS PATHOGENS,,,English,Article,,,,,,,NEUTROPHIL EXTRACELLULAR TRAPS; LUNG INJURY; MYELOPEROXIDASE; REPLICATION; INFECTION; BACTERIA; IMMUNITY; ALPHA,,"[Jenne, Craig N.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Jenne, Craig N.; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada","Jenne, CN (reprint author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.",cnjenne@ucalgary.ca,,,Canadian Institutes for Health Research,"This work was supported by the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buisson M, 2009, J MOL BIOL, V391, P717, DOI 10.1016/j.jmb.2009.06.034; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Drescher B, 2013, VIRUS RES, V171, P1, DOI 10.1016/j.virusres.2012.11.002; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Koupenova M, 2014, BLOOD, V124, P791, DOI 10.1182/blood-2013-11-536003; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moorthy AN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00056; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schoen P, 1997, BIOCHEM PHARMACOL, V53, P995, DOI 10.1016/S0006-2952(96)00876-3; Short KR, 2014, INFECT IMMUN, V82, P364, DOI 10.1128/IAI.01104-13; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053",27,24,24,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004546,10.1371/journal.ppat.1004546,,,,4,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100006,25569217.0,"DOAJ Gold, Green Published",,,16/08/2019,23,14,38,6084,1132,809,323,4952,4113,29,810,38,14,0,0,22,22,0,,48,0,47,0,0,23,23,15,14,0,0,0,0,0,0,0,0,3,6077,4,0,16,23,0,4929,1132,4,0,16,23,0,16,,0,0,0,0,10,0,0,0,0,0,0,47,0,0,4.6,5.374558303886926,1.22859450726979,0.22859450726978997,1.2326332794830372,1.0032873109796188,5.392226148409894
183,J,"Jhingran, A; Kasahara, S; Shepardson, KM; Junecko, BAF; Heung, LJ; Kumasaka, DK; Knoblaugh, SE; Lin, X; Kazmierczak, BI; Reinhart, TA; Cramer, RA; Hohl, TM",,,,"Jhingran, Anupam; Kasahara, Shinji; Shepardson, Kelly M.; Junecko, Beth A. Fallert; Heung, Lena J.; Kumasaka, Debra K.; Knoblaugh, Sue E.; Lin, Xin; Kazmierczak, Barbara I.; Reinhart, Todd A.; Cramer, Robert A.; Hohl, Tobias M.",,,Compartment-Specific and Sequential Role of MyD88 and CARD9 in Chemokine Induction and Innate Defense during Respiratory Fungal Infection,PLOS PATHOGENS,,,English,Article,,,,,,,INVASIVE PULMONARY ASPERGILLOSIS; ADAPTER PROTEIN CARD9; HOST-DEFENSE; NEUTROPHIL RECRUITMENT; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; INFLAMMATORY RESPONSES; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA INFECTION; IMMUNE RECOGNITION,"Aspergillus fumigatus forms ubiquitous airborne conidia that humans inhale on a daily basis. Although respiratory fungal infection activates the adaptor proteins CARD9 and MyD88 via C-type lectin, Toll-like, and interleukin-1 family receptor signals, defining the temporal and spatial pattern of MyD88-and CARD9-coupled signals in immune activation and fungal clearance has been difficult to achieve. Herein, we demonstrate that MyD88 and CARD9 act in two discrete phases and in two cellular compartments to direct chemokine-and neutrophil-dependent host defense. The first phase depends on MyD88 signaling because genetic deletion of MyD88 leads to delayed induction of the neutrophil chemokines CXCL1 and CXCL5, delayed neutrophil lung trafficking, and fatal pulmonary damage at the onset of respiratory fungal infection. MyD88 expression in lung epithelial cells restores rapid chemokine induction and neutrophil recruitment via interleukin-1 receptor signaling. Exogenous CXCL1 administration reverses murine mortality in MyD88-deficient mice. The second phase depends predominately on CARD9 signaling because genetic deletion of CARD9 in radiosensitive hematopoietic cells interrupts CXCL1 and CXCL2 production and lung neutrophil recruitment beyond the initial MyD88-dependent phase. Using a CXCL2 reporter mouse, we show that lung-infiltrating neutrophils represent the major cellular source of CXCL2 during CARD9-dependent recruitment. Although neutrophil-intrinsic MyD88 and CARD9 function are dispensable for neutrophil conidial uptake and killing in the lung, global deletion of both adaptor proteins triggers rapidly progressive invasive disease when mice are challenged with an inoculum that is sub-lethal for single adapter protein knockout mice. Our findings demonstrate that distinct signal transduction pathways in the respiratory epithelium and hematopoietic compartment partially overlap to ensure optimal chemokine induction, neutrophil recruitment, and fungal clearance within the respiratory tract.","[Jhingran, Anupam; Kasahara, Shinji; Heung, Lena J.; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Shepardson, Kelly M.; Cramer, Robert A.] Dartmouth Coll, Dept Microbiol & Immunol, Geisel Sch Med, Hanover, NH USA; [Junecko, Beth A. Fallert; Reinhart, Todd A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Kumasaka, Debra K.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Knoblaugh, Sue E.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10021 USA","Hohl, TM (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA.",hohlt@mskcc.org,,"Heung, Lena/0000-0002-6655-575X; Kazmierczak, Barbara/0000-0002-8162-803X","A Lucille Castori Center for Microbes, Inflammation, and Cancer (CMIC); NIH [R01 AI093808, R21 AI105617, RO1 AI081825, R01 AI81838, 5P30GM103415-03, 1P30GM106394-01]; Burroughs Wellcome Fund; Robert Sinskey Foundation","The studies were performed with support from the following funding agencies and grants: A Lucille Castori Center for Microbes, Inflammation, and Cancer (CMIC) postdoctoral fellowship to AJ, NIH grant R01 AI093808 to TMH, NIH grant R21 AI105617 to TMH, NIH RO1 AI081825 to BIK, and NIH R01 AI81838 to RAC (http://www.nih.gov). RAC and TMH are Investigators in the Pathogenesis of Infectious Diseases supported by the Burroughs Wellcome Fund. RAC and KMS received support from NIH grants 5P30GM103415-03 (Green, William PI) and 1P30GM106394-01 (Stanton, Bruce PI). TMH received support from the Robert Sinskey Foundation (http://www.guidestar.org/organizations/95-4628223/robert-m-sinskey-foundation.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.","Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Batra S, 2012, J IMMUNOL, V188, P3458, DOI 10.4049/jimmunol.1101985; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Berkova N, 2006, INT IMMUNOL, V18, P139, DOI 10.1093/intimm/dxh356; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Cornish EJ, 2008, J IMMUNOL, V180, P6854, DOI 10.4049/jimmunol.180.10.6854; Cunha C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003434; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; England H, 2014, J BIOL CHEM; Fallert BA, 2002, J VIROL METHODS, V99, P23, DOI 10.1016/S0166-0934(01)00378-0; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Gresnigt MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003936; Gresnigt MS, 2013, EUR J IMMUNOL, V43, P416, DOI 10.1002/eji.201242711; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Herjan T, 2013, J IMMUNOL, V191, P640, DOI 10.4049/jimmunol.1203315; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Jhingran A, 2012, CELL REP, V2, P1762, DOI 10.1016/j.celrep.2012.10.026; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lamoth F, 2011, MED MYCOL, V49, pS125, DOI 10.3109/13693786.2010.516408; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LeibundGut-Landmann S, 2011, J IMMUNOL, V186, P3130, DOI 10.4049/jimmunol.1003565; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Mehrad B, 2002, AM J RESP CRIT CARE, V166, P1263, DOI 10.1164/rccm.200204-367OC; Mehrad B, 1999, J IMMUNOL, V163, P6086; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Reinhart TA, 2002, BLOOD, V99, P3119, DOI 10.1182/blood.V99.9.3119; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; STRIPP BR, 1992, J BIOL CHEM, V267, P14703; Volling K, 2007, FEMS MICROBIOL LETT, V275, P250, DOI 10.1111/j.1574-6968.2007.00883.x; Volling K, 2011, CELL MICROBIOL, V13, P1130, DOI 10.1111/j.1462-5822.2011.01605.x; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017",75,41,42,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004589,10.1371/journal.ppat.1004589,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100022,25621893.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,45,20,32,7871,1240,864,376,6631,5801,28,802,32,16,0,2,45,45,0,,46,2,37,0,2,49,46,49,37,0,0,0,0,0,0,0,4,9,7891,273,0,91,173,0,6621,1240,91,0,91,173,0,30,,0,0,0,0,2,0,1,0,1,0,0,39,0,0,2.35,6.34758064516129,1.1870004524204494,0.1870004524204494,1.2572764288945861,1.0592046753906745,6.723387096774194
184,J,"Pereira, IR; Vilar-Pereira, G; Marques, V; da Silva, AA; Caetano, B; Moreira, OC; Machado, AV; Bruna-Romero, O; Rodrigues, MM; Gazzinelli, RT; Lannes-Vieira, J",,,,"Pereira, Isabela Resende; Vilar-Pereira, Glaucia; Marques, Virginia; da Silva, Andrea Alice; Caetano, Braulia; Moreira, Otacilio Cruz; Machado, Alexandre Vieira; Bruna-Romero, Oscar; Rodrigues, Mauricio Martins; Gazzinelli, Ricardo Tostes; Lannes-Vieira, Joseli",,,A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Reprograms Immune Response and Reverses Chronic Cardiomyopathy,PLOS PATHOGENS,,,English,Article,,,,,,,AMASTIGOTE SURFACE PROTEIN-2; CHRONIC CHAGAS-DISEASE; TUMOR-NECROSIS-FACTOR; PROTECTIVE IMMUNITY; NITRIC-OXIDE; PARASITIC INFECTIONS; TRANS-SIALIDASE; T-CELLS; MICE; TISSUE,"Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a prototypical neglected tropical disease. Specific immunity promotes acute phase survival. Nevertheless, one-third of CD patients develop chronic chagasic cardiomyopathy (CCC) associated with parasite persistence and immunological unbalance. Currently, the therapeutic management of patients only mitigates CCC symptoms. Therefore, a vaccine arises as an alternative to stimulate protective immunity and thereby prevent, delay progression and even reverse CCC. We examined this hypothesis by vaccinating mice with replication-defective human Type 5 recombinant adenoviruses (rAd) carrying sequences of amastigote surface protein-2 (rAdASP2) and trans-sialidase (rAdTS) T. cruzi antigens. For prophylactic vaccination, naive C57BL/6 mice were immunized with rAdASP2+rAdTS (rAdVax) using a homologous prime/boost protocol before challenge with the Colombian strain. For therapeutic vaccination, rAdVax administration was initiated at 120 days post-infection (dpi), when mice were afflicted by CCC. Mice were analyzed for electrical abnormalities, immune response and cardiac parasitism and tissue damage. Prophylactic immunization with rAdVax induced antibodies and H-2K(b)-restricted cytotoxic and interferon (IFN)gamma-producing CD8(+) T-cells, reduced acute heart parasitism and electrical abnormalities in the chronic phase. Therapeutic vaccination increased survival and reduced electrical abnormalities after the prime (analysis at 160 dpi) and the boost (analysis at 180 and 230 dpi). Post-therapy mice exhibited less heart injury and electrical abnormalities compared with pre-therapy mice. rAdVax therapeutic vaccination preserved specific IFN gamma-mediated immunity but reduced the response to polyclonal stimuli (anti-CD3 plus anti-CD28), CD107a(+) CD8(+) T-cell frequency and plasma nitric oxide (NO) levels. Moreover, therapeutic rAdVax reshaped immunity in the heart tissue as reduced the number of perforin+ cells, preserved the number of IFN gamma(+) cells, increased the expression of IFN gamma mRNA but reduced inducible NO synthase mRNA. Vaccine- based immunostimulation with rAd might offer a rational alternative for re-programming the immune response to preserve and, moreover, recover tissue injury in Chagas' heart disease.","[Pereira, Isabela Resende; Vilar-Pereira, Glaucia; Marques, Virginia; Lannes-Vieira, Joseli] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interacoes, BR-21045900 Rio De Janeiro, Brazil; [da Silva, Andrea Alice] Univ Fed Fluminense, Dept Patol, Rio De Janeiro, Brazil; [Caetano, Braulia; Gazzinelli, Ricardo Tostes] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Caetano, Braulia; Machado, Alexandre Vieira; Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Caetano, Braulia] Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil; [Moreira, Otacilio Cruz] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Bruna-Romero, Oscar] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil; [Rodrigues, Mauricio Martins] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Gazzinelli, Ricardo Tostes] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA","Lannes-Vieira, J (reprint author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interacoes, BR-21045900 Rio De Janeiro, Brazil.",lannes@ioc.fiocruz.br,"Rodrigues, Mauricio/B-8512-2012; Vieira Machado, Alexandre/G-2468-2012; BRUNA-ROMERO, OSCAR/B-3918-2010","Vieira Machado, Alexandre/0000-0003-1506-4093; BRUNA-ROMERO, OSCAR/0000-0002-8855-4969; Gazzinelli, Ricardo/0000-0003-2427-7699","Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ [APQ1-E-26/111.756/2008, CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013]; Brazilian Research Council/CNPq [474234/2012-6-Universal, 302534/2008-3, National Institute for Science and Technology for Vaccines - INCTV/DECIT/MS/CNPq 403979/2012-9-DECIT/MS/CNPq]","This work was supported in part through grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ (APQ1-E-26/111.756/2008 and CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013) and the Brazilian Research Council/CNPq (#474234/2012-6-Universal; #302534/2008-3; National Institute for Science and Technology for Vaccines - INCTV/DECIT/MS/CNPq; #403979/2012-9-DECIT/MS/CNPq). AVM, OBR, MMR, TG and JLV are CNPq research fellows. IRP is a research fellow from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ADAMS JE, 1993, CIRCULATION, V88, P750, DOI 10.1161/01.CIR.88.2.750; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; ANDRADE SG, 1991, MEM I OSWALDO CRUZ, V86, P187, DOI 10.1590/S0074-02761991000200008; Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003; Brunet LR, 2001, INT IMMUNOPHARMACOL, V1, P1457, DOI 10.1016/S1567-5769(01)00090-X; Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI 10.1586/ERV.09.45; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Carvalho CME, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001644; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Grisotto MG, 2001, IMMUNOLOGY, V102, P209, DOI 10.1046/j.1365-2567.2001.01170.x; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059434; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haolla FA, 2009, VACCINE, V27, P5644, DOI 10.1016/j.vaccine.2009.07.013; HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665; Higuchi MD, 1997, AM J TROP MED HYG, V56, P485; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Lannes-Vieira J, 2003, MEM I OSWALDO CRUZ, V98, P299, DOI 10.1590/S0074-02762003000300002; Lannes-Vieira J, 2011, ADV EXP MED BIOL, V691, P221, DOI 10.1007/978-1-4419-6612-4_23; Lannes-Vieira J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000645; Lee BY, 2012, HUM VACC IMMUNOTHER, V8, P1293, DOI 10.4161/hv.20966; Low WP, 1998, J IMMUNOL, V160, P1817; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Medeiros GA, 2009, MICROBES INFECT, V11, P264, DOI 10.1016/j.micinf.2008.11.012; Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005; Nam JH, 2009, EXPERT REV VACCINES, V8, P1535, DOI [10.1586/erv.09.115, 10.1586/ERV.09.115]; Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Paiva CN, 1999, PARASITOL RES, V85, P1012, DOI 10.1007/s004360050674; Parodi C, 2009, MEM I OSWALDO CRUZ, V104, P288, DOI 10.1590/S0074-02762009000900038; Pereira IR, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/798078; Pereira IR, 2014, MEM I OSWALDO CRUZ, V109, P289, DOI 10.1590/0074-0276140033; Perez-Fuentes R, 2003, INT J PARASITOL, V33, P293, DOI 10.1016/S0020-7519(02)00283-7; Pinto AMT, 2011, CELL MICROBIOL, V13, P1518, DOI 10.1111/j.1462-5822.2011.01636.x; Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Rodrigues MM, 2003, AN ACAD BRAS CIENC, V75, P443, DOI 10.1590/S0001-37652003000400005; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Silva JS, 2003, FRONT BIOSCI, V8, pS314, DOI 10.2741/1012; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Soares MBP, 2001, AM J PATHOL, V159, P703, DOI 10.1016/S0002-9440(10)61741-5; Strauss DG, 2011, HEART, V97, P357, DOI 10.1136/hrt.2010.210047; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Tarleton RL, 1997, P NATL ACAD SCI USA, V94, P3932, DOI 10.1073/pnas.94.8.3932; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699; Vilar-Pereira G, 2012, BRAIN BEHAV IMMUN, V26, P1136, DOI 10.1016/j.bbi.2012.07.009; Waghabi MC, 2009, MEM I OSWALDO CRUZ, V104, P1083, DOI 10.1590/S0074-02762009000800004; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009",52,31,31,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004594,10.1371/journal.ppat.1004594,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100026,25617628.0,"DOAJ Gold, Green Published",,,16/08/2019,27,56,51,8750,1292,938,354,7458,6046,32,1380,51,1,0,0,29,29,6,,141,3,72,0,3,29,29,21,24,0,0,0,0,0,0,0,55,4,8770,123,21,635,104,4,7414,1292,78,21,635,96,4,64,,1,1,0,0,6,0,5,0,0,0,0,72,0,0,26.1,6.772445820433436,1.1732367927058192,0.17323679270581926,1.2063555913113435,1.0282285714285715,6.963622291021672
185,J,"Pitzer, VE; Viboud, C; Alonso, WJ; Wilcox, T; Metcalf, CJ; Steiner, CA; Haynes, AK; Grenfell, BT",,,,"Pitzer, Virginia E.; Viboud, Cecile; Alonso, Wladimir J.; Wilcox, Tanya; Metcalf, C. Jessica; Steiner, Claudia A.; Haynes, Amber K.; Grenfell, Bryan T.",,,Environmental Drivers of the Spatiotemporal Dynamics of Respiratory Syncytial Virus in the United States,PLOS PATHOGENS,,,English,Article,,,,,,,YOUNG-CHILDREN; NATIONAL-SURVEILLANCE; MEASLES EPIDEMICS; GROUP-B; GROUP-A; TRANSMISSION DYNAMICS; SPATIAL HIERARCHIES; INFECTIOUS-DISEASES; TRACT INFECTIONS; KILIFI DISTRICT,"Epidemics of respiratory syncytial virus (RSV) are known to occur in wintertime in temperate countries including the United States, but there is a limited understanding of the importance of climatic drivers in determining the seasonality of RSV. In the United States, RSV activity is highly spatially structured, with seasonal peaks beginning in Florida in November through December and ending in the upper Midwest in February-March, and prolonged disease activity in the southeastern US. Using data on both age-specific hospitalizations and laboratory reports of RSV in the US, and employing a combination of statistical and mechanistic epidemic modeling, we examined the association between environmental variables and state-specific measures of RSV seasonality. Temperature, vapor pressure, precipitation, and potential evapotranspiration (PET) were significantly associated with the timing of RSV activity across states in univariate exploratory analyses. The amplitude and timing of seasonality in the transmission rate was significantly correlated with seasonal fluctuations in PET, and negatively correlated with mean vapor pressure, minimum temperature, and precipitation. States with low mean vapor pressure and the largest seasonal variation in PET tended to experience biennial patterns of RSV activity, with alternating years of ""early-big"" and ""ate-small"" epidemics. Our model for the transmission dynamics of RSV was able to replicate these biennial transitions at higher amplitudes of seasonality in the transmission rate. This successfully connects environmental drivers to the epidemic dynamics of RSV; however, it does not fully explain why RSV activity begins in Florida, one of the warmest states, when RSV is a winter-seasonal pathogen. Understanding and predicting the seasonality of RSV is essential in determining the optimal timing of immunoprophylaxis.","[Pitzer, Virginia E.] Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Pitzer, Virginia E.; Viboud, Cecile; Alonso, Wladimir J.; Wilcox, Tanya; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Metcalf, C. Jessica] Univ Oxford, Dept Zool, Oxford, England; [Metcalf, C. Jessica; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Steiner, Claudia A.] US Dept HHS, Healthcare Cost & Utilizat Project, Ctr Delivery Org & Markets, Agcy Healthcare Res & Qual, Rockville, MD USA; [Haynes, Amber K.] Ctr Dis Control & Prevent, Epidemiol Branch, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA","Pitzer, VE (reprint author), Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.",virginia.pitzer@yale.edu,,"Pitzer, Virginia/0000-0003-1015-2289; Alonso, Wladimir/0000-0001-7038-0801","Bill & Melinda Gates Foundation (Vaccine Modeling Initiative); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health","This work was supported by the Bill & Melinda Gates Foundation (Vaccine Modeling Initiative; https://vaccinemodeling.org/) and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (http://www.fic.nih.gov/about/staff/pages/epidemiology-population.aspx) (VEP, CJM, and BTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Acedo L, 2010, EPIDEMIOL INFECT, V138, P853, DOI 10.1017/S0950268809991373; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], POP STAT COUNT US 17; Arenas AJ, 2009, BIOSYSTEMS, V96, P206, DOI 10.1016/j.biosystems.2009.01.007; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; CDC/NVSS, 1990, US CENS BUR; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Freitas FTD, 2013, BRAZ J INFECT DIS, V17, P62, DOI 10.1016/j.bjid.2012.09.001; Donaldson GC, 2006, CLIN INFECT DIS, V42, P677, DOI 10.1086/500208; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; FLORMAN AL, 1988, J INFECT DIS, V158, P1401, DOI 10.1093/infdis/158.6.1401; GILCHRIST S, 1994, J INFECT DIS, V170, P986, DOI 10.1093/infdis/170.4.986; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1980, J INFECT DIS, V141, P98, DOI 10.1093/infdis/141.1.98; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Lapena S, 2005, EUR J EPIDEMIOL, V20, P271, DOI 10.1007/s10654-004-4539-6; Leecaster M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-105; Light M, 2008, PEDIATR INFECT DIS J, V27, P512, DOI 10.1097/INF.0b013e318168daf1; MARTIN AJ, 1978, LANCET, V2, P1035, DOI 10.1016/S0140-6736(78)92351-6; McGuiness CB, 2014, PEDIATR INFECT DIS J, V33, P589, DOI 10.1097/INF.0000000000000257; Meerhoff TJ, 2009, PEDIATR INFECT DIS J, V28, P860, DOI 10.1097/INF.0b013e3181a3e949; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mlinaric-Galinovic G, 2012, PEDIATR INT, V54, P331, DOI 10.1111/j.1442-200X.2011.03557.x; MONTO AS, 1974, AM J EPIDEMIOL, V100, P458, DOI 10.1093/oxfordjournals.aje.a112058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Noyola DE, 2008, EPIDEMIOL INFECT, V136, P1328, DOI 10.1017/S0950268807000143; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; Paiva TM, 2012, J MED VIROL, V84, P1825, DOI 10.1002/jmv.23347; Panozzo CA, 2007, PEDIATR INFECT DIS J, V26, pS41, DOI 10.1097/INF.0b013e318157da82; Panozzo CA, 2010, PEDIATRICS, V126, pE116, DOI 10.1542/peds.2009-3221; Paynter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090094; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0199; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Walton NA, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-68; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; Waris M, 2006, CLIN INFECT DIS, V43, P541, DOI 10.1086/505986; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Welliver Robert, 2009, Paediatr Respir Rev, V10 Suppl 1, P6, DOI 10.1016/S1526-0542(09)70004-1; White LJ, 2007, MATH BIOSCI, V209, P222, DOI 10.1016/j.mbs.2006.08.018; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zachariah P, 2009, PEDIATR INFECT DIS J, V28, P772, DOI 10.1097/INF.0b013e3181a3e5b6; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211; 2009, PEDIATRICS, V124, P1694, DOI DOI 10.1542/PEDS.2009-2345",71,28,29,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004591,10.1371/journal.ppat.1004591,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100023,25569275.0,"DOAJ Gold, Green Published",,,16/08/2019,28,2,25,4816,1097,748,349,3719,2911,42,766,25,2,0,0,28,28,0,,171,4,87,0,4,31,29,31,15,0,0,0,0,0,0,0,0,2,4914,72,0,199,157,2,3758,1105,72,0,199,157,2,51,,0,0,0,0,3,0,0,0,0,0,0,87,0,0,1.25,4.390154968094804,1.2949717666039258,0.29497176660392577,1.3828986286636193,1.0678986710963456,4.68824065633546
186,J,"Poenisch, M; Metz, P; Blankenburg, H; Ruggieri, A; Lee, JY; Rupp, D; Rebhan, I; Diederich, K; Kaderali, L; Domingues, FS; Albrecht, M; Lohmann, V; Erfle, H; Bartenschlager, R",,,,"Poenisch, Marion; Metz, Philippe; Blankenburg, Hagen; Ruggieri, Alessia; Lee, Ji-Young; Rupp, Daniel; Rebhan, Ilka; Diederich, Kathrin; Kaderali, Lars; Domingues, Francisco S.; Albrecht, Mario; Lohmann, Volker; Erfle, Holger; Bartenschlager, Ralf",,,Identification of HNRNPK as Regulator of Hepatitis C Virus Particle Production,PLOS PATHOGENS,,,English,Article,,,,,,,NUCLEAR RIBONUCLEOPROTEIN-K; MESSENGER-RNA; HOST FACTORS; CELLULAR COFACTORS; B-VIRUS; REPLICATION; PROTEIN; INFECTION; INTERACTS; COMPLEX,"Hepatitis C virus (HCV) is a major cause of chronic liver disease affecting around 130 million people worldwide. While great progress has been made to define the principle steps of the viral life cycle, detailed knowledge how HCV interacts with its host cells is still limited. To overcome this limitation we conducted a comprehensive whole-virus RNA interference-based screen and identified 40 host dependency and 16 host restriction factors involved in HCV entry/replication or assembly/release. Of these factors, heterogeneous nuclear ribonucleoprotein K (HNRNPK) was found to suppress HCV particle production without affecting viral RNA replication. This suppression of virus production was specific to HCV, independent from assembly competence and genotype, and not found with the related Dengue virus. By using a knock-down rescue approach we identified the domains within HNRNPK required for suppression of HCV particle production. Importantly, HNRNPK was found to interact specifically with HCV RNA and this interaction was impaired by mutations that also reduced the ability to suppress HCV particle production. Finally, we found that in HCV-infected cells, subcellular distribution of HNRNPK was altered; the protein was recruited to sites in close proximity of lipid droplets and colocalized with core protein as well as HCV plus-strand RNA, which was not the case with HNRNPK variants unable to suppress HCV virion formation. These results suggest that HNRNPK might determine efficiency of HCV particle production by limiting the availability of viral RNA for incorporation into virions. This study adds a new function to HNRNPK that acts as central hub in the replication cycle of multiple other viruses.","[Poenisch, Marion; Metz, Philippe; Ruggieri, Alessia; Lee, Ji-Young; Rupp, Daniel; Rebhan, Ilka; Diederich, Kathrin; Lohmann, Volker; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany; [Blankenburg, Hagen; Albrecht, Mario] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany; [Blankenburg, Hagen; Domingues, Francisco S.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Blankenburg, Hagen; Domingues, Francisco S.] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Kaderali, Lars] Heidelberg Univ, ViroQuant Res Grp Modeling, Heidelberg, Germany; [Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany; [Erfle, Holger] Heidelberg Univ, ViroQuant CellNetworks RNAi Screening Facil, Heidelberg, Germany","Bartenschlager, R (reprint author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.",Ralf_Bartenschlager@med.uni-heidelberg.de,"Lohmann, Volker/H-4211-2019; Albrecht, Mario/B-6694-2008; Bartenschlager, Ralf/L-2582-2015","Lohmann, Volker/0000-0001-8719-7608; Albrecht, Mario/0000-0002-3103-9624; Bartenschlager, Ralf/0000-0001-5601-9307; Kaderali, Lars/0000-0002-2359-2294; Domingues, Francisco/0000-0003-4567-4562; Ulrich, Kathrin/0000-0001-7607-3060; Ruggieri, Alessia/0000-0001-9981-3308","Deutsche Forschungsgemeinschaft [FOR1202, BA 1505/4-2]; BMBF (project ViroQuant) [0313923]; EU (project SysPatho) [260429]; ViroQuant (BMBF) [0313923]; SysPatho (European Union) [260429]; Medical Faculty of Heidelberg","Work by RB was supported by the Deutsche Forschungsgemeinschaft FOR1202, TP1; BA 1505/4-2), the BMBF (project ViroQuant, contract no. 0313923) and the EU (project SysPatho, contract no. 260429). The work of LK was funded by ViroQuant (BMBF, 0313923) and SysPatho (European Union, 7th framework program, 260429). Work of MP was supported by the Postdoc Fellowship of the Medical Faculty of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript","Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Bourai M, 2012, J VIROL, V86, P3121, DOI 10.1128/JVI.06390-11; Burnham AJ, 2007, VIROLOGY, V367, P212, DOI 10.1016/j.virol.2007.05.008; Chao TC, 2012, J VIROL, V86, P1739, DOI 10.1128/JVI.06001-11; Chatel-Chaix L, 2013, J VIROL, V87, P11704, DOI 10.1128/JVI.01474-13; Chen YC, 2010, J VIROL, V84, P7983, DOI 10.1128/JVI.00068-10; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Fan BC, 2014, MOL CELL PROTEOMICS, V13, P84, DOI 10.1074/mcp.M113.031682; Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hao LH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003235; Hara H, 2009, J VIROL, V83, P5137, DOI 10.1128/JVI.02179-08; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hernaez B, 2008, FEBS LETT, V582, P3275, DOI 10.1016/j.febslet.2008.08.031; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P924, DOI 10.1016/j.cgh.2010.06.032; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jones DM, 2010, J GEN VIROL, V91, P2238, DOI 10.1099/vir.0.022210-0; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; MacPherson JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025584; Marchand V, 2011, RNA BIOL, V8, P325, DOI 10.4161/rna/8.2.13984; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ng TI, 2007, HEPATOLOGY, V45, P1413, DOI 10.1002/hep.21608; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Real CI, 2013, ANTIVIR RES, V100, P654, DOI 10.1016/j.antiviral.2013.10.009; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; Supekova L, 2008, J BIOL CHEM, V283, P29, DOI 10.1074/jbc.M703988200; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Tsai PL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003460; Upadhyay A, 2013, MOL CELL PROTEOMICS, V12, P1539, DOI 10.1074/mcp.M112.017020; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Windisch MP, 2005, J VIROL, V79, P13778, DOI 10.1128/JVI.79.21.13778-13793.2005; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Xue Q, 2007, ARCH VIROL, V152, P955, DOI 10.1007/s00705-006-0905-x; Zeisel MB, 2013, CURR TOP MICROBIOL, V369, P87, DOI 10.1007/978-3-642-27340-7_4; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006",72,21,22,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004573,10.1371/journal.ppat.1004573,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100015,25569684.0,"DOAJ Gold, Green Published",,,16/08/2019,21,0,41,7702,1504,1043,461,6198,4977,35,1186,41,0,0,0,19,19,0,,67,0,67,0,0,22,22,20,11,0,0,0,0,0,0,0,0,0,7776,34,0,795,57,1,6250,1508,34,0,795,57,1,18,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,5.121010638297872,1.2426589222329785,0.24265892223297839,1.2692804130364634,1.0214230070111658,5.230718085106383
187,J,"Qiu, J; Smith, P; Leahy, L; Thorley-Lawson, DA",,,,"Qiu, Jin; Smith, Pamela; Leahy, Leah; Thorley-Lawson, David A.",,,The Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,LYMPHOMA CELL-LINE; BURKITTS-LYMPHOMA; LATENT MEMBRANE-PROTEIN-1; NASOPHARYNGEAL CARCINOMA; B-CELLS; MAMMALIAN-CELLS; SCID MICE; EBV; PHENOTYPE; MICRORNAS,"The human herpes virus Epstein-Barr virus (EBV) latently infects and drives the proliferation of B lymphocytes in vitro and is associated with several forms of lymphoma and carcinoma in vivo. The virus encodes similar to 30 miRNAs in the BART region, the function of most of which remains elusive. Here we have used a new mouse xenograft model of EBV driven carcinoma-genesis to demonstrate that the BART miRNAs potentiate tumor growth and development in vivo. No effect was seen on invasion or metastasis, and the growth promoting activity was not seen in vitro. In vivo tumor growth was not associated with the expression of specific BART miRNAs but with up regulation of all the BART miRNAs, consistent with previous observations that all the BART miRNAs are highly expressed in all of the EBV associated cancers. Based on these observations, we suggest that deregulated expression of the BART miRNAs potentiates tumor growth and represents a general mechanism behind EBV associated oncogenesis.","[Qiu, Jin; Thorley-Lawson, David A.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Smith, Pamela; Leahy, Leah] Tufts Med Ctr, Dept Hematol Oncol, Boston, MA USA","Thorley-Lawson, DA (reprint author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.",david.thorley-lawson@tufts.edu,,,"Public Health Service [R01 CA65883, R01 AI18757]","This work was supported by Public Health Service grants R01 CA65883 and R01 AI18757 to DATL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ANGIOLILLO AL, 1995, LEUKEMIA LYMPHOMA, V19, P267, DOI 10.3109/10428199509107897; Babcock GJ, 2000, P NATL ACAD SCI USA, V97, P12250, DOI 10.1073/pnas.200366597; Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023; Chen S., 2010, PLOS ONE, V5; Chodosh J, 1998, J INFECT DIS, V177, P1194, DOI 10.1086/515290; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; CUOMO L, 1992, INT J CANCER, V51, P949, DOI 10.1002/ijc.2910510619; Darekar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042072; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; GHETIE MA, 1990, INT J CANCER, V45, P481, DOI 10.1002/ijc.2910450318; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/2326106; Hammerschmidt W, 2004, TRENDS MOL MED, V10, P331, DOI 10.1016/j.molmed.2004.05.006; Hochberg D, 2004, J VIROL, V78, P5194, DOI 10.1128/JVI.78.10.5194-5204.2004; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; KEMPKES B, 1995, J VIROL, V69, P231; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; Kieff E, 2007, FIELDS VIROLOGY; KIRCHMAIER AL, 1995, J VIROL, V69, P1280; Klinke O, 2014, SEMIN CANCER BIOL, V26, P52, DOI 10.1016/j.semcancer.2014.02.002; Komano J, 1998, J VIROL, V72, P9150; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lei T, 2013, INT J CANCER, V133, P79, DOI 10.1002/ijc.28007; Leight ER, 2001, MOL CELL BIOL, V21, P4149, DOI 10.1128/MCB.21.13.4149-4161.2001; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; MIDDLETON T, 1994, J VIROL, V68, P4067; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; Partridge J, 2009, JOVE, DOI [10.3791/1475, DOI 10.3791/1475]; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Qiu J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002193; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; ROBERTSON ES, 1994, J VIROL, V68, P1449; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Sakakibara S, 2009, FUTURE MICROBIOL, V4, P903, DOI 10.2217/FMB.09.49; SHIMIZU N, 1994, J VIROL, V68, P6069; Smith Pamela A, 2011, Genes Cancer, V2, P1023, DOI 10.1177/1947601912440878; Thorley-Lawson DA, 1999, LIFE SCI, V65, P1433, DOI 10.1016/S0024-3205(99)00214-3; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Vereide D. T., 2013, ONCOGENE; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; VONKALLE C, 1992, INT J CANCER, V52, P887, DOI 10.1002/ijc.2910520610; Wakisaka N, 2002, CANCER RES, V62, P6337; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; WALTER J, 1992, INT J CANCER, V50, P265, DOI 10.1002/ijc.2910500217; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483; Zhang CH, 2013, J SURG RES, V182, P227, DOI 10.1016/j.jss.2012.10.052; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08",51,43,43,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004561,10.1371/journal.ppat.1004561,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100009,25590614.0,"DOAJ Gold, Green Published",,,16/08/2019,41,0,29,5965,1927,1474,453,4038,3388,25,625,29,0,0,0,33,33,0,,36,5,36,0,5,45,41,45,24,0,0,0,0,0,0,0,0,0,5976,39,0,80,61,0,4027,1927,39,0,80,61,0,22,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,3.0954852101712507,1.4772164437840516,0.47721644378405154,1.5047052996532937,1.0186085498742665,3.1530877010897767
188,J,"Sullivan, BM; Teijaro, JR; de la Torre, JC; Oldstone, MBA",,,,"Sullivan, Brian M.; Teijaro, John R.; de la Torre, Juan Carlos; Oldstone, Michael B. A.",,,Early Virus-Host Interactions Dictate the Course of a Persistent Infection,PLOS PATHOGENS,,,English,Article,,,,,,,LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8 T-CELLS; PLASMACYTOID DENDRITIC CELLS; I INTERFERON RESPONSES; S RNA SEGMENT; VIRAL PERSISTENCE; INDUCED IMMUNOSUPPRESSION; ALPHA-DYSTROGLYCAN; CLONAL EXPANSION; IMMUNE-RESPONSES,"Many persistent viral infections are characterized by a hypofunctional T cell response and the upregulation of negative immune regulators. These events occur days after the initiation of infection. However, the very early host-virus interactions that determine the establishment of viral persistence remain poorly uncharacterized. Here we show that to establish persistence, LCMV must counteract an innate anti-viral immune response within eight hours after infection. While the virus triggers cytoplasmic RNA sensing pathways soon after infection, LCMV counteracts this pathway through a rapid increase in viral titers leading to a dysfunctional immune response characterized by a high cytokine and chemokine expression profile. This altered immune environment allows for viral replication in the splenic white pulp as well as infection of immune cells essential to an effective anti-viral immune response. Our findings illustrate how early events during infection critically dictate the characteristics of the immune response to infection and facilitate either virus control and clearance or persistence.","[Sullivan, Brian M.; Teijaro, John R.; de la Torre, Juan Carlos; Oldstone, Michael B. A.] Scripps Res Inst, Viral Immunobiol Lab, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA","Sullivan, BM (reprint author), Scripps Res Inst, Viral Immunobiol Lab, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.",bsully@scripps.edu,,,"NIH [AI09484, AI077719]; American Heart fellowship [11POST7430106]","This research was supported by NIH grants AI09484 (MBAO) and AI077719 (JCT) and American Heart fellowship 11POST7430106 (JRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; Blasius AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002915; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; BORROW P, 1995, J VIROL, V69, P1059; Borrow P, 2010, VIRUSES-BASEL, V2, P2443, DOI 10.3390/v2112443; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; BUCHMEIER MJ, 1987, J VIROL, V61, P982; BUONO P, 1988, NUCLEIC ACIDS RES, V16, P4733, DOI 10.1093/nar/16.10.4733; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hayes M, 2012, VIRUSES-BASEL, V4, P2182, DOI 10.3390/v4102182; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Lee AM, 2013, VIROLOGY, V442, P114, DOI 10.1016/j.virol.2013.04.010; Lee KJ, 2000, J VIROL, V74, P3470, DOI 10.1128/JVI.74.8.3470-3477.2000; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Mackerness KJ, 2010, J IMMUNOL, V185, P3643, DOI 10.4049/jimmunol.1000841; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; MATLOUBIAN M, 1993, J VIROL, V67, P7340; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; Ng CT, 2012, P NATL ACAD SCI USA, V109, P14116, DOI 10.1073/pnas.1211910109; Ng CT, 2012, P NATL ACAD SCI USA, V109, P7823, DOI 10.1073/pnas.1205850109; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; Pythoud C, 2012, J VIROL, V86, P7728, DOI 10.1128/JVI.00187-12; Richter K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003735; RIVIERE Y, 1985, J VIROL, V53, P966; Rodrigo WWSI, 2012, J VIROL, V86, P8185, DOI 10.1128/JVI.07240-11; Rustagi A, 2014, J MOL BIOL, V426, P1161, DOI 10.1016/j.jmb.2013.12.003; SALVATO M, 1991, J VIROL, V65, P1863; SALVATO MS, 1989, VIROLOGY, V173, P1, DOI 10.1016/0042-6822(89)90216-X; Sanchez AB, 2006, VIROLOGY, V350, P370, DOI 10.1016/j.virol.2006.01.012; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sevilla N, 2003, CURR TOP MICROBIOL, V276, P125; Smelt SC, 2001, J VIROL, V75, P448, DOI 10.1128/JVI.75.1.448-457.2001; SOUTHERN PJ, 1987, VIROLOGY, V157, P145, DOI 10.1016/0042-6822(87)90323-0; Strecker T, 2003, J VIROL, V77, P10700, DOI 10.1128/JVI.77.19.10700-10705.2003; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; TISHON A, 1993, VIROLOGY, V195, P397, DOI 10.1006/viro.1993.1389; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Walsh KB, 2012, CELL HOST MICROBE, V11, P643, DOI 10.1016/j.chom.2012.04.016; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wieland SF, 2014, J VIROL, V88, P752, DOI 10.1128/JVI.01714-13; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; WRIGHT KE, 1990, VIROLOGY, V177, P175, DOI 10.1016/0042-6822(90)90471-3; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10; Zuniga EI, 2007, CURR TOP MICROBIOL, V316, P337",73,17,17,1,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004588,10.1371/journal.ppat.1004588,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100021,25569216.0,"DOAJ Gold, Green Published",,,16/08/2019,16,6,48,5651,932,654,278,4719,3731,31,957,48,6,0,0,17,17,0,,64,3,64,0,3,18,17,18,9,0,0,0,0,0,0,0,0,4,5690,16,2,51,71,1,4711,932,16,2,51,71,1,47,,0,0,0,0,4,0,0,1,0,0,0,64,0,0,2.35,6.063304721030043,1.197499470226743,0.19749947022674294,1.2242000423818606,1.022296938594939,6.198497854077253
189,J,"Tonkin, ML; Boulanger, MJ",,,,"Tonkin, Michelle L.; Boulanger, Martin J.",,,The Shear Stress of Host Cell Invasion: Exploring the Role of Biomolecular Complexes,PLOS PATHOGENS,,,English,Article,,,,,,,VIRUS GLYCOPROTEIN-D; LISTERIA-MONOCYTOGENES; PLASMODIUM-FALCIPARUM; ERYTHROCYTE INVASION; MAMMALIAN-CELLS; CD4 RECEPTOR; PARASITE; BINDING; HIV; LIGAND,"Biological fluids, such as blood and mucosal secretions, continuously flow within the human body and form prominent barriers to pathogen colonization and invasion of host cells [1, 2]. Consequently, pathogens have evolved sophisticated molecular strategies to overcome the mechanical shear forces associated with resisting the flow of biological fluids; in particular, membrane anchored biomolecular complexes enable controlled deceleration, tight adhesion and, in the case of intracellular pathogens, penetration through the host cell membrane (Fig. 1A) [3-7]. The architecture of these biomolecular complexes have been the subject of numerous structural and biophysical investigations, which have yielded high resolution molecular blueprints of the host pathogen interface. However, our understanding of precisely how these biomolecular complexes function is somewhat limited by the technical challenges associated with measuring or modelling the effects of shear flow and related forces on protein complexes in the context of biological membranes [8]; recent studies have revealed the development and application of advanced technologies, such as optical tweezers, for studying the roles that mechanical forces play during pathogen attachment, but the stresses associated with subsequent membrane penetration events remain elusive [3, 7, 9]. To highlight the potential for correlating structural and biophysical data with the extent of dynamic shear stress experienced during diverse host cell invasion processes, we review here several structurally characterized invasion complexes from protozoan, bacterial, and viral pathogens.","[Tonkin, Michelle L.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada","Boulanger, MJ (reprint author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.",mboulang@uvic.ca,,,Canadian Institutes of Health Research [MOP82915],"This work is supported by Canadian Institutes of Health Research grant MOP82915 to MJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abbas W, 2014, BBA-BIOMEMBRANES, V1838, P1132, DOI 10.1016/j.bbamem.2013.06.020; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Crick AJ, 2014, BIOPHYS J, V107, P846, DOI 10.1016/j.bpj.2014.07.010; Dasgupta S, 2014, BIOPHYS J, V107, P43, DOI 10.1016/j.bpj.2014.05.024; DAVIES PF, 1995, PHYSIOL REV, V75, P519; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dubremetz JF, 1998, TRENDS MICROBIOL, V6, P27, DOI 10.1016/S0966-842X(97)01165-7; Earl LA, 2013, TRENDS MICROBIOL, V21, P397, DOI 10.1016/j.tim.2013.06.004; Ge XP, 2014, J MED CHEM, V57, P6419, DOI 10.1021/jm500390g; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Handler CG, 1996, J VIROL, V70, P6067; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harker KS, 2014, MBIO, V5, DOI 10.1128/mBio.01111-13; Harvey KL, 2014, INT J PARASITOL, V44, P853, DOI 10.1016/j.ijpara.2014.08.001; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; Moriarty TJ, 2012, MOL MICROBIOL, V86, P1116, DOI 10.1111/mmi.12045; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Poukchanski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070637; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Vermeire K, 2005, EXPERT OPIN INV DRUG, V14, P1199, DOI 10.1517/13543784.14.10.1199; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Zhang N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1571",38,2,2,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004539,10.1371/journal.ppat.1004539,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100005,25629317.0,"DOAJ Gold, Green Published",,,16/08/2019,2,6,16,3243,430,350,80,2813,2358,9,446,16,3,0,0,2,2,0,,20,2,20,0,2,2,2,2,2,0,0,0,0,0,0,0,4,1,3258,0,0,0,30,0,2812,430,0,0,0,30,0,16,,0,0,0,0,1,0,0,0,0,0,0,20,0,0,0.5,7.5418604651162795,1.1528617134731602,0.15286171347316033,1.168858869534305,1.0138760407030527,7.6465116279069765
190,J,"Velegraki, A; Cafarchia, C; Gaitanis, G; Iatta, R; Boekhout, T",,,,"Velegraki, Aristea; Cafarchia, Claudia; Gaitanis, Georgios; Iatta, Roberta; Boekhout, Teun",,,"Malassezia Infections in Humans and Animals: Pathophysiology, Detection, and Treatment",PLOS PATHOGENS,,,English,Article,,,,,,,ASSISTED LASER-DESORPTION; FLIGHT MASS-SPECTROMETRY; SEBORRHEIC DERMATITIS; PHOSPHOLIPASE PRODUCTION; SKIN-LESIONS; CUTANEOUS MALASSEZIA; ATOPIC-DERMATITIS; IN-VITRO; MOLECULAR-DETECTION; ANTIFUNGAL AGENTS,,"[Velegraki, Aristea] Univ Athens, Mycol Res Lab, Dept Microbiol, Sch Med, Athens 11528, Greece; [Cafarchia, Claudia; Iatta, Roberta] Univ Bari Aldo Moro, Dept Vet Med, Bari, Italy; [Gaitanis, Georgios] Univ Ioannina, Sch Hlth Sci, Fac Med, Dept Skin & Venereal Dis, GR-45110 Ioannina, Greece; [Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Boekhout, Teun] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Boekhout, Teun] Second Mil Med Univ, Changzheng Hosp, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China","Boekhout, T (reprint author), CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.",t.boekhout@cbs.knaw.nl,,"Iatta, Roberta/0000-0003-2386-8542; Cafarchia, Claudia/0000-0002-5632-4472",NPRP from the Qatar National Research Fund (Qatar Foundation) [5-298-3-086]; Procter and Gamble grant; L'Oreal research grant,"This publication was supported by NPRP grant 5-298-3-086 from the Qatar National Research Fund (a member of the Qatar Foundation) to TB. The statements herein are solely the responsibility of the authors. GG and AV have received Procter and Gamble and L'Oreal research grants for Malassezia studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akaza N, 2012, J DERMATOL, V39, P613, DOI 10.1111/j.1346-8138.2011.01477.x; Al-Sweih N, 2014, MED MYCOL CASE REP, V5, P9, DOI 10.1016/j.mmcr.2014.04.004; Amend A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004277; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278; Bjelland T, 2005, MICROBIAL ECOL, V49, P598, DOI 10.1007/s00248-004-0101-z; Boekhout T, 1998, MED MYCOL, V36, P365, DOI 10.1080/02681219880000581; Bond R, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P271, DOI 10.1007/978-3-642-03616-3_10; Bond R, 2010, CLIN DERMATOL, V28, P226, DOI 10.1016/j.clindermatol.2009.12.012; Cafarchia C, 2007, MED MYCOL, V45, P11, DOI 10.1080/13693780600962718; Cafarchia C, 2005, J VET DIAGN INVEST, V17, P316, DOI 10.1177/104063870501700403; Cafarchia C, 2004, J CLIN MICROBIOL, V42, P4868, DOI 10.1128/JCM.42.10.4868-4869.2004; Cafarchia C, 2010, MED MYCOL, V48, P73, DOI 10.3109/13693780902718347; Cafarchia C, 2008, ACTA TROP, V107, P25, DOI 10.1016/j.actatropica.2008.04.008; Cafarchia C, 2008, FEMS YEAST RES, V8, P451, DOI 10.1111/j.1567-1364.2008.00358.x; Cafarchia C, 2014, MED MYCOL, V52, P350, DOI 10.1093/mmy/myt016; Cafarchia C, 2012, MED MYCOL, V50, P795, DOI 10.3109/13693786.2012.674219; Cafarchia C, 2012, VET MICROBIOL, V155, P395, DOI 10.1016/j.vetmic.2011.09.008; Cafarchia C, 2011, MOL CELL PROBE, V25, P1, DOI 10.1016/j.mcp.2010.12.003; Castella G, 2014, MED MYCOL, V52, P99, DOI 10.3109/13693786.2013.815372; Dawson TL, 2007, J INVEST DERM SYMP P, V12, P15, DOI 10.1038/sj.jidsymp.5650049; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gaitanis G, 2011, MED HYPOTHESES, V77, P47, DOI 10.1016/j.mehy.2011.03.020; Gaitanis G, 2008, J INVEST DERMATOL, V128, P1620, DOI 10.1038/sj.jid.5701252; Gaitanis G, 2009, CURR OPIN INFECT DIS, V22, P119, DOI 10.1097/QCO.0b013e328324ed19; Gaitanis G, 2009, ISME J, V3, P498, DOI 10.1038/ismej.2008.112; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gemmer CM, 2002, J CLIN MICROBIOL, V40, P3350, DOI 10.1128/JCM.40.9.3350-3357.2002; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Giusiano G, 2010, REV IBEROAM MICOL, V27, P71, DOI 10.1016/j.riam.2009.12.005; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; Gueho-Kellermann E, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P17, DOI 10.1007/978-3-642-03616-3_2; Gupta AK, 2004, J CLIN MICROBIOL, V42, P4253, DOI 10.1128/JCM.42.9.4253-4260.2004; Hald M, 2015, ACTA DERM-VENEREOL, V95, P12, DOI 10.2340/00015555-1825; Iatta R, 2014, MED MYCOL, V52, P264, DOI 10.1093/mmy/myt004; Cabanes FJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003892; Kaffenberger BH, 2014, J AM ACAD DERMATOL, V71, P480, DOI 10.1016/j.jaad.2014.04.045; Kaneko T, 2012, MED MYCOL, V50, P74, DOI 10.3109/13693786.2011.584913; Kobayashi T, 2011, VET DERMATOL, V22, P401, DOI 10.1111/j.1365-3164.2011.00961.x; Kolecka A, 2014, BRIT J DERMATOL, V170, P332, DOI 10.1111/bjd.12680; Li CH, 2014, INDIAN J DERMATOL VE, V80, P78, DOI 10.4103/0378-6323.125475; Machado MLS, 2010, MED MYCOL, V48, P889, DOI 10.3109/13693780903532080; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; MCGINLEY KJ, 1975, J INVEST DERMATOL, V64, P401, DOI 10.1111/1523-1747.ep12512335; Midreuil F, 1999, INT J SYST BACTERIOL, V49, P1287, DOI 10.1099/00207713-49-3-1287; Nagata R, 2012, PEDIATR INT, V54, P350, DOI 10.1111/j.1442-200X.2012.03563.x; Negre A, 2009, VET DERMATOL, V20, P1, DOI 10.1111/j.1365-3164.2008.00721.x; Nijima M, 2011, VET MICROBIOL, V149, P288, DOI 10.1016/j.vetmic.2010.10.010; PASSI S, 1991, Journal of Dermatological Science, V2, P84, DOI 10.1016/0923-1811(91)90016-Q; Patino-Uzcategui A, 2011, J INVEST DERMATOL, V131, P2134, DOI 10.1038/jid.2011.178; Renker C, 2003, BIOL FERT SOILS, V37, P70, DOI 10.1007/s00374-002-0556-3; Rudramurthy SM, 2014, MYCOSES, V57, P483, DOI 10.1111/myc.12186; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Stalhberger T, 2014, J BIOL CHEM, V289, P12647, DOI 10.1074/jbc.M113.547034; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P549, DOI 10.1111/j.1348-0421.2006.tb03825.x; Sugita T, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P65, DOI 10.1007/978-3-642-03616-3_3; Sun S, 2013, ECOLOGICAL GENOMICS, P215; Velegraki A, 2004, J CLIN MICROBIOL, V42, P3589, DOI [10.1128/JCM.42.8.3589-3593.2004, 10.1128/jcm.42.8.3589-3593.2004]; Vlachos C, 2013, J EUR ACAD DERMATOL, V27, P1575, DOI 10.1111/j.1468-3083.2012.04638.x; Wang QM, 2014, PERSOONIA, V33, P41, DOI 10.3767/003158514X682313; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Yamamoto M, 2014, J DERMATOL, V41, P117, DOI 10.1111/1346-8138.12364",63,59,62,0,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004523,10.1371/journal.ppat.1004523,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100004,25569140.0,"DOAJ Gold, Green Published",,,16/08/2019,67,9,76,36540,17514,16042,1472,19026,15553,42,3431,76,8,0,0,60,60,1,,235,16,118,0,16,72,72,39,14,0,0,0,0,0,0,1,12,9,36479,13,17,36,126,4,18868,17514,13,17,36,126,4,97,,5,0,0,0,11,0,3,1,0,0,0,123,0,0,48.1,2.0863309352517985,1.9205298013245033,0.9205298013245033,1.924629454430779,1.0021346469622332,2.090784515244947
191,J,"Villordo, SM; Filomatori, CV; Sanchez-Vargas, I; Blair, CD; Gamarnik, AV",,,,"Villordo, Sergio M.; Filomatori, Claudia V.; Sanchez-Vargas, Irma; Blair, Carol D.; Gamarnik, Andrea V.",,,Dengue Virus RNA Structure Specialization Facilitates Host Adaptation,PLOS PATHOGENS,,,English,Article,,,,,,,BORNE FLAVIVIRUSES; MAMMALIAN-CELLS; MOSQUITO CELLS; DIRECT REPEATS; REPLICATION; REGION; TRANSMISSION; EVOLUTION; ELEMENTS; GENOME,"Many viral pathogens cycle between humans and insects. These viruses must have evolved strategies for rapid adaptation to different host environments. However, the mechanistic basis for the adaptation process remains poorly understood. To study the mosquito-human adaptation cycle, we examined changes in RNA structures of the dengue virus genome during host adaptation. Deep sequencing and RNA structure analysis, together with fitness evaluation, revealed a process of host specialization of RNA elements of the viral 3'UTR. Adaptation to mosquito or mammalian cells involved selection of different viral populations harvesting mutations in a single stem-loop structure. The host specialization of the identified RNA structure resulted in a significant viral fitness cost in the non-specialized host, posing a constraint during host switching. Sequence conservation analysis indicated that the identified host adaptable stem loop structure is duplicated in dengue and other mosquito- borne viruses. Interestingly, functional studies using recombinant viruses with single or double stem loops revealed that duplication of the RNA structure allows the virus to accommodate mutations beneficial in one host and deleterious in the other. Our findings reveal new concepts in adaptation of RNA viruses, in which host specialization of RNA structures results in high fitness in the adapted host, while RNA duplication confers robustness during host switching.","[Villordo, Sergio M.; Filomatori, Claudia V.; Gamarnik, Andrea V.] Fdn Inst Leloir CONICET, Buenos Aires, DF, Argentina; [Sanchez-Vargas, Irma; Blair, Carol D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA","Gamarnik, AV (reprint author), Fdn Inst Leloir CONICET, Buenos Aires, DF, Argentina.",agamarnik@leloir.org.ar,,,"National Institute of Heath, NIAID [R01AI095175-01]; DARPA Prophecy [HR001111C0094]","This work was supported by grants to AVG from the National Institute of Heath, NIAID R01AI095175-01 and DARPA Prophecy HR001111C0094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Borderia AV, 2011, CURR OPIN VIROL, V1, P643, DOI 10.1016/j.coviro.2011.09.012; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Chen RB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003591; Ciota AT, 2010, VIRUSES-BASEL, V2, P2594, DOI 10.3390/v2122594; Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/fmb.12.139, 10.2217/FMB.12.139]; Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11; de Castro MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-3; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2; Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0; GRUBER AR, 2010, PAC S BIOCOMPUT, V15, P69, DOI DOI 10.1142/9789814295291_; Gubler D.J., 2007, FIELDS VIROLOGY; Hussain M, 2014, P NATL ACAD SCI USA, V111, P2746, DOI 10.1073/pnas.1320123111; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11; Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203; Tajima S, 2007, J GEN VIROL, V88, P2214, DOI 10.1099/vir.0.82661-0; Tumban E, 2011, J GEN VIROL, V92, P841, DOI 10.1099/vir.0.026997-0; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; Weeks KM, 2011, ACCOUNTS CHEM RES, V44, P1280, DOI 10.1021/ar200051h; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026",40,58,58,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004604,10.1371/journal.ppat.1004604,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100034,25635835.0,"DOAJ Gold, Green Published",,,16/08/2019,51,50,131,16018,1958,1500,458,14060,11420,24,2616,131,36,0,0,58,58,6,,192,9,192,0,9,59,59,39,41,0,0,0,0,0,0,0,14,3,16082,125,27,574,129,4,14034,1958,125,26,574,129,4,90,,0,1,0,0,20,0,5,0,0,0,0,194,0,0,19.85,8.180796731358528,1.1392603129445236,0.13926031294452348,1.161877667140825,1.01985266575103,8.34320735444331
192,J,"Wilcox, DR; Wadhwani, NR; Longnecker, R; Muller, WJ",,,,"Wilcox, Douglas R.; Wadhwani, Nitin R.; Longnecker, Richard; Muller, William J.",,,Differential Reliance on Autophagy for Protection from HSV Encephalitis between Newborns and Adults,PLOS PATHOGENS,,,English,Article,,,,,,,HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; BECLIN 1-INDEPENDENT AUTOPHAGY; MOLECULAR-WEIGHT COMPLEX; PRION PROTEIN GENE; GAMMA(1)34.5 PROTEIN; CELL-DEATH; ANTIVIRAL DEFENSE; INFECTED-CELLS; TYPE-1,"Newborns are more susceptible to severe disease from infection than adults, with maturation of immune responses implicated as a major factor. The type I interferon response delays mortality and limits viral replication in adult mice in a model of herpes simplex virus (HSV) encephalitis. We found that intact type I interferon signaling did not control HSV disease in the neonatal brain. However, the multifunctional HSV protein c34.5 involved in countering type I interferon responses was important for virulence in the brain in both age groups. To investigate this observation further, we studied a specific function of c34.5 which contributes to HSV pathogenesis in the adult brain, inhibition of the cellular process of autophagy. Surprisingly, we found that the beclin binding domain of c34.5 responsible for inhibiting autophagy was dispensable for HSV disease in the neonatal brain, as infection of newborns with the deletion mutant decreased time to mortality compared to the rescue virus. Additionally, a functional beclin binding domain in HSV c34.5 did not effectively inhibit autophagy in the neonate, unlike in the adult. Type I IFN responses promote autophagy in adult, a finding we confirmed in the adult brain after HSV infection; however, in the newborn brain we observed that autophagy was activated through a type I IFN-independent mechanism. Furthermore, autophagy in the wild-type neonatal mouse was associated with increased apoptosis in infected regions of the brain. Observations in the mouse model were consistent with those in a human case of neonatal HSV encephalitis. Our findings reveal age-dependent differences in autophagy for protection from HSV encephalitis, indicating developmental differences in induction and regulation of this innate defense mechanism after HSV infection in the neonatal brain.","[Wilcox, Douglas R.; Muller, William J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Wilcox, Douglas R.; Longnecker, Richard] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wadhwani, Nitin R.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pathol, Chicago, IL 60611 USA","Muller, WJ (reprint author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.",wjmuller@northwestern.edu,,"Muller, William J/0000-0001-7690-0695","National Institutes of Health (USA) [NCI CA060553, T32AI060523, R01CA021776, K08AI089942]","This work was supported by National Institutes of Health (USA, www.nih.gov) grants NCI CA060553 to the Robert H. Lurie Comprehensive Cancer Center, T32AI060523 to DRW, R01CA021776 to RL, and K08AI089942 to WJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Blatt NB, 2001, BIOORGAN MED CHEM, V9, P1371, DOI 10.1016/S0968-0896(01)00041-4; BOLOVAN CA, 1994, J VIROL, V68, P48; Cheng GF, 2001, VIROLOGY, V290, P115, DOI 10.1006/viro.2001.1148; Cheng GF, 2001, J VIROL, V75, P3666, DOI 10.1128/JVI.75.8.3666-3674.2001; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Gantt S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/369172; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Jones CA, 2014, CLIN INFECT DIS, V59, P525, DOI 10.1093/cid/ciu381; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003511; Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kopp SJ, 2013, J VIROL, V87, P474, DOI 10.1128/JVI.01849-12; Korom M, 2013, J VIROL, V87, P5882, DOI 10.1128/JVI.02559-12; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liang XH, 1998, J VIROL, V72, P8586; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MCKINLEY MP, 1987, DEV BIOL, V121, P105, DOI 10.1016/0012-1606(87)90143-6; Melchjorsen J, 2009, VIRUSES-BASEL, V1, P737, DOI 10.3390/v1030737; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Pinninti SG, 2013, PEDIATR CLIN N AM, V60, P351, DOI 10.1016/j.pcl.2012.12.005; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; Satoh J, 1998, J NEUROPATH EXP NEUR, V57, P131, DOI 10.1097/00005072-199802000-00004; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Underwood E, 2013, SCIENCE, V340, P1157, DOI 10.1126/science.340.6137.1157; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739",56,16,16,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004580,10.1371/journal.ppat.1004580,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100017,25569138.0,"DOAJ Gold, Green Published",,,16/08/2019,12,2,17,5075,942,623,319,4133,2651,30,1452,17,1,0,0,15,15,0,,24,7,24,0,7,16,15,16,8,0,0,0,0,0,0,0,1,0,5169,12,12,39,100,0,4146,953,12,12,39,100,0,70,,0,0,0,0,2,0,1,1,0,0,0,26,0,0,1.75,5.387473460721869,1.227921606581176,0.2279216065811759,1.2777643358335349,1.040591133004926,5.60615711252654
193,J,"Yue, L; Pfafferott, KJ; Baalwa, J; Conrod, K; Dong, CC; Chui, C; Rong, R; Claiborne, DT; Prince, JL; Tang, JM; Ribeiro, RM; Cormier, E; Hahn, BH; Perelson, AS; Shaw, GM; Karita, E; Gilmour, J; Goepfert, P; Derdeyn, CA; Allen, SA; Borrow, P; Hunter, E",,,,"Yue, Ling; Pfafferott, Katja J.; Baalwa, Joshua; Conrod, Karen; Dong, Catherine C.; Chui, Cecilia; Rong, Rong; Claiborne, Daniel T.; Prince, Jessica L.; Tang, Jianming; Ribeiro, Ruy M.; Cormier, Emmanuel; Hahn, Beatrice H.; Perelson, Alan S.; Shaw, George M.; Karita, Etienne; Gilmour, Jill; Goepfert, Paul; Derdeyn, Cynthia A.; Allen, Susan A.; Borrow, Persephone; Hunter, Eric",,,Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL REPLICATION CAPACITY; NEUTRALIZING ANTIBODY-RESPONSE; FUSION INHIBITOR T-20; LONG-TERM SURVIVORS; CLASS-I ALLELES; ELITE CONTROLLERS; TYPE-1 INFECTION; CTL ESCAPE; IMMUNE-RESPONSES,"Control of virus replication in HIV-1 infection is critical to delaying disease progression. While cellular immune responses are a key determinant of control, relatively little is known about the contribution of the infecting virus to this process. To gain insight into this interplay between virus and host in viral control, we conducted a detailed analysis of two heterosexual HIV-1 subtype A transmission pairs in which female recipients sharing three HLA class I alleles exhibited contrasting clinical outcomes: R880F controlled virus replication while R463F experienced high viral loads and rapid disease progression. Near full-length single genome amplification defined the infecting transmitted/founder (T/F) virus proteome and subsequent sequence evolution over the first year of infection for both acutely infected recipients. T/F virus replicative capacities were compared in vitro, while the development of the earliest cellular immune response was defined using autologous virus sequence-based peptides. The R880F T/F virus replicated significantly slower in vitro than that transmitted to R463F. While neutralizing antibody responses were similar in both subjects, during acute infection R880F mounted a broad T cell response, the most dominant components of which targeted epitopes from which escape was limited. In contrast, the primary HIV-specific T cell response in R463F was focused on just two epitopes, one of which rapidly escaped. This comprehensive study highlights both the importance of the contribution of the lower replication capacity of the transmitted/founder virus and an associated induction of a broad primary HIV-specific T cell response, which was not undermined by rapid epitope escape, to long-term viral control in HIV-1 infection. It underscores the importance of the earliest CD8 T cell response targeting regions of the virus proteome that cannot mutate without a high fitness cost, further emphasizing the need for vaccines that elicit a breadth of T cell responses to conserved viral epitopes.","[Yue, Ling; Dong, Catherine C.; Rong, Rong; Claiborne, Daniel T.; Prince, Jessica L.; Derdeyn, Cynthia A.; Hunter, Eric] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Pfafferott, Katja J.; Conrod, Karen; Chui, Cecilia; Borrow, Persephone] Univ Oxford, Nuffield Dept Med, Oxford, England; [Baalwa, Joshua; Tang, Jianming; Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Ribeiro, Ruy M.; Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA; [Cormier, Emmanuel; Gilmour, Jill] Int AIDS Vaccine Initiat, Human Immunol Lab, London, England; [Hahn, Beatrice H.; Shaw, George M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Karita, Etienne] Project San Francisco, Rwanda Zambia HIV Res Project, Kigali, Rwanda; [Derdeyn, Cynthia A.; Allen, Susan A.; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA","Borrow, P (reprint author), Univ Oxford, Nuffield Dept Med, Oxford, England.",persephone.borrow@ndm.ox.ac.uk; ehunte4@emory.edu,"Tang, Jianming/O-4980-2019","Hahn, Beatrice/0000-0002-9400-9887; Ribeiro, Ruy/0000-0002-3988-8241; Tang, Jianming/0000-0003-0137-7486; Borrow, Persephone/0000-0002-3877-9780","National Institute of Alergy and Infectious Diseases, National Institutes of Health [R01 AI64060, R37 AI51231]; Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation [37874]; Marie Curie Incoming International Fellowship from the European Commission [298450]; Senior Jenner Fellowship; International AIDS Vaccine Initiative (SAA), by the generous support of the American people through the United States Agency for International Development (USAID); Virology Core at the Emory Center for AIDS Research, NIAID, NIH [P30 AI050409]; Yerkes National Primate Research Center [2P51RR000165-51]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs [OD P51OD11132]; U.S. Department of Energy [DE-AC52-06NA25396]; NIH [R01-AI028433, R01-OD011095, UM1-AI100645]; Action Cycling Fellowships","This study was funded by R01 AI64060 (EH) and R37 AI51231 (EH) from the National Institute of Alergy and Infectious Diseases, National Institutes of Health, by the Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation (#37874) (GMS and PB) and a Marie Curie Incoming International Fellowship from the European Commission (298450) (KJP). PB received salary support from a Senior Jenner Fellowship and is a Jenner Institute Investigator. Field costs were provided by the International AIDS Vaccine Initiative (SAA), made possible in part by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. This work also was supported, in part, by the Virology Core at the Emory Center for AIDS Research (Grant P30 AI050409, NIAID, NIH), and in part by the Yerkes National Primate Research Center base grant (2P51RR000165-51), funded by the National Center for Research Resources P51RR165 and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. Portions of this work were done under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396 and supported by NIH grants R01-AI028433, R01-OD011095 and UM1-AI100645. DTC and JLP were supported in part by Action Cycling Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Baalwa J, 2013, VIROLOGY, V436, P33, DOI 10.1016/j.virol.2012.10.009; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103; Boutwell CL, 2013, J VIROLOGY; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Carotenuto P, 1998, AIDS, V12, P1591, DOI 10.1097/00002030-199813000-00005; Cecilia D, 1999, J INFECT DIS, V179, P1365, DOI 10.1086/314773; Chackerian B, 1997, J VIROL, V71, P7719; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferrari G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001273; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/01.aids.0000076308.76477.b8; Frleta D, 2012, J CLIN INVEST, V122, P4685, DOI 10.1172/JCI64439; Ganusov VV, 2011, J VIROL, V85, P10518, DOI 10.1128/JVI.00655-11; Gasper-Smith N, 2008, J VIROL, V82, P7700, DOI 10.1128/JVI.00605-08; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; JURRIAANS S, 1994, VIROLOGY, V204, P223, DOI 10.1006/viro.1994.1526; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Lobritz MA, 2011, CURR OPIN HIV AIDS, V6, P214, DOI 10.1097/COH.0b013e3283454cf5; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McLaren PJ, 2012, HUM MOL GENET, V21, P4334, DOI 10.1093/hmg/dds226; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470; MUNOZ A, 1995, J ACQ IMMUN DEF SYND, V8, P496, DOI 10.1097/00042560-199504120-00010; Murphy MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003173; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; OVERBAUGH J, 1992, J VIROL, V66, P5937; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poss M, 1997, AIDS RES HUM RETROV, V13, P493, DOI 10.1089/aid.1997.13.493; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Ribeiro-dos-Santos P, 2012, BLOOD, V119, P4928, DOI 10.1182/blood-2011-12-395186; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Roederer M, 2003, J IMMUNOL METHODS, V274, P221, DOI 10.1016/S0022-1759(02)00423-4; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shacklett BL, 2010, CURR OPIN HIV AIDS, V5, P128, DOI 10.1097/COH.0b013e328335c178; SHEPPARD HW, 1993, AIDS, V7, P1159, DOI 10.1097/00002030-199309000-00002; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Tang JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009629; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; van Deutekom HWM, 2013, J IMMUNOL, V191, P3277, DOI 10.4049/jimmunol.1300962; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wright JK, 2012, J VIROL, V86, P3193, DOI 10.1128/JVI.06682-11; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12",107,25,26,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004565,10.1371/journal.ppat.1004565,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100011,25569444.0,"DOAJ Gold, Green Published",,,16/08/2019,25,0,56,5488,1081,832,249,4407,3487,35,885,56,0,0,0,26,26,0,,170,9,64,0,9,26,26,21,21,0,0,0,0,0,0,0,0,1,5607,108,0,116,225,0,4415,1086,108,0,116,225,0,106,,0,0,0,0,1,0,0,0,0,0,0,64,0,0,1.0,5.076780758556891,1.2452915815747674,0.2452915815747674,1.34785568413887,1.0823615160349853,5.49491211840888
194,J,"Zhang, Y; Lee, CW; Wehner, N; Imdahl, F; Svetlana, V; Weiste, C; Droge-Laser, W; Deeken, R",,,,"Zhang, Yi; Lee, Chil-Woo; Wehner, Nora; Imdahl, Fabian; Svetlana, Veselova; Weiste, Christoph; Droege-Laser, Wolfgang; Deeken, Rosalia",,,Regulation of Oncogene Expression in T-DNA-Transformed Host Plant Cells,PLOS PATHOGENS,,,English,Article,,,,,,,WRKY TRANSCRIPTION FACTORS; CROWN-GALL TUMORIGENESIS; AUXIN RESPONSE ELEMENTS; BOX PROTEIN TIR1; AGROBACTERIUM-TUMEFACIENS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; NUCLEOTIDE-SEQUENCE; AUX/IAA PROTEINS; CYT GENE,"Virulent Agrobacterium tumefaciens strains integrate their T-DNA into the plant genome where the encoded agrobacterial oncogenes are expressed and cause crown gall disease. Essential for crown gall development are IaaH (indole-3-acetamide hydrolase), IaaM (tryptophan monooxygenase) and Ipt (isopentenyl transferase), which encode enzymes for the biosynthesis of auxin (IaaH, IaaM) and cytokinin (Ipt). Although these oncogenes are well studied as the tumor-inducing principle, nothing is known about the regulation of oncogene expression in plant cells. Our studies show that the intergenic regions (IGRs) between the coding sequences (CDS) of the three oncogenes function as promoters in plant cells. These promoters possess a eukaryotic sequence organization and cis-regulatory elements for the binding of plant transcription factors. WRKY18, WRKY40, WRKY60 and ARF5 were identified as activators of the Ipt promoter whereas IaaH and IaaM is constitutively expressed and no transcription factor further activates their promoters. Consistent with these results, the wrky triple mutant plants in particular, develops smaller crown galls than wild-type and exhibits a reduced Ipt transcription, despite the presence of an intact ARF5 gene. WRKY40 and WRKY60 gene expression is induced by A. tumefaciens within a few hours whereas the ARF5 gene is transcribed later during crown gall development. The WRKY proteins interact with ARF5 in the plant nucleus, but only WRKY40 together with ARF5 synergistically boosts the activation of the Ipt promoter in an auxin-dependent manner. From our data, we propose that A. tumefaciens initially induces WRKY40 gene expression as a pathogen defense response of the host cell. The WRKY protein is recruited to induce Ipt expression, which initiates cytokinin-dependent host cell division. With increasing auxin levels triggered by ubiquitous expression of IaaH and IaaM, ARF5 is activated and interacts with WRKY40 to potentiate Ipt expression and balance cytokinin and auxin levels for further cell proliferation.","[Zhang, Yi; Imdahl, Fabian; Deeken, Rosalia] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, D-97070 Wurzburg, Germany; [Lee, Chil-Woo] Leibniz Inst Plant Biochem, Halle, Germany; [Wehner, Nora; Weiste, Christoph; Droege-Laser, Wolfgang] Univ Wurzburg, Julius von Sachs Inst, D-97070 Wurzburg, Germany; [Svetlana, Veselova] Russian Acad Sci, Inst Biochem & Genet, Ufa Sci Ctr, Ufa, Russia","Zhang, Y (reprint author), Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, D-97070 Wurzburg, Germany.",deeken@botanik.uni-wuerzburg.de,"Veselova, Svetlana/G-2967-2015",,"Deutsche Forschungsgemeinschaft [GRK1342, SFB 567]; China Scholarship Council (CSC)","This study was financially supported by the Deutsche Forschungsgemeinschaft, GRK1342 (TP A7), SFB 567 (TP B5) and the China Scholarship Council (CSC) [to YZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","AKIYOSHI DE, 1987, J BACTERIOL, V169, P4242, DOI 10.1128/jb.169.9.4242-4248.1987; Britton Monica T., 2008, P523, DOI 10.1007/978-0-387-72290-0_14; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Chateau S, 2000, J EXP BOT, V51, P1961, DOI 10.1093/jexbot/51.353.1961; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; Cooper G. M., 2000, THE CELL A MOLECULAR; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Deeken R, 2006, PLANT CELL, V18, P3617, DOI 10.1105/tpc.106.044743; DEPATER BS, 1987, NUCLEIC ACIDS RES, V15, P8267, DOI 10.1093/nar/15.20.8267; DEPATER BS, 1987, NUCLEIC ACIDS RES, V15, P8283, DOI 10.1093/nar/15.20.8283; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; GARFINKEL DJ, 1980, J BACTERIOL, V144, P732; GARFINKEL DJ, 1981, CELL, V27, P143, DOI 10.1016/0092-8674(81)90368-8; GOLDBERG SB, 1984, NUCLEIC ACIDS RES, V12, P4665, DOI 10.1093/nar/12.11.4665; GRAY J, 1992, J BACTERIOL, V174, P1086, DOI 10.1128/jb.174.4.1086-1098.1992; Gray J, 1996, PLANT PHYSIOL, V110, P431, DOI 10.1104/pp.110.2.431; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hayashi K, 2012, PLANT CELL PHYSIOL, V53, P965, DOI 10.1093/pcp/pcs035; HEIDEKAMP F, 1983, NUCLEIC ACIDS RES, V11, P6211, DOI 10.1093/nar/11.18.6211; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hwang HH, 2013, PHYTOPATHOLOGY, V103, P888, DOI 10.1094/PHYTO-01-13-0020-R; Hwang HH, 2010, MOL PLANT PATHOL, V11, P677, DOI [10.1111/J.1364-3703.2010.00637.X, 10.1111/j.1364-3703.2010.00637.x]; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; JOOS H, 1983, CELL, V32, P1057, DOI 10.1016/0092-8674(83)90290-8; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KLEE H, 1984, P NATL ACAD SCI-BIOL, V81, P1728, DOI 10.1073/pnas.81.6.1728; Krogan NT, 2012, NEW PHYTOL, V194, P391, DOI 10.1111/j.1469-8137.2012.04064.x; Lau S, 2011, NAT CELL BIOL, V13, P611, DOI 10.1038/ncb2212; Lee CW, 2009, PLANT CELL, V21, P2948, DOI 10.1105/tpc.108.064576; LICHTENSTEIN C, 1984, Journal of Molecular and Applied Genetics, V2, P354; Liu ZQ, 2012, J EXP BOT, V63, P6371, DOI 10.1093/jxb/ers293; MORRIS RO, 1986, ANNU REV PLANT PHYS, V37, P509, DOI 10.1146/annurev.arplant.37.1.509; NESTER EW, 1984, ANNU REV PLANT PHYS, V35, P387; NEUTEBOOM STC, 1993, PLANT MOL BIOL, V22, P923, DOI 10.1007/BF00027379; NEUTEBOOM STC, 1993, PLANT J, V4, P525, DOI 10.1046/j.1365-313X.1993.04030525.x; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Peer WA, 2013, CURR OPIN PLANT BIOL, V16, P561, DOI 10.1016/j.pbi.2013.08.003; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sardesai N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004518; SCHRODER G, 1984, EUR J BIOCHEM, V138, P387, DOI 10.1111/j.1432-1033.1984.tb07927.x; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; THOMASHOW LS, 1984, P NATL ACAD SCI-BIOL, V81, P5071, DOI 10.1073/pnas.81.16.5071; THOMASHOW MF, 1986, SCIENCE, V231, P616, DOI 10.1126/science.3511528; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Ullrich CI, 2000, J EXP BOT, V51, P1951, DOI 10.1093/jexbot/51.353.1951; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Veselov D, 2003, PLANTA, V216, P512, DOI 10.1007/s00425-002-0883-5; Wehner N, 2011, PLANT J, V68, P560, DOI 10.1111/j.1365-313X.2011.04704.x; Wenzel CL, 2007, PLANT J, V49, P387, DOI 10.1111/j.1365-313X.2006.02977.x; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000",74,8,8,1,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004620,10.1371/journal.ppat.1004620,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100041,25615824.0,"DOAJ Gold, Green Published",,,16/08/2019,9,2,18,5142,1189,901,288,3953,3096,33,824,18,0,0,0,9,9,0,,23,3,23,0,3,9,9,7,5,0,0,0,0,0,0,0,2,0,5212,114,11,151,107,1,3980,1200,114,11,151,107,1,32,,0,0,0,0,1,0,0,0,0,0,0,26,0,0,0.25,4.324642556770395,1.3007842145206172,0.30078421452061727,1.3743991904882369,1.0565927654609102,4.569386038687973
195,J,"Zhu, K; Yang, JH; Luo, KM; Yang, CH; Zhang, N; Xu, RF; Chen, JX; Jin, MF; Xu, B; Guo, NN; Wang, JR; Chen, ZL; Cui, Y; Zhao, H; Wang, Y; Deng, CY; Bai, L; Ge, BX; Qin, CF; Shen, H; Yang, CF; Leng, QB",,,,"Zhu, Kai; Yang, Juhao; Luo, Kaiming; Yang, Chunhui; Zhang, Na; Xu, Ruifeng; Chen, Jianxia; Jin, Mingfei; Xu, Bin; Guo, Nining; Wang, Jianrong; Chen, Zuolong; Cui, Ying; Zhao, Hui; Wang, Yan; Deng, Chaoyang; Bai, Li; Ge, Baoxue; Qin, Cheng-Feng; Shen, Hao; Yang, Chun-Fu; Leng, Qibin",,,TLR3 Signaling in Macrophages Is Indispensable for the Protective Immunity of Invariant Natural Killer T Cells against Enterovirus 71 Infection,PLOS PATHOGENS,,,English,Article,,,,,,,NKT CELLS; MOUTH-DISEASE; PULMONARY-EDEMA; DENDRITIC CELLS; DANGER SIGNALS; I INTERFERON; ACTIVATION; CHILDREN; RESPONSES; MOUSE,"Enterovirus 71 (EV71) is the most virulent pathogen among enteroviruses that cause hand, foot and mouth disease in children but rarely in adults. The mechanisms that determine the age-dependent susceptibility remain largely unclear. Here, we found that the paucity of invariant natural killer T (iNKT) cells together with immaturity of the immune system was related to the susceptibility of neonatal mice to EV71 infection. iNKT cells were crucial antiviral effector cells to protect young mice from EV71 infection before their adaptive immune systems were fully mature. EV71 infection led to activation of iNKT cells depending on signaling through TLR3 but not other TLRs. Surprisingly, iNKT cell activation during EV71 infection required TLR3 signaling in macrophages, but not in dendritic cells (DCs). Mechanistically, interleukin (IL)-12 and endogenous CD1d-restricted antigens were both required for full activation of iNKT cells. Furthermore, CD1d-deficiency led to dramatically increased viral loads in central nervous system and more severe disease in EV71-infected mice. Altogether, our results suggest that iNKT cells may be involved in controlling EV71 infection in children when their adaptive immune systems are not fully developed, and also imply that iNKT cells might be an intervention target for treating EV71-infected patients.","[Zhu, Kai; Yang, Juhao; Luo, Kaiming; Yang, Chunhui; Zhang, Na; Jin, Mingfei; Xu, Bin; Guo, Nining; Wang, Jianrong; Cui, Ying; Deng, Chaoyang; Yang, Chun-Fu; Leng, Qibin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Xu, Ruifeng; Chen, Zuolong; Bai, Li] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Innovat Ctr Cell Biol, Inst Immunol,Sch Life Sci, Hefei 230026, Peoples R China; [Chen, Jianxia; Ge, Baoxue] Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200092, Peoples R China; [Zhao, Hui; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Yan; Shen, Hao] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA","Yang, CF (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.",yangchunfu@sibs.ac.cn; qbleng@sibs.ac.cn,"Qin, Cheng-Feng/I-6839-2019; Wang, Yan/G-5189-2017; Yang, Chunfu/S-3051-2019","Qin, Cheng-Feng/0000-0002-0632-2807; Zhang, Na/0000-0002-5510-5702; Yang, Juhao/0000-0002-0008-3200","National Basic Research Program of China (973 Programs) [2011CB504903]; National Natural Science Foundation of China [31270951, 81172807]","This work was supported by the National Basic Research Program of China (973 Programs, grants #2011CB504903), the National Natural Science Foundation of China (grant #31270951, 81172807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Deng CY, 2011, CLIN VACCINE IMMUNOL, V18, P1589, DOI 10.1128/CVI.05132-11; Diana J, 2009, EUR J IMMUNOL, V39, P3283, DOI 10.1002/eji.200939800; Fairchok MP, 2010, J CLIN VIROL, V49, P16, DOI 10.1016/j.jcv.2010.06.013; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hammond K, 1998, INT IMMUNOL, V10, P1491, DOI 10.1093/intimm/10.10.1491; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Holzapfel KL, 2014, J IMMUNOL, V192, P5490, DOI 10.4049/jimmunol.1400722; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Juno JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002838; Khong WX, 2011, J VIROL; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Liao CC, 2014, J VIROL; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Miyamura K, 2011, J GEN VIROL, V92, P287, DOI 10.1099/vir.0.022418-0; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Paget C, 2009, J IMMUNOL, V182, P1846, DOI 10.4049/jimmunol.0802492; Pei B, 2011, J IMMUNOL, V186, P1348, DOI 10.4049/jimmunol.1001008; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; SEIFF A, 2012, LANCET, V380, P206, DOI DOI 10.1016/S0140-6736(12)61201-X.PUBMED:22826834; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Skold M, 2005, MICROBES INFECT, V7, P544, DOI 10.1016/j.micinf.2004.12.012; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tomura M, 1999, J IMMUNOL, V163, P93; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Venter M, 2011, J MED VIROL, V83, P1458, DOI 10.1002/jmv.22120; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-306; Zeissig S, 2007, AM J PHYSIOL-GASTR L, V293, pG1101, DOI 10.1152/ajpgi.00342.2007; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798",53,15,19,1,22,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004613,10.1371/journal.ppat.1004613,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100039,25615690.0,"DOAJ Gold, Green Published",,,16/08/2019,14,0,22,6213,1693,1103,590,4520,3640,21,859,22,0,0,0,15,15,0,,25,5,25,0,5,16,14,16,8,0,0,0,0,0,0,0,0,1,6277,47,0,441,66,0,4541,1704,47,0,441,66,0,32,,0,0,0,0,3,0,0,0,0,0,0,25,0,0,1.5,3.6698168930891906,1.3745575221238937,0.3745575221238938,1.413716814159292,1.0284886528247223,3.77436503248671
196,J,"Apolonia, L; Schulz, R; Curk, T; Rocha, P; Swanson, CM; Schaller, T; Ule, J; Malim, MH",,,,"Apolonia, Luis; Schulz, Reiner; Curk, Tomaz; Rocha, Paula; Swanson, Chad M.; Schaller, Torsten; Ule, Jernej; Malim, Michael H.",,,Promiscuous RNA Binding Ensures Effective Encapsidation of APOBEC3 Proteins by HIV-1,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; EDITING ENZYME APOBEC3G; MURINE LEUKEMIA-VIRUS; CD4(+) T-CELLS; REVERSE TRANSCRIPTION; 7SL RNA; SMALL RIBONUCLEOPROTEINS; ANTIVIRAL ACTIVITY; LENTIVIRAL VECTOR; STRESS GRANULES,"The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins are cell-encoded cytidine deaminases, some of which, such as APOBEC3G (A3G) and APOBEC3F (A3F), act as potent human immunodeficiency virus type-1 (HIV-1) restriction factors. These proteins require packaging into HIV-1 particles to exert their antiviral activities, but the molecular mechanism by which this occurs is incompletely understood. The nucleocapsid (NC) region of HIV-1 Gag is required for efficient incorporation of A3G and A3F, and the interaction between A3G and NC has previously been shown to be RNA-dependent. Here, we address this issue in detail by first determining which RNAs are able to bind to A3G and A3F in HV-1 infected cells, as well as in cell-free virions, using the unbiased individual-nucleotide resolution UV cross-linking and immunoprecipitation (iCLIP) method. We show that A3G and A3F bind many different types of RNA, including HIV-1 RNA, cellular mRNAs and small non-coding RNAs such as the Y or 7SL RNAs. Interestingly, A3G/F incorporation is unaffected when the levels of packaged HIV-1 genomic RNA (gRNA) and 7SL RNA are reduced, implying that these RNAs are not essential for efficient A3G/F packaging. Confirming earlier work, HIV-1 particles formed with Gag lacking the NC domain (Gag Delta NC) fail to encapsidate A3G/F. Here, we exploit this system by demonstrating that the addition of an assortment of heterologous RNA-binding proteins and domains to Gag Delta NC efficiently restored A3G/F packaging, indicating that A3G and A3F have the ability to engage multiple RNAs to ensure viral encapsidation. We propose that the rather indiscriminate RNA binding characteristics of A3G and A3F promote functionality by enabling recruitment into a wide range of retroviral particles whose packaged RNA genomes comprise divergent sequences.","[Apolonia, Luis; Swanson, Chad M.; Schaller, Torsten; Malim, Michael H.] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England; [Schulz, Reiner] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Curk, Tomaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Rocha, Paula] UCL, Dept Stat Sci, London, England; [Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Ule, Jernej] UCL Inst Neurol, Dept Mol Neurosci, London, England","Malim, MH (reprint author), Kings Coll London, Dept Infect Dis, London WC2R 2LS, England.",michael.malim@kcl.ac.uk,"Ule, Jernej/C-6315-2013; Curk, Tomaz/D-9836-2015; Schulz, Reiner/A-5940-2011","Ule, Jernej/0000-0002-2452-4277; Curk, Tomaz/0000-0003-4888-7256; Schulz, Reiner/0000-0001-5047-7921; Schaller, Torsten/0000-0001-9597-4112; Malim, Michael/0000-0002-7699-2064; Swanson, Chad/0000-0002-6650-3634; Apolonia, Luis/0000-0002-9451-6117; Rocha, Paula/0000-0003-3498-6077","U.K. Medical Research Council [G1000196, G1001081]; Department of Health via a National Institute for Health Research Comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust; Engineering and Physical Sciences Research Council [836374]; Medical Research Council [MR/M001199/1, G1000196, MR/K000381/1, MC_U105185858, G1001081]","This work was supported by the U.K. Medical Research Council (G1000196 and G1001081; http://www.mrc.ac.uk/), and the Department of Health via a National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust (www.guysandstthomasbrc.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; de Lucas S, 2014, NUCLEIC ACIDS RES, V42, P4516, DOI 10.1093/nar/gku073; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Desimmie B a, 2013, J MOL BIOL, P1; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gaddis NC, 2004, J VIROL, V78, P12041, DOI 10.1128/JVI.78.21.12041-12046.2004; Gaddis NC, 2003, J VIROL, V77, P5810, DOI 10.1128/JVI.77.10.5810-5820.2003; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Garcia EL, 2009, J VIROL, V83, P12526, DOI 10.1128/JVI.01219-09; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Izumi T, 2013, J VIROL, V87, P11047, DOI 10.1128/JVI.02070-13; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MN, 2007, SURFACTANT SCI SER, V133, P1; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; LUBAN J, 1994, J VIROL, V68, P3784; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Onafuwa-Nuga AA, 2005, J VIROL, V79, P13528, DOI 10.1128/JVI.79.21.13528-13537.2005; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Phalora PK, 2012, J VIROL, V86, P11712, DOI 10.1128/JVI.00595-12; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; SIMON JHM, 1995, J VIROL, V69, P4166; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wichroski MJ, 2006, PLOS PATHOG, V2, P374, DOI 10.1371/journal.ppat.0020041; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871",68,45,45,2,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004609,10.1371/journal.ppat.1004609,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100037,25590131.0,"DOAJ Gold, Green Published",,,16/08/2019,41,10,39,4868,899,650,249,3969,3262,20,687,39,0,0,0,43,43,0,,49,0,49,0,0,44,42,44,33,0,0,0,0,0,0,0,10,2,4864,113,0,316,84,0,3951,899,113,0,316,84,0,14,,0,0,0,0,3,0,1,0,0,0,0,49,0,0,2.25,5.414905450500556,1.2265054169816074,0.22650541698160745,1.2751322751322751,1.0396466721446178,5.629588431590657
197,J,"Avican, K; Fahlgren, A; Huss, M; Heroven, AK; Beckstette, M; Dersch, P; Fallman, M",,,,"Avican, Kemal; Fahlgren, Anna; Huss, Mikael; Heroven, Ann Kathrin; Beckstette, Michael; Dersch, Petra; Fallman, Maria",,,Reprogramming of Yersinia from Virulent to Persistent Mode Revealed by Complex In Vivo RNA-seq Analysis,PLOS PATHOGENS,,,English,Article,,,,,,,ESCHERICHIA-COLI; GLOBAL REGULATOR; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; HAEMOPHILUS-INFLUENZAE; VIBRIO-CHOLERAE; III SECRETION; ARCA REGULON; PSEUDOTUBERCULOSIS; INFECTION,"We recently found that Yersinia pseudotuberculosis can be used as a model of persistent bacterial infections. We performed in vivo RNA-seq of bacteria in small cecal tissue biopsies at early and persistent stages of infection to determine strategies associated with persistence. Comprehensive analysis of mixed RNA populations from infected tissues revealed that Y. pseudotuberculosis undergoes transcriptional reprogramming with drastic down-regulation of T3SS virulence genes during persistence when the pathogen resides within the cecum. At the persistent stage, the expression pattern in many respects resembles the pattern seen in vitro at 26oC, with for example, up-regulation of flagellar genes and invA. These findings are expected to have impact on future rationales to identify suitable bacterial targets for new antibiotics. Other genes that are up-regulated during persistence are genes involved in anaerobiosis, chemotaxis, and protection against oxidative and acidic stress, which indicates the influence of different environmental cues. We found that the Crp/CsrA/RovA regulatory cascades influence the pattern of bacterial gene expression during persistence. Furthermore, arcA, fnr, frdA, and wrbA play critical roles in persistence. Our findings suggest a model for the life cycle of this enteropathogen with reprogramming from a virulent to an adapted phenotype capable of persisting and spreading by fecal shedding.","[Avican, Kemal; Fahlgren, Anna; Fallman, Maria] Umea Univ, Dept Mol Biol, UCMR, Umea, Sweden; [Avican, Kemal; Fallman, Maria] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Huss, Mikael] Royal Inst Technol, Sci Life Lab, Solna, Sweden; [Heroven, Ann Kathrin; Beckstette, Michael; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany","Fallman, M (reprint author), Umea Univ, Dept Mol Biol, UCMR, Umea, Sweden.",maria.fallman@molbiol.umu.se,,"Huss, Mikael/0000-0003-0839-2451; Avican, Kemal/0000-0003-0707-2050",Swedish Research Council [VR-MH56X-11222-20-5]; JC Kempe memorial foundation,"This work was supported by grants from the Swedish Research Council VR-MH56X-11222-20-5 (MF) and the JC Kempe memorial foundation (KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Angelichio MJ, 2002, INFECT IMMUN, V70, P6518, DOI 10.1128/IAI.70.12.6518-6523.2002; Backhans A, 2011, EPIDEMIOL INFECT, V139, P1230, DOI 10.1017/S0950268810002463; BOLIN I, 1985, INFECT IMMUN, V48, P234; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; BRUBAKER RR, 1964, J INFECT DIS, V114, P13, DOI 10.1093/infdis/114.1.13; Bucker R, 2014, J BIOL CHEM, V289, P30114, DOI 10.1074/jbc.M114.581348; Cai GS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S5; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; De Souza-Hart JA, 2003, INFECT IMMUN, V71, P163, DOI 10.1128/IAI.71.1.163-172.2003; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Durand EA, 2010, CELL MICROBIOL, V12, P1064, DOI 10.1111/j.1462-5822.2010.01451.x; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; Fahlgren A, 2014, INFECT IMMUN, V82, P3471, DOI 10.1128/IAI.01793-14; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Fukuto HS, 2010, INFECT IMMUN, V78, P3700, DOI 10.1128/IAI.00062-10; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Handley SA, 2005, INFECT IMMUN, V73, P8453, DOI 10.1128/IAI.73.12.8453-8455.2005; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapatral V, 1996, MOL MICROBIOL, V19, P1061, DOI 10.1046/j.1365-2958.1996.452978.x; Kato Y, 2007, BIOSCI BIOTECH BIOCH, V71, P77, DOI 10.1271/bbb.60375; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; La Ragione RM, 2000, EPIDEMIOL INFECT, V124, P351, DOI 10.1017/S0950268899004045; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Monack DM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010348; Monack DM, 2012, CURR OPIN MICROBIOL, V15, P100, DOI 10.1016/j.mib.2011.10.013; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nuss AM, 2014, RNA BIOL, V11, P580, DOI 10.4161/rna.28676; Oellerich MF, 2007, INFECT IMMUN, V75, P3802, DOI 10.1128/IAI.00419-07; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Puylaert JBCM, 1997, EUR RADIOL, V7, P3, DOI 10.1007/s003300050098; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Rickman L, 2004, BIOCHEM BIOPH RES CO, V314, P259, DOI 10.1016/j.bbrc.2003.12.082; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sengupta N, 2003, INFECT IMMUN, V71, P5583, DOI 10.1128/IAI.71.10.5583-5589.2003; SIMONET M, 1990, INFECT IMMUN, V58, P841; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Taveirne ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073586; Ternhag A, 2008, EMERG INFECT DIS, V14, P143, DOI 10.3201/eid1401.070524; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Westermark L, 2014, INFECT IMMUN, V82, P1181, DOI 10.1128/IAI.01634-13; Wong SMS, 2007, MOL MICROBIOL, V64, P1375, DOI 10.1111/j.1365-2958.2007.05747.x; Young GM, 2000, INFECT IMMUN, V68, P4323, DOI 10.1128/IAI.68.7.4323-4326.2000; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143",62,33,33,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004600,10.1371/journal.ppat.1004600,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100030,25590628.0,"DOAJ Gold, Green Published",,,16/08/2019,35,6,70,7872,1307,948,359,6565,5369,35,1161,70,5,0,0,30,30,0,,90,1,90,0,1,36,36,27,26,0,0,0,0,0,0,0,1,1,7879,146,29,830,60,1,6549,1307,146,29,830,60,1,23,,0,1,0,0,4,0,0,0,0,0,0,91,0,0,8.096,6.022953328232593,1.1990860624523991,0.1990860624523991,1.2315308453922316,1.0270579268292683,6.185921958684009
198,J,"Barber, BE; William, T; Grigg, MJ; Parameswaran, U; Piera, KA; Price, RN; Yeo, TW; Anstey, NM",,,,"Barber, Bridget E.; William, Timothy; Grigg, Matthew J.; Parameswaran, Uma; Piera, Kim A.; Price, Ric N.; Yeo, Tsin W.; Anstey, Nicholas M.",,,"Parasite Biomass-Related Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria",PLOS PATHOGENS,,,English,Article,,,,,,,SEVERE FALCIPARUM-MALARIA; HISTIDINE-RICH PROTEIN-2; VON-WILLEBRAND-FACTOR; RED-BLOOD-CELLS; PLASMODIUM-VIVAX; CEREBRAL MALARIA; BONE-MARROW; MALAWIAN CHILDREN; FATAL MALARIA; PLASMA-LEVELS,"Plasmodium vivax can cause severe malaria, however its pathogenesis is poorly understood. In contrast to P. falciparum, circulating vivax parasitemia is low, with minimal apparent sequestration in endothelium-lined microvasculature, and pathogenesis thought unrelated to parasite biomass. However, the relationships between vivax disease-severity and total parasite biomass, endothelial autocrine activation and microvascular dysfunction are unknown. We measured circulating parasitemia and markers of total parasite biomass (plasma parasite lactate dehydrogenase [pLDH] and PvLDH) in adults with severe (n = 9) and non-severe (n = 53) vivax malaria, and examined relationships with disease-severity, endothelial activation, and microvascular function. Healthy controls and adults with non-severe and severe falciparum malaria were enrolled for comparison. Median peripheral parasitemia, PvLDH and pLDH were 2.4-fold, 3.7-fold and 6.9-fold higher in severe compared to non-severe vivax malaria (p = 0.02, p = 0.02 and p = 0.015, respectively), suggesting that, as in falciparum malaria, peripheral P. vivax parasitemia underestimates total parasite biomass, particularly in severe disease. P. vivax schizonts were under-represented in peripheral blood. Severe vivax malaria was associated with increased angiopoietin-2 and impaired microvascular reactivity. Peripheral vivax parasitemia correlated with endothelial activation (angiopoietin-2, von-Willebrand-Factor [VWF], E-selectin), whereas markers of total vivax biomass correlated only with systemic inflammation (IL-6, IL-10). Activity of the VWF-cleaving-protease, ADAMTS13, was deficient in proportion to endothelial activation, IL-6, thrombocytopenia and vivax disease-severity, and associated with impaired microvascular reactivity in severe disease. Impaired microvascular reactivity correlated with lactate in severe vivax malaria. Findings suggest that tissue accumulation of P. vivax may occur, with the hidden biomass greatest in severe disease and capable of mediating systemic inflammatory pathology. The lack of association between total parasite biomass and endothelial activation is consistent with accumulation in parts of the circulation devoid of endothelium. Endothelial activation, associated with circulating parasites, and systemic inflammation may contribute to pathology in vivax malaria, with microvascular dysfunction likely contributing to impaired tissue perfusion.","[Barber, Bridget E.; Grigg, Matthew J.; Piera, Kim A.; Price, Ric N.; Yeo, Tsin W.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Barber, Bridget E.; Grigg, Matthew J.; Piera, Kim A.; Price, Ric N.; Yeo, Tsin W.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Barber, Bridget E.; William, Timothy; Grigg, Matthew J.; Parameswaran, Uma] Queen Elizabeth Hosp, Dept Infect Dis, Sabah, Malaysia; [Barber, Bridget E.; William, Timothy; Grigg, Matthew J.; Parameswaran, Uma] Menzies Sch Hlth Res, Clin Res Unit, Infect Dis Soc Sabah, Kota Kinabalu, Sabah, Malaysia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Yeo, Tsin W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Yeo, Tsin W.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Anstey, Nicholas M.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia","Anstey, NM (reprint author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.",nicholas.anstey@menzies.edu.au,"Barber, Bridget/W-2965-2019; Yeo, Tsin Wen/F-9505-2015","Barber, Bridget/0000-0003-1066-7960; Price, Richard/0000-0003-2000-2874","Australian National Health and Medical Research Council [496600, 1037304, 1045156, 1042072, 605831, 1074796]; Wellcome Trust Senior Research Fellowship in Clinical Science [091625]","This work was supported by the Australian National Health and Medical Research Council (Program Grants 496600 and 1037304, Project Grant 1045156, fellowships to NMA [1042072] and TWY [605831], and scholarships to BEB [605831] and MJG [1074796]). RNP was supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (091625). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; BASCO LK, 1995, EXP PARASITOL, V80, P260, DOI 10.1006/expr.1995.1032; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Lanca EFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035406; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Coatney G. R., 1971, PRIMATE MALARIAS; Conroy AL, 2012, CRIT CARE MED, V40, P952, DOI 10.1097/CCM.0b013e3182373157; Cunnington AJ, 2013, J INFECTION, V67, P220, DOI 10.1016/j.jinf.2013.04.013; de Mast Q, 2009, AM J TROP MED HYG, V80, P492, DOI 10.4269/ajtmh.2009.80.492; del Portillo HA, 2004, INT J PARASITOL, V34, P1547, DOI 10.1016/j.ijpara.2004.10.012; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Douglas NM, 2014, BMC MED IN PRESS; Druilhe P, 2007, ANTIMICROB AGENTS CH, V51, P2112, DOI 10.1128/AAC.01385-06; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Field J., 1956, MICROSCOPIC DIAGNOSI, V2; Fox LL, 2013, J INFECT DIS, V208, P500, DOI 10.1093/infdis/jit176; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; Handayani S, 2009, J INFECT DIS, V199, P445, DOI 10.1086/596048; Hehir P., 1927, MALARIA IN INDIA; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; Imirzalioglu C, 2006, J CLIN MICROBIOL, V44, P2307, DOI 10.1128/JCM.02687-05; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; Jain V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-383; Jang JW, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-181; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kerlin DH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001772; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018; Siqueira AM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001934; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; O'Donnell J, 1998, BONE MARROW TRANSPL, V21, P313, DOI 10.1038/sj.bmt.1701073; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Prapansilp P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-50; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Raghunandan J, 2012, PAEDIATR INT CHILD H, V32, P164, DOI 10.1179/2046905512Y.0000000006; Raza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081363; Ru YX, 2009, ULTRASTRUCT PATHOL, V33, P236, DOI 10.3109/01913120903251643; Rubach MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035985; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Saharan S, 2009, PEDIATR NEPHROL, V24, P623, DOI 10.1007/s00467-008-0945-4; Sinha A, 2013, CLIN EXP NEPHROL, P1; SONG SH, 1971, AM J PHYSIOL, V220, P779; Suwanarusk R, 2004, J INFECT DIS, V189, P190, DOI 10.1086/380468; Tablin F, 2002, THE COMPLETE SPLEEN, P11; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Valecha N, 2009, AM J TROP MED HYG, V81, P758, DOI 10.4269/ajtmh.2009.09-0348; WEISS L, 1991, IMMUNOL TODAY, V12, P24, DOI 10.1016/0167-5699(91)90108-6; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; WHO, 2013, WORLD MALARIA REPORT 2013, P1; William T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-390; Yeo T, 2010, PLOS PATHOG, V6, P214; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692; Yeo TW, 2010, J INFECT DIS, V202, P109, DOI 10.1086/653211; YOELI M, 1948, T ROY SOC TROP MED H, V42, P99, DOI 10.1016/0035-9203(48)90355-1",71,50,50,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004558,10.1371/journal.ppat.1004558,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100007,25569250.0,"DOAJ Gold, Green Published",,,16/08/2019,47,11,56,5126,1018,701,317,4108,3211,30,867,56,11,0,0,46,46,0,,80,4,80,0,4,55,48,55,35,0,0,0,0,0,0,0,0,4,5205,31,0,119,110,2,4135,1032,31,0,119,110,2,38,,0,0,0,0,11,0,1,0,0,0,0,80,0,0,6.2,5.035363457760314,1.247809152872444,0.247809152872444,1.301363193768257,1.0429184549356223,5.251473477406679
199,J,"Blom, K; Braun, M; Pakalniene, J; Dailidyte, L; Beziat, V; Lampen, MH; Klingstrom, J; Lagerqvist, N; Kjerstadius, T; Michaelsson, J; Lindquist, L; Ljunggren, HG; Sandberg, JK; Mickiene, A; Gredmark-Russ, S",,,,"Blom, Kim; Braun, Monika; Pakalniene, Jolita; Dailidyte, Laura; Beziat, Vivien; Lampen, Margit H.; Klingstrom, Jonas; Lagerqvist, Nina; Kjerstadius, Torbjorn; Michaelsson, Jakob; Lindquist, Lars; Ljunggren, Hans-Gustaf; Sandberg, Johan K.; Mickiene, Aukse; Gredmark-Russ, Sara",,,Specificity and Dynamics of Effector and Memory CD8 T Cell Responses in Human Tick-Borne Encephalitis Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,TRANSCRIPTION FACTOR EOMESODERMIN; TERM-FOLLOW-UP; LYME BORRELIOSIS; VIRAL-INFECTION; CLINICAL-COURSE; EPSTEIN-BARR; DIFFERENTIATION; SUBSETS; BET; EXPRESSION,"Tick-borne encephalitis virus (TBEV) is transferred to humans by ticks. The virus causes tick-borne encephalitis (TBE) with symptoms such as meningitis and meningoencephalitis. About one third of the patients suffer from long-lasting sequelae after clearance of the infection. Studies of the immune response during TBEV-infection are essential to the understanding of host responses to TBEV-infection and for the development of therapeutics. Here, we studied in detail the primary CD8 T cell response to TBEV in patients with acute TBE. Peripheral blood CD8 T cells mounted a considerable response to TBEV-infection as assessed by Ki67 and CD38 co-expression. These activated cells showed a CD45RA-CCR7-CD127-phenotype at day 7 after hospitalization, phenotypically defining them as effector cells. An immunodominant HLA-A2-restricted TBEV epitope was identified and utilized to study the characteristics and temporal dynamics of the antigen-specific response. The functional profile of TBEV-specific CD8 T cells was dominated by variants of monofunctional cells as the effector response matured. Antigen-specific CD8 T cells predominantly displayed a distinct Eomes+Ki67+T-bet+ effector phenotype at the peak of the response, which transitioned to an Eomes-Ki67-T-bet+ phenotype as the infection resolved and memory was established. These transcription factors thus characterize and discriminate stages of the antigen-specific T cell response during acute TBEV-infection. Altogether, CD8 T cells responded strongly to acute TBEV infection and passed through an effector phase, prior to gradual differentiation into memory cells with distinct transcription factor expression- patterns throughout the different phases.","[Blom, Kim; Braun, Monika; Beziat, Vivien; Lampen, Margit H.; Klingstrom, Jonas; Lagerqvist, Nina; Michaelsson, Jakob; Ljunggren, Hans-Gustaf; Sandberg, Johan K.; Gredmark-Russ, Sara] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Pakalniene, Jolita; Dailidyte, Laura; Mickiene, Aukse] Lithuanian Univ Hlth Sci, Dept Infect Dis, Kaunas, Lithuania; [Beziat, Vivien] INSERM, U1163, Imagine Inst, Human Genet Infect Dis Lab, Paris, France; [Kjerstadius, Torbjorn] Karolinska Univ Hosp Solna, Dept Clin Microbiol, Karolinska Univ Lab, Stockholm, Sweden; [Lindquist, Lars; Gredmark-Russ, Sara] Karolinska Univ Hosp Huddinge, Dept Infect Dis, Stockholm, Sweden; [Lindquist, Lars; Mickiene, Aukse] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden","Blom, K (reprint author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden.",sara.gredmark.russ@ki.se,"Beziat, Vivien/G-2971-2011","Beziat, Vivien/0000-0002-4020-824X; Pakalniene, Jolita/0000-0002-3252-3901; Klingstrom, Jonas/0000-0001-9076-1441; Lampen, Margit/0000-0001-5435-1568; Sandberg, Johan/0000-0002-6275-0750","Wenner-Gren Foundations; Jeansson Foundations; Ake Wiberg Foundation [940220814]; Siri Lindstrom Foundation; Magnus Bergvall Foundation; Swedish Society of Medicine [SLS-246811, SLS-324381]; Stockholm County Council; Karolinska Institutet; Swedish Research Council [VR K2011-56X-10907-18-6, VR 521-2013-8623]; Swedish Foundation for Strategic Research [SSF SB12-0003]","This work was supported by Wenner-Gren Foundations http://www.swgc.org/the-foundations.aspx (SGR), Jeansson Foundations http://www.jeanssonsstiftelser.se/index.html (SGR), Ake Wiberg Foundation (grant number 940220814) http://akewiberg.se/anslag-medicin (SGR), Siri Lindstrom Foundation (SGR), Magnus Bergvall Foundation http://www.magnbergvallsstiftelse.nu/ (SGR), the Swedish Society of Medicine (grant number SLS-246811, SLS-324381) http://www.sls.se/Om-SLS/In-English/(SGR), and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet http://www.forskningsstod.sll.se (SGR). Parts of this study were also supported by the Swedish Research Council (grant number VR K2011-56X-10907-18-6 and VR 521-2013-8623) http://www.vr.se/ (HGL) and the Swedish Foundation for Strategic Research (grant number SSF SB12-0003) http://www.stratresearch.se/en/ (HGL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Andersson CR, 2010, VACCINE, V28, P2827, DOI 10.1016/j.vaccine.2010.02.001; Appay V, 2004, SEMIN IMMUNOL, V16, P205, DOI 10.1016/j.smim.2004.02.007; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10; Fujii Y, 2011, VIRAL IMMUNOL, V24, P291, DOI 10.1089/vim.2011.0017; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; GERDES J, 1984, J IMMUNOL, V133, P1710; Gunther G, 1997, CLIN DIAGN VIROL, V8, P17, DOI 10.1016/S0928-0197(97)00273-0; GUSTAFSON R, 1990, SCAND J INFECT DIS, V22, P297, DOI 10.3109/00365549009027051; GUSTAFSON R, 1992, EUR J CLIN MICROBIOL, V11, P894, DOI 10.1007/BF01962369; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Lindgren T, 2011, J VIROL, V85, P10252, DOI 10.1128/JVI.05548-11; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PuchhammerStockl E, 1995, CLIN DIAGN VIROL, V4, P321, DOI 10.1016/0928-0197(95)00022-4; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roos MTL, 2000, J INFECT DIS, V182, P451, DOI 10.1086/315737; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Saksida A, 2005, J CLIN VIROL, V33, P331, DOI 10.1016/j.jcv.2004.07.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; van Aalderen MC, 2013, J VIROL, V87, P10263, DOI 10.1128/JVI.01540-13; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1",56,19,19,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004622,10.1371/journal.ppat.1004622,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100042,25611738.0,"DOAJ Gold, Green Published",,,16/08/2019,18,2,31,5230,1415,1164,251,3815,3201,32,582,31,0,0,0,20,20,0,,86,4,48,0,4,19,19,12,13,0,0,0,0,0,0,0,2,1,5292,33,0,168,98,3,3833,1422,33,0,168,98,3,37,,0,0,0,0,1,0,2,0,0,0,0,40,0,0,0.75,3.696113074204947,1.3709043250327655,0.3709043250327654,1.4214941022280472,1.0369024856596558,3.8325088339222613
200,J,"Boursier, J; Diehl, AM",,,,"Boursier, Jerome; Diehl, Anna Mae",,,Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease,PLOS PATHOGENS,,,English,Article,,,,,,,INTESTINAL MICROBIOME; ACID-METABOLISM; STEATOHEPATITIS; OBESITY; PATHOGENESIS; ENDOTOXEMIA; PREVALENCE; RESISTANCE; INTERPLAY; MICE,"It is now well established that gut flora and chronic liver diseases are closely interrelated. This association is most evident at late stages of the disease: cirrhosis and impaired liver function are associated with intestinal bacterial overgrowth, small bowel dysmotility, increased gut permeability, and decreased immunological defenses, all of which promote bacterial translocation from the gut to the systemic circulation, leading to infections that in turn aggravate liver dysfunction in a vicious circle [1]. For a long time, the implication of gut flora in the pathophysiology of less advanced chronic liver diseases has been underestimated because technical limitations allow only for the culture of a small fraction of gut bacteria. Recent technological progress and next-generation DNA sequencing have allowed for more sophisticated analysis and sampling of the gut microbiota by culture-independent methods [2]. Thanks to these recent technological advances, knowledge about the role of gut microbiota disruption (dysbiosis) in gut diseases such as colon cancer, inflammatory bowel diseases, and irritable bowel syndrome has greatly increased, with possible new therapeutic strategies. More surprisingly, gut dysbiosis has been implicated in chronic metabolic disorders such as obesity, metabolic syndrome, diabetes, and cardiovascular diseases [3]. Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic syndrome and thus evolves in the same context as these metabolic diseases [4]. It is therefore not surprising that recent literature emphasizes a potential role for gut dysbiosis in the pathophysiology of NAFLD. NAFLD encompasses a spectrum of hepatic pathology (i.e., liver phenotypes). Accumulation of triglycerides in hepatocytes (hepatic steatosis) is the most common liver phenotype in NAFLD. Some individuals with hepatic steatosis develop nonalcoholic steatohepatitis (NASH), a more severe type of liver damage characterized by hepatic inflammation and liver cell death. In some individuals with the NASH phenotype, liver regeneration cannot keep pace with the increased rate of hepatocyte death, and liver scarring (fibrosis) ensues. Over time, some of these individuals accumulate sufficient fibrosis to develop cirrhosis. Because cirrhosis dramatically increases the risk for both primary liver cancer and overall liver-related mortality, liver cirrhosis is the NAFLD phenotype that has the worst prognosis. Epidemiologic studies indicate that NAFLD is now the most common cause of liver disease in many countries, including the United States [5]. It is estimated that at least 25% of American adults have some form of NAFLD, with about 6% of the general adult population having NASH and 2%-3% having NAFLD-related cirrhosis.","[Boursier, Jerome] CHU Angers, Serv Hepatogastroenterol, Angers, France; [Boursier, Jerome] Univ LUNAM, HIFIH, UPRES 3859, SFR 4208, Angers, France; [Diehl, Anna Mae] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA","Diehl, AM (reprint author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.",diehl004@mc.duke.edu,,,,,"Alisi A, 2010, J PEDIATR GASTR NUTR, V50, P645, DOI 10.1097/MPG.0b013e3181c7bdf1; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Farhadi A, 2008, LIVER INT, V28, P1026, DOI 10.1111/j.1478-3231.2008.01723.x; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; LEROY T, 2012, GUT, V62, P1787; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Miele L, 2012, DIGEST LIVER DIS, V44, P1032, DOI 10.1016/j.dld.2012.08.005; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Ruiz AG, 2007, OBES SURG, V17, P1374; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Yuan JY, 2014, J GASTROEN HEPATOL, V29, P1292, DOI 10.1111/jgh.12510; Zhu L, 2014, PEDIAT RES; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093",30,41,42,0,41,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004559,10.1371/journal.ppat.1004559,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100008,25625278.0,"DOAJ Gold, Green Published",,,16/08/2019,43,39,102,11369,2145,1578,567,9224,7409,31,1784,102,14,0,0,39,39,0,,275,8,140,0,8,46,46,42,18,0,0,0,0,0,0,0,32,10,11513,0,0,0,104,1,9259,2163,0,0,0,104,1,91,,0,0,0,0,8,0,2,0,0,0,0,138,0,0,4.35,5.3002331002331005,1.2325455333911535,0.23254553339115352,1.2594319167389418,1.0218137039317443,5.415850815850816
201,J,"De Majumdar, S; Yu, J; Fookes, M; McAteer, SP; Llobet, E; Finn, S; Spence, S; Monahan, A; Kissenpfennig, A; Ingram, RJ; Bengoechea, J; Gally, DL; Fanning, S; Elborn, JS; Schneiders, T",,,,"De Majumdar, Shyamasree; Yu, Jing; Fookes, Maria; McAteer, Sean P.; Llobet, Enrique; Finn, Sarah; Spence, Shaun; Monahan, Avril; Kissenpfennig, Adrien; Ingram, Rebecca J.; Bengoechea, Jose; Gally, David L.; Fanning, Seamus; Elborn, Joseph S.; Schneiders, Thamarai",,,Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation,PLOS PATHOGENS,,,English,Article,,,,,,,ENTERICA SEROVAR TYPHIMURIUM; MULTIDRUG-RESISTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; ESCHERICHIA-COLI; TRANSCRIPTIONAL ACTIVATORS; ANTIMICROBIAL PEPTIDES; ANTIBIOTIC-RESISTANCE; VIRULENCE FACTORS; EFFLUX; MARA,"Klebsiella pneumoniae is a significant human pathogen, in part due to high rates of multidrug resistance. RamA is an intrinsic regulator in K. pneumoniae established to be important for the bacterial response to antimicrobial challenge; however, little is known about its possible wider regulatory role in this organism during infection. In this work, we demonstrate that RamA is a global transcriptional regulator that significantly perturbs the transcriptional landscape of K. pneumoniae, resulting in altered microbe-drug or microbe-host response. This is largely due to the direct regulation of 68 genes associated with a myriad of cellular functions. Importantly, RamA directly binds and activates the lpxC, lpxL-2 and lpxO genes associated with lipid A biosynthesis, thus resulting in modifications within the lipid A moiety of the lipopolysaccharide. RamA-mediated alterations decrease susceptibility to colistin E, polymyxin B and human cationic antimicrobial peptide LL-37. Increased RamA levels reduce K. pneumoniae adhesion and uptake into macrophages, which is supported by in vivo infection studies, that demonstrate increased systemic dissemination of ramA overexpressing K. pneumoniae. These data establish that RamA-mediated regulation directly perturbs microbial surface properties, including lipid A biosynthesis, which facilitate evasion from the innate host response. This highlights RamA as a global regulator that confers pathoadaptive phenotypes with implications for our understanding of the pathogenesis of Enterobacter, Salmonella and Citrobacter spp. that express orthologous RamA proteins.","[De Majumdar, Shyamasree; Yu, Jing; Spence, Shaun; Monahan, Avril; Kissenpfennig, Adrien; Ingram, Rebecca J.; Bengoechea, Jose; Elborn, Joseph S.; Schneiders, Thamarai] Ctr Infect & Immun, Belfast, Antrim, North Ireland; [De Majumdar, Shyamasree; Schneiders, Thamarai] Div Pathway & Infect Med, Edinburgh, Midlothian, Scotland; [Fookes, Maria] Wellcome Trust Sanger Inst, Cambridge, England; [McAteer, Sean P.; Gally, David L.] Univ Edinburgh, Roslin Inst, Div Immun & Infect, Easter Bush, Midlothian, Scotland; [McAteer, Sean P.; Gally, David L.] Univ Edinburgh, R D SVS, Easter Bush, Midlothian, Scotland; [Llobet, Enrique; Bengoechea, Jose] Fundacio Invest Sanitaria Illes Balears FISIB Rec, Lab Microbial Pathogenesis, Bunyola, Spain; [Finn, Sarah; Fanning, Seamus] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, UCD Ctr Mol Innovat & Drug Discovery, Dublin 2, Ireland","De Majumdar, S (reprint author), Ctr Infect & Immun, Belfast, Antrim, North Ireland.",thamarai.schneiders@ed.ac.uk,"Ingram, Rebecca/F-9711-2013","Ingram, Rebecca/0000-0003-1832-2457; Fanning, Seamus/0000-0002-1922-8836; Gally, David/0000-0002-2566-0844; Kissenpfennig, Adrien/0000-0002-9633-3111; elborn, joseph/0000-0002-2323-442X; Yu, Jing/0000-0001-8001-8494; Bengoechea, Jose/0000-0002-9677-8751",MRC [G0601199]; QUB start up funds; ESCMID Research Grant Award; Wellcome Trust [098051]; BBSRC; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761]; Medical Research Council [G0601199],"This work was supported by grants awarded to TS from the MRC New Investigator Grant G0601199, QUB start up funds, the ESCMID Research Grant Award and the Wellcome Trust grant 098051. DLG and SPM are supported by an Institute Strategic Programme Grant from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Bailey AM, 2010, J BACTERIOL, V192, P1607, DOI 10.1128/JB.01517-09; Barbosa TM, 2002, MOL MICROBIOL, V45, P191, DOI 10.1046/j.1365-2958.2002.03006.x; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Bennik MHJ, 2000, J BACTERIOL, V182, P3794, DOI 10.1128/JB.182.13.3794-3801.2000; Briggs GS, 2005, J BIOL CHEM, V280, P13921, DOI 10.1074/jbc.M412054200; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Cano V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-156; Casaz P, 2006, MICROBIOL-SGM, V152, P3643, DOI 10.1099/mic.0.2006/000604-0; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P2518, DOI 10.1128/AAC.48.7.2518-2523.2004; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dangi B, 2001, J MOL BIOL, V314, P113, DOI 10.1006/jmbi.2001.5106; De Majumdar S, 2013, ANTIMICROB AGENTS CH, V57, P1603, DOI 10.1128/AAC.01998-12; Fookes M, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00027-12; GEORGE AM, 1995, MICROBIOL-UK, V141, P1909, DOI 10.1099/13500872-141-8-1909; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V291, P979, DOI 10.1006/bbrc.2002.6559; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Han XL, 2011, J ANTIMICROB CHEMOTH, V66, P323, DOI 10.1093/jac/dkq427; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Llobet E, 2011, INFECT IMMUN, V79, P3718, DOI 10.1128/IAI.05226-11; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; March C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056847; Martin RG, 2000, MOL MICROBIOL, V35, P623, DOI 10.1046/j.1365-2958.2000.01732.x; Martin RG, 1999, MOL MICROBIOL, V34, P431, DOI 10.1046/j.1365-2958.1999.01599.x; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Martin RG, 2008, J MOL BIOL, V380, P278, DOI 10.1016/j.jmb.2008.05.015; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Moreira CG, 2013, P NATL ACAD SCI USA, V110, P1470, DOI 10.1073/pnas.1215416110; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Rosenblum R, 2011, INT J ANTIMICROB AG, V38, P39, DOI 10.1016/j.ijantimicag.2011.02.012; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Schneiders T, 2006, J BIOL CHEM, V281, P10049, DOI 10.1074/jbc.M512097200; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Shu HY, 2009, MICROBIOL-SGM, V155, P4170, DOI 10.1099/mic.0.029017-0; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Velkov T, 2013, INNATE IMMUN-LONDON, V19, P265, DOI 10.1177/1753425912459092; Yamasaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3078; Yassien MA, 2002, ANTIMICROB AGENTS CH, V46, P360, DOI 10.1128/AAC.46.2.360-366.2002; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022161",58,35,35,2,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004627,10.1371/journal.ppat.1004627,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100044,25633080.0,"DOAJ Gold, Green Published",,,16/08/2019,36,5,82,10024,1620,1098,522,8404,7037,18,1349,82,2,0,0,33,33,0,,103,2,103,0,2,36,36,36,25,0,0,0,0,0,0,0,3,6,10009,111,0,170,64,1,8352,1620,111,0,170,64,1,37,,0,0,0,0,9,0,2,0,0,0,0,103,0,0,5.1,6.187654320987654,1.1927653498334128,0.19276534983341265,1.2118039029033794,1.0159616919393455,6.286419753086419
202,J,"Gideon, HP; Phuah, J; Myers, AJ; Bryson, BD; Rodgers, MA; Coleman, MT; Maiello, P; Rutledge, T; Marino, S; Fortune, SM; Kirschner, DE; Lin, PL; Flynn, JL",,,,"Gideon, Hannah Priyadarshini; Phuah, JiaYao; Myers, Amy J.; Bryson, Bryan D.; Rodgers, Mark A.; Coleman, M. Teresa; Maiello, Pauline; Rutledge, Tara; Marino, Simeone; Fortune, Sarah M.; Kirschner, Denise E.; Lin, Philana Ling; Flynn, JoAnne L.",,,"Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization",PLOS PATHOGENS,,,English,Article,,,,,,,TUMOR-NECROSIS-FACTOR; CYNOMOLGUS MACAQUE MODEL; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; ANTIGEN PRESENTATION; LATENT TUBERCULOSIS; NONHUMAN-PRIMATES; HOST-RESISTANCE; IFN-GAMMA; IN-SITU,"Lung granulomas are the pathologic hallmark of tuberculosis (TB). T cells are a major cellular component of TB lung granulomas and are known to play an important role in containment of Mycobacterium tuberculosis (Mtb) infection. We used cynomolgus macaques, a non-human primate model that recapitulates human TB with clinically active disease, latent infection or early infection, to understand functional characteristics and dynamics of T cells in individual granulomas. We sought to correlate T cell cytokine response and bacterial burden of each granuloma, as well as granuloma and systemic responses in individual animals. Our results support that each granuloma within an individual host is independent with respect to total cell numbers, proportion of T cells, pattern of cytokine response, and bacterial burden. The spectrum of these components overlaps greatly amongst animals with different clinical status, indicating that a diversity of granulomas exists within an individual host. On average only about 8% of T cells from granulomas respond with cytokine production after stimulation with Mtb specific antigens, and few ""multi-functional"" T cells were observed. However, granulomas were found to be ""multi-functional"" with respect to the combinations of functional T cells that were identified among lesions from individual animals. Although the responses generally overlapped, sterile granulomas had modestly higher frequencies of T cells making IL-17, TNF and any of T-1 (IFN-gamma., IL-2, or TNF) and/or T-17 (IL-17) cytokines than non-sterile granulomas. An inverse correlation was observed between bacterial burden with TNF and T-1/T-17 responses in individual granulomas, and a combinatorial analysis of pair-wise cytokine responses indicated that granulomas with T cells producing both pro-and anti-inflammatory cytokines (e.g. IL-10 and IL-17) were associated with clearance of Mtb. Preliminary evaluation suggests that systemic responses in the blood do not accurately reflect local T cell responses within granulomas.","[Gideon, Hannah Priyadarshini; Phuah, JiaYao; Myers, Amy J.; Rodgers, Mark A.; Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Bryson, Bryan D.; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Coleman, M. Teresa; Maiello, Pauline] Univ Pittsburgh, Dept Radiol, PET Ctr, Med Ctr, Pittsburgh, PA 15260 USA; [Rutledge, Tara; Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [Marino, Simeone; Kirschner, Denise E.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA","Flynn, JL (reprint author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.",joanne@pitt.edu,"Marino, Simeone/V-9899-2018","Marino, Simeone/0000-0002-0051-8198; Gideon, Hannah/0000-0002-4443-2134; Phuah, Jia Yao/0000-0003-2240-536X","Bill and Melinda Gates Foundation; National Institutes of Health (NIH) [AI50732, HL106804, EB012579, AI094745, HL110811]","This work was supported by the Bill and Melinda Gates Foundation (PLL and JLF) and the National Institutes of Health (NIH): AI50732 (JLF), HL106804 (JLF, DEK), EB012579 (JLF, DEK), AI094745 (JLF), HL110811 (JLF, DEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Algood HMS, 2005, CLIN INFECT DIS, V41, pS189; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brighenti S, 2012, J INFECT DIS, V205, pS316, DOI 10.1093/infdis/jis043; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Canetti G, 1955, TUBERCULE BACILLUS; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chang ST, 2005, P NATL ACAD SCI USA, V102, P4530, DOI 10.1073/pnas.0500362102; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; COOPER AM, 1995, CURR OPIN IMMUNOL, V7, P512, DOI 10.1016/0952-7915(95)80096-4; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 1996, ANN NY ACAD SCI, V795, P137, DOI 10.1111/j.1749-6632.1996.tb52662.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Jafari C, 2008, EUR RESPIR J, V31, P261, DOI 10.1183/09031936.00096707; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; JoAnne F, 2010, PULMONARY TUBERCULOS, P83; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee Jinhee, 2010, J Cell Death, V3, P1; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lin PL, 2013, ANTIMICROB AGENTS CH; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Mattila JT, 2011, J IMMUNOL, V186, P3527, DOI 10.4049/jimmunol.1003773; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nikitina IY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043733; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pawar SN, 2008, AIDS RES HUM RETROV, V24, P643, DOI 10.1089/aid.2007.0238; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tameris M, 2013, TUBERCULOSIS, V93, P143, DOI 10.1016/j.tube.2013.01.003; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Via LE, 2013, INFECT IMMUN, V81, P2909, DOI 10.1128/IAI.00632-13; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731",70,107,110,1,26,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004603,10.1371/journal.ppat.1004603,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100033,25611466.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,103,12,115,8949,2224,1536,688,6725,5215,28,1482,115,12,0,0,98,98,0,,148,8,148,0,8,108,108,108,78,0,0,0,0,0,0,0,1,10,9064,316,0,153,241,0,6763,2259,81,0,153,241,0,42,,0,0,0,0,12,0,0,0,0,0,0,152,0,0,6.45,4.023830935251799,1.3307063197026023,0.3307063197026022,1.430631970260223,1.0750921890714047,4.325989208633094
203,J,"Haas, H; Petrik, M; Decristoforo, C",,,,"Haas, Hubertus; Petrik, Milos; Decristoforo, Clemens",,,"An Iron-Mimicking, Trojan Horse-Entering Fungi-Has the Time Come for Molecular Imaging of Fungal Infections?",PLOS PATHOGENS,,,English,Article,,,,,,,INVASIVE PULMONARY ASPERGILLOSIS; TRIACETYLFUSARININE-C; FUMIGATUS; SIDEROPHORES; VIRULENCE; GA-68-SIDEROPHORES; BIOSYNTHESIS; HYDROLYSIS,,"[Haas, Hubertus] Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria; [Petrik, Milos] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Decristoforo, Clemens] Med Univ Innsbruck, Clin Dept Nucl Med, A-6020 Innsbruck, Austria","Haas, H (reprint author), Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.",hubertus.haas@i-med.ac.at; clemens.decristoforo@uki.at,"Petrik, Milos/G-3490-2015","Decristoforo, Clemens/0000-0003-0566-4036; Petrik, Milos/0000-0003-1334-5916",Austrian Science Fund (FWF) [I1346-B21]; National Programme (Czech Republic) for Sustainability [LO1304],"Work in the authors' laboratories is supported by the Austrian Science Fund (FWF, currently grant I1346-B21 to HH) and the National Programme (Czech Republic) for Sustainability (LO1304 to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; EMERY T, 1980, J NUCL MED, V21, P935; Grundlinger M, 2013, APPL ENVIRON MICROB, V79, P7534, DOI 10.1128/AEM.01285-13; Gsaller F, 2012, METALLOMICS, V4, P1262, DOI 10.1039/c2mt20179h; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; Haubner R, 2010, RADIOTHER ONCOL, V96, P280, DOI 10.1016/j.radonc.2010.07.022; Hayes GE, 2013, CURR OPIN PULM MED, V19, P259, DOI 10.1097/MCP.0b013e32835f1ad1; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hissen AHT, 2005, J BIOL INORG CHEM, V10, P211, DOI 10.1007/s00775-005-0630-z; Kragl C, 2007, EUKARYOT CELL, V6, P1278, DOI 10.1128/EC.00066-07; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Lin M, 2010, INTERN MED J, V40, P19, DOI 10.1111/j.1445-5994.2009.02072.x; LLINAS M, 1970, J MOL BIOL, V52, P399, DOI 10.1016/0022-2836(70)90409-2; Lupetti A, 2011, MED MYCOL, V49, pS62, DOI 10.3109/13693786.2010.508188; Maertens JA, 2012, HAEMATOL-HEMATOL J, V97, P325, DOI 10.3324/haematol.2012.061952; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Petrik M, 2014, MOL IMAGING BIOL, V16, P102, DOI 10.1007/s11307-013-0654-7; Petrik M, 2012, EUR J NUCL MED MOL I, V39, P1175, DOI 10.1007/s00259-012-2110-3; Petrik M, 2012, NUCL MED BIOL, V39, P361, DOI 10.1016/j.nucmedbio.2011.09.012; Petrik M, 2010, J NUCL MED, V51, P639, DOI 10.2967/jnumed.109.072462; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Raymond-Bouchard I, 2012, EUKARYOT CELL, V11, P1333, DOI 10.1128/EC.00159-12; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Sia AK, 2013, CURR OPIN CHEM BIOL, V17, P150, DOI 10.1016/j.cbpa.2012.11.014; Signore A, 2011, ANN NUCL MED, V25, P681, DOI 10.1007/s12149-011-0521-z; Thornton CR, 2014, EXPERT REV CLIN IMMU, V10, P771, DOI 10.1586/1744666X.2014.904747; Velikyan I, 2014, THERANOSTICS, V4, P47, DOI 10.7150/thno.7447; Wadsak W, 2010, EUR J RADIOL, V73, P461, DOI 10.1016/j.ejrad.2009.12.022; Wang YZ, 2013, NUCL MED BIOL, V40, P89, DOI 10.1016/j.nucmedbio.2012.10.001; Yang Z, 2009, NUCL MED BIOL, V36, P259, DOI 10.1016/j.nucmedbio.2008.12.004; Yasmin S, 2012, P NATL ACAD SCI USA, V109, pE497, DOI 10.1073/pnas.1106399108",37,22,22,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004568,10.1371/journal.ppat.1004568,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100012,25634225.0,"DOAJ Gold, Green Published",,,16/08/2019,20,1,20,4856,580,429,151,4276,3662,14,600,20,0,0,0,19,19,0,,28,4,28,0,4,20,20,20,8,0,0,0,0,0,0,0,1,0,4929,28,0,129,52,0,4300,588,28,0,129,52,0,41,,0,0,0,0,0,0,1,0,0,0,0,28,0,0,0.25,8.372413793103448,1.135640785781104,0.13564078578110383,1.171421889616464,1.031507413509061,8.636206896551725
204,J,"Halverson, TWR; Wilton, M; Poon, KKH; Petri, B; Lewenza, S",,,,"Halverson, Tyler W. R.; Wilton, Mike; Poon, Karen K. H.; Petri, Bjroern; Lewenza, Shawn",,,DNA Is an Antimicrobial Component of Neutrophil Extracellular Traps,PLOS PATHOGENS,,,English,Article,,,,,,,PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; RESISTANCE MECHANISMS; PEPTIDE RESISTANCE; INFLAMMATION; ANTIBODIES; INFECTION; MEMBRANE,"Neutrophil extracellular traps (NETs) comprise an ejected lattice of chromatin enmeshed with granular and nuclear proteins that are capable of capturing and killing microbial invaders. Although widely employed to combat infection, the antimicrobial mechanism of NETs remains enigmatic. Efforts to elucidate the bactericidal component of NETs have focused on the role of NET-bound proteins including histones, calprotectin and cathepsin G protease; however, exogenous and microbial derived deoxyribonuclease (DNase) remains the most potent inhibitor of NET function. DNA possesses a rapid bactericidal activity due to its ability to sequester surface bound cations, disrupt membrane integrity and lyse bacterial cells. Here we demonstrate that direct contact and the phosphodiester backbone are required for the cation chelating, antimicrobial property of DNA. By treating NETs with excess cations or phosphatase enzyme, the antimicrobial activity of NETs is neutralized, but NET structure, including the localization and function of NET-bound proteins, is maintained. Using intravital microscopy, we visualized NET-like structures in the skin of a mouse during infection with Pseudomonas aeruginosa. Relative to other bacteria, P. aeruginosa is a weak inducer of NETosis and is more resistant to NETs. During NET exposure, we demonstrate that P. aeruginosa responds by inducing the expression of surface modifications to defend against DNA-induced membrane destabilization and NET-mediated killing. Further, we show induction of this bacterial response to NETs is largely due to the bacterial detection of DNA. Therefore, we conclude that the DNA backbone contributes both to the antibacterial nature of NETs and as a signal perceived by microbes to elicit host-resistance strategies.","[Halverson, Tyler W. R.; Wilton, Mike; Poon, Karen K. H.; Petri, Bjroern; Lewenza, Shawn] Univ Calgary, Snyder Inst Chron Dis, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada","Lewenza, S (reprint author), Univ Calgary, Snyder Inst Chron Dis, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.",slewenza@ucalgary.ca,,,Cystic Fibrosis Canada; Snyder Institute for Chronic Diseases; Canadian Foundation Innovation (CFI); ASRA; CF Canada Studentship; CF Canada Postdoctoral Fellowship,"This work was funded by Cystic Fibrosis Canada (www.cysticfibrosis.ca) and SL held the Westaim-Alberta Science and Research Authority (ASRA) Chair in Biofilm Research. Intravital microscopy infrastructure was funded by the Snyder Institute for Chronic Diseases, Canadian Foundation Innovation (CFI) and ASRA. TWRH was supported by a CF Canada Studentship and MW was supported by CF Canada Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Davidson CJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-75; FRITZLER M, 1982, J RHEUMATOL, V9, P46; Johnson L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-115; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Lewenza S, 2008, J BACTERIOL, V190, P6119, DOI 10.1128/JB.00603-08; Lewenza S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00021; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Richards RC, 2001, BIOCHEM BIOPH RES CO, V284, P549, DOI 10.1006/bbrc.2001.5020; Seper A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003614; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1003, DOI 10.1002/art.1780250814; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Virta M, 1998, APPL ENVIRON MICROB, V64, P512; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637",37,80,82,2,41,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004593,10.1371/journal.ppat.1004593,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100025,25590621.0,"DOAJ Gold, Green Published",,,16/08/2019,78,142,139,14971,5504,4259,1245,9467,7494,29,1944,139,2,1,0,72,72,0,,177,0,176,0,0,80,80,58,36,0,0,0,0,0,0,0,141,2,14982,81,38,970,92,1,9442,5504,81,38,970,92,1,36,,0,0,0,0,4,1,0,0,0,0,1,176,0,0,2.25,2.7200218023255816,1.5813879792965035,0.5813879792965037,1.6008239146508925,1.0122904281611116,2.753452034883721
205,J,"Holton, N; Nekrasov, V; Ronald, PC; Zipfel, C",,,,"Holton, Nicholas; Nekrasov, Vladimir; Ronald, Pamela C.; Zipfel, Cyril",,,The Phylogenetically-Related Pattern Recognition Receptors EFR and XA21 Recruit Similar Immune Signaling Components in Monocots and Dicots,PLOS PATHOGENS,,,English,Article,,,,,,,XA21-MEDIATED DISEASE RESISTANCE; PLANT INNATE IMMUNITY; NADPH OXIDASE RBOHD; PV. TOMATO DC3000; INTERFAMILY TRANSFER; CYTOPLASMIC KINASE; GENE FAMILY; ARABIDOPSIS; RICE; COMPLEX,"During plant immunity, surface-localized pattern recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs). The transfer of PRRs between plant species is a promising strategy for engineering broad-spectrum disease resistance. Thus, there is a great interest in understanding the mechanisms of PRR-mediated resistance across different plant species. Two well-characterized plant PRRs are the leucine-rich repeat receptor kinases (LRR-RKs) EFR and XA21 from Arabidopsis thaliana (Arabidopsis) and rice, respectively. Interestingly, despite being evolutionary distant, EFR and XA21 are phylogenetically closely related and are both members of the sub-family XII of LRR-RKs that contains numerous potential PRRs. Here, we compared the ability of these related PRRs to engage immune signaling across the monocots-dicots taxonomic divide. Using chimera between Arabidopsis EFR and rice XA21, we show that the kinase domain of the rice XA21 is functional in triggering elf18-induced signaling and quantitative immunity to the bacteria Pseudomonas syringae pv. tomato (Pto) DC3000 and Agrobacterium tumefaciens in Arabidopsis. Furthermore, the EFR: XA21 chimera associates dynamically in a ligand-dependent manner with known components of the EFR complex. Conversely, EFR associates with Arabidopsis orthologues of rice XA21-interacting proteins, which appear to be involved in EFR-mediated signaling and immunity in Arabidopsis. Our work indicates the overall functional conservation of immune components acting downstream of distinct LRR-RK-type PRRs between monocots and dicots.","[Holton, Nicholas; Nekrasov, Vladimir; Zipfel, Cyril] Sainsbury Lab, Norwich, Norfolk, England; [Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA","Zipfel, C (reprint author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.",cyril.zipfel@tsl.ac.uk,"Nekrasov, Vladimir/H-2834-2019; ZIPFEL, CYRIL/D-7103-2011; Nekrasov, Vladimir/N-4428-2017","Nekrasov, Vladimir/0000-0001-9386-1683; ZIPFEL, CYRIL/0000-0003-4935-8583; Nekrasov, Vladimir/0000-0001-9386-1683",Gatsby Charitable Foundation; Two Blades Foundation; Citrus Research & Development Foundation; Biotechnology and Biological Sciences Research Council [BB/G024936/1],"This work was funded by the Gatsby Charitable Foundation, the Two Blades Foundation and the Citrus Research & Development Foundation to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Afroz A, 2011, PLANT CELL TISS ORG, V104, P227, DOI 10.1007/s11240-010-9825-2; Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bouwmeester K, 2014, PLANT BIOTECHNOL J, V12, P10, DOI 10.1111/pbi.12111; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Burdman S, 2004, MOL PLANT MICROBE IN, V17, P602, DOI 10.1094/MPMI.2004.17.6.602; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chen XW, 2014, MOL PLANT, V7, P874, DOI 10.1093/mp/ssu003; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; da Silva FG, 2004, MOL PLANT MICROBE IN, V17, P593, DOI 10.1094/MPMI.2004.17.6.593; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Dardick Christopher, 2006, PLoS Pathogens, V2, P14; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farid A, 2013, PLANT PHYSIOL, V162, P24, DOI 10.1104/pp.113.215509; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Gagne JM, 2010, PLANT CELL, V22, P729, DOI 10.1105/tpc.109.068734; Gagne JM, 2007, PLANT SIGNAL BEHAV, V2, P245, DOI 10.4161/psb.2.4.3863; Gao LL, 2012, MOL PLANT, V5, P143, DOI 10.1093/mp/ssr062; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hwang SG, 2011, GENETICA, V139, P1023, DOI 10.1007/s10709-011-9604-y; Jiang YN, 2013, PLANT J, V73, P814, DOI 10.1111/tpj.12076; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; KGBEO T, 1990, RICE GENET NEWSL, V7, P121; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Liu ZX, 2013, P NATL ACAD SCI USA, V110, P6205, DOI 10.1073/pnas.1215543110; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Malinovsky FG, 2014, PLANT PHYSIOL, V164, P1443, DOI 10.1104/pp.113.234625; Mendes BMJ, 2010, PLANT PATHOL, V59, P68, DOI 10.1111/j.1365-3059.2009.02148.x; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Park CJ, 2013, PLANT SCI, V210, P53, DOI 10.1016/j.plantsci.2013.05.003; Park CJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1932; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; PARK CJ, 2010, PLOS BIOL, V8, DOI DOI 10.1371/JOURNAL.PONE.0009262; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shen YW, 2002, MOL MICROBIOL, V44, P37, DOI 10.1046/j.1365-2958.2002.02862.x; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Song SK, 2005, DEV BIOL, V285, P272, DOI 10.1016/j.ydbio.2005.06.020; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Tang P, 2010, PLANT SCI, V179, P399, DOI 10.1016/j.plantsci.2010.06.017; Tintor N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00065; Tripathi J. N., 2014, PLANT BIOTECHNOL J; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yamaguchi K, 2013, CELL HOST MICROBE, V13, P347, DOI 10.1016/j.chom.2013.02.007; Zan YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-318; Zeng WQ, 2010, PLANT PHYSIOL, V153, P1188, DOI 10.1104/pp.110.157016; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037",76,40,40,0,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004602,10.1371/journal.ppat.1004602,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100032,25607985.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,36,3,91,9273,1581,1171,410,7692,6270,32,1390,91,1,0,0,36,36,0,,96,0,96,0,0,42,36,42,16,0,0,0,0,0,0,0,2,2,9338,151,98,155,79,1,7718,1590,151,98,155,79,1,30,,2,0,0,0,4,0,1,0,0,0,0,96,0,0,21.0,5.8652751423149905,1.2055382215288613,0.20553822152886114,1.2438897555902235,1.0318127898199072,6.051865907653384
206,J,"Jang, JC; Chen, G; Wang, SH; Barnes, MA; Chung, JI; Camberis, M; Le Gros, G; Cooper, PJ; Steel, C; Nutman, TB; Lazar, MA; Nair, MG",,,,"Jang, Jessica C.; Chen, Gang; Wang, Spencer H.; Barnes, Mark A.; Chung, Josiah I.; Camberis, Mali; Le Gros, Graham; Cooper, Philip J.; Steel, Cathy; Nutman, Thomas B.; Lazar, Mitchell A.; Nair, Meera G.",,,Macrophage-Derived Human Resistin Is Induced in Multiple Helminth Infections and Promotes Inflammatory Monocytes and Increased Parasite Burden,PLOS PATHOGENS,,,English,Article,,,,,,,TOLL-LIKE RECEPTOR; INDUCED INTESTINAL INFLAMMATION; SMOOTH-MUSCLE-CELLS; NEMATODE INFECTION; T-CELL; INSULIN-RESISTANCE; TYPE-2 IMMUNITY; UP-REGULATION; IFN-GAMMA; ACTIVATION,"Parasitic helminth infections can be associated with lifelong morbidity such as immune-mediated organ failure. A better understanding of the host immune response to helminths could provide new avenues to promote parasite clearance and/or alleviate infection-associated morbidity. Murine resistin-like molecules (RELM) exhibit pleiotropic functions following helminth infection including modulating the host immune response; however, the relevance of human RELM proteins in helminth infection is unknown. To examine the function of human resistin (hResistin), we utilized transgenic mice expressing the human resistin gene (hRetnTg(+)). Following infection with the helminth Nippostrongylus brasiliensis (Nb), hResistin expression was significantly upregulated in infected tissue. Compared to control hRetnTg(-) 2 mice, hRetnTg(+) mice suffered from exacerbated Nb-induced inflammation characterized by weight loss and increased infiltration of inflammatory monocytes in the lung, along with elevated Nb egg burdens and delayed parasite expulsion. Genome-wide transcriptional profiling of the infected tissue revealed that hResistin promoted expression of proinflammatory cytokines and genes downstream of toll-like receptor signaling. Moreover, hResistin preferentially bound lung monocytes, and exogenous treatment of mice with recombinant hResistin promoted monocyte recruitment and proinflammatory cytokine expression. In human studies, increased serum resistin was associated with higher parasite load in individuals infected with soil-transmitted helminths or filarial nematode Wuchereria bancrofti, and was positively correlated with proinflammatory cytokines. Together, these studies identify human resistin as a detrimental factor induced by multiple helminth infections, where it promotes proinflammatory cytokines and impedes parasite clearance. Targeting the resistin/proinflammatory cytokine immune axis may provide new diagnostic or treatment strategies for helminth infection and associated immune-mediated pathology.","[Jang, Jessica C.; Chen, Gang; Wang, Spencer H.; Barnes, Mark A.; Chung, Josiah I.; Nair, Meera G.] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Camberis, Mali; Le Gros, Graham] Malaghan Inst Med Res, Wellington, New Zealand; [Cooper, Philip J.] Lab Invest FEPIS, Quininde, Ecuador; [Cooper, Philip J.] Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecciosas, Quito, Ecuador; [Cooper, Philip J.] St Georges Univ London, London, England; [Steel, Cathy; Nutman, Thomas B.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA","Nair, MG (reprint author), Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA.",meera.nair@ucr.edu,"Le Gros, Graham/C-6725-2011","Le Gros, Graham/0000-0002-5721-0442; Jang, Jessica/0000-0002-0658-6239","NIH [1R01AI091759-01A1, P01DK49210, 1S10OD016290-01A1, MRI-1429826, 1S10RR028934-01]; Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases; UCR School of Medicine initial complement and Academic Senate grant; Health Research Council of New Zealand; Wellcome Trust [088862/Z/09/Z]","These studies were supported by the NIH (1R01AI091759-01A1 to MGN; P01DK49210 to MAL), by the Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (to CS and TBN), UCR School of Medicine initial complement and Academic Senate grant to MGN, the Health Research Council of New Zealand (to GLG) and the Wellcome Trust (088862/Z/09/Z to PJC). The UCR NextGen sequencing and bioinformatics core (IIGB) are supported by NIH 1S10OD016290-01A1, MRI-1429826 and NIH 1S10RR028934-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anuradha R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002749; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Babu S, 2012, SEMIN IMMUNOPATHOL, V34, P847, DOI 10.1007/s00281-012-0346-4; Babu S, 2012, INFECT IMMUN, V80, P2509, DOI 10.1128/IAI.06179-11; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; Babu S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000420; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Cuenco KT, 2009, J INFECT DIS, V200, P1271, DOI 10.1086/605844; Gan AM, 2013, CELL TISSUE RES, V351, P161, DOI 10.1007/s00441-012-1510-9; George PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001830; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1053/S0016-5085(03)01354-4; Helmby H, 2003, EUR J IMMUNOL, V33, P2974, DOI 10.1002/eji.200324264; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hsieh YY, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-59; Jackson JA, 2006, MICROBES INFECT, V8, P487, DOI 10.1016/j.micinf.2005.07.025; Jiang SN, 2014, J IMMUNOL, V192, P4795, DOI 10.4049/jimmunol.1302764; Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015; Kuo CH, 2013, CARCINOGENESIS, V34, P2600, DOI 10.1093/carcin/bgt281; Le Goff L, 2002, INT J PARASITOL, V32, P1277, DOI 10.1016/S0020-7519(02)00125-X; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; MACDONALD TT, 1991, J CLIN PATHOL, V44, P194, DOI 10.1136/jcp.44.3.194; Migita K, 2006, CLIN EXP RHEUMATOL, V24, P698; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Moncayo AL, 2013, CLIN EXP ALLERGY, V43, P60, DOI 10.1111/cea.12040; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Osborne LC, 2013, J IMMUNOL, V190, P2292, DOI 10.4049/jimmunol.1200706; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pirvulescu MM, 2014, INT J BIOCHEM CELL B, V50, P29, DOI 10.1016/j.biocel.2014.01.022; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Semnani RT, 2011, INFECT IMMUN, V79, P3957, DOI 10.1128/IAI.05191-11; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thomas GD, 2012, BLOOD, V120, pE93, DOI 10.1182/blood-2012-07-442640; Urban J, 2000, J IMMUNOL, V164, P4250, DOI 10.4049/jimmunol.164.8.4250; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wang J, 2011, J IMMUNOL, V187, P5277, DOI 10.4049/jimmunol.1102077; WELLER PF, 1982, AM J TROP MED HYG, V31, P942, DOI 10.4269/ajtmh.1982.31.942; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093",58,19,19,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004579,10.1371/journal.ppat.1004579,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100016,25568944.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,17,9,43,6006,1135,799,336,4871,4086,42,743,42,9,0,0,18,18,3,,111,8,57,1,8,18,18,13,12,0,0,0,0,0,0,0,0,5,6027,40,3,135,146,0,4863,1135,40,3,135,146,0,29,,3,0,0,0,15,0,0,0,0,0,0,57,1,0,31.45,5.291629955947137,1.2330117019092588,0.23301170190925888,1.2755081092178198,1.0344655344655345,5.474008810572688
207,J,"Rossez, Y; Wolfson, EB; Holmes, A; Gally, DL; Holden, NJ",,,,"Rossez, Yannick; Wolfson, Eliza B.; Holmes, Ashleigh; Gally, David L.; Holden, Nicola J.",,,"Bacterial Flagella: Twist and Stick, or Dodge across the Kingdoms",PLOS PATHOGENS,,,English,Review,,,,,,,ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; SALMONELLA-ENTERICA; HELICOBACTER-PYLORI; PLANT STOMATA; POSTTRANSLATIONAL MODIFICATION; IMMUNE-RESPONSES; EPITHELIAL-CELLS; GENETIC-ANALYSIS; INNATE IMMUNITY,"The flagellum organelle is an intricate multiprotein assembly best known for its rotational propulsion of bacteria. However, recent studies have expanded our knowledge of other functions in pathogenic contexts, particularly adherence and immune modulation, e.g., for Salmonella enterica, Campylobacter jejuni, Pseudomonas aeruginosa, and Escherichia coli. Flagella-mediated adherence is important in host colonisation for several plant and animal pathogens, but the specific interactions that promote flagella binding to such diverse host tissues has remained elusive. Recent work has shown that the organelles act like probes that find favourable surface topologies to initiate binding. An emerging theme is that more general properties, such as ionic charge of repetitive binding epitopes and rotational force, allow interactions with plasma membrane components. At the same time, flagellin monomers are important inducers of plant and animal innate immunity: variation in their recognition impacts the course and outcome of infections in hosts from both kingdoms. Bacteria have evolved different strategies to evade or even promote this specific recognition, with some important differences shown for phytopathogens. These studies have provided a wider appreciation of the functions of bacterial flagella in the context of both plant and animal reservoirs.","[Rossez, Yannick; Holmes, Ashleigh; Holden, Nicola J.] James Hutton Inst, Dundee, Scotland; [Wolfson, Eliza B.; Gally, David L.] Univ Edinburgh, Roslin Inst, Div Infect & Immun, Easter Bush, Midlothian, Scotland","Holden, NJ (reprint author), James Hutton Inst, Dundee, Scotland.",nicola.holden@hutton.ac.uk,"Holden, Nicola J/B-3038-2009; Holden, Nicola/L-1653-2019","Holden, Nicola J/0000-0002-7904-4529; Holden, Nicola/0000-0002-7904-4529; Gally, David/0000-0002-2566-0844; ROSSEZ, Yannick/0000-0001-5435-1373","Leverhulme Trust [RPG-096]; BBRSC [BB/I014179/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BB/I011625/1, BB/I014179/1]","This work was supported by Leverhulme Trust (RPG-096) and the BBRSC (BB/I014179/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","ALM RA, 1993, J BACTERIOL, V175, P4448; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Arora SK, 1998, INFECT IMMUN, V66, P1000; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Berger CN, 2009, ENV MICROBIOL REP, V1, P234, DOI 10.1111/j.1758-2229.2009.00037.x; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465; Brimer CD, 1998, J BACTERIOL, V180, P3209; Bucior I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002616; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Clarke CR, 2013, NEW PHYTOL, V200, P847, DOI 10.1111/nph.12408; Clyne M, 2000, INFECT IMMUN, V68, P4335, DOI 10.1128/IAI.68.7.4335-4339.2000; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Darrasse A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-761; de Zoete MR, 2010, J BIOL CHEM, V285, P12149, DOI 10.1074/jbc.M109.070227; Dobbin HS, 2006, INFECT IMMUN, V74, P2894, DOI 10.1128/IAI.74.5.2894-2905.2006; Dons L, 2004, INFECT IMMUN, V72, P3237, DOI [10.1128/IAI.72.6.3237-3244.2004, 10.1128/IAI.72.6.3237]; Driouich A, 2013, CURR OPIN PLANT BIOL, V16, P489, DOI 10.1016/j.pbi.2013.06.010; EATON KA, 1992, J MED MICROBIOL, V37, P123, DOI 10.1099/00222615-37-2-123; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Egelman EH, 2010, CURR OPIN CELL BIOL, V22, P68, DOI 10.1016/j.ceb.2009.11.007; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Evans LDB, 2013, NATURE, V504, P287, DOI 10.1038/nature12682; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Feldman M, 1998, INFECT IMMUN, V66, P43; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Garcia AV, 2014, MOL PLANT, V7, P657, DOI 10.1093/mp/sst145; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gorski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005142; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; HAEFELE DM, 1987, APPL ENVIRON MICROB, V53, P2528; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Hann DR, 2014, NEW PHYTOL, V201, P585, DOI 10.1111/nph.12544; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Ichinose Y, 2013, J GEN PLANT PATHOL, V79, P359, DOI 10.1007/s10327-013-0464-4; Ikeda JS, 2001, INFECT IMMUN, V69, P3021, DOI 10.1128/IAI.69.5.3021-3030.2001; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Ketko AK, 2013, PLOS ONE, V8, pe82680, DOI [10.1371/ journal. pone. 0082680, DOI 10.1371/J0URNAL.P0NE.0082680]; Kim JC, 2012, BIOCHEM BIOPH RES CO, V423, P789, DOI 10.1016/j.bbrc.2012.06.041; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Lai MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072047; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; LOCKMAN HA, 1990, INFECT IMMUN, V58, P137; LOGAN SM, 1989, J BACTERIOL, V171, P3031, DOI 10.1128/jb.171.6.3031-3038.1989; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; MAHENTHIRALINGAM E, 1995, INFECT IMMUN, V63, P4519; MCCORMICK BA, 1990, INFECT IMMUN, V58, P2957; MCCORMICK BA, 1988, INFECT IMMUN, V56, P2209; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; McQuiston JR, 2008, TRENDS MICROBIOL, V16, P142, DOI 10.1016/j.tim.2008.01.009; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; MICHIELS KW, 1991, J GEN MICROBIOL, V137, P2241, DOI 10.1099/00221287-137-9-2241; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; Montillet JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001513; Olsen JE, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-67; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Peekhaus N, 1998, J BACTERIOL, V180, P3495; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro RD, 2002, PLANT SOIL, V246, P151; Popoff MY, 2003, RES MICROBIOL, V154, P173, DOI 10.1016/S0923-2508(03)00025-1; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Reid SD, 1999, J BACTERIOL, V181, P153; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rogers TJ, 2012, INFECT IMMUN, V80, P2858, DOI 10.1128/IAI.00336-12; Rossez Y, 2014, ENVIRON MICROBIOL, V16, P2181, DOI 10.1111/1462-2920.12315; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Roy D, 2013, PHYTOPATHOLOGY, V103, P326, DOI 10.1094/PHYTO-09-12-0230-FI; Roy K, 2009, NATURE, V457, P594, DOI 10.1038/nature07568; Saldana Z, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00119; Scharfman A, 2001, INFECT IMMUN, V69, P5243, DOI 10.1128/IAI.69.9.5243-5248.2001; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shaw RK, 2011, ENV MICROBIOL REP, V3, P112, DOI 10.1111/j.1758-2229.2010.00195.x; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SMITH NH, 1991, P NATL ACAD SCI USA, V88, P956, DOI 10.1073/pnas.88.3.956; Song YC, 2004, MOL MICROBIOL, V53, P541, DOI 10.1111/j.1365-2958.2004.04175.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Sun LL, 2013, J BACTERIOL, V195, P2550, DOI 10.1128/JB.00015-13; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Taguchi F, 2009, PHYSIOL MOL PLANT P, V74, P11, DOI 10.1016/j.pmpp.2009.08.001; Trda L, 2014, NEW PHYTOL, V201, P1371, DOI 10.1111/nph.12592; Troge A, 2012, INT J MED MICROBIOL, V302, P304, DOI 10.1016/j.ijmm.2012.09.004; TRONICK SR, 1971, J BACTERIOL, V105, P211; Underwood W, 2007, CELL MICROBIOL, V9, P1621, DOI 10.1111/j.1462-5822.2007.00938.x; Watt M, 2006, ENVIRON MICROBIOL, V8, P871, DOI 10.1111/j.1462-2920.2005.00973.x; Wei HL, 2013, CELL MICROBIOL, V15, P601, DOI 10.1111/cmi.12059; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yang JY, 2014, J INNATE IMMUN, V6, P47, DOI 10.1159/000351476; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zgair AK, 2011, J MED MICROBIOL, V60, P1032, DOI 10.1099/jmm.0.026377-0; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510",108,50,51,0,59,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,UNSP e1004483,10.1371/journal.ppat.1004483,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100001,25590430.0,"DOAJ Gold, Green Published",,,16/08/2019,47,48,126,11863,2457,1779,678,9406,7185,26,2195,126,21,0,0,41,41,0,,167,14,167,0,14,54,50,54,21,0,0,0,0,0,0,0,27,12,12032,9,0,151,288,9,9380,2457,9,0,151,288,9,195,,0,1,0,0,20,0,3,0,0,0,0,166,0,0,18.616,4.828245828245828,1.261216244950032,0.2612162449500319,1.3107590899425898,1.0392818005563518,5.0179080179080175
208,J,"Cabrera, JR; Viejo-Borbolla, A; Martinez-Martin, N; Blanco, S; Wandosell, F; Alcami, A",,,,"Ruben Cabrera, Jorge; Viejo-Borbolla, Abel; Martinez-Martin, Nadia; Blanco, Soledad; Wandosell, Francisco; Alcami, Antonio",,,Secreted Herpes Simplex Virus-2 Glycoprotein G Modifies NGF-TrkA Signaling to Attract Free Nerve Endings to the Site of Infection,PLOS PATHOGENS,,,English,Article,,,,,,,LATENCY-ASSOCIATED TRANSCRIPT; NEUROTROPHIC-FACTOR; GROWTH-FACTOR; LIPID RAFTS; DRG NEURONS; IN-VITRO; TYPE-1; SKIN; CHEMOKINE; SURVIVAL,"Herpes simplex virus type 1 (HSV-1) and HSV-2 are highly prevalent viruses that cause a variety of diseases, from cold sores to encephalitis. Both viruses establish latency in peripheral neurons but the molecular mechanisms facilitating the infection of neurons are not fully understood. Using surface plasmon resonance and crosslinking assays, we show that glycoprotein G (gG) from HSV-2, known to modulate immune mediators (chemokines), also interacts with neurotrophic factors, with high affinity. In our experimental model, HSV-2 secreted gG (SgG2) increases nerve growth factor (NGF)-dependent axonal growth of sympathetic neurons ex vivo, and modifies tropomyosin related kinase (Trk) A-mediated signaling. SgG2 alters TrkA recruitment to lipid rafts and decreases TrkA internalization. We could show, with microfluidic devices, that SgG2 reduced NGF-induced TrkA retrograde transport. In vivo, both HSV-2 infection and SgG2 expression in mouse hindpaw epidermis enhance axonal growth modifying the termination zone of the NGF-dependent peptidergic free nerve endings. This constitutes, to our knowledge, the discovery of the first viral protein that modulates neurotrophins, an activity that may facilitate HSV-2 infection of neurons. This dual function of the chemokine-binding protein SgG2 uncovers a novel strategy developed by HSV-2 to modulate factors from both the immune and nervous systems.","[Ruben Cabrera, Jorge; Viejo-Borbolla, Abel; Martinez-Martin, Nadia; Blanco, Soledad; Wandosell, Francisco; Alcami, Antonio] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Ruben Cabrera, Jorge; Wandosell, Francisco] Ctr Invest Biol Red Enfermedades Neurodegenerat C, Madrid, Spain","Wandosell, F (reprint author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.",fwandosell@cbm.csic.es; aalcami@cbm.csic.es,"Alcami, Antonio/F-8512-2015; Cabrera, Jorge/H-6310-2015; Wandosell, Francisco/G-6105-2015","Alcami, Antonio/0000-0002-3333-6016; Cabrera, Jorge/0000-0003-4481-0198; Wandosell, Francisco/0000-0001-6537-2321","Spanish Ministry of Science and Innovation [SAF2009-07857, SAF2009-12249-C02-01]; Instituto de Salud Carlos III [Red Espanola de Esclerosis Multiple RD12/0032/0014, CIBERNED]; I+D-BIOMEDICINA-CAM; Consejo Superior de Investigaciones Cientificas;  [EU-FP7-2009-CT222887]","This work was funded by grants from the Spanish Ministry of Science and Innovation (SAF2009-07857, SAF2009-12249-C02-01), Instituto de Salud Carlos III (Red Espanola de Esclerosis Multiple RD12/0032/0014 and CIBERNED), I+D-BIOMEDICINA-CAM 2010, and EU-FP7-2009-CT222887. AVB and NMM were funded by JAE fellowships from Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Abaitua F, 2013, J VIROL, V87, P7921, DOI 10.1128/JVI.01172-13; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BALACHANDRAN N, 1985, J VIROL, V54, P825; BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Cabrera JR, 2006, J BIOL CHEM, V281, P14330, DOI 10.1074/jbc.M509572200; CARVALHO TLL, 1986, J ANAT, V149, P121; Chalasani SH, 2003, J NEUROSCI, V23, P1360; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dillon TE, 2004, J COMP NEUROL, V470, P13, DOI 10.1002/cne.11029; Encinas M, 2008, CELL DEATH DIFFER, V15, P1510, DOI 10.1038/cdd.2008.76; Engelberg R, 2003, SEX TRANSM DIS, V30, P174, DOI 10.1097/00007435-200302000-00015; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Goodness TP, 1997, EUR J NEUROSCI, V9, P1574, DOI 10.1111/j.1460-9568.1997.tb01515.x; Guo T, 2011, NAT NEUROSCI, V14, P31, DOI 10.1038/nn.2710; Hamza MA, 2007, J NEUROVIROL, V13, P56, DOI 10.1080/13550280601156297; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Hazen Virginia M, 2010, J Vis Exp, DOI 10.3791/1853; Hiltunen JO, 2005, NEUROSCIENCE, V133, P51, DOI 10.1016/j.neuroscience.2005.01.019; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Indo Y, 2010, EXPERT REV NEUROTHER, V10, P1707, DOI [10.1586/ern.10.154, 10.1586/ERN.10.154]; INYAMA CO, 1986, NEUROSCI LETT, V69, P13, DOI 10.1016/0304-3940(86)90406-4; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li SM, 2010, J GEN VIROL, V91, P858, DOI 10.1099/vir.0.015719-0; Lisziewicz J, 2005, J INVEST DERMATOL, V124, P160, DOI 10.1111/j.0022-202X.2004.23535.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; MCGEOCH DJ, 1987, J GEN VIROL, V68, P19, DOI 10.1099/0022-1317-68-1-19; MEIGNIER B, 1988, VIROLOGY, V162, P251, DOI 10.1016/0042-6822(88)90417-5; MENSE S, 2008, SENSES COMPREHENSIVE, P11, DOI DOI 10.1186/1742-4755-5-11; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Montano JA, 2010, MICROSC RES TECHNIQ, V73, P513, DOI 10.1002/jemt.20790; Ozaktay AC, 2002, EUR SPINE J, V11, P467, DOI 10.1007/s00586-002-0430-x; Paratcha G, 2002, CURR OPIN NEUROBIOL, V12, P542, DOI 10.1016/S0959-4388(02)00363-X; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pezet S, 2006, ANNU REV NEUROSCI, V29, P507, DOI 10.1146/annurev.neuro.29.051605.112929; Puttur FK, 2010, J IMMUNOL, V185, P477, DOI 10.4049/jimmunol.0904106; Reichardt LF, 2004, CELL, V118, P141, DOI 10.1016/j.cell.2004.07.008; RICHMAN DD, 1986, J VIROL, V57, P647; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Robinson DR, 2008, MOL INTERV, V8, P242, DOI 10.1124/mi.8.5.9; ROIZMAN B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Sauerbrei A, 2011, EURO SURVEILL, V16; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; STANBERRY LR, 1992, J MED VIROL, V38, P142, DOI 10.1002/jmv.1890380213; Su BG, 2012, ANAT REC, V295, P121, DOI 10.1002/ar.21518; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Taylor AMW, 2009, J COMP NEUROL, V514, P555, DOI 10.1002/cne.22048; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Truzzi F, 2011, DERM-ENDOCRINOL, V3, P32, DOI 10.4161/derm.3.1.14661; Ueda A, 2010, MOL CELL NEUROSCI, V45, P355, DOI 10.1016/j.mcn.2010.07.008; Verdu E, 1997, EXP NEUROL, V146, P187, DOI 10.1006/exnr.1997.6517; Viejo-Borbolla A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002497; Viejo-Borbolla A, 2010, J GEN VIROL, V91, P23, DOI 10.1099/vir.0.011940-0; WEBER PC, 1987, SCIENCE, V236, P576, DOI 10.1126/science.3033824; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015",67,10,10,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004571,10.1371/journal.ppat.1004571,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100014,25611061.0,"DOAJ Gold, Green Published",,,16/08/2019,9,3,33,6103,1082,748,334,5021,4339,22,660,33,3,0,0,9,9,4,,33,3,33,0,3,12,10,12,7,0,0,2,0,0,2,123,13,3,6252,49,4,89,126,3,5093,1094,49,4,89,126,3,65,,1,0,0,0,1,0,0,0,0,0,0,32,0,0,9.25,5.640480591497227,1.2154949213304123,0.21549492133041226,1.2800238996215894,1.0530886449287236,5.93992606284658
209,J,"Schwartz, DJ; Conover, MS; Hannan, TJ; Hultgren, SJ",,,,"Schwartz, Drew J.; Conover, Matt S.; Hannan, Thomas J.; Hultgren, Scott J.",,,Uropathogenic Escherichia coli Superinfection Enhances the Severity of Mouse Bladder Infection,PLOS PATHOGENS,,,English,Article,,,,,,,URINARY-TRACT-INFECTION; INTRACELLULAR BACTERIAL COMMUNITIES; RISK-FACTORS; IN-VITRO; HOST; FIMH; PLACEBO; DESIGN; WOMEN; PERSISTENCE,"Urinary tract infections (UTIs) afflict over 9 million women in America every year, often necessitating long-term prophylactic antibiotics. One risk factor for UTI is frequent sexual intercourse, which dramatically increases the risk of UTI. The mechanism behind this increased risk is unknown; however, bacteriuria increases immediately after sexual intercourse episodes, suggesting that physical manipulation introduces periurethral flora into the urinary tract. In this paper, we investigated whether superinfection (repeat introduction of bacteria) resulted in increased risk of severe UTI, manifesting as persistent bacteriuria, high titer bladder bacterial burdens and chronic inflammation, an outcome referred to as chronic cystitis. Chronic cystitis represents unchecked luminal bacterial replication and is defined histologically by urothelial hyperplasia and submucosal lymphoid aggregates, a histological pattern similar to that seen in humans suffering chronic UTI. C57BL/6J mice are resistant to chronic cystitis after a single infection; however, they developed persistent bacteriuria and chronic cystitis when superinfected 24 hours apart. Elevated levels of interleukin-6 (IL-6), keratinocyte cytokine (KC/CXCL1), and granulocyte colony-stimulating factor (G-CSF) in the serum of C57BL/6J mice prior to the second infection predicted the development of chronic cystitis. These same cytokines have been found to precede chronic cystitis in singly infected C3H/HeN mice. Furthermore, inoculating C3H/HeN mice twice within a six-hour period doubled the proportion of mice that developed chronic cystitis. Intracellular bacterial replication, regulated hemolysin (HlyA) expression, and caspase 1/11 activation were essential for this increase. Microarrays conducted at four weeks post inoculation in both mouse strains revealed upregulation of IL-1 and antimicrobial peptides during chronic cystitis. These data suggest a mechanism by which caspase-1/11 activation and IL-1 secretion could predispose certain women to recurrent UTI after frequent intercourse, a predisposition predictable by several serum biomarkers in two murine models.","[Schwartz, Drew J.; Conover, Matt S.; Hultgren, Scott J.] Washington Univ, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Hannan, Thomas J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA","Hultgren, SJ (reprint author), Washington Univ, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA.",Hultgren@wusm.wustl.edu,,"Hannan, Thomas/0000-0003-0498-8231","NIH [F30 DK096751, F32 DK101156, K08 AI083746, SCOR P50 DK064540, R01 DK051406, U01 AI095542]; NIH NIDCD [P30DC04665]","We would like to thank the NIH for funding through grants F30 DK096751 to DJS, F32 DK101156 to MSC, K08 AI083746 to TJH, and SCOR P50 DK064540, R01 DK051406, and U01 AI095542 to SJH. The Scanning Electron Microscopy core facility is supported by NIH NIDCD grant P30DC04665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","Ahn H, 2014, IMMUNOBIOLOGY, V219, P315, DOI 10.1016/j.imbio.2013.11.003; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Bouchillon Sam, 2012, Open Microbiol J, V6, P74; BUCKLEY RM, 1978, NEW ENGL J MED, V298, P321, DOI 10.1056/NEJM197802092980607; Chen SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005497; Chen SL, 2009, P NATL ACAD SCI USA, V106, P22439, DOI 10.1073/pnas.0902179106; Chen YH, 2012, EUR J CLIN MICROBIOL, V31, P1699, DOI 10.1007/s10096-011-1457-x; Cusumano CK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003021; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; Ejrnaes K, 2006, J CLIN MICROBIOL, V44, P1776, DOI 10.1128/JCM.44.5.1776-1781.2006; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Falagas ME, 2009, J INFECTION, V58, P91, DOI 10.1016/j.jinf.2008.12.009; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Foxman B, 2000, AM J EPIDEMIOL, V151, P1194; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; FOXMAN B, 1995, EPIDEMIOLOGY, V6, P162, DOI 10.1097/00001648-199503000-00013; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Guiton PS, 2013, INFECT IMMUN, V81, P329, DOI 10.1128/IAI.00856-12; Gupta K, 2005, J ANTIMICROB CHEMOTH, V56, P243, DOI 10.1093/jac/dki169; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Gur C, 2013, CELL HOST MICROBE, V14, P664, DOI 10.1016/j.chom.2013.11.004; Han ZF, 2010, J MED CHEM, V53, P4779, DOI 10.1021/jm100438s; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hannan TJ, 2014, INHIBITION CYCLOOXYG, P1; Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Klein T, 2010, J MED CHEM, V53, P8627, DOI 10.1021/jm101011y; Kline KA, 2012, INFECT IMMUN, V80, P4186, DOI 10.1128/IAI.00684-12; Laupland KB, 2007, INFECTION, V35, P150, DOI 10.1007/s15010-007-6180-2; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; MABECK CE, 1972, POSTGRAD MED J, V48, P69, DOI 10.1136/pgmj.48.556.69; Marschall J, 2012, CLIN INFECT DIS, V54, P1692, DOI 10.1093/cid/cis252; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nicholson TF, 2009, INFECT IMMUN, V77, P5245, DOI 10.1128/IAI.00670-09; NICOLLE LE, 1982, J INFECT DIS, V146, P579, DOI 10.1093/infdis/146.5.579; PARSONS CL, 1990, J UROLOGY, V143, P139; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Robino L, 2013, PATHOG DIS, V68, P78, DOI 10.1111/2049-632X.12047; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Rosenberg M, 1999, INT J ANTIMICROB AG, V11, P247, DOI 10.1016/S0924-8579(99)00024-2; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Schlager TA, 2011, J UROLOGY, V186, P2359, DOI 10.1016/j.juro.2011.07.114; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Schwardt O, 2011, BIOORGAN MED CHEM, V19, P6454, DOI 10.1016/j.bmc.2011.08.057; Schwartz DJ, 2012, REGULATION BACTERIAL, P135; Schwartz DJ, 2013, P NATL ACAD SCI USA, V110, P15530, DOI 10.1073/pnas.1315203110; Schwartz DJ, 2011, INFECT IMMUN, V79, P4250, DOI 10.1128/IAI.05339-11; Song JM, 2009, P NATL ACAD SCI USA, V106, P14966, DOI 10.1073/pnas.0900527106; STAMM WE, 1991, REV INFECT DIS, V13, P77; Stamm WE, 2002, AM J MED, V113, p1S; Stemler KM, 2013, J UROLOGY, V189, P343, DOI 10.1016/j.juro.2012.08.189; Thumbikat P, 2006, J IMMUNOL, V176, P3080, DOI 10.4049/jimmunol.176.5.3080; Walters MS, 2011, MBIO, V3; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630",71,24,25,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JAN,2015,11,1,,,,,,,e1004599,10.1371/journal.ppat.1004599,,,,12,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CA7OF,WOS:000349106100029,25569799.0,"DOAJ Gold, Green Published",,,16/08/2019,24,8,39,6613,1792,1356,436,4821,4029,30,762,39,7,0,0,21,21,0,,43,8,43,0,8,25,25,22,17,0,0,0,0,0,0,0,1,3,6727,115,0,76,124,3,4870,1802,84,0,76,119,3,55,,0,0,0,0,6,0,0,1,0,0,0,43,0,0,4.35,3.6902901785714284,1.3717071147064925,0.3717071147064924,1.4449284380833851,1.0533797066384394,3.8872767857142856
210,J,"Abbate, JL; Kada, S; Lion, S",,,,"Abbate, Jessica L.; Kada, Sarah; Lion, Sebastien",,,Beyond Mortality: Sterility As a Neglected Component of Parasite Virulence,PLOS PATHOGENS,,,English,Article,,,,,,,HOST LIFE-HISTORY; FECUNDITY COMPENSATION; EVOLUTIONARY DYNAMICS; GENITAL-TRACT; TRADE-OFF; CASTRATION; PATHOGEN; VIRUS; TRANSMISSION; COEVOLUTION,"Virulence is generally defined as the reduction in host fitness following infection by a parasite (see Box 1 for glossary) [1]. In general, parasite exploitation of host resources may reduce host survival (mortality virulence), decrease host fecundity (sterility virulence), or even have sub-lethal effects that disturb the way individuals interact within a community (morbidity) [2,3]. In fact, the virulence of many parasites involves a combination of these various effects (Box 2). In practice, however, virulence is most often defined as disease-induced mortality [1, 4-6]. This is especially true in the theoretical literature, where the evolution of sterility virulence, morbidity, and mixed strategies of host exploitation have received relatively little attention. While the focus on mortality effects has allowed for easy comparison between models and, thus, rapid advancement of the field, we ask whether these theoretical simplifications have led us to inadvertently minimize the evolutionary importance of host sterilization and secondary virulence effects. As explicit theoretical work on morbidity is currently lacking (but see [7]), our aim in this Opinion piece is to discuss what is understood about sterility virulence evolution, its adaptive potential, and the implications for parasites that utilize a combination of host survival and reproductive resources.","[Abbate, Jessica L.; Kada, Sarah; Lion, Sebastien] Univ Montpellier, Univ Paul Valery Montpellier EPHE, CEFE, F-34059 Montpellier, France; [Abbate, Jessica L.] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland","Abbate, JL (reprint author), Univ Montpellier, Univ Paul Valery Montpellier EPHE, CEFE, F-34059 Montpellier, France.",jessica.abbate@iee.unibe.ch,"Abbate, Jessica Lee/Q-5322-2019; Abbate, Jessica/L-4876-2014; Kada, Sarah/G-3063-2016; Lion, Sebastien/K-4177-2015","Abbate, Jessica Lee/0000-0003-2485-3334; Abbate, Jessica/0000-0003-2485-3334; Kada, Sarah/0000-0002-0021-0492; Lion, Sebastien/0000-0002-4081-0038",,,,77,8,8,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005229,10.1371/journal.ppat.1005229,,,,10,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800003,26632822.0,"DOAJ Gold, Green Published",,,16/08/2019,9,65,32,2815,246,180,66,2569,2211,10,348,32,31,0,0,8,8,0,,40,0,40,0,0,9,9,5,3,0,0,0,0,0,0,0,34,20,2877,0,0,0,120,4,2581,251,0,0,0,120,4,45,,0,0,0,0,28,0,0,1,0,0,0,40,0,0,15.85,11.44308943089431,1.0957571039314908,0.09575710393149085,1.1666017905799921,1.0646536412078154,12.182926829268293
211,J,"Babuta, M; Mansuri, MS; Bhattacharya, S; Bhattacharya, A",,,,"Babuta, Mrigya; Mansuri, M. Shahid; Bhattacharya, Sudha; Bhattacharya, Alok",,,"The Entamoeba histolytica, Arp2/3 Complex Is Recruited to Phagocytic Cups through an Atypical Kinase EhAK1",PLOS PATHOGENS,,,English,Article,,,,,,,ACTIN-BINDING PROTEIN; EXPRESSION; PARASITE; ENDOCYTOSIS; SUBUNIT; FAMILY; ROLES; HOST; EHNCABP166; MIGRATION,"The parasite Entamoeba histolytica is the etiological agent of amoebiasis and phagocytosis plays a key role in virulence of this organism. Signaling pathways involved in activation of cytoskeletal dynamics required for phagocytosis remain to be elucidated. Phagocytosis is initiated with sequential recruitment of EhC2PK, EhCaBP1, EhCaBP3 and an atypical kinase EhAK1 after particle attachment. Here we show that EhARPC1, an essential subunit of the actin branching complex Arp 2/3 is recruited to the phagocytic initiation sites by EhAK1. Imaging, expression knockdown of different molecules and pull down experiments suggest that EhARPC1 interacts with EhAK1 and that it is required during initiation of phagocytosis and phagosome formation. Moreover, recruitment of EhARPC2 at the phagocytosis initiation by EhAK1 is also observed, indicating that the Arp 2/3 complex is recruited. In conclusion, these results suggests a novel mechanism of recruitment of Arp 2/3 complex during phagocytosis in E. histolytica.","[Babuta, Mrigya; Mansuri, M. Shahid; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Bhattacharya, Sudha] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Bhattacharya, Alok] Shiv Nadar Univ, Dept Life Sci, Sch Nat Sci, Noida, Uttar Pradesh, India","Babuta, M (reprint author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.",alok.bhattacharya@gmail.com,,,"Department of Science and Technology; UGC, India","AB thanks Department of Science and Technology for JC Bose Fellowship and Department of Biotechnology. MB acknowledges UGC, India for Junior and Senior Research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,54,17,17,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005310,10.1371/journal.ppat.1005310,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800030,26646565.0,"DOAJ Gold, Green Published",,,16/08/2019,15,76,10,4214,559,447,112,3655,3155,19,481,10,4,5,0,17,17,0,,16,2,16,0,2,21,17,21,7,0,0,0,0,0,0,0,72,3,4266,89,0,62,120,0,3672,568,89,0,62,120,0,26,,0,0,0,0,5,0,0,0,0,0,0,16,0,0,1.85,7.538461538461538,1.1529411764705881,0.15294117647058825,1.2243502051983584,1.0619364024679638,8.005366726296959
212,J,"de Paiva, RMC; Grazielle-Silva, V; Cardoso, MS; Nakagaki, BN; Mendonca-Neto, RP; Canavaci, AMC; Melo, NS; Martinelli, PM; Fernandes, AP; daRocha, WD; Teixeira, SMR",,,,"Cardoso de Paiva, Rita Marcia; Grazielle-Silva, Viviane; Cardoso, Mariana Santos; Nakagaki, Brenda Naemi; Mendonca-Neto, Rondon Pessoa; Cassiano Canavaci, Adriana Monte; Melo, Normanda Souza; Martinelli, Patricia Massara; Fernandes, Ana Paula; daRocha, Wanderson Duarte; Teixeira, Santuza M. R.",,,Amastin Knockdown in Leishmania braziliensis Affects Parasite-Macrophage Interaction and Results in Impaired Viability of Intracellular Amastigotes,PLOS PATHOGENS,,,English,Article,,,,,,,FAMILY ENCODING AMASTIN; RNA INTERFERENCE RNAI; COMPARATIVE GENOMICS; GENE FAMILY; EXPRESSION; SEQUENCE; CLAUDINS; PROTEIN; SYSTEM; TESTS,"Leishmaniasis, a human parasitic disease with manifestations ranging from cutaneous ulcerations to fatal visceral infection, is caused by several Leishmania species. These protozoan parasites replicate as extracellular, flagellated promastigotes in the gut of a sandfly vector and as amastigotes inside the parasitophorous vacuole of vertebrate host macrophages. Amastins are surface glycoproteins encoded by large gene families present in the genomes of several trypanosomatids and highly expressed in the intracellular amastigote stages of Trypanosoma cruzi and Leishmania spp. Here, we showed that the genome of L. braziliensis contains 52 amastin genes belonging to all four previously described amastin subfamilies and that the expression of members of all subfamilies is upregulated in L. braziliensis amastigotes. Although primary sequence alignments showed no homology to any known protein sequence, homology searches based on secondary structure predictions indicate that amastins are related to claudins, a group of proteins that are components of eukaryotic tight junction complexes. By knocking-down the expression of delta-amastins in L. braziliensis, their essential role during infection became evident. delta-amastin knockdown parasites showed impaired growth after in vitro infection of mouse macrophages and completely failed to produce infection when inoculated in BALB/c mice, an attenuated phenotype that was reverted by the re-expression of an RNAi-resistant amastin gene. Further highlighting their essential role in host-parasite interactions, electron microscopy analyses of macrophages infected with amastin knockdown parasites showed significant alterations in the tight contact that is normally observed between the surface of wild type amastigotes and the membrane of the parasitophorous vacuole.","[Cardoso de Paiva, Rita Marcia; Grazielle-Silva, Viviane; Nakagaki, Brenda Naemi; Mendonca-Neto, Rondon Pessoa; Teixeira, Santuza M. R.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Cardoso, Mariana Santos] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Cassiano Canavaci, Adriana Monte; Fernandes, Ana Paula] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil; [Melo, Normanda Souza; daRocha, Wanderson Duarte] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Martinelli, Patricia Massara] Univ Fed Minas Gerais, Dept Morfol, Belo Horizonte, MG, Brazil","de Paiva, RMC (reprint author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.",santuzat@icb.ufmg.br,"Martinelli, Patricia/H-6341-2014; Canavaci, Adriana/F-9257-2013; DaRocha, Wanderson/A-8918-2013","Canavaci, Adriana/0000-0002-2983-1081; DaRocha, Wanderson/0000-0002-8722-5143",Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [590109/2011-1]; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ04132-10],"This work was supported by funds from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br, grant #590109/2011-1), Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior (CAPES, www.capes.gov.br), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV, www.cpqrr.fiocruz.br/inctv) e Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, www.fapemig.br, grant #APQ04132-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,18,18,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005296,10.1371/journal.ppat.1005296,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800023,26641088.0,"DOAJ Gold, Green Published",,,16/08/2019,20,16,44,4592,732,512,220,3860,3091,18,751,44,13,0,0,18,18,0,,61,0,61,0,0,20,20,13,6,0,0,0,0,0,0,0,3,7,4618,40,0,48,110,2,3850,732,40,0,48,110,2,36,,0,0,0,0,15,0,2,1,0,0,0,61,0,0,7.1,6.273224043715847,1.1896373056994818,0.18963730569948187,1.2352331606217617,1.038327526132404,6.5136612021857925
213,J,"Courtot, E; Charvet, CL; Beech, RN; Harmache, A; Wolstenholme, AJ; Holden-Dye, L; O'Connor, V; Peineau, N; Woods, DJ; Neveu, C",,,,"Courtot, Elise; Charvet, Claude L.; Beech, Robin N.; Harmache, Abdallah; Wolstenholme, Adrian J.; Holden-Dye, Lindy; O'Connor, Vincent; Peineau, Nicolas; Woods, Debra J.; Neveu, Cedric",,,Functional Characterization of a Novel Class of Morantel-Sensitive Acetylcholine Receptors in Nematodes,PLOS PATHOGENS,,,English,Article,,,,,,,ELEGANS NEUROMUSCULAR-JUNCTION; HUMAN HOOKWORM INFECTIONS; SINGLE-CHANNEL LEVEL; CAENORHABDITIS-ELEGANS; HAEMONCHUS-CONTORTUS; TRICHOSTRONGYLUS-COLUBRIFORMIS; LEVAMISOLE RESISTANCE; NICOTINIC RECEPTOR; PARASITIC NEMATODES; ASCARIS-SUUM,"Acetylcholine receptors are pentameric ligand-gated channels involved in excitatory neuro-transmission in both vertebrates and invertebrates. In nematodes, they represent major targets for cholinergic agonist or antagonist anthelmintic drugs. Despite the large diversity of acetylcholine-receptor subunit genes present in nematodes, only a few receptor subtypes have been characterized so far. Interestingly, parasitic nematodes affecting human or animal health possess two closely related members of this gene family, acr-26 and acr-27 that are essentially absent in free-living or plant parasitic species. Using the pathogenic parasitic nematode of ruminants, Haemonchus contortus, as a model, we found that Hco-ACR-26 and Hco-ACR-27 are co-expressed in body muscle cells. We demonstrated that co-expression of Hco-ACR-26 and Hco-ACR-27 in Xenopus laevis oocytes led to the functional expression of an acetylcholine-receptor highly sensitive to the anthelmintics morantel and pyrantel. Importantly we also reported that ACR-26 and ACR-27, from the distantly related parasitic nematode of horses, Parascaris equorum, also formed a functional acetylcholinereceptor highly sensitive to these two drugs. In Caenorhabditis elegans, a free-living model nematode, we demonstrated that heterologous expression of the H. contortus and P. equorum receptors drastically increased its sensitivity to morantel and pyrantel, mirroring the pharmacological properties observed in Xenopus oocytes. Our results are the first to describe significant molecular determinants of a novel class of nematode body wall muscle AChR.","[Courtot, Elise; Charvet, Claude L.; Beech, Robin N.; Harmache, Abdallah; Neveu, Cedric] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Courtot, Elise; Charvet, Claude L.; Harmache, Abdallah; Neveu, Cedric] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France; [Beech, Robin N.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Wolstenholme, Adrian J.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Wolstenholme, Adrian J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Peineau, Nicolas] Univ Tours, Dept Anim Physiol, Tours, France; [Woods, Debra J.] Zoetis LLC, Vet Med Res & Dev, Kalamazoo, MI USA","Courtot, E (reprint author), INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France.",cedric.neveu@tours.inra.fr,"HARMACHE, ABDALLAH/E-7274-2011","Harmache, Abdallah/0000-0002-7377-7641","Zoetis; La Federation de Recherche en infectiologie de la region Centre; Region Centre, France; Biotechnology and Biological Sciences Research Council [BB/J006890/1]","This study was financially supported by Zoetis and ""La Federation de Recherche en infectiologie de la region Centre"". Through the co-author DJW, Zoetis was involved in the study design. However, Zoetis was not involved in the data collection, analysis or the preparation of the manuscript. The decision to publish the manuscript was jointly taken. EC is the grateful recipient of a PhD grant from the French minister of higher education and research. RNB held the position of Le Studium Research Fellow and a salary award from the Region Centre, France. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.",,90,11,11,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005267,10.1371/journal.ppat.1005267,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800010,26625142.0,"DOAJ Gold, Green Published",,,16/08/2019,11,1,8,2948,642,523,119,2306,1901,16,389,8,1,0,0,11,11,0,,18,5,18,0,5,12,11,12,9,0,0,0,0,0,0,0,0,11,2983,125,0,357,58,1,2313,647,125,0,357,58,1,23,,0,0,0,0,11,0,0,1,0,0,0,18,0,0,6.85,4.59190031152648,1.2784041630529055,0.27840416305290544,1.372940156114484,1.0739484396200814,4.931464174454828
214,J,"Cox, RG; Mainou, BA; Johnson, M; Hastings, AK; Schuster, JE; Dermody, TS; Williams, JV",,,,"Cox, Reagan G.; Mainou, Bernardo A.; Johnson, Monika; Hastings, Andrew K.; Schuster, Jennifer E.; Dermody, Terence S.; Williams, John V.",,,Human Metapneumovirus Is Capable of Entering Cells by Fusion with Endosomal Membranes,PLOS PATHOGENS,,,English,Article,,,,,,,VESICULAR STOMATITIS-VIRUS; RESPIRATORY-TRACT DISEASE; BETA-1-INTEGRIN CYTOPLASMIC TAIL; F-PROTEIN; MEDIATED ENDOCYTOSIS; INFLUENZA-VIRUS; LOW-PH; GENETIC DIVERSITY; SYNCYTIAL VIRUS; YOUNG-CHILDREN,"Human metapneumovirus (HMPV), a member of the Paramyxoviridae family, is a leading cause of lower respiratory illness. Although receptor binding is thought to initiate fusion at the plasma membrane for paramyxoviruses, the entry mechanism for HMPV is largely uncharacterized. Here we sought to determine whether HMPV initiates fusion at the plasma membrane or following internalization. To study the HMPV entry process in human bronchial epithelial (BEAS-2B) cells, we used fluorescence microscopy, an R18-dequenching fusion assay, and developed a quantitative, fluorescence microscopy assay to follow virus binding, internalization, membrane fusion, and visualize the cellular site of HMPV fusion. We found that HMPV particles are internalized into human bronchial epithelial cells before fusing with endosomes. Using chemical inhibitors and RNA interference, we determined that HMPV particles are internalized via clathrin-mediated endocytosis in a dynamin-dependent manner. HMPV fusion and productive infection are promoted by RGD-binding integrin engagement, internalization, actin polymerization, and dynamin. Further, HMPV fusion is pH-independent, although infection with rare strains is modestly inhibited by RNA interference or chemical inhibition of endosomal acidification. Thus, HMPV can enter via endocytosis, but the viral fusion machinery is not triggered by low pH. Together, our results indicate that HMPV is capable of entering host cells by multiple pathways, including membrane fusion from endosomal compartments.","[Cox, Reagan G.; Hastings, Andrew K.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Mainou, Bernardo A.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Johnson, Monika; Williams, John V.] Univ Pittsburgh, Dept Pediat, Sch Med, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA; [Schuster, Jennifer E.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Pediat, Nashville, TN 37212 USA","Cox, RG (reprint author), Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.",jvw@chp.edu,"Williams, John/F-6962-2010","Williams, John/0000-0001-8377-5175", [R01 AI08562];  [R21 AI073697];  [T32 AI7611];  [F32 AI801082];  [R01 AI32539],"This work was supported by R01 AI08562 (JVW), R21 AI073697 (JVW), T32 AI7611 (RGC), F32 AI801082 (BAM), and R01 AI32539 (TSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,20,21,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005303,10.1371/journal.ppat.1005303,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800025,26629703.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,23,41,23,3708,726,524,202,2982,2452,11,519,23,16,1,0,20,20,0,,27,2,27,0,2,23,23,22,13,0,0,0,0,0,0,0,25,15,3772,224,0,37,201,0,3013,729,78,0,37,201,0,30,,0,2,0,1,16,0,1,1,0,0,0,27,0,0,30.458,5.107438016528926,1.243460764587525,0.24346076458752516,1.4074446680080483,1.1318770226537216,5.7809917355371905
215,J,"Dunmire, SK; Grimm, JM; Schmeling, DO; Balfour, HH; Hogquist, KA",,,,"Dunmire, Samantha K.; Grimm, Jennifer M.; Schmeling, David O.; Balfour, Henry H., Jr.; Hogquist, Kristin A.",,,The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events,PLOS PATHOGENS,,,English,Article,,,,,,,NATURAL-KILLER-CELLS; PLASMACYTOID DENDRITIC CELLS; B-CELLS; MONONUCLEOSIS; PROGRESS; DISEASE,"Epstein-Barr virus (EBV) is a human herpesvirus that causes acute infectious mononucleosis and is associated with cancer and autoimmune disease. While many studies have been performed examining acute disease in adults following primary infection, little is known about the virological and immunological events during EBV's lengthy 6 week incubation period owing to the challenge of collecting samples from this stage of infection. We conducted a prospective study in college students with special emphasis on frequent screening to capture blood and oral wash samples during the incubation period. Here we describe the viral dissemination and immune response in the 6 weeks prior to onset of acute infectious mononucleosis symptoms. While virus is presumed to be present in the oral cavity from time of transmission, we did not detect viral genomes in the oral wash until one week before symptom onset, at which time viral genomes were present in high copy numbers, suggesting loss of initial viral replication control. In contrast, using a sensitive nested PCR method, we detected viral genomes at low levels in blood about 3 weeks before symptoms. However, high levels of EBV in the blood were only observed close to symptom onset-coincident with or just after increased viral detection in the oral cavity. These data imply that B cells are the major reservoir of virus in the oral cavity prior to infectious mononucleosis. The early presence of viral genomes in the blood, even at low levels, correlated with a striking decrease in the number of circulating plasmacytoid dendritic cells well before symptom onset, which remained depressed throughout convalescence. On the other hand, natural killer cells expanded only after symptom onset. Likewise, CD4+ Foxp3+ regulatory T cells decreased two fold, but only after symptom onset. We observed no substantial virus specific CD8 T cell expansion during the incubation period, although polyclonal CD8 activation was detected in concert with viral genomes increasing in the blood and oral cavity, possibly due to a systemic type I interferon response. This study provides the first description of events during the incubation period of natural EBV infection in humans and definitive data upon which to formulate theories of viral control and disease pathogenesis.","[Dunmire, Samantha K.; Grimm, Jennifer M.; Schmeling, David O.; Balfour, Henry H., Jr.; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Balfour, Henry H., Jr.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA","Dunmire, SK (reprint author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.",hogqu001@umn.edu,,,"University of Minnesota Doctoral Dissertation Fellowship; National Institutes of Health [T32 AI007313, PO1 AI35296]; University of Minnesota International Center for Antiviral Research and Epidemiology; University of Minnesota Foundation","This work was supported by a University of Minnesota Doctoral Dissertation Fellowship (to SKD) and by the National Institutes of Health (T32 AI007313 to SKD and PO1 AI35296 to KAH), the University of Minnesota International Center for Antiviral Research and Epidemiology and the University of Minnesota Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,31,31,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005286,10.1371/journal.ppat.1005286,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800017,26624012.0,"DOAJ Gold, Green Published",,,16/08/2019,30,1,44,8733,2533,2084,449,6200,5181,16,1003,44,1,0,3,32,32,0,,53,31,53,0,31,32,32,24,19,0,0,0,0,0,0,0,1,7,9208,32,0,240,401,10,6247,2625,32,0,240,401,10,336,,0,0,0,0,4,0,0,0,1,0,0,53,0,0,3.5,3.447690485590209,1.408548387096774,0.4085483870967742,1.555,1.1039734341005383,3.806158705092775
216,J,"Fajardo, T; Sung, PY; Roy, P",,,,"Fajardo, Teodoro, Jr.; Sung, Po-Yu; Roy, Polly",,,Disruption of Specific RNA-RNA Interactions in a Double-Stranded RNA Virus Inhibits Genome Packaging and Virus Infectivity,PLOS PATHOGENS,,,English,Article,,,,,,,INFLUENZA-A VIRUS; MOUTH-DISEASE VIRUS; BLUETONGUE VIRUS; REVERSE GENETICS; ANTISENSE RNAS; SEGMENTS; REPLICATION; PROTEIN; REASSORTMENT; PARTICLES,"Bluetongue virus (BTV) causes hemorrhagic disease in economically important livestock. The BTV genome is organized into ten discrete double-stranded RNA molecules (S1-S10) which have been suggested to follow a sequential packaging pathway from smallest to largest segment during virus capsid assembly. To substantiate and extend these studies, we have investigated the RNA sorting and packaging mechanisms with a new experimental approach using inhibitory oligonucleotides. Putative packaging signals present in the 3' untranslated regions of BTV segments were targeted by a number of nuclease resistant oligoribonucleotides (ORNs) and their effects on virus replication in cell culture were assessed. ORNs complementary to the 3' UTR of BTV RNAs significantly inhibited virus replication without affecting protein synthesis. Same ORNs were found to inhibit complex formation when added to a novel RNA-RNA interaction assay which measured the formation of supramolecular complexes between and among different RNA segments. ORNs targeting the 3' UTR of BTV segment 10, the smallest RNA segment, were shown to be the most potent and deletions or substitution mutations of the targeted sequences diminished the RNA complexes and abolished the recovery of viable viruses using reverse genetics. Cell-free capsid assembly/RNA packaging assay also confirmed that the inhibitory ORNs could interfere with RNA packaging and further substitution mutations within the putative RNA packaging sequence have identified the recognition sequence concerned. Exchange of 3' UTR between segments have further demonstrated that RNA recognition was segment specific, most likely acting as part of the secondary structure of the entire genomic segment. Our data confirm that genome packaging in this segmented dsRNA virus occurs via the formation of supramolecular complexes formed by the interaction of specific sequences located in the 3' UTRs. Additionally, the inhibition of packaging in-trans with inhibitory ORNs suggests this that interaction is a bona fide target for the design of compounds with antiviral activity.","[Fajardo, Teodoro, Jr.; Sung, Po-Yu; Roy, Polly] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England","Fajardo, T (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England.",polly.roy@lshtm.ac.uk,,"Roy, Polly/0000-0001-6535-6911","National Institutes of Health (NIH, USA); Biotechnology and Biological Sciences Research Council (BBSRC, UK); National Institutes of Health [R01AJ045000]; Biotechnology and Biological Sciences Research Council [BB/J014877]; Biotechnology and Biological Sciences Research Council [BB/J014877/1]","This work was supported by the National Institutes of Health (NIH, USA) and Biotechnology and Biological Sciences Research Council (BBSRC, UK). Funding for open access charge was provided by the National Institutes of Health (R01AJ045000) and Biotechnology and Biological Sciences Research Council (BB/J014877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,35,18,18,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005321,10.1371/journal.ppat.1005321,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800039,26646790.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,17,1,21,3860,507,378,129,3353,2752,17,584,21,1,0,0,19,19,0,,28,0,28,0,0,19,19,15,14,0,0,0,0,0,0,0,0,3,3879,90,0,71,51,0,3336,507,90,0,71,51,0,36,,0,0,0,0,4,0,0,1,0,0,0,28,0,0,2.35,7.613412228796844,1.1512078735460782,0.15120787354607815,1.1989263346257084,1.0414507772020725,7.928994082840236
217,J,"Ferrero, DS; Buxaderas, M; Rodriguez, JF; Verdaguer, N",,,,"Ferrero, Diego S.; Buxaderas, Monica; Rodriguez, Jose F.; Verdaguer, Nuria",,,The Structure of the RNA-Dependent RNA Polymerase of a Permutotetravirus Suggests a Link between Primer-Dependent and Primer-Independent Polymerases,PLOS PATHOGENS,,,English,Article,,,,,,,PANCREATIC NECROSIS VIRUS; BURSAL DISEASE VIRUS; THOSEA-ASIGNA VIRUS; CRYSTAL-STRUCTURE; POLIOVIRUS POLYMERASE; ACTIVE-SITE; SYSTEM; DOMAIN; POLYMERIZATION; VISUALIZATION,"Thosea asigna virus (TaV), an insect virus belonging to the Permutatetraviridae family, has a positive-sense single-stranded RNA (ssRNA) genome with two overlapping open reading frames, encoding for the replicase and capsid proteins. The particular TaV replicase includes a structurally unique RNA-dependent RNA polymerase (RdRP) with a sequence permutation in the palm sub-domain, where the active site is anchored. This non-canonical arrangement of the RdRP palm is also found in double-stranded RNA viruses of the Birnaviridae family. Both virus families also share a conserved VPg sequence motif at the polymerase N-terminus which in birnaviruses appears to be used to covalently link a fraction of the replicase molecules to the 5'-end of the genomic segments. Birnavirus VPgs are presumed to be used as primers for replication initiation. Here we have solved the crystal structure of the TaV RdRP, the first non-canonical RdRP of a ssRNA virus, in its apo-form and bound to different substrates. The enzyme arranges as a stable dimer maintained by mutual interactions between the active site cleft of one molecule and the flexible N-terminal tail of the symmetrically related RdRP. The latter, partially mimicking the RNA template backbone, is involved in regulating the polymerization activity. As expected from previous sequence-based bioinformatics predictions, the overall architecture of the TaV enzyme shows important resemblances with birnavirus polymerases. In addition, structural comparisons and biochemical analyses reveal unexpected similarities between the TaV RdRP and those of Flaviviruses. In particular, a long loop protruding from the thumb domain towards the central enzyme cavity appears to act as a platform for de novo initiation of RNA replication. Our findings strongly suggest an unexpected evolutionary relationship between the RdRPs encoded by these distant ssRNA virus groups.","[Ferrero, Diego S.; Buxaderas, Monica; Verdaguer, Nuria] CSIC, Inst Biol Mol Barcelona, Parc Cient Barcelona, Barcelona, Spain; [Ferrero, Diego S.; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain","Ferrero, DS (reprint author), CSIC, Inst Biol Mol Barcelona, Parc Cient Barcelona, Barcelona, Spain.",jfrodrig@cnb.csic.es; nvmcri@ibmb.csic.es,,"Verdaguer, Nuria/0000-0001-8826-7129; Ferrero, Diego Sebastian/0000-0001-6848-9939","Spanish Ministry of Economy and Competitiveness [BIO2011-24333, AGL2011-24758]; European Union [260644]; ESRF; SLS; fundacio ""La Caixa""","Work in Barcelona was supported by grant BIO2011-24333 from the Spanish Ministry of Economy and Competitiveness and by the SILVER Large Scale Collaborative Project, grant agreement number 260644, of the European Union 7th Framework. Work in Madrid was supported by grant AGL2011-24758 from the Spanish Ministry of Economy and Competitiveness. X-ray data were collected at the ESRF (Grenoble, France) within a Block Allocation Group (BAG Barcelona) and at the SLS (Villigen, Switzerland). Financial support was provided by the ESRF and SLS. DSF was supported by a pre-doctoral fellowship from fundacio ""La Caixa"". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,6,6,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005265,10.1371/journal.ppat.1005265,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800009,26625123.0,"DOAJ Gold, Green Published",,,16/08/2019,4,5,20,3776,616,505,111,3160,2630,17,513,20,5,0,0,6,6,0,,25,0,25,0,0,6,6,5,2,0,0,0,0,0,0,0,0,3,3925,84,0,56,317,0,3200,627,84,0,56,317,0,98,,0,0,0,0,6,0,0,1,0,0,0,25,0,0,3.35,6.12987012987013,1.1949367088607594,0.1949367088607595,1.3689873417721519,1.1456567796610169,7.0227272727272725
218,J,"Figueiredo, BC; Da'dara, AA; Oliveira, SC; Skelly, PJ",,,,"Figueiredo, Barbara C.; Da'dara, Akram A.; Oliveira, Sergio C.; Skelly, Patrick J.",,,Schistosomes Enhance Plasminogen Activation: The Role of Tegumental Enolase,PLOS PATHOGENS,,,English,Article,,,,,,,ALPHA-ENOLASE; STREPTOCOCCUS-PNEUMONIAE; PROTEOMIC ANALYSIS; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR ENOLASE; CANDIDA-ALBICANS; MANSONI; BINDING; SURFACE; IDENTIFICATION,"Schistosoma mansoni is a blood fluke parasite that causes schistosomiasis, a debilitating disease of global public health importance. These relatively large parasites are able to survive prolonged periods in the human vasculature without inducing stable blood clots around them. We show here that the intravascular life stages (schistosomula and adult males and females) can all promote significant plasminogen (PLMG) activation in the presence of tissue plasminogen activator (tPA). This results in the generation of the potent fibrinolytic agent plasmin which could degrade blood clots forming around the worms in vivo. We demonstrate that S. mansoni enolase (SmEno) is a host-interactive tegumental enzyme that, in recombinant form, can bind PLMG and promote its activation. Like classical members of the enolase protein family, SmEno can catalyze the interconversion of 2-phospho-D-glycerate (2-PGA) and phosphoenolpyruvate (PEP). The enzyme has maximal activity at pH 7.5, requires Mg2+ for optimal activity and can be inhibited by NaF but not mefloquin. Suppressing expression of the SmEno gene significantly diminishes enolase mRNA levels, protein levels and surface enzyme activity but, surprisingly, does not affect the ability of the worms to promote PLMG activation. Thus, while SmEno can enhance PLMG activation, our analysis suggests that it is not the only contributor to the parasite's ability to perform this function. We show that the worms possess several other PLMG-binding proteins in addition to SmEno and these may have a greater importance in schistosome-driven PLMG activation.","[Figueiredo, Barbara C.; Da'dara, Akram A.; Skelly, Patrick J.] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA 01536 USA; [Figueiredo, Barbara C.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Figueiredo, Barbara C.; Oliveira, Sergio C.] Conselho Nacl Desenvolvimento Cient & Tecnol, INCT DT, Minist Ciencia Tecnol & Inovacao Salvador, Salvador, Brazil","Figueiredo, BC (reprint author), Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA 01536 USA.",barbaracpf@gmail.com,,,"National Institute of Health, National Institute of Allergy and Infectious Diseases [AI-056273]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PDSE-5624/13-4]","This study was supported by grant #AI-056273 from the National Institute of Health, National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) was received by PJS. The grant #PDSE-5624/13-4 from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br) was received by BCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,23,23,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005335,10.1371/journal.ppat.1005335,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800046,26658895.0,"DOAJ Gold, Green Published",,,16/08/2019,19,4,15,3647,601,418,183,3046,2591,22,433,15,4,0,0,22,22,0,,30,1,30,0,1,21,21,16,12,0,0,0,0,0,0,1,0,3,3722,10,0,22,120,1,3063,617,10,0,22,120,1,42,,1,0,0,0,4,0,0,1,0,0,0,30,0,0,10.5,6.068219633943428,1.1973079448456994,0.19730794484569927,1.2646093237032174,1.056210584041678,6.409317803660565
219,J,"Gaglia, MM; Rycroft, CH; Glaunsinger, BA",,,,"Gaglia, Marta Maria; Rycroft, Chris H.; Glaunsinger, Britt A.",,,Transcriptome-Wide Cleavage Site Mapping on Cellular mRNAs Reveals Features Underlying Sequence-Specific Cleavage by the Viral Ribonuclease SOX,PLOS PATHOGENS,,,English,Article,,,,,,,HOST SHUTOFF; ENDONUCLEOLYTIC CLEAVAGE; PARALLEL ANALYSIS; PARE LIBRARIES; HUMAN-CELLS; PROTEIN; KSHV; DEGRADATION; TARGETS; INFECTION,"Many viruses express factors that reduce host gene expression through widespread degradation of cellular mRNA. An example of this class of proteins is the mRNA-targeting endoribonuclease SOX from the gamma-herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV). Previous studies indicated that cleavage of messenger RNAs (mRNA) by SOX occurs at specific locations defined by the sequence of the target RNA, which is at odds with the down-regulation of a large portion of cellular transcripts. In this study, we address this paradox by using high-throughput sequencing of cleavage intermediates combined with a custom bioinformatics-based analysis pipeline to identify SOX cleavage sites across the mRNA transcriptome. These data, coupled with targeted mutagenesis, reveal that while cleavage sites are specific and reproducible, they are defined by a degenerate sequence motif containing a small number of conserved residues rather than a strong consensus sequence. This degenerate element is well represented in both human and KSHV mRNA, and its presence correlates with RNA destabilization by SOX. This represents a new endonuclease targeting strategy, in which use of a degenerate targeting element enables RNA cleavage at specific locations without restricting the range of targets. Furthermore, it shows that strong target selectivity can be achieved without a high degree of sequence specificity.","[Gaglia, Marta Maria] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA; [Gaglia, Marta Maria] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Rycroft, Chris H.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rycroft, Chris H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Math, Berkeley, CA 94720 USA; [Glaunsinger, Britt A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA","Gaglia, MM (reprint author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA.",Marta.Gaglia@tufts.edu; glaunsinger@berkeley.edu,,"Gaglia, Marta/0000-0002-1791-0663","NIH [CA136367, CA160556]; Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Award; W. M. Keck Foundation Distinguished Young Scholars Award","This study was funded by the following grants to BAG: NIH CA136367, NIH CA160556, Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Award, and a W. M. Keck Foundation Distinguished Young Scholars Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,44,8,8,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005305,10.1371/journal.ppat.1005305,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800027,26646420.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,11,2955,399,297,102,2556,2144,13,399,11,0,0,0,8,8,0,,17,0,17,0,0,11,8,11,6,0,0,0,0,0,0,0,0,3,2975,82,0,47,31,0,2548,399,82,0,47,31,0,28,,0,0,0,0,2,0,0,1,0,0,0,17,0,0,0.75,7.406015037593985,1.1561032863849765,0.15610328638497653,1.2081377151799686,1.0450084602368865,7.739348370927318
220,J,"Gust, AA",,,,"Gust, Andrea A.",,,Peptidoglycan Perception in Plants,PLOS PATHOGENS,,,English,Article,,,,,,,PATTERN-RECOGNITION RECEPTORS; RICE INNATE IMMUNITY; MOLECULAR-PATTERNS; PATHOGEN EFFECTOR; ARABIDOPSIS; MOTIF; BACTERIA; PROTEINS; BINDING; KINASE,,"[Gust, Andrea A.] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Biochem, Tubingen, Germany","Gust, AA (reprint author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Biochem, Tubingen, Germany.",andrea.gust@zmbp.uni-tuebingen.de,"ZIPFEL, CYRIL/D-7103-2011","ZIPFEL, CYRIL/0000-0003-4935-8583",Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Consortium [SFB 766],"Research in the Gust lab is supported, in part, by the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Consortium SFB 766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,35,9,9,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005275,10.1371/journal.ppat.1005275,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800013,26679352.0,"DOAJ Gold, Green Published",,,16/08/2019,10,1,28,4099,871,701,170,3228,2639,22,567,28,1,0,0,7,7,0,,40,0,40,0,0,10,10,8,5,0,0,0,0,0,0,0,0,2,4114,5,14,35,43,1,3220,871,5,14,35,43,1,23,,0,0,0,0,5,0,0,1,0,0,0,42,0,0,2.85,4.7060849598163035,1.269826517967782,0.2698265179677819,1.2893432465923171,1.0153696023420347,4.7784156142365095
221,J,"Hafren, A; Lohmus, A; Makinen, K",,,,"Hafren, Anders; Lohmus, Andres; Makinen, Kristiina",,,Formation of Potato Virus A-Induced RNA Granules and Viral Translation Are Interrelated Processes Required for Optimal Virus Accumulation,PLOS PATHOGENS,,,English,Article,,,,,,,P-BODY FORMATION; STRESS GRANULES; MOSAIC-VIRUS; POSTEMBRYONIC DEVELOPMENT; SILENCING SUPPRESSORS; NICOTIANA-BENTHAMIANA; CAPSID PROTEIN; IN-PLANTA; ARABIDOPSIS; INFECTION,"RNA granules are cellular structures, which play an important role in mRNA translation, storage, and degradation. Animal (+) RNA viruses often co-opt RNA granule proteins for viral reproduction. However, the role of RNA granules in plant viral infections is poorly understood. Here we use Potato virus A (PVA) as a model potyvirus and demonstrate that the helper component-proteinase (HCpro), the potyviral suppressor of RNA silencing, induces the formation of RNA granules. We used confocal microscopy to demonstrate the presence of host RNA binding proteins including acidic ribosomal protein P0, argonaute 1 (AGO1), oligouridylate-binding protein 1 (UBP1), varicose (VCS) and eukaryotic initiation factor iso4E (eIF(iso) 4E) in these potyvirus-induced RNA granules. We show that the number of potyviral RNA granules is down-regulated by the genome-linked viral protein (VPg). We demonstrated previously that VPg is a virus-specific translational regulator that co-operates with potyviral RNA granule components P0 and eIF(iso) 4E in PVA translation. In this study we show that HCpro and varicose, components of potyviral RNA granules, stimulate VPg-promoted translation of the PVA, whereas UBP1 inhibits this process. Hence, we propose that PVA translation operates via a pathway that is interrelated with potyviral RNA granules in PVA infection. The importance of these granules is evident from the strong reduction in viral RNA and coat protein amounts that follows knock down of potyviral RNA granule components. HCpro suppresses antiviral RNA silencing during infection, and our results allow us to propose that this is also the functional context of the potyviral RNA granules we describe in this study.","[Hafren, Anders; Lohmus, Andres; Makinen, Kristiina] Univ Helsinki, Viikki Plant Sci Ctr, Dept Food & Environm Sci, Helsinki, Finland","Hafren, A (reprint author), Swedish Univ Agr Sci, Uppsala, Sweden.",kristiina.makinen@helsinki.fi,,,Academy of Finland [1138329],"This study was supported by a grant from the Academy of Finland (grant number 1138329; http://www.aka.fi) to KM. AL is a fellow of the Integrative Life Science Doctoral Program (http://www.finbionet.fi/ils). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,52,14,14,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005314,10.1371/journal.ppat.1005314,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800034,26641460.0,"DOAJ Gold, Green Published",,,16/08/2019,16,8,20,4542,495,334,161,4047,2749,20,1278,20,8,0,0,14,14,0,,31,0,31,0,0,17,17,16,8,0,0,0,0,0,0,0,0,6,4629,60,0,53,122,1,4071,506,60,0,53,122,1,52,,0,0,0,0,7,0,0,1,0,0,0,30,0,0,3.25,9.175757575757576,1.1223128243143068,0.1223128243143069,1.1887818136891524,1.0592250110083663,9.71919191919192
222,J,"Heesters, BA; Lindqvist, M; Vagefi, PA; Scully, EP; Schildberg, FA; Altfeld, M; Walker, BD; Kaufmann, DE; Carroll, MC",,,,"Heesters, Balthasar A.; Lindqvist, Madelene; Vagefi, Parsia A.; Scully, Eileen P.; Schildberg, Frank A.; Altfeld, Marcus; Walker, Bruce D.; Kaufmann, Daniel E.; Carroll, Michael C.",,,Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; COMPLEMENT-MEDIATED ENHANCEMENT; T-CELLS; LYMPHOID-TISSUE; CLASSICAL PATHWAY; IMMUNE-COMPLEXES; GERMINAL-CENTERS; B-CELLS; REPLICATION,"Despite the success of antiretroviral therapy (ART), it does not cure Human Immunodeficiency Virus (HIV) and discontinuation results in viral rebound. Follicular dendritic cells (FDC) are in direct contact with CD4+ T cells and they retain intact antigen for prolonged periods. We found that human FDC isolated from patients on ART retain infectious HIV within a non-degradative cycling compartment and transmit infectious virus to uninfected CD4+ T cells in vitro. Importantly, treatment of the HIV+ FDC with a soluble complement receptor 2 purges the FDC of HIV virions and prevents viral transmission in vitro. Our results provide an explanation for how FDC can retain infectious HIV for extended periods and suggest a therapeutic strategy to achieve cure in HIV-infected humans.","[Heesters, Balthasar A.; Carroll, Michael C.] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Heesters, Balthasar A.; Schildberg, Frank A.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Lindqvist, Madelene; Scully, Eileen P.; Altfeld, Marcus; Walker, Bruce D.; Kaufmann, Daniel E.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Lindqvist, Madelene; Scully, Eileen P.; Altfeld, Marcus; Walker, Bruce D.; Kaufmann, Daniel E.] Harvard Univ, Cambridge, MA 02138 USA; [Lindqvist, Madelene; Walker, Bruce D.; Kaufmann, Daniel E.] Scripps Res Inst, Ctr & Ctr HIV AIDS Vaccine Immunol & Immunogen Di, La Jolla, CA 92037 USA; [Vagefi, Parsia A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Scully, Eileen P.] Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Scully, Eileen P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Altfeld, Marcus] Leibniz Inst Expt Virol, Dept Viral Immunol, Hamburg, Germany; [Kaufmann, Daniel E.] Ctr Rech CHUM, Montreal, PQ, Canada; [Kaufmann, Daniel E.] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA","Heesters, BA (reprint author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.",balthasar_heesters@hms.harvard.edu,,,Ragon Institute,"This study was supported by an Innovation Award from the Ragon Institute awarded to MCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,36,37,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005285,10.1371/journal.ppat.1005285,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800016,26623655.0,"DOAJ Gold, Green Published",,,16/08/2019,36,113,49,4657,886,683,203,3771,2972,20,779,49,1,0,0,35,35,0,,55,9,55,0,9,38,36,38,27,0,0,0,0,0,0,0,112,4,4704,88,0,55,36,0,3785,902,88,0,55,36,0,17,,0,0,0,0,5,0,0,1,0,0,0,55,0,0,3.75,5.256207674943567,1.2349509413948554,0.23495094139485548,1.2802970034473615,1.0367189177582135,5.44920993227991
223,J,"Holscher, C; Sonntag, F; Henrich, K; Chen, QX; Beneke, J; Matula, P; Rohr, K; Kaderali, L; Beil, N; Erfle, H; Kleinschmidt, JA; Muller, M",,,,"Hoelscher, Christina; Sonntag, Florian; Henrich, Katharina; Chen, Qingxin; Beneke, Juergen; Matula, Petr; Rohr, Karl; Kaderali, Lars; Beil, Nina; Erfle, Holger; Kleinschmidt, Juergen A.; Mueller, Martin",,,The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses,PLOS PATHOGENS,,,English,Article,,,,,,,GROWTH-FACTOR RECEPTOR; DNA-DAMAGE RESPONSE; AAV VECTORS; INTRACELLULAR TRAFFICKING; MRE11/RAD50/NBS1 COMPLEX; EFFICIENT TRANSDUCTION; CONGENITAL AMAUROSIS; REPAIR PATHWAYS; CAPSID PROTEIN; VIRAL VECTORS,"Adeno-associated viruses are members of the genus dependoviruses of the parvoviridae family. AAV vectors are considered promising vectors for gene therapy and genetic vaccination as they can be easily produced, are highly stable and non-pathogenic. Nevertheless, transduction of cells in vitro and in vivo by AAV in the absence of a helper virus is comparatively inefficient requiring high multiplicity of infection. Several bottlenecks for AAV transduction have previously been described, including release from endosomes, nuclear transport and conversion of the single stranded DNA into a double stranded molecule. We hypothesized that the bottlenecks in AAV transduction are, in part, due to the presence of host cell restriction factors acting directly or indirectly on the AAV-mediated gene transduction. In order to identify such factors we performed a whole genome siRNA screen which identified a number of putative genes interfering with AAV gene transduction. A number of factors, yielding the highest scores, were identified as members of the SUMOylation pathway. We identified Ubc9, the E2 conjugating enzyme as well as Sae1 and Sae2, enzymes responsible for activating E1, as factors involved in restricting AAV. The restriction effect, mediated by these factors, was validated and reproduced independently. Our data indicate that SUMOylation targets entry of AAV capsids and not downstream processes of uncoating, including DNA single strand conversion or DNA damage signaling. We suggest that transiently targeting SUMOylation will enhance application of AAV in vitro and in vivo.","[Hoelscher, Christina; Sonntag, Florian; Henrich, Katharina; Chen, Qingxin; Matula, Petr; Rohr, Karl; Kleinschmidt, Juergen A.; Mueller, Martin] German Canc Res Ctr, Heidelberg, Germany; [Beneke, Juergen; Beil, Nina; Erfle, Holger] Heidelberg Univ, BIOQUANT Ctr, VIROQUANT CellNetworks RNAi Screening Facil, Heidelberg, Germany; [Matula, Petr; Rohr, Karl] Heidelberg Univ, BIOQUANT, IPMB, Dept Bioinformat & Funct Genom,Biomed Comp Vis Gr, Heidelberg, Germany; [Kaderali, Lars] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany","Holscher, C (reprint author), German Canc Res Ctr, Heidelberg, Germany.",martin.mueller@dkfz.de,"Matula, Petr/L-2119-2013","Matula, Petr/0000-0003-4125-1597; Kaderali, Lars/0000-0002-2359-2294","Forsys-ViroQuant consortium [0313923]; Federal Ministry of Education and Research (BMBF); cluster of excellence, CellNetworks at Heidelberg University [EXC81]","The Viro-Quant-CellNetworks RNAi Screening core facility represented by Holger Erfle and Lars Kaderali received funding within the Forsys-ViroQuant consortium (0313923) as well as by the Federal Ministry of Education and Research (BMBF) and the cluster of excellence, CellNetworks at Heidelberg University (EXC81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,78,5,5,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005281,10.1371/journal.ppat.1005281,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800014,26625259.0,"DOAJ Gold, Green Published",,,16/08/2019,5,0,23,3877,951,764,187,2926,2361,17,548,23,0,0,0,6,6,0,,60,0,31,0,0,6,6,5,3,0,0,0,0,0,0,0,0,6,3963,44,0,48,133,2,2954,961,44,0,48,133,2,48,,0,0,0,0,4,0,0,1,0,0,0,31,0,0,2.5,4.076761303890642,1.325017088174983,0.3250170881749829,1.414900888585099,1.0678359556358008,4.353312302839116
224,J,"Huang, L; Beiting, DP; Gebreselassie, NG; Gagliardo, LF; Ruyechan, MC; Lee, NA; Lee, JJ; Appleton, JA",,,,"Huang, Lu; Beiting, Daniel P.; Gebreselassie, Nebiat G.; Gagliardo, Lucille F.; Ruyechan, Maura C.; Lee, Nancy A.; Lee, James J.; Appleton, Judith A.",,,Eosinophils and IL-4 Support Nematode Growth Coincident with an Innate Response to Tissue Injury,PLOS PATHOGENS,,,English,Article,,,,,,,ALTERNATIVELY ACTIVATED MACROPHAGES; TRICHINELLA-SPIRALIS; GLUCOSE-UPTAKE; INSULIN-RESISTANCE; STEM-CELLS; INFECTION; INFLAMMATION; REGENERATION; METABOLISM; AUTOPHAGY,"It has become increasingly clear that the functions of eosinophils extend beyond host defense and allergy to metabolism and tissue regeneration. These influences have strong potential to be relevant in worm infections in which eosinophils are prominent and parasites rely on the host for nutrients to support growth or reproduction. The aim of this study was to investigate the mechanism underlying the observation that eosinophils promote growth of Trichinella spiralis larvae in skeletal muscle. Our results indicate that IL-4 and eosinophils are necessary for normal larval growth and that eosinophils from IL-4 competent mice are sufficient to support growth. The eosinophil-mediated effect operates in the absence of adaptive immunity. Following invasion by newborn larvae, host gene expression in skeletal muscle was compatible with a regenerative response and a shift in the source of energy in infected tissue. The presence of eosinophils suppressed local inflammation while also influencing nutrient homeostasis in muscle. Redistribution of glucose transporter 4 (GLUT4) and phosphorylation of Akt were observed in nurse cells, consistent with enhancement of glucose uptake and glycogen storage by larvae that is known to occur. The data are consistent with a mechanism in which eosinophils promote larval growth by an IL-4 dependent mechanism that limits local interferon-driven responses that otherwise alter nutrient metabolism in infected muscle. Our findings document a novel interaction between parasite and host in which worms have evolved a strategy to co-opt an innate host cell response in a way that facilitates their growth.","[Huang, Lu; Gebreselassie, Nebiat G.; Gagliardo, Lucille F.; Ruyechan, Maura C.; Appleton, Judith A.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Beiting, Daniel P.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Lee, Nancy A.] Mayo Clin Arizona, Div Hematol Oncol, Dept Biochem & Mol Biol, Scottsdale, AZ USA; [Lee, James J.] Mayo Clin Arizona, Div Pulm Med, Dept Biochem & Mol Biol, Scottsdale, AZ USA","Huang, L (reprint author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.",jaa2@cornell.edu,"Huang, Lu/G-3178-2011","Huang, Lu/0000-0002-7820-2177; Gebreselassie, Nebiat/0000-0002-8795-7483","National Institutes of Health [AI081043, AI097555, HL065228]","This work was supported by National Institutes of Health (http://www.nih.gov/) grants AI081043 and AI097555 (JAA) and HL065228 (JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,17,17,2,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005347,10.1371/journal.ppat.1005347,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800055,26720604.0,"DOAJ Gold, Green Published",,,16/08/2019,19,10,20,4318,559,377,182,3759,3254,17,488,20,9,0,0,17,17,0,,28,2,28,0,2,20,20,18,13,0,0,0,0,0,0,1,1,14,4392,13,14,33,98,8,3793,560,13,11,33,98,8,39,,1,1,0,0,16,0,1,1,0,0,0,29,0,0,22.844,7.724508050089446,1.1487097632349028,0.1487097632349029,1.197924980047885,1.0428439092172301,8.05545617173524
225,J,"Imperiale, MJ",,,,"Imperiale, Michael J.",,,A Fortuitous Journey from a Model System to a Human Pathogen,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"[Imperiale, Michael J.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Imperiale, Michael J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA","Imperiale, MJ (reprint author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.",imperial@umich.edu,,,,,,0,0,0,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005313,10.1371/journal.ppat.1005313,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800033,26658461.0,"DOAJ Gold, Green Published",,,16/08/2019,0,15,4,2796,136,111,25,2660,2463,9,188,4,15,0,0,0,0,0,,4,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,2813,0,0,0,31,1,2663,137,0,0,0,31,1,13,,0,0,0,0,16,0,0,1,0,0,0,4,0,0,8.35,20.558823529411764,1.0511278195488722,0.05112781954887218,1.069172932330827,1.0171673819742488,20.91176470588235
226,J,"Johnson, SM; McNally, BA; Ioannidis, I; Flano, E; Teng, MN; Oomens, AG; Walsh, EE; Peeples, ME",,,,"Johnson, Sara M.; McNally, Beth A.; Ioannidis, Ioannis; Flano, Emilio; Teng, Michael N.; Oomens, Antonius G.; Walsh, Edward E.; Peeples, Mark E.",,,Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures,PLOS PATHOGENS,,,English,Article,,,,,,,ATTACHMENT G-PROTEIN; CILIATED CELLS; IN-VITRO; CELLULAR RECEPTOR; INFECTION; IDENTIFICATION; FRACTALKINE; RSV; GLYCOPROTEIN; ANTIBODY,"Respiratory syncytial virus (RSV) is the most frequent cause of lower respiratory disease in infants, but no vaccine or effective therapy is available. The initiation of RSV infection of immortalized cells is largely dependent on cell surface heparan sulfate (HS), a receptor for the RSV attachment (G) glycoprotein in immortalized cells. However, RSV infects the ciliated cells in primary well differentiated human airway epithelial (HAE) cultures via the apical surface, but HS is not detectable on this surface. Here we show that soluble HS inhibits infection of immortalized cells, but not HAE cultures, confirming that HS is not the receptor on HAE cultures. Conversely, a ""non-neutralizing"" monoclonal antibody against the G protein that does not block RSV infection of immortalized cells, does inhibit infection of HAE cultures. This antibody was previously shown to block the interaction between the G protein and the chemokine receptor CX3CR1 and we have mapped the binding site for this antibody to the CX3C motif and its surrounding region in the G protein. We show that CX3CR1 is present on the apical surface of ciliated cells in HAE cultures and especially on the cilia. RSV infection of HAE cultures is reduced by an antibody against CX3CR1 and by mutations in the G protein CX3C motif. Additionally, mice lacking CX3CR1 are less susceptible to RSV infection. These findings demonstrate that RSV uses CX3CR1 as a cellular receptor on HAE cultures and highlight the importance of using a physiologically relevant model to study virus entry and antibody neutralization.","[Johnson, Sara M.; McNally, Beth A.; Ioannidis, Ioannis; Flano, Emilio; Peeples, Mark E.] Res Inst Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA; [Johnson, Sara M.; McNally, Beth A.; Ioannidis, Ioannis; Flano, Emilio; Peeples, Mark E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Teng, Michael N.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA; [Oomens, Antonius G.] Oklahoma State Univ, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Walsh, Edward E.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA","Johnson, SM (reprint author), Res Inst Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA.",mark.peeples@nationwidechildrens.org,"Teng, Michael N./I-5006-2012","Teng, Michael N./0000-0002-0722-3659",NIH [R01 AI093848]; Cystic Fibrosis Foundation Therapeutics; Nationwide Children's Hospital,"This work was supported by NIH R01 AI093848 (MEP), by Cystic Fibrosis Foundation Therapeutics (MEP), and by Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,56,57,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005318,10.1371/journal.ppat.1005318,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800037,26658574.0,"DOAJ Gold, Green Published",,,16/08/2019,58,13,60,8948,1686,974,712,7262,5903,30,1329,60,13,0,2,61,61,0,,236,2,123,0,2,63,63,39,37,0,0,0,0,0,0,1,0,7,8967,10,0,23,268,1,7228,1686,10,0,23,268,1,53,,1,0,0,0,13,0,0,1,1,0,0,118,0,0,17.1,5.30723606168446,1.2321674469843018,0.23216744698430183,1.273065271275131,1.0331917746982566,5.483392645314353
227,J,"Kroetz, DN; Allen, RM; Schaller, MA; Cavallaro, C; Ito, T; Kunkel, SL",,,,"Kroetz, Danielle N.; Allen, Ronald M.; Schaller, Matthew A.; Cavallaro, Cleyton; Ito, Toshihiro; Kunkel, Steven L.",,,Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection,PLOS PATHOGENS,,,English,Article,,,,,,,INFLUENZA-A VIRUS; INDUCED ISG15 CONJUGATION; EMBRYONIC STEM-CELLS; ALVEOLAR MACROPHAGES; DENDRITIC CELLS; T-CELLS; STREPTOCOCCUS-PNEUMONIAE; ANTIVIRAL RESPONSE; GM-CSF; INFLAMMATORY RESPONSE,"Influenza A virus (IAV) is an airborne pathogen that causes significant morbidity and mortality each year. Macrophages (M phi) are the first immune population to encounter IAV virions in the lungs and are required to control infection. In the present study, we explored the mechanism by which cytokine signaling regulates the phenotype and function of M phi via epigenetic modification of chromatin. We have found that type I interferon (IFN-I) potently upregulates the lysine methyltransferase Setdb2 in murine and human M phi, and in turn Setdb2 regulates M phi-mediated immunity in response to IAV. The induction of Setdb2 by IFN-I was significantly impaired upon inhibition of the JAK-STAT signaling cascade, and chromatin immunoprecipitation revealed that both STAT1 and interferon regulatory factor 7 bind upstream of the transcription start site to induce expression. The generation of Setdb2(LacZ) reporter mice revealed that IAV infection results in systemic upregulation of Setdb2 in myeloid cells. In the lungs, alveolar M phi expressed the highest level of Setdb2, with greater than 70% lacZ positive on day 4 post-infection. Silencing Setdb2 activity in M phi in vivo enhanced survival in lethal IAV infection. Enhanced host protection correlated with an amplified antiviral response and less obstruction to the airways. By tri-methylating H3K9, Setdb2 silenced the transcription of Mx1 and Isg15, antiviral effectors that inhibit IAV replication. Accordingly, a reduced viral load in knockout mice on day 8 post-infection was linked to elevated Isg15 and Mx1 transcript in the lungs. In addition, Setdb2 suppressed the expression of a large number of other genes with proinflammatory or immunomodulatory function. This included Ccl2, a chemokine that signals through CCR2 to regulate monocyte recruitment to infectious sites. Consistently, knockout mice produced more CCL2 upon IAV infection and this correlated with a 2-fold increase in the number of inflammatory monocytes and alveolar M phi in the lungs. Finally, Setdb2 expression by M phi suppressed IL-2, IL-10, and IFN-gamma production by CD4(+) T cells in vitro, as well as proliferation in IAV-infected lungs. Collectively, these findings identify Setdb2 as a novel regulator of the immune systemin acute respiratory viral infection.","[Kroetz, Danielle N.; Allen, Ronald M.; Schaller, Matthew A.; Cavallaro, Cleyton; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Ito, Toshihiro] Nara Med Univ, Dept Immunol, Nara, Japan","Kroetz, DN (reprint author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.",dkroetz@med.umich.edu,,,"National Institutes of Health [AI-1007413, HL-031237, HL-112897]","This work was supported by grants from the National Institutes of Health, AI-1007413, HL-031237, and HL-112897 (www.NIH.gov). Funding was received by SLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,81,21,22,2,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005338,10.1371/journal.ppat.1005338,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800048,26709698.0,"DOAJ Gold, Green Published",,,16/08/2019,21,17,37,7432,1636,1208,428,5796,4448,21,1327,37,16,0,0,21,21,0,,51,0,51,0,0,23,22,23,12,0,0,0,0,0,0,0,1,14,7541,23,0,62,67,1,5844,1656,23,0,62,67,1,41,,0,0,0,0,12,0,1,0,0,0,0,51,0,0,5.2,4.54278728606357,1.282263630089717,0.28226363008971705,1.3165976535541752,1.0267761033369214,4.66442542787286
228,J,"Kumar, D; Ristow, LC; Shi, MQ; Mukherjee, P; Caine, JA; Lee, WY; Kubes, P; Coburn, J; Chaconas, G",,,,"Kumar, Devender; Ristow, Laura C.; Shi, Meiqing; Mukherjee, Priyanka; Caine, Jennifer A.; Lee, Woo-Yong; Kubes, Paul; Coburn, Jenifer; Chaconas, George",,,Intravital Imaging of Vascular Transmigration by the Lyme Spirochete: Requirement for the Integrin Binding Residues of the B. burgdorferi P66 Protein,PLOS PATHOGENS,,,English,Article,,,,,,,BORRELIA-BURGDORFERI; DISEASE SPIROCHETE; ATTACHMENT; MOTILITY; LIGAND; CELLS; BBK32; RPOS,"Vascular extravasation, a key step in systemic infection by hematogenous microbial pathogens, is poorly understood, but has been postulated to encompass features similar to vascular transmigration by leukocytes. The Lyme disease spirochete can cause a variety of clinical manifestations, including arthritis, upon hematogenous dissemination. This pathogen encodes numerous surface adhesive proteins (adhesins) that may promote extravasation, but none have yet been implicated in this process. In this work we report the novel use of intravital microscopy of the peripheral knee vasculature to study transmigration of the Lyme spirochete in living Cd1d(-/-) mice. In the absence of INKT cells, major immune modulators in the mouse joint, spirochetes that have extravasated into joint-proximal tissue remain in the local milieu and can be enumerated accurately. We show that BBK32, a fibronectin and glycosaminoglycan adhesin of B.burgdorferi involved in early steps of endothelial adhesion, is not required for extravasation from the peripheral knee vasculature. In contrast, almost no transmigration occurs in the absence of P66, an outer membrane protein that has porin and integrin adhesin functions. Importantly, P66 mutants specifically defective in integrin binding were incapable of promoting extravasation. P66 itself does not promote detectable microvascular interactions, suggesting that vascular adhesion of B.burgdorferi mediated by other adhesins, sets the stage for P66-integrin interactions leading to transmigration. Although integrin-binding proteins with diverse functions are encoded by a variety bacterial pathogens, P66 is the first to have a documented and direct role in vascular transmigration. The emerging picture of vascular escape by the Lyme spirochete shows similarities, but distinct differences from leukocyte transmigration.","[Kumar, Devender; Shi, Meiqing; Mukherjee, Priyanka; Chaconas, George] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Kumar, Devender; Shi, Meiqing; Mukherjee, Priyanka; Chaconas, George] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Kumar, Devender; Shi, Meiqing; Mukherjee, Priyanka; Lee, Woo-Yong; Kubes, Paul; Chaconas, George] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Ristow, Laura C.; Caine, Jennifer A.; Coburn, Jenifer] Med Coll Wisconsin, Grad Program Microbiol Immunol & Mol Genet, Milwaukee, WI 53226 USA; [Ristow, Laura C.; Caine, Jennifer A.; Coburn, Jenifer] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Coburn, Jenifer] Med Coll Wisconsin, Div Infect Dis, Dept Med, Milwaukee, WI 53226 USA","Kumar, D (reprint author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.",Chaconas@ucalgary.ca,"Shi, Meiqing/K-3665-2016",,"National Institutes of Health (NIH) [R01-AI093104, R01-AI084873]; Canadian Institutes of Health Research [MOP 53086]; Canada Research Chair in the Molecular Biology of Lyme Borreliosis; Alberta Innovates - Health Solutions","Work in the authors' laboratories was funded by National Institutes of Health (NIH) grants R01-AI093104 (JC and GC), R01-AI084873 (JC) and by grant MOP 53086 (GC) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). GC was supported by a Canada Research Chair in the Molecular Biology of Lyme Borreliosis (http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx) and a Scientist Award from Alberta Innovates - Health Solutions (http://www.ahfmr.ab.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,15,15,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005333,10.1371/journal.ppat.1005333,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800045,26684456.0,"DOAJ Gold, Green Published",,,16/08/2019,15,39,18,4979,841,663,178,4138,3645,16,477,18,34,2,0,14,14,0,,24,4,24,0,4,16,16,12,11,2,0,0,2,0,0,0,10,21,5050,32,19,157,240,1,4166,850,32,18,157,240,1,34,,0,0,0,0,37,0,6,2,0,0,0,24,0,0,24.0,5.920332936979786,1.2032382793620107,0.20323827936201064,1.2861285645239247,1.068889335207873,6.328180737217598
229,J,"Li, DS; Wei, T; Rawle, DJ; Qin, FY; Wang, R; Soares, DC; Jin, HP; Sivakumaran, H; Lin, MH; Spann, K; Abbott, CM; Harrich, D",,,,"Li, Dongsheng; Wei, Ting; Rawle, Daniel J.; Qin, Fangyun; Wang, Rui; Soares, Dinesh C.; Jin, Hongping; Sivakumaran, Haran; Lin, Min-Hsuan; Spann, Kirsten; Abbott, Catherine M.; Harrich, David",,,Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; FACTOR 1 COMPLEX; TRANSLATION ELONGATION; IN-VITRO; VIRAL REPLICATION; INTERACTION TRAP; INFECTED-CELLS; FORCE-FIELD; DIDEMNIN-B; PROTEIN,"Reverse transcription is the central defining feature of HIV-1 replication. We previously reported that the cellular eukaryotic elongation factor 1 (eEF1) complex associates with the HIV-1 reverse transcription complex (RTC) and the association is important for late steps of reverse transcription. Here we show that association between the eEF1 and RTC complexes occurs by a strong and direct interaction between the subunit eEF1A and reverse transcriptase (RT). Using biolayer interferometry and co-immunoprecipitation (co-IP) assays, we show that association between the eEF1 and RTC complexes occurs by a strong (K-D similar to 3-4 nM) and direct interaction between eEF1A and reverse transcriptase (RT). Biolayer interferometry analysis of cell lysates with titrated levels of eEF1A indicates it is a predominant cellular RT binding protein. Both the RT thumb and connection domains are required for interaction with eEF1A. A single amino acid mutation, W252A, within the thumb domain impaired co-IP between eEF1A and RT, and also significantly reduced the efficiency of late reverse transcription and virus replication when incorporated into infectious HIV-1. Molecular modeling analysis indicated that interaction between W252 and L303 are important for RT structure, and their mutation to alanine did not impair heterodimerisation, but negatively impacted interaction with eEF1A. Didemnin B, which specifically binds eEF1A, potently inhibited HIV-1 reverse transcription by greater than 2 logs at subnanomolar concentrations, especially affecting reverse transcription late DNA synthesis. Analysis showed reduced levels of RTCs from HIV-1-infected HEK293T treated with didemnin B compared to untreated cells. Interestingly, HIV-1 with a W252A RT mutation was resistant to didemnin B negative effects showing that didemnin B affects HIV-1 by targeting the RT-eEF1A interaction. The combined evidence indicates a direct interaction between eEF1A and RT is crucial for HIV reverse transcription and replication, and the RT-eEF1A interaction is a potential drug target.","[Li, Dongsheng; Wei, Ting; Rawle, Daniel J.; Qin, Fangyun; Wang, Rui; Jin, Hongping; Sivakumaran, Haran; Lin, Min-Hsuan; Harrich, David] QIMR Berghofer Med Res Inst, Dept Cell & Mol Biol, Herston, Qld, Australia; [Rawle, Daniel J.; Spann, Kirsten] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Soares, Dinesh C.; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Ctr Genom & Expt Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Spann, Kirsten] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia","Li, DS (reprint author), QIMR Berghofer Med Res Inst, Dept Cell & Mol Biol, Herston, Qld, Australia.",david.harrich@qimrberghofer.edu.au,"Spann, Kirsten/B-4524-2013; Soares, Dinesh/A-4425-2012; Harrich, David/H-6668-2016","Spann, Kirsten/0000-0003-0567-8382; Soares, Dinesh/0000-0001-7557-0495; Sivakumaran, Haran/0000-0002-4691-4989; Rawle, Daniel/0000-0001-7248-0101; Harrich, David/0000-0003-3690-0150; Abbott, Catherine/0000-0001-8794-7173",National Health and Medical Research Council (AU) [APP1080465],"This study was funded by a grant from the National Health and Medical Research Council (AU) (APP1080465) to DH and DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,53,4,6,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005289,10.1371/journal.ppat.1005289,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800019,26624286.0,"DOAJ Gold, Green Published",,,16/08/2019,7,101,17,3861,646,466,180,3215,2676,16,523,17,7,0,0,6,6,0,,21,0,21,0,0,7,7,4,4,0,0,0,0,0,0,0,94,9,3911,66,0,296,131,5,3227,654,66,0,296,131,5,30,,0,0,0,0,10,0,1,1,0,0,0,21,0,0,5.8,5.976780185758514,1.2009331259720062,0.20093312597200622,1.277760497667185,1.063973063973064,6.359133126934984
230,J,"Li, RF; Liao, GL; Nirujogi, RS; Pinto, SM; Shaw, PG; Huang, TC; Wan, J; Qian, J; Gowda, H; Wu, XY; Lv, DW; Zhang, K; Manda, SS; Pandey, A; Hayward, SD",,,,"Li, Renfeng; Liao, Gangling; Nirujogi, Raja Sekhar; Pinto, Sneha M.; Shaw, Patrick G.; Huang, Tai-Chung; Wan, Jun; Qian, Jiang; Gowda, Harsha; Wu, Xinyan; Lv, Dong-Wen; Zhang, Kun; Manda, Srikanth S.; Pandey, Akhilesh; Hayward, S. Diane",,,Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING-COMPLEX; HUMAN CYTOMEGALOVIRUS-INFECTION; CELL-CYCLE; ANTIVIRAL ACTIVITY; PHOSPHORYLATION SITE; DIRECTLY BINDS; PHOSPHATASE 1; EA-D; BGLF4,"Epstein-Barr virus (EBV) is etiologically linked to infectious mononucleosis and several human cancers. EBV encodes a conserved protein kinase BGLF4 that plays a key role in the viral life cycle. To provide new insight into the host proteins regulated by BGLF4, we utilized stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics to compare site-specific phosphorylation in BGLF4-expressing Akata B cells. Our analysis revealed BGLF4-mediated hyperphosphorylation of 3,046 unique sites corresponding to 1,328 proteins. Frequency analysis of these phosphosites revealed a proline-rich motif signature downstream of BGLF4, indicating a broader substrate recognition for BGLF4 than its cellular ortholog cyclin-dependent kinase 1 (CDK1). Further, motif analysis of the hyperphosphorylated sites revealed enrichment in ATM, ATR and Aurora kinase substrates while functional analyses revealed significant enrichment of pathways related to the DNA damage response (DDR), mitosis and cell cycle. Phosphorylation of proteins associated with the mitotic spindle assembly checkpoint (SAC) indicated checkpoint activation, an event that inactivates the anaphase promoting complex/cyclosome, APC/C. Furthermore, we demonstrated that BGLF4 binds to and directly phosphorylates the key cellular proteins PP1, MPS1 and CDC20 that lie upstream of SAC activation and APC/C inhibition. Consistent with APC/C inactivation, we found that BGLF4 stabilizes the expression of many known APC/C substrates. We also noted hyperphosphorylation of 22 proteins associated the nuclear pore complex, which may contribute to nuclear pore disassembly and SAC activation. A drug that inhibits mitotic checkpoint activation also suppressed the accumulation of extracellular EBV virus. Taken together, our data reveal that, in addition to the DDR, manipulation of mitotic kinase signaling and SAC activation are mechanisms associated with lytic EBV replication. All MS data have been deposited in the ProteomeXchange with identifier PXD002411 (http://proteomecentral.proteomexchange.org/dataset/PXD002411).","[Li, Renfeng; Liao, Gangling; Hayward, S. Diane] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Li, Renfeng; Lv, Dong-Wen; Zhang, Kun; Manda, Srikanth S.; Pandey, Akhilesh] Virginia Commonwealth Univ, VCU Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA USA; [Li, Renfeng; Qian, Jiang] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Nirujogi, Raja Sekhar; Shaw, Patrick G.; Huang, Tai-Chung; Wu, Xinyan; Manda, Srikanth S.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Nirujogi, Raja Sekhar; Pinto, Sneha M.; Gowda, Harsha] Inst Bioinformat, Bangalore, Karnataka, India; [Wan, Jun] Johns Hopkins Univ, Sch Med, Wilmer Inst, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Diana Helis Henry Med Res Fdn, New Orleans, LA USA","Li, RF (reprint author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.",rli@vcu.edu; pandey@jhmi.edu; dhayward@jhmi.edu,"Pinto, Sneha/Q-7308-2018; Lv, Dongwen/F-8667-2019; Wan, Jun/H-7132-2013; Lv, DongWen/H-2693-2016","Pinto, Sneha/0000-0001-8541-8761; Lv, Dongwen/0000-0003-4677-8996; Wan, Jun/0000-0001-9286-6562; Lv, DongWen/0000-0003-4677-8996; Huang, Tai-Chung/0000-0002-1625-7295; Li, Renfeng/0000-0002-9226-4470","NIH [K99AI104828/R00AI104828, R21AI101377, R01EY024580, P30EY001765, U54GM103520, U24CA160036, HHSN268201000032C]; VCU Philips Institute for Oral Health Research; VCU NCI Designated Massey Cancer Center [NIH P30 CA016059]; Council of Scientific and Industrial Research (CSIR), Government of India","This work was supported by NIH K99AI104828/R00AI104828 to RL, NIH R21AI101377 to SDH, NIH R01EY024580 and P30EY001765 to JQ and NIH U54GM103520, U24CA160036 and HHSN268201000032C to AP (http://grants.nih.gov/grants/oer.htm). The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's disease Programs. RL received support from the VCU Philips Institute for Oral Health Research and the VCU NCI Designated Massey Cancer Center (NIH P30 CA016059). RSN is a recipient of Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.",,123,21,21,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005346,10.1371/journal.ppat.1005346,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800054,26714015.0,"DOAJ Gold, Green Published",,,16/08/2019,21,14,25,5791,1171,733,438,4620,3796,19,805,25,12,0,0,19,19,0,,32,0,32,0,0,22,22,15,13,0,0,0,0,0,0,0,4,8,5807,48,0,177,156,0,4603,1171,48,0,177,156,0,33,,0,0,0,0,14,0,1,0,0,0,0,32,0,0,7.7,4.945345858240819,1.2534632034632034,0.25346320346320345,1.301082251082251,1.0379899844586427,5.133219470538002
231,J,"Mathiason, CK",,,,"Mathiason, Candace K.",,,Silent Prions and Covert Prion Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE; ENVIRONMENT; INFECTIVITY; PROTEIN; SALIVA; TIME,,"[Mathiason, Candace K.] Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Dept Microbiol, Ft Collins, CO 80523 USA","Mathiason, CK (reprint author), Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Dept Microbiol, Ft Collins, CO 80523 USA.",candace.mathiason@colostate.edu,"Mathiason, Candace/H-9769-2017; Mathiason, Candace K/E-7843-2017","Mathiason, Candace/0000-0002-5920-4556; Mathiason, Candace K/0000-0002-5920-4556",,,,20,4,4,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005249,10.1371/journal.ppat.1005249,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800005,26661848.0,"DOAJ Gold, Green Published",,,16/08/2019,3,0,17,4951,860,665,195,4091,3652,18,421,17,0,0,0,3,3,0,,23,16,23,0,16,3,3,2,2,0,0,0,0,0,0,0,0,2,5136,0,3,0,195,6,4124,877,0,3,0,195,6,135,,1,0,0,0,4,0,1,1,0,0,0,23,0,0,11.1,5.756976744186047,1.210217550721095,0.21021755072109508,1.3031043754583231,1.0767521712785295,6.198837209302326
232,J,"Mitchell, PS; Young, JM; Emerman, M; Malik, HS",,,,"Mitchell, Patrick S.; Young, Janet M.; Emerman, Michael; Malik, Harmit S.",,,Evolutionary Analyses Suggest a Function of MxB Immunity Proteins Beyond Lentivirus Restriction,PLOS PATHOGENS,,,English,Article,,,,,,,SMOOTH ENDOPLASMIC-RETICULUM; INHIBITS HIV-1 INFECTION; POSITIVE SELECTION; ANTIVIRAL SPECIFICITY; PHYLOGENETIC ANALYSIS; VIRAL DETERMINANTS; MAXIMUM-LIKELIHOOD; NUCLEAR-ENVELOPE; INNATE IMMUNITY; GTPASE DOMAIN,"Viruses impose diverse and dynamic challenges on host defenses. Diversifying selection of codons and gene copy number variation are two hallmarks of genetic innovation in antiviral genes engaged in host-virus genetic conflicts. The myxovirus resistance (Mx) genes encode interferon-inducible GTPases that constitute a major arm of the cell-autonomous defense against viral infection. Unlike the broad antiviral activity of MxA, primate MxB was recently shown to specifically inhibit lentiviruses including HIV-1. We carried out detailed evolutionary analyses to investigate whether genetic conflict with lentiviruses has shaped MxB evolution in primates. We found strong evidence for diversifying selection in the MxB N-terminal tail, which contains molecular determinants of MxB anti-lentivirus specificity. However, we found no overlap between previously-mapped residues that dictate lentiviral restriction and those that have evolved under diversifying selection. Instead, our findings are consistent with MxB having a long-standing and important role in the interferon response to viral infection against a broader range of pathogens than is currently appreciated. Despite its critical role in host innate immunity, we also uncovered multiple functional losses of MxB during mammalian evolution, either by pseudogenization or by gene conversion from MxA genes. Thus, although the majority of mammalian genomes encode two Mx genes, this apparent stasis masks the dramatic effects that recombination and diversifying selection have played in shaping the evolutionary history of Mx genes. Discrepancies between our study and previous publications highlight the need to account for recombination in analyses of positive selection, as well as the importance of using sequence datasets with appropriate depth of divergence. Our study also illustrates that evolutionary analyses of antiviral gene families are critical towards understanding molecular principles that govern host-virus interactions and species-specific susceptibility to viral infection.","[Mitchell, Patrick S.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Mitchell, Patrick S.; Young, Janet M.; Emerman, Michael; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Emerman, Michael] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA","Mitchell, PS (reprint author), Univ Calif Berkeley, Russell Vance Lab, Div Immunol, Berkeley, CA 94720 USA.",hsmalik@fhcrc.org,"Malik, Harmit S/I-5591-2019","Malik, Harmit S/0000-0001-6005-0016","NSF; NIH [T32 CA080416, R01AI030927]; P50 grant [GM107632]; HHMI","This work was funded by NSF predoctoral fellowship (PSM), interdisciplinary NIH training grant T32 CA080416 (PSM), R01AI030927 (ME), P50 grant GM107632 (PI: Jef Boeke, NYU; subaward: HSM) and funds from HHMI (HSM). HSM is an investigator of HHMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,26,26,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005304,10.1371/journal.ppat.1005304,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800026,26658285.0,"DOAJ Gold, Green Published",,,16/08/2019,26,41,23,3851,500,367,133,3351,2740,20,591,23,11,0,0,24,24,0,,33,0,33,0,0,27,27,20,19,0,0,0,0,0,0,0,30,15,3932,84,0,52,334,4,3360,508,84,0,52,334,4,64,,0,0,0,0,17,0,1,1,0,0,0,33,0,0,9.65,7.702,1.1492091912861833,0.14920919128618323,1.298119964189794,1.1295767333160218,8.7
233,J,"Moda, F; Le, TNT; Aulic, S; Bistaffa, E; Campagnani, I; Virgilio, T; Indaco, A; Palamara, L; Andreoletti, O; Tagliavini, F; Legname, G",,,,"Moda, Fabio; Le, Thanh-Nhat T.; Aulic, Suzana; Bistaffa, Edoardo; Campagnani, Ilaria; Virgilio, Tommaso; Indaco, Antonio; Palamara, Luisa; Andreoletti, Olivier; Tagliavini, Fabrizio; Legname, Giuseppe",,,Synthetic prions with novel strain-specified properties,PLOS PATHOGENS,,,English,Article,,,,,,,AMYLOID FIBRILS; MOLECULAR-BASIS; SCRAPIE PRION; NMR STRUCTURE; IN-VITRO; PROTEIN; DIVERSITY; MECHANISM; OLIGOMERIZATION; STABILIZATION,"Prions are infectious proteins that possess multiple self-propagating structures. The information for strains and structural specific barriers appears to be contained exclusively in the folding of the pathological isoform, PrPSc. Many recent studies determined that de novo prion strains could be generated in vitro from the structural conversion of recombinant (rec) prion protein (PrP) into amyloidal structures. Our aim was to elucidate the conformational diversity of pathological recPrP amyloids and their biological activities, as well as to gain novel insights in characterizing molecular events involved in mammalian prion conversion and propagation. To this end we generated infectious materials that possess different conformational structures. Our methodology for the prion conversion of recPrP required only purified rec full-length mouse (Mo) PrP and common chemicals. Neither infected brain extracts nor amplified PrPSc were used. Following two different in vitro protocols recMoPrP converted to amyloid fibrils without any seeding factor. Mouse hypothalamic GT1 and neuroblastoma N2a cell lines were infected with these amyloid preparations as fast screening methodology to characterize the infectious materials. Remarkably, a large number of amyloid preparations were able to induce the conformational change of endogenous PrPC to harbor several distinctive proteinase-resistant PrP forms. One such preparation was characterized in vivo habouring a synthetic prion with novel strain specified neuropathological and biochemical properties.","[Moda, Fabio; Campagnani, Ilaria; Virgilio, Tommaso; Indaco, Antonio; Palamara, Luisa; Tagliavini, Fabrizio] IRCCS, Fdn Carlo Besta, Neurol Inst, Unit Neuropathol & Neurol 5, Milan, Italy; [Le, Thanh-Nhat T.; Aulic, Suzana; Bistaffa, Edoardo; Legname, Giuseppe] Scuola Int Super Studi Avanzati, Dept Neurosci, Lab Prion Biol, Trieste, Italy; [Andreoletti, Olivier] Ecole Natl Vet Toulouse, Physiopathol Infect & Parasitaire Ruminants, UMR INRA ENVT, Toulouse, France; [Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy","Moda, F (reprint author), IRCCS, Fdn Carlo Besta, Neurol Inst, Unit Neuropathol & Neurol 5, Milan, Italy.",legname@sissa.it,"INDACO, ANTONIO/F-2256-2019; Moda, Fabio/J-6445-2018; Bistaffa, Edoardo/J-7354-2018","INDACO, ANTONIO/0000-0002-0074-6166; Moda, Fabio/0000-0002-2820-9880; tagliavini, fabrizio/0000-0003-1039-7315; Bistaffa, Edoardo/0000-0001-7441-153X; Virgilio, Tommaso/0000-0002-9326-8828","European Community [222887]; Ministero dell'Istruzione, dell'Universita e della Ricerca; Italian Ministry of Health","GL has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 222887 - the PRIORITY project - and from the Ministero dell'Istruzione, dell'Universita e della Ricerca under the program PRIN 2008 ""Meccanismi Neurodegenerativi nelle Malattie da Prioni: Studi Conformazionali, Fisiopatologia della Proteina Prionica e Possibili Approcci Farmacologici"". The work was partially supported by the Italian Ministry of Health to FT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,8,8,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005354,10.1371/journal.ppat.1005354,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800058,26720726.0,"DOAJ Gold, Green Published",,,16/08/2019,7,18,27,4263,573,424,149,3690,3091,18,581,25,13,0,0,7,7,0,,2,3,0,2,3,8,8,6,4,0,0,0,0,0,0,0,5,8,4383,75,7,192,95,0,3760,582,75,7,192,95,0,41,,5,1,0,0,15,0,0,1,0,0,0,31,2,0,56.19600000000001,7.439790575916231,1.1552845528455284,0.15528455284552845,1.2338753387533876,1.0680272108843538,7.945898778359512
234,J,"Nakane, D; Kenri, T; Matsuo, L; Miyata, M",,,,"Nakane, Daisuke; Kenri, Tsuyoshi; Matsuo, Lisa; Miyata, Makoto",,,Systematic Structural Analyses of Attachment Organelle in Mycoplasma pneumoniae,PLOS PATHOGENS,,,English,Article,,,,,,,TERMINAL ORGANELLE; GLIDING MOTILITY; FLUORESCENT-PROTEIN; CYTADHERENCE PROTEINS; GENOME SEQUENCE; IN-VITRO; LOCALIZATION; BACTERIUM; STRAINS; MOBILE,"Mycoplasma pneumoniae, a human pathogenic bacterium, glides on host cell surfaces by a unique and unknown mechanism. It forms an attachment organelle at a cell pole as a membrane protrusion composed of surface and internal structures, with a highly organized architecture. In the present study, we succeeded in isolating the internal structure of the organelle by sucrose-gradient centrifugation. The negative-staining electron microscopy clarified the details and dimensions of the internal structure, which is composed of terminal button, paired plates, and bowl complex from the end of cell front. Peptide mass fingerprinting of the structure suggested 25 novel components for the organelle, and 3 of them were suggested for their involvement in the structure through their subcellular localization determined by enhanced yellow fluorescent protein (EYFP) tagging. Thirteen component proteins including the previously reported ones were mapped on the organelle systematically for the first time, in nanometer order by EYFP tagging and immunoelectron microscopy. Two, three, and six specific proteins localized specifically to the terminal button, the paired plates, and the bowl, respectively and interestingly, HMW2 molecules were aligned parallel to form the plate. The integration of these results gave the whole image of the organelle and allowed us to discuss possible gliding mechanisms.","[Nakane, Daisuke; Matsuo, Lisa] Osaka City Univ, Grad Sch Sci, Dept Biol, Sumiyoshi Ku, Osaka 558, Japan; [Nakane, Daisuke] Gakushuin Univ, Fac Sci, Dept Phys, Tokyo 171, Japan; [Kenri, Tsuyoshi] Natl Inst Infect Dis, Dept Bacteriol 2, Musashimurayama, Tokyo, Japan; [Miyata, Makoto] Osaka City Univ, OCU Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 558, Japan","Nakane, D (reprint author), Osaka City Univ, Grad Sch Sci, Dept Biol, Sumiyoshi Ku, Osaka 558, Japan.",miyata@sci.osaka-cu.ac.jp,"MIYATA, Makoto/H-5727-2019; Nakane, Daisuke/P-1325-2019; Nakane, Daisuke/W-4105-2019","MIYATA, Makoto/0000-0002-7478-7390; Nakane, Daisuke/0000-0002-8201-2608; ","MEXT KAKENHI Grants [24117002, 25117530, 15H01337, 17019067, 18018044, 20018029]; JSPS KAKENHI Grants [21249030, 24390107]; Asahi Glass Foundation; Uehara Memorial Foundation","This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas ""Harmonized Supramolecular Motility Machinery and Its Diversity"" (24117002 to MM and 25117530, 15H01337 to TK) and ""Applied Genomics"" (17019067, 18018044, 20018029 to TK) MEXT KAKENHI Grants, by Grants-in-Aid for Scientific Research (A) (21249030 to MM) and (B) (24390107 to MM) JSPS KAKENHI Grants, and by Asahi Glass Foundation and Uehara Memorial Foundation to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,57,19,19,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005299,10.1371/journal.ppat.1005299,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800024,26633540.0,"DOAJ Gold, Green Published",,,16/08/2019,19,10,7,5173,787,521,266,4386,3716,18,652,7,6,0,0,18,18,3,,14,0,14,0,0,19,19,17,14,0,0,0,0,0,0,0,4,4,5187,65,0,55,185,0,4373,787,65,0,55,185,0,27,,0,0,0,0,5,0,0,1,0,0,0,12,0,0,2.0,6.573062261753495,1.1794345645234838,0.1794345645234838,1.2396260829913361,1.0510342161221728,6.90851334180432
235,J,"Ozanic, M; Marecic, V; Abu Kwaik, Y; Santic, M",,,,"Ozanic, Mateja; Marecic, Valentina; Abu Kwaik, Yousef; Santic, Marina",,,The Divergent Intracellular Lifestyle of Francisella tularensis in Evolutionarily Distinct Host Cells,PLOS PATHOGENS,,,English,Article,,,,,,,VI-SECRETION-SYSTEM; DROSOPHILA-MELANOGASTER; PROTEIN; PATHOGENICITY; VIRULENCE; NOVICIDA; ESCAPE; MACROPHAGES; CYTOPLASM; PROLIFERATION,,"[Ozanic, Mateja; Marecic, Valentina; Santic, Marina] Univ Rijeka, Fac Med, Dept Microbiol & Parasitol, Rijeka, Croatia; [Abu Kwaik, Yousef] Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Abu Kwaik, Yousef] Univ Louisville, Coll Med, Ctr Predict Med, Louisville, KY 40292 USA","Ozanic, M (reprint author), Univ Rijeka, Fac Med, Dept Microbiol & Parasitol, Rijeka, Croatia.",marina.santic@medri.uniri.hr,"Ozanic, Mateja/N-6761-2018; Santic, Marina/N-6796-2018; Marecic, Valentina/N-6609-2018","Ozanic, Mateja/0000-0002-7028-1245; Santic, Marina/0000-0003-4138-3581; Marecic, Valentina/0000-0001-6246-8547","University of Rijeka [811.10.1111]; National Institute of Health [1R01AI120244, R21AI116517]; Commonwealth of Kentucky Research Challenge Trust Fund","This work is supported by a Grant of University of Rijeka (Grant No. 811.10.1111). YAK is supported by Public Health Service Award 1R01AI120244 and R21AI116517 from the National Institute of Health and by the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,38,18,18,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005208,10.1371/journal.ppat.1005208,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800001,26633893.0,"DOAJ Gold, Green Published",,,16/08/2019,16,11,34,4245,611,445,166,3634,2778,15,841,34,10,0,0,16,16,0,,41,5,41,0,5,19,19,11,10,0,0,0,0,0,0,0,1,9,4301,9,0,15,80,2,3628,611,9,0,15,80,2,62,,0,0,0,0,10,0,0,1,0,0,0,43,0,0,4.5,6.947626841243863,1.1681342872867364,0.16813428728673638,1.2080352228948816,1.0341578327444052,7.18494271685761
236,J,"Parikh, BA; Piersma, SJ; Pak-Wittel, MA; Yang, LP; Schreiber, RD; Yokoyama, WM",,,,"Parikh, Bijal A.; Piersma, Sytse J.; Pak-Wittel, Melissa A.; Yang, Liping; Schreiber, Robert D.; Yokoyama, Wayne M.",,,Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells,PLOS PATHOGENS,,,English,Article,,,,,,,NATURAL-KILLER-CELLS; IFN-ALPHA-BETA; VIRAL-INFECTION; MOUSE CYTOMEGALOVIRUS; INTERFERON-GAMMA; DENDRITIC CELLS; ANTIVIRAL DEFENSE; CUTTING EDGE; MICE; RESPONSES,"Natural killer (NK) cells play a critical role in controlling murine cytomegalovirus (MCMV) and can mediate both cytokine production and direct cytotoxicity. The NK cell activation receptor, Ly49H, is responsible for genetic resistance to MCMV in C57BL/6 mice. Recognition of the viral m157 protein by Ly49H is sufficient for effective control of MCMV infection. Additionally, during the host response to infection, distinct immune and non-immune cells elaborate a variety of pleiotropic cytokines which have the potential to impact viral pathogenesis, NK cells, and other immune functions, both directly and indirectly. While the effects of various immune deficiencies have been examined for general antiviral phenotypes, their direct effects on Ly49H-dependent MCMV control are poorly understood. To specifically interrogate Ly49H-dependent functions, herein we employed an in vivo viral competition approach to show Ly49H-dependent MCMV control is specifically mediated through cytotoxicity but not IFN gamma. production. Whereas m157 induced Ly49H-dependent degranulation, efficient cytotoxicity also required either IL-12 or type I interferon (IFN-I) which acted directly on NK cells to produce granzyme B. These studies demonstrate that both of these distinct NK cell-intrinsic mechanisms are integrated for optimal viral control by NK cells.","[Parikh, Bijal A.; Schreiber, Robert D.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Piersma, Sytse J.; Pak-Wittel, Melissa A.; Yang, Liping; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA","Parikh, BA (reprint author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 43205 USA.",yokoyama@wustl.edu,"Schreiber, Robert/Q-7550-2019","Parikh, Bijal/0000-0003-2490-8294","Speed Congenics Facility of NIH-supported Rheumatic Diseases Core Center [P30-AR048335]; NIH [R01-AI051345, K08-AI104991]; Netherlands Organisation for Scientific Research (Rubicon) [825.11.004]; Protein Production and Purification Core Facility","Research reported in this publication was supported by the Protein Production and Purification Core Facility and Speed Congenics Facility of the NIH-supported Rheumatic Diseases Core Center (P30-AR048335). This work was supported by NIH grants R01-AI051345 to W.M.Y. who is an investigator of the Howard Hughes Medical Institute, and K08-AI104991 to B.A.P. S.J.P. was supported by the Netherlands Organisation for Scientific Research (Rubicon grant 825.11.004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,60,13,13,1,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005323,10.1371/journal.ppat.1005323,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800041,26720279.0,"DOAJ Gold, Green Published",,,16/08/2019,11,9,14,3690,489,368,121,3201,2651,14,536,14,4,0,2,14,14,0,,18,0,18,0,0,12,12,8,8,0,0,0,0,0,0,0,5,6,3757,94,1,147,105,0,3219,501,69,1,147,97,0,37,,0,0,0,0,7,0,0,0,1,0,0,18,0,0,3.75,7.54601226993865,1.1527647610121836,0.1527647610121837,1.2358637925648235,1.0720867208672087,8.08997955010225
237,J,"Peligero, C; Argilaguet, J; Guerri-Fernandez, R; Torres, B; Ligero, C; Colomer, P; Plana, M; Knobel, H; Garcia, F; Meyerhans, A",,,,"Peligero, Cristina; Argilaguet, Jordi; Gueerri-Fernandez, Roberto; Torres, Berta; Ligero, Carmen; Colomer, Pilar; Plana, Montserrat; Knobel, Hernando; Garcia, Felipe; Meyerhans, Andreas",,,PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia,PLOS PATHOGENS,,,English,Article,,,,,,,UP-REGULATION; INHIBITORY PATHWAY; VIRUS-INFECTION; IN-VIVO; EXHAUSTION; CD4(+); EXPRESSION; DEATH-1; MEMORY; ACTIVATION,"Blocking the PD-1/PD-L1 pathway has emerged as a potential therapy to restore impaired immune responses in human immunodeficiency virus (HIV)-infected individuals. Most reports have studied the impact of the PD-L1 blockade on effector cells and neglected possible effects on regulatory T cells (Treg cells), which play an essential role in balancing immunopathology and antiviral effector responses. The aim of this study was to define the consequences of ex vivo PD-L1 blockade on Treg cells from HIV-infected individuals. We observed that HIV infection led to an increase in PD-1+ and PD-L1+ Treg cells. This upregulation correlated with disease progression and decreased under antiretroviral treatment. Treg cells from viremic individuals had a particularly high PD-1 expression and impaired proliferative capacity in comparison with Treg cells from individuals under antiretroviral treatment. PD-L1 blockade restored the proliferative capacity of Treg cells from viremic individuals but had no effect on its suppressive capacity. Moreover, it increased the viral production in cell cultures from viremic individuals. This increase in viral production correlated with an increase in Treg cell percentage and a reduction in the CD4/Treg and CD8/Treg cell ratios. In contrast to the effect of the PD-L1 blockade on Treg cells from viremic individuals, we did not observe a significant effect on the proliferative capacity of Treg cells from individuals in whom viremia was controlled (either spontaneously or by antiretroviral treatment). However, PD-L1 blockade resulted in an increased proliferative capacity of HIV-specific-CD8 T cells in all subjects. Taken together, our findings suggest that manipulating PD-L1 in vivo can be expected to influence the net gain of effector function depending on the subject's plasma viremia.","[Peligero, Cristina; Argilaguet, Jordi; Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Lab, Barcelona, Spain; [Gueerri-Fernandez, Roberto; Colomer, Pilar; Knobel, Hernando] Univ Autonoma Barcelona, Hosp del Mar, Infect Dis Unit, E-08193 Barcelona, Spain; [Torres, Berta; Ligero, Carmen; Garcia, Felipe] Hosp Clin Barcelona, Infect Dis Unit, Barcelona, Spain; [Plana, Montserrat] Univ Barcelona, Hosp Clin, AIDS Res Grp, Retrovirol & Viral Immunopathol Lab, Barcelona, Spain; [Meyerhans, Andreas] ICREA, Barcelona, Spain","Peligero, C (reprint author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Lab, Barcelona, Spain.",jordi.argilaguet@upf.edu; andreas.meyerhans@upf.edu,"Meyerhans, Andreas/S-2559-2019; , Felipe/F-4242-2014; Argilaguet, Jordi/E-5109-2016; Knobel, Hernando/B-5223-2016; Meyerhans, Andreas/D-3382-2014","Meyerhans, Andreas/0000-0003-0620-5317; , Felipe/0000-0001-7658-5832; Argilaguet, Jordi/0000-0001-5924-2774; Knobel, Hernando/0000-0003-3186-6416; Meyerhans, Andreas/0000-0003-0620-5317","Spanish Ministry of Economy and competitiveness (MINECO) [SAF2013-46077-R]; Spanish Ministry of Economy and competitiveness (MINECO), FEDER [SAF 2012-39075, FIS PI070291, FIS PI12/00969]; Russian Science Foundation [15-11-00029]; MINECO [AP2010-3248]; ICREA","This research was funded by the Spanish Ministry of Economy and competitiveness (MINECO), Grants SAF2013-46077-R and FEDER, SAF 2012-39075, FIS PI070291, FIS PI12/00969, and the Russian Science Foundation, grant number 15-11-00029. CP had a studentship funded by MINECO AP2010-3248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,53,21,21,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005270,10.1371/journal.ppat.1005270,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800011,26633181.0,"DOAJ Gold, Green Published",,,16/08/2019,22,30,27,5587,1157,819,338,4430,3637,18,775,27,29,0,1,18,18,5,,34,0,34,0,0,22,22,15,9,0,0,0,0,0,0,2,1,20,5624,69,1,45,110,0,4437,1162,69,1,45,110,0,25,,7,1,0,0,26,0,1,1,1,0,0,34,0,0,77.7,4.828867761452031,1.26117381489842,0.26117381489841984,1.3099322799097066,1.0386611777340253,5.015557476231634
238,J,"Reinke, AW; Troemel, ER",,,,"Reinke, Aaron W.; Troemel, Emily R.",,,The Development of Genetic Modification Techniques in Intracellular Parasites and Potential Applications to Microsporidia,PLOS PATHOGENS,,,English,Article,,,,,,,GREEN FLUORESCENT PROTEIN; STABLE DNA TRANSFORMATION; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; EXPRESSION; TRANSFECTION; MARKER; INTEGRATION; FUMAGILLIN,,"[Reinke, Aaron W.; Troemel, Emily R.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, San Diego, CA 92103 USA","Reinke, AW (reprint author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, San Diego, CA 92103 USA.",etroemel@ucsd.edu,,,NIAID [R01 AI087528],"ERT acknowledges support from NIAID R01 AI087528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,43,7,7,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005283,10.1371/journal.ppat.1005283,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800015,26720003.0,"DOAJ Gold, Green Published",,,16/08/2019,7,8,29,4785,598,460,138,4187,3630,20,537,29,8,0,0,7,7,0,,30,19,30,0,19,7,7,6,5,0,0,0,0,0,0,0,0,10,5043,4,32,9,307,4,4214,601,4,32,9,307,4,228,,0,0,0,0,11,0,0,1,0,0,0,30,0,0,5.45,8.001672240802675,1.1428230236446142,0.14282302364461427,1.2787198471459278,1.1189132706374085,8.953177257525084
239,J,"Riestra, AM; Gandhi, S; Sweredoski, MJ; Moradian, A; Hess, S; Urban, S; Johnson, PJ",,,,"Riestra, Angelica M.; Gandhi, Shiv; Sweredoski, Michael J.; Moradian, Annie; Hess, Sonja; Urban, Sinisa; Johnson, Patricia J.",,,A Trichomonas vaginalis Rhomboid Protease and Its Substrate Modulate Parasite Attachment and Cytolysis of Host Cells,PLOS PATHOGENS,,,English,Article,,,,,,,INTRAMEMBRANE PROTEOLYSIS; DROSOPHILA RHOMBOID-1; CYSTEINE PROTEINASES; IDENTIFICATION RATES; CLEAVAGE; FAMILY; INVASION; REVEALS; SURFACE; ROLES,"Trichomonas vaginalis is an extracellular eukaryotic parasite that causes the most common, non-viral sexually transmitted infection worldwide. Although disease burden is high, molecular mechanisms underlying T. vaginalis pathogenesis are poorly understood. Here, we identify a family of putative T. vaginalis rhomboid proteases and demonstrate catalytic activity for two, TvROM1 and TvROM3, using a heterologous cell cleavage assay. The two T. vaginalis intramembrane serine proteases display different subcellular localization and substrate specificities. TvROM1 is a cell surface membrane protein and cleaves atypical model rhomboid protease substrates, whereas TvROM3 appears to localize to the Golgi apparatus and recognizes a typical model substrate. To identify TvROM substrates, we interrogated the T. vaginalis surface proteome using both quantitative proteomic and bioinformatic approaches. Of the nine candidates identified, TVAG_166850 and TVAG_280090 were shown to be cleaved by TvROM1. Comparison of amino acid residues surrounding the predicted cleavage sites of TvROM1 substrates revealed a preference for small amino acids in the predicted transmembrane domain. Over-expression of TvROM1 increased attachment to and cytolysis of host ectocervical cells. Similarly, mutations that block the cleavage of a TvROM1 substrate lead to its accumulation on the cell surface and increased parasite adherence to host cells. Together, these data indicate a role for TvROM1 and its substrate (s) in modulating attachment to and lysis of host cells, which are key processes in T. vaginalis pathogenesis.","[Riestra, Angelica M.; Johnson, Patricia J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Gandhi, Shiv; Urban, Sinisa] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Sweredoski, Michael J.; Moradian, Annie; Hess, Sonja] CALTECH, Proteome Explorat Lab, Div Biol & Biol Engn, Beckman Inst, Pasadena, CA 91125 USA; [Urban, Sinisa] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Johnson, Patricia J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA","Riestra, AM (reprint author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.",johnsonp@ucla.edu,,"Gandhi, Shiv/0000-0002-1850-187X","National Institutes of Health [AI103182, AI066025, T32GM007445]; HHMI Gilliam Fellowship for Advanced Study; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute","This work was supported by National Institutes of Health Grant AI103182 (to PJJ), AI066025 (to SU), and T32GM007445 (to SG). AMR was supported by the HHMI Gilliam Fellowship for Advanced Study. The Proteome Exploration Laboratory (AM, MJS, SH) is supported by the Gordon and Betty Moore Foundation grant GBMF775 and the Beckman Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,81,17,17,1,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005294,10.1371/journal.ppat.1005294,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800022,26684303.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,17,15,32,4687,691,516,175,3996,3436,17,543,32,9,0,2,18,18,0,,42,0,42,0,0,21,18,21,9,0,0,0,0,0,0,1,7,5,4786,73,0,179,84,2,4029,697,73,0,179,84,2,60,,1,1,0,0,9,0,0,0,1,0,0,42,0,0,18.5,6.782923299565846,1.172922922922923,0.1729229229229229,1.236986986986987,1.0546191593770002,7.153400868306802
240,J,"Rodrigues, ML; Godinho, RMC; Zamith-Miranda, D; Nimrichter, L",,,,"Rodrigues, Marcio L.; Godinho, Rodrigo M. C.; Zamith-Miranda, Daniel; Nimrichter, Leonardo",,,Traveling into Outer Space: Unanswered Questions about Fungal Extracellular Vesicles,PLOS PATHOGENS,,,English,Article,,,,,,,GRAM-POSITIVE BACTERIA; CRYPTOCOCCUS-NEOFORMANS; CELL-WALL; MEMBRANE-VESICLES; CANDIDA-ALBICANS; BIOGENESIS; PROTEOMICS; TRANSPORT,,"[Rodrigues, Marcio L.] Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, RJ, Brazil; [Rodrigues, Marcio L.; Godinho, Rodrigo M. C.; Zamith-Miranda, Daniel; Nimrichter, Leonardo] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941 Rio De Janeiro, Brazil","Rodrigues, ML (reprint author), Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, RJ, Brazil.",marciolr@cdts.fiocruz.br; nimrichter@micro.ufrj.br,"Zamith-Miranda, Daniel/E-8877-2013; Rodrigues, Marcio/J-3727-2013","Zamith-Miranda, Daniel/0000-0001-7532-2432; Rodrigues, Marcio/0000-0002-6081-3439","CNPq [443586/2014-4, 300699/2013-1]; CAPES; FAPERJ [E-26/102.835/2012, 210.918/2015]; Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas Negligenciadas (INCT-IDN); Wellcome Trust (UK) [WT104741MA]","This work was supported by grants from the Brazilian agencies CNPq (grant numbers 443586/2014-4 and 300699/2013-1), CAPES (PNPD and Science without borders Programs), and FAPERJ (grant numbers E-26/102.835/2012 and 210.918/2015). The authors also acknowledge support from the Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas Negligenciadas (INCT-IDN). MLR is the recipient of a Pathfinder Award from the Wellcome Trust (UK, grant number WT104741MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,29,22,22,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005240,10.1371/journal.ppat.1005240,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800004,26633018.0,"DOAJ Gold, Green Published",,,16/08/2019,19,24,31,4587,459,340,119,4128,3385,14,729,31,24,0,0,23,23,0,,51,4,51,0,4,21,21,7,11,0,0,0,0,0,0,0,0,5,4681,7,0,21,98,1,4153,469,7,0,21,98,1,59,,0,0,0,0,18,0,0,1,0,0,0,51,0,0,11.25,9.993464052287582,1.1111918604651163,0.11119186046511628,1.1593992248062015,1.0433834750381512,10.427015250544663
241,J,"Russell, CW; Mulvey, MA",,,,"Russell, Colin W.; Mulvey, Matthew A.",,,The Extraintestinal Pathogenic Escherichia coli Factor RqlI Constrains the Genotoxic Effects of the RecQ-Like Helicase RqlH,PLOS PATHOGENS,,,English,Article,,,,,,,URINARY-TRACT-INFECTION; BLOOD-STREAM INFECTION; DNA HELICASES; TRANSFORMATION; GENES; PROTEIN; EPIDEMIOLOGY; BACTEREMIA; MUTATIONS; PHENOTYPE,"Extraintestinal pathogenic Escherichia coli colonize the human gut and can spread to other body sites to induce diseases such as urinary tract infections, sepsis, and meningitis. A complete understanding of the infection process is hindered by both the inherent genetic diversity of E. coli and the large number of unstudied genes. Here, we focus on the uncharacterized gene rqlI, which our lab recently uncovered in a Tn-seq screen for bacterial genes required within a zebrafish model of infection. We demonstrate that the Delta rqlI mutant experiences a growth defect and increased DNA stress in low oxygen conditions. In a genetic screen for suppressor mutations in the Delta rql strain, we found that the shortcomings of the Delta rql mutant are attributable to the activity of RqlH, which is known in other bacteria to be a helicase of the RecQ family that contains a phosphoribosyltransferase (PRTase) domain. Disruption of rqlH rescues the Delta rqlI strain in both in vivo and in vitro assays, while the expression of RqlH alone activates the SOS response coincident with bacterial filamentation, heightened sensitivity to DNA damage, and an increased mutation rate. The analysis of truncation mutants indicates that, in the absence of RqlI, RqlH toxicity is due to its PRTase domain. Complementary studies demonstrate that the toxicity of RqlH is modulated in a context-dependent fashion by overlapping domains within RqlI. This regulation is seemingly direct, given that the two proteins physically interact and form an operon. Interestingly, RqlH and RqlI orthologs are encoded by a diverse group of bacteria, but in many of these microbes, and especially in Gram-positive organisms, rqlH is found in the absence of rqlI. In total, this work shows that RqlH and RqlI can act in a strain-specific fashion akin to a toxin-antitoxin system in which toxicity is mediated by an atypical helicase-associated PRTase domain.","[Russell, Colin W.; Mulvey, Matthew A.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA","Russell, CW (reprint author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.",mulvey@path.utah.edu,,"Mulvey, Matthew/0000-0002-6016-7510; Russell, Colin/0000-0003-3942-0996",National Institutes of Health [AI095647],"Research in the Mulvey lab was funded by grant AI095647 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,8,8,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005317,10.1371/journal.ppat.1005317,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800036,26636713.0,"DOAJ Gold, Green Published",,,16/08/2019,9,39,16,3089,440,343,97,2649,2315,17,317,16,19,0,0,8,8,0,,24,0,24,0,0,9,9,4,6,0,0,0,0,0,0,1,20,9,3135,104,1,123,61,0,2664,453,104,1,123,61,0,18,,1,0,0,0,12,0,1,0,0,0,0,24,0,0,15.45,7.0204545454545455,1.1661004152510381,0.16610041525103814,1.245753114382786,1.068306895435416,7.5
242,J,"Saada, EA; DeMarco, SF; Shimogawa, MM; Hill, KL",,,,"Saada, Edwin A.; DeMarco, Stephanie F.; Shimogawa, Michelle M.; Hill, Kent L.",,,With a Little Help from My Friends-Social Motility in Trypanosoma brucei,PLOS PATHOGENS,,,English,Article,,,,,,,ADENYLATE CYCLASES; TSETSE-FLIES; AFRICAN TRYPANOSOMES; SWARMING MOTILITY; BIOFILM FORMATION; SURFACE GLYCOPROTEIN; FLAGELLAR MEMBRANE; BLOOD-STREAM; CELL-DENSITY; FLY,,"[Saada, Edwin A.; DeMarco, Stephanie F.; Shimogawa, Michelle M.; Hill, Kent L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [DeMarco, Stephanie F.; Hill, Kent L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA USA","Saada, EA (reprint author), Sandia Natl Labs, Livermore, CA USA.",kenthill@microbio.ucla.edu,,"DeMarco, Stephanie/0000-0001-8010-8027",NIH [R01AI052348]; Burroughs Wellcome Fund Investigator in Global Infectious Disease award,"Work in the authors' laboratory is supported by NIH grant R01AI052348 and a Burroughs Wellcome Fund Investigator in Global Infectious Disease award to KLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,53,6,6,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005272,10.1371/journal.ppat.1005272,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800012,26679190.0,"DOAJ Gold, Green Published",,,16/08/2019,6,52,20,3298,348,264,84,2950,2495,11,444,20,17,0,0,6,6,0,,28,4,28,0,4,8,6,8,5,0,0,0,0,0,0,0,35,10,3360,6,0,85,118,3,2975,350,6,0,85,118,3,35,,0,0,0,0,16,0,0,1,0,0,0,28,0,0,10.05,9.477011494252874,1.1179661016949152,0.11796610169491525,1.1810169491525424,1.0563978168587023,10.011494252873563
243,J,"Sakala, IG; Chaudhri, G; Scalzo, AA; Eldi, P; Newsome, TP; Buller, RM; Karupiah, G",,,,"Sakala, Isaac G.; Chaudhri, Geeta; Scalzo, Anthony A.; Eldi, Preethi; Newsome, Timothy P.; Buller, Robert M.; Karupiah, Gunasegaran",,,"Evidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naive Mice",PLOS PATHOGENS,,,English,Article,,,,,,,SECONDARY POXVIRUS INFECTION; CELL-MEDIATED RESISTANCE; NK GENE-COMPLEX; CD8(+) T-CELLS; VIRAL-INFECTION; HUMAN MONKEYPOX; VACCINIA VIRUS; ANTIVIRAL PROTECTION; BINDING-PROTEIN; LETHAL MOUSEPOX,"Orthopoxviruses (OPV), including variola, vaccinia, monkeypox, cowpox and ectromelia viruses cause acute infections in their hosts. With the exception of variola virus (VARV), the etiological agent of smallpox, other OPV have been reported to persist in a variety of animal species following natural or experimental infection. Despite the implications and significance for the ecology and epidemiology of diseases these viruses cause, those reports have never been thoroughly investigated. We used the mouse pathogen ectromelia virus (ECTV), the agent of mousepox and a close relative of VARV to investigate virus persistence in inbred mice. We provide evidence that ECTV causes a persistent infection in some susceptible strains of mice in which low levels of virus genomes were detected in various tissues late in infection. The bone marrow (BM) and blood appeared to be key sites of persistence. Contemporaneous with virus persistence, antiviral CD8 T cell responses were demonstrable over the entire 25-week study period, with a change in the immunodominance hierarchy evident during the first 3 weeks. Some virus-encoded host response modifiers were found to modulate virus persistence whereas host genes encoded by the NKC and MHC class I reduced the potential for persistence. When susceptible strains of mice that had apparently recovered from infection were subjected to sustained immunosuppression with cyclophosphamide (CTX), animals succumbed to mousepox with high titers of infectious virus in various organs. CTX treated index mice transmitted virus to, and caused disease in, co-housed naive mice. The most surprising but significant finding was that immunosuppression of disease-resistant C57BL/6 mice several weeks after recovery from primary infection generated high titers of virus in multiple tissues. Resistant mice showed no evidence of a persistent infection. This is the strongest evidence that ECTV can persist in inbred mice, regardless of their resistance status.","[Sakala, Isaac G.; Chaudhri, Geeta; Eldi, Preethi; Karupiah, Gunasegaran] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia; [Scalzo, Anthony A.] Univ Western Australia, Immunol & Virol Program, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Newsome, Timothy P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Buller, Robert M.] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA","Sakala, IG (reprint author), Flinders Univ S Australia, Flinders Med Ctr, Bedford Pk, SA 5042, Australia.",Guna.Karupiah@anu.edu.au,"Karupiah, Gunasegaran/J-4707-2013; Karupiah, Gunasegaran/S-3561-2019","Karupiah, Gunasegaran/0000-0001-6306-4405; Newsome, Timothy/0000-0002-2193-596X; Eldi, Preethi/0000-0003-0772-3095","Australian National Health and Medical Research Council [APP1007980, 471426, 632785]","The Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) funded this work through grants to GK (Grant # APP1007980, 471426 and 632785), GC (Grant # APP1007980; 471426) and TPN (632785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,73,3,3,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005342,10.1371/journal.ppat.1005342,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800050,26700306.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,3,5,4,2477,334,249,85,2143,1872,13,258,4,4,0,0,5,5,0,,0,0,0,0,0,4,4,2,3,0,0,0,0,0,0,0,1,3,2517,31,0,136,103,1,2150,337,31,0,136,103,1,30,,0,0,0,0,5,0,1,0,0,0,0,7,0,0,2.35,7.416167664670659,1.15585627624825,0.1558562762482501,1.2370508632757815,1.070246265643924,7.937125748502994
244,J,"Sali, TM; Pryke, KM; Abraham, J; Liu, A; Archer, I; Broeckel, R; Staverosky, JA; Smith, JL; Al-Shammari, A; Amsler, L; Sheridan, K; Nilsen, A; Streblow, DN; DeFilippis, VR",,,,"Sali, Tina M.; Pryke, Kara M.; Abraham, Jinu; Liu, Andrew; Archer, Iris; Broeckel, Rebecca; Staverosky, Julia A.; Smith, Jessica L.; Al-Shammari, Ahmed; Amsler, Lisi; Sheridan, Kayla; Nilsen, Aaron; Streblow, Daniel N.; DeFilippis, Victor R.",,,Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses,PLOS PATHOGENS,,,English,Article,,,,,,,"VASCULAR DISRUPTING AGENT; CYCLIC GMP-AMP; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; IFN-BETA EXPRESSION; I INTERFERON; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; IMMUNE-RESPONSE; SIGNALING PATHWAYS; ADAPTER PROTEIN","Pharmacologic stimulation of innate immune processes represents an attractive strategy to achieve multiple therapeutic outcomes including inhibition of virus replication, boosting antitumor immunity, and enhancing vaccine immunogenicity. In light of this we sought to identify small molecules capable of activating the type I interferon (IFN) response by way of the transcription factor IFN regulatory factor 3 (IRF3). A high throughput in vitro screen yielded 4-(2-chloro-6-fluorobenzyl)-N-(furan-2-ylmethyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (referred to herein as G10), which was found to trigger IRF3/IFN-associated transcription in human fibroblasts. Further examination of the cellular response to this molecule revealed expression of multiple IRF3-dependent antiviral effector genes as well as type I and III IFN subtypes. This led to the establishment of a cellular state that prevented replication of emerging Alphavirus species including Chikungunya virus, Venezuelan Equine Encephalitis virus, and Sindbis virus. To define cellular proteins essential to elicitation of the antiviral activity by the compound we employed a reverse genetics approach that utilized genome editing via CRISPR/Cas9 technology. This allowed the identification of IRF3, the IRF3-activating adaptor molecule STING, and the IFN-associated transcription factor STAT1 as required for observed gene induction and antiviral effects. Biochemical analysis indicates that G10 does not bind to STING directly, however. Thus the compound may represent the first synthetic small molecule characterized as an indirect activator of human STING-dependent phenotypes. In vivo stimulation of STING-dependent activity by an unrelated small molecule in a mouse model of Chikungunya virus infection blocked viremia demonstrating that pharmacologic activation of this signaling pathway may represent a feasible strategy for combating emerging Alphaviruses.","[Sali, Tina M.; Pryke, Kara M.; Abraham, Jinu; Liu, Andrew; Archer, Iris; Broeckel, Rebecca; Staverosky, Julia A.; Smith, Jessica L.; Al-Shammari, Ahmed; Amsler, Lisi; Streblow, Daniel N.; DeFilippis, Victor R.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA; [Archer, Iris; Broeckel, Rebecca; Amsler, Lisi; Streblow, Daniel N.; DeFilippis, Victor R.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Al-Shammari, Ahmed] Iraqi Ctr Canc & Med Genet Res, Baghdad, Iraq; [Sheridan, Kayla; Nilsen, Aaron] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA","Sali, TM (reprint author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.",defilipp@ohsu.edu,"Al-Shammari, Ahmed Majeed/A-1995-2016","Al-Shammari, Ahmed Majeed/0000-0002-2699-1514; Jones, Iris/0000-0003-4468-614X; Broeckel, Rebecca/0000-0003-3740-5442","National Institutes of Health [AI081680, AI2013168]","This work was supported by the National Institutes of Health: AI081680, AI2013168, and AI2013168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,116,22,22,0,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005324,10.1371/journal.ppat.1005324,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800042,26646986.0,"DOAJ Gold, Green Published",,,16/08/2019,25,169,94,18172,4236,3288,948,13936,11050,22,2864,94,11,0,0,23,23,3,,225,5,116,0,5,27,26,27,17,0,0,0,0,0,0,0,158,12,18216,131,0,220,431,4,13907,4236,131,0,220,431,4,73,,0,0,0,0,14,0,0,1,0,0,0,113,0,0,7.2,4.289896128423041,1.3039609644087256,0.3039609644087256,1.3474454649827785,1.0333480079242792,4.432955618508027
245,J,"Scheffers, DJ; Tol, MB",,,,"Scheffers, Dirk-Jan; Tol, Menno B.",,,LipidII: Just Another Brick in the Wall?,PLOS PATHOGENS,,,English,Review,,,,,,,BACTERIAL ACTIN MREB; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; II FLIPPASE; PEPTIDOGLYCAN BIOSYNTHESIS; STAPHYLOCOCCUS-AUREUS; MUREIN SYNTHESIS; CELL-SHAPE; MURJ MVIN; MEMBRANE,"Nearly all bacteria contain a peptidoglycan cell wall. The peptidoglycan precursor molecule is LipidII, containing the basic peptidoglycan building block attached to a lipid. Although the suitability of LipidII as an antibacterial target has long been recognized, progress on elucidating the role(s) of LipidII in bacterial cell biology has been slow. The focus of this review is on exciting new developments, both with respect to antibacterials targeting LipidII as well as the emerging role of LipidII in organizing the membrane and cell wall synthesis. It appears that on both sides of the membrane, LipidII plays crucial roles in organizing cytoskeletal proteins and peptidoglycan synthesis machineries. Finally, the recent discovery of no less than three different categories of LipidII flippases will be discussed.","[Scheffers, Dirk-Jan; Tol, Menno B.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9700 AB Groningen, Netherlands","Scheffers, DJ (reprint author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9700 AB Groningen, Netherlands.",d.j.scheffers@rug.nl,,"Scheffers, Dirk-Jan/0000-0002-9439-9168",Vidi grant from the Netherlands Organisation for Scientific Research (NWO) [864.09.010],"This work was supported by a Vidi grant from the Netherlands Organisation for Scientific Research (NWO, 864.09.010, to DJS) (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,71,19,19,0,26,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005213,10.1371/journal.ppat.1005213,,,,12,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800002,26679002.0,"DOAJ Gold, Green Published",,,16/08/2019,16,43,44,4809,569,426,143,4240,3327,46,867,44,11,0,0,15,15,0,,66,4,66,0,4,18,16,18,13,0,0,0,0,0,0,0,31,6,4858,6,0,14,138,0,4235,569,6,0,14,138,0,54,,0,0,0,0,9,0,1,1,0,0,0,65,0,0,4.75,8.451669595782073,1.1341981132075472,0.13419811320754718,1.1797169811320756,1.0401330838012062,8.790861159929701
246,J,"Schmid, B; Rinas, M; Ruggieri, A; Acosta, EG; Bartenschlager, M; Reuter, A; Fischl, W; Harder, N; Bergeest, JP; Flossdorf, M; Rohr, K; Hofer, T; Bartenschlager, R",,,,"Schmid, Bianca; Rinas, Melanie; Ruggieri, Alessia; Acosta, Eliana Gisela; Bartenschlager, Marie; Reuter, Antje; Fischl, Wolfgang; Harder, Nathalie; Bergeest, Jan-Philip; Flossdorf, Michael; Rohr, Karl; Hoefer, Thomas; Bartenschlager, Ralf",,,Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2 '-O-Methylation Mutant,PLOS PATHOGENS,,,English,Article,,,,,,,HEPATITIS-C-VIRUS; INNATE IMMUNE-RESPONSE; I INTERFERON RESPONSE; DOUBLE-STRANDED-RNA; WEST NILE VIRUS; GENE-EXPRESSION; VIRAL-INFECTION; RIG-I; 5'-TRIPHOSPHATE RNA; FLUORESCENT PROTEIN,"Dengue virus (DENV) is the most common mosquito-transmitted virus infecting similar to 390 million people worldwide. In spite of this high medical relevance, neither a vaccine nor antiviral therapy is currently available. DENV elicits a strong interferon (IFN) response in infected cells, but at the same time actively counteracts IFN production and signaling. Although the kinetics of activation of this innate antiviral defense and the timing of viral counteraction critically determine the magnitude of infection and thus disease, quantitative and kinetic analyses are lacking and it remains poorly understood how DENV spreads in IFN-competent cell systems. To dissect the dynamics of replication versus antiviral defense at the single cell level, we generated a fully viable reporter DENV and host cells with authentic reporters for IFN-stimulated antiviral genes. We find that IFN controls DENV infection in a kinetically determined manner that at the single cell level is highly heterogeneous and stochastic. Even at high-dose, IFN does not fully protect all cells in the culture and, therefore, viral spread occurs even in the face of antiviral protection of naive cells by IFN. By contrast, a vaccine candidate DENV mutant, which lacks 2'-O-methylation of viral RNA is profoundly attenuated in IFN-competent cells. Through mathematical modeling of time-resolved data and validation experiments we show that the primary determinant for attenuation is the accelerated kinetics of IFN production. This rapid induction triggered by mutant DENV precedes establishment of IFN-resistance in infected cells, thus causing a massive reduction of virus production rate. In contrast, accelerated protection of naive cells by paracrine IFN action has negligible impact. In conclusion, these results show that attenuation of the 2'-O-methylation DENV mutant is primarily determined by kinetics of autocrine IFN action on infected cells.","[Schmid, Bianca; Ruggieri, Alessia; Acosta, Eliana Gisela; Bartenschlager, Marie; Reuter, Antje; Fischl, Wolfgang; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Rinas, Melanie; Flossdorf, Michael; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, Heidelberg, Germany; [Rinas, Melanie; Harder, Nathalie; Bergeest, Jan-Philip; Flossdorf, Michael; Rohr, Karl; Hoefer, Thomas] Heidelberg Univ, BioQuant Ctr, Heidelberg, Germany; [Harder, Nathalie; Bergeest, Jan-Philip; Rohr, Karl] Heidelberg Univ, Dept Bioinformat & Funct Genom, Biomed Comp Vis Grp, Inst Pharm & Mol Biotechnol, Heidelberg, Germany","Schmid, B (reprint author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.",t.hoefer@dkfz-heidelberg.de; Ralf_Bartenschlager@med.uni-heidelberg.de,"Hofer, Thomas/G-5665-2013; Bartenschlager, Ralf/L-2582-2015","Hofer, Thomas/0000-0003-3560-8780; Rinas, Melanie/0000-0003-3393-3723; Harder, Nathalie/0000-0002-6171-6462; Bartenschlager, Ralf/0000-0001-5601-9307; Ruggieri, Alessia/0000-0001-9981-3308","Deutsche Forschungsgemeinschaft [FOR1202, TP1]; Bundesministerium fur Bildung und Forschung (BMBF)","This work was funded by the Deutsche Forschungsgemeinschaft, FOR1202, TP1 (to RB) and the Bundesministerium fur Bildung und Forschung (BMBF), project Immunoquant (to TH and RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,86,16,16,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005345,10.1371/journal.ppat.1005345,,,,36,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800053,26720415.0,"DOAJ Gold, Green Published",,,16/08/2019,15,6,45,5488,852,684,168,4636,3689,17,930,45,5,4,0,14,14,0,,57,2,57,0,2,17,15,17,11,0,0,0,0,0,0,0,1,9,5479,306,0,241,76,0,4605,852,306,0,241,76,0,22,,0,0,0,0,8,0,1,1,0,0,0,57,0,0,4.2,6.44131455399061,1.183779119930975,0.18377911993097498,1.2642364106988784,1.067966472303207,6.879107981220657
247,J,"Simon, S; Schell, U; Heuer, N; Hager, D; Albers, MF; Matthias, J; Fahrnbauer, F; Trauner, D; Eichinger, L; Hedberg, C; Hilbi, H",,,,"Simon, Sylvia; Schell, Ursula; Heuer, Natalie; Hager, Dominik; Albers, Michael F.; Matthias, Jan; Fahrnbauer, Felix; Trauner, Dirk; Eichinger, Ludwig; Hedberg, Christian; Hilbi, Hubert",,,Inter-kingdom Signaling by the Legionella Quorum Sensing Molecule LAI-1 Modulates Cell Migration through an IQGAP1-Cdc42-ARHGEF9-Dependent Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,PATHOGEN-HOST INTERACTIONS; AUTOINDUCER SYNTHASE LQSA; RESPONSE REGULATOR LQSR; DICTYOSTELIUM-DISCOIDEUM; PNEUMOPHILA; IQGAP1; GROWTH; VIBRIO; INFECTION; EFFECTOR,"Small molecule signaling promotes the communication between bacteria as well as between bacteria and eukaryotes. The opportunistic pathogenic bacterium Legionella pneumophila employs LAI-1 (3-hydroxypentadecane-4-one) for bacterial cell-cell communication. LAI-1 is produced and detected by the Lqs (Legionella quorum sensing) system, which regulates a variety of processes including natural competence for DNA uptake and pathogen-host cell interactions. In this study, we analyze the role of LAI-1 in inter-kingdom signaling. L. pneumophila lacking the autoinducer synthase LqsA no longer impeded the migration of infected cells, and the defect was complemented by plasmid-borne lqsA. Synthetic LAI-1 dose-dependently inhibited cell migration, without affecting bacterial uptake or cytotoxicity. The forward migration index but not the velocity of LAI-1-treated cells was reduced, and the cell cytoskeleton appeared destabilized. LAI-1-dependent inhibition of cell migration involved the scaffold protein IQGAP1, the small GTPase Cdc42 as well as the Cdc42-specific guanine nucleotide exchange factor ARHGEF9, but not other modulators of Cdc42, or RhoA, Rac1 or Ran GTPase. Upon treatment with LAI-1, Cdc42 was inactivated and IQGAP1 redistributed to the cell cortex regardless of whether Cdc42 was present or not. Furthermore, LAI-1 reversed the inhibition of cell migration by L. pneumophila, suggesting that the compound and the bacteria antagonistically target host signaling pathway(s). Collectively, the results indicate that the L. pneumophila quorum sensing compound LAI-1 modulates migration of eukaryotic cells through a signaling pathway involving IQGAP1, Cdc42 and ARHGEF9.","[Simon, Sylvia; Schell, Ursula; Hilbi, Hubert] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Simon, Sylvia; Hilbi, Hubert] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Heuer, Natalie; Matthias, Jan; Eichinger, Ludwig] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Hager, Dominik; Fahrnbauer, Felix; Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Albers, Michael F.; Hedberg, Christian] Umea Univ, Dept Chem, Umea, Sweden; [Albers, Michael F.; Hedberg, Christian] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Hedberg, Christian] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany","Simon, S (reprint author), Univ Munich, Max Von Pettenkofer Inst, Munich, Germany.",hilbi@imm.uzh.ch,,"Hilbi, Hubert/0000-0002-5462-9301","Swiss National Science Foundation (SNF) [CRSI33_130016, 31003A_153200]; German Research Foundation (DFG) [HI 1511/2-1, SFB914, SPP1617, SFB670 TP1]; Koln Fortune; Knut and Alice Wallenberg foundation (Sweden)","Work in the group of HH was supported by the Swiss National Science Foundation (SNF; Sinergia project CRSI33_130016, 31003A_153200) and the German Research Foundation (DFG; HI 1511/2-1, SFB914, SPP1617). LE was supported by the German Research Foundation (DFG; SFB670 TP1) and by Koln Fortune. CH and MFA thank the Knut and Alice Wallenberg foundation (Sweden) for generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,13,13,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005307,10.1371/journal.ppat.1005307,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800029,26633832.0,"DOAJ Gold, Green Published",,,16/08/2019,13,12,28,4167,724,608,116,3443,2847,17,579,28,12,0,0,12,12,0,,37,3,37,0,3,13,13,13,9,0,0,0,0,0,0,0,0,6,4282,197,0,259,141,0,3458,768,197,0,259,141,0,56,,0,0,0,0,12,0,0,1,0,0,0,37,0,0,6.3,5.755524861878453,1.2102817310485041,0.2102817310485042,1.34185303514377,1.1087113030957523,6.3812154696132595
248,J,"Song, TQ; Ma, ZC; Shen, DY; Li, Q; Li, WL; Su, LM; Ye, TY; Zhang, MX; Wang, YC; Dou, DL",,,,"Song, Tianqiao; Ma, Zhenchuan; Shen, Danyu; Li, Qi; Li, Wanlin; Su, Liming; Ye, Tingyue; Zhang, Meixiang; Wang, Yuanchao; Dou, Daolong",,,An Oomycete CRN Effector Reprograms Expression of Plant HSP Genes by Targeting their Promoters,PLOS PATHOGENS,,,English,Article,,,,,,,HEAT-STRESS-RESPONSE; TRANSCRIPTION FACTOR; PHYTOPHTHORA-SOJAE; CELL-DEATH; CYTOPLASMIC EFFECTORS; SHOCK PROTEINS; ARABIDOPSIS; DNA; RESISTANCE; RECOGNITION,"Oomycete pathogens produce a large number of CRN effectors to manipulate plant immune responses and promote infection. However, their functional mechanisms are largely unknown. Here, we identified a Phytophthora sojae CRN effector PsCRN108 which contains a putative DNA-binding helix-hairpin-helix (HhH) motif and acts in the plant cell nucleus. Silencing of the PsCRN108 gene reduced P. sojae virulence to soybean, while expression of the gene in Nicotiana benthamiana and Arabidopsis thaliana enhanced plant susceptibility to P. capsici. Moreover, PsCRN108 could inhibit expression of HSP genes in A. thaliana, N. benthamiana and soybean. Both the HhH motif and nuclear localization signal of this effector were required for its contribution to virulence and its suppression of HSP gene expression. Furthermore, we found that PsCRN108 targeted HSP promoters in an HSE- and HhH motif-dependent manner. PsCRN108 could inhibit the association of the HSE with the plant heat shock transcription factor AtHsfA1a, which initializes HSP gene expression in response to stress. Therefore, our data support a role for PsCRN108 as a nucleomodulin in down-regulating the expression of plant defense-related genes by directly targeting specific plant promoters.","[Song, Tianqiao; Ma, Zhenchuan; Shen, Danyu; Li, Qi; Li, Wanlin; Su, Liming; Ye, Tingyue; Zhang, Meixiang; Wang, Yuanchao; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China","Song, TQ (reprint author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.",ddou@njau.edu.cn,"wang, yuanchao/G-9667-2011","wang, yuanchao/0000-0001-5803-5343","National Natural Science Foundation of China [31371894, 31301613]; Natural Science Foundation of Jiangsu Province [BK2012027]; Fundamental Research Funds for the Central Universities [KYTZ201403]","This work was supported by: National Natural Science Foundation of China (31371894; 31301613), Natural Science Foundation of Jiangsu Province (BK2012027), and Fundamental Research Funds for the Central Universities (KYTZ201403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,69,25,26,3,35,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005348,10.1371/journal.ppat.1005348,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800056,26714171.0,"DOAJ Gold, Green Published",,,16/08/2019,24,16,40,6960,1136,852,284,5824,4438,20,1366,40,16,0,0,25,25,0,,95,3,49,0,3,27,25,27,12,0,0,0,0,0,0,0,0,14,7057,76,0,158,143,0,5860,1163,76,0,158,143,0,34,,0,0,0,0,20,0,0,0,0,0,0,49,0,0,9.85,6.126760563380282,1.195054945054945,0.19505494505494506,1.2493131868131868,1.0454022988505747,6.404929577464789
249,J,"Tham, WH; Lim, NTY; Weiss, GE; Lopaticki, S; Ansell, BRE; Bird, M; Lucet, I; Dorin-Semblat, D; Doerig, C; Gilson, PR; Crabb, BS; Cowman, AF",,,,"Tham, Wai-Hong; Lim, Nicholas T. Y.; Weiss, Greta E.; Lopaticki, Sash; Ansell, Brendan R. E.; Bird, Megan; Lucet, Isabelle; Dorin-Semblat, Dominique; Doerig, Christian; Gilson, Paul R.; Crabb, Brendan S.; Cowman, Alan F.",,,Plasmodium falciparum Adhesins Play an Essential Role in Signalling and Activation of Invasion into Human Erythrocytes,PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN-KINASE CK2; CATALYZES TYROSINE PHOSPHORYLATION; IMMUNOPHILIN FPR3; BINDING ANTIGEN; CELL INVASION; RECEPTOR; LIGAND; MEROZOITES; VACCINE; EVENTS,"The most severe form of malaria in humans is caused by the protozoan parasite Plasmodium falciparum. The invasive form of malaria parasites is termed a merozoite and it employs an array of parasite proteins that bind to the host cell to mediate invasion. In Plasmodium falciparum, the erythrocyte binding-like (EBL) and reticulocyte binding-like (Rh) protein families are responsible for binding to specific erythrocyte receptors for invasion and mediating signalling events that initiate active entry of the malaria parasite. Here we have addressed the role of the cytoplasmic tails of these proteins in activating merozoite invasion after receptor engagement. We show that the cytoplasmic domains of these type 1 membrane proteins are phosphorylated in vitro. Depletion of PfCK2, a kinase implicated to phosphorylate these cytoplasmic tails, blocks P. falciparum invasion of red blood cells. We identify the crucial residues within the PfRh4 cytoplasmic domain that are required for successful parasite invasion. Live cell imaging of merozoites from these transgenic mutants show they attach but do not penetrate erythrocytes implying the PfRh4 cytoplasmic tail conveys signals important for the successful completion of the invasion process.","[Tham, Wai-Hong; Lim, Nicholas T. Y.; Lopaticki, Sash; Ansell, Brendan R. E.; Lucet, Isabelle; Cowman, Alan F.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Tham, Wai-Hong; Lim, Nicholas T. Y.; Lopaticki, Sash; Ansell, Brendan R. E.; Lucet, Isabelle; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Weiss, Greta E.; Gilson, Paul R.; Crabb, Brendan S.] Burnet Inst, Melbourne, Vic, Australia; [Bird, Megan; Doerig, Christian] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Lucet, Isabelle] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Dorin-Semblat, Dominique] Univ Paris Diderot, GIP INTS, INSERM, UMR S 1134, Paris, France; [Gilson, Paul R.; Crabb, Brendan S.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Crabb, Brendan S.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia","Tham, WH (reprint author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.",cowman@wehi.edu.au,"Tham, Wai-Hong/P-6474-2019; Dorin-Semblat, Dominique/P-5845-2017; Doerig, Christian/Q-9900-2019; Tham, Wai-Hong/L-3173-2018; Ansell, Brendan/O-4150-2014","Tham, Wai-Hong/0000-0001-7950-8699; Dorin-Semblat, Dominique/0000-0002-8162-4573; Tham, Wai-Hong/0000-0001-7950-8699; Ansell, Brendan/0000-0003-0297-897X","National Health and Medical Research Council of Australia (NHMRC) [APP1026581, 637406]; Australia Research Council","This work was supported by the National Health and Medical Research Council of Australia (NHMRC) (APP1026581 and 637406) (https://www.nhmrc.gov.au). The Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS (http://www.vic.gov.au). AFC is a Howard Hughes International Scholar (https://www.hhmi.org). WHT holds a Future Fellowship from the Australia Research Council (http://www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,38,19,20,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005343,10.1371/journal.ppat.1005343,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800051,26694741.0,"DOAJ Gold, Green Published",,,16/08/2019,20,17,32,5268,806,564,242,4462,3621,24,817,32,16,4,0,20,20,0,,44,4,44,0,4,21,21,20,12,0,0,0,0,0,0,0,1,12,5328,38,0,75,63,3,4486,813,38,0,75,63,3,29,,0,0,0,0,17,0,0,0,0,0,0,44,0,0,6.85,6.535980148883374,1.180636485880771,0.18063648588077094,1.2167189601075752,1.0305618830675778,6.735732009925559
250,J,"Vinella, D; Fischer, F; Vorontsov, E; Gallaud, J; Malosse, C; Michel, V; Cavazza, C; Robbe-Saule, M; Richaud, P; Chamot-Rooke, J; Brochier-Armanet, C; De Reuse, H",,,,"Vinella, Daniel; Fischer, Frederic; Vorontsov, Egor; Gallaud, Julien; Malosse, Christian; Michel, Valerie; Cavazza, Christine; Robbe-Saule, Marie; Richaud, Pierre; Chamot-Rooke, Julia; Brochier-Armanet, Celine; De Reuse, Hilde",,,Evolution of Helicobacter: Acquisition by Gastric Species of Two Histidine-Rich Proteins Essential for Colonization,PLOS PATHOGENS,,,English,Article,,,,,,,GENOME SEQUENCE-ANALYSIS; METAL-BINDING PROPERTIES; IN-VIVO COMPLEMENTATION; NICKEL METABOLISM; PYLORI INFECTION; ACID RESISTANCE; UREASE ACTIVITY; HPN; NI2+; ROLES,"Metal acquisition and intracellular trafficking are crucial for all cells and metal ions have been recognized as virulence determinants in bacterial pathogens. Virulence of the human gastric pathogen Helicobacter pylori is dependent on nickel, cofactor of two enzymes essential for in vivo colonization, urease and [NiFe] hydrogenase. We found that two small paralogous nickel-binding proteins with high content in Histidine (Hpn and Hpn-2) play a central role in maintaining non-toxic intracellular nickel content and in controlling its intracellular trafficking. Measurements of metal resistance, intracellular nickel contents, urease activities and interactomic analysis were performed. We observed that Hpn acts as a nickel-sequestration protein, while Hpn-2 is not. In vivo, Hpn and Hpn-2 form homo-multimers, interact with each other, Hpn interacts with the UreA urease subunit while Hpn and Hpn-2 interact with the HypAB hydrogenase maturation proteins. In addition, Hpn-2 is directly or indirectly restricting urease activity while Hpn is required for full urease activation. Based on these data, we present a model where Hpn and Hpn-2 participate in a common pathway of controlled nickel transfer to urease. Using bioinformatics and top-down proteomics to identify the predicted proteins, we established that Hpn-2 is only expressed by H. pylori and its closely related species Helicobacter acinonychis. Hpn was detected in every gastric Helicobacter species tested and is absent from the enterohepatic Helicobacter species. Our phylogenomic analysis revealed that Hpn acquisition was concomitant with the specialization of Helicobacter to colonization of the gastric environment and the duplication at the origin of hpn-2 occurred in the common ancestor of H. pylori and H. acinonychis. Finally, Hpn and Hpn-2 were found to be required for colonization of the mouse model by H. pylori. Our data show that during evolution of the Helicobacter genus, acquisition of Hpn and Hpn-2 by gastric Helicobacter species constituted a decisive evolutionary event to allow Helicobacter to colonize the hostile gastric environment, in which no other bacteria persistently thrives. This acquisition was key for the emergence of one of the most successful bacterial pathogens, H. pylori.","[Vinella, Daniel; Fischer, Frederic; Gallaud, Julien; Michel, Valerie; Robbe-Saule, Marie; De Reuse, Hilde] Inst Pasteur, Dept Microbiol, Unite Pathogenese Helicobacter, ERL CNRS 3526, Paris, France; [Vorontsov, Egor; Chamot-Rooke, Julia] Inst Pasteur, Dept Biol Struct & Chim, Unite Spectrometrie Masse Struct & Prote, CNRS UMR 3528, Paris, France; [Gallaud, Julien] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Cavazza, Christine] iRTSV LCBM CEA, Grenoble, France; [Richaud, Pierre] CEA, DSV, IBEB, SBVME, St Paul Les Durance, France; [Richaud, Pierre] CNRS, UMR Biol Veget & Microbiol Environ 7265, St Paul Les Durance, France; [Richaud, Pierre] Aix Marseille Univ, BVME UMR7265, Marseille, France; [Brochier-Armanet, Celine] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France","Vinella, D (reprint author), Inst Pasteur, Dept Microbiol, Unite Pathogenese Helicobacter, ERL CNRS 3526, Paris, France.",hdereuse@pasteur.fr,"Brochier-Armanet, Celine/B-7898-2011","DE REUSE, Hilde/0000-0002-0100-4826",Investissement d'Avenir grant [ANR-10-BINF-01-01]; French Research Ministry; Institut Pasteur [494]; Donation Janssen,"This work was supported by Investissement d'Avenir grant (ANR-10-BINF-01-01 ""Ancestrome""): CBA, PhD fellowship of the French Research Ministry: JG, Roux fellowship of the Institut Pasteur: FF, Projet transversal de Recherche PTR#494 of the Institut Pasteur: DV, Donation Janssen: HDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,85,23,23,1,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005312,10.1371/journal.ppat.1005312,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800032,26641249.0,"DOAJ Gold, Green Published",,,16/08/2019,24,30,20,5650,1115,811,304,4535,3569,23,943,20,25,0,0,18,18,0,,58,5,31,0,5,25,25,20,8,0,0,0,0,0,0,0,5,16,5737,55,0,72,326,1,4553,1127,55,0,72,326,1,57,,0,1,0,0,22,0,3,1,0,0,0,31,0,0,19.75,5.067264573991031,1.2458654906284454,0.24586549062844543,1.3490628445424477,1.0828318584070797,5.486995515695067
251,J,"Wang, X; Zhu, NN; Li, WW; Zhu, FX; Wang, Y; Yuan, Y",,,,"Wang, Xin; Zhu, Nannan; Li, Wenwei; Zhu, Fanxiu; Wang, Yan; Yuan, Yan",,,Mono-ubiquitylated ORF45 Mediates Association of KSHV Particles with Internal Lipid Rafts for Viral Assembly and Egress,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; CELL-LINE; PROTEIN; DNA; PHOSPHORYLATION; RECOMBINATION; LOCALIZATION; MANIPULATION; INDUCTION; PROMOTES,"Herpesviruses acquire their envelope by budding into the lumen of cytoplasmic membrane vesicles. This process is initiated by component(s) on viral particles, which recognize the budding site where the viral glycoproteins are present and recruit cellular cargo transport and sorting machinery to the site to complete the budding process. Proteins in the tegument layer, connecting capsid and envelope, are candidates for the recognition of budding sites on vesicle membrane and induction of budding and final envelopment. We examined several outer and matrix tegument proteins of Kaposi's sarcoma-associated herpesvirus (KSHV) and found that ORF45 associates with lipid rafts (LRs) of cellular membrane. LRs are membrane micro-domains, which have been implicated as relay stations in intracellular signaling and transport including viral entry and virion assembly. The ability of ORF45 to target LR is dependent on the mono-ubiquitylation of ORF45 at Lys297 as the mutation at Lys297 (K297R) abolished LR-association of ORF45. The K297R mutation also impairs ORF45 and viral particle co-localization with trans-Golgi network and endosomes, but facilitates ORF45 and viral particles co-localizing with lysosomes. More importantly, the recombinant KSHV carrying ORF45 K297R mutant (BAC-K297R) was found severely defective in producing mature and infectious virion particles in comparison to wild type KSHV (BAC16). Taken together, our results reveal a new function of KSHV tegument protein ORF45 in targeting LR of host cell membrane, promoting viral particles co-localization with trans-Golgi and endosome vesicles and facilitating the maturation and release of virion particles, suggesting that ORF45 plays a role in bringing KSHV particles to the budding site on cytoplasmic vesicle membrane and triggering the viral budding process for final envelopment and virion maturation.","[Wang, Xin; Zhu, Nannan; Wang, Yan; Yuan, Yan] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xin; Zhu, Nannan; Wang, Yan; Yuan, Yan] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xin; Yuan, Yan] Univ Penn, Dept Microbiol, Sch Dent Med, Philadelphia, PA 19104 USA; [Li, Wenwei; Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Wang, Yan] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China","Wang, X (reprint author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.",wang93@mail.sysu.edu.cn; yuan2@pobox.upenn.edu,,,"National Institutes of Health [P01CA174439]; Natural Science Foundation of China [81171575, 81271805, 81371793]; Guangdong Innovative Research Team program [2009010058]","This work was supported by a grant from National Institutes of Health (P01CA174439), grants of Natural Science Foundation of China (Grant No. 81171575, 81271805, 81371793) and Guangdong Innovative Research Team program (No. 2009010058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,40,11,11,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005332,10.1371/journal.ppat.1005332,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800044,26650119.0,"DOAJ Gold, Green Published",,,16/08/2019,8,8,6,3332,515,372,143,2817,2308,15,494,6,7,2,0,8,8,0,,0,0,0,0,0,9,9,3,8,0,0,0,0,0,0,0,1,5,3415,68,0,32,106,0,2845,528,68,0,32,106,0,42,,0,0,0,0,5,0,0,0,0,0,0,8,0,0,2.35,6.469902912621359,1.1828186013489528,0.18281860134895278,1.2740504082357118,1.0771308523409364,6.968932038834952
252,J,"Westman, J; Papareddy, P; Dahlgren, MW; Chakrakodi, B; Norrby-Teglund, A; Smeds, E; Linder, A; Morgelin, M; Johansson-Lindbom, B; Egesten, A; Herwald, H",,,,"Westman, Johannes; Papareddy, Praveen; Dahlgren, Madelene W.; Chakrakodi, Bhavya; Norrby-Teglund, Anna; Smeds, Emanuel; Linder, Adam; Morgelin, Matthias; Johansson-Lindbom, Bengt; Egesten, Arne; Herwald, Heiko",,,Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,MAMMALIAN EPITHELIUM; INNATE IMMUNITY; INDUCED DAMAGE; LIVER-INJURY; LUNG INJURY; INFLAMMATION; MEDIATORS; SEPSIS; DEATH; MICE,"The innate immune system relies to a great deal on the interaction of pattern recognition receptors with pathogen-or damage-associated molecular pattern molecules. Extracellular histones belong to the latter group and their release has been described to contribute to the induction of systemic inflammatory reactions. However, little is known about their functions in the early immune response to an invading pathogen. Here we show that extracellular histones specifically target monocytes in human blood and this evokes the mobilization of the chemotactic chemokines CXCL9 and CXCL10 from these cells. The chemokine induction involves the toll-like receptor 4/myeloid differentiation factor 2 complex on monocytes, and is under the control of interferon-gamma. Consequently, subcutaneous challenge with extracellular histones results in elevated levels of CXCL10 in a murine air pouch model and an influx of leukocytes to the site of injection in a TLR4 dependent manner. When analyzing tissue biopsies from patients with necrotizing fasciitis caused by Streptococcus pyogenes, extracellular histone H4 and CXCL10 are immunostained in necrotic, but not healthy tissue. Collectively, these results show for the first time that extracellular histones have an important function as chemoattractants as their local release triggers the recruitment of immune cells to the site of infection.","[Westman, Johannes; Papareddy, Praveen; Smeds, Emanuel; Linder, Adam; Morgelin, Matthias; Herwald, Heiko] Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Dahlgren, Madelene W.; Johansson-Lindbom, Bengt] Biomed Ctr, Dept Expt Med Sci, Adapt Immun, Lund, Sweden; [Chakrakodi, Bhavya; Norrby-Teglund, Anna] Karolinska Univ, Huddinge Hosp, Ctr Infect Med, Karolinska Inst,Dept Med, Stockholm, Sweden; [Egesten, Arne] Biomed Ctr, Dept Clin Sci Resp Med & Allergy, Lund, Sweden","Westman, J (reprint author), Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden.",johannes.westman@med.lu.se,"Westman, Johannes/K-7472-2019","Westman, Johannes/0000-0001-6998-3939; Herwald, Heiko/0000-0002-8111-2842",foundation of Alfred Osterlund; foundation of Crafoord; foundation of Greta; foundation of Johan Kock; Knut and Alice Wallenberg Foundation [KAW2011.0037]; Ragnar Soderberg Foundation; Sten K Johnson Foundation; Sven-Olof Janson Lifework; Royal Physiographic Society in Lund; Medical Faculty at Lund University; Swedish Foundation for Strategic Research [K2014-56X-13413-15-3]; Swedish Research Council [SB12-0019],"This work was supported in part by the foundations of Alfred Osterlund (http://www.alfredosterlundsstiftelse.se), Crafoord (http://www.crafoord.se), Greta and Johan Kock (http://www.kockskastiftelsen.se), the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/kaw/, KAW2011.0037), the Ragnar Soderberg Foundation (http://ragnarsoderbergsstiftelse.se), Sten K Johnson Foundation (http://www.stenkjohnsonsstiftelse.se), Sven-Olof Janson Lifework (http://www.stiftelsen-sojansons-livsverk.se), the Royal Physiographic Society in Lund (http://www.fysiografen.se/sv/), the Medical Faculty at Lund University (http://www.med.lu.se), the Swedish Foundation for Strategic Research (http://www.stratresearch.se, K2014-56X-13413-15-3) and the Swedish Research Council (http://www.vr.se, SB12-0019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,37,21,22,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005319,10.1371/journal.ppat.1005319,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800038,26646682.0,"DOAJ Gold, Green Published",,,16/08/2019,22,0,20,4319,871,663,208,3448,2821,13,614,20,0,0,0,18,18,0,,25,0,25,0,0,22,22,21,12,0,0,0,0,0,0,0,0,6,4357,30,0,43,171,0,3457,874,30,0,43,171,0,26,,0,0,0,0,1,0,0,1,0,0,0,25,0,0,0.5,4.958668197474168,1.2526102088167053,0.2526102088167053,1.3219257540603249,1.055336883537856,5.233065442020666
253,J,"Berg, MG; Lee, D; Coller, K; Frankel, M; Aronsohn, A; Cheng, KV; Forberg, K; Marcinkus, M; Naccache, SN; Dawson, G; Brennan, C; Jensen, DM; Hackett, J; Chiu, CY",,,,"Berg, Michael G.; Lee, Deanna; Coller, Kelly; Frankel, Matthew; Aronsohn, Andrew; Cheng, Kevin; Forberg, Kenn; Marcinkus, Marilee; Naccache, Samia N.; Dawson, George; Brennan, Catherine; Jensen, Donald M.; Hackett, John, Jr.; Chiu, Charles Y.",,,Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection,PLOS PATHOGENS,,,English,Article,,,,,,,GBV-C; IDENTIFICATION; INFECTION; RNA; SEROPREVALENCE; HEPACIVIRUSES; PREVALENCE; ALIGNMENT; SOFTWARE; DISEASE,"Hepatitis C virus (HCV) and human pegivirus (HPgV), formerly GBV-C, are the only known human viruses in the Hepacivirus and Pegivirus genera, respectively, of the family Flaviviridae. We present the discovery of a second pegivirus, provisionally designated human pegivirus 2 (HPgV-2), by next-generation sequencing of plasma from an HCV-infected patient with multiple bloodborne exposures who died from sepsis of unknown etiology. HPgV-2 is highly divergent, situated on a deep phylogenetic branch in a clade that includes rodent and bat pegiviruses, with which it shares < 32% amino acid identity. Molecular and serological tools were developed and validated for high-throughput screening of plasma samples, and a panel of 3 independent serological markers strongly correlated antibody responses with viral RNA positivity (99.9% negative predictive value). Discovery of 11 additional RNA-positive samples from a total of 2440 screened (0.45%) revealed 93-94% nucleotide identity between HPgV-2 strains. All 12 HPgV-2 RNA-positive cases were identified in individuals also testing positive for HCV RNA (12 of 983; 1.22%), including 2 samples co-infected with HIV, but HPgV-2 RNA was not detected in non-HCV-infected individuals (p < 0.0001), including those singly infected by HIV (p = 0.0075) or HBV (p = 0.0077), nor in volunteer blood donors (p = 0.0082). Nine of the 12 (75%) HPgV-2 RNA positive samples were reactive for antibodies to viral serologic markers, whereas only 28 of 2,429 (1.15%) HPgV-2 RNA negative samples were seropositive. Longitudinal sampling in two individuals revealed that active HPgV-2 infection can persist in blood for at least 7 weeks, despite the presence of virus-specific antibodies. One individual harboring both HPgV-2 and HCV RNA was found to be seronegative for both viruses, suggesting a high likelihood of simultaneous acquisition of HCV and HPgV-2 infection from an acute co-transmission event. Taken together, our results indicate that HPgV-2 is a novel bloodborne infectious virus of humans and likely transmitted via the parenteral route.","[Berg, Michael G.; Coller, Kelly; Frankel, Matthew; Cheng, Kevin; Forberg, Kenn; Marcinkus, Marilee; Dawson, George; Brennan, Catherine; Hackett, John, Jr.] Abbott Labs, Abbott Pk, IL 60064 USA; [Lee, Deanna; Naccache, Samia N.; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lee, Deanna; Naccache, Samia N.; Chiu, Charles Y.] Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA; [Aronsohn, Andrew; Jensen, Donald M.] Univ Chicago, Ctr Liver Dis, Med Ctr, Chicago, IL 60637 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA","Berg, MG (reprint author), Abbott Labs, Abbott Pk, IL 60064 USA.",charles.chiu@ucsf.edu,,"Chiu, Charles/0000-0003-2915-2094",NIH [R01-HL105704]; UCSF-Abbott Pathogen Diagnostics and Discovery Award,"This work is supported by NIH grant R01-HL105704 (to CYC) and a UCSF-Abbott Pathogen Diagnostics and Discovery Award (to CYC). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Employees of Abbott Laboratories, Inc. are co-authors on this manuscript and closely involved in all aspects of its publication.",,46,33,35,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005325,10.1371/journal.ppat.1005325,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800043,26658760.0,"DOAJ Gold, Green Published",,,16/08/2019,37,49,48,11125,1731,1246,485,9394,7974,21,1399,48,36,2,0,33,33,1,,134,6,71,0,6,38,38,28,15,0,0,0,0,0,0,1,13,19,11235,66,0,118,159,1,9429,1760,66,0,118,159,1,46,,7,3,1,1,40,1,4,1,0,0,0,71,0,0,102.738,6.426920854997111,1.1842665531190122,0.18426655311901213,1.2199276133702364,1.030112359550562,6.620450606585789
254,J,"Drummond, RA; Collar, AL; Swamydas, M; Rodriguez, CA; Lim, JK; Mendez, LM; Fink, DL; Hsu, AP; Zhai, B; Karauzum, H; Mikelis, CM; Rose, SR; Ferre, EMN; Yockey, L; Lemberg, K; Kuehn, HS; Rosenzweig, SD; Lin, X; Chittiboina, P; Datta, SK; Belhorn, TH; Weimer, ET; Hernandez, ML; Hohl, TM; Kuhns, DB; Lionakis, MS",,,,"Drummond, Rebecca A.; Collar, Amanda L.; Swamydas, Muthulekha; Rodriguez, Carlos A.; Lim, Jean K.; Mendez, Laura M.; Fink, Danielle L.; Hsu, Amy P.; Zhai, Bing; Karauzum, Hatice; Mikelis, Constantinos M.; Rose, Stacey R.; Ferre, Elise M. N.; Yockey, Lynne; Lemberg, Kimberly; Kuehn, Hye Sun; Rosenzweig, Sergio D.; Lin, Xin; Chittiboina, Prashant; Datta, Sandip K.; Belhorn, Thomas H.; Weimer, Eric T.; Hernandez, Michelle L.; Hohl, Tobias M.; Kuhns, Douglas B.; Lionakis, Michail S.",,,CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System,PLOS PATHOGENS,,,English,Article,,,,,,,INHERITED CARD9 DEFICIENCY; ANTIFUNGAL IMMUNITY; CEREBROSPINAL-FLUID; CHEMOKINE RECEPTORS; MENINGITIS; MENINGOENCEPHALITIS; CANDIDIASIS; INFECTIONS; MUTATIONS; CHILDREN,"Candida is the most common human fungal pathogen and causes systemic infections that require neutrophils for effective host defense. Humans deficient in the C-type lectin pathway adaptor protein CARD9 develop spontaneous fungal disease that targets the central nervous system (CNS). However, how CARD9 promotes protective antifungal immunity in the CNS remains unclear. Here, we show that a patient with CARD9 deficiency had impaired neutrophil accumulation and induction of neutrophil-recruiting CXC chemokines in the cerebrospinal fluid despite uncontrolled CNS Candida infection. We phenocopied the human susceptibility in Card9(-/-) mice, which develop uncontrolled brain candidiasis with diminished neutrophil accumulation. The induction of neutrophil-recruiting CXC chemokines is significantly impaired in infected Card9(-/-) brains, from both myeloid and resident glial cellular sources, whereas cell-intrinsic neutrophil chemotaxis is Card9-independent. Taken together, our data highlight the critical role of CARD9-dependent neutrophil trafficking into the CNS and provide novel insight into the CNS fungal susceptibility of CARD9-deficient humans.","[Drummond, Rebecca A.; Collar, Amanda L.; Swamydas, Muthulekha; Rose, Stacey R.; Ferre, Elise M. N.; Yockey, Lynne] NIAID, Fungal Pathogenesis Unit, LCID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Rodriguez, Carlos A.; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Mendez, Laura M.; Fink, Danielle L.; Kuhns, Douglas B.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Neutrophil Monitoring Lab, Applied Dev Res Directorate, Frederick, MD USA; [Hsu, Amy P.] NIAID, Immunopathogenesis Sect, LCID, NIH, Bethesda, MD 20892 USA; [Zhai, Bing; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med, New York, NY 10021 USA; [Karauzum, Hatice; Datta, Sandip K.] NIAID, Bacterial Pathogenesis Unit, LCID, NIH, Bethesda, MD 20892 USA; [Mikelis, Constantinos M.] Texas Tech Univ, Dept Biomed Sci, Sch Pharm, Hlth Sci Ctr, Amarillo, TX USA; [Lemberg, Kimberly; Kuehn, Hye Sun; Rosenzweig, Sergio D.] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Div Basic Sci Res, Houston, TX 77030 USA; [Chittiboina, Prashant] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Belhorn, Thomas H.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Weimer, Eric T.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Hernandez, Michelle L.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA","Drummond, RA (reprint author), NIAID, Fungal Pathogenesis Unit, LCID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",lionakism@mail.nih.gov,"Drummond, Rebecca/I-3155-2019","Drummond, Rebecca/0000-0001-5424-7074; Datta, Sandip/0000-0003-0243-7815","Division of Intramural Research (DIR), NIAID, NIH; NIH [AI093808, AI105617]; Burroughs Wellcome Fund; National Cancer Institute, NIH [HHSN261200800001E]","This work was supported by the Division of Intramural Research (DIR), NIAID, NIH. TMH was supported by NIH grants AI093808 and AI105617, and by the Burroughs Wellcome Fund. LMM, DLF and DBK were funded by the National Cancer Institute, NIH, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,43,54,54,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005293,10.1371/journal.ppat.1005293,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800021,26679537.0,"DOAJ Gold, Green Published",,,16/08/2019,54,300,38,8032,1387,1003,384,6645,5574,15,1056,38,14,0,2,57,57,2,,53,34,53,0,34,62,59,62,28,0,0,0,0,0,0,2,286,15,8131,80,0,135,231,0,6697,1404,80,0,135,231,0,30,,3,0,0,0,15,0,3,1,1,0,0,57,0,0,36.45,5.790915645277577,1.2087283671933784,0.20872836719337848,1.270428893905192,1.0510458167330676,6.086517664023072
255,J,"Filkins, LM; O'Toole, GA",,,,"Filkins, Laura M.; O'Toole, George A.",,,"Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat",PLOS PATHOGENS,,,English,Article,,,,,,,PULMONARY EXACERBATION; PSEUDOMONAS-AERUGINOSA; BACTERIAL DIVERSITY; RESPIRATORY VIRUSES; MICROBIOME; RESPONSES; SAMPLES; SPUTUM,,"[Filkins, Laura M.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA","Filkins, LM (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA.",georgeo@dartmouth.edu,,,NIH [R01 2 R37 AI83256-06]; Renal Function and Disease Training Grant fellowship [T32 DK007301],"This work was supported by NIH grant R01 2 R37 AI83256-06 to GAO and a Renal Function and Disease Training Grant fellowship (T32 DK007301) to LMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,30,33,33,1,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005258,10.1371/journal.ppat.1005258,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800007,26719892.0,"DOAJ Gold, Green Published",,,16/08/2019,30,34,99,13770,1726,1362,364,12044,10200,39,1805,98,31,0,0,35,35,1,,138,70,137,1,70,33,33,28,26,0,0,0,0,0,0,0,3,14,14274,6,3,16,704,19,11970,1726,6,3,16,704,19,578,,0,0,0,0,28,0,0,1,0,0,0,135,1,0,16.3,7.977983777520278,1.1433078711391564,0.14330787113915644,1.2441049485220856,1.088162672476398,8.681344148319814
256,J,"Gonzalez-Juarbe, N; Gilley, RP; Hinojosa, CA; Bradley, KM; Kamei, A; Gao, G; Dube, PH; Bergman, MA; Orihuela, CJ",,,,"Gonzalez-Juarbe, Norberto; Gilley, Ryan Paul; Hinojosa, Cecilia Anahi; Bradley, Kelley Margaret; Kamei, Akinobu; Gao, Geli; Dube, Peter Herman; Bergman, Molly Ann; Orihuela, Carlos Javier",,,Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia,PLOS PATHOGENS,,,English,Article,,,,,,,LUNG EPITHELIAL-CELLS; DEATH; ACTIVATION; HEMOLYSIN; INFLAMMATION; PNEUMOLYSIN; INFECTIONS; MECHANISMS; APOPTOSIS; NECROSIS,"Necroptosis is a highly pro-inflammatory mode of cell death regulated by RIP (or RIPK) 1 and RIP3 kinases and mediated by the effector MLKL. We report that diverse bacterial pathogens that produce a pore-forming toxin (PFT) induce necroptosis of macrophages and this can be blocked for protection against Serratia marcescens hemorrhagic pneumonia. Following challenge with S. marcescens, Staphylococcus aureus, Streptococcus pneumoniae, Listeria monocytogenes, uropathogenic Escherichia coli (UPEC), and purified recombinant pneumolysin, macrophages pretreated with inhibitors of RIP1, RIP3, and MLKL were protected against death. Alveolar macrophages in MLKL KO mice were also protected during S. marcescens pneumonia. Inhibition of caspases had no impact on macrophage death and caspase-1 and -3/7 were determined to be inactive following challenge despite the detection of IL-1 beta in supernatants. Bone marrow-derived macrophages from RIP3 KO, but not caspase-1/11 KO or caspase-3 KO mice, were resistant to PFT-induced death. We explored the mechanisms for PFT-induced necroptosis and determined that loss of ion homeostasis at the plasma membrane, mitochondrial damage, ATP depletion, and the generation of reactive oxygen species were together responsible. Treatment of mice with necrostatin-5, an inhibitor of RIP1; GW806742X, an inhibitor of MLKL; and necrostatin-5 along with co-enzyme Q(10) (N5/C-10), which enhances ATP production; reduced the severity of S. marcescens pneumonia in a mouse intratracheal challenge model. N5/C10 protected alveolar macrophages, reduced bacterial burden, and lessened hemorrhage in the lungs. We conclude that necroptosis is the major cell death pathway evoked by PFTs in macrophages and the necroptosis pathway can be targeted for disease intervention.","[Gonzalez-Juarbe, Norberto; Hinojosa, Cecilia Anahi; Bradley, Kelley Margaret; Orihuela, Carlos Javier] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Gonzalez-Juarbe, Norberto; Gilley, Ryan Paul; Hinojosa, Cecilia Anahi; Dube, Peter Herman; Bergman, Molly Ann; Orihuela, Carlos Javier] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Kamei, Akinobu; Gao, Geli] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA","Gonzalez-Juarbe, N (reprint author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.",corihuel@uab.edu,,,"National Institutes for Health Clinical and Translational Science Award [TL1 TR001119]; Initiative for Maximizing Student Development [R25GM095480]; National Institutes for Health [AI070412, CA17286, AI113724, AI114800]","NGJ was supported by National Institutes for Health Clinical and Translational Science Award grant TL1 TR001119 and the Initiative for Maximizing Student Development grant R25GM095480. PHD was supported by National Institutes for Health grants AI070412, CA17286 and AI113724. CJO was supported by National Institutes for Health grant AI114800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,44,67,69,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005337,10.1371/journal.ppat.1005337,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800047,26659062.0,"DOAJ Gold, Green Published",,,16/08/2019,67,78,62,9484,1376,1004,372,8108,6474,27,1607,62,26,0,1,65,65,0,,153,1,79,0,1,68,68,68,47,0,0,0,0,0,0,0,52,13,9672,64,16,180,287,2,8194,1394,64,16,180,287,2,84,,0,0,0,0,24,0,1,1,1,0,0,79,0,0,14.65,6.892441860465116,1.1697089294523928,0.1697089294523927,1.2361864824864333,1.0568325601012232,7.284156976744186
257,J,"Gray, MJ; Lewis, JP; Nanjappa, P; Klocke, B; Pasmans, F; Martel, A; Stephen, C; Olea, GP; Smith, SA; Sacerdote-Velat, A; Christman, MR; Williams, JM; Olson, DH",,,,"Gray, Matthew J.; Lewis, James P.; Nanjappa, Priya; Klocke, Blake; Pasmans, Frank; Martel, An; Stephen, Craig; Parra Olea, Gabriela; Smith, Scott A.; Sacerdote-Velat, Allison; Christman, Michelle R.; Williams, Jennifer M.; Olson, Deanna H.",,,Batrachochytrium salamandrivorans: The North American Response and a Call for Action,PLOS PATHOGENS,,,English,Article,,,,,,,EMERGING DISEASE; AMPHIBIANS; CHYTRIDIOMYCOSIS; SALAMANDERS; FORESTS,,"[Gray, Matthew J.] Univ Tennessee, Ctr Wildlife Hlth, Knoxville, TN USA; [Lewis, James P.; Klocke, Blake] Amphibian Survival Alliance, Austin, TX USA; [Nanjappa, Priya] Assoc Fish & Wildlife Agencies, Washington, DC USA; [Klocke, Blake] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Pasmans, Frank; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Stephen, Craig] Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada; [Parra Olea, Gabriela] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico; [Smith, Scott A.] Maryland Dept Nat Resources, Wye Mills, MD USA; [Sacerdote-Velat, Allison] Lincoln Pk Zoo, Chicago, IL USA; [Christman, Michelle R.] US Fish & Wildlife Serv, New Mexico Ecol Serv Field Off, Albuquerque, NM USA; [Williams, Jennifer M.] Partners Amphibian & Reptile Conservat, Ft Collins, CO USA; [Olson, Deanna H.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA","Gray, MJ (reprint author), Univ Tennessee, Ctr Wildlife Hlth, Knoxville, TN USA.",mgray11@utk.edu,"Pasmans, Frank/D-3667-2014",,,,,26,25,25,0,47,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005251,10.1371/journal.ppat.1005251,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800006,26662103.0,"DOAJ Gold, Green Published",,,16/08/2019,27,109,66,11645,835,723,112,10810,9768,36,1006,66,25,4,0,23,23,10,,79,6,79,0,6,27,27,16,6,0,0,0,0,0,0,3,84,23,11883,39,51,113,308,2,10891,860,39,50,113,308,2,132,,6,2,0,0,31,0,10,1,0,0,0,79,0,0,81.46,13.946107784431138,1.0772432932469935,0.07724329324699353,1.1313598519888992,1.0502361528553028,14.646706586826348
258,J,"Gulati, S; Schoenhofen, IC; Whitfield, DM; Cox, AD; Li, JJ; Michael, FS; Vinogradov, EV; Stupak, J; Zheng, B; Ohnishi, M; Unemo, M; Lewis, LA; Taylor, RE; Landig, CS; Diaz, S; Reed, GW; Varki, A; Rice, PA; Ram, S",,,,"Gulati, Sunita; Schoenhofen, Ian C.; Whitfield, Dennis M.; Cox, Andrew D.; Li, Jianjun; Michael, Frank St.; Vinogradov, Evgeny V.; Stupak, Jacek; Zheng, Bo; Ohnishi, Makoto; Unemo, Magnus; Lewis, Lisa A.; Taylor, Rachel E.; Landig, Corinna S.; Diaz, Sandra; Reed, George W.; Varki, Ajit; Rice, Peter A.; Ram, Sanjay",,,Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics,PLOS PATHOGENS,,,English,Article,,,,,,,"MURINE GENITAL-TRACT; FACTOR-H BINDING; SERUM RESISTANCE; LEGIONAMINIC ACID; ALTERNATIVE PATHWAY; BACTERIAL VAGINOSIS; VIRULENCE FACTOR; IN-VITRO; ALPHA-2,3-SIALYLTRANSFERASE; EPITOPE","Neisseria gonorrhoeae deploys a novel immune evasion strategy wherein the lacto-N-neotetraose (LNnT) structure of lipooligosaccharide (LOS) is capped by the bacterial sialyltransferase, using host cytidine-5'-monophosphate (CMP)-activated forms of the ninecarbon nonulosonate (NulO) sugar N-acetyl-neuraminic acid (Neu5Ac), a sialic acid (Sia) abundant in humans. This allows evasion of complement-mediated killing by recruiting factor H (FH), an inhibitor of the alternative complement pathway, and by limiting classical pathway activation (""serum-resistance""). We utilized CMP salts of six additional natural or synthetic NulOs, Neu5Gc, Neu5Gc8Me, Neu5Ac9Ac, Neu5Ac9Az, legionaminic acid (Leg5Ac7Ac) and pseudaminic acid (Pse5Ac7Ac), to define structural requirements of Sia-mediated serum-resistance. While all NulOs except Pse5Ac7Ac were incorporated into the LNnT-LOS, only Neu5Gc incorporation yielded high-level serum-resistance and FH binding that was comparable to Neu5Ac, whereas Neu5Ac9Az and Leg5Ac7Ac incorporation left bacteria fully serum-sensitive and did not enhance FH binding. Neu5Ac9Ac and Neu5Gc8Me rendered bacteria resistant only to low serum concentrations. While serum-resistance mediated by Neu5Ac was associated with classical pathway inhibition (decreased IgG binding and C4 deposition), Leg5Ac7Ac and Neu5Ac9Az incorporation did not inhibit the classical pathway. Remarkably, CMP-Neu5Ac9Az and CMP-Leg5Ac7Ac each prevented serum-resistance despite a 100-fold molar excess of CMP-Neu5Ac in growth media. The concomitant presence of Leg5Ac7Ac and Neu5Ac on LOS resulted in uninhibited classical pathway activation. Surprisingly, despite near-maximal FH binding in this instance, the alternative pathway was not regulated and factor Bb remained associated with bacteria. Intravaginal administration of CMP-Leg5Ac7Ac to BALB/c mice infected with gonorrhea (including a multidrug-resistant isolate) reduced clearance times and infection burden. Bacteria recovered from CMP-Leg5Ac7Ac-treated mice were sensitive to human complement ex vivo, simulating in vitro findings. These data reveal critical roles for the Sia exocyclic side-chain in gonococcal serum-resistance. Such CMP-NulO analogs may provide a novel therapeutic strategy against the global threat of multidrug-resistant gonorrhea.","[Gulati, Sunita; Zheng, Bo; Lewis, Lisa A.; Rice, Peter A.; Ram, Sanjay] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Schoenhofen, Ian C.; Whitfield, Dennis M.; Cox, Andrew D.; Michael, Frank St.; Vinogradov, Evgeny V.; Stupak, Jacek] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON, Canada; [Ohnishi, Makoto] Natl Inst Infect Dis, Tokyo, Japan; [Unemo, Magnus] Orebro Univ Hosp, WHO Collaborating Ctr Gonorrhoea & Other STIs, Dept Lab Med Microbiol, Orebro, Sweden; [Taylor, Rachel E.; Landig, Corinna S.; Diaz, Sandra; Varki, Ajit] Univ Calif San Diego, Dept Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Taylor, Rachel E.; Landig, Corinna S.; Diaz, Sandra; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Reed, George W.] Univ Massachusetts, Sch Med, Prevent & Behav Med, Worcester, MA 01605 USA","Gulati, S (reprint author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.",ian.schoenhofen@nrc-cnrc.gc.ca; sanjay.ram@umassmed.edu,,,"Public Health Service National Institute of Allergy and Infectious Diseases (NIAID) [AI119327, AI111728, AI032725, AI118161, AI114790, AI114710]; National Institute of General Medical Sciences [R01GM32373]; National Heart, Lung, and Blood Institute [P01HL107150]","This work was supported by Public Health Service grants AI119327 (SG and SR) AI111728 (SR), AI032725 (PAR), AI118161 (SR) and AI114790 (PAR and SR) and AI114710 (PAR and SG) from the National Institute of Allergy and Infectious Diseases (NIAID), R01GM32373 (AV) from the National Institute of General Medical Sciences and P01HL107150 (AV) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,17,17,0,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005290,10.1371/journal.ppat.1005290,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800020,26630657.0,"DOAJ Gold, Green Published",,,16/08/2019,15,11,21,3998,718,551,167,3280,2481,14,785,21,10,0,0,16,16,0,,37,3,37,0,3,17,17,14,11,0,0,0,0,0,0,0,1,8,4089,87,0,97,381,5,3304,729,49,0,97,379,5,56,,0,0,0,0,13,0,1,1,0,0,0,36,0,0,6.45,5.56824512534819,1.2189024390243903,0.21890243902439024,1.389329268292683,1.1398199099549775,6.346796657381615
259,J,"Knowlson, S; Burlison, J; Giles, E; Fox, H; Macadam, AJ; Minor, PD",,,,"Knowlson, Sarah; Burlison, John; Giles, Elaine; Fox, Helen; Macadam, Andrew J.; Minor, Philip D.",,,New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication,PLOS PATHOGENS,,,English,Article,,,,,,,ATTENUATION; RNA,"Poliomyelitis has nearly been eradicated through the efforts of the World Health Organization's Global Eradication Initiative raising questions on containment of the virus after it has been eliminated in the wild. Most manufacture of inactivated polio vaccines currently requires the growth of large amounts of highly virulent poliovirus, and release from a production facility after eradication could be disastrous; WHO have therefore recommended the use of the attenuated Sabin strains for production as a safer option although it is recognised that they can revert to a transmissible paralytic form. We have exploited the understanding of the molecular virology of the Sabin vaccine strains to design viruses that are extremely genetically stable and hyperattenuated. The viruses are based on the type 3 Sabin vaccine strain and have been genetically modified in domain V of the 5' non-coding region by changing base pairs to produce a cassette into which capsid regions of other serotypes have been introduced. The viruses give satisfactory yields of antigenically and immunogenically correct viruses in culture, are without measurable neurovirulence and fail to infect non-human primates under conditions where the Sabin strains will do so.","[Knowlson, Sarah; Burlison, John; Giles, Elaine; Fox, Helen; Macadam, Andrew J.; Minor, Philip D.] Natl Inst Biol Stand & Controls, Div Virol, Potters Bar, Herts, England","Knowlson, S (reprint author), Natl Inst Biol Stand & Controls, Div Virol, Potters Bar, Herts, England.",Philip.Minor@nibsc.org,,,NIBSC (National Institute for Biological Standards and Control) through UK Department of Health,"This work was supported by NIBSC (National Institute for Biological Standards and Control) through core funding received from the UK Department of Health to fund biological standards and control. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.",,19,10,11,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005316,10.1371/journal.ppat.1005316,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800035,26720150.0,"DOAJ Gold, Green Published",,,16/08/2019,12,110,16,8561,1128,909,219,7433,6382,59,992,16,60,0,0,13,13,14,,19,36,19,0,36,14,14,11,5,0,0,0,0,0,0,5,49,50,8891,45,27,155,487,9,7465,1167,45,22,155,487,9,259,,23,3,1,0,59,0,2,1,0,0,0,19,0,0,230.996,7.589539007092198,1.1517556841113952,0.15175568411139512,1.2677250100901385,1.1006891718257212,8.35372340425532
260,J,"Lin, XC; Tsai, MH; Shumilov, A; Poirey, R; Bannert, H; Middeldorp, JM; Feederle, R; Delecluse, HJ",,,,"Lin, Xiaochen; Tsai, Ming-Han; Shumilov, Anatoliy; Poirey, Remy; Bannert, Helmut; Middeldorp, Jaap M.; Feederle, Regina; Delecluse, Henri-Jacques",,,The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN GAMMA-HERPESVIRUSES; ENCODED MICRORNAS; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; VIRAL-INFECTION; EBV; LATENCY; APOPTOSIS; LMP1; EXPRESSION,"The Epstein-Barr virus (EBV) is a B lymphotropic virus that infects the majority of the human population. All EBV strains transform B lymphocytes, but some strains, such as M81, also induce spontaneous virus replication. EBV encodes 22 microRNAs (miRNAs) that form a cluster within the BART region of the virus and have been previously been found to stimulate tumor cell growth. Here we describe their functions in B cells infected by M81. We found that the BART miRNAs are downregulated in replicating cells, and that exposure of B cells in vitro or in vivo in humanized mice to a BART miRNA knockout virus resulted in an increased proportion of spontaneously replicating cells, relative to wild type virus. The BART miRNAs subcluster 1, and to a lesser extent subcluster 2, prevented expression of BZLF1, the key protein for initiation of lytic replication. Thus, multiple BART miRNAs cooperate to repress lytic replication. The BART miRNAs also downregulated pro-and anti-apoptotic mediators such as caspase 3 and LMP1, and their deletion did not sensitize B-cells to apoptosis. To the contrary, the majority of humanized mice infected with the BART miRNA knockout mutant developed tumors more rapidly, probably due to enhanced LMP1 expression, although deletion of the BART miRNAs did not modify the virus transforming abilities in vitro. This ability to slow cell growth could be confirmed in non-humanized immunocompromized mice. Injection of resting B cells exposed to a virus that lacks the BART miRNAs resulted in accelerated tumor growth, relative to wild type controls. Therefore, we found that the M81 BART miRNAs do not enhance B-cell tumorigenesis but rather repress it. The repressive effects of the BART miRNAs on potentially pathogenic viral functions in infected B cells are likely to facilitate long-term persistence of the virus in the infected host.","[Lin, Xiaochen; Tsai, Ming-Han; Shumilov, Anatoliy; Poirey, Remy; Bannert, Helmut; Feederle, Regina; Delecluse, Henri-Jacques] German Canc Res Ctr, Div Pathogenesis Virus Associated Tumors, Heidelberg, Germany; [Lin, Xiaochen; Tsai, Ming-Han; Shumilov, Anatoliy; Poirey, Remy; Bannert, Helmut; Feederle, Regina; Delecluse, Henri-Jacques] INSERM, DKFZ, Unit U1074, Heidelberg, Germany; [Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands","Lin, XC (reprint author), German Canc Res Ctr, Div Pathogenesis Virus Associated Tumors, Heidelberg, Germany.",h.delecluse@dkfz.de,"Poirey, Remy/A-4324-2017",", Anatoliy/0000-0002-6332-5844; Delecluse, Henri-Jacques/0000-0002-1744-6274; Tsai, Ming-Han/0000-0001-5563-3057; Middeldorp, Jaap/0000-0002-0765-4125; Poirey, Remy/0000-0001-8171-3317",German Cancer Research Center (DKFZ); Inserm; Chinese Scientific council,"The study was funded by the German Cancer Research Center (DKFZ) and Inserm. XL is supported by a stipend from the Chinese Scientific council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,19,20,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005344,10.1371/journal.ppat.1005344,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800052,26694854.0,"DOAJ Gold, Green Published",,,16/08/2019,19,17,25,5793,1177,866,311,4616,3428,57,1131,25,15,0,1,17,17,0,,29,1,29,0,1,19,19,19,13,0,0,0,0,0,0,0,2,14,5895,94,0,127,114,1,4664,1197,94,0,127,114,1,34,,0,0,0,0,16,0,1,0,1,0,0,28,0,0,9.05,4.921835174171623,1.2549826689774697,0.2549826689774697,1.3221403812824957,1.0535128603486967,5.185216652506372
261,J,"Mitri, C; Bischoff, E; Takashima, E; Williams, M; Eiglmeier, K; Pain, A; Guelbeogo, WM; Gneme, A; Brito-Fravallo, E; Holm, I; Lavazec, C; Sagnon, N; Baxter, RH; Riehle, MM; Vernick, KD",,,,"Mitri, Christian; Bischoff, Emmanuel; Takashima, Eizo; Williams, Marni; Eiglmeier, Karin; Pain, Adrien; Guelbeogo, Wamdaogo M.; Gneme, Awa; Brito-Fravallo, Emma; Holm, Inge; Lavazec, Catherine; Sagnon, N'Fale; Baxter, Richard H.; Riehle, Michelle M.; Vernick, Kenneth D.",,,An Evolution-Based Screen for Genetic Differentiation between Anopheles Sister Taxa Enriches for Detection of Functional Immune Factors,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMODIUM-FALCIPARUM INFECTION; HUMAN MALARIA PARASITE; S MOLECULAR-FORMS; POSITIVE SELECTION; GENOMIC ISLANDS; GAMBIAE MOSQUITOS; SPECIAL EMPHASIS; BURKINA-FASO; COMPLEMENT; SYSTEM,"Nucleotide variation patterns across species are shaped by the processes of natural selection, including exposure to environmental pathogens. We examined patterns of genetic variation in two sister species, Anopheles gambiae and Anopheles coluzzii, both efficient natural vectors of human malaria in West Africa. We used the differentiation signature displayed by a known coordinate selective sweep of immune genes APL1 and TEP1 in A. coluzzii to design a population genetic screen trained on the sweep, classified a panel of 26 potential immune genes for concordance with the signature, and functionally tested their immune phenotypes. The screen results were strongly predictive for genes with protective immune phenotypes: genes meeting the screen criteria were significantly more likely to display a functional phenotype against malaria infection than genes not meeting the criteria (p = 0.0005). Thus, an evolution-based screen can efficiently prioritize candidate genes for labor-intensive downstream functional testing, and safely allow the elimination of genes not meeting the screen criteria. The suite of immune genes with characteristics similar to the APL1-TEP1 selective sweep appears to be more widespread in the A. coluzzii genome than previously recognized. The immune gene differentiation may be a consequence of adaptation of A. coluzzii to new pathogens encountered in its niche expansion during the separation from A. gambiae, although the role, if any of natural selection by Plasmodium is unknown. Application of the screen allowed identification of new functional immune factors, and assignment of new functions to known factors. We describe biochemical binding interactions between immune proteins that underlie functional activity for malaria infection, which highlights the interplay between pathogen specificity and the structure of immune complexes. We also find that most malaria-protective immune factors display phenotypes for either human or rodent malaria, with broad specificity a rarity.","[Mitri, Christian; Bischoff, Emmanuel; Takashima, Eizo; Eiglmeier, Karin; Pain, Adrien; Brito-Fravallo, Emma; Holm, Inge; Lavazec, Catherine; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasites & Insect Vectors, Paris, France; [Mitri, Christian; Bischoff, Emmanuel; Takashima, Eizo; Eiglmeier, Karin; Pain, Adrien; Brito-Fravallo, Emma; Holm, Inge; Lavazec, Catherine; Vernick, Kenneth D.] CNRS, Unit Hosts Vectors & Pathogens URA3012, Paris, France; [Williams, Marni; Baxter, Richard H.] Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT USA; [Guelbeogo, Wamdaogo M.; Gneme, Awa; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Riehle, Michelle M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA","Mitri, C (reprint author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasites & Insect Vectors, Paris, France.",kvernick@pasteur.fr,"Bischoff, Emmanuel/F-1197-2011; Baxter, Richard/H-8082-2019","Bischoff, Emmanuel/0000-0003-4655-4247; Baxter, Richard/0000-0001-5140-1726; Mitri, Christian/0000-0003-3882-2029","National Institutes of Health, NIAID [AI073685]; European Research Council [323173]; European Commission [228421 Infravec]; French Laboratoire d'Excellence ""Integrative Biology of Emerging Infectious Diseases"" [ANR-10-LABX-62-IBEID]","This work received financial support from the National Institutes of Health, NIAID R01 #AI073685; European Research Council, Support for frontier research, Advanced Grant #323173; European Commission, FP7 Infrastructures #228421 Infravec; and French Laboratoire d'Excellence ""Integrative Biology of Emerging Infectious Diseases"" #ANR-10-LABX-62-IBEID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,80,7,7,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005306,10.1371/journal.ppat.1005306,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800028,26633695.0,"DOAJ Gold, Green Published",,,16/08/2019,8,16,22,2942,329,259,70,2613,2275,19,319,22,12,0,0,6,6,0,,27,2,27,0,2,8,8,6,5,0,0,0,0,0,0,0,4,8,2985,50,0,52,259,1,2603,329,50,0,52,259,1,53,,0,0,0,0,15,0,0,1,0,0,0,27,0,0,7.6,8.94224924012158,1.125908916953693,0.12590891695369308,1.2606199770378874,1.1196464989802855,10.012158054711247
262,J,"Moukambi, F; Rabezanahary, H; Rodrigues, V; Racine, G; Robitaille, L; Krust, B; Andreani, G; Soundaramourty, C; Silvestre, R; Laforge, M; Estaquier, J",,,,"Moukambi, Felicien; Rabezanahary, Henintsoa; Rodrigues, Vasco; Racine, Gina; Robitaille, Lynda; Krust, Bernard; Andreani, Guadalupe; Soundaramourty, Calayselvy; Silvestre, Ricardo; Laforge, Mireille; Estaquier, Jerome",,,Early Loss of Splenic Tfh Cells in SIV-Infected Rhesus Macaques,PLOS PATHOGENS,,,English,Article,,,,,,,T-FOLLICULAR-HELPER; IMMUNODEFICIENCY VIRUS-INFECTION; CENTER B-CELL; CXC CHEMOKINE RECEPTOR-5; LYMPH-NODES; TRANSCRIPTION FACTOR; HIV-INFECTION; BCL-6 EXPRESSION; SOOTY MANGABEYS; DENDRITIC CELLS,"Follicular T helper cells (Tfh), a subset of CD4 T lymphocytes, provide crucial help to B cells in the production of antigen-specific antibodies. Although several studies have analyzed the dynamics of Tfh cells in peripheral blood and lymph nodes (LNs) during Aids, none has yet addressed the impact of SIV infection on the dynamics of Tfh cells in the spleen, the primary organ of B cell activation. We show here a significant decrease in splenic Tfh cells in SIV-mac251-infected rhesus macaques (RMs) during the acute phase of infection, which persists thereafter. This profound loss is associated with lack of sustained expression of the Tfh-defining transcription factors, Bcl-6 and c-Maf but with higher expression of the repressors KLF2 and Foxo1. In this context of Tfh abortive differentiation and loss, we found decreased percentages of memory B cell subsets and lower titers of SIV-specific IgG. We further demonstrate a drastic remodeling of the lymphoid architecture of the spleen and LNs, which disrupts the crucial cell-cell interactions necessary to maintain memory B cells and Tfh cells. Finally, our data demonstrated the early infection of Tfh cells. Paradoxically, the frequencies of SIV DNA were higher in splenic Tfh cells of RMs progressing more slowly suggesting sanctuaries for SIV in the spleen. Our findings provide important information regarding the impact of HIV/SIV infection on Tfh cells, and provide new clues for future vaccine strategies.","[Moukambi, Felicien; Rabezanahary, Henintsoa; Racine, Gina; Robitaille, Lynda; Andreani, Guadalupe; Estaquier, Jerome] Univ Laval, Fac Med, CHU Quebec Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Rodrigues, Vasco; Krust, Bernard; Soundaramourty, Calayselvy; Laforge, Mireille; Estaquier, Jerome] Paris Descartes Univ, Fac Med St Peres, CNRS FR3636, Paris, France; [Silvestre, Ricardo] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Silvestre, Ricardo] ICVS 3Bs PT Govt Associate Lab, Braga, Guimaraes, Portugal","Moukambi, F (reprint author), Univ Laval, Fac Med, CHU Quebec Res Ctr, Quebec City, PQ G1K 7P4, Canada.",estaquier@yahoo.fr,"Silvestre, Ricardo/C-7243-2011","Silvestre, Ricardo/0000-0002-9270-2717; Rodrigues, Vasco/0000-0002-6014-321X",CHIR grant (Canada); ANRS grant (France); Canada Research Chair program; FCT (Fundacao para a Ciencia e Tecnologia) [SFRH/BD/64064/2009],"This work was supported by CHIR (Canada) and ANRS grants (France). JE thanks the Canada Research Chair program for financial assistance. VR was supported by a doctoral fellowship from FCT (Fundacao para a Ciencia e Tecnologia); code SFRH/BD/64064/2009. We would like to thank the Nonhuman Primate Reagent Resource for kindly providing CXCR5 antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,97,17,17,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005287,10.1371/journal.ppat.1005287,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800018,26640894.0,"DOAJ Gold, Green Published",,,16/08/2019,15,9,19,4745,817,566,251,3928,3074,24,830,19,8,0,0,16,16,0,,24,4,24,0,4,16,15,16,14,0,0,0,0,0,0,0,2,6,4823,93,0,59,299,1,3957,829,93,0,59,299,1,37,,0,0,0,0,8,0,0,0,0,0,0,24,0,0,3.6,5.807833537331701,1.2079938900203666,0.2079938900203666,1.3276476578411405,1.0990516332982085,6.383108935128519
263,J,"Painter, MM; Morrison, JH; Zoecklein, LJ; Rinkoski, TA; Watzlawik, JO; Papke, LM; Warrington, AE; Bieber, AJ; Matchett, WE; Turkowski, KL; Poeschla, EM; Rodriguez, M",,,,"Painter, Meghan M.; Morrison, James H.; Zoecklein, Laurie J.; Rinkoski, Tommy A.; Watzlawik, Jens O.; Papke, Louisa M.; Warrington, Arthur E.; Bieber, Allan J.; Matchett, William E.; Turkowski, Kari L.; Poeschla, Eric M.; Rodriguez, Moses",,,Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT RNA-POLYMERASE; POLIOVIRUS REPLICATION COMPLEX; RIG-I; TRANSGENIC PLANTS; VIRUS-REPLICATION; RESISTANCE; INFECTION; REGION; MDA5; GENE,"For many emerging and re-emerging infectious diseases, definitive solutions via sterilizing adaptive immunity may require years or decades to develop, if they are even possible. The innate immune system offers alternative mechanisms that do not require antigen-specific recognition or a priori knowledge of the causative agent. However, it is unclear whether effective stable innate immune system activation can be achieved without triggering harmful autoimmunity or other chronic inflammatory sequelae. Here, we show that transgenic expression of a picornavirus RNA-dependent RNA polymerase (RdRP), in the absence of other viral proteins, can profoundly reconfigure mammalian innate antiviral immunity by exposing the normally membrane-sequestered RdRP activity to sustained innate immune detection. RdRP-transgenic mice have life-long, quantitatively dramatic upregulation of 80 interferon-stimulated genes (ISGs) and show profound resistance to normally lethal viral challenge. Multiple crosses with defined knockout mice (Rag1, Mda5, Mavs, Ifnar1, Ifngr1, and Tlr3) established that the mechanism operates via MDA5 and MAVS and is fully independent of the adaptive immune system. Human cell models recapitulated the key features with striking fidelity, with the RdRP inducing an analogous ISG network and a strict block to HIV-1 infection. This RdRP-mediated antiviral mechanism does not depend on secondary structure within the RdRP mRNA but operates at the protein level and requires RdRP catalysis. Importantly, despite lifelong massive ISG elevations, RdRP mice are entirely healthy, with normal longevity. Our data reveal that a powerfully augmented MDA5-mediated activation state can be a well-tolerated mammalian innate immune system configuration. These results provide a foundation for augmenting innate immunity to achieve broad-spectrum antiviral protection.","[Painter, Meghan M.; Matchett, William E.; Turkowski, Kari L.] Mayo Clin, Mayo Grad Sch Med, Rochester, MN 55902 USA; [Morrison, James H.; Rinkoski, Tommy A.; Poeschla, Eric M.] Univ Colorado, Sch Med, Dept Mol Med, Aurora, CO USA; [Morrison, James H.; Rinkoski, Tommy A.; Poeschla, Eric M.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Morrison, James H.; Poeschla, Eric M.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [Zoecklein, Laurie J.; Watzlawik, Jens O.; Papke, Louisa M.; Warrington, Arthur E.; Rodriguez, Moses] Mayo Clin, Dept Neurol, Rochester, MN USA; [Bieber, Allan J.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [Poeschla, Eric M.; Rodriguez, Moses] Mayo Clin, Dept Immunol, Rochester, MN USA","Painter, MM (reprint author), Mayo Clin, Mayo Grad Sch Med, Rochester, MN 55902 USA.",eric.poeschla@ucdenver.edu,,"Watzlawik, Jens/0000-0003-0610-0267","John H. Tietze Foundation Trust; Applebaum Foundation; Hilton Foundation; Peterson Foundation; NIH [NS032129, AI77344, AI100797]; Mayo Foundation for Medical Education and Research","Supported by grants from the John H. Tietze Foundation Trust (EMP), the the Applebaum, Hilton and Peterson Foundations (MR) and by NIH R01 grants NS032129 (MR), AI77344 (EMP) and AI100797 (EMP). Predoctoral fellowship funding was provided by the Mayo Foundation for Medical Education and Research to Mayo Graduate School students (MMP, WEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,16,16,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005311,10.1371/journal.ppat.1005311,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800031,26633895.0,"DOAJ Gold, Green Published",,,16/08/2019,15,106,24,6381,831,589,242,5550,3863,14,1673,24,14,0,0,14,14,0,,33,1,33,0,1,15,15,10,9,0,0,0,0,0,0,0,92,17,6490,131,3,82,178,1,5588,842,131,3,82,178,1,60,,0,1,0,0,18,0,0,1,0,0,0,33,0,0,17.858,7.67870036101083,1.1497297297297298,0.14972972972972973,1.225045045045045,1.0655069738285534,8.181708784596871
264,J,"Schwede, A; Macleod, OJS; MacGregor, P; Carrington, M",,,,"Schwede, Angela; Macleod, Olivia J. S.; MacGregor, Paula; Carrington, Mark",,,How Does the VSG Coat of Bloodstream Form African Trypanosomes Interact with External Proteins?,PLOS PATHOGENS,,,English,Review,,,,,,,VARIANT SURFACE GLYCOPROTEIN; HAPTOGLOBIN-HEMOGLOBIN RECEPTOR; TRANSFERRIN-BINDING PROTEIN; CONCANAVALIN-A; CELL-SURFACE; ANTIGENIC DETERMINANTS; BRUCEI-RHODESIENSE; EXPRESSION SITE; N-GLYCOSYLATION; TERMINAL DOMAIN,"Variations on the statement ""the variant surface glycoprotein (VSG) coat that covers the external face of the mammalian bloodstream form of Trypanosoma brucei acts a physical barrier"" appear regularly in research articles and reviews. The concept of the impenetrable VSG coat is an attractive one, as it provides a clear model for understanding how a trypanosome population persists; each successive VSG protects the plasma membrane and is immunologically distinct from previous VSGs. What is the evidence that the VSG coat is an impenetrable barrier, and how do antibodies and other extracellular proteins interact with it? In this review, the nature of the extracellular surface of the bloodstream form trypanosome is described, and past experiments that investigated binding of antibodies and lectins to try-panosomes are analysed using knowledge of VSG sequence and structure that was unavailable when the experiments were performed. Epitopes for some VSG monoclonal antibodies are mapped as far as possible from previous experimental data, onto models of VSG structures. The binding of lectins to some, but not to other, VSGs is revisited with more recent knowledge of the location and nature of N-linked oligosaccharides. The conclusions are: (i) Much of the variation observed in earlier experiments can be explained by the identity of the individual VSGs. (ii) Much of an individual VSG is accessible to antibodies, and the barrier that prevents access to the cell surface is probably at the base of the VSG N-terminal domain, approximately 5 nm from the plasma membrane. This second conclusion highlights a gap in our understanding of how the VSG coat works, as several plasma membrane proteins with large extracellular domains are very unlikely to be hidden from host antibodies by VSG.","[Schwede, Angela; Macleod, Olivia J. S.; MacGregor, Paula; Carrington, Mark] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England","Schwede, A (reprint author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.",mc115@cam.ac.uk,"Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018","Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; MacGregor, Paula/0000-0003-0919-3745",Wellcome Trust [093008/Z10/Z]; Medical Research Council [MR/L008246/1],"The authors' lab is funded by the Wellcome Trust (093008/Z10/Z) and the Medical Research Council (MR/L008246/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,27,27,0,30,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005259,10.1371/journal.ppat.1005259,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800008,26719972.0,"DOAJ Gold, Green Published",,,16/08/2019,27,28,71,6368,1087,876,211,5281,4398,20,863,71,3,0,0,26,26,0,,103,0,103,0,0,28,28,28,20,0,0,0,0,0,0,0,24,4,6395,13,0,132,99,1,5272,1087,13,0,132,99,1,36,,0,0,0,0,5,0,1,1,0,0,0,104,0,0,2.5,5.858325666973321,1.205832228744556,0.20583222874455595,1.2321530013255064,1.0218278894472361,5.9862005519779204
265,J,"Wilde, AD; Snyder, DJ; Putnam, NE; Valentino, MD; Hammer, ND; Lonergan, ZR; Hinger, SA; Aysanoa, EE; Blanchard, C; Dunman, PM; Wasserman, GA; Chen, J; Shopsin, B; Gilmore, MS; Skaar, EP; Cassat, JE",,,,"Wilde, Aimee D.; Snyder, Daniel J.; Putnam, Nicole E.; Valentino, Michael D.; Hammer, Neal D.; Lonergan, Zachery R.; Hinger, Scott A.; Aysanoa, Esar E.; Blanchard, Catlyn; Dunman, Paul M.; Wasserman, Gregory A.; Chen, John; Shopsin, Bo; Gilmore, Michael S.; Skaar, Eric P.; Cassat, James E.",,,Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection,PLOS PATHOGENS,,,English,Article,,,,,,,2-COMPONENT SYSTEM; GENE-EXPRESSION; UNITED-STATES; BONE-MARROW; VIRULENCE; OXYGEN; AGR; REGULATOR; IDENTIFICATION; OSTEOMYELITIS,"Staphylococcus aureus is capable of infecting nearly every organ in the human body. In order to infiltrate and thrive in such diverse host tissues, staphylococci must possess remarkable flexibility in both metabolic and virulence programs. To investigate the genetic requirements for bacterial survival during invasive infection, we performed a transposon sequencing (TnSeq) analysis of S. aureus during experimental osteomyelitis. TnSeq identified 65 genes essential for staphylococcal survival in infected bone and an additional 148 mutants with compromised fitness in vivo. Among the loci essential for in vivo survival was SrrAB, a staphylococcal two-component system previously reported to coordinate hypoxic and nitrosative stress responses in vitro. Healthy bone is intrinsically hypoxic, and intravital oxygen monitoring revealed further decreases in skeletal oxygen concentrations upon S. aureus infection. The fitness of an srrAB mutant during osteomyelitis was significantly increased by depletion of neutrophils, suggesting that neutrophils impose hypoxic and/or nitrosative stresses on invading bacteria. To more globally evaluate staphylococcal responses to changing oxygenation, we examined quorum sensing and virulence factor production in staphylococci grown under aerobic or hypoxic conditions. Hypoxic growth resulted in a profound increase in quorum sensing-dependent toxin production, and a concomitant increase in cytotoxicity toward mammalian cells. Moreover, aerobic growth limited quorum sensing and cytotoxicity in an SrrAB-dependent manner, suggesting a mechanism by which S. aureus modulates quorum sensing and toxin production in response to environmental oxygenation. Collectively, our results demonstrate that bacterial hypoxic responses are key determinants of the staphylococcal-host interaction.","[Wilde, Aimee D.; Snyder, Daniel J.; Putnam, Nicole E.; Hammer, Neal D.; Lonergan, Zachery R.; Aysanoa, Esar E.; Skaar, Eric P.; Cassat, James E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37235 USA; [Valentino, Michael D.; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Valentino, Michael D.; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA USA; [Hinger, Scott A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Blanchard, Catlyn; Dunman, Paul M.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Wasserman, Gregory A.; Shopsin, Bo] NYU, Dept Med, Sch Med, New York, NY 10016 USA; [Wasserman, Gregory A.; Shopsin, Bo] NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA; [Chen, John] NYU, Dept Microbiol, Skirball Inst Program Mol Pathogenesis, Med Ctr, New York, NY 10016 USA; [Chen, John] NYU, Dept Med, Med Ctr, New York, NY 10016 USA; [Skaar, Eric P.] Vet Affairs Tennessee Valley Healthcare Serv, Nashville, TN USA; [Cassat, James E.] Vanderbilt Univ, Dept Pediat, Div Pediat Infect Dis, Med Ctr, Nashville, TN 37235 USA","Wilde, AD (reprint author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.",jim.cassat@vanderbilt.edu,,"Wasserman, Gregory/0000-0002-0136-272X; Chen, John/0000-0002-2318-1823; Hammer, Neal/0000-0001-6148-7850; Lonergan, Zachery/0000-0001-7694-2166; Potter, Aimee/0000-0003-1473-1149","National Institute of Allergy and Infectious Diseases [1K08AI113107, R21AI107248, P01AI08321, R01AI069233, AI073843, R01-AI103268, T32AI112541]; Burroughs Wellcome Fund Career Award for Medical Scientists; National Institute of Environmental Health Sciences [5T32ES007028-41]","JEC is supported by National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) grant 1K08AI113107 and by a Burroughs Wellcome Fund (www.bwfund.org) Career Award for Medical Scientists. MSG is supported by National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) grants R21AI107248 and P01AI08321. EPS is supported by National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) grants R01AI069233 and AI073843. BS is supported by National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) grant R01-AI103268. ADW is supported by National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) training grant T32AI112541. ZRL is supported by National Institute of Environmental Health Sciences (http://www.niehs.nih.gov) training grant 5T32ES007028-41. NDH is a Cystic Fibrosis Foundation (https://www.cff.org/) Ann Weinberg Memorial Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,38,38,1,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005341,10.1371/journal.ppat.1005341,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800049,26684646.0,"DOAJ Gold, Green Published",,,16/08/2019,36,100,52,8204,1238,943,295,6966,5687,24,1255,52,26,0,0,35,35,0,,85,3,85,0,3,38,38,26,25,0,0,0,0,0,0,0,74,21,8203,137,0,214,206,1,6923,1238,137,0,214,206,1,42,,0,0,0,0,36,0,1,1,0,0,0,85,0,0,20.2,6.626817447495961,1.1777203560149296,0.17772035601492966,1.2268159632500717,1.0416869819600194,6.903069466882068
266,J,"Xu, K; Chan, YP; Bradel-Tretheway, B; Akyol-Ataman, Z; Zhu, YQ; Dutta, S; Yan, LY; Feng, YR; Wang, LF; Skiniotis, G; Lee, B; Zhou, ZH; Broder, CC; Aguilar, HC; Nikolov, DB",,,,"Xu, Kai; Chan, Yee-Peng; Bradel-Tretheway, Birgit; Akyol-Ataman, Zeynep; Zhu, Yongqun; Dutta, Somnath; Yan, Lianying; Feng, YanRu; Wang, Lin-Fa; Skiniotis, Georgios; Lee, Benhur; Zhou, Z. Hong; Broder, Christopher C.; Aguilar, Hector C.; Nikolov, Dimitar B.",,,Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly,PLOS PATHOGENS,,,English,Article,,,,,,,SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; HENDRA-VIRUS; NEUTRALIZING ANTIBODY; PARAMYXOVIRUS-F; VIRAL ENTRY; CATHEPSIN-L; N-GLYCANS; PROTEIN; PREFUSION,"Nipah virus (NiV) is a paramyxovirus that infects host cells through the coordinated efforts of two envelope glycoproteins. The G glycoprotein attaches to cell receptors, triggering the fusion (F) glycoprotein to execute membrane fusion. Here we report the first crystal structure of the pre-fusion form of the NiV-F glycoprotein ectodomain. Interestingly this structure also revealed a hexamer-of-trimers encircling a central axis. Electron tomography of Nipah virus-like particles supported the hexameric pre-fusion model, and biochemical analyses supported the hexamer-of-trimers F assembly in solution. Importantly, structure-assisted site-directed mutagenesis of the interfaces between F trimers highlighted the functional relevance of the hexameric assembly. Shown here, in both cell-cell fusion and virus-cell fusion systems, our results suggested that this hexamer-of-trimers assembly was important during fusion pore formation. We propose that this assembly would stabilize the pre-fusion F conformation prior to cell attachment and facilitate the coordinated transition to a post-fusion conformation of all six F trimers upon triggering of a single trimer. Together, our data reveal a novel and functional pre-fusion architecture of a paramyxoviral fusion glycoprotein.","[Xu, Kai; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA; [Chan, Yee-Peng; Yan, Lianying; Feng, YanRu; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Bradel-Tretheway, Birgit; Aguilar, Hector C.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Akyol-Ataman, Zeynep; Zhou, Z. Hong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Zhu, Yongqun] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Yongqun] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Dutta, Somnath; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Wang, Lin-Fa] CSIRO, Australian Anim Hlth Lab, Anim Food & Hlth Sci, Geelong, Vic, Australia; [Wang, Lin-Fa] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lee, Benhur] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA","Xu, K (reprint author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.",christopher.broder@usuhs.edu; haguilar@vetmed.wsu.edu; nikolovd@mskcc.org,"Lee, Benhur/A-8554-2016","Lee, Benhur/0000-0003-0760-1709","Department of Health and Human Services, National Institutes of Health [AI054715, AI077995, NS38586]; NIH [AI094329]; China's Fundamental Research Funds for the Central Universities; NNSFC [31370722, 81322024]; Natural Science Foundation of Zhejiang province [LR13C05001]","The studies were supported in part by the Department of Health and Human Services, National Institutes of Health, grants AI054715 and AI077995 to CCB and NS38586 to DBN. BBT and HCA were supported by NIH grant AI094329 to HCA. YZ was supported by China's Fundamental Research Funds for the Central Universities and research grants from the NNSFC (No. 31370722 and 81322024), the Natural Science Foundation of Zhejiang province (No. LR13C05001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,18,20,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005322,10.1371/journal.ppat.1005322,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800040,26646856.0,"DOAJ Gold, Green Published",,,16/08/2019,20,20,33,6015,800,587,213,5215,4243,19,953,33,16,0,0,19,19,0,,162,6,55,0,6,23,23,22,17,0,0,0,0,0,0,0,4,9,6068,67,0,72,226,2,5199,800,67,0,72,226,2,69,,0,0,0,0,17,0,2,1,0,0,0,56,0,0,8.85,7.51875,1.1534036433365293,0.15340364333652926,1.2197507190795782,1.057522859517872,7.95125
267,J,"Yu, CY; Liang, JJ; Li, JK; Lee, YL; Chang, BL; Su, CI; Huang, WJ; Lai, MMC; Lin, YL",,,,"Yu, Chia-Yi; Liang, Jian-Jong; Li, Jin-Kun; Lee, Yi-Ling; Chang, Bi-Lan; Su, Chan-I; Huang, Wei-Jheng; Lai, Michael M. C.; Lin, Yi-Ling",,,Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIVIRAL SIGNALING PROTEIN; HEPATITIS-C-VIRUS; ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; INNATE IMMUNITY; RIG-I; ADAPTER PROTEIN; AMINO-ACIDS; APOPTOSIS; PATHWAY,"Mitochondria are highly dynamic subcellular organelles participating in many signaling pathways such as antiviral innate immunity and cell death cascades. Here we found that mitochondrial fusion was impaired in dengue virus (DENV) infected cells. Two mitofusins (MFN1 and MFN2), which mediate mitochondrial fusion and participate in the proper function of mitochondria, were cleaved by DENV protease NS2B3. By knockdown and overexpression approaches, these two MFNs showed diverse functions in DENV infection. MFN1 was required for efficient antiviral retinoic acid-inducible gene I-like receptor signaling to suppress DENV replication, while MFN2 participated in maintaining mitochondrial membrane potential (MMP) to attenuate DENV-induced cell death. Cleaving MFN1 and MFN2 by DENV protease suppressed mitochondrial fusion and deteriorated DENV-induced cytopathic effects through subverting interferon production and facilitating MMP disruption. Thus, MFNs participate in host defense against DENV infection by promoting the antiviral response and cell survival, and DENV regulates mitochondrial morphology by cleaving MFNs to manipulate the outcome of infection.","[Yu, Chia-Yi] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan; [Yu, Chia-Yi; Lai, Michael M. C.] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Liang, Jian-Jong; Li, Jin-Kun; Lee, Yi-Ling; Chang, Bi-Lan; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Su, Chan-I; Huang, Wei-Jheng; Lai, Michael M. C.] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Lai, Michael M. C.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lai, Michael M. C.] China Med Univ, Taichung, Taiwan; [Lin, Yi-Ling] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan","Yu, CY (reprint author), Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan.",epitope@mail.ncku.edu.tw; yll@ibms.sinica.edu.tw,"Lin, Yi-Ling/N-7128-2018","Lin, Yi-Ling/0000-0002-1838-6410","Ministry of Science and Technology, Taiwan [NSC 101-2321-B-039-009-MY3, NSC 104-2321-B-001-018, MOST 103-2321-B-001-070]; Academia Sinica, Taiwan","This work was supported by grants from Ministry of Science and Technology, Taiwan (www.most.gov.tw) to CYY and MMCL (NSC 101-2321-B-039-009-MY3) and to YLLi (NSC 104-2321-B-001-018 and MOST 103-2321-B-001-070) and from Academia Sinica, Taiwan (www.sinica.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,30,30,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,DEC,2015,11,12,,,,,,,e1005350,10.1371/journal.ppat.1005350,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IZ,WOS:000368332800057,26717518.0,"DOAJ Gold, Green Published",,,16/08/2019,29,52,52,10726,1282,888,394,9444,7702,33,1709,52,47,2,0,30,30,0,,63,5,63,0,5,32,30,32,16,0,0,0,0,0,0,0,5,22,10832,45,0,198,320,0,9503,1300,45,0,198,320,0,29,,0,0,0,0,40,0,4,0,0,0,0,65,0,0,22.05,8.366614664586583,1.135747564591275,0.13574756459127488,1.1856204997882254,1.043911989558083,8.734009360374415
268,J,"Anderson, CJ; Clark, DE; Adli, M; Kendall, MM",,,,"Anderson, Christopher J.; Clark, David E.; Adli, Mazhar; Kendall, Melissa M.",,,Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection,PLOS PATHOGENS,,,English,Article,,,,,,,PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; CHOLINE TRANSPORT; CHROMOSOMAL GENES; PLASMA-MEMBRANE; VIRULENCE GENES; TYPHIMURIUM; EXPRESSION; REGULATOR; TRANSCRIPTION,"Chemical and nutrient signaling are fundamental for all cellular processes, including interactions between the mammalian host and the microbiota, which have a significant impact on health and disease. Ethanolamine is an essential component of cell membranes and has profound signaling activity within mammalian cells by modulating inflammatory responses and intestinal physiology. Here, we describe a virulence-regulating pathway in which the foodborne pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) exploits ethanolamine signaling to recognize and adapt to distinct niches within the host. The bacterial transcription factor EutR promotes ethanolamine metabolism in the intestine, which enables S. Typhimurium to establish infection. Subsequently, EutR directly activates expression of the Salmonella pathogenicity island 2 in the intramacrophage environment, and thus augments intramacrophage survival. Moreover, EutR is critical for robust dissemination during mammalian infection. Our findings reveal that S. Typhimurium co-opts ethanolamine as a signal to coordinate metabolism and then virulence. Because the ability to sense ethanolamine is a conserved trait among pathogenic and commensal bacteria, our work indicates that ethanolamine signaling may be a key step in the localized adaptation of bacteria within their mammalian hosts.","[Anderson, Christopher J.; Clark, David E.; Kendall, Melissa M.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Adli, Mazhar] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA","Anderson, CJ (reprint author), Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.",melissakendall@virginia.edu,,"Anderson, Christopher/0000-0003-2600-0968",National Institutes of Health [5T32AI007046],"This work was supported by the National Institutes of Health (5T32AI007046 to CJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,30,31,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005278,10.1371/journal.ppat.1005278,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000034,26565973.0,"DOAJ Gold, Green Published",,,16/08/2019,30,34,33,6204,614,430,184,5590,4732,21,837,33,15,0,0,24,24,2,,48,0,48,0,0,31,31,27,24,0,0,0,0,0,0,1,19,15,6217,124,18,72,95,0,5576,614,124,18,72,95,0,27,,4,2,0,0,18,0,0,0,0,0,0,49,0,0,52.084,10.104234527687296,1.1098389982110912,0.10983899821109123,1.1513416815742397,1.0373952288845907,10.482084690553746
269,J,"Brown, AF; Murphy, AG; Lalor, SJ; Leech, JM; O'Keeffe, KM; Mac Aogain, M; O'Halloran, DP; Lacey, KA; Tavakol, M; Hearnden, CH; Fitzgerald-Hughes, D; Humphreys, H; Fennell, JP; van Wamel, WJ; Foster, TJ; Geoghegan, JA; Lavelle, EC; Rogers, TR; McLoughlin, RM",,,,"Brown, Aisling F.; Murphy, Alison G.; Lalor, Stephen J.; Leech, John M.; O'Keeffe, Kate M.; Mac Aogain, Micheal; O'Halloran, Dara P.; Lacey, Keenan A.; Tavakol, Mehri; Hearnden, Claire H.; Fitzgerald-Hughes, Deirdre; Humphreys, Hilary; Fennell, Jerome P.; van Wamel, Willem J.; Foster, Timothy J.; Geoghegan, Joan A.; Lavelle, Ed C.; Rogers, Thomas R.; McLoughlin, Rachel M.",,,Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,HYPER-IGE SYNDROME; DELTA-T-CELLS; BLOOD-STREAM INFECTION; INTERFERON-GAMMA; CLUMPING FACTOR; CAPSULAR POLYSACCHARIDES; VIRULENCE DETERMINANT; HEMODIALYSIS-PATIENTS; BACTERIAL-INFECTION; MEDIATED-IMMUNITY,"Mechanisms of protective immunity to Staphylococcus aureus infection in humans remain elusive. While the importance of cellular immunity has been shown in mice, T cell responses in humans have not been characterised. Using a murine model of recurrent S. aureus peritonitis, we demonstrated that prior exposure to S. aureus enhanced IFN gamma responses upon subsequent infection, while adoptive transfer of S. aureus antigen-specific Th1 cells was protective in naive mice. Translating these findings, we found that S. aureus antigen-specific Th1 cells were also significantly expanded during human S. aureus bloodstream infection (BSI). These Th1 cells were CD45RO(+), indicative of a memory phenotype. Thus, exposure to S. aureus induces memory Th1 cells in mice and humans, identifying Th1 cells as potential S. aureus vaccine targets. Consequently, we developed a model vaccine comprising staphylococcal clumping factor A, which we demonstrate to be an effective human T cell antigen, combined with the Th1-driving adjuvant CpG. This novel Th1-inducing vaccine conferred significant protection during S. aureus infection in mice. This study notably advances our understanding of S. aureus cellular immunity, and demonstrates for the first time that a correlate of S. aureus protective immunity identified in mice may be relevant in humans.","[Brown, Aisling F.; Murphy, Alison G.; Lalor, Stephen J.; Leech, John M.; O'Keeffe, Kate M.; Lacey, Keenan A.; McLoughlin, Rachel M.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Host Pathogen Interact Grp, Dublin, Ireland; [Mac Aogain, Micheal; Fennell, Jerome P.; Rogers, Thomas R.] Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin, Ireland; [O'Halloran, Dara P.; Foster, Timothy J.; Geoghegan, Joan A.] Trinity Coll Dublin, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [Tavakol, Mehri; van Wamel, Willem J.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Hearnden, Claire H.; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland; [Fitzgerald-Hughes, Deirdre; Humphreys, Hilary] Royal Coll Surgeons Ireland, Dept Clin Microbiol, Dublin 2, Ireland; [Humphreys, Hilary] Beaumont Hosp, Dept Microbiol, Dublin 9, Ireland; [Fennell, Jerome P.] Adelaide Meath & Natl Childrens Hosp, Dept Clin Microbiol, Dublin, Ireland; [Lavelle, Ed C.] Trinity Coll Dublin, CRANN, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland; [Rogers, Thomas R.] St James Hosp, Dept Clin Microbiol, Dublin 8, Ireland","Brown, AF (reprint author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Host Pathogen Interact Grp, Dublin, Ireland.",rachel.mcloughlin@tcd.ie,"Fitzgerald-Hughes, Deirdre H/D-2882-2012; Fennell, Jerome/Q-6330-2019; Mac Aogain, Micheal/M-6782-2013; Lavelle, Ed/A-1716-2008","Fitzgerald-Hughes, Deirdre H/0000-0002-4843-3839; Fennell, Jerome/0000-0002-1829-1382; Mac Aogain, Micheal/0000-0002-1726-7700; Humphreys, Hilary/0000-0002-9646-2183; Lalor, Stephen/0000-0003-0882-7152; McLoughlin, Rachel/0000-0003-4553-018X; Murphy, Alison/0000-0001-8241-1660; Leech, John Martin/0000-0001-8766-4915; Lavelle, Ed/0000-0002-3167-1080; Lacey, Keenan/0000-0002-9242-0170; Rogers, Thomas/0000-0003-4336-7729",Health Research Board; Health Research Award [HRA_POR/2012/104]; Wellcome Trust [WT086515MA]; Science Foundation Ireland Investigator Award [12/IA/1421],"This project was supported primarily by a Health Research Board, Health Research Award (HRA_POR/2012/104), a Wellcome Trust Research Career Development Fellowship (WT086515MA) to RMM and in part by a Science Foundation Ireland Investigator Award (12/IA/1421) to ECL. http://www.hrb.ie/; http://www.wellcome.ac.uk; http://www.sfi.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,86,50,51,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005226,10.1371/journal.ppat.1005226,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000011,26539822.0,"DOAJ Gold, Green Published",,,16/08/2019,48,31,36,8452,1385,989,396,7067,5871,20,1176,36,27,0,2,51,51,7,,127,3,66,0,3,51,51,35,24,0,0,1,0,0,1,2,4,16,8488,107,24,85,174,2,7057,1385,74,24,85,154,2,46,,4,1,0,0,31,0,0,1,1,0,0,66,0,0,58.40600000000001,6.102527075812274,1.195981321635772,0.1959813216357719,1.2408376963350785,1.0375059157595836,6.331407942238267
270,J,"Chavez, ASO; Fairman, JW; Felsheim, RF; Nelson, CM; Herron, MJ; Higgins, L; Burkhardt, NY; Oliver, JD; Markowski, TW; Kurtti, TJ; Edwards, TE; Munderloh, UG",,,,"Chavez, Adela S. Oliva; Fairman, James W.; Felsheim, Roderick F.; Nelson, Curtis M.; Herron, Michael J.; Higgins, LeeAnn; Burkhardt, Nicole Y.; Oliver, Jonathan D.; Markowski, Todd W.; Kurtti, Timothy J.; Edwards, Thomas E.; Munderloh, Ulrike G.",,,An O-Methyltransferase Is Required for Infection of Tick Cells by Anaplasma phagocytophilum,PLOS PATHOGENS,,,English,Article,,,,,,,OUTER-MEMBRANE PROTEIN; GRANULOCYTIC EHRLICHIOSIS AGENT; RICKETTSIA-PROWAZEKII; PROTEOMIC ANALYSIS; SURFACE-PROTEINS; HOST-CELLS; METHYLATION; EXPRESSION; ADHERENCE; INVASION,"Anaplasma phagocytophilum, the causative agent of Human Granulocytic Anaplasmosis (HGA), is an obligately intracellular alpha-proteobacterium that is transmitted by Ixodes spp ticks. However, the pathogen is not transovarially transmitted between tick generations and therefore needs to survive in both a mammalian host and the arthropod vector to complete its life cycle. To adapt to different environments, pathogens rely on differential gene expression as well as the modification of proteins and other molecules. Random transposon mutagenesis of A. phagocytophilum resulted in an insertion within the coding region of an omethyltransferase (omt) family 3 gene. In wild-type bacteria, expression of omt was up-regulated during binding to tick cells (ISE6) at 2 hr post-inoculation, but nearly absent by 4 hr p. i. Gene disruption reduced bacterial binding to ISE6 cells, and the mutant bacteria that were able to enter the cells were arrested in their replication and development. Analyses of the proteomes of wild-type versus mutant bacteria during binding to ISE6 cells identified Major Surface Protein 4 (Msp4), but also hypothetical protein APH_0406, as the most differentially methylated. Importantly, two glutamic acid residues (the targets of the OMT) were methylmodified in wild-type Msp4, whereas a single asparagine (not a target of the OMT) was methylated in APH_0406. In vitro methylation assays demonstrated that recombinant OMT specifically methylated Msp4. Towards a greater understanding of the overall structure and catalytic activity of the OMT, we solved the apo (PDB_ID:4OA8), the S-adenosine homocystein- bound (PDB_ID:4OA5), the SAH-Mn2+ bound (PDB_ID:4PCA), and SAM-Mn2+ bound (PDB_ID:4PCL) X-ray crystal structures of the enzyme. Here, we characterized a mutation in A. phagocytophilum that affected the ability of the bacteria to productively infect cells from its natural vector. Nevertheless, due to the lack of complementation, we cannot rule out secondary mutations.","[Chavez, Adela S. Oliva; Felsheim, Roderick F.; Nelson, Curtis M.; Herron, Michael J.; Burkhardt, Nicole Y.; Oliver, Jonathan D.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Fairman, James W.; Edwards, Thomas E.] Emerald Bio, Bainbridge Isl, WA USA; [Fairman, James W.; Edwards, Thomas E.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA USA; [Higgins, LeeAnn; Markowski, Todd W.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA","Chavez, ASO (reprint author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.",achavez@antilles.inra.fr,,"Edwards, Thomas/0000-0002-0474-8003","National Institute of Allergy and Infectious Diseases (NIAID) [R01-AI042792]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201200025C]; Alexander and Lydia Anderson Fellowship; National Science Foundation [9871237, NSF-DBI-0215759]","This study was supported partially by the National Institute of Allergy and Infectious Diseases (NIAID) grant R01-AI042792 to UGM, with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272201200025C, and by the Alexander and Lydia Anderson Fellowship to ASOC. We thank the National Science Foundation for major research instrumentation grants 9871237 and NSF-DBI-0215759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,12,12,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005248,10.1371/journal.ppat.1005248,,,,40,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000016,26544981.0,"DOAJ Gold, Green Published",,,16/08/2019,13,3,18,3315,715,546,169,2600,2215,30,355,18,2,0,0,12,12,0,,24,5,24,0,5,13,13,13,11,0,0,0,0,0,0,0,1,4,3373,116,0,41,382,1,2620,723,116,0,41,382,1,30,,0,0,0,0,4,0,1,1,0,0,0,24,0,0,2.5,4.636363636363637,1.275,0.275,1.488846153846154,1.1677224736048266,5.413986013986014
271,J,"Choi, HS; Jain, V; Krueger, B; Marshall, V; Kim, CH; Shisler, JL; Whitby, D; Renne, R",,,,"Choi, Hong Seok; Jain, Vaibhav; Krueger, Brian; Marshall, Vickie; Kim, Chang Hee; Shisler, Joanna L.; Whitby, Denise; Renne, Rolf",,,Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-beta Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,ENDOTHELIAL-CELLS; NUCLEAR ANTIGEN; DNA-SEQUENCES; MALIGNANT-LYMPHOMA; MICRORNA CLUSTER; IN-VITRO; VIRUS; LATENCY; EXPRESSION; MIR-155,"KSHV is a DNA tumor virus that causes Kaposi's sarcoma. Upon KSHV infection, only a limited number of latent genes are expressed. We know that KSHV infection regulates host gene expression, and hypothesized that latent genes also modulate the expression of host miRNAs. Aberrant miRNA expression contributes to the development of many types of cancer. Array-based miRNA profiling revealed that all six miRNAs of the oncogenic miR-17-92 cluster are up-regulated in KSHV infected endothelial cells. Among candidate KSHV latent genes, we found that vFLIP and vCyclin were shown to activate the miR-17-92 promoter, using luciferase assay and western blot analysis. The miR-17-92 cluster was previously shown to target TGF-beta signaling. We demonstrate that vFLIP and vCyclin induce the expression of the miR-17-92 cluster to strongly inhibit the TGF-beta signaling pathway by down-regulating SMAD2. Moreover, TGF-beta activity and SMAD2 expression were fully restored when antagomirs ( inhibitors) of miR-17-92 cluster were transfected into cells expressing either vFLIP or vCyclin. In addition, we utilized viral genetics to produce vFLIP or vCyclin knock-out viruses, and studied the effects in infected TIVE cells. Infection with wildtype KSHV abolished expression of SMAD2 protein in these endothelial cells. While single-knockout mutants still showed a marked reduction in SMAD2 expression, TIVE cells infected by a double-knockout mutant virus were fully restored for SMAD2 expression, compared to non-infected TIVE cells. Expression of either vFLIP or vCycIin was sufficient to downregulate SMAD2. In summary, our data demonstrate that vFLIP and vCyclin induce the oncogenic miR-17-92 cluster in endothelial cells and thereby interfere with the TGF-beta signaling pathway. Manipulation of the TGF-beta pathway via host miRNAs represents a novel mechanism that may be important for KSHV tumorigenesis and angiogenesis, a hallmark of KS.","[Choi, Hong Seok; Jain, Vaibhav; Krueger, Brian; Renne, Rolf] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Marshall, Vickie; Kim, Chang Hee; Whitby, Denise] Leidos Biomed, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Shisler, Joanna L.] Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA; [Renne, Rolf] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA; [Renne, Rolf] Univ Florida, UF Inst Genet, Gainesville, FL USA","Choi, HS (reprint author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.",rrenne@ufl.edu,"Kim, Chang Hee/Q-6809-2018","Kim, Chang Hee/0000-0002-1032-5461; Shisler, Joanna/0000-0003-4833-1557","National Institutes of Health NCI [R01CA 119917]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]","This work was supported by grants from National Institutes of Health NCI R01CA 119917 to RR and with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,18,18,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005255,10.1371/journal.ppat.1005255,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000019,26545119.0,"DOAJ Gold, Green Published",,,16/08/2019,19,46,10,4769,690,487,203,4079,3520,14,545,10,3,0,0,20,20,1,,13,1,13,0,1,21,21,16,8,0,0,0,0,0,0,0,43,3,4814,26,10,40,118,0,4068,690,26,10,40,118,0,56,,0,0,0,0,7,0,1,1,0,0,0,13,0,0,3.95,6.91159420289855,1.1691591076244177,0.16915910762441774,1.2154939936258886,1.0396309498846719,7.185507246376812
272,J,"de La Vega, MA; Stein, D; Kobinger, GP",,,,"de La Vega, Marc-Antoine; Stein, Derek; Kobinger, Gary P.",,,Ebolavirus Evolution: Past and Present,PLOS PATHOGENS,,,English,Review,,,,,,,HEMORRHAGIC-FEVER OUTBREAKS; VIRUS GLYCOPROTEIN; RESTON VIRUS; FRUIT BATS; CONGO; DISEASE; MARBURG; IDENTIFICATION; TRANSMISSION; PHILIPPINES,"The past year has marked the most devastating Ebola outbreak the world has ever witnessed, with over 28,000 cases and over 11,000 deaths. Ebola virus (EBOV) has now been around for almost 50 years. In this review, we discuss past and present outbreaks of EBOV and how those variants evolved over time. We explore and discuss selective pressures that drive the evolution of different Ebola variants, and how they may modify the efficacy of therapeutic treatments and vaccines currently being developed. Finally, given the unprecedented size and spread of the outbreak, as well as the extended period of replication in human hosts, specific attention is given to the 2014-2015 West African outbreak variant (Makona).","[de La Vega, Marc-Antoine; Stein, Derek; Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada; [de La Vega, Marc-Antoine; Kobinger, Gary P.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Stein, Derek; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA","de La Vega, MA (reprint author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.",gary.kobinger@phac-aspc.gc.ca,,"de La Vega, Marc-Antoine/0000-0002-5969-9990",Public Health Agency of Canada (PHAC); Canadian Institute for Health Research (CIHR),"This work was supported by the Public Health Agency of Canada (PHAC). MAdLV is the recipient of a Master's Research Award from the Canadian Institute for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,72,29,29,1,52,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005221,10.1371/journal.ppat.1005221,,,,10,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000009,26562671.0,"DOAJ Gold, Green Published",,,16/08/2019,33,65,118,14353,3148,2375,773,11205,9170,25,2010,117,25,0,0,26,26,0,,131,39,130,1,39,34,34,31,17,0,0,0,0,0,0,0,40,13,14663,34,10,43,366,14,11268,3165,34,10,43,366,14,230,,0,0,1,0,20,0,1,0,0,0,0,130,1,0,13.85,4.559402795425667,1.280946006247211,0.28094600624721106,1.3443105756358769,1.049467010381105,4.784942820838627
273,J,"Dietrich, M; Muhdorfer, K; Tortosa, P; Markotter, W",,,,"Dietrich, Muriel; Muehdorfer, Kristin; Tortosa, Pablo; Markotter, Wanda",,,Leptospira and Bats: Story of an Emerging Friendship,PLOS PATHOGENS,,,English,Article,,,,,,,PERUVIAN AMAZON; PATHOGENIC LEPTOSPIRES; FLYING FOXES; SPP.; EPIDEMIOLOGY; TRANSMISSION; ANTIBODIES; MAMMALS; HUMANS; ISLAND,,"[Dietrich, Muriel; Markotter, Wanda] Univ Pretoria, Fac Nat & Agr Sci, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa; [Muehdorfer, Kristin] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Tortosa, Pablo] Univ Reunion, CNRS 9192, INSERM 1187, UMR PIMIT,IRD 249, Reunion Isl, St Clotilde, France","Dietrich, M (reprint author), Univ Pretoria, Fac Nat & Agr Sci, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa.",muriel.dietrich@gmail.com,,"Markotter, Wanda/0000-0002-7550-0080; Tortosa, Pablo/0000-0002-7928-7264; Dietrich, Muriel/0000-0002-2665-7970","National Research Foundation, South Africa [NRF - N00595]","This work was made possible by funding from the National Research Foundation, South Africa (NRF - N00595) to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,44,25,25,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005176,10.1371/journal.ppat.1005176,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000004,26562435.0,"DOAJ Gold, Green Published",,,16/08/2019,19,55,56,6035,1295,991,304,4740,3862,23,855,56,25,0,0,19,19,1,,88,7,88,0,7,21,20,21,7,0,0,2,0,0,2,0,32,21,6066,10,0,90,119,4,4725,1295,10,0,90,119,4,46,,0,1,0,0,29,0,2,0,0,0,0,87,0,0,26.742,4.66023166023166,1.2732067510548524,0.2732067510548523,1.3069620253164558,1.0265120132560066,4.783783783783784
274,J,"Dutrieux, J; Maarifi, G; Portilho, DM; Arhel, NJ; Chelbi-Alix, MK; Nisole, S",,,,"Dutrieux, Jacques; Maarifi, Ghizlane; Portilho, Debora M.; Arhel, Nathalie J.; Chelbi-Alix, Mounira K.; Nisole, Sebastien",,,PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx,PLOS PATHOGENS,,,English,Article,,,,,,,PROMYELOCYTIC LEUKEMIA PROTEIN; PML NUCLEAR-BODIES; ANTIVIRAL DEFENSE; CYTOPLASMIC PML; VIRUS-INFECTION; ENCEPHALOMYOCARDITIS VIRUS; BINDING PROTEIN; DENDRITIC CELLS; HIV-1; RESISTANCE,"PML (Promyelocytic Leukemia protein), also known as TRIM19, belongs to the family of tripartite motif (TRIM) proteins. PML is mainly expressed in the nucleus, where it forms dynamic structures known as PML nuclear bodies that recruit many other proteins, such as Sp100 and Daxx. While the role of PML/TRIM19 in antiviral defense is well documented, its effect on HIV-1 infection remains unclear. Here we show that infection by HIV-1 and other retroviruses triggers the formation of PML cytoplasmic bodies, as early as 30 minutes post-infection. Quantification of the number and size of PML cytoplasmic bodies revealed that they last approximately 8 h, with a peak at 2 h post-infection. PML re-localization is blocked by reverse-transcription inhibitors and is not observed following infection with unrelated viruses, suggesting it is specifically triggered by retroviral reverse-transcription. Furthermore, we show that PML interferes with an early step of retroviral infection since PML knockdown dramatically increases reverse-transcription efficiency. We demonstrate that PML does not inhibit directly retroviral infection but acts through the stabilization of one of its well-characterized partners, Daxx. In the presence of PML, cytoplasmic Daxx is found in the vicinity of incoming HIV-1 capsids and inhibits reverse-transcription. Interestingly, Daxx not only interferes with exogenous retroviral infections but can also inhibit retrotransposition of endogenous retroviruses, thus identifying Daxx as a broad cellular inhibitor of reverse-transcription. Altogether, these findings unravel a novel antiviral function for PML and PML nuclear body-associated protein Daxx.","[Dutrieux, Jacques; Maarifi, Ghizlane; Chelbi-Alix, Mounira K.; Nisole, Sebastien] Paris Descartes Univ, Paris, France; [Portilho, Debora M.; Arhel, Nathalie J.] St Louis Hosp, Univ Inst Hematol, Paris, France","Dutrieux, J (reprint author), Paris Descartes Univ, Paris, France.",sebastien.nisole@inserm.fr,,"Nisole, Sebastien/0000-0001-9793-419X; Arhel, Nathalie/0000-0001-5309-1725; MAARIFI, GHIZLANE/0000-0002-7974-3821",Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS); ANRS,"This work was supported by grants from the Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS). JD and DMP are funded by ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,60,16,18,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005280,10.1371/journal.ppat.1005280,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000036,26566030.0,"DOAJ Gold, Green Published",,,16/08/2019,18,0,15,4073,773,575,198,3300,2706,16,578,15,0,0,0,15,15,0,,24,0,24,0,0,18,18,14,10,0,0,0,0,0,0,1,0,1,4132,12,0,39,65,0,3318,797,12,0,39,65,0,17,,1,0,0,0,0,0,0,0,0,0,0,24,0,0,7.0,5.269081500646831,1.2342424242424241,0.23424242424242425,1.2754545454545454,1.0333906211637613,5.445019404915912
275,J,"Esteves, PJ; Abrantes, J; Bertagnoli, S; Cavadini, P; Gavier-Widen, D; Guitton, JS; Lavazza, A; Lemaitre, E; Letty, J; Lopes, AM; Neimanis, AS; Ruvoen-Clouet, N; Le Pendu, J; Marchandeau, S; Le Gall-Recule, G",,,,"Esteves, Pedro Jose; Abrantes, Joana; Bertagnoli, Stephane; Cavadini, Patrizia; Gavier-Widen, Dolores; Guitton, Jean-Sebastien; Lavazza, Antonio; Lemaitre, Evelyne; Letty, Jerome; Lopes, Ana Margarida; Neimanis, Aleksija S.; Ruvoen-Clouet, Nathalie; Le Pendu, Jacques; Marchandeau, Stephane; Le Gall-Recule, Ghislaine",,,Emergence of Pathogenicity in Lagoviruses: Evolution from Pre-existing Nonpathogenic Strains or through a Species Jump?,PLOS PATHOGENS,,,English,Article,,,,,,,RABBIT-HEMORRHAGIC-DISEASE; BROWN HARE SYNDROME; CAPSID PROTEIN GENE; RHDV VARIANT 2; POLYMERASE-CHAIN-REACTION; AUSTRALIAN WILD RABBITS; IBERIAN PENINSULA; VIRUS RHDV; MOLECULAR EPIDEMIOLOGY; ORYCTOLAGUS-CUNICULUS,,"[Esteves, Pedro Jose; Abrantes, Joana; Lopes, Ana Margarida] Univ Porto, CIBIO, InBIO Res Network Biodivers & Evolutionary Biol, Vairao, Portugal; [Esteves, Pedro Jose; Lopes, Ana Margarida] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Porto, Portugal; [Esteves, Pedro Jose] Inst Invest & Formacao Avancada Ciencias & Tecnol, CESPU, Gandra, Portugal; [Bertagnoli, Stephane] INRA, UMR 1225, Toulouse, France; [Bertagnoli, Stephane] Univ Toulouse, INP ENVT, Toulouse, France; [Cavadini, Patrizia] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Prote Unit, Brescia, Italy; [Gavier-Widen, Dolores; Neimanis, Aleksija S.] Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75007 Uppsala, Sweden; [Guitton, Jean-Sebastien; Letty, Jerome; Marchandeau, Stephane] Natl Hunting & Wildlife Agcy ONCFS, Dept Studies & Res, Nantes, France; [Lavazza, Antonio] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Virol Unit, Brescia, Italy; [Lemaitre, Evelyne; Le Gall-Recule, Ghislaine] French Agcy Food Environm & Occupat Hlth & Safety, Ploufragan Plouzane Lab, Avian & Rabbit Virol Immunol Parasitol Unit, Ploufragan, France; [Lemaitre, Evelyne; Le Gall-Recule, Ghislaine] European Univ Brittany, Rennes, France; [Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] INSERM, U892, Nantes, France; [Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] Univ Nantes, CNRS, UMR 6299, Nantes, France","Esteves, PJ (reprint author), Univ Porto, CIBIO, InBIO Res Network Biodivers & Evolutionary Biol, Campus Vairao, Vairao, Portugal.",pjesteves@cibio.up.pt,"Abrantes, Joana/D-3819-2012; Le Pendu, Jacques/F-4760-2013; Lopes, Ana/M-3285-2013; Esteves, Pedro/A-7537-2010; lavazza, antonio/G-8182-2011; Neimanis, Aleksija/E-4168-2016","Abrantes, Joana/0000-0002-8391-7134; Le Pendu, Jacques/0000-0002-4856-0387; cavadini, patrizia/0000-0002-1774-5290; Lopes, Ana/0000-0002-7176-0969; Esteves, Pedro/0000-0002-6055-8298; lavazza, antonio/0000-0002-7646-3592; Neimanis, Aleksija/0000-0001-7747-2290",,,,97,15,15,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005087,10.1371/journal.ppat.1005087,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000001,26540662.0,"DOAJ Gold, Green Published",,,16/08/2019,17,2,14,2668,376,283,93,2292,1840,19,433,14,0,2,0,16,16,0,,0,6,0,0,6,18,18,16,7,0,0,0,0,0,0,0,4,1,2698,6,0,14,289,6,2287,376,6,0,14,289,6,35,,0,0,0,1,1,0,0,1,0,0,0,17,0,0,3.5,7.095744680851064,1.1640488656195462,0.16404886561954624,1.3058464223385688,1.1218140929535232,7.960106382978723
276,J,"Gaji, RY; Johnson, DE; Treeck, M; Wang, M; Hudmon, A; Arrizabalaga, G",,,,"Gaji, Rajshekhar Y.; Johnson, Derrick E.; Treeck, Moritz; Wang, Mu; Hudmon, Andy; Arrizabalaga, Gustavo",,,Phosphorylation of a Myosin Motor by TgCDPK3 Facilitates Rapid Initiation of Motility during Toxoplasma gondii egress,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT PROTEIN-KINASE; HOST-CELL INVASION; APICOMPLEXA; GLIDEOSOME,"Members of the family of calcium dependent protein kinases (CDPK's) are abundant in certain pathogenic parasites and absent in mammalian cells making them strong drug target candidates. In the obligate intracellular parasite Toxoplasma gondii TgCDPK3 is important for calcium dependent egress from the host cell. Nonetheless, the specific substrate through which TgCDPK3 exerts its function during egress remains unknown. To close this knowledge gap we applied the proximity-based protein interaction trap BioID and identified 13 proteins that are either near neighbors or direct interactors of TgCDPK3. Among these was Myosin A (TgMyoA), the unconventional motor protein greatly responsible for driving the gliding motility of this parasite, and whose phosphorylation at serine 21 by an unknown kinase was previously shown to be important for motility and egress. Through a non-biased peptide array approach we determined that TgCDPK3 can specifically phosphorylate serines 21 and 743 of TgMyoA in vitro. Complementation of the TgmyoA null mutant, which exhibits a delay in egress, with TgMyoA in which either S21 or S743 is mutated to alanine failed to rescue the egress defect. Similarly, phosphomimetic mutations in the motor protein overcome the need for TgCDPK3. Moreover, extracellular Tgcdpk3 mutant parasites have motility defects that are complemented by expression of S21+S743 phosphomimetic of TgMyoA. Thus, our studies establish that phosphorylation of TgMyoA by TgCDPK3 is responsible for initiation of motility and parasite egress from the host-cell and provides mechanistic insight into how this unique kinase regulates the lytic cycle of Toxoplasma gondii.","[Gaji, Rajshekhar Y.; Arrizabalaga, Gustavo] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Johnson, Derrick E.; Wang, Mu; Hudmon, Andy] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Johnson, Derrick E.; Hudmon, Andy] Indiana Univ Sch Med, Stark Neurosci Res Ctr, Indianapolis, IN 46202 USA; [Treeck, Moritz] Francis Crick Inst, London, England","Gaji, RY (reprint author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.",garrizab@iu.edu,"Treeck, Moritz/Q-9078-2019; Treeck, Moritz/O-6662-2017","Treeck, Moritz/0000-0002-9727-6657; Treeck, Moritz/0000-0002-9727-6657",NIH NIAID [R21AI108393-01A1]; NIH NIAID RO1 AI [89808-01]; AHA [13GRNT1604000],"This work was supported by NIH NIAID R21AI108393-01A1 http://www.niaid.nih.gov/Pages/default.aspx, NIH NIAID RO1 AI 89808-01 http://www.niaid.nih.gov/Pages/default.aspx, and AHA 13GRNT1604000 http://my.americanheart.org/professional/Research/Research_UCM_316889_SubHomePage.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,48,29,30,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005268,10.1371/journal.ppat.1005268,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000028,26544049.0,"DOAJ Gold, Green Published",,,16/08/2019,28,23,28,5428,870,631,239,4558,3866,26,666,28,5,0,0,28,28,0,,37,0,37,0,0,28,28,22,23,0,0,0,0,0,0,1,18,4,5477,35,0,57,44,0,4576,878,35,0,57,44,0,23,,1,1,0,0,7,0,0,1,0,0,0,37,0,0,17.758,6.239080459770115,1.1908731899956122,0.19087318999561212,1.2189556823168055,1.023581429624171,6.386206896551724
277,J,"Harper, MS; Guo, KJ; Gibbert, K; Lee, EJ; Dillon, SM; Barrett, BS; McCarter, MD; Hasenkrug, KJ; Dittmer, U; Wilson, CC; Santiago, ML",,,,"Harper, Michael S.; Guo, Kejun; Gibbert, Kathrin; Lee, Eric J.; Dillon, Stephanie M.; Barrett, Bradley S.; McCarter, Martin D.; Hasenkrug, Kim J.; Dittmer, Ulf; Wilson, Cara C.; Santiago, Mario L.",,,"Interferon-alpha Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms",PLOS PATHOGENS,,,English,Article,,,,,,,IFN-ALPHA; I INTERFERON; DENDRITIC CELLS; INHIBITS HIV-1; RESTRICTION FACTORS; LYMPHOCYTES; APOBEC3G; SUPPRESSION; INDUCTION; RESPONSES,"HIV-1 is transmitted primarily across mucosal surfaces and rapidly spreads within the intestinal mucosa during acute infection. The type I interferons (IFNs) likely serve as a first line of defense, but the relative expression and antiviral properties of the 12 IFN alpha subtypes against HIV-1 infection of mucosal tissues remain unknown. Here, we evaluated the expression of all IFN alpha subtypes in HIV-1-exposed plasmacytoid dendritic cells by next-generation sequencing. We then determined the relative antiviral potency of each IFN alpha subtype ex vivo using the human intestinal Lamina Propria Aggregate Culture model. IFN alpha subtype transcripts from the centromeric half of the IFNA gene complex were highly expressed in pDCs following HIV-1 exposure. There was an inverse relationship between IFNA subtype expression and potency. IFN alpha 8, IFN alpha 6 and IFN alpha 14 were the most potent in restricting HIV-1 infection. IFN alpha 2, the clinically-approved subtype, and IFN alpha 1 were both highly expressed but exhibited relatively weak antiviral activity. The relative potencies correlated with binding affinity to the type I IFN receptor and the induction levels of HIV-1 restriction factors Mx2 and Tetherin/ BST-2 but not APOBEC3G, F and D. However, despite the lack of APOBEC3 transcriptional induction, the higher relative potency of IFN alpha 8 and IFN alpha 14 correlated with stronger inhibition of virion infectivity, which is linked to deaminase-independent APOBEC3 restriction activity. By contrast, both potent (IFN alpha 8) and weak (IFN alpha 1) subtypes significantly induced HIV-1 GG-to-AG hypermutation. The results unravel non-redundant functions of the IFN alpha subtypes against HIV-1 infection, with strong implications for HIV-1 mucosal immunity, viral evolution and IFN alpha-based functional cure strategies.","[Harper, Michael S.; Guo, Kejun; Lee, Eric J.; Dillon, Stephanie M.; Barrett, Bradley S.; Wilson, Cara C.; Santiago, Mario L.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Harper, Michael S.; Wilson, Cara C.; Santiago, Mario L.] Univ Colorado Denver, Dept Immunol & Microbiol, Aurora, CO USA; [Gibbert, Kathrin; Dittmer, Ulf] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [McCarter, Martin D.] Univ Colorado Denver, Dept Surg, Aurora, CO USA; [Hasenkrug, Kim J.] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA","Harper, MS (reprint author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.",ulf.dittmer@uni-due.de; cara.wilson@ucdenver.edu; mario.santiago@ucdenver.edu,,"Sutter, Kathrin/0000-0001-6397-6551; Santiago, Mario L./0000-0001-7792-2706",University of Colorado Department of Medicine Early Career Program; NIAID; German Research Association [DFG-TRR60]; Tim Gill Foundation endowment;  [R56 AI116271];  [R01 AI108404],"This work was supported by R56 AI116271 (MLS and CCW), R01 AI108404 (CCW), the University of Colorado Department of Medicine Early Career Program (MLS), the Intramural Research Program at the NIAID (KJH) and the German Research Association DFG-TRR60 (KGi and UD). MSH was supported in part by a Tim Gill Foundation endowment to the University of Colorado Division of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,79,33,34,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005254,10.1371/journal.ppat.1005254,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000018,26529416.0,"DOAJ Gold, Green Published",,,16/08/2019,34,2,30,4853,903,611,292,3950,3117,22,811,29,0,0,0,31,31,0,,45,1,44,1,1,37,37,35,19,0,0,0,0,0,0,0,2,4,4930,71,0,69,184,0,3976,919,71,0,69,184,0,35,,0,0,0,0,4,0,0,0,0,0,0,44,1,0,2.25,5.374307862679956,1.2286075949367088,0.22860759493670887,1.3126582278481012,1.0684112919843396,5.741971207087486
278,J,"Heitman, J",,,,"Heitman, Joseph",,,On the Discovery of TOR As the Target of Rapamycin,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"[Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol MGM, Durham, NC 27708 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Tri MMPTP, Durham, NC USA","Heitman, J (reprint author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol MGM, Durham, NC 27708 USA.",heitm001@duke.edu,,,,,,0,5,6,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005245,10.1371/journal.ppat.1005245,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000013,26540102.0,"DOAJ Gold, Green Published",,,16/08/2019,4,24,12,5536,746,587,159,4790,4282,9,499,12,21,2,0,4,4,1,,15,1,15,0,1,4,4,4,3,0,0,0,0,0,0,0,5,32,5580,0,0,0,36,0,4808,753,0,0,0,36,0,19,,0,0,0,2,41,0,0,1,0,0,0,15,0,0,26.0,7.420911528150134,1.155741127348643,0.155741127348643,1.1724425887265135,1.0144508670520231,7.528150134048257
279,J,"Johnston, PR; Rolff, J",,,,"Johnston, Paul R.; Rolff, Jens",,,Host and Symbiont Jointly Control Gut Microbiota during Complete Metamorphosis,PLOS PATHOGENS,,,English,Article,,,,,,,BACILLUS-THURINGIENSIS; BACTERIAL COMMUNITY; MIDGUT MICROBIOTA; GYPSY-MOTH; WAX MOTH; INSECT; POPULATIONS; GENERATION; LYSOZYME; MODEL,"Holometabolous insects undergo a radical anatomical re-organisation during metamorphosis. This poses a developmental challenge: the host must replace the larval gut but at the same time retain symbiotic gut microbes and avoid infection by opportunistic pathogens. By manipulating host immunity and bacterial competitive ability, we study how the host Galleria mellonella and the symbiotic bacterium Enterococcus mundtii interact to manage the composition of the microbiota during metamorphosis. Disenabling one or both symbiotic partners alters the composition of the gut microbiota, which incurs fitness costs: adult hosts with a gut microbiota dominated by pathogens such as Serratia and Staphylococcus die early. Our results reveal an interaction that guarantees the safe passage of the symbiont through metamorphosis and benefits the resulting adult host. Host-symbiont ""conspiracies"" as described here are almost certainly widespread in holometobolous insects including many disease vectors.","[Johnston, Paul R.; Rolff, Jens] Free Univ Berlin, Berlin, Germany; [Rolff, Jens] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany","Johnston, PR (reprint author), Free Univ Berlin, Berlin, Germany.",paul.johnston@fu-berlin.de; jens.rolff@fu-berlin.de,,"Johnston, Paul/0000-0002-8651-4488",European Research Council [260986]; BBSRC Genome Analysis Centre Capacity & Capability Challenge program,"This research was supported by European Research Council (http://erc.europa.eu/) grant 260986 to J.R. and by the BBSRC Genome Analysis Centre Capacity & Capability Challenge program to JR and PRJ (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,37,37,1,26,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005246,10.1371/journal.ppat.1005246,,,,11,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000014,26544881.0,"DOAJ Gold, Green Published",,,16/08/2019,37,32,103,7937,723,530,193,7214,6026,25,1163,103,21,0,0,36,36,1,,150,0,150,0,0,46,41,46,20,0,0,0,0,0,0,0,11,20,8070,44,12,86,85,1,7266,741,44,12,86,85,1,63,,0,0,0,0,27,0,0,1,0,0,0,148,0,0,13.9,10.977869986168741,1.1002217909620182,0.1002217909620183,1.1365400609925145,1.0330099533828903,11.340248962655602
280,J,"Karlsson, EA; Small, CT; Freiden, P; Feeroz, MM; Matsen, FA; San, S; Hasan, MK; Wang, D; Jones-Engel, L; Schultz-Cherry, S",,,,"Karlsson, Erik A.; Small, Christopher T.; Freiden, Pamela; Feeroz, M. M.; Matsen, Frederick A.; San, Sorn; Hasan, M. Kamrul; Wang, David; Jones-Engel, Lisa; Schultz-Cherry, Stacey",,,Non-Human Primates Harbor Diverse Mammalian and Avian Astroviruses Including Those Associated with Human Infections,PLOS PATHOGENS,,,English,Article,,,,,,,GENETIC DIVERSITY; MOLECULAR-BIOLOGY; RHESUS MACAQUES; BANGLADESH; EVOLUTION; VIRUS; CHINA; MLB1; BATS,"Astroviruses (AstVs) are positive sense, single-stranded RNA viruses transmitted to a wide range of hosts via the fecal-oral route. The number of AstV-infected animal hosts has rapidly expanded in recent years with many more likely to be discovered because of the advances in viral surveillance and next generation sequencing. Yet no study to date has identified human AstV genotypes in animals, although diverse AstV genotypes similar to animal-origin viruses have been found in children with diarrhea and in one instance of encephalitis. Here we provide important new evidence that non-human primates (NHP) can harbor a wide variety of mammalian and avian AstV genotypes, including those only associated with human infection. Serological analyses confirmed that >25% of the NHP tested had antibodies to human AstVs. Further, we identified a recombinant AstV with parental relationships to known human AstVs. Phylogenetic analysis suggests AstVs in NHP are on average evolutionarily much closer to AstVs from other animals than are AstVs from bats, a frequently proposed reservoir. Our studies not only demonstrate that human astroviruses can be detected in NHP but also suggest that NHP are unique in their ability to support diverse AstV genotypes, further challenging the paradigm that astrovirus infection is species-specific.","[Karlsson, Erik A.; Freiden, Pamela; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Small, Christopher T.; Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98104 USA; [Feeroz, M. M.; Hasan, M. Kamrul] Jahangirnagar Univ, Dept Zool, Savar, Bangladesh; [San, Sorn] Natl Inst Vet Res, Phnom Penh, Cambodia; [Wang, David] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Jones-Engel, Lisa] Univ Washington, Natl Primate Res Ctr, Seattle, WA 98195 USA","Karlsson, EA (reprint author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.",ljengel@uw.edu; stacey.schultz-cherry@stjude.org,"Schultz-Cherry, Stacey/N-2506-2018; Karlsson, Erik/M-3577-2017","Karlsson, Erik/0000-0001-6004-5671","NIH-NIAID [R01 AI078229, R01AI078229-03S1, R03 AI064865]; NIH-NCRR [P51 RR000166]; ALSAC; Hartwell Foundation; NIAID [HHSN272201400006C]","This research was supported by funding from NIH-NIAID grants R01 AI078229, R01AI078229-03S1, R03 AI064865, NIH-NCRR grant P51 RR000166 to LJE, New Development Institutional Support from the Fred Hutchinson Cancer Research Center to FAM, and funding from ALSAC, the Hartwell Foundation, and NIAID contract HHSN272201400006C to SSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,28,28,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005225,10.1371/journal.ppat.1005225,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000010,26571270.0,"DOAJ Gold, Green Published",,,16/08/2019,28,62,26,5164,565,327,238,4599,4054,43,502,26,28,0,0,29,29,3,,36,5,36,0,5,29,29,17,17,0,0,0,0,0,0,3,34,17,5223,23,1,40,93,1,4621,571,23,1,40,93,1,31,,0,2,0,0,24,0,0,0,0,0,0,36,0,0,24.98,9.139823008849557,1.1228527940856707,0.12285279408567079,1.1609045444661883,1.0338884585592565,9.449557522123893
281,J,"Kawaguchi, A; Hirohama, M; Harada, Y; Osari, S; Nagata, K",,,,"Kawaguchi, Atsushi; Hirohama, Mikako; Harada, Yoshimi; Osari, Suguru; Nagata, Kyosuke",,,Influenza Virus Induces Cholesterol-Enriched Endocytic Recycling Compartments for Budozone Formation via Cell Cycle-Independent Centrosome Maturation,PLOS PATHOGENS,,,English,Article,,,,,,,LIPID RAFTS; PERICENTRIOLAR MATERIAL; CYTOPLASMIC TAILS; ION-CHANNEL; M2 PROTEIN; A VIRUS; MEMBRANE; MICROTUBULES; RAB11; YB-1,"Influenza virus particles are assembled at the plasma membrane in concert with incorporation of the virus genome, but the details of its spatio-temporal regulation are not understood. Here we showed that influenza virus infection induces the assembly of pericentrosomal endocytic recycling compartment (ERC) through the activation of Rab11a GTPase and cell cycle-independent maturation of centrosome by YB-1, a multifunctional protein that is involved in mitotic division, RNA metabolism and tumorigenesis. YB-1 is recruited to the centrosome in infected cells and is required for anchoring microtubules to the centrosome. We also found that viral infection accumulates cholesterol in ERC and is dependent on YB-1. Depletion of YB-1 shows reduced cholesterol-enriched ERC and prevented budozone formation at the plasma membrane. These results suggest that cholesterol in recycling endosomes, which are emanated from ERC, may trigger the virus assembly concomitantly with the packaging of the virus genome. We propose that the virus genome is transported to the plasma membrane by cholesterol-enriched recycling endosomes through cell cycle-independent activation of the centrosome by YB-1.","[Kawaguchi, Atsushi; Hirohama, Mikako; Nagata, Kyosuke] Univ Tsukuba, Fac Med, Dept Infect Biol, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atsushi; Harada, Yoshimi; Osari, Suguru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan","Kawaguchi, A (reprint author), Univ Tsukuba, Fac Med, Dept Infect Biol, Tsukuba, Ibaraki, Japan.",ats-kawaguchi@md.tsukuba.ac.jp,,"Kawaguchi, Atsushi/0000-0002-5485-1578","Ministry of Education, Culture, Sports, Science, and Technology of Japan [26860299, 24115002]","This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26860299 for AK and 24115002 for KN; https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,14,16,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005284,10.1371/journal.ppat.1005284,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000037,26575487.0,"DOAJ Gold, Green Published",,,16/08/2019,14,3,25,4201,442,298,144,3759,3057,19,683,25,2,4,0,18,18,1,,29,0,29,0,0,20,15,20,13,0,0,0,0,0,0,0,1,4,4264,109,3,279,51,1,3787,448,109,3,279,51,1,29,,0,0,0,0,3,0,1,1,0,0,0,29,0,0,2.0,9.504524886877828,1.1175844639531791,0.11758446395317904,1.1769087523277468,1.0530825993810997,10.009049773755656
282,J,"Le Coupanec, A; Desforges, M; Meessen-Pinard, M; Dube, M; Day, R; Seidah, NG; Talbot, PJ",,,,"Le Coupanec, Alain; Desforges, Marc; Meessen-Pinard, Mathieu; Dube, Mathieu; Day, Robert; Seidah, Nabil G.; Talbot, Pierre J.",,,Cleavage of a Neuroinvasive Human Respiratory Virus Spike Glycoprotein by Proprotein Convertases Modulates Neurovirulence and Virus Spread within the Central Nervous System,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN CORONAVIRUS OC43; MOUSE HEPATITIS-VIRUS; TO-CELL FUSION; MURINE CORONAVIRUS; PROTEOLYTIC CLEAVAGE; BOVINE CORONAVIRUSES; PERSISTENT INFECTION; PROTEIN CLEAVAGE; FURIN CLEAVAGE; BALB/C MICE,"Human coronaviruses (HCoV) are respiratory pathogens that may be associated with the development of neurological diseases, in view of their neuroinvasive and neurotropic properties. The viral spike (S) glycoprotein is a major virulence factor for several coronavirus species, including the OC43 strain of HCoV (HCoV-OC43). In an attempt to study the role of this protein in virus spread within the central nervous system (CNS) and neurovirulence, as well as to identify amino acid residues important for such functions, we compared the sequence of the S gene found in the laboratory reference strain HCoV-OC43 ATCC VR-759 to S sequences of viruses detected in clinical isolates from the human respiratory tract. We identified one predominant mutation at amino acid 758 (from RRSR down arrow(G) under bar 758 to RRSR down arrow(R) under bar 758), which introduces a putative furin-like cleavage (down arrow) site. Using a molecular cDNA infectious clone to generate a corresponding recombinant virus, we show for the first time that such point mutation in the HCoV-OC43 S glycoprotein creates a functional cleavage site between the S1 and S2 portions of the S protein. While the corresponding recombinant virus retained its neuroinvasive properties, this mutation led to decreased neurovirulence while potentially modifying the mode of virus spread, likely leading to a limited dissemination within the CNS. Taken together, these results are consistent with the adaptation of HCoV-OC43 to the CNS environment, resulting from the selection of quasi-species harboring mutations that lead to amino acid changes in viral genes, like the S gene in HCoV-OC43, which may contribute to a more efficient establishment of a less pathogenic but persistent CNS infection. This adaptative mechanism could potentially be associated with human encephalitis or other neurological degenerative pathologies.","[Le Coupanec, Alain; Desforges, Marc; Meessen-Pinard, Mathieu; Dube, Mathieu; Talbot, Pierre J.] Univ Quebec, INRS Inst Armand Frappier, Lab Neuroimmunovirol, Laval, PQ, Canada; [Day, Robert] Univ Sherbrooke, Fac Med & Sci Sante, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada","Le Coupanec, A (reprint author), Univ Quebec, INRS Inst Armand Frappier, Lab Neuroimmunovirol, Laval, PQ, Canada.",marc.desforges@iaf.inrs.ca; pierre.talbot@iaf.inrs.ca,"Seidah, Nabil/I-3596-2013","Seidah, Nabil/0000-0001-6503-9342",Canadian Institutes of Health Research (CIHR) [MIF-79633]; CIHR's Institute of Infection and Immunity (III) [MT-9203]; Tier-1 (Senior) Canada Research Chair in Neuroimmunovirology award; Fondation Universitaire Armand-Frappier de l'INRS; Fonds de recherche Quebec - Sante,"This work was initially supported by Grant No. MIF-79633 from the Canadian Institutes of Health Research (CIHR; http://www.cihr.ca) to RD, PJT, NGS and ALC, but most of the work presented was supported by Grant No. MT-9203 from the CIHR's Institute of Infection and Immunity (III; http://www.cihr.ca/e/13533.html) to PJT, who is the holder of the Tier-1 (Senior) Canada Research Chair in Neuroimmunovirology award (http://www.chairs-chaires.gc.ca). ALC acknowledges a doctoral studentship from Fondation Universitaire Armand-Frappier de l'INRS (http://www.fondation-afrappier-inrs.ca), MMP a doctoral studentship from the Fonds de recherche Quebec - Sante (http:// www.fondation-afrappier-inrs.ca), MDu is grateful for a postdoctoral fellowship, also from the Fonds de recherche Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,6,6,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005261,10.1371/journal.ppat.1005261,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000023,26545254.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,6,20,8,3542,439,304,135,3103,2636,14,453,8,4,0,0,6,6,1,,10,1,10,0,1,6,6,6,4,0,0,0,0,0,0,3,16,0,3589,39,0,46,182,1,3112,447,39,0,46,182,1,30,,3,0,0,0,2,0,0,1,0,0,0,10,0,0,27.5,8.068337129840547,1.1414759909764745,0.14147599097647437,1.2278440219142766,1.075663466967815,8.67881548974943
283,J,"Nomura, T; Yamamoto, H; Ishii, H; Akari, H; Naruse, TK; Kimura, A; Matano, T",,,,"Nomura, Takushi; Yamamoto, Hiroyuki; Ishii, Hiroshi; Akari, Hirofumi; Naruse, Taeko K.; Kimura, Akinori; Matano, Tetsuro",,,Broadening of Virus-Specific CD8(+) T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers,PLOS PATHOGENS,,,English,Article,,,,,,,LYMPHOCYTE-BASED CONTROL; PRIMARY HIV-1 INFECTION; HIGHLY PATHOGENIC SIV; IMMUNODEFICIENCY-VIRUS; RHESUS MACAQUES; IMMUNE CONTROL; VACCINE TRIAL; AIDS; VIREMIA; ESCAPE,"Control of HIV replication is a rare immunological event, providing clues to understand the viral control mechanism. CD8(+) T-cell responses are crucial for virus control, but it is unclear whether lasting HIV containment can be achieved after establishment of infection. Here, we describe lasting SIV containment in a macaque AIDS model. Analysis of ten rhesus macaques that controlled viremia for 2 years post-infection found accumulation of proviral gag and nef CD8(+) T-cell escape mutations in four of them. These four controllers mounted CD8(+) T cells targeting Gag, Nef, and other viral proteins at 4 months, suggesting that broadening of CD8(+) T-cell targets can be an indicator of the beginning of viral control failure. The remaining six aviremic SIV controllers, however, harbored proviruses without mutations and showed no or little broadening of their CD8(+) T-cell responses in the chronic phase. Indeed, three of the latter six exhibiting no change in CD8(+) T-cell targets showed gradual decreases in SIV-specific CD8(+) T-cell frequencies, implying a concomitant reduction in viral replication. Thus, stability of the breadth of virus-specific CD8(+) T-cell responses may represent a status of lasting HIV containment by CD8(+) T cells.","[Nomura, Takushi; Yamamoto, Hiroyuki; Ishii, Hiroshi; Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Akari, Hirofumi] Kyoto Univ, Primate Res Inst, Ctr Human Evolut Modeling Res, Inuyama, Aichi 484, Japan; [Naruse, Taeko K.; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo, Japan; [Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Tokyo, Japan","Nomura, T (reprint author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.",tmatano@nih.go.jp,,"Akari, Hirofumi/0000-0003-2166-6015","Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) ([JSPS] KAKENHI) [23390115, 25893294, 15K19119, 15H04737, 15H01271]; Ministry of Health, Labor and Welfare in Japan (MHLW) [H24-AIDS-006]; Japan Agency for Medical Research and Development (AMED) [15fk0410003h0003, 15fk0410012h0001]","This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT: http://www.mext.go.jp/english/) ([JSPS] KAKENHI Grants 23390115, 25893294, 15K19119, 15H04737, and 15H01271), grants-in-aid from the Ministry of Health, Labor and Welfare in Japan (MHLW: http://www.mhlw.go.jp/english/index.html) (H24-AIDS-006), and Research Programs on HIV/AIDS, Emerging and Reemerging Infectious Diseases, and Global Health Issues from Japan Agency for Medical Research and Development (AMED: http://www.amed.go.jp/en/) (15fk0410003h0003, 15fk0410012h0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,53,3,3,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005247,10.1371/journal.ppat.1005247,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000015,26536034.0,"DOAJ Gold, Green Published",,,16/08/2019,0,18,11,2653,253,174,79,2400,2030,19,351,11,7,0,0,3,3,0,,12,0,12,0,0,3,3,3,2,0,0,0,0,0,0,0,11,6,2676,21,0,23,147,0,2398,253,21,0,23,147,0,25,,0,0,0,0,10,0,0,1,0,0,0,12,0,0,4.75,10.486166007905139,1.1054166666666667,0.10541666666666667,1.185,1.0719939690915945,11.24110671936759
284,J,"O'Neill, MB; Mortimer, TD; Pepperell, CS",,,,"O'Neill, Mary B.; Mortimer, Tatum D.; Pepperell, Caitlin S.",,,Diversity of Mycobacterium tuberculosis across Evolutionary Scales,PLOS PATHOGENS,,,English,Article,,,,,,,PHTHIOCEROL DIMYCOCEROSATE PDIM; TAGGED TRANSPOSON MUTAGENESIS; DRUG-RESISTANCE; POPULATION DIFFERENTIATION; GENETIC REQUIREMENTS; POSITIVE SELECTION; NATURAL-SELECTION; SEQUENCING DATA; MYCOLIC ACIDS; IN-VITRO,"Tuberculosis (TB) is a global public health emergency. Increasingly drug resistant strains of Mycobacterium tuberculosis (M.tb) continue to emerge and spread, highlighting adaptability of this pathogen. Most studies of M.tb evolution have relied on 'between-host' samples, in which each person with TB is represented by a single M.tb isolate. However, individuals with TB commonly harbor populations of M.tb numbering in the billions. Here, we use analyses of M.tb genomic data from within and between hosts to gain insight into influences shaping genetic diversity of this pathogen. We find that the amount of M.tb genetic diversity harbored by individuals with TB can vary dramatically, likely as a function of disease severity. Surprisingly, we did not find an appreciable impact of TB treatment on M.tb diversity. In examining genomic data from M.tb samples within and between hosts with TB, we find that genes involved in the regulation, synthesis, and transportation of immunomodulatory cell envelope lipids appear repeatedly in the extremes of various statistical measures of diversity. Many of these genes have been identified as possible targets of selection in other studies employing different methods and data sets. Taken together, these observations suggest that M.tb cell envelope lipids are targets of selection within hosts. Many of these lipids are specific to pathogenic mycobacteria and, in some cases, human-pathogenic mycobacteria. We speculate that rapid adaptation of cell envelope lipids is facilitated by functional redundancy, flexibility in their metabolism, and their roles mediating interactions with the host.","[O'Neill, Mary B.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [O'Neill, Mary B.; Mortimer, Tatum D.; Pepperell, Caitlin S.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Pepperell, Caitlin S.] Univ Wisconsin, Dept Med, Madison, WI USA","O'Neill, MB (reprint author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.",cspepper@medicine.wisc.edu,,"Pepperell, Caitlin/0000-0002-6324-1333",National Science Foundation [DGE-1255259]; National Institutes of Health [T32 GM07133],"This work was supported by the National Science Foundation Graduate Research Fellowship Program (DGE-1255259) to MBO and TDM, and the National Institutes of Health sponsored University of Wisconsin Training Grant in Genetics (T32 GM07133) to MBO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript",,114,25,27,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005257,10.1371/journal.ppat.1005257,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000021,26562841.0,"DOAJ Gold, Green Published",,,16/08/2019,30,87,88,8430,1034,767,267,7396,5956,24,1416,88,20,2,0,22,22,2,,118,26,118,0,26,31,31,30,11,0,0,0,0,0,0,1,67,15,8494,105,0,77,612,7,7361,1034,105,0,77,612,7,99,,1,1,0,1,24,0,0,1,0,0,0,118,0,0,31.75,8.152804642166345,1.13980530016225,0.13980530016224987,1.2454029204975663,1.0926453143534993,8.908123791102515
285,J,"Pakharukova, N; Garnett, JA; Tuittila, M; Paavilainen, S; Diallo, M; Xu, YQ; Matthews, SJ; Zavialov, AV",,,,"Pakharukova, Natalia; Garnett, James A.; Tuittila, Minna; Paavilainen, Sari; Diallo, Mamou; Xu, Yingqi; Matthews, Steve J.; Zavialov, Anton V.",,,Structural Insight into Archaic and Alternative Chaperone-Usher Pathways Reveals a Novel Mechanism of Pilus Biogenesis,PLOS PATHOGENS,,,English,Article,,,,,,,DRIVES FIBER FORMATION; ESCHERICHIA-COLI; ACINETOBACTER-BAUMANNII; BIOFILM FORMATION; YERSINIA-PESTIS; COMMON PILUS; FIMBRIAE; BACTERIA; COMPLEX; ANTIGEN,"Gram-negative pathogens express fibrous adhesive organelles that mediate targeting to sites of infection. The major class of these organelles is assembled via the classical, alternative and archaic chaperone-usher pathways. Although non-classical systems share a wider phylogenetic distribution and are associated with a range of diseases, little is known about their assembly mechanisms. Here we report atomic-resolution insight into the structure and biogenesis of Acinetobacter baumannii Csu and Escherichia coli ECP biofilm-mediating pili. We show that the two non-classical systems are structurally related, but their assembly mechanism is strikingly different from the classical assembly pathway. Non-classical chaperones, unlike their classical counterparts, maintain subunits in a substantially disordered conformational state, akin to a molten globule. This is achieved by a unique binding mechanism involving the register-shifted donor strand complementation and a different subunit carboxylate anchor. The subunit lacks the classical pre-folded initiation site for donor strand exchange, suggesting that recognition of its exposed hydrophobic core starts the assembly process and provides fresh inspiration for the design of inhibitors targeting chaperone-usher systems.","[Pakharukova, Natalia; Tuittila, Minna; Paavilainen, Sari; Zavialov, Anton V.] Univ Turku, Dept Chem, JBL, Turku, Finland; [Garnett, James A.; Diallo, Mamou; Xu, Yingqi; Matthews, Steve J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Struct Biol Ctr, London, England","Pakharukova, N (reprint author), Univ Turku, Dept Chem, JBL, Turku, Finland.",antzav@utu.fi,"Pakharukova, Natalia/U-7382-2019; Diallo, Mamou/O-4844-2019; Zavialov, Anton/C-7664-2015","Pakharukova, Natalia/0000-0002-8363-6105; Diallo, Mamou/0000-0001-9384-2052; Matthews, Steve/0000-0003-0676-0927; Zavialov, Anton/0000-0001-6191-5931","Finnish Academy [140959, 273075]; Sigrid Juselius Foundation; Wellcome Trust [100280, 079819]","AVZ is supported by the Finnish Academy (grants 140959 and 273075; http://sciencenordic.com/partner/academy-finland) and Sigrid Juselius Foundation (grant 2014; www.sigridjuselius.fi/foundation). SMis supported by the Wellcome Trust (Senior Investigator Award 100280, Programme grant 079819; http://www.wellcome.ac.uk) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,31,7,7,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005269,10.1371/journal.ppat.1005269,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000029,26587649.0,"DOAJ Gold, Green Published",,,16/08/2019,7,4,14,3373,533,377,156,2840,2366,15,459,14,4,0,0,8,8,0,,24,1,24,0,1,8,8,5,5,0,0,0,0,0,0,0,0,3,3378,100,0,50,99,1,2828,533,100,0,50,99,1,17,,0,0,0,0,5,0,0,1,0,0,0,24,0,0,2.85,6.328330206378987,1.1876760563380282,0.18767605633802817,1.259507042253521,1.060480284613104,6.711069418386492
286,J,"Rhein, BA; Powers, LS; Rogers, K; Anantpadma, M; Singh, BK; Sakurai, Y; Bair, T; Miller-Hunt, C; Sinn, P; Davey, RA; Monick, MM; Maury, W",,,,"Rhein, Bethany A.; Powers, Linda S.; Rogers, Kai; Anantpadma, Manu; Singh, Brajesh K.; Sakurai, Yasuteru; Bair, Thomas; Miller-Hunt, Catherine; Sinn, Patrick; Davey, Robert A.; Monick, Martha M.; Maury, Wendy",,,Interferon-gamma Inhibits Ebola Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,VESICULAR STOMATITIS-VIRUS; HUMAN ALVEOLAR MACROPHAGES; HEMORRHAGIC-FEVER; DENDRITIC CELLS; IFN-GAMMA; STIMULATED GENES; ZAIRE-EBOLAVIRUS; ENTRY REQUIRES; PRIMATE MODELS; RABIES VIRUS,"Ebola virus outbreaks, such as the 2014 Makona epidemic in West Africa, are episodic and deadly. Filovirus antivirals are currently not clinically available. Our findings suggest interferon gamma, an FDA-approved drug, may serve as a novel and effective prophylactic or treatment option. Using mouse-adapted Ebola virus, we found that murine interferon gamma administered 24 hours before or after infection robustly protects lethally-challenged mice and reduces morbidity and serum viral titers. Furthermore, we demonstrated that interferon gamma profoundly inhibits Ebola virus infection of macrophages, an early cellular target of infection. As early as six hours following in vitro infection, Ebola virus RNA levels in interferon gamma-treated macrophages were lower than in infected, untreated cells. Addition of the protein synthesis inhibitor, cycloheximide, to interferon gamma-treated macrophages did not further reduce viral RNA levels, suggesting that interferon gamma blocks life cycle events that require protein synthesis such as virus replication. Microarray studies with interferon gamma-treated human macrophages identified more than 160 interferon-stimulated genes. Ectopic expression of a select group of these genes inhibited Ebola virus infection. These studies provide new potential avenues for antiviral targeting as these genes that have not previously appreciated to inhibit negative strand RNA viruses and specifically Ebola virus infection. As treatment of interferon gamma robustly protects mice from lethal Ebola virus infection, we propose that interferon gamma should be further evaluated for its efficacy as a prophylactic and/or therapeutic strategy against filoviruses. Use of this FDA-approved drug could rapidly be deployed during future outbreaks.","[Rhein, Bethany A.; Rogers, Kai; Miller-Hunt, Catherine; Maury, Wendy] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Powers, Linda S.; Monick, Martha M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Anantpadma, Manu; Sakurai, Yasuteru; Davey, Robert A.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA; [Singh, Brajesh K.; Sinn, Patrick] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Bair, Thomas] Univ Iowa, Iowa Inst Human Genet, Iowa City, IA USA","Rhein, BA (reprint author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.",wendy-maury@uiowa.edu,"Sinn, Patrick/M-8026-2018; Singh, B/J-3344-2019","Sinn, Patrick/0000-0002-9746-966X; Singh, B/0000-0002-5311-543X; Anantpadma, Manu/0000-0001-5796-532X; Brunton, Bethany/0000-0003-3951-815X; Maury, Wendy/0000-0002-9892-4484","National Institutes of Health [RO1AI077519, RO1 HL096625, R21HL109589]; University of Iowa Environmental Health Sciences Research Center [P30ES005605]; NIH [T32AU996343]; Ewing Halsell Foundation; Department of Defense [HDTRA-1-12-1-00-2]","This research was supported by the following grants from National Institutes of Health: RO1AI077519 to WM and RO1 HL096625 and R21HL109589 to MMM. MMM also received support from the University of Iowa Environmental Health Sciences Research Center that is supported by P30ES005605. CMH was funded by NIH T32AU996343. The Ewing Halsell Foundation (http://www.ewinghalsell.org/includes/index.php) provided support to RAD along with the Department of Defense (HDTRA-1-12-1-00-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,99,29,31,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005263,10.1371/journal.ppat.1005263,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000025,26562011.0,"DOAJ Gold, Green Published",,,16/08/2019,29,49,38,10268,1706,1304,402,8562,7058,21,1483,38,32,0,0,29,29,4,,63,10,63,0,10,34,32,34,20,0,0,0,0,0,0,1,19,17,10593,88,18,106,887,6,8767,1718,88,18,106,887,6,108,,9,3,1,0,42,0,0,0,0,0,0,65,0,0,108.986,6.018757327080891,1.1992525110955383,0.19925251109553843,1.3510861948142958,1.1266069341643943,6.780773739742087
287,J,"Rodrigues, JA; Acosta-Serrano, A; Aebi, M; Ferguson, MAJ; Routier, FH; Schiller, I; Soares, S; Spencer, D; Titz, A; Wilson, IBH; Izquierdo, L",,,,"Rodrigues, Joao A.; Acosta-Serrano, Alvaro; Aebi, Markus; Ferguson, Michael A. J.; Routier, Francoise H.; Schiller, Irene; Soares, Simao; Spencer, Daniel; Titz, Alexander; Wilson, Iain B. H.; Izquierdo, Luis",,,Parasite Glycobiology: A Bittersweet Symphony,PLOS PATHOGENS,,,English,Article,,,,,,,TRYPANOSOMA-BRUCEI; PLASMODIUM-FALCIPARUM; LEISHMANIA-MAJOR; IMMUNE-RESPONSE; LINKED GLYCANS; IDENTIFICATION; BIOSYNTHESIS; CRUZI,,"[Rodrigues, Joao A.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Acosta-Serrano, Alvaro] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Aebi, Markus] ETH, Swiss Fed Inst Technol, Inst Microbiol, Dept Biol, Zurich, Switzerland; [Ferguson, Michael A. J.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Routier, Francoise H.] Hannover Med Sch, Hannover, Germany; [Schiller, Irene] Malcisbo AG, Zurich, Switzerland; [Soares, Simao] SilicoLife Lda, Guimaraes, Portugal; [Spencer, Daniel] Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England; [Titz, Alexander] Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany; [Wilson, Iain B. H.] Univ Bodenkultur Wien, A-1180 Vienna, Austria; [Izquierdo, Luis] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain","Rodrigues, JA (reprint author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.",j.rodrigues@medicina.ulisboa.pt; luis.izquierdo@isglobal.org,"Routier, Francoise/O-1611-2019; Izquierdo, Luis/L-9291-2015; Acosta-Serrano, Alvaro/L-5503-2015; Rodrigues, Joao/I-5462-2018; Titz, Alexander/E-6701-2010; Wilson, Iain/B-3326-2009","Izquierdo, Luis/0000-0002-3704-9874; Acosta-Serrano, Alvaro/0000-0002-2576-7959; Rodrigues, Joao/0000-0001-7006-3048; Routier, Francoise/0000-0002-7163-0590; Titz, Alexander/0000-0001-7408-5084; Wilson, Iain/0000-0001-8996-1518; Ferguson, Michael/0000-0003-1321-8714",GlycoPar Marie Curie Initial Training Network (EU) [GA. 608295],"This work was supported by GlycoPar Marie Curie Initial Training Network (EU FP7 funded, GA. 608295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,24,18,18,1,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005169,10.1371/journal.ppat.1005169,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000002,26562305.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,18,79,54,6368,573,408,165,5795,4795,18,982,54,39,0,0,17,17,1,,68,3,68,0,3,19,19,13,11,0,0,0,0,0,0,0,40,23,6475,9,0,18,94,1,5820,594,9,0,18,94,1,61,,0,0,0,0,34,0,1,0,0,0,0,66,0,0,20.45,11.113438045375219,1.0988783433994822,0.09887834339948232,1.1351164797239,1.0329773869346734,11.479930191972077
288,J,"Scaturro, P; Cortese, M; Chatel-Chaix, L; Fischl, W; Bartenschlager, R",,,,"Scaturro, Pietro; Cortese, Mirko; Chatel-Chaix, Laurent; Fischl, Wolfgang; Bartenschlager, Ralf",,,Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins,PLOS PATHOGENS,,,English,Article,,,,,,,WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; N-LINKED GLYCOSYLATION; VIRAL-RNA REPLICATION; NS1 PROTEIN; 3-DIMENSIONAL ARCHITECTURE; MONOCLONAL-ANTIBODIES; COMPLEMENT ACTIVATION; GLYCOPROTEIN NS1; COMMON EPITOPES,"Non-structural protein 1 (NS1) is one of the most enigmatic proteins of the Dengue virus (DENV), playing distinct functions in immune evasion, pathogenesis and viral replication. The recently reported crystal structure of DENV NS1 revealed its peculiar three-dimensional fold; however, detailed information on NS1 function at different steps of the viral replication cycle is still missing. By using the recently reported crystal structure, as well as amino acid sequence conservation, as a guide for a comprehensive site-directed mutagenesis study, we discovered that in addition to being essential for RNA replication, DENV NS1 is also critically required for the production of infectious virus particles. Taking advantage of a trans-complementation approach based on fully functional epitope-tagged NS1 variants, we identified previously unreported interactions between NS1 and the structural proteins Envelope (E) and precursor Membrane (prM). Interestingly, coimmunoprecipitation revealed an additional association with capsid, arguing that NS1 interacts via the structural glycoproteins with DENV particles. Results obtained with mutations residing either in the NS1 Wing domain or in the beta-ladder domain suggest that NS1 might have two distinct functions in the assembly of DENV particles. By using a trans-complementation approach with a C-terminally KDEL-tagged ER-resident NS1, we demonstrate that the secretion of NS1 is dispensable for both RNA replication and infectious particle production. In conclusion, our results provide an extensive genetic map of NS1 determinants essential for viral RNA replication and identify a novel role of NS1 in virion production that is mediated via interaction with the structural proteins. These studies extend the list of NS1 functions and argue for a central role in coordinating replication and assembly/release of infectious DENV particles.","[Scaturro, Pietro; Cortese, Mirko; Chatel-Chaix, Laurent; Fischl, Wolfgang; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany","Scaturro, P (reprint author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.",pietro.scaturro@med.uni-heidelberg.de; ralf.bartenschlager@med.uni-heidelberg.de,,"Scaturro, Pietro/0000-0001-9098-3087; Cortese, Mirko/0000-0003-1786-4211","Marie-Curie ITN Fellowship (EUVIRNA); European Union (EUVIRNA) [264286]; Deutsche Forschungsgemeinschaft [SFB638, SFB1129]","PS was supported by a Marie-Curie ITN Fellowship (EUVIRNA). This work was supported by grants from the European Union (EUVIRNA [grant no. 264286]) and the Deutsche Forschungsgemeinschaft (SFB638, Teilprojekt A5 and SFB1129, Teilprojekt 11), all to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,53,57,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005277,10.1371/journal.ppat.1005277,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000033,26562291.0,"DOAJ Gold, Green Published",,,16/08/2019,53,19,106,17418,2408,1640,768,15010,11503,43,3464,106,0,0,0,55,55,0,,173,5,173,0,5,58,58,42,33,0,0,0,0,0,0,0,20,0,17310,98,1,238,126,0,14862,2408,98,1,238,126,0,40,,0,1,0,0,0,0,0,0,0,0,0,172,0,0,5.008,7.233388704318937,1.1604263824117256,0.16042638241172552,1.1681545636242505,1.0066597772419337,7.28156146179402
289,J,"Schwartz, IS; Kenyon, C; Feng, PY; Govender, NP; Dukik, K; Sigler, L; Jiang, YP; Stielow, JB; Munoz, JF; Cuomo, CA; Botha, A; Stchigel, AM; de Hoog, GS",,,,"Schwartz, Ilan S.; Kenyon, Chris; Feng, Peiying; Govender, Nelesh P.; Dukik, Karolina; Sigler, Lynne; Jiang, Yanping; Stielow, J. Benjamin; Munoz, Jose F.; Cuomo, Christina A.; Botha, Alfred; Stchigel, Alberto M.; de Hoog, G. Sybren",,,50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens,PLOS PATHOGENS,,,English,Article,,,,,,,CUTANEOUS DISSEMINATED MYCOSIS; PULMONARY ADIASPIROMYCOSIS; DISSEMINATED INFECTION; BLASTOMYCES; CRESCENS; PATIENT; DERMATITIDIS; TAXONOMY; LUNG,,"[Schwartz, Ilan S.] Univ Antwerp, Dept Epidemiol & Social Med, Int Hlth Unit, B-2020 Antwerp, Belgium; [Schwartz, Ilan S.] Univ Manitoba, Fac Hlth Sci, Coll Med, Dept Med Microbiol, Winnipeg, MB, Canada; [Kenyon, Chris] Inst Trop Med, Sexually Transmitted Infect Unit, B-2000 Antwerp, Belgium; [Kenyon, Chris; Govender, Nelesh P.] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa; [Feng, Peiying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Govender, Nelesh P.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Dukik, Karolina; Stielow, J. Benjamin; de Hoog, G. Sybren] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Sigler, Lynne] Univ Alberta, Microfungus Collect & Herbarium, Devonian Bot Garden, Edmonton, AB, Canada; [Jiang, Yanping] Guizhou Med Univ, Affiliated Hosp, Dept Dermatol, Guiyang 550004, Peoples R China; [Munoz, Jose F.] CIB, Cellular & Mol Biol Unit, Medellin, Colombia; [Munoz, Jose F.] Univ Antioquia, Inst Biol, Medellin, Colombia; [Cuomo, Christina A.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Botha, Alfred] Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, Western Cape, South Africa; [Stchigel, Alberto M.] Univ Rovira & Virgili, Sch Med, Mycol Unit, E-43201 Reus, Spain; [Stchigel, Alberto M.] Univ Rovira & Virgili, Pere Virgili Inst Hlth Res, E-43201 Reus, Spain","Schwartz, IS (reprint author), Univ Antwerp, Dept Epidemiol & Social Med, Int Hlth Unit, B-2020 Antwerp, Belgium.",s.hoog@cbs.knaw.nl,"Schwartz, Ilan S./J-5666-2019; Cuomo, Christina/L-2222-2019; Stchigel, Alberto/G-1261-2016","Schwartz, Ilan S./0000-0002-7522-0281; Cuomo, Christina/0000-0002-5778-960X; Stchigel, Alberto/0000-0003-3987-7996; Botha, Alfred/0000-0003-0988-647X; Munoz, Jose/0000-0003-4987-7957","Fonds Wetenschappelijk Onderzoek-Vlaanderen [G051414N]; Association of Medical Microbiology and Infectious Diseases-Astellas post-residency research fellowship; Marie Curie International Research Staff Exchange Scheme grant; Colciencias Doctorate Program, Colciencias [1222-56934875]; Universidad de Antioquia ""Sostenibilidad""","This work was supported by a research grant from Fonds Wetenschappelijk Onderzoek-Vlaanderen (G051414N); an Association of Medical Microbiology and Infectious Diseases-Astellas post-residency research fellowship and Marie Curie International Research Staff Exchange Scheme grant (to ISS); and funding from Colciencias Doctorate Program, Colciencias grant 1222-56934875, and Universidad de Antioquia ""Sostenibilidad"" 2014/15 (to JFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,36,24,25,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005198,10.1371/journal.ppat.1005198,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000006,26584311.0,"DOAJ Gold, Green Published",,,16/08/2019,28,72,24,7322,2042,1635,407,5280,4523,27,730,24,10,0,2,31,31,0,,32,3,32,0,3,36,31,36,15,0,0,0,0,0,0,0,62,15,7460,31,25,90,83,4,5314,2104,31,25,90,83,4,42,,0,0,0,0,18,0,0,1,1,0,0,31,0,0,9.95,3.585700293829579,1.3867424242424242,0.3867424242424242,1.434469696969697,1.034416826003824,3.7091087169441725
290,J,"Scull, MA; Schneider, WM; Flatley, BR; Hayden, R; Fung, C; Jones, CT; van de Belt, M; Penin, F; Rice, CM",,,,"Scull, Margaret A.; Schneider, William M.; Flatley, Brenna R.; Hayden, Robert; Fung, Canny; Jones, Christopher T.; van de Belt, Marieke; Penin, Francois; Rice, Charles M.",,,The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production,PLOS PATHOGENS,,,English,Article,,,,,,,SUBCELLULAR-LOCALIZATION; 3-DIMENSIONAL STRUCTURE; IMINOSUGAR DERIVATIVES; MOLECULAR-DYNAMICS; E2 GLYCOPROTEIN; REPLICATION; HCV; AMANTADINE; POLYPEPTIDE; INHIBITORS,"The hepatitis C virus (HCV) p7 protein is required for infectious virus production via its role in assembly and ion channel activity. Although NMR structures of p7 have been reported, the location of secondary structural elements and orientation of the p7 transmembrane domains differ among models. Furthermore, the p7 structure-function relationship remains unclear. Here, extensive mutagenesis, coupled with infectious virus production phenotyping and molecular modeling, demonstrates that the N-terminal helical region plays a previously underappreciated yet critical functional role, especially with respect to E2/p7 cleavage efficiency. Interrogation of specific N-terminal helix residues identified as having p7-specific defects and predicted to point toward the channel pore, in a context of independent E2/p7 cleavage, further supports p7 as a structurally plastic, minimalist ion channel. Together, our findings indicate that the p7 N-terminal helical region is critical for E2/p7 processing, protein-protein interactions, ion channel activity, and infectious HCV production.","[Scull, Margaret A.; Schneider, William M.; Flatley, Brenna R.; Hayden, Robert; Fung, Canny; Jones, Christopher T.; van de Belt, Marieke; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; [Penin, Francois] Univ Lyon 1, IBCP, Bases Mol & Struct Syst Infect, Labex Ecofect, F-69365 Lyon, France; [Penin, Francois] CNRS, UMR 5086, Lyon, France","Scull, MA (reprint author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.",mscull@rockefeller.edu; ricec@rockefeller.edu,"Scull, Margaret/K-9963-2019","Scull, Margaret/0000-0002-6860-2468","National Institute of Allergy and Infectious Diseases [R01 AI075099]; Starr Foundation; Greenberg Medical Research Institute; Richard Salomon Family Foundation; Ronald A. Shellow, M.D. Memorial Fund; MGM Mirage Voice Foundation; National Research Service Awards from the National Institute of Allergy and Infectious Diseases [F32 AI091207]; National Institute of Diabetes, Digestive and Kidney Diseases [F32 DK081193]; Mapping project [ANR-11-BINF-003]; French ANRS (France Recherche, Nord & Sud, Sida-HIV et Hepatites); INSERM, France","This work was supported in part by the National Institute of Allergy and Infectious Diseases (R01 AI075099, to CMR). Additional funding was provided by the Starr Foundation, the Greenberg Medical Research Institute, the Richard Salomon Family Foundation, the Ronald A. Shellow, M.D. Memorial Fund, the MGM Mirage Voice Foundation, Gregory F. Lloyd Memorial contributions, and anonymous donors. MAS and CTJ were supported by National Research Service Awards from the National Institute of Allergy and Infectious Diseases (F32 AI091207) and the National Institute of Diabetes, Digestive and Kidney Diseases (F32 DK081193), respectively. FP is supported by the Mapping project (ANR-11-BINF-003) and the French ANRS (France Recherche, Nord & Sud, Sida-HIV et Hepatites), an autonomous agency at INSERM, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,9,9,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005297,10.1371/journal.ppat.1005297,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000040,26588073.0,"DOAJ Gold, Green Published",,,16/08/2019,9,12,9,3793,661,495,166,3132,2661,18,453,9,12,0,0,8,8,0,,0,9,0,0,9,9,9,8,6,0,0,0,0,0,0,0,0,2,3863,48,0,29,150,0,3143,674,48,0,29,150,0,46,,0,1,0,0,10,0,0,0,0,0,0,14,0,0,12.208,5.7382753403933435,1.2110472541507025,0.21104725415070244,1.2966155810983397,1.0706564724492487,6.143721633888048
291,J,"Shaw, TN; Stewart-Hutchinson, PJ; Strangward, P; Dandamudi, DB; Coles, JA; Villegas-Mendez, A; Gallego-Delgado, J; van Rooijen, N; Zindy, E; Rodriguez, A; Brewer, JM; Couper, KN; Dustin, ML",,,,"Shaw, Tovah N.; Stewart-Hutchinson, Phillip J.; Strangward, Patrick; Dandamudi, Durga B.; Coles, Jonathan A.; Villegas-Mendez, Ana; Gallego-Delgado, Julio; van Rooijen, Nico; Zindy, Egor; Rodriguez, Ana; Brewer, James M.; Couper, Kevin N.; Dustin, Michael L.",,,Perivascular Arrest of CD8(+) T Cells Is a Signature of Experimental Cerebral Malaria,PLOS PATHOGENS,,,English,Article,,,,,,,BLOOD-BRAIN-BARRIER; MICROVASCULAR ENDOTHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR VEGF; MOUSE-BRAIN; IFN-GAMMA; PROTEIN EXPRESSION; ACTIVATION; ALPHA; CNS,"There is significant evidence that brain-infiltrating CD8(+) T cells play a central role in the development of experimental cerebral malaria (ECM) during Plasmodium berghei ANKA infection of C57BL/6 mice. However, the mechanisms through which they mediate their pathogenic activity during malaria infection remain poorly understood. Utilizing intravital two-photon microscopy combined with detailed ex vivo flow cytometric analysis, we show that brain-infiltrating T cells accumulate within the perivascular spaces of brains of mice infected with both ECM-inducing (P. berghei ANKA) and non-inducing (P. berghei NK65) infections. However, perivascular T cells displayed an arrested behavior specifically during P. berghei ANKA infection, despite the brain-accumulating CD8(+) T cells exhibiting comparable activation phenotypes during both infections. We observed T cells forming long-term cognate interactions with CX3CR1-bearing antigen presenting cells within the brains during P. berghei ANKA infection, but abrogation of this interaction by targeted depletion of the APC cells failed to prevent ECM development. Pathogenic CD8(+) T cells were found to colocalize with rare apoptotic cells expressing CD31, a marker of endothelial cells, within the brain during ECM. However, cellular apoptosis was a rare event and did not result in loss of cerebral vasculature or correspond with the extensive disruption to its integrity observed during ECM. In summary, our data show that the arrest of T cells in the perivascular compartments of the brain is a unique signature of ECM-inducing malaria infection and implies an important role for this event in the development of the ECM-syndrome.","[Shaw, Tovah N.; Strangward, Patrick; Villegas-Mendez, Ana; Couper, Kevin N.] Univ Manchester, Fac Life Sci, Manchester, NH 03101 USA; [Stewart-Hutchinson, Phillip J.; Dustin, Michael L.] Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, Mol Pathogenesis Program, New York, NY USA; [Stewart-Hutchinson, Phillip J.] Washington Univ, Sch Med, Dept Pediat Res, St Louis, MO USA; [Dandamudi, Durga B.] Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, Immunol & Inflammat Program, New York, NY USA; [Coles, Jonathan A.; Brewer, James M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow, Lanark, Scotland; [Gallego-Delgado, Julio; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [van Rooijen, Nico] Vrije Univ Amsterdam Med Ctr, Dept Mol & Cell Biol, Amsterdam, Netherlands; [Zindy, Egor] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Dustin, Michael L.] Univ Oxford, Nuffield Dept Orthopaed & Musculoskeletal Sci, Kennedy Inst Rheumatol, Headington, England","Shaw, TN (reprint author), Univ Manchester, Fac Life Sci, Manchester, NH 03101 USA.",James.Brewer@glasgow.ac.uk; kevin.couper@manchester.ac.uk; michael.dustin@kennedy.ox.ac.uk,"Zindy, Egor/M-6946-2017; Brewer, James/A-7186-2010","Zindy, Egor/0000-0003-0033-0002; villegas-mendez, ana/0000-0002-8363-680X; Gallego-Delgado, Julio/0000-0002-8914-7740; Rodriguez, Ana/0000-0002-0060-3405; Shaw, Tovah/0000-0002-8107-2836; Dustin, Michael/0000-0003-4983-6389; Strangward, Patrick/0000-0001-5952-2864; Brewer, James/0000-0001-7933-0915","Medical Research Council [G0900487]; Biotechnology and Biological Sciences Research Council [I020950]; National Institutes of Health [R01AI055037, T-32-CA009161]; Wellcome Trust [100262/Z/12/Z, 088785/Z/09/Z, 085349]; Bill and Melinda Gates Foundation [OPPGH5337]; Microscopy Core via a NCRR S10 grant [RR023704-01A1]; BBSRC; University of Manchester Strategic Fund; Biotechnology and Biological Sciences Research Council [1627352, 1342401]; Medical Research Council [MR/L011840/1]","KNC was supported by a Medical Research Council (www.mrc.ac.uk) Career Development Award (G0900487) and Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) (I020950). MLD was supported by National Institutes of Health (www.nih.gov) (R01AI055037) and a Wellcome Trust (www.wellcome.ac.uk) Principal Research Fellowship (100262/Z/12/Z). PJSH was supported by a National Institutes of Health (www.nih.gov) Training Grant (T-32-CA009161). JAC was supported via the Bill and Melinda Gates Foundation (www.gatesfoundation.org) (OPPGH5337). EZ and The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, are supported by core funding from the Wellcome Trust (088785/Z/09/Z). The Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, is supported by core funding from the Wellcome Trust (085349). The Zeiss 710 MP microscope at the Skirball Institute of Biomolecular Medicine was available through the Microscopy Core via a NCRR (www.nih.gov/about/almanac/organization/NCRR) S10 grant (RR023704-01A1). The Imaris software package and microscopes utilized at the University of Manchester were purchased by the Bioimaging Facility with grants from BBSRC, Wellcome Trust and the University of Manchester Strategic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,27,29,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005210,10.1371/journal.ppat.1005210,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000008,26562533.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,32,1,37,5452,1007,755,252,4445,3609,21,815,37,1,2,1,32,32,0,,53,2,53,0,2,33,32,33,21,0,0,0,0,0,0,0,0,2,5474,212,0,54,529,0,4428,1007,182,0,54,525,0,39,,1,0,0,0,3,0,0,0,1,0,0,53,0,0,11.5,5.4141012909632575,1.2265466816647919,0.2265466816647919,1.3982002249718786,1.1399486426999266,6.171797418073486
292,J,"Sommerstein, R; Flatz, L; Remy, MM; Malinge, P; Magistrelli, G; Fischer, N; Sahin, M; Bergthaler, A; Igonet, S; ter Meulen, J; Rigo, D; Meda, P; Rabah, N; Coutard, B; Bowden, TA; Lambert, PH; Siegrist, CA; Pinschewer, DD",,,,"Sommerstein, Rami; Flatz, Lukas; Remy, Melissa M.; Malinge, Pauline; Magistrelli, Giovanni; Fischer, Nicolas; Sahin, Mehmet; Bergthaler, Andreas; Igonet, Sebastien; ter Meulen, Jan; Rigo, Dorothee; Meda, Paolo; Rabah, Nadia; Coutard, Bruno; Bowden, Thomas A.; Lambert, Paul-Henri; Siegrist, Claire-Anne; Pinschewer, Daniel D.",,,Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection,PLOS PATHOGENS,,,English,Article,,,,,,,LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ARGENTINE HEMORRHAGIC-FEVER; RESPIRATORY SYNCYTIAL VIRUS; N-LINKED GLYCANS; LASSA FEVER; JUNIN VIRUS; PROTEIN-STRUCTURE; RHESUS-MONKEYS; T-CELLS; VACCINE,"Arenaviruses such as Lassa virus (LASV) can cause severe hemorrhagic fever in humans. As a major impediment to vaccine development, delayed and weak neutralizing antibody (nAb) responses represent a unifying characteristic of both natural infection and all vaccine candidates tested to date. To investigate the mechanisms underlying arenavirus nAb evasion we engineered several arenavirus envelope-chimeric viruses and glycan-deficient variants thereof. We performed neutralization tests with sera from experimentally infected mice and from LASV-convalescent human patients. NAb response kinetics in mice correlated inversely with the N-linked glycan density in the arenavirus envelope protein's globular head. Additionally and most intriguingly, infection with fully glycosylated viruses elicited antibodies, which neutralized predominantly their glycan-deficient variants, both in mice and humans. Binding studies with monoclonal antibodies indicated that envelope glycans reduced nAb on-rate, occupancy and thereby counteracted virus neutralization. In infected mice, the envelope glycan shield promoted protracted viral infection by preventing its timely elimination by the ensuing antibody response. Thus, arenavirus envelope glycosylation impairs the protective efficacy rather than the induction of nAbs, and thereby prevents efficient antibody-mediated virus control. This immune evasion mechanism imposes limitations on antibody-based vaccination and convalescent serum therapy.","[Sommerstein, Rami; Flatz, Lukas; Remy, Melissa M.; Bergthaler, Andreas; Lambert, Paul-Henri; Siegrist, Claire-Anne; Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Sommerstein, Rami; Lambert, Paul-Henri; Siegrist, Claire-Anne; Pinschewer, Daniel D.] Univ Geneva, WHO, Collaborating Ctr Vaccine Immunol, Geneva, Switzerland; [Remy, Melissa M.; Sahin, Mehmet; Pinschewer, Daniel D.] Univ Basel, Dept Biomed, Div Expt Virol, Basel, Switzerland; [Malinge, Pauline; Magistrelli, Giovanni; Fischer, Nicolas] Novimmune SA, Plan Les Ouates, Switzerland; [Igonet, Sebastien] Inst Pasteur, Dept Virol, Unit Virol Struct, Paris, France; [Igonet, Sebastien] CNRS, UMR Virol 3569, Paris, France; [ter Meulen, Jan] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Rigo, Dorothee; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Rabah, Nadia; Coutard, Bruno] Aix Marseille Univ, CNRS UMR7257, AFMB, Marseille, France; [Bowden, Thomas A.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England","Sommerstein, R (reprint author), Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland.",Daniel.Pinschewer@unibas.ch,,"Sommerstein, Rami/0000-0003-1011-6878; Bergthaler, Andreas/0000-0003-0597-1976; Bowden, Thomas/0000-0002-8066-8785",Medical Research Council [MR/L009528/1]; European Research Council (ERC) [310962]; European Union [228292-EVA]; Klaus Tschira Stiftung gGmbH; Swiss National Science Foundation [310030_149340]; Medical Research Council [MR/J007897/1],"This work was supported by the Medical Research Council (grant MR/L009528/1 to TAB), by the European Research Council (ERC grant No. 310962 to DDP), by the European Union Seventh Framework Programme (FP7/2007-2013, ""European Virus Archive"" under the grant agreement no228292-EVA to DDP), by the Klaus Tschira Stiftung gGmbH (to DDP) and by the Swiss National Science Foundation (No. 310030_149340 to DDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,81,41,41,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005276,10.1371/journal.ppat.1005276,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000032,26587982.0,"DOAJ Gold, Green Published",,,16/08/2019,40,0,50,4821,890,655,235,3931,3145,18,768,50,0,0,0,41,41,0,,131,2,67,0,2,43,43,30,29,0,0,0,0,0,0,0,0,2,4882,54,0,288,38,0,3966,905,54,0,288,38,0,11,,0,0,0,0,2,0,0,0,0,0,0,66,0,0,1.1,5.41685393258427,1.226405494785042,0.22640549478504196,1.265326888832358,1.031736154324829,5.5887640449438205
293,J,"Tseng, CW; Biancotti, JC; Berg, BL; Gate, D; Kolar, SL; Muller, S; Rodriguez, MD; Rezai-Zadeh, K; Fan, XM; Beenhouwer, DO; Town, T; Liu, GY",,,,"Tseng, Ching Wen; Biancotti, Juan Carlos; Berg, Bethany L.; Gate, David; Kolar, Stacey L.; Mueller, Sabrina; Rodriguez, Maria D.; Rezai-Zadeh, Kavon; Fan, Xuemo; Beenhouwer, David O.; Town, Terrence; Liu, George Y.",,,Increased Susceptibility of Humanized NSG Mice to Panton-Valentine Leukocidin and Staphylococcus aureus Skin Infection,PLOS PATHOGENS,,,English,Article,,,,,,,SCID IL2R-GAMMA(NULL) MICE; TOXINS; INFLAMMATION; SPECIFICITY; ANTAGONISTS; RECEPTOR; MODEL; CB,"Staphylococcus aureus is a leading cause of skin and soft-tissue infections worldwide. Mice are the most commonly used animals for modeling human staphylococcal infections. However a supra-physiologic S. aureus inoculum is required to establish gross murine skin pathology. Moreover, many staphylococcal factors, including Panton-Valentine leukocidin (PVL) elaborated by community-associated methicillin-resistant S. aureus (CA-MRSA), exhibit selective human tropism and cannot be adequately studied in mice. To overcome these deficiencies, we investigated S. aureus infection in non-obese diabetic (NOD)/severe combined immune deficiency (SCID)/IL2r gamma(null) (NSG) mice engrafted with human CD34(+) umbilical cord blood cells. These ""humanized"" NSG mice require one to two log lower inoculum to induce consistent skin lesions compared with control mice, and exhibit larger cutaneous lesions upon infection with PVL+ versus isogenic PVL-S. aureus. Neutrophils appear important for PVL pathology as adoptive transfer of human neutrophils alone to NSG mice was sufficient to induce dermonecrosis following challenge with PVL+ S. aureus but not PVL-S. aureus. PMX53, a human C5aR inhibitor, blocked PVL-induced cellular cytotoxicity in vitro and reduced the size difference of lesions induced by the PVL+ and PVL-S. aureus, but PMX53 also reduced recruitment of neutrophils and exacerbated the infection. Overall, our findings establish humanized mice as an important translational tool for the study of S. aureus infection and provide strong evidence that PVL is a human virulence factor.","[Tseng, Ching Wen; Berg, Bethany L.; Kolar, Stacey L.; Mueller, Sabrina; Rodriguez, Maria D.; Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Tseng, Ching Wen; Berg, Bethany L.; Kolar, Stacey L.; Mueller, Sabrina; Rodriguez, Maria D.; Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Tseng, Ching Wen; Berg, Bethany L.; Kolar, Stacey L.; Mueller, Sabrina; Rodriguez, Maria D.; Liu, George Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Biancotti, Juan Carlos; Gate, David; Town, Terrence] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Gate, David; Rezai-Zadeh, Kavon] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Fan, Xuemo] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Beenhouwer, David O.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Beenhouwer, David O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA","Tseng, CW (reprint author), Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.",dolorsas@gmail.com; George.Liu@cshs.org,,,US National Institutes of Health [R01: AI074832]; California Institute for Regenerative Medicine [RM1-01735],"This work was supported by a grant from a US National Institutes of Health to GYL (R01: AI074832) and a grant from the California Institute for Regenerative Medicine to TT. (RM1-01735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,35,25,26,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005292,10.1371/journal.ppat.1005292,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000039,26618545.0,"DOAJ Gold, Green Published",,,16/08/2019,21,4,24,4064,738,547,191,3326,2617,22,687,24,3,0,0,22,22,0,,33,2,33,0,2,23,23,18,16,0,0,0,0,0,0,0,1,5,4187,85,0,64,107,1,3389,758,85,0,64,107,1,40,,0,0,0,0,7,0,0,1,0,0,0,33,0,0,3.85,5.506775067750677,1.221888153938665,0.22188815393866507,1.3165965123271197,1.077509842519685,5.93360433604336
294,J,"Zhang, HL; Guo, FG; Zhu, G",,,,"Zhang, Haili; Guo, Fengguang; Zhu, Guan",,,Cryptosporidium Lactate Dehydrogenase Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Target for Developing Therapeutics,PLOS PATHOGENS,,,English,Article,,,,,,,BINDING PROTEIN ACBP; PLASMODIUM-FALCIPARUM; KINETIC-PROPERTIES; LEUKEMIA-CELLS; PARVUM; GOSSYPOL; INHIBITION; EFFICACY; NITAZOXANIDE; GENOME,"The apicomplexan, Cryptosporidium parvum, possesses a bacterial-type lactate dehydrogenase (CpLDH). This is considered to be an essential enzyme, as this parasite lacks the Krebs cycle and cytochrome-based respiration, and mainly-if not solely, relies on glycolysis to produce ATP. Here, we provide evidence that in extracellular parasites (e.g., sporozoites and merozoites), CpLDH is localized in the cytosol. However, it becomes associated with the parasitophorous vacuole membrane (PVM) during the intracellular developmental stages, suggesting involvement of the PVM in parasite energy metabolism. We characterized the biochemical features of CpLDH and observed that, at lower micromolar levels, the LDH inhibitors gossypol and FX11 could inhibit both CpLDH activity (K-i = 14.8 mu M and 55.6 mu M, respectively), as well as parasite growth in vitro (IC50 = 11.8 mu M and 39.5 mu M, respectively). These observations not only reveal a new function for the poorly understood PVM structure in hosting the intracellular development of C. parvum, but also suggest LDH as a potential target for developing therapeutics against this opportunistic pathogen, for which fully effective treatments are not yet available.","[Zhang, Haili; Guo, Fengguang; Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA","Zhang, HL (reprint author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.",gzhu@cvm.tamu.edu,"Guo, Fengguang/E-1728-2018; Guo, Fengguang/M-4482-2019","Guo, Fengguang/0000-0002-3742-7214; ","National Institute of Food and Agriculture (NIFA); United States Department of Agriculture (USDA) [TEX09529, TEX09591]; Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE) from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [U54 AI057156]","This study was supported in part by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (USDA) (http://www.nifa.usda.gov) (project numbers TEX09529 and TEX09591 to GZ), and the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE) supported by grant number U54 AI057156 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (http://www.utmb.edu/cbeid/) (subaward to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,10,11,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005250,10.1371/journal.ppat.1005250,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000017,26562790.0,"DOAJ Gold, Green Published",,,16/08/2019,9,28,12,5048,833,612,221,4215,3463,29,723,12,18,0,0,10,10,1,,23,0,23,0,0,11,11,11,7,0,0,0,0,0,0,2,10,8,5108,23,0,67,117,0,4226,850,23,0,67,117,0,32,,1,0,0,0,16,0,1,0,0,0,0,23,0,0,20.3,6.060024009603842,1.1976275207591933,0.19762752075919335,1.2450771055753262,1.0396196513470681,6.300120048019208
295,J,"Zhuo, XY; Feschotte, C",,,,"Zhuo, Xiaoyu; Feschotte, Cedric",,,Cross-Species Transmission and Differential Fate of an Endogenous Retrovirus in Three Mammal Lineages,PLOS PATHOGENS,,,English,Article,,,,,,,LTR RETROTRANSPOSONS; COMPARATIVE GENOMICS; SEQUENCE ALIGNMENT; VIRAL EVOLUTION; BATS; VIRUS; IDENTIFICATION; INSIGHTS; PHYLOGENIES; INSERTIONS,"Endogenous retroviruses (ERVs) arise from retroviruses chromosomally integrated in the host germline. ERVs are common in vertebrate genomes and provide a valuable fossil record of past retroviral infections to investigate the biology and evolution of retroviruses over a deep time scale, including cross-species transmission events. Here we took advantage of a catalog of ERVs we recently produced for the bat Myotis lucifugus to seek evidence for infiltration of these retroviruses in other mammalian species (>100) currently represented in the genome sequence database. We provide multiple lines of evidence for the cross-ordinal transmission of a gammaretrovirus endogenized independently in the lineages of vespertilionid bats, felid cats and pangolin similar to 13-25 million years ago. Following its initial introduction, the ERV amplified extensively in parallel in both bat and cat lineages, generating hundreds of species-specific insertions throughout evolution. However, despite being derived from the same viral species, phylogenetic and selection analyses suggest that the ERV experienced different amplification dynamics in the two mammalian lineages. In the cat lineage, the ERV appears to have expanded primarily by retrotransposition of a single proviral progenitor that lost infectious capacity shortly after endogenization. In the bat lineage, the ERV followed a more complex path of germline invasion characterized by both retrotransposition and multiple infection events. The results also suggest that some of the bat ERVs have maintained infectious capacity for extended period of time and may be still infectious today. This study provides one of the most rigorously documented cases of cross-ordinal transmission of a mammalian retrovirus. It also illustrates how the same retrovirus species has transitioned multiple times from an infectious pathogen to a genomic parasite (i.e. retrotransposon), yet experiencing different invasion dynamics in different mammalian hosts.","[Zhuo, Xiaoyu; Feschotte, Cedric] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA","Zhuo, XY (reprint author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.",cedric@genetics.utah.edu,"Zhuo, Xiaoyu/H-4857-2019","Zhuo, Xiaoyu/0000-0002-1400-5609",National Institutes of Health [R01-GM077582]; University of Utah,"The work is supported by grant R01-GM077582 from National Institutes of Health (http://www.nih.gov/). XZ is also supported by University of Utah graduate research fellowship (https://gradschool.utah.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,113,18,19,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005279,10.1371/journal.ppat.1005279,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000035,26562410.0,"DOAJ Gold, Green Published",,,16/08/2019,18,42,50,4585,660,461,199,3925,3252,19,654,49,12,0,0,21,21,1,,57,5,56,1,5,25,20,25,14,0,0,0,0,0,0,0,30,18,4608,64,0,220,96,2,3912,660,64,0,220,96,2,36,,0,0,0,0,26,0,0,0,0,0,0,55,1,0,13.65,6.946969696969697,1.1681528662420382,0.1681528662420382,1.2147770700636942,1.0399127589967285,7.224242424242425
296,J,"Baquero-Perez, B; Whitehouse, A",,,,"Baquero-Perez, Belinda; Whitehouse, Adrian",,,Hsp70 Isoforms Are Essential for the Formation of Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription Compartments,PLOS PATHOGENS,,,English,Article,,,,,,,HEAT-SHOCK-PROTEIN; DNA-REPLICATION; VIRUS-REPLICATION; HSP90 INHIBITORS; NUCLEOPROTEIN STRUCTURES; LYTIC REPLICATION; TARGETING HSP70; VIRAL-PROTEINS; IN-VIVO; CELL,"Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic herpesvirus associated with various AIDS-related malignancies. Like other herpesviruses, multiple processes required for KSHV lytic replication, including viral transcription, viral DNA synthesis and capsid assembly occur in virus-induced intranuclear structures, termed replication and transcription compartments (RTCs). Here we utilised a novel methodology, combining subcellular fractionation and quantitative proteomics, to identify cellular proteins which are recruited to KSHV-induced RTCs and thus play a key role in KSHV lytic replication. We show that several isoforms of the HSP70 chaperone family, Hsc70 and iHsp70, are redistributed from the cytoplasm into the nucleus coinciding with the initial formation of KSHV-induced RTCs. We demonstrate that nuclear chaperone foci are dynamic, initially forming adjacent to newly formed KSHV RTCs, however during later time points the chaperones move within KSHV RTCs and completely co-localise with actively replicating viral DNA. The functional significance of Hsp70 isoforms recruitment into KSHV RTCs was also examined using the specific Hsp70 isoform small molecule inhibitor, VER-155008. Intriguingly, results highlight an essential role of Hsp70 isoforms in the KSHV replication cycle independent of protein stability and maturation. Notably, inhibition of Hsp70 isoforms precluded KSHV RTC formation and RNA polymerase II (RNAPII) relocalisation to the viral genome leading to the abolishment of global KSHV transcription and subsequent viral protein synthesis and DNA replication. These new findings have revealed novel mechanisms that regulate KSHV lytic replication and highlight the potential of HSP70 inhibitors as novel antiviral agents.","[Baquero-Perez, Belinda] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England","Baquero-Perez, B (reprint author), Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.",A.Whitehouse@leeds.ac.uk; B.Baquero@leeds.ac.uk,,"Whitehouse, Adrian/0000-0003-3866-7110",BBSRC [BB/K000306/1]; Yorkshire Cancer Research [L366]; Worldwide Cancer Research [121045]; Wellcome trust [089330]; Biotechnology and Biological Sciences Research Council [BB/K000306/1]; Worldwide Cancer Research [12-1045],"This work was funded in part to AW by the BBSRC (http://www.bbsrc.ac.uk), grant number BB/K000306/1; Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk), grant number L366; Worldwide Cancer Research (http://www.worldwidecancerresearch.org), grant number 121045, and Wellcome trust grant (number 089330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,107,21,21,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005274,10.1371/journal.ppat.1005274,,,,42,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000031,26587836.0,"DOAJ Gold, Green Published",,,16/08/2019,21,149,19,5019,723,509,214,4296,3625,20,651,19,11,0,0,20,20,1,,25,1,25,0,1,21,21,16,16,0,0,0,0,0,0,1,138,7,5038,126,0,259,189,0,4287,723,126,0,259,189,0,28,,1,0,0,0,11,0,0,1,0,0,0,25,0,0,17.3,6.941908713692946,1.1682960893854748,0.16829608938547486,1.2460428305400373,1.0665471209404265,7.403872752420471
297,J,"Bender, S; Reuter, A; Eberle, F; Einhorn, E; Binder, M; Bartenschlager, R",,,,"Bender, Silke; Reuter, Antje; Eberle, Florian; Einhorn, Evelyne; Binder, Marco; Bartenschlager, Ralf",,,Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIVIRAL SIGNALING PROTEIN; COMPLEMENTATION GROUP G; INNATE IMMUNE-RESPONSE; RAT-LIVER PEROXISOMES; CYCLIC GMP-AMP; RIG-I; ENDOPLASMIC-RETICULUM; IFN-LAMBDA; GENE-EXPRESSION; ZELLWEGER-SYNDROME,"Sensing viruses by pattern recognition receptors (PRR) triggers the innate immune system of the host cell and activates immune signaling cascades such as the RIG-I/IRF3 pathway. Mitochondrial antiviral-signaling protein (MAVS, also known as IPS-1, Cardif, and VISA) is the crucial adaptor protein of this pathway localized on mitochondria, peroxisomes and mitochondria-associated membranes of the endoplasmic reticulum. Activation of MAVS leads to the production of type I and type III interferons (IFN) as well as IFN stimulated genes (ISGs). To refine the role of MAVS subcellular localization for the induction of type I and III IFN responses in hepatocytes and its counteraction by the hepatitis C virus (HCV), we generated various functional and genetic knock-out cell systems that were reconstituted to express mitochondrial (mito) or peroxisomal (pex) MAVS, exclusively. Upon infection with diverse RNA viruses we found that cells exclusively expressing pexMAVS mounted sustained expression of type I and III IFNs to levels comparable to cells exclusively expressing mitoMAVS. To determine whether viral counteraction of MAVS is affected by its subcellular localization we employed infection of cells with HCV, a major causative agent of chronic liver disease with a high propensity to establish persistence. This virus efficiently cleaves MAVS via a viral protease residing in its nonstructural protein 3 (NS3) and this strategy is thought to contribute to the high persistence of this virus. We found that both mito- and pexMAVS were efficiently cleaved by NS3 and this cleavage was required to suppress activation of the IFN response. Taken together, our findings indicate comparable activation of the IFN response by pex- and mitoMAVS in hepatocytes and efficient counteraction of both MAVS species by the HCV NS3 protease.","[Bender, Silke; Eberle, Florian; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Bender, Silke; Reuter, Antje; Einhorn, Evelyne; Binder, Marco; Bartenschlager, Ralf] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany; [Einhorn, Evelyne] Univ Lyon, Ecole Normale Super Lyon, Dept Biol, Master BioSci, Lyon, France","Bender, S (reprint author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.",Ralf_Bartenschlager@med.uni-heidelberg.de,"Binder, Marco/E-9717-2011","Binder, Marco/0000-0002-5805-6109",Deutsche Forschungsgemeinschaft [FOR1202]; German Federal Ministry of Education and Research (ImmunoQuant) [0316170C],"Work by RB was supported by the Deutsche Forschungsgemeinschaft FOR1202, TP1. (http://www.dfg.de). The work of MB was funded by the German Federal Ministry of Education and Research (ImmunoQuant, 0316170C) (http://www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,40,40,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005264,10.1371/journal.ppat.1005264,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000026,26588843.0,"DOAJ Gold, Green Published",,,16/08/2019,38,0,45,9290,2006,1542,464,7284,5556,18,1710,45,0,0,0,43,43,0,,69,7,69,0,7,41,41,32,22,0,0,0,0,0,0,0,0,3,9287,120,0,103,44,1,7259,2006,120,0,103,44,1,22,,0,0,0,0,2,0,0,1,0,0,0,69,0,0,1.0,4.631106679960119,1.2753981328940143,0.27539813289401427,1.2975013728720484,1.0173304628632938,4.711365902293121
298,J,"Karijolich, J; Abernathy, E; Glaunsinger, BA",,,,"Karijolich, John; Abernathy, Emma; Glaunsinger, Britt A.",,,Infection-Induced Retrotransposon-Derived Noncoding RNAs Enhance Herpesviral Gene Expression via the NF-kappa B Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,MURINE GAMMAHERPESVIRUS 68; ALU REPEATED SEQUENCES; POLYMERASE-III; NLRP3 INFLAMMASOME; LYTIC REPLICATION; INNATE IMMUNITY; SIMPLEX-VIRUS; HUMAN GENOME; HEAT-SHOCK; IN-VIVO,"Short interspersed nuclear elements (SINEs) are highly abundant, RNA polymerase III-transcribed noncoding retrotransposons that are silenced in somatic cells but activated during certain stresses including viral infection. How these induced SINE RNAs impact the host-pathogen interaction is unknown. Here we reveal that during murine gammaherpesvirus 68 (MHV68) infection, rapidly induced SINE RNAs activate the antiviral NF-kappa B signaling pathway through both mitochondrial antiviral-signaling protein (MAVS)-dependent and independent mechanisms. However, SINE RNA-based signaling is hijacked by the virus to enhance viral gene expression and replication. B2 RNA expression stimulates IKK beta-dependent phosphorylation of the major viral lytic cycle transactivator protein RTA, thereby enhancing its activity and increasing progeny virion production. Collectively, these findings suggest that SINE RNAs participate in the innate pathogen response mechanism, but that herpesviruses have evolved to co-opt retrotransposon activation for viral benefit.","[Karijolich, John; Abernathy, Emma; Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Glaunsinger, Britt A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA","Glaunsinger, BA (reprint author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.",glaunsinger@berkeley.edu,,,"Damon Runyon Cancer Research Foundation [DRG 2121-12]; NIH [CA136367, CA160556]; Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Award; W.M. Keck Foundation Distinguished Young Investigator Award","This research was supported by a Damon Runyon Cancer Research Foundation fellowship (DRG 2121-12) to JK, as well as NIH grants CA136367 and CA160556, a Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Award, and a W.M. Keck Foundation Distinguished Young Investigator Award to BAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,73,15,15,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005260,10.1371/journal.ppat.1005260,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000022,26584434.0,"DOAJ Gold, Green Published",,,16/08/2019,16,17,21,5496,756,549,207,4740,3889,17,834,21,17,0,0,13,13,1,,27,2,27,0,2,17,17,14,14,0,0,1,0,0,1,3,0,23,5572,17,0,50,79,1,4782,768,17,0,50,79,1,22,,3,0,0,0,29,0,0,1,0,0,0,27,0,0,41.6,7.26984126984127,1.159493670886076,0.15949367088607594,1.1957805907172996,1.0312954876273654,7.497354497354498
299,J,"Kim, SH; Clark, ST; Surendra, A; Copeland, JK; Wang, PW; Ammar, R; Collins, C; Tullis, DE; Nislow, C; Hwang, DM; Guttman, DS; Cowen, LE",,,,"Kim, Sang Hu; Clark, Shawn T.; Surendra, Anuradha; Copeland, Julia K.; Wang, Pauline W.; Ammar, Ron; Collins, Cathy; Tullis, D. Elizabeth; Nislow, Corey; Hwang, David M.; Guttman, David S.; Cowen, Leah E.",,,Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation,PLOS PATHOGENS,,,English,Article,,,,,,,CANDIDA-ALBICANS; EXOPHIALA-DERMATITIDIS; ASPERGILLUS-FUMIGATUS; LUNG-TRANSPLANT; SEQUENCING DATA; RESISTANCE; BACTERIAL; DISEASE; EVOLUTION; SAMPLES,"The microbiome shapes diverse facets of human biology and disease, with the importance of fungi only beginning to be appreciated. Microbial communities infiltrate diverse anatomical sites as with the respiratory tract of healthy humans and those with diseases such as cystic fibrosis, where chronic colonization and infection lead to clinical decline. Although fungi are frequently recovered from cystic fibrosis patient sputum samples and have been associated with deterioration of lung function, understanding of species and population dynamics remains in its infancy. Here, we coupled high-throughput sequencing of the ribosomal RNA internal transcribed spacer 1 (ITS1) with phenotypic and genotypic analyses of fungi from 89 sputum samples from 28 cystic fibrosis patients. Fungal communities defined by sequencing were concordant with those defined by culture-based analyses of 1,603 isolates from the same samples. Different patients harbored distinct fungal communities. There were detectable trends, however, including colonization with Candida and Aspergillus species, which was not perturbed by clinical exacerbation or treatment. We identified considerable inter- and intra-species phenotypic variation in traits important for host adaptation, including antifungal drug resistance and morphogenesis. While variation in drug resistance was largely between species, striking variation in morphogenesis emerged within Candida species. Filamentation was uncoupled from inducing cues in 28 Candida isolates recovered from six patients. The filamentous isolates were resistant to the filamentation-repressive effects of Pseudomonas aeruginosa, implicating inter- kingdom interactions as the selective force. Genome sequencing revealed that all but one of the filamentous isolates harbored mutations in the transcriptional repressor NRG1; such mutations were necessary and sufficient for the filamentous phenotype. Six independent nrg1 mutations arose in Candida isolates from different patients, providing a poignant example of parallel evolution. Together, this combined clinical-genomic approach provides a high-resolution portrait of the fungal microbiome of cystic fibrosis patient lungs and identifies a genetic basis of pathogen adaptation.","[Kim, Sang Hu; Collins, Cathy; Cowen, Leah E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Clark, Shawn T.; Hwang, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Surendra, Anuradha; Copeland, Julia K.; Wang, Pauline W.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Wang, Pauline W.; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Ammar, Ron] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Tullis, D. Elizabeth] St Michaels Hosp, Div Respirol, Toronto, ON M5B 1W8, Canada; [Nislow, Corey] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada","Kim, SH (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.",leah.cowen@utoronto.ca,"Guttman, David/A-7839-2011","Guttman, David/0000-0001-8479-3869; Kim, Sang Hu/0000-0003-0597-0623; Nislow, Corey/0000-0002-4016-8874; Cowen, Leah/0000-0001-5797-0110","Ontario Graduate Scholarship; Canada Research Chair in Microbial Genomics and Infectious Disease; Canadian Institutes of Health Research (CIHR) [MOP-86452, MOP-119520]; CIHR Team Grant - Canadian Microbiome Initiative [CMF-108027]","SHK was supported by an Ontario Graduate Scholarship(https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRD19842319.html), LEC was supported by a Canada Research Chair in Microbial Genomics and Infectious Disease (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and by Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html) Operating Grants (MOP-86452 and MOP-119520) and CIHR Team Grant - Canadian Microbiome Initiative led by DSG (CMF-108027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,72,22,23,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005308,10.1371/journal.ppat.1005308,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000041,26588216.0,"DOAJ Gold, Green Published",,,16/08/2019,31,28,41,7773,1182,859,323,6591,5378,18,1195,41,25,0,1,28,28,6,,60,0,60,0,0,32,32,17,19,0,0,0,0,0,0,1,3,18,7799,177,3,81,350,3,6570,1182,177,3,81,350,3,47,,4,2,0,0,26,0,0,1,1,0,0,60,0,0,58.86,6.5761421319796955,1.1793354574419663,0.17933545744196633,1.263237748444849,1.071143702560144,7.04399323181049
300,J,"Lin, CJ; Sasse, C; Gerke, J; Valerius, O; Irmer, H; Frauendorf, H; Heinekamp, T; Strassburger, M; Tran, VT; Herzog, B; Braus-Stromeyer, SA; Braus, GH",,,,"Lin, Chi-Jan; Sasse, Christoph; Gerke, Jennifer; Valerius, Oliver; Irmer, Henriette; Frauendorf, Holm; Heinekamp, Thorsten; Strassburger, Maria; Van Tuan Tran; Herzog, Britta; Braus-Stromeyer, Susanna A.; Braus, Gerhard H.",,,"Transcription Factor SomA Is Required for Adhesion, Development and Virulence of the Human Pathogen Aspergillus fumigatus",PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE S288C; HUMAN FUNGAL PATHOGENS; CANDIDA-ALBICANS; GENE-EXPRESSION; ASEXUAL DEVELOPMENT; MAGNAPORTHE-GRISEA; PSEUDOHYPHAL DIFFERENTIATION; GLIOTOXIN PRODUCTION; SIGNALING PATHWAYS,"The transcription factor Flo8/Som1 controls filamentous growth in Saccharomyces cerevisiae and virulence in the plant pathogen Magnaporthe oryzae. Flo8/Som1 includes a characteristic N-terminal LUG/LUH-Flo8-single-stranded DNA binding (LUFS) domain and is activated by the cAMP dependent protein kinase A signaling pathway. Heterologous SomA from Aspergillus fumigatus rescued in yeast flo8 mutant strains several phenotypes including adhesion or flocculation in haploids and pseudohyphal growth in diploids, respectively. A. fumigatus SomA acts similarly to yeast Flo8 on the promoter of FLO11 fused with reporter gene (LacZ) in S. cerevisiae. FLO11 expression in yeast requires an activator complex including Flo8 and Mfg1. Furthermore, SomA physically interacts with PtaB, which is related to yeast Mfg1. Loss of the somA gene in A. fumigatus resulted in a slow growth phenotype and a block in asexual development. Only aerial hyphae without further differentiation could be formed. The deletion phenotype was verified by a conditional expression of somA using the inducible Tet-on system. A adherence assay with the conditional somA expression strain indicated that SomA is required for biofilm formation. A ptaB deletion strain showed a similar phenotype supporting that the SomA/PtaB complex controls A. fumigatus biofilm formation. Transcriptional analysis showed that SomA regulates expression of genes for several transcription factors which control conidiation or adhesion of A. fumigatus. Infection assays with fertilized chicken eggs as well as with mice revealed that SomA is required for pathogenicity. These data corroborate a complex control function of SomA acting as a central factor of the transcriptional network, which connects adhesion, spore formation and virulence in the opportunistic human pathogen A. fumigatus.","[Lin, Chi-Jan; Sasse, Christoph; Gerke, Jennifer; Valerius, Oliver; Irmer, Henriette; Van Tuan Tran; Herzog, Britta; Braus-Stromeyer, Susanna A.; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37073 Gottingen, Germany; [Frauendorf, Holm] Univ Gottingen, Inst Organ & Biomol Chem, D-37073 Gottingen, Germany; [Heinekamp, Thorsten; Strassburger, Maria] Leibniz Inst Nat Prod Res & Infect Biol HKI, Mol & Appl Microbiol, Jena, Germany; [Heinekamp, Thorsten; Strassburger, Maria] Univ Jena, Inst Microbiol, Jena, Germany","Lin, CJ (reprint author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37073 Gottingen, Germany.",gbraus@gwdg.de,"; Tran, Van-Tuan/F-9511-2018; Braus, Gerhard/G-3999-2012","Heinekamp, Thorsten/0000-0001-9503-9634; Tran, Van-Tuan/0000-0003-3916-2624; Braus, Gerhard/0000-0002-3117-5626; Lin, Chi-Jan/0000-0002-6873-6570",Deutsche Forschungsgemeinschaft [FOR1334]; Federal Ministry of Education and Research (BMBF) BioFung project; Eranet PathoGenoMics TRANSPAT; Deutsche Forschungsgemeinschaft CRC/Transregio [124],"GHB was supported by the Deutsche Forschungsgemeinschaft FOR1334 (http://gepris.dfg.de/gepris/projekt/140043741), the Federal Ministry of Education and Research (BMBF) BioFung project and the Eranet PathoGenoMics TRANSPAT (https://www.pathogenomics-era.net/FundedProjects). TH was supported by the Deutsche Forschungsgemeinschaft CRC/Transregio 124 ""Human-pathogenic fungi and their human host Networks of interaction - FungiNet"" (www.funginet.de). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.",,93,12,14,3,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005205,10.1371/journal.ppat.1005205,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000007,26529322.0,"DOAJ Gold, Green Published",,,16/08/2019,14,24,32,5737,1037,702,335,4700,3391,16,1293,32,4,0,0,13,13,0,,79,1,42,0,1,14,14,14,7,0,0,0,0,0,0,0,20,6,5808,89,0,74,102,1,4729,1049,89,0,74,102,1,30,,3,0,0,0,5,0,1,1,0,0,0,42,0,0,24.75,5.532304725168756,1.2206382978723405,0.22063829787234043,1.2763829787234042,1.0456684678403347,5.784956605593057
301,J,"Muslin, C; Joffret, ML; Pelletier, I; Blondel, B; Delpeyroux, F",,,,"Muslin, Claire; Joffret, Marie-Line; Pelletier, Isabelle; Blondel, Bruno; Delpeyroux, Francis",,,Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5 ' Untranslated Region,PLOS PATHOGENS,,,English,Article,,,,,,,VACCINE-DERIVED POLIOVIRUS; RIBOSOMAL ENTRY SITE; BROME-MOSAIC-VIRUS; RNA RECOMBINATION; IN-VIVO; VIRAL REPLICATION; NONCODING REGION; SPECIES C; ATTENUATION PHENOTYPE; FUNCTIONAL-ANALYSIS,"Genetic recombination shapes the diversity of RNA viruses, including enteroviruses (EVs), which frequently have mosaic genomes. Pathogenic circulating vaccine-derived poliovirus (cVDPV) genomes consist of mutated vaccine poliovirus (PV) sequences encoding capsid proteins, and sequences encoding nonstructural proteins derived from other species' C EVs, including certain coxsackieviruses A (CV-A) in particular. Many cVDPV genomes also have an exogenous 5' untranslated region (5' UTR). This region is involved in virulence and includes the cloverleaf (CL) and the internal ribosomal entry site, which play major roles in replication and the initiation of translation, respectively. We investigated the plasticity of the PV genome in terms of recombination in the 5' UTR, by developing an experimental model involving the rescue of a bipartite PV/CV-A cVDPV genome rendered defective by mutations in the CL, following the co-transfection of cells with 5' UTR RNAs from each of the four human EV species (EV-A to -D). The defective cVDPV was rescued by recombination with 5' UTR sequences from the four EV species. Homologous and nonhomologous recombinants with large deletions or insertions in three hotspots were isolated, revealing a striking plasticity of the 5' UTR. By contrast to the recombination of the cVDPV with the 5' UTR of group II (EV-A and -B), which can decrease viral replication and virulence, recombination with the 5' UTRs of group I (EV-C and -D) appeared to be evolutionarily neutral or associated with a gain in fitness. This study illustrates how the genomes of positive-strand RNA viruses can evolve into mosaic recombinant genomes through intra-or inter-species modular genetic exchanges, favoring the emergence of new recombinant lineages.","[Muslin, Claire; Joffret, Marie-Line; Pelletier, Isabelle; Blondel, Bruno; Delpeyroux, Francis] Inst Pasteur, Biol Virus Enter, Paris, France; [Muslin, Claire; Joffret, Marie-Line; Pelletier, Isabelle; Blondel, Bruno; Delpeyroux, Francis] INSERM, U994, Paris, France; [Muslin, Claire] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France","Muslin, C (reprint author), Inst Pasteur, Biol Virus Enter, Paris, France.",francis.delpeyroux@pasteur.fr,"Delpeyroux, Francis/H-8838-2016","Delpeyroux, Francis/0000-0002-4895-823X; JOFFRET, Marie-Line/0000-0002-5244-5429","Transverse Research Program, Institut Pasteur -PTR [484]; Agence Nationale de la Recherche-ANR [09 MIEN 019]; Fondation pour la Recherche Medicale-FRM [DMI20091117313]","Funding of this work has been from: The Transverse Research Program, Institut Pasteur -PTR 484 to- FD, MLJ, IP, BB, http://www.pasteur.fr/fr; The Agence Nationale de la Recherche-ANR 09 MIEN 019-to FD, MLJ, IP, BB, http://www.agence-nationale-recherche.fr/404.html; The Fondation pour la Recherche Medicale-FRM DMI20091117313-to FD, MLJ, IP, BB, http://www.frm.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,101,26,27,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005266,10.1371/journal.ppat.1005266,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000027,26562151.0,"DOAJ Gold, Green Published",,,16/08/2019,26,5,12,3358,660,464,196,2698,2117,25,556,12,5,0,0,26,26,0,,21,0,21,0,0,27,27,27,16,0,0,0,0,0,0,0,0,4,3459,98,4,72,214,0,2723,670,98,4,72,214,0,66,,0,0,0,0,5,0,0,0,0,0,0,20,0,0,3.2,5.087878787878788,1.2446256486286138,0.2446256486286138,1.3977020014825796,1.122989874925551,5.713636363636364
302,J,"Ordonez, N; Seidl, MF; Waalwijk, C; Drenth, A; Kilian, A; Thomma, BPHJ; Ploetz, RC; Kema, GHJ",,,,"Ordonez, Nadia; Seidl, Michael F.; Waalwijk, Cees; Drenth, Andre; Kilian, Andrzej; Thomma, Bart P. H. J.; Ploetz, Randy C.; Kema, Gert H. J.",,,Worse Comes to Worst: Bananas and Panama Disease-When Plant and Pathogen Clones Meet,PLOS PATHOGENS,,,English,Article,,,,,,,VEGETATIVE COMPATIBILITY GROUPS; TROPICAL RACE 4; FUSARIUM-WILT; GENETIC-VARIATION; RESISTANCE; GENOME,,"[Ordonez, Nadia; Seidl, Michael F.; Waalwijk, Cees; Thomma, Bart P. H. J.; Kema, Gert H. J.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Drenth, Andre] Univ Queensland, Ctr Plant Sci, Brisbane, Qld, Australia; [Kilian, Andrzej] Univ Canberra, Divers Arrays Technol, Canberra, ACT 2601, Australia; [Ploetz, Randy C.] Univ Florida, IFAS, Ctr Trop Res & Educ, Dept Plant Pathol, Homestead, FL 33031 USA","Ordonez, N (reprint author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.",gert.kema@wur.nl,"Drenth, Andre/A-4915-2008","Drenth, Andre/0000-0002-8510-1534; Kema, Gerrit HJ/0000-0002-2732-6911; Seidl, Michael F/0000-0002-5218-2083",Interdisciplinary Research and Education Funds (INREF) of Wageningen University; Dioraphte VSM [14.03.01.00],"This research is funded by the Interdisciplinary Research and Education Funds (INREF) of Wageningen University (grant 2012, INREF III http://www.wageningenur.nl/en/Research-Results/Projects-and-programmes/INREF/Researchprogrammes-1.htm) and Dioraphte VSM grant 14.03.01.00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,37,44,44,4,49,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005197,10.1371/journal.ppat.1005197,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000005,26584184.0,"DOAJ Gold, Green Published",,,16/08/2019,44,609,127,46031,3686,2885,801,42345,38161,94,4090,126,99,1,0,44,44,50,,178,103,175,1,103,47,47,14,14,1,0,2,1,0,2,19,519,103,47323,127,203,575,896,31,42867,3791,127,203,575,896,31,665,,73,17,1,0,136,0,8,1,0,0,0,171,1,0,789.554,12.488062940857297,1.087046876844964,0.08704687684496398,1.1417168496870942,1.0502921943907366,13.116115029842648
303,J,"Roques, M; Wall, RJ; Douglass, AP; Ramaprasad, A; Ferguson, DJP; Kaindama, ML; Brusini, L; Joshi, N; Rchiad, Z; Brady, D; Guttery, DS; Wheatley, SP; Yamano, H; Holder, AA; Pain, A; Wickstead, B; Tewari, R",,,,"Roques, Magali; Wall, Richard J.; Douglass, Alexander P.; Ramaprasad, Abhinay; Ferguson, David J. P.; Kaindama, Mbinda L.; Brusini, Lorenzo; Joshi, Nimitray; Rchiad, Zineb; Brady, Declan; Guttery, David S.; Wheatley, Sally P.; Yamano, Hiroyuki; Holder, Anthony A.; Pain, Arnab; Wickstead, Bill; Tewari, Rita",,,Plasmodium P-Type Cyclin CYC3 Modulates Endomitotic Growth during Oocyst Development in Mosquitoes,PLOS PATHOGENS,,,English,Article,,,,,,,,"Cell-cycle progression and cell division in eukaryotes are governed in part by the cyclin family and their regulation of cyclin-dependent kinases (CDKs). Cyclins are very well characterised in model systems such as yeast and human cells, but surprisingly little is known about their number and role in Plasmodium, the unicellular protozoan parasite that causes malaria. Malaria parasite cell division and proliferation differs from that of many eukaryotes. During its life cycle it undergoes two types of mitosis: endomitosis in asexual stages and an extremely rapid mitotic process during male gametogenesis. Both schizogony (producing merozoites) in host liver and red blood cells, and sporogony (producing sporozoites) in the mosquito vector, are endomitotic with repeated nuclear replication, without chromosome condensation, before cell division. The role of specific cyclins during Plasmodium cell proliferation was unknown. We show here that the Plasmodium genome contains only three cyclin genes, representing an unusual repertoire of cyclin classes. Expression and reverse genetic analyses of the single Plant (P)-type cyclin, CYC3, in the rodent malaria parasite, Plasmodium berghei, revealed a cytoplasmic and nuclear location of the GFP-tagged protein throughout the lifecycle. Deletion of cyc3 resulted in defects in size, number and growth of oocysts, with abnormalities in budding and sporozoite formation. Furthermore, global transcript analysis of the cyc3-deleted and wild type parasites at gametocyte and ookinete stages identified differentially expressed genes required for signalling, invasion and oocyst development. Collectively these data suggest that cyc3 modulates oocyst endomitotic development in Plasmodium berghei.","[Roques, Magali; Wall, Richard J.; Douglass, Alexander P.; Kaindama, Mbinda L.; Brusini, Lorenzo; Joshi, Nimitray; Brady, Declan; Guttery, David S.; Wheatley, Sally P.; Wickstead, Bill; Tewari, Rita] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2RD, England; [Ramaprasad, Abhinay; Rchiad, Zineb; Pain, Arnab] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn BESE Div, Thuwal, Saudi Arabia; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Yamano, Hiroyuki] UCL, UCL Canc Inst, London, England; [Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, London, England","Roques, M (reprint author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2RD, England.",bill.wickstead@nottingham.ac.uk; rita.tewari@nottingham.ac.uk,"Holder, Anthony/A-7554-2013; Ramaprasad, Abhinay/D-1181-2013; Pain, Arnab/L-5766-2015","Holder, Anthony/0000-0002-8490-6058; Ramaprasad, Abhinay/0000-0001-9372-5526; Tewari, Rita/0000-0003-3943-1847; Wickstead, Bill/0000-0002-4620-9091; Pain, Arnab/0000-0002-1755-2819; Guttery, David/0000-0003-0418-580X; RCHIAD, ZINEB/0000-0003-0419-8133","Cancer Research UK [C8320/A13586]; UK Medical Research Council; Wellcome Trust; MRC [MR/M010899/1, G0900109, G0900278, MR/K011782/1]; King Abdullah University of Science and Technology (KAUST); Wellcome Trust [WT094233MA]; MRC Investigator Award; BBSRC [BB/J01477X/1]; Biotechnology and Biological Sciences Research Council [BB/J01477X/1]; Cancer Research UK [13586]; Medical Research Council [1506963, G0900278, G0900109, MR/M010899/1, MR/K011782/1]; The Francis Crick Institute [10097]","AAH is supported by the Francis Crick Institute which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. Work in the HY laboratory was funded by grants from Cancer Research UK (C8320/A13586) and MRC (MR/M010899/1). Part of the work done in AP laboratory was supported by the faculty baseline funding and a CRG3 grant from King Abdullah University of Science and Technology (KAUST). Imaging was performed by SPW in the Advanced Microscopy Unit, at the University of Nottingham with a DeltaVision Elite system funded by the Wellcome Trust (WT094233MA). This project was funded by MRC Investigator Award and MRC project grants to RT [G0900109, G0900278, MR/K011782/1] and a BBSRC new investigator research grant to BW [BB/J01477X/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,0,20,20,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005273,10.1371/journal.ppat.1005273,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000030,26565797.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,18,50,48,6929,642,500,142,6287,5288,19,980,48,17,0,0,18,18,2,,55,2,55,0,2,25,19,25,17,0,0,0,0,0,0,0,33,16,6997,146,0,261,165,2,6314,650,122,0,261,163,2,33,,2,1,0,1,21,0,1,0,0,0,0,55,0,0,33.454,10.792834890965732,1.1021154763798313,0.1021154763798314,1.1623986002863052,1.0546976475681917,11.383177570093459
304,J,"Sloan, DD; Lam, CYK; Irrinki, A; Liu, LQ; Tsai, A; Pace, CS; Kaur, J; Murry, JP; Balakrishnan, M; Moore, PA; Johnson, S; Nordstrom, JL; Cihlar, T; Koenig, S",,,,"Sloan, Derek D.; Lam, Chia-Ying Kao; Irrinki, Alivelu; Liu, Liqin; Tsai, Angela; Pace, Craig S.; Kaur, Jasmine; Murry, Jeffrey P.; Balakrishnan, Mini; Moore, Paul A.; Johnson, Syd; Nordstrom, Jeffrey L.; Cihlar, Tomas; Koenig, Scott",,,Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; COMBINATION ANTIRETROVIRAL THERAPY; BROADLY NEUTRALIZING ANTIBODIES; TERM-FOLLOW-UP; EFFECTOR FUNCTION; LATENT RESERVOIR; POTENT NEUTRALIZATION; MEDIATING ANTIBODIES; MONOCLONAL-ANTIBODY; DOUBLE-BLIND,"HIV reservoirs and production of viral antigens are not eliminated in chronically infected participants treated with combination antiretroviral therapy (cART). Novel therapeutic strategies aiming at viral reservoir elimination are needed to address chronic immune dysfunction and non-AIDS morbidities that exist despite effective cART. The HIV envelope protein (Env) is emerging as a highly specific viral target for therapeutic elimination of the persistent HIV-infected reservoirs via antibody-mediated cell killing. Dual-Affinity Re-Targeting (DART) molecules exhibit a distinct mechanism of action via binding the cell surface target antigen and simultaneously engaging CD3 on cytotoxic T lymphocytes (CTLs). We designed and evaluated Env-specific DARTs (HIVxCD3 DARTs) derived from known antibodies recognizing diverse Env epitopes with or without broadly neutralizing activity. HIVxCD3 DARTs derived from PGT121, PGT145, A32, and 7B2, but not VRC01 or 10E8 antibodies, mediated potent CTL-dependent killing of quiescent primary CD4 T cells infected with diverse HIV isolates. Similar killing activity was also observed with DARTs structurally modified for in vivo half-life extension. In an ex vivo model using cells isolated from HIV-infected participants on cART, combinations of the most potent HIVxCD3 DARTs reduced HIV expression both in quiescent and activated peripheral blood mononuclear cell cultures isolated from HIV-infected participants on suppressive cART. Importantly, HIVxCD3 DARTs did not induce cell-to-cell virus spread in resting or activated CD4 T cell cultures. Collectively, these results provide support for further development of HIVxCD3 DARTs as a promising therapeutic strategy for targeting HIV reservoirs.","[Sloan, Derek D.; Irrinki, Alivelu; Tsai, Angela; Pace, Craig S.; Kaur, Jasmine; Murry, Jeffrey P.; Balakrishnan, Mini; Cihlar, Tomas] Gilead Sci Inc, Foster City, CA 94404 USA; [Lam, Chia-Ying Kao; Liu, Liqin; Moore, Paul A.; Johnson, Syd; Nordstrom, Jeffrey L.; Koenig, Scott] MacroGenics Inc, Rockville, MD USA","Sloan, DD (reprint author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.",dereksloan@yahoo.com; koenigs@macrogenics.com,,"Murry, Jeffrey/0000-0002-3716-1460",,,,95,46,46,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005233,10.1371/journal.ppat.1005233,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000012,26539983.0,"DOAJ Gold, Green Published",,,16/08/2019,40,13,40,14160,1627,1276,351,12533,10866,27,1640,40,6,0,0,39,39,3,,72,2,72,0,2,46,45,46,29,0,0,0,0,0,0,3,7,7,14184,98,0,117,389,0,12507,1627,98,0,117,389,0,50,,2,0,0,0,17,0,0,1,0,0,0,70,0,0,31.2,8.703134603564843,1.1298172823745312,0.12981728237453125,1.1705896433415783,1.036087570621469,9.01720958819914
305,J,"Son, M; Yu, J; Kim, KH",,,,"Son, Moonil; Yu, Jisuk; Kim, Kook-Hyung",,,Five Questions about Mycoviruses,PLOS PATHOGENS,,,English,Article,,,,,,,CHESTNUT BLIGHT FUNGUS; CRYPHONECTRIA-PARASITICA; FUSARIUM-GRAMINEARUM; MOLECULAR CHARACTERIZATION; SCLEROTINIA-SCLEROTIORUM; HYPOVIRUS TRANSMISSION; GENE-EXPRESSION; VIRULENCE; VIRUSES; PLANT,,"[Son, Moonil; Yu, Jisuk; Kim, Kook-Hyung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Son, Moonil; Yu, Jisuk; Kim, Kook-Hyung] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Son, Moonil; Kim, Kook-Hyung] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Yu, Jisuk; Kim, Kook-Hyung] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea","Son, M (reprint author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.",kookkim@snu.ac.kr,,,"Center for Fungal Pathogenesis - Ministry of Education, Science, and Technology (MEST) [20110000959]; Rural Development Administration [PJ01101401]; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [710001-07-05]; MEST through the Brain Korea 21 Project","This research was supported in part by grants from the Center for Fungal Pathogenesis (no. 20110000959) funded by the Ministry of Education, Science, and Technology (MEST); the Next-Generation BioGreen 21 Program (no. PJ01101401), Rural Development Administration; and the Vegetable Breeding Research Center (No. 710001-07-05) through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. M. Son and J. Yu were supported by graduate research fellowships from the MEST through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,38,17,18,1,28,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005172,10.1371/journal.ppat.1005172,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000003,26539725.0,"DOAJ Gold, Green Published",,,16/08/2019,18,26,54,11995,2603,2234,369,9392,7623,25,1744,54,17,1,0,16,16,1,,0,2,0,0,2,19,19,8,7,0,0,0,0,0,0,0,9,37,11992,11,78,29,59,0,9358,2603,11,78,29,59,0,31,,0,0,0,0,37,0,1,1,0,0,0,89,0,0,19.7,4.608144448713023,1.2771507666098807,0.27715076660988075,1.2842844974446337,1.0055856606919549,4.63388398002305
306,J,"Srikumar, S; Kroger, C; Hebrard, M; Colgan, A; Owen, SV; Sivasankaran, SK; Cameron, ADS; Hokamp, K; Hinton, JCD",,,,"Srikumar, Shabarinath; Kroeger, Carsten; Hebrard, Magali; Colgan, Aoife; Owen, Sian V.; Sivasankaran, Sathesh K.; Cameron, Andrew D. S.; Hokamp, Karsten; Hinton, Jay C. D.",,,RNA-seq Brings New Insights to the Intra-Macrophage Transcriptome of Salmonella Typhimurium,PLOS PATHOGENS,,,English,Article,,,,,,,ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; FLAGELLAR GENE-EXPRESSION; MESSENGER-RNA; BACTERIAL PATHOGENS; ESCHERICHIA-COLI; INTRACELLULAR REPLICATION; PROMOTES PATHOGENICITY; EPITHELIAL-CELLS,"Salmonella enterica serovar Typhimurium is arguably the world's best-understood bacterial pathogen. However, crucial details about the genetic programs used by the bacterium to survive and replicate in macrophages have remained obscure because of the challenge of studying gene expression of intracellular pathogens during infection. Here, we report the use of deep sequencing (RNA-seq) to reveal the transcriptional architecture and gene activity of Salmonella during infection of murine macrophages, providing new insights into the strategies used by the pathogen to survive in a bactericidal immune cell. We characterized 3583 transcriptional start sites that are active within macrophages, and highlight 11 of these as candidates for the delivery of heterologous antigens from Salmonella vaccine strains. A majority (88%) of the 280 S. Typhimurium sRNAs were expressed inside macrophages, and SPI13 and SPI2 were the most highly expressed pathogenicity islands. We identified 31 S. Typhimurium genes that were strongly up-regulated inside macrophages but expressed at very low levels during in vitro growth. The SalComMac online resource allows the visualisation of every transcript expressed during bacterial replication within mammalian cells. This primary transcriptome of intra-macrophage S.-Typhimurium describes the transcriptional start sites and the transcripts responsible for virulence traits, and catalogues the sRNAs that may play a role in the regulation of gene expression during infection.","[Srikumar, Shabarinath; Kroeger, Carsten; Hebrard, Magali; Colgan, Aoife; Sivasankaran, Sathesh K.; Hinton, Jay C. D.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Sch Genet & Microbiol, Dublin, Ireland; [Srikumar, Shabarinath; Kroeger, Carsten; Owen, Sian V.; Hinton, Jay C. D.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Cameron, Andrew D. S.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Hokamp, Karsten] Trinity Coll Dublin, Smurfit Inst Genet, Sch Genet & Microbiol, Dept Genet, Dublin, Ireland","Srikumar, S (reprint author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Sch Genet & Microbiol, Dublin, Ireland.",jay.hinton@liverpool.ac.uk,"Hinton, Jay C. D./B-2142-2008; Kroger, Carsten/D-1863-2014","Hinton, Jay C. D./0000-0003-2671-6026; Kroger, Carsten/0000-0003-0461-1530; Cameron, Andrew/0000-0003-1560-8572; Owen, Sian/0000-0001-5330-3177; Srikumar, Shabarinath/0000-0003-3775-2831; Hokamp, Karsten/0000-0001-7464-2370","Stokes Professorship from the Science Foundation of Ireland [08/IN.1/B2104, 07/IN.1/B918]","This work was supported by the Stokes Professorship awarded to JCDH from the Science Foundation of Ireland (Grants 08/IN.1/B2104 and 07/IN.1/B918; www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,109,71,73,2,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005262,10.1371/journal.ppat.1005262,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000024,26561851.0,"DOAJ Gold, Green Published",,,16/08/2019,66,93,116,13863,1980,1464,516,11883,9573,30,2280,116,69,0,0,66,66,2,,158,3,158,0,3,69,69,44,45,0,0,0,0,0,0,0,24,56,14038,125,4,166,210,1,12013,2001,125,3,166,210,1,24,,0,0,0,0,69,0,0,0,0,0,0,160,0,0,36.3,7.001515151515152,1.1666245897500631,0.1666245897500631,1.2095430446856854,1.0367885739017528,7.259090909090909
307,J,"Tirosh, O; Cohen, Y; Shitrit, A; Shani, O; Le-Trilling, VTK; Trilling, M; Friedlander, G; Tanenbaum, M; Stern-Ginossar, N",,,,"Tirosh, Osnat; Cohen, Yifat; Shitrit, Alina; Shani, Odem; Vu Thuy Khanh Le-Trilling; Trilling, Mirko; Friedlander, Gilgi; Tanenbaum, Marvin; Stern-Ginossar, Noam",,,The Transcription and Translation Landscapes during Human Cytomegalovirus Infection Reveal Novel Host-Pathogen Interactions,PLOS PATHOGENS,,,English,Article,,,,,,,CELL-CYCLE; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; DOWN-REGULATION; MESSENGER-RNAS; HLA-E; PROTEIN; STRESS; ACCUMULATION; REPLICATION,"Viruses are by definition fully dependent on the cellular translation machinery, and develop diverse mechanisms to co-opt this machinery for their own benefit. Unlike many viruses, human cytomegalovirus (HCMV) does suppress the host translation machinery, and the extent to which translation machinery contributes to the overall pattern of viral replication and pathogenesis remains elusive. Here, we combine RNA sequencing and ribosomal profiling analyses to systematically address this question. By simultaneously examining the changes in transcription and translation along HCMV infection, we uncover extensive transcriptional control that dominates the response to infection, but also diverse and dynamic translational regulation for subsets of host genes. We were also able to show that, at late time points in infection, translation of viral mRNAs is higher than that of cellular mRNAs. Lastly, integration of our translation measurements with recent measurements of protein abundance enabled comprehensive identification of dozens of host proteins that are targeted for degradation during HCMV infection. Since targeted degradation indicates a strong biological importance, this approach should be applicable for discovering central host functions during viral infection. Our work provides a framework for studying the contribution of transcription, translation and degradation during infection with any virus.","[Tirosh, Osnat; Cohen, Yifat; Shitrit, Alina; Shani, Odem; Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Vu Thuy Khanh Le-Trilling; Trilling, Mirko] Univ Duisburg Essen, Univ Klinikum Essen, Inst Virol, Essen, Germany; [Friedlander, Gilgi] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel; [Tanenbaum, Marvin] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA","Tirosh, O (reprint author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.",noam.stern-ginossar@weizmann.ac.il,,"Trilling, Mirko/0000-0003-3659-3541; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; , Noam/0000-0003-3583-5932","Human Frontiers Science Program Career Development Award; EU-FP7-PEOPLE Career integration grant; ICORE (Chromatin and RNA Gene Regulation); Israeli Science Foundation [1073/14]; Deutsche Forschungsgemeinschaft (DFG) [TRR60, GRK1949/1]","This research was supported by a research grant from Mr. Ilan Gluzman, the Human Frontiers Science Program Career Development Award, the EU-FP7-PEOPLE Career integration grant, the ICORE (Chromatin and RNA Gene Regulation) and the Israeli Science Foundation (1073/14). GF is the incumbent of the David and Stacey Cynamon Research fellow Chair in Genetics and Personalized Medicine. MT and VTKLT received funding from the Deutsche Forschungsgemeinschaft (DFG) through TRR60 (project A7N) and GRK1949/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,39,39,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005288,10.1371/journal.ppat.1005288,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000038,26599541.0,"DOAJ Gold, Green Published",,,16/08/2019,40,22,67,8688,1053,843,210,7635,6432,23,1180,67,19,0,0,37,37,1,,80,0,80,0,0,42,40,42,29,0,0,0,0,0,0,0,3,5,8791,235,0,77,110,3,7682,1072,235,0,77,110,3,37,,0,0,0,0,17,0,1,1,0,0,0,80,0,0,8.55,8.250712250712251,1.1379174852652258,0.13791748526522593,1.1965946299934511,1.0515653775322285,8.676163342830009
308,J,"Uyangaa, E; Kim, JH; Patil, AM; Choi, JY; Kim, SB; Eo, SK",,,,"Uyangaa, Erdenebileg; Kim, Jin Hyoung; Patil, Ajit Mahadev; Choi, Jin Young; Kim, Seong Bum; Eo, Seong Kug",,,Distinct Upstream Role of Type I IFN Signaling in Hematopoietic Stem Cell-Derived and Epithelial Resident Cells for Concerted Recruitment of Ly-6C(hi) Monocytes and NK Cells via CCL2-CCL3 Cascade,PLOS PATHOGENS,,,English,Article,,,,,,,SIMPLEX-VIRUS TYPE-2; CHEMOKINE RECEPTOR CCR2; BACTERIAL-INFECTION; VAGINAL INFECTION; VIRAL-INFECTION; DENDRITIC CELLS; INFLAMMATORY MONOCYTES; ANTIVIRAL DEFENSE; GAMMA-INTERFERON; BONE-MARROW,"Type I interferon (IFN-I)-dependent orchestrated mobilization of innate cells in inflamed tissues is believed to play a critical role in controlling replication and CNS-invasion of herpes simplex virus (HSV). However, the crucial regulators and cell populations that are affected by IFN-I to establish the early environment of innate cells in HSV-infected mucosal tissues are largely unknown. Here, we found that IFN-I signaling promoted the differentiation of CCL2-producing Ly-6C(hi) monocytes and IFN-gamma/granzyme B-producing NK cells, whereas deficiency of IFN-I signaling induced Ly-6C(lo) monocytes producing CXCL1 and CXCL2. More interestingly, recruitment of Ly-6C(hi) monocytes preceded that of NK cells with the levels peaked at 24 h post-infection in IFN-I-dependent manner, which was kinetically associated with the CCL2-CCL3 cascade response. Early Ly-6C(hi) monocyte recruitment was governed by CCL2 produced from hematopoietic stem cell (HSC)-derived leukocytes, whereas NK cell recruitment predominantly depended on CC chemokines produced by resident epithelial cells. Also, IFN-I signaling in HSC-derived leukocytes appeared to suppress Ly-6G(hi) neutrophil recruitment to ameliorate immunopathology. Finally, tissue resident CD11b(hi)F4/80(hi) macrophages and CD11c(hi)EpCAM+ dendritic cells appeared to produce initial CCL2 for migration-based self-amplification of early infiltrated Ly-6C(hi) monocytes upon stimulation by IFN-I produced from infected epithelial cells. Ultimately, these results decipher a detailed IFN-I-dependent pathway that establishes orchestrated mobilization of Ly-6C(hi) monocytes and NK cells through CCL2-CCL3 cascade response of HSC-derived leukocytes and epithelium-resident cells. Therefore, this cascade response of resident-to-hematopoietic- to-resident cells that drives cytokine-to-chemokine-to-cytokine production to recruit orchestrated innate cells is critical for attenuation of HSV replication in inflamed tissues.","[Uyangaa, Erdenebileg; Kim, Jin Hyoung; Patil, Ajit Mahadev; Choi, Jin Young; Kim, Seong Bum; Eo, Seong Kug] Chonbuk Natl Univ, Coll Vet Med, Iksan, South Korea; [Uyangaa, Erdenebileg; Kim, Jin Hyoung; Patil, Ajit Mahadev; Choi, Jin Young; Kim, Seong Bum; Eo, Seong Kug] Chonbuk Natl Univ, Biosafety Res Inst, Iksan, South Korea; [Eo, Seong Kug] Chonbuk Natl Univ, Grad Sch, Dept Bioact Mat Sci, Jeonju 561756, South Korea","Uyangaa, E (reprint author), Chonbuk Natl Univ, Coll Vet Med, Iksan, South Korea.",vetvirus@chonbuk.ac.kr,,,National Research Foundation of Korea (NRF) - Korea Government (MISP) [2013R1A4A1069486],"This study was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korea Government (MISP, No. 2013R1A4A1069486, http://www.nrf.re.kr). The providers of funding had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,10,11,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,NOV,2015,11,11,,,,,,,e1005256,10.1371/journal.ppat.1005256,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,DB2IR,WOS:000368332000020,26618488.0,"DOAJ Gold, Green Published",,,16/08/2019,9,1,20,2690,459,311,148,2231,1809,12,410,20,0,0,0,11,11,0,,0,3,0,0,3,10,10,8,8,0,0,0,0,0,0,0,1,7,2753,55,0,92,78,0,2259,466,55,0,92,78,0,28,,0,0,0,0,5,0,1,1,0,0,0,22,0,0,3.25,5.860566448801743,1.2057373375168086,0.20573733751680862,1.2935903182429405,1.0728624535315985,6.287581699346405
309,J,"Abate, F; Ambrosio, MR; Mundo, L; Laginestra, MA; Fuligni, F; Rossi, M; Zairis, S; Gazaneo, S; De Falco, G; Lazzi, S; Bellan, C; Rocca, BJ; Amato, T; Marasco, E; Etebari, M; Ogwang, M; Calbi, V; Ndede, I; Patel, K; Chumba, D; Piccaluga, PP; Pileri, S; Leoncini, L; Rabadan, R",,,,"Abate, Francesco; Ambrosio, Maria Raffaella; Mundo, Lucia; Laginestra, Maria Antonella; Fuligni, Fabio; Rossi, Maura; Zairis, Sakellarios; Gazaneo, Sara; De Falco, Giulia; Lazzi, Stefano; Bellan, Cristiana; Rocca, Bruno Jim; Amato, Teresa; Marasco, Elena; Etebari, Maryam; Ogwang, Martin; Calbi, Valeria; Ndede, Isaac; Patel, Kirtika; Chumba, David; Piccaluga, Pier Paolo; Pileri, Stefano; Leoncini, Lorenzo; Rabadan, Raul",,,Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma,PLOS PATHOGENS,,,English,Article,,,,,,,EPSTEIN-BARR-VIRUS; T-CELL LYMPHOMA; GENE-EXPRESSION; GASTRIC-CANCER; RNA-SEQ; NASOPHARYNGEAL CARCINOMA; MESSENGER-RNA; PCR ASSAYS; GENOME; MYC,"Endemic Burkitt lymphoma (eBL) is primarily found in children in equatorial regions and represents the first historical example of a virus-associated human malignancy. Although Epstein-Barr virus (EBV) infection and MYC translocations are hallmarks of the disease, it is unclear whether other factors may contribute to its development. We performed RNA-Seq on 20 eBL cases from Uganda and showed that the mutational and viral landscape of eBL is more complex than previously reported. First, we found the presence of other herpesviridae family members in 8 cases (40%), in particular human herpesvirus 5 and human herpesvirus 8 and confirmed their presence by immunohistochemistry in the adjacent nonneoplastic tissue. Second, we identified a distinct latency program in EBV involving lytic genes in association with TCF3 activity. Third, by comparing the eBL mutational landscape with published data on sporadic Burkitt lymphoma (sBL), we detected lower frequencies of mutations in MYC, ID3, TCF3 and TP53, and a higher frequency of mutation in ARID1A in eBL samples. Recurrent mutations in two genes not previously associated with eBL were identified in 20% of tumors: RHOA and cyclin F (CCNF). We also observed that polyviral samples showed lower numbers of somatic mutations in common altered genes in comparison to sBL specimens, suggesting dual mechanisms of transformation, mutation versus virus driven in sBL and eBL respectively.","[Abate, Francesco; Zairis, Sakellarios; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10027 USA; [Abate, Francesco; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY USA; [Ambrosio, Maria Raffaella; Mundo, Lucia; Gazaneo, Sara; De Falco, Giulia; Lazzi, Stefano; Bellan, Cristiana; Rocca, Bruno Jim; Amato, Teresa; Leoncini, Lorenzo] Univ Siena, Dept Med Biotechnol, Sect Pathol, I-53100 Siena, Italy; [Laginestra, Maria Antonella; Fuligni, Fabio; Rossi, Maura; Marasco, Elena; Etebari, Maryam; Pileri, Stefano] Univ Bologna, Sch Med, Dept Expt Diagnost & Specialty Med DIMES, S Orsola Malpighi Hosp, Bologna, Italy; [De Falco, Giulia] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Ogwang, Martin; Calbi, Valeria] Lacor Hosp, Gulu, Uganda; [Ndede, Isaac; Patel, Kirtika; Chumba, David] Moi Univ, Eldoret, Kenya; [Pileri, Stefano] European Inst Oncol, Unit Haematopathol, Milan, Italy; [Pileri, Stefano] Univ Bologna, Sch Med, Bologna, Italy","Abate, F (reprint author), Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10027 USA.",stefano.pileri@unibo.it; lorenzo.leoncini@dbm.unisi.it; rr2579@cumc.columbia.edu,"leoncini, lorenzo/P-8361-2018; BELLAN, CRISTIANA/L-3903-2013; Ambrosio, Maria Raffaella/K-8953-2016; Ambrosio, Maria Raffaella/S-2228-2019; Lazzi, Stefano/P-8265-2018","leoncini, lorenzo/0000-0002-7457-300X; BELLAN, CRISTIANA/0000-0001-6119-9007; Ambrosio, Maria Raffaella/0000-0002-1172-6902; Lazzi, Stefano/0000-0002-2218-3771; Marasco, Elena/0000-0002-1475-4853; Piccaluga, Pier Paolo/0000-0002-9432-0595; Rabadan, Raul/0000-0001-7946-9255; Rossi, Maura/0000-0002-9522-1601","Italian Association for Cancer Research (AIRC) [10007]; Programma Strategico ""Innovative approaches to the diagnosis and pharmacogenetic based therapies of primary hepatic tumours, peripheral B and T - cell lymphomas and lymphoblastic leukaemias""; Programma di Ricerca Regione-Universita: Area 1 ""Ricerca Innovativa""; MIUR; Steward Foundation; NIH [1 U54 CA121852-05]","This work was supported by grants from the Italian Association for Cancer Research (AIRC 5x1000, n. 10007) and Programma Strategico ""Innovative approaches to the diagnosis and pharmacogenetic based therapies of primary hepatic tumours, peripheral B and T - cell lymphomas and lymphoblastic leukaemias"", Programma di Ricerca Regione-Universita 2010-2012: Area 1 ""Ricerca Innovativa"" (SP); MIUR 2012 (LL); Steward Foundation and NIH 1 U54 CA121852-05 (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,83,40,41,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005158,10.1371/journal.ppat.1005158,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700012,26468873.0,"DOAJ Gold, Green Published",,,16/08/2019,40,6,33,6276,1563,1147,416,4713,3742,24,947,33,6,0,1,43,43,0,,52,7,52,0,7,48,43,48,29,0,0,1,0,0,1,0,0,6,6325,164,0,76,119,1,4685,1563,164,0,76,119,1,77,,0,0,0,0,6,0,0,1,1,0,0,51,0,0,3.5,4.015355086372361,1.331635900700191,0.33163590070019094,1.4020793549755994,1.052899936265137,4.227767114523353
310,J,"Arnold, LH; Groom, HCT; Kunzelmann, S; Schwefel, D; Caswell, SJ; Ordonez, P; Mann, MC; Rueschenbaum, S; Goldstone, DC; Pennell, S; Howell, SA; Stoye, JP; Webb, M; Taylor, IA; Bishop, KN",,,,"Arnold, Laurence H.; Groom, Harriet C. T.; Kunzelmann, Simone; Schwefel, David; Caswell, Sarah J.; Ordonez, Paula; Mann, Melanie C.; Rueschenbaum, Sabrina; Goldstone, David C.; Pennell, Simon; Howell, Steven A.; Stoye, Jonathan P.; Webb, Michelle; Taylor, Ian A.; Bishop, Kate N.",,,Phospho-dependent Regulation of SAMHD1 Oligomerisation Couples Catalysis and Restriction,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES SYNDROME; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; HIV-1 RESTRICTION; REVERSE-TRANSCRIPTASE; STRUCTURAL BASIS; LENTIVIRAL VECTOR; MAMMALIAN-CELLS; BINDING-PROTEIN; INFECTION,"SAMHD1 restricts HIV-1 infection of myeloid-lineage and resting CD4(+) T-cells. Most likely this occurs through deoxynucleoside triphosphate triphosphohydrolase activity that reduces cellular dNTP to a level where reverse transcriptase cannot function, although alternative mechanisms have been proposed recently. Here, we present combined structural and virological data demonstrating that in addition to allosteric activation and triphosphohydrolase activity, restriction correlates with the capacity of SAMHD1 to form ""long-lived"" enzymatically competent tetramers. Tetramer disruption invariably abolishes restriction but has varied effects on in vitro triphosphohydrolase activity. SAMHD1 phosphorylation also ablates restriction and tetramer formation but without affecting triphosphohydrolase steady-state kinetics. However phospho-SAMHD1 is unable to catalyse dNTP turnover under conditions of nucleotide depletion. Based on our findings we propose a model for phosphorylation-dependent regulation of SAMHD1 activity where dephosphorylation switches housekeeping SAMHD1 found in cycling cells to a high-activity stable tetrameric form that depletes and maintains low levels of dNTPs in differentiated cells.","[Arnold, Laurence H.; Groom, Harriet C. T.; Kunzelmann, Simone; Schwefel, David; Caswell, Sarah J.; Ordonez, Paula; Mann, Melanie C.; Rueschenbaum, Sabrina; Goldstone, David C.; Pennell, Simon; Howell, Steven A.; Stoye, Jonathan P.; Taylor, Ian A.; Bishop, Kate N.] Francis Crick Inst, Mill Hill Lab, London, England; [Stoye, Jonathan P.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Webb, Michelle] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Ctr Genom Med, Manchester, Lancs, England","Taylor, IA (reprint author), Francis Crick Inst, Mill Hill Lab, Mill Hill, London, England.",Ian.Taylor@crick.ac.uk; Kate.Bishop@crick.ac.uk,,"Stoye, Jonathan/0000-0003-3377-323X; Goldstone, David/0000-0003-0069-9408","UK Medical Research Council [U117512710, U117565647, U117592729]; Wellcome Trust [084955]; EMBO long-term fellowship - European Commission Marie Curie Actions [EMBOCOFUND2010, GA-2010-267146]; Medical Research Council [MC_U117512710, MC_U117592729]; The Francis Crick Institute [10042, 10015, 10178, 10162]","This work was supported by the UK Medical Research Council file references U117512710 (JPS), U117565647 (IAT), and U117592729 (KNB), the Wellcome Trust, ref 084955 (KNB) and by an EMBO long-term fellowship co-funded by the European Commission Marie Curie Actions (EMBOCOFUND2010, GA-2010-267146) (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,44,46,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005194,10.1371/journal.ppat.1005194,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700030,26431200.0,"DOAJ Gold, Green Published",,,16/08/2019,48,117,39,4991,779,571,208,4212,3410,19,783,38,1,0,0,46,46,0,,57,1,56,1,1,58,49,58,31,0,0,0,0,0,0,0,116,1,5122,113,0,114,193,0,4271,800,113,0,114,193,0,51,,0,0,0,0,2,0,0,1,0,0,0,56,1,0,1.75,6.406931964056483,1.1849477682811016,0.18494776828110163,1.288698955365622,1.087557603686636,6.96790757381258
311,J,"Bollampalli, VP; Yamashiro, LH; Feng, XG; Bierschenk, D; Gao, Y; Blom, H; Henriques-Normark, B; Nylen, S; Rothfuchs, AG",,,,"Bollampalli, Vishnu Priya; Yamashiro, Livia Harumi; Feng, Xiaogang; Bierschenk, Damien; Gao, Yu; Blom, Hans; Henriques-Normark, Birgitta; Nylen, Susanne; Rothfuchs, Antonio Gigliotti",,,BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAM(low) CD11b(high) Skin Dendritic cells to Draining Lymph Node During CD4+T-Cell Priming,PLOS PATHOGENS,,,English,Article,,,,,,,NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; LANGERHANS CELLS; TH1 RESPONSES; MICE LACKING; RECEPTOR; ANTIGEN; MECHANISMS; DISTINCT,"The transport of antigen from the periphery to the draining lymph node (DLN) is critical for T-cell priming but remains poorly studied during infection with Mycobacterium bovis Bacille Calmette-Guerin (BCG). To address this we employed a mouse model to track the traffic of Dendritic cells (DCs) and mycobacteria from the BCG inoculation site in the skin to the DLN. Detection of BCG in the DLN was concomitant with the priming of antigen-specific CD4(+) T cells at that site. We found EpCAM(low) CD11b(high) migratory skin DCs to be mobilized during the transport of BCG to the DLN. Migratory skin DCs distributed to the T-cell area of the LN, co-localized with BCG and were found in close apposition to antigen-specific CD4(+) T cells. Consequently, blockade of skin DC traffic into DLN dramatically reduced mycobacterial entry into DLN and muted T-cell priming. Interestingly, DC and mycobacterial entry into the DLN was dependent on IL-1R-I, MyD88, TNFR-I and IL-12p40. In addition, we found using DC adoptive transfers that the requirement for MyD88 in BCG-triggered migration was not restricted to the migrating DC itself and that hematopoietic expression of MyD88 was needed in part for full-fledged migration. Our observations thus identify a population of DCs that contribute towards the priming of CD4(+) T cells to BCG infection by transporting bacilli into the DLN in an IL-1R-MyD88-dependent manner and reveal both DC-intrinsic and -extrinsic requirements for MyD88 in DC migration.","[Bollampalli, Vishnu Priya; Yamashiro, Livia Harumi; Feng, Xiaogang; Bierschenk, Damien; Gao, Yu; Henriques-Normark, Birgitta; Nylen, Susanne; Rothfuchs, Antonio Gigliotti] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Yamashiro, Livia Harumi] Univ Fed Santa Catarina, Dept Pharmacol, Florianopolis, SC, Brazil; [Blom, Hans] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden","Rothfuchs, AG (reprint author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.",antonio.rothfuchs@ki.se,"Rothfuchs, Antonio/F-5981-2013; Bierschenk, Damien/C-7987-2017","Rothfuchs, Antonio/0000-0001-6001-7240; Bierschenk, Damien/0000-0003-1647-8837","EU [FP7-MC-IRG-247684]; Swedish Research Council VR [2011-2915, 2014-2794]; STINT [2912-2046]; Karolinska Institutet; Ake Wiberg Stiftelse, Magn. Bergvall Stiftelse; Swedish Society for Medicine; Stiftelsen Lars Hiertas Minne; Stiftelsen Apotekare Hedbergs Fond; Stiftelsen Clas Groschinskys Minnesfond","This work was supported by a Marie Curie International Reintegration Grant from the EU (FP7-MC-IRG-247684), a Young investigator grant from the Swedish Research Council VR (Dnr 2011-2915), a project grant from the Swedish Research Council VR (Dnr 2014-2794), a Joint-research Collaboration grant from STINT (Dnr 2912-2046), a KID Doctoral Grant from Karolinska Institutet, and project grants from Ake Wiberg Stiftelse, Magn. Bergvall Stiftelse, The Swedish Society for Medicine, Stiftelsen Lars Hiertas Minne, Stiftelsen Apotekare Hedbergs Fond, Karolinska Institutet and Stiftelsen Clas Groschinskys Minnesfond (all to AGR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,9,9,1,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005206,10.1371/journal.ppat.1005206,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700039,26440518.0,"DOAJ Gold, Green Published",,,16/08/2019,11,1,22,3651,608,433,175,3043,2447,19,577,22,0,0,1,10,10,0,,65,1,35,0,1,11,11,9,10,0,0,0,0,0,0,0,1,2,3705,59,0,125,163,0,3061,621,59,0,125,163,0,23,,0,0,0,0,4,0,0,1,1,0,0,39,0,0,2.5,6.004934210526316,1.1998028261583964,0.1998028261583963,1.2905027932960893,1.0755957271980279,6.458881578947368
312,J,"Buch, MHC; Liaci, AM; O'Hara, SD; Garcea, RL; Neu, U; Stehle, T",,,,"Buch, Michael H. C.; Liaci, A. Manuel; O'Hara, Samantha D.; Garcea, Robert L.; Neu, Ursula; Stehle, Thilo",,,Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity,PLoS Pathogens,,,English,Article,,,,,,,RECEPTOR-BINDING; TUMOR-INDUCTION; SIALYLOLIGOSACCHARIDE RECEPTORS; DEVELOPMENTAL-CHANGES; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; INFLUENZA-VIRUS; NERVOUS-SYSTEM; CHOLERA-TOXIN,"Murine polyomavirus (MuPyV) causes tumors of various origins in newborn mice and hamsters. Infection is initiated by attachment of the virus to ganglioside receptors at the cell surface. Single amino acid exchanges in the receptor-binding pocket of the major capsid protein VP1 are known to drastically alter tumorigenicity and spread in closely related MuPyV strains. The virus represents a rare example of differential receptor recognition directly influencing viral pathogenicity, although the factors underlying these differences remain unclear. We performed structural and functional analyses of three MuPyV strains with strikingly different pathogenicities: the low-tumorigenicity strain RA, the high-pathogenicity strain PTA, and the rapidly growing, lethal laboratory isolate strain LID. Using ganglioside deficient mouse embryo fibroblasts, we show that addition of specific gangliosides restores infectability for all strains, and we uncover a complex relationship between virus attachment and infection. We identify a new infectious ganglioside receptor that carries an additional linear [alpha-2,8]-linked sialic acid. Crystal structures of all three strains complexed with representative oligosaccharides from the three main pathways of ganglioside biosynthesis provide the molecular basis of receptor recognition. All strains bind to a range of sialylated glycans featuring the central [alpha-2,3]-linked sialic acid present in the established receptors GD1a and GT1b, but the presence of additional sialic acids modulates binding. An extra [alpha-2,8]-linked sialic acid engages a protein pocket that is conserved among the three strains, while another, [alpha-2,6]-linked branching sialic acid lies near the strain-defining amino acids but can be accommodated by all strains. By comparing electron density of the oligosaccharides within the binding pockets at various concentrations, we show that the [alpha-2,8]- linked sialic acid increases the strength of binding. Moreover, the amino acid exchanges have subtle effects on their affinity for the validated receptor GD1a. Our results indicate that both receptor specificity and affinity influence MuPyV pathogenesis.","[Buch, Michael H. C.; Liaci, A. Manuel; Neu, Ursula; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [O'Hara, Samantha D.; Garcea, Robert L.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [O'Hara, Samantha D.; Garcea, Robert L.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Stehle, Thilo] Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN USA","Buch, MHC (reprint author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.",uneu@nimr.mrc.ac.uk; thilo.stehle@uni-tuebingen.de,"Core, BioFrontiers Advanced Light Microscopy/O-6175-2019","Neu, Ursula/0000-0001-6852-0879",Deutsche Forschungsgemeinschaft [SFB 685]; National Institutes of Health [R01-CA37667],"MHCB, AML, UN, and TS are grateful for financial support from the Deutsche Forschungsgemeinschaft SFB 685 (www.sfb685.de). SDO and RLG acknowledge the National Institutes of Health R01-CA37667 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,6,6,2,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005104,10.1371/journal.ppat.1005104,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700004,26474293.0,"DOAJ Gold, Green Published",,,16/08/2019,7,5,23,3464,674,534,140,2790,2346,65,379,23,5,5,0,6,6,0,,29,0,29,0,0,8,8,4,4,0,0,0,0,0,0,0,0,2,3524,60,0,80,154,1,2807,687,60,0,80,154,1,30,,0,0,0,2,3,0,0,1,0,0,0,29,0,0,4.25,5.13946587537092,1.2415770609318997,0.24157706093189965,1.3397849462365592,1.0790993071593533,5.545994065281899
313,J,"Burke, HG; Heldwein, EE",,,,"Burke, Heidi G.; Heldwein, Ekaterina E.",,,Crystal Structure of the Human Cytomegalovirus Glycoprotein B,PLOS PATHOGENS,,,English,Article,,,,,,,MAJOR ENVELOPE GLYCOPROTEIN; DISINTEGRIN-LIKE DOMAIN; MEMBRANE-FUSION; TRANSPLANT RECIPIENTS; COMPLEX GB; ANTIBODIES; ENTRY; INFECTION; NEUTRALIZATION; CELLS,"Human cytomegalovirus (HCMV), a dsDNA, enveloped virus, is a ubiquitous pathogen that establishes lifelong latent infections and caused disease in persons with compromised immune systems, e.g., organ transplant recipients or AIDS patients. HCMV is also a leading cause of congenital viral infections in newborns. Entry of HCMV into cells requires the conserved glycoprotein B (gB), thought to function as a fusogen and reported to bind signaling receptors. gB also elicits a strong immune response in humans and induces the production of neutralizing antibodies although most anti-gB Abs are non-neutralizing. Here, we report the crystal structure of the HCMV gB ectodomain determined to 3.6-angstrom resolution, which is the first atomic-level structure of any betaherpesvirus glycoprotein. The structure of HCMV gB resembles the postfusion structures of HSV-1 and EBV homologs, establishing it as a new member of the class III viral fusogens. Despite structural similarities, each gB has a unique domain arrangement, demonstrating structural plasticity of gB that may accommodate virus-specific functional requirements. The structure illustrates how extensive glycosylation of the gB ectodomain influences antibody recognition. Antigenic sites that elicit neutralizing antibodies are more heavily glycosylated than those that elicit non-neutralizing antibodies, which suggest that HCMV gB uses glycans to shield neutralizing epitopes while exposing non-neutralizing epitopes. This glycosylation pattern may have evolved to direct the immune response towards generation of non-neutralizing antibodies thus helping HCMV to avoid clearance. HCMV gB structure provides a starting point for elucidation of its antigenic and immunogenic properties and aid in the design of recombinant vaccines and monoclonal antibody therapies.","[Burke, Heidi G.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Mol Microbiol, Boston, MA 02111 USA","Burke, HG (reprint author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.",katya.heldwein@tufts.edu,,"Heldwein, Ekaterina/0000-0003-3113-6958",Burroughs Wellcome Fund Award for Investigators in Pathogenesis; NIH [T32-AI007422],"This study was funded by the Burroughs Wellcome Fund Award for Investigators in Pathogenesis (EEH) and the NIH T32-AI007422 (HGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,54,54,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005227,10.1371/journal.ppat.1005227,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700050,26484870.0,"DOAJ Gold, Green Published",,,16/08/2019,57,4,46,7937,1545,1115,430,6392,5028,20,1344,46,2,0,0,48,48,0,,76,1,76,0,1,59,59,30,41,0,0,0,0,0,0,0,2,7,8085,78,0,90,481,0,6481,1565,78,0,90,481,0,39,,0,0,0,0,11,0,0,1,0,0,0,74,0,0,5.95,5.137216828478964,1.2417083854818523,0.2417083854818523,1.3523153942428034,1.08907647725841,5.594822006472492
314,J,"Chen, NC; Yoshimura, M; Guan, HH; Wang, TY; Misumi, Y; Lin, CC; Chuankhayan, P; Nakagawa, A; Chan, SI; Tsukihara, T; Chen, TY; Chen, CJ",,,,"Chen, Nai-Chi; Yoshimura, Masato; Guan, Hong-Hsiang; Wang, Ting-Yu; Misumi, Yuko; Lin, Chien-Chih; Chuankhayan, Phimonphan; Nakagawa, Atsushi; Chan, Sunney I.; Tsukihara, Tomitake; Chen, Tzong-Yueh; Chen, Chun-Jung",,,Crystal Structures of a Piscine Betanodavirus: Mechanisms of Capsid Assembly and Viral Infection,PLoS Pathogens,,,English,Article,,,,,,,SESBANIA-MOSAIC-VIRUS; X-RAY CRYSTALLOGRAPHY; BUSHY STUNT VIRUS; COAT PROTEIN GENE; ICOSAHEDRAL VIRUS; NERVOUS NECROSIS; ATOMIC-STRUCTURE; GENOMIC CLASSIFICATION; MOLECULAR REPLACEMENT; PHYLOGENETIC ANALYSIS,"Betanodaviruses cause massive mortality in marine fish species with viral nervous necrosis. The structure of a T = 3 Grouper nervous necrosis virus-like particle (GNNV-LP) is determined by the ab initio method with non-crystallographic symmetry averaging at 3.6 angstrom resolution. Each capsid protein (CP) shows three major domains: (i) the N-terminal arm, an inter-subunit extension at the inner surface; (ii) the shell domain (S-domain), a jelly-roll structure; and (iii) the protrusion domain (P-domain) formed by three-fold trimeric protrusions. In addition, we have determined structures of the T = 1 subviral particles (SVPs) of (i) the delta-P-domain mutant (residues 35-217) at 3.1 angstrom resolution; and (ii) the N-ARM deletion mutant (residues 35-338) at 7 angstrom resolution; and (iii) the structure of the individual P-domain (residues 214-338) at 1.2 angstrom resolution. The P-domain reveals a novel DxD motif asymmetrically coordinating two Ca2+ ions, and seems to play a prominent role in the calcium-mediated trimerization of the GNNV CPs during the initial capsid assembly process. The flexible N-ARM (N-terminal arginine-rich motif) appears to serve as a molecular switch for T = 1 or T = 3 assembly. Finally, we find that polyethylene glycol, which is incorporated into the P-domain during the crystallization process, enhances GNNV infection. The present structural studies together with the biological assays enhance our understanding of the role of the P-domain of GNNV in the capsid assembly and viral infection by this betanodavirus.","[Chen, Nai-Chi; Wang, Ting-Yu; Chen, Tzong-Yueh; Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan, Taiwan; [Chen, Nai-Chi; Yoshimura, Masato; Guan, Hong-Hsiang; Lin, Chien-Chih; Chuankhayan, Phimonphan; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu, Taiwan; [Misumi, Yuko; Nakagawa, Atsushi; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Chan, Sunney I.] Acad Sinica, Inst Chem, Taipei, Taiwan; [Chan, Sunney I.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Tsukihara, Tomitake] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Kamigori, Hyogo, Japan; [Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan","Chen, TY (reprint author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan, Taiwan.",ibcty@mail.ncku.edu.tw; cjchen@nsrrc.org.tw,"Chen, Chun-Jung/A-6880-2011; Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019; Chan, Sunney/F-2017-2015","Chen, Chun-Jung/0000-0002-5157-4288; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Yoshimura, Masato/0000-0002-7466-2192","Ministry of Science and Technology (MOST) [98-2313-B-009-001-MY3, 101-2628-B-213-001-MY4, 102-2627-M-213-001-MY3]; NSRRC [1023RSB02, 1023RSB14, 10324RSB02, 10324RSB14]","This work was supported in part by Ministry of Science and Technology (MOST) grants 98-2313-B-009-001-MY3, 101-2628-B-213-001-MY4, 102-2627-M-213-001-MY3 and NSRRC grants 1023RSB02, 1023RSB14, 10324RSB02 and 10324RSB14 to C-J Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,72,41,41,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005203,10.1371/journal.ppat.1005203,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700037,26491970.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,38,12,28,6965,885,677,208,6080,5073,26,981,28,0,1,0,40,40,4,,43,2,43,0,2,40,40,32,16,0,0,0,0,0,0,0,12,0,7035,94,0,101,610,0,6099,903,94,0,101,610,0,33,,1,0,0,1,0,0,0,1,0,0,0,43,0,0,11.25,7.870056497175141,1.1455592105263157,0.1455592105263158,1.272861842105263,1.111127063890883,8.744632768361582
315,J,"Chou, SF; Tsai, ML; Huang, JY; Chang, YS; Shih, CH",,,,"Chou, Shu-Fan; Tsai, Ming-Lin; Huang, Jyun-Yuan; Chang, Ya-Shu; Shih, Chiaho",,,The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion,PLoS Pathogens,,,English,Article,,,,,,,HEPATITIS-B-VIRUS; ARGININE-RICH DOMAIN; HEPATOMA-CELL LINE; MULTIVESICULAR BODY; CORE ANTIGEN; VIRAL-DNA; REVERSE TRANSCRIPTION; IMMATURE SECRETION; PROTEIN INTERACTS; HIGHLY FREQUENT,"The Endosomal Sorting Complex Required for Transport (ESCRT) is an important cellular machinery for the sorting and trafficking of ubiquitinated cargos. It is also known that ESCRT is required for the egress of a number of viruses. To investigate the relationship between ESCRT and hepatitis B virus (HBV), we conducted an siRNA screening of ESCRT components for their potential effect on HBV replication and virion release. We identified a number of ESCRT factors required for HBV replication, and focused our study here on HGS (HRS, hepatocyte growth factor-regulated tyrosine kinase substrate) in the ESCRT-0 complex. Aberrant levels of HGS suppressed HBV transcription, replication and virion secretion. Hydrodynamic delivery of HGS in a mouse model significantly suppressed viral replication in the liver and virion secretion in the serum. Surprisingly, overexpression of HGS stimulated the release of HBV naked capsids, irrespective of their viral RNA, DNA, or empty contents. Mutant core protein (HBc 1-147) containing no arginine-rich domain (ARD) failed to secrete empty virions with or without HGS. In contrast, empty naked capsids of HBc 1-147 could still be promoted for secretion by HGS. HGS exerted a strong positive effect on the secretion of naked capsids, at the expense of a reduced level of virions. The association between HGS and HBc appears to be ubiquitin-independent. Furthermore, HBc is preferentially co-localized with HGS near the cell periphery, instead of near the punctate endosomes in the cytoplasm. In summary, our work demonstrated the importance of an optimum level of HGS in HBV propagation. In addition to an effect on HBV transcription, HGS can diminish the pool size of intracellular nucleocapsids with ongoing genome maturation, probably in part by promoting the secretion of naked capsids. The secretion routes of HBV virions and naked capsids can be clearly distinguished based on the pleiotropic effect of HGS involved in the ESCRT-0 complex.","[Chou, Shu-Fan; Shih, Chiaho] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan; [Chou, Shu-Fan; Tsai, Ming-Lin; Huang, Jyun-Yuan; Chang, Ya-Shu; Shih, Chiaho] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Huang, Jyun-Yuan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan","Chou, SF (reprint author), Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan.",cshih@ibms.sinica.edu.tw,"Shih, Chiaho/S-7017-2018",,"Ministry of Science and Technology (MOST); Academia Sinica; National Health of Research Institutes (NHRI), Taiwan","This work was supported by the Ministry of Science and Technology (MOST), Academia Sinica, and National Health of Research Institutes (NHRI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,89,20,20,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005123,10.1371/journal.ppat.1005123,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700007,26431433.0,"DOAJ Gold, Green Published",,,16/08/2019,19,1,20,4616,1110,778,332,3506,2810,19,677,20,0,0,0,19,19,0,,25,1,25,0,1,20,20,13,14,0,0,0,0,0,0,0,1,0,4691,72,0,99,49,0,3533,1124,72,0,99,49,0,34,,0,0,0,0,1,0,0,1,0,0,0,25,0,0,0.5,4.158558558558559,1.3166001140901311,0.3166001140901312,1.3725042783799202,1.0424610051993068,4.335135135135135
316,J,"Ciferri, C; Chandramouli, S; Leitner, A; Donnarumma, D; Cianfrocco, MA; Gerrein, R; Friedrich, K; Aggarwal, Y; Palladino, G; Aebersold, R; Norais, N; Settembre, EC; Carfi, A",,,,"Ciferri, Claudio; Chandramouli, Sumana; Leitner, Alexander; Donnarumma, Danilo; Cianfrocco, Michael A.; Gerrein, Rachel; Friedrich, Kristian; Aggarwal, Yukti; Palladino, Giuseppe; Aebersold, Ruedi; Norais, Nathalie; Settembre, Ethan C.; Carfi, Andrea",,,Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN CYTOMEGALOVIRUS-INFECTION; GLYCOPROTEIN-H; CRYSTAL-STRUCTURE; IN-VITRO; VACCINE; DISEASE; GH/GL/UL128-131; PREVALENCE; PREVENTION; MANAGEMENT,"Human Cytomegalovirus (HCMV) is a major cause of morbidity and mortality in transplant patients and in fetuses following congenital infection. The glycoprotein complexes gH/gL/gO and gH/gL/UL128/UL130/UL131A (Pentamer) are required for HCMV entry in fibroblasts and endothelial/epithelial cells, respectively, and are targeted by potently neutralizing antibodies in the infected host. Using purified soluble forms of gH/gL/gO and Pentamer as well as a panel of naturally elicited human monoclonal antibodies, we determined the location of key neutralizing epitopes on the gH/gL/gO and Pentamer surfaces. Mass Spectrometry (MS) coupled to Chemical Crosslinking or to Hydrogen Deuterium Exchange was used to define residues that are either in proximity or part of neutralizing epitopes on the glycoprotein complexes. We also determined the molecular architecture of the gH/gL/gO- and Pentamer-antibody complexes by Electron Microscopy (EM) and 3D reconstructions. The EM analysis revealed that the Pentamer specific neutralizing antibodies bind to two opposite surfaces of the complex, suggesting that they may neutralize infection by different mechanisms. Together, our data identify the location of neutralizing antibodies binding sites on the gH/gL/gO and Pentamer complexes and provide a framework for the development of antibodies and vaccines against HCMV.","[Ciferri, Claudio; Chandramouli, Sumana; Gerrein, Rachel; Friedrich, Kristian; Aggarwal, Yukti; Palladino, Giuseppe; Settembre, Ethan C.; Carfi, Andrea] Novartis Vaccines GSK Co, Cambridge, MA USA; [Leitner, Alexander; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Donnarumma, Danilo; Norais, Nathalie] Novartis Vaccines GSK Co, Siena, Italy; [Cianfrocco, Michael A.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Cianfrocco, Michael A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02138 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland","Ciferri, C (reprint author), Genentech Inc, San Francisco, CA 94080 USA.",ciferric@gene.com; andrea.x.carfi@gsk.com,,"Chandramouli, Sumana/0000-0001-6994-506X; Leitner, Alexander/0000-0003-4126-0725",Novartis Vaccines (a GSK company),"This work was entirely funded by Novartis Vaccines (a GSK company). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,48,32,32,1,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005230,10.1371/journal.ppat.1005230,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700052,26485028.0,"DOAJ Gold, Green Published",,,16/08/2019,33,0,31,4550,794,603,191,3756,2971,15,770,31,0,0,0,29,29,0,,47,0,47,0,0,35,35,19,20,0,0,0,0,0,0,0,0,0,4620,64,0,354,121,1,3776,806,64,0,354,121,1,38,,0,0,0,0,0,0,0,1,0,0,0,47,0,0,0.25,5.730478589420655,1.211395101171459,0.211395101171459,1.2792864749733759,1.056043956043956,6.051637279596977
317,J,"Connor, MG; Pulsifer, AR; Price, CT; Abu Kwaik, Y; Lawrenz, MB",,,,"Connor, Michael G.; Pulsifer, Amanda R.; Price, Christopher T.; Abu Kwaik, Yousef; Lawrenz, Matthew B.",,,Yersinia pestis Requires Host Rab1b for Survival in Macrophages,PLOS PATHOGENS,,,English,Article,,,,,,,MYCOBACTERIAL PHAGOSOME MATURATION; RESPONSE REGULATOR PHOP; EFFECTOR PROTEIN DRRA; SMALL GTPASE RAB1; LEGIONELLA-PNEUMOPHILA; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; PNEUMONIC PLAGUE; RNAI SCREEN; REPLICATION,"Yersinia pestis is a facultative intracellular pathogen that causes the disease known as plague. During infection of macrophages Y. pestis actively evades the normal phagosomal maturation pathway to establish a replicative niche within the cell. However, the mechanisms used by Y. pestis to subvert killing by the macrophage are unknown. Host Rab GTPases are central mediators of vesicular trafficking and are commonly targeted by bacterial pathogens to alter phagosome maturation and killing by macrophages. Here we demonstrate for the first time that host Rab1b is required for Y. pestis to effectively evade killing by macrophages. We also show that Rab1b is specifically recruited to the Yersinia containing vacuole (YCV) and that Y. pestis is unable to subvert YCV acidification when Rab1b expression is knocked down in macrophages. Furthermore, Rab1b knockdown also altered the frequency of association between the YCV with the lysosomal marker Lamp1, suggesting that Rab1b recruitment to the YCV directly inhibits phagosome maturation. Finally, we show that Rab1b knockdown also impacts the pH of the Legionella pneumophila containing vacuole, another pathogen that recruits Rab1b to its vacuole. Together these data identify a novel role for Rab1b in the subversion of phagosome maturation by intracellular pathogens and suggest that recruitment of Rab1b to the pathogen containing vacuole may be a conserved mechanism to control vacuole pH.","[Connor, Michael G.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; Univ Louisville, Sch Med, Ctr Predict Med Biodefense & Emerging Infect Dis, Louisville, KY 40292 USA","Connor, MG (reprint author), Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.",matt.lawrenz@louisville.edu,,"Lawrenz, Matthew/0000-0003-1505-5429",National Institutes of Health [AI097608]; University of Louisville Center for Predictive Medicine,"This work was suported by funding from the National Institutes of Health (AI097608) and The University of Louisville Center for Predictive Medicine to MBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript",,102,13,13,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005241,10.1371/journal.ppat.1005241,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700061,26495854.0,"DOAJ Gold, Green Published",,,16/08/2019,17,59,33,5193,1026,762,264,4167,3482,17,668,33,6,0,0,17,17,0,,46,4,46,0,4,18,17,18,11,0,0,0,0,0,0,0,54,4,5333,37,0,49,342,2,4185,1038,37,0,49,342,2,110,,0,0,0,0,7,0,0,1,0,0,0,46,0,0,3.35,5.06140350877193,1.2462203023758098,0.24622030237580994,1.3707703383729302,1.0999422299248989,5.567251461988304
318,J,"De Colibus, L; Wang, XX; Tijsma, A; Neyts, J; Spyrou, JAB; Ren, JS; Grimes, JM; Puerstinger, G; Leyssen, P; Fry, EE; Rao, ZH; Stuart, DI",,,,"De Colibus, Luigi; Wang, Xiangxi; Tijsma, Aloys; Neyts, Johan; Spyrou, John A. B.; Ren, Jingshan; Grimes, Jonathan M.; Puerstinger, Gerhard; Leyssen, Pieter; Fry, Elizabeth E.; Rao, Zihe; Stuart, David I.",,,Structure Elucidation of Coxsackievirus A16 in Complex with GPP3 Informs a Systematic Review of Highly Potent Capsid Binders to Enteroviruses,PLOS PATHOGENS,,,English,Article,,,,,,,MACROMOLECULAR CRYSTALLOGRAPHY; ANGSTROM RESOLUTION; ACCURATE DOCKING; MOUTH-DISEASE; POLIOVIRUS; INHIBITORS; MECHANISM; VIRUS; GLIDE; SUITE,"The replication of enterovirus 71 (EV71) and coxsackievirus A16 (CVA16), which are the major cause of hand, foot and mouth disease (HFMD) in children, can be inhibited by the capsid binder GPP3. Here, we present the crystal structure of CVA16 in complex with GPP3, which clarifies the role of the key residues involved in interactions with the inhibitor. Based on this model, in silico docking was performed to investigate the interactions with the two next-generation capsid binders NLD and ALD, which we show to be potent inhibitors of a panel of enteroviruses with potentially interesting pharmacological properties. A meta-analysis was performed using the available structural information to obtain a deeper insight into those structural features required for capsid binders to interact effectively and also those that confer broad-spectrum anti-enterovirus activity.","[De Colibus, Luigi; Spyrou, John A. B.; Ren, Jingshan; Grimes, Jonathan M.; Stuart, David I.] Univ Oxford, Div Struct Biol, Oxford, England; [Wang, Xiangxi; Rao, Zihe] Chinese Acad Sci, Natl Lab Macromol, Inst Biophys, Beijing, Peoples R China; [Tijsma, Aloys; Neyts, Johan; Leyssen, Pieter] Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium; [Grimes, Jonathan M.; Stuart, David I.] Diamond Light Source, Didcot, Oxon, England; [Puerstinger, Gerhard] Univ Innsbruck, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Sch Med, Beijing 100084, Peoples R China","De Colibus, L (reprint author), Univ Oxford, Div Struct Biol, Oxford, England.",raozh@xtal.tsinghua.edu.cn; dave@strubi.ox.ac.uk,"Neyts, Johan/U-8267-2017","Neyts, Johan/0000-0002-0033-7514; Fry, Elizabeth/0000-0001-9754-5303; Ren, Jingshan/0000-0003-4015-1404; Stuart, David/0000-0002-3426-4210","Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020200]; National Major Project of Infectious Disease [2012ZX10004701]; Ministry of Science and Technology 973 Project [2014CB542800]; National Science Foundation [81330036]; UK Medical Research Council [G1000099]; Wellcome Trust; Medical Research Council [MR/N00065X/1, G1000099, G1100525]","This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences, grant no. XDB08020200, the National Major Project of Infectious Disease (2012ZX10004701), the Ministry of Science and Technology 973 Project (grant no. 2014CB542800), and National Science Foundation grant 81330036. DIS & EEF are supported by the UK Medical Research Council, grant (grant No. G1000099) and JR by the Wellcome Trust. This work is a contribution from the Instruct Centre, Oxford. Administrative support was provided by the Wellcome Trust (075491/Z/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,31,4,4,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005165,10.1371/journal.ppat.1005165,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700014,26485389.0,"DOAJ Gold, Green Published",,,16/08/2019,5,51,25,3424,780,504,276,2644,2038,18,588,25,0,0,0,5,5,0,,37,0,37,0,0,5,5,5,4,0,0,0,0,0,0,0,51,1,3489,33,0,72,140,0,2662,789,33,0,72,140,0,38,,0,0,0,0,1,0,0,1,0,0,0,37,0,0,0.75,4.38974358974359,1.2950075642965204,0.2950075642965204,1.3850226928895613,1.0695093457943925,4.694871794871795
319,J,"de Guillen, K; Ortiz-Vallejo, D; Gracy, J; Fournier, E; Kroj, T; Padilla, A",,,,"de Guillen, Karine; Ortiz-Vallejo, Diana; Gracy, Jerome; Fournier, Elisabeth; Kroj, Thomas; Padilla, Andre",,,Structure Analysis Uncovers a Highly Diverse but Structurally Conserved Effector Family in Phytopathogenic Fungi,PLOS PATHOGENS,,,English,Article,,,,,,,BLAST RESISTANCE GENE; MAGNAPORTHE-ORYZAE; MOLECULAR-MECHANISMS; DISEASE RESISTANCE; OBLIGATE BIOTROPHY; SECRETED PROTEINS; RICE-MAGNAPORTHE; NMR-SPECTROSCOPY; REPEAT PROTEIN; PTR TOXA,"Phytopathogenic ascomycete fungi possess huge effector repertoires that are dominated by hundreds of sequence-unrelated small secreted proteins. The molecular function of these effectors and the evolutionary mechanisms that generate this tremendous number of singleton genes are largely unknown. To get a deeper understanding of fungal effectors, we determined by NMR spectroscopy the 3-dimensional structures of the Magnaporthe oryzae effectors AVR1-CO39 and AVR-Pia. Despite a lack of sequence similarity, both proteins have very similar 6 beta-sandwich structures that are stabilized in both cases by a disulfide bridge between 2 conserved cysteins located in similar positions of the proteins. Structural similarity searches revealed that AvrPiz-t, another effector from M. oryzae, and ToxB, an effector of the wheat tan spot pathogen Pyrenophora tritici-repentis have the same structures suggesting the existence of a family of sequence-unrelated but structurally conserved fungal effectors that we named MAX-effectors (Magnaporthe Avrs and ToxB like). Structure-informed pattern searches strengthened this hypothesis by identifying MAX-effector candidates in a broad range of ascomycete phytopathogens. Strong expansion of the MAX-effector family was detected in M. oryzae and M. grisea where they seem to be particularly important since they account for 5-10% of the effector repertoire and 50% of the cloned avirulence effectors. Expression analysis indicated that the majority of M. oryzae MAX-effectors are expressed specifically during early infection suggesting important functions during biotrophic host colonization. We hypothesize that the scenario observed for MAX-effectors can serve as a paradigm for ascomycete effector diversity and that the enormous number of sequence-unrelated ascomycete effectors may in fact belong to a restricted set of structurally conserved effector families.","[de Guillen, Karine; Gracy, Jerome; Padilla, Andre] INSERM, Ctr Biochim Struct, U1054, Montpellier, France; [de Guillen, Karine; Gracy, Jerome; Padilla, Andre] Univ Montpellier, CNRS, UMR5048, F-34059 Montpellier, France; [Ortiz-Vallejo, Diana; Fournier, Elisabeth; Kroj, Thomas] INRA, BGPI, Biol & Genet Plant Pathogen Interact, F-34060 Montpellier, France; [Ortiz-Vallejo, Diana; Fournier, Elisabeth; Kroj, Thomas] CIRAD, BGPI, Biol & Genet Plant Pathogen Interact, Montpellier, France","de Guillen, K (reprint author), INSERM, Ctr Biochim Struct, U1054, Montpellier, France.",thomas.kroj@supagro.inra.fr; andre.padilla@cbs.cnrs.fr,,"de Guillen, Karine/0000-0002-5037-2115; kroj, thomas/0000-0002-3752-1788; PADILLA, ANDRE/0000-0001-9702-4612","Colombian National Agency for the Science and Technology COLCIENCIAS, COLFUTURO [528]; ""Agence nationale de la recherche"" of France [ANR-10-INSB-05-0, ANR-09-GENM-029, ANR-07-GPLA-0007]","This work was supported by a PhD grant for DO from the Colombian National Agency for the Science and Technology COLCIENCIAS, COLFUTURO (call 528) and by grants from the ""Agence nationale de la recherche"" of France ANR-10-INSB-05-0 (French Infrastructure for Integrated Structural Biology-FRISBI) to AP, KG and JG, ANR-09-GENM-029 (Analysis and comparison of genomes of the fungal pathogen Magnaporthe oryzae-GEMO) to EF and TK and ANR-07-GPLA-0007 (Molecular bases of disease and resistance in the Interaction of Rice and Magnaporthe grisea - IRMA) to TK. This work benefited from interactions promoted by COST Action FA 1208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,92,42,42,0,39,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005228,10.1371/journal.ppat.1005228,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700051,26506000.0,"DOAJ Gold, Green Published",,,16/08/2019,44,18,85,8263,1371,1094,277,6892,5489,30,1373,85,17,0,0,41,41,0,,197,4,101,0,4,50,45,50,19,0,0,0,0,0,0,0,1,17,8398,118,56,92,197,1,6956,1383,118,56,92,197,1,59,,0,0,0,0,23,0,0,0,0,0,0,101,0,0,12.65,6.026987600291758,1.1989262913522925,0.1989262913522925,1.264219384793964,1.054459639356166,6.355215171407732
320,J,"Diamond, MS",,,,"Diamond, Michael S.",,,Preparing for the Next Epidemic with Basic Virology,PLoS Pathogens,,,English,Editorial Material,,,,,,,,,"[Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA","Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.",diamond@borcim.wustl.edu,,,,,,0,1,1,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005182,10.1371/journal.ppat.1005182,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700022,26492495.0,"DOAJ Gold, Green Published",,,16/08/2019,1,51,18,5361,399,292,107,4962,4472,9,481,18,39,0,0,1,1,2,,0,24,0,0,24,1,1,1,0,0,0,0,0,0,0,0,12,29,5506,20,22,0,145,6,4957,399,0,22,0,139,6,150,,0,0,0,0,44,0,2,1,0,0,0,17,0,0,24.8,13.436090225563909,1.0804111245465537,0.0804111245465538,1.1428859330914953,1.0578250326431635,14.213032581453634
321,J,"Dubuffet, A; Zanchi, C; Boutet, G; Moreau, J; Teixeira, M; Moret, Y",,,,"Dubuffet, Aurore; Zanchi, Caroline; Boutet, Gwendoline; Moreau, Jerome; Teixeira, Maria; Moret, Yannick",,,Trans-generational Immune Priming Protects the Eggs Only against Gram-Positive Bacteria in the Mealworm Beetle,PLoS Pathogens,,,English,Article,,,,,,,TENEBRIO-MOLITOR; MATERNAL TRANSFER; COLEOPTERA-TENEBRIONIDAE; INSECT; INFECTION; PEPTIDOGLYCAN; METAMORPHOSIS; TRANSMISSION; CHALLENGE; MECHANISM,"In many vertebrates and invertebrates, offspring whose mothers have been exposed to pathogens can exhibit increased levels of immune activity and/or increased survival to infection. Such phenomena, called ""Trans-generational immune priming"" (TGIP) are expected to provide immune protection to the offspring. As the offspring and their mother may share the same environment, and consequently similar microbial threats, we expect the immune molecules present in the progeny to be specific to the microbes that immune challenged the mother. We provide evidence in the mealworm beetle Tenebrio molitor that the antimicrobial activity found in the eggs is only active against Gram-positive bacteria, even when females were exposed to Gram-negative bacteria or fungi. Fungi were weak inducers of TGIP while we obtained similar levels of anti-Gram-positive activity using different bacteria for the maternal challenge. Furthermore, we have identified an antibacterial peptide from the defensin family, the tenecin 1, which spectrum of activity is exclusively directed toward Gram-positive bacteria as potential contributor to this antimicrobial activity. We conclude that maternal transfer of antimicrobial activity in the eggs of T. molitor might have evolved from persistent Gram-positive bacterial pathogens between insect generations.","[Dubuffet, Aurore; Zanchi, Caroline; Boutet, Gwendoline; Moreau, Jerome; Teixeira, Maria; Moret, Yannick] Univ Bourgogne Franche Comte, UMR CNRS BioGeoSci 6282, Equipe Ecol Evolut, Dijon, France","Moret, Y (reprint author), Univ Bourgogne Franche Comte, UMR CNRS BioGeoSci 6282, Equipe Ecol Evolut, Dijon, France.",yannick.moret@u-bourgogne.fr,"DUBUFFET, Aurore/C-3487-2008; Moret, Yannick/I-9282-2012","DUBUFFET, Aurore/0000-0002-9529-7200; ",French ANR [ANR-08-JCJC-0006],"This work was funded by the French ANR (ANR-08-JCJC-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,23,26,2,29,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005178,10.1371/journal.ppat.1005178,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700021,26430786.0,"DOAJ Gold, Green Published",,,16/08/2019,24,4,67,4377,496,375,121,3881,3207,17,657,67,2,0,3,22,22,2,,90,1,90,0,1,26,26,26,10,0,0,0,0,0,0,0,2,2,4459,79,6,65,167,1,3898,504,79,6,65,167,1,57,,0,0,0,0,6,0,0,1,1,0,0,90,0,0,4.1,8.824596774193548,1.1278021128575109,0.12780211285751095,1.2123164132955424,1.0749371715787068,9.485887096774194
322,J,"Fimlaid, KA; Jensen, O; Donnelly, ML; Francis, MB; Sorg, JA; Shen, A",,,,"Fimlaid, Kelly A.; Jensen, Owen; Donnelly, M. Lauren; Francis, Michael B.; Sorg, Joseph A.; Shen, Aimee",,,Identification of a Novel Lipoprotein Regulator of Clostridium difficile Spore Germination,PLOS PATHOGENS,,,English,Article,,,,,,,BACILLUS-SUBTILIS SPORES; PERFRINGENS S40 SPORES; CORTEX-LYTIC ENZYME; ALANINE RACEMASE; INNER MEMBRANE; DIPICOLINIC ACID; GENE-EXPRESSION; SEVERE DISEASE; PROTEASE CSPB; PROTEINS,"Clostridium difficile is a Gram-positive spore-forming pathogen and a leading cause of nosocomial diarrhea. C. difficile infections are transmitted when ingested spores germinate in the gastrointestinal tract and transform into vegetative cells. Germination begins when the germinant receptor CspC detects bile salts in the gut. CspC is a subtilisin-like serine pseudoprotease that activates the related CspB serine protease through an unknown mechanism. Activated CspB cleaves the pro-SleC zymogen, which allows the activated SleC cortex hydrolase to degrade the protective cortex layer. While these regulators are essential for C. difficile spores to outgrow and form toxin-secreting vegetative cells, the mechanisms controlling their function have only been partially characterized. In this study, we identify the lipoprotein GerS as a novel regulator of C. difficile spore germination using targeted mutagenesis. A gerS mutant has a severe germination defect and fails to degrade cortex even though it processes SleC at wildtype levels. Using complementation analyses, we demonstrate that GerS secretion, but not lipidation, is necessary for GerS to activate SleC. Importantly, loss of GerS attenuates the virulence of C. difficile in a hamster model of infection. Since GerS appears to be conserved exclusively in related Peptostreptococcaeace family members, our results contribute to a growing body of work indicating that C. difficile has evolved distinct mechanisms for controlling the exit from dormancy relative to B. subtilis and other spore-forming organisms.","[Fimlaid, Kelly A.; Jensen, Owen; Donnelly, M. Lauren; Shen, Aimee] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Fimlaid, Kelly A.] Univ Vermont, Program Cellular Mol & Biomed Sci, Burlington, VT 05405 USA; [Francis, Michael B.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA","Fimlaid, KA (reprint author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.",aimee.shen@uvm.edu,,"Donnelly, Maeve/0000-0003-0660-5433",National Institute of Allergy and Infectious Disease (NIAID) [T32 AI055402]; American Heart Association [11SDG7160013]; NIAID [R01AI116895]; Pew Charitable Trusts; National Institute of General Medical Sciences (NIGMS) [P20 GM103496]; NIGMS [R01GM108684],"KF is supported by training grant T32 AI055402 from the National Institute of Allergy and Infectious Disease (NIAID). JAS is supported by funds from the American Heart Association (11SDG7160013) and the NIAID (R01AI116895). AS is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts, and is supported by start-up funds from Award Number P20 GM103496 from the National Institute of General Medical Sciences (NIGMS). Research in this grant benefitted from funding by Award Number R01GM108684 from NIGMS. The content is solely the responsibility of the author(s) and does not necessarily reflect the views of the Pew Charitable Trusts, the American Heart Association, NIAID, NIGMS, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,26,26,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005239,10.1371/journal.ppat.1005239,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700060,26496694.0,"DOAJ Gold, Green Published",,,16/08/2019,25,8,24,5518,1019,702,317,4499,3720,21,758,23,7,0,0,27,27,0,,37,4,36,1,4,27,27,24,24,0,0,0,0,0,0,0,1,3,5585,62,0,274,178,3,4486,1019,62,0,274,178,3,80,,0,0,0,0,7,0,0,1,0,0,0,36,1,0,3.85,5.415112855740922,1.226494776617026,0.226494776617026,1.2947321627028228,1.055636100036245,5.716388616290481
323,J,"Fonville, JM; Marshall, N; Tao, H; Steel, J; Lowen, AC",,,,"Fonville, Judith M.; Marshall, Nicolle; Tao, Hui; Steel, John; Lowen, Anice C.",,,Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles,PLOS PATHOGENS,,,English,Article,,,,,,,TEMPERATURE-SENSITIVE MUTANT; A VIRUS; RIBONUCLEOPROTEIN COMPLEXES; SPONTANEOUS MUTATION; INTERNAL DELETION; INCOMPLETE FORMS; VIRAL RNAS; DI RNAS; SEGMENT; ORIGIN,"A high particle to infectivity ratio is a feature common to many RNA viruses, with similar to 90-99% of particles unable to initiate a productive infection under low multiplicity conditions. A recent publication by Brooke et al. revealed that, for influenza A virus (IAV), a proportion of these seemingly non-infectious particles are in fact semi-infectious. Semi-infectious (SI) particles deliver an incomplete set of viral genes to the cell, and therefore cannot support a full cycle of replication unless complemented through co-infection. In addition to SI particles, IAV populations often contain defective-interfering (DI) particles, which actively interfere with production of infectious progeny. With the aim of understanding the significance to viral evolution of these incomplete particles, we tested the hypothesis that SI and DI particles promote diversification through reassortment. Our approach combined computational simulations with experimental determination of infection, co-infection and reassortment levels following co-inoculation of cultured cells with two distinct influenza A/Panama/2007/99 (H3N2)-based viruses. Computational results predicted enhanced reassortment at a given % infection or multiplicity of infection with increasing semi-infectious particle content. Comparison of experimental data to the model indicated that the likelihood that a given segment is missing varies among the segments and that most particles fail to deliver >= 1 segment. To verify the prediction that SI particles augment reassortment, we performed co-infections using viruses exposed to low dose UV. As expected, the introduction of semi-infectious particles with UV-induced lesions enhanced reassortment. In contrast to SI particles, inclusion of DI particles in modeled virus populations could not account for observed reassortment outcomes. DI particles were furthermore found experimentally to suppress detectable reassortment, relative to that seen with standard virus stocks, most likely by interfering with production of infectious progeny from co-infected cells. These data indicate that semi-infectious particles increase the rate of reassortment and may therefore accelerate adaptive evolution of IAV.","[Fonville, Judith M.] Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge CB2 1TN, England; [Marshall, Nicolle; Tao, Hui; Steel, John; Lowen, Anice C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA","Lowen, AC (reprint author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.",anice.lowen@emory.edu,,,National Institute of Allergy and Infectious Disease [R01 AI099000]; National Institute of Allergy and Infectious Disease Centers of Excellence in Influenza Research and Surveillance (CEIRS) [HHSN272201400004C]; Medical Research Council UK [MR/K021885/1]; Homerton College Cambridge; Medical Research Council [MR/K021885/1],"This work was funded in part by the National Institute of Allergy and Infectious Disease R01 AI099000 to ACL, the National Institute of Allergy and Infectious Disease Centers of Excellence in Influenza Research and Surveillance (CEIRS), contract number HHSN272201400004C (to ACL and JS), the award of a Fellowship in Biomedical Informatics from the Medical Research Council UK (MR/K021885/1) to JMF and a Junior Research Fellowship from Homerton College Cambridge to JMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,23,23,3,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005204,10.1371/journal.ppat.1005204,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700038,26440404.0,"DOAJ Gold, Green Published",,,16/08/2019,24,21,36,6341,983,683,300,5358,4319,19,1020,36,20,0,0,25,25,1,,49,5,49,0,5,25,25,23,17,1,0,0,1,0,0,0,1,7,6340,26,0,73,150,2,5327,983,26,0,73,150,2,30,,0,0,0,0,17,0,0,2,0,0,0,49,0,0,10.0,6.450661241098677,1.1834639790966779,0.18346397909667786,1.2161254199328106,1.0275981706355464,6.628687690742624
324,J,"Gluck-Thaler, E; Slot, JC",,,,"Gluck-Thaler, Emile; Slot, Jason C.",,,Dimensions of Horizontal Gene Transfer in Eukaryotic Microbial Pathogens,PLoS Pathogens,,,English,Article,,,,,,,TRICHOMONAS-VAGINALIS; BACTERIAL GENES; ECOLOGY DRIVES; EVOLUTION; CLUSTER; MECHANISMS; VIRULENCE; GENOMES; FUNGI; ACQUISITION,,"[Gluck-Thaler, Emile; Slot, Jason C.] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA","Gluck-Thaler, E (reprint author), Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA.",slot.1@osu.edu,"Slot, Jason/L-5500-2018; Slot, Jason/E-4802-2011","Gluck-Thaler, Emile/0000-0003-0438-7495",Fonds de recherche du Quebec-Nature et technologies; Ohio Agricultural Research and Development Center,"This work was partially supported by funding from the Fonds de recherche du Quebec-Nature et technologies (EGT) and the Ohio Agricultural Research and Development Center (EGT and JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,21,23,0,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005156,10.1371/journal.ppat.1005156,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700010,26513155.0,"DOAJ Gold, Green Published",,,16/08/2019,21,139,54,7078,690,547,143,6388,5490,12,886,54,47,0,0,17,17,3,,68,5,67,1,5,21,21,16,7,0,0,0,0,0,0,0,92,36,7294,41,16,99,141,5,6451,697,41,16,99,141,5,146,,0,0,0,0,63,0,0,1,0,0,0,67,1,0,38.1,10.257971014492753,1.1080150281778334,0.10801502817783344,1.1703193487789605,1.056230573608364,10.834782608695653
325,J,"Guinet, F; Ave, P; Filali, S; Huon, C; Savin, C; Huerre, M; Fiette, L; Carniel, E",,,,"Guinet, Francoise; Ave, Patrick; Filali, Sofia; Huon, Christele; Savin, Cyril; Huerre, Michel; Fiette, Laurence; Carniel, Elisabeth",,,Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMINOGEN-ACTIVATOR PLA; YERSINIA-PESTIS; O-ANTIGEN; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; SURFACE PROTEASE; OMPTIN FAMILY; CELL-DEATH; INFECTION; INVASION,"Activation and/or recruitment of the host plasmin, a fibrinolytic enzyme also active on extracellular matrix components, is a common invasive strategy of bacterial pathogens. Yersinia pestis, the bubonic plague agent, expresses the multifunctional surface protease Pla, which activates plasmin and inactivates fibrinolysis inhibitors. Pla is encoded by the pPla plasmid. Following intradermal inoculation, Y. pestis has the capacity to multiply in and cause destruction of the lymph node (LN) draining the entry site. The closely related, pPla-negative, Y. pseudotuberculosis species lacks this capacity. We hypothesized that tissue damage and bacterial multiplication occurring in the LN during bubonic plague were linked and both driven by pPla. Using a set of pPla-positive and pPla-negative Y. pestis and Y. pseudotuberculosis strains in a mouse model of intradermal injection, we found that pPla is not required for bacterial translocation to the LN. We also observed that a pPla-cured Y. pestis caused the same extensive histological lesions as the wild type strain. Furthermore, the Y. pseudotuberculosis histological pattern, characterized by infectious foci limited by inflammatory cell infiltrates with normal tissue density and follicular organization, was unchanged after introduction of pPla. However, the presence of pPla enabled Y. pseudotuberculosis to increase its bacterial load up to that of Y. pestis. Similarly, lack of pPla strongly reduced Y. pestis titers in LNs of infected mice. This pPla-mediated enhancing effect on bacterial load was directly dependent on the proteolytic activity of Pla. Immunohistochemistry of Pla-negative Y. pestis-infected LNs revealed extensive bacterial lysis, unlike the numerous, apparently intact, microorganisms seen in wild type Y. pestis-infected preparations. Therefore, our study demonstrates that tissue destruction and bacterial survival/multiplication are dissociated in the bubo and that the primary action of Pla is to protect bacteria from destruction rather than to alter the tissue environment to favor Y. pestis propagation in the host.","[Guinet, Francoise; Filali, Sofia; Huon, Christele; Savin, Cyril; Carniel, Elisabeth] Inst Pasteur, Unite Rech Yersinia, Paris, France; [Ave, Patrick; Fiette, Laurence] Inst Pasteur, Unite Histopathol Humaine & Modeles Animaux, Paris, France; [Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France","Guinet, F (reprint author), Inst Pasteur, Unite Cytokines & Inflammat, Paris, France.",francoise.guinet@pasteur.fr; elisabeth.carniel@pasteur.fr,,"Savin, Cyril/0000-0003-2659-3433",,,,78,8,8,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005222,10.1371/journal.ppat.1005222,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700047,26484539.0,"DOAJ Gold, Green Published",,,16/08/2019,8,2,13,3562,840,668,172,2722,2209,15,498,13,1,0,0,9,9,0,,16,144,16,0,144,9,8,9,6,0,0,0,0,0,0,0,1,2,5083,45,1,101,2403,13,2715,840,45,1,101,2403,13,1528,,0,0,0,0,4,0,1,1,0,0,0,16,0,0,3.0,4.2404761904761905,1.3085966201322556,0.3085966201322557,2.7667156502571637,2.114261650758001,8.96547619047619
326,J,"Gupta, PK; Godec, J; Wolski, D; Adland, E; Yates, K; Pauken, KE; Cosgrove, C; Ledderose, C; Junger, WG; Robson, SC; Wherry, EJ; Alter, G; Goulder, PJR; Klenerman, P; Sharpe, AH; Lauer, GM; Haining, WN",,,,"Gupta, Prakash K.; Godec, Jernej; Wolski, David; Adland, Emily; Yates, Kathleen; Pauken, Kristen E.; Cosgrove, Cormac; Ledderose, Carola; Junger, Wolfgang G.; Robson, Simon C.; Wherry, E. John; Alter, Galit; Goulder, Philip J. R.; Klenerman, Paul; Sharpe, Arlene H.; Lauer, Georg M.; Haining, W. Nicholas",,,CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells,PLoS Pathogens,,,English,Article,,,,,,,CHRONIC VIRAL-INFECTION; ADENOSINE-MEDIATED INHIBITION; HEPATITIS-C VIRUS; ATP-DIPHOSPHOHYDROLASE; IMMUNE SUPPRESSION; EFFECTOR FUNCTION; PD-1 EXPRESSION; ACTIVATION; PERSISTENCE; RECEPTORS,"Exhausted T cells express multiple co-inhibitory molecules that impair their function and limit immunity to chronic viral infection. Defining novel markers of exhaustion is important both for identifying and potentially reversing T cell exhaustion. Herein, we show that the ectonucleotidse CD39 is a marker of exhausted CD8(+) T cells. CD8(+) T cells specific for HCV or HIV express high levels of CD39, but those specific for EBV and CMV do not. CD39 expressed by CD8(+) T cells in chronic infection is enzymatically active, co- expressed with PD- 1, marks cells with a transcriptional signature of T cell exhaustion and correlates with viral load in HIV and HCV. In the mouse model of chronic Lymphocytic Choriomeningitis Virus infection, virus- specific CD8(+) T cells contain a population of CD39high CD8(+) T cells that is absent in functional memory cells elicited by acute infection. This CD39high CD8(+) T cell population is enriched for cells with the phenotypic and functional profile of terminal exhaustion. These findings provide a new marker of T cell exhaustion, and implicate the purinergic pathway in the regulation of T cell exhaustion.","[Gupta, Prakash K.; Godec, Jernej; Yates, Kathleen; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gupta, Prakash K.; Adland, Emily; Goulder, Philip J. R.; Klenerman, Paul] Univ Oxford, Oxford, England; [Godec, Jernej; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Godec, Jernej; Sharpe, Arlene H.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA USA; [Godec, Jernej; Sharpe, Arlene H.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Wolski, David; Lauer, Georg M.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Wolski, David; Lauer, Georg M.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Pauken, Kristen E.; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cosgrove, Cormac; Alter, Galit] Ragon Inst Massachusetts Gen Hosp Harvard Univ &, Cambridge, MA USA; [Cosgrove, Cormac; Ledderose, Carola] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA; [Sharpe, Arlene H.; Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA USA; [Haining, W. Nicholas] Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA","Haining, WN (reprint author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.",Nicholas_Haining@dfci.harvard.edu,"Lauer, Georg/J-1467-2018","Lauer, Georg/0000-0002-9792-4271","National Institute for Health Research [NF-SI-0510-10204]; NIAID NIH HHS [P30 AI045008, U19 AI082630, R01 AI046995]; Wellcome Trust [104748, 091663]",,,56,62,64,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005177,10.1371/journal.ppat.1005177,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700020,26485519.0,"DOAJ Gold, Green Published",,,16/08/2019,65,1,144,15386,2314,1649,665,13072,9884,34,3154,142,1,0,0,58,58,0,,401,0,196,2,0,68,68,42,43,0,0,0,0,0,0,0,0,5,15621,222,0,339,142,0,13219,2383,222,0,339,142,0,19,,1,1,0,0,8,0,0,1,0,0,0,193,2,0,27.708,6.649092480553155,1.1770195838433293,0.17701958384332925,1.2228427172582619,1.038931496165345,6.907951598962835
327,J,"Hammoudi, PM; Jacot, D; Mueller, C; Di Cristina, M; Dogga, SK; Marq, JB; Romano, J; Tosetti, N; Dubrot, J; Emre, Y; Lunghi, M; Coppens, I; Yamamoto, M; Sojka, D; Pino, P; Soldati-Favre, D",,,,"Hammoudi, Pierre-Mehdi; Jacot, Damien; Mueller, Christina; Di Cristina, Manlio; Dogga, Sunil Kumar; Marq, Jean-Baptiste; Romano, Julia; Tosetti, Nicolo; Dubrot, Juan; Emre, Yalin; Lunghi, Matteo; Coppens, Isabelle; Yamamoto, Masahiro; Sojka, Daniel; Pino, Paco; Soldati-Favre, Dominique",,,"Fundamental Roles of the Golgi-Associated Toxoplasma Aspartyl Protease, ASP5, at the Host-Parasite Interface",PLOS PATHOGENS,,,English,Article,,,,,,,DENSE GRANULE PROTEIN; DENDRITIC CELLS; TRANSEPITHELIAL MIGRATION; PARASITOPHOROUS VACUOLE; RHOPTRY PROTEINS; IMMUNE-RESPONSE; ACUTE VIRULENCE; PLASMEPSIN V; GONDII; EXPORT,"Toxoplasma gondii possesses sets of dense granule proteins (GRAs) that either assemble at, or cross the parasitophorous vacuole membrane (PVM) and exhibit motifs resembling the HT/PEXEL previously identified in a repertoire of exported Plasmodium proteins. Within Plasmodium spp., cleavage of the HT/PEXEL motif by the endoplasmic reticulum-resident protease Plasmepsin V precedes trafficking to and export across the PVM of proteins involved in pathogenicity and host cell remodelling. Here, we have functionally characterized the T. gondii aspartyl protease 5 (ASP5), a Golgi-resident protease that is phylogenetically related to Plasmepsin V. We show that deletion of ASP5 causes a significant loss in parasite fitness in vitro and an altered virulence in vivo. Furthermore, we reveal that ASP5 is necessary for the cleavage of GRA16, GRA19 and GRA20 at the PEXEL-like motif. In the absence of ASP5, the intravacuolar nanotubular network disappears and several GRAs fail to localize to the PVM, while GRA16 and GRA24, both known to be targeted to the host cell nucleus, are retained within the vacuolar space. Additionally, hypermigration of dendritic cells and bradyzoite cyst wall formation are impaired, critically impacting on parasite dissemination and persistence. Overall, the absence of ASP5 dramatically compromises the parasite's ability to modulate host signalling pathways and immune responses.","[Hammoudi, Pierre-Mehdi; Jacot, Damien; Mueller, Christina; Dogga, Sunil Kumar; Marq, Jean-Baptiste; Tosetti, Nicolo; Sojka, Daniel; Pino, Paco; Soldati-Favre, Dominique] Univ Geneva, Ctr Med Univ, Dept Microbiol & Mol Med, Geneva, Switzerland; [Mueller, Christina; Yamamoto, Masahiro] Osaka Univ, Microbial Dis Res Inst, Dept Immunoparasitol, Osaka, Japan; [Di Cristina, Manlio; Lunghi, Matteo] Univ Perugia, Dept Chem Biol & Biotechnol, I-06100 Perugia, Italy; [Romano, Julia; Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Dubrot, Juan; Emre, Yalin] Univ Geneva, Ctr Med Univ, Dept Pathol & Immunol, Geneva, Switzerland; [Sojka, Daniel] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic","Hammoudi, PM (reprint author), Univ Geneva, Ctr Med Univ, Dept Microbiol & Mol Med, Geneva, Switzerland.",dominique.soldati-favre@unige.ch,"Sojka, Daniel/G-8354-2014; Emre, Yalin/L-6856-2017; Di Cristina, Manlio/G-3608-2014","Emre, Yalin/0000-0003-3125-9560; Di Cristina, Manlio/0000-0003-4154-5210; Dogga, Sunil Kumar/0000-0001-9158-9612; Romano, Julia/0000-0001-8956-7377; Soldati-Favre, Dominique/0000-0003-4156-2109",Swiss National Foundation [FN3100A0-116722]; SystemsX [IPhD2014-245]; Bilateral Japanese-Swiss Science exchange program,"This project was supported by the Swiss National Foundation (FN3100A0-116722) to DSF, the SystemsX IPhD2014-245 to DSF and the Bilateral Japanese-Swiss Science exchange program. DSF is an advanced international scholar of the Howard Hughes Medical Institute (HHMI, US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,77,33,35,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005211,10.1371/journal.ppat.1005211,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700041,26473595.0,"DOAJ Gold, Green Published",,,16/08/2019,36,22,42,6911,1051,779,272,5860,4371,21,1468,42,20,1,0,36,36,1,,52,2,52,0,2,38,38,24,23,0,0,0,0,0,0,0,2,15,7007,104,0,106,237,1,5897,1073,104,0,106,237,1,37,,0,1,0,0,21,0,0,1,0,0,0,52,0,0,19.408,6.575642245480495,1.1793515358361775,0.17935153583617747,1.2539249146757678,1.0632325278541455,6.991436726926737
328,J,"Han, ZY; Madara, JJ; Herbert, A; Prugar, LI; Ruthel, G; Lu, JH; Liu, YL; Liu, WB; Liu, XH; Wrobel, JE; Reitz, AB; Dye, JM; Harty, RN; Freedman, BD",,,,"Han, Ziying; Madara, Jonathan J.; Herbert, Andrew; Prugar, Laura I.; Ruthel, Gordon; Lu, Jianhong; Liu, Yuliang; Liu, Wenbo; Liu, Xiaohong; Wrobel, Jay E.; Reitz, Allen B.; Dye, John M.; Harty, Ronald N.; Freedman, Bruce D.",,,Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention,PLOS PATHOGENS,,,English,Article,,,,,,,SMALL-MOLECULE INHIBITOR; T-CELL-ACTIVATION; ENDOPLASMIC-RETICULUM; PLAQUE-ASSAY; CA2+ INFLUX; ANTIVIRAL ACTIVITY; MEMBRANE; STIM1; STORE; CHANNELS,"Hemorrhagic fever viruses, including the filoviruses (Ebola and Marburg) and arenaviruses (Lassa and Junin viruses), are serious human pathogens for which there are currently no FDA approved therapeutics or vaccines. Importantly, transmission of these viruses, and specifically late steps of budding, critically depend upon host cell machinery. Consequently, strategies which target these mechanisms represent potential targets for broad spectrum host oriented therapeutics. An important cellular signal implicated previously in EBOV budding is calcium. Indeed, host cell calcium signals are increasingly being recognized to play a role in steps of entry, replication, and transmission for a range of viruses, but if and how filoviruses and arenaviruses mobilize calcium and the precise stage of virus transmission regulated by calcium have not been defined. Here we demonstrate that expression of matrix proteins from both filoviruses and arenaviruses triggers an increase in host cytoplasmic Ca2+ concentration by a mechanism that requires host Orai1 channels. Furthermore, we demonstrate that Orai1 regulates both VLP and infectious filovirus and arenavirus production and spread. Notably, suppression of the protein that triggers Orai activation (Stromal Interaction Molecule 1, STIM1) and genetic inactivation or pharmacological blockade of Orai1 channels inhibits VLP and infectious virus egress. These findings are highly significant as they expand our understanding of host mechanisms that may broadly control enveloped RNA virus budding, and they establish Orai and STIM1 as novel targets for broad-spectrum host-oriented therapeutics to combat these emerging BSL-4 pathogens and potentially other enveloped RNA viruses that bud via similar mechanisms.","[Han, Ziying; Madara, Jonathan J.; Ruthel, Gordon; Lu, Jianhong; Liu, Yuliang; Liu, Wenbo; Liu, Xiaohong; Harty, Ronald N.; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Herbert, Andrew; Prugar, Laura I.; Dye, John M.] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Wrobel, Jay E.; Reitz, Allen B.] Fox Chase Chem Div Ctr Inc, Doylestown, PA USA","Han, ZY (reprint author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.",rharty@vet.upenn.edu; bruce@vet.upenn.edu,,"Dye, John/0000-0002-0883-5016","National Institutes of Health [AI102104, U54-AI057168, AI060921]; Defense Threat Reduction Agency [CB3947]","RNH was supported in part by grants AI102104 and U54-AI057168 from the National Institutes of Health. AH, LIP, and JMD were supported by the Defense Threat Reduction Agency (CB3947). BDF was supported in part by grant AI060921 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,70,15,15,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005220,10.1371/journal.ppat.1005220,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700046,26513362.0,"DOAJ Gold, Green Published",,,16/08/2019,15,9,39,5292,818,578,240,4474,3661,16,797,39,6,0,0,12,12,5,,54,3,54,0,3,15,15,13,7,0,0,0,0,0,0,1,3,7,5316,57,0,68,398,0,4467,818,57,0,68,398,0,31,,8,1,0,0,9,0,2,1,0,0,0,54,0,0,75.95,6.469437652811736,1.182834152883326,0.18283415288332588,1.2898971837282074,1.0905139833711261,7.055012224938875
329,J,"Hellman, J",,,,"Hellman, Judith",,,Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis,PLOS PATHOGENS,,,English,Article,,,,,,,SEPTIC SHOCK; ACUTE-INFLAMMATION; ENDOTHELIAL-CELLS; LIPID MEDIATORS; DENDRITIC CELLS; VIRUS INFECTION; STATIN THERAPY; UNITED-STATES; TISSUE FACTOR; SIERRA-LEONE,,"Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Div Crit Care, Fac Med,Biomed Sci Immunol Programs, San Francisco, CA 94143 USA","Hellman, J (reprint author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Div Crit Care, Fac Med,Biomed Sci Immunol Programs, San Francisco, CA 94143 USA.",Judith.Hellman@ucsf.edu,,,,,,69,10,10,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005088,10.1371/journal.ppat.1005088,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700002,26425845.0,"DOAJ Gold, Green Published",,,16/08/2019,10,13,31,3967,703,520,183,3264,2752,8,504,31,12,0,0,10,10,1,,0,28,0,0,28,10,10,10,9,0,0,0,0,0,0,0,10,7,4074,17,0,79,165,6,3257,703,17,0,79,165,6,114,,0,0,0,0,11,0,0,1,0,0,0,32,0,0,8.35,5.642958748221906,1.2153799019607843,0.21537990196078433,1.303921568627451,1.0728510209226116,6.054054054054054
330,J,"Jimenez-Guardeno, JM; Regla-Nava, JA; Nieto-Torres, JL; DeDiego, ML; Castano-Rodriguez, C; Fernandez-Delgado, R; Perlman, S; Enjuanes, L",,,,"Jimenez-Guardeno, Jose M.; Regla-Nava, Jose A.; Nieto-Torres, Jose L.; DeDiego, Marta L.; Castano-Rodriguez, Carlos; Fernandez-Delgado, Raul; Perlman, Stanley; Enjuanes, Luis",,,Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine,PLOS PATHOGENS,,,English,Article,,,,,,,ACUTE RESPIRATORY SYNDROME; TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS; HOST GENE-EXPRESSION; E-PROTEIN; ENVELOPE PROTEIN; STRUCTURAL PROTEIN; IMMUNE-RESPONSES; ENTERIC TROPISM; MESSENGER-RNA; INFECTED MICE,"A SARS-CoV lacking the full-length E gene (SARS-CoV-Delta E) was attenuated and an effective vaccine. Here, we show that this mutant virus regained fitness after serial passages in cell culture or in vivo, resulting in the partial duplication of the membrane gene or in the insertion of a new sequence in gene 8a, respectively. The chimeric proteins generated in cell culture increased virus fitness in vitro but remained attenuated in mice. In contrast, during SARS-CoV-Delta E passage in mice, the virus incorporated a mutated variant of 8a protein, resulting in reversion to a virulent phenotype. When the full-length E protein was deleted or its PDZ-binding motif (PBM) was mutated, the revertant viruses either incorporated a novel chimeric protein with a PBM or restored the sequence of the PBM on the E protein, respectively. Similarly, after passage in mice, SARS-CoV-Delta E protein 8a mutated, to now encode a PBM, and also regained virulence. These data indicated that the virus requires a PBM on a transmembrane protein to compensate for removal of this motif from the E protein. To increase the genetic stability of the vaccine candidate, we introduced small attenuating deletions in E gene that did not affect the endogenous PBM, preventing the incorporation of novel chimeric proteins in the virus genome. In addition, to increase vaccine biosafety, we introduced additional attenuating mutations into the nsp1 protein. Deletions in the carboxyterminal region of nsp1 protein led to higher host interferon responses and virus attenuation. Recombinant viruses including attenuating mutations in E and nsp1 genes maintained their attenuation after passage in vitro and in vivo. Further, these viruses fully protected mice against challenge with the lethal parental virus, and are therefore safe and stable vaccine candidates for protection against SARS-CoV.","[Jimenez-Guardeno, Jose M.; Regla-Nava, Jose A.; Nieto-Torres, Jose L.; DeDiego, Marta L.; Castano-Rodriguez, Carlos; Fernandez-Delgado, Raul; Enjuanes, Luis] Campus Univ Autonoma Madrid, Ctr Nacl Biotecnol CNB CSIC, Dept Mol & Cell Biol, Madrid, Spain; [Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA","Jimenez-Guardeno, JM (reprint author), Campus Univ Autonoma Madrid, Ctr Nacl Biotecnol CNB CSIC, Dept Mol & Cell Biol, Madrid, Spain.",L.Enjuanes@cnb.csic.es,"De Diego, Marta Lopez/B-2307-2017","De Diego, Marta Lopez/0000-0002-7888-7372; FERNANDEZ-DELGADO, RAUL/0000-0001-7411-9010; Jimenez Guardeno, Jose Manuel/0000-0002-1726-8033; Perlman, Stanley/0000-0003-4213-2354; Enjuanes, Luis/0000-0002-0854-0226","government of Spain [BIO2013-42869-R]; European Community's Seventh Framework Programme under the project ""EMPERIE"" EC grant [223498]; U.S. National Institutes of Health (NIH) [5P01AI060699]","This work was supported by grants from the government of Spain (BIO2013-42869-R), the European Community's Seventh Framework Programme under the project ""EMPERIE"" EC grant agreement number 223498, and a U.S. National Institutes of Health (NIH) project (5P01AI060699). JMJG, JARN and JLNT received contracts from NIH. CCR received a contract from Fundacion La Caixa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,82,21,21,3,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005215,10.1371/journal.ppat.1005215,,,,36,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700042,26513244.0,"DOAJ Gold, Green Published",,,16/08/2019,22,12,19,5391,1131,875,256,4260,3450,16,794,19,8,1,0,21,21,7,,54,14,28,0,14,26,23,26,12,0,0,1,0,0,1,3,4,2,5453,55,1,102,124,3,4256,1131,55,1,102,124,3,66,,4,1,0,0,7,0,0,1,0,0,0,28,0,0,42.61600000000001,4.76657824933687,1.2654929577464789,0.26549295774647885,1.3220657276995305,1.044704136523836,4.979664014146773
331,J,"Jones, CJ; Utada, A; Davis, KR; Thongsomboon, W; Sanchez, DZ; Banakar, V; Cegelski, L; Wong, GCL; Yildiz, FH",,,,"Jones, Christopher J.; Utada, Andrew; Davis, Kimberly R.; Thongsomboon, Wiriya; Sanchez, David Zamorano; Banakar, Vinita; Cegelski, Lynette; Wong, Gerard C. L.; Yildiz, Fitnat H.",,,C-di-GMP Regulates Motile to Sessile Transition by Modulating MshA Pili Biogenesis and Near-Surface Motility Behavior in Vibrio cholerae,PLoS Pathogens,,,English,Article,,,,,,,MANNOSE-SENSITIVE HEMAGGLUTININ; RUGOSE COLONY MORPHOLOGY; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; EL-TOR; AQUATIC ENVIRONMENT; STRUCTURAL-ANALYSIS; TWITCHING MOTILITY; IDENTIFICATION; PROTEIN,"In many bacteria, including Vibrio cholerae, cyclic dimeric guanosine monophosphate (c-di-GMP) controls the motile to biofilm life style switch. Yet, little is known about how this occurs. In this study, we report that changes in c-di-GMP concentration impact the biosynthesis of the MshA pili, resulting in altered motility and biofilm phenotypes in V. cholerae. Previously, we reported that cdgJ encodes a c-di-GMP phosphodiesterase and a Delta cdgJ mutant has reduced motility and enhanced biofilm formation. Here we show that loss of the genes required for the mannose-sensitive hemagglutinin (MshA) pilus biogenesis restores motility in the Delta cdgJ mutant. Mutations of the predicted ATPase proteins mshE or pilT, responsible for polymerizing and depolymerizing MshA pili, impair near surface motility behavior and initial surface attachment dynamics. A Delta cdgJ mutant has enhanced surface attachment, while the Delta cdgJmshA mutant phenocopies the high motility and low attachment phenotypes observed in a Delta mshA strain. Elevated concentrations of c-di-GMP enhance surface MshA pilus production. MshE, but not PilT binds c-di-GMP directly, establishing a mechanism for c-di-GMP signaling input in MshA pilus production. Collectively, our results suggest that the dynamic nature of the MshA pilus established by the assembly and disassembly of pilin subunits is essential for transition from the motile to sessile lifestyle and that c-di-GMP affects MshA pilus assembly and function through direct interactions with the MshE ATPase.","[Jones, Christopher J.; Davis, Kimberly R.; Sanchez, David Zamorano; Banakar, Vinita; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Utada, Andrew; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Chem & Biochem, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA; [Thongsomboon, Wiriya; Cegelski, Lynette] Stanford Univ, Dept Chem, Stanford, CA 94305 USA","Jones, CJ (reprint author), Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA.",gclwong@seas.ucla.edu; fyildiz@ucsc.edu,,"Zamorano Sanchez, David/0000-0002-5580-7499","National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI102584]; Human Frontier Science Program","This study is funded by National Institutes of Health, National Institute of Allergy and Infectious Diseases (AI102584) (http://www.niaid.nih.gov/Pages/default.aspx) to FHY, and by Human Frontier Science Program, Program Grants, (http://www.hfsp.org) to GCLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,32,35,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005068,10.1371/journal.ppat.1005068,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700001,26505896.0,"DOAJ Gold, Green Published",,,16/08/2019,38,38,64,6660,1453,1090,363,5207,4159,21,1027,64,7,0,0,34,34,0,,192,3,99,0,3,40,40,40,20,0,0,0,0,0,0,0,31,6,6764,67,0,98,152,1,5254,1465,67,0,98,152,1,45,,0,0,0,0,8,0,0,1,0,0,0,99,0,0,3.35,4.583620096352375,1.2790474361436528,0.2790474361436528,1.3410793163049741,1.0484984984984984,4.805918788713008
332,J,"Ke, RA; Lewin, SR; Elliott, JH; Perelson, AS",,,,"Ke, Ruian; Lewin, Sharon R.; Elliott, Julian H.; Perelson, Alan S.",,,Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells,PLOS PATHOGENS,,,English,Article,,,,,,,CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; HISTONE DEACETYLASE INHIBITORS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; RHESUS MACAQUES; VIRAL BLIPS; P-TEFB; RESERVOIR; DYNAMICS; RNA,"Recent efforts to cure human immunodeficiency virus type-1 (HIV-1) infection have focused on developing latency reversing agents as a first step to eradicate the latent reservoir. The histone deacetylase inhibitor, vorinostat, has been shown to activate HIV RNA transcription in CD4+ T-cells and alter host cell gene transcription in HIV-infected individuals on antiretro-viral therapy. In order to understand how latently infected cells respond dynamically to vorinostat treatment and determine the impact of vorinostat on reservoir size in vivo, we have constructed viral dynamic models of latency that incorporate vorinostat treatment. We fitted these models to data collected from a recent clinical trial in which vorinostat was administered daily for 14 days to HIV-infected individuals on suppressive ART. The results show that HIV transcription is increased transiently during the first few hours or days of treatment and that there is a delay before a sustained increase of HIV transcription, whose duration varies among study participants and may depend on the long term impact of vorinostat on host gene expression. Parameter estimation suggests that in latently infected cells, HIV transcription induced by vorinostat occurs at lower levels than in productively infected cells. Furthermore, the estimated loss rate of transcriptionally induced cells remains close to baseline in most study participants, suggesting vorinostat treatment does not induce latently infected cell killing and thus reduce the latent reservoir in vivo.","[Ke, Ruian; Perelson, Alan S.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Ke, Ruian] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.; Elliott, Julian H.] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3181, Australia; [Lewin, Sharon R.; Elliott, Julian H.] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Bumet Inst, Ctr Biomed Res, Melbourne, Vic, Australia","Ke, RA (reprint author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA.",asp@lanl.gov,,"Lewin, Sharon Ruth/0000-0002-0330-8241","U.S. Department of Energy [DE-AC52-06NA25396]; NIH [R01-AI028433, R01-OD011095, UM1-AI100645]; NHMRC [4911954, 1002671]; National Institutes of Health Delaney AIDS Research Enterprise (DARE) to find a cure [U19 AI096109]; Investigator Initiated Studies Program of Merck Sharp Dohme Corp.","This work was performed under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396 and supported by NIH grants R01-AI028433, R01-OD011095 and UM1-AI100645 (ASP). SRL is an NHMRC Practitioner Fellow. This work was also supported by NHMRC project grants # 4911954 and # 1002671 and the National Institutes of Health Delaney AIDS Research Enterprise (DARE) to find a cure U19 AI096109. The clinical study of vorinostat was supported in part by a research grant from the Investigator Initiated Studies Program of Merck Sharp & Dohme Corp. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,25,25,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005237,10.1371/journal.ppat.1005237,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700058,26496627.0,"DOAJ Gold, Green Published",,,16/08/2019,21,8,25,3767,553,391,162,3214,2591,15,608,25,8,0,0,24,24,0,,34,7,34,0,7,29,24,29,18,0,0,0,0,0,0,0,0,4,3828,104,0,87,186,0,3221,562,104,0,87,186,0,45,,1,0,0,0,10,0,0,1,0,0,0,34,0,0,13.95,6.811934900542496,1.172059738643435,0.17205973864343496,1.2812694461729932,1.093177594903106,7.4466546112115735
333,J,"Khan, SH; Martin, MD; Starbeck-Miller, GR; Xue, HH; Harty, JT; Badovinac, VP",,,,"Khan, Shaniya H.; Martin, Matthew D.; Starbeck-Miller, Gabriel R.; Xue, Hai-Hui; Harty, John T.; Badovinac, Vladimir P.",,,The Timing of Stimulation and IL-2 Signaling Regulate Secondary CD8 T Cell Responses,PLoS Pathogens,,,English,Article,,,,,,,LISTERIA-MONOCYTOGENES INFECTION; PRIME-BOOST VACCINATION; RECEPTOR-ALPHA; IMMUNE-SYSTEM; CUTTING EDGE; MEMORY CELLS; IN-VIVO; DIFFERENTIATION; EFFECTOR; EXPRESSION,"Memory CD8 T cells provide protection to immune hosts by eliminating pathogen-infected cells during re-infection. While parameters influencing the generation of primary (1 degrees) CD8 T cells are well established, the factors controlling the development of secondary (1 degrees) CD8 T cell responses remain largely unknown. Here, we address the mechanisms involved in the generation and development of 2 degrees memory (M) CD8 T cells. We observed that the time at which 1 degrees M CD8 T cells enter into immune response impacts their fate and differentiation into 2 degrees M CD8 T cells. Late-entry of 1 degrees M CD8 T cells into an immune response (relative to the onset of infection) not only facilitated the expression of transcription factors associated with memory formation in 2 degrees effector CD8 T cells, but also influenced the ability of 1 degrees M CD8 T cells to localize within the lymph nodes, produce IL-2, and undergo Ag-driven proliferation. The timing of stimulation of 1 degrees M CD8 T cells also impacted the duration of expression of the high-affinity IL-2 receptor (CD25) on 2 degrees effector CD8 T cells and their sensitivity to IL-2 signaling. Importantly, by blocking or enhancing IL-2 signaling in developing 2 degrees CD8 T cells, we provide direct evidence for the role of IL-2 in controlling the differentiation of Ag-driven 2 degrees CD8 T cell responses. Thus, our data suggest that the process of 1 degrees M to 2 degrees M CD8 T cell differentiation is not fixed and can be manipulated, a notion with relevance for the design of future prime-boost vaccination approaches.","[Khan, Shaniya H.; Martin, Matthew D.; Starbeck-Miller, Gabriel R.; Xue, Hai-Hui; Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Xue, Hai-Hui; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA","Badovinac, VP (reprint author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.",vladimir-badovinac@uiowa.edu,"badovinac, Vladimir/O-7760-2015","Badovinac, Vladimir/0000-0003-3180-2439; Xue, Hai-Hui/0000-0002-9163-7669; Starbeck-Miller, Gabriel/0000-0002-6681-1274; Harty, John/0000-0001-7266-2802",NIH [AI114543]; Carver College of Medicine; Holden Comprehensive Cancer Center; Iowa City Veteran's Administration Medical Center,"Work in VPB laboratory is supported by NIH grant AI114543. The data presented herein were obtained at the Flow Cytometry Facility, which is a Carver College of Medicine/Holden Comprehensive Cancer Center core research facility at the University of Iowa. The facility is funded through user fees and the generous financial support of the Carver College of Medicine, Holden Comprehensive Cancer Center, and Iowa City Veteran's Administration Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,7,7,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005199,10.1371/journal.ppat.1005199,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700033,26431533.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,16,4145,941,762,179,3204,2679,14,511,16,0,0,0,7,7,0,,23,0,23,0,0,9,9,9,5,0,0,0,0,0,0,0,0,1,4161,68,0,266,126,1,3191,941,68,0,266,126,1,29,,0,0,0,0,1,0,0,1,0,0,0,23,0,0,0.5,4.404888416578109,1.2936953807740326,0.29369538077403246,1.359238451935081,1.0506634499396863,4.628055260361318
334,J,"Kilianski, A; Evans, NG",,,,"Kilianski, Andy; Evans, Nicholas G.",,,Effectively Communicating the Uncertainties Surrounding Ebola Virus Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,EVOLUTION; HEALTH,"The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology, including routes of transmission. The scientific community played a leading role during the outbreak-potentially, the largest of its kind-as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory. Scientists provided an invaluable resource for clinicians, public health officials, policy makers, and the lay public in understanding the progress of Ebola virus disease and the continuing outbreak. Not all of the scientific communication, however, was accurate or effective. There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points. Here, we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science, and we provide recommendations for improving the communication about unknown aspects of disease during public health crises.","[Kilianski, Andy] Edgewood Chem Biol Ctr, BioDef Branch, BioSci Div, Aberdeen Proving Ground, MD 21010 USA; [Evans, Nicholas G.] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA","Kilianski, A (reprint author), Edgewood Chem Biol Ctr, BioDef Branch, BioSci Div, Aberdeen Proving Ground, MD 21010 USA.",andrew.kilianski.ctr@mail.mil; evann@mail.med.upenn.edu,,"Kilianski, Andy/0000-0002-2350-0142; Evans, Nicholas/0000-0002-3330-0224",,,,24,2,2,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005097,10.1371/journal.ppat.1005097,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700003,26512988.0,"DOAJ Gold, Green Published",,,16/08/2019,1,107,45,5229,485,356,129,4744,4219,17,508,45,71,0,0,1,1,2,,42,92,42,0,92,2,2,1,0,0,0,0,0,0,0,0,36,68,5761,5,7,0,674,16,4752,491,0,7,0,674,16,518,,0,1,0,0,58,0,1,1,0,0,0,42,0,0,42.2,10.781443298969073,1.1022344013490726,0.10223440134907251,1.357504215851602,1.2315930388219545,13.278350515463918
335,J,"King, T; Lamb, T",,,,"King, Thayer; Lamb, Tracey",,,Interferon-gamma: The Jekyll and Hyde of Malaria,PLOS PATHOGENS,,,English,Article,,,,,,,STAGE PLASMODIUM-CHABAUDI; CD8(+) T-CELL; BLOOD-STAGE; IFN-GAMMA; PROTECTIVE IMMUNITY; RESPONSES; FALCIPARUM; ASSOCIATION; INVOLVEMENT; ACTIVATION,,"[King, Thayer; Lamb, Tracey] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA","King, T (reprint author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.",tracey.j.lamb@emory.edu,,,National Institute for Neurological Disorders and Stroke [1R21N5085382-01A1]; Emory University Immunology and Molecular Pathogenesis training grant [5T32AI007610-15]; Royal Society; Emory Egleston Children's Research Center,"This work was supported by a grant from the National Institute for Neurological Disorders and Stroke (1R21N5085382-01A1), the Emory University Immunology and Molecular Pathogenesis training grant (5T32AI007610-15), the Royal Society, and the Emory Egleston Children's Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,32,24,24,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005118,10.1371/journal.ppat.1005118,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700006,26426121.0,"DOAJ Gold, Green Published",,,16/08/2019,22,11,40,6958,1340,1051,289,5618,4760,11,847,40,0,0,0,21,21,0,,82,0,82,0,0,23,23,17,16,0,0,0,0,0,0,0,14,1,7065,7,0,27,88,0,5676,1365,7,0,27,88,0,24,,0,0,0,0,2,0,2,1,0,0,0,77,0,0,1.5,5.192537313432836,1.2385190459238162,0.23851904592381631,1.2744749021003916,1.0290313308421961,5.343283582089552
336,J,"Londono-Renteria, B; Troupin, A; Conway, MJ; Vesely, D; Ledizet, M; Roundy, CM; Cloherty, E; Jameson, S; Vanlandingham, D; Higgs, S; Fikrig, E; Colpitts, TM",,,,"Londono-Renteria, Berlin; Troupin, Andrea; Conway, Michael J.; Vesely, Diana; Ledizet, Michael; Roundy, Christopher M.; Cloherty, Erin; Jameson, Samuel; Vanlandingham, Dana; Higgs, Stephen; Fikrig, Erol; Colpitts, Tonya M.",,,Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIBODY-DEPENDENT ENHANCEMENT; ADULT FEMALE MOSQUITO; HEMORRHAGIC-FEVER; SALIVARY-GLAND; SECRETORY PROTEINS; DIPTERA-CULICIDAE; IMMUNE-RESPONSES; SERINE PROTEASES; SHOCK SYNDROME; RISK-FACTOR,"Dengue virus (DENV) is a mosquito-borne flavivirus that causes serious human disease and mortality worldwide. There is no specific antiviral therapy or vaccine for DENV infection. Alterations in gene expression during DENV infection of the mosquito and the impact of these changes on virus infection are important events to investigate in hopes of creating new treatments and vaccines. We previously identified 203 genes that were >= 5-fold differentially upregulated during flavivirus infection of the mosquito. Here, we examined the impact of silencing 100 of the most highly upregulated gene targets on DENV infection in its mosquito vector. We identified 20 genes that reduced DENV infection by at least 60% when silenced. We focused on one gene, a putative cysteine rich venom protein (SeqID AAEL000379; CRVP379), whose silencing significantly reduced DENV infection in Aedes aegypti cells. Here, we examine the requirement for CRVP379 during DENV infection of the mosquito and investigate the mechanisms surrounding this phenomenon. We also show that blocking CRVP379 protein with either RNAi or specific antisera inhibits DENV infection in Aedes aegypti. This work identifies a novel mosquito gene target for controlling DENV infection in mosquitoes that may also be used to develop broad preventative and therapeutic measures for multiple flaviviruses.","[Londono-Renteria, Berlin; Troupin, Andrea; Colpitts, Tonya M.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Conway, Michael J.] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA; [Vesely, Diana; Ledizet, Michael] L2 Diagnost, New Haven, CT USA; [Roundy, Christopher M.; Cloherty, Erin; Jameson, Samuel] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Vanlandingham, Dana; Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA; [Vanlandingham, Dana; Higgs, Stephen] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA","Colpitts, TM (reprint author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.",tonya.colpitts@uscmed.sc.edu,"Londono, Berlin/I-8830-2019","Londono, Berlin/0000-0001-5956-5274; Colpitts, Tonya/0000-0003-3915-1554; Jameson, Samuel/0000-0001-7242-3473","National Institutes of Health (NIH) [K22AI103067, UO1AI070343]","This work was supported by funding from National Institutes of Health (NIH) awards K22AI103067 (TMC) and UO1AI070343 (EF). EF is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,23,23,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005202,10.1371/journal.ppat.1005202,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700036,26491875.0,"DOAJ Gold, Green Published",,,16/08/2019,23,6,61,9413,1440,1141,299,7973,6886,19,1068,61,2,0,0,23,23,18,,82,4,82,0,4,26,23,26,12,0,0,0,0,0,0,3,4,5,9427,110,0,322,78,0,7950,1440,110,0,322,78,0,37,,5,2,0,0,9,0,1,1,0,0,0,82,0,0,61.61600000000001,6.5368055555555555,1.180609557255738,0.18060955725573813,1.2059450645930014,1.0214596834165515,6.677083333333333
337,J,"Lu, R; Herrera, BB; Eshleman, HD; Fu, Y; Bloom, A; Li, ZG; Sacks, DB; Goldberg, MB",,,,"Lu, Richard; Herrera, Bobby Brooke; Eshleman, Heather D.; Fu, Yang; Bloom, Alexander; Li, Zhigang; Sacks, David B.; Goldberg, Marcia B.",,,Shigella Effector OspB Activates mTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation,PLOS PATHOGENS,,,English,Article,,,,,,,FLEXNERI; PATHWAY; DEATH; PROTEIN; PHOSPHORYLATION; INFLAMMASOME; INACTIVATION; PATHOGENESIS; CYTOSKELETON; EXPRESSION,"The intracellular bacterial pathogen Shigella infects and spreads through the human intestinal epithelium. Effector proteins delivered by Shigella into cells promote infection by modulating diverse host functions. We demonstrate that the effector protein OspB interacts directly with the scaffolding protein IQGAP1, and that the absence of either OspB or IQGAP1 during infection leads to larger areas of S. flexneri spread through cell monolayers. We show that the effect on the area of bacterial spread is due to OspB triggering increased cell proliferation at the periphery of infected foci, thereby replacing some of the cells that die within infected foci and restricting the area of bacterial spread. We demonstrate that OspB enhancement of cell proliferation results from activation of mTORC1, a master regulator of cell growth, and is blocked by the mTORC1-specific inhibitor rapamycin. OspB activation of mTORC1, and its effects on cell proliferation and bacterial spread, depends on IQGAP1. Our results identify OspB as a regulator of mTORC1 and mTORC1-dependent cell proliferation early during S. flexneri infection and establish a role for IQGAP1 in mTORC1 signaling. They also raise the possibility that IQGAP1 serves as a scaffold for the assembly of an OspB-mTORC1 signaling complex.","[Lu, Richard; Herrera, Bobby Brooke; Eshleman, Heather D.; Fu, Yang; Bloom, Alexander; Goldberg, Marcia B.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Cambridge, MA 02142 USA; [Lu, Richard; Eshleman, Heather D.; Goldberg, Marcia B.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA","Goldberg, MB (reprint author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Cambridge, MA 02142 USA.",marcia.goldberg@mgh.harvard.edu,"Goldberg, Marcia/U-8604-2019","Herrera, Bobby Brooke/0000-0002-2438-6716; Sacks, David/0000-0003-3100-0735","NIH [F32AI073035, R01AI081724]; New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease [U54AI057159]; ICCB-Longwood facility (Harvard Medical School)","This work was supported by NIH F32AI073035 (to RL) and NIH R01AI081724 (to MBG) and by the Intramural Research Program of the NIH (to DBS). The human genome RNAi was made available through the support of the New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease (U54AI057159) and the ICCB-Longwood facility (Harvard Medical School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,11,11,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005200,10.1371/journal.ppat.1005200,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700034,26473364.0,"DOAJ Gold, Green Published",,,16/08/2019,10,1,11,3210,396,324,72,2814,2295,19,500,11,0,0,0,9,9,0,,18,0,18,0,0,11,11,7,7,0,0,0,0,0,0,0,1,1,3216,80,0,52,101,1,2807,396,80,0,52,101,1,13,,0,0,0,0,1,0,0,1,0,0,0,18,0,0,0.5,8.106060606060606,1.140724946695096,0.14072494669509594,1.207178393745558,1.0582554517133957,8.578282828282829
338,J,"Martin, MD; Kim, MT; Shan, Q; Sompallae, R; Xue, HH; Harty, JT; Badovinac, VP",,,,"Martin, Matthew D.; Kim, Marie T.; Shan, Qiang; Sompallae, Ramakrishna; Xue, Hai-Hui; Harty, John T.; Badovinac, Vladimir P.",,,Phenotypic and Functional Alterations in Circulating Memory CD8 T Cells with Time after Primary Infection,PLOS PATHOGENS,,,English,Article,,,,,,,CUTTING EDGE; ANTIVIRAL IMMUNITY; RM CELLS; EFFECTOR; RESIDENT; VIRUS; RESPONSES; DIFFERENTIATION; GENERATION; PROTECTION,"Memory CD8 T cells confer increased protection to immune hosts upon secondary viral, bacterial, and parasitic infections. The level of protection provided depends on the numbers, quality (functional ability), and location of memory CD8 T cells present at the time of infection. While primary memory CD8 T cells can be maintained for the life of the host, the full extent of phenotypic and functional changes that occur over time after initial antigen encounter remains poorly characterized. Here we show that critical properties of circulating primary memory CD8 T cells, including location, phenotype, cytokine production, maintenance, secondary proliferation, secondary memory generation potential, and mitochondrial function change with time after infection. Interestingly, phenotypic and functional alterations in the memory population are not due solely to shifts in the ratio of effector (CD62Llo) and central memory (CD62Lhi) cells, but also occur within defined CD62Lhi memory CD8 T cell subsets. CD62Lhi memory cells retain the ability to efficiently produce cytokines with time after infection. However, while it is was not formally tested whether changes in CD62Lhi memory CD8 T cells over time occur in a cell intrinsic manner or are due to selective death and/or survival, the gene expression profiles of CD62Lhi memory CD8 T cells change, phenotypic heterogeneity decreases, and mitochondrial function and proliferative capacity in either a lymphopenic environment or in response to antigen re-encounter increase with time. Importantly, and in accordance with their enhanced proliferative and metabolic capabilities, protection provided against chronic LCMV clone-13 infection increases over time for both circulating memory CD8 T cell populations and for CD62Lhi memory cells. Taken together, the data in this study reveal that memory CD8 T cells continue to change with time after infection and suggest that the outcome of vaccination strategies designed to elicit protective memory CD8 T cells using single or prime-boost immunizations depends upon the timing between antigen encounters.","[Martin, Matthew D.; Kim, Marie T.; Xue, Hai-Hui; Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Martin, Matthew D.; Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Shan, Qiang; Xue, Hai-Hui; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Sompallae, Ramakrishna] Univ Iowa, Iowa Inst, Human Genet Bioinformat Div, Iowa City, IA USA","Martin, MD (reprint author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.",vladimir-badovinac@uiowa.edu,"badovinac, Vladimir/O-7760-2015","Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439; Xue, Hai-Hui/0000-0002-9163-7669","National Institutes of Health [AI114543, AI119160, GM113961, T32AI007485]","Work in VPB, JTH and HHX laboratories is supported by the grants from the National Institutes of Health, AI114543 to VPB and JTH, AI119160 to VPB and HHX, GM113961 to VPB and T32AI007485 to MDM. The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.",,76,20,20,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005219,10.1371/journal.ppat.1005219,,,,36,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700045,26485703.0,"DOAJ Gold, Green Published",,,16/08/2019,21,0,27,4399,1030,738,292,3369,2527,24,818,27,0,0,0,18,18,0,,41,0,39,0,0,21,21,12,17,0,0,0,0,0,0,0,0,5,4476,65,13,57,209,0,3391,1049,65,13,57,209,0,36,,0,0,0,0,5,0,0,1,0,0,0,41,0,0,2.0,4.270873786407767,1.3057287028791926,0.3057287028791926,1.4099139210448204,1.0797908615594454,4.611650485436893
339,J,"Nawandar, DM; Wang, AQ; Makielski, K; Lee, D; Ma, SD; Barlow, E; Reusch, J; Jiang, R; Wille, CK; Greenspan, D; Greenspan, JS; Mertz, JE; Hutt-Fletcher, L; Johannsen, EC; Lambert, PF; Kenney, SC",,,,"Nawandar, Dhananjay M.; Wang, Anqi; Makielski, Kathleen; Lee, Denis; Ma, Shidong; Barlow, Elizabeth; Reusch, Jessica; Jiang, Ru; Wille, Coral K.; Greenspan, Deborah; Greenspan, John S.; Mertz, Janet E.; Hutt-Fletcher, Lindsey; Johannsen, Eric C.; Lambert, Paul F.; Kenney, Shannon C.",,,Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells,PLOS PATHOGENS,,,English,Article,,,,,,,NASOPHARYNGEAL CARCINOMA; B-CELLS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; IN-VIVO; TRANSCRIPTION FACTOR; GASTRIC-CANCER; TERMINAL DIFFERENTIATION; HAIRY LEUKOPLAKIA; DISRUPT LATENCY,"Epstein-Barr virus (EBV) is a human herpesvirus associated with B-cell and epithelial cell malignancies. EBV lytically infects normal differentiated oral epithelial cells, where it causes a tongue lesion known as oral hairy leukoplakia (OHL) in immunosuppressed patients. However, the cellular mechanism(s) that enable EBV to establish exclusively lytic infection in normal differentiated oral epithelial cells are not currently understood. Here we show that a cellular transcription factor known to promote epithelial cell differentiation, KLF4, induces differentiation-dependent lytic EBV infection by binding to and activating the two EBV immediate-early gene (BZLF1 and BRLF1) promoters. We demonstrate that latently EBV-infected, telomerase-immortalized normal oral keratinocyte (NOKs) cells undergo lytic viral reactivation confined to the more differentiated cell layers in organotypic raft culture. Furthermore, we show that endogenous KLF4 expression is required for efficient lytic viral reactivation in response to phorbol ester and sodium butyrate treatment in several different EBV-infected epithelial cell lines, and that the combination of KLF4 and another differentiation-dependent cellular transcription factor, BLIMP1, is highly synergistic for inducing lytic EBV infection. We confirm that both KLF4 and BLIMP1 are expressed in differentiated, but not undifferentiated, epithelial cells in normal tongue tissue, and show that KLF4 and BLIMP1 are both expressed in a patient-derived OHL lesion. In contrast, KLF4 protein is not detectably expressed in B cells, where EBV normally enters latent infection, although KLF4 over-expression is sufficient to induce lytic EBV reactivation in Burkitt lymphoma cells. Thus, KLF4, together with BLIMP1, plays a critical role in mediating lytic EBV reactivation in epithelial cells.","[Nawandar, Dhananjay M.; Wang, Anqi; Makielski, Kathleen; Lee, Denis; Ma, Shidong; Barlow, Elizabeth; Reusch, Jessica; Wille, Coral K.; Mertz, Janet E.; Johannsen, Eric C.; Lambert, Paul F.; Kenney, Shannon C.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Nawandar, Dhananjay M.; Wang, Anqi; Reusch, Jessica] Univ Wisconsin, Sch Med & Publ Hlth, Cellular & Mol Biol Grad Program, Madison, WI USA; [Jiang, Ru; Hutt-Fletcher, Lindsey] Louisiana State Univ, Hlth Sci Ctr, Ctr Mol & Tumor Virol, Dept Microbiol & Immunol, Shreveport, LA 71105 USA; [Jiang, Ru; Hutt-Fletcher, Lindsey] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Wille, Coral K.] Univ Wisconsin, Sch Med & Publ Hlth, Med Microbiol & Immunol Grad Program, Madison, WI USA; [Greenspan, Deborah; Greenspan, John S.] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA; [Johannsen, Eric C.; Kenney, Shannon C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA","Kenney, SC (reprint author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.",skenney@wisc.edu,,"Reusch, Jessica/0000-0002-2034-6282","U.S. Department of Health and Human Services National Institutes of Health [5-PO1-CA22443-37, 5-RO1-DE023939-02, 5-RO1-DE016669]","U.S. Department of Health and Human Services National Institutes of Health (http://www.nih.gov/) grants 5-PO1-CA22443-37, 5-RO1-DE023939-02 to SCK. U.S. Department of Health and Human Services National Institutes of Health (http://www.nih.gov/) grant 5-RO1-DE016669 to LHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,99,29,30,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005195,10.1371/journal.ppat.1005195,,,,35,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700031,26431332.0,"DOAJ Gold, Green Published",,,16/08/2019,28,0,22,5796,1386,1004,382,4410,3560,27,823,22,0,0,0,27,27,0,,33,11,33,0,11,33,31,33,27,0,0,0,0,0,0,0,0,4,5810,89,0,310,430,1,4380,1386,89,0,310,430,1,44,,0,0,0,0,3,0,0,1,0,0,0,32,0,0,1.6,4.181818181818182,1.3142857142857143,0.3142857142857143,1.4351473922902493,1.091959972394755,4.566378066378066
340,J,"Nishimura, Y; McLaughlin, NP; Pan, JY; Goldstein, S; Hafenstein, S; Shimizu, H; Winkler, JD; Bergelson, JM",,,,"Nishimura, Yorihiro; McLaughlin, Noel P.; Pan, Jieyan; Goldstein, Sara; Hafenstein, Susan; Shimizu, Hiroyuki; Winkler, Jeffrey D.; Bergelson, Jeffrey M.",,,The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate,PLOS PATHOGENS,,,English,Article,,,,,,,71 VACCINE; IN-VITRO; RECEPTOR; PROTEIN; INFECTION; EFFICACY; EPITOPE; SAFETY,"NF449, a sulfated compound derived from the antiparasitic drug suramin, was previously reported to inhibit infection by enterovirus A71 (EV-A71). In the current work, we found that NF449 inhibits virus attachment to target cells, and specifically blocks virus interaction with two identified receptors-the P-selectin ligand, PSGL-1, and heparan sulfate glycosaminoglycan-with no effect on virus binding to a third receptor, the scavenger receptor SCARB2. We also examined a number of commercially available suramin analogues, and newly synthesized derivatives of NF449; among these, NF110 and NM16, like NF449, inhibited virus attachment at submicromolar concentrations. PSGL-1 and heparan sulfate, but not SCARB2, are both sulfated molecules, and their interaction with EV-A71 is thought to involve positively charged capsid residues, including a conserved lysine at VP1-244, near the icosahedral 5-fold vertex. We found that mutation of VP1-244 resulted in resistance to NF449, suggesting that this residue is involved in NF449 interaction with the virus capsid. Consistent with this idea, NF449 and NF110 prevented virus interaction with monoclonal antibody MA28-7, which specifically recognizes an epitope overlapping VP1-244 at the 5-fold vertex. Based on these observations we propose that NF449 and related compounds compete with sulfated receptor molecules for a binding site at the 5-fold vertex of the EV-A71 capsid.","[Nishimura, Yorihiro; Pan, Jieyan; Bergelson, Jeffrey M.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Nishimura, Yorihiro; Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [McLaughlin, Noel P.; Goldstein, Sara; Winkler, Jeffrey D.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Hafenstein, Susan] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Bergelson, Jeffrey M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA","Nishimura, Y (reprint author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.",ynishi@nih.go.jp; winkler@sas.upenn.edu; bergelson@email.chop.edu,,"Shimizu, Hiroyuki/0000-0002-2987-2377",U.S. National Institutes of Health [R21AI1112805]; Japan Society for the Promotion of Science [15K08512]; Plotkin Endowed Chair in Infectious Diseases at the Children's Hospital of Philadelphia,"This work was supported by the U.S. National Institutes of Health (R21AI1112805 to JMB), by the Japan Society for the Promotion of Science (Grant Number 15K08512 to YN), and by the Plotkin Endowed Chair in Infectious Diseases at the Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,38,11,13,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005184,10.1371/journal.ppat.1005184,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700023,26430888.0,"DOAJ Gold, Green Published",,,16/08/2019,9,0,12,3242,645,479,166,2597,2146,13,438,12,0,0,0,10,10,0,,16,3,16,0,3,11,11,8,5,0,0,0,0,0,0,0,0,0,3249,57,0,301,70,0,2593,645,57,0,301,70,0,11,,0,0,0,0,0,0,0,1,0,0,0,16,0,0,0.25,5.026356589147287,1.248363496341933,0.248363496341933,1.299961494031575,1.0413325107958051,5.234108527131783
341,J,"Paquette, SG; Banner, D; Huang, SSH; Almansa, R; Leon, A; Xu, LL; Bartoszko, J; Kelvin, DJ; Kelvin, AA",,,,"Paquette, Stephane G.; Banner, David; Huang, Stephen S. H.; Almansa, Raquel; Leon, Alberto; Xu, Luoling; Bartoszko, Jessica; Kelvin, David J.; Kelvin, Alyson A.",,,"Influenza Transmission in the Mother-Infant Dyad Leads to Severe Disease, Mammary Gland Infection, and Pathogenesis by Regulating Host Responses",PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN BREAST-TISSUE; EPSTEIN-BARR-VIRUS; GENE-EXPRESSION; HUMAN-PAPILLOMAVIRUS; HUMAN-MILK; A H1N1; IMMUNE-RESPONSES; H5N1 INFECTION; FERRETS; CANCER,"Seasonal influenza viruses are typically restricted to the human upper respiratory tract whereas influenza viruses with greater pathogenic potential often also target extra-pulmonary organs. Infants, pregnant women, and breastfeeding mothers are highly susceptible to severe respiratory disease following influenza virus infection but the mechanisms of disease severity in the mother-infant dyad are poorly understood. Here we investigated 2009 H1N1 influenza virus infection and transmission in breastfeeding mothers and infants utilizing our developed infant-mother ferret influenza model. Infants acquired severe disease and mortality following infection. Transmission of the virus from infants to mother ferrets led to infection in the lungs and mother mortality. Live virus was also found in mammary gland tissue and expressed milk of the mothers which eventually led to milk cessation. Histopathology showed destruction of acini glandular architecture with the absence of milk. The virus was localized in mammary epithelial cells of positive glands. To understand the molecular mechanisms of mammary gland infection, we performed global transcript analysis which showed downregulation of milk production genes such as Prolactin and increased breast involution pathways indicated by a STAT5 to STAT3 signaling shift. Genes associated with cancer development were also significantly increased including JUN, FOS and M2 macrophage markers. Immune responses within the mammary gland were characterized by decreased lymphocyte-associated genes CD3e, IL2Ra, CD4 with IL1 beta upregulation. Direct inoculation of H1N1 into the mammary gland led to infant respiratory infection and infant mortality suggesting the influenza virus was able to replicate in mammary tissue and transmission is possible through breastfeeding. In vitro infection studies with human breast cells showed susceptibility to H1N1 virus infection. Together, we have shown that the host-pathogen interactions of influenza virus infection in the mother-infant dyad initiate immunological and oncogenic signaling cascades within the mammary gland. These findings suggest the mammary gland may have a greater role in infection and immunity than previously thought.","[Paquette, Stephane G.; Banner, David; Huang, Stephen S. H.; Leon, Alberto; Xu, Luoling; Kelvin, David J.; Kelvin, Alyson A.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Paquette, Stephane G.; Bartoszko, Jessica; Kelvin, David J.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Huang, Stephen S. H.; Kelvin, David J.] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada; [Almansa, Raquel] Hosp Clin Univ, Inst Estudios Ciencias Salud Castilla & Le N, Infect & Immun Med Invest Unit, Valladolid, Spain; [Kelvin, David J.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol Sperimentale & Clin, I-07100 Sassari, Italy; [Kelvin, David J.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Guangdong, Peoples R China; [Kelvin, David J.] Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Guangzhou, Guangdong, Peoples R China; [Kelvin, Alyson A.] Immune Diagnost & Res, Toronto, ON, Canada","Kelvin, AA (reprint author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Expt Therapeut, Toronto, ON, Canada.",akelvin@jidc.org,,,"Li Ka Shing Foundation of Canada; Immune Diagnostics Research; NIH [1U01AI11598-01, 0038591(123721-3)]","This study was supported by Li Ka Shing Foundation of Canada, Immune Diagnostics & Research, and NIH 1U01AI11598-01 Subaward no. 0038591(123721-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,6,6,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005173,10.1371/journal.ppat.1005173,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700017,26448646.0,"DOAJ Gold, Green Published",,,16/08/2019,8,37,23,7490,1387,970,417,6103,4881,21,1201,23,21,0,0,7,7,10,,64,5,33,0,5,10,9,10,5,0,0,0,0,0,0,2,16,8,7528,177,0,54,373,0,6079,1387,177,0,54,373,0,62,,4,2,0,0,14,0,0,1,0,0,0,33,0,0,59.908,5.400144196106705,1.2272652793708012,0.22726527937080124,1.323611338685892,1.0785046728971963,5.824080749819755
342,J,"Pol, SV",,,,"Pol, Scott Vande",,,Papillomavirus E6 Oncoproteins Take Common Structural Approaches to Solve Different Biological Problems,PLoS Pathogens,,,English,Article,,,,,,,PROTEINS; BINDING; P53; TRANSFORMATION; TYPE-16,,"Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA","Pol, SV (reprint author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.",vandepol@virginia.edu,,,National Cancer Institute [RO1CA134737],"This work was supported by National Cancer Institute funding RO1CA134737 to SVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,20,1,1,2,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005138,10.1371/journal.ppat.1005138,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700009,26470018.0,"DOAJ Gold, Green Published",,,16/08/2019,3,1,24,2453,311,208,103,2142,1819,9,314,24,0,0,0,4,4,0,,23,0,23,0,0,3,3,3,3,0,0,0,0,0,0,0,1,0,2465,6,0,18,38,0,2137,311,6,0,18,38,0,17,,0,0,0,0,1,0,0,1,0,0,0,23,0,0,0.5,7.887459807073955,1.1451914098972922,0.14519140989729226,1.1713352007469655,1.0228291887484713,8.067524115755628
343,J,"Roelofs, KG; Jones, CJ; Helman, SR; Shang, XR; Orr, MW; Goodson, JR; Galperin, MY; Yildiz, FH; Lee, VT",,,,"Roelofs, Kevin G.; Jones, Christopher J.; Helman, Sarah R.; Shang, Xiaoran; Orr, Mona W.; Goodson, Jonathan R.; Galperin, Michael Y.; Yildiz, Fitnat H.; Lee, Vincent T.",,,Systematic Identification of Cyclic-di-GMP Binding Proteins in Vibrio cholerae Reveals a Novel Class of Cyclic-di-GMP-Binding ATPases Associated with Type II Secretion Systems,PLOS PATHOGENS,,,English,Article,,,,,,,MANNOSE-SENSITIVE HEMAGGLUTININ; PILZ DOMAIN PROTEINS; N-TERMINAL DOMAIN; EL-TOR BIOTYPE; PSEUDOMONAS-AERUGINOSA; SIGNAL-TRANSDUCTION; BIOFILM FORMATION; XANTHOMONAS-CAMPESTRIS; CELLULOSE SYNTHESIS; EAL DOMAIN,"Cyclic-di-GMP (c-di-GMP) is a ubiquitous bacterial signaling molecule that regulates a variety of complex processes through a diverse set of c-di-GMP receptor proteins. We have utilized a systematic approach to identify c-di-GMP receptors from the pathogen Vibrio cholerae using the Differential Radial Capillary Action of Ligand Assay (DRaCALA). The DRaCALA screen identified a majority of known c-di-GMP binding proteins in V. cholerae and revealed a novel c-di-GMP binding protein, MshE (VC0405), an ATPase associated with the mannose sensitive hemagglutinin (MSHA) type IV pilus. The known c-di-GMP binding proteins identified by DRaCALA include diguanylate cyclases, phosphodiesterases, PilZ domain proteins and transcription factors VpsT and VpsR, indicating that the DRaCALA-based screen of open reading frame libraries is a feasible approach to uncover novel receptors of small molecule ligands. Since MshE lacks the canonical c-di-GMP-binding motifs, a truncation analysis was utilized to locate the c-di-GMP binding activity to the N-terminal T2SSE_N domain. Alignment of MshE homologs revealed candidate conserved residues responsible for c-di-GMP binding. Site-directed mutagenesis of these candidate residues revealed that the Arg9 residue is required for c-di-GMP binding. The ability of c-di-GMP binding to MshE to regulate MSHA dependent processes was evaluated. The R9A allele, in contrast to the wild type MshE, was unable to complement the Delta mshE mutant for the production of extracellular MshA to the cell surface, reduction in flagella swimming motility, attachment to surfaces and formation of biofilms. Testing homologs of MshE for binding to c-di-GMP identified the type II secretion ATPase of Pseudomonas aeruginosa (PA14_29490) as a c-di-GMP receptor, indicating that type II secretion and type IV pili are both regulated by c-di-GMP.","[Roelofs, Kevin G.; Helman, Sarah R.; Shang, Xiaoran; Orr, Mona W.; Goodson, Jonathan R.; Lee, Vincent T.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Jones, Christopher J.; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Galperin, Michael Y.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA","Roelofs, KG (reprint author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.",vtlee@umd.edu,"Galperin, Michael Y./N-1457-2019","Galperin, Michael Y./0000-0002-2265-5572; Orr, Mona/0000-0003-4570-1823; Lee, Vincent T./0000-0002-3593-0318","NIH [AI102584, R21AI096083]; NIH Intramural Research Program at the National Library of Medicine; NIH/NIAID Training Grant in Host-Pathogen Interactions [T32-AI089621]","Support was provided to FHY (NIH grant AI102584) and VTL (NIH grant R21AI096083). MYG was supported by the NIH Intramural Research Program at the National Library of Medicine. KGR and MWO were supported in part by a NIH/NIAID Training Grant in Host-Pathogen Interactions (T32-AI089621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,114,33,35,1,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005232,10.1371/journal.ppat.1005232,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700054,26506097.0,"DOAJ Gold, Green Published",,,16/08/2019,36,110,30,7323,1501,1158,343,5822,4703,21,1098,30,2,0,0,31,31,0,,80,0,80,0,0,39,39,23,20,0,0,0,0,0,0,0,108,6,7332,100,0,95,65,2,5785,1501,100,0,95,65,2,46,,0,0,0,0,7,0,0,1,0,0,0,79,0,0,4.0,4.878747501665556,1.2578151837856406,0.25781518378564067,1.2877018206801787,1.0237607537894307,4.994670219853431
344,J,"Saravia, J; You, D; Shrestha, B; Jaligama, S; Siefker, D; Lee, GI; Harding, JN; Jones, TL; Rovnaghi, C; Bagga, B; DeVincenzo, JP; Cormier, SA",,,,"Saravia, Jordy; You, Dahui; Shrestha, Bishwas; Jaligama, Sridhar; Siefker, David; Lee, Greg I.; Harding, Jeffrey N.; Jones, Tamekia L.; Rovnaghi, Cynthia; Bagga, Bindiya; DeVincenzo, John P.; Cormier, Stephania A.",,,Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33,PLOS PATHOGENS,,,English,Article,,,,,,,INNATE LYMPHOID-CELLS; ALLERGIC AIRWAY INFLAMMATION; ASTHMA DEVELOPMENT; LUNG INFLAMMATION; IMMUNE-RESPONSES; DENDRITIC CELLS; TYPE-2 IMMUNITY; OX40 LIGAND; EARLY-LIFE; CYTOKINE,"Respiratory syncytial virus (RSV) is the most common cause of infant hospitalizations and severe RSV infections are a significant risk factor for childhood asthma. The pathogenic mechanisms responsible for RSV induced immunopathophysiology remain elusive. Using an age-appropriate mouse model of RSV, we show that IL-33 plays a critical role in the immunopathogenesis of severe RSV, which is associated with higher group 2 innate lymphoid cells (ILC2s) specifically in neonates. Infection with RSV induced rapid IL-33 expression and an increase in ILC2 numbers in the lungs of neonatal mice; this was not observed in adult mice. Blocking IL-33 with antibodies or using an IL-33 receptor knockout mouse during infection was sufficient to inhibit RSV immunopathogenesis (i.e., airway hyperresponsiveness, Th2 inflammation, eosinophilia, and mucus hyperproduction); whereas administration of IL-33 to adult mice during RSV infection was sufficient to induce RSV disease. Additionally, elevated IL-33 and IL-13 were observed in nasal aspirates from infants hospitalized with RSV; these cytokines declined during convalescence. In summary, IL-33 is necessary, either directly or indirectly, to induce ILC2s and the Th2 biased immunopathophysiology observed following neonatal RSV infection. This study provides a mechanism involving IL-33 and ILC2s in RSV mediated human asthma.","[Saravia, Jordy; You, Dahui; Shrestha, Bishwas; Jaligama, Sridhar; Siefker, David; Lee, Greg I.; Harding, Jeffrey N.; Jones, Tamekia L.; Rovnaghi, Cynthia; Bagga, Bindiya; DeVincenzo, John P.; Cormier, Stephania A.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Saravia, Jordy; You, Dahui; Shrestha, Bishwas; Jaligama, Sridhar; Siefker, David; Lee, Greg I.; Harding, Jeffrey N.; Jones, Tamekia L.; Bagga, Bindiya; DeVincenzo, John P.; Cormier, Stephania A.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [DeVincenzo, John P.; Cormier, Stephania A.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA","Saravia, J (reprint author), Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA.",scormier@uthsc.edu,"Cormier, Stephania/N-8471-2019; Cormier, Stephania/I-7382-2017","Cormier, Stephania/0000-0002-6050-6172; Cormier, Stephania/0000-0002-6050-6172; Shrestha, Bishwas/0000-0002-6159-7686; Saravia, Jordy/0000-0002-2691-501X; Jaligama, Sridhar/0000-0001-6374-3336","U.S. National Institutes of Health [R01AI090059, R01ES015050, P42ES013648]","This work was supported by the U.S. National Institutes of Health grants (R01AI090059, R01ES015050, and P42ES013648) to SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,54,52,53,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005217,10.1371/journal.ppat.1005217,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700043,26473724.0,"DOAJ Gold, Green Published",,,16/08/2019,55,6,49,6607,1529,1085,444,5078,3846,17,1215,49,5,0,1,53,53,0,,144,7,74,0,7,58,58,36,33,0,0,0,0,0,0,0,1,3,6739,48,0,87,460,7,5128,1550,48,0,87,460,7,61,,0,0,0,0,7,0,1,1,1,0,0,75,0,0,4.5,4.321124918247221,1.3011027963765263,0.3011027963765262,1.4271366679795194,1.0968669592856062,4.739699149771092
345,J,"Shen, AM",,,,"Shen, Aimee",,,A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination,PLOS PATHOGENS,,,English,Article,,,,,,,INTESTINAL MICROBIOTA; BILE-SALTS; SPORULATION; INITIATION; COLONIZATION; INFECTION; DYNAMICS; ACID,,"Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA","Shen, AM (reprint author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.",aimee.shen@uvm.edu,,,"Pew Charitable Trusts; National Institute of General Medical Sciences [P20 GM103496, R01GM108684]","AS is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts; work in this manuscript was supported by start-up funds from Award Number P20 GM103496 and R01GM108684 from the National Institute of General Medical Sciences. The content is solely the responsibility of the author and does not necessarily reflect the views of the Pew Charitable Trusts or the National Institute of General Medical Sciences or the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,31,12,12,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005157,10.1371/journal.ppat.1005157,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700011,26468647.0,"DOAJ Gold, Green Published",,,16/08/2019,11,13,63,8737,1382,1041,341,7355,6025,11,1319,63,12,0,0,12,12,0,,92,23,92,0,23,16,13,16,4,0,0,0,0,0,0,0,29,8,8797,72,0,1697,101,6,7336,1382,72,0,1697,101,6,79,,0,0,0,0,12,0,1,1,0,0,0,92,0,0,6.7,6.3219971056439945,1.187899388171312,0.18789938817131202,1.2195785180149559,1.0266681927435046,6.490593342981187
346,J,"Shibata, T; Maki, K; Hadano, J; Fujikawa, T; Kitazaki, K; Koshiba, T; Kawabata, S",,,,"Shibata, Toshio; Maki, Kouki; Hadano, Jinki; Fujikawa, Takumi; Kitazaki, Kazuki; Koshiba, Takumi; Kawabata, Shun-ichiro",,,Crosslinking of a Peritrophic Matrix Protein Protects Gut Epithelia from Bacterial Exotoxins,PLoS Pathogens,,,English,Article,,,,,,,DROSOPHILA-MELANOGASTER; HOST-DEFENSE; PSEUDOMONAS-AERUGINOSA; CUTICULAR PROTEINS; ALKALINE PROTEASE; INTESTINAL MUCIN; TRANSGLUTAMINASE; INFECTION; GENE; DROSOCRYSTALLIN,"Transglutaminase (TG) catalyzes protein-protein crosslinking, which has important and diverse roles in vertebrates and invertebrates. Here we demonstrate that Drosophila TG crosslinks drosocrystallin, a peritrophic matrix protein, to form a stable fiber structure on the gut peritrophic matrix. RNA interference (RNAi) of the TG gene was highly lethal in flies and induced apoptosis of gut epithelial cells after oral infection with Pseudomonas entomophila. Moreover, AprA, a metalloprotease secreted by P. entomophila, digested non-crosslinked drosocrystallin fibers, but not drosocrystallin fibers crosslinked by TG. In vitro experiments using recombinant drosocrystallin and monalysin proteins demonstrated that monalysin, a pore-forming exotoxin of P. entomophila, was adsorbed on the crosslinked drosocrystallin fibers in the presence of P. entomophila culture supernatant. In addition, gut-specific TG-RNAi flies had a shorter lifespan than control flies after ingesting P. entomophila, whereas the lifespan after ingesting AprA-knockout P. entomophila was at control levels. We conclude that drosocrystallin fibers crosslinked by TG, but not non-crosslinked drosocrystallin fibers, form an important physical barrier against exotoxins of invading pathogenic microbes.","[Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; [Maki, Kouki; Hadano, Jinki; Fujikawa, Takumi; Kitazaki, Kazuki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan","Shibata, T (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.",skawascb@kyudai.jp,,"Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043",Uehara Memorial Foundation; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (TT type) Fund [26701];  [24570164];  [15H04353];  [24117712];  [26860333],"SK was supported by a Grant-in-Aid for Scientific Research (no. 24570164, 15H04353), a Grant-in-Aid for Scientific Research on Innovative Areas (no. 24117712), and the Uehara Memorial Foundation. TS was supported by a Grant-in-Aid for Young Scientists (B) (no. 26860333) and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (TT type) Fund (no. 26701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,32,12,12,2,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005244,10.1371/journal.ppat.1005244,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700063,26506243.0,"DOAJ Gold, Green Published",,,16/08/2019,14,4,27,5366,375,258,117,4991,4335,16,640,27,4,0,0,14,14,0,,37,0,37,0,0,14,14,11,9,0,0,0,0,0,0,0,0,4,5372,20,0,53,88,0,4981,375,20,0,53,88,0,16,,0,0,0,0,5,0,0,1,0,0,0,36,0,0,3.0,14.309333333333333,1.0751352434381887,0.07513524343818874,1.097976357443398,1.021244875139769,14.613333333333333
347,J,"Soriano-Sarabia, N; Archin, NM; Bateson, R; Dahl, NP; Crooks, AM; Kuruc, JD; Garrido, C; Margolis, DM",,,,"Soriano-Sarabia, Natalia; Archin, Nancie M.; Bateson, Rosalie; Dahl, Noelle P.; Crooks, Amanda M.; Kuruc, JoAnn D.; Garrido, Carolina; Margolis, David M.",,,Peripheral V gamma 9V delta 2 T Cells Are a Novel Reservoir of Latent HIV Infection,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIVIRAL THERAPY; REPLICATION; LYMPHOCYTES; MECHANISM; RESPONSES; ANTIGENS; RECOVERY; VIF,"Eradication of HIV infection will require the identification of all cellular reservoirs that harbor latent infection. Despite low or lack of CD4 receptor expression on V delta 2 T cells, infection of these cells has previously been reported. We found that upregulation of the CD4 receptor may render primary V delta 2 cells target for HIV infection in vitro and we propose that HIV-induced immune activation may allow infection of gamma delta T cells in vivo. We assessed the presence of latent HIV infection by measurements of DNA and outgrowth assays within V delta 2 cells in 18 aviremic patients on long-standing antiretroviral therapy. In 14 patients we recovered latent but replication-competent HIV from highly purified V delta 2 cells demonstrating that peripheral V delta 2 T cells are a previously unrecognized reservoir in which latent HIV infection is unexpectedly frequent.","[Soriano-Sarabia, Natalia; Archin, Nancie M.; Bateson, Rosalie; Dahl, Noelle P.; Crooks, Amanda M.; Kuruc, JoAnn D.; Garrido, Carolina; Margolis, David M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27516 USA; [Margolis, David M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Margolis, David M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA","Margolis, DM (reprint author), Univ N Carolina, Dept Med, Chapel Hill, NC 27516 USA.",dmargo@med.unc.edu,"Soriano-Sarabia, Natalia/P-5592-2018; Pavon, Carolina Garrido/N-6188-2018","Soriano-Sarabia, Natalia/0000-0002-2349-263X; Pavon, Carolina Garrido/0000-0001-7697-6876","National Institutes of Health [U19 AI096113, RR024383, AI50410]; UNC Flow Cytometry Core Facility - North Carolina Biotech Center Institutional Support Grant [2012-IDG-1006]; James B. Pendleton Charitable Trust; Carlos III Institutes of Health, Spain [CD10/00438]","This study was supported by National Institutes of Health grants U19 AI096113 to DMM, National Institutes of Health grants RR024383 to the UNC TRaCS Institute, AI50410 to the UNC Center for AIDS Research, the UNC Flow Cytometry Core Facility (supported in part by North Carolina Biotech Center Institutional Support Grant 2012-IDG-1006), and an equipment grant from the James B. Pendleton Charitable Trust. NSS was supported by Carlos III Institutes of Health, Spain (CD10/00438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,30,32,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005201,10.1371/journal.ppat.1005201,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700035,26473478.0,"DOAJ Gold, Green Published",,,16/08/2019,28,35,12,4176,605,402,203,3571,2924,14,633,12,9,0,0,29,29,0,,44,0,44,0,0,33,31,33,19,0,0,0,0,0,0,0,26,5,4229,34,0,38,130,0,3581,624,34,0,38,130,0,24,,0,0,0,0,11,0,0,1,0,0,0,44,0,0,6.2,6.9024793388429755,1.1694203304396527,0.16942033043965277,1.2301876225147017,1.051963601532567,7.2611570247933885
348,J,"Su, XZ",,,,"Su, Xin-zhuan",,,Translating Basic Research into Clinical Applications: Malaria Research at an NIH Lab,PLoS Pathogens,,,English,Editorial Material,,,,,,,,,"NIAID, Malaria Funct Genom Sect, Lab Malaria & Vector Res, Div Intramural Res,NIH, Bethesda, MD 20892 USA","Su, XZ (reprint author), NIAID, Malaria Funct Genom Sect, Lab Malaria & Vector Res, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",xsu@niaid.nih.gov,,"Su, Xinzhuan/0000-0003-3246-3248",Intramural NIH HHS,,,0,0,0,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005190,10.1371/journal.ppat.1005190,,,,2,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700027,26447478.0,"DOAJ Gold, Green Published",,,16/08/2019,0,10,4,3292,151,106,45,3141,2902,7,232,4,5,0,0,0,0,0,,4,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,5,10,3314,0,2,0,51,1,3144,153,0,2,0,51,1,17,,0,0,0,0,16,0,2,1,0,0,0,4,0,0,8.95,21.801324503311257,1.0480738618274434,0.04807386182744349,1.0713148678764726,1.0221749696233293,22.28476821192053
349,J,"Thaiss, CA; Levy, M; Elinav, E",,,,"Thaiss, Christoph A.; Levy, Maayan; Elinav, Eran",,,Chronobiomics: The Biological Clock as a New Principle in Host-Microbial Interactions,PLOS PATHOGENS,,,English,Article,,,,,,,CIRCADIAN CLOCK; KAIC PHOSPHORYLATION; DIURNAL OSCILLATIONS; IMMUNITY; RHYTHMS; DIFFERENTIATION; HOMEOSTASIS; SYSTEM,,"[Thaiss, Christoph A.; Levy, Maayan; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel","Thaiss, CA (reprint author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.",eran.elinav@weizmann.ac.il,,,Boehringer Ingelheim Fonds PhD Fellowship; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; European Research Council; Helmholtz foundation; German-Israel Binational foundation; Israel Science Foundation; Minerva Foundation; Rising Tide foundation; Alon Foundation,"CAT is the recipient of a Boehringer Ingelheim Fonds PhD Fellowship. EE is supported by Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council; Helmholtz foundation; the German-Israel Binational foundation; the Israel Science Foundation; the Minerva Foundation; the Rising Tide foundation; and the Alon Foundation scholar award. EE is the incumbent of the Rina Gudinski Career Development Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,24,7,7,0,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005113,10.1371/journal.ppat.1005113,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700005,26448621.0,"DOAJ Gold, Green Published",,,16/08/2019,7,42,38,6115,676,469,207,5439,4510,12,917,38,29,0,0,7,7,2,,52,4,52,0,4,10,7,10,3,1,0,0,1,0,0,0,13,10,6187,9,0,24,148,2,5429,676,9,0,24,148,2,82,,0,0,0,0,27,0,0,2,0,0,0,52,0,0,16.65,9.04585798816568,1.1242875528589815,0.12428755285898144,1.166390880676595,1.037448896156991,9.384615384615385
350,J,"Tscherner, M; Zwolanek, F; Jenull, S; Sedlazeck, FJ; Petryshyn, A; Frohner, IE; Mavrianos, J; Chauhan, N; von Haeseler, A; Kuchler, K",,,,"Tscherner, Michael; Zwolanek, Florian; Jenull, Sabrina; Sedlazeck, Fritz J.; Petryshyn, Andriy; Frohner, Ingrid E.; Mavrianos, John; Chauhan, Neeraj; von Haeseler, Arndt; Kuchler, Karl",,,The Candida albicans Histone Acetyltransferase Hat1 Regulates Stress Resistance and Virulence via Distinct Chromatin Assembly Pathways,PLOS PATHOGENS,,,English,Article,,,,,,,AZOLE ANTIFUNGAL AGENTS; RNA-POLYMERASE-II; IN-VIVO; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; CHAPERONE ASF1; DNA-REPAIR; SCHIZOSACCHAROMYCES-POMBE; DEACETYLASE INHIBITORS; YEAST,"Human fungal pathogens like Candida albicans respond to host immune surveillance by rapidly adapting their transcriptional programs. Chromatin assembly factors are involved in the regulation of stress genes by modulating the histone density at these loci. Here, we report a novel role for the chromatin assembly-associated histone acetyltransferase complex NuB4 in regulating oxidative stress resistance, antifungal drug tolerance and virulence in C. albicans. Strikingly, depletion of the NuB4 catalytic subunit, the histone acetyltransferase Hat1, markedly increases resistance to oxidative stress and tolerance to azole antifungals. Hydrogen peroxide resistance in cells lacking Hat1 results from higher induction rates of oxidative stress gene expression, accompanied by reduced histone density as well as subsequent increased RNA polymerase recruitment. Furthermore, hat1 Delta/Delta cells, despite showing growth defects in vitro, display reduced susceptibility to reactive oxygen-mediated killing by innate immune cells. Thus, clearance from infected mice is delayed although cells lacking Hat1 are severely compromised in killing the host. Interestingly, increased oxidative stress resistance and azole tolerance are phenocopied by the loss of histone chaperone complexes CAF-1 and HIR, respectively, suggesting a central role for NuB4 in the delivery of histones destined for chromatin assembly via distinct pathways. Remarkably, the oxidative stress phenotype of hat1 Delta/Delta cells is a species-specific trait only found in C. albicans and members of the CTG clade. The reduced azole susceptibility appears to be conserved in a wider range of fungi. Thus, our work demonstrates how highly conserved chromatin assembly pathways can acquire new functions in pathogenic fungi during coevolution with the host.","[Tscherner, Michael; Zwolanek, Florian; Jenull, Sabrina; Petryshyn, Andriy; Frohner, Ingrid E.; Kuchler, Karl] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, Campus Vienna Bioctr, Vienna, Austria; [Sedlazeck, Fritz J.; von Haeseler, Arndt] Univ Vienna, Med Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna,Campus Vienna Bio, Vienna, Austria; [Mavrianos, John; Chauhan, Neeraj] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA","Tscherner, M (reprint author), Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, Campus Vienna Bioctr, Vienna, Austria.",karl.kuchler@meduniwien.ac.at,"Sedlazeck, Fritz J/E-4548-2018","Sedlazeck, Fritz J/0000-0001-6040-2691; Kuchler, Karl/0000-0003-2719-5955; Tscherner, Michael/0000-0002-8768-4411; Frohner, Ingrid/0000-0002-0200-449X",Austrian Science Fund [FWF-P-25333]; University of Vienna; Medical University of Vienna; National Institutes of Health [NIH RO1AI46223],"This work was supported by a grant from the Austrian Science Fund (Project FWF-P-25333) to KK, and in part by funds from a joint research cluster of the University of Vienna and the Medical University of Vienna to KK and AvH. NC was supported by the National Institutes of Health (NIH RO1AI46223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,119,16,16,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005218,10.1371/journal.ppat.1005218,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700044,26473952.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,15,23,34,4433,862,651,211,3571,2856,30,685,34,9,0,0,18,18,0,,47,14,47,0,14,21,15,21,8,0,0,0,0,0,0,0,14,9,4547,60,1,72,237,0,3623,879,60,1,72,237,0,45,,0,0,0,0,12,0,0,1,0,0,0,47,0,0,9.2,5.142691415313225,1.2413889666760012,0.24138896667600113,1.356482777933352,1.0927137378750282,5.619489559164733
351,J,"Wang, JW; Jiang, R; Peng, SW; Chang, YN; Hung, CF; Roden, RBS",,,,"Wang, Joshua W.; Jiang, Rosie; Peng, Shiwen; Chang, Yung-Nien; Hung, Chien-Fu; Roden, Richard B. S.",,,Immunologic Control of Mus musculus Papillomavirus Type 1,PLOS PATHOGENS,,,English,Article,,,,,,,QUADRIVALENT VACCINE; PARTICLE VACCINE; CERVICAL-CANCER; NATURAL COURSE; DOUBLE-BLIND; YOUNG-WOMEN; INFECTION; DNA; VIRUS; CLASSIFICATION,"Persistent papillomas developed in similar to 10% of out-bred immune-competent SKH-1 mice following MusPV1 challenge of their tail, and in a similar fraction the papillomas were transient, suggesting potential as a model. However, papillomas only occurred in BALB/c or C57BL/6 mice depleted of T cells with anti-CD3 antibody, and they completely regressed within 8 weeks after depletion was stopped. Neither CD4+ nor CD8+ T cell depletion alone in BALB/c or C57BL/6 mice was sufficient to permit visible papilloma formation. However, low levels of MusPV1 were sporadically detected by either genomic DNA-specific PCR analysis of local skin swabs or in situ hybridization of the challenge site with an E6/E7 probe. After switching to CD3+ T cell depletion, papillomas appeared upon 14/15 of mice that had been CD4+ T cell depleted throughout the challenge phase, 1/15 of CD8+ T cell depleted mice, and none in mice without any prior T cell depletion. Both control animals and those depleted with CD8-specific antibody generated MusPV1 L1 capsid-specific antibodies, but not those depleted with CD4-specific antibody prior to T cell depletion with CD3 antibody. Thus, normal BALB/c or C57BL/6 mice eliminate the challenge dose, whereas infection is suppressed but not completely cleared if their CD4 or CD8 T cells are depleted, and recrudescence of MusPV1 is much greater in the former following treatment with CD3 antibody, possibly reflecting their failure to generate capsid antibody. Systemic vaccination of C57BL/6 mice with DNA vectors expressing MusPV1 E6 or E7 fused to calreticulin elicits potent CD8 T cell responses and these immunodominant CD8 T cell epitopes were mapped. Adoptive transfer of a MusPV1 E6-specific CD8+ T cell line controlled established MusPV1 infection and papilloma in RAG1-knockout mice. These findings suggest the potential of immunotherapy for HPV-related disease and the importance of host immunogenetics in the outcome of infection.","[Wang, Joshua W.; Jiang, Rosie; Peng, Shiwen; Hung, Chien-Fu; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Chang, Yung-Nien] Papivax LLC, Dept Res & Dev, Rockville, MD USA; [Chang, Yung-Nien] Papivax Biotech Inc, Div Immunotherapy, Taipei, Taiwan; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA","Wang, JW (reprint author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.",roden@jhmi.edu,,,"US Public Health Service grants from the National Institute of Allergy and Infectious Disease; National Cancer Institute of the National Institutes of Health [R21AI109259, R43AI112421, R01CA118790, P50CA098252]","Research reported in this publication was supported by US Public Health Service grants (grants.nih.gov) from the National Institute of Allergy and Infectious Disease, and the National Cancer Institute of the National Institutes of Health under awards numbered R21AI109259 to CFH, R43AI112421 to YNC, R01CA118790 to RBSR and P50CA098252 to CFH and RBSR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,54,6,6,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005243,10.1371/journal.ppat.1005243,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700062,26495972.0,"DOAJ Gold, Green Published",,,16/08/2019,18,107,8,3561,805,460,345,2756,2253,17,486,8,1,0,0,20,20,0,,13,6,13,0,6,18,18,18,17,0,0,0,0,0,0,0,106,1,3586,75,0,75,153,0,2749,805,75,0,75,153,0,32,,0,0,0,0,2,0,0,0,0,0,0,13,0,0,1.25,4.42360248447205,1.292089985486212,0.2920899854862119,1.38388969521045,1.0710474585790508,4.737888198757764
352,J,"Watkinson, RE; McEwan, WA; Tam, JCH; Vaysburd, M; James, LC",,,,"Watkinson, Ruth E.; McEwan, William A.; Tam, Jerry C. H.; Vaysburd, Marina; James, Leo C.",,,TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus,PLoS Pathogens,,,English,Article,,,,,,,NF-KAPPA-B; ADENOVIRUS INFECTION; IMMUNE DETECTION; RECEPTOR TRIM21; CYTOSOLIC-DNA; CELLS; RNA; RECOGNITION; ACTIVATION; INTERFERON,"Encapsidation is a strategy almost universally employed by viruses to protect their genomes from degradation and from innate immune sensors. We show that TRIM21, which targets antibody-opsonized virions for proteasomal destruction, circumvents this protection, enabling the rapid detection and degradation of viral genomes before their replication. TRIM21 triggers an initial wave of cytokine transcription that is antibody, rather than pathogen, driven. This early response is augmented by a second transcriptional program, determined by the nature of the infecting virus. In this second response, TRIM21-induced exposure of the viral genome promotes sensing of DNA and RNA viruses by cGAS and RIG-I. This mechanism allows early detection of an infection event and drives an inflammatory response in mice within hours of viral challenge.","[Watkinson, Ruth E.; McEwan, William A.; Tam, Jerry C. H.; Vaysburd, Marina; James, Leo C.] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 2QH, England","Watkinson, RE (reprint author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 2QH, England.",lcj@mrc-lmb.cam.ac.uk,,"Tam, Jerry/0000-0001-7991-1568; McEwan, William/0000-0002-4408-0407; Watkinson, Ruth/0000-0001-6218-6785",Medical Research Council (UK) [U105181010]; European Research Council [281627-IAI]; Medical Research Council [MC_U105181010],"This work was funded by the Medical Research Council (UK; U105181010) and the European Research Council (281627-IAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,39,31,32,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005253,10.1371/journal.ppat.1005253,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700064,26506431.0,"DOAJ Gold, Green Published",,,16/08/2019,30,3,45,6763,1113,756,357,5650,4434,14,1202,45,0,0,0,26,26,0,,61,0,61,0,0,32,32,22,19,0,0,0,0,0,0,0,3,1,6760,62,0,58,83,0,5625,1113,62,0,58,83,0,22,,0,0,0,0,1,0,0,1,0,0,0,65,0,0,0.5,6.076370170709794,1.196991150442478,0.19699115044247786,1.2221238938053098,1.0209965991423924,6.203953279424978
353,J,"Ye, J; Yang, JY; Sun, YW; Zhao, PZ; Gao, SQ; Jung, C; Qu, J; Fang, RX; Chua, NH",,,,"Ye, Jian; Yang, Junyi; Sun, Yanwei; Zhao, Pingzhi; Gao, Shiqiang; Jung, Choonkyun; Qu, Jing; Fang, Rongxiang; Chua, Nam-Hai",,,Geminivirus Activates ASYMMETRIC LEAVES 2 to Accelerate Cytoplasmic DCP2-Mediated mRNA Turnover and Weakens RNA Silencing in Arabidopsis,PLOS PATHOGENS,,,English,Article,,,,,,,P-BODY FORMATION; POSTEMBRYONIC DEVELOPMENT; VIRUS-RESISTANCE; LEAF DEVELOPMENT; VIRAL-INFECTION; PROTEIN; GENE; SUPPRESSOR; PLANTS; SGS3,"Aberrant viral RNAs produced in infected plant cells serve as templates for the synthesis of dsRNAs. The derived virus-related small interfering RNAs (siRNA) mediate cleavage of viral RNAs by post-transcriptional gene silencing (PTGS), thus blocking virus multiplication. Here, we identified ASYMMETRIC LEAVES2 (AS2) as a new component of plant P body complex which mediates mRNA decapping and degradation. We found that AS2 promotes DCP2 decapping activity, accelerates mRNA turnover rate, inhibits siRNA accumulation and functions as an endogenous suppressor of PTGS. Consistent with these findings, as2 mutant plants are resistant to virus infection whereas AS2 over-expression plants are hypersensitive. The geminivirus nuclear shuttle protein BV1 protein, which shuttles between nuclei and cytoplasm, induces AS2 expression, causes nuclear exit of AS2 to activate DCP2 decapping activity and renders infected plants more sensitive to viruses. These principles of gene induction and shuttling of induced proteins to promote mRNA decapping in the cytosol may be used by viral pathogens to weaken antiviral defenses in host plants.","[Ye, Jian; Sun, Yanwei; Gao, Shiqiang; Qu, Jing] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Ye, Jian; Sun, Yanwei; Zhao, Pingzhi; Fang, Rongxiang] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China; [Yang, Junyi; Jung, Choonkyun; Chua, Nam-Hai] Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; [Yang, Junyi] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan","Ye, J (reprint author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.",jianye@im.ac.cn; chua@mail.rockefeller.edu,"Gao, Shiqiang/V-4154-2019","Gao, Shiqiang/0000-0001-6190-9443","Chinese Academy of Sciences [XDB11040300]; Natural Science Foundation of China [NSFC31522046]; Singapore National Research Foundation (CRP Award) [NRF-CRP8-2011-02]; Singapore Millennium Foundation; Cooperative Research Program for Agricultural Science and Technology Development [PJ906910]; Rural Development Administration, Republic of Korea; Temasek Life Sciences Laboratory","The study was supported by the Chinese Academy of Sciences (Strategic Priority Research Program Grant NO. XDB11040300), Natural Science Foundation of China, NSFC31522046 and the Singapore National Research Foundation (CRP Award No. NRF-CRP8-2011-02) to JYe, and by grants from Singapore Millennium Foundation, the Cooperative Research Program for Agricultural Science and Technology Development (PJ906910), Rural Development Administration, Republic of Korea, and funding from Temasek Life Sciences Laboratory to NHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,12,14,0,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005196,10.1371/journal.ppat.1005196,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700032,26431425.0,"DOAJ Gold, Green Published",,,16/08/2019,11,0,39,5150,745,496,249,4405,3355,17,1033,39,0,0,0,11,11,0,,43,0,43,0,0,16,16,6,8,0,0,0,0,0,0,0,0,3,5222,110,0,101,133,0,4450,754,110,0,101,133,0,18,,0,0,0,0,4,0,0,1,0,0,0,47,0,0,1.25,6.912751677852349,1.1691259931895572,0.16912599318955732,1.2406356413166857,1.0611650485436894,7.3355704697986575
354,J,"You, J; O'Hara, SD; Velupillai, P; Castle, S; Levery, S; Garcea, RL; Benjamin, T",,,,"You, John; O'Hara, Samantha D.; Velupillai, Palanivel; Castle, Sherry; Levery, Steven; Garcea, Robert L.; Benjamin, Thomas",,,Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus,PLoS Pathogens,,,English,Article,,,,,,,MURINE POLYOMAVIRUS; TUMOR-INDUCTION; C-FOS; RECEPTOR; VIRUS; INFECTION; MICE; VP1; PROTEINS; BINDING,"Gangliosides serve as receptors for internalization and infection by members of the polyomavirus family. Specificity is determined by recognition of carbohydrate moieties on the ganglioside by the major viral capsid protein VP1. For the mouse polyomavirus (MuPyV), gangliosides with terminal sialic acids in specific linkages are essential. Although many biochemical and cell culture experiments have implicated gangliosides as MuPyV receptions, the role of gangliosides in the MuPyV-infected mouse has not been investigated. Here we report results of studies using ganglioside-deficient mice and derived cell lines. Knockout mice lacking complex gangliosides were completely resistant to the cytolytic and pathogenic effects of the virus. Embryo fibroblasts from these mice were likewise resistant to infection, and supplementation with specific gangliosides restored infectibility. Although lacking receptors for viral infection, cells from ganglioside-deficient mice retained the ability to respond to the virus. Ganglioside-deficient fibroblasts responded rapidly to virus exposure with a transient induction of c-fos as an early manifestation of a mitogenic response. Additionally, splenocytes from ganglioside-deficient mice responded to MuPyV by secretion of IL-12, previously recognized as a key mediator of the innate immune response. Thus, while gangliosides are essential for infection in the animal, gangliosides are not required for mitogenic responses and innate immune responses to the virus.","[You, John; Velupillai, Palanivel; Benjamin, Thomas] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [O'Hara, Samantha D.; Garcea, Robert L.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [O'Hara, Samantha D.; Garcea, Robert L.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Castle, Sherry; Levery, Steven] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA","Garcea, RL (reprint author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.",Robert.garcea@colorado.edu,"Core, BioFrontiers Advanced Light Microscopy/O-6175-2019",,"National Cancer Institute [RO1 CA 082395, RO1 CA 90992, RO1 CA 037667]","This work has been supported by grants to TB from the National Cancer Institute RO1 CA 082395 and RO1 CA 90992 and by grants to RLG from the National Cancer Institute RO1 CA 037667. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,38,9,9,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005175,10.1371/journal.ppat.1005175,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700019,26474471.0,"DOAJ Gold, Green Published",,,16/08/2019,10,10,9,2360,335,239,96,2025,1711,15,299,9,10,0,0,7,7,0,,11,0,11,0,0,10,10,7,8,0,0,0,0,0,0,0,0,4,2387,13,0,33,78,0,2035,341,13,0,33,78,0,11,,0,0,0,0,7,0,0,1,0,0,0,11,0,0,3.35,7.044776119402985,1.165432098765432,0.1654320987654321,1.2237037037037037,1.05,7.397014925373134
355,J,"Zhang, Y; Tam, JW; Mena, P; van der Velden, AWM; Bliska, JB",,,,"Zhang, Yue; Tam, Jason W.; Mena, Patricio; van der Velden, Adrianus W. M.; Bliska, James B.",,,CCR2(+) Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8(+) T Cell Response to the Protective YopE(69-77) Epitope during Yersinia Infection,PLoS Pathogens,,,English,Article,,,,,,,BACTERIAL-INFECTION; IN-VIVO; PSEUDOTUBERCULOSIS INFECTION; LISTERIA-MONOCYTOGENES; EUKARYOTIC CELLS; EFFECTOR YOPE; IMMUNITY; ENTEROCOLITICA; NEUTROPHILS; INTERFERON,"During Yersinia pseudotuberculosis infection of C57BL/6 mice, an exceptionally large CD8(+) T cell response to a protective epitope in the type III secretion system effector YopE is produced. At the peak of the response, up to 50% of splenic CD8(+) T cells recognize the epitope YopE(69-77). The features of the interaction between pathogen and host that result in this large CD8(+) T cell response are unknown. Here, we used Y. pseudotuberculosis strains defective for production, secretion and/or translocation of YopE to infect wild-type ormutantmice deficient in specific dendritic cells (DCs). Bacterial colonization of organs and translocation of YopE into spleen cells was measured, and flow cytometry and tetramer staining were used to characterize the cellular immune response. We show that the splenic YopE(69-77)-specific CD8(+) T cells generated during the large response are polyclonal and are produced by a ""translocation-dependent"" pathway that requires injection of YopE into host cell cytosol. Additionally, a smaller YopE(69-77)-specific CD8(+) T cell response (similar to 10% of the large expansion) can be generated in a ""translocation-independent"" pathway in which CD8 alpha(+) DCs cross present secreted YopE. CCR2-expressing inflammatory DCs were required for the large YopE(69-77)specific CD8(+) T cell expansion because this response was significantly reduced in Ccr2(-/-) mice, YopE was translocated into inflammatory DCs in vivo, inflammatory DCs purified from infected spleens activated YopE(69-77)-specific CD8(+) T cells ex vivo and promoted the expansion of YopE(69-77)-specific CD8(+) T cells in infected Ccr2(-/-) mice after adoptive transfer. A requirement for inflammatory DCs in producing a protective CD8(+) T cell response to a bacterial antigen has not previously been demonstrated. Therefore, the production of YopE(69-77)specific CD8(+) T cells by inflammatory DCs that are injected with YopE during Y. pseudotuberculosis infection represents a novel mechanism for generating a massive and protective adaptive immune response.","[Zhang, Yue] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY USA","Zhang, Y (reprint author), SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA.",james.bliska@stonybrook.edu,,,"National Institutes of Health [R01AI099222, R01AI101221, R21AI092165, P01AI055621, T32AI007539]","This work was supported by grants from the National Institutes of Health awarded to JBB (R01AI099222) and AWMVDV (R01AI101221, R21AI092165 and P01AI055621). JWT was supported by the National Institutes of Health under award number T32AI007539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,46,3,3,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005167,10.1371/journal.ppat.1005167,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700015,26468944.0,"DOAJ Gold, Green Published",,,16/08/2019,4,0,9,2164,346,254,92,1818,1535,11,272,9,0,0,0,3,3,0,,0,0,0,0,0,4,4,4,3,0,0,0,0,0,0,0,0,1,2215,69,0,60,61,0,1828,361,69,0,60,61,0,26,,0,0,0,0,1,0,0,1,0,0,0,13,0,0,1.25,6.254335260115607,1.1903190319031902,0.19031903190319033,1.28987898789879,1.0836414048059149,6.777456647398844
356,J,"Zoltner, M; Leung, KF; Alsford, S; Horn, D; Field, MC",,,,"Zoltner, Martin; Leung, Ka Fai; Alsford, Sam; Horn, David; Field, Mark C.",,,Modulation of the Surface Proteome through Multiple Ubiquitylation Pathways in African Trypanosomes,PLoS Pathogens,,,English,Article,,,,,,,BLOOD-STREAM FORMS; MEDIATED ENDOCYTOSIS; TRANSFERRIN RECEPTOR; BRUCEI-RHODESIENSE; SLEEPING SICKNESS; ESCRT MACHINERY; EXPRESSION; EVOLUTION; COMPLEX; IDENTIFICATION,"Recently we identified multiple suramin-sensitivity genes with a genome wide screen in Trypanosoma brucei that includes the invariant surface glycoprotein ISG75, the adaptin-1 (AP-1) complex and two deubiquitylating enzymes (DUBs) orthologous to ScUbp15/HsHAUSP1 and pVHL-interacting DUB1 (type I), designated TbUsp7 and TbVdu1, respectively. Here we have examined the roles of these genes in trafficking of ISG75, which appears key to suramin uptake. We found that, while AP-1 does not influence ISG75 abundance, knockdown of TbUsp7 or TbVdu1 leads to reduced ISG75 abundance. Silencing TbVdu1 also reduced ISG65 abundance. TbVdu1 is a component of an evolutionarily conserved ubiquitylation switch and responsible for rapid receptor modulation, suggesting similar regulation of ISGs in T. brucei. Unexpectedly, TbUsp7 knockdown also blocked endocytosis. To integrate these observations we analysed the impact of TbUsp7 and TbVdu1 knockdown on the global proteome using SILAC. For TbVdu1, ISG65 and ISG75 are the only significantly modulated proteins, but for TbUsp7 a cohort of integral membrane proteins, including the acid phosphatase MBAP1, that is required for endocytosis, and additional ISG-related proteins are down-regulated. Furthermore, we find increased expression of the ESAG6/7 transferrin receptor and ESAG5, likely resulting from decreased endocytic activity. Therefore, multiple ubiquitylation pathways, with a complex interplay with trafficking pathways, control surface proteome expression in trypanosomes.","[Zoltner, Martin; Horn, David; Field, Mark C.] Univ Dundee, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Leung, Ka Fai] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Alsford, Sam] London Sch Hyg & Trop Med, London WC1, England","Zoltner, M (reprint author), Univ Dundee, Div Biol Chem & Drug Discovery, Dundee, Scotland.",mfield@mac.com,,"Horn, David/0000-0001-5173-9284; Alsford, Sam/0000-0001-8621-4920","Medical Research Council (GB) [MR/K008749/1]; Medical Research Council [MR/K008749/2, MR/K008749/1]","This work was funded by the Medical Research Council (GB) (www.mrc.ac.uk) by grant number MR/K008749/1 to MCF and DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,11,11,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005236,10.1371/journal.ppat.1005236,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700057,26492041.0,"DOAJ Gold, Green Published",,,16/08/2019,13,8,41,3824,514,379,135,3310,2809,18,483,41,1,0,0,10,10,0,,48,0,48,0,0,13,13,10,11,0,0,0,0,0,0,0,7,4,3852,49,0,188,134,1,3306,514,49,0,188,134,1,32,,0,0,0,0,6,0,2,1,0,0,0,48,0,0,3.5,7.439688715953308,1.1552870090634442,0.15528700906344411,1.2190332326283988,1.0551778242677825,7.8501945525291825
357,J,[Anonymous],,,,[Anonymous],,,Expression of Concern: Misregulation of AUXIN RESPONSE FACTOR 8 Underlies the Developmental Abnormalities Caused by Three Distinct Viral Silencing Suppressors in Arabidopsis,PLoS Pathogens,,,English,Editorial Material,,,,,,,,,,,,,,,,,2,0,0,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005234,10.1371/journal.ppat.1005234,,,,1,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700055,26451730.0,"DOAJ Gold, Green Published",,,16/08/2019,0,1,0,2045,217,173,44,1828,1594,9,225,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,2064,0,0,0,7,0,1837,219,0,0,0,7,0,8,,0,0,0,0,3,0,0,0,0,0,0,2,0,0,1.0,9.423963133640553,1.1187089715536105,0.1187089715536105,1.1329321663019694,1.012713936430318,9.543778801843319
358,J,"Akhmetzyanova, I; Drabczyk, M; Neff, CP; Gibbert, K; Dietze, KK; Werner, T; Liu, J; Chen, LP; Lang, KS; Palmer, BE; Dittmer, U; Zelinskyy, G",,,,"Akhmetzyanova, Ilseyar; Drabczyk, Malgorzata; Neff, C. Preston; Gibbert, Kathrin; Dietze, Kirsten K.; Werner, Tanja; Liu, Jia; Chen, Lieping; Lang, Karl S.; Palmer, Brent E.; Dittmer, Ulf; Zelinskyy, Gennadiy",,,PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8(+) T Cell Killing,PLOS PATHOGENS,,,English,Article,,,,,,,CHRONIC VIRAL-INFECTION; MULTIPLE INHIBITORY RECEPTORS; TOLL-LIKE RECEPTOR-3; VIRUS-INFECTION; FRIEND-VIRUS; IN-VIVO; PROGRAMMED-DEATH-1 EXPRESSION; MONOCLONAL-ANTIBODIES; HCV INFECTION; HIV-INFECTION,"Cytotoxic CD8+ T Lymphocytes (CTL) efficiently control acute virus infections but can become exhausted when a chronic infection develops. Signaling of the inhibitory receptor PD-1 is an important mechanism for the development of virus-specific CD8+ T cell dysfunction. However, it has recently been shown that during the initial phase of infection virus-specific CD8+ T cells express high levels of PD-1, but are fully competent in producing cytokines and killing virus-infected target cells. To better understand the role of the PD-1 signaling pathway in CD8+ T cell cytotoxicity during acute viral infections we analyzed the expression of the ligand on retrovirus-infected cells targeted by CTLs. We observed increased levels of PD-L1 expression after infection of cells with the murine Friend retrovirus (FV) or with HIV. In FV infected mice, virus-specific CTLs efficiently eliminated infected target cells that expressed low levels of PD-L1 or that were deficient for PD-L1 but the population of PD-L1high cells escaped elimination and formed a reservoir for chronic FV replication. Infected cells with high PD-L1 expression mediated a negative feedback on CD8+ T cells and inhibited their expansion and cytotoxic functions. These findings provide evidence for a novel immune escape mechanism during acute retroviral infection based on PD-L1 expression levels on virus infected target cells.","[Akhmetzyanova, Ilseyar; Drabczyk, Malgorzata; Gibbert, Kathrin; Dietze, Kirsten K.; Werner, Tanja; Liu, Jia; Dittmer, Ulf; Zelinskyy, Gennadiy] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Neff, C. Preston; Palmer, Brent E.] Univ Colorado, Aurora, CO USA; [Liu, Jia] Huazhong Univ Sci & Technol, Union Hosp, Tonji Med Coll, Dept Infect Dis, Wuhan 430074, Peoples R China; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Lang, Karl S.] Univ Duisburg Essen, Univ Hosp Essen, Inst Immunol, Essen, Germany","Akhmetzyanova, I (reprint author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.",gennadiy.zelinskyy@uni-due.de,"Lang, Karl/R-2505-2016","Sutter, Kathrin/0000-0001-6397-6551; Chen, Lieping/0000-0002-6825-3069","Deutsche Forschungsgemeinschaft [ZE 893/1-1, Transregio 60, DI 1914/1-1]","This work was supported by the Deutsche Forschungsgemeinschaft with grants to GZ (ZE 893/1-1 and Transregio 60, Project B8N), and with a grant to UD (Transregio 60, Project B4), and to KKD (DI 1914/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,31,33,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005224,10.1371/journal.ppat.1005224,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700049,26484769.0,"DOAJ Gold, Green Published",,,16/08/2019,32,0,21,5365,1278,892,386,4087,3205,22,860,21,0,0,0,29,29,0,,30,2,30,0,2,33,33,20,25,0,0,0,0,0,0,0,0,2,5390,11,0,30,126,0,4082,1278,11,0,30,126,0,30,,0,0,0,0,4,0,0,1,0,0,0,30,0,0,2.1,4.197965571205008,1.3126988010765843,0.31269880107658427,1.3523366772693908,1.0301957129543335,4.32472613458529
359,J,"Burrack, KS; Tan, JJL; McCarthy, MK; Her, Z; Berger, JN; Ng, LFP; Morrison, TE",,,,"Burrack, Kristina S.; Tan, Jeslin J. L.; McCarthy, Mary K.; Her, Zhisheng; Berger, Jennifer N.; Ng, Lisa F. P.; Morrison, Thomas E.",,,Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,ROSS-RIVER-VIRUS; L-ARGININE METABOLISM; CHIKUNGUNYA VIRUS; REUNION ISLAND; IN-VIVO; EPIDEMIC POLYARTHRITIS; DOWN-REGULATION; SOUTH-INDIA; MOUSE MODEL; ARGINASE 1,"Arthritogenic alphaviruses, including Ross River virus (RRV) and chikungunya virus (CHIKV), are responsible for explosive epidemics involving millions of cases. These mosquito-transmitted viruses cause inflammation and injury in skeletal muscle and joint tissues that results in debilitating pain. We previously showed that arginase 1 (Arg1) was highly expressed in myeloid cells in the infected and inflamed musculoskeletal tissues of RRV-and CHIKV-infected mice, and specific deletion of Arg1 from myeloid cells resulted in enhanced viral control. Here, we show that Arg1, along with other genes associated with suppressive myeloid cells, is induced in PBMCs isolated from CHIKV-infected patients during the acute phase as well as the chronic phase, and that high Arg1 expression levels were associated with high viral loads and disease severity. Depletion of both CD4 and CD8 T cells from RRV-infected Arg1-deficient mice restored viral loads to levels detected in T cell-depleted wild-type mice. Moreover, Arg1-expressing myeloid cells inhibited virus-specific T cells in the inflamed and infected musculoskeletal tissues, but not lymphoid tissues, following RRV infection in mice, including suppression of interferon-gamma and CD69 expression. Collectively, these data enhance our understanding of the immune response following arthritogenic alphavirus infection and suggest that immunosuppressive myeloid cells may contribute to the duration or severity of these debilitating infections.","[Burrack, Kristina S.; McCarthy, Mary K.; Berger, Jennifer N.; Morrison, Thomas E.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Tan, Jeslin J. L.; Her, Zhisheng; Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore","Morrison, TE (reprint author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.",thomas.morrison@ucdenver.edu,,"Ng, Lisa/0000-0003-4071-5222","National Institutes of Health; NIH-NIAID [R01 AI108725, T32 AI052066]; James S. Porterfield Prize in International Virology; Biomedical Research Council, A*STAR","This research was supported by funds from the National Institutes of Health (http://www.nih.gov/) to TEM. (NIH-NIAID R01 AI108725) and KSB. (NIH-NIAID T32 AI052066), funds from the James S. Porterfield Prize in International Virology (http://www.wsjlab.com/international-virology-prize/) to KSB, and core grants from the Biomedical Research Council, A*STAR to LFPN. The funders had no role in study design, data collection and analyssi, decision to publish, or preparation of the manuscript.",,68,7,7,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005191,10.1371/journal.ppat.1005191,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700028,26436766.0,"DOAJ Gold, Green Published",,,16/08/2019,7,1,29,3672,731,523,208,2941,2519,14,408,29,0,0,0,9,9,0,,25,1,25,0,1,9,8,9,6,0,0,0,0,0,0,0,1,1,3768,57,0,65,307,0,2951,740,57,0,65,307,0,77,,0,0,0,0,2,0,0,1,0,0,0,25,0,0,1.0,5.023255813953488,1.2485549132947977,0.24855491329479767,1.4049642978578716,1.1252723311546842,5.652530779753762
360,J,"Fiebig, M; Kelly, S; Gluenz, E",,,,"Fiebig, Michael; Kelly, Steven; Gluenz, Eva",,,Comparative Life Cycle Transcriptomics Revises Leishmania mexicana Genome Annotation and Links a Chromosome Duplication with Parasitism of Vertebrates,PLOS PATHOGENS,,,English,Article,,,,,,,STAGE-SPECIFIC EXPRESSION; MESSENGER-RNA ABUNDANCE; 3'-UNTRANSLATED REGION; TRYPANOSOMA-BRUCEI; GENE-EXPRESSION; REGULATORY ELEMENT; PROTEOME; DIFFERENTIATION; PROMASTIGOTE; TRANSPORTER,"Leishmania spp. are protozoan parasites that have two principal life cycle stages: the motile promastigote forms that live in the alimentary tract of the sandfly and the amastigote forms, which are adapted to survive and replicate in the harsh conditions of the phagolysosome of mammalian macrophages. Here, we used Illumina sequencing of poly-A selected RNA to characterise and compare the transcriptomes of L. mexicana promastigotes, axenic amastigotes and intracellular amastigotes. These data allowed the production of the first transcriptome evidence-based annotation of gene models for this species, including genome-wide mapping of trans-splice sites and poly-A addition sites. The revised genome annotation encompassed 9,169 protein-coding genes including 936 novel genes as well as modifications to previously existing gene models. Comparative analysis of gene expression across promastigote and amastigote forms revealed that 3,832 genes are differentially expressed between promastigotes and intracellular amastigotes. A large proportion of genes that were downregulated during differentiation to amastigotes were associated with the function of the motile flagellum. In contrast, those genes that were upregulated included cell surface proteins, transporters, peptidases and many uncharacterized genes, including 293 of the 936 novel genes. Genome-wide distribution analysis of the differentially expressed genes revealed that the tetraploid chromosome 30 is highly enriched for genes that were upregulated in amastigotes, providing the first evidence of a link between this whole chromosome duplication event and adaptation to the vertebrate host in this group. Peptide evidence for 42 proteins encoded by novel transcripts supports the idea of an as yet uncharacterised set of small proteins in Leishmania spp. with possible implications for host-pathogen interactions.","[Fiebig, Michael; Gluenz, Eva] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford, England","Kelly, S (reprint author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford, England.",steven.kelly@plants.ox.ac.uk; eva.gluenz@path.ox.ac.uk,,"Gluenz, Eva/0000-0003-4346-8896",Wellcome Trust [092870/Z/10/Z]; Leverhulme Trust; Queen's College Oxford,"MF was supported by a Wellcome Trust (studentship (092870/Z/10/Z). SK was supported by a Leverhulme Trust Early Career Fellowship and the Queen's College Oxford. EG is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,92,33,33,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005186,10.1371/journal.ppat.1005186,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700024,26452044.0,"DOAJ Gold, Green Published",,,16/08/2019,34,19,57,5721,1185,938,247,4536,3723,24,789,57,11,0,0,33,33,0,,80,0,79,1,0,36,36,22,22,0,0,0,0,0,0,0,8,10,5812,343,0,103,224,2,4583,1202,343,0,103,224,2,27,,0,0,0,0,13,0,1,1,0,0,0,79,1,0,6.2,4.827848101265823,1.2612433862433863,0.2612433862433862,1.406305114638448,1.1150148575423877,5.383122362869198
361,J,"Field, KA; Johnson, JS; Lilley, TM; Reeder, SM; Rogers, EJ; Behr, MJ; Reeder, DM",,,,"Field, Kenneth A.; Johnson, Joseph S.; Lilley, Thomas M.; Reeder, Sophia M.; Rogers, Elizabeth J.; Behr, Melissa J.; Reeder, DeeAnn M.",,,The White-Nose Syndrome Transcriptome: Activation of Anti-fungal Host Responses in Wing Tissue of Hibernating Little Brown Myotis,PLOS PATHOGENS,,,English,Article,,,,,,,RNA-SEQ; PSEUDOGYMNOASCUS-DESTRUCTANS; IMMUNE-SYSTEM; CANDIDA-ALBICANS; GROUND-SQUIRRELS; TH17 CELLS; BATS; RECOGNITION; DEFENSE; RECEPTOR,"White-nose syndrome (WNS) in North American bats is caused by an invasive cutaneous infection by the psychrophilic fungus Pseudogymnoascus destructans (Pd). We compared transcriptome-wide changes in gene expression using RNA-Seq on wing skin tissue from hibernating little brown myotis (Myotis lucifugus) with WNS to bats without Pd exposure. We found that WNS caused significant changes in gene expression in hibernating bats including pathways involved in inflammation, wound healing, and metabolism. Local acute inflammatory responses were initiated by fungal invasion. Gene expression was increased for inflammatory cytokines, including interleukins (IL) IL-1 beta, IL-6, IL-17C, IL-20, IL-23A, IL-24, and G-CSF and chemokines, such as Ccl2 and Ccl20. This pattern of gene expression changes demonstrates that WNS is accompanied by an innate anti-fungal host response similar to that caused by cutaneous Candida albicans infections. However, despite the apparent production of appropriate chemokines, immune cells such as neutrophils and T cells do not appear to be recruited. We observed upregulation of acute inflammatory genes, including prostaglandin G/H synthase 2 (cyclooxygenase-2), that generate eicosanoids and other nociception mediators. We also observed differences in Pd gene expression that suggest host-pathogen interactions that might determine WNS progression. We identified several classes of potential virulence factors that are expressed in Pd during WNS, including secreted proteases that may mediate tissue invasion. These results demonstrate that hibernation does not prevent a local inflammatory response to Pd infection but that recruitment of leukocytes to the site of infection does not occur. The putative virulence factors may provide novel targets for treatment or prevention of WNS. These observations support a dual role for inflammation during WNS; inflammatory responses provide protection but excessive inflammation may contribute to mortality, either by affecting torpor behavior or causing damage upon emergence in the spring.","[Field, Kenneth A.; Johnson, Joseph S.; Lilley, Thomas M.; Reeder, Sophia M.; Rogers, Elizabeth J.; Reeder, DeeAnn M.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Behr, Melissa J.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA","Field, KA (reprint author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.",kfield@bucknell.edu,"Reeder, Sophia/N-9237-2016; Lilley, Thomas/F-2236-2015","Reeder, Sophia/0000-0003-4027-4252; Field, Kenneth/0000-0001-7417-4386; Lilley, Thomas/0000-0001-5864-4958; Reeder, DeeAnn/0000-0001-8651-2012","United States Fish and Wildlife Service [F12AP01210, F14AP00739]; Woodtiger Fund; Bucknell University","This work was supported by the United States Fish and Wildlife Service grants F12AP01210 to DMR, F14AP00739 to DMR and KAF, and also the Woodtiger Fund to DMR and KAF and Bucknell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,110,33,35,1,79,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005168,10.1371/journal.ppat.1005168,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700016,26426272.0,"DOAJ Gold, Green Published",,,16/08/2019,39,306,76,8709,801,596,205,7908,6801,32,1075,75,14,0,0,37,37,9,,110,19,109,1,19,42,39,42,21,0,0,1,0,0,1,2,292,13,8963,132,26,510,610,8,7886,801,132,26,510,609,8,276,,5,1,0,0,39,0,2,1,0,0,0,107,1,0,72.63,10.872659176029963,1.1012898330804248,0.10128983308042488,1.227238239757208,1.1143644505683776,12.116104868913858
362,J,"Freund, NT; Horwitz, JA; Nogueira, L; Sievers, SA; Scharf, L; Scheid, JF; Gazumyan, A; Liu, C; Velinzon, K; Goldenthal, A; Sanders, RW; Moore, JP; Bjorkman, PJ; Seaman, MS; Walker, BD; Klein, F; Nussenzweig, MC",,,,"Freund, Natalia T.; Horwitz, Joshua A.; Nogueira, Lilian; Sievers, Stuart A.; Scharf, Louise; Scheid, Johannes F.; Gazumyan, Anna; Liu, Cassie; Velinzon, Klara; Goldenthal, Ariel; Sanders, Rogier W.; Moore, John P.; Bjorkman, Pamela J.; Seaman, Michael S.; Walker, Bruce D.; Klein, Florian; Nussenzweig, Michel C.",,,A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; B-CELLS; BROAD; RECOGNITION; EPITOPE; EXPRESSION; EVOLUTION; INFECTION; REVEALS,"The CD4 binding site (CD4bs) on the envelope glycoprotein is a major site of vulnerability that is conserved among different HIV-1 isolates. Many broadly neutralizing antibodies (bNAbs) to the CD4bs belong to the VRC01 class, sharing highly restricted origins, recognition mechanisms and viral escape pathways. We sought to isolate new anti-CD4bs bNAbs with different origins and mechanisms of action. Using a gp120 2CC core as bait, we isolated antibodies encoded by IGVH3-21 and IGVL3-1 genes with long CDRH3s that depend on the presence of the N-linked glycan at position-276 for activity. This binding mode is similar to the previously identified antibody HJ16, however the new antibodies identified herein are more potent and broad. The most potent variant, 179NC75, had a geometric mean IC80 value of 0.42 mu g/ml against 120 Tier-2 HIV-1 pseudoviruses in the TZM.bl assay. Although this group of CD4bs glycan-dependent antibodies can be broadly and potently neutralizing in vitro, their in vivo activity has not been tested to date. Here, we report that 179NC75 is highly active when administered to HIV-1-infected humanized mice, where it selects for escape variants that lack a glycan site at position-276. The same glycan was absent from the virus isolated from the 179NC75 donor, implying that the antibody also exerts selection pressure in humans.","[Freund, Natalia T.; Horwitz, Joshua A.; Nogueira, Lilian; Scheid, Johannes F.; Gazumyan, Anna; Liu, Cassie; Velinzon, Klara; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Sievers, Stuart A.; Scharf, Louise; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Goldenthal, Ariel; Walker, Bruce D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Walker, Bruce D.; Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Klein, Florian] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Klein, Florian] Univ Cologne, CMMC, Cologne, Germany","Freund, NT (reprint author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.",nfreund@rockefeller.edu,,,"Rockefeller University; National Institutes of Health HIVRAD [1 P01 AI100148, AI110657]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grant [OPP1032144]; CA HIV/AIDS research program [CHRP F12-CT-214]","This research was supported by The Rockefeller University, by National Institutes of Health HIVRAD Grants 1 P01 AI100148 (to MCN and PJB) and AI110657 (JPM RWS) and by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grant OPP1032144 (MSS). SAS was supported by a postdoctoral fellowship from the CA HIV/AIDS research program (CHRP F12-CT-214). MCN and BDW are Howard Hughes Medical Institute investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,24,24,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005238,10.1371/journal.ppat.1005238,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700059,26516768.0,"DOAJ Gold, Green Published",,,16/08/2019,23,2,29,5618,837,630,207,4781,3924,29,828,29,0,0,0,22,22,0,,33,2,33,0,2,24,23,24,18,0,0,0,0,0,0,0,2,2,5637,66,0,56,267,2,4772,837,66,0,56,267,2,28,,0,0,0,0,7,0,0,1,0,0,0,33,0,0,3.75,6.712066905615293,1.1750679774105837,0.17506797741058355,1.2486927421041623,1.0626557493770026,7.132616487455197
363,J,"Lee, A; Park, SP; Park, CH; Kang, BH; Park, SH; Ha, SJ; Jung, KC",,,,"Lee, Ara; Park, Seung Pyo; Park, Chan Hee; Kang, Byung Hyun; Park, Seong Hoe; Ha, Sang-Jun; Jung, Kyeong Cheon",,,IL-4 Induced Innate CD8(+) T Cells Control Persistent Viral Infection,PLOS PATHOGENS,,,English,Article,,,,,,,THYMOCYTE-THYMOCYTE INTERACTION; SIGNALING PATHWAY; ZINC-FINGER; MICE; EXPRESSION; SELECTION; EXHAUSTION; RECEPTORS; LINEAGES; THERAPY,"Memory-like CD8(+) T cells expressing eomesodermin are a subset of innate T cells initially identified in a number of genetically modified mice, and also exist in wild mice and human. The acquisition of memory phenotype and function by these T cells is dependent on IL-4 produced by PLZF(+) innate T cells; however, their physiologic function is still not known. Here we found that these IL-4-induced innate CD8(+) T cells are critical for accelerating the control of chronic virus infection. In CIITA-transgenic mice, which have a substantial population of IL-4-induced innate CD8(+) T cells, this population facilitated rapid control of viremia and induction of functional anti-viral T-cell responses during infection with chronic form of lymphocytic choriomeningitis virus. Characteristically, anti-viral innate CD8(+) T cells accumulated sufficiently during early phase of infection. They produced a robust amount of IFN-gamma and TNF-alpha with enhanced expression of a degranulation marker. Furthermore, this finding was confirmed in wild-type mice. Taken together, the results from our study show that innate CD8(+) T cells works as an early defense mechanism against chronic viral infection.","[Lee, Ara; Park, Chan Hee; Ha, Sang-Jun] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Park, Seung Pyo; Park, Seong Hoe; Jung, Kyeong Cheon] Seoul Natl Univ, Coll Med, Med Res Ctr, Transplantat Res Inst, Seoul, South Korea; [Kang, Byung Hyun; Park, Seong Hoe; Jung, Kyeong Cheon] Seoul Natl Univ, Coll Med, Grad Sch Translat Med, Seoul, South Korea; [Jung, Kyeong Cheon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea","Ha, SJ (reprint author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.",sjha@yonsei.ac.kr; jungkc66@snu.ac.kr,,,"National Research Foundation (NRF) of Korea [2012M3A9A8053249]; Research Resettlement Fund for the New Faculty of Seoul National University; Basic Science and Research Program of the National Research Foundation of Korea (NRF) - Korea government (MEST) [2013R1A1A2010389]; Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Korea government (MEST) [2012M3A9B4028264]; Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI14C2680]","This work was partly supported by grants from the National Research Foundation (NRF) of Korea (2012M3A9A8053249 to SHP and KCJ). This work was also supported by the Research Resettlement Fund for the New Faculty of Seoul National University in 2013 (to KCJ), the Basic Science and Research Program (2013R1A1A2010389 to SJH) and Bio & Medical Technology Development Program (2012M3A9B4028264 to SJH) of the National Research Foundation of Korea (NRF) funded by the Korea government (MEST), and a grant from the Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (HI14C2680 to SJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,44,15,15,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005193,10.1371/journal.ppat.1005193,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700029,26452143.0,"DOAJ Gold, Green Published",,,16/08/2019,14,7,15,3770,489,352,137,3281,2725,13,543,15,1,0,0,14,14,0,,21,0,21,0,0,15,15,11,10,0,0,0,0,0,0,0,6,1,3788,35,0,39,78,0,3277,489,35,0,39,78,0,22,,0,0,0,0,2,0,0,1,0,0,0,21,0,0,1.5,7.70961145194274,1.1490399268515696,0.14903992685156964,1.188966778421213,1.0347480106100795,7.977505112474438
364,J,"Lee, MJ; Liu, H; Barker, BM; Snarr, BD; Gravelat, FN; Al Abdallah, Q; Gavino, C; Baistrocchi, SR; Ostapska, H; Xiao, TL; Ralph, B; Solis, NV; Lehoux, M; Baptista, SD; Thammahong, A; Cerone, RP; Kaminskyj, SGW; Guiot, MC; Latge, JP; Fontaine, T; Vinh, DC; Filler, SG; Sheppard, DC",,,,"Lee, Mark J.; Liu, Hong; Barker, Bridget M.; Snarr, Brendan D.; Gravelat, Fabrice N.; Al Abdallah, Qusai; Gavino, Christina; Baistrocchi, Shane R.; Ostapska, Hanna; Xiao, Tianli; Ralph, Benjamin; Solis, Norma V.; Lehoux, Melanie; Baptista, Stefanie D.; Thammahong, Arsa; Cerone, Robert P.; Kaminskyj, Susan G. W.; Guiot, Marie-Christine; Latge, Jean-Paul; Fontaine, Thierry; Vinh, Donald C.; Filler, Scott G.; Sheppard, Donald C.",,,The Fungal Exopolysaccharide Galactosaminogalactan Mediates Virulence by Enhancing Resistance to Neutrophil Extracellular Traps,PLoS Pathogens,,,English,Article,,,,,,,CHRONIC GRANULOMATOUS-DISEASE; ASPERGILLUS-FUMIGATUS; NIDULANS; PATHOGEN; MACROPHAGES; INFECTIONS; GOVERNS; NIGER,"Of the over 250 Aspergillus species, Aspergillus fumigatus accounts for up to 80% of invasive human infections. A. fumigatus produces galactosaminogalactan (GAG), an exopolysaccharide composed of galactose and N-acetyl-galactosamine (GalNAc) that mediates adherence and is required for full virulence. Less pathogenic Aspergillus species were found to produce GAG with a lower GalNAc content than A. fumigatus and expressed minimal amounts of cell wall-bound GAG. Increasing the GalNAc content of GAG of the minimally pathogenic A. nidulans, either through overexpression of the A. nidulans epimerase UgeB or by heterologous expression of the A. fumigatus epimerase Uge3 increased the amount of cell wall bound GAG, augmented adherence in vitro and enhanced virulence in corticosteroid-treated mice to levels similar to A. fumigatus. The enhanced virulence of the overexpression strain of A. nidulans was associated with increased resistance to NADPH oxidase-dependent neutrophil extracellular traps (NETs) in vitro, and was not observed in neutropenic mice or mice deficient in NADPH-oxidase that are unable to form NETs. Collectively, these data suggest that cell wall-bound GAG enhances virulence through mediating resistance to NETs.","[Lee, Mark J.; Snarr, Brendan D.; Gravelat, Fabrice N.; Al Abdallah, Qusai; Baistrocchi, Shane R.; Ostapska, Hanna; Xiao, Tianli; Ralph, Benjamin; Lehoux, Melanie; Baptista, Stefanie D.; Cerone, Robert P.; Sheppard, Donald C.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Liu, Hong; Solis, Norma V.; Filler, Scott G.] Univ Calif Los Angeles, LA Biomed Res Inst Harbor, Div Infect Dis, Torrance, CA USA; [Barker, Bridget M.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Gavino, Christina; Vinh, Donald C.] McGill Univ, Ctr Hlth, Infect Dis Susceptibil Program, Montreal, PQ, Canada; [Thammahong, Arsa] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA; [Kaminskyj, Susan G. W.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Guiot, Marie-Christine] Montreal Neurol Hosp, Dept Pathol, Montreal, PQ, Canada; [Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Aspergillus Unit, Paris, France; [Filler, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sheppard, Donald C.] McGill Univ, Dept Med, Montreal, PQ, Canada","Sheppard, DC (reprint author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.",don.sheppard@mcgill.ca,"Sheppard, Donald/B-4637-2008; Fontaine, thierry/Q-2201-2018; Barker, Bridget/H-7351-2019","Sheppard, Donald/0000-0001-8877-880X; Fontaine, thierry/0000-0002-8184-789X; Xiao, Tianli/0000-0003-4508-3973; Barker, Bridget/0000-0002-3439-4517; VINH, DONALD/0000-0003-1347-7767","Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research; National Institutes of Health, USA [R01AI073829]; Fonds de recherche du Quebec-Sante; Research Institute of the McGill University Health Center","This work was supported in part by Operating funds from the Canadian Cystic Fibrosis Foundation, the Canadian Institutes of Health Research, and grant R01AI073829 from the National Institutes of Health, USA. DCS was supported by a Chercheur-Boursier award from the Fonds de recherche du Quebec-Sante. MJL was supported by a studentship from the Research Institute of the McGill University Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,52,56,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005187,10.1371/journal.ppat.1005187,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700025,26492565.0,"DOAJ Gold, Green Published",,,16/08/2019,41,16,47,6775,1085,775,310,5690,4745,17,928,47,12,0,0,48,48,4,,149,0,76,0,0,54,42,54,31,0,0,0,0,0,0,3,4,10,6872,37,11,74,151,0,5749,1099,36,11,74,151,0,24,,4,0,0,0,19,0,1,1,0,0,0,76,0,0,45.2,6.244239631336406,1.1906854130052724,0.19068541300527242,1.2407732864674867,1.0420664206642067,6.506912442396313
365,J,"Smout, MJ; Sotillo, J; Laha, T; Papatpremsiri, A; Rinaldi, G; Pimenta, RN; Chan, LY; Johnson, MS; Turnbull, L; Whitchurch, CB; Giacomin, PR; Moran, CS; Golledge, J; Daly, N; Sripa, B; Mulvenna, JP; Brindley, PJ; Loukas, A",,,,"Smout, Michael J.; Sotillo, Javier; Laha, Thewarach; Papatpremsiri, Atiroch; Rinaldi, Gabriel; Pimenta, Rafael N.; Chan, Lai Yue; Johnson, Michael S.; Turnbull, Lynne; Whitchurch, Cynthia B.; Giacomin, Paul R.; Moran, Corey S.; Golledge, Jonathan; Daly, Norelle; Sripa, Banchob; Mulvenna, Jason P.; Brindley, Paul J.; Loukas, Alex",,,Carcinogenic Parasite Secretes Growth Factor That Accelerates Wound Healing and Potentially Promotes Neoplasia,PLOS PATHOGENS,,,English,Article,,,,,,,GRANULIN-EPITHELIN PRECURSOR; LIVER FLUKE; OPISTHORCHIS-VIVERRINI; STATISTICAL-MODEL; PROTEIN; CANCER; PROGRANULIN; RECEPTORS; CHOLANGIOCARCINOMA; PROLIFERATION,"Infection with the human liver fluke Opisthorchis viverrini induces cancer of the bile ducts, cholangiocarcinoma (CCA). Injury from feeding activities of this parasite within the human biliary tree causes extensive lesions, wounds that undergo protracted cycles of healing, and re-injury over years of chronic infection. We show that O. viverrini secreted proteins accelerated wound resolution in human cholangiocytes, an outcome that was compromised following silencing of expression of the fluke-derived gene encoding the granulin-like growth factor, Ov-GRN-1. Recombinant Ov-GRN-1 induced angiogenesis and accelerated mouse wound healing. Ov-GRN-1 was internalized by human cholangiocytes and induced gene and protein expression changes associated with wound healing and cancer pathways. Given the notable but seemingly paradoxical properties of liver fluke granulin in promoting not only wound healing but also a carcinogenic microenvironment, Ov-GRN-1 likely holds marked potential as a therapeutic wound-healing agent and as a vaccine against an infection-induced cancer of major public health significance in the developing world.","[Smout, Michael J.; Sotillo, Javier; Giacomin, Paul R.; Daly, Norelle; Loukas, Alex] James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia; [Laha, Thewarach; Papatpremsiri, Atiroch] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen 40002, Thailand; [Rinaldi, Gabriel; Pimenta, Rafael N.; Brindley, Paul J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Rinaldi, Gabriel; Pimenta, Rafael N.; Brindley, Paul J.] George Washington Univ, Res Ctr Neglected Dis Poverty, Washington, DC USA; [Chan, Lai Yue] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Johnson, Michael S.; Turnbull, Lynne; Whitchurch, Cynthia B.] Univ Technol Sydney, Microbial Imaging Facil, IThree Inst, Ultimo, NSW, Australia; [Moran, Corey S.; Golledge, Jonathan] James Cook Univ, Australian Inst Trop Hlth & Med, Queensland Res Ctr Peripheral Vasc Dis, Cairns, Qld, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Sripa, Banchob] Khon Kaen Univ, Dept Pathol, Khon Kaen, Thailand; [Mulvenna, Jason P.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia","Loukas, A (reprint author), James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia.",Alex.Loukas@jcu.edu.au,"CHAN, LAI YUE/C-6489-2014; Sotillo, Javier/B-7354-2014; golledge, jonathan/I-2371-2013; Daly, Norelle/D-4302-2013; Whitchurch, Cynthia/A-5954-2008; Loukas, Alex/B-7355-2014","CHAN, LAI YUE/0000-0002-9346-2487; Sotillo, Javier/0000-0002-1443-7233; Daly, Norelle/0000-0002-4697-6602; Whitchurch, Cynthia/0000-0003-2296-3791; Loukas, Alex/0000-0002-0896-8441; Turnbull, Lynne/0000-0002-9255-9033; Smout, Michael/0000-0001-6937-0112; Brindley, Paul/0000-0003-1765-0002","National Cancer Institute [R01CA164719]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [P50AI098639]; National Health and Medical Research Council; Queensland Government","This research was supported by awards R01CA164719 from the National Cancer Institute and P50AI098639 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Fellowship support was provided to AL, JPM and CBW from The National Health and Medical Research Council and to JG from the Queensland Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,71,34,34,1,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005209,10.1371/journal.ppat.1005209,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700040,26485648.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,35,42,34,6874,1403,1066,337,5471,4633,23,815,34,16,1,0,29,29,3,,87,8,41,0,8,35,35,25,21,0,0,0,0,0,0,1,31,24,6951,121,2,84,211,2,5490,1419,57,2,84,193,2,42,,4,3,0,0,36,0,0,1,0,0,0,40,0,0,73.434,4.899501069137562,1.2564430634253336,0.2564430634253336,1.3312008773533175,1.0594995635728832,5.191019244476123
366,J,"Soni, V; Upadhayay, S; Suryadevara, P; Samla, G; Singh, A; Yogeeswari, P; Sriram, D; Nandicoori, VK",,,,"Soni, Vijay; Upadhayay, Sandeep; Suryadevara, Priyanka; Samla, Ganesh; Singh, Archana; Yogeeswari, Perumal; Sriram, Dharmarajan; Nandicoori, Vinay Kumar",,,Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen,PLOS PATHOGENS,,,English,Article,,,,,,,SYNTHETIC ENZYME GLMU; MYCOBACTERIUM-TUBERCULOSIS; CELL-WALL; GENE-EXPRESSION; IN-VITRO; ACETYLTRANSFERASE ACTIVITY; BIOSYNTHESIS; ARABINOGALACTAN; URIDYLTRANSFERASE; INHIBITORS,"M. tuberculosis N-acetyl-glucosamine-1-phosphate uridyltransferase (GlmU(Mtb)) is a bifunctional enzyme engaged in the synthesis of two metabolic intermediates N-acetylglucosamine-1-phosphate (GlcNAc-1-P) and UDP-GlcNAc, catalyzed by the C- and N-terminal domains respectively. UDP-GlcNAc is a key metabolite essential for the synthesis of peptidoglycan, disaccharide linker, arabinogalactan and mycothiols. While glmU(Mtb) was predicted to be an essential gene, till date the role of GlmU(Mtb) in modulating the in vitro growth of Mtb or its role in survival of pathogen ex vivo / in vivo have not been deciphered. Here we present the results of a comprehensive study dissecting the role of GlmU(Mtb) in arbitrating the survival of the pathogen both in vitro and in vivo. We find that absence of GlmU(Mtb) leads to extensive perturbation of bacterial morphology and substantial reduction in cell wall thickness under normoxic as well as hypoxic conditions. Complementation studies show that the acetyl-and uridyl-transferase activities of GlmU(Mtb) are independently essential for bacterial survival in vitro, and GlmU(Mtb) is also found to be essential for mycobacterial survival in THP-1 cells as well as in guinea pigs. Depletion of GlmU(Mtb) from infected murine lungs, four weeks post infection, led to significant reduction in the bacillary load. The administration of Oxa33, a novel oxazolidine derivative that specifically inhibits GlmU(Mtb), to infected mice resulted in significant decrease in the bacillary load. Thus our study establishes GlmU(Mtb) as a strong candidate for intervention measures against established tuberculosis infections.","[Soni, Vijay; Upadhayay, Sandeep; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Soni, Vijay; Suryadevara, Priyanka; Samla, Ganesh; Yogeeswari, Perumal; Sriram, Dharmarajan] Birla Inst Technol & Sci Pilani, Dept Pharm, Hyderabad, Andhra Pradesh, India; [Singh, Archana] CSIR Inst Genom & Integrat Biol, New Delhi, India","Soni, V (reprint author), Natl Inst Immunol, New Delhi 110067, India.",vinaykn@nii.ac.in,,"Nandicoori, Vinay/0000-0002-5682-4178; SONI, VIJAY/0000-0002-3395-7429","Open Source Drug Discovery, CSIR [OSDD/HCP0001/12FYP/2012-13/FIN/2407]; Department of Biotechnology, India [BT/PR13047/Med/29/148/2009]; CSIR; INSPIRE Dept of Science and technology India [IFA12-LSBM-35]","VKN received funding from Open Source Drug Discovery, CSIR OSDD/HCP0001/12FYP/2012-13/FIN/2407 and Department of Biotechnology, India BT/PR13047/Med/29/148/2009. DS received funding from Open Source Drug Discovery, CSIR OSDD/HCP0001/12FYP/2012-13/FIN/2407. VS received Senior Research Fellowship from Open Source Drug Discovery, CSIR. SU and GS are Senior Research Fellows funded by the CSIR. PS is an INSPIRE Senior Research Fellow of the Department of Science and Technology. AS is supported by INSPIRE faculty grant IFA12-LSBM-35, from Dept of Science and technology India. The funders had no role in the study designed, data collection, analysis, decision to publish or preparation of the manuscript.",,79,11,11,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005235,10.1371/journal.ppat.1005235,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700056,26489015.0,"DOAJ Gold, Green Published",,,16/08/2019,11,17,17,4916,532,376,156,4384,3514,13,857,17,15,0,0,12,12,0,,24,1,24,0,1,13,11,13,7,0,0,0,0,0,0,0,2,7,4970,95,0,68,300,0,4397,538,95,0,68,300,0,35,,0,0,0,0,13,0,0,1,0,0,0,24,0,0,7.35,9.240601503759398,1.1213503649635037,0.12135036496350365,1.2237682481751824,1.0913344182262001,10.084586466165414
367,J,"Tafesse, FG; Rashidfarrokhi, A; Schmidt, FI; Freinkman, E; Dougan, S; Dougan, M; Esteban, A; Maruyama, T; Strijbis, K; Ploegh, HL",,,,"Tafesse, Fikadu G.; Rashidfarrokhi, Ali; Schmidt, Florian I.; Freinkman, Elizaveta; Dougan, Stephanie; Dougan, Michael; Esteban, Alexandre; Maruyama, Takeshi; Strijbis, Karin; Ploegh, Hidde L.",,,Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans,PLoS Pathogens,,,English,Article,,,,,,,RECEPTOR-MEDIATED PHAGOCYTOSIS; SERINE PALMITOYLTRANSFERASE; LIPID RAFTS; VIRUS ENTRY; PHOSPHATIDYLINOSITOL 3-KINASE; ACID SPHINGOMYELINASE; CELL-MEMBRANES; CERAMIDE; DECTIN-1; ACTIN,"The ability of phagocytes to clear pathogens is an essential attribute of the innate immune response. The role of signaling lipid molecules such as phosphoinositides is well established, but the role of membrane sphingolipids in phagocytosis is largely unknown. Using a genetic approach and small molecule inhibitors, we show that phagocytosis of Candida albicans requires an intact sphingolipid biosynthetic pathway. Blockade of serine-palmitoyltransferase (SPT) and ceramide synthase-enzymes involved in sphingolipid biosynthesisby myriocin and fumonisin B1, respectively, impaired phagocytosis by phagocytes. We used CRISPR/Cas9-mediated genome editing to generate Sptlc2-deficient DC2.4 dendritic cells, which lack serine palmitoyl transferase activity. Sptlc2-/-DC2.4 cells exhibited a stark defect in phagocytosis, were unable to bind fungal particles and failed to form a normal phagocytic cup to engulf C. albicans. Supplementing the growth media with GM1, the major ganglioside present at the cell surface, restored phagocytic activity of Sptlc2-/-DC2.4 cells. While overall membrane trafficking and endocytic pathways remained functional, Sptlc2(-/-) DC2.4 cells express reduced levels of the pattern recognition receptors Dectin-1 and TLR2 at the cell surface. Consistent with the in vitro data, compromised sphingolipid biosynthesis in mice sensitizes the animal to C. albicans infection. Sphingolipid biosynthesis is therefore critical for phagocytosis and in vivo clearance of C. albicans.","[Tafesse, Fikadu G.; Rashidfarrokhi, Ali; Schmidt, Florian I.; Freinkman, Elizaveta; Dougan, Stephanie; Dougan, Michael; Esteban, Alexandre; Maruyama, Takeshi; Strijbis, Karin; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tafesse, Fikadu G.; Rashidfarrokhi, Ali; Schmidt, Florian I.; Freinkman, Elizaveta; Dougan, Stephanie; Dougan, Michael; Esteban, Alexandre; Maruyama, Takeshi; Strijbis, Karin; Ploegh, Hidde L.] MIT, Cambridge, MA 02139 USA; [Tafesse, Fikadu G.; Rashidfarrokhi, Ali] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA","Tafesse, FG (reprint author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.",tafesse@wi.mit.edu,"Schmidt, Florian/H-7372-2012; Schmidt, Florian Ingo/J-1672-2019; Esteban, Alexandre/H-5629-2015","Schmidt, Florian/0000-0002-9979-9769; Schmidt, Florian Ingo/0000-0002-9979-9769; Strijbis, Karin/0000-0001-9167-7137; Esteban, Alexandre/0000-0002-7448-4314; Maruyama, Takeshi/0000-0003-0331-4702",Netherlands Organization for Scientific Research; National Institute of Health [AI087879]; Swiss National Science Foundation (SNSF),"This work was funded by The Netherlands Organization for Scientific Research (FGT), and the National Institute of Health grant AI087879 (HLP). FIS was supported by an Advanced Postdoc. Mobility Fellowship from the Swiss National Science Foundation (SNSF) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,90,14,15,1,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005188,10.1371/journal.ppat.1005188,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700026,26431038.0,"DOAJ Gold, Green Published",,,16/08/2019,14,1,45,7907,1359,928,431,6548,5319,17,1212,45,1,3,0,12,12,0,,68,7,68,0,7,14,14,9,8,0,0,0,0,0,0,0,8,5,7910,74,0,120,243,0,6523,1359,74,0,120,243,0,28,,0,0,1,0,5,0,0,1,0,0,0,69,0,0,6.75,5.818248712288447,1.2075442883323153,0.20754428833231522,1.256414172266341,1.0404704692045024,6.053715967623252
368,J,"Teixeira, PJPL; Thomazella, DPD; Pereira, GAG",,,,"Teixeira, Paulo Jose Pereira Lima; Thomazella, Daniela Paula de Toledo; Guimaraes Pereira, Goncalo Amarante",,,Time for Chocolate: Current Understanding and New Perspectives on Cacao Witches' Broom Disease Research,PLOS PATHOGENS,,,English,Article,,,,,,,PATHOGEN MONILIOPHTHORA-PERNICIOSA; CRINIPELLIS-PERNICIOSA; THEOBROMA-CACAO; CAUSAL AGENT; COCOA; DIVERSITY; BIOTYPES; OXIDASE; BIOLOGY; L.,"Theobroma cacao is a tropical understory tree that is one of the most important perennial crops in agriculture. Treasured by ancient civilizations in Mesoamerica for over 3,000 years, the cocoa bean now supports a multibillion-dollar industry that is involved in the production and commercialization of chocolate, a treat appreciated worldwide. The cacao tree is originally from the Amazon rainforest and is currently grown in more than 50 countries throughout the humid tropics, serving as a major source of income for over 40 million people. Each year, more than 3 million tons of cocoa beans are produced, mostly by smallholder farmers in areas of high biodiversity. Notably, the cacao tree does not require direct sunlight and naturally grows under the canopy of other, taller trees. This characteristic often encourages farmers to preserve existing forests and to plant additional trees to shelter their cacao plants [1], thereby reducing the environmental impacts of cacao cultivation. Despite its great importance, the cacao tree is affected by a number of untreatable diseases that reduce fruit production and threaten our global supply of cacao. Among them, witches' broom disease (WBD) stands out as one of the most severe problems that affect this crop, accounting for production losses of up to 90%.","[Teixeira, Paulo Jose Pereira Lima] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Thomazella, Daniela Paula de Toledo] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Guimaraes Pereira, Goncalo Amarante] Univ Estadual Campinas UNICAMP, Lab Genom & Expressao, Dept Genet Evolucao & Bioagentes, Inst Biol, Campinas, SP, Brazil","Teixeira, PJPL (reprint author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.",goncalo@unicamp.br,"UNICAMP, CCES -/J-7787-2015; Thomazella, Daniela/D-2750-2012; Pereira, Goncalo/B-7944-2012; Teixeira, Paulo/C-1546-2013","Teixeira, Paulo/0000-0002-0776-5044",Sao Paulo Research Foundation (FAPESP) [09/50119-9]; National Council for Scientific and Technological Development (CNPq) [475535/2013-8],"Research on witches' broom disease at Pereira's lab is supported by the Sao Paulo Research Foundation (FAPESP, grant 09/50119-9) and the National Council for Scientific and Technological Development (CNPq, grant 475535/2013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,11,11,0,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005130,10.1371/journal.ppat.1005130,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700008,26492417.0,"DOAJ Gold, Green Published",,,16/08/2019,11,28,35,6737,830,696,134,5907,5078,22,807,35,22,1,0,12,12,2,,51,20,51,0,20,11,11,8,6,0,0,0,0,0,0,0,6,11,6875,18,0,62,362,4,5880,830,18,0,62,362,4,165,,0,0,0,0,23,0,1,1,0,0,0,51,0,0,15.8,8.116867469879518,1.1405112578296936,0.1405112578296936,1.2282038259691892,1.0768888229182128,8.740963855421686
369,J,"Trautwein-Weidner, K; Gladiator, A; Kirchner, FR; Becattini, S; Rulicke, T; Sallusto, F; LibundGut-Landmann, S",,,,"Trautwein-Weidner, Kerstin; Gladiator, Andre; Kirchner, Florian R.; Becattini, Simone; Ruelicke, Thomas; Sallusto, Federica; LibundGut-Landmann, Salome",,,Antigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal Candidiasis,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN DECTIN-1; STEADY-STATE; HOST-DEFENSE; INDUCTION; IMMUNITY; ACTIVATION; DIFFERENTIATION; INFECTION; RESPONSES; MODEL,"Candida spp. can cause severe and chronic mucocutaneous and systemic infections in immunocompromised individuals. Protection from mucocutaneous candidiasis depends on T helper cells, in particular those secreting IL-17. The events regulating T cell activation and differentiation toward effector fates in response to fungal invasion in different tissues are poorly understood. Here we generated a Candida-specific TCR transgenic mouse reactive to a novel endogenous antigen that is conserved in multiple distant species of Candida, including the clinically highly relevant C. albicans and C. glabrata. Using TCR transgenic T cells in combination with an experimental model of oropharyngeal candidiasis (OPC) we investigated antigen presentation and Th17 priming by different subsets of dendritic cells (DCs) present in the infected oral mucosa. Candida-derived endogenous antigen accesses the draining lymph nodes and is directly presented by migratory DCs. Tissue-resident Flt3L-dependent DCs and CCR2-dependent monocyte-derived DCs collaborate in antigen presentation and T cell priming during OPC. In contrast, Langerhans cells, which are also present in the oral mucosa and have been shown to prime Th17 cells in the skin, are not required for induction of the Candida-specific T cell response upon oral challenge. This highlights the functional compartmentalization of specific DC subsets in different tissues. These data provide important new insights to our understanding of tissue-specific antifungal immunity.","[Trautwein-Weidner, Kerstin; Gladiator, Andre; Kirchner, Florian R.; Becattini, Simone; LibundGut-Landmann, Salome] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Kirchner, Florian R.; LibundGut-Landmann, Salome] Univ Zurich, Immunol Sect, Inst Virol, Zurich, Switzerland; [Becattini, Simone; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria","Trautwein-Weidner, K (reprint author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.",Salome.leibundgut-landmann@uzh.ch,,"Becattini, Simone/0000-0001-5985-0403; LeibundGut-Landmann, Salome/0000-0002-5724-4837","Swiss National Science Foundation [PP00P3_123342, 149475]; ETH Zurich [ETH-11 09-3]; European Research Council [323183 PREDICT]; Helmut Horten Foundation","The LeibundGut-lab was supported by funding from the Swiss National Science Foundation (grant PP00P3_123342; www.snf.ch) and from ETH Zurich (grant ETH-11 09-3; www.ethz.ch). The Sallusto lab is supported by funding from the European Research Council (grant 323183 PREDICT; www.erc.eu) and the Swiss National Science Foundation (grant 149475; www.snf.ch). The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation (www.helmut-horten-stiftung.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,24,24,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005164,10.1371/journal.ppat.1005164,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700013,26431538.0,"DOAJ Gold, Green Published",,,16/08/2019,21,0,29,4469,985,701,284,3484,2779,24,681,29,0,0,0,21,21,0,,43,3,43,0,3,21,21,21,17,0,0,0,0,0,0,0,2,1,4569,69,0,67,228,4,3531,1009,69,0,67,228,4,29,,0,0,0,0,1,0,0,1,0,0,0,46,0,0,1.25,4.537055837563452,1.2827210103329507,0.2827210103329506,1.396670493685419,1.0888341910942045,4.94010152284264
370,J,"Tumbarello, DA; Manna, PT; Allen, M; Bycroft, M; Arden, SD; Kendrick-Jones, J; Buss, F",,,,"Tumbarello, David A.; Manna, Paul T.; Allen, Mark; Bycroft, Mark; Arden, Susan D.; Kendrick-Jones, John; Buss, Folma",,,The Autophagy Receptor TAX1BP1 and the Molecular Motor Myosin VI Are Required for Clearance of Salmonella Typhimurium by Autophagy,PLOS PATHOGENS,,,English,Article,,,,,,,ENTERICA SEROVAR TYPHIMURIUM; MICROSCALE THERMOPHORESIS; GOLGI-COMPLEX; NDP52; BINDING; PROTEIN; BACTERIA; ADAPTER; GROWTH; PHOSPHORYLATION,"Autophagy plays a key role during Salmonella infection, by eliminating these pathogens following escape into the cytosol. In this process, selective autophagy receptors, including the myosin VI adaptor proteins optineurin and NDP52, have been shown to recognize cytosolic pathogens. Here, we demonstrate that myosin VI and TAX1BP1 are recruited to ubiquitylated Salmonella and play a key role in xenophagy. The absence of TAX1BP1 causes an accumulation of ubiquitin-positive Salmonella, whereas loss of myosin VI leads to an increase in ubiquitylated and LC3-positive bacteria. Our structural studies demonstrate that the ubiquitin-binding site of TAX1BP1 overlaps with the myosin VI binding site and point mutations in the TAX1BP1 zinc finger domains that affect ubiquitin binding also ablate binding to myosin VI. This mutually exclusive binding and the association of TAX1BP1 with LC3 on the outer limiting membrane of autophagosomes may suggest a molecular mechanism for recruitment of this motor to autophagosomes. The predominant role of TAX1BP1, a paralogue of NDP52, in xenophagy is supported by our evolutionary analysis, which demonstrates that functionally intact NDP52 is missing in Xenopus and mice, whereas TAX1BP1 is expressed in all vertebrates analysed. In summary, this work highlights the importance of TAX1BP1 as a novel autophagy receptor in myosin VI-mediated xenophagy. Our study identifies essential new machinery for the autophagy-dependent clearance of Salmonella typhimurium and suggests modulation of myosin VI motor activity as a potential therapeutic target in cellular immunity.","[Tumbarello, David A.; Manna, Paul T.; Arden, Susan D.; Buss, Folma] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Allen, Mark; Bycroft, Mark; Kendrick-Jones, John] MRC, Mol Biol Lab, Cambridge CB2 2QH, England","Tumbarello, DA (reprint author), Univ Southampton, Ctr Biol Sci, Life Sci Bldg 85,Highfield Campus, Southampton, Hants, England.",D.A.Tumbarello@soton.ac.uk; fb207@cam.ac.uk,"Bycroft, Mark/D-9446-2017","Manna, Paul Thomas/0000-0002-2260-2075; Tumbarello, David/0000-0002-5169-0561","Wellcome Trust [086743]; CIMR Strategic Award [100140]; CIMR equipment grant [093026]; Medical Research Council UK [MR/K000888/1, U105184325]; Medical Research Council [MC_U105184326, MC_U105184323, MR/K000888/1]","FB and DAT thank the Wellcome Trust (www.wellcome.ac.uk) for funding of a University Award to FB (086743), the CIMR Strategic Award (100140) and an equipment grant [093026]. FB also thanks the Medical Research Council UK (www.mrc.ac.uk) for funding of a project grant (MR/K000888/1). JKJ, MA and MB were supported by the Medical Research Council UK (www.mrc.ac.uk) (U105184325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,31,62,62,2,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005174,10.1371/journal.ppat.1005174,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700018,26451915.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,64,2,58,8846,1667,1104,563,7179,5640,52,1487,58,2,2,0,51,51,1,,88,1,88,0,1,66,66,66,41,0,0,0,0,0,0,0,1,5,8829,181,0,684,71,0,7140,1667,181,0,684,71,0,22,,0,0,0,0,7,0,0,1,0,0,0,88,0,0,4.25,5.306538692261547,1.2322050424850257,0.23220504248502577,1.264939406602591,1.0265656794031202,5.44751049790042
371,J,"Ueno, Y; Yoshida, R; Kishi-Kaboshi, M; Matsushita, A; Jiang, CJ; Goto, S; Takahashi, A; Hirochika, H; Takatsuji, H",,,,"Ueno, Yoshihisa; Yoshida, Riichiro; Kishi-Kaboshi, Mitsuko; Matsushita, Akane; Jiang, Chang-Jie; Goto, Shingo; Takahashi, Akira; Hirochika, Hirohiko; Takatsuji, Hiroshi",,,Abiotic Stresses Antagonize the Rice Defence Pathway through the Tyrosine-Dephosphorylation of OsMPK6,PLoS Pathogens,,,English,Article,,,,,,,SYSTEMIC ACQUIRED-RESISTANCE; ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; PLANT-PATHOGEN INTERACTIONS; ABSCISIC-ACID; SALICYLIC-ACID; MAGNAPORTHE-GRISEA; DISEASE RESISTANCE; MAP KINASE; BLAST RESISTANCE,"Plants, as sessile organisms, survive environmental changes by prioritizing their responses to the most life-threatening stress by allocating limited resources. Previous studies showed that pathogen resistance was suppressed under abiotic stresses. Here, we show the mechanism underlying this phenomenon. Phosphorylation of WRKY45, the central transcription factor in salicylic-acid (SA)-signalling-dependent pathogen defence in rice, via the OsMKK10-2-OsMPK6 cascade, was required to fully activate WRKY45. The activation of WRKY45 by benzothiadiazole (BTH) was reduced under low temperature and high salinity, probably through abscisic acid (ABA) signalling. An ABA treatment dephosphorylated/inactivated OsMPK6 via protein tyrosine phosphatases, OsPTP1/2, leading to the impaired activation of WRKY45 and a reduction in Magnaporthe oryzae resistance, even after BTH treatment. BTH induced a strong M. oryzae resistance in OsPTP1/2 knockdown rice, even under cold and high salinity, indicating that OsPTP1/2 is the node of SA-ABA signalling crosstalk and its down-regulation makes rice disease resistant, even under abiotic stresses. These results points to one of the directions to further improve crops by managing the trade-offs between different stress responses of plants.","[Ueno, Yoshihisa; Yoshida, Riichiro; Kishi-Kaboshi, Mitsuko; Matsushita, Akane; Jiang, Chang-Jie; Goto, Shingo; Takahashi, Akira; Hirochika, Hirohiko; Takatsuji, Hiroshi] Natl Inst Agrobiol Sci, Dis Resistant Crops Res Unit, Tsukuba, Ibaraki, Japan","Ueno, Y (reprint author), Ryukoku Univ, Dept Agr, Seta Ohe Cho, Otsu, Shiga, Japan.",takatsuh@affrc.go.jp,,"Goto, Shingo/0000-0002-2298-7016; Jiang, Chang-Jie/0000-0003-1845-541X; Kishi-Kaboshi, Mitsuko/0000-0002-1552-2608","Ministry of Agriculture, Forestry and Fishery, Japan [GMA0001, PMI0008, GMO1006]","This work was supported by grants from Ministry of Agriculture, Forestry and Fishery, Japan (GMA0001, PMI0008 and GMO1006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,22,27,1,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005231,10.1371/journal.ppat.1005231,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700053,26485146.0,"DOAJ Gold, Green Published",,,16/08/2019,22,1,24,4593,621,437,184,3972,3048,17,907,24,0,0,0,25,25,1,,36,1,36,0,1,24,24,22,8,0,0,0,0,0,0,0,1,4,4593,105,0,55,66,1,3953,621,105,0,55,66,1,19,,0,0,0,0,5,0,1,1,0,0,0,36,0,0,2.5,7.396135265700483,1.156344410876133,0.15634441087613293,1.1993957703927491,1.0372305682560419,7.671497584541063
372,J,"Wang, Q; Ma, XN; Qian, SS; Zhou, X; Sun, K; Chen, XL; Zhou, XP; Jackson, AO; Li, ZH",,,,"Wang, Qiang; Ma, Xiaonan; Qian, ShaSha; Zhou, Xin; Sun, Kai; Chen, Xiaolan; Zhou, Xueping; Jackson, Andrew O.; Li, Zhenghe",,,Rescue of a Plant Negative-Strand RNA Virus from Cloned cDNA: Insights into Enveloped Plant Virus Movement and Morphogenesis,PLoS Pathogens,,,English,Article,,,,,,,YELLOW-NET-VIRUS; CELL-TO-CELL; TRANSIENT EXPRESSION SYSTEM; RICE-STRIPE-VIRUS; BUSHY-STUNT-VIRUS; REVERSE GENETICS; NICOTIANA-BENTHAMIANA; ADAPTED RHABDOVIRUS; PROTEIN; REPLICATION,"Reverse genetics systems have been established for all major groups of plant DNA and positive-strand RNA viruses, and our understanding of their infection cycles and pathogenesis has benefitted enormously from use of these approaches. However, technical difficulties have heretofore hampered applications of reverse genetics to plant negative-strand RNA (NSR) viruses. Here, we report recovery of infectious virus from cloned cDNAs of a model plant NSR, Sonchus yellow net rhabdovirus (SYNV). The procedure involves Agrobacterium-mediated transcription of full-length SYNV antigenomic RNA and co-expression of the nucleoprotein (N), phosphoprotein (P), large polymerase core proteins and viral suppressors of RNA silencing in Nicotiana benthamiana plants. Optimization of core protein expression resulted in up to 26% recombinant SYNV (rSYNV) infections of agroinfiltrated plants. A reporter virus, rSYNV-GFP, engineered by inserting a green fluorescence protein (GFP) gene between the N and P genes was able to express GFP during systemic infections and after repeated plant-to-plant mechanical passages. Deletion analyses with rSYNV-GFP demonstrated that SYNV cell-to-cell movement requires the sc4 protein and suggested that uncoiled nucleocapsids are infectious movement entities. Deletion analyses also showed that the glycoprotein is not required for systemic infection, although the glycoprotein mutant was defective in virion morphogenesis. Taken together, we have developed a robust reverse genetics system for SYNV that provides key insights into morphogenesis and movement of an enveloped plant virus. Our study also provides a template for developing analogous systems for reverse genetic analysis of other plant NSR viruses.","[Wang, Qiang; Ma, Xiaonan; Qian, ShaSha; Zhou, Xin; Sun, Kai; Chen, Xiaolan; Zhou, Xueping; Li, Zhenghe] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Xueping] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Jackson, Andrew O.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA","Wang, Q (reprint author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.",lizh@zju.edu.cn,"Li, Zhenghe/L-9991-2013","Li, Zhenghe/0000-0001-5497-2575","National Basic Research Program of China [2014CB138400]; China National Science Foundation [31222004, 31470255]; Qianjiang Talent Program of Zhejiang Province [2013R10028]; Fundamental Research Funds for the Central Universities [2014XZZX003-31]","This work was supported by the National Basic Research Program of China (2014CB138400), China National Science Foundation (31222004 and 31470255), the Qianjiang Talent Program of Zhejiang Province (2013R10028) and the Fundamental Research Funds for the Central Universities (2014XZZX003-31) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,33,35,2,42,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,OCT,2015,11,10,,,,,,,e1005223,10.1371/journal.ppat.1005223,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CV7OE,WOS:000364462700048,26484673.0,"DOAJ Gold, Green Published",,,16/08/2019,32,8,25,6214,830,579,251,5384,4069,23,1292,25,1,0,2,33,33,0,,37,2,37,0,2,37,33,37,10,0,0,0,0,0,0,0,7,0,6312,73,0,96,101,0,5438,837,73,0,96,101,0,37,,0,0,0,0,2,0,0,1,1,0,0,37,0,0,2.75,7.486746987951808,1.1541604754829122,0.15416047548291234,1.2046805349182763,1.0437721274541358,7.814457831325301
373,J,"An, T; Li, S; Pan, W; Tien, P; Zhong, B; Shu, HB; Wu, SW",,,,"An, Tai; Li, Shu; Pan, Wei; Tien, Po; Zhong, Bo; Shu, Hong-Bing; Wu, Shuwen",,,DYRK2 Negatively Regulates Type I Interferon Induction by Promoting TBK1 Degradation via Ser527 Phosphorylation,PLOS PATHOGENS,,,English,Article,,,,,,,GLYCOGEN-SYNTHASE KINASE; CYTOSOLIC DNA SENSOR; ANTIVIRAL RESPONSE; ADAPTER PROTEIN; PATHOGEN RECOGNITION; APOPTOTIC RESPONSE; RNA-RECOGNITION; FAMILY; ACTIVATION; RECEPTOR,"Viral infection activates the transcription factors NF-kappa B and IRF3, which contribute to the induction of type I interferons (IFNs) and cellular antiviral responses. Protein kinases play a critical role in various signaling pathways by phosphorylating their substrates. Here, we identified dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) as a negative regulator of virus-triggered type I IFN induction. DYRK2 inhibited the virus-triggered induction of type I IFNs and promoted the K48-linked ubiquitination and degradation of TANK-binding kinase 1 (TBK1) in a kinase-activity-dependent manner. We further found that DYRK2 phosphorylated Ser527 of TBK1, which is essential for the recruitment of NLRP4 and for the E3 ubiquitin ligase DTX4 to degrade TBK1. These findings suggest that DYRK2 negatively regulates virus-triggered signaling by targeting TBK1 for phosphorylation and priming it for degradation, and these data provide new insights into the molecular mechanisms that dictate the cellular antiviral response.","[An, Tai; Li, Shu; Pan, Wei; Tien, Po; Zhong, Bo; Shu, Hong-Bing; Wu, Shuwen] Wuhan Univ, Modern Virol Res Ctr, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [An, Tai] Shaanxi Univ Chinese Med, Coll Basic Med Sci, Xian, Peoples R China","An, T (reprint author), Wuhan Univ, Modern Virol Res Ctr, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.",shuwenwu@hotmail.com,,,"Ministry of Science and Technology of China [2012CB910201, 2014CB542600]; National Natural Science Foundation of China [30900758, 31221061, 31371427]; Chinese National Key Programs on Infectious Disease [2012ZX10002007-003]","This study was supported by the Ministry of Science and Technology of China (2012CB910201, 2014CB542600), and the National Natural Science Foundation of China (30900758, 31221061, 31371427) and the Chinese National Key Programs on Infectious Disease (2012ZX10002007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,17,18,0,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005179,10.1371/journal.ppat.1005179,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800037,26407194.0,"DOAJ Gold, Green Published",,,16/08/2019,17,0,20,5257,1106,732,374,4151,3130,20,1001,20,0,0,0,17,17,0,,28,0,28,0,0,17,17,15,7,0,0,0,0,0,0,0,0,0,5314,118,0,170,58,1,4172,1120,118,0,170,58,1,22,,0,0,0,0,0,0,0,1,0,0,0,28,0,0,0.25,4.753164556962025,1.266441821247892,0.26644182124789206,1.3225728740062634,1.0443218565721895,4.963833634719711
374,J,"Bartosova-Sojkova, P; Oppenheim, RD; Soldati-Favre, D; Lukes, J",,,,"Bartosova-Sojkova, Pavla; Oppenheim, Rebecca D.; Soldati-Favre, Dominique; Lukes, Julius",,,"Epicellular Apicomplexans: Parasites ""On the Way In""",PLOS PATHOGENS,,,English,Article,,,,,,,HOST-CELL; FINE-STRUCTURE; CICHLID FISH; LIFE-CYCLE; CRYPTOSPORIDIUM; EIMERIA; EVOLUTION; COCCIDIA; DISTINCT; BIOLOGY,,"[Bartosova-Sojkova, Pavla; Lukes, Julius] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Oppenheim, Rebecca D.; Soldati-Favre, Dominique] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON, Canada; [Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic","Bartosova-Sojkova, P (reprint author), Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Budweis, Czech Republic.",bartosova@paru.cas.cz; jula@paru.cas.cz,"Lukes, Julius/H-6760-2012; Sojkova, Pavla/G-7314-2014","Lukes, Julius/0000-0002-0578-6618; Soldati-Favre, Dominique/0000-0003-4156-2109","Czech Science Foundation [P305/12/2261, 505/12/G112]; AMVIS [LH 12104]; Praemium Academiae award; EU [316304]; iGE3, Geneva","This work was supported by Czech Science Foundation P305/12/2261 and 505/12/G112, the AMVIS LH 12104 grant, and the Praemium Academiae award to JL. We acknowledge the use of EU research infrastructure (FP7/2007-2013) under agreement no. 316304. DSF is an International Scholar of the Howard Hughes Medical Institute and RDO is supported by iGE3, Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,26,7,7,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005080,10.1371/journal.ppat.1005080,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800002,26402329.0,"DOAJ Gold, Green Published",,,16/08/2019,10,96,32,4818,609,463,146,4209,3512,29,668,32,9,0,0,9,9,0,,38,1,38,0,1,11,11,8,2,0,0,0,0,0,0,0,87,3,4857,10,0,61,55,4,4223,615,10,0,61,55,4,19,,0,0,0,0,14,0,2,1,0,0,0,38,0,0,7.5,7.911330049261084,1.1446899501069137,0.14468995010691377,1.169398907103825,1.0215857202158571,8.082101806239738
375,J,"Bhattarai, N; McLinden, JH; Xiang, JH; Kaufman, TM; Stapleton, JT",,,,"Bhattarai, Nirjal; McLinden, James H.; Xiang, Jinhua; Kaufman, Thomas M.; Stapleton, Jack T.",,,Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation,PLOS PATHOGENS,,,English,Article,,,,,,,ADAPTIVE IMMUNE-RESPONSES; BLOOD MONONUCLEAR-CELLS; ACUTE INFECTION; VIRAL LOADS; REPLICATION; HCV; LYMPHOCYTES; PARTICLES; FAILURE; COMPLEX,"T cell receptor (TCR) signaling is required for T-cell activation, proliferation, differentiation, and effector function. Hepatitis C virus (HCV) infection is associated with impaired T-cell function leading to persistent viremia, delayed and inconsistent antibody responses, and mild immune dysfunction. Although multiple factors appear to contribute to T-cell dysfunction, a role for HCV particles in this process has not been identified. Here, we show that incubation of primary human CD4+ and CD8+ T-cells with HCV RNA-containing serum, HCV-RNA containing extracellular vesicles (EVs), cell culture derived HCV particles (HCVcc) and HCV envelope pseudotyped retrovirus particles (HCVpp) inhibited TCR-mediated signaling. Since HCVpp's contain only E1 and E2, we examined the effect of HCV E2 on TCR signaling pathways. HCV E2 expression recapitulated HCV particle-induced TCR inhibition. A highly conserved, 51 nucleotide (nt) RNA sequence was sufficient to inhibit TCR signaling. Cells expressing the HCV E2 coding RNA contained a short, virus-derived RNA predicted to be a Dicer substrate, which targeted a phosphatase involved in Srckinase signaling (PTPRE). T-cells and hepatocytes containing HCV E2 RNA had reduced PTPRE protein levels. Mutation of 6 nts abolished the predicted Dicer interactions and restored PTPRE expression and proximal TCR signaling. HCV RNA did not inhibit distal TCR signaling induced by PMA and Ionomycin; however, HCV E2 protein inhibited distal TCR signaling. This inhibition required lymphocyte-specific tyrosine kinase (Lck). Lck phosphorylated HCV E2 at a conserved tyrosine (Y613), and phospho-E2 inhibited nuclear translocation of NFAT. Mutation of Y613 restored distal TCR signaling, even in the context of HCVpps. Thus, HCV particles delivered viral RNA and E2 protein to T-cells, and these inhibited proximal and distal TCR signaling respectively. These effects of HCV particles likely aid in establishing infection and contribute to viral persistence.","[Bhattarai, Nirjal; McLinden, James H.; Xiang, Jinhua; Kaufman, Thomas M.; Stapleton, Jack T.] Vet Adm Med Ctr, Res Serv, Iowa City, IA 52240 USA; [Bhattarai, Nirjal; McLinden, James H.; Xiang, Jinhua; Kaufman, Thomas M.; Stapleton, Jack T.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA; [Bhattarai, Nirjal; McLinden, James H.; Xiang, Jinhua; Kaufman, Thomas M.; Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bhattarai, Nirjal; McLinden, James H.; Xiang, Jinhua; Kaufman, Thomas M.; Stapleton, Jack T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA","Bhattarai, N (reprint author), Vet Adm Med Ctr, Res Serv, Iowa City, IA 52240 USA.",jack-stapleton@uiowa.edu,,"Stapleton, Jack/0000-0002-2302-9055","Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Merit Review Grants [BX000207, CX000821, BX001241]","This work was supported by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Merit Review Grants BX000207, CX000821 (JTS) and BX001241 (JX). The funders had no input into the study design, data collection and analysis, decision to publish or preparation of the manuscript.",,60,9,9,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005183,10.1371/journal.ppat.1005183,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800040,26421924.0,"DOAJ Gold, Green Published",,,16/08/2019,10,2,13,4166,787,568,219,3379,2882,16,481,13,1,0,0,10,10,0,,0,3,0,0,3,10,10,8,6,0,0,0,0,0,0,0,1,0,4235,215,0,550,114,0,3398,815,215,0,550,114,0,22,,0,0,0,0,2,0,1,1,0,0,0,14,0,0,4.25,5.2935196950444725,1.232909144717372,0.232909144717372,1.3506954720331459,1.0955352856457032,5.799237611181702
376,J,"Caballero, S; Carter, R; Ke, X; Susac, B; Leiner, IM; Kim, GJ; Miller, L; Ling, LL; Manova, K; Pamer, EG",,,,"Caballero, Silvia; Carter, Rebecca; Ke, Xu; Susac, Boze; Leiner, Ingrid M.; Kim, Grace J.; Miller, Liza; Ling, Lilan; Manova, Katia; Pamer, Eric G.",,,Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae,PLOS PATHOGENS,,,English,Article,,,,,,,ESCHERICHIA-COLI; COLONIZATION RESISTANCE; CLOSTRIDIUM-DIFFICILE; ANTIBIOTIC-TREATMENT; MICROBIOTA; MICE; BACTEREMIA; DOMINATION; PATHOGENS; DEFENSE,"Antibiotic resistance among enterococci and gamma-proteobacteria is an increasing problem in healthcare settings. Dense colonization of the gut by antibiotic-resistant bacteria facilitates their spread between patients and also leads to bloodstream and other systemic infections. Antibiotic-mediated destruction of the intestinal microbiota and consequent loss of colonization resistance are critical factors leading to persistence and spread of antibiotic-resistant bacteria. The mechanisms underlying microbiota-mediated colonization resistance remain incompletely defined and are likely distinct for different antibiotic-resistant bacterial species. It is unclear whether enterococci or gamma-proteobacteria, upon expanding to high density in the gut, confer colonization resistance against competing bacterial species. Herein, we demonstrate that dense intestinal colonization with vancomycin-resistant Enterococcus faecium (VRE) does not reduce in vivo growth of carbapenem-resistant Klebsiella pneumoniae. Reciprocally, K. pneumoniae does not impair intestinal colonization by VRE. In contrast, transplantation of a diverse fecal microbiota eliminates both VRE and K. pneumoniae from the gut. Fluorescence in situ hybridization demonstrates that VRE and K. pneumoniae localize to the same regions in the colon but differ with respect to stimulation and invasion of the colonic mucus layer. While VRE and K. pneumoniae occupy the same three-dimensional space within the gut lumen, their independent growth and persistence in the gut suggests that they reside in distinct niches that satisfy their specific in vivo metabolic needs.","[Caballero, Silvia; Carter, Rebecca; Susac, Boze; Leiner, Ingrid M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Caballero, Silvia; Carter, Rebecca; Susac, Boze; Leiner, Ingrid M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA; [Caballero, Silvia; Pamer, Eric G.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Ke, Xu; Manova, Katia] Sloan Kettering Inst, Mol Cytol Core Facil, New York, NY USA; [Kim, Grace J.; Miller, Liza; Ling, Lilan; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10021 USA","Caballero, S (reprint author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.",pamere@mskcc.org,,"Ling, Lilan/0000-0001-6961-7787; Xu, Ke/0000-0003-2628-2061","US National Institutes of Health [RO1 AI42135, AI95706]; Tow Foundation; Lucille Castori Center for Microbes, Inflammation and Cancer; Howard Hughes Medical Institute; Molecular Cytology Facility at Memorial Sloan-Kettering Cancer Center [P30 CA008748]","This work by supported by grants from the US National Institutes of Health RO1 AI42135 and AI95706, the Tow Foundation and the Lucille Castori Center for Microbes, Inflammation and Cancer to EGP. SC was supported by the Gilliam Pre-doctoral Fellowship from the Howard Hughes Medical Institute. XK and KM were supported by the Core grant P30 CA008748 from the Molecular Cytology Facility at Memorial Sloan-Kettering Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,36,38,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005132,10.1371/journal.ppat.1005132,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800013,26334306.0,"DOAJ Gold, Green Published",,,16/08/2019,37,26,87,13386,1982,1284,698,11404,8855,35,2514,87,25,0,0,37,37,9,,122,9,122,0,9,42,39,42,26,0,0,0,0,0,0,3,2,34,13508,52,45,430,15,0,11497,1999,52,42,430,15,0,12,,4,2,0,0,47,0,0,0,0,0,0,123,0,0,72.49600000000002,6.753784056508577,1.1737986671343388,0.17379866713433884,1.1903717993686427,1.0141192290452712,6.849142280524722
377,J,"Carruthers, VB",,,,"Carruthers, Vern B.",,,Appetite for a Foodborne Infection,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA","Carruthers, VB (reprint author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.",vcarruth@umich.edu,,,,,,0,0,0,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005124,10.1371/journal.ppat.1005124,,,,2,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800012,26402445.0,"DOAJ Gold, Green Published",,,16/08/2019,0,11,4,3059,221,158,63,2838,2568,15,255,4,8,0,0,0,0,0,,4,1,4,0,1,0,0,0,0,0,0,0,0,0,0,0,4,15,3082,0,0,0,80,0,2835,221,0,0,0,80,0,26,,0,0,0,0,25,0,0,1,0,0,0,4,0,0,15.25,13.841628959276019,1.0778717406624383,0.07787174066243834,1.1141649048625792,1.0336711343576332,14.307692307692308
378,J,"Claflin, SB; Webb, CE",,,,"Claflin, Suzi B.; Webb, Cameron E.",,,Ross River Virus: Many Vectors and Unusual Hosts Make for an Unpredictable Pathogen,PLOS PATHOGENS,,,English,Article,,,,,,,MOSQUITO-BORNE DISEASE; WESTERN-AUSTRALIA; INFECTION; EPIDEMIC; RISK,,"[Claflin, Suzi B.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Webb, Cameron E.] Univ Sydney, Dept Med Entomol, Westmead, NSW 2145, Australia; [Webb, Cameron E.] Westmead Hosp, Pathol West ICPMR Westmead, Westmead, NSW 2145, Australia","Claflin, SB (reprint author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.",cameron.webb@health.nsw.gov.au,,"Webb, Cameron/0000-0003-1029-5140; Claflin, Suzi/0000-0001-6545-946X",,,,19,25,26,1,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005070,10.1371/journal.ppat.1005070,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800001,26335937.0,"DOAJ Gold, Green Published",,,16/08/2019,24,240,36,14029,830,637,193,13199,11922,25,1252,36,219,0,0,24,24,4,,46,3,46,0,3,24,24,19,14,0,0,10,0,0,10,24,33,124,14229,9,7,27,40,3,13345,850,9,7,27,40,3,34,,9,1,1,0,156,0,2,0,0,0,0,46,0,0,172.35,16.902409638554218,1.062883551784226,0.06288355178422608,1.081748617319494,1.0177489486064581,17.202409638554215
379,J,"Daniels, BP; Klein, RS",,,,"Daniels, Brian P.; Klein, Robyn S.",,,Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System,PLOS PATHOGENS,,,English,Article,,,,,,,MECHANISM; GAMMA; BETA,,"[Daniels, Brian P.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA","Daniels, BP (reprint author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.",rklein@dom.wustl.edu,,,"NIH/NINDS [R01 NS052632, P01 NS059560]; NIH/NIAID [U19 AI083019, DTRA1-11-16-BRCWMD-BAA]; National Science Foundation Graduate Research Fellowship [DGE-1143954]","This work was supported by NIH/NINDS R01 NS052632, P01 NS059560, NIH/NIAID U19 AI083019 and DTRA1-11-16-BRCWMD-BAA, all to RSK. BPD was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,21,8,8,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005096,10.1371/journal.ppat.1005096,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800004,26379171.0,"DOAJ Gold, Green Published",,,16/08/2019,8,5,19,4713,522,360,162,4191,3591,12,588,19,2,0,0,8,8,0,,24,21,24,0,21,9,9,6,7,0,0,0,0,0,0,0,3,1,4815,84,0,38,137,4,4183,522,69,0,38,133,4,110,,0,0,0,0,6,0,0,1,0,0,0,23,0,0,3.1,9.028735632183908,1.124552612741589,0.12455261274158912,1.20162252445717,1.0685338425631232,9.647509578544062
380,J,"Etienne, L; Bibollet-Ruche, F; Sudmant, PH; Wu, LI; Hahn, BH; Emerman, M",,,,"Etienne, Lucie; Bibollet-Ruche, Frederic; Sudmant, Peter H.; Wu, Lily I.; Hahn, Beatrice H.; Emerman, Michael",,,The Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from Monkeys,PLOS PATHOGENS,,,English,Article,,,,,,,SIMIAN IMMUNODEFICIENCY VIRUS; CROSS-SPECIES TRANSMISSION; AFRICAN-GREEN MONKEYS; PAN-TROGLODYTES-VERUS; TAI-NATIONAL-PARK; COTE-DIVOIRE; RESTRICTION FACTORS; ADAPTIVE EVOLUTION; HIV-1; VIF,"Cross-species transmissions of viruses from animals to humans are at the origin of major human pathogenic viruses. While the role of ecological and epidemiological factors in the emergence of new pathogens is well documented, the importance of host factors is often unknown. Chimpanzees are the closest relatives of humans and the animal reservoir at the origin of the human AIDS pandemic. However, despite being regularly exposed to monkey lentiviruses through hunting, chimpanzees are naturally infected by only a single simian immunodeficiency virus, SIVcpz. Here, we asked why chimpanzees appear to be protected against the successful emergence of other SIVs. In particular, we investigated the role of the chimpanzee APOBEC3 genes in providing a barrier to infection by most monkey lentiviruses. We found that most SIV Vifs, including Vif from SIVwrc infecting western-red colobus, the chimpanzee's main monkey prey in West Africa, could not antagonize chimpanzee APOBEC3G. Moreover, chimpanzee APOBEC3D, as well as APOBEC3F and APOBEC3H, provided additional protection against SIV Vif antagonism. Consequently, lentiviral replication in primary chimpanzee CD4(+) T cells was dependent on the presence of a lentiviral vif gene that could antagonize chimpanzee APOBEC3s. Finally, by identifying and functionally characterizing several APOBEC3 gene polymorphisms in both common chimpanzees and bonobos, we found that these ape populations encode APOBEC3 proteins that are uniformly resistant to antagonism by monkey lentiviruses.","[Etienne, Lucie; Wu, Lily I.; Emerman, Michael] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Etienne, Lucie; Wu, Lily I.; Emerman, Michael] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Bibollet-Ruche, Frederic; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bibollet-Ruche, Frederic; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sudmant, Peter H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA","Etienne, L (reprint author), UCBL, CIRI, Int Ctr Infectiol Res, ENS Lyon,INSERM U1111,CNRS UMR5308, Lyon, France.",lucie.etienne@ens-lyon.fr; memerman@fredhutch.org,,"Hahn, Beatrice/0000-0002-9400-9887; Sudmant, Peter/0000-0002-9573-8248; Etienne, Lucie/0000-0002-8585-7534","NIH grants [AI30937, R37 AI050529, R01 AI058715, P30 AI045008]; Yerkes Base Grant [ORIP/OD P51OD011132]; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [108499-53-RKGN]","This work was supported by NIH grants AI30937 (to ME), R37 AI050529, R01 AI058715, P30 AI045008 (to BHH), Yerkes Base Grant ORIP/OD P51OD011132 for the chimpanzee primay cells, and an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (108499-53-RKGN, to LE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,17,17,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005149,10.1371/journal.ppat.1005149,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800024,26394054.0,"DOAJ Gold, Green Published",,,16/08/2019,18,32,34,6331,552,408,144,5779,4983,75,721,33,28,0,0,14,14,4,,44,10,43,1,10,18,18,10,11,0,0,0,0,0,0,0,4,17,6342,82,20,70,146,0,5764,552,82,20,70,146,0,26,,0,0,0,0,23,0,0,1,0,0,0,43,1,0,12.2,11.469202898550725,1.0955182557535905,0.09551825575359059,1.136874891849801,1.0377507502764176,11.902173913043478
381,J,"Fletcher, SP; Chin, DJ; Gruenbaum, L; Bitter, H; Rasmussen, E; Ravindran, P; Swinney, DC; Birzele, F; Schmucki, R; Lorenz, SH; Kopetzki, E; Carter, J; Triyatni, M; Thampi, LM; Yang, JM; AlDeghaither, D; Murredu, MG; Cote, P; Menne, S",,,,"Fletcher, Simon P.; Chin, Daniel J.; Gruenbaum, Lore; Bitter, Hans; Rasmussen, Erik; Ravindran, Palanikumar; Swinney, David C.; Birzele, Fabian; Schmucki, Roland; Lorenz, Stefan H.; Kopetzki, Erhard; Carter, Jade; Triyatni, Miriam; Thampi, Linta M.; Yang, Junming; AlDeghaither, Dalal; Murredu, Marta G.; Cote, Paul; Menne, Stephan",,,Intrahepatic Transcriptional Signature Associated with Response to Interferon-alpha Treatment in the Woodchuck Model of Chronic Hepatitis B,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT ADENOVIRAL VECTOR; CD8(+) T-CELLS; VIRUS INFECTION; IFN-ALPHA; I INTERFERONS; ADEFOVIR DIPIVOXIL; ANTIGEN DECLINE; MARMOTA-MONAX; RNA-SEQ; REPLICATION,"Recombinant interferon-alpha (IFN-alpha) is an approved therapy for chronic hepatitis B (CHB), but the molecular basis of treatment response remains to be determined. The woodchuck model of chronic hepatitis B virus (HBV) infection displays many characteristics of human disease and has been extensively used to evaluate antiviral therapeutics. In this study, woodchucks with chronic woodchuck hepatitis virus (WHV) infection were treated with recombinant woodchuck IFN-alpha (wIFN-alpha) or placebo (n = 12/group) for 15 weeks. Treatment with wIFN-alpha strongly reduced viral markers in the serum and liver in a subset of animals, with viral rebound typically being observed following cessation of treatment. To define the intrahepatic cellular and molecular characteristics of the antiviral response to wIFN-alpha, we characterized the transcriptional profiles of liver biopsies taken from animals (n = 8-12/group) at various times during the study. Unexpectedly, this revealed that the antiviral response to treatment did not correlate with intrahepatic induction of the majority of IFN-stimulated genes (ISGs) by wIFN-alpha. Instead, treatment response was associated with the induction of an NK/T cell signature in the liver, as well as an intrahepatic IFN-gamma transcriptional response and elevation of liver injury biomarkers. Collectively, these data suggest that NK/T cell cytolytic and non-cytolytic mechanisms mediate the antiviral response to wIFN-alpha treatment. In summary, by studying recombinant IFN-alpha in a fully immunocompetent animal model of CHB, we determined that the immunomodulatory effects, but not the direct antiviral activity, of this pleiotropic cytokine are most closely correlated with treatment response. This has important implications for the rational design of new therapeutics for the treatment of CHB.","[Fletcher, Simon P.; Chin, Daniel J.; Gruenbaum, Lore; Bitter, Hans; Rasmussen, Erik; Ravindran, Palanikumar; Swinney, David C.; Carter, Jade] Hoffmann La Roche Inc, Pharma Res & Early Dev, Nutley, NJ 07110 USA; [Birzele, Fabian; Lorenz, Stefan H.; Kopetzki, Erhard] Roche Innovat Ctr Penzberg, Roche Pharma Res & Early Dev, Penzberg, Germany; [Schmucki, Roland; Triyatni, Miriam] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Basel, Switzerland; [Thampi, Linta M.; Yang, Junming; AlDeghaither, Dalal; Murredu, Marta G.; Cote, Paul; Menne, Stephan] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA","Fletcher, SP (reprint author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.",sm923@georgetown.edu,,,"IDIQ from Division of Microbiology and Infectious Diseases (DMID) of National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201000011I, HHSN27200001 (D06)]; Hoffmann-La Roche, Inc.","SM, PC, LMT, JY, and DA were supported by IDIQ contract HHSN272201000011I, task order HHSN27200001 (D06) to the Department of Microbiology & Immunology, Georgetown University Medical Center from the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov). The NIAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MGM was supported by a grant from Hoffmann-La Roche, Inc. (http://www.roche.com/index.htm). Roche were involved in the study design, data analysis, decision to publish, and preparation of the manuscript. SPF, DJC, LG, HB, ER, PR, DCS, FB, RS, SHL, EK, JC, MT are/were employees of Hoffmann-La Roche, Inc. (http://www.roche.com/index.htm). Roche was involved in the study design, data analysis, decision to publish, and preparation of the manuscript.",,65,16,19,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005103,10.1371/journal.ppat.1005103,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800007,26352406.0,"DOAJ Gold, Green Published",,,16/08/2019,18,1,16,4310,813,537,276,3497,2974,23,500,16,0,0,0,15,15,0,,21,3,21,0,3,19,19,17,10,0,0,0,0,0,0,0,1,3,4364,155,0,128,643,0,3508,817,155,0,128,643,0,39,,0,0,0,0,5,0,0,1,0,0,0,20,0,0,1.75,5.301353013530135,1.2324849871318273,0.23248498713182728,1.4761223906205319,1.1976798143851508,6.349323493234932
382,J,"Furuya, Y; Furuya, AKM; Roberts, S; Sanfilippo, AM; Salmon, SL; Metzger, DW",,,,"Furuya, Yoichi; Furuya, Andrea K. M.; Roberts, Sean; Sanfilippo, Alan M.; Salmon, Sharon L.; Metzger, Dennis W.",,,Prevention of Influenza Virus-Induced Immunopathology by TGF-beta Produced during Allergic Asthma,PLOS PATHOGENS,,,English,Article,,,,,,,GROWTH-FACTOR-BETA; BRONCHOALVEOLAR LAVAGE FLUID; PANDEMIC INFLUENZA; T-CELLS; A H1N1; VIRAL-INFECTIONS; EPITHELIAL-CELLS; RISK-FACTOR; LUNG; CHILDREN,"Asthma is believed to be a risk factor for influenza infection, however little experimental evidence exists to directly demonstrate the impact of asthma on susceptibility to influenza infection. Using a mouse model, we now report that asthmatic mice are actually significantly more resistant to a lethal influenza virus challenge. Notably, the observed increased resistance was not attributable to enhanced viral clearance, but instead, was due to reduced lung inflammation. Asthmatic mice exhibited a significantly reduced cytokine storm, as well as reduced total protein levels and cytotoxicity in the airways, indicators of decreased tissue injury. Further, asthmatic mice had significantly increased levels of TGF-beta 1 and the heightened resistance of asthmatic mice was abrogated in the absence of TGF-beta receptor II. We conclude that a transient increase in TGF-beta expression following acute asthma can induce protection against influenza-induced immunopathology.","[Furuya, Yoichi; Furuya, Andrea K. M.; Roberts, Sean; Sanfilippo, Alan M.; Salmon, Sharon L.; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA","Furuya, Y (reprint author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.",metzged@mail.amc.edu,"Metzger, Dennis W/I-2771-2019","Metzger, Dennis W/0000-0002-8000-9907; Roberts, Sean/0000-0001-9867-1483","American Lung Association [RT-226959-N]; US NIH [RO1 AI41715, RO1 AI75312]","This work was supported by an American Lung Association (www.lung.org) Senior Research Training Fellowship RT-226959-N to YF and by US NIH (www.nih.gov) grants RO1 AI41715 and RO1 AI75312 to DWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,15,15,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005180,10.1371/journal.ppat.1005180,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800038,26407325.0,"DOAJ Gold, Green Published",,,16/08/2019,14,0,25,4588,812,584,228,3776,3079,33,664,25,0,0,0,16,16,0,,36,2,36,0,2,16,16,16,11,0,0,0,0,0,0,0,3,3,4638,122,0,65,166,0,3764,812,122,0,65,166,0,62,,0,0,0,0,3,0,0,1,0,0,0,36,0,0,2.5,5.650246305418719,1.215042372881356,0.21504237288135594,1.3045550847457628,1.0736704446381866,6.066502463054187
383,J,"Garren, SB; Kondaveeti, Y; Duff, MO; Carmichael, GG",,,,"Garren, Seth B.; Kondaveeti, Yuvabharath; Duff, Michael O.; Carmichael, Gordon G.",,,Global Analysis of Mouse Polyomavirus Infection Reveals Dynamic Regulation of Viral and Host Gene Expression and Promiscuous Viral RNA Editing,PLOS PATHOGENS,,,English,Article,,,,,,,LARGE T-ANTIGEN; MIDDLE TUMOR-ANTIGEN; EARLY-LATE SWITCH; STRAND-SPECIFIC TRANSCRIPTION; NUCLEAR ANTISENSE RNA; LATE MESSENGER-RNAS; PRODUCTIVE INFECTION; DNA-REPLICATION; VIRUS DNA; IN-VITRO,"Mouse polyomavirus (MPyV) lytically infects mouse cells, transforms rat cells in culture, and is highly oncogenic in rodents. We have used deep sequencing to follow MPyV infection of mouse NIH3T6 cells at various times after infection and analyzed both the viral and cellular transcriptomes. Alignment of sequencing reads to the viral genome illustrated the transcriptional profile of the early-to-late switch with both early-strand and late-strand RNAs being transcribed at all time points. A number of novel insights into viral gene expression emerged from these studies, including the demonstration of widespread RNA editing of viral transcripts at late times in infection. By late times in infection, 359 host genes were seen to be significantly upregulated and 857 were downregulated. Gene ontology analysis indicated transcripts involved in translation, metabolism, RNA processing, DNA methylation, and protein turnover were upregulated while transcripts involved in extracellular adhesion, cytoskeleton, zinc finger binding, SH3 domain, and GTPase activation were downregulated. The levels of a number of long noncoding RNAs were also altered. The long noncoding RNA MALAT1, which is involved in splicing speckles and used as a marker in many late-stage cancers, was noticeably downregulated, while several other abundant noncoding RNAs were strongly upregulated. We discuss these results in light of what is currently known about the MPyV life cycle and its effects on host cell growth and metabolism.","[Garren, Seth B.; Kondaveeti, Yuvabharath; Duff, Michael O.; Carmichael, Gordon G.] UCONN Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA","Garren, SB (reprint author), UCONN Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA.",carmichael@uchc.edu,,"Kondaveeti, Yuvabharath/0000-0002-8901-8754",National Cancer Institute [CA045382],"This work was supported by grant CA045382 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,6,6,1,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005166,10.1371/journal.ppat.1005166,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800035,26407100.0,"DOAJ Gold, Green Published",,,16/08/2019,6,0,18,3711,566,430,136,3145,2649,18,478,18,0,2,0,6,6,0,,0,1,0,0,1,6,6,6,2,0,0,0,0,0,0,0,0,2,3734,151,0,172,272,1,3141,566,151,0,172,272,1,27,,0,0,0,1,2,0,0,1,0,0,0,21,0,0,4.5,6.556537102473499,1.1799682034976153,0.17996820349761528,1.3217806041335454,1.1201832390191324,7.34452296819788
384,J,"Gorasia, DG; Veith, PD; Chen, D; Seers, CA; Mitchell, HA; Chen, YY; Glew, MD; Dashper, SG; Reynolds, EC",,,,"Gorasia, Dhana G.; Veith, Paul D.; Chen, Dina; Seers, Christine A.; Mitchell, Helen A.; Chen, Yu-Yen; Glew, Michelle D.; Dashper, Stuart G.; Reynolds, Eric C.",,,Porphyromonas gingivalis Type IX Secretion Substrates Are Cleaved and Modified by a Sortase-Like Mechanism,PLOS PATHOGENS,,,English,Article,,,,,,,GRAM-POSITIVE BACTERIA; C-TERMINAL-DOMAIN; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; STRUCTURAL-ANALYSIS; OUTER-MEMBRANE; CELL-WALL; ANIONIC POLYSACCHARIDE; CYSTEINE PROTEINASE; BIOFILM FORMATION,"The type IX secretion system (T9SS) of Porphyromonas gingivalis secretes proteins possessing a conserved C-terminal domain (CTD) to the cell surface. The C-terminal signal is essential for these proteins to translocate across the outer membrane via the T9SS. On the surface the CTD of these proteins is cleaved prior to extensive glycosylation. It is believed that the modification on these CTD proteins is anionic lipopolysaccharide (A-LPS), which enables the attachment of CTD proteins to the cell surface. However, the exact site of modification and the mechanism of attachment of CTD proteins to the cell surface are unknown. In this study we characterized two wbaP (PG1964) mutants that did not synthesise A-LPS and accumulated CTD proteins in the clarified culture fluid (CCF). The CTDs of the CTD proteins in the CCF were cleaved suggesting normal secretion, however, the CTD proteins were not glycosylated. Mass spectrometric analysis of CTD proteins purified from the CCF of the wbaP mutants revealed the presence of various peptide/amino acid modifications from the growth medium at the C-terminus of the mature CTD proteins. This suggested that modification occurs at the C-terminus of T9SS substrates in the wild type P. gingivalis. This was confirmed by analysis of CTD proteins from wild type, where a 648 Da linker was identified to be attached at the C-terminus of mature CTD proteins. Importantly, treatment with proteinase K released the 648 Da linker from the CTD proteins demonstrating a peptide bond between the C-terminus and the modification. Together, this is suggestive of a mechanism similar to sortase A for the cleavage and modification/attachment of CTD proteins in P. gingivalis. PG0026 has been recognized as the CTD signal peptidase and is now proposed to be the sortase-like protein in P. gingivalis. To our knowledge, this is the first biochemical evidence suggesting a sortase-like mechanism in Gram-negative bacteria.","[Gorasia, Dhana G.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia; Univ Melbourne, Inst Bio21, Melbourne, Vic 3010, Australia","Gorasia, DG (reprint author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia.",e.reynolds@unimelb.edu.au,,"Veith, Paul/0000-0002-7344-1662; Dashper, Stuart/0000-0003-0106-8691",Australian National Health and Medical Research Council Project [1027812],"This work was supported by the Australian National Health and Medical Research Council Project Grant Number 1027812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,22,23,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005152,10.1371/journal.ppat.1005152,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800027,26340749.0,"DOAJ Gold, Green Published",,,16/08/2019,22,4,30,4768,973,729,244,3795,3147,24,624,28,2,0,0,19,19,0,,40,3,38,2,3,22,22,14,9,0,0,0,0,0,0,0,2,1,4811,173,0,79,6,0,3807,981,173,0,79,6,0,23,,0,0,0,0,4,0,0,1,0,0,0,37,2,0,2.0,4.900308324768757,1.2563899868247694,0.25638998682476943,1.3148880105401846,1.0465604026845639,5.128468653648509
385,J,"Greenwood, EJD; Schmidt, F; Kondova, I; Niphuis, H; Hodara, VL; Clissold, L; McLay, K; Guerra, B; Redrobe, S; Giavedoni, LD; Lanford, RE; Murthy, KK; Rouet, F; Heeney, JL",,,,"Greenwood, Edward J. D.; Schmidt, Fabian; Kondova, Ivanela; Niphuis, Henk; Hodara, Vida L.; Clissold, Leah; McLay, Kirsten; Guerra, Bernadette; Redrobe, Sharon; Giavedoni, Luis D.; Lanford, Robert E.; Murthy, Krishna K.; Rouet, Francois; Heeney, Jonathan L.",,,Simian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral Infections,PLOS PATHOGENS,,,English,Article,,,,,,,AFRICAN-GREEN MONKEYS; T-CELL-ACTIVATION; IMMUNE ACTIVATION; SIV INFECTION; SOOTY MANGABEYS; DISEASE PROGRESSION; HIV-INFECTION; VIRAL REPLICATION; MANDRILLUS SPHINX; PIGTAIL MACAQUES,"The virus-host relationship in simian immunodeficiency virus (SIV) infected chimpanzees is thought to be different from that found in other SIV infected African primates. However, studies of captive SIVcpz infected chimpanzees are limited. Previously, the natural SIVcpz infection of one chimpanzee, and the experimental infection of six chimpanzees was reported, with limited follow-up. Here, we present a long-term study of these seven animals, with a retrospective re-examination of the early stages of infection. The only clinical signs consistent with AIDS or AIDS associated disease was thrombocytopenia in two cases, associated with the development of anti-platelet antibodies. However, compared to uninfected and HIV-1 infected animals, SIVcpz infected animals had significantly lower levels of peripheral blood CD4+ T-cells. Despite this, levels of T-cell activation in chronic infection were not significantly elevated. In addition, while plasma levels of beta 2 microglobulin, neopterin and soluble TNF-related apoptosis inducing ligand (sTRAIL) were elevated in acute infection, these markers returned to near-normal levels in chronic infection, reminiscent of immune activation patterns in 'natural host' species. Furthermore, plasma soluble CD14 was not elevated in chronic infection. However, examination of the secondary lymphoid environment revealed persistent changes to the lymphoid structure, including follicular hyperplasia in SIVcpz infected animals. In addition, both SIV and HIV-1 infected chimpanzees showed increased levels of deposition of collagen and increased levels of Mx1 expression in the T-cell zones of the lymph node. The outcome of SIVcpz infection of captive chimpanzees therefore shares features of both non-pathogenic and pathogenic lentivirus infections.","[Greenwood, Edward J. D.; Schmidt, Fabian; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Kondova, Ivanela] Biomed Primate Res Ctr, Div Pathol & Microbiol, Rijswijk, Netherlands; [Niphuis, Henk] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Hodara, Vida L.; Guerra, Bernadette; Giavedoni, Luis D.; Lanford, Robert E.; Murthy, Krishna K.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA; [Hodara, Vida L.; Giavedoni, Luis D.; Lanford, Robert E.] Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Clissold, Leah; McLay, Kirsten] Genome Anal Ctr, Norwich, Norfolk, England; [Redrobe, Sharon] Twycross Zoo, East Midland Zool Soc, Atherstone, England; [Rouet, Francois] Ctr Int Rech Med Franceville, Lab Retrovirol, Franceville, Gabon","Greenwood, EJD (reprint author), Univ Cambridge, Dept Vet Med, Cambridge, England.",jlh66@cam.ac.uk,,"Heeney, Jonathan/0000-0003-2702-1621; Greenwood, Edward/0000-0002-5224-0263","Wellcome Trust [WT091501MA, 082874]; Biotechnology and Biological Sciences Research Council (BBSRC); NIH primate center base grant (Office of Research Infrastructure Programs/OD) [P51 RR13986, P51 OD011133]; Research Facilities Improvement Program [C06 RR 12087, C06 RR016228]","The Lab of Viral Zoonotics (PI, Heeney) is funded by the Wellcome Trust (WT091501MA). EJDG's PhD studentship was funded by the Wellcome Trust (082874), and FS was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). The transcriptomics library construction and sequencing was performed wholly by The Genome Analysis Centre (TGAC, UK), which operates a BBSRC strategically funded National Capability in Genomics. The Southwest National Primate Research Center is supported by an NIH primate center base grant (previously NCRR grant P51 RR13986; currently Office of Research Infrastructure Programs/OD P51 OD011133) and by Research Facilities Improvement Program Grants C06 RR 12087 and C06 RR016228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,10,10,1,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005146,10.1371/journal.ppat.1005146,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800021,26360709.0,"DOAJ Gold, Green Published",,,16/08/2019,10,6,19,5429,698,563,135,4731,4205,25,501,19,4,0,0,8,8,0,,26,6,25,1,6,10,10,10,6,0,0,0,0,0,0,0,2,1,5489,92,0,247,674,2,4720,698,92,0,247,674,2,71,,0,0,0,0,6,0,0,1,0,0,0,25,1,0,2.25,7.777936962750716,1.1475375184950327,0.14753751849503277,1.3221306277742548,1.1521458832197458,8.961318051575931
386,J,"Hansmann, B; Schrder, JM; Gerstel, U",,,,"Hansmann, Britta; Schrder, Jens-Michael; Gerstel, Ulrich",,,Skin-Derived C-Terminal Filaggrin-2 Fragments Are Pseudomonas aeruginosa-Directed Antimicrobials Targeting Bacterial Replication,PLOS PATHOGENS,,,English,Article,,,,,,,OUTER-MEMBRANE VESICLES; INNATE IMMUNE-RESPONSE; ECCRINE SWEAT GLANDS; ESCHERICHIA-COLI; HUMAN BETA-DEFENSIN-2; ICHTHYOSIS VULGARIS; BARRIER FUNCTION; DNA-REPLICATION; PEPTIDE; PROTEINS,"Soil- and waterborne bacteria such as Pseudomonas aeruginosa are constantly challenging body surfaces. Since infections of healthy skin are unexpectedly rare, we hypothesized that the outermost epidermis, the stratum corneum, and sweat glands directly control the growth of P. aeruginosa by surface-provided antimicrobials. Due to its high abundance in the upper epidermis and eccrine sweat glands, filaggrin-2 (FLG2), a water-insoluble 248 kDa S100 fused-type protein, might possess these innate effector functions. Indeed, recombinant FLG2 C-terminal protein fragments display potent antimicrobial activity against P. aeruginosa and other Pseudomonads. Moreover, upon cultivation on stratum corneum, P. aeruginosa release FLG2 C-terminus-containing FLG2 fragments from insoluble material, indicating liberation of antimicrobially active FLG2 fragments by the bacteria themselves. Analyses of the underlying antimicrobial mechanism reveal that FLG2 C-terminal fragments do not induce pore formation, as known for many other antimicrobial peptides, but membrane blebbing, suggesting an alternative mode of action. The association of the FLG2 fragment with the inner membrane of treated bacteria and its DNA-binding implicated an interference with the bacterial replication that was confirmed by in vitro and in vivo replication assays. Probably through in situ-activation by soil-and waterborne bacteria such as Pseudomonads, FLG2 interferes with the bacterial replication, terminates their growth on skin surface and thus may contributes to the skin's antimicrobial defense shield. The apparent absence of FLG2 at certain body surfaces, as in the lung or of burned skin, would explain their higher susceptibility towards Pseudomonas infections and make FLG2 C-terminal fragments and their derivatives candidates for new Pseudomonas-targeting antimicrobials.","[Hansmann, Britta; Schrder, Jens-Michael; Gerstel, Ulrich] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany","Hansmann, B (reprint author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.",ugerstel@dermatology.uni-kiel.de,,,"Deutsche Forschungsgemeinschaft DFG [305/6-1, 5-1]","This study was supported by grants of the Deutsche Forschungsgemeinschaft DFG (http://www.dfg.de) to JMS (Schr 305/6-1 and 5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,11,11,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005159,10.1371/journal.ppat.1005159,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800031,26371476.0,"DOAJ Gold, Green Published",,,16/08/2019,11,4,10,3926,713,525,188,3213,2742,37,434,10,2,0,0,10,10,0,,0,2,0,0,2,11,11,10,1,0,0,0,0,0,0,0,2,2,3983,50,0,56,106,0,3237,719,50,0,56,106,0,27,,0,0,0,0,13,0,0,1,0,0,0,13,0,0,6.45,5.506311360448808,1.221910986616869,0.22191098661686898,1.2882041705571117,1.054253693326541,5.805049088359047
387,J,"King, KC; Stelkens, RB; Webster, JP; Smith, DF; Brockhurst, MA",,,,"King, Kayla C.; Stelkens, Rike B.; Webster, Joanne P.; Smith, Deborah F.; Brockhurst, Michael A.",,,"Hybridization in Parasites: Consequences for Adaptive Evolution, Pathogenesis, and Public Health in a Changing World",PLOS PATHOGENS,,,English,Article,,,,,,,CLIMATE-CHANGE; SCHISTOSOMA-HAEMATOBIUM; TRYPANOSOMA-CRUZI; GENETIC EXCHANGE; INTROGRESSIVE HYBRIDIZATION; NATURAL HYBRIDIZATION; DENGUE-FEVER; POPULATIONS; RECOMBINATION; LEISHMANIA,,"[King, Kayla C.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Stelkens, Rike B.] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Webster, Joanne P.] Univ London, Royal Vet Coll, Ctr Emerging Endem & Exot Dis, Dept Pathol & Pathogen Biol, London, England; [Smith, Deborah F.; Brockhurst, Michael A.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England","King, KC (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.",michael.brockhurst@york.ac.uk,,"Brockhurst, Michael/0000-0003-0362-820X; King, Kayla/0000-0003-1393-9220",Biotechnology and Biological Sciences Research Council [BB/L018985/1],,,103,37,39,1,46,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005098,10.1371/journal.ppat.1005098,,,,12,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800005,26336070.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,37,79,55,7164,1003,808,195,6161,4936,23,1202,55,29,0,0,36,36,1,,91,4,91,0,4,40,39,40,21,0,0,0,0,0,0,0,50,15,7167,9,0,19,64,5,6135,1003,9,0,19,64,5,29,,0,0,0,0,23,0,1,1,0,0,0,92,0,0,12.3,7.142572283150549,1.1627982470378186,0.16279824703781853,1.1751339068333062,1.010608598548297,7.218344965104686
388,J,"Lynskey, NN; Banerji, S; Johnson, LA; Holder, KA; Reglinski, M; Wing, PAC; Rigby, D; Jackson, DG; Sriskandan, S",,,,"Lynskey, Nicola N.; Banerji, Suneale; Johnson, Louise A.; Holder, Kayla A.; Reglinski, Mark; Wing, Peter A. C.; Rigby, David; Jackson, David G.; Sriskandan, Shiranee",,,Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction,PLOS PATHOGENS,,,English,Article,,,,,,,HYALURONIC-ACID CAPSULE; M-PROTEIN; VIRULENCE FACTOR; SOFT-TISSUES; LYVE-1; PYOGENES; INVASION; CELLS; CD44; COLONIZATION,"The host lymphatic network represents an important conduit for pathogen dissemination. Indeed, the lethal human pathogen group A streptococcus has a predilection to induce pathology in the lymphatic system and draining lymph nodes, however the underlying basis and subsequent consequences for disease outcome are currently unknown. Here we report that the hyaluronan capsule of group A streptococci is a crucial virulence determinant for lymphatic tropism in vivo, and further, we identify the lymphatic vessel endothelial receptor-1 as the critical host receptor for capsular hyaluronan in the lymphatic system. Interference with this interaction in vivo impeded bacterial dissemination to local draining lymph nodes and, in the case of a hyper-encapsulated M18 strain, redirected streptococcal entry into the blood circulation, suggesting a pivotal role in the manifestation of streptococcal infections. Our results reveal a novel function for bacterial capsular polysaccharide in directing lymphatic tropism, with potential implications for disease pathology.","[Lynskey, Nicola N.; Reglinski, Mark; Wing, Peter A. C.; Sriskandan, Shiranee] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Banerji, Suneale; Johnson, Louise A.; Holder, Kayla A.; Rigby, David; Jackson, David G.] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England","Lynskey, NN (reprint author), Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England.",david.jackson@imm.ox.ac.uk; s.sriskandan@imperial.ac.uk,,"Johnson, Louise/0000-0001-6667-8912; Wing, Peter A C/0000-0002-2354-3281; Sriskandan, Shiranee/0000-0002-5214-4941; , david/0000-0002-4133-9364","MRC DTA studentship; Sir Henry Wellcome Postdoctoral Fellowship; MRC [MR/L008610/1, G1100134]; National Institute for Health Research Biomedical Research Centre Funding scheme; Biotechnology and Biological Sciences Research Council [BB/E52708X/1]; Medical Research Council [MR/L008610/1, G1100134, MC_UU_12010/2]","This work was supported in part by an MRC DTA studentship and Sir Henry Wellcome Postdoctoral Fellowship (NNL) and MRC grants MR/L008610/1 (SS, DGJ and G1100134 (DGJ). The research was also supported by MRC Unit funding (SB, LAJ, DGJ) and by the National Institute for Health Research Biomedical Research Centre Funding scheme (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,35,17,17,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005137,10.1371/journal.ppat.1005137,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800016,26352587.0,"DOAJ Gold, Green Published",,,16/08/2019,17,6,23,4442,877,752,125,3565,2872,24,669,23,6,0,0,19,19,0,,33,2,33,0,2,17,17,17,12,0,0,0,0,0,0,0,0,2,4536,54,0,62,240,0,3595,910,54,0,62,240,0,31,,0,0,0,0,5,0,0,0,0,0,0,33,0,0,3.5,5.064994298745724,1.2460028050490883,0.24600280504908836,1.3548387096774193,1.0873480414227825,5.507411630558723
389,J,"Matho, MH; Schlossman, A; Meng, XZ; Benhnia, MREI; Kaever, T; Buller, M; Doronin, K; Parker, S; Peters, B; Crotty, S; Xiang, Y; Zajonc, DM",,,,"Matho, Michael H.; Schlossman, Andrew; Meng, Xiangzhi; Benhnia, Mohammed Rafii-El-Idrissi; Kaever, Thomas; Buller, Mark; Doronin, Konstantin; Parker, Scott; Peters, Bjoern; Crotty, Shane; Xiang, Yan; Zajonc, Dirk M.",,,Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer,PLOS PATHOGENS,,,English,Article,,,,,,,EXTRACELLULAR VIRUS ENVELOPE; ACTIN-CONTAINING MICROVILLI; 2 INFECTIOUS FORMS; VACCINIA-VIRUS; SMALLPOX VACCINE; MONOCLONAL-ANTIBODIES; NONHUMAN-PRIMATES; MEMBRANE-PROTEIN; LETHAL VACCINIA; L1 PROTEIN,"Vaccinia virus A33 is an extracellular enveloped virus (EEV)-specific type II membrane glycoprotein that is essential for efficient EEV formation and long-range viral spread within the host. A33 is a target for neutralizing antibody responses against EEV. In this study, we produced seven murine anti-A33 monoclonal antibodies (MAbs) by immunizing mice with live VACV, followed by boosting with the soluble A33 homodimeric ectodomain. Five A33 specific MAbs were capable of neutralizing EEV in the presence of complement. All MAbs bind to conformational epitopes on A33 but not to linear peptides. To identify the epitopes, we have adetermined the crystal structures of three representative neutralizing MAbs in complex with A33. We have further determined the binding kinetics for each of the three antibodies to wild-type A33, as well as to engineered A33 that contained single alanine substitutions within the epitopes of the three crystallized antibodies. While the Fab of both MAbs A2C7 and A20G2 binds to a single A33 subunit, the Fab from MAb A27D7 binds to both A33 subunits simultaneously. A27D7 binding is resistant to single alanine substitutions within the A33 epitope. A27D7 also demonstrated high-affinity binding with recombinant A33 protein that mimics other orthopoxvirus strains in the A27D7 epitope, such as ectromelia, monkeypox, and cowpox virus, suggesting that A27D7 is a potent cross-neutralizer. Finally, we confirmed that A27D7 protects mice against a lethal challenge with ectromelia virus.","[Matho, Michael H.; Schlossman, Andrew; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Meng, Xiangzhi; Xiang, Yan] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Benhnia, Mohammed Rafii-El-Idrissi] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain; [Benhnia, Mohammed Rafii-El-Idrissi] Biomed Inst Seville IBIS, Lab Immunovirol, Unit 211, Seville, Spain; [Kaever, Thomas; Peters, Bjoern; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Buller, Mark; Doronin, Konstantin; Parker, Scott] St Louis Univ, Sch Med, St Louis, MO USA","Matho, MH (reprint author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.",dzajonc@liai.org,"rafii el idrissi benhnia, mohammed/F-3019-2015","rafii el idrissi benhnia, mohammed/0000-0001-7405-9476","DOE Office of Biological and Environmental Research; National Institutes of Health; National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; Federal funds from National Institutes of Allergy and Infectious Diseases; National Institutes of Health, Department of Health and Human Services [HHSN272200900048C, HHSN272201000021I]; MINECO, Spain [RYC-2010-07419]","The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research http://science.energy.gov/ber/), and by the National Institutes of Health (http://www.nih.gov), National Institute of General Medical Sciences (http://www.nigms.nih.gov/) (including P41GM103393) and the National Center for Research Resources (http://www.nih.gov/about/almanac/organization/NCRR.htm)(P41RR001209). This project has been funded in whole or in part with Federal funds from the National Institutes of Allergy and Infectious Diseases (http://www.niaid.nih.gov), National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900048C and HHSN272201000021I; and from MINECO (http://www.mineco.gob.es), Spain under the fellowship grant RYC-2010-07419 to MREIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,70,6,6,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005148,10.1371/journal.ppat.1005148,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800023,26325270.0,"DOAJ Gold, Green Published",,,16/08/2019,6,1,8,3347,711,554,157,2636,2295,29,312,8,0,0,0,4,4,0,,14,1,14,0,1,7,7,4,2,0,0,0,0,0,0,0,1,0,3359,64,0,47,244,0,2627,711,64,0,47,244,0,21,,0,0,0,0,1,0,0,1,0,0,0,14,0,0,0.5,4.7074542897327705,1.2697268588770865,0.2697268588770865,1.3911229135053111,1.0956080071706005,5.157524613220816
390,J,"Mehle, A",,,,"Mehle, Andrew",,,Fiat Luc: Bioluminescence Imaging Reveals In Vivo Viral Replication Dynamics,PLOS PATHOGENS,,,English,Article,,,,,,,INFLUENZA-VIRUS INFECTION; VACCINIA VIRUS; REPORTER; DISSEMINATION; EXPRESSION; DETERMINANTS; INTERFERON; PROTECTION; THERAPY; SPREAD,,"Univ Wisconsin, Med Microbiol & Immunol, Madison, WI 53706 USA","Mehle, A (reprint author), Univ Wisconsin, Med Microbiol & Immunol, Madison, WI 53706 USA.",amehle@wisc.edu,,,National Institute of General Medical Sciences [R00GM088484]; American Lung Association [RG-310016]; Wisconsin Partnership Education and Research Committee New Investigator Program grant [2563]; Shaw scientist award,"Work in the Mehle lab described here is supported by the National Institute of General Medical Sciences (R00GM088484), the American Lung Association (RG-310016), a Wisconsin Partnership Education and Research Committee New Investigator Program grant (grant 2563), and a Shaw scientist award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,26,7,7,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005081,10.1371/journal.ppat.1005081,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800003,26356297.0,"DOAJ Gold, Green Published",,,16/08/2019,8,7,11,5017,417,317,100,4600,3840,18,742,11,5,0,0,5,5,0,,22,40,22,0,40,8,8,6,4,0,0,0,0,0,0,0,2,0,5110,10,0,47,130,0,4605,424,10,0,47,130,0,81,,0,0,0,0,7,0,0,1,0,0,0,23,0,0,4.1,12.031175059952039,1.0906521739130435,0.09065217391304348,1.141304347826087,1.0464420968706398,12.589928057553957
391,J,"Naderer, T; Heng, J; Saunders, EC; Kloehn, J; Rupasinghe, TW; Brown, TJ; McConville, MJ",,,,"Naderer, Thomas; Heng, Joanne; Saunders, Eleanor C.; Kloehn, Joachim; Rupasinghe, Thusitha W.; Brown, Tracey J.; McConville, Malcolm J.",,,Intracellular Survival of Leishmania major Depends on Uptake and Degradation of Extracellular Matrix Glycosaminoglycans by Macrophages,PLOS PATHOGENS,,,English,Article,,,,,,,CUTANEOUS LEISHMANIASIS; SAND FLIES; VIRULENCE; MEXICANA; BIOSYNTHESIS; VECTOR; MICE; ACETYLTRANSFERASE; HYALURONIDASE; RESISTANCE,"Leishmania parasites replicate within the phagolysosome compartment of mammalian macrophages. Although Leishmania depend on sugars as a major carbon source during infections, the nutrient composition of the phagolysosome remains poorly described. To determine the origin of the sugar carbon source in macrophage phagolysosomes, we have generated a N-acetylglucosamine acetyltransferase (GNAT) deficient Leishmania major mutant (Delta gnat) that is auxotrophic for the amino sugar, N-acetylglucosamine (GlcNAc). This mutant was unable to grow or survive in ex vivo infected macrophages even when macrophages were cultivated in presence of exogenous GlcNAc. In contrast, the L. major Delta gnat mutant induced normal skin lesions in mice, suggesting that these parasites have access to GlcNAc in tissue macrophages. Intracellular growth of the mutant in ex vivo infected macrophages was restored by supplementation of the macrophage medium with hyaluronan, a GlcNAc-rich extracellular matrix glycosaminoglycan. Hyaluronan is present and constitutively turned-over in Leishmania-induced skin lesions and is efficiently internalized into Leishmania containing phagolysosomes. These findings suggest that the constitutive internalization and degradation of host glycosaminoglycans by macrophages provides Leishmania with essential carbon sources, creating a uniquely favorable niche for these parasites.","[Naderer, Thomas; Heng, Joanne; Saunders, Eleanor C.; Kloehn, Joachim; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Naderer, Thomas; Heng, Joanne; Saunders, Eleanor C.; Kloehn, Joachim; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3052, Australia; [Naderer, Thomas; Brown, Tracey J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rupasinghe, Thusitha W.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Metabol Australia, Parkville, Vic 3052, Australia","Naderer, T (reprint author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.",Thomas.naderer@monash.edu; malcolmm@unimelb.edu.au,,,"National Health and Medical Research Council, Canberra, Australia [1024839, 1006023]","This work was supported by the National Health and Medical Research Council, Canberra, Australia (www.nhmrc.gov.au): Project Grant 1024839 (TN) and Project Grant 1006023 (MJM). MJM is a NHMRC Principal Research Fellow (566643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,40,14,14,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005136,10.1371/journal.ppat.1005136,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800015,26334531.0,"DOAJ Gold, Green Published",,,16/08/2019,15,16,31,5045,889,645,244,4156,3434,25,697,31,0,0,0,15,15,0,,46,0,46,0,0,16,16,10,6,0,0,0,0,0,0,0,16,1,5081,68,0,68,5,0,4172,899,68,0,68,5,0,10,,0,0,0,0,3,0,1,0,0,0,0,46,0,0,1.5,5.674915635545557,1.2139076034648701,0.21390760346487006,1.2401347449470645,1.021605550049554,5.797525309336333
392,J,"Nanjappa, SG; Hernandez-Santos, N; Galles, K; Wuthrich, M; Suresh, M; Klein, BS",,,,"Nanjappa, Som Gowda; Hernandez-Santos, Nydiaris; Galles, Kevin; Wuethrich, Marcel; Suresh, M.; Klein, Bruce S.",,,Intrinsic MyD88-Akt1-mTOR Signaling Coordinates Disparate Tc17 and Tc1 Responses during Vaccine Immunity against Fungal Pneumonia,PLOS PATHOGENS,,,English,Article,,,,,,,CD8(+) T-CELLS; TOLL-LIKE RECEPTOR; ADOPTIVE TRANSFER; CLONAL EXPANSION; MEMORY FORMATION; EFFECTOR; VIRUS; MYD88; EXPRESSION; ACTIVATION,"Fungal infections have skyrocketed in immune-compromised patients lacking CD4(+) T cells, underscoring the need for vaccine prevention. An understanding of the elements that promote vaccine immunity in this setting is essential. We previously demonstrated that vaccine-induced IL-17A(+) CD8(+) T cells (Tc17) are required for resistance against lethal fungal pneumonia in CD4(+) T cell-deficient hosts, whereas the individual type I cytokines IFN-gamma, TNF-alpha and GM-CSF, are dispensable. Here, we report that T cell-intrinsic MyD88 signals are crucial for these Tc17 cell responses and vaccine immunity against lethal fungal pneumonia in mice. In contrast, IFN-gamma(+) CD8(+) cell (Tc1) responses are largely normal in the absence of intrinsic MyD88 signaling in CD8(+) T cells. The poor accumulation of MyD88-deficient Tc17 cells was not linked to an early onset of contraction, nor to accelerated cell death or diminished expression of anti-apoptotic molecules Bcl-2 or Bcl-xL. Instead, intrinsic MyD88 was required to sustain the proliferation of Tc17 cells through the activation of mTOR via Akt1. Moreover, intrinsic IL-1R and TLR2, but not IL-18R, were required for MyD88 dependent Tc17 responses. Our data identify unappreciated targets for augmenting adaptive immunity against fungi. Our findings have implications for designing fungal vaccines and immune-based therapies in immune-compromised patients.","[Nanjappa, Som Gowda; Hernandez-Santos, Nydiaris; Galles, Kevin; Wuethrich, Marcel; Klein, Bruce S.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Suresh, M.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Klein, Bruce S.] Univ Wisconsin, Dept Internal Med, Sch Med & Publ Hlth, Madison, WI USA; [Klein, Bruce S.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA","Nanjappa, SG (reprint author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.",sgnanjappa@pediatrics.wisc.edu; bsklein@wisc.edu,,,"National Institutes of Health [R01 AI040996, R01 AI093553, T32 AI007635, R21AI101976]","This work was supported by National Institutes of Health grants R01 AI040996 (BSK), R01 AI093553 (MW), T32 AI007635 (NHS), and R21AI101976 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,12,12,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005161,10.1371/journal.ppat.1005161,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800033,26367276.0,"DOAJ Gold, Green Published",,,16/08/2019,11,0,9,3248,575,406,169,2673,2303,14,356,9,0,0,0,14,14,0,,11,1,11,0,1,13,13,11,10,0,0,0,0,0,0,0,0,3,3280,45,0,45,145,0,2678,582,45,0,45,145,0,20,,0,0,0,0,9,0,0,1,0,0,0,11,0,0,4.25,5.648695652173913,1.215114104002993,0.21511410400299288,1.2981668537224094,1.0683497536945812,6.034782608695652
393,J,"Paradkar, PN; Duchemin, JB; Rodriguez-Andres, J; Trinidad, L; Walker, PJ",,,,"Paradkar, Prasad N.; Duchemin, Jean-Bernard; Rodriguez-Andres, Julio; Trinidad, Lee; Walker, Peter J.",,,Cullin4 Is Pro-Viral during West Nile Virus Infection of Culex Mosquitoes,PLOS PATHOGENS,,,English,Article,,,,,,,UBIQUITIN-PROTEASOME SYSTEM; JAK-STAT PATHWAY; GENE-EXPRESSION; SIGNALING PATHWAY; RNA INTERFERENCE; LIGASE ACTIVITY; RING FINGER; PROTEIN; HOST; REPLICATION,"Although mosquitoes serve as vectors of many pathogens of public health importance, their response to viral infection is poorly understood. It also remains to be investigated whether viruses deploy some mechanism to be able to overcome this immune response. Here, we have used an RNA-Seq approach to identify differentially regulated genes in Culex quin-quefasciatus cells following West Nile virus (WNV) infection, identifying 265 transcripts from various cellular pathways that were either upregulated or downregulated. Ubiquitin-proteasomal pathway genes, comprising 12% of total differentially regulated genes, were selected for further validation by real time RT-qPCR and functional analysis. It was found that treatment of infected cells with proteasomal inhibitor, MG-132, decreased WNV titers, indicating importance of this pathway during infection process. In infection models, the Culex ortholog of mammalian Cul4A/B (cullin RING ubiquitin ligase) was found to be upregulated in vitro as well as in vivo, especially in midguts of mosquitoes. Gene knockdown using dsRNA and overexpression studies indicated that Culex Cul4 acts as a pro-viral protein by degradation of CxSTAT via ubiquitin-proteasomal pathway. We also show that gene knockdown of Culex Cul4 leads to activation of the Jak-STAT pathway in mosquitoes leading to decrease viral replication in the body as well as saliva. Our results suggest a novel mechanism adopted by WNV to overcome mosquito immune response and increase viral replication.","[Paradkar, Prasad N.; Duchemin, Jean-Bernard; Rodriguez-Andres, Julio; Trinidad, Lee; Walker, Peter J.] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia","Paradkar, PN (reprint author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.",Prasad.Paradkar@csiro.au,"Walker, Peter/H-6059-2013; Duchemin, Jean-Bernard/D-7000-2011","Walker, Peter/0000-0003-1851-642X; Duchemin, Jean-Bernard/0000-0001-5044-4855; Rodriguez-Andres, Julio/0000-0002-9277-9925",Australian Research Council via Discovery Early Career Research Award [DE120102166],"This work was supported by Australian Research Council via Discovery Early Career Research Award to PNP (DE120102166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,14,14,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005143,10.1371/journal.ppat.1005143,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800019,26325027.0,"DOAJ Gold, Green Published",,,16/08/2019,14,0,3,3623,571,382,189,3052,2612,18,422,3,0,0,0,12,12,0,,19,5,19,0,5,14,14,8,7,0,0,0,0,0,0,0,0,0,3678,64,0,165,115,3,3060,578,64,0,165,115,3,40,,3,1,0,0,0,0,0,1,0,0,0,19,0,0,27.346,6.345008756567426,1.1870904325032765,0.18709043250327653,1.2637614678899083,1.0645873585426442,6.754816112084063
394,J,"Rall, G",,,,"Rall, Glenn",,,"Here I Am, Despite Myself",PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"Fox Chase Canc Ctr, Philadelphia, PA 19111 USA","Rall, G (reprint author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.",glenn.rall@fccc.edu,,"Rall, Glenn/0000-0003-2717-3238",,,,0,0,0,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005106,10.1371/journal.ppat.1005106,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800008,26356415.0,"DOAJ Gold, Green Published",,,16/08/2019,0,11,0,4281,244,205,39,4037,3824,15,198,0,5,0,0,0,0,1,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,10,4302,0,0,0,47,0,4043,252,0,0,0,47,0,7,,0,0,0,0,17,0,1,1,0,0,0,1,0,0,9.85,17.545081967213115,1.0604409214763437,0.06044092147634382,1.077285112707456,1.0158841392198084,17.82377049180328
395,J,"Schafer, JL; Ries, M; Guha, N; Connole, M; Colantonio, AD; Wiertz, EJ; Wilson, NA; Kaur, A; Evans, DT",,,,"Schafer, Jamie L.; Ries, Moritz; Guha, Natasha; Connole, Michelle; Colantonio, Arnaud D.; Wiertz, Emmanuel J.; Wilson, Nancy A.; Kaur, Amitinder; Evans, David T.",,,Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNOGLOBULIN-LIKE RECEPTOR; SELECTIVE DOWN-REGULATION; HIV-1 NEF PROTEIN; CLASS-I MOLECULES; HLA CLASS-I; INHIBITORY RECEPTOR; CRYSTAL-STRUCTURE; RHESUS MACAQUE; DISEASE PROGRESSION; NK CELLS,"Natural killer (NK) cell responses in primates are regulated in part through interactions between two highly polymorphic molecules, the killer-cell immunoglobulin-like receptors (KIRs) on NK cells and their major histocompatibility complex (MHC) class I ligands on target cells. We previously reported that the binding of a common MHC class I molecule in the rhesus macaque, Mamu-A1*002, to the inhibitory receptor Mamu-KIR3DL05 is stabilized by certain simian immunodeficiency virus (SIV) peptides, but not by others. Here we investigated the functional implications of these interactions by testing SIV peptides bound by Mamu-A1*002 for the ability to modulate Mamu-KIR3DL05(+) NK cell responses. Twenty-eight of 75 SIV peptides bound by Mamu-A1*002 suppressed the cytolytic activity of primary Mamu-KIR3DL05+ NK cells, including three immunodominant CD8(+) T cell epitopes previously shown to stabilize Mamu-A1*002 tetramer binding to Mamu-KIR3DL05. Substitutions at C-terminal positions changed inhibitory peptides into disinhibitory peptides, and vice versa, without altering binding to Mamu-A1*002. The functional effects of these peptide variants on NK cell responses also corresponded to their effects on Mamu-A1*002 tetramer binding to Mamu-KIR3DL05. In assays with mixtures of inhibitory and disinhibitory peptides, low concentrations of inhibitory peptides dominated to suppress NK cell responses. Consistent with the inhibition of Mamu-KIR3DL05+ NK cells by viral epitopes presented by MamuA1*002, SIV replication was significantly higher in Mamu-A1*002(+) CD4(+) lymphocytes co-cultured with Mamu-KIR3DL05+ NK cells than with Mamu-KIR3DL05(-) NK cells. These results demonstrate that viral peptides can differentially affect NK cell responses by modulating MHC class I interactions with inhibitory KIRs, and provide a mechanism by which immunodeficiency viruses may evade NK cell responses.","[Schafer, Jamie L.; Guha, Natasha; Evans, David T.] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA; [Ries, Moritz; Wilson, Nancy A.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Connole, Michelle; Colantonio, Arnaud D.; Kaur, Amitinder] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Immunol, Southborough, MA 01772 USA; [Wiertz, Emmanuel J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands","Schafer, JL (reprint author), Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA.",dtevans2@wisc.edu,,,"National Institutes of Health Public Health Service grants [AI095098, AI098485]; PHS grants [OD011103, OD010849]","This research was supported by the National Institutes of Health (http://www.nih.gov/) Public Health Service grants AI095098 and AI098485 to DTE. Additional support was provided by PHS grants OD011103 and OD010849. DTE is an Elizabeth Glaser Scientist of the Elizabeth Glaser Pediatric AIDS Foundation (http://www.pedaids.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,53,11,11,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005145,10.1371/journal.ppat.1005145,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800020,26333068.0,"DOAJ Gold, Green Published",,,16/08/2019,11,3,9,3538,443,307,136,3095,2674,19,402,9,1,0,0,10,10,0,,0,4,0,0,4,11,11,10,9,0,0,0,0,0,0,0,2,2,3563,52,0,54,247,0,3090,443,52,0,54,247,0,30,,0,0,0,0,4,0,0,0,0,0,0,13,0,0,1.75,7.986455981941309,1.1431340872374798,0.1431340872374798,1.2478190630048465,1.0915771622385528,8.717832957110609
396,J,"Shu, Q; Lennemann, NJ; Sarkar, SN; Sadovsky, Y; Coyne, CB",,,,"Shu, Qian; Lennemann, Nicholas J.; Sarkar, Saumendra N.; Sadovsky, Yoel; Coyne, Carolyn B.",,,ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry,PLOS PATHOGENS,,,English,Article,,,,,,,VESICULAR STOMATITIS-VIRUS; INTESTINAL EPITHELIAL-CELLS; WEST-NILE-VIRUS; DENGUE-VIRUS; MEMBRANE TRAFFICKING; COXSACKIEVIRUS ENTRY; BINDING-PROTEIN; CENTAURIN-ALPHA; ACRIDINE-ORANGE; TIGHT JUNCTIONS,"Interferon stimulated genes (ISGs) target viruses at various stages of their infectious life cycles, including at the earliest stage of viral entry. Here we identify ArfGAP with dual pleckstrin homology (PH) domains 2 (ADAP2) as a gene upregulated by type I IFN treatment in a STAT1-dependent manner. ADAP2 functions as a GTPase-activating protein (GAP) for Arf6 and binds to phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) and PI(3,4)P-2. We show that overexpression of ADAP2 suppresses dengue virus (DENV) and vesicular stomatitis virus (VSV) infection in an Arf6 GAP activity-dependent manner, while exerting no effect on coxsackievirus B (CVB) or Sendai virus (SeV) replication. We further show that ADAP2 expression induces macropinocytosis and that ADAP2 strongly associates with actin-enriched membrane ruffles and with Rab8a- and LAMP1-, but not EEA1- or Rab7-, positive vesicles. Utilizing two techniques-light-sensitive neutral red (NR)-containing DENV and fluorescence assays for virus internalization-we show that ADAP2 primarily restricts DENV infection at the stage of virion entry and/or intracellular trafficking and that incoming DENV and VSV particles associate with ADAP2 during their entry. Taken together, this study identifies ADAP2 as an ISG that exerts antiviral effects against RNA viruses by altering Arf6-mediated trafficking to disrupt viral entry.","[Shu, Qian] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Shu, Qian; Lennemann, Nicholas J.; Sarkar, Saumendra N.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Sarkar, Saumendra N.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA","Shu, Q (reprint author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.",coynec2@pitt.edu,"Sarkar, Saumendra N/B-5038-2011","Sarkar, Saumendra N/0000-0002-2850-6121","NIH [NIH R01-AI081759, NIH-R01-HD075665]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award","This work was supported by NIH R01-AI081759 (CBC) (http://www.niaid.nih.gov/Pages/default.aspx) and NIH-R01-HD075665 (CBC and YS) (http://www.nichd.nih.gov/Pages/index.aspx). CBC is a recipient of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award (http://www.bwfund.org/grant-programs/infectious-diseases/investigators-pathogenesis-infectious-disease-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,9,10,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005150,10.1371/journal.ppat.1005150,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800025,26372645.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,10,8,37,6892,1123,809,314,5769,4536,19,1214,35,4,12,0,11,11,1,,45,3,43,2,3,12,11,12,9,0,0,0,0,0,0,0,4,0,6991,321,0,92,175,1,5825,1138,164,0,92,175,1,28,,0,0,0,0,12,0,1,1,0,0,0,44,2,0,6.6,6.13713268032057,1.1946611197781245,0.19466111977812445,1.297798578609811,1.08633197910621,6.666963490650044
397,J,"Strnadova, P; Ren, HW; Valentine, R; Mazzon, M; Sweeney, TR; Brierley, I; Smith, GL",,,,"Strnadova, Pavla; Ren, Hongwei; Valentine, Robert; Mazzon, Michela; Sweeney, Trevor R.; Brierley, Ian; Smith, Geoffrey L.",,,Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; STEROID-HORMONE SYNTHESIS; T-CELL MEMORY; BINDING-PROTEIN; GENE-EXPRESSION; POLY(A)-BINDING PROTEIN; ANTIVIRAL RESPONSES; PROMOTES VIRULENCE; DECAPPING ENZYME; INFECTED CELLS,"Vaccinia virus (VACV) is the prototypic orthopoxvirus and the vaccine used to eradicate smallpox. Here we show that VACV strain Western Reserve protein 169 is a cytoplasmic polypeptide expressed early during infection that is excluded from virus factories and inhibits the initiation of cap-dependent and cap-independent translation. Ectopic expression of protein 169 causes the accumulation of 80S ribosomes, a reduction of polysomes, and inhibition of protein expression deriving from activation of multiple innate immune signaling pathways. A virus lacking 169 (v Delta 169) replicates and spreads normally in cell culture but is more virulent than parental and revertant control viruses in intranasal and intradermal murine models of infection. Intranasal infection by v Delta 169 caused increased pro-inflammatory cytokines and chemokines, infiltration of pulmonary leukocytes, and lung weight. These alterations in innate immunity resulted in a stronger CD8(+) T-cell memory response and better protection against virus challenge. This work illustrates how inhibition of host protein synthesis can be a strategy for virus suppression of innate and adaptive immunity.","[Strnadova, Pavla; Ren, Hongwei; Mazzon, Michela; Sweeney, Trevor R.; Brierley, Ian; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Strnadova, Pavla; Ren, Hongwei; Valentine, Robert; Mazzon, Michela; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Dept Virol, Fac Med, London, England","Strnadova, P (reprint author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.",gls37@cam.ac.uk,,"Smith, Geoffrey L/0000-0002-3730-9955; Sweeney, Trevor/0000-0003-4016-7326","Wellcome Trust [090315]; UK Medical Research Council [G0800151]; Biotechnology and Biological Sciences Research Council [BB/L000334/1, BB/G008205/1]; Medical Research Council [G0800151, MR/M011747/1]","This work was supported by grants from the Wellcome Trust (090315) and the UK Medical Research Council (G0800151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,79,16,16,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005151,10.1371/journal.ppat.1005151,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800026,26334635.0,"DOAJ Gold, Green Published",,,16/08/2019,15,1,27,4931,774,585,189,4157,3499,27,631,27,1,0,0,15,15,0,,32,0,32,0,0,17,15,17,12,0,0,0,0,0,0,0,0,7,4970,29,0,295,15,0,4171,783,29,0,295,15,0,16,,0,0,0,0,3,0,0,0,0,0,0,32,0,0,1.5,6.370801033591731,1.1861919653596344,0.18619196535963436,1.2061582872263652,1.0168322855404583,6.478036175710594
398,J,"Sun, Y; Jain, D; Koziol-White, CJ; Genoyer, E; Gilbert, M; Tapia, K; Panettieri, RA; Hodinka, RL; Lopez, CB",,,,"Sun, Yan; Jain, Deepika; Koziol-White, Cynthia J.; Genoyer, Emmanuelle; Gilbert, Micah; Tapia, Karla; Panettieri, Reynold A., Jr.; Hodinka, Richard L.; Lopez, Carolina B.",,,Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans,PLOS PATHOGENS,,,English,Article,,,,,,,INTERFERING PARTICLES; DENDRITIC CELLS; EXPRESSION; LAMBDA; ACTIVATION; CLEARANCE; RNA; IMMUNOPATHOLOGY; MECHANISMS; IMMUNITY,"Human respiratory syncytial virus (RSV) is a major cause of severe respiratory illness in children and susceptible adults. RSV blocks the development of the innate antiviral immune response and can grow to high titers in the respiratory tract. Here we demonstrate that immunostimulatory defective viral genomes (iDVGs) that are naturally generated during RSV replication are strong inducers of the innate antiviral response to RSV in mice and humans. In mice, RSV iDVGs stimulated the expression of antiviral genes, restricted viral replication, and prevented weight loss and lung inflammation. In human cells, the antiviral response to RSV iDVGs was dominated by the expression of IFN-lambda 1 over IFN-beta and was driven by rapid intranuclear accumulation of the transcription factor IRF1. RSV iDVGs were detected in respiratory secretions of hospitalized patients, and their amount positively correlated with the level of expression of antiviral genes in the samples. Infection of explanted human lung tissue from different donors revealed that most humans can respond to RSV iDVGs and that the rate of accumulation of iDVGs during infection directly correlates with the quality of the antiviral response. Taken together, our data establish iDVGs as primary triggers of robust antiviral responses to RSV and provide the first evidence for an important biological role for naturally occurring iDVGs during a paramyxovirus infection in humans.","[Sun, Yan; Jain, Deepika; Genoyer, Emmanuelle; Gilbert, Micah; Tapia, Karla; Lopez, Carolina B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Koziol-White, Cynthia J.; Panettieri, Reynold A., Jr.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hodinka, Richard L.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Hodinka, Richard L.] Childrens Hosp Philadelphia, Clin Virol Lab, Philadelphia, PA 19104 USA","Sun, Y (reprint author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.",lopezca@vet.upenn.edu,"Lopez, Carolina/A-8887-2008","Lopez, Carolina/0000-0002-7669-6572","US National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01 AI083284]; University of Pennsylvania Research Foundation","This work was supported by the US National Institutes of Health, National Institute of Allergy and Infectious Diseases (R01 AI083284 to CBL) and by The University of Pennsylvania Research Foundation (CBL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,55,29,30,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005122,10.1371/journal.ppat.1005122,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800011,26336095.0,"DOAJ Gold, Green Published",,,16/08/2019,28,6,39,6318,1055,786,269,5263,4137,25,1101,39,6,1,2,33,33,3,,59,0,59,0,0,29,29,16,26,0,0,0,0,0,0,1,3,6,6386,126,2,92,4,0,5313,1068,126,2,92,4,0,5,,7,1,0,1,11,0,1,0,1,0,0,59,0,0,66.85,5.988625592417062,1.2004560136804103,0.2004560136804104,1.2380771423142694,1.0313390313390314,6.176303317535545
399,J,"Chertow, JH; Alkaitis, MS; Nardone, G; Ikeda, AK; Cunnington, AJ; Okebe, J; Ebonyi, AO; Njie, M; Correa, S; Jayasooriya, S; Casals-Pascual, C; Billker, O; Conway, DJ; Walther, M; Ackerman, H",,,,"Chertow, Jessica H.; Alkaitis, Matthew S.; Nardone, Glenn; Ikeda, Allison K.; Cunnington, Aubrey J.; Okebe, Joseph; Ebonyi, Augustine O.; Njie, Madi; Correa, Simon; Jayasooriya, Shamanthi; Casals-Pascual, Climent; Billker, Oliver; Conway, David J.; Walther, Michael; Ackerman, Hans",,,Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis,PLOS PATHOGENS,,,English,Article,,,,,,,SERUM ASYMMETRIC DIMETHYLARGININE; ENDOGENOUS INHIBITOR; CEREBRAL MALARIA; PARASITE SEQUESTRATION; CLINICAL-FEATURES; DEPENDENT PATHWAY; AFRICAN CHILDREN; N-G; ARGININE; ADMA,"Inhibition of nitric oxide (NO) signaling may contribute to pathological activation of the vascular endothelium during severe malaria infection. Dimethylarginine dimethylaminohydrolase (DDAH) regulates endothelial NO synthesis by maintaining homeostasis between asymmetric dimethylarginine (ADMA), an endogenous NO synthase (NOS) inhibitor, and arginine, the NOS substrate. We carried out a community-based case-control study of Gambian children to determine whether ADMA and arginine homeostasis is disrupted during severe or uncomplicated malaria infections. Circulating plasma levels of ADMA and arginine were determined at initial presentation and 28 days later. Plasma ADMA/arginine ratios were elevated in children with acute severe malaria compared to 28-day follow-up values and compared to children with uncomplicated malaria or healthy children (p<0.0001 for each comparison). To test the hypothesis that DDAH1 is inactivated during Plasmodium infection, we examined DDAH1 in a mouse model of severe malaria. Plasmodium berghei ANKA infection inactivated hepatic DDAH1 via a post-transcriptional mechanism as evidenced by stable mRNA transcript number, decreased DDAH1 protein concentration, decreased enzyme activity, elevated tissue ADMA, elevated ADMA/arginine ratio in plasma, and decreased whole blood nitrite concentration. Loss of hepatic DDAH1 activity and disruption of ADMA/arginine homeostasis may contribute to severe malaria pathogenesis by inhibiting NO synthesis.","[Chertow, Jessica H.; Alkaitis, Matthew S.; Ikeda, Allison K.; Ackerman, Hans] NIAID, Lab Malaria & Vector Res, Div Intramural Res, NIH, Rockville, MD 20852 USA; [Alkaitis, Matthew S.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Headington Oxford, England; [Nardone, Glenn] NIAID, Res Technol Branch, Div Intramural Res, NIH, Rockville, MD USA; [Cunnington, Aubrey J.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England; [Okebe, Joseph; Ebonyi, Augustine O.; Njie, Madi; Correa, Simon; Jayasooriya, Shamanthi; Conway, David J.; Walther, Michael] MRC Unit, Fajara, Gambia; [Casals-Pascual, Climent] Wellcome Trust Ctr Human Genet, Oxford, England; [Billker, Oliver] Wellcome Trust Sanger Inst, Hinxton Cambridge, England; [Conway, David J.] London Sch Hyg & Trop Med, London WC1, England","Chertow, JH (reprint author), NIAID, Lab Malaria & Vector Res, Div Intramural Res, NIH, Rockville, MD 20852 USA.",hans.ackerman@nih.gov,"Ackerman, Hans/U-9621-2019; Casals-Pascual, Climent/N-7692-2018","Ackerman, Hans/0000-0003-4940-3305; Conway, David/0000-0002-8711-3037; Cunnington, Aubrey/0000-0002-1305-3529; Billker, Oliver/0000-0003-1716-168X; Okebe, Joseph/0000-0001-5466-1611; Casals-Pascual, Climent/0000-0002-0867-8954","NIAID Division of Intramural Research; Wellcome Trust [WT098051]; Medical Research Council [G0701427, MR/L006529/1, MC_U190092703]","Funding to support patient enrollment and sample collection was provided by the MRC Unit, The Gambia. Biochemical analyses of clinical samples and animal model experiments were funded by the NIAID Division of Intramural Research and the Wellcome Trust (grant WT098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,80,10,10,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005119,10.1371/journal.ppat.1005119,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800009,26407009.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,10,4,22,2924,577,432,145,2347,1969,21,357,20,4,0,0,11,11,0,,28,7,26,2,7,11,10,11,5,0,0,0,0,0,0,0,0,1,2945,69,0,124,123,0,2350,582,69,0,124,123,0,13,,0,0,0,0,5,0,0,1,0,0,0,26,2,0,2.6,5.067590987868284,1.245845760545377,0.24584576054537707,1.3365999147848318,1.0728454172366622,5.436741767764298
400,J,"Damouche, A; Lazure, T; Avettand-Fenoel, V; Huot, N; Dejucq-Rainsford, N; Satie, AP; Melard, A; David, L; Gommet, C; Ghosn, J; Noel, N; Pourcher, G; Martinez, V; Benoist, S; Bereziat, V; Cosma, A; Favier, B; Vaslin, B; Rouzioux, C; Capeau, J; Muller-Trutwin, M; Dereuddre-Bosquet, N; Le Grand, R; Lambotte, O; Bourgeois, C",,,,"Damouche, Abderaouf; Lazure, Thierry; Avettand-Fenoel, Veronique; Huot, Nicolas; Dejucq-Rainsford, Nathalie; Satie, Anne-Pascale; Melard, Adeline; David, Ludivine; Gommet, Celine; Ghosn, Jade; Noel, Nicolas; Pourcher, Guillaume; Martinez, Valerie; Benoist, Stephane; Bereziat, Veronique; Cosma, Antonio; Favier, Benoit; Vaslin, Bruno; Rouzioux, Christine; Capeau, Jacqueline; Mueller-Trutwin, Michaela; Dereuddre-Bosquet, Nathalie; Le Grand, Roger; Lambotte, Olivier; Bourgeois, Christine",,,Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; ACTIVE ANTIRETROVIRAL THERAPY; MESSENGER-RNA EXPRESSION; LONG-TERM NONPROGRESSORS; MEMORY T-CELLS; IMMUNE ACTIVATION; HUMAN ADIPOCYTES; SIVMAC251 INFECTION; METABOLIC-DISORDERS,"Two of the crucial aspects of human immunodeficiency virus (HIV) infection are (i) viral persistence in reservoirs (precluding viral eradication) and (ii) chronic inflammation (directly associated with all-cause morbidities in antiretroviral therapy (ART)-controlled HIV-infected patients). The objective of the present study was to assess the potential involvement of adipose tissue in these two aspects. Adipose tissue is composed of adipocytes and the stromal vascular fraction (SVF); the latter comprises immune cells such as CD4(+) T cells and macrophages (both of which are important target cells for HIV). The inflammatory potential of adipose tissue has been extensively described in the context of obesity. During HIV infection, the inflammatory profile of adipose tissue has been revealed by the occurrence of lipodystrophies (primarily related to ART). Data on the impact of HIV on the SVF (especially in individuals not receiving ART) are scarce. We first analyzed the impact of simian immunodeficiency virus (SIV) infection on abdominal subcutaneous and visceral adipose tissues in SIVmac251 infected macaques and found that both adipocytes and adipose tissue immune cells were affected. The adipocyte density was elevated, and adipose tissue immune cells presented enhanced immune activation and/or inflammatory profiles. We detected cell-associated SIV DNA and RNA in the SVF and in sorted CD4(+) T cells and macrophages from adipose tissue. We demonstrated that SVF cells (including CD4(+) T cells) are infected in ART-controlled HIV-infected patients. Importantly, the production of HIV RNA was detected by in situ hybridization, and after the in vitro reactivation of sorted CD4(+) T cells from adipose tissue. We thus identified adipose tissue as a crucial cofactor in both viral persistence and chronic immune activation/inflammation during HIV infection. These observations open up new therapeutic strategies for limiting the size of the viral reservoir and decreasing low-grade chronic inflammation via the modulation of adipose tissue-related pathways.","[Damouche, Abderaouf; Noel, Nicolas; Cosma, Antonio; Favier, Benoit; Vaslin, Bruno; Dereuddre-Bosquet, Nathalie; Le Grand, Roger; Lambotte, Olivier; Bourgeois, Christine] Univ Paris 11, UMR 1184, Le Kremlin Bicetre, France; [Damouche, Abderaouf; Gommet, Celine; Noel, Nicolas; Cosma, Antonio; Favier, Benoit; Vaslin, Bruno; Dereuddre-Bosquet, Nathalie; Le Grand, Roger; Lambotte, Olivier; Bourgeois, Christine] CEA, DSV iMETI, IDMIT, Fontenay Aux Roses, France; [Damouche, Abderaouf; Noel, Nicolas; Cosma, Antonio; Favier, Benoit; Vaslin, Bruno; Dereuddre-Bosquet, Nathalie; Le Grand, Roger; Lambotte, Olivier; Bourgeois, Christine] INSERM, U1184, Immunol Viral Infect & Autoimmune Dis, F-94275 Le Kremlin Bicetre, France; [Lazure, Thierry] Hop Bicetre, AP HP, Serv Anatomopathol, Le Kremlin Bicetre, France; [Avettand-Fenoel, Veronique; Melard, Adeline; David, Ludivine; Ghosn, Jade; Rouzioux, Christine] Univ Paris 05, Sorbonne Paris Cite, Fac Med, EA 7327, Paris, France; [Avettand-Fenoel, Veronique; Melard, Adeline; David, Ludivine; Rouzioux, Christine] Hop Necker Enfants Malad, AP HP, Virol Lab, Paris, France; [Huot, Nicolas; Mueller-Trutwin, Michaela] Inst Pasteur, Unite HIV Inflammat & Persistance, Paris, France; [Dejucq-Rainsford, Nathalie; Satie, Anne-Pascale] Univ Rennes 1, INSERM, IRSET U1085, Rennes, France; [Noel, Nicolas; Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France; [Pourcher, Guillaume] Hop Antoine Beclere, AP HP, Serv Chirurg Viscerale Minimale Invas, Clamart, France; [Pourcher, Guillaume] Hop Paul Brousse, INSERM U972, Villejuif, France; [Martinez, Valerie] Hop Antoine Beclere, AP HP, Serv Med Interne & Immunol Clin, Clamart, France; [Benoist, Stephane] Hop Bicetre, AP HP, Serv Chirurg Gen & Digest, Le Kremlin Bicetre, France; [Bereziat, Veronique; Capeau, Jacqueline] CDR St Antoine, INSERM UMR S938, Paris, France; [Bereziat, Veronique; Capeau, Jacqueline] Univ Paris 06, Sorbonne Univ, Paris, France; [Bereziat, Veronique; Capeau, Jacqueline] Hop Tenon, AP HP, Serv Biochim & Hormonol, F-75970 Paris, France; [Bereziat, Veronique; Capeau, Jacqueline] ICAN, Inst Cardiometab & Nutr, Paris, France","Damouche, A (reprint author), Univ Paris 11, UMR 1184, Le Kremlin Bicetre, France.",christine.bourgeois@u-psud.fr,"Bourgeois, Christine/L-5944-2018; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Avettand-Fenoel, Veronique/O-6285-2017","Bourgeois, Christine/0000-0003-1146-6087; Cosma, Antonio/0000-0002-3686-8034; Pourcher, Guillaume/0000-0001-9788-628X; Muller-Trutwin, Michaela/0000-0002-3854-2396; Avettand-Fenoel, Veronique/0000-0002-7022-2990","Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS, France)","This study was supported by the Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,80,80,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005153,10.1371/journal.ppat.1005153,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800028,26402858.0,"DOAJ Gold, Green Published",,,16/08/2019,71,20,69,8908,1815,1358,457,7093,5737,41,1315,69,14,0,0,77,77,3,,194,5,99,0,5,82,79,82,55,0,0,0,0,0,0,2,6,8,9021,81,4,104,325,1,7140,1843,81,4,104,325,1,38,,4,2,0,0,26,0,1,1,0,0,0,99,0,0,55.51600000000001,4.907988980716254,1.2558860848724094,0.25588608487240944,1.3290568165797265,1.0582622361921867,5.193939393939394
401,J,"Deymier, MJ; Ende, Z; Fenton-May, AE; Dilernia, DA; Kilembe, W; Allen, SA; Borrow, P; Hunter, E",,,,"Deymier, Martin J.; Ende, Zachary; Fenton-May, Angharad E.; Dilernia, Dario A.; Kilembe, William; Allen, Susan A.; Borrow, Persephone; Hunter, Eric",,,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS MOLECULAR CLONES; DISEASE PROGRESSION; CCR5 UTILIZATION; TRANSMITTED/FOUNDER; GLYCOSYLATION; LENGTH; NEUTRALIZATION; IDENTIFICATION; AMPLIFICATION,"Heterosexual transmission of HIV-1 is characterized by a genetic bottleneck that selects a single viral variant, the transmitted/founder (TF), during most transmission events. To assess viral characteristics influencing HIV-1 transmission, we sequenced 167 near full-length viral genomes and generated 40 infectious molecular clones (IMC) including TF variants and multiple non-transmitted (NT) HIV-1 subtype C variants from six linked heterosexual transmission pairs near the time of transmission. Consensus-like genomes sensitive to donor antibodies were selected for during transmission in these six transmission pairs. However, TF variants did not demonstrate increased viral fitness in terms of particle infectivity or viral replicative capacity in activated peripheral blood mononuclear cells (PBMC) and monocyte-derived dendritic cells (MDDC). In addition, resistance of the TF variant to the antiviral effects of interferon-a (IFN-alpha) was not significantly different from that of non-transmitted variants from the same transmission pair. Thus neither in vitro viral replicative capacity nor IFN-a resistance discriminated the transmission potential of viruses in the quasispecies of these chronically infected individuals. However, our findings support the hypothesis that within-host evolution of HIV-1 in response to adaptive immune responses reduces viral transmission potential.","[Deymier, Martin J.; Ende, Zachary; Dilernia, Dario A.; Hunter, Eric] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Fenton-May, Angharad E.; Borrow, Persephone] Univ Oxford, Nuffield Dept Med, Oxford, England; [Kilembe, William] Zambia Emory HIV Res Project, Lusaka, Zambia; [Allen, Susan A.; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA","Deymier, MJ (reprint author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.",ehunte4@emory.edu,,"Borrow, Persephone/0000-0002-3877-9780","National Institute of Allergy and Infectious Diseases, National Institutes of Health [R37 AI51231, R01 AI64060, R01s AI111789, AI114266]; Yerkes National Primate Research Center through Office of Research Infrastructure Programs [OD P51OD11132]; International AIDS Vaccine Initiative (SAA); Bill AMP; Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); Senior Jenner Fellowship; Jenner Institute Investigator; Chateaubriand Fellowship; Action Cycling Fellowships; Georgia Eminent Scholar","This study was funded by R37 AI51231 and R01 AI64060 (EH) and R01s AI111789 and AI114266 (PB) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. This work was also supported by the Yerkes National Primate Research Center base grant (OD P51OD11132) through the Office of Research Infrastructure Programs. This study is supported in part by the International AIDS Vaccine Initiative (SAA), whose work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available www.iavi.org. The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. PB received salary support from a Senior Jenner Fellowship and is a Jenner Institute Investigator. MJD was supported in part by a Chateaubriand Fellowship. MJD and DAD were supported in part by Action Cycling Fellowships. EH is a Georgia Eminent Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,54,41,42,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005154,10.1371/journal.ppat.1005154,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800029,26378795.0,"DOAJ Gold, Green Published",,,16/08/2019,40,106,47,5811,817,518,299,4994,4058,24,912,47,2,0,0,42,42,0,,62,5,62,0,5,42,42,25,36,1,0,0,1,0,0,0,103,8,5921,48,0,71,184,1,5015,833,48,0,71,184,1,73,,0,0,0,0,10,0,1,1,0,0,0,62,0,0,7.0,7.112607099143207,1.1635963155786944,0.16359631557869445,1.2320784941930316,1.0588538977800723,7.531211750305998
402,J,"Dorobantu, CM; Albulescu, L; Harak, C; Feng, Q; van Kampen, M; Strating, JRPM; Gorbalenya, AE; Lohmann, V; van der Schaar, HM; van Kuppeveld, FJM",,,,"Dorobantu, Cristina M.; Albulescu, Lucian; Harak, Christian; Feng, Qian; van Kampen, Mirjam; Strating, Jeroen R. P. M.; Gorbalenya, Alexander E.; Lohmann, Volker; van der Schaar, Hilde M.; van Kuppeveld, Frank J. M.",,,Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C Virus,PLOS PATHOGENS,,,English,Article,,,,,,,OXYSTEROL-BINDING-PROTEIN; EXCHANGE FACTOR GBF1; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; ENTEROVIRUS REPLICATION; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; III-ALPHA; REPRODUCTIVE FAILURE; COXSACKIEVIRUS B3; SECRETORY PATHWAY,"Cardioviruses, including encephalomyocarditis virus (EMCV) and the human Saffold virus, are small non-enveloped viruses belonging to the Picornaviridae, a large family of positive-sense RNA [(+)RNA] viruses. All (+) RNA viruses remodel intracellular membranes into unique structures for viral genome replication. Accumulating evidence suggests that picornaviruses from different genera use different strategies to generate viral replication organelles (ROs). For instance, enteroviruses (e.g. poliovirus, coxsackievirus, rhinovirus) rely on the Golgi-localized phosphatidylinositol 4-kinase III beta (PI4KB), while cardioviruses replicate independently of the kinase. By which mechanisms cardioviruses develop their ROs is currently unknown. Here we show that cardioviruses manipulate another PI4K, namely the ER-localized phosphatidylinositol 4-kinase III alpha (PI4KA), to generate PI4P-enriched ROs. By siRNA-mediated knockdown and pharmacological inhibition, we demonstrate that PI4KA is an essential host factor for EMCV genome replication. We reveal that the EMCV nonstructural protein 3A interacts with and is responsible for PI4KA recruitment to viral ROs. The ensuing phosphatidylinositol 4-phosphate (PI4P) proved important for the recruitment of oxysterol-binding protein (OSBP), which delivers cholesterol to EMCV ROs in a PI4P-dependent manner. PI4P lipids and cholesterol are shown to be required for the global organization of the ROs and for viral genome replication. Consistently, inhibition of OSBP expression or function efficiently blocked EMCV RNA replication. In conclusion, we describe for the first time a cellular pathway involved in the biogenesis of cardiovirus ROs. Remarkably, the same pathway was reported to promote formation of the replication sites of hepatitis C virus, a member of the Flaviviridae family, but not other picornaviruses or flaviviruses. Thus, our results highlight the convergent recruitment by distantly related (+)RNA viruses of a host lipid-modifying pathway underlying formation of viral replication sites.","[Dorobantu, Cristina M.; Albulescu, Lucian; Feng, Qian; van Kampen, Mirjam; Strating, Jeroen R. P. M.; van der Schaar, Hilde M.; van Kuppeveld, Frank J. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands; [Harak, Christian; Lohmann, Volker] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Gorbalenya, Alexander E.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Gorbalenya, Alexander E.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia","Dorobantu, CM (reprint author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands.",f.j.m.vankuppeveld@uu.nl,"Dorobantu, Cristina/C-1786-2018; Gorbalenya, Alexander/J-4818-2012; Strating, Jeroen/F-4399-2019; Lohmann, Volker/H-4211-2019","Dorobantu, Cristina/0000-0003-1854-7779; Gorbalenya, Alexander/0000-0002-4967-7341; Strating, Jeroen/0000-0003-2509-5213; Lohmann, Volker/0000-0001-8719-7608; van Kampen, Mirjam/0000-0002-3174-9650","European Union 7th Framework (EUVIRNA Marie Curie Initial Training Network) [264286]; Netherlands Organization for Scientific Research (NWO) [ALW-820.02.018, VICI-91812628, VENI-722.012.006, VENI-863.12.005]; Deutsche Forschungsgemeinschaft [LO 1556/1-2, TRR77, TPA1]; Leiden University Medical Center; Moscow State University (MoBiLe); Leiden University Fund","This work was supported by grants from the European Union 7th Framework (EUVIRNA Marie Curie Initial Training Network, grant agreement number 264286) to FJMVvK, the Netherlands Organization for Scientific Research (NWO): ALW-820.02.018 and VICI-91812628 (FJMvK), VENI-722.012.006 (JRPMS), and VENI-863.12.005 (HMvdS), the Deutsche Forschungsgemeinschaft (LO 1556/1-2 and TRR77, TPA1) to VL, and the Collaborative Agreement on Bioinformatics between Leiden University Medical Center and Moscow State University (MoBiLe) and the Leiden University Fund to AEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,88,45,47,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005185,10.1371/journal.ppat.1005185,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800041,26406250.0,"DOAJ Gold, Green Published",,,16/08/2019,47,2,54,6493,1069,736,333,5424,4148,18,1258,54,2,0,0,48,48,0,,127,2,65,0,2,49,49,49,25,0,0,0,0,0,0,0,0,0,6503,169,0,438,255,0,5399,1069,169,0,438,255,0,35,,0,0,0,0,4,0,0,1,0,0,0,65,0,0,2.6,6.073900841908325,1.1970870206489677,0.19708702064896755,1.2771017699115044,1.0668412136146619,6.479887745556595
403,J,"Drecktrah, D; Lybecker, M; Popitsch, N; Rescheneder, P; Hall, LS; Samuels, DS",,,,"Drecktrah, Dan; Lybecker, Meghan; Popitsch, Niko; Rescheneder, Philipp; Hall, Laura S.; Samuels, D. Scott",,,The Borrelia burgdorferi RelA/SpoT Homolog and Stringent Response Regulate Survival in the Tick Vector and Global Gene Expression during Starvation,PLOS PATHOGENS,,,English,Article,,,,,,,LYME-DISEASE SPIROCHETE; CYCLIC-DI-GMP; OUTER-SURFACE PROTEIN; PYROPHOSPHATE-DEPENDENT PHOSPHOFRUCTOKINASE; STRESS-RESPONSE; LIFE-CYCLE; DIFFERENTIAL REGULATION; (P)PPGPP METABOLISM; MICROARRAY ANALYSIS; IXODES-SCAPULARIS,"As the Lyme disease bacterium Borrelia burgdorferi traverses its enzootic cycle, alternating between a tick vector and a vertebrate host, the spirochete must adapt and persist in the tick midgut under prolonged nutrient stress between blood meals. In this study, we examined the role of the stringent response in tick persistence and in regulation of gene expression during nutrient limitation. Nutritionally starving B. burgdorferi in vitro increased the levels of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp), collectively referred to as (p)ppGpp, products of the bifunctional synthetase/hydrolase Rel(Bbu) (RelA/SpoT homolog). Conversely, returning B. burgdorferi to a nutrient-rich medium decreased (p) ppGpp levels. B. burgdorferi survival in ticks between the larval and nymph blood meals, and during starvation in vitro, was dependent on RelBbu. Furthermore, normal morphological conversion from a flat-wave shape to a condensed round body (RB) form during starvation was dependent on Rel(Bbu); rel(Bbu) mutants more frequently formed RBs, but their membranes were compromised. By differential RNA sequencing analyses, we found that Rel(Bbu) regulates an extensive transcriptome, both dependent and independent of nutrient stress. The Rel(Bbu) regulon includes the glp operon, which is important for glycerol utilization and persistence in the tick, virulence factors and the late phage operon of the 32-kb circular plasmid (cp32) family. In summary, our data suggest that Rel(Bbu) globally modulates transcription in response to nutrient stress by increasing (p) ppGpp levels to facilitate B. burgdorferi persistence in the tick.","[Drecktrah, Dan; Hall, Laura S.; Samuels, D. Scott] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lybecker, Meghan] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA; [Lybecker, Meghan] Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria; [Popitsch, Niko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford NIHR Biomed Res Ctr, Oxford, England; [Popitsch, Niko; Rescheneder, Philipp] Univ Vienna, Ctr Integrat Bioinformat Vienna, Max F Perutz Labs, Vienna, Austria; [Popitsch, Niko; Rescheneder, Philipp] Med Univ Vienna, Vienna, Austria; [Samuels, D. Scott] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA","Drecktrah, D (reprint author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.",dan.drecktrah@mso.umt.edu,"Samuels, D Scott/L-8726-2017; Samuels, D Scott/B-7549-2012","Samuels, D Scott/0000-0001-8352-7593; Samuels, D Scott/0000-0001-8352-7593",National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI051486]; National Center for Research Resources grant [5P20RR016455-11]; National Institute of General Medical Sciences grant [8 P20 GM103474-11],"This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health grant R01AI051486 (DSS), the National Center for Research Resources grant 5P20RR016455-11 and the National Institute of General Medical Sciences grant 8 P20 GM103474-11. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,170,37,37,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005160,10.1371/journal.ppat.1005160,,,,39,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800032,26474045.0,"DOAJ Gold, Green Published",,,16/08/2019,39,27,41,6733,929,659,270,5804,4815,22,967,41,2,0,0,31,31,0,,47,9,47,0,9,39,39,36,31,0,0,0,0,0,0,0,25,8,6820,110,4,175,534,1,5825,940,110,4,175,534,1,55,,0,0,0,0,10,0,1,1,0,0,0,47,0,0,7.0,7.247578040904198,1.1600620261888352,0.16006202618883528,1.2860096485182633,1.1085697311748106,8.034445640473628
404,J,"Gault, J; Ferber, M; Machata, S; Imhaus, AF; Malosse, C; Charles-Orszag, A; Millien, C; Bouvier, G; Bardiaux, B; Pehau-Arnaudet, G; Klinge, K; Podglajen, I; Ploy, MC; Seifert, HS; Nilges, M; Chamot-Rooke, J; Dumenil, G",,,,"Gault, Joseph; Ferber, Mathias; Machata, Silke; Imhaus, Anne-Flore; Malosse, Christian; Charles-Orszag, Arthur; Millien, Corinne; Bouvier, Guillaume; Bardiaux, Benjamin; Pehau-Arnaudet, Gerard; Klinge, Kelly; Podglajen, Isabelle; Ploy, Marie Cecile; Seifert, H. Steven; Nilges, Michael; Chamot-Rooke, Julia; Dumenil, Guillaume",,,Neisseria meningitidis Type IV Pili Composed of Sequence Invariable Pilins Are Masked by Multisite Glycosylation,PLOS PATHOGENS,,,English,Article,,,,,,,EPITHELIAL-CELLS; POSTTRANSLATIONAL MODIFICATION; PROTEIN GLYCOSYLATION; BIOSYNTHETIC-PATHWAY; ANTIGENIC VARIATION; FUNCTIONAL ANALYSES; MASS-SPECTROMETRY; PHASE VARIATION; GONORRHOEAE; IDENTIFICATION,"The ability of pathogens to cause disease depends on their aptitude to escape the immune system. Type IV pili are extracellular filamentous virulence factors composed of pilin monomers and frequently expressed by bacterial pathogens. As such they are major targets for the host immune system. In the human pathogen Neisseria meningitidis, strains expressing class I pilins contain a genetic recombination system that promotes variation of the pilin sequence and is thought to aid immune escape. However, numerous hypervirulent clinical isolates express class II pilins that lack this property. This raises the question of how they evade immunity targeting type IV pili. As glycosylation is a possible source of antigenic variation it was investigated using top-down mass spectrometry to provide the highest molecular precision on the modified proteins. Unlike class I pilins that carry a single glycan, we found that class II pilins display up to 5 glycosylation sites per monomer on the pilus surface. Swapping of pilin class and genetic background shows that the pilin primary structure determines multisite glycosylation while the genetic background determines the nature of the glycans. Absence of glycosylation in class II pilins affects pilus biogenesis or enhances pilus-dependent aggregation in a strain specific fashion highlighting the extensive functional impact of multisite glycosylation. Finally, molecular modeling shows that glycans cover the surface of class II pilins and strongly decrease antibody access to the polypeptide chain. This strongly supports a model where strains expressing class II pilins evade the immune system by changing their sugar structure rather than pilin primary structure. Overall these results show that sequence invariable class II pilins are cloaked in glycans with extensive functional and immunological consequences.","[Gault, Joseph; Malosse, Christian; Chamot-Rooke, Julia] Inst Pasteur, CNRS UMR 3528, Struct Mass Spectrometry & Prote Unit, Paris, France; [Ferber, Mathias; Bouvier, Guillaume; Bardiaux, Benjamin; Nilges, Michael] Inst Pasteur, CNRS UMR 3528, Unite Bioinformat Struct, Dept Biol Struct & Chim, Paris, France; [Machata, Silke; Imhaus, Anne-Flore; Charles-Orszag, Arthur; Millien, Corinne; Dumenil, Guillaume] Paris Cardiovasc Res Ctr, INSERM, U970, Paris, France; [Machata, Silke; Imhaus, Anne-Flore; Charles-Orszag, Arthur; Millien, Corinne; Dumenil, Guillaume] Univ Paris 05, Fac Med Paris Descartes, Paris, France; [Pehau-Arnaudet, Gerard] CNRS, UMR3528, Paris, France; [Klinge, Kelly; Seifert, H. Steven] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Podglajen, Isabelle] Hop Europeen Georges Pompidou, AP HP, Microbiol Serv, Paris, France; [Ploy, Marie Cecile] Univ Limoges, Fac Med, INSERM UMR1092, Limoges, France","Gault, J (reprint author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.",guillaume.dumenil@inserm.fr,"Ploy, Marie-Cecile/O-7501-2016; Dumenil, Guillaume/N-3377-2019; Dumenil, Guillaume/F-7567-2015; Nilges, Michael/E-4803-2011","Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Nilges, Michael/0000-0002-1451-8092; Bouvier, Guillaume/0000-0003-2792-6084; Bardiaux, Benjamin/0000-0003-4014-9195; Charles-Orszag, Arthur/0000-0002-5185-4124",Avenir INSERM Starting Grant; CODDIM equipment grant (Region Ile de France); Integrative Biology of Emerging Infectious Diseases (IBEID) laboratory of excellence; VIP European Research Council (ERC) starting grant; Wellcome Trust [WT093470AIA]; NIH [R37 AI033493]; Monge PhD scholarship at Ecole Polytechnique; European Union [FP7-IDEAS- ERC 294809],"This work was supported by: the Avenir INSERM Starting Grant (GD); a CODDIM equipment grant (Region Ile de France, GD); the Integrative Biology of Emerging Infectious Diseases (IBEID) laboratory of excellence (GD), the VIP European Research Council (ERC) starting grant (GD); the Wellcome Trust grant WT093470AIA and NIH grant R37 AI033493 (HSS); a Monge PhD scholarship at Ecole Polytechnique (JG); and the European Union (FP7-IDEAS- ERC 294809) (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,21,22,3,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005162,10.1371/journal.ppat.1005162,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800034,26367394.0,"DOAJ Gold, Green Published",,,16/08/2019,24,6,49,6015,880,669,211,5135,4327,24,784,49,4,0,0,22,22,0,,122,1,63,0,1,25,25,18,13,0,0,0,0,0,0,0,2,1,6103,69,0,173,196,2,5157,895,69,0,173,196,2,51,,0,1,0,0,10,0,0,1,0,0,0,59,0,0,12.35,6.8352272727272725,1.1713729308666017,0.17137293086660174,1.2401168451801363,1.058686616791355,7.236363636363636
405,J,"Guo, S; Yang, CY; Diao, B; Huang, XY; Jin, MH; Chen, LL; Yan, WM; Ning, Q; Zheng, LX; Wu, YZ; Chen, YW",,,,"Guo, Sheng; Yang, Chengying; Diao, Bo; Huang, Xiaoyong; Jin, Meihua; Chen, Lili; Yan, Weiming; Ning, Qin; Zheng, Lixin; Wu, Yuzhang; Chen, Yongwen",,,The NLRP3 Inflammasome and IL-1 beta Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis,PLOS PATHOGENS,,,English,Article,,,,,,,IL-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; NALP3 INFLAMMASOME; LIVER-INJURY; VIRUS; ACTIVATION; ROS; CONTRIBUTES; FGL2,"Viral fulminant hepatitis (FH) is a severe disease with high mortality resulting from excessive inflammation in the infected liver. Clinical interventions have been inefficient due to the lack of knowledge for inflammatory pathogenesis in the virus-infected liver. We show that wildtype mice infected with murine hepatitis virus strain-3 (MHV-3), a model for viral FH, manifest with severe disease and high mortality in association with a significant elevation in IL-1 beta expression in the serum and liver. Whereas, the viral infection in IL-1 beta receptor-I deficient (IL-1R1(-/-)) or IL-1R antagonist (IL-1Ra) treated mice, show reductions in virus replication, disease progress and mortality. IL-1R1 deficiency appears to debilitate the virus-induced fibrinogen-like protein-2 (FGL2) production in macrophages and CD45(+) Gr-1(high) neutrophil infiltration in the liver. The quick release of reactive oxygen species (ROS) by the infected macrophages suggests a plausible viral initiation of NLRP3 inflammasome activation. Further experiments show that mice deficient of p47(phox), a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit that controls acute ROS production, present with reductions in NLRP3 inflammasome activation and subsequent IL-1 beta secretion during viral infection, which appears to be responsible for acquiring resilience to viral FH. Moreover, viral infected animals in deficiencies of NLRP3 and Caspase-1, two essential components of the inflammasome complex, also have reduced IL-1 beta induction along with ameliorated hepatitis. Our results demonstrate that the ROS/NLRP3/IL-1 beta axis institutes an essential signaling pathway, which is over activated and directly causes the severe liver disease during viral infection, which sheds light on development of efficient treatments for human viral FH and other severe inflammatory diseases.","[Guo, Sheng; Yang, Chengying; Diao, Bo; Huang, Xiaoyong; Wu, Yuzhang; Chen, Yongwen] Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China; [Jin, Meihua] Yanbian Univ, Dept Pharmacol, Yanji, Jilin Province, Peoples R China; [Chen, Lili] Yanbian Univ, Dept Basic Med, Yanji, Jilin Province, Peoples R China; [Yan, Weiming; Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept & Inst Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Lixin] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA","Guo, S (reprint author), Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China.",wuyuzhang@tmmu.edu.cn; yongwench@163.com,,,Intramural Research Program of US National Institutes of Health,"We wish to thank Dr. Dayan Cao, Huan Xu and Xi Chen for their helpful comments and constructive suggestions. LXZ is supported by the Intramural Research Program of the US National Institutes of Health.",,49,16,17,2,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005155,10.1371/journal.ppat.1005155,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800030,26367131.0,"DOAJ Gold, Green Published",,,16/08/2019,15,0,24,6129,1554,1049,505,4575,3141,18,1416,24,0,0,0,14,14,0,,32,7,32,0,7,16,16,15,11,0,0,0,0,0,0,0,1,2,6208,65,0,78,104,1,4610,1573,65,0,78,104,1,25,,0,0,0,0,2,0,0,1,0,0,0,32,0,0,1.35,3.944015444015444,1.339672131147541,0.33967213114754097,1.393879781420765,1.0404633708598465,4.103603603603603
406,J,"Hu, MM; Wang, C; Li, W; Lu, WP; Bai, ZQ; Qin, D; Yan, Q; Zhu, JZ; Krueger, BJ; Renne, R; Gao, SJ; Lu, C",,,,"Hu, Minmin; Wang, Cong; Li, Wan; Lu, Weiping; Bai, Zhiqiang; Qin, Di; Yan, Qin; Zhu, Jianzhong; Krueger, Brian J.; Renne, Rolf; Gao, Shou-Jiang; Lu, Chun",,,A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; HIV-1 NEF; NEUTROPHIL MIGRATION; ENCODED MICRORNAS; DNA-SEQUENCES; EXPRESSION; VIRUS; REPLICATION; CHEMOTAXIS,"Kaposi's sarcoma (KS) is a highly disseminated angiogenic tumor of endothelial cells linked to infection by Kaposi's sarcoma-associated herpesvirus (KSHV). KSHV encodes more than two dozens of miRNAs but their roles in KSHV-induced tumor dissemination and metastasis remain unknown. Here, we found that ectopic expression of miR-K12-3 (miR-K3) promoted endothelial cell migration and invasion. Bioinformatics and luciferase reporter analyses showed that miR-K3 directly targeted G protein-coupled receptor (GPCR) kinase 2 (GRK2, official gene symbol ADRBK1). Importantly, overexpression of GRK2 reversed miR-K3 induction of cell migration and invasion. Furthermore, the chemokine receptor CXCR2, which was negatively regulated by GRK2, was upregulated in miR-K3-transduced endothelial cells. Knock down of CXCR2 abolished miR-K3-induced cell migration and invasion. Moreover, miR-K3 downregulation of GRK2 relieved its direct inhibitory effect on AKT. Both CXCR2 induction and the release of AKT from GRK2 were required for miR-K3 maximum activation of AKT and induction of cell migration and invasion. Finally, deletion of miR-K3 from the KSHV genome abrogated its effect on the GRK2/CXCR2/AKT pathway and KSHV-induced migration and invasion. Our data provide the first-line evidence that, by repressing GRK2, miR-K3 facilitates cell migration and invasion via activation of CXCR2/AKT signaling, which likely contribute to the dissemination of KSHV-induced tumors.","[Hu, Minmin; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Hu, Minmin; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Hu, Minmin; Li, Wan; Bai, Zhiqiang; Qin, Di; Yan, Qin; Lu, Chun] Nanjing Med Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China; [Wang, Cong] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Lu, Weiping] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Endocrinol & Metab, Huaian, Jiangsu, Peoples R China; [Zhu, Jianzhong] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA USA; [Krueger, Brian J.; Renne, Rolf] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Gao, Shou-Jiang] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA","Hu, MM (reprint author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.",yanqin@njmu.edu.cn; clu@njmu.edu.cn,"Gao, Shou-Jiang/B-8641-2012","Gao, Shou-Jiang/0000-0001-6194-1742","National Natural Science Foundation of China [81361120387, 81371824, 81171552, 31270199, 81401662]; National Basic Research Program of China (973 Program) [2011CB504803]; NIH [R01CA177377]; Ph.D. Programs Foundation of Ministry of Education of China [20123234110006]; Natural Science Youth Foundation of Jiangsu Province [BK20140908]","This work was supported by grants from National Natural Science Foundation of China (81361120387, 81371824, 81171552, 31270199, and 81401662), the National Basic Research Program of China (973 Program) (2011CB504803), a grant from NIH (R01CA177377), the Ph.D. Programs Foundation of Ministry of Education of China (20123234110006), and the Natural Science Youth Foundation of Jiangsu Province (BK20140908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,82,41,44,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005171,10.1371/journal.ppat.1005171,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800036,26402907.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,45,0,17,8638,1450,1042,408,7188,5885,20,1283,17,0,0,0,32,32,0,,22,0,22,0,0,46,46,35,23,0,0,0,0,0,0,0,0,5,8702,274,0,317,35,0,7218,1467,118,0,317,35,0,17,,0,0,0,0,7,0,0,1,0,0,0,22,0,0,3.0,5.957241379310345,1.2017250973845297,0.20172509738452976,1.2536171396772398,1.0431812919657328,6.214482758620689
407,J,"Langsfeld, ES; Bodily, JM; Laimins, LA",,,,"Langsfeld, Erika S.; Bodily, Jason M.; Laimins, Laimonis A.",,,The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT LIFE-CYCLE; HOMOLOGOUS RECOMBINATION; EPITHELIAL DIFFERENTIATION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; LONGEVITY PROTEIN; P53 ACETYLATION; CELL-LINES; TYPE-31; REPAIR,"Human papillomaviruses (HPV) regulate their differentiation-dependent life cycles by activating a number of cellular pathways, such as the DNA damage response, through control of post-translational protein modification. Sirtuin 1 (SIRT1) is a protein deacetylase that modulates the acetylation of a number of cellular substrates, resulting in activation of pathways controlling gene expression and DNA damage repair. Our studies indicate that SIRT1 levels are increased in cells containing episomes of high-risk HPV types through the combined action of the E6 and E7 oncoproteins. Knockdown of SIRT1 in these cells with shRNAs impairs viral activities including genome maintenance, amplification and late gene transcription, with minimal effects on cellular proliferation ability. Abrogation of amplification was also seen following treatment with the SIRT1 deacetylase inhibitor, EX-527. Importantly, SIRT1 binds multiple regions of the HPV genome in undifferentiated cells, but this association is lost upon of differentiation. SIRT1 regulates the acetylation of Histone H1 (Lys26) and H4 (Lys16) bound to HPV genomes and this may contribute to regulation of viral replication and gene expression. The differentiation-dependent replication of high-risk HPVs requires activation of factors in the Ataxia Telangiectasia Mutated (ATM) pathway and SIRT1 regulates the recruitment of both NBS1 and Rad51 to the viral genomes. These observations demonstrate that SIRT1 is a critical regulator of multiple aspects of the high-risk HPV life cycle.","[Langsfeld, Erika S.; Laimins, Laimonis A.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Bodily, Jason M.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA","Langsfeld, ES (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA.",l-laimins@northwestern.edu,"Bodily, Jason/S-2350-2019","Bodily, Jason/0000-0001-9743-2085","NCI [RO1CA142861, RO1CA59655]; Viral Replication Training Grant by NIAID [T31AI60523]","This work was supported by grants from the NCI to LAL (RO1CA142861 and RO1CA59655). ESL was supported by the Viral Replication Training Grant awarded to Northwestern University by NIAID (T31AI60523). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,25,26,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005181,10.1371/journal.ppat.1005181,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800039,26405826.0,"DOAJ Gold, Green Published",,,16/08/2019,25,1,22,4959,1251,692,559,3708,3004,20,684,22,0,0,0,23,23,0,,28,3,28,0,3,27,27,15,21,0,0,0,0,0,0,0,1,2,4960,54,0,249,98,0,3693,1251,54,0,249,98,0,16,,0,0,0,0,3,0,1,1,0,0,0,26,0,0,2.0,3.964028776978417,1.337378640776699,0.33737864077669905,1.3786407766990292,1.030852994555354,4.086330935251799
408,J,"Li, LF; Naseem, S; Sharma, S; Konopka, JB",,,,"Li, Lifang; Naseem, Shamoon; Sharma, Sahil; Konopka, James B.",,,Flavodoxin-Like Proteins Protect Candida albicans from Oxidative Stress and Promote Virulence,PLOS PATHOGENS,,,English,Article,,,,,,,POLYUNSATURATED FATTY-ACIDS; HUMAN FUNGAL PATHOGEN; NAD(P)H-QUINONE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; BIOCHEMICAL-CHARACTERIZATION; SUPEROXIDE DISMUTASES; 2-ELECTRON REDUCTION; QUINONE REDUCTASES; CRYSTAL-STRUCTURE,"The fungal pathogen Candida albicans causes lethal systemic infections in humans. To better define how pathogens resist oxidative attack by the immune system, we examined a family of four Flavodoxin-Like Proteins (FLPs) in C. albicans. In agreement with previous studies showing that FLPs in bacteria and plants act as NAD(P)H quinone oxidoreductases, a C. albicans quadruple mutant lacking all four FLPs (pst1 Delta, pst2 Delta, pst3 Delta, ycp4 Delta) was more sensitive to benzoquinone. Interestingly, the quadruple mutant was also more sensitive to a variety of oxidants. Quinone reductase activity confers important antioxidant effects because resistance to oxidation was restored in the quadruple mutant by expressing either Escherichia coli wrbA or mammalian NQO1, two distinct types of quinone reductases. FLPs were detected at the plasma membrane in C. albicans, and the quadruple mutant was more sensitive to linolenic acid, a polyunsaturated fatty acid that can auto-oxidize and promote lipid peroxidation. These observations suggested that FLPs reduce ubiquinone (coenzyme Q), enabling it to serve as an antioxidant in the membrane. In support of this, a C. albicans coq3 Delta mutant that fails to synthesize ubiquinone was also highly sensitive to oxidative stress. FLPs are critical for survival in the host, as the quadruple mutant was avirulent in a mouse model of systemic candidiasis under conditions where infection with wild type C. albicans was lethal. The quadruple mutant cells initially grew well in kidneys, the major site of C. albicans growth in mice, but then declined after the influx of neutrophils and by day 4 post-infection 33% of the mice cleared the infection. Thus, FLPs and ubiquinone are important new antioxidant mechanisms that are critical for fungal virulence. The potential of FLPs as novel targets for antifungal therapy is further underscored by their absence in mammalian cells.","[Li, Lifang; Naseem, Shamoon; Sharma, Sahil; Konopka, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA","Li, LF (reprint author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.",james.konopka@stonybrook.edu,,"Konopka, James/0000-0001-5989-4086",Public Health Service grant from National Institutes of Health [RO1 AI47837],"This research was supported by a Public Health Service grant awarded to JBK from the National Institutes of Health (RO1 AI47837; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,16,17,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005147,10.1371/journal.ppat.1005147,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800022,26325183.0,"DOAJ Gold, Green Published",,,16/08/2019,17,1,20,4980,781,534,247,4199,3622,21,556,20,1,0,0,15,15,2,,35,2,35,0,2,18,18,13,8,0,0,0,0,0,0,0,0,2,4964,81,0,60,305,1,4166,781,38,0,60,287,1,17,,0,0,0,0,2,0,0,1,0,0,0,34,0,0,0.75,6.376440460947503,1.185996665872827,0.18599666587282687,1.2741128840200047,1.0742971887550201,6.850192061459667
409,J,"McDonald, CR; Cahill, LS; Ho, KT; Yang, J; Kim, H; Silver, KL; Ward, PA; Mount, HT; Liles, WC; Sled, JG; Kain, KC",,,,"McDonald, Chloe R.; Cahill, Lindsay S.; Ho, Keith T.; Yang, Jimmy; Kim, Hani; Silver, Karlee L.; Ward, Peter A.; Mount, Howard T.; Liles, W. Conrad; Sled, John G.; Kain, Kevin C.",,,Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,MOUSE MODEL; COMPLEMENT ACTIVATION; PLACENTAL MALARIA; BEHAVIORAL PHENOTYPES; GROWTH RESTRICTION; PREFRONTAL CORTEX; FUNCTIONAL ROLES; CEREBRAL MALARIA; PRETERM BIRTH; KNOCKOUT MICE,"The in utero environment profoundly impacts childhood neurodevelopment and behaviour. A substantial proportion of pregnancies in Africa are at risk of malaria in pregnancy (MIP) however the impact of in utero exposure to MIP on fetal neurodevelopment is unknown. Complement activation, in particular C5a, may contribute to neuropathology and adverse outcomes during MIP. We used an experimental model of MIP and standardized neurocognitive testing, MRI, micro-CT and HPLC analysis of neurotransmitter levels, to test the hypothesis that in utero exposure to malaria alters neurodevelopment through a C5a-C5aR dependent pathway. We show that malaria-exposed offspring have persistent neurocognitive deficits in memory and affective-like behaviour compared to unexposed controls. These deficits were associated with reduced regional brain levels of major biogenic amines and BDNF that were rescued by disruption of C5a-C5aR signaling using genetic and functional approaches. Our results demonstrate that experimental MIP induces neurocognitive deficits in offspring and suggest novel targets for intervention.","[McDonald, Chloe R.; Mount, Howard T.; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [McDonald, Chloe R.; Kim, Hani; Silver, Karlee L.; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, SAR Labs, Sandra Rotman Ctr Global Hlth,Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Cahill, Lindsay S.; Sled, John G.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; [Cahill, Lindsay S.; Sled, John G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ho, Keith T.; Yang, Jimmy; Mount, Howard T.] Univ Toronto, Dept Psychiat, Div Neurol, Toronto, ON, Canada; [Ward, Peter A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Liles, W. Conrad] Univ Washington, Dept Med, Seattle, WA USA; [Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada","McDonald, CR (reprint author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.",Kevin.kain@uhn.ca,"Sled, John/D-8268-2012","Sled, John/0000-0002-4461-283X; Kain, Kevin/0000-0001-6068-1272","Canadian Institutes of Health Research [CIHR] [MOP-136813, MOP-115160]; Canadian Research Chair; Global Alliance; Bill and Melinda Gates Foundation; Grand Challenges in Global Health; Preventing Preterm Birth Initiative [12003]","This study was supported in part by the Canadian Institutes of Health Research [CIHR MOP-136813 and MOP-115160 to KCK]; Canadian Research Chair (KCK); Global Alliance to Prevent Prematurity and Stillbirth and the Bill and Melinda Gates Foundation, Grand Challenges in Global Health: Preventing Preterm Birth Initiative Grant No. 12003 [KCK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,70,9,9,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005140,10.1371/journal.ppat.1005140,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800017,26402732.0,"DOAJ Gold, Green Published",,,16/08/2019,11,24,33,4648,730,538,192,3918,3296,22,600,33,9,0,0,6,6,5,,46,15,46,0,15,13,13,9,6,0,0,0,0,0,0,2,14,1,4736,79,23,80,303,2,3946,739,79,23,80,303,2,51,,13,3,0,0,31,0,1,1,0,0,0,46,0,0,133.792,6.367123287671233,1.18631955079122,0.18631955079122,1.3062787136294027,1.101118760757315,7.010958904109589
410,J,"Sansregret, R; Dufour, V; Langlois, M; Daayf, F; Dunoyer, P; Voinnet, O; Bouarab, K",,,,"Sansregret, Raphael; Dufour, Vanessa; Langlois, Mathieu; Daayf, Fouad; Dunoyer, Patrice; Voinnet, Olivier; Bouarab, Kamal",,,"Extreme Resistance as a Host Counter-counter Defense against Viral Suppression of RNA Silencing (Retraction of vol 9, e1003435, 2013)",PLOS PATHOGENS,,,English,Correction,,,,,,,,,,,,,"Daayf, Fouad/0000-0001-8912-0460",,,,1,0,0,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005207,10.1371/journal.ppat.1005207,,,,1,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800042,26394159.0,"DOAJ Gold, Green Published",,,16/08/2019,0,13,0,4391,393,309,84,3998,3637,17,344,0,12,0,0,0,0,0,,2,0,2,0,0,1,1,0,0,0,0,1,0,0,1,0,1,1,4380,0,0,0,21,0,3981,393,0,0,0,21,0,6,,0,3,0,0,10,0,1,0,0,0,0,1,0,0,26.26,11.173027989821882,1.0982991495747874,0.0982991495747874,1.1008004002001,1.0022773855613756,11.198473282442748
411,J,"Sin, SH; Kim, Y; Eason, A; Dittmer, DP",,,,"Sin, Sang-Hoon; Kim, Yongbaek; Eason, Anthony; Dittmer, Dirk P.",,,KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; B-CELL LYMPHOMAS; PRIMARY EFFUSION LYMPHOMA; C-MYC; TRANSGENIC MICE; KAPOSI-SARCOMA; NUCLEAR ANTIGEN; CASTLEMAN-DISEASE; IN-VIVO,"Kaposi sarcoma-associated herpesvirus (KSHV) has been linked to Kaposi sarcoma and B-cell malignancies. Mechanisms of KSHV-induced oncogenesis remain elusive, however, in part due to lack of reliable in vivo models. Recently, we showed that transgenic mice expressing the KSHV latent genes, including all viral microRNAs, developed splenic B cell hyperplasia with 100% penetrance, but only a fraction converted to B cell lymphomas, suggesting that cooperative oncogenic events were missing. Myc was chosen as a possible candidate, because Myc is deregulated in many B cell lymphomas. We crossed KSHV latency locus transgenic (latency) mice to C alpha Myc transgenic (Myc) mice. By itself these Myc transgenic mice develop lymphomas only rarely. In the double transgenic mice (Myc/latency) we observed plasmacytosis, severe extramedullary hematopoiesis in spleen and liver, and increased proliferation of splenocytes. Myc/latency mice developed frank lymphoma at a higher rate than single transgenic latency or Myc mice. These data indicate that the KSHV latency locus cooperates with the deregulated Myc pathways to further lymphoma progression.","[Sin, Sang-Hoon; Eason, Anthony; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Program Global Oncol, Chapel Hill, NC 27599 USA; [Sin, Sang-Hoon; Eason, Anthony; Dittmer, Dirk P.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; [Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Dept Vet Med, Seoul, South Korea","Sin, SH (reprint author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Program Global Oncol, Chapel Hill, NC 27599 USA.",ddittmer@med.unc.edu,,"dittmer, dirk/0000-0003-4968-5656; sin, sang-hoon/0000-0002-6503-4960","faculty development award under UNC CFAR [P30 AI50410]; public health service grant [CA109232, CA019014]; NCI Center Core Support Grant [CA16086, CA016086]","This study was supported by a faculty development award to SS under UNC CFAR P30 AI50410 and public health service grants CA109232 and CA019014 (DPD). The UNC LCCC Animal Histopathology Core is supported in part by an NCI Center Core Support Grant (CA16086) to the UNC LCCC. The UNC Flow Cytometry Core Facility is supported in part by an NCI Center Core Support Grant (CA016086) to the UNC LCCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,11,11,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005135,10.1371/journal.ppat.1005135,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800014,26327622.0,"DOAJ Gold, Green Published",,,16/08/2019,9,32,8,3255,424,324,100,2831,2487,17,327,8,5,0,0,9,9,0,,12,1,12,0,1,9,9,9,5,0,0,0,0,0,0,0,27,1,3270,76,0,48,126,0,2827,424,76,0,48,126,0,19,,0,0,0,0,6,0,0,1,0,0,0,12,0,0,2.25,7.67688679245283,1.149770399152243,0.14977039915224302,1.2264217590957258,1.0666666666666667,8.18867924528302
412,J,"Sogaard, OS; Graversen, ME; Leth, S; Olesen, R; Brinkmann, CR; Nissen, SK; Kjaer, AS; Schleimann, MH; Denton, PW; Hey-Cunningham, WJ; Koelsch, KK; Pantaleo, G; Krogsgaard, K; Sommerfelt, M; Fromentin, R; Chomont, N; Rasmussen, TA; Ostergaard, L; Tolstrup, M",,,,"Sogaard, Ole S.; Graversen, Mette E.; Leth, Steffen; Olesen, Rikke; Brinkmann, Christel R.; Nissen, Sara K.; Kjaer, Anne Sofie; Schleimann, Mariane H.; Denton, Paul W.; Hey-Cunningham, William J.; Koelsch, Kersten K.; Pantaleo, Giuseppe; Krogsgaard, Kim; Sommerfelt, Maja; Fromentin, Remi; Chomont, Nicolas; Rasmussen, Thomas A.; Ostergaard, Lars; Tolstrup, Martin",,,The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL RESERVOIR; HISTONE DEACETYLASES; STEM-CELL; PERSISTENCE; INFECTION; RNA; ACTIVATION,"Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a step towards curing HIV-1 infection. However, until now, approaches to reverse HIV-1 latency in humans have yielded mixed results. Here, we report a proof-of-concept phase Ib/IIa trial where 6 aviremic HIV-1 infected adults received intravenous 5 mg/m(2) romidepsin (Celgene) once weekly for 3 weeks while maintaining ART. Lymphocyte histone H3 acetylation, a cellular measure of the pharmacodynamic response to romidepsin, increased rapidly (maximum fold range: 3.7-7.7 relative to baseline) within the first hours following each romidepsin administration. Concurrently, HIV-1 transcription quantified as copies of cell-associated un-spliced HIV-1 RNA increased significantly from baseline during treatment (range of fold-increase: 2.4-5.0; p = 0.03). Plasma HIV-1 RNA increased from <20 copies/mL at baseline to readily quantifiable levels at multiple post-infusion time-points in 5 of 6 patients (range 46-103 copies/mL following the second infusion, p = 0.04). Importantly, romidepsin did not decrease the number of HIV-specific T cells or inhibit T cell cytokine production. Adverse events (all grade 1-2) were consistent with the known side effects of romidepsin. In conclusion, romidepsin safely induced HIV-1 transcription resulting in plasma HIV-1 RNA that was readily detected with standard commercial assays demonstrating that significant reversal of HIV-1 latency in vivo is possible without blunting T cell-mediated immune responses. These finding have major implications for future trials aiming to eradicate the HIV-1 reservoir.","[Sogaard, Ole S.; Graversen, Mette E.; Leth, Steffen; Olesen, Rikke; Brinkmann, Christel R.; Nissen, Sara K.; Kjaer, Anne Sofie; Schleimann, Mariane H.; Denton, Paul W.; Rasmussen, Thomas A.; Ostergaard, Lars; Tolstrup, Martin] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Graversen, Mette E.; Leth, Steffen; Kjaer, Anne Sofie; Schleimann, Mariane H.; Denton, Paul W.; Ostergaard, Lars; Tolstrup, Martin] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Denton, Paul W.] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark; [Hey-Cunningham, William J.; Koelsch, Kersten K.] Univ New S Wales, Kirby Inst, Univ New South Wales Med, Sydney, NSW, Australia; [Pantaleo, Giuseppe] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Krogsgaard, Kim; Sommerfelt, Maja] Bionor Pharma ASA, Oslo, Norway; [Fromentin, Remi; Chomont, Nicolas] Ctr Rech CHUM, Montreal, PQ, Canada; [Chomont, Nicolas] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada","Graversen, ME (reprint author), Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.",olesoega@rm.dk,"Pantaleo, Giuseppe/K-6163-2016; Sogaard, Ole/P-6058-2016; Kjaer, Andreas/E-8932-2015","Nissen, Sara Konstantin/0000-0003-4711-0875; Denton, Paul/0000-0003-2458-8147; Kjaer, Andreas/0000-0002-2706-5547; Chomont, Nicolas/0000-0001-9747-5018; Tolstrup, Martin/0000-0001-7020-5173; Leth, Steffen/0000-0003-3194-9844; Schleimann, Mariane/0000-0001-5147-9523; Ostergaard, Lars/0000-0003-2459-0511; Rasmussen, Thomas Aagaard/0000-0001-5354-2442; Olesen, Rikke/0000-0002-5157-080X; Sogaard, Ole/0000-0001-9107-2023; Krogsgaard, Kim/0000-0002-7153-9287",Research Council of Norway (GLOBVAC) program [235955]; Bionor Pharma ASA,"This study was funded by a grant from the Research Council of Norway (GLOBVAC) program (Nr: 235955) and Bionor Pharma ASA. The Research Council of Norway had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bionor Pharma ASA contributed to the study design and the preparation of the manuscript.",,49,191,196,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005142,10.1371/journal.ppat.1005142,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800018,26379282.0,"DOAJ Gold, Green Published",,,16/08/2019,181,98,105,14150,2034,1618,416,12116,10551,42,1523,105,8,0,1,185,185,0,,172,4,170,2,4,197,188,197,136,0,0,0,0,0,0,3,94,3,14175,75,14,123,389,3,12085,2034,75,14,123,389,3,56,,5,1,0,0,14,0,6,1,1,0,0,168,2,0,69.46600000000001,6.9567354965585055,1.1678771871904918,0.1678771871904919,1.208237041928029,1.0345583038869257,7.197148475909538
413,J,"Yen, H; Sugimoto, N; Tobe, T",,,,"Yen, Hilo; Sugimoto, Nakaba; Tobe, Toru",,,Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; TISSUE-CULTURE CELLS; CITROBACTER-RODENTIUM; VIRULENCE FACTOR; PROTEIN; SECRETION; IDENTIFICATION; DEUBIQUITINATION; INFECTIONS; CASPASE-1,"Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are related strains capable of inducing severe gastrointestinal disease. For optimal infection, these pathogens actively modulate cellular functions through the deployment of effector proteins in a type three secretion system (T3SS)-dependent manner. In response to enteric pathogen invasion, the Nod-like receptor pyrin domain containing (NLRP) inflammasome has been increasingly recognized as an important cytoplasmic sensor against microbial infection by activating caspase-1 and releasing IL-1 beta. EPEC and EHEC are known to elicit inflammasome activation in macrophages and epithelial cells; however, whether the pathogens actively counteract such innate immune responses is unknown. Using a series of compound effector-gene deletion strains of EPEC, we screened and identified NleA, which could subdue host IL-1 beta secretion. It was found that the reduction is not because of blocked NF-kappa B activity; instead, the reduction results from inhibited caspase-1 activation by NleA. Immunostaining of human macrophage-like cells following infection revealed limited formation of inflammasome foci with constituents of total caspase-1, ASC and NLRP3 in the presence of NleA. Pulldown of PMA-induced differentiated THP-1 lysate with purified MBP-NleA reveals that NLRP3 is a target of NleA. The interaction was verified by an immunoprecipitation assay and direct interaction assay in which purified MBP- NleA and GST-NLRP3 were used. We further showed that the effector interacts with regions of NLRP3 containing the PYD and LRR domains. Additionally, NleA was found to associate with non-ubiquitinated and ubiquitinated NLRP3 and to interrupt de-ubiquitination of NLRP3, which is a required process for inflammasome activation. Cumulatively, our findings provide the first example of EPEC-mediated suppression of inflammasome activity in which NieA plays a novel role in controlling the host immune response through targeting of NLRP3.","[Yen, Hilo; Tobe, Toru] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Osaka, Japan; [Sugimoto, Nakaba] Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Osaka, Japan","Yen, H (reprint author), Osaka Univ, Grad Sch Med, Dept Biomed Informat, Osaka, Japan.",torutobe@sahs.med.osaka-u.ac.jp,,,"Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ohyama Health Foundation","This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant from Ohyama Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,30,31,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005121,10.1371/journal.ppat.1005121,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800010,26332984.0,"DOAJ Gold, Green Published",,,16/08/2019,32,0,51,6504,1641,1291,350,4863,3835,24,1004,51,0,0,0,29,29,0,,66,3,66,0,3,34,32,34,15,0,0,0,0,0,0,0,0,2,6564,341,0,91,63,0,4883,1666,341,0,91,63,0,15,,0,0,0,0,1,0,0,0,0,0,0,66,0,0,0.25,3.963436928702011,1.337446020974707,0.337446020974707,1.4328603742545754,1.071340713407134,4.246191346739793
414,J,"Zaika, AI; Wei, JX; Noto, JM; Peek, RM",,,,"Zaika, Alexander I.; Wei, Jinxiong; Noto, Jennifer M.; Peek, Richard M.",,,Microbial Regulation of p53 Tumor Suppressor,PLOS PATHOGENS,,,English,Review,,,,,,,HELICOBACTER-PYLORI CAGA; GASTRIC EPITHELIAL-CELLS; HUMAN-PAPILLOMAVIRUS TYPE-16; VIRULENCE FACTOR CAGA; LARGE T-ANTIGEN; DNA-DAMAGE; SV40-TRANSFORMED CELLS; CARCINOMA-CELLS; E6 PROTEINS; EXPRESSION,"p53 tumor suppressor has been identified as a protein interacting with the large T antigen produced by simian vacuolating virus 40 (SV40). Subsequent research on p53 inhibition by SV40 and other tumor viruses has not only helped to gain a better understanding of viral biology, but also shaped our knowledge of human tumorigenesis. Recent studies have found, however, that inhibition of p53 is not strictly in the realm of viruses. Some bacterial pathogens also actively inhibit p53 protein and induce its degradation, resulting in alteration of cellular stress responses. This phenomenon was initially characterized in gastric epithelial cells infected with Helicobacter pylori, a bacterial pathogen that commonly infects the human stomach and is strongly linked to gastric cancer. Besides H. pylori, a number of other bacterial species were recently discovered to inhibit p53. These findings provide novel insights into host-bacteria interactions and tumorigenesis associated with bacterial infections.","[Zaika, Alexander I.; Wei, Jinxiong] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN 37212 USA; [Zaika, Alexander I.; Wei, Jinxiong] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Zaika, Alexander I.; Peek, Richard M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Noto, Jennifer M.; Peek, Richard M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN USA","Zaika, AI (reprint author), Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN 37212 USA.",alex.zaika@vanderbilt.edu,,,National Cancer Institute [NIH CA138833]; Department of Veterans Affairs [I01 BX002115]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404],"This work was supported by grants from the National Cancer Institute grant NIH CA138833, the Department of Veterans Affairs I01 BX002115, Vanderbilt Ingram Cancer Center (P30 CA68485), and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Veterans Affairs, National Institutes of Health, or Vanderbilt University.",,57,17,19,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,SEP,2015,11,9,,,,,,,e1005099,10.1371/journal.ppat.1005099,,,,11,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CS7NH,WOS:000362269800006,26379246.0,"DOAJ Gold, Green Published",,,16/08/2019,16,6,37,6675,2508,1969,539,4167,3310,17,840,37,6,0,0,12,12,0,,50,4,50,0,4,16,16,11,12,0,0,0,0,0,0,0,0,2,6699,16,3,49,103,0,4149,2508,16,3,49,103,0,42,,0,0,0,0,10,0,0,1,0,0,0,50,0,0,5.35,2.661483253588517,1.6018718502519798,0.6018718502519799,1.6361891048716102,1.0214232209737828,2.718500797448166
415,J,"Alleaume-Butaux, A; Nicot, S; Pietri, M; Baudry, A; Dakowski, C; Tixador, P; Ardila-Osorio, H; Haeberle, AM; Bailly, Y; Peyrin, JM; Launay, JM; Kellermann, O; Schneider, B",,,,"Alleaume-Butaux, Aurelie; Nicot, Simon; Pietri, Mathea; Baudry, Anne; Dakowski, Caroline; Tixador, Philippe; Ardila-Osorio, Hector; Haeberle, Anne-Marie; Bailly, Yannick; Peyrin, Jean-Michel; Launay, Jean-Marie; Kellermann, Odile; Schneider, Benoit",,,Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation,PLOS PATHOGENS,,,English,Article,,,,,,,STRESS-INDUCIBLE PROTEIN-1; CELLULAR PRION; RHO KINASE; SEROTONIN TRANSPORTER; SIGNALING PATHWAYS; MESSENGER-RNA; PDK1; CYTOSKELETON; INHIBITION; RECEPTOR,"In prion diseases, synapse dysfunction, axon retraction and loss of neuronal polarity precede neuronal death. The mechanisms driving such polarization defects, however, remain unclear. Here, we examined the contribution of RhoA-associated coiled-coil containing kinases (ROCK), key players in neuritogenesis, to prion diseases. We found that over-activation of ROCK signaling occurred in neuronal stem cells infected by pathogenic prions (PrPSc) and impaired the sprouting of neurites. In reconstructed networks of mature neurons, PrPSc-induced ROCK overactivation provoked synapse disconnection and dendrite/axon degeneration. This overactivation of ROCK also disturbed overall neurotransmitter-associated functions. Importantly, we demonstrated that beyond its impact on neuronal polarity ROCK overactivity favored the production of PrPSc through a ROCK-dependent control of 3-phosphoinositide-dependent kinase 1 (PDK1) activity. In non-infectious conditions, ROCK and PDK1 associated within a complex and ROCK phosphorylated PDK1, conferring basal activity to PDK1. In prion-infected neurons, exacerbated ROCK activity increased the pool of PDK1 molecules physically interacting with and phosphorylated by ROCK. ROCK-induced PDK1 overstimulation then canceled the neuroprotective alpha-cleavage of normal cellular prion protein PrPC by TACE alpha-secretase, which physiologically precludes PrPSc production. In prion-infected cells, inhibition of ROCK rescued neurite sprouting, preserved neuronal architecture, restored neuronal functions and reduced the amount of PrPSc. In mice challenged with prions, inhibition of ROCK also lowered brain PrPSc accumulation, reduced motor impairment and extended survival. We conclude that ROCK overactivation exerts a double detrimental effect in prion diseases by altering neuronal polarity and triggering PrPSc accumulation. Eventually ROCK emerges as therapeutic target to combat prion diseases.","[Alleaume-Butaux, Aurelie; Nicot, Simon; Pietri, Mathea; Baudry, Anne; Dakowski, Caroline; Ardila-Osorio, Hector; Kellermann, Odile; Schneider, Benoit] INSERM, UMR S 1124, Paris, France; [Alleaume-Butaux, Aurelie; Nicot, Simon; Pietri, Mathea; Baudry, Anne; Dakowski, Caroline; Ardila-Osorio, Hector; Kellermann, Odile; Schneider, Benoit] Univ Paris 05, Sorbonne Paris Cite, UMR S 1124, Paris, France; [Tixador, Philippe; Peyrin, Jean-Michel] CNRS, Biol Adaptat & Ageing, UMR 8256, Paris, France; [Tixador, Philippe; Peyrin, Jean-Michel] Univ Paris 06, Sorbonne Univ, Biol Adaptat & Ageing, Inst Biol Paris Seine,B2A,UMR 8256, Paris, France; [Haeberle, Anne-Marie; Bailly, Yannick] CNRS, Cytol & Cytopathol Neuron, Inst Neurosci & Cellulaires & Integrat, UPR 3212, Strasbourg, France; [Peyrin, Jean-Michel] Hop Lariboisiere, AP HP, INSERM, Serv Biochim,UMR S942, F-75475 Paris, France; [Launay, Jean-Marie] Hoffmann La Roche Ltd, Pharma Res Dept, Basel, Switzerland","Alleaume-Butaux, A (reprint author), INSERM, UMR S 1124, Paris, France.",jean-marie.launay@aphp.fr; benoit.schneider@parisdescartes.fr,"Baudry, Anne/O-2624-2017","Peyrin, Jean-Michel/0000-0002-8705-8672; Peyrin, Jean-Michel/0000-0002-0108-1266","French Agence Nationale de la Recherche (PrionsSensiTNF) [131201]; INSERM; Domaine d'Interet Majeur - Maladies Infectieuses - Region Ile de France; ERANET NEURON ""MICRODEG"" project; European Joint Program on Neurodegenerative Diseases; Agence Nationale de la Recherche - ""PrPCPDK1"" [ANR-14-JPCD-0003-01]","This work was supported by the French Agence Nationale de la Recherche (Prions&SensiTNF, no 131201) and INSERM. SN is a post-doctoral fellow of French Agence Nationale de la Recherche. AAB is funded by Domaine d'Interet Majeur - Maladies Infectieuses - Region Ile de France. PT is a postdoctoral fellow funded by ERANET NEURON ""MICRODEG"" project. This work was also supported by the European Joint Program on Neurodegenerative Diseases and Agence Nationale de la Recherche - ""PrPC&PDK1"" - no ANR-14-JPCD-0003-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,69,9,9,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005073,10.1371/journal.ppat.1005073,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500017,26241960.0,"DOAJ Gold, Green Published",,,16/08/2019,8,6,15,3909,1036,827,209,2873,2266,40,567,15,4,0,0,8,8,0,,19,0,19,0,0,10,8,10,3,0,0,0,0,0,0,0,2,0,3963,48,0,98,296,1,2885,1043,48,0,98,296,1,35,,0,0,0,0,7,0,0,1,0,0,0,19,0,0,2.75,3.773166023166023,1.3605986773407588,0.3605986773407588,1.4991298294465716,1.101816321309798,4.1573359073359075
416,J,"Besbes, A; Le Goff, S; Antunes, A; Terrade, A; Hong, E; Giorgini, D; Taha, MK; Deghmane, AE",,,,"Besbes, Anissa; Le Goff, Salome; Antunes, Ana; Terrade, Aude; Hong, Eva; Giorgini, Dario; Taha, Muhamed-Kheir; Deghmane, Ala-Eddine",,,Hyperinvasive Meningococci Induce Intranuclear Cleavage of the NF-kappa B Protein p65/RelA by Meningococcal IgA Protease,PLOS PATHOGENS,,,English,Article,,,,,,,NEISSERIA-MENINGITIDIS; GENE-EXPRESSION; EPITHELIAL-CELLS; HAEMOPHILUS-INFLUENZAE; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; TERMINAL KINASE; ALPHA-PROTEINS; GONORRHOEAE,"Differential modulation of NF-kappa B during meningococcal infection is critical in innate immune response to meningococcal disease. Non-invasive isolates of Neisseria meningitidis provoke a sustained NF-kappa B activation in epithelial cells. However, the hyperinvasive isolates of the ST-11 clonal complex (ST-11) only induce an early NF-kappa B activation followed by a sustained activation of JNK and apoptosis. We show that this temporal activation of NF-kappa B was caused by specific cleavage at the C-terminal region of NF-kappa B p65/RelA component within the nucleus of infected cells. This cleavage was mediated by the secreted 150 kDa meningococcal ST-11 IgA protease carrying nuclear localisation signals (NLS) in its alpha-peptide moiety that allowed efficient intra-nuclear transport. In a collection of non-ST-11 healthy carriage isolates lacking NLS in the alpha-peptide, secreted IgA protease was devoid of intranuclear transport. This part of iga polymorphism allows non-invasive isolates lacking NLS, unlike hyperinvasive ST-11 isolates of N. meningitides habouring NLS in their alpha-peptide, to be carried asymptomatically in the human nasopharynx through selective eradication of their ability to induce apoptosis in infected epithelial cells.","[Besbes, Anissa; Le Goff, Salome; Antunes, Ana; Terrade, Aude; Hong, Eva; Giorgini, Dario; Taha, Muhamed-Kheir; Deghmane, Ala-Eddine] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France","Besbes, A (reprint author), UFR Med, Lab Therapeut Expt & Clin Infect, Nantes, France.",mktaha@pasteur.fr; ala-eddine.deghmane@pasteur.fr,,,Institut Pasteur,"This study was supported by the Institut Pasteur (www.pasteur.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,94,7,7,1,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005078,10.1371/journal.ppat.1005078,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500021,26241037.0,"DOAJ Gold, Green Published",,,16/08/2019,6,0,17,3107,594,464,130,2513,2064,27,422,17,0,0,0,6,6,0,,21,5,21,0,5,7,7,7,2,0,0,0,0,0,0,0,0,0,3125,58,0,353,271,1,2505,594,58,0,353,271,1,26,,0,0,0,0,0,0,0,1,0,0,0,21,0,0,0.25,5.230639730639731,1.2363708714683646,0.2363708714683645,1.3744528452049343,1.1116832957837142,5.814814814814815
417,J,"de Groof, A; Guelen, L; Deijs, M; van der Wal, Y; Miyata, M; Ng, KS; van Grinsven, L; Simmelink, B; Biermann, Y; Grisez, L; van Lent, J; de Ronde, A; Chang, SF; Schrier, C; van der Hoek, L",,,,"de Groof, Ad; Guelen, Lars; Deijs, Martin; van der Wal, Yorick; Miyata, Masato; Ng, Kah Sing; van Grinsven, Lotte; Simmelink, Bartjan; Biermann, Yvonne; Grisez, Luc; van Lent, Jan; de Ronde, Anthony; Chang, Siow Foong; Schrier, Carla; van der Hoek, Lia",,,A Novel Virus Causes Scale Drop Disease in Lates calcarifer,PLOS PATHOGENS,,,English,Article,,,,,,,RED-SEA BREAM; IRIDOVIRAL DISEASE; PROTEIN; VACCINE,"From 1992 onwards, outbreaks of a previously unknown illness have been reported in Asian seabass (Lates calcarifer) kept in maricultures in Southeast Asia. The most striking symptom of this emerging disease is the loss of scales. It was referred to as scale drop syndrome, but the etiology remained enigmatic. By using a next-generation virus discovery technique, VIDISCA-454, sequences of an unknown virus were detected in serum of diseased fish. The near complete genome sequence of the virus was determined, which shows a unique genome organization, and low levels of identity to known members of the Iridoviridae. Based on homology of a series of putatively encoded proteins, the virus is a novel member of the Megalocytivirus genus of the Iridoviridae family. The virus was isolated and propagated in cell culture, where it caused a cytopathogenic effect in infected Asian seabass kidney and brain cells. Electron microscopy revealed icosahedral virions of about 140 nm, characteristic for the Iridoviridae. In vitro cultured virus induced scale drop syndrome in Asian seabass in vivo and the virus could be reisolated from these infected fish. These findings show that the virus is the causative agent for the scale drop syndrome, as each of Koch's postulates is fulfilled. We have named the virus Scale Drop Disease Virus. Vaccines prepared from BEI- and formalin inactivated virus, as well as from E. coli produced major capsid protein provide efficacious protection against scale drop disease.","[de Groof, Ad; Guelen, Lars; van der Wal, Yorick; van Grinsven, Lotte; Simmelink, Bartjan; Biermann, Yvonne; Grisez, Luc; Schrier, Carla] Intervet Int Bv, Dept Discovery & Technol, MSD Anim Hlth, Boxmeer, Netherlands; [Deijs, Martin; de Ronde, Anthony] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA,Lab Expt Viro, NL-1105 AZ Amsterdam, Netherlands; [Miyata, Masato; Ng, Kah Sing; Chang, Siow Foong] MSD Anim Hlth Innovat Pte Ltd, Singapore, Singapore; [van Lent, Jan] Wageningen Univ, Virol Lab, NL-6700 AP Wageningen, Netherlands; [van Lent, Jan] Wageningen Univ, Wageningen Electron Microscopy Ctr, NL-6700 AP Wageningen, Netherlands","de Groof, A (reprint author), Intervet Int Bv, Dept Discovery & Technol, MSD Anim Hlth, Boxmeer, Netherlands.",ad.de.groof@merck.com; c.m.vanderhoek@amc.uva.nl,,,,,,28,19,19,4,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005074,10.1371/journal.ppat.1005074,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500018,26252390.0,"DOAJ Gold, Green Published",,,16/08/2019,20,5,25,12631,3493,2969,524,9138,7383,109,1646,25,4,0,0,22,22,0,,32,1,32,0,1,20,20,10,7,0,0,0,0,0,0,0,1,0,12793,133,0,318,16,0,9250,3526,133,0,318,16,0,17,,0,0,0,0,4,0,0,1,0,0,0,32,0,0,2.7,3.616089321500143,1.3822499452834318,0.3822499452834318,1.4162836506894287,1.0246219618399177,3.7051245347838533
418,J,"DiMaio, D; Burd, CG; Goodner, K",,,,"DiMaio, Daniel; Burd, Christopher G.; Goodner, Kylia",,,Riding the R Train into the Cell,PLOS PATHOGENS,,,English,Article,,,,,,,TRANS-GOLGI NETWORK; HUMAN-PAPILLOMAVIRUS; ENDOPLASMIC-RETICULUM; HOST-CELLS; ENTRY; SIMIAN-VIRUS-40; RETROMER; PROTEIN; ENDOCYTOSIS; INFECTION,,"[DiMaio, Daniel; Goodner, Kylia] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [DiMaio, Daniel] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Canc Ctr, New Haven, CT USA; [Burd, Christopher G.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA","DiMaio, D (reprint author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.",daniel.dimaio@yale.edu,,"Burd, Christopher/0000-0003-1831-8706","National Institutes of Health [AI102876, CA016038, GM060221, T32 HG003198]","The work was supported by grants from the National Institutes of Health to DD (AI102876 and CA016038) and to CGB (GM060221). KG was supported by a training grant from the National Institutes of Health (T32 HG003198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,33,0,0,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005036,10.1371/journal.ppat.1005036,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500006,26291450.0,"DOAJ Gold, Green Published",,,16/08/2019,0,25,8,3728,309,225,84,3419,3038,20,361,8,6,0,0,0,0,0,,11,1,11,0,1,0,0,0,0,0,0,0,0,0,0,0,19,2,3775,0,0,0,79,0,3433,313,0,0,0,79,0,29,,0,0,0,0,6,0,0,1,0,0,0,11,0,0,3.95,12.064724919093852,1.0903773033050599,0.09037730330505996,1.1272301842644048,1.0337982832618027,12.472491909385113
419,J,"El Sahili, A; Li, SZ; Lang, JL; Virus, C; Planamente, S; Ahmar, M; Guimaraes, BG; Aumont-Nicaise, M; Vigouroux, A; Soulere, L; Reader, J; Queneau, Y; Faure, D; Morera, S",,,,"El Sahili, Abbas; Li, Si-Zhe; Lang, Julien; Virus, Cornelia; Planamente, Sara; Ahmar, Mohammed; Guimaraes, Beatriz G.; Aumont-Nicaise, Magali; Vigouroux, Armelle; Soulere, Laurent; Reader, John; Queneau, Yves; Faure, Denis; Morera, Solange",,,A Pyranose-2-Phosphate Motif Is Responsible for Both Antibiotic Import and Quorum-Sensing Regulation in Agrobacterium tumefaciens,PLOS PATHOGENS,,,English,Article,,,,,,,TI PLASMID PTIC58; TRANSFER-RNA SYNTHETASE; AGROCIN 84; CROWN-GALL; ESCHERICHIA-COLI; BINDING-PROTEIN; CONJUGAL TRANSFER; PEPTIDE BINDING; PLANT TUMORS; ACC OPERON,"Periplasmic binding proteins (PBPs) in association with ABC transporters select and import a wide variety of ligands into bacterial cytoplasm. They can also take up toxic molecules, as observed in the case of the phytopathogen Agrobacterium tumefaciens strain C58. This organism contains a PBP called AccA that mediates the import of the antibiotic agrocin 84, as well as the opine agrocinopine A that acts as both a nutrient and a signalling molecule for the dissemination of virulence genes through quorum-sensing. Here, we characterized the binding mode of AccA using purified agrocin 84 and synthetic agrocinopine A by X-ray crystallography at very high resolution and performed affinity measurements. Structural and affinity analyses revealed that AccA recognizes an uncommon and specific motif, a pyranose-2-phosphate moiety which is present in both imported molecules via the L-arabinopyranose moiety in agrocinopine A and the D-glucopyranose moiety in agrocin 84. We hypothesized that AccA is a gateway allowing the import of any compound possessing a pyranose-2-phosphate motif at one end. This was structurally and functionally confirmed by experiments using four synthetic compounds: agrocinopine 3'-O-benzoate, L-arabinose-2-isopropylphosphate, L-arabinose-2-phosphate and D-glucose-2-phosphate. By combining affinity measurements and in vivo assays, we demonstrated that both L-arabinose-2-phosphate and D-glucose-2-phosphate, which are the AccF mediated degradation products of agrocinopine A and agrocin 84 respectively, interact with the master transcriptional regulator AccR and activate the quorum-sensing signal synthesis and Ti plasmid transfer in A. tumefaciens C58. Our findings shed light on the role of agrocinopine and antibiotic agrocin 84 on quorum-sensing regulation in A. tumefaciens and reveal how the PBP AccA acts as vehicle for the importation of both molecules by means of a key-recognition motif. It also opens future possibilities for the rational design of antibiotic and anti-virulence compounds against A. tumefaciens or other pathogens possessing similar PBPs.","[El Sahili, Abbas; Planamente, Sara; Vigouroux, Armelle; Morera, Solange] Univ Paris 11, CNRS, Dept Biophys Biochem & Struct Biol, Inst Integrat Biol Cell I2BC,CEA, Gif Sur Yvette, France; [El Sahili, Abbas; Lang, Julien; Planamente, Sara; Faure, Denis] Univ Paris 11, CNRS, Dept Microbiol, Inst Integrat Biol Cell I2BC,CEA, Gif Sur Yvette, France; [Li, Si-Zhe; Ahmar, Mohammed; Soulere, Laurent; Queneau, Yves] Univ Lyon 1, CNRS, Inst Chim & Biochim Mol & Supramol, INSA Lyon,UMR 5246,CPE Lyon, F-69622 Villeurbanne, France; [Virus, Cornelia; Reader, John] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Guimaraes, Beatriz G.] Synchrotron SOLEIL, Gif Sur Yvette, France; [Aumont-Nicaise, Magali] Univ Paris 11, CNRS, Inst Integrat Biol Cell I2BC, Protein Prot Interact Platform,CEA, F-91405 Orsay, France","El Sahili, A (reprint author), Univ Paris 11, CNRS, Dept Biophys Biochem & Struct Biol, Inst Integrat Biol Cell I2BC,CEA, Gif Sur Yvette, France.",yves.queneau@insa-lyon.fr; faure@isv.cnrs-gif.fr; morera@lebs.cnrs-gif.fr,,"El Sahili, Abbas/0000-0003-3973-686X; Gomes Guimaraes, Beatriz/0000-0002-8546-2460; Queneau, Yves/0000-0003-4052-061X; Planamente, Sara/0000-0003-2778-1356",Agence National de la Recherche (France) [ANR-12-BSV8-0003-01/02/03]; National Science Foundation [MCB-1158488],"DF, AV, MA, YQ and SM were supported by grant ANR-12-BSV8-0003-01/02/03 from Agence National de la Recherche (France) http://www.agence-nationale-recherche.fr/. JR was supported by a National Science Foundation Grant MCB-1158488 http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,52,15,15,2,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005071,10.1371/journal.ppat.1005071,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500015,26244338.0,"DOAJ Gold, Green Published",,,16/08/2019,15,13,28,3703,715,541,174,2988,2525,28,435,28,3,0,0,15,15,0,,33,0,33,0,0,16,16,16,8,0,0,0,0,0,0,0,10,1,3746,93,0,551,324,1,2977,715,93,0,551,324,1,54,,0,0,0,0,5,0,0,1,0,0,0,33,0,0,2.0,5.179020979020979,1.2392904953145918,0.2392904953145917,1.393239625167336,1.124223602484472,5.822377622377623
420,J,"Erdmann, N; Du, VY; Carlson, J; Schaefer, M; Jureka, A; Sterrett, S; Yue, L; Dilernia, D; Lakhi, S; Tang, JM; Sidney, J; Gilmour, J; Allen, S; Hunter, E; Heath, S; Bansal, A; Goepfert, PA",,,,"Erdmann, Nathan; Du, Victor Y.; Carlson, Jonathan; Schaefer, Malinda; Jureka, Alexander; Sterrett, Sarah; Yue, Ling; Dilernia, Dario; Lakhi, Shabir; Tang, Jianming; Sidney, John; Gilmour, Jill; Allen, Susan; Hunter, Eric; Heath, Sonya; Bansal, Anju; Goepfert, Paul A.",,,HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+T Cell Responses,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; VIRAL LOAD; IMMUNE ESCAPE; DISCORDANT ASSOCIATIONS; POPULATION-LEVEL; INFECTION; GAG; VIREMIA; REPLICATION,"Antiretroviral therapy, antibody and CD8(+) T cell-mediated responses targeting human immunodeficiency virus-1 (HIV-1) exert selection pressure on the virus necessitating escape; however, the ability of CD4(+) T cells to exert selective pressure remains unclear. Using a computational approach on HIV gag/pol/nef sequences and HLA-II allelic data, we identified 29 HLA-II associated HIV sequence polymorphisms or adaptations (HLA-AP) in an African cohort of chronically HIV-infected individuals. Epitopes encompassing the predicted adaptation (AE) or its non-adapted (NAE) version were evaluated for immunogenicity. Using a CD8-depleted IFN-gamma ELISpot assay, we determined that the magnitude of CD4(+) T cell responses to the predicted epitopes in controllers was higher compared to non-controllers (p<0.0001). However, regardless of the group, the magnitude of responses to AE was lower as compared to NAE (p<0.0001). CD4(+) T cell responses in patients with acute HIV infection (AHI) demonstrated poor immunogenicity towards AE as compared to NAE encoded by their transmitted founder virus. Longitudinal data in AHI off antiretroviral therapy demonstrated sequence changes that were biologically confirmed to represent CD4(+) escape mutations. These data demonstrate an innovative application of HLA-associated polymorphisms to identify biologically relevant CD4(+) epitopes and suggests CD4(+) T cells are active participants in driving HIV evolution.","[Erdmann, Nathan; Du, Victor Y.; Jureka, Alexander; Sterrett, Sarah; Tang, Jianming; Heath, Sonya; Bansal, Anju; Goepfert, Paul A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Carlson, Jonathan] Microsoft Res, Los Angeles, CA USA; [Schaefer, Malinda; Yue, Ling; Dilernia, Dario; Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Lakhi, Shabir] Zambia Emory Res Project, Lusaka, Zambia; [Sidney, John] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Gilmour, Jill] Int AIDS Vaccine Inst, London, England; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London, England","Erdmann, N (reprint author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.",paulg@uab.edu,"Tang, Jianming/O-4980-2019","Tang, Jianming/0000-0003-0137-7486","NIH [5R01AI084772-05, 1R01AI112566-01A1, 5R01AI064060-10]","This work was supported by these NIH grants: 5R01AI084772-05, 1R01AI112566-01A1, and 5R01AI064060-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,12,12,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005111,10.1371/journal.ppat.1005111,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500040,26302050.0,"DOAJ Gold, Green Published",,,16/08/2019,10,7,31,4520,692,553,139,3828,3220,23,585,31,7,0,0,12,12,0,,76,11,39,0,11,12,12,10,7,0,0,0,0,0,0,0,0,0,4561,143,0,192,212,0,3805,692,143,0,192,212,0,64,,0,0,0,0,12,0,0,1,0,0,0,39,0,0,6.1,6.531791907514451,1.180773249738767,0.180773249738767,1.284221525600836,1.0876106194690265,7.104046242774566
421,J,"Ezenwa, VO; Prieur-Richard, AH; Roche, B; Bailly, X; Becquart, P; Garcia-Pena, GE; Hosseini, PR; Keesing, F; Rizzoli, A; Suzan, G; Vignuzzi, M; Vittecoq, M; Mills, JN; Guegan, JF",,,,"Ezenwa, Vanessa O.; Prieur-Richard, Anne-Helene; Roche, Benjamin; Bailly, Xavier; Becquart, Pierre; Garcia-Pena, Gabriel E.; Hosseini, Parviez R.; Keesing, Felicia; Rizzoli, Annapaola; Suzan, Gerardo; Vignuzzi, Marco; Vittecoq, Marion; Mills, James N.; Guegan, Jean-Francois",,,Interdisciplinarity and Infectious Diseases: An Ebola Case Study,PLOS PATHOGENS,,,English,Article,,,,,,,RESPIRATORY-SYNDROME-CORONAVIRUS; ZAIRE-EBOLAVIRUS; VIRUS; INFLUENZA; BATS; TRANSMISSION; RESERVOIRS; EMERGENCE; EVOLUTION; GABON,,"[Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA; [Prieur-Richard, Anne-Helene] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Roche, Benjamin] Museum Natl Hist Nat, DIVERSITAS, Paris, France; [Bailly, Xavier] UMI IRD, UPMC 209 UMMISCO, Bondy, France; [Becquart, Pierre; Garcia-Pena, Gabriel E.; Guegan, Jean-Francois] INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France; [Garcia-Pena, Gabriel E.] Univ Montpellier, CNRS, Ctr IRD Montpellier, UMR 5290 IRD, F-34059 Montpellier, France; [Hosseini, Parviez R.] CESAB Ctr Synthese & Anal Biodivers, Aix En Provence, France; [Keesing, Felicia] EcoHlth Alliance, New York, NY USA; [Rizzoli, Annapaola] Bard Coll, Biol Program, Annandale On Hudson, NY USA; [Suzan, Gerardo] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy; [Vignuzzi, Marco] Univ Nacl Autonoma Mexico, Fac Med Vet Zootecnia, Mexico City, DF, Mexico; [Vittecoq, Marion] Inst Pasteur, Viral Populat & Pathogenesis, CNRS, UMR 3569, Paris, France; [Mills, James N.] Ctr Rech Tour du Valat, Le Sambuc, Arles, France; Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA","Ezenwa, VO (reprint author), Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA.",vezenwa@uga.edu,"Bailly, Xavier/C-6254-2011; Rizzoli, Annapaola/J-2439-2012; Guegan, Jean-Francois/F-4346-2012","Bailly, Xavier/0000-0001-6959-7974; Rizzoli, Annapaola/0000-0003-3997-6783; Guegan, Jean-Francois/0000-0002-7218-107X; Vignuzzi, Marco/0000-0002-4400-771X; Roche, Benjamin/0000-0001-7975-4232; Garcia Pena, Gabriel Ernesto/0000-0002-3515-6908",,,,39,11,11,1,40,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1004992,10.1371/journal.ppat.1004992,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500003,26247831.0,"DOAJ Gold, Green Published",,,16/08/2019,12,48,97,9193,1616,1412,204,7577,6484,17,1076,97,32,0,0,11,11,1,,108,81,108,0,81,14,13,14,4,0,0,0,0,0,0,0,18,5,9907,10,10,47,1027,18,7619,1635,10,10,47,1027,18,653,,0,0,0,0,42,0,2,1,0,0,0,110,0,0,23.65,5.688737623762377,1.2132770225682987,0.2132770225682988,1.4443711231358056,1.1904710105515066,6.772277227722772
422,J,"Frenal, K; Soldati-Favre, D",,,,"Frenal, Karine; Soldati-Favre, Dominique",,,Plasticity and Redundancy in Proteins Important for Toxoplasma Invasion,PLOS PATHOGENS,,,English,Article,,,,,,,HOST-CELL INVASION; PLASMODIUM-FALCIPARUM; GONDII; PARASITES; SYSTEMS; MALARIA; GENES,,"[Frenal, Karine; Soldati-Favre, Dominique] Univ Geneva, Ctr Med Univ, Dept Microbiol & Mol Med, Geneva, Switzerland","Frenal, K (reprint author), Univ Geneva, Ctr Med Univ, Dept Microbiol & Mol Med, Geneva, Switzerland.",karine.frenal@unige.ch,,"Soldati-Favre, Dominique/0000-0003-4156-2109","Sir Jules Thorn Charitable Overseas Trust reg., Schaan","KF received funding from the ""Sir Jules Thorn Charitable Overseas Trust reg., Schaan"" subsidy for young researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,32,8,8,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005069,10.1371/journal.ppat.1005069,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500014,26270966.0,"DOAJ Gold, Green Published",,,16/08/2019,9,10,25,4248,413,297,116,3835,3254,26,555,24,10,0,0,9,9,0,,31,0,31,0,0,9,9,8,7,0,0,0,0,0,0,0,0,3,4258,13,0,28,49,0,3828,413,13,0,28,49,0,17,,0,0,0,0,10,0,0,1,0,0,0,31,0,0,5.1,10.285714285714286,1.1076923076923078,0.1076923076923077,1.1264667535853976,1.0169491525423728,10.460048426150122
423,J,"Fuchs, SP; Martinez-Navio, JM; Piatak, M; Lifson, JD; Gao, GP; Desrosiers, RC",,,,"Fuchs, Sebastian P.; Martinez-Navio, Jose M.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Gao, Guangping; Desrosiers, Ronald C.",,,AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity,PLOS PATHOGENS,,,English,Article,,,,,,,SIMIAN IMMUNODEFICIENCY VIRUS; MUCOSAL SHIV CHALLENGE; IMMUNE-RESPONSES; RHESUS MACAQUES; HIV-1 VACCINE; VIRAL REPLICATION; GENE-TRANSFER; IN-VITRO; VECTORS; SIV,"Long-term delivery of potent broadly-neutralizing antibodies is a promising approach for the prevention of HIV-1 infection. We used AAV vector intramuscularly to deliver anti-SIV monoclonal antibodies (mAbs) in IgG1 form to rhesus monkeys. Persisting levels of delivered mAb as high as 270 mu g/ml were achieved. However, host antibody responses to the delivered antibody were observed in 9 of the 12 monkeys and these appeared to limit the concentration of delivered antibody that could be achieved. This is reflected in the wide range of delivered mAb concentrations that were achieved: 1-270 mu g/ml. Following repeated, marginal dose, intravenous challenge with the difficult-to-neutralize SIVmac239, the six monkeys in the AAV-5L7 IgG1 mAb group showed clear protective effects despite the absence of detectable neutralizing activity against the challenge virus. The protective effects included: lowering of viral load at peak height; lowering of viral load at set point; delay in the time to peak viral load from the time of the infectious virus exposure. All of these effects were statistically significant. In addition, the monkey with the highest level of delivered 5L7 mAb completely resisted six successive SIVmac239 i.v. challenges, including a final challenge with a dose of 10 i.v. infectious units. Our results demonstrate the continued promise of this approach for the prevention of HIV-1 infection in people. However, the problem of anti-antibody responses will need to be understood and overcome for the promise of this approach to be effectively realized.","[Fuchs, Sebastian P.; Martinez-Navio, Jose M.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Fuchs, Sebastian P.] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA","Fuchs, SP (reprint author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.",r.desrosiers@med.miami.edu,,,"National Institute of Health [R01AI098446, U19AI095985, P01AI100263]; National Cancer Institute; National Institutes of Health [HHSN261200800001E]","This work was supported by the National Institute of Health grants R01AI098446 and U19AI095985 to RCD, P01AI100263 to GG and RCD, and federal funds from the National Cancer Institute and National Institutes of Health under contract HHSN261200800001E to MP and JDL. Details on research support are available under: http://report.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,39,39,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005090,10.1371/journal.ppat.1005090,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500027,26248318.0,"DOAJ Gold, Green Published",,,16/08/2019,38,55,25,5474,1003,721,282,4471,3758,25,688,25,3,0,0,37,37,0,,30,2,30,0,2,41,41,25,23,0,0,0,0,0,0,0,52,1,5528,143,2,171,221,0,4497,1018,93,2,171,214,0,13,,0,0,0,0,5,0,0,1,0,0,0,30,0,0,3.1,5.4576271186440675,1.2243346007604563,0.22433460076045628,1.317825989711474,1.0763609791742783,5.874376869391824
424,J,"Ghanem, ENB; Clark, S; Roggensack, SE; McIver, SR; Alcaide, P; Haydon, PG; Leong, JM",,,,"Ghanem, Elsa N. Bou; Clark, Stacie; Roggensack, Sara E.; McIver, Sally R.; Alcaide, Pilar; Haydon, Philip G.; Leong, John M.",,,Extracellular Adenosine Protects against Streptococcus pneumoniae Lung Infection by Regulating Pulmonary Neutrophil Recruitment,PLOS PATHOGENS,,,English,Article,,,,,,,PNEUMOCOCCAL PNEUMONIA; LEUKOCYTE RECRUITMENT; RECEPTOR; SUSCEPTIBILITY; INFLAMMATION; MIGRATION; A(2B); CD73; ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE; IDENTIFICATION,"An important determinant of disease following Streptococcus pneumoniae (pneumococcus) lung infection is pulmonary inflammation mediated by polymorphonuclear leukocytes (PMNs). We found that upon intratracheal challenge of mice, recruitment of PMNs into the lungs within the first 3 hours coincided with decreased pulmonary pneumococci, whereas large numbers of pulmonary PMNs beyond 12 hours correlated with a greater bacterial burden. Indeed, mice that survived infection largely resolved inflammation by 72 hours, and PMN depletion at peak infiltration, i.e. 18 hours post-infection, lowered bacterial numbers and enhanced survival. We investigated host signaling pathways that influence both pneumococcus clearance and pulmonary inflammation. Pharmacologic inhibition and/or genetic ablation of enzymes that generate extracellular adenosine (EAD) (e.g. the ectoenzyme CD73) or degrade EAD (e.g. adenosine deaminase) revealed that EAD dramatically increases murine resistance to S. pneumoniae lung infection. Moreover, adenosine diminished PMN movement across endothelial monolayers in vitro, and although inhibition or deficiency of CD73 had no discernible impact on PMN recruitment within the first 6 hours after intratracheal inoculation of mice, these measures enhanced PMN numbers in the pulmonary interstitium after 18 hours of infection, culminating in dramatically elevated numbers of pulmonary PMNs at three days post-infection. When assessed at this time point, CD73(-/-) mice displayed increased levels of cellular factors that promote leukocyte migration, such as CXCL2 chemokine in the murine lung, as well as CXCR2 and beta-2 integrin on the surface of pulmonary PMNs. The enhanced pneumococcal susceptibility of CD73(-/-) mice was significantly reversed by PMN depletion following infection, suggesting that EAD-mediated resistance is largely mediated by its effects on PMNs. Finally, CD73-inhibition diminished the ability of PMNs to kill pneumococci in vitro, suggesting that EAD alters both the recruitment and bacteriocidal function of PMNs. The EAD-pathway may provide a therapeutic target for regulating potentially harmful inflammatory host responses during Gram-positive bacterial pneumonia.","[Ghanem, Elsa N. Bou; Clark, Stacie; Leong, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Roggensack, Sara E.] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA; [McIver, Sally R.; Haydon, Philip G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Alcaide, Pilar] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Alcaide, Pilar] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA","Ghanem, ENB (reprint author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.",John.Leong@tufts.edu,,,Life Sciences Research Foundation,"Elsa N. Bou Ghanem is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation that supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,17,17,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005126,10.1371/journal.ppat.1005126,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500047,26313746.0,"DOAJ Gold, Green Published",,,16/08/2019,16,4,20,5109,959,673,286,4150,3416,17,717,20,3,0,0,17,17,0,,22,4,22,0,4,19,17,19,15,0,0,1,0,0,1,0,1,2,5179,38,0,78,183,10,4166,968,38,0,78,183,10,45,,0,0,0,0,4,0,0,1,0,0,0,22,0,0,2.25,5.327424400417101,1.2310843373493976,0.2310843373493976,1.3012048192771084,1.0569583088667058,5.630865484880084
425,J,"Gramolelli, S; Weidner-Glunde, M; Abere, B; Viejo-Borbolla, A; Bala, K; Ruckert, J; Kremmer, E; Schulz, TF",,,,"Gramolelli, Silvia; Weidner-Glunde, Magdalena; Abere, Bizunesh; Viejo-Borbolla, Abel; Bala, Kiran; Rueckert, Jessica; Kremmer, Elisabeth; Schulz, Thomas F.",,,Inhibiting the Recruitment of PLC gamma 1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells,PLOS PATHOGENS,,,English,Article,,,,,,,PHOSPHOLIPASE C-GAMMA; NF-KAPPA-B; GENE-EXPRESSION; DNA-SEQUENCES; SH2 DOMAINS; FUNCTIONAL-CHARACTERIZATION; MEMBRANE-PROTEIN; IDENTIFICATION; ACTIVATION; INVASION,"Kaposi's sarcoma (KS), caused by Kaposi's sarcoma herpesvirus (KSHV), is a highly vascularised tumour of endothelial origin. KSHV infected endothelial cells show increased invasiveness and angiogenesis. Here, we report that the KSHV K15 protein, which we showed previously to contribute to KSHV-induced angiogenesis, is also involved in KSHV-mediated invasiveness in a PLC gamma 1-dependent manner. We identified beta PIX, GIT1 and cdc42, downstream effectors of PLC gamma 1 in cell migration, as K15 interacting partners and as contributors to KSHV-triggered invasiveness. We mapped the interaction between PLC gamma 1, PLC gamma 2 and their individual domains with two K15 alleles, P and M. We found that the PLC gamma 2 cSH2 domain, by binding to K15P, can be used as dominant negative inhibitor of the K15P-PLC gamma 1 interaction, K15P-dependent PLC gamma 1 phosphorylation, NFAT-dependent promoter activation and the increased invasiveness and angiogenic properties of KSHV infected endothelial cells. We increased the binding of the PLC gamma 2 cSH2 domain for K15P by substituting two amino acids, thereby creating an improved dominant negative inhibitor of the K15P-dependent PLC gamma 1 activation. Taken together, these results demonstrate a necessary role of K15 in the increased invasiveness and angiogenesis of KSHV infected endothelial cells and suggest the K15-PLC gamma 1 interaction as a possible new target for inhibiting the angiogenic and invasive properties of KSHV.","[Gramolelli, Silvia; Weidner-Glunde, Magdalena; Abere, Bizunesh; Viejo-Borbolla, Abel; Bala, Kiran; Rueckert, Jessica; Schulz, Thomas F.] Hannover Med Sch, Inst Virol, Hannover, Germany; [Gramolelli, Silvia; Weidner-Glunde, Magdalena; Abere, Bizunesh; Rueckert, Jessica; Schulz, Thomas F.] German Ctr Infect Res DZIF, Braunschweig, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany","Gramolelli, S (reprint author), Hannover Med Sch, Inst Virol, Hannover, Germany.",schulz.thomas@mh-hannover.de,"WEIDNER-GLUNDE, Magdalena/F-3315-2016","WEIDNER-GLUNDE, Magdalena/0000-0001-8805-0974",Deutsche Forschungsgemeinschaft (DFG) [SCHU1668-3/1]; German Centre of Infection Research (DZIF) [07.802],"This study was supported by research grant SCHU1668-3/1 of the Deutsche Forschungsgemeinschaft (DFG) and the German Centre of Infection Research (DZIF), project 07.802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,14,15,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005105,10.1371/journal.ppat.1005105,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500035,26295810.0,"DOAJ Gold, Green Published",,,16/08/2019,15,0,12,3031,453,355,98,2578,2213,18,347,12,0,0,0,15,15,0,,0,2,0,0,2,17,17,7,8,0,0,0,0,0,0,0,0,0,3059,25,0,42,100,0,2581,463,25,0,42,100,0,15,,0,0,0,0,0,0,0,1,0,0,0,14,0,0,0.25,6.690949227373069,1.1757176105508147,0.17571761055081458,1.2350659425911559,1.0504783899703067,7.02869757174393
426,J,"Harapanahalli, AK; Younes, JA; Allan, E; van der Mei, HC; Busscher, HJ",,,,"Harapanahalli, Akshay K.; Younes, Jessica A.; Allan, Elaine; van der Mei, Henny C.; Busscher, Henk J.",,,Chemical Signals and Mechanosensing in Bacterial Responses to Their Environment,PLOS PATHOGENS,,,English,Article,,,,,,,GENE-EXPRESSION; ADHESION FORCES; STAPHYLOCOCCI; SURFACES; BIOFILMS; SUSCEPTIBILITY; VIRULENCE; MATRIX,,"[Harapanahalli, Akshay K.; Younes, Jessica A.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Allan, Elaine] UCL, Div Microbial Dis, UCL Eastman Dent Inst, London, England","Harapanahalli, AK (reprint author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.",h.c.van.der.mei@umcg.nl,,,University Medical Center Groningen,"This research was funded by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,22,17,18,0,26,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005057,10.1371/journal.ppat.1005057,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500013,26313357.0,"DOAJ Gold, Green Published",,,16/08/2019,19,6,44,5204,512,393,119,4692,3831,26,835,44,3,0,0,19,19,0,,64,1,64,0,1,21,21,14,4,0,0,0,0,0,0,1,3,0,5221,43,0,145,61,0,4679,512,43,0,145,61,0,30,,0,0,0,0,3,0,0,1,0,0,0,65,0,0,1.5,10.1640625,1.1091219096334186,0.10912190963341858,1.1349104859335037,1.0232513451191392,10.400390625
427,J,"Ho, YK; Zhi, HJ; Bowlin, T; Dorjbal, B; Philip, S; Zahoor, MA; Shih, HM; Semmes, OJ; Schaefer, B; Glover, JNM; Giam, CZ",,,,"Ho, Yik-Khuan; Zhi, Huijun; Bowlin, Tara; Dorjbal, Batsukh; Philip, Subha; Zahoor, Muhammad Atif; Shih, Hsiu-Ming; Semmes, Oliver John; Schaefer, Brian; Glover, J. N. Mark; Giam, Chou-Zen",,,"HTLV-1 Tax Stimulates Ubiquitin E3 Ligase, Ring Finger Protein 8, to Assemble Lysine 63-Linked Polyubiquitin Chains for TAK1 and IKK Activation",PLOS PATHOGENS,,,English,Article,,,,,,,T-CELL LEUKEMIA; NF-KAPPA-B; VIRUS TYPE-I; DNA-DAMAGE; KINASE COMPLEX; TRANSCRIPTIONAL ACTIVATOR; 21-BASE-PAIR REPEATS; MEDIATED ACTIVATION; RAT FIBROBLASTS; ONCOPROTEIN TAX,"Human T lymphotropic virus type 1 (HTLV-1) trans-activator/oncoprotein, Tax, impacts a multitude of cellular processes, including I-kappa B kinase (IKK)/NF-kappa B signaling, DNA damage repair, and mitosis. These activities of Tax have been implicated in the development of adult T-cell leukemia (ATL) in HTLV-1-infected individuals, but the underlying mechanisms remain obscure. IKK and its upstreamkinase, TGF beta-activated kinase 1 (TAK1), contain ubiquitin-binding subunits, NEMO and TAB2/3 respectively, which interact with K63-linked polyubiquitin (K63-pUb) chains. Recruitment to K63-pUb allows cross auto-phosphorylation and activation of TAK1 to occur, followed by TAK1-catalyzed IKK phosphorylation and activation. Using cytosolic extracts of HeLa and Jurkat T cells supplemented with purified proteins we have identified ubiquitin E3 ligase, ring finger protein 8 (RNF8), and E2 conjugating enzymes, Ubc13:Uev1A and Ubc13:Uev2, to be the cellular factors utilized by Tax for TAK1 and IKK activation. In vitro, the combination of Tax and RNF8 greatly stimulated TAK1, IKK, I kappa B alpha and JNK phosphorylation. In vivo, RNF8 over-expression augmented while RNF8 ablation drastically reduced canonical NF-kappa B activation by Tax. Activation of the non-canonical NF-kappa B pathway by Tax, however, is unaffected by the loss of RNF8. Using purified components, we further demonstrated biochemically that Tax greatly stimulated RNF8 and Ubc13: Uev1A/Uev2 to assemble long K63-pUb chains. Finally, co-transfection of Tax with increasing amounts of RNF8 greatly induced K63-pUb assembly in a dose-dependent manner. Thus, Tax targets RNF8 and Ubc13:Uev1A/Uev2 to promote the assembly of K63-pUb chains, which signal the activation of TAK1 and multiple downstream kinases including IKK and JNK. Because of the roles RNF8 and K63-pUb chains play in DNA damage repair and cytokinesis, this mechanism may also explain the genomic instability of HTLV-1-transformed T cells and ATL cells.","[Ho, Yik-Khuan; Zhi, Huijun; Bowlin, Tara; Dorjbal, Batsukh; Philip, Subha; Zahoor, Muhammad Atif; Schaefer, Brian; Giam, Chou-Zen] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Semmes, Oliver John] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Glover, J. N. Mark] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada","Ho, YK (reprint author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.",chou-zen.giam@usuhs.edu,"Shih, Hsiu-Ming/S-7023-2018",,National Institutes of Health [R01CA140963]; USU intramural research program grant [R073248114],"This work is supported by grants from the National Institutes of Health (R01CA140963) and the USU intramural research program grant (R073248114) to C-ZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,14,14,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005102,10.1371/journal.ppat.1005102,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500034,26285145.0,"DOAJ Gold, Green Published",,,16/08/2019,17,6,18,4492,794,558,236,3698,3104,20,574,18,6,0,0,15,15,0,,21,2,21,0,2,18,18,17,12,0,0,0,0,0,0,0,0,3,4525,54,0,265,155,1,3714,801,54,0,265,155,1,10,,0,0,0,0,6,0,0,1,0,0,0,21,0,0,2.75,5.657430730478589,1.214710654407788,0.214710654407788,1.280151433207139,1.053873552983081,5.962216624685139
428,J,"Joubert, PE; Stapleford, K; Guivel-Benhassine, F; Vignuzzi, M; Schwartz, O; Albert, ML",,,,"Joubert, Pierre-Emmanuel; Stapleford, Kenneth; Guivel-Benhassine, Florence; Vignuzzi, Marco; Schwartz, Olivier; Albert, Matthew L.",,,Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,I INTERFERON; RAPAMYCIN; PHOSPHORYLATION; EIF4E; CELLS; AUTOPHAGY; INNATE,"Chikungunya virus (CHIKV), the causative agent of a major epidemic spanning five continents, is a positive stranded mRNA virus that replicates using the cell's cap-dependent translation machinery. Despite viral infection inhibiting mTOR, a metabolic sensor controls cap-dependent translation, viral proteins are efficiently translated. Rapalog treatment, silencing of mtor or raptor genes, but not rictor, further enhanced CHIKV infection in culture cells. Using biochemical assays and real time imaging, we demonstrate that this effect is independent of autophagy or type I interferon production. Providing in vivo evidence for the relevance of our findings, mice treated with mTORC1 inhibitors exhibited increased lethality and showed a higher sensitivity to CHIKV. A systematic evaluation of the viral life cycle indicated that inhibition of mTORC1 has a specific positive effect on viral proteins, enhancing viral replication by increasing the translation of both structural and nonstructural proteins. Molecular analysis defined a role for phosphatidylinositol-3 kinase (PI3K) and MAP kinase-activated protein kinase (MnKs) activation, leading to the hyper-phosphorylation of eIF4E. Finally, we demonstrated that in the context of CHIKV inhibition of mTORC1, viral replication is prioritized over host translation via a similar mechanism. Our study reveals an unexpected bypass pathway by which CHIKV protein translation overcomes viral induced mTORC1 inhibition.","[Joubert, Pierre-Emmanuel; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Unite Immunobiol Cellules Dendrit, F-75724 Paris 15, France; [Joubert, Pierre-Emmanuel; Albert, Matthew L.] INSERM, U818, Paris, France; [Stapleford, Kenneth; Vignuzzi, Marco] Inst Pasteur, Dept Virol, Unite Populat Virales & Pathogenese, F-75724 Paris 15, France; [Guivel-Benhassine, Florence; Schwartz, Olivier] Inst Pasteur, Dept Virol, Unite Virus & Immun, F-75724 Paris 15, France; [Albert, Matthew L.] Inst Pasteur, Dept Immunol, Ctr Immunol Humaine, F-75724 Paris 15, France","Joubert, PE (reprint author), Inst Pasteur, Dept Immunol, Unite Immunobiol Cellules Dendrit, F-75724 Paris 15, France.",pjoubert@pasteur.fr; albertm@pasteur.fr,,"Vignuzzi, Marco/0000-0002-4400-771X; Joubert, Pierre-Emmanuel/0000-0001-9859-6479; SCHWARTZ, OLIVIER/0000-0002-0729-1475; Stapleford, Kenneth/0000-0002-7796-2254",La Ligue Contre le Cancer; L'Agence Nationale de la Recherche,"This work was supported by La Ligue Contre le Cancer and L'Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,13,13,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005091,10.1371/journal.ppat.1005091,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500028,26317997.0,"DOAJ Gold, Green Published",,,16/08/2019,12,10,54,5951,1096,768,328,4855,3966,23,866,54,0,2,0,15,15,1,,107,0,54,0,0,14,14,8,9,0,0,0,0,0,0,0,10,2,5967,173,0,195,56,3,4846,1096,173,0,195,56,3,25,,0,0,0,0,1,0,0,1,0,0,0,54,0,0,1.25,5.429744525547445,1.2257466529351184,0.22574665293511845,1.2762100926879505,1.0411695513359098,5.653284671532846
429,J,"Khandige, S; Kronborg, T; Uhlin, BE; Moller-Jensen, J",,,,"Khandige, Surabhi; Kronborg, Tina; Uhlin, Bernt Eric; Moller-Jensen, Jakob",,,sRNA-Mediated Regulation of P-Fimbriae Phase Variation in Uropathogenic Escherichia coli,PLOS PATHOGENS,,,English,Article,,,,,,,URINARY-TRACT-INFECTION; GROUP-A STREPTOCOCCUS; SMALL NONCODING RNAS; PYELONEPHRITIS-ASSOCIATED PILI; MESSENGER-RNA; CHAPERONE HFQ; FUNCTIONAL-CHARACTERIZATION; POSITIVE REGULATION; TRANSPORT-SYSTEMS; CHROMOSOMAL GENES,"Uropathogenic Escherichia coli (UPEC) are capable of occupying physiologically distinct intracellular and extracellular niches within the urinary tract. This feat requires the timely regulation of gene expression and small RNAs (sRNAs) are known to mediate such rapid adjustments in response to changing environmental cues. This study aimed to uncover sRNA-mediated gene regulation in the UPEC strain UTI89, during infection of bladder epithelial cells. Hfq is an RNA chaperone known to facilitate and stabilize sRNA and target mRNA interactions with bacterial cells. The co-immunoprecipitation and high throughput RNA sequencing of Hfq bound sRNAs performed in this study, revealed distinct sRNA profiles in UPEC in the extracellular and intracellular environments. Our findings emphasize the importance of studying regulatory sRNAs in a biologically relevant niche. This strategy also led to the discovery of a novel virulence-associated trans-acting sRNA-PapR. Deletion of papR was found to enhance adhesion of UTI89 to both bladder and kidney cell lines in a manner independent of type-1 fimbriae. We demonstrate PapR mediated post-transcriptional repression of the P-fimbriae phase regulator gene papI and postulate a role for such regulation in fimbrial cross-talk at the population level in UPEC. Our results further implicate the Leucine responsive protein (LRP) as a transcriptional activator regulating PapR expression. Our study reports, for the first time, a role for sRNAs in regulation of P-fimbriae phase variation and emphasizes the importance of studying pathogenesis-specific sRNAs within a relevant biological niche.","[Khandige, Surabhi; Kronborg, Tina; Moller-Jensen, Jakob] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden; [Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea Ctr Microbial Res, Umea, Sweden","Khandige, S (reprint author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.",jakobm@bmb.sdu.dk,,"Uhlin, Bernt Eric/0000-0002-2991-8072; Moller-Jensen, Jakob/0000-0002-6008-3771",Mobility Ph.D. Stipend from the Danish Natural Sciences Research Council; Villum Fonden [7292],"This work was supported by a Mobility Ph.D. Stipend from the Danish Natural Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,91,8,8,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005109,10.1371/journal.ppat.1005109,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500038,26291711.0,"DOAJ Gold, Green Published",,,16/08/2019,10,1,32,4329,861,618,243,3468,2766,22,680,31,1,0,0,7,7,0,,41,2,40,1,2,10,10,7,7,0,0,0,0,0,0,0,0,1,4371,101,0,184,137,1,3487,867,101,0,184,137,1,17,,0,0,0,0,2,0,0,1,0,0,0,40,1,0,2.25,5.02787456445993,1.2482698961937717,0.24826989619377163,1.3290080738177623,1.0646800646800647,5.35307781649245
430,J,"Kovarova, M; Council, OD; Date, AA; Long, JM; Nochii, T; Belshan, M; Shibata, A; Vincent, H; Baker, CE; Thayer, WO; Kraus, G; Lachaud-Durand, S; Williams, P; Destache, CJ; Garcia, JV",,,,"Kovarova, Martina; Council, Olivia D.; Date, Abhijit A.; Long, Julie M.; Nochii, Tomonori; Belshan, Michael; Shibata, Annemarie; Vincent, Heather; Baker, Caroline E.; Thayer, William O.; Kraus, Guenter; Lachaud-Durand, Sophie; Williams, Peter; Destache, Christopher J.; Garcia, J. Victor",,,Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIRETROVIRAL PREEXPOSURE PROPHYLAXIS; HUMANIZED BLT MICE; PLGA NANOPARTICLES; VAGINAL GEL; INFECTION; GENERATION; PHARMACOKINETICS; MICROBICIDES; DELIVERY; MODEL,"Vaginal HIV transmission accounts for the majority of new infections worldwide. Currently, multiple efforts to prevent HIV transmission are based on pre-exposure prophylaxis with various antiretroviral drugs. Here, we describe two novel nanoformulations of the reverse transcriptase inhibitor rilpivirine for pericoital and coitus-independent HIV prevention. Topically applied rilpivirine, encapsulated in PLGA nanoparticles, was delivered in a thermosensitive gel, which becomes solid at body temperature. PLGA nanoparticles with encapsulated rilpivirine coated the reproductive tract and offered significant protection to BLT humanized mice from a vaginal high-dose HIV-1 challenge. A different nanosuspension of crystalline rilpivirine (RPV LA), administered intramuscularly, protected BLT mice from a single vaginal high-dose HIV-1 challenge one week after drug administration. Using transmitted/founder viruses, which were previously shown to establish de novo infection in humans, we demonstrated that RPV LA offers significant protection from two consecutive high-dose HIV-1 challenges one and four weeks after drug administration. In this experiment, we also showed that, in certain cases, even in the presence of drug, HIV infection could occur without overt or detectable systemic replication until levels of drug were reduced. We also showed that infection in the presence of drug can result in acquisition of multiple viruses after subsequent exposures. These observations have important implications for the implementation of long-acting antiretroviral formulations for HIV prevention. They provide first evidence that occult infections can occur, despite the presence of sustained levels of antiretroviral drugs. Together, our results demonstrate that topically-or systemically administered rilpivirine offers significant coitus-dependent or coitus-independent protection from HIV infection.","[Kovarova, Martina; Council, Olivia D.; Long, Julie M.; Nochii, Tomonori; Vincent, Heather; Baker, Caroline E.; Thayer, William O.; Garcia, J. Victor] Univ N Carolina, Div Infect Dis, Ctr AIDS Res, Sch Med, Chapel Hill, NC 27515 USA; [Date, Abhijit A.; Belshan, Michael; Shibata, Annemarie; Destache, Christopher J.] Creighton Univ, Dept Pharm Practice, Sch Pharm & Hlth Profess, Omaha, NE 68178 USA; [Kraus, Guenter; Lachaud-Durand, Sophie; Williams, Peter] Janssen Res & Dev, Beerse, Belgium","Kovarova, M (reprint author), Univ N Carolina, Div Infect Dis, Ctr AIDS Res, Sch Med, Chapel Hill, NC 27515 USA.",kovarovm@med.unc.edu; victor_garcia@med.unc.edu,"Date, Abhijit/S-1167-2019; Destache, Christopher/A-7537-2009","Date, Abhijit/0000-0001-6617-882X; Destache, Christopher/0000-0001-7923-3939; Kovarova, Martina/0000-0001-7152-1709","UNC Center for AIDS Research from the NIH-NIAID [P30AI50410]; NIH-NIAID, Nebraska Center for Virology Phase III award [R56AI095115-01]; NIH [UL1TR001111]; Japan Society for the Promotion of Science;  [R01AI073146];  [R01AI096138]","This work is supported by R01AI073146, R01AI096138, the UNC Center for AIDS Research Grant P30AI50410 from the NIH-NIAID, R56AI095115-01 from the NIH-NIAID, Nebraska Center for Virology Phase III award, UL1TR001111 from the NIH, and by the Japan Society for the Promotion of Science Research Fellowship and Young Researcher Overseas Visits Program for Vitalizing Brain Circulation. The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.",,51,45,45,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005075,10.1371/journal.ppat.1005075,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500019,26271040.0,"DOAJ Gold, Green Published",,,16/08/2019,38,20,28,6890,892,671,221,5998,5315,29,654,28,18,0,0,31,31,0,,36,6,36,0,6,40,40,28,25,0,0,0,0,0,0,0,2,0,6906,27,2,62,73,2,5989,892,27,2,62,73,2,25,,1,0,0,0,17,0,1,1,0,0,0,39,0,0,18.7,7.7242152466367715,1.1487162387462488,0.14871623874624876,1.168056018672891,1.0168359941944847,7.854260089686099
431,J,"Kuriakose, T; Tripp, RA; Watford, WT",,,,"Kuriakose, Teneema; Tripp, Ralph A.; Watford, Wendy T.",,,"Tumor Progression Locus 2 Promotes Induction of IFN lambda, Interferon Stimulated Genes and Antigen-Specific CD8(+) T Cell Responses and Protects against Influenza Virus",PLOS PATHOGENS,,,English,Article,,,,,,,SIGNAL-REGULATED KINASE; RESPIRATORY SYNCYTIAL VIRUS; NF-KAPPA-B; I-INTERFERON; A VIRUS; INCREASED MORTALITY; DENDRITIC CELLS; HOST-RESISTANCE; INNATE IMMUNITY; III IFN,"Mitogen-activated protein kinase (MAP) cascades are important in antiviral immunity through their regulation of interferon (IFN) production as well as virus replication. Although the serine-threonine MAP kinase tumor progression locus 2 (Tpl2/MAP3K8) has been implicated as a key regulator of Type I (IFN alpha/beta) and Type II (IFN gamma) IFNs, remarkably little is known about how Tpl2 might contribute to host defense against viruses. Herein, we investigated the role of Tpl2 in antiviral immune responses against influenza virus. We demonstrate that Tpl2 is an integral component of multiple virus sensing pathways, differentially regulating the induction of IFN alpha/beta and IFN gamma in a cell-type specific manner. Although Tpl2 is important in the regulation of both IFN alpha/beta and IFN gamma, only IFN gamma required Tpl2 for its induction during influenza virus infection both in vitro and in vivo. Further studies revealed an unanticipated function for Tpl2 in transducing Type I IFN signals and promoting expression of interferon-stimulated genes (ISGs). Importantly, Tpl2 signaling in nonhematopoietic cells is necessary to limit early virus replication. In addition to early innate alterations, impaired expansion of virus-specific CD8(+) T cells accompanied delayed viral clearance in Tpl2(-/-) mice at late time points. Consistent with its critical role in facilitating both innate and adaptive antiviral responses, Tpl2 is required for restricting morbidity and mortality associated with influenza virus infection. Collectively, these findings establish an essential role for Tpl2 in antiviral host defense mechanisms.","[Kuriakose, Teneema; Tripp, Ralph A.; Watford, Wendy T.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA","Kuriakose, T (reprint author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.",watfordw@uga.edu,,,National Institute of Arthritis and Musculoskeletal and Skin Diseases [K22 AR053953]; National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01 AI099058]; Office of the Vice President for Research at the University of Georgia,"Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K22 AR053953) and the National Institute Of Allergy And Infectious Diseases (R01 AI099058) of the National Institutes of Health and by startup funds provided to WTW by the Office of the Vice President for Research at the University of Georgia. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,9,11,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005038,10.1371/journal.ppat.1005038,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500008,26241898.0,"DOAJ Gold, Green Published",,,16/08/2019,9,51,18,4111,644,473,171,3467,2760,23,684,18,0,0,0,7,7,1,,25,2,25,0,2,9,9,6,6,0,0,0,0,0,0,5,51,3,4151,86,0,60,68,0,3472,664,86,0,60,68,0,15,,5,2,0,0,4,0,0,1,0,0,0,25,0,0,49.65600000000001,6.383540372670807,1.185751370060571,0.1857513700605711,1.241707528122296,1.0471904646071515,6.684782608695652
432,J,"Lopez-Medina, E; Fan, D; Coughlin, LA; Ho, EX; Lamont, IL; Reimmann, C; Hooper, LV; Koh, AY",,,,"Lopez-Medina, Eduardo; Fan, Di; Coughlin, Laura A.; Ho, Evi X.; Lamont, Iain L.; Reimmann, Cornelia; Hooper, Lora V.; Koh, Andrew Y.",,,Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis,PLOS PATHOGENS,,,English,Article,,,,,,,CYSTIC-FIBROSIS; IRON ACQUISITION; MOUSE MODEL; BACTERIAL TRANSLOCATION; CLINICAL-IMPLICATIONS; ELECTRON-MICROSCOPY; EPITHELIAL INJURY; PATHOGENIC YEASTS; ESCHERICHIA-COLI; INNATE IMMUNITY,"Bacterial-fungal interactions have important physiologic and medical ramifications, but the mechanisms of these interactions are poorly understood. The gut is host to trillions of microorganisms, and bacterial-fungal interactions are likely to be important. Using a neutropenic mouse model of microbial gastrointestinal colonization and dissemination, we show that the fungus Candida albicans inhibits the virulence of the bacterium Pseudomonas aeruginosa by inhibiting P. aeruginosa pyochelin and pyoverdine gene expression, which plays a critical role in iron acquisition and virulence. Accordingly, deletion of both P. aeruginosa pyochelin and pyoverdine genes attenuates P. aeruginosa virulence. Heat-killed C. albicans has no effect on P. aeruginosa, whereas C. albicans secreted proteins directly suppress P. aeruginosa pyoverdine and pyochelin expression and inhibit P. aeruginosa virulence in mice. Interestingly, suppression or deletion of pyochelin and pyoverdine genes has no effect on P. aeruginosa's ability to colonize the GI tract but does decrease P. aeruginosa's cytotoxic effect on cultured colonocytes. Finally, oral iron supplementation restores P. aeruginosa virulence in P. aeruginosa and C. albicans colonized mice. Together, our findings provide insight into how a bacterial-fungal interaction can modulate bacterial virulence in the intestine. Previously described bacterial-fungal antagonistic interactions have focused on growth inhibition or colonization inhibition/modulation, yet here we describe a novel observation of fungal-inhibition of bacterial effectors critical for virulence but not important for colonization. These findings validate the use of a mammalian model system to explore the complexities of polymicrobial, polykingdom infections in order to identify new therapeutic targets for preventing microbial disease.","[Lopez-Medina, Eduardo; Fan, Di; Coughlin, Laura A.; Ho, Evi X.; Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Lamont, Iain L.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Reimmann, Cornelia] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Hooper, Lora V.; Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA","Lopez-Medina, E (reprint author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.",andrew.koh@utsouthwestern.edu,"Koh, Andrew/R-6837-2019","Koh, Andrew/0000-0003-2172-5126; Lamont, Iain/0000-0002-7601-6354",Roberta I. and Norman L. Pollock Fund; Young Investigator Grant for Probiotics; US National Institutes of Health (NIH) [R01 DK060855]; Howard Hughes Medical Institute,"This study was supported in part by the Roberta I. and Norman L. Pollock Fund (AYK), Young Investigator Grant for Probiotics (AYK), US National Institutes of Health (NIH) grant R01 DK060855 (LVH), and the Howard Hughes Medical Institute (LVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,119,39,39,1,26,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005129,10.1371/journal.ppat.1005129,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500050,26313907.0,"DOAJ Gold, Green Published",,,16/08/2019,41,83,83,10693,2060,1506,554,8633,6883,65,1685,83,21,0,2,36,36,0,,102,5,102,0,5,42,42,42,24,0,0,0,0,0,0,0,62,6,10722,116,0,173,103,0,8611,2060,116,0,173,103,0,51,,0,0,0,0,25,0,0,1,1,0,0,106,0,0,14.3,5.190776699029127,1.2386192517085601,0.2386192517085602,1.2673462295841538,1.0231927429159262,5.311165048543689
433,J,"McCarthy, KR; Kirmaier, A; Autissier, P; Johnson, WE",,,,"McCarthy, Kevin R.; Kirmaier, Andrea; Autissier, Patrick; Johnson, Welkin E.",,,Evolutionary and Functional Analysis of Old World Primate TRIM5 Reveals the Ancient Emergence of Primate Lentiviruses and Convergent Evolution Targeting a Conserved Capsid Interface,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; TRIM5-ALPHA PRYSPRY DOMAIN; AMINO-TERMINAL DOMAIN; MURINE LEUKEMIA-VIRUS; PFIZER MONKEY VIRUS; SPRY B30.2 DOMAIN; SIMIAN IMMUNODEFICIENCY; RETROVIRUS RESTRICTION; HIV-1 RESTRICTION; CYCLOPHILIN-A,"The widespread distribution of lentiviruses among African primates, and the lack of severe pathogenesis in many of these natural reservoirs, are taken as evidence for long-term co-evolution between the simian immunodeficiency viruses (SIVs) and their primate hosts. Evidence for positive selection acting on antiviral restriction factors is consistent with virus-host interactions spanning millions of years of primate evolution. However, many restriction mechanisms are not virus-specific, and selection cannot be unambiguously attributed to any one type of virus. We hypothesized that the restriction factor TRIM5, because of its unique specificity for retrovirus capsids, should accumulate adaptive changes in a virus-specific fashion, and therefore, that phylogenetic reconstruction of TRIM5 evolution in African primates should reveal selection by lentiviruses closely related to modern SIVs. We analyzed complete TRIM5 coding sequences of 22 Old World primates and identified a tightly-spaced cluster of branch-specific adaptions appearing in the Cercopithecinae lineage after divergence from the Colobinae around 16 million years ago. Functional assays of both extant TRIM5 orthologs and reconstructed ancestral TRIM5 proteins revealed that this cluster of adaptations in TRIM5 specifically resulted in the ability to restrict Cercopithecine lentiviruses, but had no effect (positive or negative) on restriction of other retroviruses, including lentiviruses of non-Cercopithecine primates. The correlation between lineage-specific adaptations and ability to restrict viruses endemic to the same hosts supports the hypothesis that lentiviruses closely related to modern SIVs were present in Africa and infecting the ancestors of Cercopithecine primates as far back as 16 million years ago, and provides insight into the evolution of TRIM5 specificity.","[McCarthy, Kevin R.] Harvard Univ, Sch Med, Harvard Program Virol, Boston, MA 02163 USA; [McCarthy, Kevin R.; Kirmaier, Andrea; Autissier, Patrick; Johnson, Welkin E.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA","McCarthy, KR (reprint author), Harvard Univ, Sch Med, Harvard Program Virol, Boston, MA 02163 USA.",welkin.johnson@bc.edu,"Kirmaier, Andrea/H-4034-2019","Kirmaier, Andrea/0000-0001-7206-7640","National Institutes of Health [AI083118, AI095092]","This work was supported by grants AI083118 and AI095092 from the National Institutes of Health (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,105,13,14,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005085,10.1371/journal.ppat.1005085,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500025,26291613.0,"DOAJ Gold, Green Published",,,16/08/2019,13,144,31,9021,513,399,114,8508,7816,23,669,31,56,2,0,14,14,12,,47,3,47,0,3,17,14,17,9,1,0,0,1,0,0,2,89,6,9105,71,2,67,114,2,8523,532,71,2,67,114,2,50,,9,4,0,0,62,0,2,1,0,0,0,47,0,0,126.356,17.584795321637426,1.060296191819464,0.06029619181946404,1.0919134931828867,1.0298193104977276,18.10916179337232
434,J,"McCoy, LE; Falkowska, E; Doores, KJ; Le, K; Sok, D; van Gils, MJ; Euler, Z; Burger, JA; Seaman, MS; Sanders, RW; Schuitemaker, H; Poignard, P; Wrin, T; Burton, DR",,,,"McCoy, Laura E.; Falkowska, Emilia; Doores, Katie J.; Le, Khoa; Sok, Devin; van Gils, Marit J.; Euler, Zelda; Burger, Judith A.; Seaman, Michael S.; Sanders, Rogier W.; Schuitemaker, Hanneke; Poignard, Pascal; Wrin, Terri; Burton, Dennis R.",,,Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies,PLOS PATHOGENS,,,English,Article,,,,,,,N-GLYCAN RECOGNITION; POTENT NEUTRALIZATION; GLYCOSYLATION SITES; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; PASSIVE TRANSFER; STRUCTURAL BASIS; ENVELOPE TRIMER; SHIV CHALLENGE; VIRUS,"The broadly neutralizing HIV monoclonal antibodies (bnMAbs) PG9, PG16, PGT151, and PGT152 have been shown earlier to occasionally display an unusual virus neutralization profile with a non-sigmoidal slope and a plateau at <100% neutralization. In the current study, we were interested in determining the extent of non-sigmoidal slopes and plateaus at <100% for HIV bnMAbs more generally. Using both a 278 panel of pseudoviruses in a CD4 T-cell (U87.CCR5.CXCR4) assay and a panel of 117 viruses in the TZM-bl assay, we found that bnMAbs targeting many neutralizing epitopes of the spike had neutralization profiles for at least one virus that plateaued at <90%. Across both panels the bnMAbs targeting the V2 apex of Env and gp41 were most likely to show neutralization curves that plateaued <100%. Conversely, bnMAbs targeting the high-mannose patch epitopes were less likely to show such behavior. Two CD4 binding site (CD4bs) Abs also showed this behavior relatively infrequently. The phenomenon of incomplete neutralization was also observed in a large peripheral blood mononuclear cells (PBMC)-grown molecular virus clone panel derived from patient viral swarms. In addition, five bnMAbs were compared against an 18-virus panel of molecular clones produced in 293T cells and PBMCs and assayed in TZM-bl cells. Examples of plateaus <90% were seen with both types of virus production with no consistent patterns observed. In conclusion, incomplete neutralization and non-sigmoidal neutralization curves are possible for all HIV bnMAbs against a wide range of viruses produced and assayed in both cell lines and primary cells with implications for the use of antibodies in therapy and as tools for vaccine design.","[McCoy, Laura E.; Falkowska, Emilia; Le, Khoa; Sok, Devin; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [McCoy, Laura E.; Falkowska, Emilia; Le, Khoa; Sok, Devin; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Falkowska, Emilia; Burton, Dennis R.] MIT, Ragon Inst Massachusetts Gen Hosp, Cambridge, MA 02139 USA; [Falkowska, Emilia; Burton, Dennis R.] Harvard Univ, Cambridge, MA 02138 USA; [Doores, Katie J.] Guys Hosp, Sch Med, Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [van Gils, Marit J.; Euler, Zelda; Burger, Judith A.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Lab Viral Immunopathogenesis, NL-1105 AZ Amsterdam, Netherlands; [van Gils, Marit J.; Burger, Judith A.; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA","McCoy, LE (reprint author), Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.",burton@scripps.edu,"poignard, pascal/N-6678-2013; van Gils, Marit J./H-4791-2019","van Gils, Marit J./0000-0003-3422-8161; McCoy, Laura/0000-0001-9503-7946; Doores, Katie/0000-0002-5507-1725","International AIDS Vaccine Initiative through the Neutralizing Antibody Consortium [SFP1849]; National Institutes of Allergy and Infectious Diseases, [R01 AI033292]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant [UM1AI100663]; Ragon Institute of MGH, MIT; Bill and Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery [1032144]; Vici grant from The Netherlands Organization for Scientific Research [918.66.628]; European Community's Sixth Framework Program 'European HIV Enterprise (EUROPRISE)' (FP6) [037611]; European Community's Seventh Framework Program 'Next-Generation HIV-1 Immunogens Inducing Broadly Reactive Neutralizing Antibodies (NGIN)' (FP7) [201433]; Aids fonds Netherlands [2012041]; Vidi grant from the Netherlands Organization for Scientific Research [917.11.314]; European Research Council [ERC-StG- 2011-280829-SHEV]; Harvard Training Program","This work was supported by the International AIDS Vaccine Initiative through the Neutralizing Antibody Consortium SFP1849 (DRB and PP); National Institutes of Allergy and Infectious Diseases Grant R01 AI033292 (to DRB), Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663 (to DRB); The Ragon Institute of MGH, MIT, and Harvard (DRB) Training Program (to EF); The Bill and Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery (Grant 1032144 [to MSS]). This study was financially supported by a Vici grant to HS from The Netherlands Organization for Scientific Research (grant #918.66.628), a grant from the European Community's Sixth Framework Program 'European HIV Enterprise (EUROPRISE)' (FP6/2007-2012), under grant agreement 037611, and the European Community's Seventh Framework Program 'Next-Generation HIV-1 Immunogens Inducing Broadly Reactive Neutralizing Antibodies (NGIN)' (FP7/2007-2013), under grant agreement 201433. MJvG receives funding from the Aids fonds Netherlands (grant #2012041). RWS is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (grant #917.11.314) and a Starting Investigator Grant from the European Research Council (ERC-StG- 2011-280829-SHEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,42,42,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005110,10.1371/journal.ppat.1005110,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500039,26267277.0,"DOAJ Gold, Green Published",,,16/08/2019,43,5,31,4684,656,477,179,4028,3301,33,694,31,3,0,1,41,41,0,,42,1,42,0,1,44,44,42,38,0,0,0,0,0,0,0,2,0,4742,98,0,194,172,0,4049,667,98,0,194,172,0,26,,0,0,0,0,6,0,1,1,1,0,0,43,0,0,3.85,7.140243902439025,1.162859980139027,0.1628599801390268,1.2442899702085402,1.0700256191289497,7.640243902439025
435,J,"Mitagami, Y; Yasunaga, J; Kinosada, H; Ohshima, K; Matsuoka, M",,,,"Mitagami, Yu; Yasunaga, Jun-ichirou; Kinosada, Haruka; Ohshima, Koichi; Matsuoka, Masao",,,Interferon-gamma Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice,PLOS PATHOGENS,,,English,Article,,,,,,,VIRUS TYPE-I; NF-KAPPA-B; LEUKEMIA-CELLS; HEPATOCELLULAR-CARCINOMA; INFECTED INDIVIDUALS; GASTRIC-CANCER; TYPE-1 HTLV-1; TAX GENE; EXPRESSION; GROWTH,"Human T-cell leukemia virus type 1 (HTLV-1) is an etiological agent of several inflammatory diseases and a T-cell malignancy, adult T-cell leukemia (ATL). HTLV-1 bZIP factor (HBZ) is the only viral gene that is constitutively expressed in HTLV-1-infected cells, and it has multiple functions on T-cell signaling pathways. HBZ has important roles in HTLV-1-mediated pathogenesis, since HBZ transgenic (HBZ-Tg) mice develop systemic inflammation and T-cell lymphomas, which are similar phenotypes to HTLV-1-associated diseases. We showed previously that in HBZ-Tg mice, HBZ causes unstable Foxp3 expression, leading to an increase in regulatory T cells (Tregs) and the consequent induction of IFN-gamma-producing cells, which in turn leads to the development of inflammation in the mice. In this study, we show that the severity of inflammation is correlated with the development of lymphomas in HBZ-Tg mice, suggesting that HBZ-mediated inflammation is closely linked to oncogenesis in CD4(+) T cells. In addition, we found that IFN-gamma-producing cells enhance HBZ-mediated inflammation, since knocking out IFN-gamma significantly reduced the incidence of dermatitis as well as lymphoma. Recent studies show the critical roles of the intestinal microbiota in the development of Tregs in vivo. We found that even germ-free HBZ-Tg mice still had an increased number of Tregs and IFN-gamma-producing cells, and developed dermatitis, indicating that an intrinsic activity of HBZ evokes aberrant T-cell differentiation and consequently causes inflammation. These results show that immunomodulation by HBZ is implicated in both inflammation and oncogenesis, and suggest a causal connection between HTLV-1-associated inflammation and ATL.","[Mitagami, Yu; Yasunaga, Jun-ichirou; Kinosada, Haruka; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, Kyoto 606, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan","Mitagami, Y (reprint author), Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, Kyoto 606, Japan.",jyasunag@virus.kyoto-u.ac.jp,,"Matsuoka, Masao/0000-0002-0473-754X",,,,51,12,13,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005120,10.1371/journal.ppat.1005120,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500045,26296091.0,"DOAJ Gold, Green Published",,,16/08/2019,14,1,13,4263,690,478,212,3573,3120,29,424,13,0,0,0,10,10,0,,18,2,18,0,2,15,15,9,9,0,0,0,0,0,0,0,1,9,4264,35,0,160,39,1,3557,690,35,0,160,39,1,17,,0,0,0,0,8,0,0,1,0,0,0,20,0,0,3.75,6.178260869565217,1.1931150293870696,0.19311502938706968,1.2141057934508817,1.0175932441942295,6.28695652173913
436,J,"Pechous, RD; Goldman, WE",,,,"Pechous, Roger D.; Goldman, William E.",,,Illuminating Targets of Bacterial Secretion,PLOS PATHOGENS,,,English,Article,,,,,,,YOP TRANSLOCATION; BETA-LACTAMASE; III SECRETION; CELLS; IDENTIFICATION; NEUTROPHILS,,"[Pechous, Roger D.; Goldman, William E.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA","Pechous, RD (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.",goldman@med.unc.edu,,,,,,20,3,3,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1004981,10.1371/journal.ppat.1004981,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500002,26247771.0,"DOAJ Gold, Green Published",,,16/08/2019,4,2,23,3593,314,232,82,3279,2772,23,484,23,2,0,0,3,3,0,,31,0,31,0,0,5,5,3,1,0,0,0,0,0,0,0,0,0,3625,31,0,660,40,2,3286,321,31,0,660,40,2,18,,0,0,0,0,2,0,0,1,0,0,0,31,0,0,1.75,11.44267515923567,1.095760902714242,0.09576090271424215,1.1271729185727355,1.0286668522126357,11.770700636942674
437,J,"Ravindran, MS; Bagchi, P; Inoue, T; Tsai, B",,,,"Ravindran, Madhu Sudhan; Bagchi, Parikshit; Inoue, Takamasa; Tsai, Billy",,,A Non-enveloped Virus Hijacks Host Disaggregation Machinery to Translocate across the Endoplasmic Reticulum Membrane,PLOS PATHOGENS,,,English,Article,,,,,,,NUCLEOTIDE EXCHANGE FACTORS; UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; MOLECULAR CHAPERONES; HSP110 CHAPERONES; CHOLERA-TOXIN; FUNCTIONAL SPECIFICITY; CAVEOLAR ENDOCYTOSIS; AAA-ATPASE,"Mammalian cytosolic Hsp110 family, in concert with the Hsc70:J-protein complex, functions as a disaggregation machinery to rectify protein misfolding problems. Here we uncover a novel role of this machinery in driving membrane translocation during viral entry. The nonenveloped virus SV40 penetrates the endoplasmic reticulum (ER) membrane to reach the cytosol, a critical infection step. Combining biochemical, cell-based, and imaging approaches, we find that the Hsp110 family member Hsp105 associates with the ER membrane J-protein B14. Here Hsp105 cooperates with Hsc70 and extracts the membrane-penetrating SV40 into the cytosol, potentially by disassembling the membrane-embedded virus. Hence the energy provided by the Hsc70-dependent Hsp105 disaggregation machinery can be harnessed to catalyze a membrane translocation event.","[Ravindran, Madhu Sudhan; Bagchi, Parikshit; Inoue, Takamasa; Tsai, Billy] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA","Ravindran, MS (reprint author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.",btsai@umich.edu,"Ravindran, Madhu Sudhan/I-5325-2019","Ravindran, Madhu Sudhan/0000-0001-7450-2001",National Institutes of Health [AI 064296],"BT was supported by the National Institutes of Health (AI 064296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,78,16,16,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005086,10.1371/journal.ppat.1005086,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500026,26244546.0,"DOAJ Gold, Green Published",,,16/08/2019,18,125,14,5279,494,364,130,4785,4159,28,598,14,32,0,0,19,19,2,,22,0,22,0,0,18,18,16,12,0,0,0,0,0,0,0,93,1,5321,48,0,247,136,1,4798,502,48,0,247,136,1,21,,0,1,0,0,30,0,0,0,0,0,0,42,0,0,23.966,10.686234817813766,1.103239289446186,0.103239289446186,1.1504702194357366,1.0428111384731957,11.143724696356275
438,J,"Rennoll-Bankert, KE; Rahman, MS; Gillespie, JJ; Guillotte, ML; Kaur, SJ; Lehman, SS; Beier-Sexton, M; Azad, AF",,,,"Rennoll-Bankert, Kristen E.; Rahman, M. Sayeedur; Gillespie, Joseph J.; Guillotte, Mark L.; Kaur, Simran J.; Lehman, Stephanie S.; Beier-Sexton, Magda; Azad, Abdu F.",,,Which Way In? The RalF Arf-GEF Orchestrates Rickettsia Host Cell Invasion,PLOS PATHOGENS,,,English,Article,,,,,,,ADP-RIBOSYLATION FACTOR; ACTIN-BASED MOTILITY; NUCLEOTIDE EXCHANGE FACTOR; IV SECRETION SYSTEMS; CONORII AUTOTRANSPORTER PROTEIN; HUMAN-ENDOTHELIAL-CELLS; INTRACELLULAR PATHOGENS; ARP2/3 COMPLEX; MAMMALIAN-CELLS; PLASMA-MEMBRANE,"Bacterial Sec7-domain-containing proteins (RalF) are known only from species of Legionella and Rickettsia, which have facultative and obligate intracellular lifestyles, respectively. L. pneumophila RalF, a type IV secretion system (T4SS) effector, is a guanine nucleotide exchange factor (GEF) of ADP-ribosylation factors (Arfs), activating and recruiting host Arf1 to the Legionella-containing vacuole. In contrast, previous in vitro studies showed R. prowazekii (Typhus Group) RalF is a functional Arf-GEF that localizes to the host plasma membrane and interacts with the actin cytoskeleton via a unique C-terminal domain. As RalF is differentially encoded across Rickettsia species (e.g., pseudogenized in all Spotted Fever Group species), it may function in lineage-specific biology and pathogenicity. Herein, we demonstrate RalF of R. typhi (Typhus Group) interacts with the Rickettsia T4SS coupling protein (RvhD4) via its proximal C-terminal sequence. RalF is expressed early during infection, with its inactivation via antibody blocking significantly reducing R. typhi host cell invasion. For R. typhi and R. felis (Transitional Group), RalF ectopic expression revealed subcellular localization with the host plasma membrane and actin cytoskeleton. Remarkably, R. bellii (Ancestral Group) RalF showed perinuclear localization reminiscent of ectopically expressed Legionella RalF, for which it shares several structural features. For R. typhi, RalF co-localization with Arf6 and PI(4,5) P2 at entry foci on the host plasma membrane was determined to be critical for invasion. Thus, we propose recruitment of PI(4,5) P2 at entry foci, mediated by RalF activation of Arf6, initiates actin remodeling and ultimately facilitates bacterial invasion. Collectively, our characterization of RalF as an invasin suggests that, despite carrying a similar Arf-GEF unknown from other bacteria, different intracellular lifestyles across Rickettsia and Legionella species have driven divergent roles for RalF during infection. Furthermore, our identification of lineage-specific Arf-GEF utilization across some rickettsial species illustrates different pathogenicity factors that define diverse agents of rickettsial diseases.","[Rennoll-Bankert, Kristen E.; Rahman, M. Sayeedur; Gillespie, Joseph J.; Guillotte, Mark L.; Kaur, Simran J.; Lehman, Stephanie S.; Beier-Sexton, Magda; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA","Rennoll-Bankert, KE (reprint author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.",aazad@som.umaryland.edu,,"Gillespie, Joseph/0000-0002-5447-7264; Rennoll-Bankert, Kristen/0000-0002-1187-9255; Guillotte, Mark/0000-0002-1826-8879","National Institute of Health/National Institute of Allergy and Infectious Diseases [R01AI017828, R01AI043006, R01AI59118]; NIH/NIAID [T32AI095190]","This work was supported with funds from the National Institute of Health/National Institute of Allergy and Infectious Diseases grants (R01AI017828, R01AI043006 and R01AI59118). KERB is supported in part by the NIH/NIAID T32AI095190 Signaling Pathways in Innate Immunity grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,118,11,11,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005115,10.1371/journal.ppat.1005115,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500043,26291822.0,"DOAJ Gold, Green Published",,,16/08/2019,12,1,29,4167,939,691,248,3228,2560,22,646,29,1,0,0,10,10,0,,75,1,38,0,1,13,12,13,7,0,0,0,0,0,0,0,0,0,4262,101,0,99,156,4,3272,957,101,0,99,156,4,33,,0,0,0,0,1,0,0,1,0,0,0,38,0,0,0.5,4.437699680511182,1.2908921933085502,0.2908921933085502,1.3999380421313508,1.0844732421406287,4.812566560170394
439,J,"Roederer, M",,,,"Roederer, Mario",,,Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY VIRUS SIVMAC239; T-CELL RESPONSES; CHALLENGE EXPERIMENTS; IMMUNE-RESPONSES; RHESUS-MONKEYS; SIV CHALLENGE; MACAQUES; VACCINE; TRANSMISSION; PROTECTION,"The nonhuman primate (NHP) model is often the best experimental model for testing interventions designed to block infection by human pathogens, such as HIV, tuberculosis, and malaria. A physiological model may require the use of a limiting dose of the infectious agent, where only a fraction of animals become infected upon any given challenge. Determining the challenge dose of the pathogen in such experiments is critical to the success of the experiment: using too-high or too-low a challenge dose may lead to false negative results and an excessive use of animals. Here I define an optimized protocol for defining the dose of pathogen that infects 50% of the time (AID(50)); other challenge doses, e.g. AID(80), can be easily calculated from the same data. This protocol minimizes the number of animals, as well as resources and procedures, while providing an estimate of the AID(50) within 1.5-fold of the true value.","NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA","Roederer, M (reprint author), NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",Roederer@nih.gov,,,"Intramural Research Program of the Vaccine Research Center, NIAID, NIH","This work was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,29,3,3,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005100,10.1371/journal.ppat.1005100,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500032,26285041.0,"DOAJ Gold, Green Published",,,16/08/2019,3,2,11,2885,597,482,115,2288,1967,20,301,11,1,0,0,3,3,0,,16,8,16,0,8,3,3,0,1,0,0,0,0,0,0,0,1,1,2911,23,0,30,71,1,2280,597,23,0,30,71,1,34,,0,0,0,0,2,0,0,1,0,0,0,16,0,0,0.75,4.83249581239531,1.2609265734265733,0.26092657342657344,1.3133741258741258,1.0415944540727904,5.033500837520938
440,J,"Sarradin, P; Viglietta, C; Limouzin, C; Andreoletti, O; Daniel-Carlier, N; Barc, C; Leroux-Coyau, M; Berthon, P; Chapuis, J; Rossignol, C; Gatti, JL; Belghazi, M; Labas, V; Vilotte, JL; Beringue, V; Lantier, F; Laude, H; Houdebine, LM",,,,"Sarradin, Pierre; Viglietta, Celine; Limouzin, Claude; Andreoletti, Olivier; Daniel-Carlier, Nathalie; Barc, Celine; Leroux-Coyau, Mathieu; Berthon, Patricia; Chapuis, Jerome; Rossignol, Christelle; Gatti, Jean-Luc; Belghazi, Maya; Labas, Valerie; Vilotte, Jean-Luc; Beringue, Vincent; Lantier, Frederic; Laude, Hubert; Houdebine, Louis-Marie",,,Transgenic Rabbits Expressing Ovine PrP Are Susceptible to Scrapie,PLOS PATHOGENS,,,English,Article,,,,,,,PRION PROTEIN PRP; SHEEP SCRAPIE; MICE; INFECTION; TRANSMISSION; RESISTANT; AGENT; REPLICATION; PROPAGATION; GENOTYPE,"Transmissible spongiform encephalopathies (TSEs) are a group of neurodegenerative diseases affecting a wide range of mammalian species. They are caused by prions, a proteinaceous pathogen essentially composed of PrPSc, an abnormal isoform of the host encoded cellular prion protein PrPC. Constrained steric interactions between PrPSc and PrPC are thought to provide prions with species specificity, and to control cross-species transmission into other host populations, including humans. Transgenetic expression of foreign PrP genes has been successfully and widely used to overcome the recognized resistance of mouse to foreign TSE sources. Rabbit is one of the species that exhibit a pronounced resistance to TSEs. Most attempts to infect experimentally rabbit have failed, except after inoculation with cell-free generated rabbit prions. To gain insights on the molecular determinants of the relative resistance of rabbits to prions, we generated transgenic rabbits expressing the susceptible V(136)R(154)Q(171) allele of the ovine PRNP gene on a rabbit wild type PRNP New Zealand background and assessed their experimental susceptibility to scrapie prions. All transgenic animals developed a typical TSE 6-8 months after intracerebral inoculation, whereas wild type rabbits remained healthy more than 700 days after inoculation. Despite the endogenous presence of rabbit PrPC, only ovine PrPSc was detectable in the brains of diseased animals. Collectively these data indicate that the low susceptibility of rabbits to prion infection is not enciphered within their non-PrP genetic background.","[Sarradin, Pierre; Barc, Celine; Berthon, Patricia; Rossignol, Christelle; Lantier, Frederic] Univ Tours, INRA, ISP, UMR1282, Nouzilly, France; [Sarradin, Pierre; Limouzin, Claude; Barc, Celine] INRA, PFIE, UE1277, F-37380 Nouzilly, France; [Viglietta, Celine; Daniel-Carlier, Nathalie; Leroux-Coyau, Mathieu; Houdebine, Louis-Marie] INRA CNRS ENVA, Biol Dev & Reprod, UMR1198, Jouy En Josas, France; [Andreoletti, Olivier] UMR INRA ENVT 1225, Interact Hotes Agents Pathogenes, Toulouse, France; [Chapuis, Jerome; Beringue, Vincent; Laude, Hubert] INRA, Virol Immunol Mol, UR892, Jouy En Josas, France; [Gatti, Jean-Luc] INRA CNRS UNS, ISA, UMR1355, Sophia Antipolis, France; [Gatti, Jean-Luc; Belghazi, Maya] Univ Tours, Plate Forme Analyse Integrat Biomol, Inst Francais Cheval & Equitat Physiol Reprod & C, INRA,UMR INRA85,UMR CNRS 7247, Nouzilly, France; [Belghazi, Maya; Labas, Valerie] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, CRN2M,UMR7286, Marseille, France; [Vilotte, Jean-Luc] INRA, Genet Anim & Biol Integrat, UMR1313, Jouy En Josas, France","Sarradin, P (reprint author), Univ Tours, INRA, ISP, UMR1282, Nouzilly, France.",pierre.sarradin@tours.inra.fr; vincent.beringue@jouy.inra.fr,,,,,,44,7,7,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005077,10.1371/journal.ppat.1005077,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500020,26248157.0,"DOAJ Gold, Green Published",,,16/08/2019,6,219,14,4444,1540,1418,122,2904,2430,31,443,14,0,3,0,6,6,0,,18,5,18,0,5,6,6,6,5,0,0,0,0,0,0,1,215,0,4507,35,194,78,195,2,2899,1540,35,194,78,195,2,68,,2,0,0,0,4,0,5,1,0,0,0,18,0,0,19.5,2.8857142857142857,1.5303030303030303,0.5303030303030303,1.631198347107438,1.0659315931593158,3.075974025974026
441,J,"Schreiber, CA; Sakuma, T; Izumiya, Y; Holditch, SJ; Hickey, RD; Bressin, RK; Basu, U; Koide, K; Asokan, A; Ikeda, Y",,,,"Schreiber, Claire A.; Sakuma, Toshie; Izumiya, Yoshihiro; Holditch, Sara J.; Hickey, Raymond D.; Bressin, Robert K.; Basu, Upamanyu; Koide, Kazunori; Asokan, Aravind; Ikeda, Yasuhiro",,,An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses,PLOS PATHOGENS,,,English,Article,,,,,,,ADENOVIRUS-INFECTED CELLS; 2-MEDIATED GENE-TRANSFER; PROTEIN-TYROSINE KINASE; IN-VIVO; AAV VECTOR; MRE11/RAD50/NBS1 COMPLEX; EFFICIENT TRANSDUCTION; TRANSGENE EXPRESSION; 2ND-STRAND SYNTHESIS; NATRIURETIC PEPTIDE,"Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors.","[Schreiber, Claire A.; Sakuma, Toshie; Holditch, Sara J.; Hickey, Raymond D.; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55902 USA; [Izumiya, Yoshihiro] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Bressin, Robert K.; Basu, Upamanyu; Koide, Kazunori] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Asokan, Aravind] Univ N Carolina, Sch Med, Gene Therapy Ctr, Chapel Hill, NC USA; [Asokan, Aravind] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA","Schreiber, CA (reprint author), Mayo Clin, Dept Mol Med, Rochester, MN 55902 USA.",ikeda.yasuhiro@mayo.edu,"Basu, Upamanyu/J-2104-2019","Bressin, Robert/0000-0003-4947-1156; Izumiya, Yoshihiro/0000-0002-9184-2603","Mayo Foundation; National Institutes of Health (NIH) [R01 HL098502]; NIH [R01 CA14779]; American Cancer Society [RSG-13-383-01-MPC, R01 CA120792, R01 HL089221, P01HL112761]","This work was supported by Mayo Foundation and National Institutes of Health (NIH) R01 HL098502 to YIk, NIH R01 CA14779 and American Cancer Society RSG-13-383-01-MPC to YIz, R01 CA120792 to KK, R01 HL089221 and P01HL112761 for AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,13,13,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005082,10.1371/journal.ppat.1005082,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500022,26244496.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,15,5,41,5069,874,645,229,4195,3265,29,901,41,5,0,0,15,15,0,,56,2,56,0,2,15,15,14,8,0,0,0,0,0,0,0,0,0,5054,201,0,127,120,1,4168,874,149,0,127,120,1,12,,0,0,0,0,1,0,0,1,0,0,0,55,0,0,3.5,5.799771167048055,1.2083432657926103,0.20834326579261025,1.2812872467222884,1.060366936279345,6.149885583524028
442,J,"Seifert, H",,,,"Seifert, Hank",,,The Long and Winding Road (Apologies to the Beatles),PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA","Seifert, H (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.",h-seifert@northwestern.edu,,,,,,0,0,0,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005094,10.1371/journal.ppat.1005094,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500030,26313447.0,"DOAJ Gold, Green Published",,,16/08/2019,0,120,3,3663,182,137,45,3481,3204,22,255,3,17,0,0,0,0,2,,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,103,12,3824,0,0,0,393,3,3494,186,0,0,0,393,3,144,,0,1,0,0,28,0,1,1,0,0,0,5,0,0,21.458,20.126373626373628,1.0522838264866419,0.05228382648664177,1.211433496121804,1.1512421512421513,23.17032967032967
443,J,"Shang, YF; Feng, P; Wang, CS",,,,"Shang, Yanfang; Feng, Peng; Wang, Chengshu",,,Fungi That Infect Insects: Altering Host Behavior and Beyond,PLOS PATHOGENS,,,English,Article,,,,,,,COPTOTERMES-FORMOSANUS; MOLECULAR-MECHANISMS; EXTENDED PHENOTYPE; ANT; MANIPULATION; IMMUNITY; CLASSIFICATION; DESTRUXINS; OCTOPAMINE; RESISTANCE,,"[Shang, Yanfang; Feng, Peng; Wang, Chengshu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China","Shang, YF (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.",cswang@sibs.ac.cn,"Wang, Chengshu/A-1656-2011","Wang, Chengshu/0000-0003-1477-1466",Strategic Priority Research Program of Chinese Academy of Sciences [XDB11030100]; National Nature Science Foundation of China [31225023],"This work was supported by the Strategic Priority Research Program of Chinese Academy of Sciences (XDB11030100) and the National Nature Science Foundation of China (31225023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,36,24,24,2,122,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005037,10.1371/journal.ppat.1005037,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500007,26248013.0,"DOAJ Gold, Green Published",,,16/08/2019,20,89,86,27863,14702,13546,1156,13161,10265,31,2865,86,83,0,0,15,15,5,,126,39,126,0,39,22,22,10,6,0,0,0,0,0,0,6,10,36,28354,8,0,46,380,18,13235,14913,8,0,46,380,18,206,,8,1,0,0,117,0,0,1,0,0,1,126,0,0,135.0,1.895184328662767,2.1170883671453535,1.1170883671453538,2.1838766051211915,1.0315472131500556,1.9549721126377364
444,J,"Sionov, E; Mayer-Barber, KD; Chang, YC; Kauffman, KD; Eckhaus, MA; Salazar, AM; Barber, DL; Kwon-Chung, KJ",,,,"Sionov, Edward; Mayer-Barber, Katrin D.; Chang, Yun C.; Kauffman, Keith D.; Eckhaus, Michael A.; Salazar, Andres M.; Barber, Daniel L.; Kwon-Chung, Kyung J.",,,Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-DEFICIENCY-SYNDROME; CD8+ T-CELLS; HOST-DEFENSE; POLYRIBOCYTIDYLIC ACID; NEOFORMANS INFECTION; OPPORTUNISTIC INFECTIONS; ASPERGILLUS-FUMIGATUS; INTERFERON-PRODUCTION; LUNG INFECTION,"Cryptococcus neoformans is the most common cause of fungal meningoencephalitis in AIDS patients. Depletion of CD4 cells, such as occurs during advanced AIDS, is known to be a critical risk factor for developing cryptococcosis. However, the role of HIV-induced innate inflammation in susceptibility to cryptococcosis has not been evaluated. Thus, we sought to determine the role of Type I IFN induction in host defense against cryptococci by treatment of C. neoformans (H99) infected mice with poly-ICLC (pICLC), a dsRNA virus mimic. Unexpectedly, pICLC treatment greatly extended survival of infected mice and reduced fungal burdens in the brain. Protection from cryptococcosis by pICLC-induced Type I IFN was mediated by MDA5 rather than TLR3. PICLC treatment induced a large, rapid and sustained influx of neutrophils and Ly6C(high) monocytes into the lung while suppressing the development of eosinophilia. The pICLC-mediated protection against H99 was CD4 T cell dependent and analysis of CD4 T cell polyfunctionality showed a reduction in IL-5 producing CD4 T cells, marginal increases in Th1 cells and dramatic increases in ROR gamma t+ Th17 cells in pICLC treated mice. Moreover, the protective effect of pICLC against H99 was diminished in IFN gamma KO mice and by IL-17A neutralization with blocking mAbs. Furthermore, pICLC treatment also significantly extended survival of C. gattii infected mice with reduced fungal loads in the lungs. These data demonstrate that induction of type I IFN dramatically improves host resistance against the etiologic agents of cryptococcosis by beneficial alterations in both innate and adaptive immune responses.","[Sionov, Edward; Chang, Yun C.; Kwon-Chung, Kyung J.] NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Mayer-Barber, Katrin D.] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Kauffman, Keith D.; Barber, Daniel L.] NIAID, T Lymphocyte Biol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Eckhaus, Michael A.] NIAID, Div Vet Resources, Off Res Serv, Off Director,NIH, Bethesda, MD 20892 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA","Sionov, E (reprint author), Agr Res Org, Volcani Ctr, Inst Postharvest & Food Sci, Dept Food Qual & Safety, IL-50250 Bet Dagan, Israel.",barberd@niaid.nih.gov; jkchung@niaid.nih.gov,,,"NIAID, NIH; Division of Veterinary Resources, NIH","The funding source for ES, KDMB, YCC, KDK, DLB, and KJKC is the Intramural Research Program of NIAID, NIH. The funding source for MAE is the Division of Veterinary Resources, NIH. AMS received no specific funding for this work. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.",,72,12,12,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005040,10.1371/journal.ppat.1005040,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500010,26252005.0,"DOAJ Gold, Green Published",,,16/08/2019,11,0,17,4368,659,452,207,3709,3148,22,539,17,0,0,0,10,10,0,,18,1,18,0,1,11,11,10,8,0,0,0,0,0,0,0,0,1,4354,37,0,42,6,0,3689,659,37,0,42,6,0,6,,0,0,0,0,2,0,0,0,0,0,0,18,0,0,0.75,6.628224582701062,1.1776759234294958,0.1776759234294958,1.185494742518199,1.0066391941391941,6.672230652503794
445,J,"Stahelin, RV",,,,"Stahelin, Robert V.",,,The Ebola Virus: From Basic Research to a Global Health Crisis,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"[Stahelin, Robert V.] Indiana Univ, Sch Med South Bend, Dept Biochem & Mol Biol, South Bend, IN 46615 USA; [Stahelin, Robert V.] Univ Notre Dame, Eck Inst Global Hlth, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA","Stahelin, RV (reprint author), Indiana Univ, Sch Med South Bend, Dept Biochem & Mol Biol, South Bend, IN 46615 USA.",rstaheli@iu.edu,"Stahelin, Robert/L-3567-2019","Stahelin, Robert/0000-0001-5443-7863",NIAID NIH HHS [R01 AI081077],,,0,2,2,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005093,10.1371/journal.ppat.1005093,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500029,26270052.0,"DOAJ Gold, Green Published",,,16/08/2019,2,134,22,6016,306,215,91,5710,5291,13,406,22,41,0,0,1,1,1,,29,44,29,0,44,2,2,1,1,0,0,0,0,0,0,0,92,3,6469,0,14,0,659,3,5715,310,0,14,0,659,3,444,,0,0,0,0,49,0,2,1,0,0,0,29,0,0,26.45,19.66013071895425,1.0535901926444833,0.053590192644483364,1.248336252189142,1.184840425531915,23.294117647058822
446,J,"Stroh, LJ; Gee, GV; Blaum, BS; Dugan, AS; Feltkamp, MCW; Atwood, WJ; Stehle, T",,,,"Stroeh, Luisa J.; Gee, Gretchen V.; Blaum, Baerbel S.; Dugan, Aisling S.; Feltkamp, Mariet C. W.; Atwood, Walter J.; Stehle, Thilo",,,Trichodysplasia spinulosa-Associated Polyomavirus Uses a Displaced Binding Site on VP1 to Engage Sialylated Glycolipids,PLOS PATHOGENS,,,English,Article,,,,,,,VIRAL-ASSOCIATED TRICHODYSPLASIA; N-GLYCOLYLNEURAMINIC ACID; MAJOR CAPSID PROTEINS; NMR-SPECTROSCOPY; SIMIAN-VIRUS-40; INFECTIVITY; SPECIFICITY; DETERMINANT; MUTATIONS; SEQUENCE,"Trichodysplasia spinulosa-associated Polyomavirus (TSPyV) was isolated from a patient suffering from trichodysplasia spinulosa, a skin disease that can appear in severely immunocompromised patients. While TSPyV is one of the five members of the polyomavirus family that are directly linked to a human disease, details about molecular recognition events, the viral entry pathway, and intracellular trafficking events during TSPyV infection remain unknown. Here we have used a structure-function approach to shed light on the first steps of TSPyV infection. We established by cell binding and pseudovirus infection studies that TSPyV interacts with sialic acids during attachment and/or entry. Subsequently, we solved high-resolution X-ray structures of the major capsid protein VP1 of TSPyV in complex with three different glycans, the branched GM1 glycan, and the linear trisaccharides alpha 2,3- and alpha 2,6-sialyllactose. The terminal sialic acid of all three glycans is engaged in a unique binding site on TSPyV VP1, which is positioned about 18 angstrom from established sialic acid binding sites of other polyomaviruses. Structure-based mutagenesis of sialic acid-binding residues leads to reduction in cell attachment and pseudovirus infection, demonstrating the physiological relevance of the TSPyV VP1-glycan interaction. Furthermore, treatments of cells with inhibitors of N-, O-linked glycosylation, and glycosphingolipid synthesis suggest that glycolipids play an important role during TSPyV infection. Our findings elucidate the first molecular recognition events of cellular infection with TSPyV and demonstrate that receptor recognition by polyomaviruses is highly variable not only in interactions with sialic acid itself, but also in the location of the binding site.","[Stroeh, Luisa J.; Blaum, Baerbel S.; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Gee, Gretchen V.; Atwood, Walter J.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Dugan, Aisling S.] Assumpt Coll, Dept Nat Sci, Worcester, MA USA; [Feltkamp, Mariet C. W.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA","Stroh, LJ (reprint author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.",Walter_Atwood@brown.edu; thilo.stehle@uni-tuebingen.de,"Feltkamp, Mariet/A-3788-2010","Feltkamp, Mariet/0000-0001-5993-9846; Blaum, Baerbel/0000-0003-4312-8912; Gee, Gretchen/0000-0003-0403-3240",Baden-Wurttemberg Foundation,"This work was supported by contract research ""Glykobiologie / Glykomik"" of the Baden-Wurttemberg Foundation (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,69,7,7,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005112,10.1371/journal.ppat.1005112,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500041,26302170.0,"DOAJ Gold, Green Published",,,16/08/2019,9,29,9,3288,423,322,101,2865,2499,22,344,9,4,0,0,7,7,0,,14,0,14,0,0,9,9,5,5,0,0,0,0,0,0,0,26,1,3321,39,1,128,46,0,2875,431,34,1,128,45,0,15,,0,0,0,0,6,0,0,1,0,0,0,15,0,0,3.75,7.773049645390071,1.1476439790575916,0.14764397905759163,1.1888307155322861,1.0358880778588808,8.052009456264775
447,J,"Thompson, CC; Griffiths, C; Nicod, SS; Lowden, NM; Wigneshweraraj, S; Fisher, DJ; McClure, MO",,,,"Thompson, Christopher C.; Griffiths, Cherry; Nicod, Sophie S.; Lowden, Nicole M.; Wigneshweraraj, Sivaramesh; Fisher, Derek J.; McClure, Myra O.",,,The Rsb Phosphoregulatory Network Controls Availability of the Primary Sigma Factor in Chlamydia trachomatis and Influences the Kinetics of Growth and Development,PLOS PATHOGENS,,,English,Article,,,,,,,OBLIGATE INTRACELLULAR PATHOGEN; TRANSCRIPTION IN-VITRO; RNA P1 PROMOTER; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; GENE-EXPRESSION; STRESS-RESPONSE; CYCLE; POLYMERASE; REGULATOR,"Chlamydia trachomatis is an obligate intracellular human pathogen that exhibits stage-specific gene transcription throughout a biphasic developmental cycle. The mechanisms that control modulation in transcription and associated phenotypic changes are poorly understood. This study provides evidence that a switch-protein kinase regulatory network controls availability of sigma(66), the main sigma subunit for transcription in Chlamydia. In vitro analysis revealed that a putative switch-protein kinase regulator, RsbW, is capable of interacting directly with sigma(66), as well as phosphorylating its own antagonist, RsbV1, rendering it inactive. Conversely, the putative PP2C-like phosphatase domain of chlamydial RsbU was capable of reverting RsbV1 into its active state. Recent advances in genetic manipulation of Chlamydia were employed to inactivate rsbV1, as well as to increase the expression levels of rsbW or rsbV1, in vivo. Representative sigma(66)-dependent gene transcription was repressed in the absence of rsbV1 or upon increased expression of RsbW, and increased upon elevated expression of RsbV1. These effects on housekeeping transcription were also correlated to several measures of growth and development. A model is proposed where the relative levels of active antagonist (RsbV1) and switch-protein anti-sigma factor (RsbW) control the availability of sigma(66) and subsequently act as a molecular 'throttle' for Chlamydia growth and development.","[Thompson, Christopher C.; Griffiths, Cherry; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Jefferiss Trust Labs, London, England; [Nicod, Sophie S.; Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Mol Bacteriol & Infect, London, England; [Lowden, Nicole M.; Fisher, Derek J.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA","Thompson, CC (reprint author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Jefferiss Trust Labs, St Marys Hosp Campus, London, England.",m.mcclure@imperial.ac.uk,,"Wigneshweraraj, Sivaramesh/0000-0002-1418-4029; Fisher, Derek/0000-0002-1663-8389; Thompson, Christopher C/0000-0002-0358-6452","Jefferiss Research Trust (London, UK); National Institutes of Health [1R15AI109566-01A1, 1R21AI115238-01]","This report was funded by a post-doctoral research fellowship award from the Jefferiss Research Trust (London, UK) and by National Institutes of Health, 1R15AI109566-01A1 and 1R21AI115238-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,44,13,13,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005125,10.1371/journal.ppat.1005125,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500046,26313645.0,"DOAJ Gold, Green Published",,,16/08/2019,16,139,20,4029,585,466,119,3444,3044,22,378,20,5,0,0,13,13,0,,22,4,22,0,4,17,17,6,9,0,0,0,0,0,0,0,134,4,4096,98,0,180,234,0,3463,601,98,0,180,234,0,32,,0,0,0,0,5,0,0,1,0,0,0,22,0,0,3.85,6.887179487179488,1.1698606271777003,0.16986062717770034,1.2857142857142858,1.0990320178704394,7.569230769230769
448,J,"Toth, K; Lee, SR; Ying, BL; Spencer, JF; Tollefson, AE; Sagartz, JE; Kong, IK; Wang, ZD; Wold, WSM",,,,"Toth, Karoly; Lee, Sang R.; Ying, Baoling; Spencer, Jacqueline F.; Tollefson, Ann E.; Sagartz, John E.; Kong, Il-Keun; Wang, Zhongde; Wold, William S. M.",,,"STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control",PLOS PATHOGENS,,,English,Article,,,,,,,ONCOLYTIC ADENOVIRUS; ANTITUMOR EFFICACY; GENE-EXPRESSION; INNATE IMMUNITY; VAI RNA; IMMUNOCOMPROMISED PATIENTS; SIGNAL-TRANSDUCTION; ANTIVIRAL RESPONSE; ANIMAL-MODEL; E1A ONCOGENE,"Human adenoviruses have been studied extensively in cell culture and have been a model for studies in molecular, cellular, and medical biology. However, much less is known about adenovirus replication and pathogenesis in vivo in a permissive host because of the lack of an adequate animal model. Presently, the most frequently used permissive immunocompetent animal model for human adenovirus infection is the Syrian hamster. Species C human adenoviruses replicate in these animals and cause pathology that is similar to that seen with humans. Here, we report findings with a new Syrian hamster strain in which the STAT2 gene was functionally knocked out by site-specific gene targeting. Adenovirus-infected STAT2 knockout hamsters demonstrated an accentuated pathology compared to the wildtype control animals, and the virus load in the organs of STAT2 knockout animals was 100- to 1000-fold higher than that in wild-type hamsters. Notably, the adaptive immune response to adenovirus is not adversely affected in STAT2 knockout hamsters, and surviving hamsters cleared the infection by 7 to 10 days post challenge. We show that the Type I interferon pathway is disrupted in these hamsters, revealing the critical role of interferon-stimulated genes in controlling adenovirus infection. This is the first study to report findings with a genetically modified Syrian hamster infected with a virus. Further, this is the first study to show that the Type I interferon pathway plays a role in inhibiting human adenovirus replication in a permissive animal model. Besides providing an insight into adenovirus infection in humans, our results are also interesting from the perspective of the animal model: STAT2 knockout Syrian hamster may also be an important animal model for studying other viral infections, including Ebola-, hanta-, and dengue viruses, where Type I interferon-mediated innate immunity prevents wild type hamsters from being effectively infected to be used as animal models.","[Toth, Karoly; Ying, Baoling; Spencer, Jacqueline F.; Tollefson, Ann E.; Wold, William S. M.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63130 USA; [Lee, Sang R.; Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Sagartz, John E.] St Louis Univ, Dept Comparat Med, Sch Med, St Louis, MO USA; [Kong, Il-Keun] Gyeongsang Natl Univ, Dept Anim Sci, Div Appl Life Sci, Jinju, South Korea; [Kong, Il-Keun] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea","Toth, K (reprint author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63130 USA.",zonda.wang@usu.edu; woldws@slu.edu,,"Wang, Zhongde/0000-0003-2441-4729; Toth, Karoly/0000-0001-6624-9683","National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201000021]","This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services (www.niaid.nih.gov), under Contract No. HHSN272201000021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,70,23,23,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005084,10.1371/journal.ppat.1005084,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500024,26291525.0,"DOAJ Gold, Green Published",,,16/08/2019,22,5,39,4512,876,614,262,3636,2955,20,661,39,5,0,0,21,21,1,,0,3,0,0,3,24,24,23,16,0,0,0,0,0,0,1,0,5,4560,17,0,239,142,1,3632,876,17,0,239,142,1,52,,2,0,0,0,5,0,0,1,0,0,0,40,0,0,15.6,5.1506849315068495,1.2409240924092408,0.24092409240924093,1.2978547854785478,1.045877659574468,5.386986301369863
449,J,"Vidal, E; Fernandez-Borges, N; Pintado, B; Erana, H; Ordonez, M; Marquez, M; Chianini, F; Fondevila, D; Sanchez-Martin, MA; Andreoletti, O; Dagleish, MP; Pumarola, M; Castilla, J",,,,"Vidal, Enric; Fernandez-Borges, Natalia; Pintado, Belen; Erana, Hasier; Ordonez, Montserrat; Marquez, Mercedes; Chianini, Francesca; Fondevila, Dolors; Sanchez-Martin, Manuel A.; Andreoletti, Olivier; Dagleish, Mark P.; Pumarola, Marti; Castilla, Joaquin",,,Transgenic Mouse Bioassay: Evidence That Rabbits Are Susceptible to a Variety of Prion Isolates,PLOS PATHOGENS,,,English,Article,,,,,,,CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; IN-VITRO; SPECIES BARRIER; DOMESTIC CATS; SHEEP SCRAPIE; BSE AGENT; MICE; PROTEIN; TRANSMISSION,"Interspecies transmission of prions is a well-established phenomenon, both experimentally and under field conditions. Upon passage through new hosts, prion strains have proven their capacity to change their properties and this is a source of strain diversity which needs to be considered when assessing the potential risks associated with consumption of prion contaminated protein sources. Rabbits were considered for decades to be a prion resistant species until proven otherwise recently. To determine the extent of rabbit susceptibility to prions and to assess the effects of passage of different prion strains through this species a transgenic mouse model overexpressing rabbit PrPC was developed (TgRab). Intracerebral challenges with prion strains originating from a variety of species including field isolates (ovine SSBP/1 scrapie, Nor98-scrapie; cattle BSE, BSE-L and cervid CWD), experimental murine strains (ME7 and RML) and experimentally obtained ruminant (sheepBSE) and rabbit (de novo NZW) strains were performed. On first passage TgRab were susceptible to the majority of prions (Cattle BSE, SheepBSE, BSE-L, de novo NZW, ME7 and RML) tested with the exception of SSBP/1 scrapie, CWD and Nor98 scrapie. Furthermore, TgRab were capable of propagating strain-specific features such as differences in incubation periods, histological brain lesions, abnormal prion (PrPd) deposition profiles and proteinase-K (PK) resistant western blotting band patterns. Our results confirm previous studies proving that rabbits are not resistant to prion infection and show for the first time that rabbits are susceptible to PrPd originating in a number of other species. This should be taken into account when choosing protein sources to feed rabbits.","[Vidal, Enric; Ordonez, Montserrat] IRTA UAB, Ctr Recerca Sanitat Anim, IRTA, Bellaterra, Spain; [Fernandez-Borges, Natalia; Erana, Hasier; Castilla, Joaquin] CIC bioGUNE, Derio, Bizkaia, Spain; [Pintado, Belen] Ctr Nacl Biotecnol, Madrid, Spain; [Marquez, Mercedes; Fondevila, Dolors; Pumarola, Marti] Univ Autonoma Barcelona, Dept Anim Med & Surg, Fac Vet, E-08193 Barcelona, Catalonia, Spain; [Chianini, Francesca; Dagleish, Mark P.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Sanchez-Martin, Manuel A.] Univ Salamanca, Unidad Generac OMGs, SEA, Dept Med, E-37008 Salamanca, Spain; [Andreoletti, Olivier] Ecole Natl Vet Toulouse, Serv Pathol Betail, Toulouse, France; [Castilla, Joaquin] Ikerbasque, Basque Fdn Sci, Bilbao, Bizkaia, Spain","Vidal, E (reprint author), IRTA UAB, Ctr Recerca Sanitat Anim, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain.",castilla@joaquincastilla.com,"Fernandez-Borges, Natalia/H-1875-2012; Erana, Hasier/S-9538-2017; Sanchez-Martin, Manuel A/N-5327-2016; Vidal, Enric/P-2901-2019; Erana, Hasier/O-5126-2019; Sanchez-Martin, Manuel/L-9741-2019; Pintado, Belen/N-3233-2014; Vidal, Enric/I-1679-2014; Castilla, Joaquin/J-8414-2019; Castilla, Joaquin/D-5261-2011; Chianini, Francesca/K-1451-2013","Erana, Hasier/0000-0001-8776-4211; Sanchez-Martin, Manuel A/0000-0001-8370-1336; Vidal, Enric/0000-0002-4965-3286; Erana, Hasier/0000-0001-8776-4211; Sanchez-Martin, Manuel/0000-0001-8370-1336; Pintado, Belen/0000-0002-8485-2520; Vidal, Enric/0000-0002-4965-3286; Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; Chianini, Francesca/0000-0001-9962-446X","Basque government grant [PI2010-18]; CTP grants [CTP11-P04, CTP2013-P05]; InterReg grants [EFA205/11, EFA218/11, EFA282/13-Transprion]; Etortek Research Programs; Agencia de Salut publica de Catalunya, Departament de Salut, Generalitat de Catalunya;  [AGL2009-11553-C02-01];  [AGL2012-37988-C04-01];  [AGL2008-05296-C02]","This work was financially supported by 3 national grants from Spain [AGL2009-11553-C02-01 (JC), AGL2012-37988-C04-01 (JC) and AGL2008-05296-C02 (EV)], a Basque government grant (PI2010-18) (JC), two CTP grants (CTP11-P04 and CTP2013-P05) (JC), 3 InterReg grants [EFA205/11 and EFA218/11) (JC); EFA282/13-Transprion (MP, DF, EV)], Etortek Research Programs 2011/2013 (JC) and by Agencia de Salut publica de Catalunya, Departament de Salut, Generalitat de Catalunya (EV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,11,11,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1004977,10.1371/journal.ppat.1004977,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500001,26247589.0,"DOAJ Gold, Green Published",,,16/08/2019,10,29,19,3346,510,394,116,2836,2442,25,369,19,0,0,0,8,8,1,,22,2,22,0,2,11,10,11,7,0,0,0,0,0,0,0,29,1,3402,35,47,48,267,0,2842,518,35,47,48,267,0,42,,1,0,0,0,6,0,4,1,0,0,0,22,0,0,14.1,6.56078431372549,1.179830747531735,0.17983074753173484,1.306064880112835,1.1069934249850568,7.262745098039216
450,J,"Bergstrom, KSB; Morampudi, V; Chan, JM; Bhinder, G; Lau, J; Yang, HJ; Ma, CX; Huang, T; Ryz, N; Sham, HP; Zarepour, M; Zaph, C; Artis, D; Nair, M; Vallance, BA",,,,"Bergstrom, Kirk S. B.; Morampudi, Vijay; Chan, Justin M.; Bhinder, Ganive; Lau, Jennifer; Yang, Hyungjun; Ma, Caixia; Huang, Tina; Ryz, Natasha; Sham, Ho Pan; Zarepour, Maryam; Zaph, Colby; Artis, David; Nair, Meera; Vallance, Bruce A.",,,Goblet Cell Derived RELM-beta Recruits CD4(+) T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation,PLOS PATHOGENS,,,English,Article,,,,,,,ENTEROPATHOGENIC ESCHERICHIA-COLI; CITROBACTER-RODENTIUM; MOLECULE-BETA; HOST-DEFENSE; B-LYMPHOCYTES; RESISTIN; MICE; PATHOGEN; RELM-BETA/FIZZ2; SUSCEPTIBILITY,"Enterohemorrhagic Escherichia coli and related food and waterborne pathogens pose significant threats to human health. These attaching/effacing microbes infect the apical surface of intestinal epithelial cells (IEC), causing severe diarrheal disease. Colonizing the intestinal luminal surface helps segregate these microbes from most host inflammatory responses. Based on studies using Citrobacter rodentium, a related mouse pathogen, we speculate that hosts rely on immune-mediated changes in IEC, including goblet cells to defend against these pathogens. These changes include a CD4(+) T cell-dependent increase in IEC proliferation to replace infected IEC, as well as altered production of the goblet cell-derived mucin Muc2. Another goblet cell mediator, REsistin-Like Molecule (RELM)-beta is strongly induced within goblet cells during C. rodentium infection, and was detected in the stool as well as serum. Despite its dramatic induction, RELM-beta's role in host defense is unclear. Thus, wildtype and RELM-beta gene deficient mice (Retnlb(-/-)) were orally infected with C. rodentium. While their C. rodentium burdens were only modestly elevated, infected Retnlb(-/-) mice suffered increased mortality and mucosal ulceration due to deep pathogen penetration of colonic crypts. Immunostaining for Ki67 and BrDU revealed Retnlb(-/-) mice were significantly impaired in infection-induced IEC hyper-proliferation. Interestingly, exposure to RELM-beta did not directly increase IEC proliferation, rather RELM-beta acted as a CD4(+) T cell chemoattractant. Correspondingly, Retnlb(-/-) mice showed impaired CD4(+) T cell recruitment to their infected colons, along with reduced production of interleukin (IL)-22, a multifunctional cytokine that directly increased IEC proliferation. Enema delivery of RELM-beta to Retnlb(-/-) mice restored CD4(+) T cell recruitment, concurrently increasing IL-22 levels and IEC proliferation, while reducing mucosal pathology. These findings demonstrate that RELM-beta and goblet cells play an unexpected, yet critical role in recruiting CD4(+) T cells to the colon to protect against an enteric pathogen, in part via the induction of increased IEC proliferation.","[Bergstrom, Kirk S. B.; Morampudi, Vijay; Chan, Justin M.; Bhinder, Ganive; Lau, Jennifer; Yang, Hyungjun; Ma, Caixia; Huang, Tina; Ryz, Natasha; Sham, Ho Pan; Zarepour, Maryam; Vallance, Bruce A.] Child & Family Res Inst, Dept Pediat, Div Gastroenterol, Vancouver, BC, Canada; [Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Artis, David] Cornell Univ, West Cornell Med Coll, Joan & Sanford Weill Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Nair, Meera] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA","Bergstrom, KSB (reprint author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.",bvallance@cw.bc.ca,,"Zaph, Colby/0000-0002-9889-9848",Canadian Institutes of Health Research (CIHR); Crohn's and Colitis Canada (CCC); NSERC; NIH; CIHR; Vanier PhD award; Child and Family Research Institute (CFRI); CFRI; CIHR MSc awards,"Supported by operating grants to BAV from the Canadian Institutes of Health Research (CIHR) http://www.cihr-irsc.gc.ca/, Crohn's and Colitis Canada (CCC) www.crohnsandcolitis.ca, and NSERC www.nserc-crsng.gc.ca; and to MN from the NIH www.nih.gov/. KSBB was funded by a CIHR Doctoral Research Award, while NR was funded by a Vanier PhD award www.vanier.gc.ca. VM and MZ were both funded by fellowships from the Child and Family Research Institute (CFRI) http://www.cfri.ca/. HPS was funded by a studentship from the CFRI, while JMC and GB were funded by CIHR MSc awards. BAV is the Children with Intestinal and Liver Disorders (CH.I.L.D.) Foundation Research Chair in Pediatric Gastroenterology www.child.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,30,32,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005108,10.1371/journal.ppat.1005108,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500037,26285214.0,"DOAJ Gold, Green Published",,,16/08/2019,33,206,35,7048,1213,889,324,5835,4889,28,918,35,2,0,0,30,30,1,,59,3,59,0,3,33,33,31,22,0,0,0,0,0,0,0,205,0,7049,96,0,78,235,0,5806,1213,96,0,78,235,0,30,,0,0,0,0,16,0,1,1,0,0,0,59,0,0,9.9,5.8103874690849135,1.2078834618680376,0.20788346186803772,1.2647814910025708,1.047105561861521,6.084089035449299
451,J,"Chen, TC; Hsieh, CH; Sarnow, P",,,,"Chen, Tzu-Chun; Hsieh, Chung-Han; Sarnow, Peter",,,Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect,PLOS PATHOGENS,,,English,Article,,,,,,,STRESS GRANULES; VIRAL-RNA; INFECTION; MICRORNA; MIR-122; CELLS; COMPLEX; ABUNDANCE; PROTEINS; GENOME,"The small GTPase Rab27a has been shown to control membrane trafficking and microvesicle transport pathways, in particular the secretion of exosomes. In the liver, high expression of Rab27a correlates with the development of hepatocellular carcinoma. We discovered that low abundance of Rab27a resulted in decreased hepatitis C virus (HCV) RNA and protein abundances in virus-infected cells. Curiously, both cell-associated and extracellular virus yield decreased in Rab27a depleted cells, suggesting that reduced exosome secretion did not cause the observed effect. Instead, Rab27a enhanced viral RNA replication by a mechanism that involves the liver-specific microRNA miR-122. Rab27a surrounded lipid droplets and was enriched in membrane fractions that harbor viral replication proteins, suggesting a supporting role for Rab27a in viral gene expression. Curiously, Rab27a depletion decreased the abundance of miR-122, whereas overexpression of miR-122 in Rab27a-depleted cells rescued HCV RNA abundance. Because intracellular HCV RNA abundance is enhanced by the binding of two miR-122 molecules to the extreme 5' end of the HCV RNA genome, the diminished amounts of miR-122 in Rab27a-depleted cells could have caused destabilization of HCV RNA. However, the abundance of HCV RNA carrying mutations on both miR-122-binding sites and whose stability was supported by ectopically expressed miR-122 mimetics with compensatory mutations also decreased in Rab27a-depleted cells. This result indicates that the effect of Rab27a depletion on HCV RNA abundance does not depend on the formation of 5' terminal HCV/miR-122 RNA complexes, but that miR-122 has a Rab27a-dependent function in the HCV lifecycle, likely the downregulation of a cellular inhibitor of HCV gene expression. These findings suggest that the absence of miR-122 results in a vulnerability not only to exoribonucleases that attack the viral genome, but also to upregulation of one more cellular factor that inhibit viral gene expression.","[Chen, Tzu-Chun; Sarnow, Peter] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Hsieh, Chung-Han] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA","Chen, TC (reprint author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.",psarnow@stanford.edu,,,"National Institutes of Health [AI47365, AI069000]; Stanford Dean's Postdoctoral fellowship; Stanford Pediatric Research Fund","PS received support from the National Institutes of Health (AI47365, AI069000). TCC received support from the Stanford Dean's Postdoctoral fellowship and Stanford Pediatric Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,14,17,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005116,10.1371/journal.ppat.1005116,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500044,26305877.0,"DOAJ Gold, Green Published",,,16/08/2019,15,53,30,5070,1057,708,349,4013,3205,44,764,30,5,0,0,13,13,0,,38,1,38,0,1,15,15,8,11,0,0,0,0,0,0,0,48,4,5116,81,0,107,103,0,4036,1069,81,0,107,103,0,11,,0,0,0,0,8,0,0,1,0,0,0,37,0,0,4.2,4.796594134342478,1.263393969598804,0.2633939695988039,1.320707699975081,1.0453648915187377,5.014191106906338
452,J,"Chesarino, NM; McMichael, TM; Yount, JS",,,,"Chesarino, Nicholas M.; McMichael, Temet M.; Yount, Jacob S.",,,E3 Ubiquitin Ligase NEDD4 Promotes Influenza Virus Infection by Decreasing Levels of the Antiviral Protein IFITM3,PLOS PATHOGENS,,,English,Article,,,,,,,SENDAI-VIRUS; NS1 PROTEIN; CBL-B; ADAPTIVE IMMUNITY; S-PALMITOYLATION; HUMAN-CELLS; T-CELLS; DEGRADATION; RESISTANCE; STABILITY,"Interferon (IFN)-induced transmembrane protein 3 (IFITM3) is a cell-intrinsic factor that limits influenza virus infections. We previously showed that IFITM3 degradation is increased by its ubiquitination, though the ubiquitin ligase responsible for this modification remained elusive. Here, we demonstrate that the E3 ubiquitin ligase NEDD4 ubiquitinates IFITM3 in cells and in vitro. This IFITM3 ubiquitination is dependent upon the presence of a PPxY motif within IFITM3 and theWWdomain-containing region of NEDD4. In NEDD4 knockout mouse embryonic fibroblasts, we observed defective IFITM3 ubiquitination and accumulation of high levels of basal IFITM3 as compared to wild type cells. Heightened IFITM3 levels significantly protected NEDD4 knockout cells from infection by influenza A and B viruses. Similarly, knockdown of NEDD4 in human lung cells resulted in an increase in steady state IFITM3 and a decrease in influenza virus infection, demonstrating a conservation of this NEDD4-dependent IFITM3 regulatory mechanism in mouse and human cells. Consistent with the known association of NEDD4 with lysosomes, we demonstrate for the first time that steady state turnover of IFITM3 occurs through the lysosomal degradation pathway. Overall, this work identifies the enzyme NEDD4 as a new therapeutic target for the prevention of influenza virus infections, and introduces a new paradigm for up-regulating cellular levels of IFITM3 independently of IFN or infection.","[Chesarino, Nicholas M.; McMichael, Temet M.; Yount, Jacob S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA","Chesarino, NM (reprint author), Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.",yount.37@osu.edu,"Yount, Jacob/F-9905-2014","Chesarino, Nicholas/0000-0002-3582-8508","NIH/NIAID [R00AI095348, R56AI114826]; Ohio State University Public Health Preparedness for Infectious Diseases (PHPID) program; Ohio State University Systems and Integrative Biology Training Program (NIH/NIGMS) [T32GM068412]; American Society for Microbiology Robert D. Watkins Graduate Research Fellowship","This work was supported by NIH/NIAID grants R00AI095348 and R56AI114826 to JSY, and by the Ohio State University Public Health Preparedness for Infectious Diseases (PHPID) program. NMC is supported by the Ohio State University Systems and Integrative Biology Training Program (NIH/NIGMS grant T32GM068412) and TMM is supported by the American Society for Microbiology Robert D. Watkins Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,36,37,0,29,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005095,10.1371/journal.ppat.1005095,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500031,26263374.0,"DOAJ Gold, Green Published",,,16/08/2019,38,63,44,10068,2366,2028,338,7702,6267,30,1405,44,17,0,0,33,33,13,,60,0,60,0,0,39,39,26,29,0,0,0,0,0,0,0,46,2,10151,22,0,131,146,1,7735,2389,22,0,131,146,1,27,,3,5,0,0,14,0,2,1,0,0,0,60,0,0,67.854,4.255283178360101,1.3071929368995066,0.3071929368995066,1.3397818748377044,1.0249304727850617,4.361369399830938
453,J,"Dikshit, N; Bist, P; Fenlon, SN; Pulloor, NK; Chua, CEL; Scidmore, MA; Carlyon, JA; Tang, BL; Chen, SL; Sukumaran, B",,,,"Dikshit, Neha; Bist, Pradeep; Fenlon, Shannon N.; Pulloor, Niyas Kudukkil; Chua, Christelle En Lin; Scidmore, Marci A.; Carlyon, Jason A.; Tang, Bor Luen; Chen, Swaine L.; Sukumaran, Bindu",,,Intracellular Uropathogenic E-coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells,PLOS PATHOGENS,,,English,Article,,,,,,,MEDIATED BACTERIAL INVASION; TRACT-INFECTION; EPITHELIAL-CELLS; MYCOBACTERIUM-TUBERCULOSIS; TRANSFERRIN RECEPTOR; OXIDATIVE STRESS; UROTHELIAL CELLS; CATHEPSIN-D; COMMUNITIES; MECHANISMS,"Recurrent urinary tract infections (UTIs) caused by uropathogenic E. coli (UPEC) are common and morbid infections with limited therapeutic options. Previous studies have demonstrated that persistent intracellular infection of bladder epithelial cells (BEC) by UPEC contributes to recurrent UTI in mouse models of infection. However, the mechanisms employed by UPEC to survive within BEC are incompletely understood. In this study we aimed to understand the role of host vesicular trafficking proteins in the intracellular survival of UPEC. Using a cell culture model of intracellular UPEC infection, we found that the small GTPase Rab35 facilitates UPEC survival in UPEC-containing vacuoles (UCV) within BEC. Rab35 plays a role in endosomal recycling of transferrin receptor (TfR), the key protein responsible for transferrin-mediated cellular iron uptake. UPEC enhance the expression of both Rab35 and TfR and recruit these proteins to the UCV, thereby supplying UPEC with the essential nutrient iron. Accordingly, Rab35 or TfR depleted cells showed significantly lower intracellular iron levels and reduced ability to support UPEC survival. In the absence of Rab35, UPEC are preferentially trafficked to degradative lysosomes and killed. Furthermore, in an in vivo murine model of persistent intracellular infection, Rab35 also colocalizes with intracellular UPEC. We propose a model in which UPEC subverts two different vesicular trafficking pathways (endosomal recycling and degradative lysosomal fusion) by modulating Rab35, thereby simultaneously enhancing iron acquisition and avoiding lysosomal degradation of the UCV within bladder epithelial cells. Our findings reveal a novel survival mechanism of intracellular UPEC and suggest a potential avenue for therapeutic intervention against recurrent UTI.","[Dikshit, Neha; Bist, Pradeep; Pulloor, Niyas Kudukkil; Sukumaran, Bindu] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Fenlon, Shannon N.; Chen, Swaine L.] Genome Inst Singapore, Infect Dis Grp, Singapore, Singapore; [Fenlon, Shannon N.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Fenlon, Shannon N.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Chua, Christelle En Lin; Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Scidmore, Marci A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Carlyon, Jason A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA; [Chen, Swaine L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Div Infect Dis, Dept Med, Singapore 117548, Singapore","Dikshit, N (reprint author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.",bindu.sukumaran@duke-nus.edu.sg,"Tang, Bor Luen/E-4548-2012","Tang, Bor Luen/0000-0002-1925-636X; Chen, Swaine/0000-0002-0107-2861; Fenlon, Shannon/0000-0002-7506-8945","Duke-NUS Signature Research Program - Agency for Science Technology and Research (A*STAR) AMP; Ministry of Health, Singapore; Exploratory/Developmental grant (EDG) programme by National Medical Research Council, Singapore [NMRC/EDG/1047/2011]; Singapore Ministry of Health's National Medical Research Council under its Clinician-Scientist Individual Research Grant [NMRC/CIRG/1357/2013]; Singapore National Research Foundation, Prime Minister's Office, Singapore under its NRF Research Fellowship Scheme [NRF-RF2010-10]; Genome Institute of Singapore (GIS)/Agency for Science, Technology and Research (A*STAR); National Institutes of Health [2 R01 AI072683]; National Center for Advancing Translational Sciences [UL1TR000058]; VCU Center for Clinical and Translational Research Endowment fund","This work was supported by Duke-NUS Signature Research Program funded by Agency for Science Technology and Research (A*STAR) & Ministry of Health, Singapore to BS; Exploratory/Developmental grant (EDG) programme by National Medical Research Council (NMRC/EDG/1047/2011), Singapore to (BS); Singapore Ministry of Health's National Medical Research Council under its Clinician-Scientist Individual Research Grant (NMRC/CIRG/1357/2013) (SLC, SNF); Singapore National Research Foundation, Prime Minister's Office, Singapore under its NRF Research Fellowship Scheme (NRF-RF2010-10) (SLC); the Genome Institute of Singapore (GIS)/Agency for Science, Technology and Research (A*STAR) (SLC, SNF); National Institutes of Health grant 2 R01 AI072683 (JAC); National Center for Advancing Translational Sciences grant UL1TR000058 (awarded to Virginia Commonwealth University [VCU]; JAC); and the VCU Center for Clinical and Translational Research Endowment fund (JAC). Disclaimer: The research described in this article was completed while Marci Scidmore was an employee of Cornell University. The opinions expressed in this article are the author's own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,83,16,16,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005083,10.1371/journal.ppat.1005083,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500023,26248231.0,"DOAJ Gold, Green Published",,,16/08/2019,16,4,37,6094,1345,1007,338,4749,3945,30,774,37,3,0,0,15,15,0,,2,9,2,0,9,17,17,13,12,0,0,0,0,0,0,0,1,1,6190,227,0,85,143,3,4776,1364,115,0,85,135,3,50,,0,0,0,0,4,0,0,1,0,0,0,1,0,0,1.75,4.530855018587361,1.2832175194777848,0.2832175194777848,1.381343440724363,1.0764686576960945,4.877323420074349
454,J,"Dunn, G; Klapsa, D; Wilton, T; Stone, L; Minor, PD; Martin, J",,,,"Dunn, Glynis; Klapsa, Dimitra; Wilton, Thomas; Stone, Lindsay; Minor, Philip D.; Martin, Javier",,,Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative,PLOS PATHOGENS,,,English,Article,,,,,,,VACCINE-DERIVED POLIOVIRUS; POLIOMYELITIS ERADICATION; TYPE-1 POLIOVIRUS; PATIENT; EVOLUTION; IMMUNOGENICITY; RECOMBINATION; TRANSMISSION; INACTIVATION; POPULATION,"There are currently huge efforts by the World Health Organization and partners to complete global polio eradication. With the significant decline in poliomyelitis cases due to wild poliovirus in recent years, rare cases related to the use of live-attenuated oral polio vaccine assume greater importance. Poliovirus strains in the oral vaccine are known to quickly revert to neurovirulent phenotype following replication in humans after immunisation. These strains can transmit from person to person leading to poliomyelitis outbreaks and can replicate for long periods of time in immunodeficient individuals leading to paralysis or chronic infection, with currently no effective treatment to stop excretion from these patients. Here, we describe an individual who has been excreting type 2 vaccine-derived poliovirus for twenty eight years as estimated by the molecular clock established with VP1 capsid gene nucleotide sequences of serial isolates. This represents by far the longest period of excretion described from such a patient who is the only identified individual known to be excreting highly evolved vaccine-derived poliovirus at present. Using a range of in vivo and in vitro assays we show that the viruses are very virulent, antigenically drifted and excreted at high titre suggesting that such chronic excreters pose an obvious risk to the eradication programme. Our results in virus neutralization assays with human sera and immunisation-challenge experiments using transgenic mice expressing the human poliovirus receptor indicate that while maintaining high immunisation coverage will likely confer protection against paralytic disease caused by these viruses, significant changes in immunisation strategies might be required to effectively stop their occurrence and potential widespread transmission. Eventually, new stable live-attenuated polio vaccines with no risk of reversion might be required to respond to any poliovirus isolation in the post-eradication era.","[Dunn, Glynis; Klapsa, Dimitra; Wilton, Thomas; Stone, Lindsay; Minor, Philip D.; Martin, Javier] Natl Inst Biol Stand & Controls, Div Virol, Potters Bar, Herts, England","Dunn, G (reprint author), Natl Inst Biol Stand & Controls, Div Virol, Potters Bar, Herts, England.",Javier.Martin@nibsc.org,,"Martin, Javier/0000-0001-5326-7081",NIBSC; Regulatory Science Research Unit of the UK Department of Health,"The study was funded by NIBSC core funds and partly by the Regulatory Science Research Unit of the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,41,43,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005114,10.1371/journal.ppat.1005114,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500042,26313548.0,"DOAJ Gold, Green Published",,,16/08/2019,39,777,51,23014,1083,819,264,21931,19056,47,2828,51,109,0,0,44,44,33,,68,35,68,0,35,46,42,46,28,3,0,2,3,0,2,2,781,38,23347,141,29,161,385,1,22042,1090,141,29,161,385,1,215,,15,7,0,0,124,0,12,1,0,0,0,67,0,0,248.978,21.250230840258542,1.049382153116593,0.04938215311659295,1.0885504536956818,1.0373251064569393,22.043397968605724
455,J,"Elias-Villalobos, A; Fernandez-Alvarez, A; Moreno-Sanchez, I; Helmlinger, D; Ibeas, JI",,,,"Elias-Villalobos, Alberto; Fernandez-Alvarez, Alfonso; Moreno-Sanchez, Ismael; Helmlinger, Dominique; Ibeas, Jose I.",,,The Hos2 Histone Deacetylase Controls Ustilago maydis Virulence through Direct Regulation of Mating-Type Genes,PLOS PATHOGENS,,,English,Article,,,,,,,FUNGUS MAGNAPORTHE-ORYZAE; TRANSCRIPTION FACTOR PRF1; CORN SMUT FUNGUS; PATHOGENIC DEVELOPMENT; FILAMENTOUS GROWTH; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MAPK PHOSPHORYLATION; REPLACEMENT MUTANTS; SIGNALING PATHWAYS,"Morphological changes are critical for host colonisation in plant pathogenic fungi. These changes occur at specific stages of their pathogenic cycle in response to environmental signals and are mediated by transcription factors, which act as master regulators. Histone deacetylases (HDACs) play crucial roles in regulating gene expression, for example by locally modulating the accessibility of chromatin to transcriptional regulators. It has been reported that HDACs play important roles in the virulence of plant fungi. However, the specific environment-sensing pathways that control fungal virulence via HDACs remain poorly characterised. Here we address this question using the maize pathogen Ustilago maydis. We find that the HDAC Hos2 is required for the dimorphic switch and pathogenic development in U. maydis. The deletion of hos2 abolishes the cAMP-dependent expression of mating type genes. Moreover, ChIP experiments detect Hos2 binding to the gene bodies of mating-type genes, which increases in proportion to their expression level following cAMP addition. These observations suggest that Hos2 acts as a downstream component of the cAMP-PKA pathway to control the expression of mating-type genes. Interestingly, we found that Clr3, another HDAC present in U. maydis, also contributes to the cAMP-dependent regulation of mating-type gene expression, demonstrating that Hos2 is not the only HDAC involved in this control system. Overall, our results provide new insights into the role of HDACs in fungal phytopathogenesis.","[Elias-Villalobos, Alberto; Fernandez-Alvarez, Alfonso; Moreno-Sanchez, Ismael; Ibeas, Jose I.] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Sevilla Consejo Super Invest Cient Junta Andaluci, Seville, Spain; [Elias-Villalobos, Alberto; Helmlinger, Dominique] Univ Montpellier, Ctr Rech Biochim Macromol, CNRS, UMR5237, F-34059 Montpellier, France","Elias-Villalobos, A (reprint author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Sevilla Consejo Super Invest Cient Junta Andaluci, Seville, Spain.",alberto.elias-villalobos@crbm.cnrs.fr; joibecor@upo.es,"Elias-Villalobos, Alberto/P-1026-2019; Corcelles, Jose Ignacio Ibeas/B-7615-2015; Fernandez-Alvarez, Alfonso/N-1249-2016; Moreno-Sanchez, Ismael/I-3901-2016; Elias-Villalobos, Alberto/Y-1973-2018; Alvarez, Alfonso Fernandez/S-2227-2019","Elias-Villalobos, Alberto/0000-0001-8299-2063; Corcelles, Jose Ignacio Ibeas/0000-0002-2394-7075; Fernandez-Alvarez, Alfonso/0000-0002-7455-1425; Moreno-Sanchez, Ismael/0000-0001-5606-4028; Elias-Villalobos, Alberto/0000-0001-8299-2063; Alvarez, Alfonso Fernandez/0000-0002-7455-1425; Helmlinger, Dom/0000-0003-1501-0423","MICIN [BIO2010-16787, BIO2013-48858-P]; MEC from Spain; CNRS; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale [SPF20130526854]","This work was funded by BIO2010-16787 and BIO2013-48858-P from MICIN and MEC from Spain, by an ATIP-Avenir Grant from the CNRS, a Marie Curie Actions Career Integration Grants (FP7-PEOPLE-2012-CIG/COACTIVATOR), and the Centre National de la Recherche Scientifique (CNRS) to DH. AEV was supported by a Postdoctoral Fellowship from the Fondation pour la Recherche Medicale (SPF20130526854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,72,9,9,0,22,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005134,10.1371/journal.ppat.1005134,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500052,26317403.0,"DOAJ Gold, Green Published",,,16/08/2019,8,5,20,4612,836,582,254,3776,3087,27,662,20,5,0,0,8,8,1,,34,0,34,0,0,9,9,9,5,0,0,0,0,0,0,0,0,1,4629,139,0,106,46,0,3753,836,139,0,106,46,0,40,,0,0,0,0,6,0,1,1,0,0,0,34,0,0,4.6,5.516746411483253,1.2213983050847457,0.22139830508474576,1.27489406779661,1.0437987857762359,5.758373205741627
456,J,"Grahl, N; Demers, EG; Lindsay, AK; Harty, CE; Willger, SD; Piispanen, AE; Hogan, DA",,,,"Grahl, Nora; Demers, Elora G.; Lindsay, Allia K.; Harty, Colleen E.; Willger, Sven D.; Piispanen, Amy E.; Hogan, Deborah A.",,,Mitochondrial Activity and Cyr1 Are Key Regulators of Ras1 Activation of C. albicans Virulence Pathways,PLOS PATHOGENS,,,English,Article,,,,,,,PSEUDOMONAS-AERUGINOSA PYOCYANIN; BROAD-SPECTRUM ANTIBIOTICS; CANDIDA-ALBICANS; PROTEIN-KINASE; SIGNALING PATHWAY; METHYLENE-BLUE; HYPHAL GROWTH; ELECTRON-TRANSPORT; ADENYLYL-CYCLASE; ENERGY SENSOR,"Candida albicans is both a major fungal pathogen and a member of the commensal human microflora. The morphological switch from yeast to hyphal growth is associated with disease and many environmental factors are known to influence the yeast-to-hyphae switch. The Ras1-Cyr1-PKA pathway is a major regulator of C. albicans morphogenesis as well as biofilm formation and white-opaque switching. Previous studies have shown that hyphal growth is strongly repressed by mitochondrial inhibitors. Here, we show that mitochondrial inhibitors strongly decreased Ras1 GTP-binding and activity in C. albicans and similar effects were observed in other Candida species. Consistent with there being a connection between respiratory activity and GTP-Ras1 binding, mutants lacking complex I or complex IV grew as yeast in hypha-inducing conditions, had lower levels of GTP-Ras1, and Ras1 GTP-binding was unaffected by respiratory inhibitors. Mitochondria-perturbing agents decreased intracellular ATP concentrations and metabolomics analyses of cells grown with different respiratory inhibitors found consistent perturbation of pyruvate metabolism and the TCA cycle, changes in redox state, increased catabolism of lipids, and decreased sterol content which suggested increased AMP kinase activity. Biochemical and genetic experiments provide strong evidence for a model in which the activation of Ras1 is controlled by ATP levels in an AMP kinase independent manner. The Ras1 GTPase activating protein, Ira2, but not the Ras1 guanine nucleotide exchange factor, Cdc25, was required for the reduction of Ras1-GTP in response to inhibitor-mediated reduction of ATP levels. Furthermore, Cyr1, a well-characterized Ras1 effector, participated in the control of Ras1-GTP binding in response to decreased mitochondrial activity suggesting a revised model for Ras1 and Cyr1 signaling in which Cyr1 and Ras1 influence each other and, together with Ira2, seem to form a master-regulatory complex necessary to integrate different environmental and intracellular signals, including metabolic status, to decide the fate of cellular morphology.","[Grahl, Nora; Demers, Elora G.; Lindsay, Allia K.; Harty, Colleen E.; Willger, Sven D.; Piispanen, Amy E.; Hogan, Deborah A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA","Grahl, N (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.",deborah.a.hogan@dartmouth.edu,,"Willger, Sven/0000-0002-9736-2926",National Institutes of Health (NIH) [RO1GM108492],"DAH is funded by National Institutes of Health (NIH) through RO1GM108492. NG is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation (www.lsrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,88,33,34,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005133,10.1371/journal.ppat.1005133,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500051,26317337.0,"DOAJ Gold, Green Published",,,16/08/2019,33,72,29,6278,1115,796,319,5163,4126,26,1011,29,0,0,0,34,34,0,,36,2,36,0,2,39,35,39,25,0,0,0,0,0,0,0,72,4,6273,88,4,48,72,1,5140,1115,88,4,48,72,1,18,,0,0,0,0,4,0,0,1,0,0,0,35,0,0,3.25,5.6304932735426005,1.2159597133449545,0.21595971334495448,1.2459810187875267,1.0246893915259636,5.769506726457399
457,J,"Kong, GH; Zhao, Y; Jing, MF; Huang, J; Yang, J; Xia, YQ; Kong, L; Ye, WW; Xiong, Q; Qiao, YL; Dong, SM; Ma, WB; Wang, YC",,,,"Kong, Guanghui; Zhao, Yao; Jing, Maofeng; Huang, Jie; Yang, Jin; Xia, Yeqiang; Kong, Liang; Ye, Wenwu; Xiong, Qin; Qiao, Yongli; Dong, Suomeng; Ma, Wenbo; Wang, Yuanchao",,,The Activation of Phytophthora Effector Avr3b by Plant Cyclophilin is Required for the Nudix Hydrolase Activity of Avr3b,PLOS PATHOGENS,,,English,Article,,,,,,,CIS-TRANS ISOMERASE; CYCLOSPORINE-A-BINDING; RXLR EFFECTOR; CELL-DEATH; EUKARYOTIC CYCLOPHILIN; REDOX HOMEOSTASIS; ARABIDOPSIS; IMMUNITY; PROTEIN; REGULATOR,"Plant pathogens secrete an arsenal of effector proteins to impair host immunity. Some effectors possess enzymatic activities that can modify their host targets. Previously, we demonstrated that a Phytophthora sojae RXLR effector Avr3b acts as a Nudix hydrolase when expressed in planta; and this enzymatic activity is required for full virulence of P. sojae strain P6497 in soybean (Glycine max). Interestingly, recombinant Avr3b produced by E. coli does not have the hydrolase activity unless it was incubated with plant protein extracts. Here, we report the activation of Avr3b by a prolyl-peptidyl isomerase (PPIase), cyclophilin, in plant cells. Avr3b directly interacts with soybean cyclophilin GmCYP1, which activates the hydrolase activity of Avr3b in a PPIase activity-dependent manner. Avr3b contains a putative Glycine-Proline (GP) motif; which is known to confer cyclophilin-binding in other protein substrates. Substitution of the Proline (P132) in the putative GP motif impaired the interaction of Avr3b with GmCYP1; as a result, the mutant Avr3bP132A can no longer be activated by GmCYP1, and is also unable to promote Phytophthora infection. Avr3b elicits hypersensitive response (HR) in soybean cultivars producing the resistance protein Rps3b, but Avr3bP132A lost its ability to trigger HR. Furthermore, silencing of GmCYP1 rendered reduced cell death triggered by Avr3b, suggesting that GmCYP1-mediated Avr3b maturation is also required for Rps3b recognition. Finally, cyclophilins of Nicotiana benthamiana can also interact with Avr3b and activate its enzymatic activity. Overall, our results demonstrate that cyclophilin is a ""helper"" that activates the enzymatic activity of Avr3b after it is delivered into plant cells; as such, cyclophilin is required for the avirulence and virulence functions of Avr3b.","[Kong, Guanghui; Zhao, Yao; Jing, Maofeng; Huang, Jie; Yang, Jin; Xia, Yeqiang; Kong, Liang; Ye, Wenwu; Xiong, Qin; Dong, Suomeng; Wang, Yuanchao] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Qiao, Yongli; Ma, Wenbo] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Qiao, Yongli] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China","Wang, YC (reprint author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.",wangyc@njau.edu.cn,"Ye, Wenwu/J-5624-2014; wang, yuanchao/G-9667-2011","Ye, Wenwu/0000-0001-7347-8935; wang, yuanchao/0000-0001-5803-5343; XIONG, QIN/0000-0003-2033-5062","National Natural Science Foundation [31430073, 31225022]; US Department of Agriculture (USDA)-National Institute of Food and Agriculture [2013-02974]; USDA Agricultural Experiment Station [CA-R-PPA-5075-H]","This work is supported by the key program of National Natural Science Foundation Grant No. 31430073 and National Science Fund for Distinguished Young Scholars Grant No. 31225022 of China to YW from National Natural Science Foundation (http://www.nsfc.gov.cn/publish/portal1/). WM is supported by US Department of Agriculture (USDA)-National Institute of Food and Agriculture Grant 2013-02974 and USDA Agricultural Experiment Station Research Support Allocation Process Grant CA-R-PPA-5075-H (http://www.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,43,48,0,31,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005139,10.1371/journal.ppat.1005139,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500053,26317500.0,"DOAJ Gold, Green Published",,,16/08/2019,22,4,34,7453,835,536,299,6618,5418,26,1174,34,4,0,0,21,21,2,,94,3,48,0,3,24,24,23,11,0,0,0,0,0,0,0,0,0,7492,119,0,348,25,0,6632,842,119,0,348,25,0,18,,0,0,0,0,3,0,0,1,0,0,0,48,0,0,2.1,8.925748502994011,1.1261710486551828,0.12617104865518283,1.153822907222726,1.02455387092446,9.144910179640718
458,J,"Kraeva, N; Butenko, A; Hlavacova, J; Kostygov, A; Myskova, J; Grybchuk, D; Lestinova, T; Votypka, J; Volf, P; Opperdoes, F; Flegontov, P; Lukes, J; Yurchenko, V",,,,"Kraeva, Natalya; Butenko, Anzhelika; Hlavacova, Jana; Kostygov, Alexei; Myskova, Jitka; Grybchuk, Danyil; Lestinova, Tereza; Votypka, Jan; Volf, Petr; Opperdoes, Fred; Flegontov, Pavel; Lukes, Julius; Yurchenko, Vyacheslav",,,"Leptomonas seymouri: Adaptations to the Dixenous Life Cycle Analyzed by Genome Sequencing, Transcriptome Profiling and Co-infection with Leishmania donovani",PLOS PATHOGENS,,,English,Article,,,,,,,INSECT TRYPANOSOMATIDS; COSTA-RICA; RNA VIRUS; SP-N; MUCOCUTANEOUS LEISHMANIASIS; GENUS WALLACEINA; POSITIVE PATIENT; KALA-AZAR; CRITHIDIA; PARASITES,"The co-infection cases involving dixenous Leishmania spp. (mostly of the L. donovani complex) and presumably monoxenous trypanosomatids in immunocompromised mammalian hosts including humans are well documented. The main opportunistic parasite has been identified as Leptomonas seymouri of the sub-family Leishmaniinae. The molecular mechanisms allowing a parasite of insects to withstand elevated temperature and substantially different conditions of vertebrate tissues are not understood. Here we demonstrate that L. seymouri is well adapted for the environment of the warm-blooded host. We sequenced the genome and compared the whole transcriptome profiles of this species cultivated at low and high temperatures (mimicking the vector and the vertebrate host, respectively) and identified genes and pathways differentially expressed under these experimental conditions. Moreover, Leptomonas seymouri was found to persist for several days in two species of Phlebotomus spp. implicated in Leishmania donovani transmission. Despite of all these adaptations, L. seymouri remains a predominantly monoxenous species not capable of infecting vertebrate cells under normal conditions.","[Kraeva, Natalya; Butenko, Anzhelika; Kostygov, Alexei; Grybchuk, Danyil; Flegontov, Pavel; Yurchenko, Vyacheslav] Univ Ostrava, Fac Sci, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic; [Hlavacova, Jana; Myskova, Jitka; Lestinova, Tereza; Votypka, Jan; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Kostygov, Alexei] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Votypka, Jan; Flegontov, Pavel; Lukes, Julius; Yurchenko, Vyacheslav] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Opperdoes, Fred] de Duve Inst, Brussels, Belgium; [Opperdoes, Fred] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON, Canada; [Yurchenko, Vyacheslav] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA","Kraeva, N (reprint author), Univ Ostrava, Fac Sci, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic.",vyacheslav.yurchenko@osu.cz,"Flegontov, Pavel/U-6664-2017; Yurchenko, Vyacheslav/E-4532-2013; Opperdoes, Fred/N-9922-2019; Opperdoes, Frederik/C-8897-2018; Votypka, Jan/C-5313-2012; Myskova, Jitka/C-5083-2014; Hlavacova, Jana/A-1357-2017; Lukes, Julius/H-6760-2012; Flegontov, Pavel/G-9748-2014; Volf, Petr/C-4300-2012; Lestinova, Tereza/H-1121-2017; Kostygov, Alexei/D-3931-2015","Yurchenko, Vyacheslav/0000-0003-4765-3263; Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik/0000-0003-1984-3764; Votypka, Jan/0000-0002-0552-9363; Myskova, Jitka/0000-0003-1034-1792; Hlavacova, Jana/0000-0003-4973-3451; Lukes, Julius/0000-0002-0578-6618; Volf, Petr/0000-0003-1790-1123; Lestinova, Tereza/0000-0001-5518-2268; Kostygov, Alexei/0000-0002-1516-437X; Flegontov, Pavel/0000-0001-9759-4981","EU [316304, FP7-261504]; Moravskoslezsky Kraj research initiative [DT1/RRC/2014, 00955/RRC/2015]; Czech Science Foundation [P506/13/24983S, P305/14/23986S]; EurNegVec COST Action [TD1303/ LD14076]","We acknowledge the use of research infrastructure that has received funding from the EU 7th Framework Programme, grant agreement No. 316304 (http://cordis.europa.eu/fp7/home_en.html) to JL. This work was supported by the funds of the Moravskoslezsky Kraj research initiative (http://www.kr-moravskoslezsky.cz/) DT1/RRC/2014 (to VY, AK, PF) and 00955/RRC/2015 (to VY). VY and JL are funded by the Czech Science Foundation (www.gacr.cz): P506/13/24983S (VY) and P305/14/23986S (JL). JV and PV are supported by the EurNegVec COST Action TD1303/ LD14076 and EU grant FP7-261504 EDENext and the manuscript was catalogued by the EDENext Steering Committee as EDENext235 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,94,37,38,2,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005127,10.1371/journal.ppat.1005127,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500048,26317207.0,"DOAJ Gold, Green Published",,,16/08/2019,38,1,47,4993,1049,842,207,3944,3283,27,634,47,0,0,0,35,35,0,,122,1,64,0,1,39,39,39,18,0,0,0,0,0,0,0,1,1,5021,116,0,88,117,0,3938,1049,116,0,88,117,0,34,,0,0,0,0,2,0,1,1,0,0,0,63,0,0,1.75,4.759771210676835,1.265973630831643,0.265973630831643,1.3321501014198782,1.0522731824554377,5.008579599618685
459,J,"Kueck, T; Foster, TL; Weinelt, J; Sumner, JC; Pickering, S; Neil, SJD",,,,"Kueck, Tonya; Foster, Toshana L.; Weinelt, Julia; Sumner, Jonathan C.; Pickering, Suzanne; Neil, Stuart J. D.",,,Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors,PLOS PATHOGENS,,,English,Article,,,,,,,CELL-MEDIATED CYTOTOXICITY; CASEIN KINASE-II; CYTOPLASMIC DOMAIN; BETA-TRCP; VIRION RELEASE; PROTEIN VPU; BST-2; RESTRICTION; MOTIF; SURFACE,"HIV-1 Vpu prevents incorporation of tetherin (BST2/CD317) into budding virions and targets it for ESCRT-dependent endosomal degradation via a clathrin-dependent process. This requires a variant acidic dileucine-sorting motif (ExxxLV) in Vpu. Structural studies demonstrate that recombinant Vpu/tetherin fusions can form a ternary complex with the clathrin adaptor AP-1. However, open questions still exist about Vpu's mechanism of action. Particularly, whether endosomal degradation and the recruitment of the E3 ubiquitin ligase SCF beta TRCP1/2 to a conserved phosphorylated binding site, DSGNES, are required for antagonism. Re-evaluation of the phenotype of Vpu phosphorylation mutants and naturally occurring allelic variants reveals that the requirement for the Vpu phosphoserine motif in tetherin antagonism is dissociable from SCF beta TRCP1/2 and ESCRT-dependent tetherin degradation. Vpu phospho-mutants phenocopy ExxxLV mutants, and can be rescued by direct clathrin interaction in the absence of SCF beta TRCP1/2 recruitment. Moreover, we demonstrate physical interaction between Vpu and AP-1 or AP-2 in cells. This requires Vpu/tetherin transmembrane domain interactions as well as the ExxxLV motif. Importantly, it also requires the Vpu phosphoserine motif and adjacent acidic residues. Taken together these data explain the discordance between the role of SCF beta TRCP1/2 and Vpu phosphorylation in tetherin antagonism, and indicate that phosphorylation of Vpu in Vpu/tetherin complexes regulates promiscuous recruitment of adaptors, implicating clathrin-dependent sorting as an essential first step in tetherin antagonism.","[Kueck, Tonya; Foster, Toshana L.; Weinelt, Julia; Sumner, Jonathan C.; Pickering, Suzanne; Neil, Stuart J. D.] Kings Coll London, Dept Infect Dis, Sch Life Sci & Med, Guys Hosp, London WC2R 2LS, England","Kueck, T (reprint author), Kings Coll London, Dept Infect Dis, Sch Life Sci & Med, Guys Hosp, London WC2R 2LS, England.",stuart.neil@kcl.ac.uk,,"Neil, Stuart/0000-0003-3306-5831; Foster, Toshana/0000-0001-7752-8987",European Research Council [281598]; Wellcome Trust [WT098049AIA]; Medical Research Council [G0801937],"This work was funded by a European Research Council Consolidator Grant (281598) and a Wellcome Trust Senior Research Fellowship (WT098049AIA) to SJDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,31,31,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005141,10.1371/journal.ppat.1005141,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500054,26317613.0,"DOAJ Gold, Green Published",,,16/08/2019,29,0,20,4618,756,555,201,3862,3178,25,659,20,0,1,0,29,29,0,,37,2,37,0,2,34,30,34,25,0,0,0,0,0,0,0,0,0,4626,62,0,50,187,1,3855,756,62,0,50,187,1,15,,0,0,0,0,0,0,0,1,0,0,0,36,0,0,0.25,6.108465608465608,1.1957534955981357,0.19575349559813568,1.2622993267736924,1.055651797314855,6.448412698412699
460,J,"Leeansyah, E; Svard, J; Dias, J; Buggert, M; Nystrom, J; Quigley, MF; Moll, M; Sonnerborg, A; Nowak, P; Sandberg, JK",,,,"Leeansyah, Edwin; Svard, Jenny; Dias, Joana; Buggert, Marcus; Nystrom, Jessica; Quigley, Maire F.; Moll, Markus; Sonnerborg, Anders; Nowak, Piotr; Sandberg, Johan K.",,,Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection,PLOS PATHOGENS,,,English,Article,,,,,,,INVARIANT T-CELLS; VITAMIN-B METABOLITES; ANTIRETROVIRAL THERAPY; BACTERIAL-INFECTION; MR1; ACTIVATION; EFFECTOR; ERA; RECOGNITION; EXPRESSION,"Mucosa-associated invariant T (MAIT) cells represent a large innate-like evolutionarily conserved antimicrobial T-cell subset in humans. MAIT cells recognize microbial riboflavin metabolites from a range of microbes presented by MR1 molecules. MAIT cells are impaired in several chronic diseases including HIV-1 infection, where they show signs of exhaustion and decline numerically. Here, we examined the broader effector functions of MAIT cells in this context and strategies to rescue their functions. Residual MAIT cells from HIV-infected patients displayed aberrant baseline levels of cytolytic proteins, and failed to mobilize cytolytic molecules in response to bacterial antigen. In particular, the induction of granzyme B (GrzB) expression was profoundly defective. The functionally impaired MAIT cell population exhibited abnormal T-bet and Eomes expression patterns that correlated with the deficiency in cytotoxic capacity and cytokine production. Effective antiretroviral therapy (ART) did not fully restore these aberrations. Interestingly, IL-7 was capable of arming resting MAIT cells from healthy donors into cytotoxic GrzB+ effector T cells capable of killing bacteria-infected cells and producing high levels of pro-inflammatory cytokines in an MR1-dependent fashion. Furthermore, IL-7 treatment enhanced the sensitivity of MAIT cells to detect low levels of bacteria. In HIV-infected patients, plasma IL-7 levels were positively correlated with MAIT cell numbers and function, and IL-7 treatment in vitro significantly restored MAIT cell effector functions even in the absence of ART. These results indicate that the cytolytic capacity in MAIT cells is severely defective in HIV-1 infected patients, and that the broad-based functional defect in these cells is associated with deficiency in critical transcription factors. Furthermore, IL-7 induces the arming of effector functions and enhances the sensitivity of MAIT cells, and may be considered in immunotherapeutic approaches to restore MAIT cells.","[Leeansyah, Edwin; Dias, Joana; Quigley, Maire F.; Moll, Markus; Sandberg, Johan K.] Karolinska Univ Hosp Huddinge, Dept Med, Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Svard, Jenny; Sonnerborg, Anders; Nowak, Piotr] Karolinska Univ Hosp Huddinge, Dept Med, Karolinska Inst, Infect Dis Unit, Stockholm, Sweden; [Buggert, Marcus; Nystrom, Jessica; Sonnerborg, Anders; Nowak, Piotr] Karolinska Univ Hosp Huddinge, Dept Lab Med, Karolinska Inst, Div Clin Microbiol, Stockholm, Sweden","Leeansyah, E (reprint author), Karolinska Univ Hosp Huddinge, Dept Med, Karolinska Inst, Ctr Infect Med, Stockholm, Sweden.",edwin.leeansyah@ki.se; johan.sandberg@ki.se,"Buggert, Marcus/F-4663-2018; Leeansyah, Edwin/J-1017-2019; Sonnerborg, Anders/W-2011-2019","Buggert, Marcus/0000-0003-0633-1719; Leeansyah, Edwin/0000-0003-0505-4967; Sonnerborg, Anders/0000-0001-8928-3374; Sandberg, Johan/0000-0002-6275-0750; Moll, Markus/0000-0003-4592-3063; Nowak, Piotr/0000-0003-2747-0734","Swedish Research Council; Swedish Cancer Foundation; Petrus and Augusta Hedlund Foundation; Stockholm County Council; Lindhes Law Firm; Physicians against AIDS Foundation; Clas Groschinsky Memorial Fund; Swedish Society for Medicine; Swedish Institute Postdoctoral Fellowship; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/85290/2012, QREN-POPH-typology 4.1]","This research was supported by grants from the Swedish Research Council, the Swedish Cancer Foundation, the Petrus and Augusta Hedlund Foundation, and the Stockholm County Council (JKS). Further support came from the Lindhes Law Firm, Physicians against AIDS Foundation, the Clas Groschinsky Memorial Fund, and Swedish Society for Medicine (EL). EL was a recipient of a Swedish Institute Postdoctoral Fellowship. JD is supported by Fundacao para a Ciencia e a Tecnologia (SFRH/BD/85290/2012, doctoral fellowship), through program QREN-POPH-typology 4.1. JKS is a Senior Research Fellow of the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,72,73,1,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005072,10.1371/journal.ppat.1005072,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500016,26295709.0,"DOAJ Gold, Green Published",,,16/08/2019,72,31,56,5472,899,622,277,4573,3680,25,868,56,1,0,0,73,73,0,,76,3,76,0,3,78,77,78,42,0,0,0,0,0,0,0,30,4,5475,106,0,322,103,0,4551,899,106,0,322,103,0,25,,0,0,0,0,7,0,1,1,0,0,0,76,0,0,3.5,6.086763070077864,1.1965886726437787,0.1965886726437787,1.242947736715504,1.0387426900584795,6.32258064516129
461,J,"Leoz, M; Feyertag, F; Kfutwah, A; Mauclere, P; Lachenal, G; Damond, F; De Oliveira, F; Lemee, V; Simon, F; Robertson, DL; Plantier, JC",,,,"Leoz, Marie; Feyertag, Felix; Kfutwah, Anfumbom; Mauclere, Philippe; Lachenal, Guillaume; Damond, Florence; De Oliveira, Fabienne; Lemee, Veronique; Simon, Francois; Robertson, David L.; Plantier, Jean-Christophe",,,The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon,PLOS PATHOGENS,,,English,Article,,,,,,,HEPATITIS-C VIRUS; IATROGENIC TRANSMISSION; PHYLOGENETIC ANALYSIS; SEQUENCE-ANALYSIS; TYPE-1; STRAINS; DIVERSITY; INFECTION; EPIDEMIC; EVOLUTION,"Unlike the pandemic form of HIV-1 (group M), group O viruses are endemic in west central Africa, especially in Cameroon. However, little is known about group O's genetic evolution, and why this highly divergent lineage has not become pandemic. Using a unique and large set of group O sequences from samples collected from 1987 to 2012, we find that this lineage has evolved in successive slow and fast phases of diversification, with a most recent common ancestor estimated to have existed around 1930 (1914-1944). The most rapid periods of diversification occurred in the 1950s and in the 1980s, and could be linked to favourable epidemiological contexts in Cameroon. Group O genetic diversity reflects this two-phase evolution, with two distinct populations potentially having different viral properties. The currently predominant viral population emerged in the 1980s, from an ancient population which had first developed in the 1950s, and is characterized by higher growth and evolutionary rates, and the natural presence of the Y181C resistance mutation, thought to confer a phenotypic advantage. Our findings show that although this evolutionary pattern is specific to HIV-1 group O, it paralleled the early spread of HIV-1 group M in the Democratic Republic of Congo. Both viral lineages are likely to have benefited from similar epidemiological contexts. The relative role of virological and social factors in the distinct epidemic histories of HIV-1 group O and M needs to be reassessed.","[Leoz, Marie; De Oliveira, Fabienne; Plantier, Jean-Christophe] CHU Charles Nicolle, Virol Lab, Rouen, France; [Leoz, Marie; Lemee, Veronique; Plantier, Jean-Christophe] Univ Rouen, GRAM EA 2656, Rouen, France; [Feyertag, Felix; Robertson, David L.] Univ Manchester, Computat & Evolutionary Biol, Fac Life Sci, Manchester, Lancs, England; [Kfutwah, Anfumbom; Mauclere, Philippe] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon; [Mauclere, Philippe] Serv Sante, Direct Interarmees, Noumea, New Caledonia; [Lachenal, Guillaume] Univ Paris Diderot, Lab SPHERE, UMR 7219, Paris, France; [Lachenal, Guillaume] Inst Univ France, Paris, France; [Damond, Florence] CHU Bichat Claude Bernard, AP HP, Fac Med Paris Diderot, Serv Virol, Paris, France; [Lemee, Veronique; Plantier, Jean-Christophe] CHU Charles Nicolle, Lab Assoc, Ctr Natl Reference VIH, Rouen, France; [Simon, Francois] CHU St Louis, AP HP, Microbiol Serv, Fac Med Paris Diderot, Paris, France","Leoz, M (reprint author), CHU Charles Nicolle, Virol Lab, Rouen, France.",jean-christophe.plantier@chu-rouen.fr,,"PLANTIER, Jean-Christophe/0000-0001-6417-4083",Institut de Veille Sanitaire; Universitary Hospital of Rouen; University of Rouen; Centre Pasteur du Cameroun; BBSRC studentship,"This work was supported by the Institut de Veille Sanitaire, the Universitary Hospital of Rouen, the University of Rouen and the Centre Pasteur du Cameroun. FF is funded by a BBSRC studentship to DLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,11,11,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005029,10.1371/journal.ppat.1005029,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500005,26241860.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,11,16,12,3546,559,398,161,2987,2583,17,387,12,6,0,0,10,10,0,,18,2,18,0,2,12,12,8,3,0,0,0,0,0,0,0,10,4,3634,48,0,35,235,1,3007,578,48,0,35,235,1,49,,0,0,0,0,9,0,1,0,0,0,0,18,0,0,4.6,6.343470483005366,1.1871442919317041,0.18714429193170404,1.3113491797790424,1.104624929498026,7.007155635062611
462,J,"Lukes, J; Stensvold, CR; Jirku-Pomajbikova, K; Parfrey, LW",,,,"Lukes, Julius; Stensvold, Christen Rune; Jirku-Pomajbikova, Katerina; Parfrey, Laura Wegener",,,Are Human Intestinal Eukaryotes Beneficial or Commensals?,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN GUT MICROBIOTA; BLASTOCYSTIS; INFECTION; DIVERSITY; PARASITES; IMPACT,,"[Lukes, Julius; Jirku-Pomajbikova, Katerina] Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic; [Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Lukes, Julius; Parfrey, Laura Wegener] Canadian Inst Adv Res, Toronto, ON, Canada; [Stensvold, Christen Rune] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Parfrey, Laura Wegener] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Parfrey, Laura Wegener] Univ British Columbia, Dept Zool, Vancouver, BC, Canada","Lukes, J (reprint author), Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic.",jula@paru.cas.cz; lwparfrey@botany.ubc.ca,"Jirku Pomajbikova, Katerina/G-9858-2014; Lukes, Julius/H-6760-2012","Lukes, Julius/0000-0002-0578-6618",Czech Grant Agency [P305/12/2261]; Modbiolin FP7 [316304]; Praemium Academiae award; HFSP [RGY0078/2015],"This work was supported by the Czech Grant Agency P305/12/2261, the Modbiolin FP7 agreement 316304, the Praemium Academiae award to JL, and the HFSP Research Grant RGY0078/2015 to KJP and LWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,26,45,47,1,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005039,10.1371/journal.ppat.1005039,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500009,26270819.0,"DOAJ Gold, Green Published",,,16/08/2019,47,138,119,12740,2848,2472,376,9892,8204,45,1643,119,44,0,2,47,47,2,,300,0,152,0,0,52,49,52,18,0,0,0,0,0,0,0,93,10,12965,11,0,21,126,1,10021,2904,11,0,21,126,1,40,,0,3,0,0,71,0,5,2,1,0,0,151,0,0,61.396,4.473314606741573,1.2879094217549536,0.2879094217549535,1.324504650222402,1.028414442700157,4.600421348314606
463,J,"Michels, K; Nemeth, E; Ganz, T; Mehrad, B",,,,"Michels, Kathryn; Nemeth, Elizabeta; Ganz, Tomas; Mehrad, Borna",,,Hepcidin and Host Defense against Infectious Diseases,PLOS PATHOGENS,,,English,Review,,,,,,,IRON-DEFICIENCY ANEMIA; HEPATITIS-C; HEREDITARY HEMOCHROMATOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL ACTIVITY; PEPTIDE HEPCIDIN; GENE-EXPRESSION; HFE-DEFICIENT; MOUSE MODEL; MALARIA,"Hepcidin is the master regulator of iron homeostasis in vertebrates. The synthesis of hepcidin is induced by systemic iron levels and by inflammatory stimuli. While the role of hepcidin in iron regulation is well established, its contribution to host defense is emerging as complex and multifaceted. In this review, we summarize the literature on the role of hepcidin as a mediator of antimicrobial immunity. Hepcidin induction during infection causes depletion of extracellular iron, which is thought to be a general defense mechanism against many infections by withholding iron from invading pathogens. Conversely, by promoting iron sequestration in macrophages, hepcidin may be detrimental to cellular defense against certain intracellular infections, although critical in vivo studies are needed to confirm this concept. It is not yet clear whether hepcidin exerts any iron-independent effects on host defenses.","[Michels, Kathryn; Mehrad, Borna] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Nemeth, Elizabeta; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Mehrad, Borna] Univ Virginia, Carter Ctr Immunol, Charlottesville, VA USA; [Mehrad, Borna] Univ Virginia, Dept Internal Med, Charlottesville, VA USA","Michels, K (reprint author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.",mehrad@virginia.edu,"Mehrad, Borna/D-9363-2015; Ganz, Tomas/D-4567-2009","Mehrad, Borna/0000-0001-5198-065X; Ganz, Tomas/0000-0002-2830-5469; Michels, Kathryn/0000-0002-8227-8238","NIH [HL098526, HL098329, AI117397, DK090554]","This work was supported by NIH grants HL098526, HL098329, AI117397 and DK090554. The funders had no role in decision to publish or preparation of the manuscript.",,100,71,75,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1004998,10.1371/journal.ppat.1004998,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500004,26291319.0,"DOAJ Gold, Green Published",,,16/08/2019,69,114,77,11561,3706,2868,838,7855,6036,18,1801,77,18,0,0,65,65,0,,218,6,111,0,6,72,72,71,26,1,0,0,1,0,0,0,96,8,11555,103,0,1159,191,1,7797,3706,103,0,1159,191,1,52,,0,0,0,0,16,0,0,1,0,0,0,109,0,0,9.5,3.119535887749595,1.4718014003819224,0.47180140038192236,1.5084659452577975,1.024911339849494,3.197247706422018
464,J,"Nomikou, K; Hughes, J; Wash, R; Kellam, P; Breard, E; Zientara, S; Palmarini, M; Biek, R; Mertens, P",,,,"Nomikou, Kyriaki; Hughes, Joseph; Wash, Rachael; Kellam, Paul; Breard, Emmanuel; Zientara, Stephan; Palmarini, Massimo; Biek, Roman; Mertens, Peter",,,Widespread Reassortment Shapes the Evolution and Epidemiology of Bluetongue Virus following European Invasion,PLOS PATHOGENS,,,English,Article,,,,,,,UNITED-STATES; MOLECULAR EPIDEMIOLOGY; GENETIC REASSORTMENT; MIXED INFECTION; GENOME; SEROTYPES; INFLUENZA; STRAINS; SEGMENTS; VACCINES,"Genetic exchange by a process of genome-segment 'reassortment' represents an important mechanism for evolutionary change in all viruses with segmented genomes, yet in many cases a detailed understanding of its frequency and biological consequences is lacking. We provide a comprehensive assessment of reassortment in bluetongue virus (BTV), a globally important insect-borne pathogen of livestock, during recent outbreaks in Europe. Full-genome sequences were generated and analysed for over 150 isolates belonging to the different BTV serotypes that have emerged in the region over the last 5 decades. Based on this novel dataset we confirm that reassortment is a frequent process that plays an important and on-going role in evolution of the virus. We found evidence for reassortment in all ten segments without a significant bias towards any particular segment. However, we observed biases in the relative frequency at which particular segments were associated with each other during reassortment. This points to selective constraints possibly caused by functional relationships between individual proteins or genome segments and genome-wide epistatic interactions. Sites under positive selection were more likely to undergo amino acid changes in newly reassorted viruses, providing additional evidence for adaptive dynamics as a consequence of reassortment. We show that the live attenuated vaccines recently used in Europe have repeatedly reassorted with field strains, contributing to their genotypic, and potentially phenotypic, variability. The high degree of plasticity seen in the BTV genome in terms of segment origin suggests that current classification schemes that are based primarily on serotype, which is determined by only a single genome segment, are inadequate. Our work highlights the need for a better understanding of the mechanisms and epidemiological consequences of reassortment in BTV, as well as other segmented RNA viruses.","[Nomikou, Kyriaki; Mertens, Peter] Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England; [Hughes, Joseph; Palmarini, Massimo; Biek, Roman] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Wash, Rachael; Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England; [Kellam, Paul] UCL, Div Infect & Immun, Res Dept Infect, London, England; [Breard, Emmanuel; Zientara, Stephan] French Agcy Food Environm & Occupat Hlth & Safety, Maisons Alfort, France; [Biek, Roman] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland","Nomikou, K (reprint author), Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England.",roman.biek@glasgow.ac.uk; peter.mertens@pirbright.ac.uk,"Nomikou, Kyriaki/P-1840-2018; Hughes, Joseph/B-7711-2009; Nomikou, Kyriaki/Q-5555-2016","Nomikou, Kyriaki/0000-0002-7013-1853; Hughes, Joseph/0000-0003-2556-2563; Nomikou, Kyriaki/0000-0002-7013-1853; Mertens, Peter/0000-0002-3438-3738; Kellam, Paul/0000-0003-3166-4734; Biek, Roman/0000-0003-3471-5357; Palmarini, Massimo/0000-0001-7007-4070","Wellcome Trust [092806/B/10/Z]; RAPIDD programme of the Science and Technology Directorate of the Department of Homeland Security; NIH Fogarty International Centre; Biotechnology and Biological Sciences Research Council [BB/I017224/1, BBS/E/I/00001720]; Medical Research Council [G0801822]","This work was funded by the Wellcome Trust grant 092806/B/10/Z. RB is supported by the RAPIDD programme of the Science and Technology Directorate of the Department of Homeland Security and NIH Fogarty International Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,79,39,40,0,22,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005056,10.1371/journal.ppat.1005056,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500012,26252219.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,41,21,45,6252,843,655,188,5409,4513,28,868,42,16,0,0,42,42,1,,117,2,59,3,2,45,45,35,27,0,0,0,0,0,0,1,5,4,6252,74,1,51,10,1,5393,843,74,1,51,10,1,16,,1,0,0,0,25,0,2,1,0,0,0,58,3,0,24.25,7.4163701067615655,1.1558513588463672,0.15585135884636717,1.1713810316139768,1.0134357005758157,7.516014234875445
465,J,"Salomon, D; Klimko, JA; Trudgian, DC; Kinch, LN; Grishin, NV; Mirzaei, H; Orth, K",,,,"Salomon, Dor; Klimko, John A.; Trudgian, David C.; Kinch, Lisa N.; Grishin, Nick V.; Mirzaei, Hamid; Orth, Kim",,,Type VI Secretion System Toxins Horizontally Shared between Marine Bacteria,PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN; EFFECTORS; IDENTIFICATION; SUPERFAMILY; GENERATION; IMMUNITY; GENES; MODEL; VOPQ,"The type VI secretion system (T6SS) is a widespread protein secretion apparatus used by Gram-negative bacteria to deliver toxic effector proteins into adjacent bacterial or host cells. Here, we uncovered a role in interbacterial competition for the two T6SSs encoded by the marine pathogen Vibrio alginolyticus. Using comparative proteomics and genetics, we identified their effector repertoires. In addition to the previously described effector V12G01_02265, we identified three new effectors secreted by T6SS1, indicating that the T6SS1 secretes at least four antibacterial effectors, of which three are members of the MIX-effector class. We also showed that the T6SS2 secretes at least three antibacterial effectors. Our findings revealed that many MIX-effectors belonging to clan V are ""orphan"" effectors that neighbor mobile elements and are shared between marine bacteria via horizontal gene transfer. We demonstrated that a MIX V-effector from V. alginolyticus is a functional T6SS effector when ectopically expressed in another Vibrio species. We propose that mobile MIX V-effectors serve as an environmental reservoir of T6SS effectors that are shared and used to diversify antibacterial toxin repertoires in marine bacteria, resulting in enhanced competitive fitness.","[Salomon, Dor; Klimko, John A.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Trudgian, David C.; Grishin, Nick V.; Mirzaei, Hamid; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA","Salomon, D (reprint author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.",Dor.Salomon@utsouthwestern.edu; Kim.Orth@utsouthwestern.edu,,"Orth, Kim/0000-0002-0678-7620; Salomon, Dor/0000-0002-2009-9453","Cancer Prevention and Research Institute of Texas [R1121, RP120613]; National Institutes of Health (NIH) [GM094575]; Welch Foundation [I-1505, I-1561]; NIH [R01-AI056404]; National Institute of Allergy And Infectious Diseases of the NIH [K99AI116948]","This work was supported by Cancer Prevention and Research Institute of Texas Grants R1121 and RP120613 (to HM); in part by the National Institutes of Health (NIH) Grant GM094575 and the Welch Foundation Grant I-1505 (to NVG); by NIH Grant R01-AI056404 and Grant I-1561 from the Welch Foundation (to KO). DS is supported by the National Institute of Allergy And Infectious Diseases of the NIH under Award Number K99AI116948. KO is a Burroughs Welcome Investigator in Pathogenesis of Infectious Disease, Beckman Young Investigator, and W. W. Caruth, Jr., Biomedical Scholar, and has an Earl A. Forsythe Chair in Biomedical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,22,22,0,29,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005128,10.1371/journal.ppat.1005128,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500049,26305100.0,"DOAJ Gold, Green Published",,,16/08/2019,22,35,52,5703,740,545,195,4963,4027,25,911,52,12,0,0,23,23,1,,71,2,71,0,2,26,23,26,18,0,0,0,0,0,0,0,23,1,5736,82,0,75,121,0,4946,740,82,0,75,121,0,50,,0,0,0,0,16,0,0,1,0,0,0,71,0,0,9.1,7.706756756756757,1.149103364900262,0.14910336490026194,1.1966552488414266,1.0413817289146063,8.025675675675675
466,J,"Santra, S; Tomaras, GD; Warrier, R; Nicely, NI; Liao, HX; Pollara, J; Liu, PH; Alam, SM; Zhang, RJ; Cocklin, SL; Shen, XY; Duffy, R; Xia, SM; Schutte, RJ; Pemble, CW; Dennison, SM; Li, H; Chao, A; Vidnovic, K; Evans, A; Klein, K; Kumar, A; Robinson, J; Landucci, G; Forthal, DN; Montefiori, DC; Kaewkungwal, J; Nitayaphan, S; Pitisuttithum, P; Rerks-Ngarm, S; Robb, ML; Michael, NL; Kim, JH; Soderberg, KA; Giorgi, EE; Blair, L; Korber, BT; Moog, C; Shattock, RJ; Letvin, NL; Schmitz, JE; Moody, MA; Gao, F; Ferrari, G; Shaw, GM; Haynes, BF",,,,"Santra, Sampa; Tomaras, Georgia D.; Warrier, Ranjit; Nicely, Nathan I.; Liao, Hua-Xin; Pollara, Justin; Liu, Pinghuang; Alam, S. Munir; Zhang, Ruijun; Cocklin, Sarah L.; Shen, Xiaoying; Duffy, Ryan; Xia, Shi-Mao; Schutte, Robert J.; Pemble, Charles W.; Dennison, S. Moses; Li, Hui; Chao, Andrew; Vidnovic, Kora; Evans, Abbey; Klein, Katja; Kumar, Amit; Robinson, James; Landucci, Gary; Forthal, Donald N.; Montefiori, David C.; Kaewkungwal, Jaranit; Nitayaphan, Sorachai; Pitisuttithum, Punnee; Rerks-Ngarm, Supachai; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Soderberg, Kelly A.; Giorgi, Elena E.; Blair, Lily; Korber, Bette T.; Moog, Christiane; Shattock, Robin J.; Letvin, Norman L.; Schmitz, Joern E.; Moody, M. A.; Gao, Feng; Ferrari, Guido; Shaw, George M.; Haynes, Barton F.",,,Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT CELLULAR CYTOTOXICITY; PROXIMAL EXTERNAL REGION; VACCINE EFFICACY TRIAL; NEUTRALIZING ANTIBODIES; RECEPTOR-BINDING; HIV-1-INFECTED INDIVIDUALS; INHIBITORY ANTIBODIES; IMMUNODOMINANT DOMAIN; MEDIATING ANTIBODIES; EFFECTOR FUNCTION,"HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across mucosal epithelium to infect CD4(+) T cells. Although broadly neutralizing antibodies (bnAbs) are the type of HIV-1 antibodies that are most likely protective, they are not induced with current vaccine candidates. In contrast, antibodies that do not neutralize primary HIV-1 strains in the TZM-bl infection assay are readily induced by current vaccine candidates and have also been implicated as secondary correlates of decreased HIV-1 risk in the RV144 vaccine efficacy trial. Here, we have studied the capacity of anti-Env monoclonal antibodies (mAbs) against either the immunodominant region of gp41 (7B2 IgG1), the first constant region of gp120 (A32 IgG1), or the third variable loop (V3) of gp120 (CH22 IgG1) to modulate in vivo rectal mucosal transmission of a high-dose simian-human immunodeficiency virus (SHIV-BaL) in rhesus macaques. 7B2 IgG1 or A32 IgG1, each containing mutations to enhance Fc function, was administered passively to rhesus macaques but afforded no protection against productive clinical infection while the positive control antibody CH22 IgG1 prevented infection in 4 of 6 animals. Enumeration of transmitted/founder (T/F) viruses revealed that passive infusion of each of the three antibodies significantly reduced the number of T/F genomes. Thus, some antibodies that bind HIV-1 Env but fail to neutralize virus in traditional neutralization assays may limit the number of T/F viruses involved in transmission without leading to enhancement of viral infection. For one of these mAbs, gp41 mAb 7B2, we provide the first co-crystal structure in complex with a common cyclical loop motif demonstrated to be critical for infection by other retroviruses.","[Santra, Sampa; Cocklin, Sarah L.; Letvin, Norman L.; Schmitz, Joern E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Sch Med, Boston, MA 02215 USA; [Tomaras, Georgia D.; Nicely, Nathan I.; Liao, Hua-Xin; Pollara, Justin; Liu, Pinghuang; Alam, S. Munir; Zhang, Ruijun; Shen, Xiaoying; Duffy, Ryan; Xia, Shi-Mao; Schutte, Robert J.; Pemble, Charles W.; Dennison, S. Moses; Kumar, Amit; Montefiori, David C.; Soderberg, Kelly A.; Moody, M. A.; Gao, Feng; Ferrari, Guido; Haynes, Barton F.] Duke Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Warrier, Ranjit; Li, Hui; Chao, Andrew; Vidnovic, Kora; Shaw, George M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Evans, Abbey; Klein, Katja; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Robinson, James] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Kaewkungwal, Jaranit] Mahidol Univ, Trop Hyg, Bangkok 10700, Thailand; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Clin Trop Med, Bangkok 10700, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil Res Program, Silver Spring, MD USA; [Giorgi, Elena E.; Blair, Lily; Korber, Bette T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Moog, Christiane] Univ Strasbourg, INSERM, U1109, Strasbourg, Alsace, France","Santra, S (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Sch Med, Boston, MA 02215 USA.",ssantra@bidmc.harvard.edu; gdt@duke.edu; hayne002@mc.duke.edu,"Moog, Christiane/E-3962-2016; Schmitz, Joern/A-4929-2018; Ferrari, Guido/A-6088-2015; Tomaras, Georgia/J-5041-2016","Moog, Christiane/0000-0002-0916-156X; Schmitz, Joern/0000-0001-8803-0922; Ferrari, Guido/0000-0001-7747-3349; Kaewkungwal, Jaranit/0000-0001-7916-8460; Korber, Bette/0000-0002-2026-5757","National Institutes of Health (NIH/NIAID/ DAIDS): Center for HIV/AIDS Vaccine Immunology Grant [U01 AI067854]; Bill and Melinda Gates Foundation [1033098]; NIH/NIAID Reagent Resource Support Program for AIDS Vaccine Development (Quality Biological, Inc.) [HHSN272201100023C]; Immunology Virology Quality Assessment (IVQA) Center Laboratory Shared Resource; NIH [AI097315]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]","This work was supported by National Institutes of Health (NIH/NIAID/ DAIDS): Center for HIV/AIDS Vaccine Immunology Grant (U01 AI067854) and the Collaboration for AIDS Vaccine Discovery Grants from the Bill and Melinda Gates Foundation (1033098), the NIH/NIAID Reagent Resource Support Program for AIDS Vaccine Development (Quality Biological, Inc.), Contract HHSN272201100023C, Immunology Virology Quality Assessment (IVQA) Center Laboratory Shared Resource, and the NIH grant AI097315. Crystallography was performed in the Duke University X-ray Crystallography Shared Resource. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. SER-CAT supporting institutions may be found at www.ser-cat.org/members.html. The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,120,69,72,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005042,10.1371/journal.ppat.1005042,,,,38,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500011,26237403.0,"DOAJ Gold, Green Published",,,16/08/2019,69,21,45,8737,1417,1032,385,7320,6162,28,1130,45,16,0,0,73,73,0,,55,7,55,0,7,75,75,50,54,0,0,0,0,0,0,0,7,1,8777,88,0,100,895,1,7309,1417,88,0,100,895,1,51,,0,0,0,0,14,0,0,1,0,0,0,55,0,0,6.85,6.1658433309809455,1.1935792349726777,0.1935792349726776,1.3333333333333333,1.1170882453931557,6.887791107974595
467,J,"Sit, B; Crowley, SM; Bhullar, K; Lai, CCL; Tang, C; Hooda, Y; Calmettes, C; Khambati, H; Ma, CX; Brumell, JH; Schryvers, AB; Vallance, BA; Moraes, TF",,,,"Sit, Brandon; Crowley, Shauna M.; Bhullar, Kirandeep; Lai, Christine Chieh-Lin; Tang, Calvin; Hooda, Yogesh; Calmettes, Charles; Khambati, Husain; Ma, Caixia; Brumell, John H.; Schryvers, Anthony B.; Vallance, Bruce A.; Moraes, Trevor F.",,,Active Transport of Phosphorylated Carbohydrates Promotes Intestinal Colonization and Transmission of a Bacterial Pathogen,PLOS PATHOGENS,,,English,Article,,,,,,,CITROBACTER-RODENTIUM INFECTION; SYSTEM; IRON; GROWTH; IDENTIFICATION; METABOLISM; SECRETION; VIRULENCE; SEQUENCE; CLONING,"Efficient acquisition of extracellular nutrients is essential for bacterial pathogenesis, however the identities and mechanisms for transport of many of these substrates remain unclear. Here, we investigate the predicted iron-binding transporter AfuABC and its role in bacterial pathogenesis in vivo. By crystallographic, biophysical and in vivo approaches, we show that AfuABC is in fact a cyclic hexose/heptose-phosphate transporter with high selectivity and specificity for a set of ubiquitous metabolites (glucose-6-phosphate, fructose-6-phosphate and sedoheptulose-7-phosphate). AfuABC is conserved across a wide range of bacterial genera, including the enteric pathogens EHEC O157:H7 and its murine-specific relative Citrobacter rodentium, where it lies adjacent to genes implicated in sugar sensing and acquisition. C. rodentium Delta afuA was significantly impaired in an in vivo murine competitive assay as well as its ability to transmit infection from an afflicted to a naive murine host. Sugar-phosphates were present in normal and infected intestinal mucus and stool samples, indicating that these metabolites are available within the intestinal lumen for enteric bacteria to import during infection. Our study shows that AfuABC-dependent uptake of sugar-phosphates plays a critical role during enteric bacterial infection and uncovers previously unrecognized roles for these metabolites as important contributors to successful pathogenesis.","[Sit, Brandon; Lai, Christine Chieh-Lin; Tang, Calvin; Hooda, Yogesh; Calmettes, Charles; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Crowley, Shauna M.; Bhullar, Kirandeep; Ma, Caixia; Vallance, Bruce A.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Crowley, Shauna M.; Bhullar, Kirandeep; Ma, Caixia; Vallance, Bruce A.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Khambati, Husain; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Khambati, Husain; Schryvers, Anthony B.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Brumell, John H.] SickKids Inflammatory Bowel Dis Ctr, Toronto, ON, Canada","Sit, B (reprint author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.",bvallance@cw.bc.ca; trevor.moraes@utoronto.ca,,"calmettes, charles/0000-0002-2542-4382; Sit, Brandon/0000-0003-2378-3039","Natural Sciences and Engineering Research Council of Canada (NSERC) [40197]; Canadian Institutes of Health Research (CIHR) [115182, 126051, 115180]; Ontario Ministry of Research and Innovation [13-09-149]; NSERC; CIHR Vanier Award","Operating support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (DG #40197 to TFM), the Canadian Institutes of Health Research (CIHR) (MOP #115182 to TFM and MOP #126051 and 115180 to BAV) and the Ontario Ministry of Research and Innovation (ER #13-09-149 to TFM). Infrastructure support was provided by the Canada Foundation for Innovation (CFI) to both TFM and the Centre for the Study of Complex Childhood Diseases (CSCCD). BS was supported by an NSERC Undergraduate Student Research Award, KB holds a CIHR Vanier Award, BAV is the CH.I.L.D. Foundation Research Chair in Pediatric Gastroenterology, JHB holds the Pitblado Chair in Cell Biology and TFM is a Tier II CRC in the Structural Biology of Membrane Proteins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,3,3,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005107,10.1371/journal.ppat.1005107,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500036,26295949.0,"DOAJ Gold, Green Published",,,16/08/2019,3,103,24,6128,894,712,182,5234,4498,20,716,24,4,0,0,3,3,0,,25,10,25,0,10,3,3,0,3,0,0,0,0,0,0,0,99,1,6213,70,0,58,237,1,5249,907,70,0,58,237,1,57,,0,1,0,0,8,0,0,1,0,0,0,25,0,0,11.25,6.854586129753915,1.1708062667176156,0.1708062667176156,1.2457011845624761,1.0639686684073106,7.293064876957494
468,J,"Tuero, I; Mohanram, V; Musich, T; Miller, L; Vargas-Inchaustegui, DA; Demberg, T; Venzon, D; Kalisz, I; Kalyanaraman, VS; Pal, R; Ferrari, MG; LaBranche, C; Montefiori, DC; Rao, M; Vaccari, M; Franchini, G; Barnett, SW; Robert-Guroff, M",,,,"Tuero, Iskra; Mohanram, Venkatramanan; Musich, Thomas; Miller, Leia; Vargas-Inchaustegui, Diego A.; Demberg, Thorsten; Venzon, David; Kalisz, Irene; Kalyanaraman, V. S.; Pal, Ranajit; Ferrari, Maria Grazia; LaBranche, Celia; Montefiori, David C.; Rao, Mangala; Vaccari, Monica; Franchini, Genoveffa; Barnett, Susan W.; Robert-Guroff, Marjorie",,,Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY VIRUS-INFECTION; DEPENDENT CELLULAR CYTOTOXICITY; ESTROGEN-RECEPTOR-BETA; SIMIAN IMMUNODEFICIENCY; IMMUNE-RESPONSES; FC-GLYCOSYLATION; NONNEUTRALIZING ANTIBODIES; ENVELOPE PROTEIN; HIV-1 INFECTION; SEX-DIFFERENCES,"Many viral infections, including HIV, exhibit sex-based pathogenic differences. However, few studies have examined vaccine-related sex differences. We compared immunogenicity and protective efficacy of monomeric SIV gp120 with oligomeric SIV gp140 in a pre-clinical rhesus macaque study and explored a subsequent sex bias in vaccine outcome. Each immunization group (16 females, 8 males) was primed twice mucosally with replication-competent Ad-recombinants encoding SIV(smH4)env/rev, SIV(239)gag and SIV(239)nef Delta(1-13) and boosted twice intramuscularly with SIVmac239 monomeric gp120 or oligomeric gp140 in MF59 adjuvant. Controls (7 females, 5 males) received empty Ad and MF59. Up to 9 weekly intrarectal challenges with low-dose SIVmac251 were administered until macaques became infected. We assessed vaccine-induced binding, neutralizing, and non-neutralizing antibodies, Env-specific memory B cells and plasmablasts/plasma cells (PB/PC) in bone marrow and rectal tissue, mucosal Env-specific antibodies, and Env-specific T-cells. Post-challenge, only one macaque (gp140-immunized) remained uninfected. However, SIV acquisition was significantly delayed in vaccinated females but not males, correlated with Env-specific IgA in rectal secretions, rectal Env-specific memory B cells, and PC in rectal tissue. These results extend previous correlations of mucosal antibodies and memory B cells with protective efficacy. The gp140 regimen was more immunogenic, stimulating elevated gp140 and cyclic V2 binding antibodies, ADCC and ADCP activities, bone marrow Env-specific PB/PC, and rectal gp140-specific IgG. However, immunization with gp120, the form of envelope immunogen used in RV144, the only vaccine trial to show some efficacy, provided more significant acquisition delay. Further over 40 weeks of follow-up, no gp120 immunized macaques met euthanasia criteria in contrast to 7 gp140-immunized and 2 control animals. Although males had higher binding antibodies than females, ADCC and ADCP activities were similar. The complex challenge outcomes may reflect differences in IgG subtypes, Fc glycosylation, Fc-R polymorphisms, and/or the microbiome, key areas for future studies. This first demonstration of a sex-difference in SIV vaccine-induced protection emphasizes the need for sex-balancing in vaccine trials. Our results highlight the importance of mucosal immunity and memory B cells at the SIV exposure site for protection.","[Tuero, Iskra; Mohanram, Venkatramanan; Musich, Thomas; Miller, Leia; Vargas-Inchaustegui, Diego A.; Demberg, Thorsten; Robert-Guroff, Marjorie] NCI, Immune Biol Retroviral Infect Sect, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA; [Kalisz, Irene; Kalyanaraman, V. S.; Pal, Ranajit; Ferrari, Maria Grazia] Adv Biosci Labs Inc, Rockville, MD USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Rao, Mangala] Walter Reed Army Inst Res, USMHRP, Silver Spring, MD USA; [Vaccari, Monica; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Barnett, Susan W.] Novartis Vaccines, Cambridge, MA USA","Tuero, I (reprint author), NCI, Immune Biol Retroviral Infect Sect, Vaccine Branch, NIH, Bethesda, MD 20892 USA.",guroffm@mail.nih.gov,"Mohanram, Venkatramanan/I-3652-2016","Tuero, Iskra/0000-0002-5788-1051","NIH [HHSN27201100016C]; NIH grant [5 PO1 AI066287-02]; Intramural Research Program of the National Institutes of Health, National Cancer Institute","This study was supported in part by NIH contract HHSN27201100016C to DCM, in part by NIH grant 5 PO1 AI066287-02 to SWB, and in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,79,32,32,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,AUG,2015,11,8,,,,,,,e1005101,10.1371/journal.ppat.1005101,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CQ7VD,WOS:000360812500033,26267144.0,"DOAJ Gold, Green Published",,,16/08/2019,31,19,18,4547,656,485,171,3891,3296,21,574,18,19,0,0,30,30,1,,24,1,24,0,1,31,31,25,25,0,0,0,0,0,0,0,0,2,4585,248,0,67,410,0,3898,673,248,0,67,410,0,14,,0,0,0,0,12,0,0,1,0,0,0,24,0,0,5.85,6.9314024390243905,1.1685941917244924,0.16859419172449241,1.3474685170907221,1.1530679568946558,7.992378048780488
469,J,"Anderson, DM; Feix, JB; Frank, DW",,,,"Anderson, David M.; Feix, Jimmy B.; Frank, Dara W.",,,Cross Kingdom Activators of Five Classes of Bacterial Effectors,PLOS PATHOGENS,,,English,Article,,,,,,,PSEUDOMONAS-AERUGINOSA; EXOENZYME-S; RICKETTSIA-PROWAZEKII; AEROMONAS-HYDROPHILA; PHOSPHOLIPASE A(1); STRUCTURAL BASIS; CHOLERA-TOXIN; PROTEIN; CYCLASE; YERSINIA,,"[Anderson, David M.; Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Anderson, David M.; Frank, Dara W.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Feix, Jimmy B.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA","Anderson, DM (reprint author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.",frankd@mcw.edu,,,National Institutes of Health / National Institute of Allergy and Infectious Disease [1R01 AI104922]; National Institutes of Health / General Medicine [1R01 GM114234],"Funding: This work was supported by National Institutes of Health / National Institute of Allergy and Infectious Disease grant 1R01 AI104922 to DWF and National Institutes of Health / General Medicine grant 1R01 GM114234 to JBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,4,4,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004944,10.1371/journal.ppat.1004944,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200009,26203905.0,"DOAJ Gold, Green Published",,,16/08/2019,4,5,21,3821,377,281,96,3444,2974,20,450,21,5,0,0,4,4,0,,0,3,0,0,3,4,4,4,4,0,0,0,0,0,0,0,0,0,3836,7,0,40,75,3,3443,377,7,0,40,75,3,16,,0,0,0,0,5,0,0,1,0,0,0,25,0,0,1.75,10.13527851458886,1.109465737514518,0.109465737514518,1.137630662020906,1.02538602460089,10.392572944297083
470,J,"Ansari, MA; Dutta, S; Veettil, MV; Dutta, D; Iqbal, J; Kumar, B; Roy, A; Chikoti, L; Singh, VV; Chandran, B",,,,"Ansari, Mairaj Ahmed; Dutta, Sujoy; Veettil, Mohanan Valiya; Dutta, Dipanjan; Iqbal, Jawed; Kumar, Binod; Roy, Arunava; Chikoti, Leela; Singh, Vivek Vikram; Chandran, Bala",,,"Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-beta Responses",PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; INFECTION; DNA; ACTIVATION; PROTEIN; LATENCY; SENSOR; CELLS; PHOSPHORYLATION; DEGRADATION,"The IL-1 beta and type I interferon-beta (IFN-beta) molecules are important inflammatory cytokines elicited by the eukaryotic host as innate immune responses against invading pathogens and danger signals. Recently, a predominantly nuclear gamma-interferon-inducible protein 16 (IFI16) involved in transcriptional regulation has emerged as an innate DNA sensor which induced IL-1 beta and IFN-beta production through inflammasome and STING activation, respectively. Herpesvirus (KSHV, EBV, and HSV-1) episomal dsDNA genome recognition by IFI16 leads to IFI16-ASC-procaspase-1 inflammasome association, cytoplasmic translocation and IL-1 beta production. Independent of ASC, HSV-1 genome recognition results in IFI16 interaction with STING in the cytoplasm to induce interferon-beta production. However, the mechanisms of IFI16-inflammasome formation, cytoplasmic redistribution and STING activation are not known. Our studies here demonstrate that recognition of herpesvirus genomes in the nucleus by IFI16 leads into its interaction with histone acetyltransferase p300 and IFI16 acetylation resulting in IFI16-ASC interaction, inflammasome assembly, increased interaction with Ran-GTPase, cytoplasmic redistribution, caspase-1 activation, IL-1 beta production, and interaction with STING which results in IRF-3 phosphorylation, nuclear pIRF-3 localization and interferon-beta production. ASC and STING knockdowns did not affect IFI16 acetylation indicating that this modification is upstream of inflammasome-assembly and STING-activation. Vaccinia virus replicating in the cytoplasm did not induce nuclear IFI16 acetylation and cytoplasmic translocation. IFI16 physically associates with KSHV and HSV-1 genomes as revealed by proximity ligation microscopy and chromatin-immunoprecipitation studies which is not hampered by the inhibition of acetylation, thus suggesting that acetylation of IFI16 is not required for its innate sensing of nuclear viral genomes. Collectively, these studies identify the increased nuclear acetylation of IFI16 as a dynamic essential post-genome recognition event in the nucleus that is common to the IFI16-mediated innate responses of inflammasome induction and IFN-beta production during herpesvirus (KSHV, EBV, HSV-1) infections.","[Ansari, Mairaj Ahmed; Dutta, Sujoy; Veettil, Mohanan Valiya; Dutta, Dipanjan; Iqbal, Jawed; Kumar, Binod; Roy, Arunava; Chikoti, Leela; Singh, Vivek Vikram; Chandran, Bala] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Chicago Med Sch, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA","Chandran, B (reprint author), Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Chicago Med Sch, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA.",bala.chandran@rosalindfranklin.edu,"Kumar, Binod/I-4818-2019; Kumar, Binod/I-4230-2019","Kumar, Binod/0000-0002-2077-8501; Roy, Arunava/0000-0002-8486-0539","National Institute of Health [CA 180758, AI 113391]","Funding: BC received funding from the National Institute of Health CA 180758 http://www.cancer.gov/. BC received funding from the National Institute of Health AI 113391 http://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,39,40,1,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005019,10.1371/journal.ppat.1005019,,,,40,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200033,26134128.0,"DOAJ Gold, Green Published",,,16/08/2019,41,2,34,6614,1375,923,452,5239,3848,32,1359,34,0,0,0,41,41,0,,49,0,49,0,0,41,41,33,30,0,0,1,0,0,1,0,2,2,6670,43,0,856,39,0,5254,1394,43,0,856,39,0,22,,0,0,0,0,2,0,0,1,0,0,0,49,0,0,0.75,4.810181818181818,1.2624546669211683,0.26245466692116814,1.2887955716739836,1.020864832174176,4.9105454545454545
471,J,"Asante, EA; Grimshaw, A; Smidak, M; Jakubcova, T; Tomlinson, A; Jeelani, A; Hamdan, S; Powell, C; Joiner, S; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J",,,,"Asante, Emmanuel A.; Grimshaw, Andrew; Smidak, Michelle; Jakubcova, Tatiana; Tomlinson, Andrew; Jeelani, Asif; Hamdan, Shyma; Powell, Caroline; Joiner, Susan; Linehan, Jacqueline M.; Brandner, Sebastian; Wadsworth, Jonathan D. F.; Collinge, John",,,Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS,PLOS PATHOGENS,,,English,Article,,,,,,,CREUTZFELDT-JAKOB-DISEASE; STRAUSSLER-SCHEINKER-DISEASE; MICE EXPRESSING HUMAN; WILD-TYPE; PHENOTYPIC HETEROGENEITY; PROTEIN MUTATION; GERSTMANN; VARIANT; STRAIN; FAMILY,"Inherited prion disease (IPD) is caused by autosomal-dominant pathogenic mutations in the human prion protein (PrP) gene (PRNP). A proline to leucine substitution at PrP residue 102 (P102L) is classically associated with Gerstmann-Straussler-Scheinker (GSS) disease but shows marked clinical and neuropathological variability within kindreds that may be caused by variable propagation of distinct prion strains generated from either PrP 102L or wild type PrP. To-date the transmission properties of prions propagated in P102L patients remain ill-defined. Multiple mouse models of GSS have focused on mutating the corresponding residue of murine PrP (P101L), however murine PrP 101L, a novel PrP primary structure, may not have the repertoire of pathogenic prion conformations necessary to accurately model the human disease. Here we describe the transmission properties of prions generated in human PrP 102L expressing transgenic mice that were generated after primary challenge with ex vivo human GSS P102L or classical CJD prions. We show that distinct strains of prions were generated in these mice dependent upon source of the inoculum (either GSS P102L or CJD brain) and have designated these GSS-102L and CJD-102L prions, respectively. GSS-102L prions have transmission properties distinct from all prion strains seen in sporadic and acquired human prion disease. Significantly, GSS-102L prions appear incapable of transmitting disease to conventional mice expressing wild type mouse PrP, which contrasts strikingly with the reported transmission properties of prions generated in GSS P102L-challenged mice expressing mouse PrP 101L. We conclude that future transgenic modeling of IPDs should focus exclusively on expression of mutant human PrP, as other approaches may generate novel experimental prion strains that are unrelated to human disease.","[Collinge, John] Natl Hosp Neurol & Neurosurg, MRC Prion Unit, UCL Inst Neurol, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England","Collinge, J (reprint author), Natl Hosp Neurol & Neurosurg, MRC Prion Unit, UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.",j.collinge@prion.ucl.ac.uk,,"Asante, Emmanuel A/0000-0003-3771-4843; Wadsworth, Jonathan/0000-0002-4797-2259","Department of Health's NIHR Biomedical Research Centres; Wellcome Trust; Medical Research Council (UK); European Commission; Medical Research Council [MC_U123160655, MC_U123192748, MC_U123160653]","Funding: Some of the work was undertaken at University College London Hospital NHS Foundation Trust which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. This research was initiated with funding from the Wellcome Trust and has been supported by the Medical Research Council (UK) and the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,18,18,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004953,10.1371/journal.ppat.1004953,,,,15,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200013,26135918.0,"DOAJ Gold, Green Published",,,16/08/2019,17,0,15,3172,731,583,148,2441,2016,27,398,15,0,0,0,13,13,1,,23,3,23,0,3,18,18,11,10,0,0,0,0,0,0,2,0,1,3243,25,0,79,138,0,2451,743,25,0,79,138,0,49,,2,0,0,0,2,0,0,1,0,0,0,23,0,0,21.25,4.339261285909712,1.2994674313805816,0.29946743138058174,1.3953297828758706,1.0737704918032787,4.6593707250342
472,J,"Avalos-Padilla, Y; Betanzos, A; Javier-Reyna, R; Garcia-Rivera, G; Chavez-Munguia, B; Lagunes-Guillen, A; Ortega, J; Orozco, E",,,,"Avalos-Padilla, Yunuen; Betanzos, Abigail; Javier-Reyna, Rosario; Garcia-Rivera, Guillermina; Chavez-Munguia, Bibiana; Lagunes-Guillen, Anel; Ortega, Jaime; Orozco, Esther",,,EhVps32 Is a Vacuole-Associated Protein Involved in Pinocytosis and Phagocytosis of Entamoeaba histolytica,PLOS PATHOGENS,,,English,Article,,,,,,,ACID-RICH PROTEIN; ESCRT-III; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; MULTIVESICULAR BODIES; CYSTEINE PROTEASE; STRUCTURAL BASIS; LYSINE-RICH; ENDOSOME; COMPLEX,"Here, we investigated the role of EhVps32 protein (a member of the endosomal-sorting complex required for transport) in endocytosis of Entamoeba histolytica, a professional phagocyte. Confocal microscopy, TEM and cell fractionation revealed EhVps32 in cytoplasmic vesicles and also located adjacent to the plasma membrane. Between 5 to 30 min of phagocytosis, EhVps32 was detected on some erythrocytes-containing phagosomes of acidic nature, and at 60 min it returned to cytoplasmic vesicles and also appeared adjacent to the plasma membrane. TEM images revealed it in membranous structures in the vicinity of ingested erythrocytes. EhVps32, EhADH (an ALIX family member), Gal/GalNac lectin and actin co-localized in the phagocytic cup and in some erythrocytes-containing phagosomes, but EhVps32 was scarcely detected in late phagosomes. During dextran uptake, EhVps32, EhADH and Gal/GalNac lectin, but not actin, co-localized in pinosomes. EhVps32 recombinant protein formed oligomers composed by rings and filaments. Antibodies against EhVps32 monomers stained cytoplasmic vesicles but not erythrocytes-containing phagosomes, suggesting that in vivo oligomers are formed on phagosome membranes. The involvement of EhVps32 in phagocytosis was further study in pNeoEhvps32-HA-transfected trophozoites, which augmented almost twice their rate of erythrophagocytosis as well as the membranous concentric arrays built by filaments, spirals and tunnel-like structures. Some of these structures apparently connected phagosomes with the phagocytic cup. In concordance, the EhVps32-silenced G3 trophozoites ingested 80% less erythrocytes than the G3 strain. Our results suggest that EhVps32 participates in E. histolytica phagocytosis and pinocytosis. It forms oligomers on erythrocytes-containing phagosomes, probably as a part of the scission machinery involved in membrane invagination and intraluminal vesicles formation.","[Avalos-Padilla, Yunuen; Betanzos, Abigail; Javier-Reyna, Rosario; Garcia-Rivera, Guillermina; Chavez-Munguia, Bibiana; Lagunes-Guillen, Anel; Orozco, Esther] Ctr Invest & Estudios Avanzados, IPN, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico; [Ortega, Jaime] Ctr Invest & Estudios Avanzados, IPN, Dept Biotecnol & Bioingn, Mexico City, DF, Mexico","Orozco, E (reprint author), Ctr Invest & Estudios Avanzados, IPN, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico.",esther@cinvestav.mx,"Avalos Padilla, Yunuen/M-9004-2018","Avalos Padilla, Yunuen/0000-0003-4074-5624; Betanzos, Abigail/0000-0003-1761-0481",National Council of Science and Technology of Mexico (CONACYT) [220049]; CONACYT [243275],"This study was supported by the National Council of Science and Technology of Mexico (CONACYT; Grant number 220049). Yunuen Avalos-Padilla received a fellowship from CONACYT (No. 243275). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,13,13,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005079,10.1371/journal.ppat.1005079,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200071,26230715.0,"DOAJ Gold, Green Published",,,16/08/2019,14,310,15,4431,740,529,211,3691,3073,22,596,15,1,0,0,15,15,0,,19,1,19,0,1,16,15,16,8,0,0,0,0,0,0,0,308,0,4446,41,0,456,154,1,3688,740,41,0,456,154,1,18,,0,0,0,0,2,0,0,1,0,0,0,19,0,0,1.0,5.987837837837838,1.2004876727174207,0.20048767271742074,1.2573828230831754,1.04739336492891,6.271621621621621
473,J,"Avey, D; Tepper, S; Li, WW; Turpin, Z; Zhu, FX",,,,"Avey, Denis; Tepper, Sarah; Li, Wenwei; Turpin, Zachary; Zhu, Fanxiu",,,Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; PROTEIN-COUPLED RECEPTOR; INITIATION-FACTOR 4B; RIBOSOMAL S6 KINASE; IMMUNODEFICIENCY-VIRUS TYPE-1; AKT SIGNALING PATHWAY; LARGE GENE LISTS; KAPOSIS-SARCOMA; G-QUADRUPLEXES; NUCLEOCYTOPLASMIC TRANSPORT,"Kaposi's Sarcoma-Associated Herpesvirus (KSHV) is an oncogenic virus which has adapted unique mechanisms to modulate the cellular microenvironment of its human host. The pathogenesis of KSHV is intimately linked to its manipulation of cellular signaling pathways, including the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway. We have previously shown that KSHV ORF45 contributes to the sustained activation of both ERK and p90 ribosomal S6 kinase (RSK, a major functional mediator of ERK/MAPK signaling) during KSHV lytic replication. ORF45-activated RSK is required for optimal KSHV lytic gene expression and progeny virion production, though the underlying mechanisms downstream of this activation are still unclear. We hypothesized that the activation of RSK by ORF45 causes differential phosphorylation of cellular and viral substrates, affecting biological processes essential for efficient KSHV lytic replication. Accordingly, we observed widespread and significant differences in protein phosphorylation upon induction of lytic replication. Mass-spectrometry-based phosphoproteomic screening identified putative substrates of ORF45-activated RSK in KSHV-infected cells. Bioinformatic analyses revealed that nuclear proteins, including several transcriptional regulators, were overrepresented among these candidates. We validated the ORF45/RSK-dependent phosphorylation of several putative substrates by employing KSHV BAC mutagenesis, kinase inhibitor treatments, and/or CRISPR-mediated knockout of RSK in KSHV-infected cells. Furthermore, we assessed the consequences of knocking out these substrates on ORF45/RSK-dependent regulation of gene expression and KSHV progeny virion production. Finally, we show data to support that ORF45 regulates the translational efficiency of a subset of viral/cellular genes with complex secondary structure in their 5' UTR. Altogether, these data shed light on the mechanisms by which KSHV ORF45 manipulates components of the host cell machinery via modulation of RSK activity. Thus, this study has important implications for the pathobiology of KSHV and other diseases in which RSK activity is dysregulated.","[Avey, Denis; Tepper, Sarah; Li, Wenwei; Turpin, Zachary; Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA","Zhu, FX (reprint author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.",fzhu@bio.fsu.edu,,,National Institute of Dental and Craniofacial Research [R01DE016680]; National Cancer Institute [F31CA183250],"Funding: FZ received funding from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/ R01DE016680). DA received funding from the National Cancer Institute (http://www.cancer.gov/ F31CA183250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,109,19,19,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004993,10.1371/journal.ppat.1004993,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200023,26133373.0,"DOAJ Gold, Green Published",,,16/08/2019,18,0,18,3713,794,577,217,2919,2301,39,579,18,0,0,0,19,19,0,,30,3,29,0,3,21,19,21,13,0,0,0,0,0,0,0,0,0,3715,50,0,878,89,0,2900,794,50,0,878,89,0,21,,0,0,0,0,1,0,0,1,0,0,0,28,0,0,0.75,4.67632241813602,1.2720109626584446,0.27201096265844465,1.3203151764302843,1.0379746835443038,4.853904282115869
474,J,"Bahn, YS",,,,"Bahn, Yong-Sun",,,Exploiting Fungal Virulence-Regulating Transcription Factors As Novel Antifungal Drug Targets,PLOS PATHOGENS,,,English,Article,,,,,,,CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; NRG1; PATHOGEN; PATHWAY; NETWORKS; GENES,,"Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea","Bahn, YS (reprint author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.",ysbahn@yonsei.ac.kr,"Bahn, Yong-Sun/C-1211-2012","Bahn, Yong-Sun/0000-0001-9573-5752","National Research Foundation of Korea from MEST [2008-0061963, 2010-0029117]","Funding: This work was supported by National Research Foundation of Korea grants (nos 2008-0061963 and 2010-0029117) from MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,9,9,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004936,10.1371/journal.ppat.1004936,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200008,26181382.0,"DOAJ Gold, Green Published",,,16/08/2019,13,15,18,4554,569,429,140,3985,3313,26,646,18,15,0,0,10,10,0,,25,4,25,0,4,13,13,9,8,0,0,0,0,0,0,0,16,1,4607,7,0,46,64,1,4002,577,7,0,46,64,1,28,,0,0,0,0,13,0,0,1,0,0,0,24,0,0,7.45,8.003514938488577,1.1427854454203261,0.14278544542032623,1.1739021329987454,1.0272288098375055,8.221441124780316
475,J,"Bego, MG; Cote, E; Aschman, N; Mercier, J; Weissenhorn, W; Cohen, EA",,,,"Bego, Mariana G.; Cote, Edouard; Aschman, Nick; Mercier, Johanne; Weissenhorn, Winfried; Cohen, Eric A.",,,Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED CELLS; INTERFERON-PRODUCTION; HUMANIZED MICE; HUMAN TETHERIN; T-CELLS; TYPE-1; RELEASE; PROTEIN; DETERMINANTS,"Plasmacytoid dendritic cells (pDCs) constitute a major source of type-I interferon (IFN-I) production during acute HIV infection. Their activation results primarily from TLR7-mediated sensing of HIV-infected cells. However, the interactions between HIV-infected T cells and pDCs that modulate this sensing process remain poorly understood. BST2/Tetherin is a restriction factor that inhibits HIV release by cross-linking virions onto infected cell surface. BST2 was also shown to engage the ILT7 pDC-specific inhibitory receptor and repress TLR7/9-mediated IFN-I production by activated pDCs. Here, we show that Vpu, the HIV-1 antagonist of BST2, suppresses TLR7-mediated IFN-I production by pDC through a mechanism that relies on the interaction of BST2 on HIV-producing cells with ILT7. Even though Vpu downregulates surface BST2 as a mean to counteract the restriction on HIV-1 release, we also find that the viral protein re-locates remaining BST2 molecules outside viral assembly sites where they are free to bind and activate ILT7 upon cell-to-cell contact. This study shows that through a targeted regulation of surface BST2, Vpu promotes HIV-1 release and limits pDC antiviral responses upon sensing of infected cells. This mechanism of innate immune evasion is likely to be important for an efficient early viral dissemination during acute infection.","[Bego, Mariana G.; Cote, Edouard; Mercier, Johanne; Cohen, Eric A.] IRCM, Montreal, PQ, Canada; [Aschman, Nick; Weissenhorn, Winfried] Univ Grenoble Alpes, UVHCI, CNRS, Grenoble, France; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada","Cohen, EA (reprint author), IRCM, Montreal, PQ, Canada.",eric.cohen@ircm.qc.ca,,,"Canadian Institutes of Health Research (CIHR) [MOP-111226]; Canadian HIV Cure Enterprise Grant from CIHR [HIG-133050]; CANFAR; IAS; Fonds de Recherche du Quebec-Sante AIDS network; ANRS; Grenoble Partnership for Structural Biology platforms (ISBG CNRS-CEA-UJF-EMBL) - FRISBI [UMS 3518, ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]; Canada Research Chair in Human Retrovirology; Gabriel-Marquis Foundation; Fond National de la Recherche Luxembourg","Funding: This work was supported by a Canadian Institutes of Health Research (CIHR) grant MOP-111226 and by the Canadian HIV Cure Enterprise Grant HIG-133050 from the CIHR partnership with CANFAR and IAS to EAC as well as by a pilot grant from the Fonds de Recherche du Quebec-Sante AIDS network to MGB and EAC. WW acknowledges support from the ANRS, and the Grenoble Partnership for Structural Biology platforms (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) funded by FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01). EAC is a recipient of the Canada Research Chair in Human Retrovirology and EC received a studentship from the Gabriel-Marquis Foundation. NA was supported by a PhD fellowship from the Fond National de la Recherche Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,21,21,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005024,10.1371/journal.ppat.1005024,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200038,26172439.0,"DOAJ Gold, Green Published",,,16/08/2019,20,21,31,6514,892,621,271,5622,4892,18,712,31,13,0,0,20,20,10,,81,2,41,0,2,20,20,17,16,0,0,0,0,0,0,11,0,1,6525,40,0,76,57,0,5607,892,40,0,76,57,0,26,,3,0,0,0,15,0,1,1,0,0,0,41,0,0,34.9,7.302690582959642,1.1586623977232302,0.15866239772323018,1.1778726431874778,1.0165796745471292,7.423766816143497
476,J,"Boyle, MJ; Jagannathan, P; Farrington, LA; Eccles-James, I; Wamala, S; McIntyre, TI; Vance, HM; Bowen, K; Nankya, F; Auma, A; Nalubega, M; Sikyomu, E; Naluwu, K; Rek, J; Katureebe, A; Bigira, V; Kapisi, J; Tappero, J; Muhindo, MK; Greenhouse, B; Arinaitwe, E; Dorsey, G; Kamya, MR; Feeney, ME",,,,"Boyle, Michelle J.; Jagannathan, Prasanna; Farrington, Lila A.; Eccles-James, Ijeoma; Wamala, Samuel; McIntyre, Tara I.; Vance, Hilary M.; Bowen, Katherine; Nankya, Felistas; Auma, Ann; Nalubega, Mayimuna; Sikyomu, Esther; Naluwu, Kate; Rek, John; Katureebe, Agaba; Bigira, Victor; Kapisi, James; Tappero, Jordan; Muhindo, Mary K.; Greenhouse, Bryan; Arinaitwe, Emmanuel; Dorsey, Grant; Kamya, Moses R.; Feeney, Margaret E.",,,Decline of FoxP3+Regulatory CD4 T Cells in Peripheral Blood of Children Heavily Exposed to Malaria,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMODIUM-FALCIPARUM; TGF-BETA; REGULATORY-CELLS; TRANSMISSION INTENSITY; FOXP3 EXPRESSION; SOLUBLE EXTRACTS; CORD BLOOD; INFECTION; ACTIVATION; RESPONSES,"FoxP3+ regulatory CD4 T cells (T-regs) help to maintain the delicate balance between pathogen-specific immunity and immune-mediated pathology. Prior studies suggest that T-regs are induced by P. falciparum both in vivo and in vitro; however, the factors influencing T-reg homeostasis during acute and chronic infections, and their role in malaria immunopathogenesis, remain unclear. We assessed the frequency and phenotype of T-regs in well-characterized cohorts of children residing in a region of high malaria endemicity in Uganda. We found that both the frequency and absolute numbers of FoxP3+ T-regs in peripheral blood declined markedly with increasing prior malaria incidence. Longitudinal measurements confirmed that this decline occurred only among highly malaria-exposed children. The decline of T-regs from peripheral blood was accompanied by reduced in vitro induction of T-regs by parasite antigen and decreased expression of TNFR2 on T-regs among children who had intense prior exposure to malaria. While T-reg frequencies were not associated with protection from malaria, there was a trend toward reduced risk of symptomatic malaria once infected with P. falciparum among children with lower T-reg frequencies. These data demonstrate that chronic malaria exposure results in altered T-reg homeostasis, which may impact the development of antimalarial immunity in naturally exposed populations.","[Boyle, Michelle J.; Jagannathan, Prasanna; Farrington, Lila A.; Eccles-James, Ijeoma; McIntyre, Tara I.; Vance, Hilary M.; Bowen, Katherine; Greenhouse, Bryan; Dorsey, Grant; Feeney, Margaret E.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94115 USA; [Boyle, Michelle J.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Wamala, Samuel; Nankya, Felistas; Auma, Ann; Nalubega, Mayimuna; Sikyomu, Esther; Naluwu, Kate; Rek, John; Katureebe, Agaba; Bigira, Victor; Kapisi, James; Muhindo, Mary K.; Arinaitwe, Emmanuel] Infect Dis Res Collaborat, Kampala, Uganda; [Tappero, Jordan] CDC, Atlanta, GA 30333 USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Feeney, Margaret E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA","Feeney, ME (reprint author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94115 USA.",margaret.feeney@ucsf.edu,"Boyle, Michelle/P-7297-2019; Boyle, Michelle/D-4223-2018","Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X","National Institute of Health, National Institute of Allergy and Infectious Diseases [R01AI093615, K24AI113002, U19AI089674, K23 AI100949]; Centers for Disease Control and Prevention [U62P024421]; University of California San Francisco, Centers for AIDS Research [P30AI027763]; University of California San Francisco Resource Allocation Global Health Policy Award Program; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene; National Health and Medical Research Council Australia; Victorian State Government Operational Infrastructure Support","This work was supported by National Institute of Health, National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) R01AI093615 (MEF), K24AI113002 (MEF), U19AI089674 (MEF, BG and GD) and K23 AI100949 (PJ), Centers for Disease Control and Prevention (http://www.cdc.gov/) Cooperative Agreement No U62P024421, the University of California San Francisco, Centers for AIDS Research (http://cfar.ucsf.edu/) P30AI027763 (MEF), the University of California San Francisco Resource Allocation Global Health Policy Award Program (http://globalhealthsciences.ucsf.edu/) (MJB), the Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene (http://www.astmh.org/) (PJ), the National Health and Medical Research Council Australia (https://www.nhmrc.gov.au/) Early-Career Fellowship (MJB). The Burnet Institute is supported by the National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme and by the Victorian State Government Operational Infrastructure Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.",,62,22,23,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005041,10.1371/journal.ppat.1005041,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200048,26182204.0,"DOAJ Gold, Green Published",,,16/08/2019,22,0,29,3376,658,442,216,2718,2143,20,555,29,0,0,2,22,22,0,,45,2,45,0,2,22,22,19,16,0,0,0,0,0,0,0,0,1,3451,92,0,72,302,2,2740,677,92,0,72,302,2,34,,0,0,0,0,2,0,0,1,1,0,0,45,0,0,1.75,5.130699088145897,1.2420897718910964,0.2420897718910964,1.4146431199411331,1.1389218009478672,5.843465045592705
477,J,"Cho, H; Jeong, DW; Liu, Q; Yeo, WS; Vogl, T; Skaar, EP; Chazin, WJ; Bae, T",,,,"Cho, Hoonsik; Jeong, Do-Won; Liu, Qian; Yeo, Won-Sik; Vogl, Thomas; Skaar, Eric P.; Chazin, Walter J.; Bae, Taeok",,,Calprotectin Increases the Activity of the SaeRS Two Component System and Murine Mortality during Staphylococcus aureus Infections,PLOS PATHOGENS,,,English,Article,,,,,,,NEUTROPHIL EXTRACELLULAR TRAPS; ALPHA-TOXIN; IMMUNE EVASION; GENE-EXPRESSION; VIRULENCE; SEQUESTRATION; ACTIVATION; DEFENSINS; MIGRATION; PROMOTER,"Calprotectin, the most abundant cytoplasmic protein in neutrophils, suppresses the growth of Staphylococcus aureus by sequestering the nutrient metal ions Zn and Mn. Here we show that calprotectin can also enhance the activity of the SaeRS two component system (TCS), a signaling system essential for production of over 20 virulence factors in S. aureus. The activity of the SaeRS TCS is repressed by certain divalent ions found in blood or neutrophil granules; however, the Zn bound-form of calprotectin relieves this repression. During staphylococcal encounter with murine neutrophils or staphylococcal infection of the murine peritoneal cavity, calprotectin increases the activity of the SaeRS TCS as well as the production of proinflammatory cytokines such as IL-1 beta and TNF-alpha, resulting in higher murine mortality. These results suggest that, under certain conditions, calprotectin can be exploited by S. aureus to increase bacterial virulence and host mortality.","[Cho, Hoonsik; Jeong, Do-Won; Liu, Qian; Yeo, Won-Sik; Bae, Taeok] Indiana Univ Sch Med Northwest, Gary, IN 46408 USA; [Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Biochem & Chem, Nashville, TN 37235 USA; [Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA","Bae, T (reprint author), Indiana Univ Sch Med Northwest, Gary, IN 46408 USA.",tbae@iun.edu,,"Jeong, Do-Won/0000-0001-6586-748X; Bae, Taeok/0000-0002-0576-2851",National Institute of Allergy and Infectious Diseases [AI077564],"Funding: This study was supported by AI077564 to TB from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,21,21,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005026,10.1371/journal.ppat.1005026,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200040,26147796.0,"DOAJ Gold, Green Published",,,16/08/2019,21,4,21,3901,657,488,169,3244,2642,19,583,21,3,0,0,19,19,0,,27,0,27,0,0,22,22,21,15,0,0,0,0,0,0,0,1,3,3948,56,0,55,55,0,3263,673,56,0,55,55,0,12,,0,0,0,0,5,0,0,1,0,0,0,27,0,0,3.0,5.937595129375952,1.2025277435265105,0.20252774352651048,1.2512330456226881,1.040502435273007,6.178082191780822
478,J,"Collins, DR; Lubow, J; Lukic, Z; Mashiba, M; Collins, KL",,,,"Collins, David R.; Lubow, Jay; Lukic, Zana; Mashiba, Michael; Collins, Kathleen L.",,,Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4(+) T Lymphocytes,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; VIROLOGICAL SYNAPSES; DENDRITIC CELLS; NEUTRALIZING ANTIBODIES; PROTEASOMAL DEGRADATION; TYPE-1 REPLICATION; INTERFERON-ALPHA; PROGENITOR CELLS; MOLECULAR CLONE,"Vpr is a conserved primate lentiviral protein that promotes infection of T lymphocytes in vivo by an unknown mechanism. Here we demonstrate that Vpr and its cellular co-factor, DCAF1, are necessary for efficient cell-to-cell spread of HIV-1 from macrophages to CD4(+) T lymphocytes when there is inadequate cell-free virus to support direct T lymphocyte infection. Remarkably, Vpr functioned to counteract a macrophage-specific intrinsic antiviral pathway that targeted Env-containing virions to LAMP1(+) lysosomal compartments. This restriction of Env also impaired virological synapses formed through interactions between HIV-1 Env on infected macrophages and CD4 on T lymphocytes. Treatment of infected macrophages with exogenous interferon-alpha induced virion degradation and blocked synapse formation, overcoming the effects of Vpr. These results provide a mechanism that helps explain the in vivo requirement for Vpr and suggests that a macrophage-dependent stage of HIV-1 infection drives the evolutionary conservation of Vpr.","[Collins, David R.; Lubow, Jay; Collins, Kathleen L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Lukic, Zana; Collins, Kathleen L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Mashiba, Michael; Collins, Kathleen L.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Mashiba, Michael; Collins, Kathleen L.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA","Collins, DR (reprint author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.",klcollin@umich.edu,,,"NIH [RO1AI051192, R56AI051192, RO1AI046998]; Burroughs Wellcome Fund; University of Michigan Molecular Mechanisms in Microbial Pathogenesis Training Grant [5T32AI007528]; University of Michigan Research Training in Experimental Immunology Training Grant [T32AI007413]; University of Michigan Medical Scientist Training Grant [5T32GM007863]","This research was supported by the NIH (RO1AI051192, R56AI051192, RO1AI046998) and the Burroughs Wellcome Fund. DRC was also supported by the University of Michigan Molecular Mechanisms in Microbial Pathogenesis Training Grant (5T32AI007528). MM was supported by the University of Michigan Research Training in Experimental Immunology Training Grant (T32AI007413) and Medical Scientist Training Grant (5T32GM007863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,14,14,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005054,10.1371/journal.ppat.1005054,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200058,26186441.0,"DOAJ Gold, Green Published",,,16/08/2019,13,0,4,5430,794,584,210,4636,3858,17,761,2,0,0,0,13,13,0,,46,14,44,2,14,14,14,12,14,0,0,0,0,0,0,0,0,0,5479,44,0,263,36,0,4655,807,44,0,263,36,0,17,,0,0,0,0,0,0,0,1,0,0,0,44,2,0,0.25,6.838790931989925,1.1712683347713546,0.1712683347713546,1.1990940465918896,1.0237569060773481,7.001259445843829
479,J,"Cortez, V; Wang, BJ; Dingens, A; Chen, MM; Ronen, K; Georgiev, IS; McClelland, RS; Overbaugh, J",,,,"Cortez, Valerie; Wang, Bingjie; Dingens, Adam; Chen, Mitchell M.; Ronen, Keshet; Georgiev, Ivelin S.; McClelland, R. Scott; Overbaugh, Julie",,,The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; B-CELL RESPONSES; MONOCLONAL-ANTIBODIES; VACCINE DEVELOPMENT; DEPENDENT EPITOPE; BREADTH; SPECIFICITIES; VARIANTS; CD4; VULNERABILITY,"HIV-1 vaccines designed to date have failed to elicit neutralizing antibodies (Nabs) that are capable of protecting against globally diverse HIV-1 subtypes. One relevant setting to study the development of a strong, cross-reactive Nab response is HIV-1 superinfection (SI), defined as sequential infections from different source partners. SI has previously been shown to lead to a broader and more potent Nab response when compared to single infection, but it is unclear whether SI also impacts epitope specificity and if the epitopes targeted after SI differ from those targeted after single infection. Here the post-SI Nab responses were examined from 21 Kenyan women collectively exposed to subtypes A, C, and D and superinfected after a median time of similar to 1.07 years following initial infection. Plasma samples chosen for analysis were collected at a median time point similar to 2.72 years post-SI. Because previous studies of singly infected populations with broad and potent Nab responses have shown that the majority of their neutralizing activity can be mapped to 4 main epitopes on the HIV-1 Envelope, we focused on these targets, which include the CD4-binding site, a V1/V2 glycan, the N332 supersite in V3, and the membrane proximal external region of gp41. Using standard epitope mapping techniques that were applied to the previous cohorts, the present study demonstrates that SI did not induce a dominant Nab response to any one of these epitopes in the 21 women. Computational sera delineation analyses also suggested that 20 of the 21 superinfected women's Nab responses could not be ascribed a single specificity with high confidence. These data are consistent with a model in which SI with diverse subtypes promotes the development of a broad polyclonal Nab response, and thus would provide support for vaccine designs using multivalent HIV immunogens to elicit a diverse repertoire of Nabs.","[Cortez, Valerie; Dingens, Adam] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Cortez, Valerie; Wang, Bingjie; Dingens, Adam; Chen, Mitchell M.; Ronen, Keshet; Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Georgiev, Ivelin S.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA USA","Overbaugh, J (reprint author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.",joverbau@fhcrc.org,,"Dingens, Adam/0000-0001-9603-9409","National Institutes of Health [R01 AI103981, R37 AI038518, T32 AI714036]","Funding: The study was funded by the National Institutes of Health R01 AI103981 and R37 AI038518 awarded to JO and T32 AI714036 awarded to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,17,18,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004973,10.1371/journal.ppat.1004973,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200016,26158467.0,"DOAJ Gold, Green Published",,,16/08/2019,19,6,35,5049,615,453,162,4434,3862,26,546,35,5,0,0,20,20,3,,38,4,38,0,4,21,20,21,13,0,0,0,0,0,0,3,1,0,5075,40,0,79,144,0,4429,615,40,0,79,144,0,31,,3,0,0,0,6,0,4,1,0,0,0,38,0,0,29.75,8.209756097560975,1.138700947225981,0.13870094722598106,1.1860622462787551,1.041592394533571,8.551219512195122
480,J,"Davis, DA; Naiman, NE; Wang, V; Shrestha, P; Haque, M; Hu, DS; Anagho, HA; Carey, RF; Davidoff, KS; Yarchoan, R",,,,"Davis, David A.; Naiman, Nicole E.; Wang, Victoria; Shrestha, Prabha; Haque, Muzammel; Hu, Duosha; Anagho, Holda A.; Carey, Robert F.; Davidoff, Katharine S.; Yarchoan, Robert",,,Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; ENDOTHELIAL-CELLS; VIRAL-INFECTION; PROTEIN; APOPTOSIS; INFLAMMASOMES; ACTIVATION; HOMOLOG; REPLICATION,"Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the causative agent of three hyperproliferative disorders: Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman's disease. During viral latency a small subset of viral genes are produced, including KSHV latency-associated nuclear antigen (LANA), which help the virus thwart cellular defense responses. We found that exposure of KSHV-infected cells to oxidative stress, or other inducers of apoptosis and caspase activation, led to processing of LANA and that this processing could be inhibited with the pan-caspase inhibitor Z-VAD-FMK. Using sequence, peptide, and mutational analysis, two caspase cleavage sites within LANA were identified: a site for caspase-3 type caspases at the N-terminus and a site for caspase-1 and -3 type caspases at the C-terminus. Using LANA expression plasmids, we demonstrated that mutation of these cleavage sites prevents caspase-1 and caspase-3 processing of LANA. This indicates that these are the principal sites that are susceptible to caspase cleavage. Using peptides spanning the identified LANA cleavage sites, we show that caspase activity can be inhibited in vitro and that a cell-permeable peptide spanning the C-terminal cleavage site could inhibit cleavage of poly (ADP-ribose) polymerase and increase viability in cells undergoing etoposide-induced apoptosis. The C-terminal peptide of LANA also inhibited interleukin-1beta (IL-1 beta) production from lipopoly-saccharide-treated THP-1 cells by more than 50%. Furthermore, mutation of the two cleavage sites in LANA led to a significant increase in IL-1 beta production in transfected THP-1 cells; this provides evidence that these sites function to blunt the inflammasome, which is known to be activated in latently infected PEL cells. These results suggest that specific caspase cleavage sites in KSHV LANA function to blunt apoptosis as well as interfere with the caspase-1-mediated inflammasome, thus thwarting key cellular defense mechanisms.","[Davis, David A.; Naiman, Nicole E.; Wang, Victoria; Shrestha, Prabha; Haque, Muzammel; Hu, Duosha; Anagho, Holda A.; Carey, Robert F.; Davidoff, Katharine S.; Yarchoan, Robert] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA","Davis, DA (reprint author), NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA.",dadavis@helix.nih.gov,,,,,,52,11,11,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005064,10.1371/journal.ppat.1005064,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200066,26218605.0,"DOAJ Gold, Green Published",,,16/08/2019,11,2,11,3517,654,461,193,2863,2396,19,448,11,1,0,0,10,10,0,,0,0,0,0,0,11,11,10,10,0,0,0,0,0,0,0,1,0,3523,54,0,427,159,0,2855,654,54,0,427,159,0,14,,0,0,0,0,1,0,0,1,0,0,0,13,0,0,1.25,5.377675840978593,1.2284317149842823,0.22843171498428222,1.3049249039469089,1.0622689792436737,5.712538226299694
481,J,"Elsner, RA; Hastey, CJ; Olsen, KJ; Baumgarth, N",,,,"Elsner, Rebecca A.; Hastey, Christine J.; Olsen, Kimberly J.; Baumgarth, Nicole",,,Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN GRANULOCYTIC EHRLICHIOSIS; MULTICOLOR FLOW-CYTOMETRY; LYME-DISEASE; ANTIBODY-RESPONSES; ERYTHEMA MIGRANS; SURFACE-PROTEINS; PLASMA-CELLS; MEMORY B; T-CELLS; MICE,"Lyme Disease caused by infection with Borrelia burgdorferi is an emerging infectious disease and already by far the most common vector-borne disease in the U.S. Similar to many other infections, infection with B. burgdorferi results in strong antibody response induction, which can be used clinically as a diagnostic measure of prior exposure. However, clinical studies have shown a sometimes-precipitous decline of such antibodies shortly following antibiotic treatment, revealing a potential deficit in the host's ability to induce and/or maintain long-term protective antibodies. This is further supported by reports of frequent repeat infections with B. burgdorferi in endemic areas. The mechanisms underlying such a lack of long-term humoral immunity, however, remain unknown. We show here that B. burgdorferi infected mice show a similar rapid disappearance of Borrelia-specific antibodies after infection and subsequent antibiotic treatment. This failure was associated with development of only short-lived germinal centers, micro-anatomical locations from which long-lived immunity originates. These showed structural abnormalities and failed to induce memory B cells and long-lived plasma cells for months after the infection, rendering the mice susceptible to reinfection with the same strain of B. burgdorferi. The inability to induce long-lived immune responses was not due to the particular nature of the immunogenic antigens of B. burgdorferi, as antibodies to both T-dependent and T-independent Borrelia antigens lacked longevity and B cell memory induction. Furthermore, influenza immunization administered at the time of Borrelia infection also failed to induce robust antibody responses, dramatically reducing the protective antiviral capacity of the humoral response. Collectively, these studies show that B. burgdorferi-infection results in targeted and temporary immunosuppression of the host and bring new insight into the mechanisms underlying the failure to develop long-term immunity to this emerging disease threat.","[Elsner, Rebecca A.; Hastey, Christine J.; Olsen, Kimberly J.; Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Elsner, Rebecca A.; Hastey, Christine J.; Baumgarth, Nicole] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Baumgarth, Nicole] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA","Baumgarth, N (reprint author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.",nbaumgarth@ucdavis.edu,,,"National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases [AI073911, AI051354, AI085568]; NIH [T32-AI060555, T32-AI074550]","Funding: This work was supported by grants from the National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases grant AI073911, AI051354 and AI085568 and training grants from the NIH: T32-AI060555 and T32-AI074550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,46,32,33,0,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004976,10.1371/journal.ppat.1004976,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200018,26136236.0,"DOAJ Gold, Green Published",,,16/08/2019,28,1239,28,28126,1978,1622,356,26148,24299,40,1809,28,80,0,0,27,27,5,,65,23,65,0,23,29,29,29,22,0,0,0,0,0,0,3,1402,206,28158,132,108,167,150,3,26093,1978,132,96,167,150,3,87,,4,2,0,0,103,0,45,1,0,0,1,65,0,0,128.85,14.219413549039434,1.0756463209423284,0.07564632094232829,1.0876548875631022,1.0111640475005332,14.378159757330637
482,J,"Guignot, J; Segura, A; Nhieu, GTV",,,,"Guignot, Julie; Segura, Audrey; Guy Tran Van Nhieu",,,The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System,PLOS PATHOGENS,,,English,Article,,,,,,,EPITHELIAL-CELLS; SURFACE APPENDAGES; PLASMA-MEMBRANE; TRANSLOCATION; AUTOTRANSPORTERS; TOXIN; GENES; ENTEROBACTERIACEAE; EXPRESSION; PROTEINS,"Type III secretion systems (T3SSs) are specialized macromolecular machines critical for bacterial virulence, and allowing the injection of bacterial effectors into host cells. The T3SS-dependent injection process requires the prior insertion of a protein complex, the translocon, into host cell membranes consisting of two-T3SS hydrophobic proteins, associated with pore-forming activity. In all described T3SS to date, a hydrophilic protein connects one hydrophobic component to the T3SS needle, presumably insuring the continuum between the hollow needle and the translocon. In the case of Enteropathogenic Escherichia coli (EPEC), the hydrophilic component EspA polymerizes into a filament connecting the T3SS needle to the translocon composed of the EspB and EspD hydrophobic proteins. Here, we identify EspA and EspD as targets of EspC, a serine protease autotransporter of Enterobacteriaceae (SPATE). We found that in vitro, EspC preferentially targets EspA associated with EspD, but was less efficient at proteolyzing EspA alone. Consistently, we found that EspC did not regulate EspA filaments at the surface of primed bacteria that was devoid of EspD, but controlled the levels of EspD and EspA secreted in vitro or upon cell contact. While still proficient for T3SS-mediated injection of bacterial effectors and cytoskeletal reorganization, an espC mutant showed increased levels of cell-associated EspA and EspD, as well as increased pore formation activity associated with cytotoxicity. EspP from enterohaemorrhagic E. coli (EHEC) also targeted translocator components and its activity was interchangeable with that of EspC, suggesting a common and important function of these SPATEs. These findings reveal a novel regulatory mechanism of T3SS-mediated pore formation and cytotoxicity control during EPEC/EHEC infection.","[Guignot, Julie; Segura, Audrey; Guy Tran Van Nhieu] Coll France, Equipe Commun Intercellulaire & Infect Microbienn, CIRB, F-75231 Paris, France; [Guignot, Julie; Segura, Audrey; Guy Tran Van Nhieu] INSERM, U1050, Paris, France; [Guignot, Julie; Segura, Audrey; Guy Tran Van Nhieu] CNRS, UMR7241, Paris, France; [Guignot, Julie; Segura, Audrey; Guy Tran Van Nhieu] MEMOLIFE Lab Excellence & Paris Sci Lettre, Paris, France","Nhieu, GTV (reprint author), Coll France, Equipe Commun Intercellulaire & Infect Microbienn, CIRB, F-75231 Paris, France.",guy.tran-van-nhieu@college-de-france.fr,"Van Nhieu, Guy Tran/Y-6359-2018","Van Nhieu, Guy Tran/0000-0002-3901-2186; Guignot, Julie/0000-0001-8890-4028","Inserm; CNRS; College de France; LABEX MEMOLIFE Laboratory of Excellence; Paris Sciences et Lettres, Paris","Funding: This work was supported by grants from the Inserm, the CNRS, the College de France and the LABEX MEMOLIFE Laboratory of Excellence and Paris Sciences et Lettres, Paris 75005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,21,22,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005013,10.1371/journal.ppat.1005013,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200031,26132339.0,"DOAJ Gold, Green Published",,,16/08/2019,18,11,24,4600,850,563,287,3750,2892,29,829,24,5,0,0,14,14,0,,34,2,34,0,2,18,18,14,14,0,0,0,0,0,0,0,6,0,4664,183,0,65,39,2,3787,858,183,0,65,39,2,19,,0,0,0,0,6,0,1,0,0,0,0,34,0,0,2.25,5.411764705882353,1.2266666666666666,0.22666666666666666,1.3029333333333333,1.0621739130434782,5.748235294117647
483,J,"Huang, JH; Lin, CY; Wu, SY; Chen, WY; Chu, CL; Brown, GD; Chuu, CP; Wu-Hsieh, BA",,,,"Huang, Juin-Hua; Lin, Ching-Yu; Wu, Sheng-Yang; Chen, Wen-Yu; Chu, Ching-Liang; Brown, Gordon D.; Chuu, Chih-Pin; Wu-Hsieh, Betty A.",,,CR3 and Dectin-1 Collaborate in Macrophage Cytokine Response through Association on Lipid Rafts and Activation of Syk-JNK-AP-1 Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,PATTERN-RECOGNITION RECEPTOR; INNATE ANTIFUNGAL IMMUNITY; CANDIDA-ALBICANS YEAST; BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTOR-2; SYK TYROSINE KINASE; HISTOPLASMA-CAPSULATUM; DENDRITIC CELLS; COMPLEMENT RECEPTOR-3; FUNGAL-INFECTION,"Collaboration between heterogeneous pattern recognition receptors (PRRs) leading to synergistic coordination of immune response is important for the host to fight against invading pathogens. Although complement receptor 3 (CR3) and Dectin-1 are major PRRs to detect fungi, crosstalk between these two receptors in antifungal immunity is largely undefined. Here we took advantage of Histoplasma capsulatum which is known to interact with both CR3 and Dectin-1 and specific particulate ligands to study the collaboration of CR3 and Dectin-1 in macrophage cytokine response. By employing Micro-Western Array (MWA), genetic approach, and pharmacological inhibitors, we demonstrated that CR3 and Dectin-1 act collaboratively to trigger macrophage TNF and IL-6 response through signaling integration at Syk kinase, allowing subsequent enhanced activation of Syk-JNK-AP-1 pathway. Upon engagement, CR3 and Dectin-1 colocalize and form clusters on lipid raft microdomains which serve as a platform facilitating their cooperation in signaling activation and cytokine production. Furthermore, in vivo studies showed that CR3 and Dectin-1 cooperatively participate in host defense against disseminated histoplasmosis and instruct adaptive immune response. Taken together, our findings define the mechanism of receptor crosstalk between CR3 and Dectin-1 and demonstrate the importance of their collaboration in host defense against fungal infection.","[Huang, Juin-Hua; Wu, Sheng-Yang; Chen, Wen-Yu; Chu, Ching-Liang; Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Lin, Ching-Yu; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Brown, Gordon D.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland","Wu-Hsieh, BA (reprint author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.",bwh@ntu.edu.tw,"Chuu, Chih-Pin/N-6697-2019","Chu, Ching-Liang/0000-0002-8463-526X; WU-HSIEH, BETTY AN-YE/0000-0003-1522-2055",Ministry of Science and Technology [101-2320-B-002-030-MY3]; Academia Sinica [AS-101-TP-B06-3]; Welcome Trust [102705],"Funding: This work is supported by research grants 101-2320-B-002-030-MY3 from the Ministry of Science and Technology (http://www.most.gov.tw) and AS-101-TP-B06-3 from Academia Sinica (http://www.sinica.edu.tw) to BAWH. GDB is funded by research grant 102705 from Welcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,23,24,1,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004985,10.1371/journal.ppat.1004985,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200020,26132276.0,"DOAJ Gold, Green Published",,,16/08/2019,26,25,41,6496,1419,1001,418,5077,3985,26,1066,41,0,0,0,26,26,0,,60,0,60,0,0,26,26,20,13,0,0,0,0,0,0,0,25,2,6484,80,0,81,88,0,5050,1419,80,0,81,88,0,15,,0,0,0,0,1,0,0,0,0,0,0,60,0,0,0.25,4.577871740662438,1.2794957652156786,0.27949576521567854,1.310222572385267,1.0240147783251232,4.6878083157152926
484,J,"Jiang, GC; Mendes, EA; Kaiser, P; Wong, DP; Tang, YY; Cai, I; Fenton, A; Melcher, GP; Hildreth, JEK; Thompson, GR; Wong, JK; Dandekar, S",,,,"Jiang, Guochun; Mendes, Erica A.; Kaiser, Philipp; Wong, Daniel P.; Tang, Yuyang; Cai, Ivy; Fenton, Anne; Melcher, Gregory P.; Hildreth, James E. K.; Thompson, George R.; Wong, Joseph K.; Dandekar, Satya",,,"Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation",PLOS PATHOGENS,,,English,Article,,,,,,,VIRUS TYPE-1 INFECTION; LYMPHOID-TISSUE; T-CELLS; KAPPA-B; RESERVOIR; INGENOL; RESTORATION; INHIBITORS; APOPTOSIS; QUANTIFICATION,"Although anti-retroviral therapy (ART) is highly effective in suppressing HIV replication, it fails to eradicate the virus from HIV-infected individuals. Stable latent HIV reservoirs are rapidly established early after HIV infection. Therefore, effective strategies for eradication of the HIV reservoirs are urgently needed. We report that ingenol-3-angelate (PEP005), the only active component in a previously FDA approved drug (PICATO) for the topical treatment of precancerous actinic keratosis, can effectively reactivate latent HIV in vitro and ex vivo with relatively low cellular toxicity. Biochemical analysis showed that PEP005 reactivated latent HIV through the induction of the pS643/S676-PKC delta/theta-I kappa B alpha/epsilon-NF-kappa B signaling pathway. Importantly, PEP005 alone was sufficient to induce expression of fully elongated and processed HIV RNAs in primary CD4+ T cells from HIV infected individuals receiving suppressive ART. Furthermore, PEP005 and the P-TEFb agonist, JQ1, exhibited synergism in reactivation of latent HIV with a combined effect that is 7.5-fold higher than the effect of PEP005 alone. Conversely, PEP005 suppressed HIV infection of primary CD4+ T cells through down-modulation of cell surface expression of HIV co-receptors. This anti-cancer compound is a potential candidate for advancing HIV eradication strategies.","[Jiang, Guochun; Mendes, Erica A.; Cai, Ivy; Fenton, Anne; Thompson, George R.; Dandekar, Satya] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Kaiser, Philipp; Wong, Joseph K.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kaiser, Philipp; Wong, Daniel P.] San Francisco Vet Affairs Med Ctr VMAC, San Francisco, CA USA; [Wong, Daniel P.] Williams Coll, Dept Phys, Williamstown, MA 01267 USA; [Tang, Yuyang; Hildreth, James E. K.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Melcher, Gregory P.; Thompson, George R.; Dandekar, Satya] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA","Jiang, GC (reprint author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.",sdandekar@ucdavis.edu,"Mendes, Erica/L-7333-2018; Jiang, Guochun/H-8809-2019","Mendes, Erica/0000-0001-9007-1053; ","NIH [DK61297, AI43274]; UC Davis Research Investments in Science and Engineering (RISE); CAPES/Brazil [BEX 2951/12-6]; Swiss National Science Foundation [PBZHP3_147260]","This study is supported by NIH grants DK61297, AI43274, and UC Davis Research Investments in Science and Engineering (RISE) grant to SD and a post-doctoral fellowship from CAPES/Brazil (BEX 2951/12-6) to EAM. PK is supported by the Swiss National Science Foundation (PBZHP3_147260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,82,82,1,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005066,10.1371/journal.ppat.1005066,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200068,26225771.0,"DOAJ Gold, Green Published",,,16/08/2019,80,172,72,22946,1489,1051,438,21457,19121,34,2302,71,31,2,1,81,81,31,,184,3,95,1,3,83,83,56,61,0,0,0,0,0,0,3,150,3,23050,31,28,213,110,0,21512,1514,31,28,213,110,0,24,,17,5,0,0,40,0,8,1,1,0,0,94,1,0,187.438,15.410342511752853,1.069394603159808,0.06939460315980799,1.0808127883674326,1.0106772422208663,15.574882471457354
485,J,"Kakisaka, M; Sasaki, Y; Yamada, K; Kondoh, Y; Hikono, H; Osada, H; Tomii, K; Saito, T; Aida, Y",,,,"Kakisaka, Michinori; Sasaki, Yutaka; Yamada, Kazunori; Kondoh, Yasumitsu; Hikono, Hirokazu; Osada, Hiroyuki; Tomii, Kentaro; Saito, Takehiko; Aida, Yoko",,,"A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein",PLOS PATHOGENS,,,English,Article,,,,,,,H5N1 NUCLEOPROTEIN; CRYSTAL-STRUCTURE; MATRIX PROTEIN; UNITED-STATES; AMINO-ACIDS; OLIGOMERIZATION; IDENTIFICATION; POLYMERASE; RIBONUCLEOPROTEINS; ENDONUCLEASE,"Developing antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface structures without affecting host cell function. We recently identified the antiviral compound, RK424, by screening a library of 50,000 compounds using cell-based infection assays. RK424 showed potent antiviral activity against many different subtypes of IAV in vitro and partially protected mice from a lethal dose of A/WSN/1933 (H1N1) virus in vivo. Here, we show that RK424 inhibits viral ribonucleoprotein complex (vRNP) activity, causing the viral nucleoprotein (NP) to accumulate in the cell nucleus. In silico docking analysis revealed that RK424 bound to a small pocket in the viral NP. This pocket was surrounded by three functionally important domains: the RNA binding groove, the NP dimer interface, and nuclear export signal (NES) 3, indicating that it may be involved in the RNA binding, oligomerization, and nuclear export functions of NP. The accuracy of this binding model was confirmed in a NP-RK424 binding assay incorporating photo-cross-linked RK424 affinity beads and in a plaque assay evaluating the structure-activity relationship of RK424. Surface plasmon resonance (SPR) and pull-down assays showed that RK424 inhibited both the NP-RNA and NP-NP interactions, whereas size exclusion chromatography showed that RK424 disrupted viral RNA-induced NP oligomerization. In addition, in vitro nuclear export assays confirmed that RK424 inhibited nuclear export of NP. The amino acid residues comprising the NP pocket play a crucial role in viral replication and are highly conserved in more than 7,000 NP sequences from avian, human, and swine influenza viruses. Furthermore, we found that the NP pocket has a surface structure different from that of the pocket in host molecules. Taken together, these results describe a promising new approach to developing influenza virus drugs that target a novel pocket structure within NP.","[Kakisaka, Michinori; Sasaki, Yutaka; Yamada, Kazunori; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Yamada, Kazunori; Tomii, Kentaro] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan; [Kondoh, Yasumitsu; Osada, Hiroyuki] RIKEN CSRS, Chem Biol Grp, Wako, Saitama, Japan; [Osada, Hiroyuki; Saito, Takehiko] Natl Agr & Food Res Org NARO, Influenza & Prion Dis Res Ctr, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan","Kakisaka, M (reprint author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.",aida@riken.jp,"KONDOH, Yasumitsu/C-7461-2017; Osada, Hiroyuki/N-4305-2014; Tomii, Kentaro/B-1135-2017","KONDOH, Yasumitsu/0000-0002-3481-5481; Tomii, Kentaro/0000-0002-4567-4768","RIKEN Program for Drug Discovery and Medical Technology Platforms; Adaptable and Seamless Technology Transfer Program through target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Agriculture, Forestry and Fisheries of Japan","This study was supported in part by a RIKEN Program for Drug Discovery and Medical Technology Platforms, by the Adaptable and Seamless Technology Transfer Program through target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST), Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by research project for improving food safety and animal health from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,52,23,25,0,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005062,10.1371/journal.ppat.1005062,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200064,26222066.0,"DOAJ Gold, Green Published",,,16/08/2019,26,0,31,6481,1196,776,420,5285,4173,21,1091,31,0,0,0,23,23,0,,37,9,37,0,9,26,26,23,9,0,0,0,0,0,0,0,1,0,6562,190,0,400,440,0,5307,1207,190,0,400,440,0,48,,0,0,0,0,1,0,0,1,0,0,0,37,0,0,0.75,5.418896321070235,1.2263008514664144,0.22630085146641438,1.3608325449385053,1.1097052923931492,6.013377926421405
486,J,"Kataoka, C; Suzuki, T; Kotani, O; Iwata-Yoshikawa, N; Nagata, N; Ami, Y; Wakita, T; Nishimura, Y; Shimizu, H",,,,"Kataoka, Chikako; Suzuki, Tadaki; Kotani, Osamu; Iwata-Yoshikawa, Naoko; Nagata, Noriyo; Ami, Yasushi; Wakita, Takaji; Nishimura, Yorihiro; Shimizu, Hiroyuki",,,The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model,PLOS PATHOGENS,,,English,Article,,,,,,,SELECTIN GLYCOPROTEIN LIGAND-1; CAPSID PROTEIN VP1; CENTRAL-NERVOUS-SYSTEM; MOLECULAR EPIDEMIOLOGY; NATURAL-SELECTION; MOUSE ADAPTATION; MOUTH-DISEASE; INFECTION; RECEPTOR; STRAIN,"Enterovirus 71 (EV71), a major causative agent of hand, foot, and mouth disease, occasionally causes severe neurological symptoms. We identified P-selectin glycoprotein ligand-1 (PSGL-1) as an EV71 receptor and found that an amino acid residue 145 in the capsid protein VP1 (VP1-145) defined PSGL-1-binding (PB) and PSGL-1-nonbinding (non-PB) phenotypes of EV71. However, the role of PSGL-1-dependent EV71 replication in neuropathogenesis remains poorly understood. In this study, we investigated viral replication, genetic stability, and the pathogenicity of PB and non-PB strains of EV71 in a cynomolgus monkey model. Monkeys were intravenously inoculated with cDNA-derived PB and non-PB strains of EV71, EV71-02363-EG and EV71-02363-KE strains, respectively, with two amino acid differences at VP1-98 and VP1-145. Mild neurological symptoms, transient lymphocytopenia, and inflammatory cytokine responses, were found predominantly in the 02363-KE-inoculated monkeys. During the early stage of infection, viruses were frequently detected in clinical samples from 02363-KE-inoculated monkeys but rarely in samples from 02363-EG-inoculated monkeys. Histopathological analysis of central nervous system (CNS) tissues at 10 days postinfection revealed that 02363-KE induced neuropathogenesis more efficiently than that induced by 02363-EG. After inoculation with 02363-EG, almost all EV71 variants detected in clinical samples, CNS, and non-CNS tissues, possessed a G to E amino acid substitution at VP1-145, suggesting a strong in vivo selection of VP1-145E variants and CNS spread presumably in a PSGL-1-independent manner. EV71 variants with VP1-145G were identified only in peripheral blood mononuclear cells in two out of four 02363-EG-inoculated monkeys. Thus, VP1-145E variants are mainly responsible for the development of viremia and neuropathogenesis in a non-human primate model, further suggesting the in vivo involvement of amino acid polymorphism at VP1-145 in cell-specific viral replication, in vivo fitness, and pathogenesis in EV71-infected individuals.","[Kataoka, Chikako; Wakita, Takaji; Nishimura, Yorihiro; Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Suzuki, Tadaki; Kotani, Osamu; Iwata-Yoshikawa, Naoko; Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Ami, Yasushi] Natl Inst Infect Dis, Div Expt Anim Res, Tokyo, Japan; [Nishimura, Yorihiro] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA","Shimizu, H (reprint author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.",hshimizu@nih.go.jp,,"Shimizu, Hiroyuki/0000-0002-2987-2377",,,,63,27,30,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005033,10.1371/journal.ppat.1005033,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200045,26181772.0,"DOAJ Gold, Green Published",,,16/08/2019,27,0,21,4816,1350,881,469,3466,2658,28,780,21,0,0,0,26,26,0,,22,10,22,0,10,28,28,22,17,0,0,0,0,0,0,0,0,0,4859,100,0,133,115,0,3477,1363,100,0,133,115,0,19,,0,0,0,0,0,0,0,1,0,0,0,23,0,0,0.25,3.5674074074074076,1.3894979803808425,0.3894979803808425,1.463935372186959,1.0535714285714286,3.7585185185185184
487,J,"Khare, S; Roach, SL; Barnes, SW; Hoepfner, D; Walker, JR; Chatterjee, AK; Neitz, RJ; Arkin, MR; McNamara, CW; Ballard, J; Lai, Y; Fu, Y; Molteni, V; Yeh, V; McKerrow, JH; Glynne, RJ; Supek, F",,,,"Khare, Shilpi; Roach, Steven L.; Barnes, S. Whitney; Hoepfner, Dominic; Walker, John R.; Chatterjee, Arnab K.; Neitz, R. Jeffrey; Arkin, Michelle R.; McNamara, Case W.; Ballard, Jaime; Lai, Yin; Fu, Yue; Molteni, Valentina; Yeh, Vince; McKerrow, James H.; Glynne, Richard J.; Supek, Frantisek",,,Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease,PLOS PATHOGENS,,,English,Article,,,,,,,MITOCHONDRIAL ELECTRON-TRANSPORT; TRYPANOSOMA-CRUZI INFECTION; PLASMODIUM-FALCIPARUM; BC(1) COMPLEX; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; MUTANTS RESISTANT; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ILICICOLIN-H,"Unbiased phenotypic screens enable identification of small molecules that inhibit pathogen growth by unanticipated mechanisms. These small molecules can be used as starting points for drug discovery programs that target such mechanisms. A major challenge of the approach is the identification of the cellular targets. Here we report GNF7686, a small molecule inhibitor of Trypanosoma cruzi, the causative agent of Chagas disease, and identification of cytochrome b as its target. Following discovery of GNF7686 in a parasite growth inhibition high throughput screen, we were able to evolve a GNF7686-resistant culture of T. cruzi epimastigotes. Clones from this culture bore a mutation coding for a substitution of leucine by phenylalanine at amino acid position 197 in cytochrome b. Cytochrome b is a component of complex III (cytochrome bc(1)) in the mitochondrial electron transport chain and catalyzes the transfer of electrons from ubiquinol to cytochrome c by a mechanism that utilizes two distinct catalytic sites, Q(N) and Q(P). The L197F mutation is located in the Q(N) site and confers resistance to GNF7686 in both parasite cell growth and biochemical cytochrome b assays. Additionally, the mutant cytochrome b confers resistance to antimycin A, another Q(N) site inhibitor, but not to strobilurin or myxothiazol, which target the Q(P) site. GNF7686 represents a promising starting point for Chagas disease drug discovery as it potently inhibits growth of intracellular T. cruzi amastigotes with a half maximal effective concentration (EC50) of 0.15 mu M, and is highly specific for T. cruzi cytochrome b. No effect on the mammalian respiratory chain or mammalian cell proliferation was observed with up to 25 mu M of GNF7686. Our approach, which combines T. cruzi chemical genetics with biochemical target validation, can be broadly applied to the discovery of additional novel drug targets and drug leads for Chagas disease.","[Khare, Shilpi; Barnes, S. Whitney; Walker, John R.; McNamara, Case W.; Ballard, Jaime; Lai, Yin; Fu, Yue; Glynne, Richard J.; Supek, Frantisek] Novartis Res Fdn, Genom Inst, Dept Genet & Neglected Dis, San Diego, CA 92121 USA; [Roach, Steven L.; Chatterjee, Arnab K.; Molteni, Valentina; Yeh, Vince] Novartis Res Fdn, Genom Inst, Dept Med Chem, San Diego, CA USA; [Hoepfner, Dominic] Novartis Inst BioMed Res, Basel, Switzerland; [Neitz, R. Jeffrey; Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Neitz, R. Jeffrey; Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [McKerrow, James H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA","Khare, S (reprint author), Novartis Res Fdn, Genom Inst, Dept Genet & Neglected Dis, San Diego, CA 92121 USA.",fsupek@gnf.org,,,National Institute of Allergy and Infectious Diseases [1R01AI090605],"This work was partly funded from the 1R01AI090605 grant awarded to JHM by National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,24,24,1,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005058,10.1371/journal.ppat.1005058,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200060,26186534.0,"DOAJ Gold, Green Published",,,16/08/2019,25,30,37,5774,707,511,196,5067,4258,21,788,36,25,0,0,23,23,0,,45,0,44,1,0,26,26,17,9,0,0,0,0,0,0,0,5,1,5861,20,0,103,206,1,5089,716,20,0,103,206,1,56,,0,0,0,0,22,0,2,1,0,0,0,44,1,0,11.9,8.166902404526168,1.1395302940596013,0.13953029405960135,1.2013025458851392,1.0542085209560097,8.609618104667609
488,J,"Li, QX; Wilkie, AR; Weller, M; Liu, XQ; Cohen, JI",,,,"Li, Qingxue; Wilkie, Adrian R.; Weller, Melodie; Liu, Xueqiao; Cohen, Jeffrey I.",,,THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,GROWTH-FACTOR RECEPTOR; GLYCOPROTEIN COMPLEX GB; DISINTEGRIN-LIKE DOMAIN; HERPES-SIMPLEX-VIRUS; SMOOTH-MUSCLE-CELLS; DESIGNATED GC-II; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; HUMAN FIBROBLASTS; ZAIRE-EBOLAVIRUS,"Human cytomegalovirus (HCMV) infects about 50% of the US population, is the leading infectious cause of birth defects, and is considered the most important infectious agent in transplant recipients. The virus infects many cell types in vivo and in vitro. While previous studies have identified several cellular proteins that may function at early steps of infection in a cell type dependent manner, the mechanism of virus entry is still poorly understood. Using a computational biology approach, correlating gene expression with virus infectivity in 54 cell lines, we identified THY-1 as a putative host determinant for HCMV infection in these cells. With a series of loss-of-function, gain-of-function and protein-protein interaction analyses, we found that THY-1 mediates HCMV infection at the entry step and is important for infection that occurs at a low m.o.i. THY-1 antibody that bound to the cell surface blocked HCMV during the initial 60 minutes of infection in a dose-dependent manner. Down-regulation of THY-1 with siRNA impaired infectivity occurred during the initial 60 minutes of inoculation. Both THY-1 antibody and siRNA inhibited HCMV-induced activation of the PI3-K/Akt pathway required for entry. Soluble THY-1 protein blocked HCMV infection during, but not after, virus internalization. Expression of exogenous THY-1 enhanced entry in cells expressing low levels of the protein. THY-1 interacted with HCMV gB and gH and may form a complex important for entry. However, since gB and gH have previously been shown to interact, it is uncertain if THY-1 directly binds to both of these proteins. Prior observations that THY-1 (a) interacts with alpha V beta 3 integrin and recruits paxillin (implicated in HCMV entry), (b) regulates leukocyte extravasation (critical for HCMV viremia), and (c) is expressed on many cells targeted for HCMV infection including epithelial and endothelial cells, fibroblast, and CD34+/CD38- stem cells, all support a role for THY-1 as an HCMV entry mediator in a cell type dependent manner. THY-1 may function through a complex setting, that would include viral gB and gH, and other cellular factors, thus links virus entry with signaling in host cells that ultimately leads to virus infection.","[Li, Qingxue; Wilkie, Adrian R.; Liu, Xueqiao; Cohen, Jeffrey I.] NIH, Med Virol Sect, Infect Dis Lab, Bethesda, MD 20892 USA; [Weller, Melodie] NIH, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, Bethesda, MD 20892 USA","Cohen, JI (reprint author), NIH, Med Virol Sect, Infect Dis Lab, Bldg 10, Bethesda, MD 20892 USA.",jcohen@niaid.nih.gov,,,National Institute of Allergy and Infectious Diseases,"Funding: This work was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,89,15,15,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004999,10.1371/journal.ppat.1004999,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200025,26147640.0,"DOAJ Gold, Green Published",,,16/08/2019,17,1,17,4139,1020,811,209,3119,2599,18,502,17,0,0,0,16,16,0,,22,6,22,0,6,18,18,18,12,0,0,0,0,0,0,0,1,0,4218,203,0,70,139,1,3149,1033,203,0,70,139,1,36,,0,0,0,0,1,0,1,1,0,0,0,22,0,0,0.75,4.057843137254902,1.3270278935556268,0.3270278935556268,1.4620070535428022,1.1017153901908674,4.470588235294118
489,J,"Liu, GG; Xu, JJ; Wu, H; Sun, DL; Zhang, XQ; Zhu, XP; Magez, S; Shi, MQ",,,,"Liu, Gongguan; Xu, Jinjun; Wu, Hui; Sun, Donglei; Zhang, Xiquan; Zhu, Xiaoping; Magez, Stefan; Shi, Meiqing",,,IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4(+) T Cells and IFN-gamma,PLOS PATHOGENS,,,English,Article,,,,,,,VARIANT SURFACE GLYCOPROTEIN; NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; CONGOLENSE INFECTIONS; INTERFERON-GAMMA; IMMUNOLOGICAL CLEARANCE; IMMUNE-RESPONSES; BRUCEI INFECTION; RESISTANCE; IL-10,"African trypanosomes are extracellular protozoan parasites causing a chronic debilitating disease associated with a persistent inflammatory response. Maintaining the balance of the inflammatory response via downregulation of activation of M1-type myeloid cells was previously shown to be crucial to allow prolonged survival. Here we demonstrate that infection with African trypanosomes of IL-27 receptor-deficient (IL-27R(-/-)) mice results in severe liver immunopathology and dramatically reduced survival as compared to wild-type mice. This coincides with the development of an exacerbated Th1-mediated immune response with overactivation of CD4(+) T cells and strongly enhanced production of inflammatory cytokines including IFN-gamma. What is important is that IL-10 production was not impaired in infected IL-27R(-/-) mice. Depletion of CD4(+) T cells in infected IL-27R(-/-) mice resulted in a dramatically reduced production of IFN-gamma, preventing the early mortality of infected IL-27R(-/-) mice. This was accompanied by a significantly reduced inflammatory response and a major amelioration of liver pathology. These results could be mimicked by treating IL-27R(-/-) mice with a neutralizing anti-IFN-gamma antibody. Thus, our data identify IL-27 signaling as a novel pathway to prevent early mortality via inhibiting hyperactivation of CD4(+) Th1 cells and their excessive secretion of IFN-gamma during infection with African trypanosomes. These data are the first to demonstrate the essential role of IL-27 signaling in regulating immune responses to extracellular protozoan infections.","[Liu, Gongguan; Xu, Jinjun; Wu, Hui; Sun, Donglei; Zhu, Xiaoping; Shi, Meiqing] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Div Immunol, College Pk, MD 20742 USA; [Zhang, Xiquan] South China Agr Univ, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Magez, Stefan] Vrije Univ Brussels, Lab Cellular & Mol Immunol, Brussels, Belgium; [Magez, Stefan] VIB, Struct Biol Res Ctr, Brussels, Belgium","Liu, GG (reprint author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, Div Immunol, College Pk, MD 20742 USA.",mshi@umd.edu,"Shi, Meiqing/K-3665-2016; Sun, Donglei/H-7572-2013; Magez, Stefan/D-9497-2014","Magez, Stefan/0000-0003-3760-7968",University of Maryland,"This work was supported by the University of Maryland startup funds (MS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,60,4,4,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005065,10.1371/journal.ppat.1005065,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200067,26222157.0,"DOAJ Gold, Green Published",,,16/08/2019,10,1,12,3803,674,511,163,3129,2601,20,508,12,0,0,0,9,9,0,,20,0,20,0,0,10,10,8,7,0,0,0,0,0,0,0,1,1,3810,43,0,286,73,0,3117,674,43,0,286,73,0,19,,0,0,0,0,3,0,1,1,0,0,0,19,0,0,1.5,5.642433234421365,1.2154042825183764,0.21540428251837648,1.2547139661233622,1.0323428871943203,5.824925816023739
490,J,"Liu, W; Chen, YT; Jiang, X; Xia, M; Yang, Y; Tan, M; Li, XM; Rao, ZH",,,,"Liu, Wu; Chen, Yutao; Jiang, Xi; Xia, Ming; Yang, Yang; Tan, Ming; Li, Xuemei; Rao, Zihe",,,A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface,PLOS PATHOGENS,,,English,Article,,,,,,,BLOOD GROUP ANTIGENS; STRAIN-SPECIFIC INTERACTION; NORWALK VIRUS-INFECTION; CAPSID PROTEIN FORMS; STRUCTURAL BASIS; CRYSTALLOGRAPHIC STRUCTURE; HOST INTERACTION; GII-4 NOROVIRUS; P-DOMAIN; RECOGNITION,"Norovirus (NoV) causes epidemic acute gastroenteritis in humans, whereby histo-blood group antigens (HBGAs) play an important role in host susceptibility. Each of the two major genogroups (GI and GII) of human NoVs recognizes a unique set of HBGAs through a distinct binding interface that is conserved within a genogroup, indicating a distinct evolutionary path for each genogroup. Here, we characterize a Lewis a (Le(a)) antigen binding strain (OIF virus) in the GII. 21 genotype that does not share the conserved GII binding interface, revealing a new evolution lineage with a distinct HBGA binding interface. Sequence alignment showed that the major residues contributing to the new HBGA binding interface are conserved among most members of the GII. 21, as well as a closely related GII. 13 genotype. In addition, we found that glycerol inhibits OIF binding to HBGAs, potentially allowing production of cheap antivirals against human NoVs. Taken together, our results reveal a new evolutionary lineage of NoVs selected by HBGAs, a finding that is important for understanding the diversity and widespread nature of NoVs.","[Liu, Wu] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Chen, Yutao; Yang, Yang; Li, Xuemei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Jiang, Xi; Xia, Ming; Tan, Ming] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Jiang, Xi; Tan, Ming] Univ Cincinnati, Coll Med, Cincinnati, OH USA","Tan, M (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.",Ming.Tan@cchmc.org; lixm@sun5.ibp.ac.cn,,,"National Natural Science Foundation of China [31400639, 31170702]; National Basic Research Program (973 Program) [2011CB910304, 2011CB915501, 2014CBA02003]; US National Institute of Health (NIH) [RO1AI089634]; US Agriculture and Food Research Initiative Competitive Grants Program of the USDA NIFA Award [2011-68003-30005]; Cincinnati Children's Hospital Medical Center","Funding: This work was supported by the National Natural Science Foundation of China (Grant No. 31400639 and 31170702) and the National Basic Research Program (973 Program) (No. 2011CB910304, 2011CB915501, and 2014CBA02003) to ZR and XL. This study was also supported by US National Institute of Health (NIH) (RO1AI089634), the US Agriculture and Food Research Initiative Competitive Grants Program of the USDA NIFA Award (2011-68003-30005), and Cincinnati Children's Hospital Medical Center (T1 and Innovation Fund) to XJ and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript",,50,22,24,1,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005025,10.1371/journal.ppat.1005025,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200039,26147716.0,"DOAJ Gold, Green Published",,,16/08/2019,22,2,19,4611,1446,1116,330,3165,2382,22,761,19,1,0,0,20,20,0,,23,0,23,0,0,23,23,20,19,0,0,0,0,0,0,0,1,0,4672,10,0,66,68,1,3173,1468,10,0,66,68,1,31,,0,0,0,0,1,0,0,1,0,0,0,23,0,0,0.75,3.1887966804979255,1.456872037914692,0.45687203791469194,1.5007898894154819,1.0301453047061375,3.284923928077455
491,J,"Martinez, J; Ok, S; Smith, S; Snoeck, K; Day, JP; Jiggins, FM",,,,"Martinez, Julien; Ok, Suzan; Smith, Sophie; Snoeck, Kiana; Day, Jon P.; Jiggins, Francis M.",,,Should Symbionts Be Nice or Selfish? Antiviral Effects of Wolbachia Are Costly but Reproductive Parasitism Is Not,PLOS PATHOGENS,,,English,Article,,,,,,,INCOMPATIBILITY-INDUCING MICROBES; CYTOPLASMIC INCOMPATIBILITY; AEDES-AEGYPTI; DENGUE VIRUS; DROSOPHILA-MELANOGASTER; INFECTION; EVOLUTION; PROTECTION; DENSITY; FITNESS,"Symbionts can have mutualistic effects that increase their host's fitness and/or parasitic effects that reduce it. Which of these strategies evolves depends in part on the balance of their costs and benefits to the symbiont. We have examined these questions in Wolbachia, a vertically transmitted endosymbiont of insects that can provide protection against viral infection and/or parasitically manipulate its hosts' reproduction. Across multiple symbiont strains we find that the parasitic phenotype of cytoplasmic incompatibility and antiviral protection are uncorrelated. Strong antiviral protection is associated with substantial reductions in other fitness-related traits, whereas no such trade-off was detected for cytoplasmic incompatibility. The reason for this difference is likely that antiviral protection requires high symbiont densities but cytoplasmic incompatibility does not. These results are important for the use of Wolbachia to block dengue virus transmission by mosquitoes, as natural selection to reduce these costs may lead to reduced symbiont density and the loss of antiviral protection.","[Martinez, Julien; Ok, Suzan; Smith, Sophie; Snoeck, Kiana; Day, Jon P.; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England","Martinez, J (reprint author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.",jtm35@cam.ac.uk,,"Jiggins, Francis Michael/0000-0001-7470-8157; Martinez, Julien/0000-0001-8210-2921; Bayley, Sophie/0000-0003-3928-4760",Wellcome Trust [WT094664MA]; Royal Society,"Funding: This study was funded by the Wellcome Trust grant WT094664MA (http://www.wellcome.ac.uk/). FMJ received the funding. FMJ is also supported by a Royal Society Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,78,31,31,1,42,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005021,10.1371/journal.ppat.1005021,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200035,26132467.0,"DOAJ Gold, Green Published",,,16/08/2019,33,57,88,4529,483,340,143,4046,3249,27,770,88,32,0,0,33,33,0,,104,5,104,0,5,35,33,35,22,0,0,0,0,0,0,0,25,2,4614,25,21,44,170,0,4058,492,25,21,44,170,0,64,,0,0,0,0,35,0,0,0,0,0,0,104,0,0,18.35,9.376811594202898,1.1193771626297577,0.11937716262975778,1.1885813148788926,1.061823802163833,9.956521739130435
492,J,"Minassian, A; Zhang, JJ; He, SP; Zhao, J; Zandi, E; Saito, T; Liang, CY; Feng, PH",,,,"Minassian, Arlet; Zhang, Junjie; He, Shanping; Zhao, Jun; Zandi, Ebrahim; Saito, Takeshi; Liang, Chengyu; Feng, Pinghui",,,An Internally Translated MAVS Variant Exposes Its Amino-terminal TRAF-Binding Motifs to Deregulate Interferon Induction,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIVIRAL SIGNALING PROTEIN; INNATE IMMUNE-RESPONSE; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; STRUCTURAL BASIS; SPLICE VARIANT; IKK-EPSILON; RECOGNITION; VIRUS,"Activation of pattern recognition receptors and proper regulation of downstream signaling are crucial for host innate immune response. Upon infection, the NF-kappa B and interferon regulatory factors (IRF) are often simultaneously activated to defeat invading pathogens. Mechanisms concerning differential activation of NF-kappa B and IRF are not well understood. Here we report that a MAVS variant inhibits interferon (IFN) induction, while enabling NF-kappa B activation. Employing herpesviral proteins that selectively activate NF-kappa B signaling, we discovered that a MAVS variant of similar to 50 kDa, thus designated MAVS50, was produced from internal translation initiation. MAVS50 preferentially interacts with TRAF2 and TRAF6, and activates NF-kappa B. By contrast, MAVS50 inhibits the IRF activation and suppresses IFN induction. Biochemical analysis showed that MAVS50, exposing a degenerate TRAF-binding motif within its N-terminus, effectively competed with full-length MAVS for recruiting TRAF2 and TRAF6. Ablation of the TRAF-binding motif of MAVS50 impaired its inhibitory effect on IRF activation and IFN induction. These results collectively identify a new means by which signaling events is differentially regulated via exposing key internally embedded interaction motifs, implying a more ubiquitous regulatory role of truncated proteins arose from internal translation and other related mechanisms.","[Minassian, Arlet; Zhang, Junjie; He, Shanping; Zhao, Jun; Zandi, Ebrahim; Saito, Takeshi; Liang, Chengyu; Feng, Pinghui] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA","Minassian, A (reprint author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.",pinghui.feng@usc.edu,"Saito, Takeshi/N-2788-2014","Saito, Takeshi/0000-0002-6165-664X; Zhang, Junjie/0000-0003-3812-3850","NIH [CA134241, DE021445, CA180779, AI105340]; American Cancer Society [RSG-11-162-01-MPC]","This work was supported by grants from NIH (CA134241, DE021445, CA180779 and AI105340) and American Cancer Society (RSG-11-162-01-MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,4,4,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005060,10.1371/journal.ppat.1005060,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200062,26221961.0,"DOAJ Gold, Green Published",,,16/08/2019,4,1,7,3005,465,353,112,2540,1967,17,556,7,1,0,0,5,5,0,,9,0,9,0,0,5,4,5,2,0,0,0,0,0,0,0,0,1,3010,55,0,196,73,0,2525,465,55,0,196,73,0,20,,0,0,0,0,3,0,0,1,0,0,0,9,0,0,1.25,6.462365591397849,1.1830708661417322,0.1830708661417323,1.2354330708661416,1.044259567387687,6.748387096774193
493,J,"Mora-Bau, G; Platt, AM; van Rooijen, N; Randolph, GJ; Albert, ML; Ingersoll, MA",,,,"Mora-Bau, Gabriela; Platt, Andrew M.; van Rooijen, Nico; Randolph, Gwendalyn J.; Albert, Matthew L.; Ingersoll, Molly A.",,,Macrophages Subvert Adaptive Immunity to Urinary Tract Infection,PLOS PATHOGENS,,,English,Article,,,,,,,UROPATHOGENIC ESCHERICHIA-COLI; DENDRITIC CELLS; BONE-MARROW; NEUTROPHIL RECRUITMENT; BACTERIAL CLEARANCE; T-CELLS; BLADDER; MONOCYTES; MIGRATION; RESPONSES,"Urinary tract infection (UTI) is one of the most common bacterial infections with frequent recurrence being a major medical challenge. Development of effective therapies has been impeded by the lack of knowledge of events leading to adaptive immunity. Here, we establish conclusive evidence that an adaptive immune response is generated during UTI, yet this response does not establish sterilizing immunity. To investigate the underlying deficiency, we delineated the naive bladder immune cell compartment, identifying resident macrophages as the most populous immune cell. To evaluate their impact on the establishment of adaptive immune responses following infection, we measured bacterial clearance in mice depleted of either circulating monocytes, which give rise to macrophages, or bladder resident macrophages. Surprisingly, mice depleted of resident macrophages, prior to primary infection, exhibited a nearly 2-log reduction in bacterial burden following secondary challenge compared to untreated animals. This increased bacterial clearance, in the context of a challenge infection, was dependent on lymphocytes. Macrophages were the predominant antigen presenting cell to acquire bacteria post-infection and in their absence, bacterial uptake by dendritic cells was increased almost 2-fold. These data suggest that bacterial uptake by tissue macrophages impedes development of adaptive immune responses during UTI, revealing a novel target for enhancing host responses to bacterial infection of the bladder.","[Mora-Bau, Gabriela; Albert, Matthew L.; Ingersoll, Molly A.] Inst Pasteur, Dept Immunol, Unite Immunobiol Cellules Dendrit, F-75724 Paris, France; [Mora-Bau, Gabriela; Albert, Matthew L.; Ingersoll, Molly A.] INSERM, U818, Paris, France; [Platt, Andrew M.; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Platt, Andrew M.; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [van Rooijen, Nico] Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands","Ingersoll, MA (reprint author), Inst Pasteur, Dept Immunol, Unite Immunobiol Cellules Dendrit, F-75724 Paris, France.",molly.ingersoll@pasteur.fr,"Albert, Matthew/C-9782-2009",,Ruth Chemers Neustein Postdoctoral Fellowship award; European Union [PCIG11-GA-2012-3221170]; Immuno-Oncology LabEx (MAI); National Institutes of Health [AI049653],"This project was supported in part by funding from a Ruth Chemers Neustein Postdoctoral Fellowship award, European Union Seventh Framework Programme Marie Curie Action (PCIG11-GA-2012-3221170, and the Immuno-Oncology LabEx (MAI). GMB is a scholar from the Pasteur-Paris University (PPU) International PhD program. GJR was supported by National Institutes of Health AI049653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,21,21,1,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005044,10.1371/journal.ppat.1005044,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200050,26182347.0,"DOAJ Gold, Green Published",,,16/08/2019,21,62,34,6873,1769,1443,326,5104,4218,24,862,34,0,0,1,21,21,0,,50,6,50,0,6,23,22,23,13,0,0,0,0,0,0,0,62,4,6922,98,0,108,164,2,5088,1769,98,0,108,164,2,65,,0,0,0,0,5,0,0,1,1,0,0,50,0,0,4.5,3.8852459016393444,1.3465909090909092,0.3465909090909091,1.4075235109717867,1.0452495271351665,4.061051441492369
494,J,"Naseem, S; Konopka, JB",,,,"Naseem, Shamoon; Konopka, James B.",,,N-acetylglucosamine Regulates Virulence Properties in Microbial Pathogens,PLOS PATHOGENS,,,English,Article,,,,,,,CANDIDA-ALBICANS; ESCHERICHIA-COLI; GLCNAC; GENE; INDUCTION; RESPONSES; IDENTIFICATION; GLCNACYLATION; TRANSCRIPTION; BIOSYNTHESIS,,"[Naseem, Shamoon; Konopka, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA","Naseem, S (reprint author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.",james.konopka@stonybrook.edu,,"Konopka, James/0000-0001-5989-4086","National Institutes of Health [R21DE025200, RO1AI47837]","Funding: Research in our lab is supported by grants from the National Institutes of Health awarded to James B. Konopka. http://www.nih.gov R21DE025200 RO1AI47837 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,36,8,8,0,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004947,10.1371/journal.ppat.1004947,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200010,26226264.0,"DOAJ Gold, Green Published",,,16/08/2019,8,1,21,5950,789,614,175,5161,4305,20,836,21,1,0,0,8,8,0,,32,0,32,0,0,9,8,9,6,0,0,0,0,0,0,0,0,0,6030,42,0,118,47,1,5207,805,15,0,118,40,1,18,,0,0,0,0,3,0,0,1,0,0,0,32,0,0,1.5,7.541191381495564,1.152877349350901,0.152877349350901,1.1856229412904475,1.0284033613445378,7.755386565272497
495,J,"Ogbechi, J; Ruf, MT; Hall, BS; Bodman-Smith, K; Vogel, M; Wu, HL; Stainer, A; Esmon, CT; Ahnstrom, J; Pluschke, G; Simmonds, RE",,,,"Ogbechi, Joy; Ruf, Marie-Therese; Hall, Belinda S.; Bodman-Smith, Katherine; Vogel, Moritz; Wu, Hua-Lin; Stainer, Alexander; Esmon, Charles T.; Ahnstroem, Josefin; Pluschke, Gerd; Simmonds, Rachel E.",,,Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions,PLOS PATHOGENS,,,English,Article,,,,,,,ACTIVATED PROTEIN-C; TUMOR-NECROSIS-FACTOR; HOST IMMUNE-RESPONSE; MYCOBACTERIUM-ULCERANS; ANTICOAGULANT PATHWAY; HUMAN KERATINOCYTES; CYTOKINE PRODUCTION; DISEASE; INFECTION; TOXIN,"A well-known histopathological feature of diseased skin in Buruli ulcer (BU) is coagulative necrosis caused by the Mycobacterium ulcerans macrolide exotoxin mycolactone. Since the underlying mechanism is not known, we have investigated the effect of mycolactone on endothelial cells, focussing on the expression of surface anticoagulant molecules involved in the protein C anticoagulant pathway. Congenital deficiencies in this natural anticoagulant pathway are known to induce thrombotic complications such as purpura fulimans and spontaneous necrosis. Mycolactone profoundly decreased thrombomodulin (TM) expression on the surface of human dermal microvascular endothelial cells (HDMVEC) at doses as low as 2ng/ml and as early as 8hrs after exposure. TM activates protein C by altering thrombin's substrate specificity, and exposure of HDMVEC to mycolactone for 24 hours resulted in an almost complete loss of the cells' ability to produce activated protein C. Loss of TM was shown to be due to a previously described mechanism involving mycolactone-dependent blockade of Sec61 translocation that results in proteasome-dependent degradation of newly synthesised ER-transiting proteins. Indeed, depletion from cells determined by live-cell imaging of cells stably expressing a recombinant TM-GFP fusion protein occurred at the known turnover rate. In order to determine the relevance of these findings to BU disease, immunohistochemistry of punch biopsies from 40 BU lesions (31 ulcers, nine plaques) was performed. TM abundance was profoundly reduced in the subcutis of 78% of biopsies. Furthermore, it was confirmed that fibrin deposition is a common feature of BU lesions, particularly in the necrotic areas. These findings indicate that there is decreased ability to control thrombin generation in BU skin. Mycolactone's effects on normal endothelial cell function, including its ability to activate the protein C anticoagulant pathway are strongly associated with this. Fibrin-driven tissue ischemia could contribute to the development of the tissue necrosis seen in BU lesions.","[Ogbechi, Joy; Hall, Belinda S.; Bodman-Smith, Katherine; Simmonds, Rachel E.] Univ Surrey, Dept Microbial & Cellular Sci, Sch Biosci & Med, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Ruf, Marie-Therese; Pluschke, Gerd] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Ruf, Marie-Therese; Pluschke, Gerd] Univ Basel, Basel, Switzerland; [Vogel, Moritz] Univ Heidelberg Hosp, Sect Clin Trop Med, Heidelberg, Germany; [Wu, Hua-Lin] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Stainer, Alexander] Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England; [Esmon, Charles T.] Oklahoma Med Res Fdn, Coagulat Biol Lab, Oklahoma City, OK 73104 USA; [Ahnstroem, Josefin] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ctr Haematol, London, England","Simmonds, RE (reprint author), Univ Surrey, Dept Microbial & Cellular Sci, Sch Biosci & Med, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.",rachel.simmonds@surrey.ac.uk,"Simmonds, Rachel E/M-7122-2016","Simmonds, Rachel E/0000-0003-4843-8266; Stainer, Alexander/0000-0002-7589-7292; Hall, Belinda/0000-0002-3753-1978",University of Surrey FHMS PhD Scholarship; Wellcome Trust [WTWT080114MA]; Infectious Disease Research Trust; Stop Buruli consortium by UBS Optimus Foundation; British Heart Foundation; British Heart Foundation [FS/12/60/29874],"Funding: This work was funded by a University of Surrey FHMS PhD Scholarship to JO, the Wellcome Trust (http://www.wellcome.ac.uk/ WTWT080114MA; RES/BSH), the Infectious Disease Research Trust (JO), the Stop Buruli consortium funded by the UBS Optimus Foundation (http://www.ubs.com/global/en/wealth_management/optimusfoundation.html MTR, GP) and the British Heart Foundation (http://www.bhf.org.uk/FS/12/60/29874; JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,18,19,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005011,10.1371/journal.ppat.1005011,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200030,26181660.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,15,10,17,3908,644,473,171,3264,2751,24,489,17,9,4,0,15,15,3,,22,0,22,0,0,18,15,18,10,0,0,0,0,0,0,0,1,0,3920,46,12,102,57,0,3256,644,46,12,102,57,0,20,,1,0,0,0,7,0,0,0,0,0,0,22,0,0,13.75,6.068322981366459,1.1973039215686274,0.19730392156862744,1.2325367647058822,1.0294268167860798,6.246894409937888
496,J,"Perlman, S",,,,"Perlman, Stanley",,,Research Driven by Curiosity: The Journey from Basic Molecular Biology and Virology to Studies of Human Pathogenic Coronaviruses,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"[Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Perlman, Stanley] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA","Perlman, S (reprint author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.",Stanley-Perlman@uiowa.edu,,"Perlman, Stanley/0000-0003-4213-2354",NIAID NIH HHS [P01 AI060699],,,0,1,1,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005023,10.1371/journal.ppat.1005023,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200037,26172373.0,"DOAJ Gold, Green Published",,,16/08/2019,1,88,2,8463,275,225,50,8188,7836,11,341,2,28,0,0,1,1,1,,2,12,2,0,12,1,1,0,1,0,0,1,0,0,1,2,65,5,8528,0,5,0,112,2,8185,275,0,5,0,112,2,68,,4,0,0,0,23,0,3,1,0,0,0,2,0,0,47.65,30.774545454545454,1.0335857352222766,0.0335857352222765,1.0552027357107963,1.0209145693016661,31.418181818181818
497,J,"Pickup, DJ",,,,"Pickup, David J.",,,Extracellular Virions: The Advance Guard of Poxvirus Infections,PLOS PATHOGENS,,,English,Article,,,,,,,ACTIN-BASED MOTILITY; VACCINIA VIRUS; COWPOX VIRUS; INFLAMMATORY RESPONSE; RABBITPOX VIRUS; ENVELOPED VIRUS; IN-VIVO; DISSEMINATION; INHIBITION; MEMBRANES,,"Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA","Pickup, DJ (reprint author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.",david.pickup@dm.duke.edu,,,NIH/NIAID [AI102747],"Funding: This work was supported by NIH/NIAID award AI102747 (http://www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,28,2,2,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004904,10.1371/journal.ppat.1004904,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200003,26135739.0,"DOAJ Gold, Green Published",,,16/08/2019,1,1,10,3150,616,530,86,2534,2104,17,413,10,1,0,0,1,1,0,,11,1,11,0,1,2,2,1,0,0,0,0,0,0,0,0,0,0,3160,7,4,34,51,1,2525,616,7,4,34,51,1,19,,0,0,0,0,0,0,2,0,0,0,0,11,0,0,0.5,5.113636363636363,1.2430939226519337,0.2430939226519337,1.2699289660615627,1.0215873015873016,5.224025974025974
498,J,"Pizzato, M; McCauley, SM; Neagu, MR; Pertel, T; Firrito, C; Ziglio, S; Dauphin, A; Zufferey, M; Berthoux, L; Luban, J",,,,"Pizzato, Massimo; McCauley, Sean Matthew; Neagu, Martha R.; Pertel, Thomas; Firrito, Claudia; Ziglio, Serena; Dauphin, Ann; Zufferey, Madeleine; Berthoux, Lionel; Luban, Jeremy",,,Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration,PLOS PATHOGENS,,,English,Article,,,,,,,SIMIAN IMMUNODEFICIENCY VIRUS; MURINE LEUKEMIA-VIRUS; HIV-1 INFECTION; CYCLOPHILIN-A; RETROVIRUS RESTRICTION; REVERSE TRANSCRIPTION; DENDRITIC CELLS; NUCLEAR IMPORT; OLD-WORLD; IN-VIVO,"HIV-2 and SIVMAC are AIDS-causing, zoonotic lentiviruses that jumped to humans and rhesus macaques, respectively, from SIVSM-bearing sooty mangabey monkeys. Cross-species transmission events such as these sometimes necessitate virus adaptation to species-specific, host restriction factors such as TRIM5. Here, a new human restriction activity is described that blocks viruses of the SIVSM/SIVMAC/HIV-2 lineage. Human T, B, and myeloid cell lines, peripheral blood mononuclear cells and dendritic cells were 4 to >100-fold less transducible by VSV G-pseudotyped SIVMAC, HIV-2, or SIVSM than by HIV-1. In contrast, transduction of six epithelial cell lines was equivalent to that by HIV-1. Substitution of HIV-1 CA with the SIVMAC or HIV-2 CA was sufficient to reduce HIV-1 transduction to the level of the respective vectors. Among such CA chimeras there was a general trend such that CAs from epidemic HIV-2 Group A and B isolates were the most infectious on human T cells, CA from a 1 degrees sooty mangabey isolate was the least infectious, and non-epidemic HIV-2 Group D, E, F, and G CAs were in the middle. The CA-specific decrease in infectivity was observed with either HIV-1, HIV-2, ecotropic MLV, or ALV Env pseudotypes, indicating that it was independent of the virus entry pathway. As2O3, a drug that suppresses TRIM5-mediated restriction, increased human blood cell transduction by SIVMAC but not by HIV-1. Nonetheless, elimination of TRIM5 restriction activity did not rescue SIVMAC transduction. Also, in contrast to TRIM5-mediated restriction, the SIVMAC CA-specific block occurred after completion of reverse transcription and the formation of 2-LTR circles, but before establishment of the provirus. Transduction efficiency in heterokaryons generated by fusing epithelial cells with T cells resembled that in the T cells, indicative of a dominant-acting SIVMAC restriction activity in the latter. These results suggest that the nucleus of human blood cells possesses a restriction factor specific for the CA of HIV-2/SIVMAC/SIVSM and that cross-species transmission of SIVSM to human T cells necessitated adaptation of HIV-2 to this putative restriction factor.","[Pizzato, Massimo; Neagu, Martha R.; Pertel, Thomas; Firrito, Claudia; Zufferey, Madeleine; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Pizzato, Massimo; Ziglio, Serena] Univ Trento, Ctr Integrat Biol, Trento, Italy; [McCauley, Sean Matthew; Dauphin, Ann; Luban, Jeremy] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Berthoux, Lionel] Univ Quebec Trois Rivieres, Lab Retrovirol, Trois Rivieres, PQ GA9 5H7, Canada","Pizzato, M (reprint author), Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland.",jeremy.luban@umassmed.edu,,"Pertel, Thomas/0000-0002-2286-6011; Luban, Jeremy/0000-0001-5650-4054","National Institute of Health [RO1AI59159, DP1DA034990]; Swiss National Science Foundation [3100A0-128655]; European Union Marie Curie Grant [237265]; European Union Career Integration Grant [322130]; Canadian Institutes for Health Research [102712]","This work was supported by the National Institute of Health (http://www.nih.gov/) grant RO1AI59159 to JL, National Institute of Health (http://www.nih.gov/) Grant DP1DA034990 to JL, and Swiss National Science Foundation (http://www.snf.ch) grant 3100A0-128655 to JL; European Union Marie Curie (http://ec.europa.eu/research/mariecurieactions/index_en.htm) Grant 237265 to MP and JL; European Union Career Integration (http://ec.europa.eu/research/mariecurieactions/index_en.htm) Grant 322130 to MP; and Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant 102712 to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,109,8,8,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005050,10.1371/journal.ppat.1005050,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200054,26181333.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,24,2890,555,440,115,2335,1920,17,398,24,0,0,0,8,8,0,,55,4,28,0,4,8,8,8,7,0,0,0,0,0,0,0,0,1,2954,69,0,84,267,0,2346,563,16,0,84,262,0,45,,0,0,0,0,1,0,0,1,0,0,0,28,0,0,1.25,5.207207207207207,1.2376873661670236,0.23768736616702354,1.4089935760171306,1.1384083044982698,5.927927927927928
499,J,"Pollitt, LC; Bram, JT; Blanford, S; Jones, MJ; Read, AF",,,,"Pollitt, Laura C.; Bram, Joshua T.; Blanford, Simon; Jones, Matthew J.; Read, Andrew F.",,,Existing Infection Facilitates Establishment and Density of Malaria Parasites in Their Mosquito Vector,PLOS PATHOGENS,,,English,Article,,,,,,,RESISTANT PLASMODIUM-FALCIPARUM; DRUG-RESISTANCE; POPULATION; EVOLUTION; TRANSMISSION; COMPETITION; BLOOD; MORTALITY; VIRULENCE; DYNAMICS,"Very little is known about how vector-borne pathogens interact within their vector and how this impacts transmission. Here we show that mosquitoes can accumulate mixed strain malaria infections after feeding on multiple hosts. We found that parasites have a greater chance of establishing and reach higher densities if another strain is already present in a mosquito. Mixed infections contained more parasites but these larger populations did not have a detectable impact on vector survival. Together these results suggest that mosquitoes taking multiple infective bites may disproportionally contribute to malaria transmission. This will increase rates of mixed infections in vertebrate hosts, with implications for the evolution of parasite virulence and the spread of drug-resistant strains. Moreover, control measures that reduce parasite prevalence in vertebrate hosts will reduce the likelihood of mosquitoes taking multiple infective feeds, and thus disproportionally reduce transmission. More generally, our study shows that the types of strain interactions detected in vertebrate hosts cannot necessarily be extrapolated to vectors.","[Pollitt, Laura C.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Pollitt, Laura C.; Bram, Joshua T.; Blanford, Simon; Jones, Matthew J.; Read, Andrew F.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, State Coll, PA USA; [Pollitt, Laura C.; Bram, Joshua T.; Blanford, Simon; Jones, Matthew J.; Read, Andrew F.] Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, State Coll, PA USA; [Read, Andrew F.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA","Pollitt, LC (reprint author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.",laura.pollitt@gmail.com,,,"Institute of General Medical Science of the National Institutes of Health [R01 GM089932]; Wellcome Trust Centre for Infection, Immunology and Evolution at the University of Edinburgh; Eberly College of Science Undergraduate Research Grant from Pennsylvania State University","Funding: This study was funded by the Institute of General Medical Science (R01 GM089932 to AFR) of the National Institutes of Health. LCP was also supported by a fellowship from the Wellcome Trust Centre for Infection, Immunology and Evolution at the University of Edinburgh. JTB was supported by an Eberly College of Science Undergraduate Research Grant from the Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.",,59,10,10,0,25,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005003,10.1371/journal.ppat.1005003,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200027,26181518.0,"DOAJ Gold, Green Published",,,16/08/2019,10,34,55,6226,366,263,103,5860,4985,47,828,55,29,0,0,10,10,7,,72,9,64,0,9,12,10,12,8,0,0,0,0,0,0,2,5,5,6268,179,68,289,236,2,5854,366,179,68,289,236,2,48,,6,4,0,0,36,0,4,1,0,0,0,63,0,0,90.806,17.010928961748633,1.062457337883959,0.062457337883959047,1.1404436860068259,1.0734018631545132,18.259562841530055
500,J,"Rausch, P; Steck, N; Suwandi, A; Seidel, JA; Kunzel, S; Bhullar, K; Basic, M; Bleich, A; Johnsen, JM; Vallance, BA; Baines, JF; Grassl, GA",,,,"Rausch, Philipp; Steck, Natalie; Suwandi, Abdulhadi; Seidel, Janice A.; Kuenzel, Sven; Bhullar, Kirandeep; Basic, Marijana; Bleich, Andre; Johnsen, Jill M.; Vallance, Bruce A.; Baines, John F.; Grassl, Guntram A.",,,Expression of the Blood-Group-Related Gene B4galnt2 Alters Susceptibility to Salmonella Infection,PLOS PATHOGENS,,,English,Article,,,,,,,ENTERICA SEROTYPE TYPHIMURIUM; VON-WILLEBRAND-FACTOR; HUMAN GUT MICROBIOTA; GLYCOSYLTRANSFERASE B4GALNT2; PHYLOGENETIC DIVERSITY; CARBOHYDRATE ANTIGEN; ECOSYSTEM STABILITY; HELICOBACTER-PYLORI; COMMUNITY ECOLOGY; SPECIES RICHNESS,"Glycans play important roles in host-microbe interactions. Tissue-specific expression patterns of the blood group glycosyltransferase beta-1,4-N-acetylgalactosaminyltransferase 2 (B4galnt2) are variable in wild mouse populations, and loss of B4galnt2 expression is associated with altered intestinal microbiota. We hypothesized that variation in B4galnt2 expression alters susceptibility to intestinal pathogens. To test this, we challenged mice genetically engineered to express different B4galnt2 tissue-specific patterns with a Salmonella Typhimurium infection model. We found B4galnt2 intestinal expression was strongly associated with bacterial community composition and increased Salmonella susceptibility as evidenced by increased intestinal inflammatory cytokines and infiltrating immune cells. Fecal transfer experiments demonstrated a crucial role of the B4galnt2-dependent microbiota in conferring susceptibility to intestinal inflammation, while epithelial B4galnt2 expression facilitated epithelial invasion of S. Typhimurium. These data support a critical role for B4galnt2 in gastrointestinal infections. We speculate that B4galnt2-specific differences in host susceptibility to intestinal pathogens underlie the strong signatures of balancing selection observed at the B4galnt2 locus in wild mouse populations.","[Rausch, Philipp; Steck, Natalie; Suwandi, Abdulhadi; Seidel, Janice A.; Baines, John F.; Grassl, Guntram A.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Rausch, Philipp; Kuenzel, Sven; Baines, John F.] Max Planck Inst Evolutionary Biol, Plon, Germany; [Steck, Natalie; Grassl, Guntram A.] Res Ctr Borstel, Models Inflammat, Borstel, Germany; [Bhullar, Kirandeep; Vallance, Bruce A.] Univ British Columbia, Dept Pediat, Div Gastroenterol, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Basic, Marijana; Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Johnsen, Jill M.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Johnsen, Jill M.] Univ Washington, Dept Med, Seattle, WA USA","Baines, JF (reprint author), Univ Kiel, Inst Expt Med, Kiel, Germany.",baines@evolbio.mpg.de; grassl.guntram@mh-hannover.de,"Baines, John/B-3580-2010; Rausch, Philipp/J-4258-2017","Baines, John/0000-0002-8132-4909; Rausch, Philipp/0000-0003-3133-5674","Vanier Canada Graduate Scholarship; Canadian Institutes of Health Research; Crohn's and Colitis Canada; Puget Sound Blood Center; German Research Foundation [SPP 1656, GR 2666/5-1, BA 2863/5-1]; German Research Foundation Excellence Cluster ""Inflammation at Interfaces"" [EXC306]","Funding: KB was funded by Vanier Canada Graduate Scholarship (http://www.vanier.gc.ca/) while BAV is the Children with Intestinal and Liver Disorders (CHILD) Foundation (http://www.child.ca/) Research Chair in Pediatric Gastroenterology. This work was supported by operating grants to BAV from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/), and Crohn's and Colitis Canada (http://www.crohnsandcolitis.ca). This work was also supported by the Puget Sound Blood Center to JMJ and by the German Research Foundation (http://www.dfg.de) Priority Program SPP 1656 grant numbers GR 2666/5-1 to GAG and BA 2863/5-1 to JFB and by the German Research Foundation Excellence Cluster ""Inflammation at Interfaces"" EXC306 to JFB and GAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,117,12,12,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005008,10.1371/journal.ppat.1005008,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200029,26133982.0,"DOAJ Gold, Green Published",,,16/08/2019,14,59,27,4545,626,471,155,3919,2603,50,1266,27,1,0,0,12,12,0,,36,0,36,0,0,15,15,14,8,0,0,0,0,0,0,0,58,0,4644,103,0,117,328,1,3956,654,103,0,117,328,1,34,,0,0,0,0,3,0,0,0,0,0,0,39,0,0,1.5,7.26038338658147,1.159734626180148,0.159734626180148,1.2949732074508804,1.1166116611661165,8.10702875399361
501,J,"Richner, JM; Gmyrek, GB; Govero, J; Tu, YZ; van der Windt, GJW; Metcalf, TU; Haddad, EK; Textor, J; Miller, MJ; Diamond, MS",,,,"Richner, Justin M.; Gmyrek, Grzegorz B.; Govero, Jennifer; Tu, Yizheng; van der Windt, Gerritje J. W.; Metcalf, Talibah U.; Haddad, Elias K.; Textor, Johannes; Miller, Mark J.; Diamond, Michael S.",,,Age-Dependent Cell Trafficking Defects in Draining Lymph Nodes Impair Adaptive Immunity and Control of West Nile Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,CD4 T-CELLS; CENTRAL-NERVOUS-SYSTEM; MEMORY B-CELLS; ALPHA/BETA-INTERFERON; COMPLEMENT ACTIVATION; 2-PHOTON MICROSCOPY; HELPER FUNCTION; MICE; RESPONSES; ANTIBODY,"Impaired immune responses in the elderly lead to reduced vaccine efficacy and increased susceptibility to viral infections. Although several groups have documented age-dependent defects in adaptive immune priming, the deficits that occur prior to antigen encounter remain largely unexplored. Herein, we identify novel mechanisms for compromised adaptive immunity that occurs with aging in the context of infection with West Nile virus (WNV), an encephalitic flavivirus that preferentially causes disease in the elderly. An impaired IgM and IgG response and enhanced vulnerability to WNV infection during aging was linked to delayed germinal center formation in the draining lymph node (DLN). Adoptive transfer studies and two-photon intravital microscopy revealed a decreased trafficking capacity of donor naive CD4(+) T cells from old mice, which manifested as impaired T cell diapedesis at high endothelial venules and reduced cell motility within DLN prior to antigen encounter. Furthermore, leukocyte accumulation in the DLN within the first few days of WNV infection or antigen-adjuvant administration was diminished more generally in old mice and associated with a second aging-related defect in local cytokine and chemokine production. Thus, age-dependent cell-intrinsic and environmental defects in the DLN result in delayed immune cell recruitment and antigen recognition. These deficits compromise priming of early adaptive immune responses and likely contribute to the susceptibility of old animals to acute WNV infection.","[Richner, Justin M.; Gmyrek, Grzegorz B.; Govero, Jennifer; Tu, Yizheng; Miller, Mark J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [van der Windt, Gerritje J. W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Metcalf, Talibah U.; Haddad, Elias K.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Textor, Johannes] Univ Utrecht, Dept Theoret Biol & Bioinformat, Utrecht, Netherlands; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA","Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.",diamond@borcim.wustl.edu,"Textor, Johannes/E-1792-2016","Textor, Johannes/0000-0002-0459-9458","NIH [HHSN272201100017C, R01-AI091965, R01-AI07760, F32-AG043223]; Netherlands Organisation for Scientific Research (NWO) [823.02.014]","This work was supported by NIH contracts and grants (HHSN272201100017C, R01-AI091965, and R01-AI07760 to MSD) and a F32 post-doctoral fellowship (F32-AG043223 to JMR). JT was supported by grant nr. 823.02.014 (to Can Kesmir) from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,24,24,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005027,10.1371/journal.ppat.1005027,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200041,26204259.0,"DOAJ Gold, Green Published",,,16/08/2019,26,8,26,5785,808,602,206,4977,4335,21,621,26,5,4,1,27,27,1,,36,2,36,0,2,27,27,24,21,0,0,0,0,0,0,2,3,3,5808,106,76,99,208,2,4954,808,72,76,99,198,2,46,,5,0,0,0,33,0,1,1,1,0,0,36,0,0,59.9,7.159653465346534,1.1623467952581876,0.16234679525818765,1.2300582680329515,1.0582541054451167,7.576732673267327
502,J,"Rosato, PC; Leib, DA",,,,"Rosato, Pamela C.; Leib, David A.",,,Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis,PLOS PATHOGENS,,,English,Article,,,,,,,SUPERFICIAL DORSAL-HORN; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; PERIOCULAR DISEASE; ZOSTERIFORM SPREAD; ANTIVIRAL ACTIVITY; TLR3 DEFICIENCY; SENSORY NEURONS; INFECTION; TYPE-1,"Interferon (IFN) responses are critical for controlling herpes simplex virus 1 (HSV-1). The importance of neuronal IFN signaling in controlling acute and latent HSV-1 infection remains unclear. Compartmentalized neuron cultures revealed that mature sensory neurons respond to IFN beta at both the axon and cell body through distinct mechanisms, resulting in control of HSV-1. Mice specifically lacking neural IFN signaling succumbed rapidly to HSV-1 corneal infection, demonstrating that IFN responses of the immune system and non-neuronal tissues are insufficient to confer survival following virus challenge. Furthermore, neurovirulence was restored to an HSV strain lacking the IFN-modulating gene, gamma 34.5, despite its expected attenuation in peripheral tissues. These studies define a crucial role for neuronal IFN signaling for protection against HSV-1 pathogenesis and replication, and they provide a novel framework to enhance our understanding of the interface between host innate immunity and neurotropic pathogens.","[Rosato, Pamela C.; Leib, David A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA","Leib, DA (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.",david.a.leib@dartmouth.edu,,,National Institutes of Health; National Center for Research Resources [P30RR016437]; Geisel School of Medicine Microbiology and Molecular Pathogenesis Program Training Grant [5T32AI007519];  [RO1 EY09083];  [PO1 AI098681],"This study was supported by National Institutes of Health grant to DAL. (RO1 EY09083, and project 3 of PO1 AI098681 (Don Coen PI)). The project was also supported by P30RR016437 from the National Center for Research Resources to Dartmouth. Training Grant support from the Geisel School of Medicine Microbiology and Molecular Pathogenesis Program Training Grant (5T32AI007519) to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,72,34,34,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005028,10.1371/journal.ppat.1005028,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200042,26153886.0,"DOAJ Gold, Green Published",,,16/08/2019,35,2,28,7035,1260,963,297,5775,4893,25,857,28,0,0,0,33,33,0,,48,4,48,0,4,36,36,35,27,0,0,0,0,0,0,0,2,1,7057,35,0,69,117,0,5762,1260,35,0,69,117,0,35,,0,0,0,0,2,0,1,0,0,0,0,48,0,0,0.75,5.583333333333333,1.2181818181818183,0.21818181818181817,1.2483116883116883,1.0247334754797441,5.7214285714285715
503,J,"Ryan, RP; An, SQ; Allan, JH; McCarthy, Y; Dow, JM",,,,"Ryan, Robert P.; An, Shi-qi; Allan, John H.; McCarthy, Yvonne; Dow, J. Maxwell",,,The DSF Family of Cell-Cell Signals: An Expanding Class of Bacterial Virulence Regulators,PLOS PATHOGENS,,,English,Review,,,,,,,QUORUM-SENSING SIGNAL; CYCLIC DI-GMP; GYP DOMAIN PROTEIN; XANTHOMONAS-CAMPESTRIS; XYLELLA-FASTIDIOSA; FATTY-ACID; PSEUDOMONAS-AERUGINOSA; CIS-2-DECENOIC ACID; GENE-EXPRESSION; SYSTEM,"Many pathogenic bacteria use cell-cell signaling systems involving the synthesis and perception of diffusible signal molecules to control virulence as a response to cell density or confinement to niches. Bacteria produce signals of diverse structural classes. Signal molecules of the diffusible signal factor (DSF) family are cis-2-unsaturated fatty acids. The paradigm is cis-11-methyl-2-dodecenoic acid from Xanthomonas campestris pv. campestris (Xcc), which controls virulence in this plant pathogen. Although DSF synthesis was thought to be restricted to the xanthomonads, it is now known that structurally related molecules are produced by the unrelated bacteria Burkholderia cenocepacia and Pseudomonas aeruginosa. Furthermore, signaling involving these DSF family members contributes to bacterial virulence, formation of biofilms and antibiotic tolerance in these important human pathogens. Here we review the recent advances in understanding DSF signaling and its regulatory role in different bacteria. These advances include the description of the pathway/mechanism of DSF biosynthesis, identification of novel DSF synthases and new members of the DSF family, the demonstration of a diversity of DSF sensors to include proteins with a Per-Arnt-Sim (PAS) domain and the description of some of the signal transduction mechanisms that impinge on virulence factor expression. In addition, we address the role of DSF family signals in interspecies signaling that modulates the behavior of other microorganisms. Finally, we consider a number of recently reported approaches for the control of bacterial virulence through the modulation of DSF signaling.","[Ryan, Robert P.; An, Shi-qi; Allan, John H.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland; [McCarthy, Yvonne; Dow, J. Maxwell] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Sch Microbiol, Cork, Ireland","Ryan, RP (reprint author), Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland.",rpryan@dundee.ac.uk; m.dow@ucc.ie,,"An, Shi-qi/0000-0002-2593-9642; Ryan, Rober/0000-0002-7353-0913",Wellcome Trust [WT100204AIA]; European Union [603038],"Funding: The work of the authors has been supported in part by grants awarded by the Wellcome Trust (WT100204AIA senior fellowship grant to RPR) and the European Union's Seventh Framework Programme (Grant No. 603038 to RPR and JMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,51,54,1,47,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004986,10.1371/journal.ppat.1004986,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200021,26181439.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,56,0,84,7502,1568,1071,497,5934,4344,25,1565,84,0,0,0,51,51,0,,107,6,107,0,6,65,59,65,30,0,0,0,0,0,0,0,0,0,7521,33,12,686,89,1,5909,1568,33,12,686,89,1,44,,0,0,0,0,2,0,0,1,0,0,0,105,0,0,2.1,4.784438775510204,1.2642399730367375,0.26423997303673746,1.2880013481631278,1.0187949880031992,4.874362244897959
504,J,"Sakowski, ET; Koster, S; Celhay, CP; Park, HS; Shrestha, E; Hetzenecker, SE; Maurer, K; Cadwell, K; Philips, JA",,,,"Sakowski, Erik T.; Koster, Stefan; Celhay, Cynthia Portal; Park, Heidi S.; Shrestha, Elina; Hetzenecker, Stefanie E.; Maurer, Katie; Cadwell, Ken; Philips, Jennifer A.",,,Ubiquilin 1 Promotes IFN-gamma- Induced Xenophagy of Mycobacterium tuberculosis,PLOS PATHOGENS,,,English,Article,,,,,,,AUTOPHAGY; PROTEINS; UBIQUITINATION; DEGRADATION; PROTEASOME; PROTECTS; SURVIVAL; BACTERIA; BCG,"The success of Mycobacterium tuberculosis (Mtb) as a pathogen rests upon its ability to grow intracellularly in macrophages. Interferon-gamma (IFN-gamma) is critical in host defense against Mtb and stimulates macrophage clearance of Mtb through an autophagy pathway. Here we show that the host protein ubiquilin 1 (UBQLN1) promotes IFN-gamma-mediated autophagic clearance of Mtb. Ubiquilin family members have previously been shown to recognize proteins that aggregate in neurodegenerative disorders. We find that UBQLN1 can interact with Mtb surface proteins and associates with the bacilli in vitro. In IFN-gamma activated macrophages, UBQLN1 co-localizes with Mtb and promotes the anti-mycobacterial activity of IFN-gamma. The association of UBQLN1 with Mtb depends upon the secreted bacterial protein, EsxA, which is involved in permeabilizing host phagosomes. In autophagy-deficient macrophages, UBQLN1 accumulates around Mtb, consistent with the idea that it marks bacilli that traffic through the autophagy pathway. Moreover, UBQLN1 promotes ubiquitin, p62, and LC3 accumulation around Mtb, acting independently of the E3 ligase parkin. In summary, we propose a model in which UBQLN1 recognizes Mtb and in turn recruits the autophagy machinery thereby promoting intracellular control of Mtb. Thus, polymorphisms in ubiquilins, which are known to influence susceptibility to neurodegenerative illnesses, might also play a role in host defense against Mtb.","[Sakowski, Erik T.; Koster, Stefan; Celhay, Cynthia Portal; Park, Heidi S.; Hetzenecker, Stefanie E.; Philips, Jennifer A.] NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10003 USA; [Shrestha, Elina; Cadwell, Ken; Philips, Jennifer A.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Maurer, Katie; Cadwell, Ken] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr Biol & Med, New York, NY USA; [Philips, Jennifer A.] NYU, Sch Med, Dept Pathol, New York, NY USA","Sakowski, ET (reprint author), NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10003 USA.",jphilips@dom.wustl.edu,,"Cadwell, Ken/0000-0002-5860-0661","National Institute of Health (NIH) [R21 AI105298, R01 AI087682, R01 DK093668, T32 GM0738, AI100853, F30 DK098925]; Edward Mallinckrodt, Jr. Foundation; Doris Duke Charitable Foundation; NYU School of Medicine; New York University Physician-Scientist Training Program; American Heart Association [12GRNT12030041]","Funding was provided by the National Institute of Health (NIH) R21 AI105298 and R01 AI087682 to JAP, R01 DK093668 to KC, Training Grant T32 GM0738, AI100853, and F30 DK098925 to KM. In addition, the Edward Mallinckrodt, Jr. Foundation (JAP), Doris Duke Charitable Foundation (JAP), NYU School of Medicine (JAP), New York University Physician-Scientist Training Program (CPC), and the American Heart Association 12GRNT12030041 (KC) provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,31,33,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005076,10.1371/journal.ppat.1005076,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200070,26225865.0,"DOAJ Gold, Green Published",,,16/08/2019,29,0,13,5554,1015,673,342,4539,3523,23,993,13,0,0,0,29,29,0,,59,0,57,0,0,32,32,23,27,0,0,0,0,0,0,0,0,0,5574,335,0,84,98,0,4532,1015,335,0,84,98,0,27,,0,0,0,0,2,0,0,0,0,0,0,57,0,0,0.5,5.471921182266009,1.2236175369024014,0.2236175369024014,1.3234192553425865,1.0815628375945265,5.918226600985221
505,J,"Salmela, H; Amdam, GV; Freitak, D",,,,"Salmela, Heli; Amdam, Gro V.; Freitak, Dalial",,,Transfer of Immunity from Mother to Offspring Is Mediated via Egg-Yolk Protein Vitellogenin,PLOS PATHOGENS,,,English,Article,,,,,,,HONEY-BEE; EVOLUTION; PARASITES; BINDING; DAMAGE,"Insect immune systems can recognize specific pathogens and prime offspring immunity. High specificity of immune priming can be achieved when insect females transfer immune elicitors into developing oocytes. The molecular mechanism behind this transfer has been a mystery. Here, we establish that the egg-yolk protein vitellogenin is the carrier of immune elicitors. Using the honey bee, Apis mellifera, model system, we demonstrate with microscopy and western blotting that vitellogenin binds to bacteria, both Paenibacillus larvae - the gram-positive bacterium causing American foulbrood disease - and to Escherichia coli that represents gram-negative bacteria. Next, we verify that vitellogenin binds to pathogen-associated molecular patterns; lipopolysaccharide, peptidoglycan and zymosan, using surface plasmon resonance. We document that vitellogenin is required for transport of cell-wall pieces of E. coli into eggs by imaging tissue sections. These experiments identify vitellogenin, which is distributed widely in oviparous species, as the carrier of immune-priming signals. This work reveals a molecular explanation for trans-generational immunity in insects and a previously undescribed role for vitellogenin.","[Salmela, Heli; Freitak, Dalial] Univ Helsinki, Ctr Excellence Biol Interact, Helsinki, Finland; [Salmela, Heli; Freitak, Dalial] Univ Jyvaskyla, Jyvaskyla, Finland; [Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway","Freitak, D (reprint author), Univ Helsinki, Ctr Excellence Biol Interact, Helsinki, Finland.",dalial.freitak@helsinki.fi,,"Salmela, Heli/0000-0002-6917-2922; Freitak, Dalial/0000-0001-8574-0531","Academy of Finland [265971, 251337, 252411]; Norwegian Research Council [180504, 191699]; University of Helsinki","Funding: HS was funded by Academy of Finland grant number 265971. www.aka.fi/en-GB/A/ GVA was funded by Norwegian Research Council grant number 180504 and 191699. www.forskningsradet.no/en/Home_page/1177315753906 DF was funded by Academy of Finland grant number 251337 and 252411. HS and DF were also supported by University of Helsinki www.helsinki.fi/university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,64,66,10,151,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005015,10.1371/journal.ppat.1005015,,,,12,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200032,26230630.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,66,169,157,20077,1260,955,305,18817,15707,73,3037,157,81,0,2,65,65,26,,190,4,190,0,4,73,70,73,30,1,0,0,1,0,0,5,176,7,20238,105,0,105,145,6,18889,1276,105,0,105,145,6,73,,19,3,0,0,67,0,13,1,1,0,1,192,0,0,200.874,15.934126984126983,1.0669607270021788,0.06696072700217888,1.08880267842908,1.0204711859341535,16.26031746031746
506,J,"Sanchez, EL; Carroll, PA; Thalhofer, AB; Lagunoff, M",,,,"Sanchez, Erica L.; Carroll, Patrick A.; Thalhofer, Angel B.; Lagunoff, Michael",,,Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; FATTY-ACID SYNTHESIS; KAPOSIS-SARCOMA; CANCER; MYC; METABOLISM; ACTIVATION; MAINTENANCE; INDUCTION; WARBURG,"Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS). KSHV establishes a predominantly latent infection in the main KS tumor cell type, the spindle cell, which is of endothelial cell origin. KSHV requires the induction of multiple metabolic pathways, including glycolysis and fatty acid synthesis, for the survival of latently infected endothelial cells. Here we demonstrate that latent KSHV infection leads to increased levels of intracellular glutamine and enhanced glutamine uptake. Depletion of glutamine from the culture media leads to a significant increase in apoptotic cell death in latently infected endothelial cells, but not in their mock-infected counterparts. In cancer cells, glutamine is often required for glutaminolysis to provide intermediates for the tri-carboxylic acid (TCA) cycle and support for the production of biosynthetic and bioenergetic precursors. In the absence of glutamine, the TCA cycle intermediates alpha-ketoglutarate (alpha KG) and pyruvate prevent the death of latently infected cells. Targeted drug inhibition of glutaminolysis also induces increased cell death in latently infected cells. KSHV infection of endothelial cells induces protein expression of the glutamine transporter, SLC1A5. Chemical inhibition of SLC1A5, or knockdown by siRNA, leads to similar cell death rates as glutamine deprivation and, similarly, can be rescued by alpha KG. KSHV also induces expression of the heterodimeric transcription factors c-Myc-Max and related heterodimer MondoA-Mlx. Knockdown of MondoA inhibits expression of both Mlx and SLC1A5 and induces a significant increase in cell death of only cells latently infected with KSHV, again, fully rescued by the supplementation of alpha KG. Therefore, during latent infection of endothelial cells, KSHV activates and requires the Myc/MondoA-network to upregulate the glutamine transporter, SLC1A5, leading to increased glutamine uptake for glutaminolysis. These findings expand our understanding of the required metabolic pathways that are activated during latent KSHV infection of endothelial cells, and demonstrate a novel role for the extended Myc-regulatory network, specifically MondoA, during latent KSHV infection.","[Sanchez, Erica L.; Lagunoff, Michael] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Sanchez, Erica L.; Thalhofer, Angel B.; Lagunoff, Michael] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Carroll, Patrick A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA","Sanchez, EL (reprint author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.",lagunoff@u.washington.edu,,"Carroll, Patrick/0000-0001-8147-5750","National Cancer Institute [RO1CA189986]; National Dental and Craniofacial Institute [PO1DE02195]; National Science Foundation [DGE-0718124, DGE-1256082]; NCI/NIH [RO1CA57138]; NIH PREP [R25GM086304-02]","Research for this publication was supported by grants to ML from the National Cancer Institute (RO1CA189986) and the National Dental and Craniofacial Institute (PO1DE02195). ELS was supported by a National Science Foundation graduate research fellowship (DGE-0718124 and DGE-1256082). PAC was supported by NCI/NIH grant (RO1CA57138). ABT was supported by NIH PREP (R25GM086304-02). The content of this report is solely our responsibility and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,36,31,33,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005052,10.1371/journal.ppat.1005052,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200056,26197457.0,"DOAJ Gold, Green Published",,,16/08/2019,35,4,40,5030,822,598,224,4208,3507,25,676,40,3,0,0,32,32,0,,45,0,45,0,0,35,35,21,20,0,0,0,0,0,0,0,1,0,5071,13,0,77,54,0,4233,830,13,0,77,54,0,8,,0,0,0,0,3,0,1,0,0,0,0,46,0,0,1.0,6.119221411192214,1.195342205323194,0.1953422053231939,1.2210076045627376,1.0214711729622266,6.250608272506082
507,J,"Schulfer, A; Blaser, MJ",,,,"Schulfer, Anjelique; Blaser, Martin J.",,,Risks of Antibiotic Exposures Early in Life on the Developing Microbiome,PLOS PATHOGENS,,,English,Article,,,,,,,GUT MICROBIOTA; IMPACTS,,"[Schulfer, Anjelique; Blaser, Martin J.] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Schulfer, Anjelique; Blaser, Martin J.] NYU, Langone Med Ctr, Dept Microbiol, New York, NY USA; [Blaser, Martin J.] VA Med Ctr, New York, NY USA; [Blaser, Martin J.] NYU, Dept Biol, New York, NY USA","Schulfer, A (reprint author), NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA.",martin.blaser@nyumc.org,,,"National Institutes of Health, Diane Belfer Program for Human Microbial Ecology [R01 DK090989, R01 AI 63270, T32-AI007180]; Ziff Family Fund","Funding: This work was supported in part by: R01 DK090989, R01 AI 63270, and T32-AI007180 from the National Institutes of Health, Diane Belfer Program for Human Microbial Ecology, and the Ziff Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,24,33,35,0,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004903,10.1371/journal.ppat.1004903,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200002,26135581.0,"DOAJ Gold, Green Published",,,16/08/2019,33,80,130,26117,16638,15774,864,9479,7518,30,1931,130,70,1,0,32,32,1,,336,55,168,0,55,36,35,36,24,0,0,0,0,0,0,0,54,11,26853,15,1,50,264,16,9531,17105,15,1,50,264,16,217,,0,1,0,0,83,0,7,0,0,0,0,168,0,0,58.85,1.5697199182594062,2.7552484439286844,1.7552484439286844,2.862327249709885,1.0388635754489413,1.6307248467363866
508,J,"Sloan, E; Tatham, MH; Groslambert, M; Glass, M; Orr, A; Hay, RT; Everett, RD",,,,"Sloan, Elizabeth; Tatham, Michael H.; Groslambert, Marine; Glass, Mandy; Orr, Anne; Hay, Ronald T.; Everett, Roger D.",,,Analysis of the SUMO2 Proteome during HSV-1 Infection,PLOS PATHOGENS,,,English,Article,,,,,,,HERPES-SIMPLEX-VIRUS; LEUKEMIA NUCLEAR-BODIES; IMMEDIATE-EARLY PROTEIN; UBIQUITIN LIGASE ICP0; TRANSCRIPTIONAL REGULATION; INTERACTION DOMAIN; POSTTRANSLATIONAL MODIFICATION; REPRESSES TRANSCRIPTION; SUMOYLATION SYSTEM; REGULATORY PROTEIN,"Covalent linkage to members of the small ubiquitin-like (SUMO) family of proteins is an important mechanism by which the functions of many cellular proteins are regulated. Sumoylation has roles in the control of protein stability, activity and localization, and is involved in the regulation of transcription, gene expression, chromatin structure, nuclear transport and RNA metabolism. Sumoylation is also linked, both positively and negatively, with the replication of many different viruses both in terms of modification of viral proteins and modulation of sumoylated cellular proteins that influence the efficiency of infection. One prominent example of the latter is the widespread reduction in the levels of cellular sumoylated species induced by herpes simplex virus type 1 (HSV-1) ubiquitin ligase ICP0. This activity correlates with relief from intrinsic immunity antiviral defence mechanisms. Previous work has shown that ICP0 is selective in substrate choice, with some sumoylated proteins such the promyelocytic leukemia protein PML being extremely sensitive, while RanGAP is completely resistant. Here we present a comprehensive proteomic analysis of changes in the cellular SUMO2 proteome during HSV-1 infection. Amongst the 877 potentially sumoylated species detected, we identified 124 whose abundance was decreased by a factor of 3 or more by the virus, several of which were validated by western blot and expression analysis. We found many previously undescribed substrates of ICP0 whose degradation occurs by a range of mechanisms, influenced or not by sumoylation and/or the SUMO2 interaction motif within ICP0. Many of these proteins are known or are predicted to be involved in the regulation of transcription, chromatin assembly or modification. These results present novel insights into mechanisms and host cell proteins that might influence the efficiency of HSV-1 infection.","[Sloan, Elizabeth; Groslambert, Marine; Glass, Mandy; Orr, Anne; Everett, Roger D.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Tatham, Michael H.; Hay, Ronald T.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland","Sloan, E (reprint author), Univ Glasgow, MRC, Ctr Virus Res, Sir Michael Stoker Bldg,Garscube Campus, Glasgow, Lanark, Scotland.",roger.everett@glasgow.ac.uk,"Glass, Mandy/L-8807-2015; Tatham, Michael/E-9622-2010; Hay, Ronald T/F-9338-2011; Hay, Ronald/S-3233-2019","Glass, Mandy/0000-0002-4601-9079; Tatham, Michael/0000-0001-6986-1691; Hay, Ronald T/0000-0001-7113-9024; Hay, Ronald/0000-0001-7113-9024; Sloan, Elizabeth/0000-0002-4702-1699; Groslambert, Marine/0000-0003-3258-0268","Medical Research Council [MC_U130169966, MC_UU_12014/4]; MRC Centenary Fund; Cancer Research UK [C434/A13067]; Wellcome Trust [098391/Z/12/Z]; ENS Lyon; Cancer Research UK [13067]; Medical Research Council [MC_UU_12014/4]; Medical Research Foundation [MRF-149-0001-RG-GLASS]","The work in the laboratory of RDE is funded by the Medical Research Council (mrc.ac.uk) (Projects MC_U130169966 and MC_UU_12014/4, with additional support to ES from the MRC Centenary Fund). M.H.T. is funded through a Cancer Research UK programme grant (C434/A13067) (cancerresearch.org). R.T.H. holds a Wellcome Trust Senior Investigator Award (098391/Z/12/Z) (wellcome.ac.uk). MGr was supported by an internship from ENS Lyon (ens-lyon.eu) during her project work towards a Master's degree. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,104,23,25,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005059,10.1371/journal.ppat.1005059,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200061,26200910.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,21,1,19,6016,1455,866,589,4561,3529,79,953,19,0,0,2,22,22,0,,31,0,31,0,0,21,21,10,15,0,0,0,0,0,0,0,1,2,6095,97,0,90,72,1,4586,1477,97,0,90,72,1,32,,0,0,0,0,6,0,2,1,1,0,0,31,0,0,4.0,4.134707903780069,1.319008989256742,0.3190089892567419,1.3733830300372725,1.0412234042553192,4.3051546391752575
509,J,"Stevenson, L; Laursen, E; Cowan, GJ; Bandoh, B; Barfod, L; Cavanagh, DR; Andersen, GR; Hviid, L",,,,"Stevenson, Liz; Laursen, Erik; Cowan, Graeme J.; Bandoh, Betty; Barfod, Lea; Cavanagh, David R.; Andersen, Gregers R.; Hviid, Lars",,,alpha(2)-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized Erythrocytes,PLOS PATHOGENS,,,English,Article,,,,,,,GROUP-G STREPTOCOCCI; INFECTED ERYTHROCYTES; MALARIA PARASITE; IN-VITRO; HUMAN ALPHA-2-MACROGLOBULIN; ENDOTHELIAL-CELLS; ROSETTE FORMATION; COMPLEX-FORMATION; AFRICAN CHILDREN; CEREBRAL MALARIA,"Rosetting, the adhesion of Plasmodium falciparum-infected erythrocytes to uninfected erythrocytes, involves clonal variants of the parasite protein P. falciparum erythrocyte membrane protein 1 (PfEMP1) and soluble serum factors. While rosetting is a well-known phenotypic marker of parasites associated with severe malaria, the reason for this association remains unclear, as do the molecular details of the interaction between the infected erythrocyte (IE) and the adhering erythrocytes. Here, we identify for the first time a single serum factor, the abundant serum protease inhibitor alpha(2)-macroglobulin (alpha M-2), which is both required and sufficient for rosetting mediated by the PfEMP1 protein HB3VAR06 and some other rosette-mediating PfEMP1 proteins. We map the alpha M-2 binding site to the C terminal end of HB3VAR06, and demonstrate that alpha M-2 can bind at least four HB3VAR06 proteins, plausibly augmenting their combined avidity for host receptors. IgM has previously been identified as a rosette-facilitating soluble factor that acts in a similar way, but it cannot induce rosetting on its own. This is in contrast to alpha M-2 and probably due to the more limited cross-linking potential of IgM. Nevertheless, we show that IgM works synergistically with alpha M-2 and markedly lowers the concentration of alpha M-2 required for rosetting. Finally, HB3VAR06(+) IEs share the capacity to bind alpha M-2 with subsets of genotypically distinct P. falciparum isolates forming rosettes in vitro and of patient parasite isolates ex vivo. Together, our results are evidence that P. falciparum parasites exploit alpha M-2 (and IgM) to expand the repertoire of host receptors available for PfEMP1-mediated IE adhesion, such as the erythrocyte carbohydrate moieties that lead to formation of rosettes. It is likely that this mechanism also affects IE adhesion to receptors on vascular endothelium. The study opens opportunities for broad-ranging immunological interventions targeting the alpha M-2-(and IgM-) binding domains of PfEMP1, which would be independent of the host receptor specificity of clinically important PfEMP1 antigens.","[Stevenson, Liz; Laursen, Erik; Bandoh, Betty; Barfod, Lea; Hviid, Lars] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol ISIM, Copenhagen, Denmark; [Stevenson, Liz; Laursen, Erik; Bandoh, Betty; Barfod, Lea; Hviid, Lars] Copenhagen Univ Hosp Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Cavanagh, David R.] Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Bandoh, Betty] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Andersen, Gregers R.] Univ Aarhus, Dept Mol Biol & Genet, Aarhus, Denmark","Hviid, L (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol ISIM, Copenhagen, Denmark.",lhviid@sund.ku.dk,"Cowan, Graeme/F-2842-2011; Hviid, Lars/G-3705-2012","Cowan, Graeme/0000-0002-1949-4253; Hviid, Lars/0000-0002-1698-4927; Andersen, Gregers Rom/0000-0001-6292-3319; Barfod, Lea/0000-0001-6510-495X; Cavanagh, David/0000-0003-4360-2637","Danish Council for Independent Research [DFF FSS 11 115707, 11 120879]; Danish Consultative Committee for Development Research [FFU 12 081RH]; European Community [242095 - EVIMalaR]; Lundbeck Foundation [R839-A7627]; Novo Nordisk Foundation; EVIMalaR; FFU; DFF FSS; Lundbeck Foundation [R83-2011-7627]","Funding: The research leading to these results received funding from the Danish Council for Independent Research (DFF FSS 11 115707 and 11 120879), the Danish Consultative Committee for Development Research (FFU 12 081RH), the European Community's Seventh Framework Program (FP7/2007-2013, grant 242095 - EVIMalaR), The Lundbeck Foundation (R839-A7627) and Novo Nordisk Foundation (""Immune evasion of malaria parasites: binding of nonimmune IgM to infected erythrocytes""). LS, BB, and LB were supported by EVIMalaR, FFU, and DFF FSS, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,23,23,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005022,10.1371/journal.ppat.1005022,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200036,26134405.0,"DOAJ Gold, Green Published",,,16/08/2019,23,3,21,3367,673,495,178,2694,2178,21,495,21,3,0,0,20,20,0,,24,4,24,0,4,24,24,19,15,0,0,0,0,0,0,0,0,2,3385,12,0,54,96,0,2690,673,12,0,54,96,0,22,,0,0,0,0,5,0,0,1,0,0,0,24,0,0,1.75,5.00297176820208,1.2498144023756497,0.24981440237564959,1.2965850037119524,1.0374220374220373,5.190193164933135
510,J,"Tavares, AH; Burgel, PH; Bocca, AL",,,,"Tavares, Aldo Henrique; Buergel, Pedro Henrique; Bocca, Anamelia Lorenzetti",,,Turning Up the Heat: Inflammasome Activation by Fungal Pathogens,PLOS PATHOGENS,,,English,Article,,,,,,,NLRP3 INFLAMMASOME; CANDIDA-ALBICANS; HOST-DEFENSE; DECTIN-1; INDUCTION; MACROPHAGES; RESPONSES; KINASE; BETA; RECOGNITION,,"[Tavares, Aldo Henrique; Buergel, Pedro Henrique; Bocca, Anamelia Lorenzetti] Univ Brasilia, Inst Biol, Dept Biol Celular, Lab Imunol Aplicada, Brasilia, DF, Brazil","Tavares, AH (reprint author), Univ Brasilia, Inst Biol, Dept Biol Celular, Lab Imunol Aplicada, Brasilia, DF, Brazil.",atavares@unb.br,"TAVARES, ALDO HENRIQUE/L-5662-2015; Bocca, Anamelia Lorenzetti/K-4758-2018","Bocca, Anamelia Lorenzetti/0000-0003-3323-5300",CNPq; CAPES,"Funding: This work was funded by CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,38,14,14,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004948,10.1371/journal.ppat.1004948,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200011,26204108.0,"DOAJ Gold, Green Published",,,16/08/2019,15,17,24,5233,1134,852,282,4099,3403,21,675,24,0,0,0,14,14,0,,31,2,31,0,2,15,15,12,10,0,0,0,0,0,0,0,17,0,5281,13,0,33,67,0,4123,1142,13,0,33,67,0,16,,0,0,0,0,1,0,1,1,0,0,0,30,0,0,1.0,4.614638447971782,1.2766528421566237,0.27665284215662356,1.307879970724567,1.0244601566978788,4.727513227513228
511,J,"Theiss, JM; Gunther, T; Alawi, M; Neumann, F; Tessmer, U; Fischer, N; Grundhoff, A",,,,"Theiss, Juliane Marie; Guenther, Thomas; Alawi, Malik; Neumann, Friederike; Tessmer, Uwe; Fischer, Nicole; Grundhoff, Adam",,,A Comprehensive Analysis of Replicating Merkel Cell Polyomavirus Genomes Delineates the Viral Transcription Program and Suggests a Role for mcv-miR-M1 in Episomal Persistence,PLOS PATHOGENS,,,English,Article,,,,,,,PAPILLOMAVIRUS E2 PROTEIN; LARGE T-ANTIGEN; EARLY-LATE SWITCH; DNA-REPLICATION; IN-VIVO; VIRUS; RNA; GENE; MICRORNAS; BRD4,"Merkel cell polyomavirus (MCPyV) is considered the etiological agent of Merkel cell carcinoma and persists asymptomatically in the majority of its healthy hosts. Largely due to the lack of appropriate model systems, the mechanisms of viral replication and MCPyV persistence remain poorly understood. Using a semi-permissive replication system, we here report a comprehensive analysis of the role of the MCPyV-encoded microRNA (miRNA) mcv-miR-M1 during short and long-term replication of authentic MCPyV episomes. We demonstrate that cells harboring intact episomes express high levels of the viral miRNA, and that expression of mcv-miR-M1 limits DNA replication. Furthermore, we present RACE, RNA-seq and ChIP-seq studies which allow insight in the viral transcription program and mechanisms of miRNA expression. While our data suggest that mcv-miR-M1 can be expressed from canonical late strand transcripts, we also present evidence for the existence of an independent miRNA promoter that is embedded within early strand coding sequences. We also report that MCPyV genomes can establish episomal persistence in a small number of cells for several months, a time period during which viral DNA as well as LT-Ag and viral miRNA expression can be detected via western blotting, FISH, qPCR and southern blot analyses. Strikingly, despite enhanced replication in short term DNA replication assays, a mutant unable to express the viral miRNA was severely limited in its ability to establish long-term persistence. Our data suggest that MCPyV may have evolved strategies to enter a non-or low level vegetative stage of infection which could aid the virus in establishing and maintaining a lifelong persistence.","[Theiss, Juliane Marie; Guenther, Thomas; Alawi, Malik; Tessmer, Uwe; Grundhoff, Adam] Leibniz Inst Expt Virol, Heinrich Pette Inst, Res Grp Virus Genom, Hamburg, Germany; [Theiss, Juliane Marie; Neumann, Friederike; Fischer, Nicole] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, Hamburg, Germany","Fischer, N (reprint author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.",nfischer@uke.de; adam.grundhoff@hpi.uni-hamburg.de,,"Grundhoff, Adam/0000-0003-0940-7045",Erich and Gertrud Roggenbuck Stiftung; Studienstiftung des Deutschen Volkes,"Funding: This study was supported by a grant given to NF and AG by the Erich and Gertrud Roggenbuck Stiftung. JMT was supported by the Studienstiftung des Deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,95,22,22,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004974,10.1371/journal.ppat.1004974,,,,41,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200017,26218535.0,"DOAJ Gold, Green Published",,,16/08/2019,20,6,26,4217,955,736,219,3262,2596,16,650,26,5,0,0,18,18,0,,29,8,29,0,8,21,21,19,11,0,0,0,0,0,0,0,1,0,4300,189,0,175,76,0,3299,981,189,0,175,76,0,20,,0,0,0,1,10,0,1,1,0,0,0,29,0,0,7.85,4.4157068062827225,1.2927651747394238,0.29276517473942365,1.399448191293685,1.0825231207019208,4.780104712041885
512,J,"Vyas, A",,,,"Vyas, Ajai",,,Mechanisms of Host Behavioral Change in Toxoplasma gondii Rodent Association,PLOS PATHOGENS,,,English,Article,,,,,,,MEDIAL AMYGDALA; RAT-BRAIN; INFECTION; MANIPULATION; ANXIETY; ODOR; CAT; PERSONALITY; COPULATION; EXPRESSION,,"Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore","Vyas, A (reprint author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.",avyas@ntu.edu.sg,"Vyas, Ajai/A-2223-2011","Vyas, Ajai/0000-0002-2592-6796","Ministry of Education, Singapore","Funding: This work was supported by grants from Ministry of Education, Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,39,18,18,1,75,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004935,10.1371/journal.ppat.1004935,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200007,26203656.0,"DOAJ Gold, Green Published",,,16/08/2019,22,32,36,10701,3126,2698,428,7575,6492,24,1059,36,23,0,0,21,21,0,,72,8,72,0,8,23,23,14,11,0,0,0,0,0,0,0,9,12,10917,0,1,0,201,9,7634,3156,0,1,0,201,9,127,,1,1,0,0,30,0,1,1,0,0,0,72,0,0,32.306,3.423224568138196,1.4126732673267326,0.41267326732673265,1.4677227722772277,1.0389683207176899,3.5566218809980805
513,J,"Wang, TT; Si, MR; Song, YH; Zhu, WH; Gao, F; Wang, Y; Zhang, L; Zhang, WP; Wei, GH; Luo, ZQ; Shen, XH",,,,"Wang, Tietao; Si, Meiru; Song, Yunhong; Zhu, Wenhan; Gao, Fen; Wang, Yao; Zhang, Lei; Zhang, Weipeng; Wei, Gehong; Luo, Zhao-Qing; Shen, Xihui",,,Type VI Secretion System Transports Zn2+ to Combat Multiple Stresses and Host Immunity,PLOS PATHOGENS,,,English,Article,,,,,,,ZINC-BINDING; YERSINIA-PESTIS; METAL-BINDING; OXIDATIVE STRESS; PROTEIN; COMPETITION; PROTECTION; EFFECTORS; MECHANISM; ZNUA,"Type VI secretion systems (T6SSs) are widespread multi-component machineries that translocate effectors into either eukaryotic or prokaryotic cells, for virulence or for interbacterial competition. Herein, we report that the T6SS-4 from Yersinia pseudotuberculosis displays an unexpected function in the transportation of Zn2+ to combat diverse stresses and host immunity. Environmental insults such as oxidative stress induce the expression of T6SS-4 via OxyR, the transcriptional factor that also regulates many oxidative response genes. Zinc transportation is achieved by T6SS-4-mediated translocation of a novel Zn2+-binding protein substrate YezP (YPK_3549), which has the capacity to rescue the sensitivity to oxidative stress exhibited by T6SS-4 mutants when added to extracellular milieu. Disruption of the classic zinc transporter ZnuABC together with T6SS-4 or yezP results in mutants that almost completely lost virulence against mice, further highlighting the importance of T6SS-4 in resistance to host immunity. These results assigned an unconventional role to T6SSs, which will lay the foundation for studying novel mechanisms of metal ion uptake by bacteria and the role of this process in their resistance to host immunity and survival in harmful environments.","[Wang, Tietao; Si, Meiru; Song, Yunhong; Gao, Fen; Wang, Yao; Zhang, Lei; Zhang, Weipeng; Wei, Gehong; Shen, Xihui] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Tietao; Si, Meiru; Song, Yunhong; Gao, Fen; Wang, Yao; Zhang, Lei; Zhang, Weipeng; Wei, Gehong; Shen, Xihui] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhu, Wenhan; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA","Shen, XH (reprint author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.",xihuishen@nwsuaf.edu.cn,,"Luo, Zhao-Qing/0000-0001-8890-6621","National High Technology Research and Development Program of China (863 program) [2013AA102802]; National Natural Science Foundation of China [31170121, 31370150]; National Institutes of Health [K02AI085403]","Funding: This work was supported by the National High Technology Research and Development Program of China (863 program: grant 2013AA102802 to XS): National Natural Science Foundation of China 31170121 (XS): 31370150 (YW): and National Institutes of Health Grant K02AI085403 (ZQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,35,36,2,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005020,10.1371/journal.ppat.1005020,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200034,26134274.0,"DOAJ Gold, Green Published",,,16/08/2019,48,1,42,6787,1357,991,366,5430,4368,24,1038,42,1,0,0,53,53,1,,76,4,76,0,4,54,54,34,24,0,0,0,0,0,0,0,5,0,6787,246,0,111,36,2,5404,1357,246,0,111,36,2,26,,0,0,0,0,1,0,1,1,0,0,0,75,0,0,1.5,5.001473839351511,1.2499079189686924,0.24990791896869244,1.301841620626151,1.0415500221010756,5.209285187914517
514,J,"Wang, XH; McGovern, G; Zhang, Y; Wang, F; Zha, L; Jeffrey, M; Ma, JY",,,,"Wang, Xinhe; McGovern, Gillian; Zhang, Yi; Wang, Fei; Zha, Liang; Jeffrey, Martin; Ma, Jiyan",,,Intraperitoneal Infection of Wild-Type Mice with Synthetically Generated Mammalian Prion,PLOS PATHOGENS,,,English,Article,,,,,,,BOVINE SPONGIFORM ENCEPHALOPATHY; MISFOLDING CYCLIC AMPLIFICATION; PRP ACCUMULATION; PROTEIN PRP; SCRAPIE; DISEASE; BRAIN; SHEEP; STRAINS; AGENT,"The prion hypothesis postulates that the infectious agent in transmissible spongiform encephalopathies (TSEs) is an unorthodox protein conformation based agent. Recent successes in generating mammalian prions in vitro with bacterially expressed recombinant prion protein provide strong support for the hypothesis. However, whether the pathogenic properties of synthetically generated prion (rec-Prion) recapitulate those of naturally occurring prions remains unresolved. Using end-point titration assay, we showed that the in vitro prepared rec-Prions have infectious titers of around 10(4) LD50/mu g. In addition, intraperitoneal (i.p.) inoculation of wild-type mice with rec-Prion caused prion disease with an average survival time of 210-220 days post inoculation. Detailed pathological analyses revealed that the nature of rec-Prion induced lesions, including spongiform change, disease specific prion protein accumulation (PrP-d) and the PrP-d dissemination amongst lymphoid and peripheral nervous system tissues, the route and mechanisms of neuroinvasion were all typical of classical rodent prions. Our results revealed that, similar to naturally occurring prions, the rec-Prion has a titratable infectivity and is capable of causing prion disease via routes other than direct intra-cerebral challenge. More importantly, our results established that the rec-Prion caused disease is pathogenically and pathologically identical to naturally occurring contagious TSEs, supporting the concept that a conformationally altered protein agent is responsible for the infectivity in TSEs.","[Wang, Xinhe; Wang, Fei; Ma, Jiyan] Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA; [Wang, Xinhe; Zhang, Yi; Wang, Fei; Zha, Liang; Ma, Jiyan] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [McGovern, Gillian] Anim & Plant Hlth Agcy, Lasswade Lab, Penicuik, Midlothian, Scotland; [Zhang, Yi; Ma, Jiyan] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Brain Funct Genom, Key Lab Brain Funct Genom,Minist Educ, Shanghai 200062, Peoples R China","Ma, JY (reprint author), Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA.",Jiyan.Ma@vai.org,,,"National Institutes of Health [R01 NS071035, R01 NS 060729]","Funding: This study was supported by National Institutes of Health Grants R01 NS071035 and R01 NS 060729 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,76,4,4,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004958,10.1371/journal.ppat.1004958,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200014,26136122.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,16,3364,453,324,129,2911,2431,24,456,16,0,0,0,7,7,2,,19,7,19,0,7,8,8,8,7,0,0,0,0,0,0,2,0,0,3411,35,0,86,131,0,2928,463,35,0,86,131,0,20,,2,3,0,0,2,0,0,1,0,0,0,19,0,0,42.274,7.4260485651214125,1.155616626588801,0.1556166265888011,1.2287873582961182,1.0633174791914388,7.896247240618101
515,J,"Watkins, ER; Penman, BS; Lourenco, J; Buckee, CO; Maiden, MCJ; Gupta, S",,,,"Watkins, Eleanor R.; Penman, Bridget S.; Lourenco, Jose; Buckee, Caroline O.; Maiden, Martin C. J.; Gupta, Sunetra",,,Vaccination Drives Changes in Metabolic and Virulence Profiles of Streptococcus pneumoniae,PLOS PATHOGENS,,,English,Article,,,,,,,PNEUMOCOCCAL CONJUGATE VACCINE; UNITED-STATES; NASOPHARYNGEAL CARRIAGE; ACQUIRED-IMMUNITY; SEROTYPES; EVOLUTION; MASSACHUSETTS; DISEASE; PILUS; POPULATIONS,"The bacterial pathogen, Streptococcus pneumoniae (the pneumococcus), is a leading cause of life-threatening illness and death worldwide. Available conjugate vaccines target only a small subset (up to 13) of >90 known capsular serotypes of S. pneumoniae and, since their introduction, increases in non-vaccine serotypes have been recorded in several countries: a phenomenon termed Vaccine Induced Serotype Replacement (VISR). Here, using a combination of mathematical modelling and whole genome analysis, we show that targeting particular serotypes through vaccination can also cause their metabolic and virulence-associated components to transfer through recombination to non-vaccine serotypes: a phenomenon we term Vaccine-Induced Metabolic Shift (VIMS). Our results provide a novel explanation for changes observed in the population structure of the pneumococcus following vaccination, and have important implications for strain-targeted vaccination in a range of infectious disease systems.","[Watkins, Eleanor R.; Penman, Bridget S.; Lourenco, Jose; Maiden, Martin C. J.; Gupta, Sunetra] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA","Gupta, S (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.",sunetra.gupta@zoo.ox.ac.uk,"Maiden, Martin/N-6805-2019","Maiden, Martin/0000-0001-6321-5138; Lourenco, Jose/0000-0002-9318-2581; Penman, Bridget/0000-0001-9803-5209","Merton College, Oxford University; National Institute of General Medical Sciences [U54GM088558]; Wellcome Trust [ATRPWK00]; European Research Council under the European Union [268904 - DIVERSITY];  [096063]","ERW is funded by Merton College, Oxford University (Jackson Scholarship) (www.merton.ox.ac.uk). COB is supported by Award Number U54GM088558 from the National Institute of General Medical Sciences (www.nigms.nih.gov). BSP is a Sir Henry Wellcome Postdoctoral fellow (Grant 096063) and a Junior Research Fellow at Merton College, Oxford University (www.wellcome.ac.uk; www.merton.ox.ac.uk). MCJM is a Wellcome Trust Senior Fellow, grant code ATRPWK00 (www.wellcome.ac.uk). SG is a Royal Society Wolfson Research Fellow and also receives funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no. 268904 - DIVERSITY (www.erc.europa.eu; www.royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,43,18,18,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005034,10.1371/journal.ppat.1005034,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200046,26181911.0,"DOAJ Gold, Green Published",,,16/08/2019,16,25,49,5676,637,440,197,5039,4215,18,806,49,23,0,0,18,18,0,,119,2,63,0,2,16,16,16,14,0,0,0,0,0,0,0,2,1,5692,191,4,74,184,1,5022,637,191,4,74,184,1,33,,0,0,0,0,28,0,1,1,0,0,0,62,0,0,16.25,8.910518053375196,1.1264139710259973,0.12641397102599722,1.2040087318912482,1.0688865398167724,9.524332810047095
516,J,"Westaway, D",,,,"Westaway, David",,,"Basic Prion Science ""Spreads"" Insight",PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Westaway, David] Univ Alberta, Prion Dis, Edmonton, AB, Canada","Westaway, D (reprint author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.",david.westaway@ualberta.ca,,,,,,0,0,0,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005092,10.1371/journal.ppat.1005092,,,,3,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200072,26226044.0,"DOAJ Gold, Green Published",,,16/08/2019,0,138,7,2925,228,156,72,2697,2401,16,280,7,6,0,0,0,0,0,,11,7,11,0,7,0,0,0,0,0,0,0,0,0,0,0,131,3,2941,0,0,0,70,0,2693,228,0,0,0,70,0,20,,0,0,0,0,12,0,4,0,0,0,0,11,0,0,7.45,12.828947368421053,1.0845383759733036,0.08453837597330367,1.1164256581386727,1.0294017094017094,13.206140350877194
517,J,"Yang, WS; Hsu, HW; Campbell, M; Cheng, CY; Chang, PC",,,,"Yang, Wan-Shan; Hsu, Hung-Wei; Campbell, Mel; Cheng, Chia-Yang; Chang, Pei-Ching",,,K-bZIP Mediated SUMO-2/3 Specific Modification on the KSHV Genome Negatively Regulates Lytic Gene Expression and Viral Reactivation,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; DNA-REPLICATION; CHROMATIN MODIFICATION; PROTEIN; LATENCY; TRANSACTIVATOR; TRANSCRIPTION; SUMOYLATION; MODIFIER,"SUMOylation is associated with epigenetic regulation of chromatin structure and transcription. Epigenetic modifications of herpesviral genomes accompany the transcriptional switch of latent and lytic genes during the virus life cycle. Here, we report a genome-wide comparison of SUMO paralog modification on the KSHV genome. Using chromatin immunoprecipitation in conjunction with high-throughput sequencing, our study revealed highly distinct landscape changes of SUMO paralog genomic modifications associated with KSHV reactivation. A rapid and widespread deposition of SUMO-2/3, compared with SUMO-1, modification across the KSHV genome upon reactivation was observed. Interestingly, SUMO-2/3 enrichment was inversely correlated with H3K9me3 mark after reactivation, indicating that SUMO-2/3 may be responsible for regulating the expression of viral genes located in low heterochromatin regions during viral reactivation. RNA-sequencing analysis showed that the SUMO-2/3 enrichment pattern positively correlated with KSHV gene expression profiles. Activation of KSHV lytic genes located in regions with high SUMO-2/3 enrichment was enhanced by SUMO-2/3 knockdown. These findings suggest that SUMO-2/3 viral chromatin modification contributes to the diminution of viral gene expression during reactivation. Our previous study identified a SUMO-2/3-specific viral E3 ligase, K-bZIP, suggesting a potential role of this enzyme in regulating SUMO-2/3 enrichment and viral gene repression. Consistent with this prediction, higher K-bZIP binding on SUMO-2/3 enrichment region during reactivation was observed. Moreover, a K-bZIP SUMO E3 ligase dead mutant, K-bZIP-L75A, in the viral context, showed no SUMO-2/3 enrichment on viral chromatin and higher expression of viral genes located in SUMO-2/3 enriched regions during reactivation. Importantly, virus production significantly increased in both SUMO-2/3 knockdown and KSHV K-bZIP-L75A mutant cells. These results indicate that SUMO-2/3 modification of viral chromatin may function to counteract KSHV reactivation. As induction of herpesvirus reactivation may activate cellular antiviral regimes, our results suggest that development of viral SUMO E3 ligase specific inhibitors may be an avenue for anti-virus therapy.","[Yang, Wan-Shan; Hsu, Hung-Wei; Cheng, Chia-Yang; Chang, Pei-Ching] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Campbell, Mel] Univ Calif Davis, UC Davis Canc Ctr, Davis, CA 95616 USA; [Chang, Pei-Ching] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan","Yang, WS (reprint author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.",pcchang@ym.edu.tw,,,Ministry of Science and Technology [NSC 103-2321-B-010-006]; National Health Research Institute [NHRI-EX102-10215BC]; National Yang-Ming University,"This work was supported by a grant from the Ministry of Science and Technology (NSC 103-2321-B-010-006 to PCC) and from the National Health Research Institute (NHRI-EX102-10215BC to PCC). This work was also supported partly with National Yang-Ming University on manuscript publication to PCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,15,15,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005051,10.1371/journal.ppat.1005051,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200055,26197391.0,"DOAJ Gold, Green Published",,,16/08/2019,16,5,9,3501,632,459,173,2869,2342,23,504,9,3,0,0,13,13,0,,16,2,16,0,2,16,16,13,11,0,0,0,0,0,0,0,2,1,3538,148,0,514,75,0,2881,642,148,0,514,75,0,15,,0,0,0,0,6,0,1,0,0,0,0,16,0,0,2.75,5.5395569620253164,1.2202858138724295,0.22028581387242943,1.3109097246427326,1.0742644958583263,5.950949367088608
518,J,"Zuhlsdorf, M; Werten, S; Klupp, BG; Palm, GJ; Mettenleiter, TC; Hinrichs, W",,,,"Zuehlsdorf, Martin; Werten, Sebastiaan; Klupp, Barbara G.; Palm, Gottfried J.; Mettenleiter, Thomas C.; Hinrichs, Winfried",,,"Dimerization-Induced Allosteric Changes of the Oxyanion-Hole Loop Activate the Pseudorabies Virus Assemblin pUL26N, a Herpesvirus Serine Protease",PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN CYTOMEGALOVIRUS PROTEASE; MAJOR CAPSID PROTEIN; SMALL-ANGLE SCATTERING; SIMPLEX-VIRUS; CRYSTAL-STRUCTURE; MACROMOLECULAR STRUCTURES; SCAFFOLDING PROTEIN; CATALYTIC ACTIVITY; PHASE INFORMATION; TYPE-1 PROTEASE,"Herpesviruses encode a characteristic serine protease with a unique fold and an active site that comprises the unusual triad Ser-His-His. The protease is essential for viral replication and as such constitutes a promising drug target. In solution, a dynamic equilibrium exists between an inactive monomeric and an active dimeric form of the enzyme, which is believed to play a key regulatory role in the orchestration of proteolysis and capsid assembly. Currently available crystal structures of herpesvirus proteases correspond either to the dimeric state or to complexes with peptide mimetics that alter the dimerization interface. In contrast, the structure of the native monomeric state has remained elusive. Here, we present the three-dimensional structures of native monomeric, active dimeric, and diisopropyl fluorophosphate-inhibited dimeric protease derived from pseudorabies virus, an alphaherpes-virus of swine. These structures, solved by X-ray crystallography to respective resolutions of 2.05, 2.10 and 2.03 angstrom, allow a direct comparison of the main conformational states of the protease. In the dimeric form, a functional oxyanion hole is formed by a loop of 10 amino-acid residues encompassing two consecutive arginine residues (Arg136 and Arg137); both are strictly conserved throughout the herpesviruses. In the monomeric form, the top of the loop is shifted by approximately 11 angstrom, resulting in a complete disruption of the oxyanion hole and loss of activity. The dimerization-induced allosteric changes described here form the physical basis for the concentration-dependent activation of the protease, which is essential for proper virus replication. Small-angle X-ray scattering experiments confirmed a concentration-dependent equilibrium of monomeric and dimeric protease in solution.","[Zuehlsdorf, Martin; Werten, Sebastiaan; Palm, Gottfried J.; Hinrichs, Winfried] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany; [Klupp, Barbara G.; Mettenleiter, Thomas C.] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany","Zuhlsdorf, M (reprint author), Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany.",winfried.hinrichs@uni-greifswald.de,,"Werten, Sebastiaan/0000-0003-2244-9688; Hinrichs, Winfried/0000-0002-0435-4565; Zuhlsdorf, Martin/0000-0002-7869-2081",,,,96,7,7,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005045,10.1371/journal.ppat.1005045,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200051,26161660.0,"DOAJ Gold, Green Published",,,16/08/2019,7,0,6,3194,508,405,103,2686,2260,27,399,6,0,1,0,6,6,0,,0,0,0,0,0,7,7,7,4,0,0,0,0,0,0,0,0,0,3244,77,0,105,162,1,2698,520,77,0,105,162,1,26,,0,0,0,0,0,0,0,1,0,0,0,8,0,0,0.25,6.28740157480315,1.1891288160833955,0.18912881608339538,1.2967237527922562,1.0904821540388228,6.856299212598425
519,J,"Bazot, Q; Paschos, K; Skalska, L; Kalchschmidt, JS; Parker, GA; Allday, MJ",,,,"Bazot, Quentin; Paschos, Kostas; Skalska, Lenka; Kalchschmidt, Jens S.; Parker, Gillian A.; Allday, Martin J.",,,Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57(KIP2),PLOS PATHOGENS,,,English,Article,,,,,,,NUCLEAR ANTIGEN 3C; 2ND-SITE HOMOLOGOUS RECOMBINATION; THYROID PAPILLARY CARCINOMAS; PROSTATE CARCINOMA; DOWN-REGULATION; MEDIATED REPRESSION; HISTONE DEACETYLASE; TUMOR-SUPPRESSOR; MIR-143 AND-145; NONCODING RNAS,"We show that two host-encoded primary RNAs (pri-miRs) and the corresponding microRNA (miR) clusters - widely reported to have cell transformation-associated activity - are regulated by EBNA3A and EBNA3C. Utilising a variety of EBV-transformed lymphoblastoid cell lines (LCLs) carrying knockout-, revertant-or conditional-EBV recombinants, it was possible to demonstrate unambiguously that EBNA3A and EBNA3C are both required for transactivation of the oncogenic miR-221/miR-222 cluster that is expressed at high levels in multiple human tumours - including lymphoma/leukemia. ChIP, ChIP-seq, and chromosome conformation capture analyses indicate that this activation results from direct targeting of both EBV proteins to chromatin at the miR-221/miR-222 genomic locus and activation via a long-range interaction between enhancer elements and the transcription start site of a long noncoding pri-miR located 28kb upstream of the miR sequences. Reduced levels of miR-221/miR-222 produced by inactivation or deletion of EBNA3A or EBNA3C resulted in increased expression of the cyclin-dependent kinase inhibitor p57(KIP2), a well-established target of miR-221/miR-222. MiR blocking experiments confirmed that miR-221/miR-222 target p57(KIP2) expression in LCLs. In contrast, EBNA3A and EBNA3C are necessary to silence the tumour suppressor cluster miR-143/miR-145, but here ChIP-seq suggests that repression is probably indirect. This miR cluster is frequently down-regulated or deleted in human cancer, however, the targets in B cells are unknown. Together these data indicate that EBNA3A and EBNA3C contribute to B cell transformation by inhibiting multiple tumour suppressor proteins, not only by direct repression of protein-encoding genes, but also by the manipulation of host long non-coding pri-miRs and miRs.","[Bazot, Quentin; Paschos, Kostas; Skalska, Lenka; Kalchschmidt, Jens S.; Parker, Gillian A.; Allday, Martin J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Mol Virol, London, England","Allday, MJ (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Mol Virol, London, England.",m.allday@imperial.ac.uk,,"Kalchschmidt, Jens/0000-0002-5200-0139; Bazot, Quentin/0000-0003-1735-8765",Wellcome Trust [099273/Z/12/Z],"Funding was provided by the Wellcome Trust (www.wellcome.ac.uk) through a Senior Investigator award to MJA (099273/Z/12/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,93,24,27,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005031,10.1371/journal.ppat.1005031,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200043,26153983.0,"DOAJ Gold, Green Published",,,16/08/2019,25,0,19,4095,769,540,229,3326,2828,24,474,19,0,0,0,21,21,0,,22,6,22,0,6,26,26,21,13,0,0,0,0,0,0,0,0,0,4105,122,0,169,125,0,3305,769,122,0,169,125,0,31,,0,0,0,0,3,0,0,1,0,0,0,22,0,0,1.25,5.325097529258778,1.2312086590499098,0.2312086590499098,1.3084786530366808,1.0627594627594628,5.659297789336801
520,J,"Chen, JC; Ng, MML; Chu, JJH",,,,"Chen, Jincheng; Ng, Mary Mah-Lee; Chu, Justin Jang Hann",,,Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,TOLL-LIKE RECEPTORS; INNATE IMMUNE-SYSTEM; TUMOR-NECROSIS-FACTOR; ANTIBODY-DEPENDENT ENHANCEMENT; PATTERN-RECOGNITION RECEPTORS; BLOOD MONONUCLEAR-CELLS; ORIGINAL ANTIGENIC SIN; HEMORRHAGIC-FEVER; IN-VITRO; CYTOKINE PRODUCTION,"Dengue virus (DV) infection is the most prevalent mosquito-borne viral disease and its manifestation has been shown to be contributed in part by the host immune responses. In this study, pathogen recognition receptors, Toll-like receptor (TLR) 2 and TLR6 were found to be up-regulated in DV-infected human PBMC using immunofluorescence staining, flow cytometry and Western blot analyses. Using ELISA, IL-6 and TNF-alpha, cytokines downstream of TLR2 and TLR6 signaling pathways were also found to be up-regulated in DV-infected PBMC. IL-6 and TNF-alpha production by PBMC were reduced when TLR2 and TLR6 were blocked using TLR2 and TLR6 neutralizing antibodies during DV infection. These results suggested that signaling pathways of TLR2 and TLR6 were activated during DV infection and its activation contributed to IL-6 and TNF-alpha production. DV NS1 protein was found to significantly increase the production of IL-6 and TNF-alpha when added to PBMC. The amount of IL-6 and TNF-alpha stimulated by DV NS1 protein was reduced when TLR2 and TLR6 were blocked, suggesting that DV NS1 protein is the viral protein responsible for the activation of TLR2 and TLR6 during DV infection. Secreted alkaline phosphatase (SEAP) reporter assay was used to further confirm activation of TLR2 and TLR6 by DV NS1 protein. In addition, DV-infected and DV NS1 protein-treated TLR6(-/-) mice have higher survivability compared to DV-infected and DV NS1 protein-treated wild-type mice. Hence, activation of TLR6 via DV NS1 protein could potentially play an important role in the immunopathogenesis of DV infection.","[Chen, Jincheng; Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies,Dept Mic, Singapore 117595, Singapore; [Ng, Mary Mah-Lee] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Flavivirol Lab,Dept Microbiol, Singapore 117595, Singapore","Chen, JC (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies,Dept Mic, Singapore 117595, Singapore.",miccjh@nus.edu.sg,,,MINDEF DSTA DIRP Grant [R 182-000-210-232],"This study is funded by MINDEF DSTA DIRP Grant (R 182-000-210-232) http://www.mindef.gov.sg/imindef/mindef_websites/atozlistings/drtech/Technology_Collaboration/dirp.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,112,42,44,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005053,10.1371/journal.ppat.1005053,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200057,26226614.0,"DOAJ Gold, Green Published",,,16/08/2019,33,1,84,7781,2083,1410,673,5698,4329,18,1351,84,0,0,0,32,32,0,,106,1,106,0,1,38,36,38,17,0,0,0,0,0,0,0,1,1,7761,119,0,92,122,1,5651,2083,119,0,92,122,1,27,,0,0,0,0,1,0,0,1,0,0,0,106,0,0,0.5,3.7354776764282285,1.3655668655668656,0.3655668655668656,1.4043524043524043,1.0284025189564323,3.841574651944311
521,J,"Coomes, SM; Pelly, VS; Kannan, Y; Okoye, IS; Czieso, S; Entwistle, LJ; Perez-Lloret, J; Nikolov, N; Potocnik, AJ; Biro, J; Langhorne, J; Wilson, MS",,,,"Coomes, Stephanie M.; Pelly, Victoria S.; Kannan, Yashaswini; Okoye, Isobel S.; Czieso, Stephanie; Entwistle, Lewis J.; Perez-Lloret, Jimena; Nikolov, Nikolay; Potocnik, Alexandre J.; Biro, Judit; Langhorne, Jean; Wilson, Mark S.",,,IFN gamma and IL-12 Restrict Th2 Responses during Helminth/Plasmodium Co-Infection and Promote IFN gamma from Th2 Cells,PLOS PATHOGENS,,,English,Article,,,,,,,CD4(+) T-CELLS; GASTROINTESTINAL NEMATODE INFECTION; LYMPHOPENIA-INDUCED PROLIFERATION; HELIGMOSOMOIDES-POLYGYRUS; PLASMODIUM-CHABAUDI; HELMINTH INFECTIONS; SCHISTOSOMA-MANSONI; MALARIA COINFECTION; CONCURRENT INFECTION; PROTECTIVE IMMUNITY,"Parasitic helminths establish chronic infections in mammalian hosts. Helminth/Plasmodium co-infections occur frequently in endemic areas. However, it is unclear whether Plasmodium infections compromise anti-helminth immunity, contributing to the chronicity of infection. Immunity to Plasmodium or helminths requires divergent CD4(+) T cell-driven responses, dominated by IFN gamma or IL-4, respectively. Recent literature has indicated that Th cells, including Th2 cells, have phenotypic plasticity with the ability to produce non-lineage associated cytokines. Whether such plasticity occurs during co-infection is unclear. In this study, we observed reduced anti-helminth Th2 cell responses and compromised anti-helminth immunity during Heligmosomoides polygyrus and Plasmodium chabaudi co-infection. Using newly established triple cytokine reporter mice (Il4(gfp)Ifng(yfp)Il17a(FP635)), we demonstrated that Il4(gfp+) Th2 cells purified from in vitro cultures or isolated ex vivo from helminthinfected mice up-regulated IFN. following adoptive transfer into Rag1(-/-) mice infected with P. chabaudi. Functionally, Th2 cells that up-regulated IFN. were transcriptionally re-wired and protected recipient mice from high parasitemia. Mechanistically, TCR stimulation and responsiveness to IL-12 and IFN gamma, but not type I IFN, was required for optimal IFN. production by Th2 cells. Finally, blockade of IL-12 and IFN gamma during co-infection partially preserved anti-helminth Th2 responses. In summary, this study demonstrates that Th2 cells retain substantial plasticity with the ability to produce IFN gamma during Plasmodium infection. Consequently, co-infection with Plasmodium spp. may contribute to the chronicity of helminth infection by reducing anti-helminth Th2 cells and converting them into IFN gamma-secreting cells.","[Coomes, Stephanie M.; Pelly, Victoria S.; Kannan, Yashaswini; Okoye, Isobel S.; Czieso, Stephanie; Entwistle, Lewis J.; Perez-Lloret, Jimena; Potocnik, Alexandre J.; Biro, Judit; Wilson, Mark S.] Francis Crick Inst, Div Mol Immunol, London, England; [Nikolov, Nikolay] Francis Crick Inst, Div Syst Biol, London, England; [Langhorne, Jean] Mill Hill Labs, Div Parasitol, London, England","Wilson, MS (reprint author), Francis Crick Inst, Div Mol Immunol, London, England.",mark.wilson@crick.ac.uk,,"Perez-Lloret, Jimena/0000-0002-2666-3764; Langhorne, Jean/0000-0002-2257-9733; Potocnik, Alexandre/0000-0002-4730-8593","Medical Research Council (MRC) [MC UP A253 1028]; Medical Research Council [MC_U117584248, MC_U117565359]; The Francis Crick Institute [10220, 10101]","Funding: This work was supported by the Medical Research Council (MRC File Reference number MC UP A253 1028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,27,27,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004994,10.1371/journal.ppat.1004994,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200024,26147567.0,"DOAJ Gold, Green Published",,,16/08/2019,26,1,52,5916,797,590,207,5119,4376,32,711,51,0,0,0,21,21,0,,62,3,61,1,3,27,27,23,13,0,0,0,0,0,0,0,1,3,5986,27,0,124,79,0,5154,814,27,0,124,79,0,18,,0,0,0,0,4,0,0,1,0,0,0,60,1,0,1.25,7.422835633626097,1.1556944715764799,0.15569447157647978,1.1900761867552256,1.0297498309668696,7.64366373902133
522,J,"Coussens, AK; Wilkinson, RJ; Martineau, AR",,,,"Coussens, Anna K.; Wilkinson, Robert J.; Martineau, Adrian R.",,,"Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D-3",PLOS PATHOGENS,,,English,Article,,,,,,,VITAMIN-D-RECEPTOR; GENE-EXPRESSION; HISTONE ACETYLATION; HUMAN CATHELICIDIN; BUTYRATE; DIFFERENTIATION; INDUCTION; GROWTH; CELLS; LL-37,"Adjunctive vitamin D treatment for pulmonary tuberculosis enhances resolution of inflammation but has modest effects on bacterial clearance. Sodium 4-phenylbutyrate (PBA) is in clinical use for a range of conditions and has been shown to synergise with vitamin D metabolites to upregulate cathelicidin antimicrobial peptide (CAMP) expression. We investigated whether clinically attainable plasma concentrations of PBA (0.4-4mM) directly affect Mycobacterium tuberculosis (Mtb) growth and human macrophage and PBMC response to infection. We also tested the ability of PBA to enhance the immunomodulatory actions of the vitamin D metabolite 25(OH)D-3 during infection and synergistically inhibit intracellular Mtb growth. PBA inhibited Mtb growth in broth with an MIC99 of 1mM, which was reduced to 0.25mM by lowering pH. During human macrophage infection, PBA treatment restricted Mtb uptake, phagocytic receptor expression and intracellular growth in a dose-dependent manner. PBA independently regulated CCL chemokine secretion and induced expression of the antimicrobial LTF (lactoferrin), the anti-inflammatory PROC (protein C) and multiple genes within the NLRP3 inflammasome pathway. PBA co-treatment with 25(OH)D-3 synergistically modulated expression of numerous vitamin D-response genes, including CAMP, CYP24A1, CXCL10 and IL-37. This synergistic effect was dependent on MAPK signalling, while the effect of PBA on LTF, PROC and NLRP3 was MAPK-independent. During PBA and 25(OH)D-3 co-treatment of human macrophages, in the absence of exogenous proteinase 3 (PR3) to activate cathelicidin, Mtb growth restriction was dominated by the effect of PBA, while the addition of PR3 enhanced growth restriction by 25(OH)D-3 and PBA co-treatment. This suggests that PBA augments vitamin D-mediated cathelicidin-dependent Mtb growth restriction by human macrophages and independently induces antimicrobial and anti-inflammatory action. Therefore through both host-directed and bacterial-directed mechanisms PBA and vitamin D may prove an effective combinatorial adjunct therapy for tuberculosis to both resolve immunopathology and enhance bacterial clearance.","[Coussens, Anna K.; Wilkinson, Robert J.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Coussens, Anna K.; Martineau, Adrian R.] MRC Natl Inst Med Res, Div Mycobacterial Res, London, England; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Wilkinson, Robert J.] Francis Crick Inst, Mill Hill Lab, London, England; [Martineau, Adrian R.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med, London, England","Wilkinson, RJ (reprint author), Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa.",r.j.wilkinson@imperial.ac.uk,"Martineau, Adrian/A-3083-2010","Wilkinson, Robert/0000-0002-2753-1800; Coussens, Anna/0000-0002-7086-2621","UK Medical Research Council [U1175 22141]; Academy of Science of South Africa; Wellcome Trust [088316, 084323]; British Lung Foundation [TB05/11]; The Francis Crick Institute [10218]","Funding: The study was funded by UK Medical Research Council (programme number U1175 22141, http://www.mrc.ac.uk). AKC also receives funding from Academy of Science of South Africa (Sydney Brenner Fellowship, www.assaf.co.za); RJW also receives support from the Wellcome Trust (ref 088316, 084323, http://www.wellcome.ac.uk/) and ARM also receives funding from The British Lung Foundation (ref TB05/11, http://www.blf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,24,24,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005007,10.1371/journal.ppat.1005007,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200028,26133770.0,"DOAJ Gold, Green Published",,,16/08/2019,24,3,32,4884,1199,821,378,3685,2603,28,1054,32,1,0,0,23,23,0,,54,20,54,0,20,25,24,25,15,0,0,0,0,0,0,0,2,0,4911,116,0,68,56,2,3678,1199,116,0,68,56,2,34,,0,0,0,0,3,0,0,1,0,0,0,54,0,0,2.0,4.073394495412844,1.3253731343283581,0.3253731343283582,1.3793758480325644,1.0407452907452908,4.239366138448707
523,J,"Darcis, G; Kula, A; Bouchat, S; Fujinaga, K; Corazza, F; Ait-Ammar, A; Delacourt, N; Melard, A; Kabeya, K; Vanhulle, C; Van Driessche, B; Gatot, JS; Cherrier, T; Pianowski, LF; Gama, L; Schwartz, C; Vila, J; Burny, A; Clumeck, N; Moutschen, M; De Wit, S; Peterlin, BM; Rouzioux, C; Rohr, O; Van Lint, C",,,,"Darcis, Gilles; Kula, Anna; Bouchat, Sophie; Fujinaga, Koh; Corazza, Francis; Ait-Ammar, Amina; Delacourt, Nadege; Melard, Adeline; Kabeya, Kabamba; Vanhulle, Caroline; Van Driessche, Benoit; Gatot, Jean-Stephane; Cherrier, Thomas; Pianowski, Luiz F.; Gama, Lucio; Schwartz, Christian; Vila, Jorge; Burny, Arsene; Clumeck, Nathan; Moutschen, Michel; De Wit, Stephane; Peterlin, B. Matija; Rouzioux, Christine; Rohr, Olivier; Van Lint, Carine",,,An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression,PLOS PATHOGENS,,,English,Article,,,,,,,CD4(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; BET BROMODOMAIN INHIBITION; SMALL NUCLEAR RIBONUCLEOPROTEIN; HISTONE DEACETYLASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD MONOCYTES; P-TEFB; TRANSCRIPTION ELONGATION,"The persistence of latently infected cells in patients under combinatory antiretroviral therapy (cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are needed and activation of viral gene expression in latently infected cells is one promising strategy. Bromodomain and Extraterminal (BET) bromodomain inhibitors (BETi) are compounds able to reactivate latent proviruses in a positive transcription elongation factor b (P-TEFb)-dependent manner. In this study, we tested the reactivation potential of protein kinase C (PKC) agonists (prostratin, bryostatin-1 and ingenol-B), which are known to activate NF-kappa B signaling pathway as well as P-TEFb, used alone or in combination with P-TEFb-releasing agents (HMBA and BETi (JQ1, I-BET, I-BET151)). Using in vitro HIV-1 post-integration latency model cell lines of T-lymphoid and myeloid lineages, we demonstrated that PKC agonists and P-TEFb-releasing agents alone acted as potent latencyreversing agents (LRAs) and that their combinations led to synergistic activation of HIV-1 expression at the viral mRNA and protein levels. Mechanistically, combined treatments led to higher activations of P-TEFb and NF-kappa B than the corresponding individual drug treatments. Importantly, we observed in ex vivo cultures of CD8+-depleted PBMCs from 35 cART-treated HIV-1+ aviremic patients that the percentage of reactivated cultures following combinatory bryostatin-1+ JQ1 treatment was identical to the percentage observed with anti-CD3+anti-CD28 antibodies positive control stimulation. Remarkably, in ex vivo cultures of resting CD4+T cells isolated from 15 HIV-1+ cART-treated aviremic patients, the combinations bryostatin-1+ JQ1 and ingenol-B+JQ1 released infectious viruses to levels similar to that obtained with the positive control stimulation. The potent effects of these two combination treatments were already detected 24 hours post-stimulation. These results constitute the first demonstration of LRA combinations exhibiting such a potent effect and represent a proof-of-concept for the co-administration of two different types of LRAs as a potential strategy to reduce the size of the latent HIV-1 reservoirs.","[Darcis, Gilles; Kula, Anna; Bouchat, Sophie; Delacourt, Nadege; Vanhulle, Caroline; Van Driessche, Benoit; Vila, Jorge; Burny, Arsene; Van Lint, Carine] Univ Libre Bruxelles, IBMM, Serv Mol Virol, Gosselies, Belgium; [Darcis, Gilles; Moutschen, Michel] Univ Liege, Ctr Hosp Univ CHU Liege, Serv Malad Infect, Liege, Belgium; [Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Corazza, Francis] Univ Libre Bruxelles, Brugmann Univ Hosp, Immunol Lab, Brussels, Belgium; [Ait-Ammar, Amina; Schwartz, Christian; Rohr, Olivier] Univ Strasbourg, Inst Univ Technol Louis Pasteur Schiltigheim, Schiltigheim, France; [Melard, Adeline; Rouzioux, Christine] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Virol, Paris, France; [Kabeya, Kabamba; Clumeck, Nathan; De Wit, Stephane] ULB, CHU St Pierre, Serv Malad Infect, Brussels, Belgium; [Gatot, Jean-Stephane] Ctr Hosp Univ CHU Liege, Serv Genet, Liege, Belgium; [Cherrier, Thomas] IGBMC, Illkirch Graffenstaden, France; [Pianowski, Luiz F.] Kyolab, Sao Paulo, Brazil; [Gama, Lucio] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Rohr, Olivier] Univ Strasbourg, EA7292, Inst Parasitol & Pathol Trop, Strasbourg, France","Darcis, G (reprint author), Univ Libre Bruxelles, IBMM, Serv Mol Virol, Gosselies, Belgium.",cvlint@ulb.ac.be,"CHERRIER, Thomas/W-2470-2019","CHERRIER, Thomas/0000-0002-0707-9204; Gama, Lucio/0000-0001-9511-012X; Darcis, Gilles/0000-0001-8192-1351","Agence Nationale de Recherches sur le SIDA (ANRS, France); Belgian Fund for Scientific Research (FRS-FNRS, Belgium); Fondation Roi Baudouin; NEAT program; Walloon Region (the Excellence Program ""Cibles""); Institut Universitaire de France (IUF)","We acknowledge grant support from the ""Agence Nationale de Recherches sur le SIDA"" (ANRS, France), the Belgian Fund for Scientific Research (FRS-FNRS, Belgium), the ""Fondation Roi Baudouin"", the NEAT program, the Walloon Region (the Excellence Program ""Cibles"") and the ""Institut Universitaire de France (IUF)"" (to OR). AK is a postdoctoral fellow of ""Les Amis des Instituts Pasteur a Bruxelles, asbl"". SB is a fellow of the Belgian ""Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)"". BVD is an ANRS post-doctoral fellow. GD and CVL are Aspirant fellow and Research Director of the FRS-FNRS, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,115,117,0,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005063,10.1371/journal.ppat.1005063,,,,36,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200065,26225566.0,"DOAJ Gold, Green Published",,,16/08/2019,118,50,78,9463,2303,1708,595,7160,5762,39,1359,77,5,0,0,114,114,1,,120,0,119,1,0,121,121,95,78,0,0,0,0,0,0,3,45,3,9578,174,0,121,657,3,7209,2328,174,0,121,657,3,41,,5,1,0,0,4,0,0,1,0,0,0,118,1,0,47.938,4.108988276161528,1.3216480446927374,0.32164804469273744,1.4537709497206703,1.0999682975800487,4.519756838905775
524,J,"Dickson, RP; Huffnagle, GB",,,,"Dickson, Robert P.; Huffnagle, Gary B.",,,The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease,PLOS PATHOGENS,,,English,Article,,,,,,,EXACERBATIONS; ASPIRATION,,"[Dickson, Robert P.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA","Dickson, RP (reprint author), Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.",ghuff@umich.edu,,,"NIH [T32HL00774921, U01HL098961, R01HL114447]; Host Microbiome Initiative of the University of Michigan","Funding: Funding provided by NIH grants T32HL00774921 (RPD), U01HL098961 (GBH), R01HL114447 (GBH). Support provided by the Host Microbiome Initiative of the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,25,109,114,1,25,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004923,10.1371/journal.ppat.1004923,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200005,26158874.0,"DOAJ Gold, Green Published",,,16/08/2019,113,86,256,35194,4368,3401,967,30826,25842,73,4911,256,32,0,0,109,109,4,,698,16,358,0,16,117,115,117,70,0,0,0,0,0,0,6,74,5,35601,9,2,40,204,7,30972,4482,9,2,40,204,7,147,,8,0,0,0,30,0,2,1,0,0,0,352,0,0,78.6,8.057234432234432,1.1416985661454617,0.1416985661454616,1.1618114578602479,1.0176166391998636,8.199175824175825
525,J,"Ermert, D; Shaughnessy, J; Joeris, T; Kaplan, J; Pang, CJ; Kurt-Jones, EA; Rice, PA; Ram, S; Blom, AM",,,,"Ermert, David; Shaughnessy, Jutamas; Joeris, Thorsten; Kaplan, Jakub; Pang, Catherine J.; Kurt-Jones, Evelyn A.; Rice, Peter A.; Ram, Sanjay; Blom, Anna M.",,,Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors,PLOS PATHOGENS,,,English,Article,,,,,,,C4B-BINDING PROTEIN C4BP; FACTOR-H; MOLECULAR-MECHANISM; SERUM RESISTANCE; SURFACE PROTEIN; BINDING; PYOGENES; INFECTIONS; ACTIVATION; DEPOSITION,"Streptococcus pyogenes, also known as Group A Streptococcus (GAS), is an important human bacterial pathogen that can cause invasive infections. Once it colonizes its exclusively human host, GAS needs to surmount numerous innate immune defense mechanisms, including opsonization by complement and consequent phagocytosis. Several strains of GAS bind to human-specific complement inhibitors, C4b-binding protein (C4BP) and/or Factor H (FH), to curtail complement C3 (a critical opsonin) deposition. This results in diminished activation of phagocytes and clearance of GAS that may lead to the host being unable to limit the infection. Herein we describe the course of GAS infection in three human complement inhibitor transgenic (tg) mouse models that examined each inhibitor (human C4BP or FH) alone, or the two inhibitors together (C4BPxFH or 'double' tg). GAS infection with strains that bound C4BP and FH resulted in enhanced mortality in each of the three transgenic mouse models compared to infection in wild type mice. In addition, GAS manifested increased virulence in C4BPxFH mice: higher organism burdens and greater elevations of pro-inflammatory cytokines and they died earlier than single transgenic or wt controls. The effects of hu-C4BP and hu-FH were specific for GAS strains that bound these inhibitors because strains that did not bind the inhibitors showed reduced virulence in the 'double' tg mice compared to strains that did bind; mortality was also similar in wild-type and C4BPxFH mice infected by non-binding GAS. Our findings emphasize the importance of binding of complement inhibitors to GAS that results in impaired opsonization and phagocytic killing, which translates to enhanced virulence in a humanized whole animal model. This novel hu-C4BPxFH tg model may prove invaluable in studies of GAS pathogenesis and for developing vaccines and therapeutics that rely on human complement activation for efficacy.","[Ermert, David; Kaplan, Jakub; Blom, Anna M.] Lund Univ, Dept Translat Med, Div Med Prot Chem, Malmo, Sweden; [Ermert, David; Shaughnessy, Jutamas; Pang, Catherine J.; Kurt-Jones, Evelyn A.; Rice, Peter A.; Ram, Sanjay] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Joeris, Thorsten] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Frederiksberg C, Denmark; [Joeris, Thorsten] Lund Univ, Dept Expt Med Sci, Immunol Sect, Lund, Sweden","Blom, AM (reprint author), Lund Univ, Dept Translat Med, Div Med Prot Chem, Malmo, Sweden.",anna.blom@med.lu.se,"Blom, Anna/B-9607-2009","Blom, Anna/0000-0002-1348-1734","Swedish Research Council [K2012-66X-14928-09-5]; Swedish Government Funds for Clinical research (ALF); Torsten Soderberg Foundation [MN 2/12]; Crafoord Foundation [20130978]; Lars Hierta Memorial [FO2013-0429]; Osterlund Foundation; Greta and Johan Kock Foundation; Gustav V 80-years anniversary Foundation; Department of Medicine, University of Massachusetts Medical School","This work was supported by Swedish Research Council (K2012-66X-14928-09-5, www.vr.se, to AMB); the Swedish Government Funds for Clinical research (ALF, to AMB; Kungl fysiografiska sallskapet (www.fysiografen.se, to DE); The Torsten Soderberg Foundation (MN 2/12, http://www.torstensoderbergsstiftelse.se, to AMB); Crafoord Foundation (20130978, www.crafoord.se, to DE); Lars Hierta Memorial (FO2013-0429, www.larshiertasminne.se, to DE); Osterlund Foundation (http://www.alfredosterlundsstiftelse.se, to AMB); Greta and Johan Kock Foundation (http://www.kockskastiftelsen.se, to AMB); Gustav V 80-years anniversary Foundation (www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond.4.11deaee4147afe3f46050da.html, to AMB) and unrestricted funds from the Department of Medicine, University of Massachusetts Medical School (to PAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,20,20,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005043,10.1371/journal.ppat.1005043,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200049,26200783.0,"DOAJ Gold, Green Published",,,16/08/2019,19,23,16,4617,771,549,222,3846,3197,23,626,16,17,0,0,21,21,0,,23,4,23,0,4,22,22,18,11,0,0,0,0,0,0,0,6,2,4710,79,0,71,186,2,3879,790,38,0,71,184,2,41,,0,0,0,0,18,0,0,1,0,0,0,23,0,0,9.75,5.988326848249027,1.2004680187207488,0.20046801872074882,1.2935517420696827,1.0775395278319255,6.4526588845654995
526,J,"Fukui, T; Kawamoto, M; Shoji, K; Kiuchi, T; Sugano, S; Shimada, T; Suzuki, Y; Katsuma, S",,,,"Fukui, Takahiro; Kawamoto, Munetaka; Shoji, Keisuke; Kiuchi, Takashi; Sugano, Sumio; Shimada, Toru; Suzuki, Yutaka; Katsuma, Susumu",,,The Endosymbiotic Bacterium Wolbachia Selectively Kills Male Hosts by Targeting the Masculinizing Gene,PLOS PATHOGENS,,,English,Article,,,,,,,SEX DETERMINATION; BOMBYX-MORI; OSTRINIA-SCAPULALIS; DOSAGE COMPENSATION; DOUBLESEX HOMOLOG; CHROMOSOMES; DROSOPHILA; SILKWORM; LEPIDOPTERA; PROTEIN,"Pathogens are known to manipulate the reproduction and development of their hosts for their own benefit. Wolbachia is an endosymbiotic bacterium that infects a wide range of insect species. Wolbachia is known as an example of a parasite that manipulates the sex of its host's progeny. Infection of Ostrinia moths by Wolbachia causes the production of all-female progeny, however, the mechanism of how Wolbachia accomplishes this male-specific killing is unknown. Here we show for the first time that Wolbachia targets the host masculinizing gene of Ostrinia to accomplish male-killing. We found that Wolbachia-infected O. furnacalis embryos do not express the male-specific splice variant of doublesex, a gene which acts at the downstream end of the sex differentiation cascade, throughout embryonic development. Transcriptome analysis revealed that Wolbachia infection markedly reduces the mRNA level of Masc, a gene that encodes a protein required for both masculinization and dosage compensation in the silkworm Bombyx mori. Detailed bioinformatic analysis also elucidated that dosage compensation of Z-linked genes fails in Wolbachia-infected O. furnacalis embryos, a phenomenon that is extremely similar to that observed in Masc mRNA-depleted male embryos of B. mori. Finally, injection of in vitro transcribed Masc cRNA into Wolbachia-infected embryos rescued male progeny. Our results show that Wolbachia-induced male-killing is caused by a failure of dosage compensation via repression of the host masculinizing gene. Our study also shows a novel strategy by which a pathogen hijacks the host sex determination cascade.","[Fukui, Takahiro; Kawamoto, Munetaka; Shoji, Keisuke; Kiuchi, Takashi; Shimada, Toru; Katsuma, Susumu] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan","Fukui, T (reprint author), Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.",katsuma@ss.ab.a.u-tokyo.ac.jp,"Shimada, Toru/A-2033-2011","Shimada, Toru/0000-0002-5791-0000","Japan Society for the Promotion of Science [15K14893]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26034A]","This work was supported by grants from Japan Society for the Promotion of Science grant number 15K14893, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry grant number 26034A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,24,17,17,0,46,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005048,10.1371/journal.ppat.1005048,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200052,26172536.0,"DOAJ Gold, Green Published",,,16/08/2019,16,33,68,7183,898,649,249,6285,5194,22,1069,68,8,0,0,16,16,4,,182,11,95,0,11,20,17,20,9,0,0,0,0,0,0,0,25,4,7312,30,15,102,371,2,6269,898,30,15,102,371,2,145,,0,1,0,0,16,0,0,1,0,0,0,95,0,0,16.656,7.998886414253898,1.1428798727128082,0.14287987271280828,1.2272076372315035,1.0737853264652653,8.589086859688196
527,J,"Gilman, MSA; Moin, SM; Mas, V; Chen, M; Patel, NK; Kramer, K; Zhu, Q; Kabeche, SC; Kumar, A; Palomo, C; Beaumont, T; Baxa, U; Ulbrandt, ND; Melero, JA; Graham, BS; McLellan, JS",,,,"Gilman, Morgan S. A.; Moin, Syed M.; Mas, Vicente; Chen, Man; Patel, Nita K.; Kramer, Kari; Zhu, Qing; Kabeche, Stephanie C.; Kumar, Azad; Palomo, Concepcion; Beaumont, Tim; Baxa, Ulrich; Ulbrandt, Nancy D.; Melero, Jose A.; Graham, Barney S.; McLellan, Jason S.",,,"Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein",PLOS PATHOGENS,,,English,Article,,,,,,,RESPIRATORY-SYNCYTIAL-VIRUS; 2 DISTINCT SITES; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; F-GLYCOPROTEIN; IN-VITRO; PROTEIN; INFANTS; CONFORMATION,"Prevention efforts for respiratory syncytial virus (RSV) have been advanced due to the recent isolation and characterization of antibodies that specifically recognize the prefusion conformation of the RSV fusion (F) glycoprotein. These potently neutralizing antibodies are in clinical development for passive prophylaxis and have also aided the design of vaccine antigens that display prefusion-specific epitopes. To date, prefusion-specific antibodies have been shown to target two antigenic sites on RSV F, but both of these sites are also present on monomeric forms of F. Here we present a structural and functional characterization of human antibody AM14, which potently neutralized laboratory strains and clinical isolates of RSV from both A and B subtypes. The crystal structure and location of escape mutations revealed that AM14 recognizes a quaternary epitope that spans two protomers and includes a region that undergoes extensive conformational changes in the pre- to post-fusion F transition. Binding assays demonstrated that AM14 is unique in its specific recognition of trimeric furin-cleaved prefusion F, which is the mature form of F on infectious virions. These results demonstrate that the prefusion F trimer contains potent neutralizing epitopes not present on monomers and that AM14 should be particularly useful for characterizing the conformational state of RSV F-based vaccine antigens.","[Gilman, Morgan S. A.; Kabeche, Stephanie C.; McLellan, Jason S.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Moin, Syed M.; Chen, Man; Kumar, Azad; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Mas, Vicente; Palomo, Concepcion; Melero, Jose A.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Mas, Vicente; Palomo, Concepcion; Melero, Jose A.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Patel, Nita K.; Kramer, Kari; Zhu, Qing; Ulbrandt, Nancy D.] Medimmune Inc, Gaithersburg, MD 20878 USA; [Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, NL-1105 AZ Amsterdam, Netherlands; [Baxa, Ulrich] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Canc Res Technol Program, Electron Microscopy Lab, Frederick, MD USA","McLellan, JS (reprint author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.",Jason.S.McLellan@Dartmouth.edu,"Mas, Vicente/M-4776-2015","Mas, Vicente/0000-0002-0887-0743; Melero, Jose A./0000-0001-8148-6521","NSF AMP; NIH/NIGMS via NSF award [DMR-1332208]; NIH/NIGMS [GM-103485]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; MedImmune Inc; ""Plan Nacional I+D+I"" (Ministerio de Economia y Competitividad) [SAF2012-31217]; National Institute of Allergy and Infectious Diseases; National Institutes of Health [1R43AI112124]","Data collection at CHESS is supported by the NSF & NIH/NIGMS via NSF award DMR-1332208, and the MacCHESS resource is supported by NIH/NIGMS award GM-103485. Results shown in this report were also derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. Work performed by UB was funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. NKP, KK, QZ and NDU were employed by MedImmune Inc, which funded the data collection and analysis of their experiments (neutralization assays, MARM isolation and affinity of D25 for peptide). JAM received funding from ""Plan Nacional I+D+I"" (Ministerio de Economia y Competitividad), grant SAF2012-31217. BSG was supported by funding from the intramural program of the National Institute of Allergy and Infectious Diseases. JSM received funding from the National Institutes of Health, grant 1R43AI112124. With the exception of MedImmune's involvement stated above, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,52,58,59,0,38,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005035,10.1371/journal.ppat.1005035,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200047,26161532.0,"DOAJ Gold, Green Published",,,16/08/2019,56,31,44,10120,2709,2084,625,7411,5917,28,1466,44,0,0,0,58,58,0,,102,1,52,0,1,61,61,47,41,0,0,0,0,0,0,0,31,0,10252,116,0,458,92,1,7491,2736,116,0,458,92,1,25,,0,0,0,0,2,0,1,1,0,0,0,52,0,0,7.75,3.7356958287190847,1.365537714208609,0.3655377142086088,1.4114154635002023,1.033596837944664,3.861203396087117
528,J,"Heung, LJ; Jhingran, A; Hohl, TM",,,,"Heung, Lena J.; Jhingran, Anupam; Hohl, Tobias M.",,,Deploying FLAREs to Visualize Functional Outcomes of Host-Pathogen Encounters,PLOS PATHOGENS,,,English,Article,,,,,,,FLUORESCENT PROTEINS; DENDRITIC CELLS; MACROPHAGES; REPORTER; INTERNALIZATION; DEGRADATION; SALMONELLA; MONOCYTES; BACTERIAL; DYNAMICS,,"[Heung, Lena J.; Jhingran, Anupam; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA","Heung, LJ (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA.",hohlt@mskcc.org,,"Heung, Lena/0000-0002-6655-575X","NIH [R01 AI093808, R21 AI105617]; Burroughs Wellcome Fund; Lucille Castori Center for Microbes, Inflammation, and Cancer","Funding: TMH is supported by NIH grant R01 AI093808, NIH grant R21 AI105617, and the Burroughs Wellcome Fund as an Investigator in the Pathogenesis of Infectious Diseases. AJ is supported by a postdoctoral fellowship from the Lucille Castori Center for Microbes, Inflammation, and Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,24,5,5,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004912,10.1371/journal.ppat.1004912,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200004,26158781.0,"DOAJ Gold, Green Published",,,16/08/2019,4,40,10,3580,321,243,78,3259,2839,25,395,10,0,0,0,4,4,0,,10,0,10,0,0,5,4,4,5,0,0,0,0,0,0,0,40,0,3592,6,0,37,42,1,3253,321,6,0,37,42,1,18,,0,0,0,0,1,0,0,1,0,0,0,11,0,0,1.25,11.152647975077882,1.0984964713102179,0.09849647131021785,1.1169070266953054,1.0167597765363128,11.33956386292835
529,J,"Khan, SA; Kong, EF; Meiller, TF; Jabra-Rizk, MA",,,,"Khan, Shariq A.; Kong, Eric F.; Meiller, Timothy F.; Jabra-Rizk, Mary Ann",,,"Periodontal Diseases: Bug Induced, Host Promoted",PLOS PATHOGENS,,,English,Article,,,,,,,COMPLEMENT; ARTHRITIS; INNATE; MODELS,,"[Khan, Shariq A.; Meiller, Timothy F.; Jabra-Rizk, Mary Ann] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Kong, Eric F.] Univ Maryland, Grad Program Life Sci, Mol Microbiol & Immunol Program, Baltimore, MD 21201 USA; [Kong, Eric F.; Jabra-Rizk, Mary Ann] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA","Jabra-Rizk, MA (reprint author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.",mrizk@umaryland.edu,,"Khandelwal, Sourabh/0000-0001-8833-6462",NIH [R01DE020939],"Funding: This work was funded by NIH grant R01DE020939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,24,43,44,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004952,10.1371/journal.ppat.1004952,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200012,26226364.0,"DOAJ Gold, Green Published",,,16/08/2019,27,12,38,8869,1424,1056,368,7445,5886,37,1522,38,0,0,0,22,22,0,,57,71,57,0,71,28,28,12,16,0,0,0,0,0,0,0,12,0,9338,32,0,289,448,10,7554,1451,32,0,289,448,10,333,,0,0,0,0,0,0,0,1,0,0,0,58,0,0,0.25,6.228230337078652,1.1912693082605776,0.19126930826057756,1.318737407656145,1.107001916788815,6.894662921348314
530,J,"Marine, M; Brown, NA; Riano-Pachon, DM; Goldman, GH",,,,"Marine, Marcal; Brown, Neil Andrew; Riano-Pachon, Diego Mauricio; Goldman, Gustavo Henrique",,,On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon Species,PLOS PATHOGENS,,,English,Article,,,,,,,DESORPTION IONIZATION-TIME; BLOOD-STREAM INFECTIONS; MOLECULAR-IDENTIFICATION; GENOME SEQUENCE; MURINE MODEL; ASAHII; SUSCEPTIBILITY; VORICONAZOLE; EFFICACY; MALIGNANCIES,,"[Marine, Marcal; Brown, Neil Andrew; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Riano-Pachon, Diego Mauricio; Goldman, Gustavo Henrique] CTBE, Lab Nacl Ciencia & Tecnol Bioetanol, Campinas, SP, Brazil","Goldman, GH (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil.",ggoldman@usp.br,"Riano-Pachon, Diego Mauricio/B-4891-2014; Riano-Pachon, Diego/A-1755-2010; Goldman, Gustavo Henrique/F-1848-2013","Riano-Pachon, Diego Mauricio/0000-0001-9803-3465; Riano-Pachon, Diego/0000-0001-9803-3465; Goldman, Gustavo Henrique/0000-0002-2986-350X; Brown, Neil/0000-0002-3555-5765",Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP),"Funding: We would like to thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,14,16,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004982,10.1371/journal.ppat.1004982,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200019,26226483.0,"DOAJ Gold, Green Published",,,16/08/2019,14,43,20,7626,1482,1203,279,6144,5278,29,837,20,5,0,0,12,12,0,,27,11,27,0,11,14,14,9,7,0,0,0,0,0,0,0,51,0,7812,44,52,107,135,1,6213,1521,44,52,107,135,1,78,,0,0,0,0,15,0,1,2,0,0,0,26,0,0,8.95,5.145748987854251,1.2412109375,0.2412109375,1.3006184895833333,1.0478625753999475,5.392037786774629
531,J,"Misawa, Y; Kelley, KA; Wang, XG; Wang, LH; Park, WB; Birtel, J; Saslowsky, D; Lee, JC",,,,"Misawa, Yoshiki; Kelley, Kathryn A.; Wang, Xiaogang; Wang, Linhui; Park, Wan Beom; Birtel, Johannes; Saslowsky, David; Lee, Jean C.",,,"Staphylococcus aureus Colonization of the Mouse Gastrointestinal Tract Is Modulated by Wall Teichoic Acid, Capsule, and Surface Proteins",PLOS PATHOGENS,,,English,Article,,,,,,,METHICILLIN-RESISTANT; NASAL COLONIZATION; MOLECULAR CHARACTERIZATION; ENDOTHELIAL-CELLS; MAJOR AUTOLYSIN; CARRIAGE; FIBRINOGEN; FREQUENCY; VIRULENCE; MODEL,"Staphylococcus aureus colonizes the nose, throat, skin, and gastrointestinal (GI) tract of humans. GI carriage of S. aureus is difficult to eradicate and has been shown to facilitate the transmission of the bacterium among individuals. Although staphylococcal colonization of the GI tract is asymptomatic, it increases the likelihood of infection, particularly skin and soft tissue infections caused by USA300 isolates. We established a mouse model of persistent S. aureus GI colonization and characterized the impact of selected surface antigens on colonization. In competition experiments, an acapsular mutant colonized better than the parental strain Newman, whereas mutants defective in sortase A and clumping factor A showed impaired ability to colonize the GI tract. Mutants lacking protein A, clumping factor B, poly-N-acetyl glucosamine, or SdrCDE showed no defect in colonization. An S. aureus wall teichoic acid (WTA) mutant (Delta tagO) failed to colonize the mouse nose or GI tract, and the tagO and clfA mutants showed reduced adherence in vitro to intestinal epithelial cells. The tagO mutant was recovered in lower numbers than the wild type strain in the murine stomach and duodenum 1 h after inoculation. This reduced fitness correlated with the in vitro susceptibility of the tagO mutant to bile salts, proteases, and a gut-associated defensin. Newman Delta tagO showed enhanced susceptibility to autolysis, and an autolysin (atl) tagO double mutant abrogated this phenotype. However, the atl tagO mutant did not survive better in the mouse GI tract than the tagO mutant. Our results indicate that the failure of the tagO mutant to colonize the GI tract correlates with its poor adherence and susceptibility to bactericidal factors within the mouse gut, but not to enhanced activity of its major autolysin.","[Misawa, Yoshiki; Kelley, Kathryn A.; Wang, Xiaogang; Wang, Linhui; Park, Wan Beom; Birtel, Johannes; Lee, Jean C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis,Dept Med, Boston, MA 02115 USA; [Park, Wan Beom] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Saslowsky, David] Harvard Univ, Boston Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA","Misawa, Y (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis,Dept Med, Boston, MA 02115 USA.",jclee@rics.bwh.harvard.edu,,"Lee, Jean/0000-0002-8094-5180",Seoul National University Hospital; Chinese Scholarship Council; National Institutes of Health [R01 AI088754],"YM was supported by a Grant-in-Aid for Human Resources Development in Clinical Laboratory Medicine via Professor Kunihiko Kobayashi at Chubu University, Nagoya, Japan. WBP was supported by Seoul National University Hospital. LW was supported in part by the Chinese Scholarship Council. The work was supported in part by National Institutes of Health R01 AI088754 to JCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,20,20,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005061,10.1371/journal.ppat.1005061,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200063,26201029.0,"DOAJ Gold, Green Published",,,16/08/2019,19,10,45,6716,1029,767,262,5687,4681,25,981,45,6,0,0,17,17,0,,60,2,60,0,2,19,19,11,10,0,0,0,0,0,0,0,4,0,6806,95,0,112,267,1,5718,1051,95,0,112,267,1,37,,0,0,0,0,10,0,0,1,0,0,0,60,0,0,4.85,6.5267249757045676,1.180938983646914,0.18093898364691402,1.2604184983295235,1.0673019654556284,6.965986394557823
532,J,"Pinkevych, M; Cromer, D; Tolstrup, M; Grimm, AJ; Cooper, DA; Lewin, SR; Sogaard, OS; Rasmussen, TA; Kent, SJ; Kelleher, AD; Davenport, MP",,,,"Pinkevych, Mykola; Cromer, Deborah; Tolstrup, Martin; Grimm, Andrew J.; Cooper, David A.; Lewin, Sharon R.; Sogaard, Ole S.; Rasmussen, Thomas A.; Kent, Stephen J.; Kelleher, Anthony D.; Davenport, Miles P.",,,HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission,PLOS PATHOGENS,,,English,Article,,,,,,,SUPPRESSIVE ANTIRETROVIRAL THERAPY; STRUCTURED TREATMENT INTERRUPTIONS; CD4(+) T-CELLS; ANTIVIRAL THERAPY; VIRAL RESERVOIR; CLINICAL-TRIAL; IN-VIVO; INFECTION; DYNAMICS; VIREMIA,"HIV infection can be effectively controlled by anti-retroviral therapy (ART) inmost patients. However therapy must be continued for life, because interruption of ART leads to rapid recrudescence of infection fromlong-lived latently infected cells. A number of approaches are currently being developed to 'purge' the reservoir of latently infected cells in order to either eliminate infection completely, or significantly delay the time to viral recrudescence after therapy interruption. A fundamental question in HIV research is how frequently the virus reactivates from latency, and thus how much the reservoir might need to be reduced to produce a prolonged antiretroviral-free HIV remission. Here we provide the first direct estimates of the frequency of viral recrudescence after ART interruption, combining data from four independent cohorts of patients undergoing treatment interruption, comprising 100 patients in total. We estimate that viral replication is initiated on average once every approximate to 6 days (range 5.1-7.6 days). This rate is around 24 times lower than previous thought, and is very similar across the cohorts. In addition, we analyse data on the ratios of different 'reactivation founder' viruses in a separate cohort of patients undergoing ART-interruption, and estimate the frequency of successful reactivation to be once every 3.6 days. This suggests that a reduction in the reservoir size of around 50-70-fold would be required to increase the average time-to-recrudescence to about one year, and thus achieve at least a short period of anti-retroviral free HIV remission. Our analyses suggests that time-to-recrudescence studies will need to be large in order to detect modest changes in the reservoir, and that macaque models of SIV latency may have much higher frequencies of viral recrudescence after ART interruption than seen in human HIV infection. Understanding the mean frequency of recrudescence from latency is an important first step in approaches to prolong antiretroviral-free viral remission in HIV.","[Pinkevych, Mykola; Cromer, Deborah; Grimm, Andrew J.; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Tolstrup, Martin; Sogaard, Ole S.; Rasmussen, Thomas A.] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Cooper, David A.; Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Lewin, Sharon R.] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic 3004, Australia; [Kent, Stephen J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia","Davenport, MP (reprint author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.",m.davenport@unsw.edu.au,"Sogaard, Ole/P-6058-2016","Lewin, Sharon Ruth/0000-0002-0330-8241; Davenport, Miles/0000-0002-4751-1831; Tolstrup, Martin/0000-0001-7020-5173; Sogaard, Ole/0000-0001-9107-2023; Rasmussen, Thomas Aagaard/0000-0001-5354-2442; Kent, Stephen/0000-0002-8539-4891","Australian National Health and Medical Research Council (NHMRC) [1052979, 630 542, 1041832, 1042654, 10220536]; Danish Council for Independent Research","Funding: This work was funded by a Australian National Health and Medical Research Council (NHMRC) Program Grant (1052979, to MPD, ADK, SJK, DAC and SRL), NHMRC Fellowships to MPD (630 542), SJK (1041832), SRL (1042654), and ADK (10220536), and by the Danish Council for Independent Research (OSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,44,50,50,1,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005000,10.1371/journal.ppat.1005000,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200026,26133551.0,"DOAJ Gold, Green Published",,,16/08/2019,49,27,66,8887,850,610,240,8037,6893,22,1122,63,16,0,0,47,47,4,,150,6,75,3,6,57,51,57,39,0,0,0,0,0,0,0,11,1,8982,41,4,100,172,3,8069,859,41,4,100,172,3,54,,0,1,0,0,26,0,5,1,0,0,0,75,3,0,23.05,10.455294117647059,1.1057608560408112,0.10576085604081124,1.1440836132885406,1.0346573646899966,10.81764705882353
533,J,"Poppe, S; Dorsheimer, L; Happel, P; Stukenbrock, EH",,,,"Poppe, Stephan; Dorsheimer, Lena; Happel, Petra; Stukenbrock, Eva Holtgrewe",,,Rapidly Evolving Genes Are Key Players in Host Specialization and Virulence of the Fungal Wheat Pathogen Zymoseptoria tritici (Mycosphaerella graminicola),PLOS PATHOGENS,,,English,Article,,,,,,,SEQUENCE ALIGNMENT; PROTEIN-STRUCTURE; METABOLISM; INSIGHTS; SELECTION; REVEALS; GENOME; MODEL; RCC1,"The speciation of pathogens can be driven by divergent host specialization. Specialization to a new host is possible via the acquisition of advantageous mutations fixed by positive selection. Comparative genome analyses of closely related species allows for the identification of such key substitutions via inference of genome-wide signatures of positive selection. We previously used a comparative genomics framework to identify genes that have evolved under positive selection during speciation of the prominent wheat pathogen Zymoseptoria tritici (synonym Mycosphaerella graminicola). In this study, we conducted functional analyses of four genes exhibiting strong signatures of positive selection in Z. tritici. We deleted the four genes in Z. tritici and confirm a virulence-related role of three of the four genes Delta Zt80707, Delta Zt89160 and Delta Zt103264. The two mutants Delta Zt80707 and Delta Zt103264 show a significant reduction in virulence during infection of wheat; the Delta Zt89160 mutant causes a hypervirulent phenotype in wheat. Mutant phenotypes of Delta Zt80707, Delta Zt89160 and Delta Zt103264 can be restored by insertion of the wild-type genes. However, the insertion of the Zt80707 and Zt89160 orthologs from Z. pseudotritici and Z. ardabiliae do not restore wild-type levels of virulence, suggesting that positively selected substitutions in Z. tritici may relate to divergent host specialization. Interestingly, the gene Zt80707 encodes also a secretion signal that targets the protein for cell secretion. This secretion signal is however only transcribed in Z. tritici, suggesting that Z. tritici-specific substitutions relate to a new function of the protein in the extracellular space of the wheat-Z. tritici interaction. Together, the results presented here highlight that Zt80707, Zt103264 and Zt89160 represent key genes involved in virulence and host-specific disease development of Z. tritici. Our findings illustrate that evolutionary predictions provide a powerful tool for the identification of novel traits crucial for host adaptation and pathogen evolution.","[Poppe, Stephan; Dorsheimer, Lena; Happel, Petra; Stukenbrock, Eva Holtgrewe] Max Planck Inst Terr Microbiol, Max Planck Res Grp Fungal Biodivers, D-35043 Marburg, Germany","Poppe, S (reprint author), Max Planck Inst Terr Microbiol, Max Planck Res Grp Fungal Biodivers, D-35043 Marburg, Germany.",estukenbrock@bot.uni-kiel.de,"Holtgrewe Stukenbrock, Eva/I-4333-2016","Holtgrewe Stukenbrock, Eva/0000-0001-8590-3345",Max Planck Society,"This study was funded by intramural funding to EHS by the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,46,38,38,1,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005055,10.1371/journal.ppat.1005055,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200059,26225424.0,"DOAJ Gold, Green Published",,,16/08/2019,36,31,75,8462,542,419,123,7920,6802,59,1059,75,26,0,0,38,38,2,,98,0,98,0,0,47,36,47,17,0,0,0,0,0,0,0,5,11,8461,138,0,101,128,5,7888,542,138,0,101,128,5,31,,0,0,0,0,17,0,0,1,0,0,0,99,0,0,8.75,15.612546125461254,1.0684343434343435,0.06843434343434343,1.1018939393939393,1.031316473646892,16.10147601476015
534,J,"Reh, L; Magnus, C; Schanz, M; Weber, J; Uhr, T; Rusert, P; Trkola, A",,,,"Reh, Lucia; Magnus, Carsten; Schanz, Merle; Weber, Jacqueline; Uhr, Therese; Rusert, Peter; Trkola, Alexandra",,,Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSE; T-CELLS; MONOCLONAL-ANTIBODIES; ENTRY INHIBITORS; PASSIVE TRANSFER; FC-RECEPTOR; TYPE-1; SPREAD; INFECTION,"An increasing number of broadly neutralizing antibodies (bnAbs) are considered leads for HIV-1 vaccine development and novel therapeutics. Here, we systematically explored the capacity of bnAbs to neutralize HIV-1 prior to and post-CD4 engagement and to block HIV-1 cell-cell transmission. Cell-cell spread is known to promote a highly efficient infection with HIV-1 which can inflict dramatic losses in neutralization potency compared to free virus infection. Selection of bnAbs that are capable of suppressing HIV irrespective of the transmission mode therefore needs to be considered to ascertain their in vivo activity in therapeutic use and vaccines. Employing assay systems that allow for unambiguous discrimination between free virus and cell-cell transmission to T cells, we probed a panel of 16 bnAbs for their activity against 11 viruses from subtypes A, B and C during both transmission modes. Over a wide range of bnAb-virus combinations tested, inhibitory activity against HIV-1 cell-cell transmission was strongly decreased compared to free virus transmission. Activity loss varied considerably between virus strains and was inversely associated with neutralization of free virus spread for V1V2- and V3-directed bnAbs. In rare bnAb-virus combinations, inhibition for both transmission modes was comparable but no bnAb potently blocked cell-cell transmission across all probed virus strains. Mathematical analysis indicated an increased probability of bnAb resistance mutations to arise in cell-cell rather than free virus spread, further highlighting the need to block this pathway. Importantly, the capacity to efficiently neutralize prior to CD4 engagement correlated with the inhibition efficacy against free virus but not cell-cell transmitted virus. Pre-CD4 attachment activity proved strongest amongst CD4bs bnAbs and varied substantially for V3 and V1V2 loop bnAbs in a strain-dependent manner. In summary, bnAb activity against divergent viruses varied depending on the transmission mode and differed depending on the window of action during the entry process, underscoring that powerful combinations of bnAbs are needed for in vivo application.","[Reh, Lucia; Magnus, Carsten; Schanz, Merle; Weber, Jacqueline; Uhr, Therese; Rusert, Peter; Trkola, Alexandra] Univ Zurich, Inst Med Virol, Zurich, Switzerland","Trkola, A (reprint author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.",trkola.alexandra@virology.uzh.ch,"Trkola, Alexandra/K-2115-2012","Trkola, Alexandra/0000-0003-1013-876X; Magnus, Carsten/0000-0003-1125-2783",Swiss National Science Foundation [310030 152663],"Funding: Financial support was provided by the Swiss National Science Foundation (http://www.snf.ch, grant 310030 152663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,33,33,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004966,10.1371/journal.ppat.1004966,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200015,26158270.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,33,16,28,5840,884,674,210,4956,4256,27,673,27,14,0,0,31,31,2,,38,2,37,1,2,34,34,33,28,0,0,0,0,0,0,3,2,0,5906,222,3,123,89,2,4971,903,222,3,123,89,2,32,,3,0,0,0,15,0,4,1,0,0,0,37,1,0,35.55,6.606334841628959,1.1783696529459242,0.17836965294592413,1.2544390637610976,1.064554794520548,7.032805429864253
535,J,"Spence, PJ; Brugat, T; Langhorne, J",,,,"Spence, Philip J.; Brugat, Thibaut; Langhorne, Jean",,,Mosquitoes Reset Malaria Parasites,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMODIUM; VIRULENCE; TRANSMISSION; INFECTIONS; EXPRESSION,,"[Spence, Philip J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Spence, Philip J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Brugat, Thibaut; Langhorne, Jean] Mill Hill Lab, Francis Crick Inst, London, England","Spence, PJ (reprint author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.",Philip.Spence@ed.ac.uk; Jean.Langhorne@crick.ac.uk,,"Spence, Phil/0000-0002-5506-2773; Langhorne, Jean/0000-0002-2257-9733","The Francis Crick Institute [10352, 10101]; Medical Research Council [U117584248, MC_U117584248]; Wellcome Trust [095831, 048684]",,,24,5,5,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004987,10.1371/journal.ppat.1004987,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200022,26133171.0,"DOAJ Gold, Green Published",,,16/08/2019,4,20,37,4967,765,634,131,4202,3552,11,639,37,7,0,0,6,6,1,,49,4,49,0,4,4,4,4,3,0,0,0,0,0,0,0,13,1,4985,18,0,22,62,0,4194,765,18,0,22,62,0,26,,0,1,0,0,11,0,3,1,0,0,0,49,0,0,13.732,6.49281045751634,1.1820561637315563,0.1820561637315564,1.2053783912422655,1.019730219448359,6.620915032679738
536,J,"Thomas, S; Klobuch, S; Podlech, J; Plachter, B; Hoffmann, P; Renzaho, A; Theobald, M; Reddehase, MJ; Herr, W; Lemmermann, NAW",,,,"Thomas, Simone; Klobuch, Sebastian; Podlech, Juergen; Plachter, Bodo; Hoffmann, Petra; Renzaho, Angelique; Theobald, Matthias; Reddehase, Matthias J.; Herr, Wolfgang; Lemmermann, Niels A. W.",,,Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNE EVASION PROTEINS; BONE-MARROW-TRANSPLANTATION; ADOPTIVE TRANSFER; ANIMAL-MODELS; HIGH-AFFINITY; MURINE MODEL; MEMORY; INFECTION; ANTIGEN; IMMUNOTHERAPY,"Reactivation of human cytomegalovirus (HCMV) can cause severe disease in recipients of hematopoietic stem cell transplantation. Although preclinical research in murine models as well as clinical trials have provided 'proof of concept' for infection control by pre-emptive CD8 T-cell immunotherapy, there exists no predictive model to experimentally evaluate parameters that determine antiviral efficacy of human T cells in terms of virus control in functional organs, prevention of organ disease, and host survival benefit. We here introduce a novel mouse model for testing HCMV epitope-specific human T cells. The HCMV UL83/pp65-derived NLV-peptide was presented by transgenic HLA-A2.1 in the context of a lethal infection of NOD/SCID/IL-2rg(-/-) mice with a chimeric murine CMV, mCMV-NLV. Scenarios of HCMV-seropositive and -seronegative human T-cell donors were modeled by testing peptide-restimulated and T-cell receptor-transduced human T cells, respectively. Upon transfer, the T cells infiltrated host tissues in an epitope-specific manner, confining the infection to nodular inflammatory foci. This resulted in a significant reduction of viral load, diminished organ pathology, and prolonged survival. The model has thus proven its potential for a preclinical testing of the protective antiviral efficacy of HCMV epitope-specific human T cells in the evaluation of new approaches to an immunotherapy of CMV disease.","[Thomas, Simone; Klobuch, Sebastian; Hoffmann, Petra; Herr, Wolfgang] Univ Hosp Regensburg, Dept Internal Med Hematol & Oncol 3, Regensburg, Germany; [Thomas, Simone; Hoffmann, Petra; Herr, Wolfgang] Univ Regensburg, Regensburg Ctr Intervent Immunol, D-93053 Regensburg, Germany; [Thomas, Simone; Klobuch, Sebastian; Theobald, Matthias; Herr, Wolfgang] Johannes Gutenberg Univ Mainz, Dept Internal Med Hematol Oncol & Pneumol 3, Univ Med Ctr, D-55122 Mainz, Germany; [Podlech, Juergen; Plachter, Bodo; Renzaho, Angelique; Reddehase, Matthias J.; Lemmermann, Niels A. W.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Virol, D-55122 Mainz, Germany; [Podlech, Juergen; Plachter, Bodo; Renzaho, Angelique; Reddehase, Matthias J.; Lemmermann, Niels A. W.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, D-55122 Mainz, Germany","Thomas, S (reprint author), Univ Hosp Regensburg, Dept Internal Med Hematol & Oncol 3, Regensburg, Germany.",simone.thomas@ukr.de,"Thomas, Simone/G-7445-2019; Lemmermann, Niels/I-3717-2013","Thomas, Simone/0000-0001-6308-3649; Lemmermann, Niels/0000-0001-9190-6497; Reddehase, Matthias/0000-0002-3509-7573","Deutsche Forschungsgemeinschaft, Clinical Research Group KFO 183; University Medical Center, Mainz, Germany","This work was supported by the Deutsche Forschungsgemeinschaft, Clinical Research Group KFO 183, individual projects 10 (ST, MT, WH) and 8 (NAWL, BP, MJR). NAWL received intramural funding in the young investigator program MAIFOR of the University Medical Center, Mainz, Germany. ST was awarded a scholarship in the Science Transfer program of the University Medical Center, Mainz, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,114,14,14,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005049,10.1371/journal.ppat.1005049,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200053,26181057.0,"DOAJ Gold, Green Published",,,16/08/2019,15,0,13,3955,906,653,253,3049,2506,27,516,13,0,0,0,15,15,0,,22,7,22,0,7,15,15,15,11,0,0,0,0,0,0,0,0,0,3997,97,0,164,95,4,3046,906,97,0,164,95,4,45,,0,0,0,0,1,0,0,1,0,0,0,22,0,0,0.75,4.365342163355408,1.297146605444408,0.297146605444408,1.3738930796982618,1.0591656131479141,4.623620309050772
537,J,"Ukaegbu, UE; Deitsch, KW",,,,"Ukaegbu, Uchechi E.; Deitsch, Kirk W.",,,The Emerging Role for RNA Polymerase II in Regulating Virulence Gene Expression in Malaria Parasites,PLOS PATHOGENS,,,English,Article,,,,,,,CARBOXYL-TERMINAL DOMAIN; LONG NONCODING RNAS; PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; METHYLTRANSFERASE; ERYTHROCYTES; METHYLATION; MECHANISMS; FAMILY; MEMORY,,"[Ukaegbu, Uchechi E.; Deitsch, Kirk W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA","Ukaegbu, UE (reprint author), Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA.",kwd2001@med.cornell.edu,,,"National Institutes of Health [AI052390, GM097980]","Funding: The work was funded by grant number AI052390 from the National Institutes of Health to KWD and grant number GM097980 from the National Institutes of Health to UEU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,37,4,4,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004926,10.1371/journal.ppat.1004926,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200006,26181323.0,"DOAJ Gold, Green Published",,,16/08/2019,4,1,15,3240,418,320,98,2822,2341,17,464,15,1,0,0,4,4,0,,19,0,19,0,0,4,4,4,2,0,0,0,0,0,0,0,0,3,3271,6,0,28,60,2,2832,424,6,0,28,60,2,15,,0,0,0,0,5,0,0,1,0,0,0,19,0,0,2.0,7.751196172248804,1.1481218993621545,0.1481218993621545,1.1824946846208362,1.0299382716049383,7.983253588516747
538,J,"Vijaykrishna, D; Mukerji, R; Smith, GJD",,,,"Vijaykrishna, Dhanasekaran; Mukerji, Reshmi; Smith, Gavin J. D.",,,RNA Virus Reassortment: An Evolutionary Mechanism for Host Jumps and Immune Evasion,PLOS PATHOGENS,,,English,Article,,,,,,,INFLUENZA-A-VIRUS; HOMOLOGOUS RECOMBINATION; GENETIC REASSORTMENT; PACKAGING SIGNALS; B VIRUS; SWINE; H1N1; EMERGENCE; DYNAMICS; GENOME,,"[Vijaykrishna, Dhanasekaran; Mukerji, Reshmi; Smith, Gavin J. D.] Duke NUS Grad Med Sch, Singapore, Singapore; [Vijaykrishna, Dhanasekaran] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Vijaykrishna, Dhanasekaran] Singapore Gen Hosp, SingHlth, Dept Pathol, Singapore, Singapore; [Smith, Gavin J. D.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA","Vijaykrishna, D (reprint author), Duke NUS Grad Med Sch, Singapore, Singapore.",vijay.dhanasekaran@duke-nus.edu.sg,"Vijaykrishna, Dhanasekaran/D-1011-2010","Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Smith, Gavin JD/0000-0001-5031-468X","Duke-NUS Signature Research Program - Ministry of Health, Singapore; National Medical Research Council, Singapore [NMRC/GMS/1251/2010]; Singapore Ministry of Education Academic Research Fund [MOE2011-T2-2-049]; National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, United States [HHSN272201400006C]","Funding: This work was supported by the Duke-NUS Signature Research Program funded by the Ministry of Health, Singapore; the National Medical Research Council, Singapore (NMRC/GMS/1251/2010); and the Singapore Ministry of Education Academic Research Fund grant (MOE2011-T2-2-049). Further support was provided by contract HHSN272201400006C from the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,25,26,1,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1004902,10.1371/journal.ppat.1004902,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200001,26158697.0,"DOAJ Gold, Green Published",,,16/08/2019,23,15,66,9305,3013,2603,410,6292,5058,22,1212,66,15,0,0,24,24,0,,89,0,89,0,0,25,25,19,12,0,0,0,0,0,0,0,1,1,9283,12,0,27,40,3,6247,3013,12,0,27,40,3,23,,0,0,0,0,21,0,0,2,0,0,0,92,0,0,12.15,3.0882841022236973,1.4788620470438651,0.4788620470438652,1.4836300063572792,1.0032240730789899,3.098240955857949
539,J,"Xia, HJ; Wang, PP; Wang, GC; Yang, J; Sun, XL; Wu, WZ; Qiu, Y; Shu, T; Zhao, XL; Yin, L; Qin, CF; Hu, YY; Zhou, X",,,,"Xia, Hongjie; Wang, Peipei; Wang, Guang-Chuan; Yang, Jie; Sun, Xianlin; Wu, Wenzhe; Qiu, Yang; Shu, Ting; Zhao, Xiaolu; Yin, Lei; Qin, Cheng-Feng; Hu, Yuanyang; Zhou, Xi",,,Human Enterovirus Nonstructural Protein 2C(ATPase) Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone,PLOS PATHOGENS,,,English,Article,,,,,,,NUCLEIC-ACID CHAPERONE; NEGATIVE-STRAND RNA; DEAD-BOX PROTEINS; ADENOASSOCIATED VIRUS TYPE-2; 2C PROTEIN; VPG URIDYLYLATION; DNA HELICASE; NS3 PROTEIN; POLIOVIRUS; REPLICATION,"RNA helicases and chaperones are the two major classes of RNA remodeling proteins, which function to remodel RNA structures and/or RNA-protein interactions, and are required for all aspects of RNA metabolism. Although some virus-encoded RNA helicases/chaperones have been predicted or identified, their RNA remodeling activities in vitro and functions in the viral life cycle remain largely elusive. Enteroviruses are a large group of positive-stranded RNA viruses in the Picornaviridae family, which includes numerous important human pathogens. Herein, we report that the nonstructural protein 2C(ATPase) of enterovirus 71 (EV71), which is the major causative pathogen of hand-foot-and-mouth disease and has been regarded as the most important neurotropic enterovirus after poliovirus eradication, functions not only as an RNA helicase that 3'-to-5' unwinds RNA helices in an adenosine triphosphate (ATP)-dependent manner, but also as an RNA chaperone that destabilizes helices bidirectionally and facilitates strand annealing and complex RNA structure formation independently of ATP. We also determined that the helicase activity is based on the EV71 2C(ATPase) middle domain, whereas the C-terminus is indispensable for its RNA chaperoning activity. By promoting RNA template recycling, 2CATPase facilitated EV71 RNA synthesis in vitro; when 2C(ATPase) helicase activity was impaired, EV71 RNA replication and virion production were mostly abolished in cells, indicating that 2C(ATPase)-mediated RNA remodeling plays a critical role in the enteroviral life cycle. Furthermore, the RNA helicase and chaperoning activities of 2C(ATPase) are also conserved in coxsackie A virus 16 (CAV16), another important enterovirus. Altogether, our findings are the first to demonstrate the RNA helicase and chaperoning activities associated with enterovirus 2C(ATPase), and our study provides both in vitro and cellular evidence for their potential roles during viral RNA replication. These findings increase our understanding of enteroviruses and the two types of RNA remodeling activities.","[Xia, Hongjie; Wang, Peipei; Yang, Jie; Sun, Xianlin; Wu, Wenzhe; Qiu, Yang; Shu, Ting; Zhao, Xiaolu; Yin, Lei; Hu, Yuanyang; Zhou, Xi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wang, Guang-Chuan; Qiu, Yang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China","Xia, HJ (reprint author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.",zhouxi@whu.edu.cn,"Xia, Hongjie/M-9241-2019; Qin, Cheng-Feng/I-6839-2019","Xia, Hongjie/0000-0002-2520-7038; Qin, Cheng-Feng/0000-0002-0632-2807; yin, lei/0000-0001-5203-2766; Wang, Guangchuan/0000-0001-5315-1599; Zhou, Xi/0000-0002-3846-5079","National Basic Research Program of China (973 Program) [2014CB542603, 2014CB910103]; National High-tech R&D Program of China (863 Program) [2015AA020939]; National Natural Science Foundation of China [31270190, 31400141]","This work was supported by the National Basic Research Program of China (973 Program, 2014CB542603, to XZho), the National High-tech R&D Program of China (863 Program, 2015AA020939 to XZho), the National Basic Research Program of China (973 Program, 2014CB910103 to LY), the National Natural Science Foundation of China grants No. 31270190 (to XZho) and No. 31400141 (to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,20,22,2,22,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005067,10.1371/journal.ppat.1005067,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200069,26218680.0,"DOAJ Gold, Green Published",,,16/08/2019,16,10,22,6014,1016,708,308,4998,4023,24,951,22,5,0,0,20,20,1,,32,7,32,0,7,19,19,13,15,0,0,0,0,0,0,0,5,0,6100,167,0,474,159,0,5037,1026,167,0,474,159,0,37,,0,0,0,0,5,0,1,1,0,0,0,32,0,0,4.0,5.919291338582677,1.20328131252501,0.20328131252501,1.2857142857142858,1.068506817426006,6.324803149606299
540,J,"Yelamanchili, SV; Lamberty, BG; Rennard, DA; Morsey, BM; Hochfelder, CG; Meays, BM; Levy, E; Fox, HS",,,,"Yelamanchili, Sowmya V.; Lamberty, Benjamin G.; Rennard, Deborah A.; Morsey, Brenda M.; Hochfelder, Colleen G.; Meays, Brittney M.; Levy, Efrat; Fox, Howard S.",,,MiR-21 in Extracellular Vesicles Leads to Neurotoxicity via TLR7 Signaling in SIV Neurological Disease,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS ENCEPHALITIS; SINGLE-STRANDED RNA; CELL-DEATH; MOLECULAR-MECHANISMS; PROGRAMMED NECROSIS; MICRORNA EXPRESSION; APOPTOSIS; EXOSOMES; NEURONS; NEURODEGENERATION,"Recent studies have found that extracellular vesicles (EVs) play an important role in normal and disease processes. In the present study, we isolated and characterized EVs from the brains of rhesus macaques, both with and without simian immunodeficiency virus (SIV) induced central nervous system (CNS) disease. Small RNA sequencing revealed increased miR-21 levels in EVs from SIV encephalitic (SIVE) brains. In situ hybridization revealed increased miR-21 expression in neurons and macrophage/microglial cells/nodules during SIV induced CNS disease. In vitro culture of macrophages revealed that miR-21 is released into EVs and is neurotoxic when compared to EVs derived from miR-21(-/-) knockout animals. A mutation of the sequence within miR-21, predicted to bind TLR7, eliminates this neurotoxicity. Indeed miR-21 in EV activates TLR7 in a reporter cell line, and the neurotoxicity is dependent upon TLR7, as neurons isolated from TLR7(-/-) knockout mice are protected from neurotoxicity. Further, we show that EVs isolated from the brains of monkeys with SIV induced CNS disease activates TLR7 and were neurotoxic when compared to EVs from control animals. Finally, we show that EV-miR-21 induced neurotoxicity was unaffected by apoptosis inhibition but could be prevented by a necroptosis inhibitor, necrostatin-1, highlighting the actions of this pathway in a growing number of CNS disorders.","[Yelamanchili, Sowmya V.; Lamberty, Benjamin G.; Rennard, Deborah A.; Morsey, Brenda M.; Hochfelder, Colleen G.; Meays, Brittney M.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Levy, Efrat] Nathan S Kline Inst, Orangeburg, NY USA; [Levy, Efrat] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY USA","Yelamanchili, SV (reprint author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.",yelamanchili@unmc.edu,,,"National Institute of Mental Health [R01 MH073490, P30 MH062261]","This work was supported by grants R01 MH073490 and P30 MH062261 from the National Institute of Mental Health (http://www.nimh.nih.gov) awarded to HSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,70,33,34,0,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUL,2015,11,7,,,,,,,e1005032,10.1371/journal.ppat.1005032,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CO7TQ,WOS:000359365200044,26154133.0,"DOAJ Gold, Green Published",,,16/08/2019,30,2,30,5736,1270,905,365,4466,3486,30,950,30,0,0,0,28,28,0,,80,1,41,0,1,35,35,32,22,0,0,0,0,0,0,0,2,0,5799,75,0,311,121,0,4503,1282,27,0,311,117,0,14,,0,0,0,0,0,0,0,0,0,0,0,41,0,0,3.0,4.5165354330708665,1.2843708016121809,0.2843708016121809,1.3423645320197044,1.0451534170153418,4.7204724409448815
541,J,"Abel, S; Wiesch, PAZ; Davis, BM; Waldor, MK",,,,"Abel, Soeren; Wiesch, Pia Abel zur; Davis, Brigid M.; Waldor, Matthew K.",,,Analysis of Bottlenecks in Experimental Models of Infection,PLOS PATHOGENS,,,English,Article,,,,,,,POPULATION-DYNAMICS; ESCHERICHIA-COLI; TRANSMISSION; EVOLUTION; SELECTION; VIRUS; HIV-1; HOST; COLONIZATION; MUTATIONS,,"[Abel, Soeren; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02138 USA; [Abel, Soeren; Davis, Brigid M.; Waldor, Matthew K.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Abel, Soeren; Wiesch, Pia Abel zur] Arctic Univ Norway, Univ Tromso UiT, Dept Pharm, Tromso, Norway; [Wiesch, Pia Abel zur] Yale Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA","Abel, S (reprint author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02138 USA.",soren.abel@uit.no; mwaldor@research.bwh.harvard.edu,"Wiesch, Pia Abel zur/M-1980-2019","Wiesch, Pia Abel zur/0000-0001-9420-9005","Swiss National Science Foundation [P300P3_155287/1, PBEZP3_140163]; German Academic Exchange Service [D/11/45747]; US National Institutes of Health [R37 AI-042347]; Howard Hughes Medical Institute","This work was supported by Swiss National Science Foundation (www.snf.ch) grant P300P3_155287/1 (SA), PBEZP3_140163 (PAzW), German Academic Exchange Service (www.daad.org) grant D/11/45747 (PAzW), and the US National Institutes of Health grant R37 AI-042347 and Howard Hughes Medical Institute (MKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,33,40,41,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004823,10.1371/journal.ppat.1004823,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900003,26066486.0,"DOAJ Gold, Green Published",,,16/08/2019,34,17,76,7785,807,657,150,6978,5496,27,1455,76,16,3,0,32,32,0,,102,0,102,0,0,35,35,24,26,0,0,0,0,0,0,0,1,5,7919,18,6,66,38,0,7054,846,18,6,66,38,0,19,,0,0,0,0,2,0,0,1,0,0,0,102,0,0,1.0,9.646840148698885,1.1156491831470334,0.11564918314703354,1.1428776153625682,1.0244059087989723,9.882280049566296
542,J,"Abu Kwaik, Y; Bumann, D",,,,"Abu Kwaik, Yousef; Bumann, Dirk",,,Host Delivery of Favorite Meals for Intracellular Pathogens,PLOS PATHOGENS,,,English,Article,,,,,,,LEGIONELLA-PNEUMOPHILA; BACTERIAL PATHOGENS; POSSIBLE LINKS; METABOLISM; MACROPHAGES; INFECTION; VIRULENCE; GROWTH; PERSISTENCE; ADAPTATION,,"[Abu Kwaik, Yousef] Univ Louisville, Coll Med, Ctr Predict Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland","Abu Kwaik, Y (reprint author), Univ Louisville, Coll Med, Ctr Predict Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.",abukwaik@louisville.edu; dirk.bumann@unibas.ch,,,"Public Health Service from NIAID [R21AI107978, R21AI116517]; Commonwealth of Kentucky Research Challenge Trust Fund; SystemsX.ch; Swiss National Science Foundation; EU-EFPIA Innovative Medicines Initiative","The YAK lab is supported by Public Health Service Awards R21AI107978 and R21AI116517 from NIAID and by the Commonwealth of Kentucky Research Challenge Trust Fund. The DB lab is supported by SystemsX.ch, the Swiss National Science Foundation, and the EU-EFPIA Innovative Medicines Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,40,19,19,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004866,10.1371/journal.ppat.1004866,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900011,26110434.0,"DOAJ Gold, Green Published",,,16/08/2019,22,34,50,7599,840,642,198,6759,5119,23,1617,49,11,0,0,24,24,2,,69,4,68,1,4,26,23,26,15,0,0,0,0,0,0,0,24,0,7666,13,0,271,29,3,6796,851,13,0,271,29,3,19,,0,0,0,0,13,0,1,1,0,0,0,68,1,0,7.55,9.04642857142857,1.1242787394584999,0.12427873945849978,1.1404053854120433,1.0143439926306093,9.176190476190476
543,J,"Adland, E; Paioni, P; Thobakgale, C; Laker, L; Mori, L; Muenchhoff, M; Csala, A; Clapson, M; Flynn, J; Novelli, V; Hurst, J; Naidoo, V; Shapiro, R; Huang, KHG; Frater, J; Prendergast, A; Prado, JG; Ndung'u, T; Walker, BD; Carrington, M; Jooste, P; Goulder, PJR",,,,"Adland, Emily; Paioni, Paolo; Thobakgale, Christina; Laker, Leana; Mori, Luisa; Muenchhoff, Maximilian; Csala, Anna; Clapson, Margaret; Flynn, Jacquie; Novelli, Vas; Hurst, Jacob; Naidoo, Vanessa; Shapiro, Roger; Huang, Kuan-Hsiang Gary; Frater, John; Prendergast, Andrew; Prado, Julia G.; Ndung'u, Thumbi; Walker, Bruce D.; Carrington, Mary; Jooste, Pieter; Goulder, Philip J. R.",,,Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection,PLOS PATHOGENS,,,English,Article,,,,,,,T-LYMPHOCYTE RESPONSE; CLASS-I ALLELES; ESCAPE MUTATIONS; GAG-PROTEASE; SELECTION PRESSURE; ELITE CONTROLLERS; CELL RESPONSES; IMMUNE CONTROL; IMMUNODEFICIENCY; TRANSMISSION,"HLA class I polymorphism has a major influence on adult HIV disease progression. An important mechanism mediating this effect is the impact on viral replicative capacity (VRC) of the escape mutations selected in response to HLA-restricted CD8+ T-cell responses. Factors that contribute to slow progression in pediatric HIV infection are less well understood. We here investigate the relationship between VRC and disease progression in pediatric infection, and the effect of HLA on VRC and on disease outcome in adult and pediatric infection. Studying a South African cohort of >350 ART-naive, HIV-infected children and their mothers, we first observed that pediatric disease progression is significantly correlated with VRC. As expected, VRCs in mother-child pairs were strongly correlated (p = 0.004). The impact of the protective HLA alleles, HLA-B*57, HLA-B*58:01 and HLA-B*81:01, resulted in significantly lower VRCs in adults (p<0.0001), but not in children. Similarly, in adults, but not in children, VRCs were significantly higher in subjects expressing the disease-susceptible alleles HLA-B*18:01/45:01/58:02 (p = 0.007). Irrespective of the subject, VRCs were strongly correlated with the number of Gag CD8+ T-cell escape mutants driven by HLA-B*57/58:01/81:01 present in each virus (p = 0.0002). In contrast to the impact of VRC common to progression in adults and children, the HLA effects on disease outcome, that are substantial in adults, are small and statistically insignificant in infected children. These data further highlight the important role that VRC plays both in adult and pediatric progression, and demonstrate that HLA-independent factors, yet to be fully defined, are predominantly responsible for pediatric non-progression.","[Adland, Emily; Paioni, Paolo; Muenchhoff, Maximilian; Csala, Anna; Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Pathogen Res Oxford, Oxford, England; [Thobakgale, Christina; Muenchhoff, Maximilian; Naidoo, Vanessa; Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip J. R.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Clapson, Margaret; Flynn, Jacquie; Novelli, Vas; Goulder, Philip J. R.] Great Ormond St Hosp Sick Children, Dept Paediat Infect Dis, London WC1N 3JH, England; [Hurst, Jacob; Huang, Kuan-Hsiang Gary; Frater, John] Univ Oxford, Oxford Martin Sch, Inst Emerging Infect, Oxford, England; [Hurst, Jacob; Huang, Kuan-Hsiang Gary; Frater, John] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Hurst, Jacob; Frater, John] Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; [Shapiro, Roger] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Prendergast, Andrew] Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England; [Prendergast, Andrew] Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe; [Prado, Julia G.] Inst dInvest Ciencies Salut Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Barcelona, Spain; [Ndung'u, Thumbi; Walker, Bruce D.; Carrington, Mary] MIT, MGH, Ragon Inst, Boston, MA USA; [Ndung'u, Thumbi; Walker, Bruce D.; Carrington, Mary] Harvard Univ, Boston, MA 02115 USA; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany; [Carrington, Mary] NCI, Ctr Canc Res, Frederick, MD 21701 USA","Adland, E (reprint author), Univ Oxford, Dept Paediat, Pathogen Res Oxford, Oxford, England.",philip.goulder@paediatrics.ox.ac.uk,"Prado, Julia G/R-7177-2019","Prado, Julia G/0000-0002-5439-4645; Thobakgale-Tshabalala, Christina/0000-0001-5619-8894; Ndung'u, Thumbi/0000-0003-2962-3992; Frater, John/0000-0001-7163-7277","Wellcome Trust [WT104748MA]; South African DST/NRF Research Chairs Initiative; Victor Daitz Foundation; Howard Hughes Medical Institute; National Health institute ISCIII [MS09/00279]; Medical Research Council [MR/L006588/1, G0500384]; National Institute for Health Research [857]","This work was funded by the Wellcome Trust (WT104748MA, PJRG). TN received additional funding from the South African DST/NRF Research Chairs Initiative, the Victor Daitz Foundation and an International Early Career Scientist Award from the Howard Hughes Medical Institute. JGP holds a Miguel Servet Contract (MS09/00279) funded by National Health institute ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,24,27,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,UNSP e1004954,10.1371/journal.ppat.1004954,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900032,26076345.0,"DOAJ Gold, Green Published",,,16/08/2019,25,21,43,3861,784,570,214,3077,2289,22,766,43,14,0,0,23,23,0,,0,11,0,0,11,26,26,16,21,0,0,0,0,0,0,0,7,3,3858,49,0,60,8,0,3064,784,49,0,60,8,0,10,,0,0,0,0,14,0,3,1,0,0,0,57,0,0,8.6,4.924744897959184,1.254793630159246,0.254793630159246,1.2723431914202146,1.013986013986014,4.9936224489795915
544,J,"Aeberhard, L; Banhart, S; Fischer, M; Jehmlich, N; Rose, L; Koch, S; Laue, M; Renard, BY; Schmidt, F; Heuer, D",,,,"Aeberhard, Lukas; Banhart, Sebastian; Fischer, Martina; Jehmlich, Nico; Rose, Laura; Koch, Sophia; Laue, Michael; Renard, Bernhard Y.; Schmidt, Frank; Heuer, Dagmar",,,The Proteome of the Isolated Chlamydia trachomatis Containing Vacuole Reveals a Complex Trafficking Platform Enriched for Retromer Components,PLOS PATHOGENS,,,English,Article,,,,,,,SALMONELLA-CONTAINING VACUOLE; TO-TGN TRANSPORT; INCLUSION MEMBRANE; SORTING NEXINS; PHAGOSOME MATURATION; RETROGRADE TRANSPORT; SYNTAXIN 6; QUANTIFICATION; CURVATURE; RECEPTOR,"Chlamydia trachomatis is an important human pathogen that replicates inside the infected host cell in a unique vacuole, the inclusion. The formation of this intracellular bacterial niche is essential for productive Chlamydia infections. Despite its importance for Chlamydia biology, a holistic view on the protein composition of the inclusion, including its membrane, is currently missing. Here we describe the host cell-derived proteome of isolated C. trachomatis inclusions by quantitative proteomics. Computational analysis indicated that the inclusion is a complex intracellular trafficking platform that interacts with host cells' antero- and retrograde trafficking pathways. Furthermore, the inclusion is highly enriched for sorting nexins of the SNX-BAR retromer, a complex essential for retrograde trafficking. Functional studies showed that in particular, SNX5 controls the C. trachomatis infection and that retrograde trafficking is essential for infectious progeny formation. In summary, these findings suggest that C. trachomatis hijacks retrograde pathways for effective infection.","[Aeberhard, Lukas; Banhart, Sebastian; Rose, Laura; Koch, Sophia; Heuer, Dagmar] Robert Koch Inst, Jr Res Grp Sexually Transmitted Bacterial Patho, Berlin, Germany; [Fischer, Martina; Renard, Bernhard Y.] Robert Koch Inst, Jr Res Grp Bioinformat, Berlin, Germany; [Jehmlich, Nico; Schmidt, Frank] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Functi Genom, Greifswald, Germany; [Laue, Michael] Robert Koch Inst, Adv Light & Elect Microscopy ZBS 4, Berlin, Germany; [Schmidt, Frank] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, ZIK FunGene Jr Res Grp Appl Prote, Greifswald, Germany","Aeberhard, L (reprint author), Robert Koch Inst, Jr Res Grp Sexually Transmitted Bacterial Patho, Berlin, Germany.",heuerd@rki.de,"Schmidt, Frank, ZIK FunGene/B-6075-2009; Jehmlich, Nico/B-5403-2009","Jehmlich, Nico/0000-0002-5638-6868; Renard, Bernhard/0000-0003-4589-9809; Banhart, Sebastian/0000-0003-4720-9330; Schmidt, Frank/0000-0001-5406-3988","Deutsche Forschungsgemeinschaft [SPP 1580, HE6008/1-1, HE6008/1-2, RE3474/2-1]","This work was financially supported by the Deutsche Forschungsgemeinschaft (www.dfg.de): SPP 1580 to DH (HE6008/1-1 and HE6008/1-2) and RE3474/2-1 to BYR. Federal Ministry of Education and Research (BMBF) (www.bmbf.de) in the framework of the national research network ""Zoonotic Chlamydia - Models of chronic and persistent infections in humans and animals"" to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,57,33,34,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004883,10.1371/journal.ppat.1004883,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900016,26042774.0,"DOAJ Gold, Green Published",,,16/08/2019,31,5,43,6212,905,674,231,5307,4296,28,983,43,5,0,0,33,33,0,,54,0,54,0,0,38,34,38,18,0,0,1,0,0,1,0,0,4,6211,137,0,122,67,0,5288,905,137,0,122,67,0,18,,0,0,0,0,8,0,0,1,0,0,0,57,0,0,5.8,6.864088397790055,1.1705294893536837,0.1705294893536838,1.2087808554739023,1.0326786864133934,7.088397790055248
545,J,"Belon, C; Soscia, C; Bernut, A; Laubier, A; Bleves, S; Blanc-Potard, AB",,,,"Belon, Claudine; Soscia, Chantal; Bernut, Audrey; Laubier, Aurelie; Bleves, Sophie; Blanc-Potard, Anne-Beatrice",,,A Macrophage Subversion Factor Is Shared by Intracellular and Extracellular Pathogens,PLOS PATHOGENS,,,English,Article,,,,,,,MGTC VIRULENCE FACTOR; PSEUDOMONAS-AERUGINOSA; SALMONELLA-ENTERICA; BIOFILM FORMATION; MYCOBACTERIUM-TUBERCULOSIS; INTRAMACROPHAGE SURVIVAL; MAGNESIUM LIMITATION; MURINE MACROPHAGES; EPITHELIAL-CELLS; SECRETION SYSTEM,"Pathogenic bacteria have developed strategies to adapt to host environment and resist host immune response. Several intracellular bacterial pathogens, including Salmonella enterica and Mycobacterium tuberculosis, share the horizontally-acquired MgtC virulence factor that is important for multiplication inside macrophages. MgtC is also found in pathogenic Pseudomonas species. Here we investigate for the first time the role of MgtC in the virulence of an extracellular pathogen, Pseudomonas aeruginosa. A P. aeruginosa mgtC mutant is attenuated in the systemic infection model of zebrafish embryos, and strikingly, the attenuated phenotype is dependent on the presence of macrophages. In ex vivo experiments, the P. aeruginosa mgtC mutant is more sensitive to macrophage killing than the wild-type strain. However, wild-type and mutant strains behave similarly toward macrophage killing when macrophages are treated with an inhibitor of the vacuolar proton ATPase. Importantly, P. aeruginosa mgtC gene expression is strongly induced within macrophages and phagosome acidification contributes to an optimal expression of the gene. Thus, our results support the implication of a macrophage intracellular stage during P. aeruginosa acute infection and suggest that Pseudomonas MgtC requires phagosome acidification to play its intracellular role. Moreover, we demonstrate that P. aeruginosa MgtC is required for optimal growth in Mg2+ deprived medium, a property shared by MgtC factors from intracellular pathogens and, under Mg2+ limitation, P. aeruginosa MgtC prevents biofilm formation. We propose that MgtC shares a similar function in intracellular and extracellular pathogens, which contributes to macrophage resistance and fine-tune adaptation to host immune response in relation to the different bacterial lifestyles. In addition, the phenotypes observed with the mgtC mutant in infection models can be mimicked in wild-type P. aeruginosa strain by producing a MgtC antagonistic peptide, thus highlighting MgtC as a promising new target for anti-virulence strategies.","[Belon, Claudine; Bernut, Audrey; Blanc-Potard, Anne-Beatrice] Univ Montpellier, CNRS, UMR5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34059 Montpellier, France; [Soscia, Chantal; Laubier, Aurelie; Bleves, Sophie] CNRS, Marseille, France; [Soscia, Chantal; Laubier, Aurelie; Bleves, Sophie] Aix Marseille Univ, Lab Ingn Syst Macromol, UMR7255, Marseille, France","Belon, C (reprint author), Univ Montpellier, CNRS, UMR5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34059 Montpellier, France.",bleves@imm.cnrs.fr; anne.blanc-potard@univ-montp2.fr,,,"Vaincre La Mucoviscidose [IC1002, IC0902, RF20110600446/1/1/47]; MRT fellowship from the French Ministry of Research; Fondation for Medical Research [FRM FDT20140930905]; VLM fellowship [RF20110600446/1/1/47]","This work is supported by Vaincre La Mucoviscidose (IC1002, IC0902 and RF20110600446/1/1/47). CB is supported by a MRT fellowship from the French Ministry of Research and the Fondation for Medical Research (FRM FDT20140930905). AB is supported by a VLM fellowship (RF20110600446/1/1/47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,7,8,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004969,10.1371/journal.ppat.1004969,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900043,26080006.0,"DOAJ Gold, Green Published",,,16/08/2019,7,29,46,5485,1021,751,270,4464,3550,22,892,46,11,0,0,8,8,0,,105,8,53,0,8,8,8,4,2,0,0,0,0,0,0,0,18,11,5555,85,0,340,83,3,4484,1040,85,0,340,83,3,31,,0,0,0,0,12,0,1,1,0,0,0,53,0,0,5.7,5.372184133202742,1.2287186379928314,0.22871863799283154,1.2820340501792116,1.0433910665451231,5.605288932419197
546,J,"Bozick, BA; Real, LA",,,,"Bozick, Brooke A.; Real, Leslie A.",,,The Role of Human Transportation Networks in Mediating the Genetic Structure of Seasonal Influenza in the United States,PLOS PATHOGENS,,,English,Article,,,,,,,A H3N2; DYNAMICS; EVOLUTION; SPREAD; DETERMINANTS; EPIDEMICS; COMPLEX; IMPACT; VIRUS; MODEL,"Recent studies have demonstrated the importance of accounting for human mobility networks when modeling epidemics in order to accurately predict spatial dynamics. However, little is known about the impact these movement networks have on the genetic structure of pathogen populations and whether these effects are scale-dependent. We investigated how human movement along the aviation and commuter networks contributed to intra-seasonal genetic structure of influenza A epidemics in the continental United States using spatially-referenced hemagglutinin nucleotide sequences collected from 2003-2013 for both the H3N2 and H1N1 subtypes. Comparative analysis of these transportation networks revealed that the commuter network is highly spatially-organized and more heavily traveled than the aviation network, which instead is characterized by high connectivity between all state pairs. We found that genetic distance between sequences often correlated with distance based on interstate commuter network connectivity for the H1N1 subtype, and that this correlation was not as prevalent when geographic distance or aviation network connectivity distance was assessed against genetic distance. However, these patterns were not as apparent for the H3N2 subtype at the scale of the continental United States. Finally, although sequences were spatially referenced at the level of the US state of collection, a community analysis based on county to county commuter connections revealed that commuting communities did not consistently align with state geographic boundaries, emphasizing the need for the greater availability of more specific sequence location data. Our results highlight the importance of utilizing host movement data in characterizing the underlying genetic structure of pathogen populations and demonstrate a need for a greater understanding of the differential effects of host movement networks on pathogen transmission at various spatial scales.","[Bozick, Brooke A.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [Bozick, Brooke A.; Real, Leslie A.] Emory Univ, Ctr Dis Ecol, Atlanta, GA 30322 USA; [Real, Leslie A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA","Bozick, BA (reprint author), Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA.",bbozick@emory.edu,,,"NIH [RO1 AI047498, T32 AI055404]; RAPIDD Programme of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health","This research was supported by NIH grant RO1 AI047498 to L.A.R and a NIH Training Grant Fellowship to B.A.B (T32 AI055404), the RAPIDD Programme of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript",,51,10,10,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004898,10.1371/journal.ppat.1004898,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900018,26086273.0,"DOAJ Gold, Green Published",,,16/08/2019,9,83,28,7232,275,188,87,6957,6163,32,762,28,49,0,0,10,10,5,,41,4,38,0,4,9,9,7,5,0,0,0,0,0,0,2,34,12,7275,75,0,65,147,2,6952,275,75,0,65,147,2,48,,6,3,0,0,41,0,5,0,0,0,0,38,0,0,90.196,26.298181818181817,1.0395285324133965,0.03952853241339658,1.0776196636481241,1.0366426991150441,27.26181818181818
547,J,"Cnops, J; De Trez, C; Stijlemans, B; Keirsse, J; Kauffmann, F; Barkhuizen, M; Keeton, R; Boon, L; Brombacher, F; Magez, S",,,,"Cnops, Jennifer; De Trez, Carl; Stijlemans, Benoit; Keirsse, Jiri; Kauffmann, Florence; Barkhuizen, Mark; Keeton, Roanne; Boon, Louis; Brombacher, Frank; Magez, Stefan",,,"NK-, NKT- and CD8-Derived IFN gamma Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia",PLOS PATHOGENS,,,English,Article,,,,,,,VARIANT SURFACE GLYCOPROTEIN; AFRICAN TRYPANOSOMIASIS; MACROPHAGE ACTIVATION; INTERFERON-GAMMA; T-CELLS; INFECTION; BRUCEI; RESPONSES; ALPHA; IMMUNOPATHOLOGY,"African trypanosomes are the causative agents of Human African Trypanosomosis (HAT/Sleeping Sickness) and Animal African Trypanosomosis (AAT/Nagana). A common hallmark of African trypanosome infections is inflammation. In murine trypanosomosis, the onset of inflammation occurs rapidly after infection and is manifested by an influx of myeloid cells in both liver and spleen, accompanied by a burst of serum pro-inflammatory cytokines. Within 48 hours after reaching peak parasitemia, acute anemia develops and the percentage of red blood cells drops by 50%. Using a newly developed in vivo erythrophagocytosis assay, we recently demonstrated that activated cells of the myeloid phagocytic system display enhanced erythrophagocytosis causing acute anemia. Here, we aimed to elucidate the mechanism and immune pathway behind this phenomenon in a murine model for trypanosomosis. Results indicate that IFN gamma plays a crucial role in the recruitment and activation of erythrophagocytic myeloid cells, as mice lacking the IFN gamma receptor were partially protected against trypanosomosis-associated inflammation and acute anemia. NK and NKT cells were the earliest source of IFN gamma during T. b. brucei infection. Later in infection, CD8+ and to a lesser extent CD4+ T cells become the main IFN gamma producers. Cell depletion and transfer experiments indicated that during infection the absence of NK, NKT and CD8+ T cells, but not CD4+ T cells, resulted in a reduced anemic phenotype similar to trypanosome infected IFN gamma R-/- mice. Collectively, this study shows that NK, NKT and CD8+ T cell-derived IFN gamma is a critical mediator in trypanosomosis-associated pathology, driving enhanced erythrophagocytosis by myeloid phagocytic cells and the induction of acute inflammation-associated anemia.","[Cnops, Jennifer; De Trez, Carl; Stijlemans, Benoit; Keirsse, Jiri; Kauffmann, Florence; Magez, Stefan] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Cnops, Jennifer; De Trez, Carl; Kauffmann, Florence; Magez, Stefan] VIB, Dept Biol Struct, Brussels, Belgium; [Stijlemans, Benoit; Keirsse, Jiri] VIB, Dept Myeloid Cell Immunol, Brussels, Belgium; [Barkhuizen, Mark; Brombacher, Frank] Cape Town Component, Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Barkhuizen, Mark; Keeton, Roanne; Brombacher, Frank; Magez, Stefan] Univ Cape Town, Div Immunol, IDM, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Boon, Louis] Bioceros, Utrecht, Netherlands","Cnops, J (reprint author), Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium.",stemagez@vub.ac.be; stemagez@vub.ac.be,"Magez, Stefan/D-9497-2014","Magez, Stefan/0000-0003-3760-7968; Stijlemans, Benoit/0000-0003-0082-9751","Fonds voor Wetenschappelijk Onderzoek (FWO) [fwoTM597]; FWO-NRF bilateral Flanders-Shout Africa grant [GA10410N]; Interuniversity Attraction Pole Program (PAI-IAP) [P7/41]; South African Medical Research Council (SAMRC), the Research Chair initiative (SARCHi) by DST; South African Medical Research Council (SAMRC), the Research Chair initiative (SARCHi) by NRF","This work was supported by the Fonds voor Wetenschappelijk Onderzoek (FWO) Project fwoTM597, the FWO-NRF bilateral Flanders-Shout Africa grant no GA10410N, the Interuniversity Attraction Pole Program (PAI-IAP N. P7/41) and the South African Medical Research Council (SAMRC), the Research Chair initiative (SARCHi) by DST and NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,37,17,17,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004964,10.1371/journal.ppat.1004964,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900040,26070118.0,"DOAJ Gold, Green Published",,,16/08/2019,18,4,26,2777,488,376,112,2289,1919,23,347,26,4,0,0,15,15,0,,69,19,38,0,19,19,19,18,12,0,0,0,0,0,0,0,0,3,2774,56,0,160,49,1,2276,488,56,0,160,49,1,10,,0,0,0,0,6,0,0,1,0,0,0,38,0,0,2.6,5.690573770491803,1.2131935342944518,0.21319353429445173,1.2577544779379641,1.0367302844796542,5.899590163934426
548,J,"Deng, YZ; Qu, ZW; Naqvi, NI",,,,"Deng, Yi Zhen; Qu, Ziwei; Naqvi, Naweed I.",,,"Twilight, a Novel Circadian-Regulated Gene, Integrates Phototropism with Nutrient and Redox Homeostasis during Fungal Development",PLOS PATHOGENS,,,English,Article,,,,,,,RICE BLAST FUNGUS; ACTIVATED PROTEIN-KINASE; MAGNAPORTHE-GRISEA; NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; ASEXUAL DIFFERENTIATION; CLOCK; AUTOPHAGY; ACETYLATION; ORYZAE,"Phototropic regulation of circadian clock is important for environmental adaptation, organismal growth and differentiation. Light plays a critical role in fungal development and virulence. However, it is unclear what governs the intracellular metabolic response to such dark-light rhythms in fungi. Here, we describe a novel circadian-regulated Twilight (TWL) function essential for phototropic induction of asexual development and pathogenesis in the rice-blast fungus Magnaporthe oryzae. The TWL transcript oscillates during circadian cycles and peaks at subjective twilight. GFP-Twl remains acetylated and cytosolic in the dark, whereas light-induced phosphorylation (by the carbon sensor Snf1 kinase) drives it into the nucleus. The mRNA level of the transcription/repair factor TFB5, was significantly down regulated in the twl Delta mutant. Overexpression of TFB5 significantly suppressed the conidiation defects in the twl Delta mutant. Furthermore, Tfb5-GFP translocates to the nucleus during the phototropic response and under redox stress, while it failed to do so in the twl Delta mutant. Thus, we provide mechanistic insight into Twl-based regulation of nutrient and redox homeostasis in response to light during pathogen adaptation to the host milieu in the rice blast pathosystem.","[Deng, Yi Zhen; Qu, Ziwei; Naqvi, Naweed I.] Natl Univ Singapore, Dept Biol Sci, Temasek Life Sci Lab, Singapore 117548, Singapore; [Deng, Yi Zhen] South China Agr Univ, Coll Agron, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China; [Naqvi, Naweed I.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore","Deng, YZ (reprint author), Natl Univ Singapore, Dept Biol Sci, Temasek Life Sci Lab, Singapore 117548, Singapore.",dengyz@scau.edu.cn; naweed@tll.org.sg,,,"National Research Foundation (Prime Minister's Office); Temasek Life Sciences Laboratory, Singapore","This research was funded by grants from the National Research Foundation (Prime Minister's Office) and the Temasek Life Sciences Laboratory, Singapore. http://www.nrf.gov.sg/ http://www.tll.org.sg/ group-leaders/naweed-isaak-naqvi/Funded to NIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,8,10,2,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004972,10.1371/journal.ppat.1004972,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900045,26102503.0,"DOAJ Gold, Green Published",,,16/08/2019,9,21,19,4263,561,384,177,3702,2964,23,715,19,13,0,0,7,7,1,,25,4,25,0,4,11,11,9,5,0,0,0,0,0,0,0,17,1,4289,92,0,88,64,1,3692,561,92,0,88,64,1,36,,1,0,0,0,16,0,2,0,0,0,0,24,0,0,18.95,7.598930481283422,1.1515397082658023,0.15153970826580226,1.2007023230686116,1.0426929392446633,7.923351158645277
549,J,"Deval, J; Hong, J; Wang, GY; Taylor, J; Smith, LK; Fung, A; Stevens, SK; Liu, H; Jin, ZN; Dyatkina, N; Prhavc, M; Stoycheva, D; Serebryany, V; Liu, JW; Smith, DB; Tam, Y; Zhang, QL; Moore, ML; Fearns, R; Chanda, SM; Blatt, LM; Symons, JA; Beigelman, L",,,,"Deval, Jerome; Hong, Jin; Wang, Guangyi; Taylor, Josh; Smith, Lucas K.; Fung, Amy; Stevens, Sarah K.; Liu, Hong; Jin, Zhinan; Dyatkina, Natalia; Prhavc, Marija; Stoycheva, D.; Serebryany, Vladimir; Liu, Jyanwei; Smith, David B.; Tam, Yuen; Zhang, Qingling; Moore, Martin L.; Fearns, Rachel; Chanda, Sushmita M.; Blatt, Lawrence M.; Symons, Julian A.; Beigelman, Leo",,,Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2 '-Fluoro-4 '-Chloromethyl-Cytidine Triphosphate,PLOS PATHOGENS,,,English,Article,,,,,,,T-705 FAVIPIRAVIR; STRUCTURAL BASIS; CELL-CULTURE; ACTIVE-SITE; INFECTION; REPLICATION; SEQUENCE; TRANSCRIPTASE; INFLUENZA; DOMAINS,"Respiratory syncytial virus (RSV) causes severe lower respiratory tract infections, yet no vaccines or effective therapeutics are available. ALS-8176 is a first-in-class nucleoside analog prodrug effective in RSV-infected adult volunteers, and currently under evaluation in hospitalized infants. Here, we report the mechanism of inhibition and selectivity of ALS-8176 and its parent ALS-8112. ALS-8176 inhibited RSV replication in non-human primates, while ALS-8112 inhibited all strains of RSV in vitro and was specific for paramyxoviruses and rhabdoviruses. The antiviral effect of ALS-8112 was mediated by the intracellular formation of its 5'-triphosphate metabolite (ALS-8112-TP) inhibiting the viral RNA polymerase. ALS-8112 selected for resistance-associated mutations within the region of the L gene of RSV encoding the RNA polymerase. In biochemical assays, ALS-8112-TP was efficiently recognized by the recombinant RSV polymerase complex, causing chain termination of RNA synthesis. ALS-8112-TP did not inhibit polymerases from host or viruses unrelated to RSV such as hepatitis C virus (HCV), whereas structurally related molecules displayed dual RSV/HCV inhibition. The combination of molecular modeling and enzymatic analysis showed that both the 2'F and the 4'ClCH2 groups contributed to the selectivity of ALS-8112-TP. The lack of antiviral effect of ALS-8112-TP against HCV polymerase was caused by Asn291 that is well-conserved within positive-strand RNA viruses. This represents the first comparative study employing recombinant RSV and HCV polymerases to define the selectivity of clinically relevant nucleotide analogs. Understanding nucleotide selectivity towards distant viral RNA polymerases could not only be used to repurpose existing drugs against new viral infections, but also to design novel molecules.","[Deval, Jerome; Hong, Jin; Wang, Guangyi; Taylor, Josh; Smith, Lucas K.; Fung, Amy; Stevens, Sarah K.; Liu, Hong; Jin, Zhinan; Dyatkina, Natalia; Prhavc, Marija; Stoycheva, D.; Serebryany, Vladimir; Liu, Jyanwei; Smith, David B.; Tam, Yuen; Zhang, Qingling; Chanda, Sushmita M.; Blatt, Lawrence M.; Symons, Julian A.; Beigelman, Leo] Alios BioPharma Inc, San Francisco, CA 94080 USA; [Moore, Martin L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Fearns, Rachel] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA","Deval, J (reprint author), Alios BioPharma Inc, San Francisco, CA 94080 USA.",jdeval@aliosbiopharma.com; lbeigelman@aliosbiopharma.com,,,,,,43,25,27,1,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004995,10.1371/journal.ppat.1004995,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900055,26098424.0,"DOAJ Gold, Green Published",,,16/08/2019,27,7,22,6779,2066,1461,605,4713,3702,26,985,22,6,0,0,28,28,0,,67,1,34,0,1,29,29,19,15,0,0,0,0,0,0,0,1,0,7273,55,0,822,89,1,4748,2479,55,0,822,89,1,46,,0,0,0,0,6,0,1,0,0,0,0,34,0,0,2.75,3.2812197483059053,1.4383619775090175,0.4383619775090176,1.5737322300021217,1.0941141761321729,3.590029041626331
550,J,"Di Giallonardo, F; Holmes, EC",,,,"Di Giallonardo, Francesca; Holmes, Edward C.",,,Exploring Host-Pathogen Interactions through Biological Control,PLOS PATHOGENS,,,English,Article,,,,,,,HEMORRHAGIC-DISEASE RHD; VIRAL BIOCONTROL; MARION-ISLAND; FERAL CATS; RABBIT; TRANSMISSION; MYXOMATOSIS; AUSTRALIA; ERADICATION; EMERGENCE,"Invasive pests impose a major burden on the agricultural industries and the natural environment, threatening some native species with extinction. Although chemical agents are often deployed to eliminate pests, unspecific toxicity makes their use undesirable. Biological agents are of interest as an alternative method to cull specific pest species with little residual environmental harm. The deliberate release of microbial pathogens, referred to as biological control (biocontrol), has, to date, largely involved viruses. Here, we summarise the past and proposed applications of the biocontrol of vertebrate pests. Despite understandable fears, vertebrate biocontrol has yet to be associated with adverse effects, and provides large-scale natural experiments by which to understand the intimate interactions between hosts and their pathogens.","[Di Giallonardo, Francesca; Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Di Giallonardo, Francesca; Holmes, Edward C.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Di Giallonardo, Francesca; Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Di Giallonardo, Francesca; Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia","Di Giallonardo, F (reprint author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.",francesca.digiallonardo@sydney.edu.au,,"Holmes, Edward/0000-0001-9596-3552",Swiss National Science Foundation [P2ZHP3_151594]; NHMRC Australia [AF30]; ARC [DP140103362]; NIH [R01 AI093804-01A1],"FDG is support by the Swiss National Science Foundation grant number P2ZHP3_151594 (http://www.snf.ch/de/Seiten/default.aspx). ECH is supported by an NHMRC Australia Fellowship (AF30) (https://www.nhmrc.gov.au/), ARC grant DP140103362 (http://www.arc.gov.au/), and NIH grant R01 AI093804-01A1 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,21,6,6,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004865,10.1371/journal.ppat.1004865,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900010,26110272.0,"DOAJ Gold, Green Published",,,16/08/2019,6,7,26,4614,412,322,90,4202,3437,49,716,26,5,0,0,4,4,1,,73,4,37,0,4,6,6,5,1,0,0,0,0,0,0,0,2,0,4655,10,0,90,83,1,4189,412,10,0,90,83,1,54,,0,0,0,0,7,0,1,1,0,0,0,37,0,0,4.85,11.199029126213592,1.0980485483103284,0.09804854831032842,1.1299381247025226,1.0290420459471175,11.524271844660195
551,J,"Dutta, D; Dutta, S; Veettil, MV; Roy, A; Ansari, MA; Iqbal, J; Chikoti, L; Kumar, B; Johnson, KE; Chandran, B",,,,"Dutta, Dipanjan; Dutta, Sujoy; Veettil, Mohanan Valiya; Roy, Arunava; Ansari, Mairaj Ahmed; Iqbal, Jawed; Chikoti, Leela; Kumar, Binod; Johnson, Karen E.; Chandran, Bala",,,BRCA1 Regulates IFI16 Mediated Nuclear Innate Sensing of Herpes Viral DNA and Subsequent Induction of the Innate Inflammasome and Interferon-beta Responses,PLOS PATHOGENS,,,English,Article,,,,,,,CHROMATIN CONTROL; DAMAGE RESPONSE; INFECTION; PROTEIN; RECOGNITION; LATENCY; CELLS; ACTIVATION; IMMUNITY; BINDING,"The innate immune system pattern recognition receptors (PRR) are the first line of host defenses recognizing the various pathogen-or danger-associated molecular patterns and eliciting defenses by regulating the production of pro-inflammatory cytokines such as IL-1 beta, IL-18 or interferon beta (IFN-beta). NOD-like receptors (NLRs) and AIM2-like receptors (ALRs) are cytoplasmic inflammasome sensors of foreign molecules, including DNA. IFI16, a sequence-independent nuclear innate sensor ALR, recognizes episomal dsDNA genomes of herpes viruses such as KSHV, EBV, and HSV-1 in the infected cell nuclei, forms an inflammasome complex with ASC and procaspase1, and relocates into the cytoplasm leading into Caspase-1 and IL-1 beta generation. IFI16 also induces IFN-beta during HSV-1 infection via the cytoplasmic STING-TBK1-IRF3 pathway. Thus far, whether IFI16 recognizes foreign DNA directly or utilizes other host protein(s) is unknown. Here, we demonstrate that BRCA1, a DNA damage repair sensor and transcription regulator, is in complex with IFI16 in the host cell nucleus, and their association increases in the presence of nuclear viral genomes during de novo KSHV, EBV and HSV-1 infection, and in latent KSHV or EBV infection, but not by DNA damage responses (DDR) induced by bleomycin and vaccinia virus cytoplasmic dsDNA. BRCA1 is a constituent of the triggered IFI16-inflammasome and is translocated into the cytoplasm after genome recognition along with the IFI16-inflammasome. The absence of BRCA1 abrogated IFI16-viral genome association, inflammasome assembly, IFI16 cytoplasmic localization, and Caspase-1 and IL-1 beta production. The absence of BRCA1 also abolished the cytoplasmic IFI16-STING interaction, downstream IRF3 phosphorylation, nuclear translocation of pIRF3 and IFN-beta production during de novo KSHV and HSV-1 infection. These findings highlight that BRCA1 plays a hitherto unidentified innate immunomodulatory role by facilitating nuclear foreign DNA sensing by IFI16, subsequent assembly and cytoplasmic distribution of IFI16-inflammasomes leading into IL-1 beta formation and the induction of IFN-beta via cytoplasmic signaling through IFI16-STING, TBK1 and IRF3.","[Dutta, Dipanjan; Dutta, Sujoy; Veettil, Mohanan Valiya; Roy, Arunava; Ansari, Mairaj Ahmed; Iqbal, Jawed; Chikoti, Leela; Kumar, Binod; Johnson, Karen E.; Chandran, Bala] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA","Dutta, D (reprint author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA.",bala.chandran@rosalindfranklin.edu,"Kumar, Binod/I-4818-2019; Kumar, Binod/I-4230-2019","Kumar, Binod/0000-0002-2077-8501; Roy, Arunava/0000-0002-8486-0539","Public Health Service [CA 180758, AI 113391]; Rosalind Franklin University of Medicine and Science H.M. Bligh Cancer Research Fund","This study was supported in part by Public Health Service grants CA 180758 and AI 113391, and the Rosalind Franklin University of Medicine and Science H.M. Bligh Cancer Research Fund to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,36,37,3,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005030,10.1371/journal.ppat.1005030,,,,47,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900069,26121674.0,"DOAJ Gold, Green Published",,,16/08/2019,33,3,53,9053,1870,1229,641,7183,4878,24,2281,52,2,1,0,32,32,0,,66,11,65,1,11,35,35,28,22,0,0,0,0,0,0,0,1,2,9079,40,0,751,154,0,7156,1870,40,0,751,154,0,53,,0,0,0,1,6,0,1,0,0,0,0,64,1,0,5.25,4.841176470588235,1.2603369065849923,0.26033690658499237,1.2909647779479325,1.0243013365735116,4.958823529411765
552,J,"Funk, C; Ott, M; Raschbichler, V; Nagel, CH; Binz, A; Sodeik, B; Bauerfeind, R; Bailer, SM",,,,"Funk, Christina; Ott, Melanie; Raschbichler, Verena; Nagel, Claus-Henning; Binz, Anne; Sodeik, Beate; Bauerfeind, Rudolf; Bailer, Susanne M.",,,"The Herpes Simplex Virus Protein pUL31 Escorts Nucleocapsids to Sites of Nuclear Egress, a Process Coordinated by Its N-Terminal Domain",PLOS PATHOGENS,,,English,Article,,,,,,,OPEN READING FRAME; PSEUDORABIES VIRUS; U(L)31 GENE; HERPES-SIMPLEX-VIRUS-1 U(L)31; REPLICATION COMPARTMENTS; VESICLE FORMATION; DELETION MUTANT; TYPE-1 U(L)34; UL31 PROTEIN; MEMBRANE,"Progeny capsids of herpesviruses leave the nucleus by budding through the nuclear envelope. Two viral proteins, the membrane protein pUL34 and the nucleo-phosphoprotein pUL31 form the nuclear egress complex that is required for capsid egress out of the nucleus. All pUL31 orthologs are composed of a diverse N-terminal domain with 1 to 3 basic patches and a conserved C-terminal domain. To decipher the functions of the N-terminal domain, we have generated several Herpes simplex virus mutants and show here that the N-terminal domain of pUL31 is essential with basic patches being critical for viral propagation. pUL31 and pUL34 entered the nucleus independently of each other via separate routes and the N-terminal domain of pUL31 was required to prevent their premature interaction in the cytoplasm. Unexpectedly, a classical bipartite nuclear localization signal embedded in this domain was not required for nuclear import of pUL31. In the nucleus, pUL31 associated with the nuclear envelope and newly formed capsids. Viral herpesviralmutants lacking the N-terminal domain or with its basic patches neutralized still associated with nucleocapsids but were unable to translocate them to the nuclear envelope. Replacing the authentic basic patches with a novel artificial one resulted in HSV1(17(+)) Lox-UL31-hbpmp1mp2, that was viable but delayed in nuclear egress and compromised in viral production. Thus, while the C-terminal domain of pUL31 is sufficient for the interaction with nucleocapsids, the N-terminal domain was essential for capsid translocation to sites of nuclear egress and a coordinated interaction with pUL34. Our data indicate an orchestrated sequence of events with pUL31 binding to nucleocapsids and escorting them to the inner nuclear envelope. We propose a common mechanism for herpesviral nuclear egress: pUL31 is required for intranuclear translocation of nucleocapsids and subsequent interaction with pUL34 thereby coupling capsid maturation with primary envelopment.","[Funk, Christina; Bailer, Susanne M.] Univ Stuttgart, Inst Interfacial Engn & Plasma Technol IGVP, D-70174 Stuttgart, Germany; [Ott, Melanie; Raschbichler, Verena; Bailer, Susanne M.] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Nagel, Claus-Henning; Binz, Anne; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Bauerfeind, Rudolf] Hannover Med Sch, Inst Cell Biol, Hannover, Germany; [Bailer, Susanne M.] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Stuttgart, Germany","Funk, C (reprint author), Univ Stuttgart, Inst Interfacial Engn & Plasma Technol IGVP, D-70174 Stuttgart, Germany.",susanne.bailer@igvp.uni-stuttgart.de,,,"German Research Foundation (DFG) [BA1165/5-1, SPP1175]; German Research Foundation (DFG Excellence Cluster EXC 62); German Research Foundation (REBIRTH - From Regenerative Biology to Reconstructive Therapy); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony","These studies were supported by the German Research Foundation (DFG grant BA1165/5-1 to SB; DFG Excellence Cluster EXC 62, REBIRTH - From Regenerative Biology to Reconstructive Therapy to BS; DFG Program Project Grant SPP1175 to RB and BS; www.dfg.de) and the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony (http://www.tiho-hannover.de/forschung/n-rennt/).",,72,33,34,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004957,10.1371/journal.ppat.1004957,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900034,26083367.0,"DOAJ Gold, Green Published",,,16/08/2019,33,2,12,3797,667,483,184,3130,2550,33,547,12,2,0,0,27,27,0,,17,0,17,0,0,33,33,27,21,0,0,0,0,0,0,0,0,0,3804,40,0,77,51,3,3124,667,40,0,77,51,3,13,,0,0,0,0,2,0,0,1,0,0,0,17,0,0,0.75,5.692653673163418,1.2130990415335463,0.21309904153354634,1.244408945686901,1.0258098498814854,5.839580209895052
553,J,"Fusco, ML; Hashiguchi, T; Cassan, R; Biggins, JE; Murin, CD; Warfield, KL; Li, S; Holtsberg, FW; Shulenin, S; Vu, H; Olinger, GG; Kim, DH; Whaley, KJ; Zeitlin, L; Ward, AB; Nykiforuk, C; Aman, MJ; Berry, J; Saphire, EO",,,,"Fusco, Marnie L.; Hashiguchi, Takao; Cassan, Robyn; Biggins, Julia E.; Murin, Charles D.; Warfield, Kelly L.; Li, Sheng; Holtsberg, Frederick W.; Shulenin, Sergey; Vu, Hong; Olinger, Gene G.; Kim, Do H.; Whaley, Kevin J.; Zeitlin, Larry; Ward, Andrew B.; Nykiforuk, Cory; Aman, M. Javad; Berry, Jody; Saphire, Erica Ollmann",,,Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs,PLOS PATHOGENS,,,English,Article,,,,,,,NIEMANN-PICK C1; EBOLA-VIRUS; HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; RECEPTOR-BINDING; RHESUS MACAQUES; GLYCOPROTEIN; ANTIBODIES; INFECTION; DISEASE,"The filoviruses, which include the marburg- and ebolaviruses, have caused multiple outbreaks among humans this decade. Antibodies against the filovirus surface glycoprotein (GP) have been shown to provide life-saving therapy in nonhuman primates, but such antibodies are generally virus-specific. Many monoclonal antibodies (mAbs) have been described against Ebola virus. In contrast, relatively few have been described against Marburg virus. Here we present ten mAbs elicited by immunization of mice using recombinant mucin-deleted GPs from different Marburg virus (MARV) strains. Surprisingly, two of the mAbs raised against MARV GP also cross-react with the mucin-deleted GP cores of all tested ebolaviruses (Ebola, Sudan, Bundibugyo, Reston), but these epitopes are masked differently by the mucin-like domains themselves. The most efficacious mAbs in this panel were found to recognize a novel ""wing"" feature on the GP2 subunit that is unique to Marburg and does not exist in Ebola. Two of these anti-wing antibodies confer 90 and 100% protection, respectively, one hour post-exposure in mice challenged with MARV.","[Fusco, Marnie L.; Hashiguchi, Takao; Murin, Charles D.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Hashiguchi, Takao] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan; [Cassan, Robyn; Nykiforuk, Cory; Berry, Jody] Emergent BioSolut, Winnipeg, MB, Canada; [Biggins, Julia E.; Olinger, Gene G.] US Army Res Inst Infect Dis, Div Virol, Ft Detrick, MD USA; [Biggins, Julia E.; Warfield, Kelly L.; Holtsberg, Frederick W.; Shulenin, Sergey; Vu, Hong; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA; [Murin, Charles D.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Olinger, Gene G.] NIAID, Integrated Res Facil, NIH, Frederick, MD USA; [Kim, Do H.; Whaley, Kevin J.; Zeitlin, Larry] Mapp Biopharmaceut Inc, San Diego, CA USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA","Fusco, ML (reprint author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.",erica@scripps.edu,"Ward, Andrew/F-9203-2014","Ward, Andrew/0000-0001-7153-3769; Saphire, Erica Ollmann/0000-0002-1206-7451; Olinger, Gene/0000-0001-7338-0292; Hashiguchi, Takao/0000-0001-7578-7571","Center of Excellence in Translational Research [R01 AI089498, U19 AI109762]; NSF; JSPS; Uehara Memorial Foundation; Investigators in the Pathogenesis of Infectious Disease award from The Burroughs Wellcome Fund;  [U01AI082156];  [R43 AI082744]","The authors gratefully acknowledge R01 AI089498 (EOS, CN, KLW, MJA, HV, SS and JB), U19 AI109762 ""Center of Excellence in Translational Research"" (EOS, ABW, CN), U01AI082156 (EOS), R43 AI082744 (LZ, DHK, and KJW), NSF predoctoral fellowship (CDM), JSPS Postdoctoral Fellowships for Research Abroad (TH), Research Fellowship of The Uehara Memorial Foundation (TH), and an Investigators in the Pathogenesis of Infectious Disease award from The Burroughs Wellcome Fund (EOS) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,17,18,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005016,10.1371/journal.ppat.1005016,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900066,26115029.0,"DOAJ Gold, Green Published",,,16/08/2019,19,362,48,5911,1231,996,235,4680,3866,25,789,48,16,0,0,15,15,4,,51,14,51,0,14,19,19,17,12,0,0,0,0,0,0,2,339,0,6038,24,226,105,253,2,4735,1256,24,226,105,253,2,47,,4,0,0,0,23,0,3,0,0,0,0,51,0,0,40.9,4.80178716490658,1.263034188034188,0.26303418803418804,1.3493589743589745,1.0683471493825072,5.129975629569456
554,J,"Gil-Ranedo, J; Hernando, E; Riolobos, L; Dominguez, C; Kann, M; Almendral, JM",,,,"Gil-Ranedo, Jon; Hernando, Eva; Riolobos, Laura; Dominguez, Carlos; Kann, Michael; Almendral, Jose M.",,,The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly,PLOS PATHOGENS,,,English,Article,,,,,,,MINUTE VIRUS; NUCLEOCYTOPLASMIC TRANSPORT; ANTIGEN PCNA; HOST-RANGE; S PHASE; MICE; DNA; REPLICATION; PROTEIN; ACTIVATION,"It is unknown whether the mammalian cell cycle could impact the assembly of viruses maturing in the nucleus. We addressed this question using MVM, a reference member of the icosahedral ssDNA nuclear parvoviruses, which requires cell proliferation to infect by mechanisms partly understood. Constitutively expressed MVM capsid subunits (VPs) accumulated in the cytoplasm of mouse and human fibroblasts synchronized at G0, G1, and G1/S transition. Upon arrest release, VPs translocated to the nucleus as cells entered S phase, at efficiencies relying on cell origin and arrest method, and immediately assembled into capsids. In synchronously infected cells, the consecutive virus life cycle steps (gene expression, proteins nuclear translocation, capsid assembly, genome replication and encapsidation) proceeded tightly coupled to cell cycle progression from G0/G1 through S into G2 phase. However, a DNA synthesis stress caused by thymidine irreversibly disrupted virus life cycle, as VPs became increasingly retained in the cytoplasm hours poststress, forming empty capsids in mouse fibroblasts, thereby impairing encapsidation of the nuclear viral DNA replicative intermediates. Synchronously infected cells subjected to density-arrest signals while traversing early S phase also blocked VPs transport, resulting in a similar misplaced cytoplasmic capsid assembly in mouse fibroblasts. In contrast, thymidine and density arrest signals deregulating virus assembly neither perturbed nuclear translocation of the NS1 protein nor viral genome replication occurring under S/G2 cycle arrest. An underlying mechanism of cell cycle control was identified in the nuclear translocation of phosphorylated VPs trimeric assembly intermediates, which accessed a non-conserved route distinct from the importin alpha 2/beta 1 and transportin pathways. The exquisite cell cycle-dependence of parvovirus nuclear capsid assembly conforms a novel paradigm of time and functional coupling between cellular and virus life cycles. This junction may determine the characteristic parvovirus tropism for proliferative and cancer cells, and its disturbance could critically contribute to persistence in host tissues.","[Gil-Ranedo, Jon; Hernando, Eva; Riolobos, Laura; Dominguez, Carlos; Almendral, Jose M.] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Kann, Michael] Univ Bordeaux, Microbiol Fondamentale & Pathogenic, UMR 5234, Bordeaux, France; [Kann, Michael] CNRS, Microbiol Fondamentale & Pathogenic, UMR 5234, Bordeaux, France; [Kann, Michael] Ctr Hosp Univ Bordeaux, Serv Virol, Bordeaux, France","Gil-Ranedo, J (reprint author), Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain.",jmalmendral@cbm.csic.es,,,"Plan Nacional I+D of the Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2011-29403]; Fundacion Ramon Areces to the Centro de Biologia Molecular ""Severo Ochoa"" (CSIC-UAM)","This work was supported by the grant SAF2011-29403 from the Plan Nacional I+D of the Spanish Ministerio de Ciencia e Innovacion (MICINN) to JMA. The institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular ""Severo Ochoa"" (CSIC-UAM) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,88,4,4,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004920,10.1371/journal.ppat.1004920,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900022,26067441.0,"DOAJ Gold, Green Published",,,16/08/2019,4,4,13,3634,799,595,204,2835,2303,27,505,13,4,0,0,4,4,1,,0,0,0,0,0,4,4,4,3,0,0,0,0,0,0,0,0,2,3683,25,0,71,156,1,2847,808,25,0,71,156,1,28,,0,0,0,0,4,0,0,1,0,0,0,15,0,0,2.0,4.548185231539424,1.2818342151675486,0.2818342151675485,1.362962962962963,1.0632911392405062,4.8360450563204
555,J,"Greene, NG; Narciso, AR; Filipe, SR; Camilli, A",,,,"Greene, Neil G.; Narciso, Ana R.; Filipe, Sergio R.; Camilli, Andrew",,,Peptidoglycan Branched Stem Peptides Contribute to Streptococcus pneumoniae Virulence by Inhibiting Pneumolysin Release,PLOS PATHOGENS,,,English,Article,,,,,,,CELL-WALL; ANTIBIOTIC-RESISTANCE; PENICILLIN RESISTANCE; PHOSPHOLIPASE-C; NEGATIVE MUTANT; MURMN OPERON; COLONIZATION; TRANSFORMATION; ACTIVATION; GENE,"Streptococcus pneumoniae (the pneumococcus) colonizes the human nasopharynx and is a significant pathogen worldwide. Pneumolysin (Ply) is a multi-functional, extracellular virulence factor produced by this organism that is critical for pathogenesis. Despite the absence of any apparent secretion or cell surface attachment motifs, Ply localizes to the cell envelope of actively growing cells. We sought to characterize the consequences of this surface localization. Through functional assays with whole cells and subcellular fractions, we determined that Ply activity and its release into the extracellular environment are inhibited by peptidoglycan (PG) structure. The ability of PG to inhibit Ply release was dependent on the stem peptide composition of this macromolecule, which was manipulated by mutation of the murMN operon that encodes proteins responsible for branched stem peptide synthesis. Additionally, removal of choline-binding proteins from the cell surface significantly reduced Ply release to levels observed in a mutant with a high proportion of branched stem peptides suggesting a link between this structural feature and surface-associated choline-binding proteins involved in PG metabolism. Of clinical relevance, we also demonstrate that a hyperactive, mosaic murMN allele associated with penicillin resistance causes decreased Ply release with concomitant increases in the amount of branched stem peptides. Finally, using a murMN deletion mutant, we observed that increased Ply release is detrimental to virulence during a murine model of pneumonia. Taken together, our results reveal a novel role for branched stem peptides in pneumococcal pathogenesis and demonstrate the importance of controlled Ply release during infection. These results highlight the importance of PG composition in pathogenesis and may have broad implications for the diverse PG structures observed in other bacterial pathogens.","[Greene, Neil G.; Camilli, Andrew] Tufts Univ, Sackler Sch Grad Biomed Sci, Howard Hughes Med Inst, Grad Program Mol Microbiol,Sch Med, Boston, MA 02111 USA; [Greene, Neil G.; Camilli, Andrew] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Narciso, Ana R.; Filipe, Sergio R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Oeiras, Portugal","Greene, NG (reprint author), Tufts Univ, Sackler Sch Grad Biomed Sci, Howard Hughes Med Inst, Grad Program Mol Microbiol,Sch Med, Boston, MA 02111 USA.",andrew.camilli@tufts.edu,"Narciso, Ana/T-9021-2017; Filipe, Sergio Raposo/B-9167-2008","Narciso, Ana/0000-0003-1316-3856; Filipe, Sergio Raposo/0000-0002-4485-832X",National Institute of General Medical Sciences [T32GM07310]; Molecular Biosciences Fundacao para a Ciencia e Tecnologia [SFRH/BD/52203/2013],"This work was supported by National Institute of General Medical Sciences (URL: http://www.nigms.nih.gov/) training grant T32GM07310 (NGG), Molecular Biosciences Fundacao para a Ciencia e Tecnologia (URL: http://www.fct.pt/) PhD Program fellowship SFRH/BD/52203/2013 (ARN). AC is a Howard Hughes Medical Institute (URL: http://www.hhmi.org/) Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,13,13,0,25,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004996,10.1371/journal.ppat.1004996,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900056,26114646.0,"DOAJ Gold, Green Published",,,16/08/2019,13,36,32,4502,870,647,223,3632,2870,18,744,32,3,0,0,13,13,0,,40,6,40,0,6,15,15,15,8,0,0,0,0,0,0,0,33,2,4603,39,0,85,72,1,3673,879,39,0,85,72,1,51,,0,0,0,0,3,0,0,0,0,0,0,42,0,0,1.75,5.174712643678161,1.2395374449339207,0.2395374449339207,1.297907488986784,1.0470901821412706,5.418390804597701
556,J,"Haldar, K",,,,"Haldar, Kasturi",,,From Cell and Organismal Biology to Drugs,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"[Haldar, Kasturi] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA","Haldar, K (reprint author), Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.",khaldar@nd.edu,,,,,,0,0,0,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005002,10.1371/journal.ppat.1005002,,,,2,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900059,26110763.0,"DOAJ Gold, Green Published",,,16/08/2019,0,18,5,4044,189,127,62,3855,3469,41,345,5,11,0,0,0,0,5,,6,0,6,0,0,0,0,0,0,0,0,0,0,0,0,2,7,3,4051,0,0,0,37,0,3848,189,0,0,0,37,0,14,,2,0,0,0,11,0,2,0,0,0,0,6,0,0,27.45,21.396825396825395,1.0490272373540857,0.0490272373540856,1.0604409857328145,1.0108803165182987,21.62962962962963
557,J,"Hammami, A; Charpentier, T; Smans, M; Stager, S",,,,"Hammami, Akil; Charpentier, Tania; Smans, Melina; Staeger, Simona",,,IRF-5-Mediated Inflammation Limits CD8(+) T Cell Expansion by Inducing HIF-1 alpha and Impairing Dendritic Cell Functions during Leishmania Infection,PLOS PATHOGENS,,,English,Article,,,,,,,INTERFERON REGULATORY FACTOR; TUMOR-NECROSIS-FACTOR; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TOLL-LIKE RECEPTORS; CUTTING EDGE; IN-VIVO; VISCERAL LEISHMANIASIS; ADENOSINE RECEPTORS; DONOVANI INFECTION; CLONAL EXPANSION,"Inflammation is known to be necessary for promoting, sustaining, and tuning CD8(+) T cell responses. Following experimental Leishmania donovani infection, the inflammatory response is mainly induced by the transcription factor IRF-5. IRF-5 is responsible for the activation of several genes encoding key pro-inflammatory cytokines, such as IL-6 and TNF. Here, we investigate the role of IRF-5-mediated inflammation in regulating antigenspecific CD8(+) T cell responses during L. donovani infection. Our data demonstrate that the inflammatory response induced by IRF-5 limits CD8(+) T cell expansion and induces HIF-1 alpha in dendritic cells. Ablation of HIF-1 alpha in CD11c(+) cells resulted into a higher frequency of short-lived effector cells (SLEC), enhanced CD8(+) T cell expansion, and increased IL-12 expression by splenic DCs. Moreover, mice with a targeted depletion of HIF-1 alpha in CD11c(+) cells had a significantly lower splenic parasite burden, suggesting that induction of HIF-1 alpha may represent an immune evasive mechanism adopted by Leishmania parasites to establish persistent infections.","[Hammami, Akil; Charpentier, Tania; Smans, Melina; Staeger, Simona] INRS Inst Armand Frappier, Laval, PQ, Canada","Hammami, A (reprint author), INRS Inst Armand Frappier, Laval, PQ, Canada.",simona.stager@iaf.inrs.ca,,,Canadian Institute of Health Research,"This work was funded by the Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,91,21,22,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004938,10.1371/journal.ppat.1004938,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900025,26046638.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,21,1,20,4274,886,642,244,3388,2612,21,755,20,0,0,0,20,20,0,,29,1,29,0,1,23,23,23,14,0,0,0,0,0,0,0,1,5,4289,50,0,57,55,0,3381,886,50,0,57,55,0,22,,0,0,0,0,5,0,1,1,0,0,0,29,0,0,2.5,4.823927765237021,1.2615112160566706,0.2615112160566706,1.296930342384888,1.0280767430978006,4.959367945823928
558,J,"Holmes, M; Zhang, FW; Bieniasz, PD",,,,"Holmes, Mowgli; Zhang, Fengwen; Bieniasz, Paul D.",,,Single-Cell and Single-Cycle Analysis of HIV-1 Replication,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 MATRIX PROTEIN; REV TRANS-ACTIVATOR; MEMBRANE-BINDING; NUCLEAR EXPORT; IN-VIVO; REVERSE TRANSCRIPTION; INFECTED INDIVIDUALS; INTRACELLULAR DELAY; ENTRY INHIBITORS,"The dynamics of the late stages of the HIV-1 life cycle are poorly documented. Viral replication dynamics are typically measured in populations of infected cells, but asynchrony that is introduced during the early steps of HIV-1 replication complicates the measurement of the progression of subsequent steps and can mask replication dynamics and their variation in individual infected cells. We established microscopy-based methods to dynamically measure HIV-1-encoded reporter gene and antiviral gene expression in individual infected cells. We coupled these measurements with conventional analyses to quantify delays in the HIV-1 replication cycle imposed by the biphasic nature of HIV-1 gene expression and by the assembly-inhibiting property of the matrix domain of Gag. We further related the dynamics of restriction factor (APOBEC3G) removal to the dynamics of HIV-1 replication in individual cells. These studies provide a timeline for key events in the HIV-1 replication cycle, and reveal that the interval between the onset of early and late HIV-1 gene expression is only similar to 3h, but matrix causes a similar to 6-12h delay in the generation of extracellular virions. Interestingly, matrix delays particle assembly to a time at which APOBEC3G has largely been removed from the cell. Thus, a need to prepare infected cells to be efficient producers of infectious HIV-1 may provide an impetus for programmed delays in HIV-1 virion genesis. Our findings also emphasize the significant heterogeneity in the length of the HIV-1 replication cycle in homogenous cell populations and suggest that a typical infected cell generates new virions for only a few hours at the end of a 48h lifespan. Therefore, small changes in the lifespan of infected cells might have a large effect on viral yield in a single cycle and the overall clinical course in infected individuals.","[Holmes, Mowgli] Columbia Univ, New York, NY 10025 USA; [Holmes, Mowgli; Zhang, Fengwen; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Holmes, Mowgli; Zhang, Fengwen; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10021 USA; [Bieniasz, Paul D.] Howard Hughes Med Inst, New York, NY USA","Holmes, M (reprint author), Columbia Univ, New York, NY 10025 USA.",pbienias@adarc.org,,,"NIH [R01AI50111, P50GM103297]","This work was supported by grants from the NIH (R01AI50111 and P50GM103297) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,60,16,16,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004961,10.1371/journal.ppat.1004961,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900037,26086614.0,"DOAJ Gold, Green Published",,,16/08/2019,18,3,59,8813,1606,1218,388,7207,5374,19,1814,58,3,8,2,18,18,0,,86,4,85,1,4,18,18,15,11,0,0,0,0,0,0,0,0,3,8983,114,0,81,171,1,7281,1624,114,0,81,171,1,78,,0,0,0,0,7,0,0,1,1,0,0,85,1,0,5.2,5.487546699875467,1.2228389066185652,0.22283890661856529,1.2859719716941862,1.051628276409849,5.770859277708593
559,J,"Horner, SM; Naggie, S",,,,"Horner, Stacy M.; Naggie, Susanna",,,Successes and Challenges on the Road to Cure Hepatitis C,PLOS PATHOGENS,,,English,Article,,,,,,,DACLATASVIR PLUS ASUNAPREVIR; GENOTYPE 1B; SOFOSBUVIR; RIBAVIRIN; HIV; CIRRHOSIS; ALPHA-2A,,"[Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Horner, Stacy M.; Naggie, Susanna] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Naggie, Susanna] Duke Clin Res Inst, Durham, NC USA","Horner, SM (reprint author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.",susanna.naggie@duke.edu,,,"National Institute of Allergy and Infectious Disease of the National Institutes of Health [1K23AI096913, K22AI100935]; Duke University Center for AIDS Research (CFAR); NIH [5P30 A1064518]; Whitehead Scholar Award","SN is supported by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under grant 1K23AI096913. SMH is supported by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under grant K22AI100935, as well as the Duke University Center for AIDS Research (CFAR), an NIH funded program (5P30 A1064518), and a Whitehead Scholar Award. The funders had no role in the preparation of this manuscript and the views expressed here do not necessarily reflect those of the funders.",,32,22,22,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004854,10.1371/journal.ppat.1004854,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900008,26087286.0,"DOAJ Gold, Green Published",,,16/08/2019,26,16,21,6066,816,649,167,5250,4415,22,813,21,13,0,0,28,28,1,,0,42,0,0,42,30,26,30,12,0,0,0,0,0,0,0,3,4,6193,23,0,59,148,16,5260,822,23,0,59,148,16,111,,0,0,0,0,12,0,2,1,0,0,0,22,0,0,8.3,7.4338235294117645,1.1554285714285715,0.15542857142857142,1.2121904761904763,1.0491262776129244,7.799019607843137
560,J,"Howland, SW; Poh, CM; Renia, L",,,,"Howland, Shanshan W.; Poh, Chek Meng; Renia, Laurent",,,Activated Brain Endothelial Cells Cross-Present Malaria Antigen,PLOS PATHOGENS,,,English,Article,,,,,,,EXPERIMENTAL CEREBRAL MALARIA; CD8(+) T-CELLS; PLASMODIUM-BERGHEI INFECTION; BARRIER-SPECIFIC PROPERTIES; MHC CLASS-I; IFN-GAMMA; DENDRITIC CELLS; PATHOGENESIS; LYMPHOTOXIN; LYMPHOCYTES,"In the murine model of cerebral malaria caused by P. berghei ANKA (PbA), parasite-specific CD8(+) T cells directly induce pathology and have long been hypothesized to kill brain endothelial cells that have internalized PbA antigen. We previously reported that brain microvessel fragments from infected mice cross-present PbA epitopes, using reporter cells transduced with epitope-specific T cell receptors. Here, we confirm that endothelial cells are the population responsible for cross-presentation in vivo, not pericytes or microglia. PbA antigen cross-presentation by primary brain endothelial cells in vitro confers susceptibility to killing by CD8(+) T cells from infected mice. IFN gamma stimulation is required for brain endothelial cross-presentation in vivo and in vitro, which occurs by a proteasome-and TAP-dependent mechanism. Parasite strains that do not induce cerebral malaria were phagocytosed and cross-presented less efficiently than PbA in vitro. The main source of antigen appears to be free merozoites, which were avidly phagocytosed. A human brain endothelial cell line also phagocytosed P. falciparum merozoites. Besides being the first demonstration of cross-presentation by brain endothelial cells, our results suggest that interfering with merozoite phagocytosis or antigen processing may be effective strategies for cerebral malaria intervention.","[Howland, Shanshan W.; Poh, Chek Meng; Renia, Laurent] ASTAR, Agcy Sci, Singapore Immunol Network, Singapore, Singapore; [Poh, Chek Meng; Renia, Laurent] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore","Howland, SW (reprint author), ASTAR, Agcy Sci, Singapore Immunol Network, Singapore, Singapore.",shanshan_howland@immunol.a-star.edu.sg; renia_laurent@immunol.a-star.edu.sg,"Howland, Shanshan/I-2245-2014","Howland, Shanshan/0000-0003-4794-1564","Singapore's Agency for Science, Technology and Research; Yong Loo Lin School of Medicine, National University of Singapore","This work was supported by an intramural grant from Singapore's Agency for Science, Technology and Research. CMP is supported by a postgraduate scholarship from the Yong Loo Lin School of Medicine, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,60,43,43,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004963,10.1371/journal.ppat.1004963,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900039,26046849.0,"DOAJ Gold, Green Published",,,16/08/2019,40,6,48,5299,1006,756,250,4293,3457,27,809,48,6,0,0,37,37,0,,57,8,57,0,8,43,40,43,29,0,0,0,0,0,0,1,1,5,5312,32,0,88,40,3,4276,1006,32,0,88,40,3,30,,1,0,0,0,7,0,0,1,0,0,0,57,0,0,12.5,5.2673956262425445,1.2343349638947123,0.2343349638947123,1.2541346377824365,1.0160407624080015,5.351888667992048
561,J,"Kieser, KJ; Boutte, CC; Kester, JC; Baer, CE; Barczak, AK; Meniche, X; Chao, MC; Rego, EH; Sassetti, CM; Fortune, SM; Rubin, EJ",,,,"Kieser, Karen J.; Boutte, Cara C.; Kester, Jemila C.; Baer, Christina E.; Barczak, Amy K.; Meniche, Xavier; Chao, Michael C.; Rego, E. Hesper; Sassetti, Christopher M.; Fortune, Sarah M.; Rubin, Eric J.",,,Phosphorylation of the Peptidoglycan Synthase PonA1 Governs the Rate of Polar Elongation in Mycobacteria,PLOS PATHOGENS,,,English,Article,,,,,,,PENICILLIN-BINDING PROTEINS; CELL-WALL SYNTHESIS; TUBERCULOSIS; GROWTH; MORPHOLOGY; VIRULENCE; PLATFORM; MUREIN; PBP1A,"Cell growth and division are required for the progression of bacterial infections. Most rod-shaped bacteria grow by inserting new cell wall along their mid-section. However, mycobacteria, including the human pathogen Mycobacterium tuberculosis, produce new cell wall material at their poles. How mycobacteria control this different mode of growth is incompletely understood. Here we find that PonA1, a penicillin binding protein (PBP) capable of transglycosylation and transpeptidation of cell wall peptidoglycan (PG), is a major governor of polar growth in mycobacteria. PonA1 is required for growth of Mycobacterium smegmatis and is critical for M. tuberculosis during infection. In both cases, PonA1's catalytic activities are both required for normal cell length, though loss of transglycosylase activity has a more pronounced effect than transpeptidation. Mutations that alter the amount or the activity of PonA1 result in abnormal formation of cell poles and changes in cell length. Moreover, altered PonA1 activity results in dramatic differences in antibiotic susceptibility, suggesting that a balance between the two enzymatic activities of PonA1 is critical for survival. We also find that phosphorylation of a cytoplasmic region of PonA1 is required for normal activity. Mutations in a critical phosphorylated residue affect transglycosylase activity and result in abnormal rates of cell elongation. Together, our data indicate that PonA1 is a central determinant of polar growth in mycobacteria, and its governance of cell elongation is required for robust cell fitness during both host-induced and antibiotic stress.","[Kieser, Karen J.; Boutte, Cara C.; Kester, Jemila C.; Chao, Michael C.; Rego, E. Hesper; Fortune, Sarah M.; Rubin, Eric J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Baer, Christina E.; Meniche, Xavier; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Barczak, Amy K.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Rubin, Eric J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA","Kieser, KJ (reprint author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.",erubin@hsph.harvard.edu,,"Boutte, Cara/0000-0001-7645-6221; Baer, Christina/0000-0002-8909-2583; Chao, Michael/0000-0002-6046-585X","US National Institutes of Health [U01-GM094568]; National Institute of Allergy and Infectious Disease [AI095208, AI064282, R01 AI09719101A3]; Howard Hughes Medical Institute; National Institutes of Health; National Science Foundation [DGE0946799, DGE-1144152]","This work was supported by the US National Institutes of Health grant U01-GM094568 (to EJR), National Institute of Allergy and Infectious Disease grants AI095208 and AI064282 and the Howard Hughes Medical Institute (to CMS), National Institutes of Health and National Institute of Allergy and Infectious Disease grant R01 AI09719101A3 (to SMF), and National Science Foundation Graduate Research Fellowships DGE0946799 and DGE-1144152 (to KJK) and DGE-1144152 (to JCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,28,28,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005010,10.1371/journal.ppat.1005010,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900063,26114871.0,"DOAJ Gold, Green Published",,,16/08/2019,28,5,44,5806,958,700,258,4848,3871,20,957,44,5,0,0,28,28,0,,169,6,58,0,6,33,32,33,17,0,0,0,0,0,0,0,0,0,5902,179,0,152,84,1,4894,974,142,0,152,80,1,34,,0,0,0,0,5,0,0,0,0,0,0,63,0,0,2.25,6.060542797494781,1.1976072607260726,0.1976072607260726,1.2716584158415842,1.0618325869789873,6.435281837160751
562,J,"Kremer, EJ; Nemerow, GR",,,,"Kremer, Eric J.; Nemerow, Glen R.",,,Adenovirus Tales: From the Cell Surface to the Nuclear Pore Complex,PLOS PATHOGENS,,,English,Article,,,,,,,IN-VIVO; RECEPTOR; VECTORS; NEURONS; COXSACKIE; INTERNALIZATION; TRANSDUCTION; DISRUPTION; ATTACHMENT; TRANSPORT,,"[Kremer, Eric J.] CNRS, Inst Genet Mol Montpellier, F-34033 Montpellier, France; [Kremer, Eric J.] Univ Montpellier, F-34059 Montpellier, France; [Nemerow, Glen R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA","Kremer, EJ (reprint author), CNRS, Inst Genet Mol Montpellier, F-34033 Montpellier, France.",eric.kremer@igmm.cnrs.fr; gnemerow@scripps.edu,"Kremer, EJ/P-9838-2019; Kremer, Eric/D-3734-2013","Kremer, EJ/0000-0001-6114-7530; ","European Commission [290002, 286071, 222992]; Fondation Researche Medicale; E-Rare Fondation Maladies Rare; Agence National Recherche; Fondation de France; Region Languedoc Roussillon; National Institutes of Health (NIH) [AI103692, AI070771, HL054352]","The Kremer lab has been supported by grants from the European Commission (grants 290002, 286071 222992), Fondation Researche Medicale, E-Rare Fondation Maladies Rare, Agence National Recherche, Fondation de France, and the Region Languedoc Roussillon. The Nemerow lab has been supported by grants from the National Institutes of Health (NIH) AI103692, AI070771, and HL054352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,33,13,14,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004821,10.1371/journal.ppat.1004821,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900002,26042599.0,"DOAJ Gold, Green Published",,,16/08/2019,13,10,35,5353,997,720,277,4356,3223,22,1111,35,10,1,0,12,12,1,,47,2,47,0,2,13,13,13,8,0,0,0,0,0,0,0,0,9,5444,67,0,73,90,0,4374,1015,67,0,73,90,0,55,,0,0,0,0,17,0,0,1,0,0,0,46,0,0,10.35,5.369107321965898,1.2288797061524335,0.22887970615243342,1.2858126721763086,1.0463291612180086,5.617853560682046
563,J,"Leveque, N; Semler, BL",,,,"Leveque, Nicolas; Semler, Bert L.",,,A 21st Century Perspective of Poliovirus Replication,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT RNA-POLYMERASE; MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; SECRETORY PATHWAY; RIBONUCLEIC ACID; IN-VITRO; VIRUS; PROTEIN; CELLS,,"[Leveque, Nicolas] Univ Reims, Sch Med, Clin & Mol Virol Unit CardioVir EA 4684, Reims, France; [Semler, Bert L.] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Ctr Virus Res, Irvine, CA 92717 USA","Leveque, N (reprint author), Univ Reims, Sch Med, Clin & Mol Virol Unit CardioVir EA 4684, Reims, France.",blsemler@uci.edu,,"Leveque, Nicolas/0000-0001-6991-2532","Public Health Service from the National Institutes of Health [AI022693, AI026765, AI110782]; Marie Curie International Outgoing Fellowship for Career Development from the European Commission; Philippe Foundation; Champagne-Ardenne region","Research in the authors' lab was supported by Public Health Service grants AI022693, AI026765, and AI110782 from the National Institutes of Health (to BLS). NL is supported by a Marie Curie International Outgoing Fellowship for Career Development from the European Commission and by grants from the Philippe Foundation and the Champagne-Ardenne region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,39,9,9,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004825,10.1371/journal.ppat.1004825,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900004,26042673.0,"DOAJ Gold, Green Published",,,16/08/2019,9,16,40,9982,1796,1465,331,8186,6496,38,1652,40,10,0,0,5,5,0,,50,5,50,0,5,9,9,6,5,0,0,0,0,0,0,0,6,5,10060,9,5,40,171,1,8153,1796,9,5,40,171,1,111,,0,1,0,0,13,0,3,1,0,0,0,51,0,0,14.765999999999998,5.557906458797327,1.219398973857806,0.21939897385780602,1.2509161983874908,1.025846523742737,5.701559020044543
564,J,"Liu, HQ; Zhang, SJ; Ma, JW; Dai, YF; Li, CH; Lyu, XL; Wang, CF; Xu, JR",,,,"Liu, Huiquan; Zhang, Shijie; Ma, Jiwen; Dai, Yafeng; Li, Chaohui; Lyu, Xueliang; Wang, Chenfang; Xu, Jin-Rong",,,Two Cdc2 Kinase Genes with Distinct Functions in Vegetative and Infectious Hyphae in Fusarium graminearum,PLOS PATHOGENS,,,English,Article,,,,,,,RICE BLAST FUNGUS; CYCLIN-DEPENDENT KINASES; PROTEIN-KINASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; FISSION YEAST; AURORA-A; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION,"Eukaryotic cell cycle involves a number of protein kinases important for the onset and progression through mitosis, most of which are well characterized in the budding and fission yeasts and conserved in other fungi. However, unlike the model yeast and filamentous fungi that have a single Cdc2 essential for cell cycle progression, the wheat scab fungus Fusarium graminearum contains two CDC2 orthologs. The cdc2A and cdc2B mutants had no obvious defects in growth rate and conidiation but deletion of both of them is lethal, indicating that these two CDC2 orthologs have redundant functions during vegetative growth and asexual reproduction. However, whereas the cdc2B mutant was normal, the cdc2A mutant was significantly reduced in virulence and rarely produced ascospores. Although deletion of CDC2A had no obvious effect on the formation of penetration branches or hyphopodia, the cdc2A mutant was limited in the differentiation and growth of infectious growth in wheat tissues. Therefore, CDC2A plays stage-specific roles in cell cycle regulation during infectious growth and sexual reproduction. Both CDC2A and CDC2B are constitutively expressed but only CDC2A was up-regulated during plant infection and ascosporogenesis. Localization of Cdc2A-GFP to the nucleus but not Cdc2B-GFP was observed in vegetative hyphae, ascospores, and infectious hyphae. Complementation assays with chimeric fusion constructs showed that both the N-and C-terminal regions of Cdc2A are important for its functions in pathogenesis and ascosporogenesis but only the N-terminal region is important for its subcellular localization. Among the Sordariomycetes, only three Fusarium species closely related to F. graminearum have two CDC2 genes. Furthermore, F. graminearum uniquely has two Aurora kinase genes and one additional putative cyclin gene, and its orthologs of CAK1 and other four essential mitotic kinases in the budding yeast are dispensable for viability. Overall, our data indicate that cell cycle regulation is different between vegetative and infectious hyphae in F. graminearum and Cdc2A, possibly by interacting with a stage-specific cyclin, plays a more important role than Cdc2B during ascosporogenesis and plant infection.","[Liu, Huiquan; Zhang, Shijie; Ma, Jiwen; Dai, Yafeng; Li, Chaohui; Wang, Chenfang] Northwest Agr & Forestry Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Huiquan; Lyu, Xueliang; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA","Liu, HQ (reprint author), Northwest Agr & Forestry Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.",jinrong@purdue.edu,"Liu, Huiquan/M-1587-2013","Liu, Huiquan/0000-0002-4723-845X","National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Basic Research Program of China (973 program) [2012CB114002, 2013CB127702]; Special Fund for Agro-scientific Research in the Public Interest [201303016]","This work was supported by the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003), the National Basic Research Program of China (973 program) (2012CB114002 and 2013CB127702), and the Special Fund for Agro-scientific Research in the Public Interest (201303016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,6,8,0,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004913,10.1371/journal.ppat.1004913,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900021,26083253.0,"DOAJ Gold, Green Published",,,16/08/2019,22,3,20,4488,790,523,267,3698,2803,27,868,20,2,0,0,19,19,0,,0,7,0,0,7,23,23,19,7,0,0,1,0,0,1,0,1,5,4472,173,0,1836,102,0,3666,790,173,0,1836,102,0,16,,0,1,0,0,3,0,0,1,0,0,0,22,0,0,8.554,5.681012658227848,1.2136289886425096,0.21362898864250945,1.2836668469442942,1.0577094474153297,6.008860759493671
565,J,"Luo, X; Wasilko, DJ; Liu, Y; Sun, JY; Wu, XC; Luo, ZQ; Mao, YX",,,,"Luo, Xi; Wasilko, David J.; Liu, Yao; Sun, Jiayi; Wu, Xiaochun; Luo, Zhao-Qing; Mao, Yuxin",,,"Structure of the Legionella Virulence Factor, SidC Reveals a Unique PI(4)P-Specific Binding Domain Essential for Its Targeting to the Bacterial Phagosome",PLOS PATHOGENS,,,English,Article,,,,,,,PLECKSTRIN HOMOLOGY DOMAINS; EFFECTOR PROTEIN DRRA; RAB GTPASE FUNCTION; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; ENDOPLASMIC-RETICULUM; LEGIONNAIRES-DISEASE; PHOSPHOINOSITIDE PHOSPHATASE; INTRACELLULAR GROWTH; UBIQUITIN LIGASES; PLASMA-MEMBRANE,"The opportunistic intracellular pathogen Legionella pneumophila is the causative agent of Legionnaires' disease. L. pneumophila delivers nearly 300 effector proteins into host cells for the establishment of a replication-permissive compartment known as the Legionella-containing vacuole (LCV). SidC and its paralog SdcA are two effectors that have been shown to anchor on the LCV via binding to phosphatidylinositol-4-phosphate [PI(4)P] to facilitate the recruitment of ER proteins to the LCV. We recently reported that the N-terminal SNL ((S) under bar idC (N) under bar -terminal E3 (L) under bar igase) domain of SidC is a ubiquitin E3 ligase, and its activity is required for the recruitment of ER proteins to the LCV. Here we report the crystal structure of SidC (1-871). The structure reveals that SidC contains four domains that are packed into an arch-like shape. The P4C domain ((P) under barI((4) under bar )P binding of Sid (C) under bar) comprises a four alpha-helix bundle and covers the ubiquitin ligase catalytic site of the SNL domain. Strikingly, a pocket with characteristic positive electrostatic potentials is formed at one end of this bundle. Liposome binding assays of the P4C domain further identified the determinants of phosphoinositide recognition and membrane interaction. Interestingly, we also found that binding with PI(4) P stimulates the E3 ligase activity, presumably due to a conformational switch induced by PI(4) P from a closed form to an open active form. Mutations of key residues involved in PI(4) P binding significantly reduced the association of SidC with the LCV and abolished its activity in the recruitment of ER proteins and ubiquitin signals, highlighting that PI(4) P-mediated targeting of SidC is critical to its function in the remodeling of the bacterial phagosome membrane. Finally, a GFP-fusion with the P4C domain was demonstrated to be specifically localized to PI(4) P-enriched compartments in mammalian cells. This domain shows the potential to be developed into a sensitive and accurate PI(4) P probe in living cells.","[Luo, Xi; Wasilko, David J.; Wu, Xiaochun; Mao, Yuxin] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA; [Luo, Xi; Wasilko, David J.; Wu, Xiaochun; Mao, Yuxin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Liu, Yao; Sun, Jiayi; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA","Luo, X (reprint author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA.",ym253@cornell.edu,,"Luo, Zhao-Qing/0000-0001-8890-6621","National Institutes of Health (NIH) [RO1-GM094347, R56AI103168-01, K02AI085403, R21AI105714]","This work was supported by National Institutes of Health (NIH) Grants RO1-GM094347 (YM), R56AI103168-01 (ZQL), K02AI085403 (ZQL) and R21AI105714 (ZQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,70,30,30,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004965,10.1371/journal.ppat.1004965,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900041,26067986.0,"DOAJ Gold, Green Published",,,16/08/2019,30,1,17,4770,860,663,197,3910,3127,24,759,17,1,0,0,28,28,1,,66,2,36,0,2,36,31,36,20,0,0,0,0,0,0,0,0,0,4856,81,0,249,66,1,3958,870,81,0,249,66,1,28,,0,1,0,0,1,0,0,1,0,0,0,36,0,0,7.82,5.546511627906977,1.2199488491048593,0.21994884910485935,1.279539641943734,1.0488469601677148,5.817441860465117
566,J,"Martin-Gayo, E; Buzon, MJ; Ouyang, ZY; Hickman, T; Cronin, J; Pimenova, D; Walker, BD; Lichterfeld, M; Yu, XG",,,,"Martin-Gayo, Enrique; Buzon, Maria Jose; Ouyang, Zhengyu; Hickman, Taylor; Cronin, Jacqueline; Pimenova, Dina; Walker, Bruce D.; Lichterfeld, Mathias; Yu, Xu G.",,,Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; RESTRICTION FACTOR SAMHD1; CYTOSOLIC DNA; CYCLIC DINUCLEOTIDE; INNATE IMMUNITY; SENSOR CGAS; EX-VIVO; IN-VIVO; INFECTION; RECOGNITION,"The majority of HIV-1 elite controllers (EC) restrict HIV-1 replication through highly functional HIV-1-specific T cell responses, but mechanisms supporting the evolution of effective HIV-1-specific T cell immunity in these patients remain undefined. Cytosolic immune recognition of HIV-1 in conventional dendritic cells (cDC) can facilitate priming and expansion of HIV-1-specific T cells; however, HIV-1 seems to be able to avoid intracellular immune recognition in cDCs in most infected individuals. Here, we show that exposure of cDCs from EC to HIV-1 leads to a rapid and sustained production of type I interferons and upregulation of several interferon-stimulated effector genes. Emergence of these cell-intrinsic immune responses was associated with a reduced induction of SAMHD1 and LEDGF/p75, and an accumulation of viral reverse transcripts, but inhibited by pharmacological blockade of viral reverse transcription or siRNA-mediated silencing of the cytosolic DNA sensor cGAS. Importantly, improved cell-intrinsic immune recognition of HIV-1 in cDCs from elite controllers translated into stronger abilities to stimulate and expand HIV-1-specific CD8 T cell responses. These data suggest an important role of cell-intrinsic type I interferon secretion in dendritic cells for the induction of effective HIV-1-specific CD8 T cells, and may be helpful for eliciting functional T cell immunity against HIV-1 for preventative or therapeutic clinical purposes.","[Martin-Gayo, Enrique; Buzon, Maria Jose; Ouyang, Zhengyu; Hickman, Taylor; Cronin, Jacqueline; Pimenova, Dina; Walker, Bruce D.; Lichterfeld, Mathias; Yu, Xu G.] MIT, Ragon Inst MGH, Boston, MA USA; [Martin-Gayo, Enrique; Buzon, Maria Jose; Ouyang, Zhengyu; Hickman, Taylor; Cronin, Jacqueline; Pimenova, Dina; Walker, Bruce D.; Lichterfeld, Mathias; Yu, Xu G.] Harvard, Boston, MA USA; [Buzon, Maria Jose; Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lichterfeld, Mathias] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA","Martin-Gayo, E (reprint author), MIT, Ragon Inst MGH, Boston, MA USA.",xyu@partners.org,"Buzon, Maria J/G-8286-2015; Lichterfeld, Mathias/B-2042-2008","Buzon, Maria J/0000-0003-4427-9413; Lichterfeld, Mathias/0000-0001-9865-8350","US National Institutes of Health [AI078799, AI089339, HL121890, AI098484, HL126554, AI116228, AI087452, AI098487, AI106468]; Harvard University Center of AIDS research (HU CFAR NIH/NIAID) [5P30AI060354-10]; Bill and Melinda Gates Foundation [OPP 1066973]; Mark and Lisa Swartz Foundation; Ragon Institute of MGH, MIT and Harvard; International HIV Controller Consortium","This work was supported for the US National Institutes of Health (grants AI078799, AI089339, HL121890, AI098484, HL126554, AI116228 and AI087452 to XGY; AI098487 and AI106468 to ML). EMG is supported by the Harvard University Center of AIDS research (HU CFAR NIH/NIAID fund 5P30AI060354-10). PBMC sample collection was supported by the Bill and Melinda Gates Foundation (OPP 1066973), the Mark and Lisa Swartz Foundation, the Ragon Institute of MGH, MIT and Harvard, and the International HIV Controller Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,69,35,36,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004930,10.1371/journal.ppat.1004930,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900023,26067651.0,"DOAJ Gold, Green Published",,,16/08/2019,32,75,55,9424,1019,737,282,8405,6956,30,1419,54,39,0,0,32,32,16,,72,4,71,1,4,34,34,27,24,0,0,0,0,0,0,3,36,24,9437,66,3,379,65,0,8387,1019,66,3,379,65,0,31,,6,0,0,0,35,0,3,1,0,0,0,71,1,0,76.15,9.24828263002944,1.1212373587150506,0.12123735871505056,1.13837001784652,1.0152801358234296,9.389597644749754
567,J,"McFadden, G",,,,"McFadden, Grant",,,The Curious Road from Basic Pathogen Research to Clinical Translation,PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"Univ Florida, Dept Mol Genet & Mol Biol, Gainesville, FL 32611 USA","McFadden, G (reprint author), Univ Florida, Dept Mol Genet & Mol Biol, Gainesville, FL 32611 USA.",grantmcf@ufl.edu,,,,,,0,0,0,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004997,10.1371/journal.ppat.1004997,,,,2,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900057,26110645.0,"DOAJ Gold, Green Published",,,16/08/2019,1,86,2,4395,196,133,63,4199,3828,37,334,2,26,0,0,0,0,5,,2,0,2,0,0,1,1,0,0,0,0,0,0,0,0,0,60,6,4418,0,48,0,23,0,4207,199,0,48,0,23,0,12,,0,0,0,0,58,0,2,0,0,0,0,2,0,0,36.05,22.4234693877551,1.0466777804239105,0.04667778042391046,1.057632769707073,1.010466439135381,22.658163265306122
568,J,"McFadden, G; Haldar, K",,,,"McFadden, Grant; Haldar, Kasturi",,,"Introducing ""Research Matters""",PLOS PATHOGENS,,,English,Editorial Material,,,,,,,,,"[McFadden, Grant] Univ Florida, Dept Mol Genet & Mol Biol, Gainesville, FL 32611 USA; [Haldar, Kasturi] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA","McFadden, G (reprint author), Univ Florida, Dept Mol Genet & Mol Biol, Gainesville, FL 32611 USA.",grantmcf@ufl.edu; khaldar@nd.edu,,,,,,0,0,0,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005014,10.1371/journal.ppat.1005014,,,,1,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900065,,"DOAJ Gold, Green Published",,,16/08/2019,0,73,5,5036,113,69,44,4923,4675,12,236,5,53,0,0,0,0,6,,5,0,5,0,0,0,0,0,0,0,0,0,0,0,0,2,25,12,5040,0,42,0,18,0,4920,113,0,42,0,18,0,7,,2,1,0,0,58,0,3,0,0,0,0,5,0,0,60.48,44.56637168141593,1.022953483648182,0.022953483648182,1.0274223034734917,1.0043685464654488,44.76106194690266
569,J,"Mehta, SC; Rice, K; Palzkill, T",,,,"Mehta, Shrenik C.; Rice, Kacie; Palzkill, Timothy",,,Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability,PLOS PATHOGENS,,,English,Article,,,,,,,A BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; PROTEIN STABILITY; SUBSTRATE-SPECIFICITY; BACTERIA; EVOLUTION; ENTEROBACTERIACEAE; ACINETOBACTER; SUBSTITUTION,"The spread of beta-lactamases that hydrolyze penicillins, cephalosporins and carbapenems among Gram-negative bacteria has limited options for treating bacterial infections. Initially, Klebsiella pneumoniae carbapenemase-2 (KPC-2) emerged as a widespread carbapenem hydrolyzing beta-lactamase that also hydrolyzes penicillins and cephalosporins but not cephamycins and ceftazidime. In recent years, single and double amino acid substitution variants of KPC-2 have emerged among clinical isolates that show increased resistance to ceftazidime. Because it confers multi-drug resistance, KPC beta-lactamase is a threat to public health. In this study, the evolution of KPC-2 function was determined in nine clinically isolated variants by examining the effects of the substitutions on enzyme kinetic parameters, protein stability and antibiotic resistance profile. The results indicate that the amino acid substitutions associated with KPC-2 natural variants lead to increased catalytic efficiency for ceftazidime hydrolysis and a consequent increase in ceftazidime resistance. Single substitutions lead to modest increases in catalytic activity while the double mutants exhibit significantly increased ceftazidime hydrolysis and resistance levels. The P104R, V240G and H274Y substitutions in single and double mutant combinations lead to the largest increases in ceftazidime hydrolysis and resistance. Molecular modeling suggests that the P104R and H274Y mutations could facilitate ceftazidime hydrolysis through increased hydrogen bonding interactions with the substrate while the V240G substitution may enhance backbone flexibility so that larger substrates might be accommodated in the active site. Additionally, we observed a strong correlation between gain of catalytic function for ceftazidime hydrolysis and loss of enzyme stability, which is in agreement with the 'stability-function tradeoff' phenomenon. The high T-m of KPC-2 (66.5 degrees C) provides an evolutionary advantage as compared to other class A enzymes such as TEM (51.5 degrees C) and CTX-M (51 degrees C) in that it can acquire multiple destabilizing substitutions without losing the ability to fold into a functional enzyme.","[Mehta, Shrenik C.; Rice, Kacie; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA","Mehta, SC (reprint author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.",timothyp@bcm.edu,,,National Institutes of Health [AI32956],"The work was funded by National Institutes of Health grant AI32956 to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,27,27,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004949,10.1371/journal.ppat.1004949,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900030,26030609.0,"DOAJ Gold, Green Published",,,16/08/2019,27,2,19,5610,1586,1183,403,4024,3241,23,760,19,1,0,0,29,29,0,,38,5,38,0,5,29,27,29,19,0,0,0,0,0,0,0,1,7,5609,21,0,71,88,0,3997,1586,21,0,71,88,0,26,,0,0,0,0,17,0,1,0,0,0,0,37,0,0,8.9,3.537200504413619,1.3941351888667992,0.3941351888667992,1.4209741550695825,1.0192513368983958,3.6052963430012612
570,J,"Melehani, JH; James, DBA; DuMont, AL; Torres, VJ; Duncan, JA",,,,"Melehani, Jason H.; James, David B. A.; DuMont, Ashley L.; Torres, Victor J.; Duncan, Joseph A.",,,"Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular",PLOS PATHOGENS,,,English,Article,,,,,,,PANTON-VALENTINE LEUKOCIDIN; PORE-FORMING TOXINS; ALPHA-HEMOLYSIN; K+ EFFLUX; INFLAMMASOME ACTIVATION; HUMAN NEUTROPHILS; MURINE MODEL; MOUSE MODEL; CELL-DEATH; CASPASE-1,"Staphylococcus aureus infections are a growing health burden worldwide, and paramount to this bacterium's pathogenesis is the production of virulence factors, including pore-forming leukotoxins. Leukocidin A/B (LukAB) is a recently discovered toxin that kills primary human phagocytes, though the underlying mechanism of cell death is not understood. We demonstrate here that LukAB is a major contributor to the death of human monocytes. Using a variety of in vitro and ex vivo intoxication and infection models, we found that LukAB activates Caspase 1, promotes IL-1 beta secretion and induces necrosis in human monocytes. Using THP1 cells as a model for human monocytes, we found that the inflammasome components NLRP3 and ASC are required for LukAB-mediated IL-1 beta secretion and necrotic cell death. S. aureus was shown to kill human monocytes in a LukAB dependent manner under both extracellular and intracellular ex vivo infection models. Although LukAB-mediated killing of THP1 monocytes from extracellular S. aureus requires ASC, NLRP3 and the LukAB-receptor CD11b, LukAB-mediated killing from phagocytosed S. aureus is independent of ASC or NLRP3, but dependent on CD11b. Altogether, this study provides insight into the nature of LukAB-mediated killing of human monocytes. The discovery that S. aureus LukAB provokes differential host responses in a manner dependent on the cellular contact site is critical for the development of anti-infective/anti-inflammatory therapies that target the NLRP3 inflammasome.","[Melehani, Jason H.; Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27514 USA; [James, David B. A.; DuMont, Ashley L.; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA","Melehani, JH (reprint author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27514 USA.",Victor.Torres@nyumc.org; jaduncan@med.unc.edu,,"Torres, Victor/0000-0002-7126-0489","National Institutes of Health [R01AI088255, R01AI099394, R01AI105129]; National Institutes of Health: UNC MSTP [T32GM008719]; National Institutes of Health: UNC Predoctoral Training in Pharmacologic Sciences [T32GM007040]; Public Health Service Institutional Research Training Award [T32AI007180]; Burroughs Wellcome Fund Career Award for Medical Scientists; NIAID/NIH [HHSN272200700055C]","This work was supported by grants from the National Institutes of Health: R01AI088255 to JAD and R01AI099394 and R01AI105129 to VJT. JHM was supported by training grants from the National Institutes of Health: UNC MSTP T32GM008719 and UNC Predoctoral Training in Pharmacologic Sciences T32GM007040. DBAJ was supported in part by a Public Health Service Institutional Research Training Award T32AI007180. JAD was supported by the Burroughs Wellcome Fund Career Award for Medical Scientists. VJT is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases. Several MRSA isolates were obtained from the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program, which was supported under NIAID/NIH contract HHSN272200700055C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,42,43,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004970,10.1371/journal.ppat.1004970,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900044,26069969.0,"DOAJ Gold, Green Published",,,16/08/2019,36,3,40,6015,1302,969,333,4713,3739,26,948,40,2,0,0,38,38,0,,55,2,55,0,2,41,39,41,23,0,0,0,0,0,0,0,1,1,6098,17,0,186,100,2,4755,1328,17,0,186,100,2,15,,0,0,0,0,3,0,1,1,0,0,0,55,0,0,1.25,4.619815668202765,1.276257161043921,0.27625716104392106,1.3186929768724804,1.0332502078137988,4.7734254992319505
571,J,"Noble, GP; Wang, DW; Walsh, DJ; Barone, JR; Miller, MB; Nishina, KA; Li, S; Supattapone, S",,,,"Noble, Geoffrey P.; Wang, Daphne W.; Walsh, Daniel J.; Barone, Justin R.; Miller, Michael B.; Nishina, Koren A.; Li, Sheng; Supattapone, Surachai",,,A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers,PLOS PATHOGENS,,,English,Article,,,,,,,SCRAPIE PRION PROTEIN; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; IN-VITRO; HYDROGEN/DEUTERIUM EXCHANGE; MAMMALIAN PRIONS; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; STRAIN PROPERTIES; AMYLOID FIBRILS; TRANSGENIC MICE,"Infectious prions contain a self-propagating, misfolded conformer of the prion protein termed PrPSc. A critical prediction of the protein-only hypothesis is that autocatalytic PrPSc molecules should be infectious. However, some autocatalytic recombinant PrPSc molecules have low or undetectable levels of specific infectivity in bioassays, and the essential determinants of recombinant prion infectivity remain obscure. To identify structural and functional features specifically associated with infectivity, we compared the properties of two autocatalytic recombinant PrP conformers derived from the same original template, which differ by >10(5)-fold in specific infectivity for wild-type mice. Structurally, hydrogen/deuterium exchange mass spectrometry (DXMS) studies revealed that solvent accessibility profiles of infectious and non-infectious autocatalytic recombinant PrP conformers are remarkably similar throughout their protease-resistant cores, except for two domains encompassing residues 91-115 and 144-163. Raman spectroscopy and immunoprecipitation studies confirm that these domains adopt distinct conformations within infectious versus non-infectious autocatalytic recombinant PrP conformers. Functionally, in vitro prion propagation experiments show that the non-infectious conformer is unable to seed mouse PrPC substrates containing a glycosylphosphatidylinositol (GPI) anchor, including native PrPC. Taken together, these results indicate that having a conformation that can be specifically adopted by post-translationally modified PrPC molecules is an essential determinant of biological infectivity for recombinant prions, and suggest that this ability is associated with discrete features of PrPSc structure.","[Noble, Geoffrey P.; Walsh, Daniel J.; Miller, Michael B.; Nishina, Koren A.; Supattapone, Surachai] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Noble, Geoffrey P.; Walsh, Daniel J.; Miller, Michael B.; Nishina, Koren A.; Supattapone, Surachai] Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA; [Wang, Daphne W.; Li, Sheng] Univ Calif San Diego, Med & Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Barone, Justin R.] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA","Noble, GP (reprint author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.",supattapone@dartmouth.edu,,,National Institutes of Health [2R01 NS046478],"This work was funded by a research grant from the National Institutes of Health (2R01 NS046478) to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,16,16,1,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005017,10.1371/journal.ppat.1005017,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900067,26125623.0,"DOAJ Gold, Green Published",,,16/08/2019,15,10,25,3164,512,355,157,2652,2120,21,511,25,9,0,0,15,15,0,,31,0,31,0,0,15,15,12,12,0,0,0,0,0,0,0,1,1,3211,39,0,57,45,1,2675,516,38,0,57,45,1,20,,0,0,0,0,10,0,1,0,0,0,0,31,0,0,4.25,6.1796875,1.1930618401206636,0.19306184012066366,1.2424585218702866,1.0414032869785081,6.435546875
572,J,"Ocvirk, S; Sava, IG; Lengfelder, I; Lagkouvardos, I; Steck, N; Roh, JH; Tchaptchet, S; Bao, Y; Hansen, JJ; Huebner, J; Carroll, IM; Murray, BE; Sartor, RB; Haller, D",,,,"Ocvirk, Soeren; Sava, Irina G.; Lengfelder, Isabella; Lagkouvardos, Ilias; Steck, Natalie; Roh, Jung H.; Tchaptchet, Sandrine; Bao, Yinyin; Hansen, Jonathan J.; Huebner, Johannes; Carroll, Ian M.; Murray, Barbara E.; Sartor, R. Balfour; Haller, Dirk",,,Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels,PLOS PATHOGENS,,,English,Article,,,,,,,INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; CROHNS-DISEASE; MANDUCA-SEXTA; ULCERATIVE-COLITIS; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; POLYSACCHARIDE BIOSYNTHESIS; INTESTINAL INFLAMMATION; EPITHELIAL BARRIER,"The commensal Enterococcus faecalis is among the most common causes of nosocomial infections. Recent findings regarding increased abundance of enterococci in the intestinal microbiota of patients with inflammatory bowel diseases and induction of colitis in IL-10-deficient (IL-10-/-) mice put a new perspective on the contribution of E. faecalis to chronic intestinal inflammation. Based on the expression of virulence-related genes in the inflammatory milieu of IL-10-/- mice using RNA-sequencing analysis, we characterized the colitogenic role of two bacterial structures that substantially impact on E. faecalis virulence by different mechanisms: the enterococcal polysaccharide antigen and cell surface-associated lipoproteins. Germ-free wild type and IL-10-/- mice were monoassociated with E. faecalis wild type OG1RF or the respective isogenic mutants for 16 weeks. Intestinal tissue and mesenteric lymph nodes (MLN) were collected to characterize tissue pathology, loss of intestinal barrier function, bacterial adhesion to intestinal epithelium and immune cell activation. Bone marrow-derived dendritic cells (BMDC) were stimulated with bacterial lysates and E. faecalis virulence was additionally investigated in three invertebrate models. Colitogenic activity of wild type E. faecalis (OG1RF score: 7.2 +/- 1.2) in monoassociated IL-10-/- mice was partially impaired in E. faecalis lacking enterococcal polysaccharide antigen (Delta epaB score: 4.7 +/- 2.3; p<0.05) and was almost completely abrogated in E. faecalis deficient for lipoproteins (Delta lgt score: 2.3 +/- 2.3; p<0.0001). Consistently both E. faecalis mutants showed significantly impaired virulence in Galleria mellonella and Caenorhabditis elegans. Loss of E-cadherin in the epithelium was shown for all bacterial strains in inflamed IL-10-/- but not wild type mice. Inactivation of epaB in E. faecalis reduced microcolony and biofilm formation in vitro, altered bacterial adhesion to intestinal epithelium of germ-free Manduca sexta larvae and impaired penetration into the colonic mucus layer of IL-10-/- mice. Lipoprotein-deficient E. faecalis exhibited an impaired TLR2-mediated activation of BMDCs in vitro despite their ability to fully reactivate MLN cells as well as MLN-derived colitogenic T cells ex vivo. E. faecalis virulence factors accounting for bacterial adhesion to mucosal surfaces as well as intestinal barrier disruption partially contribute to colitogenic activity of E. faecalis. Beyond their well-known role in infections, cell surface-associated lipoproteins are essential structures for colitogenic activity of E. faecalis by mediating innate immune cell activation.","[Ocvirk, Soeren; Sava, Irina G.; Lengfelder, Isabella; Lagkouvardos, Ilias; Steck, Natalie; Haller, Dirk] Tech Univ Munich, Chair Nutr & Immunol, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Roh, Jung H.; Murray, Barbara E.] Univ Texas Med Sch Houston, Dept Internal Med, Div Infect Dis, Houston, TX USA; [Tchaptchet, Sandrine; Hansen, Jonathan J.; Carroll, Ian M.; Sartor, R. Balfour] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bao, Yinyin; Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany","Ocvirk, S (reprint author), Tech Univ Munich, Chair Nutr & Immunol, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany.",dirk.haller@tum.de,,"Haller, Dirk/0000-0002-6977-4085; Lagkouvardos, Ilias/0000-0001-9337-4033; Ocvirk, Soeren/0000-0001-6547-2445","German Research Foundation [DFG - GRK1482]; National Gnotobiotic Rodent Resource Center at University of North Carolina [5-P39-DK034987, 5-P40-OD010995]; NIAID from the National Institutes of Health (USA) [R01 AI 47923]; NCI Cancer Center Support Grant [P30 CA91842]; ICTS/CTSA from the NationalCenter for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1RR024992]; NIH Roadmap for Medical Research","This work was supported by the German Research Foundation (DFG - GRK1482). Gnotobiotic mice were obtained from the National Gnotobiotic Rodent Resource Center at University of North Carolina (grant ID: 5-P39-DK034987 and 5-P40-OD010995). Parts of the study were supported by NIAID grant R01 AI 47923 from the National Institutes of Health (USA). The Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1RR024992 from the NationalCenter for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,88,22,22,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004911,10.1371/journal.ppat.1004911,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900020,26067254.0,"DOAJ Gold, Green Published",,,16/08/2019,21,6,37,5114,1137,879,258,3977,3132,30,815,37,6,0,0,23,23,0,,106,6,55,0,6,27,23,27,8,0,0,0,0,0,0,0,0,12,5234,59,0,139,99,0,4027,1171,59,0,139,99,0,36,,0,0,0,0,8,0,0,1,0,0,0,55,0,0,3.5,4.497801231310466,1.2858938898667338,0.2858938898667337,1.355795825999497,1.054360578803285,4.742304309586632
573,J,"Orru, CD; Groveman, BR; Raymond, LD; Hughson, AG; Nonno, R; Zou, WQ; Ghetti, B; Gambetti, P; Caughey, B",,,,"Orru, Christina D.; Groveman, Bradley R.; Raymond, Lynne D.; Hughson, Andrew G.; Nonno, Romolo; Zou, Wenquan; Ghetti, Bernardino; Gambetti, Pierluigi; Caughey, Byron",,,Bank Vole Prion Protein As an Apparently Universal Substrate for RT-QuIC-Based Detection and Discrimination of Prion Strains,PLOS PATHOGENS,,,English,Article,,,,,,,QUAKING-INDUCED CONVERSION; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; CEREBROSPINAL-FLUID; SEEDED CONVERSION; DIFFERENT CONFORMATIONS; SEEDING ACTIVITY; RESISTANT FORMS; PRP AMYLOIDS; SCRAPIE,"Prions propagate as multiple strains in a wide variety of mammalian species. The detection of all such strains by a single ultrasensitive assay such as Real Time Quaking-induced Conversion (RT-QuIC) would facilitate prion disease diagnosis, surveillance and research. Previous studies have shown that bank voles, and transgenic mice expressing bank vole prion protein, are susceptible to most, if not all, types of prions. Here we show that bacterially expressed recombinant bank vole prion protein (residues 23-230) is an effective substrate for the sensitive RT-QuIC detection of all of the different prion types that we have tested so far - a total of 28 from humans, cattle, sheep, cervids and rodents, including several that have previously been undetectable by RT-QuIC or Protein Misfolding Cyclic Amplification. Furthermore, comparison of the relative abilities of different prions to seed positive RT-QuIC reactions with bank vole and not other recombinant prion proteins allowed discrimination of prion strains such as classical and atypical L-type bovine spongiform encephalopathy, classical and atypical Nor98 scrapie in sheep, and sporadic and variant Creutzfeldt-Jakob disease in humans. Comparison of protease-resistant RT-QuIC conversion products also aided strain discrimination and suggested the existence of several distinct classes of prion templates among the many strains tested.","[Orru, Christina D.; Groveman, Bradley R.; Raymond, Lynne D.; Hughson, Andrew G.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Nihon Univ, Hamilton, MT 59840 USA; [Nonno, Romolo] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Zou, Wenquan; Gambetti, Pierluigi] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA","Orru, CD (reprint author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Nihon Univ, Hamilton, MT 59840 USA.",bcaughey@nih.gov,"NONNO, ROMOLO/C-8323-2015","NONNO, ROMOLO/0000-0001-7556-1564",Intramural Research Program of the NIAID [ZIA AI001086-06]; Alliance BioSecure Research Foundation under the aegis of the Fondation pour la Recherche Medicale [FABS 201401];  [CDC 1051CK000100];  [NIH/NIADS R01 NS083687];  [NIH/NINDS P01 1AI106705-01AI],"This study was funded in part by the Intramural Research Program of the NIAID (ZIA AI001086-06 to BC) and the Alliance BioSecure Research Foundation under the aegis of the Fondation pour la Recherche Medicale (FABS 201401; http://www.fondation-alliance-biosecure.org/new_eng/) to BC. Support was also provided by grants CDC 1051CK000100, NIH/NIADS R01 NS083687, and NIH/NINDS P01 1AI106705-01AI to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,52,62,64,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004983,10.1371/journal.ppat.1004983,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900050,26284358.0,"DOAJ Gold, Green Published",,,16/08/2019,56,4,34,4965,1056,748,308,3909,3054,27,828,34,3,0,0,49,49,0,,46,5,46,0,5,57,57,41,40,0,0,1,0,0,1,0,1,5,4960,11,0,124,101,0,3882,1056,11,0,124,101,0,22,,0,1,0,0,6,0,1,1,0,0,0,46,0,0,10.0,4.701704545454546,1.2701458173445894,0.2701458173445894,1.2975185469429522,1.0215508559919435,4.803030303030303
574,J,"Pfoh, R; Lacdao, IK; Georges, AA; Capar, A; Zheng, H; Frappier, L; Saridakis, V",,,,"Pfoh, Roland; Lacdao, Ira Kay; Georges, Anna A.; Capar, Adam; Zheng, Hong; Frappier, Lori; Saridakis, Vivian",,,Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7,PLOS PATHOGENS,,,English,Article,,,,,,,GMP-SYNTHETASE; PROTEASE 7; P53 STABILIZATION; GENE-EXPRESSION; RECRUITS USP7; BINDING-SITE; E3 LIGASE; USP7/HAUSP; HAUSP; DEUBIQUITINATION,"Herpes simplex virus-1 immediate-early protein ICP0 activates viral genes during early stages of infection, affects cellular levels of multiple host proteins and is crucial for effective lytic infection. Being a RING-type E3 ligase prone to auto-ubiquitination, ICP0 relies on human deubiquitinating enzyme USP7 for protection against 26S proteasomal mediated degradation. USP7 is involved in apoptosis, epigenetics, cell proliferation and is targeted by several herpesviruses. Several USP7 partners, including ICP0, GMPS, and UHRF1, interact through its C-terminal domain (CTD), which contains five ubiquitin-like (Ubl) structures. Despite the fact that USP7 has emerged as a drug target for cancer therapy, structural details of USP7 regulation and the molecular mechanism of interaction at its CTD have remained elusive. Here, we mapped the binding site between an ICP0 peptide and USP7 and determined the crystal structure of the first three Ubl domains bound to the ICP0 peptide, which showed that ICP0 binds to a loop on Ubl2. Sequences similar to the USP7-binding site in ICP0 were identified in GMPS and UHRF1 and shown to bind USP7-CTD through Ubl2. In addition, co-immunoprecipitation assays in human cells comparing binding to USP7 with and without a Ubl2 mutation, confirmed the importance of the Ubl2 binding pocket for binding ICP0, GMPS and UHRF1. Therefore we have identified a novel mechanism of USP7 recognition that is used by both viral and cellular proteins. Our structural information was used to generate a model of near full-length USP7, showing the relative position of the ICP0/GMPS/UHRF1 binding pocket and the structural basis by which it could regulate enzymatic activity.","[Pfoh, Roland; Lacdao, Ira Kay; Capar, Adam; Zheng, Hong; Saridakis, Vivian] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Georges, Anna A.; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada","Pfoh, R (reprint author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.",vsaridak@yorku.ca,,,Canadian Institutes of Health Research (CIHR) [106583]; Natural Sciences and Engineering Research Council of Canada (NSERC); Cancer Research Society (CRS); Canada Foundation for Innovation Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program,"This research was supported by operating grants to VS from the Canadian Institutes of Health Research (CIHR; http://cihr-irsc.gc.ca/) (grant number 106583) and from the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/), and by an operating grant to LF from the Cancer Research Society (CRS; http://www.crs-src.ca/). Infrastructure was funded by the Canada Foundation for Innovation Leaders Opportunity Fund Program and the Ontario Research Fund Research Infrastructure Program to VS. LF is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,21,21,1,39,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004950,10.1371/journal.ppat.1004950,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900031,26046769.0,"DOAJ Gold, Green Published",,,16/08/2019,24,0,38,7529,1269,1027,242,6260,5115,27,1118,38,0,0,0,20,20,0,,58,3,58,0,3,24,24,13,11,0,0,0,0,0,0,0,0,0,7588,61,0,199,77,0,6289,1288,61,0,199,77,0,11,,0,0,0,0,0,0,0,1,0,0,0,58,0,0,0.25,5.933018124507486,1.2027156549520768,0.2027156549520767,1.234185303514377,1.0261654934254216,6.088258471237195
575,J,"Pickard, A; McDade, SS; McFarland, M; McCluggage, WG; Wheeler, CM; McCance, DJ",,,,"Pickard, Adam; McDade, Simon S.; McFarland, Marie; McCluggage, W. Glenn; Wheeler, Cosette M.; McCance, Dennis J.",,,HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-PAPILLOMAVIRUS TYPE-16; UTERINE CERVICAL-CANCER; GENE-EXPRESSION; BREAST-CANCER; HUMAN KERATINOCYTES; NATURAL-HISTORY; RETINOBLASTOMA PROTEIN; PROSTATE-CANCER; E7 ONCOPROTEIN; MESSENGER-RNA,"Cervical cancer is a multi-stage disease caused by human papillomaviruses (HPV) infection of cervical epithelial cells, but the mechanisms regulating disease progression are not clearly defined. Using 3-dimensional organotypic cultures, we demonstrate that HPV16 E6 and E7 proteins alter the secretome of primary human keratinocytes resulting in local epithelial invasion. Mechanistically, absence of the IGF-binding protein 2 (IGFBP2) caused increases in IGFI/II signalling and through crosstalk with KGF/FGFR2b/AKT, cell invasion. Repression of IGFBP2 is mediated by histone deacetylation at the IGFBP2 promoter and was reversed by treatment with histone deacetylase (HDAC) inhibitors. Our in vitro findings were confirmed in 50 invasive cancers and 79 cervical intra-epithelial neoplastic lesions caused by HPV16 infection, where IGFBP2 levels were reduced with increasing disease severity. In summary, the loss of IGFBP2 is associated with progression of premalignant disease, and sensitises cells to pro-invasive IGF signalling, and together with stromal derived factors promotes epithelial invasion.","[Pickard, Adam; McDade, Simon S.; McCluggage, W. Glenn; McCance, Dennis J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [McFarland, Marie; McCluggage, W. Glenn] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Wheeler, Cosette M.; McCance, Dennis J.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA","Pickard, A (reprint author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.",a.pickard@qub.ac.uk; dmccance@salud.unm.edu,"McDade, Simon/E-5730-2017","McDade, Simon/0000-0002-3024-4773; pickard, adam/0000-0001-9757-143X",Medical Research Council [G1001692],"Work was supported by a grant from the Medical Research Council (G1001692) to DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,10,10,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004988,10.1371/journal.ppat.1004988,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900052,26107517.0,"DOAJ Gold, Green Published",,,16/08/2019,10,5,12,3440,855,553,302,2585,1956,22,607,12,4,0,0,10,10,0,,0,0,0,0,0,11,10,11,5,0,0,0,0,0,0,0,1,0,3463,42,0,238,93,0,2577,855,42,0,238,93,0,31,,0,0,0,0,4,0,1,0,0,0,0,19,0,0,2.1,4.023391812865497,1.3307543520309477,0.3307543520309478,1.3918762088974854,1.0459302325581394,4.208187134502924
576,J,"Posch, W; Steger, M; Knackmuss, U; Blatzer, M; Baldauf, HM; Doppler, W; White, TE; Hortnagl, P; Diaz-Griffero, F; Lass-Florl, C; Hackl, H; Moris, A; Keppler, OT; Wilflingseder, D",,,,"Posch, Wilfried; Steger, Marion; Knackmuss, Ulla; Blatzer, Michael; Baldauf, Hanna-Mari; Doppler, Wolfgang; White, Tommy E.; Hoertnagl, Paul; Diaz-Griffero, Felipe; Lass-Floerl, Cornelia; Hackl, Hubert; Moris, Arnaud; Keppler, Oliver T.; Wilflingseder, Doris",,,Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; HUMORAL RESPONSE; VIRAL-INFECTION; CUTTING EDGE; SAMHD1; INNATE; TRANSMISSION,"DCs express intrinsic cellular defense mechanisms to specifically inhibit HIV-1 replication. Thus, DCs are productively infected only at very low levels with HIV-1, and this non-permissiveness of DCs is suggested to go along with viral evasion. We now illustrate that complement-opsonized HIV-1 (HIV-C) efficiently bypasses SAMHD1 restriction and productively infects DCs including BDCA-1 DCs. Efficient DC infection by HIV-C was also observed using single-cycle HIV-C, and correlated with a remarkable elevated SAMHD1 T592 phosphorylation but not SAMHD1 degradation. If SAMHD1 phosphorylation was blocked using a CDK2-inhibitor HIV-C-induced DC infection was also significantly abrogated. Additionally, we found a higher maturation and co-stimulatory potential, aberrant type I interferon expression and signaling as well as a stronger induction of cellular immune responses in HIV-C-treated DCs. Collectively, our data highlight a novel protective mechanism mediated by complement opsonization of HIV to effectively promote DC immune functions, which might be in the future exploited to tackle HIV infection.","[Posch, Wilfried; Steger, Marion; Knackmuss, Ulla; Blatzer, Michael; Lass-Floerl, Cornelia; Wilflingseder, Doris] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Baldauf, Hanna-Mari; Keppler, Oliver T.] Goethe Univ Frankfurt, Inst Med Virol, D-60054 Frankfurt, Germany; [Doppler, Wolfgang] Med Univ Innsbruck, Div Med Biochem, Bioctr, A-6020 Innsbruck, Austria; [White, Tommy E.; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Hoertnagl, Paul] Med Univ Innsbruck, Cent Inst Blood Transfus, A-6020 Innsbruck, Austria; [Hoertnagl, Paul] Med Univ Innsbruck, Dept Immunol, A-6020 Innsbruck, Austria; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Moris, Arnaud] Univ Paris 06, Sorbonne Univ, Ctr Immunol & Microbial Infect, Ctr Immunol & Malad Infect CIMI Paris, Paris, France; [Moris, Arnaud] INSERM, U1135, Ctr Immunol & Microbial Infect, Ctr Immunol & Malad Infect CIMI Paris, Paris, France; [Moris, Arnaud] CNRS, ERL 8255, Ctr Immunol & Microbial Infect, CIMI Paris, Paris, France; [Moris, Arnaud] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France","Posch, W (reprint author), Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria.",doris.wilflingseder@i-med.ac.at,"; Hackl, Hubert/B-3168-2018","Wilflingseder, Doris/0000-0002-5888-5118; Moris, Arnaud/0000-0002-5052-1678; Hackl, Hubert/0000-0003-4055-3841","Austrian Science Fund [P24598, P25389]; Oesterreichische Nationalbank Anniversary Fund [14875]","The work was funded by the Austrian Science Fund (P24598 to DW, P25389 to WP) and the Oesterreichische Nationalbank Anniversary Fund (project number: 14875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,17,17,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005005,10.1371/journal.ppat.1005005,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900061,26121641.0,"DOAJ Gold, Green Published",,,16/08/2019,17,5,30,4395,701,509,192,3694,2957,23,714,28,5,0,0,15,15,0,,37,0,35,2,0,18,18,9,8,0,0,0,0,0,0,3,0,1,4451,43,0,110,85,0,3718,714,43,0,110,85,0,19,,4,0,0,0,6,0,0,0,0,0,0,35,2,0,35.25,6.269614835948645,1.1897671900378992,0.1897671900378993,1.2395776935571197,1.0418657565415244,6.532097004279601
577,J,"Ptaschinski, C; Mukherjee, S; Moore, ML; Albert, M; Helin, K; Kunkel, SL; Lukacs, NW",,,,"Ptaschinski, Catherine; Mukherjee, Sumanta; Moore, Martin L.; Albert, Mareike; Helin, Kristian; Kunkel, Steven L.; Lukacs, Nicholas W.",,,RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,RESPIRATORY-SYNCYTIAL-VIRUS; EPIGENETIC SIGNATURE; INTERFERON RESPONSE; EPITHELIAL-CELLS; IMMUNE-SYSTEM; US CHILDREN; INFECTION; BRONCHIOLITIS; PROTEIN; BETA,"Respiratory syncytial virus (RSV) infection can result in severe disease partially due to its ability to interfere with the initiation of Th1 responses targeting the production of type I interferons (IFN) and promoting a Th2 immune environment. Epigenetic modulation of gene transcription has been shown to be important in regulating inflammatory pathways. RSV-infected bone marrow-derived DCs (BMDCs) upregulated expression of Kdm5b/Jarid1b H3K4 demethylase. Kdm5b-specific siRNA inhibition in BMDC led to a 10-fold increase in IFN-beta as well as increases in IL-6 and TNF-alpha compared to control-transfected cells. The generation of Kdm5b(fl/fl)-CD11c-Cre(+) mice recapitulated the latter results during in vitro DC activation showing innate cytokine modulation. In vivo, infection of Kdm5b(fl/fl)-CD11c-Cre(+) mice with RSV resulted in higher production of IFN-gamma and reduced IL-4 and IL-5 compared to littermate controls, with significantly decreased inflammation, IL-13, and mucus production in the lungs. Sensitization with RSV-infected DCs into the airways of naive mice led to an exacerbated response when mice were challenged with live RSV infection. When Kdm5b was blocked in DCs with siRNA or DCs from Kdm5b(fl/fl)-CD11c-CRE mice were used, the exacerbated response was abrogated. Importantly, human monocyte-derived DCs treated with a chemical inhibitor for KDM5B resulted in increased innate cytokine levels as well as elicited decreased Th2 cytokines when co-cultured with RSV reactivated CD4(+) T cells. These results suggest that KDM5B acts to repress type I IFN and other innate cytokines to promote an altered immune response following RSV infection that contributes to development of chronic disease.","[Ptaschinski, Catherine; Mukherjee, Sumanta; Kunkel, Steven L.; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Albert, Mareike; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Albert, Mareike; Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr, Copenhagen, Denmark","Ptaschinski, C (reprint author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.",nlukacs@med.umich.edu,"Helin, Kristian/K-2526-2019","Albert, Mareike/0000-0001-9855-9344; Helin, Kristian/0000-0003-1975-6097",National Institutes of Health [RO1AI036302]; European Molecular Biology Organization Long Term Postdoctoral Fellowship; Danish National Research Foundation; Danish Medical Research Council; Novo Nordisk Fonden [NNF15CC0018344],"NWL is funded by the National Institutes of Health grant # RO1AI036302 (http://www.nih.gov). MA is funded by the European Molecular Biology Organization Long Term Postdoctoral Fellowship (http://www.embo.org). KH is funded by the Danish National Research Foundation (http://dg.dk/en/). KH is funded by the Danish Medical Research Council (http://ufm.dk/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,17,17,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004978,10.1371/journal.ppat.1004978,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900047,26083387.0,"DOAJ Gold, Green Published",,,16/08/2019,17,3,29,4108,1059,761,298,3049,2351,22,676,29,3,0,0,16,16,0,,70,1,37,0,1,18,18,9,12,0,0,0,0,0,0,0,0,6,4165,48,0,145,53,0,3062,1077,48,0,145,53,0,26,,0,0,0,0,6,0,0,1,0,0,0,37,0,0,3.1,3.879131255901794,1.3473269924565432,0.34732699245654314,1.3991472613971794,1.0384615384615385,4.028328611898017
578,J,"Rancan, C; Schirrmann, L; Huls, C; Zeidler, R; Moosmann, A",,,,"Rancan, Chiara; Schirrmann, Leah; Huels, Corinna; Zeidler, Reinhard; Moosmann, Andreas",,,Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,EPSTEIN-BARR-VIRUS; HLA-CLASS-I; BOVINE LEUKEMIA-VIRUS; CYTOTOXIC T-CELLS; NUCLEAR ANTIGEN 1; B-CELLS; GROWTH TRANSFORMATION; BURKITTS-LYMPHOMA; REGULATES REACTIVATION; ENCODED INTERLEUKIN-10,"The common pathogen Epstein-Barr virus (EBV) transforms normal human B cells and can cause cancer. Latent membrane protein 2A (LMP2A) of EBV supports activation and proliferation of infected B cells and is expressed in many types of EBV-associated cancer. It is not clear how latent EBV infection and cancer escape elimination by host immunity, and it is unknown whether LMP2A can influence the interaction of EBV-infected cells with the immune system. We infected primary B cells with EBV deleted for LMP2A, and established lymphoblastoid cell lines (LCLs). We found that CD8+ T cell clones showed higher reactivity against LMP2A-deficient LCLs compared to LCLs infected with complete EBV. We identified several potential mediators of this immunomodulatory effect. In the absence of LMP2A, expression of some EBV latent antigens was elevated, and cell surface expression of MHC class I was marginally increased. LMP2A-deficient LCLs produced lower amounts of IL-10, although this did not directly affect CD8+ T cell recognition. Deletion of LMP2A led to several changes in the cell surface immunophenotype of LCLs. Specifically, the agonistic NKG2D ligands MICA and ULBP4 were increased. Blocking experiments showed that NKG2D activation contributed to LCL recognition by CD8+ T cell clones. Our results demonstrate that LMP2A reduces the reactivity of CD8+ T cells against EBV-infected cells, and we identify several relevant mechanisms.","[Rancan, Chiara; Schirrmann, Leah; Zeidler, Reinhard; Moosmann, Andreas] Klinikum Univ Munchen, Dept Med 3, Clin Cooperat Grp Immunooncol, Munich, Germany; [Rancan, Chiara; Schirrmann, Leah; Huels, Corinna; Zeidler, Reinhard; Moosmann, Andreas] Helmholtz Zentrum Munchen, Res Unit Gene Vectors, Munich, Germany; [Rancan, Chiara; Zeidler, Reinhard; Moosmann, Andreas] German Ctr Infect Res DZIF, Munich, Germany; [Zeidler, Reinhard] Klinikum Univ Munchen, Dept Otorhinolaryngol, Munich, Germany","Rancan, C (reprint author), Klinikum Univ Munchen, Dept Med 3, Clin Cooperat Grp Immunooncol, Munich, Germany.",andreas.moosmann@helmholtz-muenchen.de,"Zeidler, Reinhard/M-9837-2014","Zeidler, Reinhard/0000-0002-3357-4954; Moosmann, Andreas/0000-0001-8044-5146","Deutsche Forschungsgemeinschaft [SFB-Transregio 36, ZE 419/14-1]","This work was supported by Deutsche Forschungsgemeinschaft (SFB-Transregio 36, project A4, to AM; individual grant ZE 419/14-1, to RZ; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,93,21,22,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004906,10.1371/journal.ppat.1004906,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900019,26067064.0,"DOAJ Gold, Green Published",,,16/08/2019,20,24,20,5947,1197,960,237,4750,3966,28,756,20,4,0,0,18,18,3,,26,14,26,0,14,20,20,18,14,0,0,0,0,0,0,8,21,3,5953,15,0,70,87,1,4734,1197,15,0,70,87,1,22,,11,1,0,0,6,0,4,1,0,0,0,25,0,0,92.256,4.968253968253968,1.252,0.252,1.2747368421052632,1.0181604170169833,5.058479532163743
579,J,"Rangel, SM; Diaz, MH; Knoten, CA; Zhang, A; Hauser, AR",,,,"Rangel, Stephanie M.; Diaz, Maureen H.; Knoten, Claire A.; Zhang, Angelica; Hauser, Alan R.",,,The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia,PLOS PATHOGENS,,,English,Article,,,,,,,VENTILATOR-ASSOCIATED PNEUMONIA; III SECRETION SYSTEM; ACUTE LUNG INJURY; EXOENZYME-S; IN-VITRO; NOSOCOMIAL PNEUMONIA; PROTEIN SECRETION; ESCHERICHIA-COLI; BETA-LACTAMASE; HOST-CELLS,"Hospital-acquired pneumonia is associated with high rates of morbidity and mortality, and dissemination to the bloodstream is a recognized risk factor for particularly poor outcomes. Yet the mechanism by which bacteria in the lungs gain access to the bloodstream remains poorly understood. In this study, we used a mouse model of Pseudomonas aeruginosa pneumonia to examine this mechanism. P. aeruginosa uses a type III secretion system to deliver effector proteins such as ExoS directly into the cytosol of eukaryotic cells. ExoS, a bi-functional GTPase activating protein (GAP) and ADP-ribosyltransferase (ADPRT), inhibits phagocytosis during pneumonia but has also been linked to a higher incidence of dissemination to the bloodstream. We used a novel imaging methodology to identify ExoS intoxicated cells during pneumonia and found that ExoS is injected into not only leukocytes but also epithelial cells. Phagocytic cells, primarily neutrophils, were targeted for injection with ExoS early during infection, but type I pneumocytes became increasingly injected at later time points. Interestingly, injection of these pneumocytes did not occur randomly but rather in discrete regions, which we designate """"fields of cell injection"" (FOCI). These FOCI increased in size as the infection progressed and contained dead type I pneumocytes. Both of these phenotypes were attenuated in infections caused by bacteria secreting ADPRT-deficient ExoS, indicating that FOCI growth and type I pneumocyte death were dependent on the ADPRT activity of ExoS. During the course of infection, increased FOCI size was associated with enhanced disruption of the pulmonary-vascular barrier and increased bacterial dissemination into the blood, both of which were also dependent on the ADPRT activity of ExoS. We conclude that the ADPRT activity of ExoS acts upon type I pneumocytes to disrupt the pulmonary-vascular barrier during P. aeruginosa pneumonia, leading to bacterial dissemination.","[Rangel, Stephanie M.; Diaz, Maureen H.; Knoten, Claire A.; Zhang, Angelica; Hauser, Alan R.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol, Chicago, IL 60611 USA; [Rangel, Stephanie M.; Diaz, Maureen H.; Knoten, Claire A.; Zhang, Angelica; Hauser, Alan R.] Northwestern Univ, Feinberg Sch Med, Dept Immunol, Chicago, IL 60611 USA; [Hauser, Alan R.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA","Rangel, SM (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol, Chicago, IL 60611 USA.",ahauser@northwestern.edu,,,"National Institute of Health [AI089015, AI053674, AI075191, AI099269, AI04831, AI088286]; Northwestern University Interdepartmental Immunobiology Flow Cytometry Core Facility; Northwestern University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant [NCI CA060553]; NCI CCSG [P30 CA060553]","This work was supported by the National Institute of Health: AI089015 (SMR); AI053674, AI075191, AI099269, AI04831, and AI088286 (ARH). Additional support was provided by the Northwestern University Interdepartmental Immunobiology Flow Cytometry Core Facility, the Northwestern University Mouse Histology and Phenotyping Laboratory, and a Cancer Center Support Grant (NCI CA060553). Imaging work was performed at the Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,23,23,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004945,10.1371/journal.ppat.1004945,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900028,26090668.0,"DOAJ Gold, Green Published",,,16/08/2019,24,10,28,5353,885,636,249,4468,3559,21,888,28,10,0,2,18,18,2,,41,1,41,0,1,24,24,22,17,0,0,0,0,0,0,0,0,9,5414,237,0,54,91,1,4491,896,237,0,54,91,1,27,,0,0,0,0,11,0,0,1,1,0,0,42,0,0,6.45,6.048587570621469,1.1980752014324083,0.19807520143240823,1.2851387645478962,1.0726695311040537,6.488135593220339
580,J,"Read, J; Clancy, EK; Sarker, M; de Antueno, R; Langelaan, DN; Parmar, HB; Shin, K; Rainey, JK; Duncan, R",,,,"Read, Jolene; Clancy, Eileen K.; Sarker, Muzaddid; de Antueno, Roberto; Langelaan, David N.; Parmar, Hiren B.; Shin, Kyungsoo; Rainey, Jan K.; Duncan, Roy",,,Reovirus FAST Proteins Drive Pore Formation and Syncytiogenesis Using a Novel Helix-Loop-Helix Fusion-Inducing Lipid Packing Sensor,PLOS PATHOGENS,,,English,Article,,,,,,,PROXIMAL CYTOPLASMIC DOMAIN; SMALL TRANSMEMBRANE PROTEIN; VIRAL MEMBRANE-FUSION; SYNCYTIUM FORMATION; CELL-FUSION; BABOON REOVIRUS; MEDIATED FUSION; PEPTIDE MOTIF; CURVATURE; ENLARGEMENT,"Pore formation is the most energy-demanding step during virus-induced membrane fusion, where high curvature of the fusion pore rim increases the spacing between lipid head-groups, exposing the hydrophobic interior of the membrane to water. How protein fusogens breach this thermodynamic barrier to pore formation is unclear. We identified a novel fusion-inducing lipid packing sensor (FLiPS) in the cytosolic endodomain of the baboon reovirus p15 fusion-associated small transmembrane (FAST) protein that is essential for pore formation during cell-cell fusion and syncytiogenesis. NMR spectroscopy and mutational studies indicate the dependence of this FLiPS on a hydrophobic helix-loop-helix structure. Biochemical and biophysical assays reveal the p15 FLiPS preferentially partitions into membranes with high positive curvature, and this partitioning is impeded by bis-ANS, a small molecule that inserts into hydrophobic defects in membranes. Most notably, the p15 FLiPS can be functionally replaced by heterologous amphipathic lipid packing sensors (ALPS) but not by other membrane-interactive amphipathic helices. Furthermore, a previously unrecognized amphipathic helix in the cytosolic domain of the reptilian reovirus p14 FAST protein can functionally replace the p15 FLiPS, and is itself replaceable by a heterologous ALPS motif. Anchored near the cytoplasmic leaflet by the FAST protein transmembrane domain, the FLiPS is perfectly positioned to insert into hydrophobic defects that begin to appear in the highly curved rim of nascent fusion pores, thereby lowering the energy barrier to stable pore formation.","[Read, Jolene; Clancy, Eileen K.; Sarker, Muzaddid; de Antueno, Roberto; Parmar, Hiren B.; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Sarker, Muzaddid; Langelaan, David N.; Shin, Kyungsoo; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Rainey, Jan K.] Dalhousie Univ, Dept Chem, Halifax, NS, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada","Duncan, R (reprint author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.",roy.duncan@dal.ca,"Rainey, Jan/P-4627-2019; Rainey, Jan/C-1927-2008","Rainey, Jan/0000-0003-0793-5573; Rainey, Jan/0000-0003-0793-5573; Clancy, Eileen/0000-0001-9565-7985",Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation (NSHRF); Eliza Ritchie scholarship; NSHRF; Killam Foundation; Cancer Research Training Program (CRTP); Dalhousie Cancer Research Program (DCRP); NSERC; CIHR New Investigator Award,"This work was supported by a grant to RD from the Canadian Institutes of Health Research (CIHR) and by a Scotia Support Grant from the Nova Scotia Health Research Foundation (NSHRF) to JKR and RD. JR was supported by an Eliza Ritchie scholarship, and by scholarships from the Canadian Institutes of Health Research (CIHR), the NSHRF, and the Killam Foundation. EKC was funded by scholarships from the NSHRF and the Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP). DNL was supported by scholarships from NSERC. JKR is supported by a CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,76,3,3,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004962,10.1371/journal.ppat.1004962,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900038,26061049.0,"DOAJ Gold, Green Published",,,16/08/2019,3,16,11,3168,396,297,99,2772,2307,25,440,11,15,0,0,4,4,0,,29,0,16,0,0,4,4,3,2,0,0,0,0,0,0,0,1,9,3219,32,0,592,58,0,2793,405,32,0,592,58,0,21,,0,0,0,0,13,0,1,1,0,0,0,18,0,0,8.75,8.0,1.1428571428571428,0.14285714285714285,1.1937229437229437,1.0445075757575757,8.356060606060606
581,J,"Ross, ZP; Komadina, N; Deng, YM; Spirason, N; Kelly, HA; Sullivan, SG; Barr, IG; Holmes, EC",,,,"Ross, Zoe Patterson; Komadina, Naomi; Deng, Yi-Mo; Spirason, Natalie; Kelly, Heath A.; Sullivan, Sheena G.; Barr, Ian G.; Holmes, Edward C.",,,Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence,PLOS PATHOGENS,,,English,Article,,,,,,,PHYLOGENETIC ANALYSIS; VACCINE EFFECTIVENESS; H3N2 VIRUSES; A VIRUSES; AUSTRALIA; EVOLUTION; REVEALS; MIGRATION; LINEAGES; HUMIDITY,"The factors that determine the characteristic seasonality of influenza remain enigmatic. Current models predict that occurrences of influenza outside the normal surveillance season within a temperate region largely reflect the importation of viruses from the alternate hemisphere or from equatorial regions in Asia. To help reveal the drivers of seasonality we investigated the origins and evolution of influenza viruses sampled during inter-seasonal periods in Australia. To this end we conducted an expansive phylogenetic analysis of 9912, 3804, and 3941 hemagglutinnin (HA) sequences from influenza A/H1N1pdm, A/H3N2, and B, respectively, collected globally during the period 2009-2014. Of the 1475 viruses sampled from Australia, 396 (26.8% of Australian, or 2.2% of global set) were sampled outside the monitored temperate influenza surveillance season (1 May - 31 October). Notably, rather than simply reflecting short-lived importations of virus from global localities with higher influenza prevalence, we documented a variety of more complex inter-seasonal transmission patterns including ""stragglers"" from the preceding season and ""heralds"" of the forthcoming season, and which included viruses sampled from clearly temperate regions within Australia. We also provide evidence for the persistence of influenza B virus between epidemic seasons, in which transmission of a viral lineage begins in one season and continues throughout the inter-seasonal period into the following season. Strikingly, a disproportionately high number of inter-seasonal influenza transmission events occurred in tropical and subtropical regions of Australia, providing further evidence that climate plays an important role in shaping patterns of influenza seasonality.","[Ross, Zoe Patterson; Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Ross, Zoe Patterson; Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Komadina, Naomi; Deng, Yi-Mo; Spirason, Natalie; Sullivan, Sheena G.; Barr, Ian G.] World Hlth Org Collaborating Ctr Reference & Res, Peter Doherty Inst, Melbourne, Vic, Australia; [Kelly, Heath A.; Barr, Ian G.] Peter Doherty Inst, VIDRL, Melbourne, Vic, Australia; [Kelly, Heath A.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia","Ross, ZP (reprint author), Univ Sydney, Sch Biol Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.",edward.holmes@sydney.edu.au,"Gegenwart, Philipp/A-7291-2017","Patterson Ross, Zoe/0000-0001-8228-0234; Barr, Ian/0000-0002-7351-418X; sullivan, sheena/0000-0002-0856-0294; Deng, Yi-Mo/0000-0003-2177-8308; Holmes, Edward/0000-0001-9596-3552",Australian Postgraduate Award; NHMRC Australia Fellowship [AF30]; Australian Government Department of Health,"ZPR is funded by an Australian Postgraduate Award (https://education.gov.au/australian-postgraduate-awards). ECH is funded by an NHMRC (http://www.nhmrc.gov.au/) Australia Fellowship (AF30). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health (http://www.health.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,43,10,10,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004991,10.1371/journal.ppat.1004991,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900054,26107631.0,"DOAJ Gold, Green Published",,,16/08/2019,10,13,38,4663,1164,877,287,3499,2789,32,678,37,11,0,0,12,12,0,,50,6,49,1,6,11,11,9,5,0,0,0,0,0,0,1,2,2,4680,62,0,1466,89,0,3466,1164,62,0,1466,89,0,50,,0,0,0,0,14,0,2,0,0,0,0,49,1,0,7.95,4.006013745704467,1.332666476136039,0.3326664761360389,1.3806801943412403,1.0360283079562513,4.150343642611684
582,J,"Shoemaker, JE; Fukuyama, S; Eisfeld, AJ; Zhao, DM; Kawakami, E; Sakabe, S; Maemura, T; Gorai, T; Katsura, H; Muramoto, Y; Watanabe, S; Watanabe, T; Fuji, K; Matsuoka, Y; Kitano, H; Kawaoka, Y",,,,"Shoemaker, Jason E.; Fukuyama, Satoshi; Eisfeld, Amie J.; Zhao, Dongming; Kawakami, Eiryo; Sakabe, Saori; Maemura, Tadashi; Gorai, Takeo; Katsura, Hiroaki; Muramoto, Yukiko; Watanabe, Shinji; Watanabe, Tokiko; Fuji, Ken; Matsuoka, Yukiko; Kitano, Hiroaki; Kawaoka, Yoshihiro",,,An Ultrasensitive Mechanism Regulates Influenza Virus-Induced Inflammation,PLOS PATHOGENS,,,English,Article,,,,,,,RIG-I; A-VIRUS; TRANSCRIPTOMIC ANALYSIS; ANTIVIRAL RESPONSES; NETWORK ANALYSIS; INNATE IMMUNITY; RNA VIRUSES; INFECTION; RECOGNITION; APOPTOSIS,"Influenza viruses present major challenges to public health, evident by the 2009 influenza pandemic. Highly pathogenic influenza virus infections generally coincide with early, high levels of inflammatory cytokines that some studies have suggested may be regulated in a strain-dependent manner. However, a comprehensive characterization of the complex dynamics of the inflammatory response induced by virulent influenza strains is lacking. Here, we applied gene co-expression and nonlinear regression analysis to time-course, microarray data developed from influenza-infected mouse lung to create mathematical models of the host inflammatory response. We found that the dynamics of inflammation-associated gene expression are regulated by an ultrasensitive-like mechanism in which low levels of virus induce minimal gene expression but expression is strongly induced once a threshold virus titer is exceeded. Cytokine assays confirmed that the production of several key inflammatory cytokines, such as interleukin 6 and monocyte chemotactic protein 1, exhibit ultrasensitive behavior. A systematic exploration of the pathways regulating the inflammatory-associated gene response suggests that the molecular origins of this ultrasensitive response mechanism lie within the branch of the Toll-like receptor pathway that regulates STAT1 phosphorylation. This study provides the first evidence of an ultrasensitive mechanism regulating influenza virus-induced inflammation in whole lungs and provides insight into how different virus strains can induce distinct temporal inflammation response profiles. The approach developed here should facilitate the construction of gene regulatory models of other infectious diseases.","[Shoemaker, Jason E.; Fukuyama, Satoshi; Zhao, Dongming; Kawakami, Eiryo; Sakabe, Saori; Muramoto, Yukiko; Watanabe, Shinji; Watanabe, Tokiko; Fuji, Ken; Matsuoka, Yukiko; Kitano, Hiroaki; Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan; [Shoemaker, Jason E.; Fukuyama, Satoshi; Zhao, Dongming; Maemura, Tadashi; Katsura, Hiroaki; Muramoto, Yukiko; Watanabe, Tokiko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Eisfeld, Amie J.; Gorai, Takeo; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Influenza Res Inst, Sch Vet Med, Madison, WI 53706 USA; [Kawakami, Eiryo; Kitano, Hiroaki] RIKEN Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokosuka, Kanagawa, Japan; [Sakabe, Saori] Nagasaki Univ, Inst Trop Med, Dept Emerging Infect Dis, Nagasaki 852, Japan; [Watanabe, Shinji] Miyazaki Univ, Dept Vet Sci, Lab Vet Microbiol, Miyazaki, Japan; [Fuji, Ken] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Matsuoka, Yukiko; Kitano, Hiroaki] Syst Biol Inst, Tokyo, Japan; [Kitano, Hiroaki] Okinawa Inst Sci & Technol, Onna, Okinawa, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Dept Special Pathogens, Int Res Ctr Infect Dis, Tokyo, Japan","Shoemaker, JE (reprint author), Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan.",kawaoka@ims.u-tokyo.ac.jp,"Shoemaker, Jason/B-8137-2011","Shoemaker, Jason/0000-0003-3315-7103","Japan Science and Technology Agency's Exploratory Research for Advanced Technology (ERATO) program; Strategic Basic Research Programs; Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; National Institute of Allergy and Infectious Diseases Public Health Service; JSPS","This research was supported by the Japan Science and Technology Agency's Exploratory Research for Advanced Technology (ERATO) program and Strategic Basic Research Programs. This work was also supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; by grants-in-aid from the Ministry of Health, Labour and Welfare, Japan; and by National Institute of Allergy and Infectious Diseases Public Health Service research grants. HKa is supported by JSPS Research Fellowships for young scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,16,16,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004856,10.1371/journal.ppat.1004856,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900009,26046528.0,"DOAJ Gold, Green Published",,,16/08/2019,15,21,30,5393,982,687,295,4411,3517,21,873,29,1,0,0,16,16,0,,37,0,36,1,0,16,15,16,10,0,0,0,0,0,0,0,20,4,5456,275,0,85,158,2,4436,992,275,0,85,158,2,28,,0,0,0,0,11,0,0,1,0,0,0,36,1,0,6.1,5.491853360488799,1.2226252550442076,0.22262525504420766,1.3350714123781455,1.091971073613944,5.9969450101833
583,J,"Srivastava, A; Creek, DJ; Evans, KJ; De Souza, D; Schofield, L; Muller, S; Barrett, MP; McConville, MJ; Waters, AP",,,,"Srivastava, Anubhav; Creek, Darren J.; Evans, Krystal J.; De Souza, David; Schofield, Louis; Mueller, Sylke; Barrett, Michael P.; McConville, Malcolm J.; Waters, Andrew P.",,,Host Reticulocytes Provide Metabolic Reservoirs That Can Be Exploited by Malaria Parasites,PLOS PATHOGENS,,,English,Article,,,,,,,PENTOSE-PHOSPHATE PATHWAY; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; ERYTHROCYTE INVASION; ASPARTATE-AMINOTRANSFERASE; GLUTATHIONE BIOSYNTHESIS; PYRIMIDINE METABOLISM; SELECTIVE ACTIVITY; BERGHEI; PURINE,"Human malaria parasites proliferate in different erythroid cell types during infection. Whilst Plasmodium vivax exhibits a strong preference for immature reticulocytes, the more pathogenic P. falciparum primarily infects mature erythrocytes. In order to assess if these two cell types offer different growth conditions and relate them to parasite preference, we compared the metabolomes of human and rodent reticulocytes with those of their mature erythrocyte counterparts. Reticulocytes were found to have a more complex, enriched metabolic profile than mature erythrocytes and a higher level of metabolic overlap between reticulocyte resident parasite stages and their host cell. This redundancy was assessed by generating a panel of mutants of the rodent malaria parasite P. berghei with defects in intermediary carbon metabolism (ICM) and pyrimidine biosynthesis known to be important for P. falciparum growth and survival in vitro in mature erythrocytes. P. berghei ICM mutants (pbpepc(-), phosphoenolpyruvate carboxylase and pbmdh(-), malate dehydrogenase) multiplied in reticulocytes and committed to sexual development like wild type parasites. However, P. berghei pyrimidine biosynthesis mutants (pboprt(-), orotate phosphoribosyltransferase and pbompdc(-), orotidine 5'-monophosphate decarboxylase) were restricted to growth in the youngest forms of reticulocytes and had a severe slow growth phenotype in part resulting from reduced merozoite production. The pbpepc(-), pboprt(-) and pbompdc(-) mutants retained virulence in mice implying that malaria parasites can partially salvage pyrimidines but failed to complete differentiation to various stages in mosquitoes. These findings suggest that species-specific differences in Plasmodium host cell tropism result in marked differences in the necessity for parasite intrinsic metabolism. These data have implications for drug design when targeting mature erythrocyte or reticulocyte resident parasites.","[Srivastava, Anubhav; Creek, Darren J.; Barrett, Michael P.; Waters, Andrew P.] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Srivastava, Anubhav; Creek, Darren J.; Mueller, Sylke; Barrett, Michael P.; Waters, Andrew P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Creek, Darren J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville, Vic, Australia; [Evans, Krystal J.; Schofield, Louis] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3050, Australia; [De Souza, David; McConville, Malcolm J.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Metabol Australia, Parkville, Vic 3052, Australia; [Schofield, Louis] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia; [McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia","Srivastava, A (reprint author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland.",Andy.Waters@glasgow.ac.uk,"De Souza, David P/O-9800-2016; Srivastava, Anubhav/F-6254-2013","De Souza, David P/0000-0002-7225-2632; Srivastava, Anubhav/0000-0003-4802-2404; Barrett, Mike/0000-0001-9447-3519; Creek, Darren/0000-0001-7497-7082",Wellcome Trust [083811/Z/07/Z]; National Health and Medical Research Council [1059530]; European Virtual Institute of Malaria Research; University of Glasgow,"This study was supported by Wellcome Trust (http://www.wellcome.ac.uk/) grant 083811/Z/07/Z (holder APW); National Health and Medical Research Council (http://www.nhmrc.gov.au/) grant 1059530 (holder MJM); European Virtual Institute of Malaria Research (http://www.evimalar.org/) grant FP7-PEOPLE-2010-IRSES Project 5 (holder AS) and University of Glasgow Staff Research Scholarship 2009-14 (holder AS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,29,29,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004882,10.1371/journal.ppat.1004882,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900015,26042734.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,30,386,65,7163,1220,902,318,5943,4675,22,1246,65,6,0,1,30,30,3,,85,5,85,0,5,33,31,33,22,0,0,0,0,0,0,2,375,4,7238,70,234,91,93,1,5976,1231,70,234,91,93,1,31,,5,0,0,0,15,0,3,1,1,0,0,85,0,0,54.6,5.871311475409836,1.205283526838297,0.20528352683829715,1.2453306410903584,1.0332263018288426,6.06639344262295
584,J,"Van Doorslaer, K; DeSalle, R; Einstein, MH; Burk, RD",,,,"Van Doorslaer, Koenraad; DeSalle, Rob; Einstein, Mark H.; Burk, Robert D.",,,Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche,PLOS PATHOGENS,,,English,Article,,,,,,,HPV E6 PROTEINS; HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; SEQUENCE ALIGNMENT; BINDING MOTIF; TUMOR-CELLS; DOMAIN; RISK; EXPRESSION; CARCINOGENICITY,"In order to complete their life cycle, papillomaviruses have evolved to manipulate a plethora of cellular pathways. The products of the human Alphapapillomavirus E6 proteins specifically interact with and target PDZ containing proteins for degradation. This viral phenotype has been suggested to play a role in viral oncogenesis. To analyze the association of HPV E6 mediated PDZ-protein degradation with cervical oncogenesis, a high-throughput cell culture assay was developed. Degradation of an epitope tagged human MAGI1 isoform was visualized by immunoblot. The correlation between HPV E6-induced degradation of hMAGI1 and epidemiologically determined HPV oncogenicity was evaluated using a Bayesian approach within a phylogenetic context. All tested oncogenic types degraded the PDZ-containing protein hMAGI1d; however, E6 proteins isolated from several related albeit non-oncogenic viral types were equally efficient at degrading hMAGI1. The relationship between both traits (oncogenicity and PDZ degradation potential) is best explained by a model in which the potential to degrade PDZ proteins was acquired prior to the oncogenic phenotype. This analysis provides evidence that the ancestor of both oncogenic and non-oncogenic HPVs acquired the potential to degrade human PDZ-containing proteins. This suggests that HPV E6 directed degradation of PDZ-proteins represents an ancient ecological niche adaptation. Phylogenetic modeling indicates that this phenotype is not specifically correlated with oncogenic risk, but may act as an enabling phenotype. The role of PDZ protein degradation in HPV fitness and oncogenesis needs to be interpreted in the context of Alphapapillomavirus evolution.","[Van Doorslaer, Koenraad; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Einstein, Mark H.; Burk, Robert D.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Dept Pediat, Bronx, NY 10467 USA","Van Doorslaer, K (reprint author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.",robert.burk@einstein.yu.edu,,"Van Doorslaer, Koenraad/0000-0002-2985-0733",National Cancer Institute [CA78527]; Einstein-Montefiore Center for AIDS - NIH [AI-51519]; Einstein Cancer Research Center from the National Cancer Institute [P30CA013330],"This work was supported in part by the National Cancer Institute (CA78527) (RDB), the Einstein-Montefiore Center for AIDS funded by the NIH (AI-51519) and the Einstein Cancer Research Center (P30CA013330) from the National Cancer Institute. KVD was employed by Albert Einstein College of Medicine at the time of this work. KVD is currently employed by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,55,8,8,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004980,10.1371/journal.ppat.1004980,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900049,26086730.0,"DOAJ Gold, Green Published",,,16/08/2019,9,1,13,2157,383,285,98,1774,1451,21,302,13,1,0,0,9,9,0,,21,3,21,0,3,9,9,9,5,0,0,0,0,0,0,0,0,0,2170,58,0,84,73,1,1769,383,58,0,84,73,1,18,,0,0,0,0,1,0,0,1,0,0,0,21,0,0,0.5,5.631853785900783,1.2158962795941375,0.21589627959413754,1.2970687711386697,1.066759388038943,6.007832898172324
585,J,"Van Slyke, GA; Arnold, JJ; Lugo, AJ; Griesemer, SB; Moustafa, IM; Kramer, LD; Cameron, CE; Ciota, AT",,,,"Van Slyke, Greta A.; Arnold, Jamie J.; Lugo, Alex J.; Griesemer, Sara B.; Moustafa, Ibrahim M.; Kramer, Laura D.; Cameron, Craig E.; Ciota, Alexander T.",,,Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT RNA-POLYMERASE; ERROR-PRONE REPLICATION; MOUTH-DISEASE VIRUS; LOUIS ENCEPHALITIS-VIRUS; IN-VIVO; COOPERATIVE INTERACTIONS; PURIFYING SELECTION; LETHAL MUTAGENESIS; CRYSTAL-STRUCTURE; MUTANT SPECTRUM,"High rates of error-prone replication result in the rapid accumulation of genetic diversity of RNA viruses. Recent studies suggest that mutation rates are selected for optimal viral fitness and that modest variations in replicase fidelity may be associated with viral attenuation. Arthropod-borne viruses (arboviruses) are unique in their requirement for host cycling and may necessitate substantial genetic and phenotypic plasticity. In order to more thoroughly investigate the correlates, mechanisms and consequences of arbovirus fidelity, we selected fidelity variants of West Nile virus (WNV; Flaviviridae, Flavivirus) utilizing selection in the presence of a mutagen. We identified two mutations in the WNV RNA-dependent RNA polymerase associated with increased fidelity, V793I and G806R, and a single mutation in the WNV methyltransferase, T248I, associated with decreased fidelity. Both deep-sequencing and in vitro biochemical assays confirmed strain-specific differences in both fidelity and mutational bias. WNV fidelity variants demonstrated host-specific alterations to replicative fitness in vitro, with modest attenuation in mosquito but not vertebrate cell culture. Experimental infections of colonized and field populations of Cx. quinquefaciatus demonstrated that WNV fidelity alterations are associated with a significantly impaired capacity to establish viable infections in mosquitoes. Taken together, these studies (i) demonstrate the importance of allosteric interactions in regulating mutation rates, (ii) establish that mutational spectra can be both sequence and strain-dependent, and (iii) display the profound phenotypic consequences associated with altered replication complex function of flaviviruses.","[Van Slyke, Greta A.; Griesemer, Sara B.; Kramer, Laura D.; Ciota, Alexander T.] New York State Dept Hlth, Wadsworth Ctr, Arbovirus Lab, Slingerlands, NY 12237 USA; [Arnold, Jamie J.; Lugo, Alex J.; Moustafa, Ibrahim M.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Kramer, Laura D.; Ciota, Alexander T.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA","Van Slyke, GA (reprint author), New York State Dept Hlth, Wadsworth Ctr, Arbovirus Lab, Slingerlands, NY 12237 USA.",alexander.ciota@health.ny.gov,"Ciota, Alexander/E-1634-2017","Ciota, Alexander/0000-0001-6589-4728; Van Slyke, Greta/0000-0003-2646-3030",National Institute of Health [RO1-AI-077669],"This work was supported by federal funds from the National Institute of Health (grant number RO1-AI-077669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,34,34,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005009,10.1371/journal.ppat.1005009,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900062,26114757.0,"DOAJ Gold, Green Published",,,16/08/2019,26,8,33,3922,576,420,156,3346,2749,25,572,33,5,0,0,32,32,0,,36,2,36,0,2,36,26,36,24,0,0,0,0,0,0,0,3,1,3968,10,0,42,99,1,3362,586,10,0,42,99,1,20,,0,0,0,0,8,0,1,0,0,0,0,36,0,0,4.6,6.809027777777778,1.1721458457860132,0.17214584578601316,1.2184698147041244,1.0395206527282,7.078125
586,J,"Wager, CML; Wormley, FL",,,,"Wager, Chrissy M. Leopold; Wormley, Floyd L., Jr.",,,Is Development of a Vaccine against Cryptococcus neoformans Feasible?,PLOS PATHOGENS,,,English,Article,,,,,,,CLASSICAL MACROPHAGE ACTIVATION; DENDRITIC CELLS; PULMONARY CRYPTOCOCCOSIS; PROTECTIVE IMMUNITY; HOST-DEFENSE; IN-VIVO; INFECTION; GAMMA; MICE; REINFECTION,,"[Wager, Chrissy M. Leopold; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Wager, Chrissy M. Leopold; Wormley, Floyd L., Jr.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA","Wager, CML (reprint author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.",floyd.wormley@utsa.edu,,"Leopold Wager, Chrissy/0000-0002-3828-055X","National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [2RO1AI071752, R21AI100893]; Army Research Office of the Department of Defense [W911NF-11-1-0136 f]","This work was supported by research grant 2RO1AI071752 and R21AI100893 from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and by Army Research Office of the Department of Defense No. W911NF-11-1-0136 f (FLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript",,32,13,13,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004843,10.1371/journal.ppat.1004843,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900006,26087178.0,"DOAJ Gold, Green Published",,,16/08/2019,13,56,22,5280,1107,917,190,4173,3570,20,583,22,10,0,0,11,11,0,,28,4,28,0,4,13,13,12,8,0,0,0,0,0,0,0,46,3,5358,9,0,24,67,0,4203,1115,9,0,24,67,0,40,,0,0,0,0,10,0,0,1,0,0,0,30,0,0,4.6,4.769647696476965,1.2652767792954709,0.2652767792954709,1.3021806853582554,1.0291666666666666,4.908762420957543
587,J,"Zerboni, L; Arvin, A",,,,"Zerboni, Leigh; Arvin, Ann",,,Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo,PLOS PATHOGENS,,,English,Article,,,,,,,NERVE GROWTH-FACTOR; POSTHERPETIC NEURALGIA; NEUROPATHIC PAIN; GLIAL-CELLS; IMMUNE-RESPONSE; INITIAL SEGMENT; SENSORY GANGLIA; MOUSE KIDNEY; AXON HILLOCK; PROTEIN,"Varicella zoster virus (VZV), a human alphaherpesvirus, causes varicella during primary infection. VZV reactivation from neuronal latency may cause herpes zoster, post herpetic neuralgia (PHN) and other neurologic syndromes. To investigate VZV neuropathogenesis, we developed a model using human dorsal root ganglia (DRG) xenografts in immunodeficient (SCID) mice. The SCID DRG model provides an opportunity to examine characteristics of VZV infection that occur in the context of the specialized architecture of DRG, in which nerve cell bodies are ensheathed by satellite glial cells (SGC) which support neuronal homeostasis. We hypothesized that VZV exhibits neuron-subtype specific tropism and that VZV tropism for SGC contributes to VZV-related ganglionopathy. Based on quantitative analyses of viral and cell protein expression in DRG tissue sections, we demonstrated that, whereas DRG neurons had an immature neuronal phenotype prior to implantation, subtype heterogeneity was observed within 20 weeks and SGC retained the capacity to maintain neuronal homeostasis longterm. Profiling VZV protein expression in DRG neurons showed that VZV enters peripherin+ nociceptive and RT97+ mechanoreceptive neurons by both axonal transport and contiguous spread from SGC, but replication in RT97+ neurons is blocked. Restriction occurs even when the SGC surrounding the neuronal cell body were infected and after entry and ORF61 expression, but before IE62 or IE63 protein expression. Notably, although contiguous VZV spread with loss of SGC support would be predicted to affect survival of both nociceptive and mechanoreceptive neurons, RT97+ neurons showed selective loss relative to peripherin+ neurons at later times in DRG infection. Profiling cell factors that were upregulated in VZV-infected DRG indicated that VZV infection induced marked pro-inflammatory responses, as well as proteins of the interferon pathway and neuroprotective responses. These neuropathologic changes observed in sensory ganglia infected with VZV may help to explain the neurologic sequelae often associated with zoster and PHN.","[Zerboni, Leigh; Arvin, Ann] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Arvin, Ann] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA","Zerboni, L (reprint author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.",zerboni@stanford.edu,,,"National Institute of Allergy and Infectious Diseases [AI05346, AI20459, AI081994]","This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI05346, AI20459 and AI081994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,57,11,12,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004989,10.1371/journal.ppat.1004989,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900053,26090802.0,"DOAJ Gold, Green Published",,,16/08/2019,12,8,18,5256,982,656,326,4274,2912,22,1340,18,7,0,0,9,9,0,,19,11,19,0,11,12,12,7,7,0,0,0,0,0,0,0,1,7,5304,79,2,115,128,0,4263,982,79,2,115,128,0,59,,0,0,0,0,9,0,1,1,0,0,0,19,0,0,3.5,5.352342158859471,1.2297613476836686,0.22976134768366868,1.2894244267664952,1.04851598173516,5.612016293279022
588,J,"Zhai, YJ; Franco, LM; Atmar, RL; Quarles, JM; Arden, N; Bucasas, KL; Wells, JM; Nino, D; Wang, XQ; Zapata, GE; Shaw, CA; Belmont, JW; Couch, RB",,,,"Zhai, Yijie; Franco, Luis M.; Atmar, Robert L.; Quarles, John M.; Arden, Nancy; Bucasas, Kristine L.; Wells, Janet M.; Nino, Diane; Wang, Xueqing; Zapata, Gladys E.; Shaw, Chad A.; Belmont, John W.; Couch, Robert B.",,,Host Transcriptional Response to Influenza and Other Acute Respiratory Viral Infections - A Prospective Cohort Study,PLOS PATHOGENS,,,English,Article,,,,,,,SEASONAL INFLUENZA; NETWORK ANALYSIS; VIRUS-INFECTION; MICROARRAY DATA; BLOOD; IMMUNITY; ILLNESS; ACTIVATION; PATTERNS; ANTIBODY,"To better understand the systemic response to naturally acquired acute respiratory viral infections, we prospectively enrolled 1610 healthy adults in 2009 and 2010. Of these, 142 subjects were followed for detailed evaluation of acute viral respiratory illness. We examined peripheral blood gene expression at 7 timepoints: enrollment, 5 illness visits and the end of each year of the study. 133 completed all study visits and yielded technically adequate peripheral blood microarray gene expression data. Seventy-three (55%) had an influenza virus infection, 64 influenza A and 9 influenza B. The remaining subjects had a rhinovirus infection (N = 32), other viral infections (N = 4), or no viral agent identified (N = 24). The results, which were replicated between two seasons, showed a dramatic upregulation of interferon pathway and innate immunity genes. This persisted for 2-4 days. The data show a recovery phase at days 4 and 6 with differentially expressed transcripts implicated in cell proliferation and repair. By day 21 the gene expression pattern was indistinguishable from baseline (enrollment). Influenza virus infection induced a higher magnitude and longer duration of the shared expression signature of illness compared to the other viral infections. Using lineage and activation state-specific transcripts to produce cell composition scores, patterns of B and T lymphocyte depressions accompanied by a major activation of NK cells were detected in the acute phase of illness. The data also demonstrate multiple dynamic gene modules that are reorganized and strengthened following infection. Finally, we examined pre- and post-infection anti-influenza antibody titers defining novel gene expression correlates.","[Zhai, Yijie; Bucasas, Kristine L.; Shaw, Chad A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhai, Yijie; Wang, Xueqing; Zapata, Gladys E.; Belmont, John W.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Franco, Luis M.] NIAID, Lab Syst Biol, DIR, NIH, Bethesda, MD 20892 USA; [Atmar, Robert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Atmar, Robert L.; Wells, Janet M.; Couch, Robert B.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Quarles, John M.; Arden, Nancy] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA; [Belmont, John W.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA","Zhai, YJ (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.",jbelmont@bcm.tmc.edu,,,U.S. National Institutes of Health [NO1-AI030039]; Burroughs Wellcome Fund - The Houston Laboratory; Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UT Health Medical School (BWF) [1008200]; F31-Ruth L. Kirschtein NRSA Individual Pre-doctoral Training Grant [F31AI071372-03],"This work is supported by a contract from the U.S. National Institutes of Health (NO1-AI030039). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. YZ is supported by a training fellowship from the Burroughs Wellcome Fund - The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UT Health Medical School (BWF Grant No. 1008200). KLB was supported by F31-Ruth L. Kirschtein NRSA Individual Pre-doctoral Training Grant (F31AI071372-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,30,30,2,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004869,10.1371/journal.ppat.1004869,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900013,26070066.0,"DOAJ Gold, Green Published",,,16/08/2019,29,12,56,8232,1357,1015,342,6875,5467,32,1376,56,8,0,0,35,35,0,,81,8,81,0,8,30,30,25,24,0,0,0,0,0,0,0,4,10,8236,111,0,1443,181,1,6847,1357,111,0,1443,181,1,32,,0,0,0,0,13,0,1,1,0,0,0,82,0,0,6.5,6.0663227708179805,1.197381818181818,0.19738181818181819,1.2404363636363636,1.0359572400388728,6.2844509948415626
589,J,"Zhang, JJ; Zhu, LN; Lu, XL; Feldman, ER; Keyes, LR; Wang, Y; Fan, H; Feng, H; Xia, ZX; Sun, JY; Jiang, TJ; Gao, SJ; Tibbetts, SA; Feng, PH",,,,"Zhang, Junjie; Zhu, Lining; Lu, Xiaolu; Feldman, Emily R.; Keyes, Lisa R.; Wang, Yi; Fan, Hui; Feng, Hao; Xia, Zanxian; Sun, Jiya; Jiang, Taijiao; Gao, Shou-jiang; Tibbetts, Scott A.; Feng, Pinghui",,,Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; DNA-SEQUENCES; CONSTITUTIVE ACTIVITY; GENE-EXPRESSION; INFECTION; LYMPHOMA; LATENCY; CELLS; AIDS,"Human gamma herpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), are capable of inducing tumors, particularly in in immune-compromised individuals. Due to the stringent host tropism, rodents are resistant to infection by human gamma herpesviruses, creating a significant barrier for the in vivo study of viral genes that contribute to tumorigenesis. The closely-related murine gamma herpesvirus 68 (gamma HV68) efficiently infects laboratory mouse strains and establishes robust persistent infection without causing apparent disease. Here, we report that a recombinant gamma HV68 carrying the KSHV G protein-coupled receptor (kGPCR) in place of its murine counterpart induces angiogenic tumors in infected mice. Although viral GPCRs are conserved in all gamma herpesviruses, kGPCR potently activated downstream signaling and induced tumor formation in nude mouse, whereas gamma HV68 GPCR failed to do so. Recombinant gamma HV68 carrying kGPCR demonstrated more robust lytic replication ex vivo than wild-type gamma HV68, although both viruses underwent similar acute and latent infection in vivo. Infection of immunosuppressed mice with gamma HV68 carrying kGPCR, but not wild-type gamma HV68, induced tumors in mice that exhibited angiogenic and inflammatory features shared with human Kaposi's sarcoma. Immunohistochemistry staining identified abundant latently-infected cells and a small number of cells supporting lytic replication in tumor tissue. Thus, mouse infection with a recombinant gamma HV68 carrying kGPCR provides a useful small animal model for tumorigenesis induced by a human gamma herpesvirus gene in the setting of a natural course of infection.","[Zhang, Junjie; Zhu, Lining; Lu, Xiaolu; Wang, Yi; Gao, Shou-jiang; Feng, Pinghui] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Feldman, Emily R.; Keyes, Lisa R.; Tibbetts, Scott A.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Fan, Hui; Feng, Hao] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Xia, Zanxian] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Xia, Zanxian] Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China; [Sun, Jiya; Jiang, Taijiao] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100730, Peoples R China; [Sun, Jiya; Jiang, Taijiao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Jiya; Jiang, Taijiao] Suzhou Inst Syst Med, Suzhou, Peoples R China; [Jiang, Taijiao] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China","Zhang, JJ (reprint author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.",Pinghui.Feng@usc.edu,"Gao, Shou-Jiang/B-8641-2012","Gao, Shou-Jiang/0000-0001-6194-1742; Zhang, Junjie/0000-0003-3812-3850","NIH [CA134241, DE021445, AI105340]; ACS [RSG-11-162-01-MPC]; National Natural Science Foundation of China [81471963]; Norris Comprehensive Cancer grant [P30CA014089-35]","This work is supported by grant from NIH (CA134241, DE021445 and AI105340) and ACS (RSG-11-162-01-MPC) (PF), National Natural Science Foundation of China (81471963) (HFe), and core services performed through Norris Comprehensive Cancer grant P30CA014089-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,54,9,9,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005001,10.1371/journal.ppat.1005001,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900058,26107716.0,"DOAJ Gold, Green Published",,,16/08/2019,9,2,6,2962,698,487,211,2264,1781,20,463,6,2,0,0,10,10,0,,0,0,0,0,0,9,9,5,6,0,0,0,0,0,0,0,0,2,3024,50,0,53,106,0,2281,708,50,0,53,106,0,35,,0,0,0,0,3,0,0,0,0,0,0,8,0,0,1.25,4.243553008595988,1.308303886925795,0.3083038869257951,1.4045936395759717,1.073598919648886,4.555873925501433
590,J,"Campbell, GR; Rawat, P; Bruckman, RS; Spector, SA",,,,"Campbell, Grant R.; Rawat, Pratima; Bruckman, Rachel S.; Spector, Stephen A.",,,Human Immunodeficiency Virus Type 1 Nef Inhibits Autophagy through Transcription Factor EB Sequestration,PLOS PATHOGENS,,,English,Article,,,,,,,TOLL-LIKE RECEPTORS; HIV-1 INFECTION; BECLIN 1; LYSOSOMAL BIOGENESIS; TRIGGERS AUTOPHAGY; DENDRITIC CELLS; T-CELLS; MACROPHAGES; PROTEIN; LINKS,"HIV Nef acts as an anti-autophagic maturation factor through interaction with beclin-1 (BECN1). We report that exposure of macrophages to infectious or non-infectious purified HIV induces toll-like receptor 8 (TLR8) and BECN1 dependent dephosphorylation and nuclear translocation of TFEB and that this correlates with an increase in autophagy markers. RNA interference for ATG13, TFEB, TLR8, or BECN1 inhibits this HIV-induced autophagy. However, once HIV establishes a productive infection, TFEB phosphorylation and cytoplasmic sequestration are increased resulting in decreased autophagy markers. Moreover, by 7 d post-infection, autophagy levels are similar to mock infected controls. Conversely, although Nef deleted HIV similarly induces TFEB dephosphorylation and nuclear localization, and increases autophagy, these levels remain elevated during continued productive infection. Thus, the interaction between HIV and TLR8 serves as a signal for autophagy induction that is dependent upon the dephosphorylation and nuclear translocation of TFEB. During permissive infection, Nef binds BECN1 resulting in mammalian target of rapamycin (MTOR) activation, TFEB phosphorylation and cytosolic sequestration, and the inhibition of autophagy. To our knowledge, this is the first report of a virus modulating TFEB localization and helps to explain how HIV modulates autophagy to promote its own replication and cell survival.","[Campbell, Grant R.; Rawat, Pratima; Bruckman, Rachel S.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA USA","Campbell, GR (reprint author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA.",saspector@ucsd.edu,"Rawat, Pratima/F-5847-2017; Campbell, Grant/C-9018-2011; Rawat, Pratima/B-5615-2019","Campbell, Grant/0000-0003-3927-1994; ",National Institute of Neurological Disorders and Stroke [R01 NS084912]; California HIV/AIDS Research Program [ID12-SD-255],"This work was supported by the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) (R01 NS084912 to SAS), and the California HIV/AIDS Research Program (http://www.californiaaidsresearch.org/) (ID12-SD-255 to GRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,36,37,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005018,10.1371/journal.ppat.1005018,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900068,26115100.0,"DOAJ Gold, Green Published",,,16/08/2019,39,2,34,6773,1423,967,456,5350,4210,22,1118,33,2,0,0,39,39,0,,56,2,55,1,2,42,40,42,27,0,0,0,0,0,0,0,0,0,6767,92,0,373,68,1,5332,1423,92,0,373,68,1,12,,0,0,0,0,3,0,0,0,0,0,0,55,1,0,1.35,4.759662684469431,1.265981308411215,0.265981308411215,1.294766355140187,1.0227373394359958,4.867884750527056
591,J,"Chavez, L; Calvanese, V; Verdin, E",,,,"Chavez, Leonard; Calvanese, Vincenzo; Verdin, Eric",,,HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; INFECTION; REPLICATION; RESERVOIR; LYMPHOCYTES; SAMHD1; MEMORY; ENTRY; PERMISSIVENESS,"Highly active antiretroviral therapy (HAART) suppresses human immunodeficiency virus (HIV) replication to undetectable levels but cannot fully eradicate the virus because a small reservoir of CD4(+) T cells remains latently infected. Since HIV efficiently infects only activated CD4(+) T cells and since latent HIV primarily resides in resting CD4(+) T cells, it is generally assumed that latency is established when a productively infected cell recycles to a resting state, trapping the virus in a latent state. In this study, we use a dual reporter virus-HIV Duo-Fluo I, which identifies latently infected cells immediately after infection-to investigate how T cell activation affects the estab-lishment of HIV latency. We show that HIV latency can arise from the direct infection of both resting and activated CD4(+) T cells. Importantly, returning productively infected cells to a resting state is not associated with a significant silencing of the integrated HIV. We further show that resting CD4(+) T cells from human lymphoid tissue (tonsil, spleen) show increased latency after infection when compared to peripheral blood. Our findings raise significant questions regarding the most commonly accepted model for the establishment of latent HIV and suggest that infection of both resting and activated primary CD4(+) T cells produce latency.","[Chavez, Leonard; Calvanese, Vincenzo; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Chavez, Leonard] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA USA","Chavez, L (reprint author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.",everdin@gladstone.ucsf.edu,"Calvanese, Vincenzo/E-1145-2016","Calvanese, Vincenzo/0000-0002-7937-1511; Verdin, Eric/0000-0003-3703-3183; Chavez, Leonard/0000-0003-3226-0897",National Institute on Drug Abuse (NIDA) Avant-Garde award program [1DP1 DA031126]; NIDA [1R01 DA030216]; Collaboratory of AIDS Researchers for Eradication (CARE) [UNC/NIH-Federal-5-31532],"Funding for this project was provided by the National Institute on Drug Abuse (NIDA) Avant-Garde award program, 1DP1 DA031126 (http://www.drugabuse.gov); NIDA, 1R01 DA030216; and the Collaboratory of AIDS Researchers for Eradication (CARE), UNC/NIH-Federal-5-31532 (https://www.delaneycare.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,93,97,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004955,10.1371/journal.ppat.1004955,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900033,26067822.0,"DOAJ Gold, Green Published",,,16/08/2019,89,93,142,15944,1792,1306,486,14152,11639,29,2484,139,4,0,0,85,85,0,,200,8,194,3,8,93,90,93,52,0,0,0,0,0,0,0,90,5,16102,116,8,231,86,1,14233,1834,116,8,231,86,1,35,,0,0,0,0,24,0,4,2,0,0,0,191,3,0,17.95,8.897321428571429,1.1266252119841718,0.12662521198417184,1.152063312605992,1.0225790265930759,9.098214285714286
592,J,"Ding, PF; McFarland, KA; Jin, SJ; Tong, G; Duan, B; Yang, A; Hughes, TR; Liu, J; Dove, SL; Navarre, WW; Xia, B",,,,"Ding, Pengfei; McFarland, Kirsty A.; Jin, Shujuan; Tong, Grace; Duan, Bo; Yang, Ally; Hughes, Timothy R.; Liu, Jun; Dove, Simon L.; Navarre, William Wiley; Xia, Bin",,,A Novel AT-Rich DNA Recognition Mechanism for Bacterial Xenogeneic Silencer MvaT,PLOS PATHOGENS,,,English,Article,,,,,,,H-NS PROTEIN; NUCLEOID-ASSOCIATED PROTEIN; VIRULENCE GENE-EXPRESSION; FAMILY-MEMBER MVAT; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; FOREIGN DNA; MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTIONAL REGULATOR,"Bacterial xenogeneic silencing proteins selectively bind to and silence expression from many AT rich regions of the chromosome. They serve as master regulators of horizontally acquired DNA, including a large number of virulence genes. To date, three distinct families of xenogeneic silencers have been identified: H-NS of Proteobacteria, Lsr2 of the Actinomycetes, and MvaT of Pseudomonas sp. Although H-NS and Lsr2 family proteins are structurally different, they all recognize the AT-rich DNA minor groove through a common AT-hooklike motif, which is absent in the MvaT family. Thus, the DNA binding mechanism of MvaT has not been determined. Here, we report the characteristics of DNA sequences targeted by MvaT with protein binding microarrays, which indicates that MvaT prefers binding flexible DNA sequences with multiple TpA steps. We demonstrate that there are clear differences in sequence preferences between MvaT and the other two xenogeneic silencer families. We also determined the structure of the DNA-binding domain of MvaT in complex with a high affinity DNA dodecamer using solution NMR. This is the first experimental structure of a xenogeneic silencer in complex with DNA, which reveals that MvaT recognizes the AT-rich DNA both through base readout by an ""AT-pincer"" motif inserted into the minor groove and through shape readout by multiple lysine side chains interacting with the DNA sugar-phosphate backbone. Mutations of key MvaT residues for DNA binding confirm their importance with both in vitro and in vivo assays. This novel DNA binding mode enables MvaT to better tolerate GC-base pair interruptions in the binding site and less prefer A tract DNA when compared to H-NS and Lsr2. Comparison of MvaT with other bacterial xenogeneic silencers provides a clear picture that nature has evolved unique solutions for different bacterial genera to distinguish foreign from self DNA.","[Ding, Pengfei; Jin, Shujuan; Duan, Bo; Xia, Bin] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Sch Life Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [McFarland, Kirsty A.; Dove, Simon L.] Harvard Univ, Sch Med, Div Infect Dis, Boston Childrens Hosp, Boston, MA USA; [Tong, Grace; Yang, Ally; Hughes, Timothy R.; Liu, Jun; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada","Ding, PF (reprint author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Sch Life Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.",simon.dove@childrens.harvard.edu; william.navarre@utoronto.ca; binxia@pku.edu.cn,,"Liu, Jun/0000-0002-0522-6733; Ding, Pengfei/0000-0003-1824-724X; McFarland, Kirsty/0000-0003-2150-1771","National Basic Research Program of China 973 Program [2012CB910703]; Canada Institutes for Health Research [MOP-86683, MOP-111007]; National Institutes of Health [AI105013]; National Natural Science Foundation of China [31128005]; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC)","BX is supported by a grant from the National Basic Research Program of China 973 Program (2012CB910703) (www.most.gov.cn). WWN is supported by an Operating Grant from the Canada Institutes for Health Research (MOP-86683) (http://www.cihr-irsc.gc.ca/). SLD was supported by National Institutes of Health grant AI105013 (www.nih.gov). JL was supported by a grant from National Natural Science Foundation of China (31128005) (www.nsfc.gov.cn). TRH is supported by a grant from the Canada Institutes for Health Research (MOP-111007) (http://www.cihr-irsc.gc.ca/). GT is supported by an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,77,15,16,0,34,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004967,10.1371/journal.ppat.1004967,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900042,26068099.0,"DOAJ Gold, Green Published",,,16/08/2019,19,2,36,4827,986,773,213,3841,3120,24,697,36,2,0,0,18,18,0,,95,6,48,0,6,23,19,23,12,0,0,0,0,0,0,0,0,2,4824,77,0,377,106,2,3820,986,77,0,377,106,2,18,,0,0,0,0,3,0,0,1,0,0,0,48,0,0,2.75,4.895537525354969,1.2567039833376725,0.25670398333767247,1.3035667794845092,1.0372902423865755,5.078093306288032
593,J,"Fu, BS; Wang, LY; Ding, H; Schwamborn, JC; Li, ST; Dorf, ME",,,,"Fu, Bishi; Wang, Lingyan; Ding, Hao; Schwamborn, Jens C.; Li, Shitao; Dorf, Martin E.",,,TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase,PLOS PATHOGENS,,,English,Article,,,,,,,MUSCULAR-DYSTROPHY 2H; BARDET-BIEDL-SYNDROME; NEURAL STEM-CELLS; RNA-POLYMERASE; INTERACTION NETWORK; PROTEIN-KINASE; KAPPA-B; LIGASE; DIFFERENTIATION; MUTATION,"Polymerase basic protein 1 (PB1) is the catalytic core of the influenza A virus (IAV) RNA polymerase complex essential for viral transcription and replication. Understanding the intrinsic mechanisms which block PB1 function could stimulate development of new anti-influenza therapeutics. Affinity purification coupled with mass spectrometry (AP-MS) was used to identify host factors interacting with PB1. Among PB1 interactors, the E3 ubiquitin ligase TRIM32 interacts with PB1 proteins derived from multiple IAV strains. TRIM32 senses IAV infection by interacting with PB1 and translocates with PB1 to the nucleus following influenza infection. Ectopic TRIM32 expression attenuates IAV infection. Conversely, RNAi depletion and knockout of TRIM32 increase susceptibility of tracheal and lung epithelial cells to IAV infection. Reconstitution of trim32(-/-) mouse embryonic fibroblasts with TRIM32, but not a catalytically inactive mutant, restores viral restriction. Furthermore, TRIM32 directly ubiquitinates PB1, leading to PB1 protein degradation and subsequent reduction of polymerase activity. Thus, TRIM32 is an intrinsic IAV restriction factor which senses and targets the PB1 polymerase for ubiquitination and protein degradation. TRIM32 represents a model of intrinsic immunity, in which a host protein directly senses and counters viral infection in a species specific fashion by directly limiting viral replication.","[Fu, Bishi; Wang, Lingyan; Dorf, Martin E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Schwamborn, Jens C.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Li, Shitao] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA","Fu, BS (reprint author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA.",lishitao@hotmail.com; dorf@hms.harvard.edu,"Schwamborn, Jens C/F-9395-2011","Schwamborn, Jens C/0000-0003-4496-0559; Li, Shitao/0000-0002-1398-8519","NIH from Boehringer Ingelheim, Corp [AI089829, AI099860]","This work was supported by NIH grants AI089829 (MED) and AI099860 (MED) plus a grant from Boehringer Ingelheim, Corp (SL and MED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,40,40,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004960,10.1371/journal.ppat.1004960,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900036,26057645.0,"DOAJ Gold, Green Published",,,16/08/2019,39,18,40,6538,1319,908,411,5219,3902,25,1292,40,8,0,0,38,38,0,,55,0,55,0,0,39,39,32,28,0,0,0,0,0,0,0,10,5,6530,109,0,445,123,0,5198,1319,109,0,445,123,0,13,,0,0,0,0,8,0,3,1,0,0,0,55,0,0,4.75,4.956785443517816,1.2527304081241617,0.2527304081241617,1.2956505077601073,1.0342612419700214,5.12661106899166
594,J,"Gall, AM; Marinas, BJ; Lu, Y; Shisler, JL",,,,"Gall, Aimee M.; Marinas, Benito J.; Lu, Yi; Shisler, Joanna L.",,,Waterborne Viruses: A Barrier to Safe Drinking Water,PLOS PATHOGENS,,,English,Article,,,,,,,STRUCTURAL INTEGRITY; DISINFECTION; MECHANISMS; PROTEIN; DNA,,"[Gall, Aimee M.; Marinas, Benito J.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Gall, Aimee M.; Marinas, Benito J.; Lu, Yi; Shisler, Joanna L.] Univ Illinois, Safe Global Water Inst, Urbana, IL 61801 USA; [Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Shisler, Joanna L.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Shisler, Joanna L.] Univ Illinois, Coll Med, Urbana, IL 61801 USA","Gall, AM (reprint author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.",jshisler@illinois.edu,"Lu, Yi/B-5461-2010","Lu, Yi/0000-0003-1221-6709; Shisler, Joanna/0000-0003-4833-1557","Center of Advanced Materials for the Purification of Water with Systems (WaterCAMPWS), a National Science Foundation Science and Technology Center [CTS-0120978]; National Science Foundation Graduate Research Fellowship Program [DGE-1144245]; University of Illinois at Urbana-Champaign Institute for Sustainability Energy and Environment (iSEE)","This material is based upon work supported by the Center of Advanced Materials for the Purification of Water with Systems (WaterCAMPWS), a National Science Foundation Science and Technology Center, under award no. CTS-0120978, the National Science Foundation Graduate Research Fellowship Program under grant no. DGE-1144245, and the University of Illinois at Urbana-Champaign Institute for Sustainability Energy and Environment (iSEE). Any opinions, findings, and conclusions or recommendations expressed in this manuscript are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,29,28,29,2,23,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004867,10.1371/journal.ppat.1004867,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900012,26110535.0,"DOAJ Gold, Green Published",,,16/08/2019,34,16,65,29268,3542,3189,353,25726,23518,37,2171,65,11,1,0,28,28,0,,118,118,118,0,118,39,39,26,1,0,0,0,0,0,0,1,12,2,30944,6,4,58,960,30,26115,4043,6,4,58,960,30,786,,0,0,0,1,23,0,2,1,0,0,0,117,0,0,17.95,8.263128176171655,1.1376817227707379,0.13768172277073779,1.2403793827256473,1.0902692360256936,9.009034443817052
595,J,"Hill, TM; Gilchuk, P; Cicek, BB; Osina, MA; Boyd, KL; Durrant, DM; Metzger, DW; Khanna, KM; Joyce, S",,,,"Hill, Timothy M.; Gilchuk, Pavlo; Cicek, Basak B.; Osina, Maria A.; Boyd, Kelli L.; Durrant, Douglas M.; Metzger, Dennis W.; Khanna, Kamal M.; Joyce, Sebastian",,,Border Patrol Gone Awry: Lung NKT Cell Activation by Francisella tularensis Exacerbates Tularemia-Like Disease,PLOS PATHOGENS,,,English,Article,,,,,,,LIVE VACCINE STRAIN; KILLER T-CELLS; NATURAL-KILLER; PULMONARY INFECTION; RESPIRATORY-INFECTION; C57BL/6 MICE; PROTECTION; IMMUNITY; NEUTROPHILS; PATHOGEN,"The respiratory mucosa is a major site for pathogen invasion and, hence, a site requiring constant immune surveillance. The type I, semi-invariant natural killer T (NKT) cells are enriched within the lung vasculature. Despite optimal positioning, the role of NKT cells in respiratory infectious diseases remains poorly understood. Hence, we assessed their function in a murine model of pulmonary tularemia-because tularemia is a sepsis-like proinflammatory disease and NKT cells are known to control the cellular and humoral responses underlying sepsis. Here we show for the first time that respiratory infection with Francisella tularensis live vaccine strain resulted in rapid accumulation of NKT cells within the lung interstitium. Activated NKT cells produced interferon-gamma and promoted both local and systemic proinflammatory responses. Consistent with these results, NKT cell-deficient mice showed reduced inflammatory cytokine and chemokine response yet they survived the infection better than their wild type counterparts. Strikingly, NKT cell-deficient mice had increased lymphocytic infiltration in the lungs that organized into tertiary lymphoid structures resembling induced bronchus-associated lymphoid tissue (iBALT) at the peak of infection. Thus, NKT cell activation by F. tularensis infection hampers iBALT formation and promotes a systemic proinflammatory response, which exacerbates severe pulmonary tularemia-like disease in mice.","[Hill, Timothy M.; Gilchuk, Pavlo; Joyce, Sebastian] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Gilchuk, Pavlo; Boyd, Kelli L.; Joyce, Sebastian] Vet Adm Tennessee Valley Healthcare Syst, Nashville, TN USA; [Cicek, Basak B.; Khanna, Kamal M.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Osina, Maria A.] Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN 37235 USA; [Durrant, Douglas M.; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA","Hill, TM (reprint author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.",sebastian.joyce@vanderbilt.edu,"Metzger, Dennis W/I-2771-2019","Metzger, Dennis W/0000-0002-8000-9907; JOYCE, Sebastian/0000-0002-3183-1451","VA Merit Award [BX001444]; Core Grants [CA068485, DK058404]; US Army;  [AI042284];  [HL121139];  [AI097375]","Supported by a VA Merit Award (BX001444) as well as Research Grants (AI042284, HL121139, and AI097375), and Core Grants (CA068485 and DK058404). TMH is supported by the US Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,83,10,10,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004975,10.1371/journal.ppat.1004975,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900046,26068662.0,"DOAJ Gold, Green Published",,,16/08/2019,11,21,22,3088,435,327,108,2653,2213,25,415,22,0,0,0,10,10,0,,26,9,26,0,9,12,11,12,8,0,0,0,0,0,0,0,21,3,3112,87,0,69,126,4,2645,435,54,0,69,124,4,32,,0,0,0,0,4,0,0,1,0,0,0,27,0,0,2.0,7.098850574712643,1.163965322276668,0.16396532227666794,1.2532981530343008,1.0767487046632125,7.64367816091954
596,J,"Kang, D; Skalsky, RL; Cullen, BR",,,,"Kang, Dong; Skalsky, Rebecca L.; Cullen, Bryan R.",,,EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival,PLOS PATHOGENS,,,English,Article,,,,,,,GASTRIC-CARCINOMA; NASOPHARYNGEAL CARCINOMA; PAR-CLIP; VIRUS; EXPRESSION; IDENTIFICATION; PROGRESSION; SUPPRESSOR; INFECTION; LYMPHOMA,"Epstein-Barr virus (EBV) is a ubiquitous human.-herpesvirus that can give rise to cancers of both B-cell and epithelial cell origin. In EBV-induced cancers of epithelial origin, including nasopharyngeal carcinomas (NPCs) and gastric carcinomas, the latent EBV genome expresses very high levels of a cluster of 22 viral pre-miRNAs, called the miR-BARTs, and these have previously been shown to confer a degree of resistance to pro-apoptotic drugs. Here, we present an analysis of the ability of individual miR-BART pre-miRNAs to confer an anti-apoptotic phenotype and report that five of the 22 miR-BARTs demonstrate this ability. We next used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) to globally identify the mRNA targets bound by these miR-BARTs in latently infected epithelial cells. This led to the identification of ten mRNAs encoding proapoptotic mRNA targets, all of which could be confirmed as valid targets for the five anti-apoptotic miR-BARTs by indicator assays and by demonstrating that ectopic expression of physiological levels of the relevant miR-BART in the epithelial cell line AGS resulted in a significant repression of the target mRNA as well as the encoded protein product. Using RNA interference, we further demonstrated that knockdown of at least seven of these cellular miR-BART target transcripts phenocopies the anti-apoptotic activity seen upon expression of the relevant EBV miR-BART miRNA. Together, these observations validate previously published reports arguing that the miR-BARTs can exert an anti-apoptotic effect in EBV-infected epithelial cells and provide a mechanistic explanation for this activity. Moreover, these results identify and validate a substantial number of novel mRNA targets for the antiapoptotic miR-BARTs.","[Kang, Dong; Skalsky, Rebecca L.; Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Kang, Dong; Skalsky, Rebecca L.; Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC USA","Kang, D (reprint author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA.",bryan.cullen@duke.edu,,,National Institutes of Health [R01-AI067968]; Duke Center for AIDS Research (CFAR) [P30-AI064518];  [T32-CA009111],"This research was supported by National Institutes of Health grant R01-AI067968 to BRC. RLS was supported by T32-CA009111 and by a small grant from the Duke Center for AIDS Research (CFAR) (P30-AI064518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,47,46,48,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004979,10.1371/journal.ppat.1004979,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900048,26070070.0,"DOAJ Gold, Green Published",,,16/08/2019,48,28,34,6892,1395,1011,384,5497,4521,24,952,34,0,0,0,37,37,0,,49,1,49,0,1,49,49,29,29,0,0,0,0,0,0,0,28,1,6897,142,0,103,55,0,5481,1395,142,0,103,55,0,21,,0,0,0,0,1,0,0,1,0,0,0,49,0,0,0.5,4.940501792114695,1.2537747862470439,0.25377478624704386,1.2905221029652538,1.0293093441671504,5.085304659498208
597,J,"Lurie-Weinberger, MN; Gophna, U",,,,"Lurie-Weinberger, Mor N.; Gophna, Uri",,,Archaea in and on the Human Body: Health Implications and Future Directions,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN SUBGINGIVAL PLAQUE; LATERAL GENE-TRANSFER; HUMAN GUT; METHANOBREVIBACTER-SMITHII; GENOME SEQUENCE; METHANOSPHAERA-STADTMANAE; 7TH ORDER; METHANOGENIC BACTERIA; MICROBIAL-FLORA; DENTAL PLAQUE,"Although they are abundant and even dominant members of animal microbiomes (microbiotas), from sponges and termites to mice and cattle, archaea in our own microbiomes have received much less attention than their bacterial counterparts. The fact that human-associated archaea have been relatively little-studied may be at least partially attributed to the lack of any established archaeal human pathogens [1,2]. Clinically oriented microbiology courses often do not mention archaea at all, and most medical school and biology students are only aware of archaea as exotic extremophiles that have strange and eukaryotic-like molecular machinery. Since archaea have been known to be associated with the human gut for several decades, one would think that human microbiome studies may unravel new facets of archaea-human interactions. However, adequate universal primers that amplify both bacterial and archaeal small 16S rRNA genes but not any host rRNA genes were only published in mid-2011 [3], and thus, many studies chose to focus on bacteria alone rather than multiply effort and expense to cover taxa that are considered secondary in importance, if not altogether rare. Here, we provide a brief overview of what is currently known about archaea in and on the human body and their potential effects on human health (for additional reviews on archaea and their potential involvement in human disease, see [4-8]).","[Lurie-Weinberger, Mor N.; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel","Lurie-Weinberger, MN (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.",urigo@tauex.tau.ac.il,,"Gophna, Uri/0000-0001-5129-5652",,,,64,23,23,0,38,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004833,10.1371/journal.ppat.1004833,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900005,26066650.0,"DOAJ Gold, Green Published",,,16/08/2019,26,46,80,28718,4810,4496,314,23908,21344,61,2503,80,34,4,0,26,26,0,,107,36,107,0,36,33,26,33,13,0,0,3,0,0,3,4,48,15,29503,14,22,111,267,5,24411,4917,14,22,111,267,5,175,,9,2,0,0,38,0,1,1,0,0,0,110,0,0,107.876,5.97047817047817,1.2011878868997825,0.2011878868997825,1.2457754726451398,1.0371195765721848,6.192099792099792
598,J,"Ma, WJ; Garcia-Sastre, A; Schwemmle, M",,,,"Ma, Wenjun; Garcia-Sastre, Adolfo; Schwemmle, Martin",,,Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses,PLOS PATHOGENS,,,English,Article,,,,,,,POLYMERASE; SITE,"Influenza A viruses (IAVs) are important zoonotic pathogens that cause epidemic outbreaks in poultry, wild birds, swine, and other mammals. In humans, IAVs cause severe respiratory illness, and zoonotic transmission of IAVs from avian reservoirs poses a constant threat to the public health, as exemplified by the recent outbreak of an avian IAV of the H7N9 subtype [1]. Aquatic birds are considered to be the major reservoir of IAVs, and 16 hemagglutinin (HA) and nine neuraminidase (NA) viral subtypes have been isolated from avian species to date. It is now well documented that from time to time IAVs overcome the species barrier and establish new lineages in other animals, including domestic animals, sea mammals, and humans (Fig 1). Our understanding of IAVs was recently challenged by the identification of two novel genome sequences of influenza A-like viruses from bat specimens by next-generation sequencing. These viruses were provisionally designated ""H17N10"" (from yellow-shouldered fruit bats [Sturnira lilium] in Guatemala) and ""H18N11"" (from flat-faced fruit bats [Artibeus planirostris] in Peru) [2,3], which might signal an expansion of IAV host range (Fig 1).","[Ma, Wenjun] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Schwemmle, Martin] Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany","Ma, WJ (reprint author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.",wma@vet.k-state.edu; Adolfo.Garcia-Sastre@mssm.edu; martin.schwemmle@uniklinik-freiburg.de,,"Garcia-Sastre, Adolfo/0000-0002-6551-1827","European Commission [FP7-GA258084]; CEIRS (Center of Excellence for Influenza Research and Surveillance) program of the National Institute of Allergy and Infectious Disease (NIAID), National Institute of Health (CEIRS) [HHSN272201400006C]; CRIP (Center for Research on Influenza Pathogenesis) under the CEIRS NIAID program (CEIRS) [HHSN272201400008C]; German Research Foundation (DFG)","Work on influenza virus is supported to WM by the European Commission (FP7-GA258084) and the CEIRS (Center of Excellence for Influenza Research and Surveillance) program of the National Institute of Allergy and Infectious Disease (NIAID), National Institute of Health (CEIRS contract # HHSN272201400006C); to AGS by CRIP (Center for Research on Influenza Pathogenesis), also under the CEIRS NIAID program (CEIRS contract # HHSN272201400008C); and to MS by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,16,18,19,0,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004819,10.1371/journal.ppat.1004819,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900001,26042416.0,"DOAJ Gold, Green Published",,,16/08/2019,16,8,43,5465,752,512,240,4713,3737,30,946,43,4,0,0,17,17,1,,62,4,62,0,4,17,17,14,12,0,0,0,0,0,0,1,4,4,5459,3,4,31,51,0,4681,752,3,4,31,51,0,26,,1,2,1,0,9,0,1,1,0,0,0,62,0,0,28.31,7.267287234042553,1.159558667515383,0.15955866751538297,1.1697432633142373,1.008783165599268,7.3311170212765955
599,J,"Markus, A; Lebenthal-Loinger, I; Yang, IH; Kinchington, PR; Goldstein, RS",,,,"Markus, Amos; Lebenthal-Loinger, Ilana; Yang, In Hong; Kinchington, Paul R.; Goldstein, Ronald S.",,,An In Vitro Model of Latency and Reactivation of Varicella Zoster Virus in Human Stem Cell-Derived Neurons,PLOS PATHOGENS,,,English,Article,,,,,,,HERPES-SIMPLEX-VIRUS; DORSAL-ROOT GANGLIA; PRODUCTIVE INFECTION; VIRAL REPLICATION; SENSORY NEURONS; HSV-1 LATENCY; TRANSCRIPTION; MECHANISMS; PROTEIN; EXPRESSION,"Varicella zoster virus (VZV) latency in sensory and autonomic neurons has remained enigmatic and difficult to study, and experimental reactivation has not yet been achieved. We have previously shown that human embryonic stem cell (hESC)-derived neurons are permissive to a productive and spreading VZV infection. We now demonstrate that hESC-derived neurons can also host a persistent non-productive infection lasting for weeks which can subsequently be reactivated by multiple experimental stimuli. Quiescent infections were established by exposing neurons to low titer cell-free VZV either by using acyclovir or by infection of axons in compartmented microfluidic chambers without acyclovir. VZV DNA and low levels of viral transcription were detectable by qPCR for up to seven weeks. Quiescently-infected human neuronal cultures were induced to undergo renewed viral gene and protein expression by growth factor removal or by inhibition of PI3-Kinase activity. Strikingly, incubation of cultures induced to reactivate at a lower temperature (34 degrees C) resulted in enhanced VZV reactivation, resulting in spreading, productive infections. Comparison of VZV genome transcription in quiescently-infected to productively-infected neurons using RNA-Seq revealed preferential transcription from specific genome regions, especially the duplicated regions. These experiments establish a powerful new system for modeling the VZV latent state, and reveal a potential role for temperature in VZV reactivation and disease.","[Markus, Amos; Lebenthal-Loinger, Ilana; Goldstein, Ronald S.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Yang, In Hong] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Yang, In Hong] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Singapore 117548, Singapore; [Kinchington, Paul R.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Kinchington, Paul R.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA","Markus, A (reprint author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.",ron.goldstein@biu.ac.il,,"Yang, In Hong/0000-0002-1020-0538",Israel Science Foundation [238/11]; National Institutes of Health [NS082662]; United States-Israel Binational Science Foundation [2013072]; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness; CORE grant for vision research [EY08098]; Maximilian Goode Foundation,"This work was funded by the Israel Science Foundation, http://www.isf.org.il/, 238/11, to RSG; the National Institutes of Health, NS082662, http://www.nih.gov/, to PRK, RSG; the United States-Israel Binational Science Foundation, http://bsf.org.il/BSFPublic/Default.aspx, 2013072, to RSG, PRK; the Eye and Ear Foundation of Pittsburgh, http://www.eyeandear.org/, to PRK; Research to Prevent Blindness, http://www.rpbusa.org/rpb/, to PRK; CORE grant for vision research, https://www.nei.nih.gov/funding/, EY08098, to PRK; the Maximilian Goode Foundation, donation, to RSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,25,25,1,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004885,10.1371/journal.ppat.1004885,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900017,26042814.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,24,9,31,6238,1312,960,352,4926,4061,22,843,31,6,0,1,23,23,4,,45,3,45,0,3,28,24,28,20,0,0,0,0,0,0,0,3,10,6301,115,25,85,133,2,4912,1312,47,25,85,133,2,77,,1,1,0,0,16,0,0,1,1,0,0,45,0,0,22.458,4.754573170731708,1.2663418595209095,0.26634185952090944,1.3294762484774665,1.0498557229881371,4.991615853658536
600,J,"Marty, AJ; Broman, AT; Zarnowski, R; Dwyer, TG; Bond, LM; Sahraoui, ALH; Fontaine, J; Ntambi, JM; Keles, S; Kendziorski, C; Gauthier, GM",,,,"Marty, Amber J.; Broman, Aimee T.; Zarnowski, Robert; Dwyer, Teigan G.; Bond, Laura M.; Sahraoui, Anissa Lounes-Hadj; Fontaine, Joeal; Ntambi, James M.; Keles, Suenduez; Kendziorski, Christina; Gauthier, Gregory M.",,,"Fungal Morphology, Iron Homeostasis, and Lipid Metabolism Regulated by a GATA Transcription Factor in Blastomyces dermatitidis",PLOS PATHOGENS,,,English,Article,,,,,,,PATHOGEN HISTOPLASMA-CAPSULATUM; CELL-WALL COMPOSITION; SCHIZOSACCHAROMYCES-POMBE; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; MYCELIAL FORMS; DNA-BINDING; PARACOCCIDIOIDES-BRASILIENSIS; SIDEROPHORE BIOSYNTHESIS,"In response to temperature, Blastomyces dermatitidis converts between yeast and mold forms. Knowledge of the mechanism(s) underlying this response to temperature remains limited. In B. dermatitidis, we identified a GATA transcription factor, SREB, important for the transition to mold. Null mutants (SREB.) fail to fully complete the conversion to mold and cannot properly regulate siderophore biosynthesis. To capture the transcriptional response regulated by SREB early in the phase transition (0-48 hours), gene expression microarrays were used to compare SREB. to an isogenic wild type isolate. Analysis of the time course microarray data demonstrated SREB functioned as a transcriptional regulator at 37 degrees C and 22 degrees C. Bioinformatic and biochemical analyses indicated SREB was involved in diverse biological processes including iron homeostasis, biosynthesis of triacylglycerol and ergosterol, and lipid droplet formation. Integration of microarray data, bioinformatics, and chromatin immunoprecipitation identified a subset of genes directly bound and regulated by SREB in vivo in yeast (37 degrees C) and during the phase transition to mold (22 degrees C). This included genes involved with siderophore biosynthesis and uptake, iron homeostasis, and genes unrelated to iron assimilation. Functional analysis suggested that lipid droplets were actively metabolized during the phase transition and lipid metabolism may contribute to filamentous growth at 22 degrees C. Chromatin immunoprecipitation, RNA interference, and overexpression analyses suggested that SREB was in a negative regulatory circuit with the bZIP transcription factor encoded by HAPX. Both SREB and HAPX affected morphogenesis at 22 degrees C; however, large changes in transcript abundance by gene deletion for SREB or strong overexpression for HAPX were required to alter the phase transition.","[Marty, Amber J.; Zarnowski, Robert; Dwyer, Teigan G.; Gauthier, Gregory M.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Broman, Aimee T.; Keles, Suenduez; Kendziorski, Christina] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Bond, Laura M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Sahraoui, Anissa Lounes-Hadj; Fontaine, Joeal] Univ Littoral Cote dOpale, Unit Chim Environm & Interact Vivant, Calais, France; [Ntambi, James M.] Univ Wisconsin, Dept Biochem, Dept Nutr Sci, Madison, WI 53705 USA; [Keles, Suenduez] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA","Marty, AJ (reprint author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.",gmg@medicine.wisc.edu,"Zarnowski, Robert/A-2786-2009","Zarnowski, Robert/0000-0001-6343-1500","National Institutes of Health [5K08AI071004, K08AI071004-04S1, 1R21AI105537]; American Diabetes Association [7-13-BS-118]; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427];  [NHGRI - HG003747]","Funding sources for GMG included 5K08AI071004, K08AI071004-04S1 (American Recovery and Reinvestment Act Supplement), and 1R21AI105537 from the National Institutes of Health. Funding source for LMB included T32 GM07215 from the National Institutes of Health. Funding source for JMN included 7-13-BS-118 from the American Diabetes Association. Funding source for SK included NHGRI - HG003747. Funding source for ATB and CK included a Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,89,7,7,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004959,10.1371/journal.ppat.1004959,,,,40,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900035,26114571.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,25,3907,844,643,201,3063,2410,25,628,25,0,0,0,8,8,0,,30,4,30,0,4,9,8,9,3,0,0,0,0,0,0,0,0,0,3999,172,0,171,177,1,3099,851,172,0,171,177,1,49,,0,0,0,0,2,0,0,0,0,0,0,29,0,0,0.5,4.62914691943128,1.2755468494939601,0.2755468494939602,1.4195233431276526,1.1128743281289992,5.151658767772512
601,J,"Nguyen, MT; Kraft, B; Yu, WQ; Demicrioglu, DD; Hertlein, T; Burian, M; Schmaler, M; Boller, K; Bekeredjian-Ding, I; Ohlsen, K; Schittek, B; Gotz, F",,,,"Minh Thu Nguyen; Kraft, Beatrice; Yu, Wenqi; Demicrioglu, Dogan Doruk; Hertlein, Tobias; Burian, Marc; Schmaler, Mathias; Boller, Klaus; Bekeredjian-Ding, Isabelle; Ohlsen, Knut; Schittek, Birgit; Goetz, Friedrich",,,The vSa alpha Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells,PLOS PATHOGENS,,,English,Article,,,,,,,RESISTANT STAPHYLOCOCCUS-AUREUS; FIBRONECTIN-BINDING PROTEIN; TOLL-LIKE RECEPTOR-2; BACTERIAL LIPOPROTEINS; EPITHELIAL-CELLS; GENOME SEQUENCE; INTERNALIZATION; ACTIVATION; MECHANISMS; EVOLUTION,"All Staphylococcus aureus genomes contain a genomic island, which is termed vSa alpha and characterized by two clusters of tandem repeat sequences, i.e. the exotoxin (set) and 'lipoprotein-like' genes (lpl). Based on their structural similarities the vSa alpha islands have been classified as type I to IV. The genomes of highly pathogenic and particularly epidemic S. aureus strains (USA300, N315, Mu50, NCTC8325, Newman, COL, JH1 or JH9) belonging to the clonal complexes CC5 and CC8 bear a type I vSa alpha island. Since the contribution of the lpl gene cluster encoded in the vSa alpha island to virulence is unclear to date, we deleted the entire lpl gene cluster in S. aureus USA300. The results showed that the mutant was deficient in the stimulation of pro-inflammatory cytokines in human monocytes, macrophages and keratinocytes. Purified lipoprotein Lpl1 was further shown to elicit a TLR2-dependent response. Furthermore, heterologous expression of the USA300 lpl cluster in other S. aureus strains enhanced their immune stimulatory activity. Most importantly, the lpl cluster contributed to invasion of S. aureus into human keratinocytes and mouse skin and the non-invasive S. carnosus expressing the lpl gene cluster became invasive. Additionally, in a murine kidney abscess model the bacterial burden in the kidneys was higher in wild type than in mutant mice. In this infection model the lpl cluster, thus, contributes to virulence. The present report is one of the first studies addressing the role of the vSa alpha encoded lpl gene cluster in staphylococcal virulence. The finding that the lpl gene cluster contributes to internalization into non-professional antigen presenting cells such as keratinocytes high-lights the lpl as a new cell surface component that triggers host cell invasion by S. aureus. Increased invasion in murine skin and an increased bacterial burden in a murine kidney abscess model suggest that the lpl gene cluster serves as an important virulence factor.","[Minh Thu Nguyen; Yu, Wenqi; Demicrioglu, Dogan Doruk; Goetz, Friedrich] Univ Tubingen, Dept Microbial Genet, Tubingen, Germany; [Kraft, Beatrice; Burian, Marc; Schittek, Birgit] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Hertlein, Tobias; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Schmaler, Mathias] Univ Basel, Dept Biomed, Immunoregulat, Basel, Switzerland; [Schmaler, Mathias] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Boller, Klaus; Bekeredjian-Ding, Isabelle] Fed Regulatory Agcy Vaccines & Biomed, Paul Ehrlich Inst, Langen, Germany; [Bekeredjian-Ding, Isabelle] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany","Nguyen, MT (reprint author), Univ Tubingen, Dept Microbial Genet, Tubingen, Germany.",friedrich.goetz@uni-tuebingen.de,"Bekeredjian-Ding, Isabelle/I-6197-2013; Nguyen, Minh-Thu/A-3964-2019","Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Nguyen, Minh-Thu/0000-0001-6510-0684","Deutsche Forschungsgemeinschaft (DFG) [GO 371/9-1, SFB 766, TRR34 A3, Z3, SCHI510/7-1, SCHI510/8-1, BE3841/2-1]; Tuebingen University","This work was supported by the Deutsche Forschungsgemeinschaft (DFG): GO 371/9-1, SFB 766, TRR34 A3 and Z3, SCHI510/7-1, SCHI510/8-1, BE3841/2-1 and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,31,32,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004984,10.1371/journal.ppat.1004984,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900051,26083414.0,"DOAJ Gold, Green Published",,,16/08/2019,36,3,28,4079,586,477,109,3493,2923,27,543,28,2,0,0,29,29,0,,39,0,39,0,0,38,38,33,17,0,0,0,0,0,0,0,1,4,4087,72,0,104,78,0,3473,586,72,0,104,78,0,28,,0,0,0,0,6,0,1,1,0,0,0,39,0,0,2.25,6.960750853242321,1.1677640996278271,0.1677640996278271,1.212997423418265,1.0387349840647218,7.23037542662116
602,J,"Nilsson, SK; Childs, LM; Buckee, C; Marti, M",,,,"Nilsson, Sandra K.; Childs, Lauren M.; Buckee, Caroline; Marti, Matthias",,,Targeting Human Transmission Biology for Malaria Elimination,PLOS PATHOGENS,,,English,Review,,,,,,,PLASMODIUM-FALCIPARUM-GAMETOCYTES; RED-BLOOD-CELLS; BONE-MARROW; ANOPHELES-GAMBIAE; SEXUAL DEVELOPMENT; REPRODUCTIVE RESTRAINT; POPULATION-STRUCTURE; TRANSCRIPTION FACTOR; IN-VITRO; PARASITES,"Malaria remains one of the leading causes of death worldwide, despite decades of public health efforts. The recent commitment by many endemic countries to eliminate malaria marks a shift away from programs aimed at controlling disease burden towards one that emphasizes reducing transmission of the most virulent human malaria parasite, Plasmodium falciparum. Gametocytes, the only developmental stage of malaria parasites able to infect mosquitoes, have remained understudied, as they occur in low numbers, do not cause disease, and are difficult to detect in vivo by conventional methods. Here, we review the transmission biology of P. falciparum gametocytes, featuring important recent discoveries of genes affecting parasite commitment to gametocyte formation, microvesicles enabling parasites to communicate with each other, and the anatomical site where immature gametocytes develop. We propose potential parasite targets for future intervention and highlight remaining knowledge gaps.","[Nilsson, Sandra K.; Marti, Matthias] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Childs, Lauren M.; Buckee, Caroline] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam & Dept Epidemiol, Boston, MA USA","Nilsson, SK (reprint author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.",cbuckee@hsph.harvard.edu; mmarti@hsph.harvard.edu,,"Childs, Lauren/0000-0003-3904-3895","National Institutes of Health [5R01AI077558, 1R21AI105328]; Svenska Sallskapet for Medicinsk Forskning (Sweden); American Heart Association; Burroughs Wellcome Fund; National Institute Of General Medical Sciences [U54GM088558]","The authors are supported by grants 5R01AI077558 and 1R21AI105328 from the National Institutes of Health (SKN, MM), postdoctoral fellowships from the Svenska Sallskapet for Medicinsk Forskning (Sweden) and the American Heart Association (SKN), a career development award from the Burroughs Wellcome Fund (MM), and Award Number U54GM088558 from the National Institute Of General Medical Sciences (LMC, CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,104,36,37,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004871,10.1371/journal.ppat.1004871,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900014,26086192.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,37,67,117,10507,1519,995,524,8988,5593,33,3362,116,51,0,0,39,39,1,,159,8,159,0,8,41,37,41,26,0,0,0,0,0,0,1,18,17,10733,953,0,12164,164,4,9060,1563,953,0,12164,164,4,110,,1,0,0,0,15,0,3,1,0,0,0,166,0,0,18.3,6.917050691244239,1.1690031152647975,0.1690031152647975,1.3184245660881175,1.1278195488721805,7.8011849901250825
603,J,"Seed, KD",,,,"Seed, Kimberley D.",,,Battling Phages: How Bacteria Defend against Viral Attack,PLOS PATHOGENS,,,English,Article,,,,,,,PATHOGENICITY ISLAND INTERFERENCE; ABORTIVE INFECTION SYSTEM; PROTEIN; RESTRICTION; BACTERIOPHAGES; TRANSCRIPTION; MECHANISMS; ENCODES; ENZYMES; BIOLOGY,,"Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA","Seed, KD (reprint author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.",kdseed@umich.edu,,,,,,28,53,55,2,28,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004847,10.1371/journal.ppat.1004847,,,,5,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900007,26066799.0,"DOAJ Gold, Green Published",,,16/08/2019,57,50,185,28550,10262,9325,937,18288,15578,32,2678,185,37,0,0,54,54,0,,289,14,289,0,14,57,57,32,33,0,0,0,0,0,0,0,16,19,28533,10,50,35,113,4,18198,10262,10,50,35,113,4,73,,0,1,0,0,53,0,2,1,0,0,0,288,0,0,37.516,2.7821087507308517,1.561132983377078,0.5611329833770778,1.5669291338582678,1.0037127845884413,2.792438121223933
604,J,"Sei, JJ; Haskett, S; Kaminsky, LW; Lin, E; Truckenmiller, ME; Bellone, CJ; Buller, RM; Norbury, CC",,,,"Sei, Janet J.; Haskett, Scott; Kaminsky, Lauren W.; Lin, Eugene; Truckenmiller, Mary E.; Bellone, Clifford J.; Buller, R. Mark; Norbury, Christopher C.",,,"Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation",PLOS PATHOGENS,,,English,Article,,,,,,,CD8-ALPHA(+) DENDRITIC CELLS; CD8(+) T-CELLS; ANTIVIRAL IMMUNITY; CROSS-PRESENTATION; CUTTING EDGE; VIRUS; INFECTION; VIVO; MATURATION; CTL,"Naive anti-viral CD8(+) T cells (TCD8+) are activated by the presence of peptide-MHC Class I complexes (pMHC-I) on the surface of professional antigen presenting cells (pAPC). Increasing the number of pMHC-I in vivo can increase the number of responding TCD8+. Antigen can be presented directly or indirectly (cross presentation) from virus-infected and uninfected cells, respectively. Here we determined the relative importance of these two antigen presenting pathways in mousepox, a natural disease of the mouse caused by the poxvirus, ectromelia (ECTV). We demonstrated that ECTV infected several pAPC types (macrophages, B cells, and dendritic cells (DC), including DC subsets), which directly presented pMHC-I to naive TCD8+ with similar efficiencies in vitro. We also provided evidence that these same cell-types presented antigen in vivo, as they form contacts with antigen-specific TCD8+. Importantly, the number of pMHC-I on infected pAPC (direct presentation) vastly outnumbered those on uninfected cells (cross presentation), where presentation only occurred in a specialized subset of DC. In addition, prior maturation of DC failed to enhance antigen presentation, but markedly inhibited ECTV infection of DC. These results suggest that direct antigen presentation is the dominant pathway in mice during mousepox. In a broader context, these findings indicate that if a virus infects a pAPC then the presentation by that cell is likely to dominate over cross presentation as the most effective mode of generating large quantities of pMHC-I is on the surface of pAPC that endogenously express antigens. Recent trends in vaccine design have focused upon the introduction of exogenous antigens into the MHC Class I processing pathway (cross presentation) in specific pAPC populations. However, use of a pantropic viral vector that targets pAPC to express antigen endogenously likely represents a more effective vaccine strategy than the targeting of exogenous antigen to a limiting pAPC subpopulation.","[Sei, Janet J.; Kaminsky, Lauren W.; Lin, Eugene; Truckenmiller, Mary E.; Norbury, Christopher C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Haskett, Scott; Bellone, Clifford J.; Buller, R. Mark] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA","Sei, JJ (reprint author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA.",ccn1@psu.edu,,,"NIH [U19 AI083008, AI056094, AI070537, AI097787];  [5 T32 CA60395-15]","This work was supported by NIH grants U19 AI083008 (P.I. Luis Sigal, Fox Chase Cancer Center), AI056094, AI070537 and AI097787 to CCN. EL was supported by training grant 5 T32 CA60395-15 (P.I. Harriet Isom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,39,14,14,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004941,10.1371/journal.ppat.1004941,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900026,26107264.0,"DOAJ Gold, Green Published",,,16/08/2019,14,2,22,2834,460,353,107,2374,1939,17,418,22,2,2,0,13,13,0,,25,1,25,0,1,14,14,12,8,0,0,0,0,0,0,0,0,0,2910,14,0,54,138,1,2411,470,14,0,54,138,1,29,,0,0,0,1,3,0,0,0,0,0,0,25,0,0,5.1,6.160869565217391,1.1937657961246841,0.1937657961246841,1.2898062342038754,1.0804516584333097,6.656521739130435
605,J,"Siegel, SJ; Tamashiro, E; Weiser, JN",,,,"Siegel, Steven J.; Tamashiro, Edwin; Weiser, Jeffrey N.",,,Clearance of Pneumococcal Colonization in Infants Is Delayed through Altered Macrophage Trafficking,PLOS PATHOGENS,,,English,Article,,,,,,,STREPTOCOCCUS-PNEUMONIAE COLONIZATION; LISTERIA-MONOCYTOGENES INFECTION; IMPAIRED INNATE; IMMUNE-RESPONSE; MURINE MODEL; CARRIAGE; CHILDREN; DISEASE; HOST; MICE,"Infections are a common cause of infant mortality worldwide, especially due to Streptococcus pneumoniae. Colonization is the prerequisite to invasive pneumococcal disease, and is particularly frequent and prolonged in children, though the mechanisms underlying this susceptibility are unknown. We find that infant mice exhibit prolonged pneumococcal carriage, and are delayed in recruiting macrophages, the effector cells of clearance, into the nasopharyngeal lumen. This lack of macrophage recruitment is paralleled by a failure to upregulate chemokine (C-C) motif ligand 2 (Ccl2 or Mcp-1), a macrophage chemoattractant that is required in adult mice to promote clearance. Baseline expression of Ccl2 and the related chemokine Ccl7 is higher in the infant compared to the adult upper respiratory tract, and this effect requires the infant microbiota. These results demonstrate that signals governing macrophage recruitment are altered at baseline in infant mice, which prevents the development of appropriate innate cell infiltration in response to pneumococcal colonization, delaying clearance of pneumococcal carriage.","[Siegel, Steven J.; Tamashiro, Edwin; Weiser, Jeffrey N.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Tamashiro, Edwin] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Sao Paulo, Brazil; [Weiser, Jeffrey N.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA","Siegel, SJ (reprint author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.",weiser@mail.med.upenn.edu,"Tamashiro, Edwin/C-5062-2012","Tamashiro, Edwin/0000-0002-3153-6292; Weiser, Jeffrey/0000-0001-7168-8090","National Institutes of Health [AI038446, AI105168, HL119030]; Sao Paulo Research Foundation [2014-00027-9]","This work was funded by National Institutes of Health (www.nih.gov) grants AI038446 and AI105168 to JNW, HL119030 to SJS, and Sao Paulo Research Foundation (www.fapesp.br) grant 2014-00027-9 to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,43,17,18,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005004,10.1371/journal.ppat.1005004,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900060,26107875.0,"DOAJ Gold, Green Published",,,16/08/2019,16,2,27,3340,852,662,190,2488,1972,19,497,27,2,0,0,16,16,0,,35,4,34,0,4,17,17,17,13,0,0,0,0,0,0,0,0,2,3349,12,0,41,136,0,2482,852,12,0,41,136,0,15,,0,0,0,0,5,0,0,0,0,0,0,34,0,0,2.25,3.92018779342723,1.342443729903537,0.342443729903537,1.4055466237942122,1.0470059880239522,4.104460093896714
606,J,"Unciti-Broceta, JD; Arias, JL; Maceira, J; Soriano, M; Ortiz-Gonzalez, M; Hemandez-Quero, J; Munoz-Torres, M; de Koning, HP; Magez, S; Garcia-Salcedo, JA",,,,"Unciti-Broceta, Juan D.; Arias, Jose L.; Maceira, Jose; Soriano, Miguel; Ortiz-Gonzalez, Matilde; Hemandez-Quero, Jose; Munoz-Torres, Manuel; de Koning, Harry P.; Magez, Stefan; Garcia-Salcedo, Jose A.",,,Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis,PLOS PATHOGENS,,,English,Article,,,,,,,NUCLEOSIDE TRANSPORTER; LEISHMANIA-INFANTUM; CROSS-RESISTANCE; DIAMIDINE DRUGS; BRUCEI; PENTAMIDINE; NANOPARTICLES; EXPRESSION; DELIVERY; CHITOSAN,"African trypanosomiasis is a deadly neglected disease caused by the extracellular parasite Trypanosoma brucei. Current therapies are characterized by high drug toxicity and increasing drug resistance mainly associated with loss-of-function mutations in the transporters involved in drug import. The introduction of new antiparasitic drugs into therapeutic use is a slow and expensive process. In contrast, specific targeting of existing drugs could represent a more rapid and cost-effective approach for neglected disease treatment, impacting through reduced systemic toxicity and circumventing resistance acquired through impaired compound uptake. We have generated nanoparticles of chitosan loaded with the trypanocidal drug pentamidine and coated by a single domain nanobody that specifically targets the surface of African trypanosomes. Once loaded into this nanocarrier, pentamidine enters trypanosomes through endocytosis instead of via classical cell surface transporters. The curative dose of pentamidine-loaded nanobody-chitosan nanoparticles was 100-fold lower than pentamidine alone in a murine model of acute African trypanosomiasis. Crucially, this new formulation displayed undiminished in vitro and in vivo activity against a trypanosome cell line resistant to pentamidine as a result of mutations in the surface transporter aquaglyceroporin 2. We conclude that this new drug delivery system increases drug efficacy and has the ability to overcome resistance to some anti-protozoal drugs.","[Unciti-Broceta, Juan D.; Maceira, Jose; Ortiz-Gonzalez, Matilde; Hemandez-Quero, Jose; Garcia-Salcedo, Jose A.] Univ Granada, Hosp Univ Granada, Inst Invest Biosanit Ibs, Unidad Enfermedades Infecciosas & Microbiol, Granada, Spain; [Unciti-Broceta, Juan D.; Maceira, Jose; Garcia-Salcedo, Jose A.] Inst Parasitol & Biomed Lopez Neyra IPBLN CSIC, Pts Granada, Armilla, Spain; [Unciti-Broceta, Juan D.; Maceira, Jose; Soriano, Miguel; Ortiz-Gonzalez, Matilde; Garcia-Salcedo, Jose A.] Ctr Pfizer Univ Granada, Junta Andalucia Genom & Invest Oncol GENYO, Granada, Spain; [Arias, Jose L.] Univ Granada, Fac Farm, Dept Farm & Tecnol Farmaceut, Granada, Spain; [Soriano, Miguel] Univ Almeria, Dept Agron, Almeria, Spain; [Munoz-Torres, Manuel] Univ Granada, Hosp Univ Granada, Inst Invest Biosanit Ibs, Unidad Metab Oseo, Granada, Spain; [de Koning, Harry P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Magez, Stefan] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Magez, Stefan] Vrije Univ Brussel, Dept Biol Struct, Brussels, Belgium","Unciti-Broceta, JD (reprint author), Univ Granada, Hosp Univ Granada, Inst Invest Biosanit Ibs, Unidad Enfermedades Infecciosas & Microbiol, Granada, Spain.",jags@genyo.es,"Munoz Torres, Manuel/O-2330-2016; Arias Mediano, Jose Luis/B-8986-2017; Magez, Stefan/D-9497-2014; Soriano, Miguel/L-9532-2014","Munoz Torres, Manuel/0000-0002-9645-3260; Arias Mediano, Jose Luis/0000-0002-3437-3791; Magez, Stefan/0000-0003-3760-7968; Soriano Rodriguez, Miguel/0000-0002-1838-3615; Unciti-Broceta, Juan Diego/0000-0002-4068-5943; De Koning, Harry/0000-0002-9963-1827","European Union [FP7-HEALTH-2007-B-2.3.4-1.223048]; NANOTRYP; Ministerio de Economia y Competitividad, Spain Plan Nacional de Investigacion grant [SAF2011-30528]; Instituto de Salud Carlos III, Spain [FIS. 11/02571]; Medical Research Council [84733]; Medical Research Council [G0701258]","JAGS was funded by the European Union, grant FP7-HEALTH-2007-B-2.3.4-1.223048, NANOTRYP and Ministerio de Economia y Competitividad, Spain Plan Nacional de Investigacion grant SAF2011-30528. JLA was funded by Instituto de Salud Carlos III, Spain, grant FIS. 11/02571. HPdK was supported by a grant from the Medical Research Council (84733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,53,25,25,0,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004942,10.1371/journal.ppat.1004942,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900027,26110623.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,26,80,43,5336,974,709,265,4362,3452,21,889,43,0,0,0,21,21,1,,157,2,80,0,2,28,28,26,11,0,0,0,0,0,0,2,80,0,5421,39,0,175,122,0,4394,987,39,0,175,122,0,40,,5,2,0,0,7,0,0,0,0,0,0,80,0,0,55.18,5.478439425051334,1.2232920678587804,0.22329206785878036,1.2796882164144887,1.0461019490254873,5.731006160164271
607,J,"van 't Wout, EFA; van Schadewijk, A; van Boxtel, R; Dalton, LE; Clarke, HJ; Tommassen, J; Marciniak, SJ; Hiemstra, PS",,,,"van 't Wout, Emily F. A.; van Schadewijk, Annemarie; van Boxtel, Ria; Dalton, Lucy E.; Clarke, Hanna J.; Tommassen, Jan; Marciniak, Stefan J.; Hiemstra, Pieter S.",,,Virulence Factors of Pseudomonas aeruginosa Induce Both the Unfolded Protein and Integrated Stress Responses in Airway Epithelial Cells,PLOS PATHOGENS,,,English,Article,,,,,,,ENDOPLASMIC-RETICULUM STRESS; XBP1 MESSENGER-RNA; EUKARYOTIC INITIATION FACTOR-2-ALPHA; OBSTRUCTIVE PULMONARY-DISEASE; INNATE IMMUNE-RESPONSES; INDUCED GENE-EXPRESSION; BOX BINDING PROTEIN-1; CYSTIC-FIBROSIS; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTOR,"Pseudomonas aeruginosa infection can be disastrous in chronic lung diseases such as cystic fibrosis and chronic obstructive pulmonary disease. Its toxic effects are largely mediated by secreted virulence factors including pyocyanin, elastase and alkaline protease (AprA). Efficient functioning of the endoplasmic reticulum (ER) is crucial for cell survival and appropriate immune responses, while an excess of unfolded proteins within the ER leads to ""ER stress"" and activation of the ""unfolded protein response"" (UPR). Bacterial infection and Toll-like receptor activation trigger the UPR most likely due to the increased demand for protein folding of inflammatory mediators. In this study, we show that cell-free conditioned medium of the PAO1 strain of P. aeruginosa, containing secreted virulence factors, induces ER stress in primary bronchial epithelial cells as evidenced by splicing of XBP1 mRNA and induction of CHOP, GRP78 and GADD34 expression. Most aspects of the ER stress response were dependent on TAK1 and p38 MAPK, except for the induction of GADD34 mRNA. Using various mutant strains and purified virulence factors, we identified pyocyanin and AprA as inducers of ER stress. However, the induction of GADD34 was mediated by an ER stress-independent integrated stress response (ISR) which was at least partly dependent on the iron-sensing eIF2 alpha kinase HRI. Our data strongly suggest that this increased GADD34 expression served to protect against Pseudomonas-induced, iron-sensitive cell cytotoxicity. In summary, virulence factors from P. aeruginosa induce ER stress in airway epithelial cells and also trigger the ISR to improve cell survival of the host.","[van 't Wout, Emily F. A.; van Schadewijk, Annemarie; Hiemstra, Pieter S.] Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands; [van 't Wout, Emily F. A.; Dalton, Lucy E.; Clarke, Hanna J.; Marciniak, Stefan J.] Univ Cambridge, Cambridge Inst Med Res CIMR, Cambridge, England; [van Boxtel, Ria; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, Utrecht, Netherlands","van 't Wout, EFA (reprint author), Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands.",P.S.Hiemstra@lumc.nl,"Tommassen, Jan/I-1690-2016; Hiemstra, Pieter S/K-8587-2018; /V-8478-2019","Tommassen, Jan/0000-0001-7633-4945; Hiemstra, Pieter S/0000-0002-0238-5982; /0000-0002-0238-5982; Marciniak, Stefan/0000-0001-8472-7183",Medical Research Council UK [G1002610]; Netherlands Asthma Foundation [3.2.08.0032]; British Lung Foundation [APHD11-4]; Medical Research Council [G1002610],"This work was supported by the Medical Research Council UK [G1002610 to SJM] and the Netherlands Asthma Foundation [grant # 3.2.08.0032 to EFAvtW and PSH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,26,27,2,17,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004946,10.1371/journal.ppat.1004946,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900029,26083346.0,"DOAJ Gold, Green Published",,,16/08/2019,28,4,81,19905,3161,2558,603,16744,14631,36,2077,81,4,0,0,24,24,1,,229,3,117,0,3,28,28,25,14,0,0,0,0,0,0,0,0,4,19870,38,0,154,63,4,16658,3161,38,0,154,63,4,51,,0,0,0,0,11,0,0,1,0,0,0,116,0,0,6.9,6.297057893071813,1.1887840420449116,0.18878404204491162,1.1927257525083612,1.0033157498116052,6.317937361594432
608,J,"Wang, YH; Hu, Y; Xing, LS; Jiang, H; Hu, SN; Raikhel, AS; Zou, Z",,,,"Wang, Yan-Hong; Hu, Yang; Xing, Long-Sheng; Jiang, Hong; Hu, Song-Nian; Raikhel, Alexander S.; Zou, Zhen",,,A Critical Role for CLSP2 in the Modulation of Antifungal Immune Response in Mosquitoes,PLOS PATHOGENS,,,English,Article,,,,,,,GENOME-WIDE ANALYSIS; AEDES-AEGYPTI; INNATE IMMUNITY; MANDUCA-SEXTA; FUNGAL-INFECTIONS; ANOPHELES-GAMBIAE; HOST-DEFENSE; DROSOPHILA; TOLL; COMPLEMENT,"Entomopathogenic fungi represent a promising class of bio-insecticides for mosquito control. Thus, detailed knowledge of the molecular mechanisms governing anti-fungal immune response in mosquitoes is essential. In this study, we show that CLSP2 is a modulator of immune responses during anti-fungal infection in the mosquito Aedes aegypti. With a fungal infection, the expression of the CLSP2 gene is elevated. CLSP2 is cleaved upon challenge with Beauveria bassiana conidia, and the liberated CLSP2 CTL-type domain binds to fungal cell components and B. bassiana conidia. Furthermore, CLPS2 RNA interference silencing significantly increases the resistance to the fungal challenge. RNA-sequencing transcriptome analysis showed that the majority of immune genes were highly upregulated in the CLSP2-depleted mosquitoes infected with the fungus. The up-regulated immune gene cohorts belong to melanization and Toll pathways, but not to the IMD or JAK-STAT. A thioester-containing protein (TEP22), a member of alpha(2)-macroglobulin family, has been implicated in the CLSP2-modulated mosquito antifungal defense. Our study has contributed to a greater understanding of immune-modulating mechanisms in mosquitoes.","[Wang, Yan-Hong; Xing, Long-Sheng; Jiang, Hong; Zou, Zhen] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Hu, Yang; Hu, Song-Nian] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Hu, Yang] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Xing, Long-Sheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA","Wang, YH (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.",alexander.raikhel@ucr.edu; zouzhen@ioz.ac.cn,"zou, zhen/C-6134-2016","zou, zhen/0000-0003-3550-7656","National Basic Research Program of China [2014CB138405]; Strategic Priority Research Program of the CAS [XDB11030600]; National Natural Science Foindation of China [31272367, 31402013]; NIH [RO1 AI036959]","This work was supported by the National Basic Research Program of China (No. 2014CB138405) ZZ; Strategic Priority Research Program of the CAS (No. XDB11030600) ZZ; National Natural Science Foindation of China (No. 31272367 and No. 31402013) ZZ; and NIH RO1 AI036959, ASR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,31,36,2,33,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1004931,10.1371/journal.ppat.1004931,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900024,26057557.0,"DOAJ Gold, Green Published",,,16/08/2019,34,10,34,3625,682,488,194,2943,2276,22,645,34,9,0,0,31,31,0,,39,4,39,0,4,34,34,26,20,0,0,0,0,0,0,0,1,8,3670,124,0,88,54,0,2961,688,124,0,88,54,0,21,,0,0,0,0,12,0,1,1,0,0,0,39,0,0,5.5,5.31524926686217,1.2317363234794427,0.23173632347944276,1.307509344206592,1.0615172413793104,5.642228739002933
609,J,"Wang, YM; Lian, QS; Yang, B; Yan, SS; Zhou, HY; He, L; Lin, GM; Lian, ZX; Jiang, ZF; Sun, B",,,,"Wang, Yanming; Lian, Qiaoshi; Yang, Bo; Yan, Shanshan; Zhou, Haiyan; He, Lan; Lin, Guomei; Lian, Zhexiong; Jiang, Zhengfan; Sun, Bing",,,TRIM30 alpha Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING,PLOS PATHOGENS,,,English,Article,,,,,,,DOUBLE-STRANDED-RNA; CYCLIC GMP-AMP; NF-KAPPA-B; CYTOSOLIC DNA; RIG-I; INNATE IMMUNITY; DENDRITIC CELLS; INFLAMMASOME; ACTIVATION; SENSOR,"Uncontrolled immune responses to intracellular DNA have been shown to induce autoimmune diseases. Homeostasis regulation of immune responses to cytosolic DNA is critical for limiting the risk of autoimmunity and survival of the host. Here, we report that the E3 ubiquitin ligase tripartite motif protein 30 alpha (TRIM30 alpha) was induced by herpes simplex virus type 1 (HSV-1) infection in dendritic cells (DCs). Knockdown or genetic ablation of TRIM30 alpha augmented the type I IFNs and interleukin-6 response to intracellular DNA and DNA viruses. Trim30 alpha-deficient mice were more resistant to infection by DNA viruses. Biochemical analyses showed that TRIM30 alpha interacted with the stimulator of interferon genes (STING), which is a critical regulator of the DNA-sensing response. Overexpression of TRIM30 alpha promoted the degradation of STING via K48-linked ubiquitination at Lys275 through a proteasome-dependent pathway. These findings indicate that E3 ligase TRIM30 alpha is an important negative-feedback regulator of innate immune responses to DNA viruses by targeting STING.","[Wang, Yanming; Lian, Qiaoshi; Zhou, Haiyan; He, Lan; Lin, Guomei; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Wang, Yanming; Yang, Bo; Yan, Shanshan; Lian, Zhexiong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Jiang, Zhengfan] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Jiang, Zhengfan] Peking Univ Tsinghua Univ Joint Ctr Life Sci, Beijing, Peoples R China; [Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China","Wang, YM (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China.",bsun@sibs.ac.cn,,"Lian, Qiaoshi/0000-0002-3628-9390","national key project of 973 [2013CB530504]; National Natural Science Foundation of China [31030029, 31230024, 81361120409]","This work was supported by grants from the national key project of 973 (2013CB530504) and the National Natural Science Foundation of China (31030029, 31230024, 81361120409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,32,20,23,1,21,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,JUN,2015,11,6,,,,,,,e1005012,10.1371/journal.ppat.1005012,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CM0WW,WOS:000357400900064,26114947.0,"DOAJ Gold, Green Published",,,16/08/2019,48,0,38,5982,1364,977,387,4618,3367,22,1229,37,0,0,0,49,49,0,,51,0,50,1,0,48,48,39,29,0,0,0,0,0,0,0,0,2,5978,41,0,92,33,0,4601,1364,41,0,92,33,0,13,,0,0,0,0,3,0,0,0,0,0,0,49,1,0,1.75,4.385630498533724,1.2953659592897357,0.2953659592897358,1.310524036379385,1.0117017719826145,4.436950146627566
610,J,"Ader-Ebert, N; Khosravi, M; Herren, M; Avila, M; Alves, L; Bringolf, F; Orvell, C; Langedijk, JP; Zurbriggen, A; Plemper, RK; Plattet, P",,,,"Ader-Ebert, Nadine; Khosravi, Mojtaba; Herren, Michael; Avila, Mislay; Alves, Lisa; Bringolf, Fanny; Orvell, Claes; Langedijk, Johannes P.; Zurbriggen, Andreas; Plemper, Richard K.; Plattet, Philippe",,,Sequential Conformational Changes in the Morbillivirus Attachment Protein Initiate the Membrane Fusion Process,PLOS PATHOGENS,,,English,Article,,,,,,,CANINE-DISTEMPER VIRUS; EPITHELIAL-CELL RECEPTOR; MEASLES-VIRUS; PARAMYXOVIRUS FUSION; STALK DOMAIN; FUNCTIONAL INTERACTION; BINDING PROTEIN; 4-HELIX BUNDLE; IMMUNE CELLS; F PROTEIN,"Despite large vaccination campaigns, measles virus (MeV) and canine distemper virus (CDV) cause major morbidity and mortality in humans and animals, respectively. The MeV and CDV cell entry system relies on two interacting envelope glycoproteins: the attachment protein (H), consisting of stalk and head domains, co-operates with the fusion protein (F) to mediate membrane fusion. However, how receptor-binding by the H-protein leads to F-triggering is not fully understood. Here, we report that an anti-CDV-H monoclonal antibody (mAb-1347), which targets the linear H-stalk segment 126-133, potently inhibits membrane fusion without interfering with H receptor-binding or F-interaction. Rather, mAb-1347 blocked the F-triggering function of H-proteins regardless of the presence or absence of the head domains. Remarkably, mAb-1347 binding to headless CDV H, as well as standard and engineered bioactive stalk-elongated CDV H-constructs treated with cells expressing the SLAM receptor, was enhanced. Despite proper cell surface expression, fusion promotion by most H-stalk mutants harboring alanine substitutions in the 126-138 ""spacer"" section was substantially impaired, consistent with deficient receptor-induced mAb-1347 binding enhancement. However, a previously reported F-triggering defective H-I98A variant still exhibited the receptor-induced ""head-stalk"" rearrangement. Collectively, our data spotlight a distinct mechanism for morbillivirus membrane fusion activation: prior to receptor contact, at least one of the morbillivirus H-head domains interacts with the membrane-distal ""spacer"" domain in the H-stalk, leaving the F-binding site located further membrane-proximal in the stalk fully accessible. This ""head-to-spacer"" interaction conformationally stabilizes H in an auto-repressed state, which enables intracellular H-stalk/F engagement while preventing the inherent H-stalk's bioactivity that may prematurely activate F. Receptor-contact disrupts the ""head-to-spacer"" interaction, which subsequently ""unlocks"" the stalk, allowing it to rearrange and trigger F. Overall, our study reveals essential mechanistic requirements governing the activation of the morbillivirus membrane fusion cascade and spotlights the H-stalk ""spacer"" microdomain as a possible drug target for antiviral therapy.","[Ader-Ebert, Nadine; Khosravi, Mojtaba; Herren, Michael; Avila, Mislay; Alves, Lisa; Bringolf, Fanny; Zurbriggen, Andreas; Plattet, Philippe] Univ Bern, Div Neurol Sci, Dept Clin Res & Vet Publ Hlth DCR VPH, Vetsuisse Fac, Bern, Switzerland; [Ader-Ebert, Nadine; Khosravi, Mojtaba; Herren, Michael; Avila, Mislay; Alves, Lisa; Bringolf, Fanny] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Orvell, Claes] Karolinska Univ, Huddinge Hosp, Div Lab Med, Stockholm, Sweden; [Langedijk, Johannes P.] Janssen Infect Dis & Vaccines, Leiden, Netherlands; [Plemper, Richard K.] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA","Ader-Ebert, N (reprint author), Univ Bern, Div Neurol Sci, Dept Clin Res & Vet Publ Hlth DCR VPH, Vetsuisse Fac, Bern, Switzerland.",philippe.plattet@vetsuisse.unibe.ch,,,Swiss National Science Foundation [310030_153281]; Novartis Foundation for Biomedical Research [14A08]; Public Health Service [AI083402]; NIH/NIAID [AI071002],"This work was supported by the Swiss National Science Foundation (310030_153281 to PP; http://www.snf.ch) and the Novartis Foundation for Biomedical Research (14A08 to PP; http://www.stiftungmedbiol.novartis.com) and, in part, by the Public Health Service grants (AI083402 to RKP) and the NIH/NIAID (AI071002 to RKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,14,16,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004880,10.1371/journal.ppat.1004880,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300029,25946112.0,"DOAJ Gold, Green Published",,,16/08/2019,16,0,19,4722,1001,720,281,3721,2968,27,726,19,0,0,0,16,16,0,,29,5,29,0,5,17,17,17,12,0,0,0,0,0,0,0,0,0,4762,41,0,313,72,0,3712,1001,41,0,313,72,0,49,,0,0,0,0,2,0,0,1,0,0,0,29,0,0,1.25,4.717282717282718,1.2690137059930127,0.2690137059930126,1.3101316850309057,1.0324015247776366,4.87012987012987
611,J,"Barquero-Calvo, E; Mora-Cartin, R; Arce-Gorvel, V; de Diego, JL; Chacon-Diaz, C; Chaves-Olarte, E; Guzman-Verri, C; Buret, AG; Gorvel, JP; Moreno, E",,,,"Barquero-Calvo, Elias; Mora-Cartin, Ricardo; Arce-Gorvel, Vilma; de Diego, Juana L.; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Guzman-Verri, Caterina; Buret, Andre G.; Gorvel, Jean-Pierre; Moreno, Edgardo",,,Brucella abortus Induces the Premature Death of Human Neutrophils through the Action of Its Lipopolysaccharide,PLOS PATHOGENS,,,English,Article,,,,,,,PROGRAMMED CELL-DEATH; TOLL-LIKE RECEPTOR-4; NADPH OXIDASE; TNF-ALPHA; IN-VITRO; BIOLOGICAL-ACTIVITIES; ROUGH STRAINS; III SECRETION; APOPTOSIS; PHAGOCYTOSIS,"Most bacterial infections induce the activation of polymorphonuclear neutrophils (PMNs), enhance their microbicidal function, and promote the survival of these leukocytes for protracted periods of time. Brucella abortus is a stealthy pathogen that evades innate immunity, barely activates PMNs, and resists the killing mechanisms of these phagocytes. Intriguing clinical signs observed during brucellosis are the low numbers of Brucella infected PMNs in the target organs and neutropenia in a proportion of the patients; features that deserve further attention. Here we demonstrate that B. abortus prematurely kills human PMNs in a dose-dependent and cell-specific manner. Death of PMNs is concomitant with the intracellular Brucella lipopolysaccharide (Br-LPS) release within vacuoles. This molecule and its lipid A reproduce the premature cell death of PMNs, a phenomenon associated to the low production of proinflammatory cytokines. Blocking of CD14 but not TLR4 prevents the Br-LPS-induced cell death. The PMNs cell death departs from necrosis, NETosis and classical apoptosis. The mechanism of PMN cell death is linked to the activation of NADPH-oxidase and a modest but steadily increase of ROS mediators. These effectors generate DNA damage, recruitments of check point kinase 1, caspases 5 and to minor extent of caspase 4, RIP1 and Ca++ release. The production of IL-1 beta by PMNs was barely stimulated by B. abortus infection or Br-LPS treatment. Likewise, inhibition of caspase 1 did not hamper the Br-LPS induced PMN cell death, suggesting that the inflammasome pathway was not involved. Although activation of caspases 8 and 9 was observed, they did not seem to participate in the initial triggering mechanisms, since inhibition of these caspases scarcely blocked PMN cell death. These findings suggest a mechanism for neutropenia in chronic brucellosis and reveal a novel Brucella-host cross-talk through which B. abortus is able to hinder the innate function of PMN.","[Barquero-Calvo, Elias; Mora-Cartin, Ricardo; Chaves-Olarte, Esteban; Guzman-Verri, Caterina; Moreno, Edgardo] Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica; [Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Guzman-Verri, Caterina] Univ Costa Rica, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] Aix Marseille Univ, UM2, CIML, Marseille, France; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] INSERM, U1104, F-13258 Marseille, France; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] CNRS, UMR7280, Marseille, France; [de Diego, Juana L.] Max Planck Inst Infect Biol, Dept Cell Microbiol, Berlin, Germany; [Buret, Andre G.] Univ Calgary, Biol Sci, Inflammat Res Network, Calgary, AB, Canada; [Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica","Barquero-Calvo, E (reprint author), Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica.",gorvel@ciml.univ-mrs.fr; emoreno@racsa.co.cr,"Gorvel, Jean-Pierre/O-1332-2018","Gorvel, Jean-Pierre/0000-0002-2829-9804; Arce-Gorvel, Vilma/0000-0003-0090-837X","grants Fondo Especial de la Educacion Superior (FEES-CONARE), Costa Rica [0500-13, 0504-13, 0505-13, 0248-13]; Fondation de la Recherche Medicale; Fondation Mediterranee Infection; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Aix-Marseille Universite; SEP-UCR; CONICIT-Costa Rica","This work was partially supported by grants Fondo Especial de la Educacion Superior (FEES-CONARE) grant numbers 0500-13, 0504-13, 0505-13, 0248-13, Costa Rica; the Fondation de la Recherche Medicale; The Fondation Mediterranee Infection; the Centre National de la Recherche Scientifique; the Institut National de la Sante et de la Recherche Medicale and the Aix-Marseille Universite. EB-C received a fellowship from SEP-UCR and CONICIT-Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,107,20,24,2,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004853,10.1371/journal.ppat.1004853,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300018,25946018.0,"DOAJ Gold, Green Published",,,16/08/2019,21,1,56,6942,1765,1289,476,5177,4113,28,1036,56,1,0,0,20,20,0,,71,3,71,0,3,23,23,21,12,0,0,0,0,0,0,0,0,4,7015,85,0,143,279,3,5197,1777,29,0,143,81,3,41,,0,0,0,0,1,0,0,1,0,0,0,75,0,0,0.5,3.9331444759206797,1.3409310411435194,0.3409310411435194,1.4253428626617732,1.0629501584557763,4.180736543909348
612,J,"Bergeron, E; Zivcec, M; Chakrabarti, AK; Nichol, ST; Albarino, CG; Spiropoulou, CF",,,,"Bergeron, Eric; Zivcec, Marko; Chakrabarti, Ayan K.; Nichol, Stuart T.; Albarino, Cesar G.; Spiropoulou, Christina F.",,,Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin,PLOS PATHOGENS,,,English,Article,,,,,,,EBOLA-VIRUS; TERMINAL CLEAVAGE; CDNA; IDENTIFICATION; REPLICATION; GENERATION; PROTEASES; PROTEIN; RESCUE; SKI-1,"Crimean Congo hemorrhagic fever virus (CCHFV) is a negative-strand RNA virus of the family Bunyaviridae (genus: Nairovirus). In humans, CCHFV causes fever, hemorrhage, severe thrombocytopenia, and high fatality. A major impediment in precisely determining the basis of CCHFV's high pathogenicity has been the lack of methodology to produce recombinant CCHFV. We developed a reverse genetics system based on transfecting plasmids into BSR-T7/5 and Huh7 cells. In our system, bacteriophage T7 RNA polymerase produced complementary RNA copies of the viral S, M, and L segments that were encapsidated with the support, in trans, of CCHFV nucleoprotein and L polymerase. The system was optimized to systematically recover high yields of infectious CCHFV. Additionally, we tested the ability of the system to produce specifically designed CCHFV mutants. The M segment encodes a polyprotein that is processed by host proprotein convertases (PCs), including the site-1 protease (S1P) and furin-like PCs. S1P and furin cleavages are necessary for producing the non-structural glycoprotein GP38, while S1P cleavage yields structural Gn. We studied the role of furin cleavage by rescuing a recombinant CCHFV encoding a virus glycoprotein precursor lacking a functional furin cleavage motif (RSKR mutated to ASKA). The ASKA mutation blocked glycoprotein precursor's maturation to GP38, and Gn precursor's maturation to Gn was slightly diminished. Furin cleavage was not essential for replication, as blocking furin cleavage resulted only in transient reduction of CCHFV titers, suggesting that either GP38 and/or decreased Gn maturation accounted for the reduced virion production. Our data demonstrate that nairoviruses can be produced by reverse genetics, and the utility of our system uncovered a function for furin cleavage. This viral rescue system could be further used to study the CCHFV replication cycle and facilitate the development of efficacious vaccines to counter this biological and public health threat.","[Bergeron, Eric; Zivcec, Marko; Chakrabarti, Ayan K.; Nichol, Stuart T.; Albarino, Cesar G.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA","Bergeron, E (reprint author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.",ebergeron@cdc.gov,"Bergeron, Eric/N-9566-2019","Bergeron, Eric/0000-0003-3398-8628; Zivcec, Marko/0000-0003-4337-8487",CDC; CDC foundation - NIAID [R01AI109008],"These studies were supported by CDC and CDC foundation project funded by NIAID grant R01AI109008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,19,20,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004879,10.1371/journal.ppat.1004879,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300028,25933376.0,"DOAJ Gold, Green Published",,,16/08/2019,22,5,39,6393,1151,828,323,5242,4377,28,837,39,4,0,0,21,21,0,,53,4,53,0,4,23,23,14,12,0,0,0,0,0,0,0,1,1,6458,60,0,145,106,1,5277,1165,60,0,145,106,1,16,,0,0,0,0,6,0,1,1,0,0,0,53,0,0,3.6,5.554300608166812,1.2195726821823731,0.21957268218237314,1.263639832125143,1.0361332707648991,5.754995655951347
613,J,"Borderia, AV; Isakov, O; Moratorio, G; Henningsson, R; Aguera-Gonzalez, S; Organtini, L; Gnadig, NF; Blanc, H; Alcover, A; Hafenstein, S; Fontes, M; Shomron, N; Vignuzzi, M",,,,"Borderia, Antonio V.; Isakov, Ofer; Moratorio, Gonzalo; Henningsson, Rasmus; Agueera-Gonzalez, Sonia; Organtini, Lindsey; Gnaedig, Nina F.; Blanc, Herve; Alcover, Andres; Hafenstein, Susan; Fontes, Magnus; Shomron, Noam; Vignuzzi, Marco",,,Group Selection and Contribution of Minority Variants during Virus Adaptation Determines Virus Fitness and Phenotype,PLOS PATHOGENS,,,English,Article,,,,,,,DECAY-ACCELERATING FACTOR; COXSACKIEVIRUS B3; NUCLEOTIDE-SEQUENCE; CLONAL INTERFERENCE; INFLUENZA-VIRUS; RNA VIRUS; EVOLUTION; POPULATION; DYNAMICS; RECEPTOR,"Understanding how a pathogen colonizes and adapts to a new host environment is a primary aim in studying emerging infectious diseases. Adaptive mutations arise among the thousands of variants generated during RNA virus infection, and identifying these variants will shed light onto how changes in tropism and species jumps can occur. Here, we adapted Coxsackie virus B3 to a highly permissive and less permissive environment. Using deep sequencing and bioinformatics, we identified a multi-step adaptive process to adaptation involving residues in the receptor footprints that correlated with receptor availability and with increase in virus fitness in an environment-specific manner. We show that adaptation occurs by selection of a dominant mutation followed by group selection of minority variants that together, confer the fitness increase observed in the population, rather than selection of a single dominant genotype.","[Borderia, Antonio V.; Moratorio, Gonzalo; Henningsson, Rasmus; Gnaedig, Nina F.; Blanc, Herve; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, Paris, France; [Borderia, Antonio V.; Henningsson, Rasmus; Fontes, Magnus] Inst Pasteur, Int Grp Data Anal, Paris, France; [Isakov, Ofer; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Henningsson, Rasmus; Fontes, Magnus] Lund Univ, Ctr Math Sci, Lund, Sweden; [Agueera-Gonzalez, Sonia; Alcover, Andres] Inst Pasteur, Lymphocyte Cell Biol Unit, CNRS, URA 1960, Paris, France; [Organtini, Lindsey; Hafenstein, Susan] Penn State Coll Med, Div Infect Dis, Hershey, PA USA","Borderia, AV (reprint author), Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, Paris, France.",marco.vignuzzi@pasteur.fr,,"Alcover, Andres/0000-0002-9507-3450; Vignuzzi, Marco/0000-0002-4400-771X; Borderia, Antonio V./0000-0003-0623-1988",European Research Council (ERC) [242719]; NIH [K22 A179271]; Institut Pasteur; French National grant [ANR-09-JCJC-0118-1]; Fondation ARC postdoctoral fellowship,"This work was supported by a European Research Council (ERC Starting Grant no. 242719) to MV, a NIH K22 A179271 grant to SH, and funding from the Institut Pasteur to MV, AA and SAG. Salary for AVB was provided by the French National grant ANR-09-JCJC-0118-1 and for SAG was supported by a Fondation ARC postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,27,55,55,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004838,10.1371/journal.ppat.1004838,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300014,25941809.0,"DOAJ Gold, Green Published",,,16/08/2019,43,34,78,6358,771,561,210,5587,4471,23,1093,78,4,2,0,52,52,1,,111,4,111,0,4,59,45,59,39,0,0,0,0,0,0,0,30,4,6417,57,6,125,61,2,5614,779,57,6,125,61,2,24,,0,0,0,0,13,0,2,0,0,0,0,111,0,0,7.5,8.246433203631646,1.1379989260783963,0.13799892607839628,1.1696796133882226,1.0278389430638566,8.476005188067445
614,J,"Carruthers, VB",,,,"Carruthers, Vern B.",,,Parasites and Their Heterophagic Appetite for Disease,PLOS PATHOGENS,,,English,Article,,,,,,,ENTAMOEBA-HISTOLYTICA; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-BRUCEI; HUMAN SERUM; RECEPTOR; ERYTHROCYTES; PHAGOCYTOSIS; RESISTANCE; MECHANISMS; TRANSPORT,,"Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA","Carruthers, VB (reprint author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.",vcarruth@umich.edu,,,"NIH [R21AI097099, R01AI046675]","This work was supported by NIH R21AI097099 and R01AI046675 to VBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,22,0,0,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004803,10.1371/journal.ppat.1004803,,,,4,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300007,25996683.0,"DOAJ Gold, Green Published",,,16/08/2019,0,18,15,3404,305,254,51,3099,2549,234,316,15,14,0,0,0,0,0,,18,14,18,0,14,0,0,0,0,0,0,0,0,0,0,0,4,5,3418,0,0,0,68,0,3095,305,0,0,0,68,0,18,,0,0,0,0,14,0,1,1,0,0,0,18,0,0,8.85,11.160655737704918,1.0984188447886416,0.09841884478864149,1.1248789932236205,1.0240893066980024,11.429508196721311
615,J,"Cheng, AT; Ottemann, KM; Yildiz, FH",,,,"Cheng, Andrew T.; Ottemann, Karen M.; Yildiz, Fitnat H.",,,Vibrio cholerae Response Regulator VxrB Controls Colonization and Regulates the Type VI Secretion System,PLOS PATHOGENS,,,English,Article,,,,,,,VIRULENCE GENE-EXPRESSION; 2-COMPONENT SIGNAL-TRANSDUCTION; BIOFILM FORMATION; TRANSCRIPTIONAL ACTIVATORS; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; TOXIN PRODUCTION; O1 STRAINS; TN-SEQ; PROTEIN,"Two-component signal transduction systems (TCS) are used by bacteria to sense and respond to their environment. TCS are typically composed of a sensor histidine kinase (HK) and a response regulator (RR). The Vibrio cholerae genome encodes 52 RR, but the role of these RRs in V. cholerae pathogenesis is largely unknown. To identify RRs that control V. cholerae colonization, in-frame deletions of each RR were generated and the resulting mutants analyzed using an infant mouse intestine colonization assay. We found that 12 of the 52 RR were involved in intestinal colonization. Mutants lacking one previously uncharacterized RR, VCA0566 (renamed VxrB), displayed a significant colonization defect. Further experiments showed that VxrB phosphorylation state on the predicted conserved aspartate contributes to intestine colonization. The VxrB regulon was determined using whole genome expression analysis. It consists of several genes, including those genes that create the type VI secretion system (T6SS). We determined that VxrB is required for T6SS expression using several in vitro assays and bacterial killing assays, and furthermore that the T6SS is required for intestinal colonization. vxrB is encoded in a four gene operon and the other vxr operon members also modulate intestinal colonization. Lastly, though Delta vxrB exhibited a defect in single-strain intestinal colonization, the Delta vxrB strain did not show any in vitro growth defect. Overall, our work revealed that a small set of RRs is required for intestinal colonization and one of these regulators, VxrB affects colonization at least in part through its regulation of T6SS genes.","[Cheng, Andrew T.; Ottemann, Karen M.; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA","Yildiz, FH (reprint author), Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA.",fyildiz@ucsc.edu,,,"National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI055987, AI102584]","This study is funded by National Institutes of Health, National Institute of Allergy and Infectious Diseases (AI055987 and AI102584) (http://www.niaid.nih.gov to FHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,69,22,22,1,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004933,10.1371/journal.ppat.1004933,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300059,26000450.0,"DOAJ Gold, Green Published",,,16/08/2019,22,9,41,6192,1143,844,299,5049,4237,21,791,41,5,0,0,23,23,0,,52,2,52,0,2,26,23,26,16,0,0,0,0,0,0,0,5,1,6264,77,0,97,41,0,5083,1155,77,0,97,41,0,26,,0,0,0,0,5,0,0,1,0,0,0,58,0,0,2.1,5.417322834645669,1.2263814616755793,0.22638146167557932,1.2640126757773817,1.0306847545219637,5.5835520559930005
616,J,"Chiesa, R",,,,"Chiesa, Roberto",,,The Elusive Role of the Prion Protein and the Mechanism of Toxicity in Prion Disease,PLOS PATHOGENS,,,English,Article,,,,,,,SCRAPIE; PRP; NEURODEGENERATION; EXCITOTOXICITY; TRANSMISSION; NEURONS; MOUSE,"PrPSc, a misfolded, aggregation-prone isoform of the cellular prion protein (PrPC), is the infectious prion agent responsible for incurable brain diseases such as scrapie of sheep, bovine spongiform encephalopathy, and its human counterpart, variant Creutzfeldt-Jakob disease. In these disorders, collectively known as prion diseases, exogenous PrPSc propagates in the infected host by imprinting its aberrant conformation onto endogenous PrPC, eventually triggering a rapidly progressing neurodegenerative process that invariably leads to death. But what is the function of PrPC besides serving as a substrate for the generation of PrPSc? And how does PrPC misfolding cause neurological disease?","IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy","Chiesa, R (reprint author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy.",roberto.chiesa@marionegri.it,"Chiesa, Roberto/G-1561-2017; Chiesa, Roberto/Q-4295-2019","Chiesa, Roberto/0000-0002-3842-3733; Chiesa, Roberto/0000-0002-3842-3733","Telethon-Italy [TDRC00508TU, GGP12115]; Italian Ministry of Health [RF-INN-2008-1215065, RF-2010-2314035]; Fondazione Cariplo [2010-0828, 2012-0560]","This work was supported by grants from Telethon-Italy (TDRC00508TU and GGP12115; https://www.telethon.it/en), the Italian Ministry of Health (RF-INN-2008-1215065 and RF-2010-2314035; http://www.salute.gov.it/) and Fondazione Cariplo (2010-0828 and 2012-0560; http://www.fondazionecariplo.it/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,30,20,20,0,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004745,10.1371/journal.ppat.1004745,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300002,25951168.0,"DOAJ Gold, Green Published",,,16/08/2019,20,7,53,6503,1909,1593,316,4594,3650,15,929,52,7,0,0,17,17,1,,72,24,71,1,24,21,21,20,8,0,0,0,0,0,0,0,0,4,6666,2,0,43,242,3,4619,1922,2,0,43,242,3,125,,2,0,0,0,6,0,0,1,0,0,0,71,1,0,19.75,3.4064955474070193,1.415542011319112,0.4155420113191119,1.5041358293426208,1.0625864985391358,3.6196961760083814
617,J,"Cocita, C; Guiton, R; Bessou, G; Chasson, L; Boyron, M; Crozat, K; Dalod, M",,,,"Cocita, Clement; Guiton, Rachel; Bessou, Gilles; Chasson, Lionel; Boyron, Marilyn; Crozat, Karine; Dalod, Marc",,,Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMACYTOID DENDRITIC CELLS; CD8 T-CELLS; MURINE CYTOMEGALOVIRUS; VIRAL-INFECTION; CUTTING EDGE; NK CELLS; INTERFERON-ALPHA/BETA; BACTERIAL-INFECTIONS; PROTECTIVE IMMUNITY; ANTIVIRAL RESPONSE,"In mice, plasmacytoid dendritic cells (pDC) and natural killer (NK) cells both contribute to resistance to systemic infections with herpes viruses including mouse Cytomegalovirus (MCMV). pDCs are the major source of type I IFN (IFN-I) during MCMV infection. This response requires pDC-intrinsic MyD88-dependent signaling by Toll-Like Receptors 7 and 9. Provided that they express appropriate recognition receptors such as Ly49H, NK cells can directly sense and kill MCMV-infected cells. The loss of any one of these responses increases susceptibility to infection. However, the relative importance of these antiviral immune responses and how they are related remain unclear. In humans, while IFN-I responses are essential, MyD88 is dispensable for antiviral immunity. Hence, a higher redundancy has been proposed in the mechanisms promoting protective immune responses against systemic infections by herpes viruses during natural infections in humans. It has been assumed, but not proven, that mice fail to mount protective MyD88-independent IFN-I responses. In humans, the mechanism that compensates MyD88 deficiency has not been elucidated. To address these issues, we compared resistance to MCMV infection and immune responses between mouse strains deficient for MyD88, the IFN-I receptor and/or Ly49H. We show that selective depletion of pDC or genetic deficiencies for MyD88 or TLR9 drastically decreased production of IFN-I, but not the protective antiviral responses. Moreover, MyD88, but not IFN-I receptor, deficiency could largely be compensated by Ly49H-mediated antiviral NK cell responses. Thus, contrary to the current dogma but consistent with the situation in humans, we conclude that, in mice, in our experimental settings, MyD88 is redundant for IFN-I responses and overall defense against a systemic herpes virus infection. Moreover, we identified direct NK cell sensing of infected cells as one mechanism able to compensate for MyD88 deficiency in mice. Similar mechanisms likely contribute to protect MyD88- or IRAK4-deficient patients from viral infections.","[Cocita, Clement; Guiton, Rachel; Bessou, Gilles; Chasson, Lionel; Boyron, Marilyn; Crozat, Karine; Dalod, Marc] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Univ UM2, Marseille, France; [Cocita, Clement; Guiton, Rachel; Bessou, Gilles; Chasson, Lionel; Boyron, Marilyn; Crozat, Karine; Dalod, Marc] INSERM, U1104, Marseille, France; [Cocita, Clement; Guiton, Rachel; Bessou, Gilles; Chasson, Lionel; Boyron, Marilyn; Crozat, Karine; Dalod, Marc] CNRS, UMR7280, Marseille, France","Dalod, M (reprint author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, Univ UM2, Parc Sci & Technol Luminy, Marseille, France.",dalod@ciml.univ-mrs.fr,"Crozat, Karine/L-7297-2019","Crozat, Karine/0000-0003-4761-3675; Dalod, Marc/0000-0002-6436-7966; Guiton, Rachel/0000-0002-7155-8736","Agence Nationale de la Recherche (ANR)(EMICIF) [ANR-08-MIEN-008-02]; Fondation pour la Recherche Medicale (FRM) [DEQ20110421284]; DCBIOL Labex [ANR-11-LABEX-0043, ANR-10-IDEX-0001-02 PSL*]; A*MIDEX project - French Government [ANR-11-IDEX-0001-02]; FRM; DCBIOL Labex","This research was funded by grants from Agence Nationale de la Recherche (ANR)(EMICIF, reference ANR-08-MIEN-008-02) and from Fondation pour la Recherche Medicale (FRM, reference DEQ20110421284), as well as by institutional support from CNRS, Inserm and Aix-Marseille Universite. We also acknowledge support from the DCBIOL Labex (ANR-11-LABEX-0043, grant ANR-10-IDEX-0001-02 PSL*) and the A*MIDEX project (ANR-11-IDEX-0001-02) funded by the French Government's ""Investissements d'Avenir"" program managed by the ANR. CC was supported by the FRM and by the DCBIOL Labex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,82,5,5,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004897,10.1371/journal.ppat.1004897,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300041,25954804.0,"DOAJ Gold, Green Published",,,16/08/2019,6,1,13,4084,735,535,200,3349,2806,22,521,13,0,0,0,5,5,0,,16,0,16,0,0,6,6,5,5,0,0,0,0,0,0,0,1,4,4118,30,0,72,132,0,3359,742,30,0,72,132,0,17,,0,0,0,0,5,0,0,1,0,0,0,16,0,0,2.5,5.556462585034014,1.2194684980591222,0.21946849805912214,1.277993430874888,1.0479921645445642,5.8231292517006805
618,J,"de Macedo, JP; Burkard, GS; Niemann, M; Barrett, MP; Vial, H; Maser, P; Roditi, I; Schneider, A; Butikofer, P",,,,"de Macedo, Juan P.; Burkard, Gabriela Schumann; Niemann, Moritz; Barrett, Michael P.; Vial, Henri; Maeser, Pascal; Roditi, Isabel; Schneider, Andre; Buetikofer, Peter",,,An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei,PLOS PATHOGENS,,,English,Article,,,,,,,BLOOD-STREAM FORMS; AFRICAN TRYPANOSOMES; IN-VITRO; PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTIVITY; PHOSPHOLIPID-METABOLISM; POTENT ANTIMALARIALS; PROTOZOAN PARASITES; AQUAGLYCEROPORIN 2; RESISTANCE,"Elucidating the mechanism of action of trypanocidal compounds is an important step in the development of more efficient drugs against Trypanosoma brucei. In a screening approach using an RNAi library in T. brucei bloodstream forms, we identified a member of the mitochondrial carrier family, TbMCP14, as a prime candidate mediating the action of a group of anti-parasitic choline analogs. Depletion of TbMCP14 by inducible RNAi in both bloodstream and procyclic forms increased resistance of parasites towards the compounds by 7-fold and 3-fold, respectively, compared to uninduced cells. In addition, down-regulation of TbMCP14 protected bloodstream form mitochondria from a drug-induced decrease in mitochondrial membrane potential. Conversely, over-expression of the carrier in procyclic forms increased parasite susceptibility more than 13-fold. Metabolomic analyses of parasites over-expressing TbMCP14 showed increased levels of the proline metabolite, pyrroline-5-carboxylate, suggesting a possible involvement of TbMCP14 in energy production. The generation of TbMCP14 knock-out parasites showed that the carrier is not essential for survival of T. brucei bloodstream forms, but reduced parasite proliferation under standard culture conditions. In contrast, depletion of TbMCP14 in procyclic forms resulted in growth arrest, followed by parasite death. The time point at which parasite proliferation stopped was dependent on the major energy source, i.e. glucose versus proline, in the culture medium. Together with our findings that proline-dependent ATP production in crude mitochondria from TbMCP14-depleted trypanosomes was reduced compared to control mitochondria, the study demonstrates that TbMCP14 is involved in energy production in T. brucei. Since TbMCP14 belongs to a trypanosomatid-specific clade of mitochondrial carrier family proteins showing very poor similarity to mitochondrial carriers of mammals, it may represent an interesting target for drug action or targeting.","[de Macedo, Juan P.; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [de Macedo, Juan P.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Burkard, Gabriela Schumann; Roditi, Isabel] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Niemann, Moritz; Schneider, Andre] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Barrett, Michael P.] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Barrett, Michael P.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow Poly, Glasgow, Lanark, Scotland; [Vial, Henri] Univ Montpellier 2, Dynam Mol Interact Membranaires, CNRS, UMR 5235, Montpellier, France; [Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Maeser, Pascal] Univ Basel, Basel, Switzerland","de Macedo, JP (reprint author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.",peter.buetikofer@ibmm.unibe.ch,"Macedo, Juan/B-4151-2017","Macedo, Juan/0000-0001-5759-1196; Roditi, Isabel/0000-0003-2812-6513; Barrett, Mike/0000-0001-9447-3519","Sinergia grants from the Swiss National Science Foundation [CRSII3_127300, CRSII3_141913]; Swiss National Science Foundation [149353, 138355]; Howard Hughes Medical Institute","This work was supported by Sinergia grants CRSII3_127300 and CRSII3_141913 from the Swiss National Science Foundation (to PB and PM) and, in part, by Swiss National Science Foundation grants 149353 (to PB) and 138355 (to AS), and a grant from the Howard Hughes Medical Institute (to IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,6,6,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004875,10.1371/journal.ppat.1004875,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300026,25946070.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,10,1,33,3774,623,476,147,3151,2685,27,439,33,1,0,0,9,9,0,,70,3,36,0,3,10,10,9,4,0,0,0,0,0,0,0,0,2,3830,48,0,45,102,0,3167,637,48,0,45,102,0,26,,0,0,0,0,2,0,0,1,0,0,0,37,0,0,1.0,6.057784911717496,1.197715011107585,0.19771501110758488,1.2630910821961283,1.0545839957604664,6.388443017656501
619,J,"Dembowski, JA; DeLuca, NA",,,,"Dembowski, Jill A.; DeLuca, Neal A.",,,Selective Recruitment of Nuclear Factors to Productively Replicating Herpes Simplex Virus Genomes,PLOS PATHOGENS,,,English,Article,,,,,,,RNA-POLYMERASE-II; REGULATORY PROTEIN ICP4; URACIL-DNA GLYCOSYLASE; EPSTEIN-BARR-VIRUS; LYTIC INFECTION; GENE-EXPRESSION; NASCENT DNA; TYPE-1 DNA; HOMOLOGOUS RECOMBINATION; MACROMOLECULAR-SYNTHESIS,"Much of the HSV-1 life cycle is carried out in the cell nucleus, including the expression, replication, repair, and packaging of viral genomes. Viral proteins, as well as cellular factors, play essential roles in these processes. Isolation of proteins on nascent DNA (iPOND) was developed to label and purify cellular replication forks. We adapted aspects of this method to label viral genomes to both image, and purify replicating HSV-1 genomes for the identification of associated proteins. Many viral and cellular factors were enriched on viral genomes, including factors that mediate DNA replication, repair, chromatin remodeling, transcription, and RNA processing. As infection proceeded, packaging and structural components were enriched to a greater extent. Among the more abundant proteins that copurified with genomes were the viral transcription factor ICP4 and the replication protein ICP8. Furthermore, all seven viral replication proteins were enriched on viral genomes, along with cellular PCNA and topoisomerases, while other cellular replication proteins were not detected. The chromatin-remodeling complexes present on viral genomes included the INO80, SWI/SNF, NURD, and FACT complexes, which may prevent chromatinization of the genome. Consistent with this conclusion, histones were not readily recovered with purified viral genomes, and imaging studies revealed an underrepresentation of histones on viral genomes. RNA polymerase II, the mediator complex, TFIID, TFIIH, and several other transcriptional activators and repressors were also affinity purified with viral DNA. The presence of INO80, NURD, SWI/SNF, mediator, TFIID, and TFIIH components is consistent with previous studies in which these complexes copurified with ICP4. Therefore, ICP4 is likely involved in the recruitment of these key cellular chromatin remodeling and transcription factors to viral genomes. Taken together, iPOND is a valuable method for the study of viral genome dynamics during infection and provides a comprehensive view of how HSV-1 selectively utilizes cellular resources.","[Dembowski, Jill A.; DeLuca, Neal A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA","DeLuca, NA (reprint author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.",ndeluca@pitt.edu,,"Dembowski, Jill/0000-0002-0309-8053",NIH [R01AI030612],"This work was funded by a grant to NAD from the NIH, R01AI030612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,88,32,33,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004939,10.1371/journal.ppat.1004939,,,,35,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300062,26018390.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,30,2,33,8485,1087,807,280,7398,5182,26,2190,33,2,0,0,32,32,0,,51,0,51,0,0,33,33,27,24,0,0,0,0,0,0,0,0,2,8468,233,0,163,97,0,7349,1087,68,0,163,97,0,32,,0,0,0,0,4,0,0,1,0,0,0,51,0,0,1.75,7.8058877644894205,1.1469316031359826,0.1469316031359827,1.1892403352257366,1.0368886269888038,8.093836246550138
620,J,"Friberg, A; Thumann, S; Hennig, J; Zou, PJ; Nossner, E; Ling, PD; Sattler, M; Kempkes, B",,,,"Friberg, Anders; Thumann, Sybille; Hennig, Janosch; Zou, Peijian; Noessner, Elfriede; Ling, Paul D.; Sattler, Michael; Kempkes, Bettina",,,The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation,PLOS PATHOGENS,,,English,Article,,,,,,,EPSTEIN-BARR-VIRUS; NUCLEAR-PROTEIN 2; LYMPHOCYTE GROWTH TRANSFORMATION; NUCLEAR-PROTEIN-2 ACIDIC DOMAIN; RBP-J-KAPPA; BINDING-PROTEIN; CELL-LINES; IN-VITRO; TRANSCRIPTION; ANTIGEN-2,"Epstein-Barr virus (EBV) is a gamma-herpesvirus that may cause infectious mononucleosis in young adults. In addition, epidemiological and molecular evidence links EBV to the pathogenesis of lymphoid and epithelial malignancies. EBV has the unique ability to transform resting B cells into permanently proliferating, latently infected lymphoblastoid cell lines. Epstein-Barr virus nuclear antigen 2 (EBNA-2) is a key regulator of viral and cellular gene expression for this transformation process. The N-terminal region of EBNA-2 comprising residues 1-58 appears to mediate multiple molecular functions including self-association and transactivation. However, it remains to be determined if the N-terminus of EBNA-2 directly provides these functions or if these activities merely depend on the dimerization involving the N-terminal domain. To address this issue, we determined the three-dimensional structure of the EBNA-2 N-terminal dimerization (END) domain by heteronuclear NMR-spectroscopy. The END domain monomer comprises a small fold of four beta-strands and an a-helix which form a parallel dimer by interaction of two beta-strands from each protomer. A structure-guided mutational analysis showed that hydrophobic residues in the dimer interface are required for self-association in vitro. Importantly, these interface mutants also displayed severely impaired self-association and transactivation in vivo. Moreover, mutations of solvent-exposed residues or deletion of the alpha-helix do not impair dimerization but strongly affect the functional activity, suggesting that the EBNA-2 dimer presents a surface that mediates functionally important intra- and/or intermolecular interactions. Our study shows that the END domain is a novel dimerization fold that is essential for functional activity. Since this specific fold is a unique feature of EBNA-2 it might provide a novel target for anti-viral therapeutics.","[Friberg, Anders; Hennig, Janosch; Zou, Peijian; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, Natl Res Ctr Environm Hlth, Neuherberg, Germany; [Friberg, Anders; Hennig, Janosch; Zou, Peijian; Sattler, Michael] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Chair Biomol NMR Spect, Dept Chem, Garching, Germany; [Thumann, Sybille; Kempkes, Bettina] Helmholtz Zentrum Munchen, Dept Gene Vectors, Natl Res Ctr Environm Hlth, Hematologikum, Neuherberg, Germany; [Zou, Peijian; Sattler, Michael] Chinese Acad Sci, Ind Enzymes Natl Engn Lab, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Noessner, Elfriede] Helmholtz Zentrum Munchen, Inst Mol Immunol, Natl Res Ctr Environm Hlth, Hematologikum, Neuherberg, Germany; [Ling, Paul D.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA","Sattler, M (reprint author), Helmholtz Zentrum Munchen, Inst Biol Struct, Natl Res Ctr Environm Hlth, Neuherberg, Germany.",sattler@helmholtz-muenchen.de; kempkes@helmholtz-muenchen.de,"Sattler, Michael/A-2407-2012; Kempkes, Bettina/B-3322-2013","Sattler, Michael/0000-0002-1594-0527; Friberg, Anders/0000-0002-3912-8162","Helmholtz Zentrum Munchen (HMGU); International PhD program in Protein Dynamics from Elitenetzwerk Bayern; Swedish Research Council (Vetenskapsradet); European Molecular Biology Organization (EMBO) [ALTF-276-2010]; HELENA graduate school; Deutsche Forschungsgemeinschaft [GRK1721, SFB1035]; Deutsche Krebshilfe [109258]; Deutsche Carreras Leukamie Stiftung DJCLS [R07/11]","AF was supported by a PhD fellowship from Helmholtz Zentrum Munchen (HMGU), and by the International PhD program in Protein Dynamics from Elitenetzwerk Bayern. JH gratefully acknowledges the Swedish Research Council (Vetenskapsradet) and the European Molecular Biology Organization (EMBO, ALTF-276-2010) for postdoctoral fellowships. ST was supported by the HELENA graduate school. The authors acknowledge NMR measurement time at the Bavarian NMR Centre, Garching, Germany. This work was supported by the Deutsche Forschungsgemeinschaft, GRK1721 (MS) and SFB1035 (MS), by the Deutsche Krebshilfe 109258 (BK) and Deutsche Carreras Leukamie Stiftung DJCLS R07/11 (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,69,2,2,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004910,10.1371/journal.ppat.1004910,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300049,26024477.0,"DOAJ Gold, Green Published",,,16/08/2019,2,91,6,4184,767,652,115,3417,2948,19,450,6,0,0,0,3,3,0,,7,0,7,0,0,4,3,4,2,0,0,0,0,0,0,0,90,1,4241,42,0,130,93,0,3441,787,42,0,130,93,0,13,,0,0,0,0,3,0,0,1,0,0,0,9,0,0,1.0,5.455019556714472,1.2244659057652911,0.22446590576529118,1.2806555458004096,1.0458891013384322,5.705345501955671
621,J,"Gatta, V; Petrovic, B; Campadelli-Fiume, G",,,,"Gatta, Valentina; Petrovic, Biljana; Campadelli-Fiume, Gabriella",,,The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors,PLOS PATHOGENS,,,English,Article,,,,,,,HERPES-SIMPLEX-VIRUS; PRO-FUSION DOMAIN; GLYCOPROTEIN-D; PSEUDORABIES VIRUS; ENTER CELLS; POLIOVIRUS RECEPTOR; 1 ENTRY; TYPE-1; RECOMBINANT; GB,"Herpes simplex virus (HSV) enters cells by means of four essential glycoproteins - gD, gH/gL, gB, activated in a cascade fashion by gD binding to one of its receptors, nectin1 and HVEM. We report that the engineering in gH of a heterologous ligand - a single-chain antibody (scFv) to the cancer-specific HER2 receptor - expands the HSV tropism to cells which express HER2 as the sole receptor. The significance of this finding is twofold. It impacts on our understanding of HSV entry mechanism and the design of retargeted oncolytic-HSVs. Specifically, entry of the recombinant viruses carrying the scFv-HER2-gH chimera into HER2(+) cells occurred in the absence of gD receptors, or upon deletion of key residues in gD that constitute the nectin1/HVEM binding sites. In essence, the scFv in gH substituted for gD-mediated activation and rendered a functional gD non-essential for entry via HER2. The activation of the gH moiety in the chimera was carried out by the scFv in cis, not in trans as it occurs with wt-gD. With respect to the design of oncolytic-HSVs, previous retargeting strategies were based exclusively on insertion in gD of ligands to cancer-specific receptors. The current findings show that (i) gH accepts a heterologous ligand. The viruses retargeted via gH (ii) do not require the gD-dependent activation, and (iii) replicate and kill cells at high efficiency. Thus, gH represents an additional tool for the design of fully-virulent oncolytic-HSVs retargeted to cancer receptors and detargeted from gD receptors.","[Gatta, Valentina; Petrovic, Biljana; Campadelli-Fiume, Gabriella] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy","Campadelli-Fiume, G (reprint author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.",gabriella.campadelli@unibo.it,,"GATTA, VALENTINA/0000-0001-7935-284X; PETROVIC, BILJANA/0000-0002-1312-8842; Campadelli-Fiume, Gabriella/0000-0002-6012-6081; GATTA, Valentina/0000-0002-9999-5823",ERC [340060]; Italian Association for Cancer Research (AIRC) [14535]; University of Bologna RFO (Ricerca Fondamentale Orientata); Italian Ministry for University and Research (PRIN project); Pallotti Funds from our Department,"This work was funded by ERC Advanced grant # 340060; by Italian Association for Cancer Research (AIRC) # 14535; by the University of Bologna RFO (Ricerca Fondamentale Orientata); by the Italian Ministry for University and Research (PRIN project) and by Pallotti Funds from our Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,62,17,17,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004907,10.1371/journal.ppat.1004907,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300046,25996983.0,"DOAJ Gold, Green Published",,,16/08/2019,17,5,7,3325,678,478,200,2647,2234,18,395,7,5,0,0,16,16,0,,12,3,12,0,3,17,17,17,14,0,0,0,0,0,0,0,0,1,3316,61,0,62,53,0,2626,678,61,0,62,53,0,12,,0,0,0,0,4,0,0,1,0,0,0,12,0,0,5.0,4.904129793510324,1.2561390253116735,0.2561390253116736,1.2958065734794106,1.0315789473684212,5.058997050147493
622,J,"Greenfeld, H; Takasaki, K; Walsh, MJ; Ersing, I; Bernhardt, K; Ma, YJ; Fu, BS; Ashbaugh, CW; Cabo, J; Mollo, SB; Zhou, HF; Li, ST; Gewurz, BE",,,,"Greenfeld, Hannah; Takasaki, Kaoru; Walsh, Michael J.; Ersing, Ina; Bernhardt, Katharina; Ma, Yijie; Fu, Bishi; Ashbaugh, Camille W.; Cabo, Jackson; Mollo, Sarah B.; Zhou, Hufeng; Li, Shitao; Gewurz, Benjamin E.",,,TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; MEMBRANE-PROTEIN 1; RECEPTOR-ASSOCIATED FACTOR-1; LATENT INFECTION MEMBRANE-PROTEIN-1; CHAIN ASSEMBLY COMPLEX; WIDE SIRNA SCREEN; LYMPHOCYTE TRANSFORMATION; LINEAR UBIQUITINATION; INTERACTION NETWORK; STRUCTURAL BASIS,"The Epstein-Barr virus (EBV) encoded oncoprotein Latent Membrane Protein 1 (LMP1) signals through two C-terminal tail domains to drive cell growth, survival and transformation. The LMP1 membrane-proximal TES1/CTAR1 domain recruits TRAFs to activate MAP kinase, non-canonical and canonical NF-kB pathways, and is critical for EBV-mediated B-cell transformation. TRAF1 is amongst the most highly TES1-induced target genes and is abundantly expressed in EBV-associated lymphoproliferative disorders. We found that TRAF1 expression enhanced LMP1 TES1 domain-mediated activation of the p38, JNK, ERK and canonical NF-kB pathways, but not non-canonical NF-kB pathway activity. To gain insights into how TRAF1 amplifies LMP1 TES1 MAP kinase and canonical NF-kB pathways, we performed proteomic analysis of TRAF1 complexes immuno-purified from cells uninduced or induced for LMP1 TES1 signaling. Unexpectedly, we found that LMP1 TES1 domain signaling induced an association between TRAF1 and the linear ubiquitin chain assembly complex (LUBAC), and stimulated linear (M1)-linked polyubiquitin chain attachment to TRAF1 complexes. LMP1 or TRAF1 complexes isolated from EBV-transformed lymphoblastoid B cell lines (LCLs) were highly modified by M1-linked polyubiqutin chains. The M1-ubiquitin binding proteins IKK-gamma/NEMO, A20 and ABIN1 each associate with TRAF1 in cells that express LMP1. TRAF2, but not the cIAP1 or cIAP2 ubiquitin ligases, plays a key role in LUBAC recruitment and M1-chain attachment to TRAF1 complexes, implicating the TRAF1: TRAF2 heterotrimer in LMP1 TES1-dependent LUBAC activation. Depletion of either TRAF1, or the LUBAC ubiquitin E3 ligase subunit HOIP, markedly impaired LCL growth. Likewise, LMP1 or TRAF1 complexes purified from LCLs were decorated by lysine 63 (K63)-linked polyubiqutin chains. LMP1 TES1 signaling induced K63-polyubiquitin chain attachment to TRAF1 complexes, and TRAF2 was identified as K63-Ub chain target. Co-localization of M1-and K63-linked polyubiquitin chains on LMP1 complexes may facilitate downstream canonical NF-kB pathway activation. Our results highlight LUBAC as a novel potential therapeutic target in EBV-associated lymphoproliferative disorders.","[Greenfeld, Hannah; Takasaki, Kaoru; Walsh, Michael J.; Ersing, Ina; Bernhardt, Katharina; Ma, Yijie; Ashbaugh, Camille W.; Cabo, Jackson; Mollo, Sarah B.; Zhou, Hufeng; Gewurz, Benjamin E.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Fu, Bishi; Li, Shitao] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA USA","Greenfeld, H (reprint author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.",bgewurz@partners.org,"Zhou, Hufeng/M-1307-2014","Zhou, Hufeng/0000-0001-9382-5674; Li, Shitao/0000-0002-1398-8519","Burroughs Wellcome Fund Career Award in Medical Sciences; National Cancer institute [K08 CA140780, RO1 CA085180]; National Institute of Allergy and Infectious Diseases [RO1 AI089829]","This study was funded by a Burroughs Wellcome Fund Career Award in Medical Sciences www.bwf.org and a National Cancer institute K08 CA140780 to BEG, National Cancer Institute RO1 CA085180, and National Institute of Allergy and Infectious Diseases RO1 AI089829. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,100,23,25,0,13,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004890,10.1371/journal.ppat.1004890,,,,35,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300034,25996949.0,"DOAJ Gold, Green Published",,,16/08/2019,24,7,16,5167,1212,925,287,3955,3291,29,635,16,7,0,0,24,24,1,,20,0,20,0,0,25,25,16,18,0,0,0,0,0,0,0,0,4,5214,107,0,119,143,1,3970,1230,107,0,119,143,1,14,,0,0,0,0,10,0,0,1,0,0,0,20,0,0,5.45,4.263201320132013,1.3064475347661189,0.30644753476611886,1.3815423514538558,1.0574801625701569,4.508250825082508
623,J,"Gupta, S; Garg, NJ",,,,"Gupta, Shivali; Garg, Nisha J.",,,"A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi",PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN CHAGAS-DISEASE; AMERICAN TRYPANOSOMIASIS; UNITED-STATES; INFECTION; MICE; MEMORY; CARDIOMYOPATHY; RESISTANCE; CANDIDATES; EXPRESSION,"In this study, we evaluated the long-term efficacy of a two-component subunit vaccine against Trypanosoma cruzi infection. C57BL/6 mice were immunized with TcG2/TcG4 vaccine delivered by a DNA-prime/Protein-boost (D/P) approach and challenged with T. cruzi at 120 or 180 days post-vaccination (dpv). We examined whether vaccine-primed T cell immunity was capable of rapid expansion and intercepting the infecting T. cruzi. Our data showed that D/P vaccine elicited CD4(+) (30-38%) and CD8(+) (22-42%) T cells maintained an effector phenotype up to 180 dpv, and were capable of responding to antigenic stimulus or challenge infection by a rapid expansion (CD8>CD4) with type 1 cytokine (IFN gamma(+) and TFN alpha(+)) production and cytolytic T lymphocyte (CTL) activity. Subsequently, challenge infection at 120 or 180 dpv, resulted in 2-3-fold lower parasite burden in vaccinated mice than was noted in unvaccinated/infected mice. Co-delivery of IL-12- and GMCSF-encoding expression plasmids provided no significant benefits in enhancing the anti-parasite efficacy of the vaccine-induced T cell immunity. Booster immunization (bi) with recombinant TcG2/TcG4 proteins 3-months after primary vaccine enhanced the protective efficacy, evidenced by an enhanced expansion (1.2-2.8-fold increase) of parasite-specific, type 1 CD4(+) and CD8(+) T cells and a potent CTL response capable of providing significantly improved (3-4.5-fold) control of infecting T. cruzi. Further, CD8(+) T cells in vaccinated/bi mice were predominantly of central memory phenotype, and capable of responding to challenge infection 4-6-months post bi by a rapid expansion to a poly-functional effector phenotype, and providing a 1.5-2.3-fold reduction in tissue parasite replication. We conclude that the TcG2/TcG4 D/P vaccine provided long-term anti-T. cruzi T cell immunity, and bi would be an effective strategy to maintain or enhance the vaccine-induced protective immunity against T. cruzi infection and Chagas disease.","[Gupta, Shivali; Garg, Nisha J.] Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garg, Nisha J.] Univ Texas Med Branch, Sch Med, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha J.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha J.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA","Gupta, S (reprint author), Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA.",shgupta@utmb.edu; nigarg@utmb.edu,,,National Institutes of Health/National Institute of Allergy and Infectious Diseases [2RO1AI05478-07]; Sealy Center for Vaccine Development (SCVD) post-doctoral fellowship,"This work was supported in part by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (2RO1AI05478-07) to NJG. SG was a recipient of a Sealy Center for Vaccine Development (SCVD) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,60,23,23,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004828,10.1371/journal.ppat.1004828,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300012,25951312.0,"DOAJ Gold, Green Published",,,16/08/2019,21,76,31,6228,663,484,179,5565,4847,24,694,31,41,0,3,18,18,11,,55,4,55,0,4,21,21,19,12,0,0,0,0,0,0,1,35,15,6332,20,0,104,61,3,5552,663,20,0,104,61,3,117,,8,2,0,0,49,0,2,1,1,0,0,55,0,0,107.482,9.393665158371041,1.1191374663072777,0.11913746630727763,1.1523809523809523,1.0297045600513808,9.672699849170437
624,J,"Hillmer, RA",,,,"Hillmer, Rachel A.",,,Systems Biology for Biologists,PLOS PATHOGENS,,,English,Article,,,,,,,CELL,,"[Hillmer, Rachel A.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Hillmer, Rachel A.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA","Hillmer, RA (reprint author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.",hillm101@umn.edu,,,"National Science Foundation [IOS-1121425, DBI-1146819]; University of Minnesota","This work has been supported by the grants IOS-1121425 and DBI-1146819 from the National Science Foundation (http://www.nsf.gov/) and by a Doctoral Dissertation Fellowship from the University of Minnesota (http://www1.umn.edu/twincities/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,18,3,3,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004786,10.1371/journal.ppat.1004786,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300004,25973920.0,"DOAJ Gold, Green Published",,,16/08/2019,2,115,78,12173,1908,1704,204,10265,8792,16,1457,70,19,0,0,5,5,0,,96,4,87,9,4,4,4,2,1,0,0,0,0,0,0,0,95,17,12235,5,24,20,130,13,10220,1908,5,24,20,130,13,107,,0,0,0,0,42,0,3,2,0,0,0,86,8,0,27.55,6.379979035639413,1.185874330248417,0.18587433024841696,1.205065757428154,1.0161833566088885,6.483228511530398
625,J,"Hyodo, K; Taniguchi, T; Manabe, Y; Kaido, M; Mise, K; Sugawara, T; Taniguchi, H; Okuno, T",,,,"Hyodo, Kiwamu; Taniguchi, Takako; Manabe, Yuki; Kaido, Masanori; Mise, Kazuyuki; Sugawara, Tatsuya; Taniguchi, Hisaaki; Okuno, Tetsuro",,,Phosphatidic Acid Produced by Phospholipase D Promotes RNA Replication of a Plant RNA Virus,PLOS PATHOGENS,,,English,Article,,,,,,,CAP-INDEPENDENT TRANSLATION; MOSAIC-VIRUS; VIRAL-RNA; DISEASE RESISTANCE; DEFENSE RESPONSES; UNTRANSLATED REGION; ARABIDOPSIS; PROTEIN; ACTIVATION; BINDING,"Eukaryotic positive-strand RNA [(+) RNA] viruses are intracellular obligate parasites replicate using the membrane-bound replicase complexes that contain multiple viral and host components. To replicate, (+) RNA viruses exploit host resources and modify host metabolism and membrane organization. Phospholipase D (PLD) is a phosphatidylcholine-and phosphatidylethanolamine-hydrolyzing enzyme that catalyzes the production of phosphatidic acid (PA), a lipid second messenger that modulates diverse intracellular signaling in various organisms. PA is normally present in small amounts (less than 1% of total phospholipids), but rapidly and transiently accumulates in lipid bilayers in response to different environmental cues such as biotic and abiotic stresses in plants. However, the precise functions of PLD and PA remain unknown. Here, we report the roles of PLD and PA in genomic RNA replication of a plant (+) RNA virus, Red clover necrotic mosaic virus (RCNMV). We found that RCNMV RNA replication complexes formed in Nicotiana benthamiana contained PLD alpha and PLD beta. Gene-silencing and pharmacological inhibition approaches showed that PLDs and PLDs-derived PA are required for viral RNA replication. Consistent with this, exogenous application of PA enhanced viral RNA replication in plant cells and plant-derived cell-free extracts. We also found that a viral auxiliary replication protein bound to PA in vitro, and that the amount of PA increased in RCNMV-infected plant leaves. Together, our findings suggest that RCNMV hijacks host PA-producing enzymes to replicate.","[Hyodo, Kiwamu; Kaido, Masanori; Mise, Kazuyuki; Okuno, Tetsuro] Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan; [Taniguchi, Takako; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan; [Manabe, Yuki; Sugawara, Tatsuya] Kyoto Univ, Lab Marine Bioprod Technol, Grad Sch Agr, Kyoto, Japan","Okuno, T (reprint author), Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan.",okuno@kais.kyoto-u.ac.jp,,"Hyodo, Kiwamu/0000-0003-3849-7975; Sugawara, Tatsuya/0000-0002-1203-5521; Manabe, Yuki/0000-0002-5663-0074","Japan Society for the Promotion of Science [22248002, 25115509]","This study was supported by a Grant-in Aid for Science Research (A) (22248002) and by a Grant-in Aid for Science Research on Innovative Areas (25115509) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,77,21,21,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004909,10.1371/journal.ppat.1004909,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300048,26020241.0,"DOAJ Gold, Green Published",,,16/08/2019,21,0,19,4538,478,351,127,4060,3306,26,728,19,0,0,0,22,22,0,,32,0,32,0,0,22,21,22,11,0,0,0,0,0,0,0,0,1,4534,128,0,271,29,1,4039,478,128,0,271,29,1,17,,0,0,0,0,1,0,0,1,0,0,0,32,0,0,0.5,9.493723849372385,1.1177339901477832,0.11773399014778325,1.1554187192118226,1.0337152930806524,9.813807531380753
626,J,"Jaouannet, M; Morris, JA; Hedley, PE; Bos, JIB",,,,"Jaouannet, Maelle; Morris, Jenny A.; Hedley, Peter E.; Bos, Jorunn I. B.",,,Characterization of Arabidopsis Transcriptional Responses to Different Aphid Species Reveals Genes that Contribute to Host Susceptibility and Non-host Resistance,PLOS PATHOGENS,,,English,Article,,,,,,,GREEN PEACH APHID; EMBRYOGENESIS ABUNDANT PROTEINS; VEGETATIVE STORAGE PROTEIN; MYZUS-PERSICAE; PLANT DEFENSE; BREVICORYNE-BRASSICAE; OXIDATIVE STRESS; MYOINOSITOL OXYGENASE; HETERODERA-SCHACHTII; RUSSIAN WHEAT,"Aphids are economically important pests that display exceptional variation in host range. The determinants of diverse aphid host ranges are not well understood, but it is likely that molecular interactions are involved. With significant progress being made towards understanding host responses upon aphid attack, the mechanisms underlying non-host resistance remain to be elucidated. Here, we investigated and compared Arabidopsis thaliana host and non-host responses to aphids at the transcriptional level using three different aphid species, Myzus persicae, Myzus cerasi and Rhopalosiphum pisum. Gene expression analyses revealed a high level of overlap in the overall gene expression changes during the host and non-host interactions with regards to the sets of genes differentially expressed and the direction of expression changes. Despite this overlap in transcriptional responses across interactions, there was a stronger repression of genes involved in metabolism and oxidative responses specifically during the host interaction with M. persicae. In addition, we identified a set of genes with opposite gene expression patterns during the host versus non-host interactions. Aphid performance assays on Arabidopsis mutants that were selected based on our transcriptome analyses identified novel genes contributing to host susceptibility, host defences during interactions with M. persicae as well to non-host resistance against R. padi. Understanding how plants respond to aphid species that differ in their ability to infest plant species, and identifying the genes and signaling pathways involved, is essential for the development of novel and durable aphid control in crop plants.","[Jaouannet, Maelle; Morris, Jenny A.; Hedley, Peter E.; Bos, Jorunn I. B.] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland; [Jaouannet, Maelle; Bos, Jorunn I. B.] Dundee Effector Consortium, Dundee, Scotland; [Bos, Jorunn I. B.] Univ Dundee, Div Plant Sci, Coll Life Sci, Dundee, Scotland","Bos, JIB (reprint author), James Hutton Inst, Cell & Mol Sci, Dundee, Scotland.",j.bos@dundee.ac.uk,"Bos, Jorunn/E-4703-2011; Hedley, Peter/F-1149-2011","Bos, Jorunn/0000-0003-3222-8643; Hedley, Peter/0000-0003-0866-324X",European Research Council; Royal Society of Edinburgh Fellowship; Marie Curie,"This work was funded by European Research Council Starting Grant ""APHIDHOST"" http://erc.europa.eu/molecular-determinants-aphid-host-range awarded to JIBB and a Royal Society of Edinburgh Fellowship (co-funded by Marie Curie) awarded to JIBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,57,17,17,0,40,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004918,10.1371/journal.ppat.1004918,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300052,25993686.0,"DOAJ Gold, Green Published",,,16/08/2019,16,8,33,5033,814,614,200,4219,3327,24,868,33,8,0,0,14,14,0,,43,7,43,0,7,16,16,12,11,0,0,0,0,0,0,0,0,3,5136,311,1,81,105,2,4260,831,311,1,81,105,2,45,,0,0,0,0,8,0,0,1,0,0,0,42,0,0,5.7,6.183046683046683,1.1929367148613415,0.19293671486134156,1.315951647309789,1.1031194118815815,6.820638820638821
627,J,"Landais, I; Pelton, C; Streblow, D; DeFilippis, V; McWeeney, S; Nelson, JA",,,,"Landais, Igor; Pelton, Chantel; Streblow, Daniel; DeFilippis, Victor; McWeeney, Shannon; Nelson, Jay A.",,,Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NF kappa B Signaling Pathway,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; HERPESVIRUS MICRORNAS TARGET; VARICELLA-ZOSTER-VIRUS; RECEPTOR 2; VIRAL MIRNAS; RISK-FACTOR; EXPRESSION; POLYMORPHISM; RECOGNITION; TOLL-LIKE-RECEPTOR-2,"Human Cytomegalovirus (HCMV) encodes multiple microRNAs (miRNAs) whose functions are just beginning to be uncovered. Using in silico approaches, we identified the Toll-Like Receptor (TLR) innate immunity pathway as a possible target of HCMV miRNAs. Luciferase reporter assay screens further identified TLR2 as a target of HCMV miR-UL112-3p. TLR2 plays a major role in innate immune response by detecting both bacterial and viral ligands, including HCMV envelope proteins gB and gH. TLR2 activates a variety of signal transduction routes including the NF kappa B pathway. Furthermore, TLR2 plays an important role in controlling CMV infection both in humans and in mice. Immunoblot analysis of cells transfected with a miR-UL112-3p mimic revealed that endogenous TLR2 is down-regulated by miR-UL112-3p with similar efficiency as a TLR2-targeting siRNA (siTLR2). We next found that TLR2 protein level decreases at late times during HCMV infection and correlates with miR-UL112-3p accumulation in fibroblasts and monocytic THP1 cells. Confirming direct miR-UL112-3p targeting, down-regulation of endogenous TLR2 was not observed in cells infected with HCMV mutants deficient in miR-UL112-3p expression, but transfection of miR-UL112-3p in these cells restored TLR2 down-regulation. Using a NF kappa B reporter cell line, we found that miR-UL112-3p transfection significantly inhibited NF kappa B-dependent luciferase activity with similar efficiency as siTLR2. Consistent with this observation, miR-UL112-3p transfection significantly reduced the expression of multiple cytokines (IL-1 beta, IL-6 and IL-8) upon stimulation with a TLR2 agonist. Finally, miR-UL112-3p transfection significantly inhibited the TLR2-induced post-translational activation of IRAK1, a kinase located in the upstream section of the TLR2/NF kappa B signaling axis. To our knowledge, this is the first identified mechanism of TLR2 modulation by HCMV and is the first report of functional targeting of TLR2 by a viral miRNA. These results provide a novel mechanism through which a HCMV miRNA regulates the innate immune response by down-regulating TLR-2 expression.","[Landais, Igor; Pelton, Chantel; Streblow, Daniel; DeFilippis, Victor; Nelson, Jay A.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Prevent Med, Portland, OR 97201 USA","Landais, I (reprint author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.",nelsonj@ohsu.edu,,,National Institute of Health [AI21640],"National Institute of Health (NIH.gov) grant AI21640 to JAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,75,33,39,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004881,10.1371/journal.ppat.1004881,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300030,25955717.0,"DOAJ Gold, Green Published",,,16/08/2019,39,18,27,4886,1387,943,444,3499,2786,20,693,27,2,0,0,33,33,0,,40,2,40,0,2,41,41,38,22,0,0,0,0,0,0,0,16,5,4928,39,0,57,70,0,3518,1395,39,0,57,70,0,15,,0,0,0,0,4,0,0,1,0,0,0,40,0,0,1.5,3.522710886806056,1.3963989711346099,0.39639897113460987,1.4395541583309517,1.0309046254604994,3.6315789473684212
628,J,"Lebarbenchon, C; Jaeger, A; Feare, C; Bastien, M; Dietrich, M; Larose, C; Lagadec, E; Rocamora, G; Shah, N; Pascalis, H; Boulinier, T; Le Corre, M; Stallknecht, DE; Dellagi, K",,,,"Lebarbenchon, Camille; Jaeger, Audrey; Feare, Chris; Bastien, Matthieu; Dietrich, Muriel; Larose, Christine; Lagadec, Erwan; Rocamora, Gerard; Shah, Nirmal; Pascalis, Herve; Boulinier, Thierry; Le Corre, Matthieu; Stallknecht, David E.; Dellagi, Koussay",,,Influenza A Virus on Oceanic Islands: Host and Viral Diversity in Seabirds in the Western Indian Ocean,PLOS PATHOGENS,,,English,Article,,,,,,,REVERSE TRANSCRIPTION-PCR; TERNS STERNA-FUSCATA; WILD BIRDS; MOLECULAR CHARACTERIZATION; MIGRATION; HEMAGGLUTININ; DUCKS; H9N2; REASSORTMENT; ANTIBODIES,"Ducks and seabirds are natural hosts for influenza A viruses (IAV). On oceanic islands, the ecology of IAV could be affected by the relative diversity, abundance and density of seabirds and ducks. Seabirds are the most abundant and widespread avifauna in the Western Indian Ocean and, in this region, oceanic islands represent major breeding sites for a large diversity of potential IAV host species. Based on serological assays, we assessed the host range of IAV and the virus subtype diversity in terns of the islands of the Western Indian Ocean. We further investigated the spatial variation in virus transmission patterns between islands and identified the origin of circulating viruses using a molecular approach. Our findings indicate that terns represent a major host for IAV on oceanic islands, not only for seabird-related virus subtypes such as H16, but also for those commonly isolated in wild and domestic ducks (H3, H6, H9, H12 subtypes). We also identified strong species-associated variation in virus exposure that may be associated to differences in the ecology and behaviour of terns. We discuss the role of tern migrations in the spread of viruses to and between oceanic islands, in particular for the H2 and H9 IAV subtypes.","[Lebarbenchon, Camille; Jaeger, Audrey; Bastien, Matthieu; Dietrich, Muriel; Lagadec, Erwan; Pascalis, Herve; Dellagi, Koussay] GIS CRVOI Ctr Rech & Veille Malad Emergentes Ocea, St Clotilde, Reunion, Reunion; [Lebarbenchon, Camille; Jaeger, Audrey; Lagadec, Erwan; Pascalis, Herve; Dellagi, Koussay] Univ La Reunion, UMR PIMIT Proc Infect Milieu Insulaire Trop, INSERM 1187, CNRS 9192,IRD 249, St Denis, Reunion, France; [Jaeger, Audrey; Bastien, Matthieu; Le Corre, Matthieu] Univ La Reunion, Lab Ecol Marine, FRE INEE CNRS 3560, St Denis, Reunion, France; [Feare, Chris; Larose, Christine] Grayswood Common, WildWings Bird Management, Haslemere, Surrey, England; [Lagadec, Erwan; Pascalis, Herve; Dellagi, Koussay] Inst Rech Dev, St Clotilde, Reunion, Reunion; [Rocamora, Gerard] Isl Conservat Soc, Mahe, Seychelles; [Shah, Nirmal] Nat Seychelles, Ctr Environm & Educ, Roche Caiman, Mahe, Seychelles; [Boulinier, Thierry] Ctr Natl Rech Sci, Ctr Ecol Fonct & Evolut, Montpellier, France; [Stallknecht, David E.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA","Lebarbenchon, C (reprint author), GIS CRVOI Ctr Rech & Veille Malad Emergentes Ocea, St Clotilde, Reunion, Reunion.",camille.lebarbenchon@univ-reunion.fr,"Pascalis, Herve/M-9410-2019; Pascalis, Herve/F-5726-2014; Lebarbenchon, Camille/H-7245-2013","Pascalis, Herve/0000-0002-6822-7311; Pascalis, Herve/0000-0002-6822-7311; Lebarbenchon, Camille/0000-0002-0922-7573; Abid, sayda/0000-0003-2488-1431; Dietrich, Muriel/0000-0002-2665-7970; Boulinier, Thierry/0000-0002-5898-7667","FEDER ""Pathogenes associes a la Faune Sauvage Ocean Indien"" (Programme Operationnel de Cooperation Territoriale) [31189]; CNRS - INEE / TAAF (AAP Iles Eparses ""PathOrnithoTiques"" project); CNRS - INEE / TAAF (""OMABIO"" project); Federation de Recherche Environnement-Biodiversite-Sante"" at the ""Universite de La Reunion""; National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200700007C]; FEDER ""Pathogenes associes a la Faune Sauvage Ocean Indien"" (Programme Operationnel de Cooperation Territoriale) [31189]; CNRS - INEE / TAAF (AAP Iles Eparses ""PathOrnithoTiques"" project); CNRS - INEE / TAAF (""OMABIO"" project); Federation de Recherche Environnement-Biodiversite-Sante"" at the ""Universite de La Reunion""; National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200700007C]","This work was funded by the FEDER ""Pathogenes associes a la Faune Sauvage Ocean Indien"" (Programme Operationnel de Cooperation Territoriale 2007-2013; no. 31189); the CNRS - INEE / TAAF (AAP Iles Eparses ""PathOrnithoTiques"" and ""OMABIO"" projects); the ""Federation de Recherche Environnement-Biodiversite-Sante"" at the ""Universite de La Reunion""; and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (contract no. HHSN266200700007C). CLe, AJ and MD post-doctoral fellowships were supported by the ""Run Emerge"" European Union's Seventh Framework Program (FP7/2007-2013; grant agreement no. 263958). The funding agencies did not have any involvement in the study design, implementation, or publishing of this study and the research presented herein represents the opinions of the authors, but not necessarily the opinions of the funding agencies.",,64,7,7,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004925,10.1371/journal.ppat.1004925,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300055,25996394.0,"DOAJ Gold, Green Published",,,16/08/2019,9,5,20,3498,494,366,128,3004,2536,20,448,20,5,0,0,7,7,0,,25,5,25,0,5,9,9,7,2,0,0,0,0,0,0,0,0,6,3502,51,0,74,85,1,2994,494,51,0,74,85,1,14,,0,0,0,0,9,0,1,1,0,0,0,25,0,0,4.7,7.080971659919029,1.1644474034620507,0.1644474034620506,1.211051930758988,1.0400228702115495,7.364372469635628
629,J,"Lee, J; Tian, YJ; Chan, ST; Kim, JY; Cho, C; Ou, JHJ",,,,"Lee, Jiyoung; Tian, Yongjun; Chan, Stephanie Tze; Kim, Ja Yeon; Cho, Cecilia; Ou, Jing-hsiung James",,,TNF-alpha Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism,PLOS PATHOGENS,,,English,Article,,,,,,,TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; NF-KAPPA-B; MOLECULAR-BIOLOGY; ACTIVATION; INFECTION; ENTRY; COMPARTMENTALIZATION; RECOGNITION,"Invasion by infectious pathogens can elicit a range of cytokine responses from host cells. These cytokines provide the initial host defense mechanism. In this report, we demonstrate that TNF-alpha, a pro-inflammatory cytokine, can be induced by hepatitis C virus (HCV) in its host cells in a biphasic manner. The initial induction of TNF-alpha by HCV was prompt and could be blocked by the antibody directed against the HCV E2 envelope protein and by chemicals that inhibit endocytosis, indicating the specificity of endocytic uptake of HCV in this induction. Further studies indicated that the induction of TNF-alpha was dependent on toll-like receptors 7 and 8 (TLR7/8) but not on other intracellular pattern recognition receptors. Consistently, siRNA-mediated gene silencing of the downstream effectors in the TLR7/8 signaling pathway including MyD88, IRAK1, TRAF6, TAK1 and p65 NF-kappa B suppressed the expression of TNF-alpha. The role of p65 NF-kappa B in the induction of TNF-alpha via transcriptional up-regulation was further confirmed by the chromatin immunoprecipitation assay. TNF-alpha induced by HCV could activate its own receptor TNFR1 on hepatocytes to suppress HCV replication. This suppressive effect of TNF-alpha on HCV was due to its role in supporting interferon signaling, as the suppression of its expression led to the loss of IFNAR2 and impaired interferon signaling and the induction of interferon-stimulated genes. In conclusion, our results indicate that hepatocytes can sense HCV infection via TLR7/8 to induce the expression of TNF-alpha, which inhibits HCV replication via an autocrine mechanism to support interferon signaling.","[Lee, Jiyoung; Tian, Yongjun; Chan, Stephanie Tze; Kim, Ja Yeon; Cho, Cecilia; Ou, Jing-hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA","Ou, JHJ (reprint author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.",jamesou@hsc.usc.edu,,,"NIH [AI083025, DK094652]","The work described in this manuscript was supported by NIH grants AI083025 and DK094652 (to JhJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,33,33,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004937,10.1371/journal.ppat.1004937,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300061,26023919.0,"DOAJ Gold, Green Published",,,16/08/2019,29,7,17,5512,1018,781,237,4494,3722,15,757,17,6,0,0,24,24,0,,29,4,29,0,4,29,29,20,17,0,0,0,0,0,0,0,1,5,5595,59,0,48,33,0,4534,1046,59,0,48,33,0,15,,0,0,0,0,11,0,0,1,0,0,0,29,0,0,4.25,5.414538310412573,1.2265242545616377,0.22652425456163774,1.265465064530485,1.0317489114658926,5.586444007858546
630,J,"Lewis, ERG; Bowers, JR; Barker, BM",,,,"Lewis, Eric R. G.; Bowers, Jolene R.; Barker, Bridget M.",,,Dust Devil: The Life and Times of the Fungus That Causes Valley Fever,PLOS PATHOGENS,,,English,Article,,,,,,,COCCIDIOIDES-IMMITIS; BAJA-CALIFORNIA; POSADASII; INFECTION; POPULATION; SOIL; MACROPHAGES; IMMUNITY; RECEPTOR; ARIZONA,,"[Lewis, Eric R. G.; Barker, Bridget M.] Translat Genom Inst, Northern Arizona Ctr Valley Fever Res, Flagstaff, AZ USA; [Barker, Bridget M.] No Arizona Univ, Ctr Microbial Genet & Genom, Dept Biol, Flagstaff, AZ 86011 USA",,elewis@tgen.org; jbowers@tgen.org; bbarker@tgen.org,"Barker, Bridget/H-7351-2019","Barker, Bridget/0000-0002-3439-4517",NIH/NIAID [5K22A-104801-02],"The preparation of this manuscript was supported by funding from NIH/NIAID award 5K22A-104801-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.",,45,15,15,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004762,10.1371/journal.ppat.1004762,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300003,25973899.0,"DOAJ Gold, Green Published",,,16/08/2019,19,116,16,8690,927,759,168,7763,5214,22,2527,16,4,1,0,17,17,0,,28,56,28,0,56,20,20,13,13,0,0,0,0,0,0,0,113,15,8973,112,2,2067,572,5,7629,927,112,2,2067,572,5,417,,0,0,0,0,37,0,5,1,0,0,0,30,0,0,23.55,9.374325782092772,1.1194125982223366,0.11941259822233673,1.2439778436171582,1.1112773302646721,10.41747572815534
631,J,"Litvintseva, AP; Brandt, ME; Mody, RK; Lockhart, SR",,,,"Litvintseva, Anastasia P.; Brandt, Mary E.; Mody, Rajal K.; Lockhart, Shawn R.",,,Investigating Fungal Outbreaks in the 21st Century,PLOS PATHOGENS,,,English,Article,,,,,,,INFECTION; MUCORMYCOSIS,,"[Litvintseva, Anastasia P.; Brandt, Mary E.; Mody, Rajal K.; Lockhart, Shawn R.] Ctr Dis Control & Prevent, Mycot Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA","Litvintseva, AP (reprint author), Ctr Dis Control & Prevent, Mycot Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.",frq8@cdc.gov,,,CDC,"This study was funded by CDC internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,21,8,8,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004804,10.1371/journal.ppat.1004804,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300008,25996829.0,"DOAJ Gold, Green Published",,,16/08/2019,8,76,18,7187,890,728,162,6297,5416,26,855,18,23,0,0,8,8,0,,26,4,25,0,4,9,9,9,7,0,0,0,0,0,0,7,49,10,7209,7,2,58,114,1,6287,890,7,2,58,114,1,32,,0,0,0,0,25,0,2,1,0,0,0,24,0,0,14.9,8.075280898876404,1.1413371446720662,0.14133714467206607,1.1640463712879148,1.0198970363155697,8.235955056179776
632,J,"Liu, MF; Lin, L; Gebremariam, T; Luo, GPS; Skory, CD; French, SW; Chou, TF; Edwards, JE; Ibrahim, AS",,,,"Liu, Mingfu; Lin, Lin; Gebremariam, Teclegiorgis; Luo, Guanpingsheng; Skory, Christopher D.; French, Samuel W.; Chou, Tsui-Fen; Edwards, John E., Jr.; Ibrahim, Ashraf S.",,,Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine,PLOS PATHOGENS,,,English,Article,,,,,,,SACCHAROMYCES-CEREVISIAE; IMPROVES SURVIVAL; INVASIVE ZYGOMYCOSIS; DESFERRIOXAMINE-B; DIALYSIS PATIENTS; IN-VITRO; MUCORMYCOSIS; SIDEROPHORE; TRANSPORT; MECHANISM,"Dialysis patients with chronic renal failure receiving deferoxamine for treating iron overload are uniquely predisposed for mucormycosis, which is most often caused by Rhizopus oryzae. Although the deferoxamine siderophore is not secreted by Mucorales, previous studies established that Rhizopus species utilize iron from ferrioxamine (iron-rich form of deferoxamine). Here we determined that the CBS domain proteins of Fob1 and Fob2 act as receptors on the cell surface of R. oryzae during iron uptake from ferrioxamine. Fob1 and Fob2 cell surface expression was induced in the presence of ferrioxamine and bound radiolabeled ferrioxamine. A R. oryzae strain with targeted reduced Fob1/Fob2 expression was impaired for iron uptake, germinating, and growing on medium with ferrioxamine as the sole source of iron. This strain also exhibited reduced virulence in a deferoxamine-treated, but not the diabetic ketoacidotic (DKA), mouse model of mucormycosis. The mechanism by which R. oryzae obtains iron from ferrioxamine involves the reductase/permease uptake system since the growth on ferrioxamine supplemented medium is associated with elevated reductase activity and the use of the ferrous chelator bathophenanthroline disulfonate abrogates iron uptake and growth on medium supplemented with ferrioxamine as a sole source of iron. Finally, R. oryzae mutants with reduced copies of the high affinity iron permease (FTR1) or with decreased FTR1 expression had an impaired iron uptake from ferrioxamine in vitro and reduced virulence in the deferoxamine-treated mouse model of mucormycosis. These two receptors appear to be conserved in Mucorales, and can be the subject of future novel therapy to maintain the use of deferoxamine for treating iron-overload.","[Liu, Mingfu; Lin, Lin; Gebremariam, Teclegiorgis; Luo, Guanpingsheng; French, Samuel W.; Edwards, John E., Jr.; Ibrahim, Ashraf S.] Harbor Univ Calif, Los Angeles Biomed Res Inst, Div Infect Dis, Los Angeles UCLA Med Ctr, Torrance, CA 90501 USA; [Lin, Lin; Edwards, John E., Jr.; Ibrahim, Ashraf S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Skory, Christopher D.] USDA, Natl Ctr Agr Utilizat Res, Peoria, IL USA; [French, Samuel W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [French, Samuel W.] Harbor Univ Calif, Div Med Genet, Dept Pediat, Los Angeles Med Ctr, Torrance, CA USA; [Chou, Tsui-Fen] Harbor Univ Calif, Div Med Genet, Dept Pediat, Los Angeles Med Ctr, Torrance, CA USA; [Chou, Tsui-Fen] Los Angeles Biomed Res Inst, Torrance, CA USA","Ibrahim, AS (reprint author), Harbor Univ Calif, Los Angeles Biomed Res Inst, Div Infect Dis, Los Angeles UCLA Med Ctr, Torrance, CA 90501 USA.",ibrahim@labiomed.org,,,Public Health Service [R01 AI063503],"This work was supported by Public Health Service grants R01 AI063503 to ASI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,15,15,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004842,10.1371/journal.ppat.1004842,,,,33,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300016,25974051.0,"DOAJ Gold, Green Published",,,16/08/2019,15,0,21,3183,776,610,166,2407,1979,24,404,21,0,0,0,12,12,0,,27,1,27,0,1,15,15,13,10,0,0,0,0,0,0,1,0,1,3193,50,0,119,61,0,2399,776,50,0,119,61,0,18,,0,0,0,0,1,0,0,1,0,0,0,27,0,0,0.5,4.10180412371134,1.3223930203572913,0.3223930203572912,1.3726630660573327,1.038014451775055,4.257731958762887
633,J,"Matar, CG; Anthony, NR; O'Flaherty, BM; Jacobs, NT; Priyamvada, L; Engwerda, CR; Speck, SH; Lamb, TJ",,,,"Matar, Caline G.; Anthony, Neil R.; O'Flaherty, Brigid M.; Jacobs, Nathan T.; Priyamvada, Lalita; Engwerda, Christian R.; Speck, Samuel H.; Lamb, Tracey J.",,,Gammaherpesvirus Co-infection with Malaria Suppresses Anti-parasitic Humoral Immunity,PLOS PATHOGENS,,,English,Article,,,,,,,EPSTEIN-BARR-VIRUS; PLASMODIUM-FALCIPARUM MALARIA; GERMINAL CENTER B; T-CELL IMMUNITY; ANTIBODY-RESPONSES; GAMMA-HERPESVIRUS; GAMBIAN CHILDREN; CLINICAL MALARIA; VIRAL-INFECTION; HIV-INFECTION,"Immunity to non-cerebral severe malaria is estimated to occur within 1-2 infections in areas of endemic transmission for Plasmodium falciparum. Yet, nearly 20% of infected children die annually as a result of severe malaria. Multiple risk factors are postulated to exacerbate malarial disease, one being co-infections with other pathogens. Children living in Sub-Saharan Africa are seropositive for Epstein Barr Virus (EBV) by the age of 6 months. This timing overlaps with the waning of protective maternal antibodies and susceptibility to primary Plasmodium infection. However, the impact of acute EBV infection on the generation of anti-malarial immunity is unknown. Using well established mouse models of infection, we show here that acute, but not latent murine gammaherpesvirus 68 (MHV68) infection suppresses the anti-malarial humoral response to a secondary malaria infection. Importantly, this resulted in the transformation of a non-lethal P. yoelii XNL infection into a lethal one; an outcome that is correlated with a defect in the maintenance of germinal center B cells and T follicular helper (Tfh) cells in the spleen. Furthermore, we have identified the MHV68 M2 protein as an important virus encoded protein that can: (i) suppress anti-MHV68 humoral responses during acute MHV68 infection; and (ii) plays a critical role in the observed suppression of anti-malarial humoral responses in the setting of co-infection. Notably, co-infection with an M2-null mutant MHV68 eliminates lethality of P. yoelii XNL. Collectively, our data demonstrates that an acute gammaherpesvirus infection can negatively impact the development of an anti-malarial immune response. This suggests that acute infection with EBV should be investigated as a risk factor for non-cerebral severe malaria in young children living in areas endemic for Plasmodium transmission.","[Matar, Caline G.; O'Flaherty, Brigid M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Matar, Caline G.; O'Flaherty, Brigid M.; Priyamvada, Lalita] Emory Univ, Microbiol & Mol Genet Grad Program, Laney Grad Sch, Atlanta, GA 30322 USA; [Anthony, Neil R.; Jacobs, Nathan T.; Priyamvada, Lalita; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis,Emory Childrens Ctr, Atlanta, GA USA; [Jacobs, Nathan T.] Emory Univ, Populat Biol Ecol & Evolut Grad Program, Laney Grad Sch, Atlanta, GA 30322 USA; [Engwerda, Christian R.] QIMR Berghofer Med Res Inst, Immunol & Infect Lab, Brisbane, Qld, Australia; [Speck, Samuel H.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA","Matar, CG (reprint author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.",sspeck@emory.edu; tracey.j.lamb@emory.edu,"Engwerda, Christian/I-3072-2015; Priyamvada, Lalita/J-6252-2019; Speck, Samuel/L-5893-2019","Priyamvada, Lalita/0000-0002-0479-0164; Engwerda, Christian/0000-0003-2813-4804",Queensland-USA Technology Alliance;  [R21 AI099847],"This work was supported by R21 AI099847 to SHS and a pilot grant from the Queensland-USA Technology Alliance to SHS and CRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,71,15,16,1,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004858,10.1371/journal.ppat.1004858,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300021,25996913.0,"DOAJ Gold, Green Published",,,16/08/2019,17,27,33,6625,770,610,160,5855,5035,22,798,33,22,0,0,17,17,4,,38,14,38,0,14,17,17,17,13,0,0,0,0,0,0,2,0,12,6636,43,34,59,182,1,5839,770,43,34,59,182,1,27,,4,2,0,0,29,0,0,1,0,0,0,38,0,0,59.708,8.603896103896103,1.1315115286080273,0.13151152860802734,1.1718189581554228,1.035622641509434,8.910389610389611
634,J,"McArthur, MA; Fresnay, S; Magder, LS; Darton, TC; Jones, C; Waddington, CS; Blohmke, CJ; Dougan, G; Angus, B; Levine, MM; Pollard, AJ; Sztein, MB",,,,"McArthur, Monica A.; Fresnay, Stephanie; Magder, Laurence S.; Darton, Thomas C.; Jones, Claire; Waddington, Claire S.; Blohmke, Christoph J.; Dougan, Gordon; Angus, Brian; Levine, Myron M.; Pollard, Andrew J.; Sztein, Marcelo B.",,,Activation of Salmonella Typhi-Specific Regulatory T Cells in Typhoid Disease in a Wild-Type S. Typhi Challenge Model,PLOS PATHOGENS,,,English,Article,,,,,,,TH17 CELLS; VOLUNTEERS; TY21A; EXPRESSION; RESPONSES; EFFECTOR; VACCINE; CD4(+); INTERLEUKIN-17; IMMUNIZATION,"Salmonella Typhi (S. Typhi), the causative agent of typhoid fever, causes significant morbidity and mortality worldwide. Currently available vaccines are moderately efficacious, and identification of immunological responses associated with protection or disease will facilitate the development of improved vaccines. We investigated S. Typhi-specific modulation of activation and homing potential of circulating regulatory T cells (T-reg) by flow and mass cytometry using specimens obtained from a human challenge study. Peripheral blood mononuclear cells were obtained from volunteers pre-and at multiple time-points post-challenge with wild-type S. Typhi. We identified differing patterns of S. Typhi-specific modulation of the homing potential of circulating T-reg between volunteers diagnosed with typhoid (TD) and those who were not (No TD). TD volunteers demonstrated up-regulation of the gut homing molecule integrin alpha 4 beta 7 pre-challenge, followed by a significant down-regulation post-challenge consistent with T-reg homing to the gut. Additionally, S. Typhi-specific T-reg from TD volunteers exhibited up-regulation of activation molecules post-challenge (e.g., HLA-DR, LFA-1). We further demonstrate that depletion of T-reg results in increased S. Typhi-specific cytokine production by CD8+ T-EM in vitro. These results suggest that the tissue distribution of activated T-reg, their characteristics and activation status may play a pivotal role in typhoid fever, possibly through suppression of S. Typhi-specific effector T cell responses. These studies provide important novel insights into the regulation of immune responses that are likely to be critical in protection against typhoid and other enteric infectious diseases.","[McArthur, Monica A.; Fresnay, Stephanie; Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Magder, Laurence S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Darton, Thomas C.; Jones, Claire; Waddington, Claire S.; Blohmke, Christoph J.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Darton, Thomas C.; Jones, Claire; Waddington, Claire S.; Blohmke, Christoph J.; Pollard, Andrew J.] Natl Inst Hlth Res Oxford Biomed Res Ctr, Oxford, England; [Dougan, Gordon] Wellcome Trust Sanger Inst, Microbial Pathogenesis Grp, Hinxton, England; [Angus, Brian] Univ Oxford, Nuffield Dept Med, Oxford, England","Sztein, MB (reprint author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.",msztein@medicine.umaryland.edu,"Darton, Thomas/H-2816-2017; Darton, Thomas/J-3611-2013; Angus, Brian/L-9246-2019","Darton, Thomas/0000-0003-2209-9956; Darton, Thomas/0000-0003-2209-9956; Angus, Brian/0000-0003-3598-7784","Wellcome Trust [092661]; NIHR Oxford Biomedical Research Centre; Jenner Institute; Oxford Martin School; NIAID, NIH, DHHS [R01-AI036525, U19 AI082655, U19-AI109776]; Passano Foundation Clinical Investigator Award; NIH [T32-AI07524]; European Union","This work was funded, in part, by a Strategic Translation award from the Wellcome Trust [grant number 092661], the NIHR Oxford Biomedical Research Centre [Clinical Research Fellowships to CSW and TCD], the Jenner Institute, the Oxford Martin School, the European Union [FP7, Marie Curie Research Fellowship to CJB], by NIAID, NIH, DHHS grants R01-AI036525, U19 AI082655 (Cooperative Center for Human Immunology [CCHI]) and U19-AI109776 (Center of Excellence for Translational Research [CETR], and a Passano Foundation Clinical Investigator Award (to MAM). SF was funded in part by NIH Fellowship Training Program in Vaccinology T32-AI07524. Fellowship Training Program in Vaccinology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the National Health Service, the National Institute for Health Research (NIHR) or the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,23,23,1,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004914,10.1371/journal.ppat.1004914,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300050,26001081.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,25,10,42,4614,902,675,227,3712,3057,18,637,40,10,0,0,24,24,0,,105,10,52,2,10,25,25,17,16,0,0,0,0,0,0,0,0,9,4662,29,0,204,167,0,3695,902,29,0,204,167,0,65,,0,0,0,0,9,0,0,1,0,0,0,51,2,0,4.2,5.11529933481153,1.2429956896551724,0.2429956896551724,1.308728448275862,1.0528825314260946,5.385809312638581
635,J,"Morias, Y; Abels, C; Laoui, D; Van Overmeire, E; Guilliams, M; Schouppe, E; Tacke, F; Devries, CJ; De Baetselier, P; Beschin, A",,,,"Morias, Yannick; Abels, Chloe; Laoui, Damya; Van Overmeire, Eva; Guilliams, Martin; Schouppe, Elio; Tacke, Frank; deVries, Carlie J.; De Baetselier, Patrick; Beschin, Alain",,,Ly6C(-) Monocytes Regulate Parasite-Induced Liver Inflammation by Inducing the Differentiation of Pathogenic Ly6C(+) Monocytes into Macrophages,PLOS PATHOGENS,,,English,Article,,,,,,,TRYPANOSOMA-CONGOLENSE INFECTIONS; CONVENTIONAL DENDRITIC CELLS; NITRIC-OXIDE SYNTHASE; MYELOID CELLS; AFRICAN TRYPANOSOMIASIS; T-CELLS; TISSUE MACROPHAGES; M2 MACROPHAGES; KUPFFER CELLS; IN-VIVO,"Monocytes consist of two well-defined subsets, the Ly6C(+) and Ly6C(-) monocytes. Both CD11b(+) myeloid cells populations have been proposed to infiltrate tissues during inflammation. While infiltration of Ly6C(+) monocytes is an established pathogenic factor during hepatic inflammation, the role of Ly6C(-) monocytes remains elusive. Mice suffering experimental African trypanosome infection die from systemic inflammatory response syndrome (SIRS) that is initiated by phagocytosis of parasites by liver myeloid cells and culminates in apoptosis/necrosis of liver myeloid and parenchymal cells that reduces host survival. C57BL/6 mice are considered as trypanotolerant to Trypanosoma congolense infection. We have reported that in these animals, IL-10, produced among others by myeloid cells, limits the liver damage caused by pathogenic TNF-producing Ly6C(+) monocytes, ensuring prolonged survival. Here, the heterogeneity and dynamics of liver myeloid cells in T. congolense-infected C57/BL6 mice was further dissected. Moreover, the contribution of Ly6C(-) monocytes to try-panotolerance was investigated. By using FACS analysis and adoptive transfer experiments, we found that the accumulation of Ly6C(-) monocytes and macrophages in the liver of infected mice coincided with a drop in the pool of Ly6C(+) monocytes. Pathogenic TNF mainly originated from Ly6C(+) monocytes while Ly6C(-) monocytes and macrophages were major and equipotent sources of IL-10 within myeloid cells. Moreover, Nr4a1 (Nur77) transcription factor-dependent Ly6C(-) monocytes exhibited IL-10-dependent and cell contact-dependent regulatory properties contributing to trypanotolerance by suppressing the production of TNF by Ly6C(+) monocytes and by promoting the differentiation of the latter cells into macrophages. Thus, Ly6C(-) monocytes can dampen liver damage caused by an extensive Ly6C(+) monocyte-associated inflammatory immune response in T. congolense trypanotolerant animals. In a more general context, Ly6C(-) or Ly6C(+) monocyte targeting may represent a therapeutic approach in liver pathogenicity induced by chronic infection.","[Morias, Yannick; Abels, Chloe; Laoui, Damya; Van Overmeire, Eva; Schouppe, Elio; De Baetselier, Patrick; Beschin, Alain] Vlaams Inst Biotechnol VIB, Myeloid Cell Immunol Lab, Brussels, Belgium; [Morias, Yannick; Abels, Chloe; Laoui, Damya; Van Overmeire, Eva; Schouppe, Elio; De Baetselier, Patrick; Beschin, Alain] Vrije Univ Brussel, Cellular & Mol Immunol Unit, Brussels, Belgium; [Guilliams, Martin] Vlaams Inst Biotechnol VIB, Inflammat Res Ctr, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Tacke, Frank] Univ Hosp Aachen, RWTH, Dept Med 3, Aachen, Germany; [deVries, Carlie J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands","Morias, Y (reprint author), Vlaams Inst Biotechnol VIB, Myeloid Cell Immunol Lab, Brussels, Belgium.",abeschin@vub.ac.be,"Beschin, Alain/L-2154-2014; Guilliams, Martin MG/N-7803-2013","Beschin, Alain/0000-0001-8478-6941; Guilliams, Martin MG/0000-0003-3525-7570","Interuniversity Attraction Poles Programme-Belgian Science Policy [P7/41]; ""Agentschap voor Innovatie door Wetenschap en Technologie"" (IWT-Vlaanderen); ""Fonds Wetenschappelijk Onderzoek-Vlaanderen"" (FWO)","The work was supported by the ""Interuniversity Attraction Poles Programme""-Belgian Science Policy (www.belspo.be)(P7/41). YM and DL are funded by the ""Agentschap voor Innovatie door Wetenschap en Technologie"" (IWT-Vlaanderen, www.iwt.be). CA, EVO, and ES are funded by ""Fonds Wetenschappelijk Onderzoek-Vlaanderen"" (FWO, http://www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,16,17,1,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004873,10.1371/journal.ppat.1004873,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300024,26020782.0,"DOAJ Gold, Green Published",,,16/08/2019,16,13,42,6712,1971,1584,387,4741,3735,27,979,42,13,0,0,14,14,1,,56,0,54,0,0,16,16,14,10,0,0,0,0,0,0,4,0,7,6712,319,0,82,100,0,4722,1971,319,0,82,100,0,19,,4,0,0,0,8,0,0,1,0,0,0,55,0,0,38.2,3.4053779807204463,1.4157350769879773,0.41573507698797724,1.5041130563172327,1.0624255065554231,3.617960426179604
636,J,"Mortimer, L; Moreau, F; Cornick, S; Chadee, K",,,,"Mortimer, Leanne; Moreau, France; Cornick, Steve; Chadee, Kris",,,The NLRP3 Inflammasome Is a Pathogen Sensor for Invasive Entamoeba histolytica via Activation of alpha 5 beta 1 Integrin at the Macrophage-Amebae Intercellular Junction,PLOS PATHOGENS,,,English,Article,,,,,,,CYSTEINE PROTEINASES; NALP3 INFLAMMASOME; ATP RELEASE; PANNEXIN-1; CELLS; EXPRESSION; PERMEABILITY; PATHWAYS; CHANNELS; COMPLEX,"Entamoeba histolytica (Eh) is an extracellular protozoan parasite of humans that invades the colon to cause life-threatening intestinal and extra-intestinal amebiasis. Colonized Eh is asymptomatic, however, when trophozoites adhere to host cells there is a considerable inflammatory response that is critical in the pathogenesis of amebiasis. The host and/or parasite factors that trigger the inflammatory response to invading Eh are not well understood. We recently identified that Eh adherence to macrophages induces inflammasome activation and in the present study we sought to determine the molecular events upon contact that coordinates this response. Here we report that Eh contact-dependent activation of alpha 5 beta 1 integrin is critical for activation of the NLRP3 inflammasome. Eh-macrophage contact triggered recruitment of alpha 5 beta 1 integrin and NLRP3 into the intercellular junction, where alpha 5 beta 1 integrin underwent activation by an integrin-binding cysteine protease on the parasite surface, termed EhCP5. As a result of its activation, alpha 5 beta 1 integrin induced ATP release into the extracellular space through opening of pannexin-1 channels that signalled through P2X7 receptors to deliver a critical co-stimulatory signal that activated the NLRP3 inflammasome. Both the cysteine protease activity and integrin-binding domain of EhCP5 were required to trigger alpha 5 beta 1 integrin that led to ATP release and NLRP3 inflammasome activation. These findings reveal engagement of alpha 5 beta 1 integrin across the parasite-host junction is a key regulatory step that initiates robust inflammatory responses to Eh. We propose that alpha 5 beta 1 integrin distinguishes Eh direct contact and functions with NLRP3 as pathogenicity sensor for invasive Eh infection.","[Mortimer, Leanne; Moreau, France; Cornick, Steve; Chadee, Kris] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Calgary, AB, Canada","Mortimer, L (reprint author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Calgary, AB, Canada.",kchadee@ucalgary.ca,,"Cornick, Steve/0000-0003-3883-6033",Canadian Institute of Health Research [12249]; Alberta Innovates Health Solutions graduate studentship; Canada Graduate Scholarship,"This work was funded by the Canadian Institute of Health Research grant number 12249. LM is the recipient of an Alberta Innovates Health Solutions graduate studentship and Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,46,30,30,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004887,10.1371/journal.ppat.1004887,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300032,25955828.0,"DOAJ Gold, Green Published",,,16/08/2019,39,1,28,4519,1010,732,278,3509,2838,20,651,28,1,0,0,35,35,0,,31,7,31,0,7,41,41,32,25,0,0,0,0,0,0,0,0,2,4626,27,0,66,64,0,3568,1040,27,0,66,64,0,18,,0,0,0,0,3,0,0,1,0,0,0,31,0,0,1.25,4.474257425742574,1.2878312909660872,0.2878312909660872,1.3442576232544885,1.0438150033193185,4.6702970297029704
637,J,"Muller, M; Hutin, S; Marigold, O; Li, KH; Burlingame, A; Glaunsinger, BA",,,,"Muller, Mandy; Hutin, Stephanie; Marigold, Oliver; Li, Kathy H.; Burlingame, Al; Glaunsinger, Britt A.",,,A Ribonucleoprotein Complex Protects the Interleukin-6 mRNA from Degradation by Distinct Herpesviral Endonucleases,PLOS PATHOGENS,,,English,Article,,,,,,,SARCOMA-ASSOCIATED HERPESVIRUS; HOST-SHUTOFF FUNCTION; CELLULAR TRANSLATION FACTOR; VIRUS HSV INFECTIONS; SIMPLEX-VIRUS; GENE-EXPRESSION; BINDING PROTEIN; INDUCED STABILIZATION; CASTLEMANS-DISEASE; VHS PROTEIN,"During lytic Kaposi's sarcoma-associated herpesvirus (KSHV) infection, the viral endonuclease SOX promotes widespread degradation of cytoplasmic messenger RNA (mRNA). However, select mRNAs escape SOX-induced cleavage and remain robustly expressed. Prominent among these is interleukin-6 (IL-6), a growth factor important for survival of KSHV infected B cells. IL-6 escape is notable because it contains a sequence within its 3' untranslated region (UTR) that can confer protection when transferred to a SOX-targeted mRNA, and thus overrides the endonuclease targeting mechanism. Here, we pursued how this protective RNA element functions to maintain mRNA stability. Using affinity purification and mass spectrometry, we identified a set of proteins that associate specifically with the protective element. Although multiple proteins contributed to the escape mechanism, depletion of nucleolin (NCL) most severely impacted protection. NCL was re-localized out of the nucleolus during lytic KSHV infection, and its presence in the cytoplasm was required for protection. After loading onto the IL-6 3' UTR, NCL differentially bound to the translation initiation factor eIF4H. Disrupting this interaction, or depleting eIF4H, reinstated SOX targeting of the RNA, suggesting that interactions between proteins bound to distant regions of the mRNA are important for escape. Finally, we found that the IL-6 3' UTR was also protected against mRNA degradation by the vhs endonuclease encoded by herpes simplex virus, despite the fact that its mechanism of mRNA targeting is distinct from SOX. These findings highlight how a multitude of RNA-protein interactions can impact endonuclease targeting, and identify new features underlying the regulation of the IL-6 mRNA.","[Muller, Mandy; Hutin, Stephanie; Marigold, Oliver; Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Li, Kathy H.; Burlingame, Al] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA","Glaunsinger, BA (reprint author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.",glaunsinger@berkeley.edu,,,"NIH [CA160556, CA136367]; Burroughs Wellcome Investigator in the Pathogenesis of Infectious Diseases Award; NIGMS [8P41GM103481]","This research was supported by NIH grants CA160556 and CA136367 (http://www.nih.gov/) and a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Diseases Award (http://www.bwfund.org/grant-programs/infectious-diseases/investigators-in-pathogenesis-of-infectious-disease) to BAG; NIGMS 8P41GM103481 (http://www.nigms.nih.gov/) to AB and MM is a HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2207-14) (http://www.damonrunyon.org/). Thefunders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,86,11,11,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004899,10.1371/journal.ppat.1004899,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300042,25965334.0,"DOAJ Gold, Green Published",,,16/08/2019,12,19,20,5072,977,754,223,4095,3482,29,584,20,0,3,0,12,12,0,,27,0,26,0,0,14,12,14,7,0,0,0,0,0,0,0,19,0,5062,234,0,83,145,0,4077,977,234,0,83,145,0,8,,0,0,0,1,0,0,0,1,0,0,0,26,0,0,3.25,5.191402251791198,1.2385836385836386,0.2385836385836386,1.3286935286935286,1.0727523659305993,5.569089048106449
638,J,"Ong, CWM; Elkington, PT; Brilha, S; Ugarte-Gil, C; Tome-Esteban, MT; Tezera, LB; Pabisiak, PJ; Moores, RC; Sathyamoorthy, T; Patel, V; Gilman, RH; Porter, JC; Friedland, JS",,,,"Ong, Catherine W. M.; Elkington, Paul T.; Brilha, Sara; Ugarte-Gil, Cesar; Tome-Esteban, Maite T.; Tezera, Liku B.; Pabisiak, Przemyslaw J.; Moores, Rachel C.; Sathyamoorthy, Tarangini; Patel, Vimal; Gilman, Robert H.; Porter, Joanna C.; Friedland, Jon S.",,,Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis,PLOS PATHOGENS,,,English,Article,,,,,,,ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; INNATE IMMUNITY; EXTRACELLULAR TRAPS; LUNG INFLAMMATION; IN-VITRO; T-CELLS; INFECTION,"Pulmonary cavities, the hallmark of tuberculosis (TB), are characterized by high mycobacterial load and perpetuate the spread of M. tuberculosis. The mechanism of matrix destruction resulting in cavitation is not well defined. Neutrophils are emerging as key mediators of TB immunopathology and their influx are associated with poor outcomes. We investigated neutrophil-dependent mechanisms involved in TB-associated matrix destruction using a cellular model, a cohort of 108 patients, and in separate patient lung biopsies. Neutrophil-derived NF-kB-dependent matrix metalloproteinase-8 (MMP-8) secretion was up-regulated in TB and caused matrix destruction both in vitro and in respiratory samples of TB patients. Collagen destruction induced by TB infection was abolished by doxycycline, a licensed MMP inhibitor. Neutrophil extracellular traps (NETs) contain MMP-8 and are increased in samples from TB patients. Neutrophils lined the circumference of human pulmonary TB cavities and sputum MMP-8 concentrations reflected TB radiological and clinical disease severity. AMPK, a central regulator of catabolism, drove neutrophil MMP-8 secretion and neutrophils from AMPK-deficient patients secrete lower MMP-8 concentrations. AMPK-expressing neutrophils are present in human TB lung biopsies with phospho-AMPK detected in nuclei. These data demonstrate that neutrophil-derived MMP-8 has a key role in the immunopathology of TB and is a potential target for host-directed therapy in this infectious disease.","[Ong, Catherine W. M.; Elkington, Paul T.; Brilha, Sara; Ugarte-Gil, Cesar; Tezera, Liku B.; Pabisiak, Przemyslaw J.; Moores, Rachel C.; Sathyamoorthy, Tarangini; Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, London, England; [Ong, Catherine W. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Div Infect Dis, Dept Med, Singapore 117595, Singapore; [Elkington, Paul T.; Tezera, Liku B.] Univ Southampton, Natl Inst Hlth Res NIHR Resp Biomed Res Unit, Fac Med, Southampton, Hants, England; [Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Tome-Esteban, Maite T.; Patel, Vimal] Univ Coll London Hosp, Heart Hosp, London, England; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] Univ Peruana Cayetano Heredia, Asociac Benef Proyectos Informat Salud Med & Agr, Lima, Peru; [Porter, Joanna C.] UCL, Ctr Inflammat & Tissue Repair, Dept Med, London, England","Friedland, JS (reprint author), Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, Hammersmith Campus, London, England.",j.friedland@imperial.ac.uk,"Porter, Joanna/C-7162-2009; Esteban, Maria Teresa Tome/E-1196-2019; Esteban, Maria Teresa Tome/L-6432-2019; Ugarte-Gil, Cesar/E-6074-2013","Porter, Joanna/0000-0002-7307-169X; Esteban, Maria Teresa Tome/0000-0002-8962-3524; Esteban, Maria Teresa Tome/0000-0002-8962-3524; Brilha, Sara/0000-0003-2608-4444; Ong, Catherine/0000-0003-1103-0451; Friedland, Jonathan S/0000-0001-7789-9649; Elkington, Paul/0000-0003-0390-0613; Ugarte-Gil, Cesar/0000-0002-2833-9087",Singapore National Medical Research Council on an NRF-MOH Healthcare Research Scholarship; Wellcome Trust Master Fellowship of Tropical Medicine and Public Health [085777/Z/08/Z]; Biomedical Research Centre at Imperial College; Breathing Matters; Medical Research Council [MR/K004158/1],"CWMO is funded by the Singapore National Medical Research Council on an NRF-MOH Healthcare Research Scholarship. CUG was supported by the Wellcome Trust Master Fellowship of Tropical Medicine and Public Health (Grant 085777/Z/08/Z). RCM is a Wellcome Trust Clinical Research Fellow and TS an MRC Clinical Research Fellow. JSF and PE acknowledge support of the Biomedical Research Centre at Imperial College. JCP received support from Breathing Matters. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,59,61,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004917,10.1371/journal.ppat.1004917,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300051,25996154.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,58,14,63,6473,1402,1011,391,5071,4051,29,991,63,8,0,0,50,50,0,,91,17,91,0,17,61,61,54,41,0,0,0,0,0,0,0,6,6,6483,36,0,61,160,0,5054,1402,36,0,61,160,0,27,,0,0,0,0,8,0,0,1,0,0,0,92,0,0,4.2,4.6169757489301,1.2764740682311182,0.27647406823111814,1.3170972194833366,1.0318245017766106,4.763908701854493
639,J,"Rowley, AF; Smith, AL; Davies, CE",,,,"Rowley, Andrew F.; Smith, Amanda L.; Davies, Charlotte E.",,,How Does the Dinoflagellate Parasite Hematodinium Outsmart the Immune System of Its Crustacean Hosts?,PLOS PATHOGENS,,,English,Article,,,,,,,CRABS CHIONOECETES-OPILIO; LOBSTER NEPHROPS-NORVEGICUS; CALLINECTES-SAPIDUS; CANCER-PAGURUS; NORWAY LOBSTER; BLUE CRABS; PORTUNUS-TRITUBERCULATUS; NECORA-PUBER; WEST-COAST; INFECTION,,"[Rowley, Andrew F.; Smith, Amanda L.; Davies, Charlotte E.] Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales","Rowley, AF (reprint author), Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales.",a.f.rowley@swansea.ac.uk,,"Davies, Charlotte Eve/0000-0002-5853-1934",,,,43,2,2,0,28,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004724,10.1371/journal.ppat.1004724,,,,9,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300001,25951086.0,"DOAJ Gold, Green Published",,,16/08/2019,2,15,22,4016,677,576,101,3339,2759,21,559,21,15,0,0,1,1,0,,32,6,32,0,6,2,2,2,0,0,0,0,0,0,0,0,0,13,4057,10,0,45,57,4,3335,677,10,0,45,57,4,45,,0,0,0,0,14,0,0,1,0,0,0,31,0,0,7.0,5.93205317577548,1.2027553159628632,0.20275531596286314,1.235100329439952,1.0268924302788844,6.091580502215657
640,J,"Sack, BK; Keitany, GJ; Vaughan, AM; Miller, JL; Wang, RB; Kappe, SHI",,,,"Sack, Brandon K.; Keitany, Gladys J.; Vaughan, Ashley M.; Miller, Jessica L.; Wang, Ruobing; Kappe, Stefan H. I.",,,Mechanisms of Stage-Transcending Protection Following Immunization of Mice with Late Liver Stage-Arresting Genetically Attenuated Malaria Parasites,PLOS PATHOGENS,,,English,Article,,,,,,,CD8(+) T-CELLS; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM MALARIA; GLUTAMATE-RICH PROTEIN; MEDIATED PROTECTION; IMMUNE-RESPONSES; ANTIMALARIAL ANTIBODIES; SPOROZOITE INOCULATION; VACCINE DEVELOPMENT; STERILE PROTECTION,"Malaria, caused by Plasmodium parasite infection, continues to be one of the leading causes of worldwide morbidity and mortality. Development of an effective vaccine has been encumbered by the complex life cycle of the parasite that has distinct pre-erythrocytic and erythrocytic stages of infection in the mammalian host. Historically, malaria vaccine development efforts have targeted each stage in isolation. An ideal vaccine, however, would target multiple life cycle stages with multiple arms of the immune system and be capable of eliminating initial infection in the liver, the subsequent blood stage infection, and would prevent further parasite transmission. We have previously shown that immunization of mice with Plasmodium yoelii genetically attenuated parasites (GAP) that arrest late in liver stage development elicits stage-transcending protection against both a sporozoite challenge and a direct blood stage challenge. Here, we show that this immunization strategy engenders both T-and B-cell responses that are essential for stage-transcending protection, but the relative importance of each is determined by the host genetic background. Furthermore, potent anti-blood stage antibodies elicited after GAP immunization rely heavily on FC-mediated functions including complement fixation and FC receptor binding. These protective antibodies recognize the merozoite surface but do not appear to recognize the immunodominant merozoite surface protein-1. The antigen(s) targeted by stage-transcending immunity are present in both the late liver stages and blood stage parasites. The data clearly show that GAP-engendered protective immune responses can target shared antigens of pre-erythrocytic and erythrocytic parasite life cycle stages. As such, this model constitutes a powerful tool to identify novel, protective and stage-transcending T and B cell targets for incorporation into a multi-stage subunit vaccine.","[Sack, Brandon K.; Vaughan, Ashley M.; Miller, Jessica L.; Wang, Ruobing; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Keitany, Gladys J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA","Sack, BK (reprint author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.",Stefan.Kappe@seattlebiomed.org,,,"National Institutes of Health [F32 AI114113-01, R01AI095178]","This work was funded by grant numbers F32 AI114113-01 and R01AI095178 from the National Institutes of Health (NIH.gov) issued to BKS and SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,82,19,19,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004855,10.1371/journal.ppat.1004855,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300019,25974076.0,"DOAJ Gold, Green Published",,,16/08/2019,20,1,33,4309,750,546,204,3559,2934,22,603,32,0,0,0,19,19,0,,80,10,40,1,10,21,21,13,10,0,0,0,0,0,0,0,1,2,4375,28,0,191,82,3,3571,760,28,0,191,82,3,44,,0,0,0,0,2,0,1,1,0,0,0,39,1,0,1.0,5.745333333333333,1.2107333520651868,0.21073335206518684,1.2601854453498174,1.0408447435599908,5.98
641,J,"Sanin, DE; Prendergast, CT; Bourke, CD; Mountford, AP",,,,"Sanin, David E.; Prendergast, Catriona T.; Bourke, Claire D.; Mountford, Adrian P.",,,Helminth Infection and Commensal Microbiota Drive Early IL-10 Production in the Skin by CD4(+) T Cells That Are Functionally Suppressive,PLOS PATHOGENS,,,English,Article,,,,,,,INNATE IMMUNE-RESPONSE; SCHISTOSOMA-MANSONI; DENDRITIC CELLS; RESIDENT; MICE; LYMPHOCYTES; EXPRESSION; SECRETION; LARVAE; LEISHMANIASIS,"The skin provides an important first line of defence and immunological barrier to invasive pathogens, but immune responses must also be regulated to maintain barrier function and ensure tolerance of skin surface commensal organisms. In schistosomiasis-endemic regions, populations can experience repeated percutaneous exposure to schistosome larvae, however little is known about how repeated exposure to pathogens affects immune regulation in the skin. Here, using a murinemodel of repeated infection with Schistosoma mansoni larvae, we show that the skin infection site becomes rich in regulatory IL-10, whilst in its absence, inflammation, neutrophil recruitment, and local lymphocyte proliferation is increased. Whilst CD4(+) T cells are the primary cellular source of regulatory IL-10, they expressed none of the markers conventionally associated with T regulatory (T-reg) cells (i.e. FoxP3, Helios, Nrp1, CD223, or CD49b). Nevertheless, these IL-10(+) CD4(+) T cells in the skin from repeatedly infectedmice are functionally suppressive as they reduced proliferation of responsive CD4(+) T cells from the skin draining lymph node. Moreover, the skin of infected Rag(-/-) mice had impaired IL-10 production and increased neutrophil recruitment. Finally, we show that the mechanism behind IL-10 production by CD4(+) T cells in the skin is due to a combination of an initial (day 1) response specific to skin commensal bacteria, and then over the following days schistosome-specific CD4(+) T cell responses, which together contribute towards limiting inflammation and tissue damage following schistosome infection. We propose CD4(+) T cells in the skin that do not express markers of conventional T regulatory cell populations have a significant role in immune regulation after repeated pathogen exposure and speculate that these cells may also help to maintain skin barrier function in the context of repeated percutaneous insult by other skin pathogens.","[Sanin, David E.; Prendergast, Catriona T.; Bourke, Claire D.; Mountford, Adrian P.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England","Sanin, DE (reprint author), Washington Univ, Sch Med, Div Immunobiol, Dept Pathol & Immunol, St Louis, MO 63130 USA.",adrian.mountford@york.ac.uk,,"Bourke, Claire/0000-0002-7244-0895; Sanin, David E/0000-0003-0188-7267; Prendergast, Catriona/0000-0002-3777-5382",Wellcome Trust [092745/Z/10/Z],"This work was supported by The Wellcome Trust, grant number: 092745/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,80,12,13,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004841,10.1371/journal.ppat.1004841,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300015,25974019.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,13,64,33,4982,959,494,465,4023,3409,21,593,32,5,0,0,11,11,2,,46,5,45,1,5,15,14,15,5,0,0,0,0,0,0,2,59,11,5021,32,1,38,44,0,4013,959,32,1,38,44,0,49,,3,1,0,0,20,0,1,1,0,0,0,45,1,0,44.244,5.194994786235662,1.2383793189162318,0.23837931891623168,1.26696495152871,1.023083099156965,5.314911366006257
642,J,"Savory, F; Leonard, G; Richards, TA",,,,"Savory, Fiona; Leonard, Guy; Richards, Thomas A.",,,The Role of Horizontal Gene Transfer in the Evolution of the Oomycetes,PLOS PATHOGENS,,,English,Article,,,,,,,GENOME; MECHANISMS; INNOVATION; ORIGINS; FUNGI,"Horizontal gene transfer (HGT) or lateral gene transfer (LGT) involves the transmission of genetic material between distinct evolutionary lineages and can be an important source of biological innovation. For instance, the acquisition of foreign genes can allow recipient organisms to adapt to new lifestyles or to exploit a novel ecological niche, such as a host environment. HGT has long been recognised as an important factor contributing to the evolution of prokaryotic lineages especially in connection to the evolution of pathogencity [1,2]. However, it is becoming increasingly apparent that HGT has also played a role in the evolution of pathogenic traits in eukaryotes [3,4]. Here, we consider how HGT has contributed to genome evolution in the oomycetes.","[Savory, Fiona; Leonard, Guy; Richards, Thomas A.] Univ Exeter, Biosci, Exeter, Devon, England; [Richards, Thomas A.] Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON, Canada","Savory, F (reprint author), Univ Exeter, Biosci, Geoffrey Pope Bldg, Exeter, Devon, England.",t.a.richards@exeter.ac.uk,"Leonard, Guy/B-2096-2010","Leonard, Guy/0000-0002-4607-2064; Richards, Thomas/0000-0002-9692-0973",,,,20,27,27,1,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004805,10.1371/journal.ppat.1004805,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300009,26020232.0,"DOAJ Gold, Green Published",,,16/08/2019,29,59,59,7713,1206,1009,197,6507,5548,62,897,58,31,0,0,27,27,0,,79,4,79,0,4,29,29,24,13,0,0,0,0,0,0,0,28,37,7767,34,54,488,80,2,6488,1206,34,54,488,80,2,73,,0,0,0,0,39,0,0,1,0,0,0,77,0,0,21.55,6.395522388059701,1.1853388658367912,0.18533886583679116,1.2111572153065928,1.0217814080124465,6.534825870646766
643,J,"Shingai, M; Welbourn, S; Brenchley, JM; Acharya, P; Miyagi, E; Plishka, RJ; Buckler-White, A; Kwong, PD; Nishimura, Y; Strebel, K; Martin, MA",,,,"Shingai, Masashi; Welbourn, Sarah; Brenchley, Jason M.; Acharya, Priyamvada; Miyagi, Eri; Plishka, Ronald J.; Buckler-White, Alicia; Kwong, Peter D.; Nishimura, Yoshiaki; Strebel, Klaus; Martin, Malcolm A.",,,The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4(+) Memory T Cells,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 INFECTION; GASTROINTESTINAL-TRACT; IMMUNE RECONSTITUTION; PIGTAIL MACAQUES; PROTEIN; RESTRICTION; PHOSPHORYLATION; DEPLETION; MONKEYS,"For nearly 20 years, the principal biological function of the HIV-2/SIV Vpx gene has been thought to be required for optimal virus replication in myeloid cells. Mechanistically, this Vpx activity was recently reported to involve the degradation of Sterile Alpha Motif and HD domain-containing protein 1 (SAMHD1) in this cell lineage. Here we show that when macaques were inoculated with either the T cell tropic SIVmac239 or the macrophage tropic SIVmac316 carrying a Vpx point mutation that abrogates the recruitment of DCAF1 and the ensuing degradation of endogenous SAMHD1 in cultured CD4(+) T cells, virus acquisition, progeny virion production in memory CD4(+) T cells during acute infection, and the maintenance of set-point viremia were greatly attenuated. Revertant viruses emerging in two animals exhibited an augmented replication phenotype in memory CD4(+) T lymphocytes both in vitro and in vivo, which was associated with reduced levels of endogenous SAMHD1. These results indicate that a critical role of Vpx in vivo is to promote the degradation of SAMHD1 in memory CD4(+) T lymphocytes, thereby generating high levels of plasma viremia and the induction of immunodeficiency.","[Shingai, Masashi; Welbourn, Sarah; Brenchley, Jason M.; Miyagi, Eri; Plishka, Ronald J.; Buckler-White, Alicia; Nishimura, Yoshiaki; Strebel, Klaus; Martin, Malcolm A.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Acharya, Priyamvada; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA","Martin, MA (reprint author), NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA.",malm@nih.gov,,,"Intramural Research Program; Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health","This work was supported by the Intramural Research Program and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript",,47,13,13,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004928,10.1371/journal.ppat.1004928,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300056,25996507.0,"DOAJ Gold, Green Published",,,16/08/2019,13,8,12,9028,492,363,129,8536,8054,27,455,12,6,0,0,11,11,0,,14,0,14,0,0,13,13,12,8,0,0,0,0,0,0,0,2,2,9024,50,0,94,79,0,8526,492,50,0,94,79,0,6,,0,0,0,0,9,0,1,1,0,0,0,14,0,0,4.95,18.349593495934958,1.057638238050609,0.057638238050609185,1.072282099343955,1.013845813026141,18.603658536585368
644,J,"Smirnova, E; Firth, AE; Miller, WA; Scheidecker, D; Brault, V; Reinbold, C; Rakotondrafara, AM; Chung, BYW; Ziegler-Graff, V",,,,"Smirnova, Ekaterina; Firth, Andrew E.; Miller, W. Allen; Scheidecker, Daniele; Brault, Veronique; Reinbold, Catherine; Rakotondrafara, Aurelie M.; Chung, Betty Y. -W.; Ziegler-Graff, Veronique",,,Discovery of a Small Non-AUG-Initiated ORF in Poleroviruses and Luteoviruses That Is Required for Long-Distance Movement,PLOS PATHOGENS,,,English,Article,,,,,,,POTATO-LEAFROLL-VIRUS; YELLOW DWARF VIRUS; CAP-INDEPENDENT TRANSLATION; INFECTIOUS CDNA-CLONE; APHID TRANSMISSION; COAT PROTEIN; MOSAIC-VIRUS; READTHROUGH PROTEIN; CODING SEQUENCES; IN-VIVO,"Viruses in the family Luteoviridae have positive-sense RNA genomes of around 5.2 to 6.3 kb, and they are limited to the phloem in infected plants. The Luteovirus and Polerovirus genera include all but one virus in the Luteoviridae. They share a common gene block, which encodes the coat protein (ORF3), a movement protein (ORF4), and a carboxy-terminal extension to the coat protein (ORF5). These three proteins all have been reported to participate in the phloem-specific movement of the virus in plants. All three are translated from one subgenomic RNA, sgRNA1. Here, we report the discovery of a novel short ORF, termed ORF3a, encoded near the 5' end of sgRNA1. Initially, this ORF was predicted by statistical analysis of sequence variation in large sets of aligned viral sequences. ORF3a is positioned upstream of ORF3 and its translation initiates at a non-AUG codon. Functional analysis of the ORF3a protein, P3a, was conducted with Turnip yellows virus (TuYV), a polerovirus, for which translation of ORF3a begins at an ACG codon. ORF3a was translated from a transcript corresponding to sgRNA1 in vitro, and immunodetection assays confirmed expression of P3a in infected protoplasts and in agroinoculated plants. Mutations that prevent expression of P3a, or which overexpress P3a, did not affect TuYV replication in protoplasts or inoculated Arabidopsis thaliana leaves, but prevented virus systemic infection (long-distance movement) in plants. Expression of P3a from a separate viral or plasmid vector complemented movement of a TuYV mutant lacking ORF3a. Subcellular localization studies with fluorescent protein fusions revealed that P3a is targeted to the Golgi apparatus and plasmodesmata, supporting an essential role for P3a in viral movement.","[Smirnova, Ekaterina; Miller, W. Allen; Scheidecker, Daniele; Ziegler-Graff, Veronique] Univ Strasbourg, Inst Biol Mol Plantes, CNRS, UPR 2357, Strasbourg, France; [Firth, Andrew E.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Miller, W. Allen] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Brault, Veronique; Reinbold, Catherine] UMR 1131 SVQV INRA UDS, Colmar, France; [Rakotondrafara, Aurelie M.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Chung, Betty Y. -W.] Univ Cambridge, Dept Plant Sci, Cambridge, England","Smirnova, E (reprint author), Univ Strasbourg, Inst Biol Mol Plantes, CNRS, UPR 2357, Strasbourg, France.",aef24@cam.ac.uk; wamiller@iastate.edu; veronique.ziegler-graff@ibmp-cnrs.unistra.fr,,"Firth, Andrew/0000-0002-7986-9520","Gutenberg Chair (Region Alsace); Wellcome Trust [088789]; UK Biotechnology and Biological Research Council (BBSRC) [BB/J007072/1, BB/J015652/1]; Fulbright Foundation Research Scholarship; NIH Institute of General Medical Sciences [5R01GM067104-09]; Biotechnology and Biological Sciences Research Council [BB/J007072/1, BB/J015652/1]","ES and WAM were financed through a Gutenberg Chair (Region Alsace) grant awarded to WAM. Work in the AEF lab was funded by grants from the Wellcome Trust (088789) and the UK Biotechnology and Biological Research Council (BBSRC) (BB/J007072/1 and BB/J015652/1). WAM was also funded by a Fulbright Foundation Research Scholarship and grant number 5R01GM067104-09 from the NIH Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,41,42,0,49,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004868,10.1371/journal.ppat.1004868,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300023,25946037.0,"DOAJ Gold, Green Published",,,16/08/2019,43,27,37,6098,948,647,301,5150,3941,30,1179,37,5,0,0,46,46,0,,107,2,54,0,2,48,45,48,19,0,0,0,0,0,0,0,22,3,6093,140,0,97,60,1,5128,948,77,0,97,54,1,17,,0,0,0,0,7,0,1,1,0,0,0,56,0,0,3.5,6.432489451476793,1.1840776699029125,0.18407766990291263,1.2219417475728156,1.0319776976057724,6.6381856540084385
645,J,"Stenglein, MD; Jacobson, ER; Chang, LW; Sanders, C; Hawkins, MG; Guzman, DSM; Drazenovich, T; Dunker, F; Kamaka, EK; Fisher, D; Reavill, DR; Meola, LF; Levens, G; DeRisi, JL",,,,"Stenglein, Mark D.; Jacobson, Elliott R.; Chang, Li-Wen; Sanders, Chris; Hawkins, Michelle G.; Guzman, David S-M.; Drazenovich, Tracy; Dunker, Freeland; Kamaka, Elizabeth K.; Fisher, Debbie; Reavill, Drury R.; Meola, Linda F.; Levens, Gregory; DeRisi, Joseph L.",,,"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections",PLOS PATHOGENS,,,English,Article,,,,,,,LYMPHOCYTIC CHORIOMENINGITIS VIRUS; INCLUSION-BODY DISEASE; TEMPERATURE-SENSITIVE MUTANTS; UPDATED PHYLOGENETIC ANALYSIS; BOID SNAKES; RNA VIRUS; EVOLUTION; MECHANISM; COINFECTION; GENERATION,"Arenaviruses are one of the largest families of human hemorrhagic fever viruses and are known to infect both mammals and snakes. Arenaviruses package a large (L) and small (S) genome segment in their virions. For segmented RNA viruses like these, novel genotypes can be generated through mutation, recombination, and reassortment. Although it is believed that an ancient recombination event led to the emergence of a new lineage of mammalian arenaviruses, neither recombination nor reassortment has been definitively documented in natural arenavirus infections. Here, we used metagenomic sequencing to survey the viral diversity present in captive arenavirus-infected snakes. From 48 infected animals, we determined the complete or near complete sequence of 210 genome segments that grouped into 23 L and 11 S genotypes. The majority of snakes were multiply infected, with up to 4 distinct S and 11 distinct L segment genotypes in individual animals. This S/L imbalance was typical: in all cases intrahost L segment genotypes outnumbered S genotypes, and a particular S segment genotype dominated in individual animals and at a population level. We corroborated sequencing results by qRT-PCR and virus isolation, and isolates replicated as ensembles in culture. Numerous instances of recombination and reassortment were detected, including recombinant segments with unusual organizations featuring 2 intergenic regions and superfluous content, which were capable of stable replication and transmission despite their atypical structures. Overall, this represents intrahost diversity of an extent and form that goes well beyond what has been observed for arenaviruses or for viruses in general. This diversity can be plausibly attributed to the captive intermingling of sub-clinically infected wild-caught snakes. Thus, beyond providing a unique opportunity to study arenavirus evolution and adaptation, these findings allow the investigation of unintended anthropogenic impacts on viral ecology, diversity, and disease potential.","[Stenglein, Mark D.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Jacobson, Elliott R.; Chang, Li-Wen] Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA; [Sanders, Chris] Wildwood Vet Hosp, Portola Valley, CA USA; [Hawkins, Michelle G.; Guzman, David S-M.; Drazenovich, Tracy] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [Dunker, Freeland] Calif Acad Sci, San Francisco, CA 94118 USA; [Kamaka, Elizabeth K.] Kamaka Exot Anim Vet Serv, Mountlake Terrace, WA USA; [Fisher, Debbie] Acacia Anim Hosp, Escondito, CA USA; [Reavill, Drury R.] Zoo Exot Pathol Serv, West Sacramento, CA USA; [Meola, Linda F.] Arkansas Livestock & Poultry Commiss Vet Diagnost, Little Rock, AR USA; [Levens, Gregory] Cincinnati Zoo, Cincinnati, OH USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD USA","Stenglein, MD (reprint author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.",mark.stenglein@colostate.edu; joe@derisilab.ucsf.edu,"Stenglein, Mark/E-3541-2017; Reavill, Drury/W-3069-2019","Stenglein, Mark/0000-0002-0993-813X; Reavill, Drury/0000-0002-4725-3174",Howard Hughes Medical Institute; National Instutes of Health [5T32HL007185-34]; Pacific Southwest Regional Center of Excellence (PSWRCE) [U54 AI065359],"JLD is supported by the Howard Hughes Medical Institute (http://www.hhmi.org/). MDS is supported by National Instutes of Health (http://www.nih.gov/) grant 5T32HL007185-34 and the Pacific Southwest Regional Center of Excellence (PSWRCE, grant U54 AI065359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,78,30,31,1,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004900,10.1371/journal.ppat.1004900,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300043,25993603.0,"DOAJ Gold, Green Published",,,16/08/2019,28,160,36,5703,1416,933,483,4287,3564,26,697,36,4,0,0,26,26,0,,114,0,59,0,0,31,31,31,18,0,0,0,0,0,0,0,158,3,5717,92,0,65,112,0,4279,1416,92,0,65,112,0,22,,0,0,0,0,5,0,1,1,0,0,0,59,0,0,2.75,4.0275423728813555,1.330300909727082,0.33030090972708187,1.3811523209703755,1.0382254953533228,4.181497175141243
646,J,"Taylor, HE; Simmons, GE; Mathews, TP; Khatua, AK; Popik, W; Lindsley, CW; D'Aquila, RT; Brown, HA",,,,"Taylor, Harry E.; Simmons, Glenn E., Jr.; Mathews, Thomas P.; Khatua, Atanu K.; Popik, Waldemar; Lindsley, Craig W.; D'Aquila, Richard T.; Brown, H. Alex",,,Phospholipase D1 Couples CD4(+) T Cell Activation to c-Myc-Dependent Deoxyribonucleotide Pool Expansion and HIV-1 Replication,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; PHOSPHATIDIC-ACID; ANTIGEN RECEPTORS; DOWN-REGULATION; CANCER CELLS; INFECTION; LYMPHOCYTES; PROTEIN; INHIBITION; TYPE-1,"Quiescent CD4+ T cells restrict human immunodeficiency virus type 1 (HIV-1) infection at early steps of virus replication. Low levels of both deoxyribonucleotide triphosphates (dNTPs) and the biosynthetic enzymes required for their de novo synthesis provide one barrier to infection. CD4+ T cell activation induces metabolic reprogramming that reverses this block and facilitates HIV-1 replication. Here, we show that phospholipase D1 (PLD1) links T cell activation signals to increased HIV-1 permissivity by triggering a c-Myc-dependent transcriptional program that coordinates glucose uptake and nucleotide biosynthesis. Decreasing PLD1 activity pharmacologically or by RNA interference diminished c-Myc-dependent expression during T cell activation at the RNA and protein levels. PLD1 inhibition of HIV-1 infection was partially rescued by adding exogenous deoxyribonucleosides that bypass the need for de novo dNTP synthesis. Moreover, the data indicate that low dNTP levels that impact HIV-1 restriction involve decreased synthesis, and not only increased catabolism of these nucleotides. These findings uncover a unique mechanism of action for PLD1 inhibitors and support their further development as part of a therapeutic combination for HIV-1 and other viral infections dependent on host nucleotide biosynthesis.","[Taylor, Harry E.; D'Aquila, Richard T.] Northwestern Univ, Dept Med, Northwestern HIV Translat Res Ctr, Div Infect Dis,Feinberg Sch Med, Chicago, IL 60611 USA; [Simmons, Glenn E., Jr.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Mathews, Thomas P.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN USA; [Mathews, Thomas P.; Lindsley, Craig W.] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37235 USA; [Khatua, Atanu K.; Popik, Waldemar] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Lindsley, Craig W.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA; [Brown, H. Alex] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA","Taylor, HE (reprint author), Northwestern Univ, Dept Med, Northwestern HIV Translat Res Ctr, Div Infect Dis,Feinberg Sch Med, Chicago, IL 60611 USA.",harry.taylor@northwestern.edu; alex.brown@Vanderbilt.edu,"Simmons Jr, Glenn/A-1777-2015","Simmons Jr, Glenn/0000-0003-2081-5672",National Institutes of Health National Institute of Mental Health [U54-MH084659]; Vanderbilt Institute of Chemical Biology; Bixler-Johnson-Mayes Endowed Chair; William K. Warren Jr. Chair in Medicine; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [5R21DK094735]; Vanderbilt Institute for Clinical and Translational Research Scholar Award [5KL2RR024977]; Northwestern University Flow Cytometry Facility; Cancer Center Support Grant [NCI CA060553],"This research was supported in part by the National Institutes of Health National Institute of Mental Health (U54-MH084659) and the Vanderbilt Institute of Chemical Biology, Bixler-Johnson-Mayes Endowed Chair (HAB), and the William K. Warren Jr. Chair in Medicine (CWL). Vanderbilt University is a member of the National Institutes of Health Molecular Libraries Probe Production Centers Network and houses the Vanderbilt Specialized Chemistry Center for Accelerated Probe Development. WP acknowledges support from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (5R21DK094735). HET and RTD gratefully acknowledge Northwestern Medicine and Northwestern University Feinberg School of Medicine institutional support for the HIV Translational Research Center, the Howard Taylor Ricketts Chair (RTD), and the Vanderbilt Institute for Clinical and Translational Research Scholar Award (5KL2RR024977) (HET) that enabled this work. This work was supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,49,12,13,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004864,10.1371/journal.ppat.1004864,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300022,26020637.0,"DOAJ Gold, Green Published",,,16/08/2019,12,49,27,10343,251,198,53,10092,9066,26,1000,27,11,0,0,10,10,57,,32,5,30,0,5,13,13,8,7,0,0,0,0,0,0,0,38,10,10394,14,1,245,130,0,10107,267,14,1,245,130,0,20,,5,0,0,0,21,0,8,1,0,0,0,30,0,0,55.15,41.20717131474104,1.0248711850971066,0.02487118509710662,1.0441934205311139,1.0188533307551,41.98406374501992
647,J,"Vagima, Y; Zauberman, A; Levy, Y; Gur, D; Tidhar, A; Aftalion, M; Shafferman, A; Mamroud, E",,,,"Vagima, Yaron; Zauberman, Ayelet; Levy, Yinon; Gur, David; Tidhar, Avital; Aftalion, Moshe; Shafferman, Avigdor; Mamroud, Emanuelle",,,Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague,PLOS PATHOGENS,,,English,Article,,,,,,,SIGNATURE-TAGGED MUTAGENESIS; RESPIRATORY-TRACT INFECTION; CHEMOKINE RECEPTOR CXCR2; YERSINIA OUTER PROTEINS; NECROSIS-FACTOR-ALPHA; III SECRETION; INFLAMMATORY RESPONSE; SIGNALING RESPONSES; CHROMOSOMAL GENES; IMMUNE-RESPONSES,"Pneumonic plague is a fatal disease caused by Yersinia pestis that is associated with a delayed immune response in the lungs. Because neutrophils are the first immune cells recruited to sites of infection, we investigated the mechanisms responsible for their delayed homing to the lung. During the first 24 hr after pulmonary infection with a fully virulent Y. pestis strain, no significant changes were observed in the lungs in the levels of neutrophils infiltrate, expression of adhesion molecules, or the expression of the major neutrophil chemoattractants keratinocyte cell-derived chemokine (KC), macrophage inflammatory protein 2 (MIP-2) and granulocyte colony stimulating factor (G-CSF). In contrast, early induction of chemokines, rapid neutrophil infiltration and a reduced bacterial burden were observed in the lungs of mice infected with an avirulent Y. pestis strain. In vitro infection of lung-derived cell-lines with a YopJ mutant revealed the involvement of YopJ in the inhibition of chemoattractants expression. However, the recruitment of neutrophils to the lungs of mice infected with the mutant was still delayed and associated with rapid bacterial propagation and mortality. Interestingly, whereas KC, MIP-2 and G-CSF mRNA levels in the lungs were up-regulated early after infection with the mutant, their protein levels remained constant, suggesting that Y. pestis may employ additional mechanisms to suppress early chemoattractants induction in the lung. It therefore seems that prevention of the early influx of neutrophils to the lungs is of major importance for Y. pestis virulence. Indeed, pulmonary instillation of KC and MIP-2 to G-CSF-treated mice infected with Y. pestis led to rapid homing of neutrophils to the lung followed by a reduction in bacterial counts at 24 hr post-infection and improved survival rates. These observations shed new light on the virulence mechanisms of Y. pestis during pneumonic plague, and have implications for the development of novel therapies against this pathogen.","[Vagima, Yaron; Zauberman, Ayelet; Levy, Yinon; Gur, David; Tidhar, Avital; Aftalion, Moshe; Shafferman, Avigdor; Mamroud, Emanuelle] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel","Vagima, Y (reprint author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.",emmym@iibr.gov.il,,,Israel Institute for Biological Research [SB/354/5112],"Israel Institute for Biological Research, grant number SB/354/5112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,81,20,21,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004893,10.1371/journal.ppat.1004893,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300037,25974210.0,"DOAJ Gold, Green Published",,,16/08/2019,21,0,21,3321,565,406,159,2756,2316,18,422,21,0,0,3,23,23,0,,25,11,25,0,11,25,24,25,12,0,0,0,0,0,0,0,0,2,3374,30,0,131,120,4,2736,565,30,0,131,120,4,73,,0,0,0,0,1,0,0,1,1,0,0,25,0,0,1.5,5.87787610619469,1.2050072568940493,0.20500725689404933,1.2786647314949202,1.0611261668172238,6.23716814159292
648,J,"Vanha-aho, LM; Anderl, I; Vesala, L; Hultmark, D; Valanne, S; Ramet, M",,,,"Vanha-aho, Leena-Maija; Anderl, Ines; Vesala, Laura; Hultmark, Dan; Valanne, Susanna; Ramet, Mika",,,Edin Expression in the Fat Body Is Required in the Defense Against Parasitic Wasps in Drosophila melanogaster,PLOS PATHOGENS,,,English,Article,,,,,,,CELLULAR IMMUNE-RESPONSE; BLOOD-CELLS; LEPTOPILINA-BOULARDI; SUSCEPTIBLE STRAINS; GRANULOMA-FORMATION; HEMOCYTE LINEAGES; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; APOPTOTIC CELLS; INSECT IMMUNITY,"The cellular immune response against parasitoid wasps in Drosophila involves the activation, mobilization, proliferation and differentiation of different blood cell types. Here, we have assessed the role of Edin (elevated during infection) in the immune response against the parasitoid wasp Leptopilina boulardi in Drosophila melanogaster larvae. The expression of edin was induced within hours after a wasp infection in larval fat bodies. Using tissue-specific RNAi, we show that Edin is an important determinant of the encapsulation response. Although edin expression in the fat body was required for the larvae to mount a normal encapsulation response, it was dispensable in hemocytes. Edin expression in the fat body was not required for lamellocyte differentiation, but it was needed for the increase in plasmatocyte numbers and for the release of sessile hemocytes into the hemolymph. We conclude that edin expression in the fat body affects the outcome of a wasp infection by regulating the increase of plasmatocyte numbers and the mobilization of sessile hemocytes in Drosophila larvae.","[Vanha-aho, Leena-Maija; Valanne, Susanna; Ramet, Mika] Univ Tampere, Expt Immunol Lab, BioMediTech, FIN-33101 Tampere, Finland; [Anderl, Ines; Vesala, Laura; Hultmark, Dan] Univ Tampere, Lab Genet Immunol, BioMediTech, FIN-33101 Tampere, Finland; [Anderl, Ines; Hultmark, Dan] Umea Univ, Dept Mol Biol, Umea, Sweden; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Ramet, Mika] Univ Oulu, PEDEGO Res Ctr, Oulu, Finland; [Ramet, Mika] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland","Vanha-aho, LM (reprint author), Univ Tampere, Expt Immunol Lab, BioMediTech, FIN-33101 Tampere, Finland.",mika.ramet@uta.fi,"Hultmark, Dan/C-5058-2013","Hultmark, Dan/0000-0002-6506-5855; Vanha-aho, Leena-Maija/0000-0001-7933-7711",Academy of Finland; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Swedish Cancer Society; Tampere Tuberculosis Foundation; Tampere Graduate Program in Biotechnology and Biomedicine; Competitive State Research Financing of the Tampere University Hospital; Competitive State Research Financing of the Oulu University Hospital,"The study was financially supported by the Academy of Finland (MR, DH and LV), the Jane and Aatos Erkko Foundation (MR), the Sigrid Juselius Foundation (MR, DH), the Swedish Cancer Society (DH), the Tampere Tuberculosis Foundation (MR), the Tampere Graduate Program in Biotechnology and Biomedicine (LMV), the Competitive State Research Financing of the Tampere University Hospital (MR) and the Competitive State Research Financing of the Oulu University Hospital (MR). The Drosophila work was carried out at the University of Tampere Drosophila core facility supported by Biocenter Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,55,15,16,0,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004895,10.1371/journal.ppat.1004895,,,,18,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300039,25965263.0,"DOAJ Gold, Green Published",,,16/08/2019,17,50,32,3999,626,479,147,3373,2830,20,523,32,0,0,1,15,15,0,,36,15,36,0,15,17,17,15,11,0,0,0,0,0,0,0,50,7,4058,18,0,69,62,0,3398,635,18,0,69,62,0,25,,0,0,0,0,8,0,2,1,1,0,0,36,0,0,4.35,6.388178913738019,1.1855914616068781,0.18559146160687814,1.2268010672991403,1.0347586896724181,6.610223642172524
649,J,"Wood, S; Goldufsky, J; Shafikhani, SH",,,,"Wood, Stephen; Goldufsky, Josef; Shafikhani, Sasha H.",,,Pseudomonas aeruginosa ExoT Induces Atypical Anoikis Apoptosis in Target Host Cells by Transforming Crk Adaptor Protein into a Cytotoxin,PLOS PATHOGENS,,,English,Article,,,,,,,FOCAL ADHESION KINASE; GTPASE-ACTIVATING PROTEIN; SECRETED TOXIN EXOT; EXOENZYME-S; BETA-CATENIN; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; III CYTOTOXIN; IN-VIVO,"Previously, we demonstrated that Pseudomonas aeruginosa ExoT induces potent apoptosis in host epithelial cells in a manner that primarily depends on its ADP-ribosyltransferase domain (ADPRT) activity. However, the mechanism underlying ExoT/ADPRT-induced apoptosis remains undetermined. We now report that ExoT/ADPRT disrupts focal adhesion sites, activates p38 beta and JNK, and interferes with integrin-mediated survival signaling; causing atypical anoikis. We show that ExoT/ADPRT-induced anoikis is mediated by the Crk adaptor protein. We found that Crk(-/-) knockout cells are significantly more resistant to ExoT-induced apoptosis, while Crk(-/-) cells complemented with Crk are rendered sensitive to ExoT-induced apoptosis. Moreover, a dominant negative (DN) mutant form of Crk phenocopies ExoT-induced apoptosis both kinetically and mechanistically. Crk is generally believed to be a component of focal adhesion (FA) and its role in cellular survival remains controversial in that it has been found to be either pro-survival or pro-apoptosis. Our data demonstrate that although Crk is recruited to FA sites, its function is likely not required for FA assembly or for survival per se. However, when modified by ExoT or by mutagenesis, it can be transformed into a cytotoxin that induces anoikis by disrupting FA sites and interfering with integrin survival signaling. To our knowledge, this is the first example whereby a bacterial toxin exerts its cytotoxicity by subverting the function of an innocuous host cellular protein and turning it against the host cell.","[Wood, Stephen; Goldufsky, Josef; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Shafikhani, Sasha H.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA","Shafikhani, SH (reprint author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.",Sasha_Shafikhani@rush.edu,,,National Institutes of Health [R21 AI110685-01]; Brian Piccolo Cancer Research Fund [62270],"This work was supported by a National Institutes of Health grant R21 AI110685-01 (to SHS), and The Brian Piccolo Cancer Research Fund #62270 (to SHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,6,6,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004934,10.1371/journal.ppat.1004934,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300060,26020630.0,"DOAJ Gold, Green Published",,,16/08/2019,7,0,11,2918,452,317,135,2466,2003,25,438,11,0,8,2,6,6,0,,13,1,13,0,1,7,7,7,7,0,0,0,0,0,0,0,0,2,2935,47,0,58,17,1,2470,455,47,0,58,17,1,10,,0,0,0,0,3,0,0,1,1,0,0,13,0,0,2.75,6.45575221238938,1.1832927818329277,0.18329278183292783,1.216139497161395,1.0277587388622345,6.634955752212389
650,J,"Alhamdi, Y; Neill, DR; Abrams, ST; Malak, HA; Yahya, R; Barrett-Jolley, R; Wang, GZ; Kadioglu, A; Toh, CH",,,,"Alhamdi, Yasir; Neill, Daniel R.; Abrams, Simon T.; Malak, Hesham A.; Yahya, Reham; Barrett-Jolley, Richard; Wang, Guozheng; Kadioglu, Aras; Toh, Cheng-Hock",,,Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection,PLOS PATHOGENS,,,English,Article,,,,,,,ENDOPLASMIC-RETICULUM STRESS; COMMUNITY-ACQUIRED PNEUMONIA; PROTEIN-KINASE-C; PROGRAMMED CELL-DEATH; STREPTOCOCCUS-PNEUMONIAE; SEPTIC SHOCK; HEART-FAILURE; TROPONIN-I; CONTRACTILE DYSFUNCTION; CARDIOVASCULAR-DISEASE,"Streptococcus pneumoniae accounts for more deaths worldwide than any other single pathogen through diverse disease manifestations including pneumonia, sepsis and meningitis. Life-threatening acute cardiac complications are more common in pneumococcal infection compared to other bacterial infections. Distinctively, these arise despite effective antibiotic therapy. Here, we describe a novel mechanism of myocardial injury, which is triggered and sustained by circulating pneumolysin (PLY). Using a mouse model of invasive pneumococcal disease (IPD), we demonstrate that wild type PLY-expressing pneumococci but not PLY-deficient mutants induced elevation of circulating cardiac troponins (cTns), well-recognized biomarkers of cardiac injury. Furthermore, elevated cTn levels linearly correlated with pneumococcal blood counts (r=0.688, p=0.001) and levels were significantly higher in non-surviving than in surviving mice. These cTn levels were significantly reduced by administration of PLY-sequestering liposomes. Intravenous injection of purified PLY, but not a non-pore forming mutant (PdB), induced substantial increase in cardiac troponins to suggest that the pore-forming activity of circulating PLY is essential for myocardial injury in vivo. Purified PLY and PLY-expressing pneumococci also caused myocardial inflammatory changes but apoptosis was not detected. Exposure of cultured cardiomyocytes to PLY-expressing pneumococci caused dose-dependent cardiomyocyte contractile dysfunction and death, which was exacerbated by further PLY release following antibiotic treatment. We found that high PLY doses induced extensive cardiomyocyte lysis, but more interestingly, sub-lytic PLY concentrations triggered profound calcium influx and overload with subsequent membrane depolarization and progressive reduction in intracellular calcium transient amplitude, a key determinant of contractile force. This was coupled to activation of signalling pathways commonly associated with cardiac dysfunction in clinical and experimental sepsis and ultimately resulted in depressed cardiomyocyte contractile performance along with rhythm disturbance. Our study proposes a detailed molecular mechanism of pneumococcal toxin-induced cardiac injury and highlights the major translational potential of targeting circulating PLY to protect against cardiac complications during pneumococcal infections.","[Alhamdi, Yasir; Neill, Daniel R.; Abrams, Simon T.; Malak, Hesham A.; Yahya, Reham; Wang, Guozheng; Kadioglu, Aras; Toh, Cheng-Hock] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Barrett-Jolley, Richard] Univ Liverpool, Dept Musculoskeletal Biol, Inst Aging & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Toh, Cheng-Hock] Royal Liverpool Univ Hosp, Roald Dahl Haemostasis & Thrombosis Ctr, Liverpool, Merseyside, England","Alhamdi, Y (reprint author), Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.",A.kadioglu@liv.ac.uk,"Neill, Daniel/Q-6290-2019","Neill, Daniel/0000-0002-7911-8153; kadioglu, aras/0000-0003-1137-6321","British Heart Foundation (BHF) [FS/07/047]; Institute of Infection and Global Health (IGH) of University of Liverpool; Medical Research Council [MC_PC_13068, G0400488]","This work was supported by awards from the British Heart Foundation (BHF, FS/07/047) to (CHT) and Institute of Infection and Global Health (IGH) of University of Liverpool to (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,79,44,44,1,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004836,10.1371/journal.ppat.1004836,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300013,25973949.0,"DOAJ Gold, Green Published",,,16/08/2019,42,10,38,5839,1047,753,294,4792,3977,29,786,38,7,1,2,39,39,0,,39,8,38,1,8,42,42,41,22,0,0,1,0,0,1,1,3,8,5854,25,0,213,258,2,4780,1047,25,0,213,258,2,27,,4,0,0,0,12,0,0,1,1,0,0,39,0,0,39.55,5.576886341929322,1.2184891485809684,0.21848914858096827,1.2806761268781301,1.0510361363247132,5.861509073543457
651,J,"Almagro-Moreno, S; Pruss, K; Taylor, RK",,,,"Almagro-Moreno, Salvador; Pruss, Kali; Taylor, Ronald K.",,,Intestinal Colonization Dynamics of Vibrio cholerae,PLOS PATHOGENS,,,English,Review,,,,,,,VIRULENCE GENE-EXPRESSION; OUTER-MEMBRANE PROTEIN; REGULATORY CASCADE; BIOFILM FORMATION; ACID TOLERANCE; FATTY-ACIDS; EL-TOR; TOXT; HOST; BILE,"To cause the diarrheal disease cholera, Vibrio cholerae must effectively colonize the small intestine. In order to do so, the bacterium needs to successfully travel through the stomach and withstand the presence of agents such as bile and antimicrobial peptides in the intestinal lumen and mucus. The bacterial cells penetrate the viscous mucus layer covering the epithelium and attach and proliferate on its surface. In this review, we discuss recent developments and known aspects of the early stages of V. cholerae intestinal colonization and highlight areas that remain to be fully understood. We propose mechanisms and postulate a model that covers some of the steps that are required in order for the bacterium to efficiently colonize the human host. A deeper understanding of the colonization dynamics of V. cholerae and other intestinal pathogens will provide us with a variety of novel targets and strategies to avoid the diseases caused by these organisms.","[Almagro-Moreno, Salvador; Pruss, Kali; Taylor, Ronald K.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA","Almagro-Moreno, S (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.",Salvador.Almagro-Moreno@Dartmouth.edu,"Almagro-Moreno, Salvador/L-3036-2019; Ibrahim, Essam H./G-1960-2018","Almagro-Moreno, Salvador/0000-0002-1121-1204; Ibrahim, Essam H./0000-0003-0130-2257",National Institute of Health [AI39654]; Dartmouth College's E. E. Just Postdoctoral Fellowship,"This work was supported by a National Institute of Health grant AI39654 to RKT and Dartmouth College's E. E. Just Postdoctoral Fellowship to SAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,49,49,3,34,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004787,10.1371/journal.ppat.1004787,,,,11,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300005,25996593.0,"DOAJ Gold, Green Published",,,16/08/2019,55,32,101,17234,6124,5097,1027,11110,9028,30,2052,101,31,1,0,53,53,0,,167,24,167,0,24,59,58,59,32,0,0,0,0,0,0,0,3,7,17723,12,3,26,238,10,11284,6272,11,3,26,238,10,167,,0,0,0,1,26,0,2,1,0,0,0,167,0,0,18.45,2.8141737426518616,1.5512151215121512,0.5512151215121512,1.6177317731773178,1.0428803527909944,2.934846505551927
652,J,"Boergeling, Y; Rozhdestvensky, TS; Schmolke, M; Resa-Infante, P; Robeck, T; Randau, G; Wolff, T; Gabriel, G; Brosius, J; Ludwig, S",,,,"Boergeling, Yvonne; Rozhdestvensky, Timofey S.; Schmolke, Mirco; Resa-Infante, Patricia; Robeck, Thomas; Randau, Gerrit; Wolff, Thorsten; Gabriel, Guelsah; Brosius, Juergen; Ludwig, Stephan",,,Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein,PLOS PATHOGENS,,,English,Article,,,,,,,ANTIVIRAL SIGNALING PROTEIN; A-VIRUS; RIG-I; VIRAL-RNA; INCREASED VIRULENCE; INTERNAL DELETION; ADAPTER PROTEIN; BETA INTERFERON; INFECTED-CELLS; MESSENGER-RNA,"Influenza A virus (IAV) defective RNAs are generated as byproducts of error-prone viral RNA replication. They are commonly derived from the larger segments of the viral genome and harbor deletions of various sizes resulting in the generation of replication incompatible viral particles. Furthermore, small subgenomic RNAs are known to be strong inducers of pattern recognition receptor RIG-I-dependent type I interferon (IFN) responses. The present study identifies a novel IAV-induced defective RNA derived from the PB2 segment of A/Thailand/1(KAN-1)/2004 (H5N1). It encodes a 10 kDa protein (PB2(Delta)) sharing the N-terminal amino acid sequence of the parental PB2 protein followed by frame shift after internal deletion. PB2(Delta) induces the expression of IFN beta and IFN-stimulated genes by direct interaction with the cellular adapter protein MAVS, thereby reducing viral replication of IFN-sensitive viruses such as IAV or vesicular stomatitis virus. This induction of IFN is completely independent of the defective RNA itself that usually serves as pathogen-associated pattern and thus does not require the cytoplasmic sensor RIG-I. These data suggest that not only defective RNAs, but also some defective RNA-encoded proteins can act immunostimulatory. In this particular case, the KAN-1-induced defective RNA-encoded protein PB2(Delta) enhances the overwhelming immune response characteristic for highly pathogenic H5N1 viruses, leading to a more severe phenotype in vivo.","[Boergeling, Yvonne; Schmolke, Mirco; Ludwig, Stephan] Univ Munster, IMV, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Rozhdestvensky, Timofey S.; Robeck, Thomas; Randau, Gerrit; Brosius, Juergen] Univ Munster, Inst Expt Pathol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Resa-Infante, Patricia; Gabriel, Guelsah] Leibniz Inst Expt Virol, Heinrich Pette Inst, Viral Zoonosis & Adaptat, Hamburg, Germany; [Wolff, Thorsten] Robert Koch Inst, Div Influenza Viruses & Other Resp Viruses, Berlin, Germany; [Brosius, Juergen] Brandenburg Med Sch MHB, Inst Evolutionary & Med Genom, Neuruppin, Germany; [Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, Fac Med, D-48149 Munster, Germany; [Ludwig, Stephan] Univ Munster, Cells In Mot Cluster Excellence, D-48149 Munster, Germany","Ludwig, S (reprint author), Univ Munster, IMV, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany.",ludwigs@uni-muenster.de,"Rozhdestvensky, Timofey/R-2270-2019; Brosius, Jurgen/F-5029-2016; Infante, Patricia Resa/D-3843-2018","Rozhdestvensky, Timofey/0000-0002-3384-925X; Brosius, Jurgen/0000-0003-1650-2059; Infante, Patricia Resa/0000-0002-1727-592X; Ludwig, Stephan/0000-0003-4490-3052","Deutsche Forschungsgemeinschaft [Lu477/12-1, SFB1009 B2, Wo554/4-1]","This work was supported by different grants of the Deutsche Forschungsgemeinschaft (e.g. Lu477/12-1, SFB1009 B2, Wo554/4-1). The IMV is a member of the FluResearchNet, a German-wide research network on zoonotic influenza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,73,11,12,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004924,10.1371/journal.ppat.1004924,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300054,26024522.0,"DOAJ Gold, Green Published",,,16/08/2019,8,10,30,7394,852,626,226,6542,5490,34,1018,30,4,0,0,11,11,0,,44,3,44,0,3,13,8,13,7,0,0,0,0,0,0,0,6,3,7396,71,0,107,515,0,6518,852,71,0,107,515,0,26,,0,0,0,0,6,0,0,1,0,0,0,44,0,0,4.6,8.678403755868544,1.1302354020177316,0.1302354020177316,1.220116172424335,1.0795239383283743,9.368544600938968
653,J,"Carvalho, F; Atilano, ML; Pombinho, R; Covas, G; Gallo, RL; Filipe, SR; Sousa, S; Cabanes, D",,,,"Carvalho, Filipe; Atilano, Magda L.; Pombinho, Rita; Covas, Goncalo; Gallo, Richard L.; Filipe, Sergio R.; Sousa, Sandra; Cabanes, Didier",,,L-Rhamnosylation of Listeria monocytogenes Wall Teichoic Acids Promotes Resistance to Antimicrobial Peptides by Delaying Interaction with the Membrane,PLOS PATHOGENS,,,English,Article,,,,,,,GRAM-POSITIVE BACTERIA; RHAMNOSE PATHWAY GENES; STAPHYLOCOCCUS-AUREUS; CELL-WALL; TRANSPOSON MUTAGENESIS; METHICILLIN RESISTANCE; COMPARATIVE GENOMICS; LIPOTEICHOIC ACIDS; BACILLUS-SUBTILIS; GENUS LISTERIA,"Listeria monocytogenes is an opportunistic Gram-positive bacterial pathogen responsible for listeriosis, a human foodborne disease. Its cell wall is densely decorated with wall teichoic acids (WTAs), a class of anionic glycopolymers that play key roles in bacterial physiology, including protection against the activity of antimicrobial peptides (AMPs). In other Gram-positive pathogens, WTA modification by amine-containing groups such as D-alanine was largely correlated with resistance to AMPs. However, in L. monocytogenes, where WTA modification is achieved solely via glycosylation, WTA-associated mechanisms of AMP resistance were unknown. Here, we show that the L-rhamnosylation of L. monocytogenes WTAs relies not only on the rmlACBD locus, which encodes the biosynthetic pathway for L-rhamnose, but also on rmlT encoding a putative rhamnosyltransferase. We demonstrate that this WTA tailoring mechanism promotes resistance to AMPs, unveiling a novel link between WTA glycosylation and bacterial resistance to host defense peptides. Using in vitro binding assays, fluorescence-based techniques and electron microscopy, we show that the presence of L-rhamnosylated WTAs at the surface of L. monocytogenes delays the crossing of the cell wall by AMPs and postpones their contact with the listerial membrane. We propose that WTA L-rhamnosylation promotes L. monocytogenes survival by decreasing the cell wall permeability to AMPs, thus hindering their access and detrimental interaction with the plasma membrane. Strikingly, we reveal a key contribution of WTA L-rhamnosylation for L. monocytogenes virulence in a mouse model of infection.","[Carvalho, Filipe; Pombinho, Rita; Sousa, Sandra; Cabanes, Didier] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Carvalho, Filipe; Pombinho, Rita; Sousa, Sandra; Cabanes, Didier] Inst Biol Mol & Celular, Grp Mol Microbiol, Oporto, Portugal; [Carvalho, Filipe; Pombinho, Rita] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Atilano, Magda L.; Covas, Goncalo; Filipe, Sergio R.] Univ Nova Lisboa, Lab Bacterial Cell Surfaces & Pathogenesis, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA","Cabanes, D (reprint author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.",didier@ibmc.up.pt,"Sousa, Sandra/K-3934-2013; Cabanes, Didier/P-3052-2019; Filipe, Sergio Raposo/B-9167-2008; Sousa, Sandra/P-2133-2019; Covas, Goncalo/F-5019-2010","Sousa, Sandra/0000-0001-8578-0461; Cabanes, Didier/0000-0002-4001-1332; Filipe, Sergio Raposo/0000-0002-4485-832X; Sousa, Sandra/0000-0001-8578-0461; Covas, Goncalo/0000-0001-7765-2056; Atilano, Magda/0000-0002-3819-2023; Carvalho, Filipe/0000-0002-6828-1772; Pombinho, Rita/0000-0001-7654-2568","Fundo Europeu de Desenvolvimento Regional (FEDER), through the Operational Competitiveness Programme (COMPETE); national funds through FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/SAU-IMU/111806/2009, PTDC/SAU-MIC/111581/2009FCOMP-01-0124-FEDER-015844]; ERANet-Pathogenomics LISTRESS [ERA-PTG/0003/2010, Infect-ERA/0001/2013 PROANTILIS]; Programa Operacional Regional do Norte (ON.2-O Novo Norte) under the Quadro de Referencia Estrategico Nacional (QREN), through FEDER; Programa Operacional Regional do Norte (ON.2-O Novo Norte) under the Quadro de Referencia Estrategico Nacional (QREN), through FCT; FCT [SFRH/BD/61825/2009, SFRH/BD/28440/2006, SFRH/BD/89542/2012, SFRH/BD/52207/2013]; FCT Investigator programs;  [NORTE-07-0124-FEDER-000002-Host-Pathogen Interactions]","This work was funded by the Fundo Europeu de Desenvolvimento Regional (FEDER), through the Operational Competitiveness Programme (COMPETE), and by national funds through FCT (Fundacao para a Ciencia e a Tecnologia), under projects PTDC/SAU-IMU/111806/2009, PTDC/SAU-MIC/111581/2009FCOMP-01-0124-FEDER-015844, ERANet-Pathogenomics LISTRESS ERA-PTG/0003/2010, Infect-ERA/0001/2013 PROANTILIS, and by project ""NORTE-07-0124-FEDER-000002-Host-Pathogen Interactions"", co-funded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional (QREN), through FEDER and FCT. FC, MLA, RP and GC were supported by FCT doctoral fellowships (SFRH/BD/61825/2009, SFRH/BD/28440/2006, SFRH/BD/89542/2012 and SFRH/BD/52207/2013). SS was supported by the Ciencia 2008 and FCT Investigator programs (COMPETE, POPH and FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,80,23,25,1,24,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004919,10.1371/journal.ppat.1004919,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300053,26001194.0,"DOAJ Gold, Green Published",,,16/08/2019,23,37,51,5908,940,655,285,4968,4130,23,815,51,5,0,0,24,24,0,,132,4,69,0,4,24,24,22,16,0,0,0,0,0,0,0,32,10,5932,39,0,144,123,1,4939,940,39,0,144,123,1,53,,0,0,0,0,11,0,1,1,0,0,0,69,0,0,5.8,6.285106382978723,1.1892109500805152,0.1892109500805153,1.2266505636070852,1.0314827352742044,6.482978723404256
654,J,"Crooks, ET; Tong, T; Chakrabarti, B; Narayan, K; Georgiev, IS; Menis, S; Huang, XX; Kulp, D; Osawa, K; Muranaka, J; Stewart-Jones, G; Destefano, J; O'Dell, S; LaBranche, C; Robinson, JE; Montefiori, DC; McKee, K; Du, SX; Doria-Rose, N; Kwong, PD; Mascola, JR; Zhu, P; Schief, WR; Wyatt, RT; Whalen, RG; Binley, JM",,,,"Crooks, Ema T.; Tong, Tommy; Chakrabarti, Bimal; Narayan, Kristin; Georgiev, Ivelin S.; Menis, Sergey; Huang, Xiaoxing; Kulp, Daniel; Osawa, Keiko; Muranaka, Janelle; Stewart-Jones, Guillaume; Destefano, Joanne; O'Dell, Sijy; LaBranche, Celia; Robinson, James E.; Montefiori, David C.; McKee, Krisha; Du, Sean X.; Doria-Rose, Nicole; Kwong, Peter D.; Mascola, John R.; Zhu, Ping; Schief, William R.; Wyatt, Richard T.; Whalen, Robert G.; Binley, James M.",,,Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site,PLOS PATHOGENS,,,English,Article,,,,,,,HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN TRIMERS; MONOCLONAL-ANTIBODIES; ENV TRIMERS; COMPARATIVE IMMUNOGENICITY; CONFORMATIONAL EPITOPE; POTENT NEUTRALIZATION; BROAD NEUTRALIZATION; GP41-GP120 INTERFACE; DEPENDENT EPITOPE,"Eliciting broad tier 2 neutralizing antibodies (nAbs) is a major goal of HIV-1 vaccine research. Here we investigated the ability of native, membrane-expressed JR-FL Env trimers to elicit nAbs. Unusually potent nAb titers developed in 2 of 8 rabbits immunized with virus-like particles (VLPs) expressing trimers (trimer VLP sera) and in 1 of 20 rabbits immunized with DNA expressing native Env trimer, followed by a protein boost (DNA trimer sera). All 3 sera neutralized via quaternary epitopes and exploited natural gaps in the glycan defenses of the second conserved region of JR-FL gp120. Specifically, trimer VLP sera took advantage of the unusual absence of a glycan at residue 197 (present in 98.7% of Envs). Intriguingly, removing the N197 glycan (with no loss of tier 2 phenotype) rendered 50% or 16.7% (n = 18) of clade B tier 2 isolates sensitive to the two trimer VLP sera, showing broad neutralization via the surface masked by the N197 glycan. Neutralizing sera targeted epitopes that overlap with the CD4 binding site, consistent with the role of the N197 glycan in a putative ""glycan fence"" that limits access to this region. A bioinformatics analysis suggested shared features of one of the trimer VLP sera and monoclonal antibody PG9, consistent with its trimer-dependency. The neutralizing DNA trimer serum took advantage of the absence of a glycan at residue 230, also proximal to the CD4 binding site and suggesting an epitope similar to that of monoclonal antibody 8ANC195, albeit lacking tier 2 breadth. Taken together, our data show for the first time that strain-specific holes in the glycan fence can allow the development of tier 2 neutralizing antibodies to native spikes. Moreover, cross-neutralization can occur in the absence of protecting glycan. Overall, our observations provide new insights that may inform the future development of a neutralizing antibody vaccine.","[Chakrabarti, Bimal; Menis, Sergey; Kulp, Daniel; Schief, William R.; Wyatt, Richard T.] Scripps Res Inst, Int AIDS Vaccine Initiat IAVI Neutralizing Antibo, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Narayan, Kristin; Muranaka, Janelle; Du, Sean X.; Whalen, Robert G.] Altravax Inc, Sunnyvale, CA USA; [Georgiev, Ivelin S.; Stewart-Jones, Guillaume; O'Dell, Sijy; McKee, Krisha; Doria-Rose, Nicole; Kwong, Peter D.; Mascola, John R.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Menis, Sergey; Kulp, Daniel; Schief, William R.; Wyatt, Richard T.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Huang, Xiaoxing; Zhu, Ping] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Stewart-Jones, Guillaume] Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Destefano, Joanne] Design & Dev Lab, Int AIDS Vaccine Initiat, Brooklyn, NY USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Robinson, James E.] Tulane Natl Primate Res Ctr, Covington, LA USA; [Schief, William R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA",,jbinley@sdbri.org,,,"National Institutes of Health [RO1AI93278, RO1AI58763, R33AI84714, P01 AI056375]; Department of Defense [W9113M-08-1-0008]; International AIDS Vaccine Initiative; National Natural Science Foundation of China [81261120418]; National Institutes of Health Intramural Research Program; US-China Program in Biomedical Research Cooperation [AI58763]","This work was supported by National Institutes of Health (www.nih.gov) grants RO1AI93278, RO1AI58763 and R33AI84714 (JMB); National Institutes of Health grant P01 AI056375 and Department of Defense grant W9113M-08-1-0008 (RGW); the International AIDS Vaccine Initiative (www.iavi.org) Intramural Research Program (RTW); supplements provided by the US-China Program in Biomedical Research Cooperation to National Institutes of Health grant AI58763 (JMB) and National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) grant 81261120418 (PZ); and the National Institutes of Health Intramural Research Program (ISG, SO, GSJ, NDR, PDK, and JRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,90,77,77,1,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004932,10.1371/journal.ppat.1004932,,,,34,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300058,26023780.0,"DOAJ Gold, Green Published",,,16/08/2019,75,28,45,6775,1050,763,287,5725,4696,37,992,45,5,0,0,79,79,0,,62,8,62,0,8,80,78,80,70,0,0,0,0,0,0,0,23,4,6793,114,1,561,244,0,5709,1050,114,1,561,244,0,34,,0,0,0,0,7,0,1,2,0,0,0,61,0,0,4.35,6.4523809523809526,1.1834061135371179,0.18340611353711792,1.2490829694323144,1.0554981549815499,6.810476190476191
655,J,"Divis, PCS; Singh, B; Anderios, F; Hisam, S; Matusop, A; Kocken, CH; Assefa, SA; Duffy, CW; Conway, DJ",,,,"Divis, Paul C. S.; Singh, Balbir; Anderios, Fread; Hisam, Shamilah; Matusop, Asmad; Kocken, Clemens H.; Assefa, Samuel A.; Duffy, Craig W.; Conway, David J.",,,Admixture in Humans of Two Divergent Plasmodium knowlesi Populations Associated with Different Macaque Host Species,PLOS PATHOGENS,,,English,Article,,,,,,,MALARIA PARASITE; HIGH PROPORTION; ADAPTATION; FALCIPARUM; DIVERSITY; ORIGIN; SABAH; TRANSMISSION; INFECTIONS; SOFTWARE,"Human malaria parasite species were originally acquired from other primate hosts and subsequently became endemic, then spread throughout large parts of the world. A major zoonosis is now occurring with Plasmodium knowlesi from macaques in Southeast Asia, with a recent acceleration in numbers of reported cases particularly in Malaysia. To investigate the parasite population genetics, we developed sensitive and species-specific microsatellite genotyping protocols and applied these to analysis of samples from 10 sites covering a range of >1,600 km within which most cases have occurred. Genotypic analyses of 599 P. knowlesi infections (552 in humans and 47 in wild macaques) at 10 highly polymorphic loci provide radical new insights on the emergence. Parasites from sympatric long-tailed macaques (Macaca fascicularis) and pig-tailed macaques (M. nemestrina) were very highly differentiated (FST = 0.22, and K-means clustering confirmed two host-associated subpopulations). Approximately two thirds of human P. knowlesi infections were of the long-tailed macaque type (Cluster 1), and one third were of the pig-tailed-macaque type (Cluster 2), with relative proportions varying across the different sites. Among the samples from humans, there was significant indication of genetic isolation by geographical distance overall and within Cluster 1 alone. Across the different sites, the level of multi-locus linkage disequilibrium correlated with the degree of local admixture of the two different clusters. The widespread occurrence of both types of P. knowlesi in humans enhances the potential for parasite adaptation in this zoonotic system.","[Divis, Paul C. S.; Assefa, Samuel A.; Duffy, Craig W.; Conway, David J.] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London WC1, England; [Divis, Paul C. S.; Singh, Balbir; Matusop, Asmad; Conway, David J.] Univ Malaysia Sarawak, Malaria Res Ctr, Fac Med & Hlth Sci, Kuching, Sarawak, Malaysia; [Anderios, Fread] Sabah State Publ Hlth Lab, Kota Kinabalu, Sabah, Malaysia; [Hisam, Shamilah] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Matusop, Asmad] Sarawak State Hlth Dept, Kuching, Sarawak, Malaysia; [Kocken, Clemens H.] Biomed Primate Res Ctr, Rijswijk, Netherlands","Divis, PCS (reprint author), London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London WC1, England.",paul.divis@lshtm.ac.uk; bskhaira55@gmail.com; david.conway@lshtm.ac.uk,,"Singh, Balbir/0000-0002-9143-3965; Duffy, Craig/0000-0001-9359-4888; Conway, David/0000-0002-8711-3037; Kocken, Clemens/0000-0002-4784-1734","UNIMAS [E14054/F05/54PK1/09/2012(01), 01(TD03)/1003/2013(01)]; UK Medical Research Council [G1100123]; ERC Advanced Award [AdG-2011-294428]; Ministry of Education in Malaysia; Medical Research Council [G1100123]","The research was supported by grants from UNIMAS to BS (grant number E14054/F05/54PK1/09/2012(01) and 01(TD03)/1003/2013(01)), the UK Medical Research Council to DJC (G1100123), an ERC Advanced Award to DJC (AdG-2011-294428) and a postgraduate scholarship for PCSD from the Ministry of Education in Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,48,38,38,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004888,10.1371/journal.ppat.1004888,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300033,26020959.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,41,26,41,5324,528,375,153,4796,4060,23,713,41,21,0,0,42,42,4,,129,3,66,0,3,46,44,46,32,0,0,0,0,0,0,3,5,15,5374,196,7,135,77,3,4817,544,196,7,135,77,3,13,,4,2,1,0,26,0,4,1,0,0,0,66,0,0,63.832,10.083333333333334,1.110091743119266,0.11009174311926606,1.17743953294412,1.0606686701728023,10.695075757575758
656,J,"Duron, O; Noel, V; Mccoy, KD; Bonazzi, M; Sidi-Boumedine, K; Morel, O; Vavre, F; Zenner, L; Jourdain, E; Durand, P; Arnathau, C; Renaud, F; Trape, JF; Biguezoton, AS; Cremaschi, J; Dietrich, M; Leger, E; Appelgren, A; Dupraz, M; Gomez-Diaz, E; Diatta, G; Dayo, GK; Adakal, H; Zoungrana, S; Vial, L; Chevillon, C",,,,"Duron, Olivier; Noel, Valerie; McCoy, Karen D.; Bonazzi, Matteo; Sidi-Boumedine, Karim; Morel, Olivier; Vavre, Fabrice; Zenner, Lionel; Jourdain, Elsa; Durand, Patrick; Arnathau, Celine; Renaud, Francois; Trape, Jean-Francois; Biguezoton, Abel S.; Cremaschi, Julie; Dietrich, Muriel; Leger, Elsa; Appelgren, Anais; Dupraz, Marlene; Gomez-Diaz, Elena; Diatta, Georges; Dayo, Guiguigbaza-Kossigan; Adakal, Hassane; Zoungrana, Sebastien; Vial, Laurence; Chevillon, Christine",,,"The Recent Evolution of a Maternally-Inherited Endosymbiont of Ticks Led to the Emergence of the Q Fever Pathogen, Coxiella burnetii",PLOS PATHOGENS,,,English,Article,,,,,,,LONE STAR TICK; VECTOR AMBLYOMMA-AMERICANUM; RHIPICEPHALUS-SANGUINEUS; INTRACELLULAR SYMBIONTS; BACTERIAL ENDOSYMBIONTS; GENOME SEQUENCE; SEABIRD TICKS; DIVERSITY; WOLBACHIA; ARSENOPHONUS,"Q fever is a highly infectious disease with a worldwide distribution. Its causative agent, the intracellular bacterium Coxiella burnetii, infects a variety of vertebrate species, including humans. Its evolutionary origin remains almost entirely unknown and uncertainty persists regarding the identity and lifestyle of its ancestors. A few tick species were recently found to harbor maternally-inherited Coxiella-like organisms engaged in symbiotic interactions, but their relationships to the Q fever pathogen remain unclear. Here, we extensively sampled ticks, identifying new and atypical Coxiella strains from 40 of 58 examined species, and used this data to infer the evolutionary processes leading to the emergence of C. burnetii. Phylogenetic analyses of multi-locus typing and whole-genome sequencing data revealed that Coxiella-like organisms represent an ancient and monophyletic group allied to ticks. Remarkably, all known C. burnetii strains originate within this group and are the descendants of a Coxiella-like progenitor hosted by ticks. Using both colony-reared and field-collected gravid females, we further establish the presence of highly efficient maternal transmission of these Coxiella-like organisms in four examined tick species, a pattern coherent with an endosymbiotic lifestyle. Our laboratory culture assays also showed that these Coxiella-like organisms were not amenable to culture in the vertebrate cell environment, suggesting different metabolic requirements compared to C. burnetii. Altogether, this corpus of data demonstrates that C. burnetii recently evolved from an inherited symbiont of ticks which succeeded in infecting vertebrate cells, likely by the acquisition of novel virulence factors.","[Duron, Olivier; Noel, Valerie; McCoy, Karen D.; Durand, Patrick; Arnathau, Celine; Renaud, Francois; Trape, Jean-Francois; Biguezoton, Abel S.; Cremaschi, Julie; Dietrich, Muriel; Leger, Elsa; Appelgren, Anais; Dupraz, Marlene; Gomez-Diaz, Elena; Chevillon, Christine] Univ Montpellier, Lab MIVEGEC Malad Infect & Vecteurs Ecol Genet Ev, Inst Rech & Dev UR 224, CNRS,UMR5290, F-34059 Montpellier, France; [Bonazzi, Matteo] Univ Montpellier, CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, F-34059 Montpellier, France; [Sidi-Boumedine, Karim] French Agcy Food Environm & Occupat Hlth Safety A, Natl Reference Lab Fever Q, Sophia Antipolis, France; [Morel, Olivier; Vavre, Fabrice; Zenner, Lionel] Univ Lyon 1, CNRS, UMR5558, LBBE, F-69622 Villeurbanne, France; [Jourdain, Elsa] INRA, UR346, Unite Epidemiol Anim, St Genes Champanelle, France; [Dayo, Guiguigbaza-Kossigan; Adakal, Hassane; Zoungrana, Sebastien] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Unite Rech Bases Biol Lutte Integree URBIO, Bobo Dioulasso, Burkina Faso; [Gomez-Diaz, Elena] Emory Univ, Dept Biol, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Diatta, Georges] Aix Marseille Univ, URMITE, CNRS, UMR6236, Dakar, Senegal; [Adakal, Hassane] Univ Dan Dicko Dan Koulodo, Dept Sci & Tech Elevage DSTE FASE, Maradi, Niger; [Vial, Laurence] Ctr Cooperat Int Rech Agron Dev CIRAD, Prades Le Lez, France","Duron, O (reprint author), Univ Montpellier, Lab MIVEGEC Malad Infect & Vecteurs Ecol Genet Ev, Inst Rech & Dev UR 224, CNRS,UMR5290, F-34059 Montpellier, France.",olivier.duron@ird.fr,"Zenner, lionel/V-4413-2018; Gomez-Diaz, Elena/G-2503-2011; Chevillon, Christine/L-4645-2013; Bonazzi, Matteo/G-1623-2011; vavre, fabrice/N-2945-2017; McCoy, Karen D/F-7061-2012; Chevillon, Christine/M-9770-2019","Zenner, lionel/0000-0001-5637-8799; Gomez-Diaz, Elena/0000-0002-4146-9003; Chevillon, Christine/0000-0002-1262-5839; Bonazzi, Matteo/0000-0001-5499-8759; vavre, fabrice/0000-0003-0909-2936; McCoy, Karen D/0000-0002-8972-3808; Chevillon, Christine/0000-0002-1262-5839; Sidi-Boumedine, Karim/0000-0003-2746-9629; Duron, Olivier/0000-0002-7426-782X; Dietrich, Muriel/0000-0002-2665-7970","CNRS-INEE; French Polar Institue (IPEV) [333]; CNRS-INEE/TAAF; Agence Nationale de la Recherche [ANR-11-BSV7-003-02, ANR-13-BSV7-0018-01, ANR-3215AO-3R077-STEV, ANR-11-LABX-0048]","Financial support was provided by the CNRS-INEE (Programme PEPS-Ecologie de la Sante 2014, 'SYMPATTIQUES': OD LZ; http://www.cnrs.fr/inee/outils/PEPS2014.htm), French Polar Institue (IPEV, programme no. 333: KDMcC; http://www.institut-polaire.fr/ipev/programmes_de_recherche), the CNRS-INEE/TAAF (Programme Iles Eparses ""PathOrnithoTiques"": KDMcC; http://www.cnrs.fr/inee/recherche/programmes/iles_eparses.htm), and the Agence Nationale de la Recherche (ANR-11-BSV7-003-02: KDMcC, ANR-13-BSV7-0018-01: KDMcC, ANR-3215AO-3R077-STEV: FR, PD, CA, JFT, ANR-11-LABX-0048: FV, OM, LZ, EJ; http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,80,83,2,47,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004892,10.1371/journal.ppat.1004892,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300036,25978383.0,"DOAJ Gold, Green Published",,,16/08/2019,86,53,89,8015,1273,947,326,6742,5366,40,1336,89,38,0,0,75,75,2,,224,7,117,0,7,87,87,57,40,0,0,1,0,0,1,0,15,19,8150,57,0,253,170,2,6807,1302,57,0,253,170,2,41,,0,1,0,0,31,0,2,1,0,0,0,126,0,0,27.056,6.296150824823252,1.188816374962919,0.188816374962919,1.2425096410560665,1.0451653150343108,6.580518460329929
657,J,"Grubaugh, ND; Smith, DR; Brackney, DE; Bosco-Lauth, AM; Fauver, JR; Campbell, CL; Felix, TA; Romo, H; Duggal, NK; Dietrich, EA; Eike, T; Beane, JE; Bowen, RA; Black, WC; Brault, AC; Ebel, GD",,,,"Grubaugh, Nathan D.; Smith, Darci R.; Brackney, Doug E.; Bosco-Lauth, Angela M.; Fauver, Joseph R.; Campbell, Corey L.; Felix, Todd A.; Romo, Hannah; Duggal, Nisha K.; Dietrich, Elizabeth A.; Eike, Tyler; Beane, Jennifer E.; Bowen, Richard A.; Black, William C.; Brault, Aaron C.; Ebel, Gregory D.",,,Experimental Evolution of an RNA Virus in Wild Birds: Evidence for Host-Dependent Impacts on Population Structure and Competitive Fitness,PLOS PATHOGENS,,,English,Article,,,,,,,WEST-NILE-VIRUS; STRONG PURIFYING SELECTION; NEW-YORK-STATE; ALPHA/BETA-INTERFERON; PHYLOGENETIC ANALYSIS; SEQUENCING DATA; AMERICAN CROWS; HOUSE SPARROWS; DENGUE VIRUS; MOSQUITOS,"Within hosts, RNA viruses form populations that are genetically and phenotypically complex. Heterogeneity in RNA virus genomes arises due to error-prone replication and is reduced by stochastic and selective mechanisms that are incompletely understood. Defining how natural selection shapes RNA virus populations is critical because it can inform treatment paradigms and enhance control efforts. We allowed West Nile virus (WNV) to replicate in wild-caught American crows, house sparrows and American robins to assess how natural selection shapes RNA virus populations in ecologically relevant hosts that differ in susceptibility to virus-induced mortality. After five sequential passages in each bird species, we examined the phenotype and population diversity of WNV through fitness competition assays and next generation sequencing. We demonstrate that fitness gains occur in a species-specific manner, with the greatest replicative fitness gains in robin-passaged WNV and the least in WNV passaged in crows. Sequencing data revealed that intrahost WNV populations were strongly influenced by purifying selection and the overall complexity of the viral populations was similar among passaged hosts. However, the selective pressures that control WNV populations seem to be bird species-dependent. Specifically, crow-passaged WNV populations contained the most unique mutations (similar to 1.7x more than sparrows, similar to 3.4x more than robins) and defective genomes (similar to 1.4x greater than sparrows, similar to 2.7x greater than robins), but the lowest average mutation frequency (about equal to sparrows, similar to 2.6x lower than robins). Therefore, our data suggest that WNV replication in the most disease-susceptible bird species is positively associated with virus mutational tolerance, likely via complementation, and negatively associated with the strength of selection. These differences in genetic composition most likely have distinct phenotypic consequences for the virus populations. Taken together, these results reveal important insights into how different hosts may contribute to the emergence of RNA viruses.","[Grubaugh, Nathan D.; Smith, Darci R.; Brackney, Doug E.; Bosco-Lauth, Angela M.; Fauver, Joseph R.; Campbell, Corey L.; Romo, Hannah; Eike, Tyler; Black, William C.; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Felix, Todd A.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Lakewood, CO USA; [Romo, Hannah; Duggal, Nisha K.; Dietrich, Elizabeth A.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Beane, Jennifer E.] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA; [Bowen, Richard A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA","Grubaugh, ND (reprint author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.",gregory.ebel@colostate.edu,"Ebel, Gregory/D-8324-2017","Grubaugh, Nathan/0000-0003-2031-1933; Beane-Ebel, Jennifer/0000-0002-6699-2132","National Institute of Allergy and Infectious Disease, National Institutes of Health [AI067380]","This work was funded by a grant from the National Institute of Allergy and Infectious Disease, National Institutes of Health under grant number AI067380 (GDE). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.",,56,23,23,0,19,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004874,10.1371/journal.ppat.1004874,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300025,25993022.0,"DOAJ Gold, Green Published",,,16/08/2019,18,189,46,6314,723,557,166,5591,4686,23,882,46,16,0,0,25,25,0,,128,7,67,0,7,26,19,26,17,0,0,0,0,0,0,0,173,14,6399,25,3,63,223,2,5613,732,25,2,63,223,2,54,,0,0,0,0,19,0,2,1,0,0,0,67,0,0,10.1,8.733056708160442,1.1293149704882848,0.12931497048828475,1.18887497764264,1.0527399429838453,9.193637621023512
658,J,"Hurrell, BP; Schuster, S; Grun, E; Coutaz, M; Williams, RA; Held, W; Malissen, B; Malissen, M; Yousefi, S; Simon, HU; Muller, AJ; Tacchini-Cottier, F",,,,"Hurrell, Benjamin P.; Schuster, Steffen; Gruen, Eva; Coutaz, Manuel; Williams, Roderick A.; Held, Werner; Malissen, Bernard; Malissen, Marie; Yousefi, Shida; Simon, Hans-Uwe; Mueller, Andreas J.; Tacchini-Cottier, Fabienne",,,Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion,PLOS PATHOGENS,,,English,Article,,,,,,,DRAINING LYMPH-NODES; CD4 T-CELLS; EXTRACELLULAR TRAPS; DENDRITIC CELLS; CUTANEOUS LEISHMANIASIS; SAND FLIES; IN-VIVO; LUTZOMYIA-LONGIPALPIS; MITOCHONDRIAL-DNA; IL-12 PRODUCTION,"The protozoan Leishmania mexicana parasite causes chronic non-healing cutaneous lesions in humans and mice with poor parasite control. The mechanisms preventing the development of a protective immune response against this parasite are unclear. Here we provide data demonstrating that parasite sequestration by neutrophils is responsible for disease progression in mice. Within hours of infection L. mexicana induced the local recruitment of neutrophils, which ingested parasites and formed extracellular traps without markedly impairing parasite survival. We further showed that the L. mexicana-induced recruitment of neutrophils impaired the early recruitment of dendritic cells at the site of infection as observed by intravital 2-photon microscopy and flow cytometry analysis. Indeed, infection of neutropenic Genista mice and of mice depleted of neutrophils at the onset of infection demonstrated a prominent role for neutrophils in this process. Furthermore, an increase in monocyte-derived dendritic cells was also observed in draining lymph nodes of neutropenic mice, correlating with subsequent increased frequency of IFN.-secreting T helper cells, and better parasite control leading ultimately to complete healing of the lesion. Altogether, these findings show that L. mexicana exploits neutrophils to block the induction of a protective immune response and impairs the control of lesion development. Our data thus demonstrate an unanticipated negative role for these innate immune cells in host defense, suggesting that in certain forms of cutaneous leishmaniasis, regulating neutrophil recruitment could be a strategy to promote lesion healing.","[Hurrell, Benjamin P.; Schuster, Steffen; Gruen, Eva; Coutaz, Manuel; Mueller, Andreas J.; Tacchini-Cottier, Fabienne] Univ Lausanne, WHO Immunol Res & Training Ctr, Dept Biochem, CH-1066 Epalinges, Switzerland; [Williams, Roderick A.] Univ West Scotland, Sch Sci & Sport, Paisley, Renfrew, Scotland; [Held, Werner] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Malissen, Bernard; Malissen, Marie] Aix Marseille Univ, CIML, UM2, Marseille, France; [Malissen, Bernard; Malissen, Marie] INSERM, U1104, F-13258 Marseille, France; [Malissen, Bernard; Malissen, Marie] CNRS, UMR7280, Marseille, France; [Yousefi, Shida; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Mueller, Andreas J.] Univ Magdeburg, D-39106 Magdeburg, Germany; [Mueller, Andreas J.] Helmholtz Ctr Infect Res Braunschweig, Magdeburg, Germany","Tacchini-Cottier, F (reprint author), Univ Lausanne, WHO Immunol Res & Training Ctr, Dept Biochem, CH-1066 Epalinges, Switzerland.",Fabienne.Tacchini-Cottier@unil.ch,"Williams, Roderick/V-4317-2019; Yousefi, Shida/L-9689-2016","Williams, Roderick/0000-0001-5065-9768; Yousefi, Shida/0000-0002-9855-4305; Tacchini-Cottier, Fabienne/0000-0003-3561-0207; Simon, Hans-Uwe/0000-0002-9404-7736; Muller, Andreas/0000-0002-0281-6383; Malissen, Marie/0000-0003-2331-1445","Swiss National Foundation [310030.146187/1, PDFMP3-129700/1]","This study was funded by the Swiss National Foundation, www.snf.ch: grant 310030.146187/1 to FTC for all of the work, grant PDFMP3-129700/1 to FTC for performing FACS experiments, grant 310030.146187/1 to SY for immuno-histochemistry and analysis of in vivo neutrophil extracellular traps formation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,72,45,46,0,14,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004929,10.1371/journal.ppat.1004929,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300057,26020515.0,"DOAJ Gold, Green Published",,,16/08/2019,45,60,60,6394,1239,873,366,5155,3891,43,1221,60,3,4,0,42,42,0,,174,2,89,0,2,47,47,46,26,0,0,0,0,0,0,0,57,5,6391,73,0,97,56,0,5141,1239,73,0,97,56,0,11,,1,1,0,0,4,0,0,1,0,0,0,89,0,0,17.33,5.160613397901534,1.240349175557711,0.24034917555771096,1.2647914645974783,1.019705974350954,5.262308313155771
659,J,"Kaneko, I; Iwanaga, S; Kato, T; Kobayashi, I; Yuda, M",,,,"Kaneko, Izumi; Iwanaga, Shiroh; Kato, Tomomi; Kobayashi, Issei; Yuda, Masao",,,"Genome-Wide Identification of the Target Genes of AP2-O, a Plasmodium AP2-Family Transcription Factor",PLOS PATHOGENS,,,English,Article,,,,,,,MOSQUITO MIDGUT INVASION; MALARIA PARASITES; DNA-BINDING; SEXUAL DEVELOPMENT; TOXOPLASMA-GONDII; PROTEIN FAMILY; MEMBRANE; SPOROZOITES; TRANSMISSION; NETWORKS,"Stage-specific transcription is a fundamental biological process in the life cycle of the Plasmodium parasite. Proteins containing the AP2 DNA-binding domain are responsible for stage-specific transcriptional regulation and belong to the only known family of transcription factors in Plasmodium parasites. Comprehensive identification of their target genes will advance our understanding of the molecular basis of stage-specific transcriptional regulation and stage-specific parasite development. AP2-O is an AP2 family transcription factor that is expressed in the mosquito midgut-invading stage, called the ookinete, and is essential for normal morphogenesis of this stage. In this study, we identified the genome-wide target genes of AP2-O by chromatin immunoprecipitation-sequencing and elucidate how this AP2 family transcription factor contributes to the formation of this motile stage. The analysis revealed that AP2-O binds specifically to the upstream genomic regions of more than 500 genes, suggesting that approximately 10% of the parasite genome is directly regulated by AP2-O. These genes are involved in distinct biological processes such as morphogenesis, locomotion, midgut penetration, protection against mosquito immunity and preparation for subsequent oocyst development. This direct and global regulation by AP2-O provides a model for gene regulation in Plasmodium parasites and may explain how these parasites manage to control their complex life cycle using a small number of sequence-specific AP2 transcription factors.","[Kaneko, Izumi; Iwanaga, Shiroh; Kato, Tomomi; Yuda, Masao] Mie Univ, Dept Med Zool, Grad Sch Med, Tsu, Mie 514, Japan; [Kobayashi, Issei] Mie Univ, Core Lab, Grad Sch Reg Innovat Studies, Tsu, Mie 514, Japan","Yuda, M (reprint author), Mie Univ, Dept Med Zool, Grad Sch Med, Tsu, Mie 514, Japan.",m-yuda@doc.medic.mie-u.ac.jp,,,JSPS KAKENHI [90293779],"This work was supported by JSPS KAKENHI Grant Number 90293779. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,23,24,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004905,10.1371/journal.ppat.1004905,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300045,26018192.0,"DOAJ Gold, Green Published",,,16/08/2019,22,7,63,5809,934,678,256,4875,3959,20,896,62,6,0,0,27,27,0,,76,3,75,1,3,25,25,21,17,0,0,0,0,0,0,0,1,6,5877,45,0,64,36,0,4921,942,45,0,64,36,0,14,,0,0,0,0,7,0,1,1,0,0,0,75,1,0,4.25,6.21948608137045,1.1915897435897436,0.1915897435897436,1.2221538461538461,1.0256498536753313,6.379014989293362
660,J,"Kisiela, DI; Avagyan, H; Friend, D; Jalan, A; Gupta, S; Interlandi, G; Liu, Y; Tchesnokova, V; Rodriguez, VB; Sumida, JP; Strong, RK; Wu, XR; Thomas, WE; Sokurenko, EV",,,,"Kisiela, Dagmara I.; Avagyan, Hovhannes; Friend, Della; Jalan, Aachal; Gupta, Shivani; Interlandi, Gianluca; Liu, Yan; Tchesnokova, Veronika; Rodriguez, Victoria B.; Sumida, John P.; Strong, Roland K.; Wu, Xue-Ru; Thomas, Wendy E.; Sokurenko, Evgeni V.",,,Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli,PLOS PATHOGENS,,,English,Article,,,,,,,URINARY-TRACT-INFECTIONS; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; BINDING-PROTEIN; INDUCED-FIT; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; BIOCHEMICAL-MECHANISMS; RECEPTOR-BINDING,"Attachment proteins from the surface of eukaryotic cells, bacteria and viruses are critical receptors in cell adhesion or signaling and are primary targets for the development of vaccines and therapeutic antibodies. It is proposed that the ligand-binding pocket in receptor proteins can shift between inactive and active conformations with weak and strong ligand-binding capability, respectively. Here, using monoclonal antibodies against a vaccine target protein - fimbrial adhesin FimH of uropathogenic Escherichia coli, we demonstrate that unusually strong receptor inhibition can be achieved by antibody that binds within the binding pocket and displaces the ligand in a non-competitive way. The non-competitive antibody binds to a loop that interacts with the ligand in the active conformation of the pocket but is shifted away from ligand in the inactive conformation. We refer to this as a parasteric inhibition, where the inhibitor binds adjacent to the ligand in the binding pocket. We showed that the receptor-blocking mechanism of parasteric antibody differs from that of orthosteric inhibition, where the inhibitor replaces the ligand or allosteric inhibition where the inhibitor binds at a site distant from the ligand, and is very potent in blocking bacterial adhesion, dissolving surface-adherent biofilms and protecting mice from urinary bladder infection.","[Kisiela, Dagmara I.; Avagyan, Hovhannes; Jalan, Aachal; Tchesnokova, Veronika; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Friend, Della; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Gupta, Shivani; Interlandi, Gianluca; Rodriguez, Victoria B.; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Sumida, John P.] Univ Washington, Analyt Biopharm Core, Seattle, WA 98195 USA","Kisiela, DI (reprint author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.",dagk@uw.edu; evs@uw.edu,,"Thomas, Wendy/0000-0001-8602-0819","National Institutes of Health [AI050940, AI103846]; National Science Foundation [CBET-1132860]","This work was supported by National Institutes of Health Grants AI050940 and AI103846 (EVS), National Science Foundation CBET-1132860 (WET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,16,17,1,18,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004857,10.1371/journal.ppat.1004857,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300020,25974133.0,"DOAJ Gold, Green Published",,,16/08/2019,17,134,30,6381,601,472,129,5780,4814,21,945,30,31,0,0,15,15,4,,38,1,38,0,1,18,18,17,11,0,0,0,0,0,0,0,103,15,6386,64,5,346,46,0,5768,601,64,5,346,46,0,17,,2,0,0,0,17,0,0,0,0,0,0,39,0,0,28.6,10.61730449251248,1.1039792387543252,0.10397923875432526,1.1238754325259515,1.0180222535652719,10.808652246256239
661,J,"Latner, DR; Hickman, CJ",,,,"Latner, Donald R.; Hickman, Carole J.",,,Remembering Mumps,PLOS PATHOGENS,,,English,Article,,,,,,,VACCINATED POPULATIONS; RUBELLA VACCINE; UNITED-STATES; B-CELLS; VIRUS; ANTIBODY; MEASLES; OUTBREAK; EPIDEMIOLOGY; INFECTION,,"[Latner, Donald R.; Hickman, Carole J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA","Latner, DR (reprint author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.",dlatner@cdc.gov,,,,,,23,12,13,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004791,10.1371/journal.ppat.1004791,,,,4,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300006,25951183.0,"DOAJ Gold, Green Published",,,16/08/2019,11,14,23,7941,1774,1276,498,6167,5172,32,963,21,10,1,0,15,15,1,,34,50,31,2,50,13,13,12,5,0,0,0,0,0,0,0,9,8,8366,0,3,0,472,11,6147,1774,0,3,0,472,11,445,,0,1,0,1,11,0,0,1,0,0,0,31,2,0,18.958,4.476324689966178,1.2876601264796497,0.2876601264796497,1.4331117236906112,1.1129580657347942,4.98196166854566
662,J,"Meyer, AG; Wilke, CO",,,,"Meyer, Austin G.; Wilke, Claus O.",,,Geometric Constraints Dominate the Antigenic Evolution of Influenza H3N2 Hemagglutinin,PLOS PATHOGENS,,,English,Article,,,,,,,A VIRUS; RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; POSITIVE SELECTION; PROTEIN EVOLUTION; MEMBRANE-FUSION; PACKING DENSITY; SITES; SUBSTITUTIONS; FLEXIBILITY,"We have carried out a comprehensive analysis of the determinants of human influenza A H3 hemagglutinin evolution. We consider three distinct predictors of evolutionary variation at individual sites: solvent accessibility (as a proxy for protein fold stability and/or conservation), Immune Epitope Database (IEDB) epitope sites (as a proxy for host immune bias), and proximity to the receptor-binding region (as a proxy for one of the functions of hemagglutinin-to bind sialic acid). Individually, these quantities explain approximately 15% of the variation in site-wise dN/dS. In combination, solvent accessibility and proximity explain 32% of the variation in dN/dS; incorporating IEDB epitope sites into the model adds only an additional 2 percentage points. Thus, while solvent accessibility and proximity perform largely as independent predictors of evolutionary variation, they each overlap with the epitope-sites predictor. Furthermore, we find that the historical H3 epitope sites, which date back to the 1980s and 1990s, only partially overlap with the experimental sites from the IEDB, and display similar overlap in predictive power when combined with solvent accessibility and proximity. We also find that sites with dN/dS > 1, i.e., the sites most likely driving seasonal immune escape, are not correctly predicted by either historical or IEDB epitope sites, but only by proximity to the receptor-binding region. In summary, a simple geometric model of HA evolution outperforms a model based on epitope sites. These results suggest that either the available epitope sites do not accurately represent the true influenza antigenic sites or that host immune bias may be less important for influenza evolution than commonly thought.","[Meyer, Austin G.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Integrat Biol, Austin, TX 78712 USA; [Meyer, Austin G.; Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Meyer, Austin G.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA","Wilke, CO (reprint author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Integrat Biol, Austin, TX 78712 USA.",wilke@austin.utexas.edu,,"Meyer, Austin/0000-0002-0581-800X",National Institutes of Health [R01 GM088344]; Army Research Office [W911NF-12-1-0390]; Defense Threat Reduction Agency [HDTRA1-12-C-0007]; National Science Foundation [DBI-0939454],"This work was supported by National Institutes of Health (http://www.nih.gov/) grant R01 GM088344, Army Research Office (http://www.arl.army.mil/www/default.cfm?page=29) grant W911NF-12-1-0390, Defense Threat Reduction Agency (http://www.dtra.mil/) grant HDTRA1-12-C-0007, and National Science Foundation (http://www.nsf.gov/) Cooperative Agreement No. DBI-0939454 (BEACON Center, http://beacon-center.org/) to COW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,51,26,26,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004940,10.1371/journal.ppat.1004940,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300063,26020774.0,"DOAJ Gold, Green Published",,,16/08/2019,24,50,39,5672,497,356,141,5175,4376,29,770,37,31,0,0,23,23,1,,45,4,43,2,4,24,24,23,19,0,0,0,0,0,0,0,19,21,5733,21,0,214,112,0,5193,506,21,0,214,112,0,34,,0,0,0,0,24,0,1,1,0,0,0,43,2,0,14.3,11.412474849094567,1.0960386473429953,0.09603864734299516,1.1335265700483093,1.034203102961918,11.80281690140845
663,J,"Nunes-Alves, C; Booty, MG; Carpenter, SM; Rothchild, AC; Martin, CJ; Desjardins, D; Steblenko, K; Kloverpris, HN; Madansein, R; Ramsuran, D; Leslie, A; Correia-Neves, M; Behar, SM",,,,"Nunes-Alves, Cludio; Booty, Matthew G.; Carpenter, Stephen M.; Rothchild, Alissa C.; Martin, Constance J.; Desjardins, Danielle; Steblenko, Katherine; Kloverpris, Henrik N.; Madansein, Rajhmun; Ramsuran, Duran; Leslie, Alasdair; Correia-Neves, Margarida; Behar, Samuel M.",,,Human and Murine Clonal CD8+T Cell Expansions Arise during Tuberculosis Because of TCR Selection,PLOS PATHOGENS,,,English,Article,,,,,,,CD4 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; IMMUNE-RESPONSE; REPERTOIRE; EPITOPE; ESAT-6; DIVERSITY; INFECTION; FREQUENCY,"The immune system can recognize virtually any antigen, yet T cell responses against several pathogens, including Mycobacterium tuberculosis, are restricted to a limited number of immunodominant epitopes. The host factors that affect immunodominance are incompletely understood. Whether immunodominant epitopes elicit protective CD8+ T cell responses or instead act as decoys to subvert immunity and allow pathogens to establish chronic infection is unknown. Here we show that anatomically distinct human granulomas contain clonally expanded CD8+ T cells with overlapping T cell receptor (TCR) repertoires. Similarly, the murine CD8+ T cell response against M. tuberculosis is dominated by TB10.44-11-specific T cells with extreme TCR beta bias. Using a retrogenic model of TB10.44-11-specific CD8+ T cells, we show that TCR dominance can arise because of competition between clonotypes driven by differences in affinity. Finally, we demonstrate that TB10.4-specific CD8+ T cells mediate protection against tuberculosis, which requires interferon-gamma production and TAP1-dependent antigen presentation in vivo. Our study of how immunodominance, biased TCR repertoires, and protection are inter-related, provides a new way to measure the quality of T cell immunity, which if applied to vaccine evaluation, could enhance our understanding of how to elicit protective T cell immunity.","[Nunes-Alves, Cludio; Booty, Matthew G.; Carpenter, Stephen M.; Rothchild, Alissa C.; Steblenko, Katherine; Behar, Samuel M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Nunes-Alves, Cludio; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Nunes-Alves, Cludio; Correia-Neves, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Booty, Matthew G.; Rothchild, Alissa C.] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA; [Carpenter, Stephen M.; Desjardins, Danielle] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Carpenter, Stephen M.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA USA; [Martin, Constance J.] Harvard Univ, Dept Immunol & Infect Dis, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kloverpris, Henrik N.; Ramsuran, Duran; Leslie, Alasdair] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Kloverpris, Henrik N.; Madansein, Rajhmun; Leslie, Alasdair] Univ KwaZulu Natal, Nelson Mandela Sch Med, Durban, South Africa; [Kloverpris, Henrik N.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark","Nunes-Alves, C (reprint author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.",samuel.behar@umassmed.edu,"Correia-Neves, Margarida/C-9122-2009","Correia-Neves, Margarida/0000-0002-2202-5431; Kloverpris, Henrik/0000-0002-2165-3313; Carpenter, Stephen/0000-0001-9879-327X; Rothchild, Alissa/0000-0001-7484-1193; leslie, alasdair/0000-0003-2538-6467; Booty, Matthew/0000-0002-0835-3439; Behar, Samuel/0000-0002-3374-6699; Nunes-Alves, Claudio/0000-0001-9639-0477",Portuguese Foundation for Science and Technology individual fellowship; National Institutes of Health [R01 AI106725]; Center for AIDS Research [P30 AI 060354],"This work was supported by the Portuguese Foundation for Science and Technology individual fellowship (CNA) www.fct.pt, a National Institutes of Health Grant R01 AI106725 (SMB) www.nih.gov, and a Center for AIDS Research Grant P30 AI 060354 (SMB) www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,56,17,17,0,3,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004849,10.1371/journal.ppat.1004849,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300017,25945999.0,"DOAJ Gold, Green Published",,,16/08/2019,15,8,43,5255,1366,1122,244,3889,3183,22,684,43,8,0,0,16,16,0,,48,24,48,0,24,18,16,18,13,0,0,0,0,0,0,0,7,5,5265,149,0,93,473,1,3873,1366,91,0,93,466,1,26,,0,0,0,0,7,0,1,1,0,0,0,48,0,0,3.75,3.8469985358711565,1.351247107225508,0.35124710722550784,1.5137567498071485,1.120266412940057,4.309663250366032
664,J,"Panackal, AA; Wuest, SC; Lin, YC; Wu, TX; Zhang, NN; Kosa, P; Komori, M; Blake, A; Browne, SK; Rosen, LB; Hagen, F; Meis, J; Levitz, SM; Quezado, M; Hammoud, D; Bennett, JE; Bielekova, B; Williamson, PR",,,,"Panackal, Anil A.; Wuest, Simone C.; Lin, Yen-Chih; Wu, Tianxia; Zhang, Nannan; Kosa, Peter; Komori, Mika; Blake, Andrew; Browne, Sarah K.; Rosen, Lindsey B.; Hagen, Ferry; Meis, Jacques; Levitz, Stuart M.; Quezado, Martha; Hammoud, Dima; Bennett, John E.; Bielekova, Bibi; Williamson, Peter R.",,,Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis,PLOS PATHOGENS,,,English,Article,,,,,,,RECONSTITUTION INFLAMMATORY SYNDROME; ALLERGIC BRONCHOPULMONARY-MYCOSIS; T-CELL RESPONSES; NEOFORMANS INFECTION; CEREBROSPINAL-FLUID; ANTIRETROVIRAL THERAPY; TRANSPLANT RECIPIENTS; ACTIVATED MACROPHAGES; ANTIFUNGAL THERAPY; IFN-GAMMA,"The fungus Cryptococcus is a major cause of meningoencephalitis in HIV-infected as well as HIV-uninfected individuals with mortalities in developed countries of 20% and 30%, respectively. In HIV-related disease, defects in T-cell immunity are paramount, whereas there is little understanding of mechanisms of susceptibility in non-HIV related disease, especially that occurring in previously healthy adults. The present description is the first detailed immunological study of non-HIV-infected patients including those with severe central nervous system (s-CNS) disease to 1) identify mechanisms of susceptibility as well as 2) understand mechanisms underlying severe disease. Despite the expectation that, as in HIV, T-cell immunity would be deficient in such patients, cerebrospinal fluid (CSF) immunophenotyping, T-cell activation studies, soluble cytokine mapping and tissue cellular phenotyping demonstrated that patients with s-CNS disease had effective microbiological control, but displayed strong intrathecal expansion and activation of cells of both the innate and adaptive immunity including HLA-DR+ CD4+ and CD8+ cells and NK cells. These expanded CSF T cells were enriched for cryptococcal-antigen specific CD4+ cells and expressed high levels of IFN-gamma as well as a lack of elevated CSF levels of typical T-cell specific Th2 cytokines -IL-4 and IL-13. This inflammatory response was accompanied by elevated levels of CSF NFL, a marker of axonal damage, consistent with ongoing neurological damage. However, while tissue macrophage recruitment to the site of infection was intact, polarization studies of brain biopsy and autopsy specimens demonstrated an M2 macrophage polarization and poor phagocytosis of fungal cells. These studies thus expand the paradigm for cryptococcal disease susceptibility to include a prominent role for macrophage activation defects and suggest a spectrum of disease whereby severe neurological disease is characterized by immune-mediated host cell damage.","[Panackal, Anil A.; Zhang, Nannan; Browne, Sarah K.; Rosen, Lindsey B.; Bennett, John E.; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Panackal, Anil A.] Uniformed Serv Univ Hlth Sci, Div Infect Dis, Dept Med, F Hebert Sch Med, Bethesda, MD 20814 USA; [Wuest, Simone C.; Lin, Yen-Chih; Wu, Tianxia; Kosa, Peter; Komori, Mika; Blake, Andrew; Bielekova, Bibi] NINDS, Neuroimmunol Dis Unit, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Hagen, Ferry; Meis, Jacques] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands; [Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Quezado, Martha] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hammoud, Dima] NIH, Ctr Infect Dis Imaging Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA","Panackal, AA (reprint author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",Bibi.Bielekova@nih.gov; williamsonpr@mail.nih.gov,"Bielekova, Bibiana/V-1452-2017; JF, Meis/A-9241-2010; Meis, J.F.G.M./L-4518-2015; Hammoud, Dima A/C-2286-2015; Hagen, Ferry/B-9044-2009","Bielekova, Bibiana/0000-0002-0959-9430; JF, Meis/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916","National Institute of Allergy and Infectious Diseases (NIAID) [AI001123-01, AI001124-01]; National Institute of Neurological Diseases and Stroke (NINDS) at the National Institutes of Health; extramural NIH support [RO1 AI026780]","This research was supported by the Intramural Research Program (Grant # AI001123-01 and AI001124-01) of the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Neurological Diseases and Stroke (NINDS) at the National Institutes of Health as well as extramural NIH support RO1 AI026780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,67,48,50,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004884,10.1371/journal.ppat.1004884,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300031,26020932.0,"DOAJ Gold, Green Published",,,16/08/2019,52,4,51,9388,2163,1452,711,7225,5951,26,1248,51,2,0,0,50,50,0,,151,4,81,0,4,55,55,39,36,0,0,0,0,0,0,0,2,10,9527,81,0,188,170,4,7285,2212,20,0,188,161,4,30,,0,0,0,0,11,0,1,1,0,0,0,80,0,0,6.0,4.340268146093389,1.2993771626297579,0.2993771626297578,1.353356401384083,1.0415423945462292,4.520573277854831
665,J,"Ramdani, G; Naissant, B; Thompson, E; Breil, F; Lorthiois, A; Dupuy, F; Cummings, R; Duffier, Y; Corbett, Y; Mercereau-Puijalon, O; Vernick, K; Taramelli, D; Baker, DA; Langsley, G; Lavazec, C",,,,"Ramdani, Ghania; Naissant, Bernina; Thompson, Eloise; Breil, Florence; Lorthiois, Audrey; Dupuy, Florian; Cummings, Ross; Duffier, Yoann; Corbett, Yolanda; Mercereau-Puijalon, Odile; Vernick, Kenneth; Taramelli, Donatella; Baker, David A.; Langsley, Gordon; Lavazec, Catherine",,,cAMP-Signalling Regulates Gametocyte-Infected Erythrocyte Deformability Required for Malaria Parasite Transmission,PLOS PATHOGENS,,,English,Article,,,,,,,DEPENDENT PROTEIN-KINASE; PLASMODIUM-FALCIPARUM; PHOSPHODIESTERASE INHIBITORS; BONE-MARROW; IN-VITRO; BLOOD; EXPRESSION; PHOSPHORYLATION; MODULATION; MATURATION,"Blocking Plasmodium falciparum transmission to mosquitoes has been designated a strategic objective in the global agenda of malaria elimination. Transmission is ensured by gametocyte-infected erythrocytes (GIE) that sequester in the bone marrow and at maturation are released into peripheral blood from where they are taken up during a mosquito blood meal. Release into the blood circulation is accompanied by an increase in GIE deformability that allows them to pass through the spleen. Here, we used a microsphere matrix to mimic splenic filtration and investigated the role of cAMP-signalling in regulating GIE deformability. We demonstrated that mature GIE deformability is dependent on reduced cAMP-signalling and on increased phosphodiesterase expression in stage V gametocytes, and that parasite cAMP-dependent kinase activity contributes to the stiffness of immature gametocytes. Importantly, pharmacological agents that raise cAMP levels in transmissible stage V gametocytes render them less deformable and hence less likely to circulate through the spleen. Therefore, phosphodiesterase inhibitors that raise cAMP levels in P. falciparum infected erythrocytes, such as sildenafil, represent new candidate drugs to block transmission of malaria parasites.","[Ramdani, Ghania; Langsley, Gordon] Univ Paris 05, Sorbonne Paris Cite, Lab Biol Celluaire Comparat Apicomplexes, Fac Med, Paris, France; [Ramdani, Ghania; Naissant, Bernina; Lorthiois, Audrey; Dupuy, Florian; Duffier, Yoann; Langsley, Gordon; Lavazec, Catherine] INSERM, U1016, Inst Cochin, CNRS,UMR8104, F-75654 Paris 13, France; [Naissant, Bernina; Lorthiois, Audrey; Dupuy, Florian; Duffier, Yoann; Lavazec, Catherine] Univ Paris 05, Sorbonne Paris Cite, Lab Biol Transmiss Plasmodium, Fac Med, Paris, France; [Thompson, Eloise; Cummings, Ross; Baker, David A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Breil, Florence; Lorthiois, Audrey; Vernick, Kenneth; Lavazec, Catherine] Inst Pasteur, Unite Genet & Genom Insectes Vecteurs, CNRS, URA 3012, Paris, France; [Corbett, Yolanda; Taramelli, Donatella] Univ Milan, Dipartimento Sci Farmacol & Biomol DiSFeB, Milan, Italy; [Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, CNRS, URA 2581, Paris, France","Langsley, G (reprint author), Univ Paris 05, Sorbonne Paris Cite, Lab Biol Celluaire Comparat Apicomplexes, Fac Med, Paris, France.",gordon.langsley@inserm.fr; catherine.lavazec@inserm.fr,,"Baker, David/0000-0002-5490-8933; Taramelli, Donatella/0000-0001-5108-4492; Corbett, Yolanda/0000-0002-7629-846X","Fonds Inkermann; Bill & Melinda Gates Foundation [OPP1043892]; Inserm, CNRS; Labex Gr-Ex; Labex ParaFrap [ANR-11-LABX-0024]; Wellcome Trust [094752]; Medical Research Council [G1000779]","CL was supported by the Fonds Inkermann and by a grant OPP1043892 from the Bill & Melinda Gates Foundation. CL & GL acknowledge support from Inserm, CNRS; CL the Labex Gr-Ex and GL the Labex ParaFrap (ANR-11-LABX-0024). DAB acknowledges support from the Wellcome Trust Ref: 094752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,25,25,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004815,10.1371/journal.ppat.1004815,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300011,25951195.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,23,354,68,18363,1173,851,322,17190,14801,42,2347,67,193,0,0,24,24,45,,175,4,89,1,4,25,25,17,14,0,0,0,0,0,0,2,170,26,18380,14,10,104,58,0,17184,1173,14,10,104,58,0,23,,26,4,0,0,129,0,5,1,0,0,0,88,1,0,313.132,15.654731457800512,1.068237347294939,0.06823734729493892,1.0734147760325772,1.0048467026085062,15.730605285592498
666,J,"Reed, P; Atilano, ML; Alves, R; Hoiczyk, E; Sher, X; Reichmann, NT; Pereira, PM; Roemer, T; Filipe, SR; Pereira-Leal, JB; Ligoxygakis, P; Pinho, MG",,,,"Reed, Patricia; Atilano, Magda L.; Alves, Renato; Hoiczyk, Egbert; Sher, Xinwei; Reichmann, Nathalie T.; Pereira, Pedro M.; Roemer, Terry; Filipe, Sergio R.; Pereira-Leal, Jose B.; Ligoxygakis, Petros; Pinho, Mariana G.",,,Staphylococcus aureus Survives with a Minimal Peptidoglycan Synthesis Machine but Sacrifices Virulence and Antibiotic Resistance,PLOS PATHOGENS,,,English,Article,,,,,,,PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; CELL-WALL SYNTHESIS; INSERTIONAL INACTIVATION; METHICILLIN RESISTANCE; MUREIN SACCULUS; DROSOPHILA TOLL; ESSENTIAL GENES; DIVISION; HOLOENZYME,"Many important cellular processes are performed by molecular machines, composed of multiple proteins that physically interact to execute biological functions. An example is the bacterial peptidoglycan (PG) synthesis machine, responsible for the synthesis of the main component of the cell wall and the target of many contemporary antibiotics. One approach for the identification of essential components of a cellular machine involves the determination of its minimal protein composition. Staphylococcus aureus is a Gram-positive pathogen, renowned for its resistance to many commonly used antibiotics and prevalence in hospitals. Its genome encodes a low number of proteins with PG synthesis activity (9 proteins), when compared to other model organisms, and is therefore a good model for the study of a minimal PG synthesis machine. We deleted seven of the nine genes encoding PG synthesis enzymes from the S. aureus genome without affecting normal growth or cell morphology, generating a strain capable of PG biosynthesis catalyzed only by two penicillin-binding proteins, PBP1 and the bi-functional PBP2. However, multiple PBPs are important in clinically relevant environments, as bacteria with a minimal PG synthesis machinery became highly susceptible to cell wall-targeting antibiotics, host lytic enzymes and displayed impaired virulence in a Drosophila infection model which is dependent on the presence of specific peptidoglycan receptor proteins, namely PGRP-SA. The fact that S. aureus can grow and divide with only two active PG synthesizing enzymes shows that most of these enzymes are redundant in vitro and identifies the minimal PG synthesis machinery of S. aureus. However a complex molecular machine is important in environments other than in vitro growth as the expendable PG synthesis enzymes play an important role in the pathogenicity and antibiotic resistance of S. aureus.","[Reed, Patricia; Reichmann, Nathalie T.; Pereira, Pedro M.; Pinho, Mariana G.] Univ Nova Lisboa, Lab Bacterial Cell Biol, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Atilano, Magda L.; Filipe, Sergio R.] Univ Nova Lisboa, Lab Bacterial Cell Surface & Pathogenesis, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Atilano, Magda L.; Ligoxygakis, Petros] Univ Oxford, Dept Biochem, Lab Genes & Dev, Oxford OX1 3QU, England; [Alves, Renato; Pereira-Leal, Jose B.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Hoiczyk, Egbert] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Hoiczyk, Egbert] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sher, Xinwei] Merck Res Labs IT, Boston, MA USA; [Roemer, Terry] Merck Res Labs, Infect Dis Res, Kenilworth, NJ USA","Pinho, MG (reprint author), Univ Nova Lisboa, Lab Bacterial Cell Biol, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal.",mgpinho@itqb.unl.pt,"Pinho, Mariana/B-9192-2008; Filipe, Sergio Raposo/B-9167-2008; Pereira, Pedro M/I-9375-2014","Pinho, Mariana/0000-0002-7132-8842; Filipe, Sergio Raposo/0000-0002-4485-832X; Pereira, Pedro M/0000-0002-1426-9540; Alves, Renato/0000-0002-7212-0234; Reichmann, Nathalie/0000-0003-1003-6376; Reed, Patricia/0000-0002-4263-6993; Atilano, Magda/0000-0002-3819-2023; Pereira Leal, Jose/0000-0002-3111-7119","Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-MIC/099151/2008]; European Research Council [ERC-2012-StG-310987]; FCT [PTDC/BIA-MIC/100747/2008, PEst-OE/EQB/LA0004/2011, SFRH/BPD/23812/2005, SFRH/BD/41119/2007, SFRH/BD/28440/2006]; National Institute of General Medical Sciences [GM85024]; European Molecular Biology Organization long-term fellowship [ALTF 782-2012]; Medical Research Council [G0300170]","This work was funded by grants PTDC/BIA-MIC/099151/2008 from Fundacao para a Ciencia e Tecnologia (FCT) and ERC-2012-StG-310987 from the European Research Council (to MGP); PTDC/BIA-MIC/100747/2008 from FCT (to SRF); PEst-OE/EQB/LA0004/2011 from FCT (to ITQB); GM85024 from the National Institute of General Medical Sciences (to EH) and FCT fellowships SFRH/BPD/23812/2005 (to PR), SFRH/BD/41119/2007 (to PMP), and SFRH/BD/28440/2006 and European Molecular Biology Organization long-term fellowship (ALTF 782-2012) (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,23,23,0,27,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004891,10.1371/journal.ppat.1004891,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300035,25951442.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,26,82,86,10480,2982,2376,606,7498,6045,32,1421,86,12,0,0,22,22,0,,117,8,117,0,8,29,29,29,14,0,0,0,0,0,0,0,70,15,10520,261,0,280,167,2,7451,2982,261,0,280,167,2,87,,0,0,0,0,19,0,0,1,0,0,0,115,0,0,10.55,3.5144198524480212,1.397706054947986,0.3977060549479861,1.460122699386503,1.0446564885496183,3.671361502347418
667,J,"Rumah, KR; Ma, YH; Linden, JR; Oo, ML; Anrather, J; Schaeren-Wiemers, N; Alonso, MA; Fischetti, VA; McClain, MS; Vartanian, T",,,,"Rumah, Kareem Rashid; Ma, Yinghua; Linden, Jennifer R.; Oo, Myat Lin; Anrather, Josef; Schaeren-Wiemers, Nicole; Alonso, Miguel A.; Fischetti, Vincent A.; McClain, Mark S.; Vartanian, Timothy",,,The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens epsilon-Toxin,PLOS PATHOGENS,,,English,Article,,,,,,,DARBY CANINE KIDNEY; HUMAN T-LYMPHOCYTES; INFLUENZA-VIRUS HEMAGGLUTININ; APICAL SORTING MACHINERY; RAFT-ASSOCIATED PROTEIN; PORE-FORMING TOXIN; MDCK CELLS; PLASMA-MEMBRANE; NERVOUS-SYSTEM; INTESTINAL INFECTIONS,"Clostridium perfringens epsilon-toxin (ETX) is a potent pore-forming toxin responsible for a central nervous system (CNS) disease in ruminant animals with characteristics of blood-brain barrier (BBB) dysfunction and white matter injury. ETX has been proposed as a potential causative agent for Multiple Sclerosis (MS), a human disease that begins with BBB breakdown and injury to myelin forming cells of the CNS. The receptor for ETX is unknown. Here we show that both binding of ETX to mammalian cells and cytotoxicity requires the tetraspan proteolipid Myelin and Lymphocyte protein (MAL). While native Chinese Hamster Ovary (CHO) cells are resistant to ETX, exogenous expression of MAL in CHO cells confers both ETX binding and susceptibility to ETX-mediated cell death. Cells expressing rat MAL are similar to 100 times more sensitive to ETX than cells expressing similar levels of human MAL. Insertion of the FLAG sequence into the second extracellular loop of MAL abolishes ETX binding and cytotoxicity. ETX is known to bind specifically and with high affinity to intestinal epithelium, renal tubules, brain endothelial cells and myelin. We identify specific binding of ETX to these structures and additionally show binding to retinal microvasculature and the squamous epithelial cells of the sclera in wild-type mice. In contrast, there is a complete absence of ETX binding to tissues from MAL knockout (MAL-/-) mice. Furthermore, MAL-/- mice exhibit complete resistance to ETX at doses in excess of 1000 times the symptomatic dose for wild-type mice. We conclude that MAL is required for both ETX binding and cytotoxicity.","[Rumah, Kareem Rashid; Ma, Yinghua; Linden, Jennifer R.; Oo, Myat Lin; Anrather, Josef; Vartanian, Timothy] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY 10065 USA; [Rumah, Kareem Rashid; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Schaeren-Wiemers, Nicole] Univ Basel, Neurobiol, Dept Biomedicine, Univ Basel Hosp, Basel, Switzerland; [Alonso, Miguel A.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [McClain, Mark S.] Vanderbilt Univ, Dept Med, Div Infect Dis, Nashville, TN USA; [McClain, Mark S.] Vanderbilt Univ, Dept Med, Sch Med, Div Infect Dis, Nashville, TN USA","Rumah, KR (reprint author), Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY 10065 USA.",tiv2002@med.cornell.edu,"Alonso, Miguel A/J-3945-2016; McClain, Mark S/A-6942-2009","Alonso, Miguel A/0000-0002-7001-8826; McClain, Mark S/0000-0002-9857-4883","Laurence Tisch Family Research Fund; Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research; MS Hope Foundation; Rockefeller University Funds; Swiss National Science Foundation [3100A0-112583, 31003A_141185]","This work was generously supported in part by the Laurence Tisch Family Research Fund, the Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research, the MS Hope Foundation, and the Rockefeller University Funds to the Laboratory of Bacterial Pathogenesis and Immunology. The work of NSW was supported by the Swiss National Science Foundation (Grant 3100A0-112583 and 31003A_141185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,100,26,27,0,15,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004896,10.1371/journal.ppat.1004896,,,,29,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300040,25993478.0,"DOAJ Gold, Green Published",,,16/08/2019,22,75,26,8029,1068,794,274,6961,5657,24,1280,26,1,1,0,23,23,1,,82,6,42,0,6,27,24,27,13,0,0,0,0,0,0,0,78,3,8045,89,0,66,70,3,6948,1068,89,0,66,70,3,29,,0,0,0,0,3,0,0,1,0,0,0,41,0,0,1.75,7.5177902621722845,1.153426231863238,0.15342623186323803,1.1785662979456974,1.021795989537925,7.681647940074907
668,J,"Santiago-Tirado, FH; Peng, T; Yang, M; Hang, HC; Doering, TL",,,,"Santiago-Tirado, Felipe H.; Peng, Tao; Yang, Meng; Hang, Howard C.; Doering, Tamara L.",,,"A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic Outcome",PLOS PATHOGENS,,,English,Article,,,,,,,PLASMA-MEMBRANE LOCALIZATION; CELL-WALL INTEGRITY; FUNGAL PATHOGEN; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; NEOFORMANS; PALMITOYLATION; VIRULENCE; CHITOSAN; REVEALS,"Cryptococcus neoformans is an opportunistic yeast that kills over 625,000 people yearly through lethal meningitis. Host phagocytes serve as the first line of defense against this pathogen, but fungal engulfment and subsequent intracellular proliferation also correlate with poor patient outcome. Defining the interactions of this facultative intracellular pathogen with host phagocytes is key to understanding the latter's opposing roles in infection and how they contribute to fungal latency, dissemination, and virulence. We used high-content imaging and a human monocytic cell line to screen 1,201 fungal mutants for strains with altered host interactions and identified multiple genes that influence fungal adherence and phagocytosis. One of these genes was PFA4, which encodes a protein S-acyl transferase (PAT), one of a family of DHHC domain-containing proteins that catalyzes lipid modification of proteins. Deletion of PFA4 caused dramatic defects in cryptococcal morphology, stress tolerance, and virulence. Bioorthogonal palmitoylome-profiling identified Pfa4-specific protein substrates involved in cell wall synthesis, signal transduction, and membrane trafficking responsible for these phenotypic alterations. We demonstrate that a single PAT is responsible for the modification of a subset of proteins that are critical in cryptococcal pathogenesis. Since several of these palmitoylated substrates are conserved in other pathogenic fungi, protein palmitoylation represents a potential avenue for new antifungal therapeutics.","[Santiago-Tirado, Felipe H.; Yang, Meng; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Peng, Tao; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10021 USA","Doering, TL (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.",doering@wustl.edu,,"Santiago-Tirado, Felipe/0000-0002-6453-4904","National Institutes of Health [5T32AI007172]; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award; Alexander and Gertrude Berg Fellowship; National Institute of Allergy and Infectious Disease [AI78795, AI102882]; National Institute of General Medical Sciences [GM087544]; Starr Cancer Consortium [I7-A717]","FHST was partly supported by National Institutes of Health Training Grant 5T32AI007172 and by a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award; MY was partly supported by an Alexander and Gertrude Berg Fellowship; and research in the laboratory of TLD on host: fungal interactions was supported by National Institute of Allergy and Infectious Disease R01 awards AI78795 and AI102882. HCH acknowledges support from National Institute of General Medical Sciences GM087544 and Starr Cancer Consortium I7-A717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,65,24,26,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004908,10.1371/journal.ppat.1004908,,,,28,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300047,25970403.0,"DOAJ Gold, Green Published",,,16/08/2019,24,4,21,4207,560,389,171,3647,3091,22,534,21,3,2,0,22,22,0,,37,0,37,0,0,28,25,28,16,0,0,0,0,0,0,0,1,3,4201,148,0,78,39,0,3631,560,93,0,78,36,0,10,,0,0,0,0,7,0,1,1,0,0,0,35,0,0,3.6,7.5125,1.1535508637236085,0.15355086372360843,1.2031806964628462,1.0430235322082244,7.835714285714285
669,J,"Sperschneider, J; Dodds, PN; Gardiner, DM; Manners, JM; Singh, KB; Taylor, JM",,,,"Sperschneider, Jana; Dodds, Peter N.; Gardiner, Donald M.; Manners, John M.; Singh, Karam B.; Taylor, Jennifer M.",,,Advances and Challenges in Computational Prediction of Effectors from Plant Pathogenic Fungi,PLOS PATHOGENS,,,English,Article,,,,,,,RUST AVIRULENCE PROTEINS; CANDIDATE EFFECTORS; COMPARATIVE GENOMICS; SECRETED PROTEINS; PTR TOXA; GENE; INTERNALIZATION; ABSENCE; CELLS; MOTIF,,"[Sperschneider, Jana; Singh, Karam B.] CSIRO Agr Flagship, Ctr Environm & Life Sci, Perth, WA, Australia; [Gardiner, Donald M.] CSIRO Agr Flagship, Black Mt Labs, Canberra, ACT, Australia; [Gardiner, Donald M.] CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld, Australia; [Singh, Karam B.] Univ Western Australia, Inst Agr, Crawley, WA, Australia","Sperschneider, J (reprint author), CSIRO Agr Flagship, Ctr Environm & Life Sci, Perth, WA, Australia.",jana.sperschneider@csiro.au,"Singh, Karam B/C-3235-2012; Sperschneider, Jana/I-3390-2012; dodds, peter/D-1181-2009; Taylor, Jennifer/A-1686-2010; Gardiner, Donald/A-1297-2010; Manners, John/A-4922-2008","Singh, Karam B/0000-0002-2777-7448; dodds, peter/0000-0003-0620-5923; Taylor, Jennifer/0000-0003-4231-0181; Gardiner, Donald/0000-0002-2162-8716; Sperschneider, Jana/0000-0002-9385-8588",,,,31,62,64,0,40,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004806,10.1371/journal.ppat.1004806,,,,7,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300010,26020524.0,"DOAJ Gold, Green Published",,,16/08/2019,63,6,108,10267,996,729,267,9271,7234,36,2001,108,6,0,0,63,63,0,,303,1,153,0,1,72,65,72,30,0,0,0,0,0,0,0,0,13,10257,11,22,92,33,1,9243,996,11,22,92,33,1,18,,0,0,0,0,16,0,0,1,0,0,0,157,1,0,9.45,10.308232931726907,1.1074317765073887,0.10743177650738864,1.1110991263078416,1.0033115807928314,10.342369477911646
670,J,"Sullivan, RT; Kim, CC; Fontana, MF; Feeney, ME; Jagannathan, P; Boyle, MJ; Drakeley, CJ; Ssewanyana, I; Nankya, F; Mayanja-Kizza, H; Dorsey, G; Greenhouse, B",,,,"Sullivan, Richard T.; Kim, Charles C.; Fontana, Mary F.; Feeney, Margaret E.; Jagannathan, Prasanna; Boyle, Michelle J.; Drakeley, Chris J.; Ssewanyana, Isaac; Nankya, Felistas; Mayanja-Kizza, Harriet; Dorsey, Grant; Greenhouse, Bryan",,,FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure,PLOS PATHOGENS,,,English,Article,,,,,,,SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERACTING PROTEIN KINASE-2; ACQUIRED-IMMUNITY; PLASMA-CELLS; HUMAN NAIVE; T-CELLS; MALARIA; EXPRESSION; RECEPTOR; GENE,"Exposure to Plasmodium falciparum is associated with circulating ""atypical"" memory B cells (atMBCs), which appear similar to dysfunctional B cells found in HIV-infected individuals. Functional analysis of atMBCs has been limited, with one report suggesting these cells are not dysfunctional but produce protective antibodies. To better understand the function of malaria-associated atMBCs, we performed global transcriptome analysis of these cells, obtained from individuals living in an area of high malaria endemicity in Uganda. Comparison of gene expression data suggested down-modulation of B cell receptor signaling and apoptosis in atMBCs compared to classical MBCs. Additionally, in contrast to previous reports, we found upregulation of Fc receptor-like 5 (FCRL5), but not FCRL4, on atMBCs. Atypical MBCs were poor spontaneous producers of antibody ex vivo, and higher surface expression of FCRL5 defined a distinct subset of atMBCs compromised in its ability to produce antibody upon stimulation. Moreover, higher levels of P. falciparum exposure were associated with increased frequencies of FCRL5(+) atMBCs. Together, our findings suggest that FCLR5(+) identifies a functionally distinct, and perhaps dysfunctional, subset of MBCs in individuals exposed to P. falciparum.","[Sullivan, Richard T.; Dorsey, Grant; Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Kim, Charles C.; Fontana, Mary F.; Feeney, Margaret E.; Boyle, Michelle J.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Jagannathan, Prasanna] Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Boyle, Michelle J.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Drakeley, Chris J.; Ssewanyana, Isaac] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda","Sullivan, RT (reprint author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.",Bryan.Greenhouse@ucsf.edu,"Boyle, Michelle/P-7297-2019; Boyle, Michelle/D-4223-2018","Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Kim, Charles/0000-0001-6474-8227; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Greenhouse, Bryan/0000-0003-0287-9111","National Institutes of Health [R00 AI085035, R21 AI107200, R01AI093615]; National Institutes of Health International Centers of Excellence in Malaria Research (ICMER) program [U19AI089674]; National Institutes of Health/National Institute of Allergy and Infectious Disease [K23 AI100949]; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene; University of California San Francisco Centers for AIDS Research [P30AI027763]; National Health and Medical Research Council Australian Early-Career Fellowship; National Health and Research Council Infrastructure for Research Institutes Support Scheme and Victoria State Government Operational Infrastructure Support; National Center for Advancing Translational Sciences, National Institutes of Health through University of California San Francisco Clinical Translational Science Institute [UL1 TR000004]; Doris Duke Charitable Foundation","This work was supported by National Institutes of Health (www.NIH.gov) R00 AI085035 (CCK), the National Institutes of Health International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674) (CCK, MEF and BG), National Institutes of Health R21 AI107200 (BG), National Institutes of Health R01AI093615 (MEF), National Institutes of Health/National Institute of Allergy and Infectious Disease (www.niaid.nih.gov) K23 AI100949 (PJ), Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene (www.befund.org) (PJ), University of California San Francisco Centers for AIDS Research (cfar.ucsf.edu) P30AI027763 (MEF), an National Health and Medical Research Council Australian Early-Career Fellowship (www.nhmrc.gov.au) (MJB), the National Health and Research Council Infrastructure for Research Institutes Support Scheme and Victoria State Government Operational Infrastructure Support (The Burnet Institute www.burnet.edu.au), National Center for Advancing Translational Sciences, National Institutes of Health, through University of California San Francisco Clinical Translational Science Institute (www.ctsi.ucsf.edu) UL1 TR000004 (BG), and by the Doris Duke Charitable Foundation (Doris Duke Clinical Scientist Development Award to BG). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or any funding institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,36,37,0,1,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004894,10.1371/journal.ppat.1004894,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300038,25993340.0,"DOAJ Gold, Green Published, Green Accepted",,,16/08/2019,36,124,32,5603,946,745,201,4657,3783,23,851,32,2,0,0,36,36,1,,91,2,47,0,2,41,37,41,22,0,0,0,0,0,0,0,122,3,5673,35,0,70,83,1,4695,965,35,0,70,83,1,13,,0,0,0,0,4,0,1,1,0,0,0,47,0,0,2.25,5.922832980972516,1.2031350654928066,0.20313506549280652,1.2435044019755208,1.0335534535070499,6.121564482029599
671,J,"Verweij, MC; Wellish, M; Whitmer, T; Malouli, D; Lapel, M; Jonjic, S; Haas, JG; DeFilippis, VR; Mahalingam, R; Fruh, K",,,,"Verweij, Marieke C.; Wellish, Mary; Whitmer, Travis; Malouli, Daniel; Lapel, Martin; Jonjic, Stipan; Haas, Juergen G.; DeFilippis, Victor R.; Mahalingam, Ravi; Frueh, Klaus",,,Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms,PLOS PATHOGENS,,,English,Article,,,,,,,FRAME-66 PROTEIN-KINASE; ZOSTER-VIRUS; SIMIAN VARICELLA; GENE-EXPRESSION; IFN-LAMBDA; REGULATORY PROTEIN; IMMUNE-RESPONSE; II INTERFERON; DNA-SEQUENCE; ALPHA,"Varicella zoster virus (VZV) causes chickenpox in humans and, subsequently, establishes latency in the sensory ganglia from where it reactivates to cause herpes zoster. Infection of rhesus macaques with simian varicella virus (SVV) recapitulates VZV pathogenesis in humans thus representing a suitable animal model for VZV infection. While the type I interferon (IFN) response has been shown to affect VZV replication, the virus employs counter mechanisms to prevent the induction of anti-viral IFN stimulated genes (ISG). Here, we demonstrate that SVV inhibits type I IFN-activated signal transduction via the JAK-STAT pathway. SVV-infected rhesus fibroblasts were refractory to IFN stimulation displaying reduced protein levels of IRF9 and lacking STAT2 phosphorylation. Since previous work implicated involvement of the VZV immediate early gene product ORF63 in preventing ISG-induction we studied the role of SVV ORF63 in generating resistance to IFN treatment. Interestingly, SVV ORF63 did not affect STAT2 phosphorylation but caused IRF9 degradation in a proteasome-dependent manner, suggesting that SVV employs multiple mechanisms to counteract the effect of IFN. Control of SVV ORF63 protein levels via fusion to a dihydrofolate reductase (DHFR)-degradation domain additionally confirmed its requirement for viral replication. Our results also show a prominent reduction of IRF9 and inhibition of STAT2 phosphorylation in VZV-infected cells. In addition, cells expressing VZV ORF63 blocked IFN-stimulation and displayed reduced levels of the IRF9 protein. Taken together, our data suggest that varicella ORF63 prevents ISG-induction both directly via IRF9 degradation and indirectly via transcriptional control of viral proteins that interfere with STAT2 phosphorylation. SVV and VZV thus encode multiple viral gene products that tightly control IFN-induced anti-viral responses.","[Verweij, Marieke C.; Whitmer, Travis; Malouli, Daniel; DeFilippis, Victor R.; Frueh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Wellish, Mary; Lapel, Martin; Mahalingam, Ravi] Univ Colorado, Dept Neurol, Sch Med, Aurora, CO USA; [Jonjic, Stipan] Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka, Croatia; [Haas, Juergen G.] Univ Edinburgh, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland","Fruh, K (reprint author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.",freuhk@ohsu.edu,"Jonjic, Stipan/C-5657-2016","Jonjic, Stipan/0000-0001-5003-3108",EMBO Long Term Fellowship; Public Health Service from the National Institute of Health [AG032958]; American Heart Association [0730325N]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P51OD011092]; Medical Research Council [G0501453],"This work was supported by an EMBO Long Term Fellowship (http://www.embo.org/funding-awards/fellowships/long-term-fellowships) awarded to MCV, by Public Health Service grant AG032958 from the National Institute of Health (http://grants.nih.gov/grants/oer.htm) to RM. This project was also supported by the American Heart Association (http://www.heart.org/HEARTORG/) through grant 0730325N to VRD and the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) through grant P51OD011092 to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,77,24,24,2,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,e1004901,10.1371/journal.ppat.1004901,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300044,25973608.0,"DOAJ Gold, Green Published",,,16/08/2019,21,0,21,5770,1180,827,353,4590,3752,25,813,21,0,0,0,23,23,0,,37,0,37,0,0,22,22,12,14,0,0,0,0,0,0,0,0,3,5883,19,0,56,174,2,4618,1194,19,0,56,174,2,71,,0,0,0,0,2,0,0,1,0,0,0,37,0,0,1.5,4.889830508474576,1.2570806100217864,0.2570806100217865,1.3237472766884533,1.0530329289428075,5.149152542372882
672,J,"Zhou, J; Zeng, LZ; Liu, J; Xing, D",,,,"Zhou, Jun; Zeng, Lizhang; Liu, Jian; Xing, Da",,,Manipulation of the Xanthophyll Cycle Increases Plant Susceptibility to Sclerotinia sclerotiorum,PLOS PATHOGENS,,,English,Article,,,,,,,PHOTOSYSTEM-II ANTENNA; ABSCISIC-ACID BIOSYNTHESIS; PROGRAMMED CELL-DEATH; DE-EPOXIDASE ACTIVITY; EXCESS LIGHT ENERGY; CHLOROPHYLL FLUORESCENCE; OXALIC-ACID; ARABIDOPSIS-THALIANA; PATHOGEN INTERACTIONS; MOLECULAR MECHANISM,"The xanthophyll cycle is involved in dissipating excess light energy to protect the photosynthetic apparatus in a process commonly assessed from non-photochemical quenching (NPQ) of chlorophyll fluorescence. Here, it is shown that the xanthophyll cycle is modulated by the necrotrophic pathogen Sclerotinia sclerotiorum at the early stage of infection. Incubation of Sclerotinia led to a localized increase in NPQ even at low light intensity. Further studies showed that this abnormal change in NPQ was closely correlated with a decreased pH caused by Sclerotinia-secreted oxalate, which might decrease the ATP synthase activity and lead to a deepening of thylakoid lumen acidification under continuous illumination. Furthermore, suppression (with dithiothreitol) or a defect (in the npq1-2 mutant) of violaxanthin deepoxidase (VDE) abolished the Sclerotinia-induced NPQ increase. HPLC analysis showed that the Sclerotinia-inoculated tissue accumulated substantial quantities of zeaxanthin at the expense of violaxanthin, with a corresponding decrease in neoxanthin content. Immunoassays revealed that the decrease in these xanthophyll precursors reduced de novo abscisic acid (ABA) biosynthesis and apparently weakened tissue defense responses, including ROS induction and callose deposition, resulting in enhanced plant susceptibility to Sclerotinia. We thus propose that Sclerotinia antagonizes ABA biosynthesis to suppress host defense by manipulating the xanthophyll cycle in early pathogenesis. These findings provide a model of how photoprotective metabolites integrate into the defense responses, and expand the current knowledge of early plant-Sclerotinia interactions at infection sites.","[Zhou, Jun] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China","Zhou, J (reprint author), S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.",scnubip@gmail.com,,,Program for Changjiang Scholars and Innovative Research Team in University [IRT0829]; Key Program of NSFC-Guangdong Joint Funds of China [U0931005]; National High Technology Research and Development Program of China (863 Program) [2007AA10Z204],"This research is supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0829), the Key Program of NSFC-Guangdong Joint Funds of China (U0931005) and the National High Technology Research and Development Program of China (863 Program) (2007AA10Z204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,15,16,1,33,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,MAY,2015,11,5,,,,,,,UNSP e1004878,10.1371/journal.ppat.1004878,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CJ1UF,WOS:000355269300027,25993128.0,"DOAJ Gold, Green Published",,,16/08/2019,10,2,27,5343,1066,842,224,4277,3355,24,898,27,1,4,0,10,10,0,,36,0,36,0,0,11,11,10,5,0,0,0,0,0,0,0,2,1,5423,90,0,123,96,0,4322,1073,90,0,123,96,0,28,,0,0,0,0,3,0,1,1,0,0,0,36,0,0,1.5,5.012195121951219,1.249240121580547,0.24924012158054712,1.3114332476034605,1.0497847651132324,5.261726078799249
673,J,"Bouybayoune, I; Mantovani, S; Del Gallo, F; Bertani, I; Restelli, E; Comerio, L; Tapella, L; Baracchi, F; Fernandez-Borges, N; Mangieri, M; Bisighini, C; Beznoussenko, GV; Paladini, A; Balducci, C; Micotti, E; Forloni, G; Castilla, J; Fiordaliso, F; Tagliavini, F; Imeri, L; Chiesa, R",,,,"Bouybayoune, Ihssane; Mantovani, Susanna; Del Gallo, Federico; Bertani, Ilaria; Restelli, Elena; Comerio, Liliana; Tapella, Laura; Baracchi, Francesca; Fernandez-Borges, Natalia; Mangieri, Michela; Bisighini, Cinzia; Beznoussenko, Galina V.; Paladini, Alessandra; Balducci, Claudia; Micotti, Edoardo; Forloni, Gianluigi; Castilla, Joaquin; Fiordaliso, Fabio; Tagliavini, Fabrizio; Imeri, Luca; Chiesa, Roberto",,,Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease,PLOS PATHOGENS,,,English,Article,,,,,,,CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; DE-NOVO GENERATION; PROTEIN PRP; MUTANT PRP; THALAMIC DEGENERATION; INSERTIONAL MUTATION; DNA POLYMORPHISM; MOUSE MODEL; SCRAPIE,"Fatal familial insomnia (FFI) and a genetic form of Creutzfeldt-Jakob disease (CJD(178)) are clinically different prion disorders linked to the D178N prion protein (PrP) mutation. The disease phenotype is determined by the 129 M/V polymorphism on the mutant allele, which is thought to influence D178N PrP misfolding, leading to the formation of distinctive prion strains with specific neurotoxic properties. However, the mechanism by which misfolded variants of mutant PrP cause different diseases is not known. We generated transgenic (Tg) mice expressing the mouse PrP homolog of the FFI mutation. These mice synthesize a misfolded form of mutant PrP in their brains and develop a neurological illness with severe sleep disruption, highly reminiscent of FFI and different from that of analogously generated Tg(CJD) mice modeling CJD(178). No prion infectivity was detectable in Tg(FFI) and Tg(CJD) brains by bioassay or protein misfolding cyclic amplification, indicating that mutant PrP has disease-encoding properties that do not depend on its ability to propagate its misfolded conformation. Tg(FFI) and Tg(CJD) neurons have different patterns of intracellular PrP accumulation associated with distinct morphological abnormalities of the endoplasmic reticulum and Golgi, suggesting that mutation-specific alterations of secretory transport may contribute to the disease phenotype.","[Bouybayoune, Ihssane; Mantovani, Susanna; Bertani, Ilaria; Restelli, Elena; Comerio, Liliana; Tapella, Laura; Paladini, Alessandra; Balducci, Claudia; Micotti, Edoardo; Forloni, Gianluigi; Chiesa, Roberto] IRCCS Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy; [Del Gallo, Federico; Baracchi, Francesca; Imeri, Luca] Univ Milan, Sch Med, Dept Hlth Sci, Milan, Italy; [Fernandez-Borges, Natalia; Castilla, Joaquin] CIC BioGUNE, Derio, Spain; [Mangieri, Michela; Tagliavini, Fabrizio] IRCCS Fdn Carlo Besta Natl Neurol Inst, Div Neuropathol & Neurol, Milan, Italy; [Bisighini, Cinzia; Fiordaliso, Fabio] IRCCS Mario Negri Inst Pharmacol Res, Dept Cardiovasc Res, Bioimaging Unit, Milan, Italy; [Beznoussenko, Galina V.] IFOM FIRC Inst Mol Oncol, Milan, Italy; [Castilla, Joaquin] Basque Fdn Sci, Ikerbasque, Bilbao, Spain","Bouybayoune, I (reprint author), IRCCS Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy.",roberto.chiesa@marionegri.it,"Chiesa, Roberto/Q-4295-2019; Chiesa, Roberto/G-1561-2017; Restelli, Elena/J-7449-2018; Castilla, Joaquin/J-8414-2019; Fernandez-Borges, Natalia/H-1875-2012; Castilla, Joaquin/D-5261-2011","Chiesa, Roberto/0000-0002-3842-3733; Chiesa, Roberto/0000-0002-3842-3733; Restelli, Elena/0000-0002-6081-5178; Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; IMERI, LUCA/0000-0003-0753-004X; Del Gallo, Federico/0000-0003-0248-2456; Mantovani, Susanna/0000-0001-7046-6541; tagliavini, fabrizio/0000-0003-1039-7315","Telethon-Italy [TDRC00508TU, GGP12115]; Italian Ministry of Health [RF-INN-2008-1215065, RF-2010-2314035]; Fondazione Cariplo [2010-0828, 2012-0560]","Funding: This work was supported by grants from Telethon-Italy (TDRC00508TU and GGP12115; https://www.telethon.it/en) to RC, the Italian Ministry of Health (RF-INN-2008-1215065 and RF-2010-2314035; http://www.salute.gov.it/) to RC and FT, and Fondazione Cariplo (2010-0828 and 2012-0560; http://www.fondazionecariplo.it/en/index.html) to RC and FT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,82,29,29,1,32,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,UNSP e1004796,10.1371/journal.ppat.1004796,,,,35,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000023,25880443.0,"DOAJ Gold, Green Published",,,16/08/2019,32,3,28,7416,1439,1087,352,5977,4996,23,958,28,0,0,0,27,27,8,,38,12,38,0,12,32,32,32,20,0,0,0,0,0,0,0,3,6,7617,20,0,330,171,3,6000,1449,20,0,330,171,3,168,,1,2,1,0,11,0,1,0,0,0,0,38,0,0,29.28,5.153578874218207,1.2407562322235235,0.24075623222352352,1.3063409737326417,1.0528586839266452,5.425990271021543
674,J,"Casadevall, A; Pirofski, LA",,,,"Casadevall, Arturo; Pirofski, Liise-anne",,,The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases,PLOS PATHOGENS,,,English,Article,,,,,,,MONOCLONAL-ANTIBODY; SERUM,,"[Casadevall, Arturo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Pirofski, Liise-anne] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Pirofski, Liise-anne] Albert Einstein Coll Med, Dept Med Infect Dis, New York, NY USA","Casadevall, A (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.",acasade1@jhu.edu,,,"PHS [AI097096, AI045044, AI033774, HL059842, 2R37AI033142]","Funding: The authors were funded by PHS grants: AI097096, AI045044, AI033774, HL059842 and 2R37AI033142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,22,12,12,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004717,10.1371/journal.ppat.1004717,,,,6,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000005,25905897.0,"DOAJ Gold, Green Published",,,16/08/2019,0,20,28,7212,589,437,152,6623,5848,16,759,28,5,0,0,8,8,0,,36,14,36,0,14,13,13,10,5,0,0,0,0,0,0,0,15,10,7292,0,0,0,121,3,6617,589,0,0,0,121,3,86,,0,0,0,0,12,0,3,1,0,0,0,36,0,0,7.35,12.244482173174873,1.0889325079269214,0.08893250792692134,1.1192812924656501,1.0278702163061564,12.585738539898133
675,J,"Clemmons, AW; Lindsay, SA; Wasserman, SA",,,,"Clemmons, Alexa W.; Lindsay, Scott A.; Wasserman, Steven A.",,,An Effector Peptide Family Required for Drosophila Toll-Mediated Immunity,PLOS PATHOGENS,,,English,Article,,,,,,,PEPTIDOGLYCAN RECOGNITION PROTEIN; POSITIVE BACTERIAL-INFECTIONS; GENOME-WIDE ANALYSIS; ANTIMICROBIAL PEPTIDE; ANTIFUNGAL PEPTIDE; INSECT IMMUNITY; INNATE IMMUNITY; DEFICIENCY IMD; PATHWAY; MELANOGASTER,"In Drosophila melanogaster, recognition of an invading pathogen activates the Toll or Imd signaling pathway, triggering robust upregulation of innate immune effectors. Although the mechanisms of pathogen recognition and signaling are now well understood, the functions of the immune-induced transcriptome and proteome remain much less well characterized. Through bioinformatic analysis of effector gene sequences, we have defined a family of twelve genes - the Bomanins (Boms) - that are specifically induced by Toll and that encode small, secreted peptides of unknown biochemical activity. Using targeted genome engineering, we have deleted ten of the twelve Bom genes. Remarkably, inactivating these ten genes decreases survival upon microbial infection to the same extent, and with the same specificity, as does eliminating Toll pathway function. Toll signaling, however, appears unaffected. Assaying bacterial load post-infection in wild-type and mutant flies, we provide evidence that the Boms are required for resistance to, rather than tolerance of, infection. In addition, by generating and assaying a deletion of a smaller subset of the Bom genes, we find that there is overlap in Bom activity toward particular pathogens. Together, these studies deepen our understanding of Toll-mediated immunity and provide a new in vivo model for exploration of the innate immune effector repertoire.","[Clemmons, Alexa W.; Lindsay, Scott A.; Wasserman, Steven A.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA","Wasserman, SA (reprint author), Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA.",stevenw@ucsd.edu,,,National Institutes of Health (NIH.gov) [R01 GM050545-16],"This work was supported by National Institutes of Health (NIH.gov) grant R01 GM050545-16 (to SAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,63,20,20,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004876,10.1371/journal.ppat.1004876,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000054,25915418.0,"DOAJ Gold, Green Published",,,16/08/2019,20,1,49,4361,680,523,157,3681,2966,18,697,48,0,1,2,16,16,0,,62,0,61,1,0,20,20,13,11,0,0,0,0,0,0,0,1,8,4441,27,0,72,53,3,3728,696,27,0,72,53,3,17,,0,0,0,1,7,0,1,1,1,0,0,61,1,0,6.25,6.413235294117647,1.184732409671285,0.184732409671285,1.228198859005705,1.0366888328365054,6.648529411764706
676,J,"Collins, CM; Speck, SH",,,,"Collins, Christopher M.; Speck, Samuel H.",,,Interleukin 21 Signaling in B Cells Is Required for Efficient Establishment of Murine Gammaherpesvirus Latency,PLOS PATHOGENS,,,English,Article,,,,,,,EPSTEIN-BARR-VIRUS; FOLLICULAR-HELPER-CELLS; SARCOMA-ASSOCIATED HERPESVIRUS; GERMINAL CENTER RESPONSES; TERMINAL DIFFERENTIATION; GENE-EXPRESSION; IN-VIVO; REGULATES EXPRESSION; PLASMA-CELLS; T-CELLS,"The human gammaherpesviruses take advantage of normal B cell differentiation pathways to establish life-long infection in memory B cells. Murine gammaherpesvirus 68 (MHV68) infection of laboratory strains of mice also leads to life-long infection in memory B cells. To gain access to the memory B cell population, MHV68 infected B cells pass through the germinal center reaction during the onset of latency and require signals from T follicular helper (T-FH) cells for proliferation. Interleukin 21 (IL-21), one of the secreted factors produced by T-FH cells, plays an important role in both the maintenance of the germinal center response as well as in the generation of long-lived plasma cells. Using IL-21R deficient mice, we show that IL-21 signaling is required for efficient establishment of MHV68 infection. In the absence of IL-21 signaling, fewer infected splenocytes are able to gain access to either the germinal center B cell population or the plasma cell population - the latter being a major site of MHV68 reactivation. Furthermore, the germinal center B cell population in IL-21R(-/-) mice is skewed towards the non-proliferating centrocyte phenotype, resulting in reduced expansion of infected B cells. Additionally, the reduced frequency of infected plasma cells results in a significant reduction in the frequency of splenocytes capable of reactivating virus. This defect in establishment of MHV68 infection is intrinsic to B cells, as MHV68 preferentially establishes infection in IL-21R sufficient B cells in mixed bone marrow chimeric mice. Taken together, these data indicate that IL-21 signaling plays multiple roles during establishment of MHV68 infection, and identify IL-21 as a critical T-FH cell-derived factor for efficient establishment of gammaherpesvirus B cell latency.","[Collins, Christopher M.; Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Collins, Christopher M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA","Collins, CM (reprint author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.",sspeck@emory.edu,"Speck, Samuel/L-5893-2019",,NIH [R01 CA095318],"Funding: This research was funded by NIH R01 CA095318 to SHS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,46,6,6,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004831,10.1371/journal.ppat.1004831,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000039,25875847.0,"DOAJ Gold, Green Published",,,16/08/2019,8,0,7,2586,455,330,125,2131,1707,19,405,7,0,0,0,6,6,0,,12,0,12,0,0,8,8,5,6,0,0,0,0,0,0,0,0,0,2605,11,0,204,75,0,2139,457,11,0,204,75,0,9,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,5.683516483516484,1.2135147817925855,0.21351478179258565,1.2627874237447207,1.0406032482598608,5.914285714285715
677,J,"Cornforth, DM; Matthews, A; Brown, SP; Raymond, B",,,,"Cornforth, Daniel M.; Matthews, Andrew; Brown, Sam P.; Raymond, Ben",,,Bacterial Cooperation Causes Systematic Errors in Pathogen Risk Assessment due to the Failure of the Independent Action Hypothesis,PLOS PATHOGENS,,,English,Article,,,,,,,BACILLUS-THURINGIENSIS; DOSE-RESPONSE; SALMONELLA-TYPHIMURIUM; CRYSTAL PROTEINS; FATAL INFECTIONS; SINGLE ORGANISM; VIRULENCE; MICROORGANISMS; ANTHRAX; MODELS,"The Independent Action Hypothesis (IAH) states that pathogenic individuals (cells, spores, virus particles etc.) behave independently of each other, so that each has an independent probability of causing systemic infection or death. The IAH is not just of basic scientific interest; it forms the basis of our current estimates of infectious disease risk in humans. Despite the important role of the IAH in managing disease interventions for food and water-borne pathogens, experimental support for the IAH in bacterial pathogens is indirect at best. Moreover since the IAH was first proposed, cooperative behaviors have been discovered in a wide range of microorganisms, including many pathogens. A fundamental principle of cooperation is that the fitness of individuals is affected by the presence and behaviors of others, which is contrary to the assumption of independent action. In this paper, we test the IAH in Bacillus thuringiensis (B.t), a widely occurring insect pathogen that releases toxins that benefit others in the inoculum, infecting the diamondback moth, Plutella xylostella. By experimentally separating B.t. spores from their toxins, we demonstrate that the IAH fails because there is an interaction between toxin and spore effects on mortality, where the toxin effect is synergistic and cannot be accommodated by independence assumptions. Finally, we show that applying recommended IAH dose-response models to high dose data leads to systematic overestimation of mortality risks at low doses, due to the presence of synergistic pathogen interactions. Our results show that cooperative secretions can easily invalidate the IAH, and that such mechanistic details should be incorporated into pathogen risk analysis.","[Cornforth, Daniel M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Matthews, Andrew; Raymond, Ben] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Brown, Sam P.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Immun, Edinburgh, Midlothian, Scotland","Cornforth, DM (reprint author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.",dcornforth@gmail.com; b.raymond@imperial.ac.uk,"Brown, Sam/B-5234-2009","Brown, Sam/0000-0003-1892-9275",Engineering and Physical Sciences Research Council [EP/H032436/1]; Natural Environment Research Council [NE/E012671/1]; University of Oxford Clarendon Fund Scholarship; University of Edinburgh,"Funding: This work was funded by an Engineering and Physical Sciences Research Council grant to SPB (EP/H032436/1, http://www.epsrc.ac.uk/), a Natural Environment Research Council Fellowship to BR (NE/E012671/1, http://www.nerc.ac.uk), and DMC was supported by a University of Oxford Clarendon Fund Scholarship and a University of Edinburgh studentship. This study is a contribution from the Imperial College Grand Challenges in Ecosystems and the Environment initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,16,16,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004775,10.1371/journal.ppat.1004775,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000013,25909384.0,"DOAJ Gold, Green Published",,,16/08/2019,17,3,40,3728,560,472,88,3168,2749,22,397,40,2,0,0,16,16,2,,45,3,44,0,3,18,18,18,7,0,0,0,0,0,0,1,1,10,3747,38,0,149,109,1,3162,560,38,0,149,109,1,25,,1,1,0,0,17,0,1,1,0,0,0,44,0,0,24.18,6.6571428571428575,1.1767676767676767,0.17676767676767677,1.2291666666666667,1.0445278969957081,6.953571428571428
678,J,"Dobon, A; Canet, JV; Garcia-Andrade, J; Angulo, C; Neumetzler, L; Persson, S; Vera, P",,,,"Dobon, Albor; Vicente Canet, Juan; Garcia-Andrade, Javier; Angulo, Carlos; Neumetzler, Lutz; Persson, Staffan; Vera, Pablo",,,Novel Disease Susceptibility Factors for Fungal Necrotrophic Pathogens in Arabidopsis,PLOS PATHOGENS,,,English,Article,,,,,,,TRANSCRIPTION FACTOR; BOTRYTIS-CINEREA; ARABINOGALACTAN-PROTEINS; IMMUNE-RESPONSE; PLANT IMMUNITY; CELL-SURFACE; ROOT-GROWTH; RESISTANCE; RECEPTOR; BIOSYNTHESIS,"Host cells use an intricate signaling system to respond to invasions by pathogenic microorganisms. Although several signaling components of disease resistance against necrotrophic fungal pathogens have been identified, our understanding for how molecular components and host processes contribute to plant disease susceptibility is rather sparse. Here, we identified four transcription factors (TFs) from Arabidopsis that limit pathogen spread. Arabidopsis mutants defective in any of these TFs displayed increased disease susceptibility to Botrytis cinerea and Plectosphaerella cucumerina, and a general activation of non-immune host processes that contribute to plant disease susceptibility. Transcriptome analyses revealed that the mutants share a common transcriptional signature of 77 up-regulated genes. We characterized several of the up-regulated genes that encode peptides with a secretion signal, which we named PROVIR (for provirulence) factors. Forward and reverse genetic analyses revealed that many of the PROVIRs are important for disease susceptibility of the host to fungal necrotrophs. The TFs and PROVIRs identified in our work thus represent novel genetic determinants for plant disease susceptibility to necrotrophic fungal pathogens.","[Dobon, Albor; Vicente Canet, Juan; Garcia-Andrade, Javier; Angulo, Carlos; Vera, Pablo] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain; [Neumetzler, Lutz; Persson, Staffan] Max Planck Inst Mol Plant Physiol, Golm, Germany; [Persson, Staffan] Univ Melbourne, Sch Bot, ARC Ctr Excellence Plant Cell Walls, Melbourne, Vic 3010, Australia","Dobon, A (reprint author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain.",vera@ibmcp.upv.es,"Persson, Staffan/S-8399-2016","Persson, Staffan/0000-0002-6377-5132; Vera, Pablo/0000-0002-7787-7519; Garcia-Andrade, Javier/0000-0002-9044-6983",Spanish MINECO (BFU); Generalitat Valenciana [Prometeo2014/020],"Funding: This work was supported by the Spanish MINECO (BFU2012 to PV), and Generalitat Valenciana (Prometeo2014/020 to PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,66,10,10,0,28,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004800,10.1371/journal.ppat.1004800,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000026,25830627.0,"DOAJ Gold, Green Published",,,16/08/2019,12,8,72,8973,1828,1474,354,7145,5849,31,1265,72,0,0,0,11,11,2,,169,0,85,0,0,14,14,5,8,0,0,0,0,0,0,0,8,16,9047,145,0,100,32,0,7173,1859,145,0,100,32,0,15,,0,0,0,0,22,0,3,0,0,0,0,86,0,0,12.3,4.908643326039387,1.2558432470258922,0.25584324702589223,1.2909727081875437,1.0279728073108214,5.0459518599562365
679,J,"Dorr, T; Davis, BM; Waldor, MK",,,,"Doerr, Tobias; Davis, Brigid M.; Waldor, Matthew K.",,,Endopeptidase-Mediated Beta Lactam Tolerance,PLOS PATHOGENS,,,English,Article,,,,,,,BACTERIAL-CELL-WALL; D-AMINO ACIDS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PERSISTER CELLS; VIBRIO-CHOLERAE; PEPTIDOGLYCAN; SEPARATION; MUREIN; ANTIBIOTICS,"In many bacteria, inhibition of cell wall synthesis leads to cell death and lysis. The pathways and enzymes that mediate cell lysis after exposure to cell wall-acting antibiotics (e.g. beta lactams) are incompletely understood, but the activities of enzymes that degrade the cell wall ('autolysins') are thought to be critical. Here, we report that Vibrio cholerae, the cholera pathogen, is tolerant to antibiotics targeting cell wall synthesis. In response to a wide variety of cell wall-acting antibiotics, this pathogen loses its rod shape, indicative of cell wall degradation, and becomes spherical. Genetic analyses revealed that paradoxically, V. cholerae survival via sphere formation required the activity of D,D endopeptidases, enzymes that cleave the cell wall. Other autolysins proved dispensable for this process. Our findings suggest the enzymes that mediate cell wall degradation are critical for determining bacterial cell fate - sphere formation vs. lysis - after treatment with antibiotics that target cell wall synthesis.","[Doerr, Tobias; Davis, Brigid M.; Waldor, Matthew K.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Doerr, Tobias; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Doerr, Tobias; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA","Waldor, MK (reprint author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.",mwaldor@research.bwh.harvard.edu,,,Howard Hughes Medical Institute (HHMI); NIH [R37 AI - 042347]; Deutsche Forschungsgemeinschaft (DFG) [DO 1684/1-1],"Research in the Waldor lab is supported by Howard Hughes Medical Institute (HHMI) and NIH grant R37 AI - 042347. TD is a recipient of postdoctoral fellowship DO 1684/1-1 from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,37,11,11,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004850,10.1371/journal.ppat.1004850,,,,16,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000048,25884840.0,"DOAJ Gold, Green Published",,,16/08/2019,10,22,34,5618,708,545,163,4910,2972,23,1915,34,0,0,0,12,12,0,,45,2,45,0,2,16,13,16,9,0,0,0,0,0,0,0,22,6,5697,44,19,95,55,1,4942,712,44,18,95,55,1,43,,0,0,0,0,9,0,0,0,0,0,0,47,0,0,3.5,7.935028248587571,1.144195519348269,0.14419551934826885,1.1804480651731162,1.0316838732645068,8.186440677966102
680,J,"Dong, YH; Li, Y; Zhao, MM; Jing, MF; Liu, XY; Liu, MX; Guo, XX; Zhang, X; Chen, Y; Liu, YF; Liu, YH; Ye, WW; Zhang, HF; Wang, YC; Zheng, XB; Wang, P; Zhang, ZG",,,,"Dong, Yanhan; Li, Ying; Zhao, Miaomiao; Jing, Maofeng; Liu, Xinyu; Liu, Muxing; Guo, Xianxian; Zhang, Xing; Chen, Yue; Liu, Yongfeng; Liu, Yanhong; Ye, Wenwu; Zhang, Haifeng; Wang, Yuanchao; Zheng, Xiaobo; Wang, Ping; Zhang, Zhengguang",,,"Global Genome and Transcriptome Analyses of Magnaporthe oryzae Epidemic Isolate 98-06 Uncover Novel Effectors and Pathogenicity-Related Genes, Revealing Gene Gain and Lose Dynamics in Genome Evolution",PLOS PATHOGENS,,,English,Article,,,,,,,RICE BLAST FUNGUS; FILAMENTOUS PLANT-PATHOGENS; CHITIN-TRIGGERED IMMUNITY; AVIRULENCE GENE; FULL VIRULENCE; SALICYLIC-ACID; DISEASE RESISTANCE; SECRETED PROTEINS; HOST-SPECIFICITY; EXPRESSED GENES,"Genome dynamics of pathogenic organisms are driven by pathogen and host co-evolution, in which pathogen genomes are shaped to overcome stresses imposed by hosts with various genetic backgrounds through generation of a variety of isolates. This same principle applies to the rice blast pathogen Magnaporthe oryzae and the rice host; however, genetic variations among different isolates of M. oryzae remain largely unknown, particularly at genome and transcriptome levels. Here, we applied genomic and transcriptomic analytical tools to investigate M. oryzae isolate 98-06 that is the most aggressive in infection of susceptible rice cultivars. A unique 1.4 Mb of genomic sequences was found in isolate 98-06 in comparison to reference strain 70-15. Genome-wide expression profiling revealed the presence of two critical expression patterns of M. oryzae based on 64 known pathogenicity-related (PaR) genes. In addition, 134 candidate effectors with various segregation patterns were identified. Five tested proteins could suppress BAX-mediated programmed cell death in Nicotiana benthamiana leaves. Characterization of isolate-specific effector candidates Iug6 and Iug9 and PaR candidate Iug18 revealed that they have a role in fungal propagation and pathogenicity. Moreover, Iug6 and Iug9 are located exclusively in the biotrophic interfacial complex (BIC) and their overexpression leads to suppression of defense-related gene expression in rice, suggesting that they might participate in biotrophy by inhibiting the SA and ET pathways within the host. Thus, our studies identify novel effector and PaR proteins involved in pathogenicity of the highly aggressive M. oryzae field isolate 98-06, and reveal molecular and genomic dynamics in the evolution of M. oryzae and rice host interactions.","[Dong, Yanhan; Li, Ying; Zhao, Miaomiao; Jing, Maofeng; Liu, Xinyu; Liu, Muxing; Guo, Xianxian; Zhang, Xing; Chen, Yue; Ye, Wenwu; Zhang, Haifeng; Wang, Yuanchao; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Dong, Yanhan; Li, Ying; Zhao, Miaomiao; Jing, Maofeng; Liu, Xinyu; Liu, Muxing; Guo, Xianxian; Zhang, Xing; Chen, Yue; Ye, Wenwu; Zhang, Haifeng; Wang, Yuanchao; Zheng, Xiaobo; Zhang, Zhengguang] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Liu, Yongfeng; Liu, Yanhong] BGI Shenzhen, Shenzhen, Peoples R China; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA","Zhang, ZG (reprint author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.",zhgzhang@njau.edu.cn,"Ye, Wenwu/J-5624-2014; wang, yuanchao/G-9667-2011","Ye, Wenwu/0000-0001-7347-8935; wang, yuanchao/0000-0001-5803-5343","National Science Foundation for Distinguished Young Scholars of China [31325022]; National Basic Research Program of China [2012CB114000]; Natural Science Foundation of China [31271998]; Jiangsu, China","Funding: This research was supported by the National Science Foundation for Distinguished Young Scholars of China (Grant No. 31325022 to ZZ), National Basic Research Program of China (Grant No: 2012CB114000, ZZ), Natural Science Foundation of China (Grant No: 31271998, ZZ), and the especially appointed professorship (Jiangsu, China). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.",,100,44,50,6,68,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004801,10.1371/journal.ppat.1004801,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000027,25837042.0,"DOAJ Gold, Green Published",,,16/08/2019,43,13,76,11467,2082,1475,607,9385,7273,28,2084,75,2,0,0,45,45,3,,105,1,104,1,1,49,46,49,19,0,0,0,0,0,0,0,11,21,11433,375,20,224,118,0,9335,2082,375,20,224,118,0,16,,0,0,0,0,44,1,1,1,0,0,0,104,1,0,23.1,5.507684918347743,1.2218433670751199,0.22184336707511987,1.2707511987213638,1.0400279061655184,5.728146013448607
681,J,"Finney, CAM; Kamhawi, S; Wasmuth, JD",,,,"Finney, Constance A. M.; Kamhawi, Shaden; Wasmuth, James D.",,,Does the Arthropod Microbiota Impact the Establishment of Vector-Borne Diseases in Mammalian Hosts?,PLOS PATHOGENS,,,English,Article,,,,,,,BACTERIAL COMMUNITIES; SPOROGONIC DEVELOPMENT; ANOPHELES-GAMBIAE; IMMUNE-RESPONSES; MIDGUT BACTERIA; GUT MICROBIOTA; RIBOSOMAL-RNA; DIVERSITY; SYMBIONT; TRANSMISSION,"The impact of the microbiota on the immune status of its host is a source of intense research and publicity. In comparison, the effect of arthropod microbiota on vector-borne infectious diseases has received little attention. A better understanding of the vector microbiota in relation to mammalian host immune responses is vital, as it can lead to strategies that affect transmission and improve vaccine design in a field of research where few vaccines exist and effective treatment is rare. Recent demonstrations of how microbiota decrease pathogen development in arthropods, and thus alter vector permissiveness to vector-borne diseases (VBDs), have led to renewed interest. However, hypotheses on the interactions between the arthropod-derived microbiota and the mammalian hosts have yet to be addressed. Advances in DNA sequencing technology, increased yield and falling costs, mean that these studies are now feasible for many microbiologists and entomologists. Here, we distill current knowledge and put forward key questions and experimental designs to shed light on this burgeoning research topic.","[Finney, Constance A. M.] Univ Calgary, Dept Biol Sci, Fac Sci, Calgary, AB T2N 1N4, Canada; [Kamhawi, Shaden] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Wasmuth, James D.] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada","Finney, CAM (reprint author), Univ Calgary, Dept Biol Sci, Fac Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.",constance.finney@ucalgary.ca,,"Finney, Constance AM/0000-0002-8459-8462; Wasmuth, James/0000-0002-9516-212X",Intramural NIH HHS,,,44,18,18,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004646,10.1371/journal.ppat.1004646,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000002,25856431.0,"DOAJ Gold, Green Published",,,16/08/2019,18,9,67,6025,777,578,199,5248,4233,20,995,67,0,0,0,16,16,0,,166,1,87,0,1,18,18,15,11,0,0,0,0,0,0,0,9,13,6036,5,16,30,92,2,5235,777,5,16,30,92,2,24,,0,0,0,0,24,0,1,0,0,0,0,92,0,0,11.95,7.754182754182755,1.1480564024390243,0.1480564024390244,1.1686356707317074,1.0179253112033195,7.893178893178893
682,J,"Genin, P; Cuvelier, F; Lambin, S; Filipe, JCR; Autrusseau, E; Laurent, C; Laplantine, E; Weil, R",,,,"Genin, Pierre; Cuvelier, Frederique; Lambin, Sandrine; Filipe, Josina Corte-Real; Autrusseau, Elodie; Laurent, Christine; Laplantine, Emmanuel; Weil, Robert",,,Optineurin Regulates the Interferon Response in a Cell Cycle-Dependent Manner,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; BINDING KINASE 1; TUMOR-SUPPRESSOR CYLD; MEDIATED ANTIVIRAL RESPONSE; HEMATOPOIETIC STEM-CELLS; IFN-BETA PRODUCTION; I INTERFERON; RIG-I; LINEAR UBIQUITINATION; NEGATIVE REGULATOR,"Viral invasion into a host is initially recognized by the innate immune system, mainly through activation of the intracellular cytosolic signaling pathway and coordinated activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-kappa B) transcription factors that promote type I interferon gene induction. The TANK-binding Kinase 1 (TBK1) phosphorylates and activates IRF3. Here, we show that Optineurin (Optn) dampens the antiviral innate immune response by targeting the deubiquitinating enzyme CYLD to TBK1 in order to inhibit its enzymatic activity. Importantly, we found that this regulatory mechanism is abolished at the G2/M phase as a consequence of the nuclear translocation of CYLD and Optn. As a result, we observed, at this cell division stage, an increased activity and phosphorylation of TBK1 that lead to its relocalization to mitochondria and to enhanced interferon production, suggesting that this process, which relies on Optn function, might be of major importance to mount a preventive antiviral response during mitosis.","[Genin, Pierre; Cuvelier, Frederique; Lambin, Sandrine; Filipe, Josina Corte-Real; Autrusseau, Elodie; Laplantine, Emmanuel; Weil, Robert] Inst Pasteur, CNRS, UMR3691, Lab Signalisat & Pathogenese, Paris, France; [Laurent, Christine] Inst Pasteur, Plate Forme Proteom, Paris, France","Genin, P (reprint author), Inst Pasteur, CNRS, UMR3691, Lab Signalisat & Pathogenese, Paris, France.",pierre.genin@pasteur.fr,,,CNRS; Fundacao para a Ciencia e Tecnologia fellowship; l'Institut National du Cancer (INCa); Association pour la Recherche sur le Cancer (ARC),"PG, EL and RW were supported by CNRS. JCRF was a recipient of the Fundacao para a Ciencia e Tecnologia fellowship. Work in the laboratory of RW is supported by l'Institut National du Cancer (INCa) and by the Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,71,13,13,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004877,10.1371/journal.ppat.1004877,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000055,26068459.0,"DOAJ Gold, Green Published",,,16/08/2019,10,1,19,4155,1019,751,268,3136,2533,20,583,19,0,0,0,8,8,0,,31,0,31,0,0,10,10,7,7,0,0,0,0,0,0,0,1,2,4194,67,7,74,73,1,3153,1028,67,7,74,73,1,13,,0,0,0,0,2,0,0,1,0,0,0,31,0,0,1.0,4.077526987242394,1.324936224489796,0.3249362244897959,1.382015306122449,1.043080625752106,4.253189401373896
683,J,"He, WH; Ren, BJ; Mao, FF; Jing, ZY; Li, YF; Liu, Y; Peng, B; Yan, H; Qi, YH; Sun, YY; Guo, JT; Sui, JH; Wang, FC; Li, WH",,,,"He, Wenhui; Ren, Bijie; Mao, Fengfeng; Jing, Zhiyi; Li, Yunfei; Liu, Yang; Peng, Bo; Yan, Huan; Qi, Yonghe; Sun, Yinyan; Guo, Ju-Tao; Sui, Jianhua; Wang, Fengchao; Li, Wenhui",,,Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide,PLOS PATHOGENS,,,English,Article,,,,,,,DELTA VIRUS; RNA; REPLICATION; GENOME; LIVER; SUSCEPTIBILITY; TRANSMISSION; INTERFERONS; ADENOSINE; IMMUNITY,"Hepatitis D virus (HDV) is the smallest virus known to infect human. About 15 million people worldwide are infected by HDV among those 240 million infected by its helper hepatitis B virus (HBV). Viral hepatitis D is considered as one of the most severe forms of human viral hepatitis. No specific antivirals are currently available to treat HDV infection and antivirals against HBV do not ameliorate hepatitis D. Liver sodium taurocholate co-transporting polypeptide (NTCP) was recently identified as a common entry receptor for HDV and HBV in cell cultures. Here we show HDV can infect mice expressing human NTCP (hNTCP-Tg). Antibodies against critical regions of HBV envelope proteins blocked HDV infection in the hNTCP-Tg mice. The infection was acute yet HDV genome replication occurred efficiently, evident by the presence of antigenome RNA and edited RNA species specifying large delta antigen in the livers of infected mice. The resolution of HDV infection appears not dependent on adaptive immune response, but might be facilitated by innate immunity. Liver RNA-seq analyses of HDV infected hNTCP-Tg and type I interferon receptor 1 (IFN alpha/beta R1) null hNTCP-Tg mice indicated that in addition to induction of type I IFN response, HDV infection was also associated with up-regulation of novel cellular genes that may modulate HDV infection. Our work has thus proved the concept that NTCP is a functional receptor for HDV infection in vivo and established a convenient small animal model for investigation of HDV pathogenesis and evaluation of antiviral therapeutics against the early steps of infection for this important human pathogen.","[He, Wenhui; Li, Wenhui] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [He, Wenhui; Li, Wenhui] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Wenhui; Ren, Bijie; Mao, Fengfeng; Jing, Zhiyi; Li, Yunfei; Liu, Yang; Peng, Bo; Yan, Huan; Qi, Yonghe; Sun, Yinyan; Sui, Jianhua; Wang, Fengchao; Li, Wenhui] Natl Inst Biol Sci, Beijing, Peoples R China; [Qi, Yonghe] Beijing Normal Univ, Grad Sch, Beijing 100875, Peoples R China; [Guo, Ju-Tao] Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virol Res, Doylestown, PA USA","Li, WH (reprint author), Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China.",liwenhui@nibs.ac.cn,,"Li, Wenhui/0000-0003-1305-7404; SUI, JIANHUA/0000-0002-1272-9662","National Science and Technology Major Project, China [2013ZX09509102]; Ministry of Science and Technology, China [2010CB530101, 2011CB812501]; Science and Technology Bureau of Beijing Municipal Government","This work was funded by the National Science and Technology Major Project, China (2013ZX09509102), the Ministry of Science and Technology, China (2010CB530101,2011CB812501), and the Science and Technology Bureau of Beijing Municipal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,45,49,53,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004840,10.1371/journal.ppat.1004840,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000045,25902143.0,"DOAJ Gold, Green Published",,,16/08/2019,52,6,34,8009,1678,1010,668,6331,5062,36,1233,34,4,0,0,52,52,1,,44,5,44,0,5,54,54,53,24,0,0,0,0,0,0,0,2,8,8072,231,0,167,72,0,6367,1696,231,0,167,72,0,9,,0,0,0,0,12,0,2,1,0,0,0,44,0,0,5.85,4.7729439809296785,1.2650450165850577,0.26504501658505764,1.3228557889748855,1.0456985890872768,4.991060786650775
684,J,"Kamenyeva, O; Boularan, C; Kabat, J; Cheung, GYC; Cicala, C; Yeh, AJ; Chan, JL; Periasamy, S; Otto, M; Kehrl, JH",,,,"Kamenyeva, Olena; Boularan, Cedric; Kabat, Juraj; Cheung, Gordon Y. C.; Cicala, Claudia; Yeh, Anthony J.; Chan, June L.; Periasamy, Saravanan; Otto, Michael; Kehrl, John H.",,,Neutrophil Recruitment to Lymph Nodes Limits Local Humoral Response to Staphylococcus aureus,PLOS PATHOGENS,,,English,Article,,,,,,,IMMUNE-RESPONSE; BONE-MARROW; DENDRITIC CELLS; HOST-DEFENSE; MIGRATION; INFECTIONS; PROTEIN; MICE; ANTIGEN; INNATE,"Neutrophils form the first line of host defense against bacterial pathogens. They are rapidly mobilized to sites of infection where they help marshal host defenses and remove bacteria by phagocytosis. While splenic neutrophils promote marginal zone B cell antibody production in response to administered T cell independent antigens, whether neutrophils shape humoral immunity in other lymphoid organs is controversial. Here we investigate the neutrophil influx following the local injection of Staphylococcus aureus adjacent to the inguinal lymph node and determine neutrophil impact on the lymph node humoral response. Using intravital microscopy we show that local immunization or infection recruits neutrophils from the blood to lymph nodes in waves. The second wave occurs temporally with neutrophils mobilized from the bone marrow. Within lymph nodes neutrophils infiltrate the medulla and interfollicular areas, but avoid crossing follicle borders. In vivo neutrophils form transient and long-lived interactions with B cells and plasma cells, and their depletion augments production of antigen-specific IgG and IgM in the lymph node. In vitro activated neutrophils establish synapse-and nanotube-like interactions with B cells and reduce B cell IgM production in a TGF-beta 1 dependent manner. Our data reveal that neutrophils mobilized from the bone marrow in response to a local bacterial challenge dampen the early humoral response in the lymph node.","[Kamenyeva, Olena; Boularan, Cedric; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Kabat, Juraj] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Cheung, Gordon Y. C.; Yeh, Anthony J.; Chan, June L.; Periasamy, Saravanan; Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Cicala, Claudia] NIAID, Immunopathogenesis Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA","Kamenyeva, O (reprint author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.",jkehrl@niaid.nih.gov,,"Otto, Michael/0000-0002-2222-4115",National Institutes of Allergy and Infectious Diseases,"Funding: This research was supported by the intramural program of the National Institutes of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,59,38,38,0,10,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004827,10.1371/journal.ppat.1004827,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000038,25884622.0,"DOAJ Gold, Green Published",,,16/08/2019,41,26,53,10608,1456,1084,372,9152,7118,36,1998,53,0,0,1,34,34,0,,71,0,71,0,0,42,42,38,17,1,0,0,1,0,0,0,26,4,10705,206,4,395,155,1,9199,1480,206,4,395,155,1,26,,0,0,0,0,7,0,2,2,1,0,1,74,0,0,6.5,7.285714285714286,1.1590909090909092,0.1590909090909091,1.2091346153846154,1.0431749622926094,7.600274725274725
685,J,"Kazakov, T; Yang, F; Ramanathan, HN; Kohlway, A; Diamond, MS; Lindenbach, BD",,,,"Kazakov, Teymur; Yang, Feng; Ramanathan, Harish N.; Kohlway, Andrew; Diamond, Michael S.; Lindenbach, Brett D.",,,Hepatitis C Virus RNA Replication Depends on Specific Cis- and Trans-Acting Activities of Viral Nonstructural Proteins,PLOS PATHOGENS,,,English,Article,,,,,,,DEFECTIVE INTERFERING RNAS; NS3 HELICASE; CELL-CULTURE; IN-VITRO; SUBGENOMIC REPLICON; CRYSTAL-STRUCTURE; POLIOVIRUS RNA; NS5A PROTEIN; MEMBRANOUS REPLICATION; TRANSMEMBRANE DOMAIN,"Many positive-strand RNA viruses encode genes that can function in trans, whereas other genes are required in cis for genome replication. The mechanisms underlying trans-and cis-preferences are not fully understood. Here, we evaluate this concept for hepatitis C virus (HCV), an important cause of chronic liver disease and member of the Flaviviridae family. HCV encodes five nonstructural (NS) genes that are required for RNA replication. To date, only two of these genes, NS4B and NS5A, have been trans-complemented, leading to suggestions that other replicase genes work only in cis. We describe a new quantitative system to measure the cis- and trans-requirements for HCV NS gene function in RNA replication and identify several lethal mutations in the NS3, NS4A, NS4B, NS5A, and NS5B genes that can be complemented in trans, alone or in combination, by expressing the NS3-5B polyprotein from a synthetic mRNA. Although NS5B RNA binding and polymerase activities can be supplied in trans, NS5B protein expression was required in cis, indicating that NS5B has a cis-acting role in replicase assembly distinct from its known enzymatic activity. Furthermore, the RNA binding and NTPase activities of the NS3 helicase domain were required in cis, suggesting that these activities play an essential role in RNA template selection. A comprehensive complementation group analysis revealed functional linkages between NS3-4A and NS4B and between NS5B and the upstream NS3-5A genes. Finally, NS5B polymerase activity segregated with a daclatasvir-sensitive NS5A activity, which could explain the synergy of this antiviral compound with nucleoside analogs in patients. Together, these studies define several new aspects of HCV replicase structure-function, help to explain the potency of HCV-specific combination therapies, and provide an experimental framework for the study of cis- and trans-acting activities in positive-strand RNA virus replication more generally.","[Kazakov, Teymur; Yang, Feng; Ramanathan, Harish N.; Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Kohlway, Andrew] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA","Kazakov, T (reprint author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.",brett.lindenbach@yale.edu,,,National Institutes of Health [AI089826],"Funding: This project was supported by National Institutes of Health Grant AI089826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,135,15,15,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004817,10.1371/journal.ppat.1004817,,,,30,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000032,25875808.0,"DOAJ Gold, Green Published",,,16/08/2019,15,43,44,5312,1100,812,288,4212,3293,23,896,44,0,0,0,15,15,0,,2,0,2,0,0,16,16,13,10,0,0,0,0,0,0,0,43,0,5374,199,0,539,9,0,4252,1108,160,0,539,6,0,14,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,4.829090909090909,1.261158594491928,0.2611585944919278,1.325261158594492,1.050828313253012,5.074545454545454
686,J,"Kielmanowicz, MG; Inberg, A; Lerner, IM; Golani, Y; Brown, N; Turner, CL; Hayes, GJR; Ballam, JM",,,,"Kielmanowicz, Merav Gleit; Inberg, Alex; Lerner, Inbar Maayan; Golani, Yael; Brown, Nicholas; Turner, Catherine Louise; Hayes, Gerald J. R.; Ballam, Joan M.",,,Prospective Large-Scale Field Study Generates Predictive Model Identifying Major Contributors to Colony Losses,PLOS PATHOGENS,,,English,Article,,,,,,,DEFORMED-WING VIRUS; HONEYBEES APIS-MELLIFERA; MITES VARROA-DESTRUCTOR; ACUTE PARALYSIS VIRUS; KASHMIR-BEE-VIRUS; NOSEMA-CERANAE; COLLAPSE DISORDER; INFECTION; WINTER; TRANSMISSION,"Over the last decade, unusually high losses of colonies have been reported by beekeepers across the USA. Multiple factors such as Varroa destructor, bee viruses, Nosema ceranae, weather, beekeeping practices, nutrition, and pesticides have been shown to contribute to colony losses. Here we describe a large-scale controlled trial, in which different bee pathogens, bee population, and weather conditions across winter were monitored at three locations across the USA. In order to minimize influence of various known contributing factors and their interaction, the hives in the study were not treated with antibiotics or miticides. Additionally, the hives were kept at one location and were not exposed to potential stress factors associated with migration. Our results show that a linear association between load of viruses (DWV or IAPV) in Varroa and bees is present at high Varroa infestation levels (>3 mites per 100 bees). The collection of comprehensive data allowed us to draw a predictive model of colony losses and to show that Varroa destructor, along with bee viruses, mainly DWV replication, contributes to approximately 70% of colony losses. This correlation further supports the claim that insufficient control of the virus-vectoring Varroa mite would result in increased hive loss. The predictive model also indicates that a single factor may not be sufficient to trigger colony losses, whereas a combination of stressors appears to impact hive health.","[Kielmanowicz, Merav Gleit; Inberg, Alex; Lerner, Inbar Maayan; Golani, Yael; Brown, Nicholas; Turner, Catherine Louise; Hayes, Gerald J. R.; Ballam, Joan M.] Monsanto Co, Chesterfield, MO 63017 USA","Kielmanowicz, MG (reprint author), Monsanto Co, Chesterfield, MO 63017 USA.",merav.gleit@beeologics.com,,,Monsanto Co.,"Funding: This work was sponsored by Monsanto Co. Employees of Monsanto Co. and its affiliates were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript",,55,18,18,0,68,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004816,10.1371/journal.ppat.1004816,,,,20,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000031,25875764.0,"DOAJ Gold, Green Published",,,16/08/2019,17,93,61,6289,1042,868,174,5247,4362,49,836,61,4,0,0,18,18,2,,63,244,63,0,244,19,18,19,10,0,0,0,0,0,0,0,89,4,7464,15,0,131,1831,31,5271,1064,15,0,131,1831,31,1129,,0,0,0,0,5,0,5,0,0,0,0,63,0,0,3.5,6.035508637236084,1.1985896702877834,0.1985896702877835,1.7743472460453593,1.4803625377643506,8.934740882917467
687,J,"Kropp, KA; Hsieh, WY; Isern, E; Forster, T; Krause, E; Brune, W; Angulo, A; Ghazal, P",,,,"Kropp, Kai A.; Hsieh, Wei Yuan; Isern, Elena; Forster, Thorsten; Krause, Eva; Brune, Wolfram; Angulo, Ana; Ghazal, Peter",,,A Temporal Gate for Viral Enhancers to Co-opt Toll-Like-Receptor Transcriptional Activation Pathways upon Acute Infection,PLOS PATHOGENS,,,English,Article,,,,,,,NF-KAPPA-B; INTERFERON REGULATORY FACTOR; IMMEDIATE-EARLY GENE; HUMAN CYTOMEGALOVIRUS ENHANCER; PATTERN-RECOGNITION RECEPTORS; INNATE ANTIVIRAL RESPONSE; RETINOIC ACID RECEPTORS; NECROSIS-FACTOR-ALPHA; MURINE CYTOMEGALOVIRUS; MOUSE-CYTOMEGALOVIRUS,"Viral engagement with macrophages activates Toll-Like-Receptors (TLRs) and viruses must contend with the ensuing inflammatory responses to successfully complete their replication cycle. To date, known counter-strategies involve the use of viral-encoded proteins that often employ mimicry mechanisms to block or redirect the host response to benefit the virus. Whether viral regulatory DNA sequences provide an opportunistic strategy by which viral enhancer elements functionally mimic innate immune enhancers is unknown. Here we find that host innate immune genes and the prototypical viral enhancer of cytomegalovirus (CMV) have comparable expression kinetics, and positively respond to common TLR agonists. In macrophages but not fibroblasts we show that activation of NF kappa B at immediate-early times of infection is independent of virion-associated protein, M45. We find upon virus infection or transfection of viral genomic DNA the TLR-agonist treatment results in significant enhancement of the virus transcription-replication cycle. In macrophage time-course infection experiments we demonstrate that TLR-agonist stimulation of the viral enhancer and replication cycle is strictly delimited by a temporal gate with a determined half-maximal time for enhancer-activation of 6 h; after which TLR-activation blocks the viral transcription-replication cycle. By performing a systematic siRNA screen of 149 innate immune regulatory factors we identify not only anticipated anti-viral and pro-viral contributions but also new factors involved in the CMV transcription-replication cycle. We identify a central convergent NF kappa B-SP1-RXR-IRF axis downstream of TLR-signalling. Activation of the RXR component potentiated direct and indirect TLR-induced activation of CMV transcription-replication cycle; whereas chromatin binding experiments using wild-type and enhancer-deletion virus revealed IRF3 and 5 as new pro-viral host transcription factor interactions with the CMV enhancer in macrophages. In a series of pharmacologic, siRNA and genetic loss-of-function experiments we determined that signalling mediated by the TLR-adaptor protein MyD88 plays a vital role for governing the inflammatory activation of the CMV enhancer in macrophages. Downstream TLR-regulated transcription factor binding motif disruption for NF kappa B, AP1 and CREB/ATF in the CMV enhancer demonstrated the requirement of these inflammatory signal-regulated elements in driving viral gene expression and growth in cells as well as in primary infection of neonatal mice. Thus, this study shows that the prototypical CMV enhancer, in a restricted time-gated manner, co-opts through DNA regulatory mimicry elements, innate-immune transcription factors to drive viral expression and replication in the face of on-going pro-inflammatory antiviral responses in vitro and in vivo and; suggests an unexpected role for inflammation in promoting acute infection and has important future implications for regulating latency.","[Kropp, Kai A.; Hsieh, Wei Yuan; Forster, Thorsten; Ghazal, Peter] Univ Edinburgh, Edinburgh Infect Dis, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Isern, Elena; Angulo, Ana] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Krause, Eva; Brune, Wolfram] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Ghazal, Peter] Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland","Kropp, KA (reprint author), Hanover Med Sch, Dept Virol, Hannover, Germany.",Kropp.Kai@mh-hannover.de; P.Ghazal@ed.ac.uk,"Forster, Thorsten/F-4483-2017; Brune, Wolfram/H-5058-2019","Forster, Thorsten/0000-0002-4483-3069; Brune, Wolfram/0000-0002-6078-5255; Kropp, Kai Alexander/0000-0001-8505-3440; Angulo, Ana/0000-0002-5792-1164; Ghazal, Peter/0000-0003-0035-2228","Wellcome Trust [WT066784/Z/02/Z]; BBSRC/EPSRC; Centre for Integrative Systems Biology (CISB) [BB/D019621/1]; RNAi Global Initiative; University of Edinburgh College Studentship; Deutsche Forschungsgemeinschaft (DFG) [KR-3890/1-1]; Innovation Initiative Grant from University of Edinburgh Development Trust [GR000943]; Ministerio de Ciencia e Innovacion [SAF2008-00382, SAF2011-25155]; Biotechnology and Biological Sciences Research Council [BB/D019621/1]","Funding: This work was supported by: The Wellcome Trust (WT066784/Z/02/Z), the BBSRC/EPSRC to SynthSys, a Centre for Integrative Systems Biology (CISB) reference BB/D019621/1 and reagent support from RNAi Global Initiative to PG. WYH was supported by a University of Edinburgh College Studentship. KAK was supported by the Deutsche Forschungsgemeinschaft (DFG) with a research fellowship (KR-3890/1-1) and an Innovation Initiative Grant (GR000943) from the University of Edinburgh Development Trust. AA was supported by the Ministerio de Ciencia e Innovacion (SAF2008-00382 and SAF2011-25155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,140,3,3,0,2,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004737,10.1371/journal.ppat.1004737,,,,41,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000007,25856589.0,"DOAJ Gold, Green Published",,,16/08/2019,3,2,20,3801,786,583,203,3015,2485,27,503,20,0,0,0,2,2,1,,28,0,28,0,0,3,3,2,1,0,0,0,0,0,0,0,2,5,3842,93,0,46,74,0,3032,789,93,0,46,74,0,21,,0,0,0,0,8,0,0,0,0,0,0,28,0,0,3.85,4.83587786259542,1.2606965174129354,0.2606965174129353,1.3296849087893865,1.054722441462773,5.100508905852418
688,J,"Laurenceau, R; Krasteva, PV; Diallo, A; Ouarti, S; Duchateau, M; Malosse, C; Chamot-Rooke, J; Fronzes, R",,,,"Laurenceau, Raphael; Krasteva, Petya V.; Diallo, Amy; Ouarti, Sahra; Duchateau, Magalie; Malosse, Christian; Chamot-Rooke, Julia; Fronzes, Remi",,,Conserved Streptococcus pneumoniae Spirosomes Suggest a Single Type of Transformation Pilus in Competence,PLOS PATHOGENS,,,English,Article,,,,,,,DNA-UPTAKE; PROTEIN; SYSTEM; IDENTIFICATION; LOCALIZATION; FRATRICIDE; SECRETION; MACHINERY; BACTERIA; SEARCH,"The success of S. pneumoniae as a major human pathogen is largely due to its remarkable genomic plasticity, allowing efficient escape from antimicrobials action and host immune response. Natural transformation, or the active uptake and chromosomal integration of exogenous DNA during the transitory differentiated state competence, is the main mechanism for horizontal gene transfer and genomic makeover in pneumococci. Although transforming DNA has been proposed to be captured by Type 4 pili (T4P) in Gram-negative bacteria, and a competence-inducible comG operon encoding proteins homologous to T4P-biogenesis components is present in transformable Gram-positive bacteria, a prevailing hypothesis has been that S. pneumoniae assembles only short pseudopili to destabilize the cell wall for DNA entry. We recently identified a micrometer-sized T4P-like pilus on competent pneumococci, which likely serves as initial DNA receptor. A subsequent study, however, visualized a different structure - short, 'plaited' polymers - released in the medium of competent S. pneumoniae. Biochemical observation of concurrent pilin secretion led the authors to propose that the 'plaited' structures correspond to transformation pili acting as peptidoglycan drills that leave DNA entry pores upon secretion. Here we show that the 'plaited' filaments are not related to natural transformation as they are released by non-competent pneumococci, as well as by cells with disrupted pilus biogenesis components. Combining electron microscopy visualization with structural, biochemical and proteomic analyses, we further identify the 'plaited' polymers as spirosomes: macromolecular assemblies of the fermentative acetaldehyde-alcohol dehydrogenase enzyme AdhE that is well conserved in a broad range of Gram-positive and Gram-negative bacteria.","[Laurenceau, Raphael; Krasteva, Petya V.; Diallo, Amy; Ouarti, Sahra; Fronzes, Remi] Inst Pasteur, Unite Biol Struct Secret Bacterienne G5, Paris, France; [Laurenceau, Raphael; Krasteva, Petya V.; Diallo, Amy; Ouarti, Sahra; Duchateau, Magalie; Malosse, Christian; Chamot-Rooke, Julia; Fronzes, Remi] Inst Pasteur, CNRS, UMR 3528, Paris, France; [Duchateau, Magalie; Malosse, Christian; Chamot-Rooke, Julia] Inst Pasteur, Spectrometrie Masse Struct & Proteom, Paris, France; [Duchateau, Magalie; Malosse, Christian; Chamot-Rooke, Julia] Inst Pasteur, Plate Forme Proteom, Paris, France","Krasteva, PV (reprint author), Inst Pasteur, Unite Biol Struct Secret Bacterienne G5, Paris, France.",krasteva@pasteur.fr; remi.fronzes@pasteur.fr,"Krasteva, Petya/E-4132-2014","Krasteva, Petya/0000-0002-1858-8127; Fronzes, Remi/0000-0003-3031-9824",European research Council; DIM Malinf grant from the region Ile-de-France,"This work was funded by the European research Council to RF (Grant MolStructTransfo). Funding for the LTQ-Orbitrap Velos acquisition was secured through a DIM Malinf grant from the region Ile-de-France to JCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,12,13,0,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004835,10.1371/journal.ppat.1004835,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000042,25876066.0,"DOAJ Gold, Green Published",,,16/08/2019,12,0,29,4354,305,232,73,4049,3301,23,725,29,0,0,0,12,12,0,,45,4,45,0,4,12,12,12,6,0,0,0,0,0,0,0,0,2,4422,74,0,1265,110,1,4068,311,74,0,1265,110,1,43,,0,0,0,0,3,0,0,0,0,0,0,45,0,0,2.1,14.275409836065574,1.0753272412941468,0.0753272412941467,1.1375648308224253,1.0578778135048232,15.101639344262296
689,J,"Law, WJ; Wuescher, LM; Ortega, A; Hapiak, VM; Komuniecki, PR; Komuniecki, R",,,,"Law, Wenjing; Wuescher, Leah M.; Ortega, Amanda; Hapiak, Vera M.; Komuniecki, Patricia R.; Komuniecki, Richard",,,Heterologous Expression in Remodeled C. elegans: A Platform for Monoaminergic Agonist Identification and Anthelmintic Screening,PLOS PATHOGENS,,,English,Article,,,,,,,PROTEIN-COUPLED RECEPTOR; GATED CHLORIDE CHANNEL; HAEMONCHUS-CONTORTUS; FUNCTIONAL RECONSTITUTION; INDUCED PARALYSIS; IN-VIVO; RESISTANCE; INFECTIONS; SEROTONIN; BIOACTIVITY,"Monoamines, such as 5-HT and tyramine (TA), paralyze both free-living and parasitic nematodes when applied exogenously and serotonergic agonists have been used to clear Haemonchus contortus infections in vivo. Since nematode cell lines are not available and animal screening options are limited, we have developed a screening platform to identify monoamine receptor agonists. Key receptors were expressed heterologously in chimeric, genetically-engineered Caenorhabditis elegans, at sites likely to yield robust phenotypes upon agonist stimulation. This approach potentially preserves the unique pharmacologies of the receptors, while including nematode-specific accessory proteins and the nematode cuticle. Importantly, the sensitivity of monoamine-dependent paralysis could be increased dramatically by hypotonic incubation or the use of bus mutants with increased cuticular permeabilities. We have demonstrated that the monoamine-dependent inhibition of key interneurons, cholinergic motor neurons or body wall muscle inhibited locomotion and caused paralysis. Specifically, 5-HT paralyzed C. elegans 5-HT receptor null animals expressing either nematode, insect or human orthologues of a key G alpha(o)-coupled 5-HT1-like receptor in the cholinergic motor neurons. Importantly, 8-OH-DPAT and PAPP, 5-HT receptor agonists, differentially paralyzed the transgenic animals, with 8-OH-DPAT paralyzing mutant animals expressing the human receptor at concentrations well below those affecting its C. elegans or insect orthologues. Similarly, 5-HT and TA paralyzed C. elegans 5-HT or TA receptor null animals, respectively, expressing either C. elegans or H. contortus 5-HT or TA-gated Cl- channels in either C. elegans cholinergic motor neurons or body wall muscles. Together, these data suggest that this heterologous, ectopic expression screening approach will be useful for the identification of agonists for key monoamine receptors from parasites and could have broad application for the identification of ligands for a host of potential anthelmintic targets.","[Law, Wenjing; Wuescher, Leah M.; Ortega, Amanda; Hapiak, Vera M.; Komuniecki, Patricia R.; Komuniecki, Richard] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA","Law, WJ (reprint author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.",komlaboratory@gmail.com,,,National Institutes of Health [AI-145147]; Gates Foundation [OPP1087209],"Funding: This work was supported by National Institutes of Health grant (AI-145147) and Gates Foundation grant (OPP1087209) awarded to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,71,12,12,0,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004794,10.1371/journal.ppat.1004794,,,,17,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000021,25928899.0,"DOAJ Gold, Green Published",,,16/08/2019,12,3,16,3348,514,407,107,2834,2446,20,368,16,3,0,0,8,8,0,,23,7,23,0,7,12,12,12,7,0,0,0,0,0,0,0,0,9,3428,81,0,150,91,1,2855,521,81,0,150,91,1,52,,0,0,0,0,13,0,0,1,0,0,0,23,0,0,7.3,6.5136186770428015,1.1813690896259703,0.18136908962597037,1.2702893436838392,1.075268817204301,7.003891050583658
690,J,"Li, CY; Jiao, SZ; Wang, GJ; Gao, YZ; Liu, C; He, XJ; Zhang, C; Xiao, J; Li, WY; Zhang, GQ; Wei, B; Chen, HL; Wang, HY",,,,"Li, Chunyang; Jiao, Shaozhuo; Wang, Guojun; Gao, Yunzhen; Liu, Chang; He, Xijun; Zhang, Chi; Xiao, Jun; Li, Weiyun; Zhang, Guoquan; Wei, Bin; Chen, Hualan; Wang, Hongyan",,,The Immune Adaptor ADAP Regulates Reciprocal TGF-beta 1-Integrin Crosstalk to Protect from Influenza Virus Infection,PLOS PATHOGENS,,,English,Article,,,,,,,GROWTH-FACTOR-BETA; CD8(+) T-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; ACTIVATION; EXPRESSION; SMAD; MICE; PATHWAYS; BINDING; GENE,"Highly pathogenic avian influenza virus (HPAI, such as H5N1) infection causes severe cytokine storm and fatal respiratory immunopathogenesis in human and animal. Although TGF-beta 1 and the integrin CD103 in CD8(+) T cells play protective roles in H5N1 virus infection, it is not fully understood which key signaling proteins control the TGF-beta 1-integrin crosstalk in CD8(+) T cells to protect from H5N1 virus infection. This study showed that ADAP (Adhesion and Degranulation-promoting Adapter Protein) formed a complex with TRAF6 and TAK1 in CD8(+) T cells, and activated SMAD3 to increase autocrine TGF-beta 1 production. Further, TGF-beta 1 induced CD103 expression via an ADAP-, TRAF6- and SMAD3-dependent manner. In response to influenza virus infection (i.e. H5N1 or H1N1), lung infiltrating ADAP(-/-)CD8(+) T cells significantly reduced the expression levels of TGF-beta 1, CD103 and VLA-1. ADAP(-/-) mice as well as Rag1(-/-) mice receiving ADAP(-/-) T cells enhanced mortality with significant higher levels of inflammatory cytokines and chemokines in lungs. Together, we have demonstrated that ADAP regulates the positive feedback loop of TGF-beta 1 production and TGF-beta 1-induced CD103 expression in CD8(+) T cells via the T beta RI-TRAF6-TAK1-SMAD3 pathway and protects from influenza virus infection. It is critical to further explore whether the SNP polymorphisms located in human ADAP gene are associated with disease susceptibility in response to influenza virus infection.","[Li, Chunyang; Jiao, Shaozhuo; Gao, Yunzhen; Liu, Chang; Zhang, Chi; Xiao, Jun; Li, Weiyun; Wang, Hongyan] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Innovat Ctr Cell Signaling Network,Key Lab Syst B, Shanghai, Peoples R China; [Wang, Guojun; He, Xijun; Zhang, Guoquan; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Wei, Bin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China","Li, CY (reprint author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Innovat Ctr Cell Signaling Network,Key Lab Syst B, Shanghai, Peoples R China.",chenhualan@caas.cn; hongyanwang@sibcb.ac.cn,,"Jiao, Shaozhuo/0000-0003-1514-7200","Ministry of Science and Technology of China [2012CB910800]; National Natural Science Foundation of China [31422018, 31070778, 31370859]; WIV ""One-Three-Five"" Strategic Programs; Shanghai Pujiang program [11PJ1410700]; Hundred Talents Program of the Chinese Academy of Sciences","Funding: This work was funded by: The Ministry of Science and Technology of China, 2012CB910800, HW; National Natural Science Foundation of China, (31422018, 31070778 & 31370859), HW; WIV ""One-Three-Five"" Strategic Programs, BW; Shanghai Pujiang program, 11PJ1410700, HW and the Hundred Talents Program of the Chinese Academy of Sciences, HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,48,5,6,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004824,10.1371/journal.ppat.1004824,,,,23,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000036,25909459.0,"DOAJ Gold, Green Published",,,16/08/2019,7,20,21,5302,1180,787,393,4122,3372,18,732,21,17,0,0,4,4,0,,23,0,23,0,0,7,7,4,4,0,0,0,0,0,0,0,3,9,5324,22,0,220,69,1,4114,1180,22,0,220,69,1,30,,0,0,0,0,17,0,2,1,0,0,0,23,0,0,10.05,4.4932203389830505,1.2862688015526444,0.28626880155264434,1.3136826783114992,1.0213127121840815,4.588983050847458
691,J,"Liang, GX; Liu, GY; Kitamura, K; Wang, Z; Chowdhury, S; Monjurul, AM; Wakae, K; Koura, M; Shimadu, M; Kinoshita, K; Muramatsu, M",,,,"Liang, Guoxin; Liu, Guangyan; Kitamura, Kouichi; Wang, Zhe; Chowdhury, Sajeda; Monjurul, Ahasan Md; Wakae, Kousho; Koura, Miki; Shimadu, Miyuki; Kinoshita, Kazuo; Muramatsu, Masamichi",,,TGF-beta Suppression of HBV RNA through AID-Dependent Recruitment of an RNA Exosome Complex,PLOS PATHOGENS,,,English,Article,,,,,,,HEPATITIS-B-VIRUS; INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; HUMAN HEPATOCYTES; APOBEC PROTEINS; CELLS; EXPRESSION; INFECTION; DNA,"Transforming growth factor (TGF)-beta inhibits hepatitis B virus (HBV) replication although the intracellular effectors involved are not determined. Here, we report that reduction of HBV transcripts by TGF-beta is dependent on AID expression, which significantly decreases both HBV transcripts and viral DNA, resulting in inhibition of viral replication. Immunoprecipitation reveals that AID physically associates with viral P protein that binds to specific virus RNA sequence called epsilon. AID also binds to an RNA degradation complex (RNA exosome proteins), indicating that AID, RNA exosome, and P protein form an RNP complex. Suppression of HBV transcripts by TGF-beta was abrogated by depletion of either AID or RNA exosome components, suggesting that AID and the RNA exosome involve in TGF-beta mediated suppression of HBV RNA. Moreover, AID-mediated HBV reduction does not occur when P protein is disrupted or when viral transcription is inhibited. These results suggest that induced expression of AID by TGF-beta causes recruitment of the RNA exosome to viral RNP complex and the RNA exosome degrades HBV RNA in a transcription-coupled manner.","[Liang, Guoxin; Liu, Guangyan; Kitamura, Kouichi; Wang, Zhe; Chowdhury, Sajeda; Monjurul, Ahasan Md; Wakae, Kousho; Koura, Miki; Shimadu, Miyuki; Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa, Japan; [Liang, Guoxin] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Wang, Zhe] Dalian Univ, Affiliated Zhongshan Hosp, Div Med Oncol, Dalian 116012, Peoples R China; [Kinoshita, Kazuo] Shiga Med Ctr, Res Inst, Evolutionary Med, Moriyama, Japan","Liang, GX (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa, Japan.",muramatu@med.kanazawa-u.ac.jp,"Kitamura, Kouichi/L-3654-2015","Kitamura, Kouichi/0000-0001-9692-8724","Founding Program for Next Generation World-Leading Researchers; Ministry of Education, Science, Sports, and Culture of Japan; Hokkoku Foundation for Cancer Research","Funding: This study was supported by the Founding Program for Next Generation World-Leading Researchers, and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Science, Sports, and Culture of Japan, and the Hokkoku Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,43,17,19,1,12,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004780,10.1371/journal.ppat.1004780,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000014,25836330.0,"DOAJ Gold, Green Published",,,16/08/2019,18,1,34,6749,1908,1380,528,4841,3856,20,965,34,0,0,0,18,18,3,,39,0,39,0,0,19,19,12,10,0,0,0,0,0,0,0,1,0,6811,81,0,172,45,0,4861,1923,81,0,172,45,0,27,,0,0,0,0,1,0,1,0,0,0,0,39,0,0,0.5,3.5372117400419287,1.3941334435034083,0.3941334435034084,1.4329683949597192,1.0278559786635058,3.6357442348008386
692,J,"Lin, AE; Beasley, FC; Olson, J; Keller, N; Shalwitz, RA; Hannan, TJ; Hultgren, SJ; Nizet, V",,,,"Lin, Ann E.; Beasley, Federico C.; Olson, Joshua; Keller, Nadia; Shalwitz, Robert A.; Hannan, Thomas J.; Hultgren, Scott J.; Nizet, Victor",,,Role of Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) in Innate Defense against Uropathogenic Escherichia coli Infection,PLOS PATHOGENS,,,English,Article,,,,,,,URINARY-TRACT-INFECTION; INTRACELLULAR BACTERIAL COMMUNITIES; BLADDER EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; PROLYL HYDROXYLASE; HOST DEFENSES; EXPRESSION; ACTIVATION; INVASION; IMMUNITY,"Uropathogenic E. coli (UPEC) is the primary cause of urinary tract infections (UTI) affecting approximately 150 million people worldwide. Here, we revealed the importance of transcriptional regulator hypoxia-inducible factor-1 alpha subunit (HIF-1 alpha) in innate defense against UPEC-mediated UTI. The effects of AKB-4924, a HIF-1 alpha stabilizing agent, were studied using human uroepithelial cells (5637) and a murine UTI model. UPEC adherence and invasion were significantly reduced in 5637 cells when HIF-1 alpha protein was allowed to accumulate. Uroepithelial cells treated with AKB-4924 also experienced reduced cell death and exfoliation upon UPEC challenge. In vivo, fewer UPEC were recovered from the urine, bladders and kidneys of mice treated transurethrally with AKB-4924, whereas increased bacteria were recovered from bladders of mice with a HIF-1 alpha deletion. Bladders and kidneys of AKB-4924 treated mice developed less inflammation as evidenced by decreased pro-inflammatory cytokine release and neutrophil activity. AKB-4924 impairs infection in uroepithelial cells and bladders, and could be correlated with enhanced production of nitric oxide and antimicrobial peptides cathelicidin and beta-defensin-2. We conclude that HIF-1 alpha transcriptional regulation plays a key role in defense of the urinary tract against UPEC infection, and that pharmacological HIF-1 alpha boosting could be explored further as an adjunctive therapy strategy for serious or recurrent UTI.","[Lin, Ann E.; Beasley, Federico C.; Olson, Joshua; Keller, Nadia; Nizet, Victor] Univ Calif San Diego, Div Pediat Pharmacol & Drug Discovery, La Jolla, CA 92093 USA; [Shalwitz, Robert A.] Aerpio Therapeut, Cincinnati, OH USA; [Hannan, Thomas J.; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Hannan, Thomas J.; Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nizet, Victor] Rady Childrens Hosp, San Diego, CA USA","Lin, AE (reprint author), Univ Calif San Diego, Div Pediat Pharmacol & Drug Discovery, La Jolla, CA 92093 USA.",vnizet@ucsd.edu,,"Nizet, Victor/0000-0003-3847-0422; Hannan, Thomas/0000-0003-0498-8231","NIH [AI093451, AI057153, HD071600, DK098870, AI048689]; Canadian Institute of Health Research; American Association of Anatomists; Aerpio Therapeutics","Funding: The research was supported by NIH grants to VN (AI093451, AI057153, HD071600) and SJH (DK098870, AI048689). AEL was supported by postdoctoral fellowships from the Canadian Institute of Health Research and the American Association of Anatomists. RAS was an employee of Aerpio Therapeutics and received salary support from the company. None of the grant funders nor Aerpio Therapeutics had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,21,21,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004818,10.1371/journal.ppat.1004818,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000033,25927232.0,"DOAJ Gold, Green Published",,,16/08/2019,24,126,36,16311,1522,1120,402,14789,13650,29,1110,36,11,0,0,20,20,6,,63,9,63,0,9,24,24,21,14,0,0,0,0,0,0,2,115,9,16189,126,58,81,141,2,14627,1522,80,58,81,134,2,40,,4,2,0,0,13,0,9,1,0,0,0,60,0,0,58.344,10.716819973718792,1.102914328216918,0.10291432821691798,1.1127189127053891,1.0088897063331494,10.81208935611038
693,J,"Liu, Q; Cho, H; Yeo, WS; Bae, T",,,,"Liu, Qian; Cho, Hoonsik; Yeo, Won-Sik; Bae, Taeok",,,The Extracytoplasmic Linker Peptide of the Sensor Protein SaeS Tunes the Kinase Activity Required for Staphylococcal Virulence in Response to Host Signals,PLOS PATHOGENS,,,English,Article,,,,,,,SENSING HISTIDINE KINASES; 2-COMPONENT SYSTEM; GENE-EXPRESSION; BACILLUS-SUBTILIS; ABC TRANSPORTER; BINDING-SITES; AUREUS; RESISTANCE; PROMOTER; IDENTIFICATION,"Bacterial pathogens often employ two-component systems (TCSs), typically consisting of a sensor kinase and a response regulator, to control expression of a set of virulence genes in response to changing host environments. In Staphylococcus aureus, the SaeRS TCS is essential for in vivo survival of the bacterium. The intramembrane-sensing histidine kinase SaeS contains, along with a C-terminal kinase domain, a simple N-terminal domain composed of two transmembrane helices and a nine amino acid-long extracytoplasmic linker peptide. As a molecular switch, SaeS maintains low but significant basal kinase activity and increases its kinase activity in response to inducing signals such as human neutrophil peptide 1 (HNP1). Here we show that the linker peptide of SaeS controls SaeS's basal kinase activity and that the amino acid sequence of the linker peptide is highly optimized for its function. Without the linker peptide, SaeS displays aberrantly elevated kinase activity even in the absence of the inducing signal, and does not respond to HNP1. Moreover, SaeS variants with alanine substitution of the linker peptide amino acids exhibit altered basal kinase activity and/or irresponsiveness to HNP1. Biochemical assays reveal that those SaeS variants have altered autokinase and phosphotransferase activities. Finally, animal experiments demonstrate that the linker peptide-mediated fine tuning of SaeS kinase activity is critical for survival of the pathogen. Our results indicate that the function of the linker peptide in SaeS is a highly evolved feature with very optimized amino acid sequences, and we propose that, in other SaeS-like intramembrane sensing histidine kinases, the extracytoplasmic linker peptides actively fine-control their kinases.","[Liu, Qian; Cho, Hoonsik; Yeo, Won-Sik; Bae, Taeok] Indiana Univ Sch Med Northwest, Dept Microbiol & Immunol, Gary, IN USA","Liu, Q (reprint author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Lab Med, Shanghai 200030, Peoples R China.",tbae@iun.edu,,"Bae, Taeok/0000-0002-0576-2851",National Institute of Allergy and Infectious Diseases [AI077564],"Funding: This study was supported by AI077564 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,17,17,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004799,10.1371/journal.ppat.1004799,,,,27,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000025,25849574.0,"DOAJ Gold, Green Published",,,16/08/2019,17,1,22,3607,547,408,139,3060,2628,18,414,21,0,0,0,16,16,0,,29,0,28,1,0,18,18,10,17,0,0,0,0,0,0,0,1,6,3673,64,18,106,59,0,3051,547,64,18,106,59,0,75,,0,0,0,0,8,0,1,1,0,0,0,28,1,0,4.45,6.594149908592322,1.1787581699346406,0.17875816993464053,1.2405228758169935,1.0523981147768229,6.939670932358318
694,J,"Ma, Y; Yuan, B; Zhuang, R; Zhang, YS; Liu, B; Zhang, CM; Zhang, Y; Yu, HT; Yi, J; Yang, AG; Jin, BQ",,,,"Ma, Ying; Yuan, Bin; Zhuang, Ran; Zhang, Yusi; Liu, Bei; Zhang, Chunmei; Zhang, Yun; Yu, Haitao; Yi, Jing; Yang, Angang; Jin, Boquan",,,Hantaan Virus Infection Induces Both Th1 and ThGranzyme B plus Cell Immune Responses That Associated with Viral Control and Clinical Outcome in Humans,PLOS PATHOGENS,,,English,Article,,,,,,,CD4(+) T-CELLS; HANTAVIRUS PULMONARY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; RENAL SYNDROME CORRELATION; ACUTE HEPATITIS-C; HEMORRHAGIC-FEVER; NUCLEOCAPSID PROTEIN; INTERFERON-GAMMA; DISEASE SEVERITY; CTL EPITOPES,"Hantaviruses infection causing severe emerging diseases with high mortality rates in humans has become public health concern globally. The potential roles of CD4(+)T cells in viral control have been extensively studied. However, the contribution of CD4(+)T cells to the host response against Hantaan virus (HTNV) infection remains unclear. Here, based on the T-cell epitopes mapped on HTNV glycoprotein, we studied the effects and characteristics of CD4(+)T-cell responses in determining the outcome of hemorrhagic fever with renal syndrome. A total of 79 novel 15-mer T-cell epitopes on the HTNV glycoprotein were identified, among which 20 peptides were dominant target epitopes. Importantly, we showed the presence of both effective Th1 responses with polyfunctional cytokine secretion and ThGranzyme B+ cell responses with cytotoxic mediators production against HTNV infection. The HTNV glycoprotein-specific CD4(+)T-cell responses inversely correlated with the plasma HTNV RNA load in patients. Individuals with milder disease outcomes showed broader epitopes targeted and stronger CD4(+)T-cell responses against HTNV glycoproteins compared with more severe patients. The CD4(+)T cells characterized by broader antigenic repertoire, stronger polyfunctional responses, better expansion capacity and highly differentiated effector memory phenotype (CD27(-)CD28(-)CCR7(-)CD45RA(-)CD127(hi)) would elicit greater defense against HTNV infection and lead to much milder outcome of the disease. The host defense mediated by CD4(+)T cells may through the inducing antiviral condition of the host cells and cytotoxic effect of ThGranzyme B+ cells. Thus, these findings highlight the efforts of CD4(+)T-cell immunity to HTNV control and provide crucial information to better understand the immune defense against HTNV infection.","[Ma, Ying; Zhuang, Ran; Zhang, Yusi; Liu, Bei; Zhang, Chunmei; Zhang, Yun; Yi, Jing; Yang, Angang; Jin, Boquan] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China; [Yuan, Bin] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China; [Yu, Haitao] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Peoples R China","Ma, Y (reprint author), Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China.",immu_jin@fmmu.edu.cn,"Zhuang, Ran/I-7336-2019","Zhuang, Ran/0000-0002-3614-0422",National Natural Science Foundation of China [30930087]; National Basic Research Program of China [2012CB518905],"Funding: This work was supported through funding from the National Natural Science Foundation of China (No. 30930087) and the National Basic Research Program of China (No. 2012CB518905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,80,16,17,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004788,10.1371/journal.ppat.1004788,,,,31,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000018,25836633.0,"DOAJ Gold, Green Published",,,16/08/2019,15,1,8,2943,631,455,176,2312,1926,19,367,8,0,0,0,14,14,1,,17,1,17,0,1,15,15,15,10,0,0,0,0,0,0,0,1,5,2957,53,0,48,50,1,2310,631,53,0,48,50,1,16,,0,0,0,0,8,0,1,1,0,0,0,17,0,0,4.35,4.664025356576862,1.272923875432526,0.27292387543252594,1.3235294117647058,1.039755351681957,4.849445324881141
695,J,"Maule, AF; Wright, DP; Weiner, JJ; Han, LL; Peterson, FC; Volkman, BF; Silvaggi, NR; Ulijasz, AT",,,,"Maule, Andrew F.; Wright, David P.; Weiner, Joshua J.; Han, Lanlan; Peterson, Francis C.; Volkman, Brian F.; Silvaggi, Nicholas R.; Ulijasz, Andrew T.",,,"The Aspartate-Less Receiver (ALR) Domains: Distribution, Structure and Function",PLOS PATHOGENS,,,English,Article,,,,,,,BACTERIAL RESPONSE REGULATORS; CRYSTAL-STRUCTURE; X-RAY; CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; DNA-BINDING; PROTEIN; PHOSPHORYLATION; ACTIVATION; MECHANISM,"Two-component signaling systems are ubiquitous in bacteria, Archaea and plants and play important roles in sensing and responding to environmental stimuli. To propagate a signaling response the typical system employs a sensory histidine kinase that phosphorylates a Receiver (REC) domain on a conserved aspartate (Asp) residue. Although it is known that some REC domains are missing this Asp residue, it remains unclear as to how many of these divergent REC domains exist, what their functional roles are and how they are regulated in the absence of the conserved Asp. Here we have compiled all deposited REC domains missing their phosphorylatable Asp residue, renamed here as the Aspartate-Less Receiver (ALR) domains. Our data show that ALRs are surprisingly common and are enriched for when attached to more rare effector outputs. Analysis of our informatics and the available ALR atomic structures, combined with structural, biochemical and genetic data of the ALR archetype RitR from Streptococcus pneumoniae presented here suggest that ALRs have reorganized their active pockets to instead take on a constitutive regulatory role or accommodate input signals other than Asp phosphorylation, while largely retaining the canonical post-phosphorylation mechanisms and dimeric interface. This work defines ALRs as an atypical REC subclass and provides insights into shared mechanisms of activation between ALR and REC domains.","[Maule, Andrew F.; Weiner, Joshua J.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Wright, David P.; Ulijasz, Andrew T.] Univ London Imperial Coll Sci Technol & Med, MRC, CMBI, London, England; [Weiner, Joshua J.; Han, Lanlan; Silvaggi, Nicholas R.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA","Maule, AF (reprint author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.",silvaggi@uwm.edu; a.ulijasz@imperial.ac.uk,,,"University of Wisconsin Milwaukee; Imperial College London Department of Medicine, a United Kingdom Medical Research Council (MRC); National Institutes of Health (NIH) [AI058072]; U.S. Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Medical Research Council [MR/J006874/1B, MR/J006874/1]","Funding: This work was supported from funding to ATU and NRS from the University of Wisconsin Milwaukee, to ATU and DPW from Imperial College London Department of Medicine, a United Kingdom Medical Research Council (MRC) grant for the Centre for Molecular Bacteriology and Infection (CMBI) and National Institutes of Health (NIH) grant AI058072 to BFV and FCP. Use of the Advanced Photon Source was supported by the U.S. Department of Energy under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,84,10,10,0,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004795,10.1371/journal.ppat.1004795,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000022,25875291.0,"DOAJ Gold, Green Published",,,16/08/2019,12,16,14,3473,528,412,116,2945,2475,25,445,14,0,0,0,10,10,0,,16,0,16,0,0,13,12,13,9,0,0,0,0,0,0,0,16,5,3495,89,0,66,206,0,2937,528,89,0,66,206,0,30,,0,0,0,0,7,0,1,0,0,0,0,16,0,0,3.5,6.577651515151516,1.1792869269949067,0.17928692699490661,1.2869269949066213,1.091275554275842,7.178030303030303
696,J,"Moller-Tank, S; Maury, W",,,,"Moller-Tank, Sven; Maury, Wendy",,,Ebola Virus Entry: A Curious and Complex Series of Events,PLOS PATHOGENS,,,English,Article,,,,,,,DENDRITIC CELLS; GLYCOPROTEIN; RECEPTOR; REQUIRES; ACTIVATION; TRIGGER; TIM,,"[Moller-Tank, Sven] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Moller-Tank, Sven; Maury, Wendy] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA","Moller-Tank, S (reprint author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.",wendy-maury@uiowa.edu,,"Maury, Wendy/0000-0002-9892-4484",NIAID NIH HHS [T32 AI007533],,,33,35,35,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004731,10.1371/journal.ppat.1004731,,,,8,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000006,25928849.0,"DOAJ Gold, Green Published",,,16/08/2019,34,58,94,14116,1290,946,344,12826,10746,24,2056,91,51,0,0,36,36,0,,117,59,114,3,59,38,35,38,20,0,0,0,0,0,0,0,7,24,14549,29,0,414,604,8,12802,1290,29,0,414,604,8,457,,0,0,0,0,42,0,3,1,0,0,0,119,3,0,23.55,10.942635658914728,1.1005769530640885,0.10057695306408856,1.1836893809449556,1.0755171436667612,11.768992248062016
697,J,"Nystrom, K; Abrantes, J; Lopes, AM; Le Moullac-Vaidye, B; Marchandeau, S; Rocher, J; Ruvoen-Clouet, N; Esteves, PJ; Le Pendu, J",,,,"Nystrom, Kristina; Abrantes, Joana; Lopes, Ana Margarida; Le Moullac-Vaidye, Beatrice; Marchandeau, Stephane; Rocher, Jezabel; Ruvoen-Clouet, Nathalie; Esteves, Pedro J.; Le Pendu, Jacques",,,"Neofunctionalization of the Sec1 alpha 1,2fucosyltransferase Paralogue in Leporids Contributes to Glycan Polymorphism and Resistance to Rabbit Hemorrhagic Disease Virus",PLOS PATHOGENS,,,English,Article,,,,,,,BLOOD GROUP ANTIGENS; D-GALACTOSIDE 2-ALPHA-L-FUCOSYL-TRANSFERASE; ORYCTOLAGUS-CUNICULUS; MOLECULAR-CLONING; BETA-GALACTOSIDE; PHYLOGENETIC ANALYSIS; HUMAN-SERUM; GENE; EXPRESSION; EVOLUTION,"RHDV (rabbit hemorrhagic disease virus), a virulent calicivirus, causes high mortalities in European rabbit populations (Oryctolagus cuniculus). It uses alpha 1,2fucosylated glycans, histo-blood group antigens (HBGAs), as attachment factors, with their absence or low expression generating resistance to the disease. Synthesis of these glycans requires an alpha 1,2fucosyltransferase. In mammals, there are three closely located alpha 1,2fucosyltransferase genes rSec1, rFut2 and rFut1 that arose through two rounds of duplications. In most mammalian species, Sec1 has clearly become a pseudogene. Yet, in leporids, it does not suffer gross alterations, although we previously observed that rabbit Sec1 variants present either low or no activity. Still, a low activity rSec1 allele correlated with survival to an RHDV outbreak. We now confirm the association between the alpha 1,2fucosyltransferase loci and survival. In addition, we show that rabbits express homogenous rFut1 and rFut2 levels in the small intestine. Comparison of rFut1 and rFut2 activity showed that type 2 A, B and H antigens recognized by RHDV strains were mainly synthesized by rFut1, and all rFut1 variants detected in wild animals were equally active. Interestingly, rSec1 RNA levels were highly variable between individuals and high expression was associated with low binding of RHDV strains to the mucosa. Co-transfection of rFut1 and rSec1 caused a decrease in rFut1-generated RHDV binding sites, indicating that in rabbits, the catalytically inactive rSec1 protein acts as a dominant-negative of rFut1. Consistent with neofunctionalization of Sec1 in leporids, gene conversion analysis showed extensive homogenization between Sec1 and Fut2 in leporids, at variance with its limited degree in other mammals. Gene conversion additionally involving Fut1 was also observed at the C-terminus. Thus, in leporids, unlike in most other mammals where it became extinct, Sec1 evolved a new function with a dominant-negative effect on rFut1, contributing to fucosylated glycan diversity, and allowing herd protection from pathogens such as RHDV.","[Nystrom, Kristina; Abrantes, Joana; Le Moullac-Vaidye, Beatrice; Rocher, Jezabel; Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] INSERM, U892, Nantes, France; [Nystrom, Kristina; Abrantes, Joana; Le Moullac-Vaidye, Beatrice; Rocher, Jezabel; Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] CNRS, UMR6299, Nantes, France; [Nystrom, Kristina; Abrantes, Joana; Le Moullac-Vaidye, Beatrice; Rocher, Jezabel; Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] Univ Nantes, Nantes, France; [Nystrom, Kristina] Univ Gothenburg, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden; [Abrantes, Joana; Lopes, Ana Margarida; Esteves, Pedro J.] Univ Porto, InBIO Res Network Biodivers & Evolutionary Biol, CIBIO, Vairao, Portugal; [Lopes, Ana Margarida; Esteves, Pedro J.] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Marchandeau, Stephane] Off Natl Chasse & Faune Sauvage, Direct Etud & Rech, CS 42355, Nantes, France; [Ruvoen-Clouet, Nathalie] Ecole Natl Vet Agroalimentaire & Alimentat, Oniris, Nantes, France; [Esteves, Pedro J.] CESPU, IPSN, CITS, Gandra, Portugal","Nystrom, K (reprint author), INSERM, U892, Nantes, France.",Jacques.le-pendu@univ-nantes.fr,"Le Pendu, Jacques/F-4760-2013; Ruvoen-clouet, Nathalie/K-9609-2015; Nystrom, Kristina/N-3125-2014; Esteves, Pedro/A-7537-2010; Lopes, Ana/M-3285-2013","Le Pendu, Jacques/0000-0002-4856-0387; Esteves, Pedro/0000-0002-6055-8298; Lopes, Ana/0000-0002-7176-0969","Region des Pays de la Loire; Agence Nationale de la Recherche; Federation Nationale des Chasseurs; FCT [PTDC/CVT/108490/2008]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/73512/2010, SFRH/BD/78738/2011]","Funding: This work was partially supported by the Region des Pays de la Loire, the Agence Nationale de la Recherche (Project Calilago), the Federation Nationale des Chasseurs and the FCT Project PTDC/CVT/108490/2008. The Portuguese Foundation for Science and Technology (FCT) supported the postdoctoral fellowship of JA (SFRH/BPD/73512/2010) and the doctoral fellowship of AML (SFRH/BD/78738/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,64,4,4,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004759,10.1371/journal.ppat.1004759,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000010,25875017.0,"DOAJ Gold, Green Published",,,16/08/2019,4,1,4,1935,412,310,102,1523,1256,19,248,3,0,0,0,2,2,0,,8,4,7,1,4,4,4,3,2,0,0,0,0,0,0,0,1,1,1951,30,0,67,120,4,1513,412,30,0,67,120,4,26,,0,0,0,0,2,0,1,0,0,0,0,7,1,0,1.5,4.696601941747573,1.2705187130663165,0.2705187130663165,1.3795141168745897,1.0857881136950904,5.099514563106796
698,J,"Ohashi, M; Holthaus, AM; Calderwood, MA; Lai, CY; Krastins, B; Sarracino, D; Johannsen, E",,,,"Ohashi, Makoto; Holthaus, Amy M.; Calderwood, Michael A.; Lai, Chiou-Yan; Krastins, Bryan; Sarracino, David; Johannsen, Eric",,,The EBNA3 Family of Epstein-Barr Virus Nuclear Proteins Associates with the USP46/USP12 Deubiquitination Complexes to Regulate Lymphoblastoid Cell Line Growth,PLOS PATHOGENS,,,English,Article,,,,,,,RBP-J-KAPPA; TRANSFORMATION IN-VITRO; FANCONI-ANEMIA PATHWAY; ANTIGEN 3C; TUMOR-SUPPRESSOR; B-LYMPHOCYTES; DNA-BINDING; RECEPTOR EXPRESSION; GENE-EXPRESSION; C-MYC,"The Epstein-Barr virus (EBV) nuclear proteins EBNA3A, EBNA3B, and EBNA3C interact with the cell DNA binding protein RBPJ and regulate cell and viral genes. Repression of the CDKN2A tumor suppressor gene products p16(INK4A) and p14(ARF) by EBNA3A and EBNA3C is critical for EBV mediated transformation of resting B lymphocytes into immortalized lymphoblastoid cell lines (LCLs). To define the composition of endogenous EBNA3 protein complexes, we generated lymphoblastoid cell lines (LCLs) expressing flag-HA tagged EBNA3A, EBNA3B, or EBNA3C and used tandem affinity purification to isolate each EBNA3 complex. Our results demonstrated that each EBNA3 protein forms a distinct complex with RBPJ. Mass-spectrometry revealed that the EBNA3A and EBNA3B complexes also contained the deubquitylation complex consisting of WDR48, WDR20, and USP46 (or its paralog USP12) and that EBNA3C complexes contained WDR48. Immunoprecipitation confirmed that EBNA3A, EBNA3B, and EBNA3C association with the USP46 complex. Using chromatin immunoprecipitation, we demonstrate that WDR48 and USP46 are recruited to the p14(ARF) promoter in an EBNA3C dependent manner. Mapping studies were consistent with WDR48 being the primary mediator of EBNA3 association with the DUB complex. By ChIP assay, WDR48 was recruited to the p14(ARF) promoter in an EBNA3C dependent manner. Importantly, WDR48 associated with EBNA3A and EBNA3C domains that are critical for LCL growth, suggesting a role for USP46/USP12 in EBV induced growth transformation.","[Ohashi, Makoto; Johannsen, Eric] Univ Wisconsin, McArdle Lab Canc Res, Dept Med, Madison, WI 53706 USA; [Ohashi, Makoto; Johannsen, Eric] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53706 USA; [Holthaus, Amy M.; Calderwood, Michael A.; Lai, Chiou-Yan] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Holthaus, Amy M.; Calderwood, Michael A.; Lai, Chiou-Yan] Harvard Univ, Sch Med, Boston, MA USA; [Krastins, Bryan; Sarracino, David] Thermo Fisher Sci, BRIMS, Cambridge, MA USA","Ohashi, M (reprint author), Univ Wisconsin, McArdle Lab Canc Res, Dept Med, 1400 Univ Ave, Madison, WI 53706 USA.",ejohannsen@medicine.wisc.edu,"Calderwood, Mike/B-2475-2014","Calderwood, Mike/0000-0001-6475-1418","National Cancer Institute of the USPHS [CA47006]; University of Wisconsin-Madision, Department of Medicine","Funding: This research was supported by a grant from the National Cancer Institute of the USPHS (CA47006) to (PI = Elliott Kieff, EJ Investigator) and new investigator funding from the University of Wisconsin-Madision, Department of Medicine (EJ). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,87,18,20,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004822,10.1371/journal.ppat.1004822,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000035,25855980.0,"DOAJ Gold, Green Published",,,16/08/2019,20,0,19,4657,1257,1005,252,3400,2753,28,619,19,0,0,0,18,18,0,,20,10,20,0,10,21,21,17,12,0,0,0,0,0,0,0,0,2,4731,122,0,676,90,5,3420,1276,122,0,676,90,5,35,,0,0,0,0,4,0,0,0,0,0,0,21,0,0,2.2,3.7048528241845666,1.369705882352941,0.36970588235294116,1.4538235294117647,1.061412926776895,3.9323786793953857
699,J,"Ramsey, KM; Osborne, ML; Vvedenskaya, IO; Su, C; Nickels, BE; Dove, SL",,,,"Ramsey, Kathryn M.; Osborne, Melisa L.; Vvedenskaya, Irina O.; Su, Cathy; Nickels, Bryce E.; Dove, Simon L.",,,Ubiquitous Promoter-Localization of Essential Virulence Regulators in Francisella tularensis,PLOS PATHOGENS,,,English,Article,,,,,,,BACTERIAL TRANSCRIPTION INITIATION; PROTEIN-PROTEIN CONTACTS; COLI RNA-POLYMERASE; ESCHERICHIA-COLI; GENE-EXPRESSION; PATHOGENICITY ISLAND; BINDING-SITES; PROKARYOTIC TRANSCRIPTION; INTRAMACROPHAGE GROWTH; INTRACELLULAR SURVIVAL,"Francisella tularensis is a Gram-negative bacterium whose ability to replicate within macrophages and cause disease is strictly dependent upon the coordinate activities of three transcription regulators called MglA, SspA, and PigR. MglA and SspA form a complex that associates with RNA polymerase (RNAP), whereas PigR is a putative DNA-binding protein that functions by contacting the MglA-SspA complex. Most transcription activators that bind the DNA are thought to occupy only those promoters whose activities they regulate. Here we show using chromatin immunoprecipitation coupled with high-throughput DNA sequencing (ChIP-Seq) that PigR, MglA, and SspA are found at virtually all promoters in F. tularensis and not just those of regulated genes. Furthermore, we find that the ability of PigR to associate with promoters is dependent upon the presence of MglA, suggesting that interaction with the RNAP-associated MglA-SspA complex is what directs PigR to promoters in F. tularensis. Finally, we present evidence that the ability of PigR (and thus MglA and SspA) to positively control the expression of genes is dictated by a specific 7 base pair sequence element that is present in the promoters of regulated genes. The three principal regulators of virulence gene expression in F. tularensis therefore function in a non-classical manner with PigR interacting with the RNAP-associated MglA-SspA complex at the majority of promoters but only activating transcription from those that contain a specific sequence element. Our findings reveal how transcription factors can exert regulatory effects at a restricted set of promoters despite being associated with most or all. This distinction between occupancy and regulatory effect uncovered by our data may be relevant to the study of RNAP-associated transcription regulators in other pathogenic bacteria.","[Ramsey, Kathryn M.; Osborne, Melisa L.; Su, Cathy; Dove, Simon L.] Harvard Univ, Sch Med, Div Infect Dis, Boston Childrens Hosp, Boston, MA 02138 USA; [Vvedenskaya, Irina O.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Vvedenskaya, Irina O.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA","Ramsey, KM (reprint author), Harvard Univ, Sch Med, Div Infect Dis, Boston Childrens Hosp, Boston, MA 02138 USA.",simon.dove@childrens.harvard.edu,,"Nickels, Bryce/0000-0001-7449-8831","National Institutes of Health [AI081693, GM096454, GM088343, P30 DK034854]","Funding: This work was supported by National Institutes of Health grants AI081693 (S.L.D.), GM096454 (B.E.N. and S.L.D.) and GM088343 (B.E.N.). The Harvard Digestive Disease Center was supported by National Institutes of Health grant P30 DK034854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,58,11,11,1,6,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004793,10.1371/journal.ppat.1004793,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000020,25830507.0,"DOAJ Gold, Green Published",,,16/08/2019,11,58,19,3473,561,414,147,2912,2482,17,413,18,0,0,0,11,11,2,,24,0,23,1,0,11,11,11,11,0,0,0,0,0,0,0,58,5,3504,88,14,59,42,0,2922,566,88,14,59,42,0,16,,0,0,0,0,9,0,1,0,0,0,0,23,1,0,3.85,6.190730837789661,1.192651098901099,0.1926510989010989,1.2479395604395604,1.0463576158940397,6.477718360071301
700,J,"Scordel, C; Huttin, A; Cochet-Bernoin, M; Szelechowski, M; Poulet, A; Richardson, J; Benchoua, A; Gonzalez-Dunia, D; Eloit, M; Coulpier, M",,,,"Scordel, Chloe; Huttin, Alexandra; Cochet-Bernoin, Marielle; Szelechowski, Marion; Poulet, Aurelie; Richardson, Jennifer; Benchoua, Alexandra; Gonzalez-Dunia, Daniel; Eloit, Marc; Coulpier, Muriel",,,Borna Disease Virus Phosphoprotein Impairs the Developmental Program Controlling Neurogenesis and Reduces Human GABAergic Neurogenesis,PLOS PATHOGENS,,,English,Article,,,,,,,NEURONAL DIFFERENTIATION; PERSISTENT INFECTION; NUCLEAR-LOCALIZATION; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; VIRAL PERSISTENCE; PROTEIN-KINASE; DENTATE GYRUS; STEM-CELLS; P-PROTEIN,"It is well established that persistent viral infection may impair cellular function of specialized cells without overt damage. This concept, when applied to neurotropic viruses, may help to understand certain neurologic and neuropsychiatric diseases. Borna disease virus (BDV) is an excellent example of a persistent virus that targets the brain, impairs neural functions without cell lysis, and ultimately results in neurobehavioral disturbances. Recently, we have shown that BDV infects human neural progenitor cells (hNPCs) and impairs neurogenesis, revealing a new mechanism by which BDV may interfere with brain function. Here, we sought to identify the viral proteins and molecular pathways that are involved. Using lentiviral vectors for expression of the bdv-p and bdv-x viral genes, we demonstrate that the phosphoprotein P, but not the X protein, diminishes human neurogenesis and, more particularly, GABAergic neurogenesis. We further reveal a decrease in pro-neuronal factors known to be involved in neuronal differentiation (ApoE, Noggin, TH and Scg10/Stathmin2), demonstrating that cellular dysfunction is associated with impairment of specific components of the molecular program that controls neurogenesis. Our findings thus provide the first evidence that a viral protein impairs GABAergic human neurogenesis, a process that is dysregulated in several neuropsychiatric disorders. They improve our understanding of the mechanisms by which a persistent virus may interfere with brain development and function in the adult.","[Scordel, Chloe; Huttin, Alexandra; Cochet-Bernoin, Marielle; Richardson, Jennifer; Coulpier, Muriel] INRA, UMR 1161, Maisons Alfort, France; [Scordel, Chloe; Huttin, Alexandra; Cochet-Bernoin, Marielle; Richardson, Jennifer; Coulpier, Muriel] ANSES, UMR Virol, Maisons Alfort, France; [Scordel, Chloe; Huttin, Alexandra; Cochet-Bernoin, Marielle; Richardson, Jennifer; Eloit, Marc; Coulpier, Muriel] Univ Paris Est, Ecole Natl Vet Alfort, UMR Virol, Maisons Alfort, France; [Szelechowski, Marion; Gonzalez-Dunia, Daniel] Fac Med Toulouse, INSERM, UMR 1043, F-31073 Toulouse, France; [Szelechowski, Marion; Gonzalez-Dunia, Daniel] CNRS, UMR 5282, Toulouse, France; [Szelechowski, Marion; Gonzalez-Dunia, Daniel] Univ Toulouse 3, F-31062 Toulouse, France; [Poulet, Aurelie; Benchoua, Alexandra] AFM, I STEM, CECS, Evry, France; [Eloit, Marc] Inst Pasteur, INSERM, U1117, Pathogen Discovery Lab,Biol Infect Unit, F-75724 Paris, France","Coulpier, M (reprint author), INRA, UMR 1161, Maisons Alfort, France.",mcoulpier@vet-alfort.fr,"Dunia, Daniel/K-1090-2014","Dunia, Daniel/0000-0002-2837-7120; Benchoua, Alexandra/0000-0002-9980-6471; , Szelechowski/0000-0002-2929-7413; Richardson, Jennifer/0000-0002-4137-3984","French National Institute for Agricultural Research (INRA); INRA; French Ministery of Agriculture; Paris-Ile-de-France Cluster of Life and Environmental Sciences and Technologies (Pole STVE); French Agency for Food, Environmental and Occupational Health and Safety (ANSES); Region Ile-de-France","This study was financially supported by the French National Institute for Agricultural Research (INRA). CS was financially supported by INRA, the French Ministery of Agriculture and the Paris-Ile-de-France Cluster of Life and Environmental Sciences and Technologies (Pole STVE) and the French Agency for Food, Environmental and Occupational Health and Safety (ANSES). AH was financially supported by a grant from Region Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,61,6,6,0,7,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004859,10.1371/journal.ppat.1004859,,,,25,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000051,25923687.0,"DOAJ Gold, Green Published",,,16/08/2019,8,1,19,3593,790,580,210,2803,2082,21,700,19,0,0,0,6,6,0,,25,2,25,0,2,8,8,5,3,0,0,0,0,0,0,0,1,2,3640,31,0,85,59,0,2815,799,31,0,85,59,0,26,,0,0,0,0,3,0,1,1,0,0,0,24,0,0,1.75,4.548101265822785,1.2818408847663219,0.2818408847663218,1.3307170888333928,1.0381296966323406,4.7215189873417724
701,J,"Subbarayal, P; Karunakaran, K; Winkler, AC; Rother, M; Gonzalez, E; Meyer, TF; Rudel, T",,,,"Subbarayal, Prema; Karunakaran, Karthika; Winkler, Ann-Cathrin; Rother, Marion; Gonzalez, Erik; Meyer, Thomas F.; Rudel, Thomas",,,EphrinA2 Receptor (EphA2) Is an Invasion and Intracellular Signaling Receptor for Chlamydia trachomatis,PLOS PATHOGENS,,,English,Article,,,,,,,OVARIAN-CANCER; PROTEIN; APOPTOSIS; CELLS; ENTRY; PNEUMONIAE; ACTIVATION; MECHANISMS; RESISTANCE; INHIBITION,"The obligate intracellular bacterium Chlamydia trachomatis invades into host cells to replicate inside a membrane-bound vacuole called inclusion. Multiple different host proteins are recruited to the inclusion and are functionally modulated to support chlamydial development. Invaded and replicating Chlamydia induces a long-lasting activation of the PI3 kinase signaling pathway that is required for efficient replication. We identified the cell surface tyrosine kinase EphrinA2 receptor (EphA2) as a chlamydial adherence and invasion receptor that induces PI3 kinase (PI3K) activation, promoting chlamydial replication. Interfering with binding of C. trachomatis serovar L2 (Ctr) to EphA2, downregulation of EphA2 expression or inhibition of EphA2 activity significantly reduced Ctr infection. Ctr interacts with and activates EphA2 on the cell surface resulting in Ctr and receptor internalization. During chlamydial replication, EphA2 remains active accumulating around the inclusion and interacts with the p85 regulatory subunit of PI3K to support the activation of the PI3K/Akt signaling pathway that is required for normal chlamydial development. Overexpression of full length EphA2, but not the mutant form lacking the intracellular cytoplasmic domain, enhanced PI3K activation and Ctr infection. Despite the depletion of EphA2 from the cell surface, Ctr infection induces upregulation of EphA2 through the activation of the ERK pathway, which keeps the infected cell in an apoptosis-resistant state. The significance of EphA2 as an entry and intracellular signaling receptor was also observed with the urogenital C. trachomatis-serovar D. Our findings provide the first evidence for a host cell surface receptor that is exploited for invasion as well as for receptor-mediated intracellular signaling to facilitate chlamydial replication. In addition, the engagement of a cell surface receptor at the inclusion membrane is a new mechanism by which Chlamydia subverts the host cell and induces apoptosis resistance.","[Subbarayal, Prema; Karunakaran, Karthika; Winkler, Ann-Cathrin; Rudel, Thomas] Univ Wurzburg, Bioctr, Dept Microbiol, D-97070 Wurzburg, Germany; [Rother, Marion; Gonzalez, Erik; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Rother, Marion] Steinbeis Innovat gGmbH, Ctr Syst Biomed, Stuttgart, Germany","Rudel, T (reprint author), Univ Wurzburg, Bioctr, Dept Microbiol, D-97070 Wurzburg, Germany.",thomas.rudel@biozentrum.uni-wuerzburg.de,"Meyer, Thomas F./J-2485-2013","Meyer, Thomas F./0000-0002-6120-8679",Bundesministerium fur Bildung und Forschung (BMBF) in the Medical Infection Genomics Initiative [0315834A]; German Research Foundation (DFG); University of Wuerzburg,"This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) in the Medical Infection Genomics Initiative, 0315834A and the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,55,47,52,0,5,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004846,10.1371/journal.ppat.1004846,,,,32,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000046,25906164.0,"DOAJ Gold, Green Published",,,16/08/2019,47,11,34,8415,1593,1193,400,6822,5806,25,991,34,0,0,1,46,46,0,,43,0,43,0,0,51,48,51,26,0,0,0,0,0,0,0,29,0,8512,23,0,151,52,0,6856,1627,23,0,151,52,0,29,,0,0,0,0,1,0,0,0,1,0,0,43,0,0,1.25,5.2824858757062145,1.233509234828496,0.23350923482849603,1.2587217824684842,1.0204396910279263,5.390458254865035
702,J,"Talundzic, E; Okoth, SA; Congpuong, K; Plucinski, MM; Morton, L; Goldman, IF; Kachur, PS; Wongsrichanalai, C; Satimai, W; Barnwell, JW; Udhayakumar, V",,,,"Talundzic, Eldin; Okoth, Sheila Akinyi; Congpuong, Kanungnit; Plucinski, Mateusz M.; Morton, Lindsay; Goldman, Ira F.; Kachur, Patrick S.; Wongsrichanalai, Chansuda; Satimai, Wichai; Barnwell, John W.; Udhayakumar, Venkatachalam",,,Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign,PLOS PATHOGENS,,,English,Article,,,,,,,PLASMODIUM-FALCIPARUM; GENETIC DIVERSITY; MALARIA; MEFLOQUINE; CLEARANCE; PROVINCES; PROJECT; ORIGINS; SWEEPS,"The recent emergence of artemisinin resistance in the Greater Mekong Subregion poses a major threat to the global effort to control malaria. Tracking the spread and evolution of artemisinin-resistant parasites is critical in aiding efforts to contain the spread of resistance. A total of 417 patient samples from the year 2007, collected during malaria surveillance studies across ten provinces in Thailand, were genotyped for the candidate Plasmodium falciparum molecular marker of artemisinin resistance K13. Parasite genotypes were examined for K13 propeller mutations associated with artemisinin resistance, signatures of positive selection, and for evidence of whether artemisinin-resistant alleles arose independently across Thailand. A total of seven K13 mutant alleles were found (N458Y, R539T, E556D, P574L, R575K, C580Y, S621F). Notably, the R575K and S621F mutations have previously not been reported in Thailand. The most prevalent artemisinin resistance-associated K13 mutation, C580Y, carried two distinct haplotype profiles that were separated based on geography, along the Thai-Cambodia and Thai-Myanmar borders. It appears these two haplotypes may have independent evolutionary origins. In summary, parasites with K13 propeller mutations associated with artemisinin resistance were widely present along the Thai-Cambodia and Thai-Myanmar borders prior to the implementation of the artemisinin resistance containment project in the region.","[Talundzic, Eldin; Plucinski, Mateusz M.; Morton, Lindsay; Goldman, Ira F.; Kachur, Patrick S.; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30329 USA; [Talundzic, Eldin; Okoth, Sheila Akinyi] Atlanta VA Med Ctr, Atlanta Res & Educ Fdn, Atlanta, GA USA; [Congpuong, Kanungnit; Satimai, Wichai] Minist Publ Hlth, Bur Vector Borne Dis, Nonthaburi, Thailand; [Congpuong, Kanungnit] Bansomdej Chaopraya Rajabhat Univ, Bangkok, Thailand","Talundzic, E (reprint author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30329 USA.",etalundzic@cdc.gov,,,"American Society for Microbiology (ASM); Centers for Disease Control and Prevention Postdoctoral Fellowship; Atlanta Research and Education Foundation, Atlanta, GA; CDC Antimicrobial Resistance Working Group","Funding: ET is supported by an American Society for Microbiology (ASM) and Centers for Disease Control and Prevention Postdoctoral Fellowship. We acknowledge support from the Atlanta Research and Education Foundation, Atlanta, GA, and the CDC Antimicrobial Resistance Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,34,53,59,0,11,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004789,10.1371/journal.ppat.1004789,,,,14,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000019,25836766.0,"DOAJ Gold, Green Published",,,16/08/2019,45,6,67,6727,1095,756,339,5632,4680,19,933,67,0,0,0,45,45,2,,85,3,85,0,3,46,46,46,42,0,0,0,0,0,0,0,6,4,6775,54,0,223,69,1,5646,1101,54,0,223,69,1,28,,0,0,1,0,10,0,0,1,0,0,0,84,0,0,10.55,6.14337899543379,1.1944247159090908,0.1944247159090909,1.2247869318181819,1.0254199494574103,6.299543378995434
703,J,"Tay, HL; Kaiko, GE; Plank, M; Li, JJ; Maltby, S; Essilfie, AT; Jarnicki, A; Yang, M; Mattes, J; Hansbro, PM; Foster, PS",,,,"Tay, Hock L.; Kaiko, Gerard E.; Plank, Maximilian; Li, JingJing; Maltby, Steven; Essilfie, Ama-Tawiah; Jarnicki, Andrew; Yang, Ming; Mattes, Joerg; Hansbro, Philip M.; Foster, Paul S.",,,Antagonism of miR-328 Increases the Antimicrobial Function of Macrophages and Neutrophils and Rapid Clearance of Nontypeable Haemophilus Influenzae (NTHi) from Infected Lung,PLOS PATHOGENS,,,English,Article,,,,,,,OBSTRUCTIVE PULMONARY-DISEASE; BONE MARROW TRANSPLANT; BACTERIAL-INFECTION; INFLAMMATORY RESPONSES; IMPAIRED PHAGOCYTOSIS; SURVEILLANCE PROGRAM; MICRORNA RESPONSE; IMMUNE-RESPONSES; INDUCTION; ALVEOLAR,"Pathogenic bacterial infections of the lung are life threatening and underpin chronic lung diseases. Current treatments are often ineffective potentially due to increasing antibiotic resistance and impairment of innate immunity by disease processes and steroid therapy. Manipulation miRNA directly regulating anti-microbial machinery of the innate immune system may boost host defence responses. Here we demonstrate that miR-328 is a key element of the host response to pulmonary infection with non-typeable haemophilus influenzae and pharmacological inhibition in mouse and human macrophages augments phagocytosis, the production of reactive oxygen species, and microbicidal activity. Moreover, inhibition of miR-328 in respiratory models of infection, steroid-induced immunosuppression, and smoke-induced emphysema enhances bacterial clearance. Thus, miRNA pathways can be targeted in the lung to enhance host defence against a clinically relevant microbial infection and offer a potential new anti-microbial approach for the treatment of respiratory diseases.","[Tay, Hock L.; Kaiko, Gerard E.; Plank, Maximilian; Li, JingJing; Maltby, Steven; Essilfie, Ama-Tawiah; Jarnicki, Andrew; Hansbro, Philip M.; Foster, Paul S.] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Sch Pharm & Biomed Sci, Dept Microbiol & Immunol,Fac Hlth, Newcastle, NSW 2300, Australia; [Tay, Hock L.; Kaiko, Gerard E.; Plank, Maximilian; Li, JingJing; Maltby, Steven; Essilfie, Ama-Tawiah; Jarnicki, Andrew; Mattes, Joerg; Hansbro, Philip M.; Foster, Paul S.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Mattes, Joerg] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Sch Med & Publ Hlth, Discipline Paediat & Child Hlth,Fac Hlth, Newcastle, NSW 2300, Australia","Tay, HL (reprint author), Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Sch Pharm & Biomed Sci, Dept Microbiol & Immunol,Fac Hlth, Newcastle, NSW 2300, Australia.",Paul.Foster@newcastle.edu.au,"MATTES, JOERG/M-5179-2019","Maltby, Steven/0000-0003-1240-5964",National Health Medical Research Council (NHMRC),"Funding: This study was supported by the National Health Medical Research Council (NH&MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,54,34,34,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004549,10.1371/journal.ppat.1004549,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000001,25894560.0,"DOAJ Gold, Green Published",,,16/08/2019,29,4,17,4280,845,589,256,3435,2882,22,531,17,0,0,0,29,29,0,,29,2,29,0,2,30,30,29,20,0,0,0,0,0,0,0,4,12,4346,82,1,59,92,1,3461,859,82,1,59,92,1,26,,0,0,0,0,18,0,2,0,0,0,0,30,0,0,10.55,5.06508875739645,1.2459970887918486,0.24599708879184862,1.3158660844250365,1.0560747663551402,5.349112426035503
704,J,"Tuchscherr, L; Bischoff, M; Lattar, SM; Llana, MN; Pfortner, H; Niemann, S; Geraci, J; Van de Vyver, H; Fraunholz, MJ; Cheung, AL; Herrmann, M; Volker, U; Sordelli, DO; Peters, G; Loffler, B",,,,"Tuchscherr, Lorena; Bischoff, Markus; Lattar, Santiago M.; Noto Llana, Mariangeles; Pfoertner, Henrike; Niemann, Silke; Geraci, Jennifer; Van de Vyver, Helene; Fraunholz, Martin J.; Cheung, Ambrose L.; Herrmann, Mathias; Voelker, Uwe; Sordelli, Daniel O.; Peters, Georg; Loeffler, Bettina",,,Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections,PLOS PATHOGENS,,,English,Article,,,,,,,SMALL-COLONY VARIANTS; GENE REGULATOR AGR; ENDOTHELIAL-CELLS; ALPHA-TOXIN; MODULATES VIRULENCE; EPITHELIAL-CELLS; DEATH PATHWAY; SAR LOCUS; IN-VITRO; FACTOR-B,"Staphylococcus aureus is a major human pathogen that causes a range of infections from acute invasive to chronic and difficult-to-treat. Infection strategies associated with persisting S. aureus infections are bacterial host cell invasion and the bacterial ability to dynamically change phenotypes from the aggressive wild-type to small colony variants (SCVs), which are adapted for intracellular long-term persistence. The underlying mechanisms of the bacterial switching and adaptation mechanisms appear to be very dynamic, but are largely unknown. Here, we analyzed the role and the crosstalk of the global S. aureus regulators agr, sarA and SigB by generating single, double and triple mutants, and testing them with proteome analysis and in different in vitro and in vivo infection models. We were able to demonstrate that SigB is the crucial factor for adaptation in chronic infections. During acute infection, the bacteria require the simultaneous action of the agr and sarA loci to defend against invading immune cells by causing inflammation and cytotoxicity and to escape from phagosomes in their host cells that enable them to settle an infection at high bacterial density. To persist intracellularly the bacteria subsequently need to silence agr and sarA. Indeed agr and sarA deletion mutants expressed a much lower number of virulence factors and could persist at high numbers intracellularly. SigB plays a crucial function to promote bacterial intracellular persistence. In fact, Delta sigB-mutants did not generate SCVs and were completely cleared by the host cells within a few days. In this study we identified SigB as an essential factor that enables the bacteria to switch from the highly aggressive phenotype that settles an acute infection to a silent SCV-phenotype that allows for long-term intracellular persistence. Consequently, the SigB-operon represents a possible target to develop preventive and therapeutic strategies against chronic and therapy-refractory infections.","[Tuchscherr, Lorena; Geraci, Jennifer; Loeffler, Bettina] Jena Univ Hosp, Inst Med Microbiol, Jena, Germany; [Bischoff, Markus; Herrmann, Mathias] Univ Saarland, Med Ctr, Inst Med Microbiol & Hyg, Homburg, Germany; [Lattar, Santiago M.; Noto Llana, Mariangeles; Sordelli, Daniel O.] Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med IMPaM UBA, CONICET, Buenos Aires, DF, Argentina; [Lattar, Santiago M.; Noto Llana, Mariangeles; Sordelli, Daniel O.] Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina; [Pfoertner, Henrike; Voelker, Uwe] Univ Med Greifswald, Inst Genet & Funct Genom, Greifswald, Germany; [Niemann, Silke; Van de Vyver, Helene; Peters, Georg] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Fraunholz, Martin J.] Univ Wurzburg, Dept Microbiol, Bioctr, D-97070 Wurzburg, Germany; [Cheung, Ambrose L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA","Loffler, B (reprint author), Jena Univ Hosp, Inst Med Microbiol, Jena, Germany.",bettina.loeffler@med.uni-jena.de,"Herrmann, Mathias/B-6475-2013; Lattar, Santiago/S-1697-2019; Bischoff, Markus/D-2130-2014; Lattar, Santiago/B-8311-2017","Lattar, Santiago/0000-0001-5703-8024; Bischoff, Markus/0000-0001-6734-2732; Fraunholz, Martin/0000-0002-4581-6244; Volker, Uwe/0000-0002-5689-3448",Transregional Collaborative Research Centre 34 [C12]; IZKF [Lof2/030/10]; DAAD-MINCyT PROALAR [57161981 (DA-13-06)]; ANPCyT [2013-00941]; UBACyT [20020130100331BA]; DFG [BI 1350/1-2];  [EXE 1003 - CiM],"This work was supported by grants of the Transregional Collaborative Research Centre 34 (C12; http://www.staphaureus.org), of the IZKF (Lof2/030/10; http://campus.uni-muenster.de/izkf.html) and by the EXE 1003 - CiM (http://www.uni-muenster.de/Cells-in-Motion/de) to BL. LT was supported by a grant from DAAD-MINCyT PROALAR 57161981 (DA-13-06) (http://www.daad.org.ar/es/22137/index.html). DOS was supported by grants from ANPCyT 2013-00941 and UBACyT 20020130100331BA (http://www.uba.ar/secyt). MB was supported by the DFG grant BI 1350/1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,82,50,53,0,20,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004870,10.1371/journal.ppat.1004870,,,,26,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000053,25923704.0,"DOAJ Gold, Green Published",,,16/08/2019,52,1,85,9445,2687,1998,689,6758,5071,34,1653,85,1,0,0,49,49,0,,252,1,127,0,1,54,54,53,35,0,0,0,0,0,0,1,1,4,9413,306,31,119,105,0,6701,2687,306,31,119,105,0,25,,0,0,0,0,6,0,0,1,0,0,0,129,0,0,2.75,3.5150725716412357,1.3976028410772419,0.3976028410772418,1.453684522047943,1.0401270513499206,3.6561220692221807
705,J,"Verweij, MC; Horst, D; Griffin, BD; Luteijn, RD; Davison, AJ; Ressing, ME; Wiertz, EJHJ",,,,"Verweij, Marieke C.; Horst, Danielle; Griffin, Bryan D.; Luteijn, Rutger D.; Davison, Andrew J.; Ressing, Maaike E.; Wiertz, Emmanuel J. H. J.",,,Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution,PLOS PATHOGENS,,,English,Review,,,,,,,HERPES-SIMPLEX-VIRUS; CLASS-I MOLECULES; PEPTIDE-LOADING COMPLEX; EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; CD8(+) T-CELLS; CYTOMEGALOVIRUS US6 GLYCOPROTEIN; HETERODIMERIC ABC TRANSPORTER; VARICELLA-ZOSTER-VIRUS; NATURAL-KILLER-CELLS,"Herpesviruses are large DNA viruses that are highly abundant within their host populations. Even in the presence of a healthy immune system, these viruses manage to cause lifelong infections. This persistence is partially mediated by the virus entering latency, a phase of infection characterized by limited viral protein expression. Moreover, herpesviruses have devoted a significant part of their coding capacity to immune evasion strategies. It is believed that the close coexistence of herpesviruses and their hosts has resulted in the evolution of viral proteins that specifically attack multiple arms of the host immune system. Cytotoxic T lymphocytes (CTLs) play an important role in antiviral immunity. CTLs recognize their target through viral peptides presented in the context of MHC molecules at the cell surface. Every herpesvirus studied to date encodes multiple immune evasion molecules that effectively interfere with specific steps of the MHC class I antigen presentation pathway. The transporter associated with antigen processing (TAP) plays a key role in the loading of viral peptides onto MHC class I molecules. This is reflected by the numerous ways herpesviruses have developed to block TAP function. In this review, we describe the characteristics and mechanisms of action of all known virus-encoded TAP inhibitors. Orthologs of these proteins encoded by related viruses are identified, and the conservation of TAP inhibition is discussed. A phylogenetic analysis of members of the family Herpesviridae is included to study the origin of these molecules. In addition, we discuss the characteristics of the first TAP inhibitor identified outside the herpesvirus family, namely, in cowpox virus. The strategies of TAP inhibition employed by viruses are very distinct and are likely to have been acquired independently during evolution. These findings and the recent discovery of a non-herpesvirus TAP inhibitor represent a striking example of functional convergent evolution.","[Verweij, Marieke C.; Horst, Danielle; Griffin, Bryan D.; Luteijn, Rutger D.; Ressing, Maaike E.; Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Davison, Andrew J.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland","Verweij, MC (reprint author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97003 USA.",e.wiertz@umcutrecht.nl,,,"UK Medical Research Council [MC_UU_12014/3]; Netherlands Scientific Organization (NWO) [Vidi 917.76.330-1]; Medical Research Council [G0801822, MC_UU_12014/3]","Funding: This work was supported by the UK Medical Research Council (MC_UU_12014/3 www.mrc.ac.uk to AJD) and the Netherlands Scientific Organization (NWO Vidi 917.76.330-1 www.nwo.nl/en to MER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,132,25,25,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004743,10.1371/journal.ppat.1004743,,,,19,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000008,25880312.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,29,60,42,6798,1427,1088,339,5371,4449,19,903,42,0,0,0,26,26,0,,54,2,54,0,2,31,31,30,12,0,0,0,0,0,0,0,60,4,6797,59,0,1445,12,2,5353,1427,59,0,1445,12,2,17,,0,0,0,0,4,0,3,0,0,0,0,54,0,0,2.75,4.763840224246671,1.2656860919754236,0.2656860919754236,1.278719046732452,1.0102971462194763,4.812894183601962
706,J,"Bagdonaite, I; Norden, R; Joshi, HJ; Dabelsteen, S; Nystrom, K; Vakhrushev, SY; Olofsson, S; Wandall, HH",,,,"Bagdonaite, Ieva; Norden, Rickard; Joshi, Hiren J.; Dabelsteen, Sally; Nystrom, Kristina; Vakhrushev, Sergey Y.; Olofsson, Sigvard; Wandall, Hans H.",,,A Strategy for O-Glycoproteomics of Enveloped Viruses-the O-Glycoproteome of Herpes Simplex Virus Type 1,PLOS PATHOGENS,,,English,Article,,,,,,,CELL-INDUCED DIFFERENCES; LINKED GLYCOSYLATION; CRYSTAL-STRUCTURE; FC-RECEPTOR; MONOCLONAL-ANTIBODIES; N-GLYCOSYLATION; PILR-ALPHA; IN-VIVO; GLYCANS; PROTEINS,"Glycosylation of viral envelope proteins is important for infectivity and interaction with host immunity, however, our current knowledge of the functions of glycosylation is largely limited to N-glycosylation because it is difficult to predict and identify site-specific O-glycosylation. Here, we present a novel proteome-wide discovery strategy for O-glycosylation sites on viral envelope proteins using herpes simplex virus type 1 (HSV-1) as a model. We identified 74 O-linked glycosylation sites on 8 out of the 12 HSV-1 envelope proteins. Two of the identified glycosites found in glycoprotein B were previously implicated in virus attachment to immune cells. We show that HSV-1 infection distorts the secretory pathway and that infected cells accumulate glycoproteins with truncated O-glycans, nonetheless retaining the ability to elongate most of the surface glycans. With the use of precise gene editing, we further demonstrate that elongated O-glycans are essential for HSV-1 in human HaCaT keratinocytes, where HSV-1 produced markedly lower viral titers in HaCaT with abrogated O-glycans compared to the isogenic counterpart with normal O-glycans. The roles of O-linked glycosylation for viral entry, formation, secretion, and immune recognition are poorly understood, and the O-glycoproteomics strategy presented here now opens for unbiased discovery on all enveloped viruses.","[Bagdonaite, Ieva; Joshi, Hiren J.; Vakhrushev, Sergey Y.; Wandall, Hans H.] Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark; [Norden, Rickard; Nystrom, Kristina; Olofsson, Sigvard] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Virol, Gothenburg, Sweden; [Dabelsteen, Sally] Univ Copenhagen, Inst Odontol, Copenhagen, Denmark","Bagdonaite, I (reprint author), Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark.",hhw@sund.ku.dk,"Nystrom, Kristina/N-3125-2014; Joshi, Hiren/B-5739-2016","Bagdonaite, Ieva/0000-0002-9383-8448; Joshi, Hiren/0000-0002-8192-2829; Dabelsteen, Sally/0000-0002-4279-8060; Norden, Rickard/0000-0002-3866-7228; Wandall, Hans H./0000-0003-0240-9232",Danish Research Councils [1331-00133B]; University of Copenhagen [CDO2016: 2016CDO04210]; Danish National Research Foundation [DNRF107]; Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation,"Funding: This work was in part supported by The Danish Research Councils (1331-00133B), http://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes (IB, SD, HHW); a programme of excellence 2016 (Copenhagen as the next leader in precise genetic engineering CDO2016: 2016CDO04210) from the University of Copenhagen http://www.cdo.ku.dk/ http://research.ku.dk/strengths/excellence-programmes/ (IB, HHW); The Danish National Research Foundation (DNRF107) http://dg.dk/en/ (IB, HHJ, SYV, HHW); Carl Emil Friis og hustru Olga Doris Friis Foundation (HHW); The Lundbeck Foundation http://www.lundbeckfoundation.com/ (HHW), A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal http://www.apmollerfonde.dk/ (HHW), Kirsten og Freddy Johansen Fonden http://www.kf-j.dk/ (HHW), Mizutani Foundation http://www.mizutanifdn.or.jp/ (SYV) and The Novo Nordisk Foundation http://www.novonordiskfonden.dk/en (HHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,92,17,17,1,8,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004784,10.1371/journal.ppat.1004784,,,,22,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000017,25830354.0,"DOAJ Gold, Green Published",,,16/08/2019,16,0,23,4613,897,652,245,3716,3001,22,693,23,0,0,0,18,18,3,,35,0,35,0,0,18,17,18,7,0,0,0,0,0,0,0,1,0,4635,82,0,159,93,0,3711,897,82,0,159,93,0,27,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,5.142697881828316,1.241388589881593,0.24138858988159312,1.2944025834230355,1.0427053977888576,5.36231884057971
707,J,"Berngruber, TW; Lion, S; Gandon, S",,,,"Berngruber, Thomas W.; Lion, Sebastien; Gandon, Sylvain",,,"Spatial Structure, Transmission Modes and the Evolution of Viral Exploitation Strategies",PLOS PATHOGENS,,,English,Article,,,,,,,PARASITE VIRULENCE; EPIDEMIOLOGY; SUPERINFECTION; POPULATION; ADAPTATION; PATHOGENS; INVASION; DYNAMICS; TRAGEDY; LATENCY,"Spatial structure and local migration are predicted to promote the evolution of less aggressive host exploitation strategies in horizontally transmitted pathogens. Here we explore the effect of spatial structure on the evolution of pathogens that can use both horizontal and vertical routes of transmission. First, we analyse theoretically how vertical transmission can alter evolutionary trajectories and confirm that space can impede the spread of virulent pathogens. Second, we test this prediction using the latent phage. which transmits horizontally and vertically in Escherichia coli populations. We show that the latent phage. wins competition against the virulent mutant lambda cI857 in spatially structured epidemics, but loses when spatial structure is eroded. The vertical transmission of phage. immunizes its local host pool against superinfection and prevents the spread of the virulent lambda cI857. This effect breaks down when mixing facilitates horizontal transmission to uninfected hosts. We thus confirm the importance of spatial structure for the evolutionary maintenance of prudent infection strategies in latent viruses.","[Berngruber, Thomas W.] Phage Technol Ctr GmbH, Bonen, Germany; [Berngruber, Thomas W.; Lion, Sebastien; Gandon, Sylvain] Univ Montpellier 3, Univ Montpellier, EPHE, CNRS,CEFE,UMR 5175, F-34032 Montpellier, France","Berngruber, TW (reprint author), Phage Technol Ctr GmbH, Bonen, Germany.",berngruber@gmail.com,"Lion, Sebastien/K-4177-2015","Lion, Sebastien/0000-0002-4081-0038; Gandon, Sylvain/0000-0003-2624-7856",European Research Council [243054]; Agence Nationale pour la Recherche [10-PDOC-017-01],"Funding: This research was funded by European Research Council starting grant 243054 'EVOLEPID' (http://erc.europa.eu) to SG and Agence Nationale pour la Recherche grant 10-PDOC-017-01 'SPATEVOLEPID' (http://www.agence-nationale-recherche.fr/) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,41,19,19,0,16,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004810,10.1371/journal.ppat.1004810,,,,13,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000028,25898324.0,"DOAJ Gold, Green Published",,,16/08/2019,18,36,49,4275,228,176,52,4047,3026,19,1002,49,35,0,0,18,18,0,,58,1,58,0,1,20,18,20,10,0,0,0,0,0,0,0,1,35,4356,121,0,53,51,1,4094,229,121,0,53,51,1,33,,0,0,0,0,27,0,1,1,0,0,0,58,0,0,15.7,18.75,1.056338028169014,0.056338028169014086,1.1188534717074377,1.0591812865497077,19.859649122807017
708,J,"Bradford, RD; Yoo, YG; Golemac, M; Pugel, EP; Jonjic, S; Britt, WJ",,,,"Bradford, Russell D.; Yoo, Young-Gun; Golemac, Mijo; Pugel, Ester Pernjak; Jonjic, Stipan; Britt, William J.",,,Murine CMV-Induced Hearing Loss Is Associated with Inner Ear Inflammation and Loss of Spiral Ganglia Neurons,PLOS PATHOGENS,,,English,Article,,,,,,,CONGENITAL CYTOMEGALOVIRUS-INFECTION; COCHLEAR NUCLEUS; CRITICAL PERIOD; LABYRINTHITIS; DISEASE; BRAIN; MOUSE; DEATH; PATHOGENESIS; HOMEOSTASIS,"Congenital human cytomegalovirus (HCMV) occurs in 0.5-1% of live births and approximately 10% of infected infants develop hearing loss. The mechanism(s) of hearing loss remain unknown. We developed a murine model of CMV induced hearing loss in which murine cytomegalovirus (MCMV) infection of newborn mice leads to hematogenous spread of virus to the inner ear, induction of inflammatory responses, and hearing loss. Characteristics of the hearing loss described in infants with congenital HCMV infection were observed including, delayed onset, progressive hearing loss, and unilateral hearing loss in this model and, these characteristics were viral inoculum dependent. Viral antigens were present in the inner ear as were CD3+ mononuclear cells in the spiral ganglion and stria vascularis. Spiral ganglion neuron density was decreased after infection, thus providing a mechanism for hearing loss. The lack of significant inner ear histopathology and persistence of inflammation in cochlea of mice with hearing loss raised the possibility that inflammation was a major component of the mechanism(s) of hearing loss in MCMV infected mice.","[Bradford, Russell D.; Yoo, Young-Gun; Britt, William J.] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL USA; [Golemac, Mijo; Pugel, Ester Pernjak; Jonjic, Stipan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia; [Britt, William J.] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Britt, William J.] Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL USA","Bradford, RD (reprint author), Pegus Res, Salt Lake City, UT 84101 USA.",wbritt@peds.uab.edu,"Jonjic, Stipan/C-5657-2016; Pernjak Pugel, Ester/R-5126-2018; Golemac, Mijo/S-8136-2018; Pugel, Ester Pernjak/O-1130-2019","Jonjic, Stipan/0000-0001-5003-3108; Pernjak Pugel, Ester/0000-0002-6714-483X; Golemac, Mijo/0000-0002-4486-1887; Bradford, Russell/0000-0001-8911-6314",National Institutes of Health (National Institute of Neurological Diseases and Stroke) [NS065845]; National Institutes of Allergy and Infectious Diseases [AI089956],"Funding: This work was supported by grants from the National Institutes of Health (National Institute of Neurological Diseases and Stroke (NS065845 to WJB) and National Institutes of Allergy and Infectious Diseases (AI089956 to WJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,50,19,21,0,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004774,10.1371/journal.ppat.1004774,,,,21,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000012,25875183.0,"DOAJ Gold, Green Published",,,16/08/2019,20,2,19,5333,1119,797,322,4214,3508,23,683,19,0,0,0,20,20,0,,58,6,31,0,6,23,23,20,16,0,0,0,0,0,0,0,2,22,5438,54,0,382,102,2,4256,1125,54,0,382,102,2,57,,0,0,0,0,38,0,2,0,0,0,0,31,0,0,22.55,4.76586237712243,1.2655434266729948,0.2655434266729948,1.3274798291409586,1.048940558784924,4.999106344950849
709,J,"Hsu, JL; van den Boomen, DJH; Tomasec, P; Weekes, MP; Antrobus, R; Stanton, RJ; Ruckova, E; Sugrue, D; Wilkie, GS; Davison, AJ; Wilkinson, GWG; Lehner, PJ",,,,"Hsu, Jye-Lin; van den Boomen, Dick J. H.; Tomasec, Peter; Weekes, Michael P.; Antrobus, Robin; Stanton, Richard J.; Ruckova, Eva; Sugrue, Daniel; Wilkie, Gavin S.; Davison, Andrew J.; Wilkinson, Gavin W. G.; Lehner, Paul J.",,,Plasma Membrane Profiling Defines an Expanded Class of Cell Surface Proteins Selectively Targeted for Degradation by HCMV US2 in Cooperation with UL141,PLOS PATHOGENS,,,English,Article,,,,,,,NATURAL-KILLER-CELLS; CLASS-I MOLECULES; HUMAN CYTOMEGALOVIRUS-INFECTION; DENDRITIC CELLS; DOWN-REGULATION; PEPTIDE TRANSLOCATION; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; ALPHA(4) INTEGRINS; HEAVY-CHAINS,"Human cytomegalovirus (HCMV) US2, US3, US6 and US11 act in concert to prevent immune recognition of virally infected cells by CD8+ T-lymphocytes through downregulation of MHC class I molecules (MHC-I). Here we show that US2 function goes far beyond MHC-I degradation. A systematic proteomic study using Plasma Membrane Profiling revealed US2 was unique in downregulating additional cellular targets, including: five distinct integrin alpha-chains, CD112, the interleukin-12 receptor, PTPRJ and thrombomodulin. US2 recruited the cellular E3 ligase TRC8 to direct the proteasomal degradation of all its targets, reminiscent of its degradation of MHC-I. Whereas integrin alpha-chains were selectively degraded, their integrin beta 1 binding partner accumulated in the ER. Consequently integrin signaling, cell adhesion and migration were strongly suppressed. US2 was necessary and sufficient for degradation of the majority of its substrates, but remarkably, the HCMV NK cell evasion function UL141 requisitioned US2 to enhance downregulation of the NK cell ligand CD112. UL141 retained CD112 in the ER from where US2 promoted its TRC8-dependent retrotranslocation and degradation. These findings redefine US2 as a multifunctional degradation hub which, through recruitment of the cellular E3 ligase TRC8, modulates diverse immune pathways involved in antigen presentation, NK cell activation, migration and coagulation; and highlight US2's impact on HCMV pathogenesis.","[Hsu, Jye-Lin; van den Boomen, Dick J. H.; Weekes, Michael P.; Antrobus, Robin; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Tomasec, Peter; Stanton, Richard J.; Sugrue, Daniel; Wilkinson, Gavin W. G.] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Ruckova, Eva] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol RECAMO, Brno, Czech Republic; [Wilkie, Gavin S.; Davison, Andrew J.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland","Hsu, JL (reprint author), China Med Univ, Res Ctr Tumor Med Sci, Taichung, Taiwan.",pjl30@cam.ac.uk,"Wilkinson, Gavin/J-6388-2015; Stanton, Richard/B-4695-2008","Wilkinson, Gavin/0000-0002-5623-0126; Stanton, Richard/0000-0002-6799-1182; Weekes, Michael/0000-0003-3196-5545; Lehner, Paul Joseph/0000-0001-9383-1054","Taiwan National Science Council [101-2917-I-564-035]; Wellcome Trust [093966/Z/10/Z, G1000236, WT090323MA, 084957/Z/08/Z]; MRC; European Regional Development Fund; State Budget of Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; Medical Research Council (MRC) [MC_UU_1201/3]; Cambridge Biomedical Research Centre, UK; Health and Care Research Wales [HS-14-11]; Medical Research Council [MC_UU_12014/3, G1000236, G0700142, MR/L008734/1, G0801822, MR/L018373/1]","Funding: This study was financially supported by grant 101-2917-I-564-035 from the Taiwan National Science Council to JLH; by a Wellcome Trust Fellowship (093966/Z/10/Z) to MPW; an MRC Project Grant and Wellcome Trust Programme Grant (G1000236, WT090323MA) to GWW and PT, European Regional Development Fund and the State Budget of Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101) to ER; a Wellcome Trust Principal Research Fellowship (084957/Z/08/Z) to PJL; and a Medical Research Council (MRC) grant (MC_UU_1201/3) to GSW and AJD. This study was additionally supported by the Cambridge Biomedical Research Centre, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,68,31,31,0,0,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1553-7366,1553-7374,,PLOS PATHOG,PLoS Pathog.,APR,2015,11,4,,,,,,,e1004811,10.1371/journal.ppat.1004811,,,,24,Microbiology; Parasitology; Virology,Microbiology; Parasitology; Virology,CI7XE,WOS:000354978000029,25875600.0,"DOAJ Gold, Green Accepted, Green Published",,,16/08/2019,31,0,39,4877,869,665,204,4008,3268,34,706,39,0,0,0,27,27,0,,53,2,53,0,2,33,33,21,21,0,0,0,0,0,0,0,0,2,4883,78,0,220,148,0,3994,869,78,0,220,148,0,20,,0,0,0,0,3,0,0,0,0,0,0,53,0,0,2.5,5.612197928653625,1.216816367265469,0.21681636726546907,1.2747005988023952,1.0475702275989338,5.879171461449943
